PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	HORISBERGER, JD; JAUNIN, P; REUBEN, MA; LASATER, LS; CHOW, DC; FORTE, JG; SACHS, G; ROSSIER, BC; GEERING, K				HORISBERGER, JD; JAUNIN, P; REUBEN, MA; LASATER, LS; CHOW, DC; FORTE, JG; SACHS, G; ROSSIER, BC; GEERING, K			THE H,K-ATPASE BETA-SUBUNIT CAN ACT AS A SURROGATE FOR THE BETA-SUBUNIT OF NA,K-PUMPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TISSUE-SPECIFIC EXPRESSION; GASTRIC H+/K+-ATPASE; ALPHA-SUBUNITS; K+-ATPASE; NA,K-ATPASE; CLONING; ALDOSTERONE; MATURATION; TRANSPORT; KIDNEY	Na,K-ATPase and H,K-ATPase are the only members of the P-type ATPases in which a glycosylated beta-subunit is part of the purified active enzyme. In this study, we have followed the synthesis and the posttranslational processing of the beta-subunit of H,K-ATPase (beta-HK) in Xenopus oocytes injected with beta-HK cRNA and have tested whether it can act as a surrogate for the beta-subunit of Na,K-ATPase (beta-NaK) to support the functional expression of Na,K-pumps. In Xenopus oocytes, beta-HK is processed from an Endo H-sensitive 51-kDa coreglycosylated form to an Endo H-resistant 71-kDa fully glycosylated form. Similar to beta-NaK, beta-HK can stabilize and increase the trypsin resistance of alpha-subunits of Na,K-ATPase (alpha-NaK). Finally, expression of beta-HK together with alpha-NaK leads to an increased number of ouabain binding sites at the plasma membrane accompanied by an increased Rb+ uptake and Na,K-pump current. Our data suggest that beta-HK, similar to alpha-NaK, can assemble to alpha-NaK, support the structural maturation and the intracellular transport of catalytic alpha-NaK, and ultimately form active alpha-NaK-beta-HK complexes with Na,K-pump transport properties.	UNIV LAUSANNE,INST PHARMACOL & TOXICOL,CH-1005 LAUSANNE,SWITZERLAND; UNIV CALIF LOS ANGELES,DEPT PHYSIOL & MED,LOS ANGELES,CA 90024; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,LIFE SCI ADDIT,BERKELEY,CA 94720	University of Lausanne; University of California System; University of California Los Angeles; University of California System; University of California Berkeley			Horisberger, Jean-Daniel/A-2538-2009					ACKERMANN U, 1990, FEBS LETT, V269, P105, DOI 10.1016/0014-5793(90)81130-G; BALDWIN GS, 1990, FEBS LETT, V272, P159, DOI 10.1016/0014-5793(90)80473-V; CANFIELD VA, 1990, J BIOL CHEM, V265, P19878; CHOW D, 1989, FASEB Journal, V3, pA873; COLMAN A, 1984, TRANSCRIPTION TRANSL, P271; FORTE JG, 1989, HDB PHYSL, V3, P207; GEERING K, 1990, J MEMBRANE BIOL, V115, P109, DOI 10.1007/BF01869450; GEERING K, 1982, J BIOL CHEM, V257, P338; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; GEERING K, 1985, J BIOL CHEM, V260, P5154; GEERING K, 1991, FEBS LETT, V286, P189; GIRARDET M, 1981, BIOCHEMISTRY-US, V20, P6684, DOI 10.1021/bi00526a025; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; GOOD PJ, 1988, J VIROL, V62, P944, DOI 10.1128/JVI.62.3.944-953.1988; HALL K, 1990, BIOCHEMISTRY-US, V29, P701, DOI 10.1021/bi00455a016; HORISBERGER JD, 1991, IN PRESS P NATL ACAD; JAUNIN P, 1991, SODIUM PUMP RECENT D; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTINVASALLO P, 1989, J BIOL CHEM, V264, P4613; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLER RP, 1990, BIOCHEMISTRY-US, V29, P1524, DOI 10.1021/bi00458a025; OKAMOTO CT, 1990, BIOCHIM BIOPHYS ACTA, V1037, P360, DOI 10.1016/0167-4838(90)90038-H; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; SHULL GE, 1990, J BIOL CHEM, V265, P12123; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SMOLKA A, 1983, AM J PHYSIOL, V245, pG589, DOI 10.1152/ajpgi.1983.245.4.G589; TOH BH, 1990, P NATL ACAD SCI USA, V87, P6418, DOI 10.1073/pnas.87.16.6418; VERREY F, 1987, J CELL BIOL, V104, P1231, DOI 10.1083/jcb.104.5.1231; WALLMARK B, 1990, J INTERN MED, V228, P3, DOI 10.1111/j.1365-2796.1990.tb01465.x; ZAMOFING D, 1988, J MEMBRANE BIOL, V104, P69, DOI 10.1007/BF01871903	32	102	103	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19131	19134						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717460				2022-12-27	WOS:A1991GK66700002
J	BARRUECO, JR; SIROTNAK, FM				BARRUECO, JR; SIROTNAK, FM			EVIDENCE FOR THE FACILITATED TRANSPORT OF METHOTREXATE POLYGLUTAMATES INTO LYSOSOMES DERIVED FROM S180 CELLS - BASIC PROPERTIES AND SPECIFICITY FOR POLYGLUTAMATE CHAIN-LENGTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN FIBROBLAST LYSOSOMES; FOLATE ANALOG TRANSPORT; AMINO-ACID TRANSPORT; GAMMA-GLUTAMYL; DIHYDROFOLATE-REDUCTASE; SIALIC-ACID; RAT-LIVER; SYSTEM; MEMBRANE; INVITRO	Evidence is presented outlining basic properties of a previously undescribed facilitative transport system mediating transfer of methotrexate (MTX) polyglutamates from the cytoplasmic to the lysosomal compartment of the cell. These experiments were conducted using purified lysosomes prepared from murine S180 cells, and a model substrate ([H-3]MTX + G1; methotrexate with 1 additional glutamyl residue) to examine biological aspects as well as pharmacological significance of this process in a tumor cell model. The data, expressed as a function of latent beta-hexosaminidase activity, a measure of lysosomal integrity, show that [H-3]MTX + G1 uptake in lysosomes is temperature-dependent, is stimulated specifically by magnesium chloride and potassium chloride with maximal enhancement observed in the presence of both agents together, exhibits Michaelis-Menten saturation kinetics with K(m) and V(max) values of 346 +/- 39-mu-M and 2.8 +/- 0.3 pmol/min/unit of beta-hexosaminidase activity, respectively, and is competitively inhibited by longer chain polyglutamates with increasing effectiveness as shown by Ki values of 334 +/- 19, 201 +/- 16, 106 +/- 13, and 42 +/- 8-mu-M, for MTX + G1, MTX + G2, MTX + G3, and MTX + G4, respectively. In addition, uptake is inversely related to medium osmolarity indicating that the phenomenon we observe represents internalization of the [H-3]MTX + G1 and not adsorption to a possible surface binding site. As a whole, the data are consistent with a single mediated transport system shared by all MTX polyglutamates for entry into lysosomes. It is our view that this transport system represents the initial step in the degradation of polyglutamates in the cell. In addition, based on a comparative analysis of the kinetics for hydrolysis and transport, we suggest that it is also the limiting step in this process and, as such, regulates the extent of degradation of the free cellular pools of these compounds.			BARRUECO, JR (corresponding author), MEM SLOAN KETTERING CANC CTR,MOLEC THERAPEUT LAB,NEW YORK,NY 10021, USA.				NATIONAL CANCER INSTITUTE [P01CA018856, R01CA022764, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [CA 08748, CA 18856, CA 22764] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARRUECO JR, 1988, P AM ASSOC CANC RES, V29, P282; BAUGH CM, 1971, ANN NY ACAD SCI, V186, P7; BAUGH CM, 1973, BIOCHEM BIOPH RES CO, V52, P27, DOI 10.1016/0006-291X(73)90949-2; BERNAR J, 1986, J BIOL CHEM, V261, P7107; ELSENHANS B, 1984, J BIOL CHEM, V259, P6364; FRY DW, 1982, J BIOL CHEM, V257, P1890; GAHL WA, 1982, J BIOL CHEM, V257, P9570; GALIVAN J, 1979, CANCER RES, V39, P735; GALIVAN J, 1980, MOL PHARMACOL, V17, P105; GEWIRTZ DA, 1979, CANCER RES, V39, P2914; GREENE AA, 1990, J BIOL CHEM, V265, P9888; Hall C W, 1978, Methods Enzymol, V50, P439; HARMS E, 1980, P NATL ACAD SCI-BIOL, V77, P6139, DOI 10.1073/pnas.77.10.6139; JOLIVET J, 1983, J CLIN INVEST, V72, P773, DOI 10.1172/JCI111048; JONAS AJ, 1982, J BIOL CHEM, V257, P13185; JONAS AJ, 1989, J BIOL CHEM, V264, P4953; KISLIUK RL, 1984, FOLATE ANTAGONISTS T, V1, P1; LESLIE GI, 1974, BIOCHEMISTRY-US, V13, P4957, DOI 10.1021/bi00721a013; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MCGUIRE JJ, 1985, CANCER RES, V45, P6395; MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686; MCGUIRE JJ, 1984, FOLATES PTERINS, V1, P135; Neame K. D., 1972, ELEMENTARY KINETICS; PISONI RL, 1989, J BIOL CHEM, V264, P4850; PISONI RL, 1990, J CELL BIOL, V110, P327, DOI 10.1083/jcb.110.2.327; PISONI RL, 1987, J BIOL CHEM, V262, P15011; PISONI RL, 1987, J BIOL CHEM, V262, P6010; PISONI RL, 1985, J BIOL CHEM, V260, P4791; PRIEST DG, 1982, MOL CELL BIOCHEM, V43, P81, DOI 10.1007/BF00423095; SAMUELS LL, 1985, CANCER RES, V45, P1488; SCHILSKY RL, 1980, P NATL ACAD SCI-BIOL, V77, P2919, DOI 10.1073/pnas.77.5.2919; SILINK M, 1975, J BIOL CHEM, V250, P5982; SIROTNAK FM, 1978, BIOCHEM PHARMACOL, V27, P1821, DOI 10.1016/0006-2952(78)90025-4; SIROTNAK FM, 1980, PHARMACOL THERAPEUT, V8, P71, DOI 10.1016/0163-7258(80)90060-1; TIETZE F, 1989, J BIOL CHEM, V264, P15316; WANG TTY, 1986, J BIOL CHEM, V261, P3551; WHITEHEAD VM, 1975, CANCER RES, V35, P2985; Windholz M., 1983, MERCK INDEX; YANG CH, 1979, J BIOL CHEM, V254, P1402	39	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11732	11737						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711038				2022-12-27	WOS:A1991FT76200050
J	CHERNOUSOV, MA; FOGERTY, FJ; KOTELIANSKY, VE; MOSHER, DF				CHERNOUSOV, MA; FOGERTY, FJ; KOTELIANSKY, VE; MOSHER, DF			ROLE OF THE I-9 AND III-1 MODULES OF FIBRONECTIN IN FORMATION OF AN EXTRACELLULAR FIBRONECTIN MATRIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA FIBRONECTIN; MEDIATED CROSS-LINKING; CELL-LAYERS; MONOCLONAL-ANTIBODIES; DOMAIN-STRUCTURE; BINDING DOMAIN; FIBROBLASTS; FRAGMENTS; POLYPEPTIDES; NITROCELLULOSE	Cultured fibroblasts bind soluble protomeric fibronectin and mediate its conversion to insoluble disulfide-bonded multimers. The disulfide-bonded multimers are deposited in fibrillar pericellular matrix. Antifibronectin monoclonal antibodies were analyzed to identify domains of fibronectin required for assembly into matrix. Two antibodies, L8 and 9D2, inhibited binding and insolubilization of I-125-labeled plasma fibronectin by fibroblasts but did not inhibit binding of labeled amino-terminal 70-kDa fragment of fibronectin to matrix assembly sites. Immunoblotting of fibronectin fragments showed that the epitope for 9D2 is in the first type III homology sequence (III-1) whereas the epitope for L8 requires that the last type I sequence of the gelatin binding region (I-9) be contiguous to III-1 and is sensitive to reduction of disulfides in I-9. A 56-kDa gelatin-binding thermolysin fragment of fibronectin that contains III-1 and the L8 and 9D2 epitopes inhibited binding of fibronectin to cell layers 10-fold better than a 40-kDa gelatin-binding fragment that lacks III-1 and the antigenic sites. This 56-kDa fragment, however, did not bind specifically to cell layers. These results indicate that the I-9 and III-1 modules of fibronectin form a functional unit that mediates an interaction, perhaps between protomers, important in the assembly of fibronectin.	UNIV WISCONSIN,DEPT PHYSIOL,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	CHERNOUSOV, MA (corresponding author), ACAD MED SCI USSR,CARDIOL RES CTR,INST EXPTL CARDIOL,3RD CHEREPKOVSKAYASTR 15A,MOSCOW 121552,USSR.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R43HD007118] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL21644] Funding Source: Medline; NICHD NIH HHS [HD07118] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLIO AE, 1988, J CELL PHYSIOL, V135, P459, DOI 10.1002/jcp.1041350313; BARON M, 1990, NATURE, V345, P642, DOI 10.1038/345642a0; BARRY ELR, 1988, J BIOL CHEM, V263, P10464; BARRY ELR, 1989, J BIOL CHEM, V264, P4179; CALAYCAY J, 1985, J BIOL CHEM, V260, P2136; CASTELLANI P, 1986, J CELL BIOL, V103, P1671, DOI 10.1083/jcb.103.5.1671; CHERNOUSOV MA, 1987, FEBS LETT, V217, P124, DOI 10.1016/0014-5793(87)81255-3; CHERNOUSOV MA, 1985, FEBS LETT, V183, P365, DOI 10.1016/0014-5793(85)80811-5; CLICK EM, 1985, BIOCHEMISTRY-US, V24, P6685, DOI 10.1021/bi00344a058; COLVIN RB, 1989, FIBRONECTIN, P213; EHRISMANN R, 1982, J BIOL CHEM, V257, P7381; EHRISMANN R, 1981, J BIOL CHEM, V256, P4056; Engvall E, 1980, Methods Enzymol, V70, P419; GAY S, 1976, P NATL ACAD SCI USA, V73, P4037, DOI 10.1073/pnas.73.11.4037; Hardy R. R., 1986, HDB EXPT IMMUNOLOGY, V1; HARLOW E, 1988, ANTIBODIES LABORATOR, P494; HEDMAN K, 1989, FIBRONECTIN, P123; HEREMANS A, 1990, J BIOL CHEM, V265, P8716; HOMANDBERG GA, 1986, BIOCHEMISTRY-US, V25, P6917, DOI 10.1021/bi00370a027; HYNES RO, 1981, CELL BIOL EXTRACELLU, P295; INGHAM KC, 1989, J BIOL CHEM, V264, P16977; KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KOTELIANSKY VE, 1982, FEBS LETT, V142, P199, DOI 10.1016/0014-5793(82)80133-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landon, 1977, Methods Enzymol, V47, P145; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; MCDONALD JA, 1987, J BIOL CHEM, V262, P2957; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; MCKEOWNLONGO PJ, 1984, J BIOL CHEM, V259, P2210; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; MCKEOWNLONGO PJ, 1987, J CELL BIOL, V104, P601, DOI 10.1083/jcb.104.3.601; MCKEOWNLONGO PJ, 1989, FIBRONECTIN, P163; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; Mosher, 1989, FIBRONECTIN, P1; Mosher D F, 1980, Prog Hemost Thromb, V5, P111; MOSHER DF, 1984, ANNU REV MED, V35, P561, DOI 10.1146/annurev.me.35.020184.003021; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; MOSHER DF, 1985, BIOPOLYMERS, V24, P199, DOI 10.1002/bip.360240116; MOSHER DF, 1980, SCIENCE, V209, P927, DOI 10.1126/science.7403857; Oi V.T., 1980, SELECTED METHODS CEL, P351; PARHAM P, 1986, HDB EXPT IMMUNOLOGY, V1, pCH14; PATTHY L, 1990, CELL, V61, P13, DOI 10.1016/0092-8674(90)90208-V; PATTHY L, 1985, CELL, V41, P657, DOI 10.1016/S0092-8674(85)80046-5; PESCIOTTAPETERS DM, 1987, J CELL BIOL, V104, P121; PRINTSEVA OY, 1987, EXP CELL RES, V169, P85, DOI 10.1016/0014-4827(87)90227-8; QUADE BJ, 1988, J BIOL CHEM, V263, P19602; ROSENBAUM LC, 1989, ANAL BIOCHEM, V183, P250, DOI 10.1016/0003-2697(89)90475-2; SCHWARZBAUER JE, 1987, P NATL ACAD SCI USA, V84, P754, DOI 10.1073/pnas.84.3.754; SEKIGUCHI K, 1981, J BIOL CHEM, V256, P6452; SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x; THIERY JP, 1989, FIBRONECTIN, P181; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Yamada KM, 1989, FIBRONECTIN, P47	54	135	143	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					10851	10858						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710215				2022-12-27	WOS:A1991FQ77400026
J	PALMER, CJ; SCOTT, BT; JONES, LR				PALMER, CJ; SCOTT, BT; JONES, LR			PURIFICATION AND COMPLETE SEQUENCE DETERMINATION OF THE MAJOR PLASMA-MEMBRANE SUBSTRATE FOR CAMP-DEPENDENT PROTEIN-KINASE AND PROTEIN-KINASE-C IN MYOCARDIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC SARCOLEMMAL VESICLES; SKELETAL-MUSCLE SARCOLEMMA; RAT AORTIC MYOCYTES; AMINO-ACID SEQUENCE; 16 KDA PROTEIN; SARCOPLASMIC-RETICULUM; INTACT MYOCARDIUM; PHOSPHORYLATION; PHOSPHOLAMBAN; STIMULATION	A protein of apparent M(r) = 15,000 on sodium dodecyl sulfate-polyacrylamide gel electrophoresis is the major plasma membrane substrate for cAMP-dependent protein kinase (PK-A) and protein kinase C (PK-C) in several different tissues. In the work described here, we purified, cloned, and sequenced the canine cardiac sarcolemmal "15-kDa protein." The amino terminus of the purified protein was not blocked, allowing determination of 50 consecutive residues by standard Edman degradation. Overlapping proteolytic phosphopeptides yielded 22 additional residues at the carboxyl terminus. Dideoxy sequencing of the full-length cDNA confirmed that the 15-kDa protein contains 72 amino acids, plus a 20-residue signal sequence. The mature protein has a calculated M(r) = 8409. There is one hydrophobic membrane-spanning segment composed of residues 18-37. The acidic amino-terminal end (residues 1-17) of the protein is oriented extracellularly, whereas the basic carboxyl-terminal end (residues 38-72) projects into the cytoplasm. The positively charged carboxyl terminus contains the phosphorylation sites for PK-A and PK-C. In the transmembrane region, the 15-kDa protein exhibits 52% amino acid identity with the "gamma" subunit of Na,K-ATPase. High stringency Northern blot analysis revealed that 15-kDa mRNA is present in heart, skeletal muscle, smooth muscle, and liver but absent from brain and kidney. We propose the name "phospholemman" for the 15-kDa protein, which denotes the protein's location within the plasma membrane and its characteristic multisite phosphorylation.	INDIANA UNIV, SCH MED, DEPT MED, INDIANAPOLIS, IN 46202 USA; INDIANA UNIV, SCH MED, DEPT PHARMACOL, INDIANAPOLIS, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	PALMER, CJ (corresponding author), INDIANA UNIV, SCH MED, KRANNERT INST CARDIOL, INDIANAPOLIS, IN 46202 USA.				NHLBI NIH HHS [HL28556, HLO6308] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028556] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3; BOULANGERSAUNIER C, 1985, FEBS LETT, V193, P283, DOI 10.1016/0014-5793(85)80169-1; BOULANGERSAUNIER C, 1987, BIOCHEM BIOPH RES CO, V143, P517, DOI 10.1016/0006-291X(87)91384-2; CALE SE, 1991, J BIOL CHEM, V266, P391; CHIESI M, 1989, FEBS LETT, V244, P241, DOI 10.1016/0014-5793(89)81201-3; COLLINS JH, 1987, BIOCHEMISTRY-US, V26, P8665, DOI 10.1021/bi00400a026; COOPER RH, 1984, FEBS LETT, V166, P125, DOI 10.1016/0014-5793(84)80057-5; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; JONES LR, 1980, J BIOL CHEM, V255, P9971; JONES LR, 1981, BIOCHIM BIOPHYS ACTA, V641, P242, DOI 10.1016/0005-2736(81)90588-5; JONES LR, 1979, J BIOL CHEM, V254, P530; JONES LR, 1985, J BIOL CHEM, V260, P7721; JONES LR, 1988, METHOD ENZYMOL, V157, P85; JORGENSEN AO, 1986, J BIOL CHEM, V261, P3775; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDEMANN JP, 1986, J BIOL CHEM, V261, P4860; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MANALAN AS, 1982, J BIOL CHEM, V257, P52; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; PRESTI CF, 1985, J BIOL CHEM, V260, P3879; PRESTI CF, 1985, J BIOL CHEM, V260, P3860; PROUDFOOT JM, 1976, NATURE, V265, P211; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARCEVIC B, 1989, J BIOL CHEM, V264, P20648; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SOIERO R, 1966, J MOL BIOL, V19, P362; TADA M, 1989, BIOESSAYS, V10, P157, DOI 10.1002/bies.950100505; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WALAAS SI, 1988, BIOCHIM BIOPHYS ACTA, V968, P127, DOI 10.1016/0167-4889(88)90052-3; WALAAS SI, 1988, ARCH BIOCHEM BIOPHYS, V262, P245, DOI 10.1016/0003-9861(88)90186-5; WEGNER AD, 1989, J BIOL CHEM, V264, P11468; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; WIDMAIER EP, 1986, ENDOCRINOLOGY, V118, P701, DOI 10.1210/endo-118-2-701	39	242	250	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11126	11130						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710217				2022-12-27	WOS:A1991FQ77400066
J	HUTCHISON, KA; MATIC, G; MESHINCHI, S; BRESNICK, EH; PRATT, WB				HUTCHISON, KA; MATIC, G; MESHINCHI, S; BRESNICK, EH; PRATT, WB			REDOX MANIPULATION OF DNA-BINDING ACTIVITY AND BUGR EPITOPE REACTIVITY OF THE GLUCOCORTICOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID-BINDING; SULFHYDRYL-GROUPS; DEXAMETHASONE 21-MESYLATE; COVALENT MODIFICATION; MONOCLONAL-ANTIBODY; FUNCTIONAL DOMAINS; AMINO-ACID; IDENTIFICATION; EXPRESSION; PROTEIN	Treatment of the transformed glucocorticoid receptor with hydrogen peroxide promotes the formation of disulfide bonds and inhibits the ability of the receptor to bind to DNA (Tienrungroj, W., Meshinchi, S., Sanchez, E. R., Pratt, S. E., Grippo, J. F., Holmgren, A., and Pratt, W. B. (1987) J. Biol. Chem. 262, 6992-7000). It has not been determined whether the inhibition of DNA binding activity is due to disulfide bonds formed within the DNA binding domain or between the DNA binding domain and another region of the receptor. In this paper, we examined the ability of hydrogen peroxide to inactivate the DNA binding activity of the mouse glucocorticoid receptor. We show that inhibition of DNA binding activity caused by hydrogen peroxide can be accounted for entirely by the formation of disulfide bonds between cysteine residues lying within the 15-kDa tryptic fragment containing the DNA binding domain of the receptor. Reversal of the peroxide-induced inactivation of DNA binding activity requires both zinc and a thiol-disulfide exchange reagent, such as dithiothreitol. Peroxide also eliminates recognition of the intact receptor and the 15-kDa tryptic fragment by the BuGR monoclonal antibody, and the reactivity of the BuGR epitope is restored by reduction without a requirement for zinc. Pretreatment of the receptor with methyl methanethiosulfonate inhibits much of the peroxide mediated inactivation of the BuGR epitope but pretreatment with N-ethylmaleimide does not. Similarly, DNA binding activity of the receptor is inhibited by methyl methanethiosulfonate but not by N-ethylmaleimide. These results are consistent with the proposal that peroxide promotes the formation of disulfide bonds between thiols that lie spatially close to one another in the 15-kDa tryptic fragment, resulting in rapid elimination of zinc. Restoration of the zinc finger structure restores DNA-binding activity but restoration of the BuGR epitope requires only reduction without restoration of the zinc fingers.	UNIV MICHIGAN,SCH MED,DEPT PHARMACOL,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan			Matic, Gordana/N-7134-2014	Matic, Gordana/0000-0002-0142-1056	NIDDK NIH HHS [DK31578] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BODWELL JE, 1984, BIOCHEMISTRY-US, V23, P1392, DOI 10.1021/bi00302a009; BODWELL JE, 1984, BIOCHEMISTRY-US, V23, P4237, DOI 10.1021/bi00313a034; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; BROCKLEHURST K, 1979, INT J BIOCHEM, V10, P259, DOI 10.1016/0020-711X(79)90088-0; CARLSTEDTDUKE J, 1988, J BIOL CHEM, V263, P6842; CARLSTEDTDUKE J, 1987, P NATL ACAD SCI USA, V84, P4437, DOI 10.1073/pnas.84.13.4437; DALMAN FC, 1988, J BIOL CHEM, V263, P12259; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; EISEN LP, 1985, J BIOL CHEM, V260, P1805; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GAMETCHU B, 1984, ENDOCRINOLOGY, V114, P274, DOI 10.1210/endo-114-1-274; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; LOPEZ S, 1990, J BIOL CHEM, V265, P16039; MESHINCHI S, 1990, J BIOL CHEM, V265, P11643; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MILLER NR, 1988, J BIOL CHEM, V263, P15217; PRATT WB, 1987, J CELL BIOCHEM, V35, P51, DOI 10.1002/jcb.240350105; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SEVERNE Y, 1988, EMBO J, V7, P2503, DOI 10.1002/j.1460-2075.1988.tb03097.x; SILVA CM, 1989, J BIOL CHEM, V264, P6638; SIMONS SS, 1987, J BIOL CHEM, V262, P9676; SIMONS SS, 1990, J BIOL CHEM, V265, P1938; SMITH LI, 1988, BIOCHEMISTRY-US, V27, P3747, DOI 10.1021/bi00410a034; TIENRUNGROJ W, 1987, J BIOL CHEM, V262, P6992; YOUNG HA, 1975, P NATL ACAD SCI USA, V72, P3060, DOI 10.1073/pnas.72.8.3060	26	82	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10505	10509						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709934				2022-12-27	WOS:A1991FP08600077
J	COLLET, X; PERRET, B; SIMARD, G; RAFFAI, E; MARCEL, YL				COLLET, X; PERRET, B; SIMARD, G; RAFFAI, E; MARCEL, YL			DIFFERENTIAL-EFFECTS OF LECITHIN AND CHOLESTEROL ON THE IMMUNOREACTIVITY AND CONFORMATION OF APOLIPOPROTEIN-A-I IN HIGH-DENSITY-LIPOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORMAL HUMAN-PLASMA; MONOCLONAL-ANTIBODIES; ESTERIFIED CHOLESTEROL; HEPATIC LIPASE; CELLS; SERUM; HDL; PHOSPHATIDYLCHOLINE; HYDROLYSIS; MODULATION	Recently identified epitopes in apoA-I define a distinct N-terminal region with a complex tertiary structure, characterized by multiple discontinuous epitopes. Other epitopes are constituted of short domains centered either on beta-turns or random coils or on the 22-mer amphipathic alpha-helices (Marcel, Y. L., Provost, P. R., Koa, H., Raffai, E., Vu Dac, N., Fruchart, J.-C., and Rassart, E. (1991) J. Biol. Chem. 266, 3644-3653). The compared immunoreactivity of seven epitopes studied here in response first to delipidation of high density lipoprotein (HDL) apoA-I by detergents, and second to modifications of HDL lipid composition by phospholipase A2 or by enrichment in surface lipids demonstrates that apoA-I has a flexible conformation which is readily responsive to the nature and concentration of bound lipids and that the structure of lipid-free apoA-I is significantly different from that of HDL-bound apoA-I, possibly representing a condensed molecule with several masked domains. In HDL apoA-I, these epitopes define five distinct domains which are characterized by particular responses to lipid modifications. However, two domains, each starting at the N-terminal beta-turn of an amphiphatic alpha-helical repeat (residues 99-121 and 186-209, respectively) have almost identical immunoreactivity whether after detergent treatment or after changes in cholesterol and phospholipid levels, a property which probably reflects the known periodicity of apoA-I structural 22-mers. The immunoreactivity of a discontinuous epitope, representative of the N-terminal domain, is inversely related to the concentration of phospholipids, a unique characteristic among the epitopes tested here which indicates that the complex N-terminal region interacts with phospholipids, either directly or indirectly. These studies demonstrate that the conformation of multiple domains of HDL apoA-I is dependent on lipid phase composition and differentially affected by cholesterol and phospholipids.	INST RECH CLIN MONTREAL, LIPOPROT METAB LAB, 110 PINE AVE W, MONTREAL H2W 1R7, QUEBEC, CANADA; CHU PURPAN, INSERM, U326, TOULOUSE, FRANCE	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)			PERRET, Bertrand/Y-2326-2019; Collet, Xavier/M-6938-2017					BAMBERGER M, 1985, BIOCHEMISTRY-US, V24, P3693, DOI 10.1021/bi00335a044; BLAU L, 1982, BIOCHIM BIOPHYS ACTA, V712, P437, DOI 10.1016/0005-2760(82)90270-3; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; CHAP HJ, 1977, BIOCHIM BIOPHYS ACTA, V467, P146, DOI 10.1016/0005-2736(77)90192-4; CHEUNG MC, 1987, J LIPID RES, V28, P913; COLLET X, 1990, BIOCHIM BIOPHYS ACTA, V1043, P301, DOI 10.1016/0005-2760(90)90031-R; COLLET X, 1988, BIOCHIM BIOPHYS ACTA, V958, P81, DOI 10.1016/0005-2760(88)90248-2; CURRY MD, 1978, CLIN CHEM, V24, P280; CURTISS LK, 1988, J BIOL CHEM, V263, P13779; EISENBERG S, 1984, J LIPID RES, V25, P1017; FAROOQUI J, 1986, BIOCH BIOL PLASMA LI, P225; GROOT PHE, 1981, FEBS LETT, V129, P269, DOI 10.1016/0014-5793(81)80181-0; JONAS A, 1978, BIOCHIM BIOPHYS ACTA, V528, P45; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUNDKATZ S, 1981, BIOCHEM BIOPH RES CO, V100, P1735, DOI 10.1016/0006-291X(81)90719-1; MARCEL YL, 1987, J LIPID RES, V28, P768; MARCEL YL, 1991, J BIOL CHEM, V266, P3644; MILLER NE, 1985, NATURE, V314, P109, DOI 10.1038/314109a0; MILNE RW, 1981, J CLIN INVEST, V68, P111, DOI 10.1172/JCI110225; MILTHORP P, 1986, ARTERIOSCLEROSIS, V6, P285, DOI 10.1161/01.ATV.6.3.285; MILTHORP P, 1986, HUMAN APOLIPOPROTEIN, P103; OHTUSUKI M, 1977, P NATL ACAD SCI USA, V74, P5001; PARINAUD J, 1987, J CLIN ENDOCR METAB, V64, P409, DOI 10.1210/jcem-64-3-409; PATTNAIK NM, 1976, J BIOL CHEM, V251, P1984; PERRET BP, 1987, EUR J BIOCHEM, V162, P279, DOI 10.1111/j.1432-1033.1987.tb10597.x; PERRET BP, 1983, EUR J CLIN INVEST, V13, P419, DOI 10.1111/j.1365-2362.1983.tb00123.x; PETIT E, 1987, BIOCHIM BIOPHYS ACTA, V919, P287, DOI 10.1016/0005-2760(87)90268-2; ROSCHLAU P, 1974, Z KLIN CHEM KLIN BIO, V12, P403; SIMARD G, 1989, BIOCHIM BIOPHYS ACTA, V1001, P225, DOI 10.1016/0005-2760(89)90152-5; SKIPSKI VP, 1964, BIOCHEM J, V90, P374, DOI 10.1042/bj0900374; WAHEFELD AW, 1974, METHODEN ENZYMODISCH, V2, P178; WEECH PK, 1985, BIOCHIM BIOPHYS ACTA, V835, P390, DOI 10.1016/0005-2760(85)90296-6	34	57	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					9145	9152						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709164				2022-12-27	WOS:A1991FM03800074
J	LI, W; YEUNG, YG; STANLEY, ER				LI, W; YEUNG, YG; STANLEY, ER			TYROSINE PHOSPHORYLATION OF A COMMON 57-KDA PROTEIN IN GROWTH FACTOR-STIMULATED AND FACTOR-TRANSFORMED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; CSF-1 RECEPTOR; EGF RECEPTOR; LINE; DIFFERENTIATION; IDENTIFICATION; INTERLEUKIN-3; KINASES	Protein tyrosine phosphorylation was studied in macrophages and fibroblasts to identify putative components of post-receptor mitogenic pathways that might be functionally conserved in different cell types. Nondenaturing conditions were established for the approximately quantitative recovery of anti-phosphotyrosine antibody (alpha-PY)-reactive proteins from cells. A common, 57-kDa alpha-PY-reactive protein was identified by V8 protease peptide mapping in colony-stimulating factor-1 (CSF-1)- or granulocyte-macrophage colony-stimulating factor (GM-CSF)-stimulated BAC1.2F5 macrophages, in platelet-derived growth factor-stimulated NIH-3T3 cells, and in CSF-1-stimulated NIH-3T3 cells expressing the c-fms/CSF-1 receptor. The 57-kDa protein was phosphorylated on serine and tyrosine and was the only alpha-PY-reactive protein band whose phosphorylation was reproducibly increased in GM-CSF-stimulated cells. The effect of the growth factors on the tyrosine phosphorylation of the 57-kDa protein could be mimicked by treatment of the cells with orthovanadate, a phosphotyrosine protein phosphatase inhibitor. In the absence of growth factors, tyrosine phosphorylation of the 57-kDa protein was higher in v-fms or c-fms (F969, S301)-transformed NIH-3T3 cells than in untransformed NIH-3T3 (c-fms) and NIH-3T3 (c-fms, F969) cells. These data indicate that the 57-kDa protein is a common target for growth factor-stimulated tyrosine phosphorylation and potentially important for growth factor mitogenic signaling.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT DEV BIOL & CANC,1300 MORRIS PK AVE,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine					NATIONAL CANCER INSTITUTE [R01CA032551, K04CA001330, R37CA026504, R01CA026504] Funding Source: NIH RePORTER; NCI NIH HHS [P30-CA 1330, CA 26504, CA 32551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COOPER JA, 1985, MOL CELL BIOL, V5, P3304, DOI 10.1128/MCB.5.11.3304; FOULKES JG, 1983, CURR TOP MICROBIOL, V107, P163; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; GEARING DP, 1989, EMBO J, V8, P3657; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GUILBERT LJ, 1986, J BIOL CHEM, V261, P4024; Hartmann T, 1990, GROWTH FACTORS, V2, P289; HUHN RD, 1989, J CELL BIOCHEM, V39, P129, DOI 10.1002/jcb.240390205; Isfort RJ, 1990, GROWTH FACTORS, V2, P213, DOI 10.3109/08977199009071507; KOYASU S, 1987, EMBO J, V6, P3979, DOI 10.1002/j.1460-2075.1987.tb02740.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATHER PA, 1988, P NATL ACAD SCI USA, V85, P6788; MERIDA I, 1990, J BIOL CHEM, V265, P5690; MILLS GB, 1990, J BIOL CHEM, V265, P3561; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; MORLA AO, 1988, MOL CELL BIOL, V8, P2214, DOI 10.1128/MCB.8.5.2214; NURSE P, 1985, TRENDS GENET, V1, P51, DOI 10.1016/0168-9525(85)90023-X; PIERCE JH, 1988, SCIENCE, V239, P628, DOI 10.1126/science.3257584; ROHRSCHNEIDER LR, 1989, MOL CELL BIOL, V9, P5081, DOI 10.1128/MCB.9.11.5081; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; ROUSSEL MF, 1988, CELL, V55, P979, DOI 10.1016/0092-8674(88)90243-7; RUDEN TV, 1988, EMBO J, V7, P2749; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SORENSEN P, 1989, J BIOL CHEM, V264, P19253; SORENSEN PHB, 1989, BLOOD, V73, P406; STANLEY ER, 1985, METHOD ENZYMOL, V116, P564; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WANG HM, 1989, EMBO J, V8, P3677, DOI 10.1002/j.1460-2075.1989.tb08542.x; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268	33	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					6808	6814						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707876				2022-12-27	WOS:A1991FG72700028
J	NIEUWLANDT, DT; HAAS, ES; DANIELS, CJ				NIEUWLANDT, DT; HAAS, ES; DANIELS, CJ			THE RNA COMPONENT OF RNASE-P FROM THE ARCHAEBACTERIUM HALOFERAX-VOLCANII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBONUCLEASE-P; SECONDARY STRUCTURE; ESCHERICHIA-COLI; RIBONUCLEOPROTEIN ENZYME; HALOBACTERIUM-VOLCANII; ION DEPENDENCE; HELA-CELLS; EXPRESSION; SEQUENCE; GENES	RNase P, an endoribonuclease responsible for generating the mature 5' termini of tRNA precursors, is composed of both RNA and protein. It has been demonstrated that the eubacterial RNase P RNA will, under the appropriate reaction conditions, exhibit catalytic activity in vitro. Evidence has not been obtained for catalytic activity by the RNAs of eukaryotic RNase P enzymes. Using a cDNA probe prepared from RNA copurifying with RNase P activity from the archaebacterium Haloferax volcanii, we have characterized the gene encoding the RNase P RNA. The proposed transcript from this gene can assume a structure resembling the eubacterial RNase P RNA and includes many of the highly conserved sequences of these RNAs. This RNA was incapable of cleaving pre-tRNA substrates in the absence of protein under a variety of in vitro conditions. Catalytic activity was observed when this RNA was combined with the protein subunit of the Bacillus subtilis RNase P complex. Similarities among the archaebacterial, eubacterial, and eukaryotic RNase P RNA sequences and structures are discussed.	OHIO STATE UNIV, DEPT MICROBIOL, 484 W 12TH AVE, COLUMBUS, OH 43210 USA; INDIANA UNIV, DEPT BIOL, BLOOMINGTON, IN 47405 USA	Ohio State University; Indiana University System; Indiana University Bloomington								ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; BAER M, 1989, NUCLEIC ACIDS MOL BI, V3, P231; BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; BROWN JW, 1989, CRIT REV MICROBIOL, V16, P287, DOI 10.3109/10408418909105479; CHARLEBOIS RL, 1989, CAN J MICROBIOL, V35, P21, DOI 10.1139/m89-004; CHRISTIAN JHB, 1962, BIOCHIM BIOPHYS ACTA, V65, P506, DOI 10.1016/0006-3002(62)90453-5; DANIELS CJ, 1985, MOL GEN GENET, V198, P270, DOI 10.1007/BF00383005; DANIELS CJ, 1986, MICROBIOLOGY 1986, P349; DARR SC, 1990, J BIOL CHEM, V265, P12927; DENNIS PP, 1985, J MOL BIOL, V186, P457, DOI 10.1016/0022-2836(85)90117-2; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; GARDINER KJ, 1985, J BIOL CHEM, V260, P5415; GOLD HA, 1986, CELL, V44, P243, DOI 10.1016/0092-8674(86)90758-0; GREENE JM, 1987, CURRENT PROTOCOLS MO; GROPP F, 1989, CAN J MICROBIOL, V35, P182, DOI 10.1139/m89-028; GUERRIERTAKADA C, 1986, BIOCHEMISTRY-US, V25, P1509, DOI 10.1021/bi00355a006; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; KJEMS J, 1987, EMBO J, V6, P3521, DOI 10.1002/j.1460-2075.1987.tb02678.x; KRUPP G, 1986, EMBO J, V5, P1697, DOI 10.1002/j.1460-2075.1986.tb04413.x; LAWRENCE N, 1987, COLD SPRING HARB SYM, V52, P233, DOI 10.1101/SQB.1987.052.01.028; LEE JY, 1989, MOL CELL BIOL, V9, P2536, DOI 10.1128/MCB.9.6.2536; LUMELSKY N, 1988, J MOL BIOL, V202, P443, DOI 10.1016/0022-2836(88)90277-X; Maniatis T., 1982, MOL CLONING; OORSTEIN WR, 1989, METHOD ENZYMOL, V180, P347; PACE NR, 1987, COLD SPRING HARB SYM, V52, P239, DOI 10.1101/SQB.1987.052.01.029; PACE NR, 1989, GENE, V82, P65, DOI 10.1016/0378-1119(89)90031-0; PACE NR, 1990, J BIOL CHEM, V265, P3587; REICH C, 1986, J BIOL CHEM, V261, P7888; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; SHIRAISHI H, 1986, EMBO J, V5, P3673, DOI 10.1002/j.1460-2075.1986.tb04698.x; THOMM M, 1988, NUCLEIC ACIDS RES, V16, P151, DOI 10.1093/nar/16.1.151; THOMM M, 1989, CAN J MICROBIOL, V35, P30, DOI 10.1139/m89-005; THOMPSON LD, 1988, J BIOL CHEM, V263, P17951; VIOQUE A, 1988, J MOL BIOL, V202, P835, DOI 10.1016/0022-2836(88)90562-1; WAUGH DS, 1989, THESIS INDIANA U; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987	39	52	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5689	5695						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706337				2022-12-27	WOS:A1991FD37000052
J	NIES, DE; HEMESATH, TJ; KIM, JH; GULCHER, JR; STEFANSSON, K				NIES, DE; HEMESATH, TJ; KIM, JH; GULCHER, JR; STEFANSSON, K			THE COMPLETE CDNA SEQUENCE OF HUMAN HEXABRACHION (TENASCIN) - A MULTIDOMAIN PROTEIN CONTAINING UNIQUE EPIDERMAL GROWTH-FACTOR REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX PROTEIN; EPITHELIAL MESENCHYMAL INTERACTIONS; HEPARAN-SULFATE PROTEOGLYCAN; CELL ATTACHMENT; SYNTHETIC FRAGMENTS; MOLECULAR-FORMS; SKELETAL-MUSCLE; N-CAM; FIBRONECTIN; CYTOTACTIN	Hexabrachion (Tenascin) is a large glycoprotein that appears in extracellular matrices as a disulfide-linked multimer. It is synthesized in an ordered fashion at particular sites during development, is made in large amounts by certain tumors, and is found in restricted tissue locations in the adult. In this report, we describe the sequence of a full length cDNA of human hexabrachion. The encoded protein contains a total of 2203 amino acids and is a linear array of discrete reiterated domains. At the 5' end are encoded hydrophobic residues and 8 flanking cysteines predicted to be responsible for assembly of hexabrachion polypeptides into a radially arranged, six-armed complex. Following this region are 14 1/2 contiguous 31-amino acid epidermal growth factor-like repeats that have a unique structure with respect to the known examples of this type of domain. Immediately adjacent to these repeats lie 15 uninterrupted segments of approximately 90 amino acids which are similar to the Type III units found in fibronectin. At the carboxyl terminus of the protein is a 210-amino acid domain that is similar to fibrinogen. The domain structure of this protein is consistent with the potential for interaction with multiple ligands and for roles in cell adhesion and/or signaling.	UNIV CHICAGO,DEPT NEUROL,5841 S MARYLAND AVE,CHICAGO,IL 60637; UNIV CHICAGO,DEPT PATHOL NEUROPATHOL,CHICAGO,IL 60637; UNIV CHICAGO,COMM NEUROBIOL,CHICAGO,IL 60637; UNIV CHICAGO,COMM IMMUNOL,CHICAGO,IL 60637	University of Chicago; University of Chicago; University of Chicago; University of Chicago			Stefansson, Kari/AAE-7187-2019		AHRQ HHS [5 P01 HS-21442-03] Funding Source: Medline; NINDS NIH HHS [1 P01 NS-24575-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS024575] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		APPELLA E, 1988, FEBS LETT, V231, P1, DOI 10.1016/0014-5793(88)80690-2; AUFDERHEIDE E, 1988, J CELL BIOL, V107, P2341, DOI 10.1083/jcb.107.6.2341; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; BOURDON MA, 1983, CANCER RES, V43, P2796; CARPENTER G, 1983, P NATL ACAD SCI-BIOL, V80, P5627, DOI 10.1073/pnas.80.18.5627; CHIQUET M, 1984, J CELL BIOL, V98, P1937, DOI 10.1083/jcb.98.6.1937; CHIQUET M, 1989, DEV NEUROSCI-BASEL, V11, P266, DOI 10.1159/000111905; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; COOKE RM, 1987, NATURE, V327, P339, DOI 10.1038/327339a0; CROSSIN KL, 1986, J CELL BIOL, V102, P1917, DOI 10.1083/jcb.102.5.1917; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6; ERICKSON HP, 1984, NATURE, V311, P267, DOI 10.1038/311267a0; ERICKSON HP, 1987, J CELL BIOL, V105, P1387, DOI 10.1083/jcb.105.3.1387; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDLANDER DR, 1988, J CELL BIOL, V107, P2329, DOI 10.1083/jcb.107.6.2329; GATCHALIAN CL, 1989, J CELL BIOL, V108, P1873, DOI 10.1083/jcb.108.5.1873; GRAY A, 1983, NATURE, V303, P722, DOI 10.1038/303722a0; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; GULCHER JR, 1986, P NATL ACAD SCI USA, V83, P2118, DOI 10.1073/pnas.83.7.2118; GULCHER JR, 1990, GENOMICS, V6, P616, DOI 10.1016/0888-7543(90)90495-G; GULCHER JR, 1989, P NATL ACAD SCI USA, V86, P1588, DOI 10.1073/pnas.86.5.1588; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOFFMAN S, 1988, J CELL BIOL, V106, P519, DOI 10.1083/jcb.106.2.519; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JONES FS, 1989, P NATL ACAD SCI USA, V86, P1905, DOI 10.1073/pnas.86.6.1905; KOMORIYA A, 1984, P NATL ACAD SCI-BIOL, V81, P1351, DOI 10.1073/pnas.81.5.1351; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; LAZAR E, 1989, MOL CELL BIOL, V9, P860, DOI 10.1128/MCB.9.2.860; LIGHTNER VA, 1989, J CELL BIOL, V108, P2483, DOI 10.1083/jcb.108.6.2483; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MACKIE EJ, 1988, DEVELOPMENT, V102, P237; MARTON LS, 1989, J BIOL CHEM, V264, P13145; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PIERSCHBACHER MD, 1982, J BIOL CHEM, V257, P9593; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SLEMP C A, 1988, Journal of Cell Biology, V107, p232A; SPRING J, 1989, CELL, V59, P325, DOI 10.1016/0092-8674(89)90294-8; SUDOFF TC, 1985, SCIENCE, V228, P893; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAN SS, 1987, P NATL ACAD SCI USA, V84, P7977, DOI 10.1073/pnas.84.22.7977; TAYLOR HC, 1989, J CELL BIOCHEM, V41, P71, DOI 10.1002/jcb.240410204; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; THESLEFF I, 1987, DEVELOPMENT, V101, P289; VAINIO S, 1989, J CELL BIOL, V108, P1945, DOI 10.1083/jcb.108.5.1945; VAUGHAN L, 1987, EMBO J, V6, P349, DOI 10.1002/j.1460-2075.1987.tb04761.x; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X	56	102	107	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2818	2823						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704365				2022-12-27	WOS:A1991EX60000026
J	MALOSIO, ML; GRENNINGLOH, G; KUHSE, J; SCHMIEDEN, V; SCHMITT, B; PRIOR, P; BETZ, H				MALOSIO, ML; GRENNINGLOH, G; KUHSE, J; SCHMIEDEN, V; SCHMITT, B; PRIOR, P; BETZ, H			ALTERNATIVE SPLICING GENERATES 2 VARIANTS OF THE ALPHA-1-SUBUNIT OF THE INHIBITORY GLYCINE RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CENTRAL NERVOUS-SYSTEM; RAT SPINAL-CORD; FUNCTIONAL EXPRESSION; BETA-SUBUNIT; GENE FAMILY; HETEROGENEITY; PROTEIN; DNA; BRAIN	The inhibitory glycine receptor (GlyR) in mammalian spinal cord displays pharmacological and molecular heterogeneity of its strychnine binding alpha-subunit. Here, cDNAs were isolated which encode a variant (alpha-1-ins) of the rat GlyR alpha-1 subunit that contains eight additional amino acids in its putative cytoplasmic domain. Analysis of the corresponding genomic sequence showed that alpha-1-ins transcripts result from alternative splice acceptor site selection. S1 nuclease protection experiments, Northern blot analysis, and RNA amplification by polymerase chain reaction revealed alpha-1 and alpha-1-ins mRNA in postnatal spinal cord, but not in other brain regions. Expression of synthetic alpha-1-ins RNA in Xenopus oocytes generated glycine-gated strychnine-sensitive chloride channels. These data indicate that alternative splicing contributes to GlyR alpha-subunit heterogeneity in the mammalian central nervous system.	MAX PLANCK INST HIRNFORSCH,DEUTSCHORDENSTR 46,W-6000 FRANKFURT 71,GERMANY; UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,W-6900 HEIDELBERG,GERMANY	Max Planck Society; Ruprecht Karls University Heidelberg			Kuhse, Jochen/T-3864-2019; Malosio, Maria Luisa/C-1695-2013	Malosio, Maria Luisa/0000-0003-0626-3066				AKAGI H, 1988, SCIENCE, V242, P270, DOI 10.1126/science.2845580; Aprison MH, 1978, ADV NEUROCHEM, V3, P203; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BECKER CM, 1986, J NEUROSCI, V6, P1358; BEESON D, 1990, EMBO J, V9, P2101, DOI 10.1002/j.1460-2075.1990.tb07378.x; BETZ H, 1990, BIOCHEMISTRY-US, V29, P3591, DOI 10.1021/bi00467a001; BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; CASEY J, 1977, NUCLEIC ACIDS RES, V4, P1539, DOI 10.1093/nar/4.5.1539; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CURTIS DR, 1968, EXP BRAIN RES, V6, P1; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DENERIS ES, 1988, NEURON, V1, P45, DOI 10.1016/0896-6273(88)90208-5; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; ECONS MJ, 1990, GENOMICS, V7, P439, DOI 10.1016/0888-7543(90)90180-3; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GOLDMAN D, 1989, NUCLEIC ACIDS RES, V17, P3049, DOI 10.1093/nar/17.8.3049; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; GRAHAM D, 1985, BIOCHEMISTRY-US, V24, P990, DOI 10.1021/bi00325a027; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V330, P25, DOI 10.1038/330025b0; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HOCH W, 1989, NEURON, V3, P339, DOI 10.1016/0896-6273(89)90258-4; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; KUHSE J, 1990, J BIOL CHEM, V265, P22317; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; LEVITAN ES, 1988, NATURE, V335, P76, DOI 10.1038/335076a0; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; RIENITZ A, 1989, EMBO J, V8, P2879, DOI 10.1002/j.1460-2075.1989.tb08436.x; RUIZ-GOMEZ A, 1989, Journal of Neurochemistry, V52, pS58; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHMITT B, 1987, BIOCHEMISTRY-US, V26, P805, DOI 10.1021/bi00377a022; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; UNWIN N, 1989, NEURON, V3, P665, DOI 10.1016/0896-6273(89)90235-3; WEIH F, 1988, NUCLEIC ACIDS RES, V16, P1628, DOI 10.1093/nar/16.4.1628; WERMAN R, 1967, NATURE, V214, P681, DOI 10.1038/214681a0; YMER S, 1989, EMBO J, V8, P1665, DOI 10.1002/j.1460-2075.1989.tb03557.x; ZOPF D, 1989, GLIA, V2, P241, DOI 10.1002/glia.440020405	46	112	115	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2048	2053						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703526				2022-12-27	WOS:A1991EV51500009
J	PAZ, MA; FLUCKIGER, R; BOAK, A; KAGAN, HM; GALLOP, PM				PAZ, MA; FLUCKIGER, R; BOAK, A; KAGAN, HM; GALLOP, PM			SPECIFIC DETECTION OF QUINOPROTEINS BY REDOX-CYCLING STAINING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							BOUND PYRROLOQUINOLINE QUINONE; DOPAMINE BETA-HYDROXYLASE; PLASMA AMINE OXIDASE; NITROBLUE TETRAZOLIUM; ORGANIC COFACTOR; PROSTHETIC GROUP; LYSYL OXIDASE; PQQ; DEHYDROGENASE; RATS	Quinones and related quinonoid substances catalyze redox cycling at an alkaline pH in the presence of excess glycine as reductant. With nitroblue tetrazolium and oxygen present there is concomitant reduction of the tetrazolium to formazan. This property of quinonoid compounds is used for the specific staining of quinoproteins, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electroblotted onto nitrocellulose. The dopa-containing vitelline proteins and the 6-hydroxydopa-containing bovine serum amine oxidase are stained with the nitroblue tetrazolium/glycinate reagent. Also, the mammalian quinoproteins, diamine oxidase and lysyl oxidase, purported to contain pyrroloquinoline quinone, tested positive in this procedure. No quinonoid components were detected in three putative pyrroloquinoline quinone-containing quinoproteins, dopamine beta-hydroxylase, lipoxygenase, and peptidylglycine-amidating monoxygenase. Redox-cycling staining therefore confirms the presence of covalently bound quinones in the copper-dependent amine oxidases, but not in two putative quinoprotein oxygenases. Clarification of the biological significance of quinolation should be facilitated by identification of quinoproteins using this approach.	HARVARD UNIV,SCH MED,BOSTON,MA 02146; HARVARD UNIV,SCH DENT MED,BOSTON,MA 02146; BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Boston University	PAZ, MA (corresponding author), CHILDRENS HOSP MED CTR,HUMAN BIOCHEM LAB,ENDERS 12,320 LONGWOOD AVE,BOSTON,MA 02115, USA.			Fluckiger, Rudolf/0000-0002-4655-2244	NIAMS NIH HHS [AR 18880] Funding Source: Medline; NIA NIH HHS [AG04727, AG07723] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018880, R01AR018880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007723, P01AG004727] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMEYAMA M, 1985, AGR BIOL CHEM TOKYO, V49, P3623, DOI 10.1080/00021369.1985.10867320; DUINE JA, 1989, ANNU REV BIOCHEM, V58, P403; FLUCKIGER R, 1988, BIOCHEM BIOPH RES CO, V153, P353, DOI 10.1016/S0006-291X(88)81230-0; GALLOP PM, 1989, TRENDS BIOCHEM SCI, V14, P343, DOI 10.1016/0968-0004(89)90169-2; GROEN BW, 1988, FEBS LETT, V237, P98, DOI 10.1016/0014-5793(88)80179-0; HOBARA N, 1988, PHARMACOLOGY, V37, P264, DOI 10.1159/000138475; JANES SM, 1990, SCIENCE, V248, P981, DOI 10.1126/science.2111581; KENNEY WC, 1983, BIOCHEMISTRY-US, V22, P3858, DOI 10.1021/bi00285a022; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; KNOWLES PF, 1987, BIOCHEM J, V241, P603, DOI 10.1042/bj2410603; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOBENSTEINVERBEEK CL, 1984, FEBS LETT, V170, P305, DOI 10.1016/0014-5793(84)81333-2; MCINTIRE WS, 1990, METHOD ENZYMOL, V188, P227; NISHIGORI H, 1989, LIFE SCI, V45, P593, DOI 10.1016/0024-3205(89)90044-1; PAZ MA, 1989, PQQ AND QUINOPROTEINS, P131; PAZ MA, 1988, BIOCHEM BIOPH RES CO, V154, P1330, DOI 10.1016/0006-291X(88)90285-9; ROBERTSON JG, 1989, J BIOL CHEM, V264, P19916; TANG SS, 1983, J BIOL CHEM, V258, P4331; VANDERMEER RA, 1986, FEBS LETT, V206, P111, DOI 10.1016/0014-5793(86)81350-3; VANDERMEER RA, 1988, FEBS LETT, V231, P303, DOI 10.1016/0014-5793(88)80838-X; VANDERMEER RA, 1986, BIOCHEM J, V239, P789, DOI 10.1042/bj2390789; VANDERMEER RA, 1988, FEBS LETT, V235, P194, DOI 10.1016/0014-5793(88)81261-4; VELDINK GA, 1990, FEBS LETT, V270, P135, DOI 10.1016/0014-5793(90)81252-J; WAITE JH, 1989, BIOCHEMISTRY-US, V28, P6104, DOI 10.1021/bi00440a056; WATANABE A, 1988, CURR THER RES CLIN E, V44, P896; WATANABE K, 1970, J BIOL CHEM, V245, P4612; WILLIAMSON PR, 1986, J BIOL CHEM, V261, P6302	27	317	326	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					689	692						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702437				2022-12-27	WOS:A1991ET17700004
J	HUSSAINI, IM; SRIKUMAR, K; QUESENBERRY, PJ; GONIAS, SL				HUSSAINI, IM; SRIKUMAR, K; QUESENBERRY, PJ; GONIAS, SL			COLONY-STIMULATING FACTOR-I MODULATES ALPHA-2-MACROGLOBULIN RECEPTOR EXPRESSION IN MURINE BONE-MARROW MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV VIRGINIA, HLTH SCI CTR, DEPT PATHOL, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT INTERNAL MED, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT BIOCHEM, CHARLOTTESVILLE, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia					NHLBI NIH HHS [HL-02272] Funding Source: Medline; NIAID NIH HHS [R01-AI23869] Funding Source: Medline; NIDDK NIH HHS [P01-DK40031] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K04HL002272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK040031] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BORTH W, 1989, J BIOL CHEM, V264, P5818; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; CORVERA S, 1989, J BIOL CHEM, V264, P10133; DAS SK, 1982, J BIOL CHEM, V257, P13679; DELAIN E, 1988, J BIOL CHEM, V263, P2981; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; GLIEMANN J, 1989, BIOCHIM BIOPHYS ACTA, V980, P326, DOI 10.1016/0005-2736(89)90320-9; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; GUILBERT LJ, 1986, J BIOL CHEM, V261, P4024; HANOVER JA, 1986, J BIOL CHEM, V261, P6732; HORIGUCHI J, 1986, BIOCHEM BIOPH RES CO, V141, P924, DOI 10.1016/S0006-291X(86)80131-0; HORIGUCHI J, 1987, BLOOD, V69, P1259; HUANG JS, 1984, P NATL ACAD SCI-BIOL, V81, P342, DOI 10.1073/pnas.81.2.342; IMBER MJ, 1982, J BIOL CHEM, V257, P5129; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; KAPLAN J, 1979, J BIOL CHEM, V254, P7323; KAPLAN J, 1980, CELL, V19, P197, DOI 10.1016/0092-8674(80)90401-8; KAPLAN J, 1981, CELL, V24, P925, DOI 10.1016/0092-8674(81)90118-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATSUDA T, 1989, J IMMUNOL, V142, P148; MAXFIELD FR, 1981, BIOCHEMISTRY-US, V20, P5353, DOI 10.1021/bi00521a041; NEY KA, 1984, BIOCHEMISTRY-US, V23, P3395, DOI 10.1021/bi00310a003; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; ORLOFSKY A, 1987, EMBO J, V6, P2947, DOI 10.1002/j.1460-2075.1987.tb02599.x; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; PIZZO SV, 1984, RECEPTORS, V1, P178; QUESENBERRY P, 1987, BLOOD, V69, P827; RETTENMIER CW, 1987, MOL CELL BIOL, V7, P2378, DOI 10.1128/MCB.7.7.2378; RETTENMIER CW, 1988, J CELL SCI, P27; RONNE H, 1979, BIOCHEM BIOPH RES CO, V87, P330, DOI 10.1016/0006-291X(79)91683-8; SEELENTAG WK, 1987, EMBO J, V6, P2261, DOI 10.1002/j.1460-2075.1987.tb02499.x; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SHADDUCK RK, 1979, BLOOD CELLS, V5, P421; SHERR CJ, 1990, BLOOD, V75, P1; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONG ZX, 1985, BLOOD, V66, P273; Sottrup-Jensen L, 1987, PLASMA PROTEINS STRU, V5, P192; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; VANLEUVEN F, 1980, CELL, V20, P37, DOI 10.1016/0092-8674(80)90232-9; VANLEUVEN F, 1979, J BIOL CHEM, V254, P5155; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268	46	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19441	19446						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1700978				2022-12-27	WOS:A1990EJ18800016
J	FALKENBERG, C; GRUBB, A; AKERSTROM, B				FALKENBERG, C; GRUBB, A; AKERSTROM, B			ISOLATION OF RAT SERUM ALPHA-1-MICROGLOBULIN - IDENTIFICATION OF A COMPLEX WITH ALPHA-1-INHIBITOR-3, A RAT ALPHA-2-MACROGLOBULIN HOMOLOG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV LUND,DEPT MED & PHYSIOL CHEM,POB 94,S-22100 LUND,SWEDEN; UNIV HOSP LUND,DEPT CLIN CHEM,S-22100 LUND,SWEDEN	Lund University; Lund University; Skane University Hospital				Grubb, Anders/0000-0002-0125-3662				AKERSTROM B, 1985, J BIOL CHEM, V260, P4839; AKERSTROM B, 1985, EUR J BIOCHEM, V146, P353; AKERSTROM B, 1979, EUR J BIOCHEM, V101, P215, DOI 10.1111/j.1432-1033.1979.tb04234.x; AKERSTROM B, 1987, EUR J BIOCHEM, V170, P143, DOI 10.1111/j.1432-1033.1987.tb13678.x; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BORTH W, 1989, J BIOL CHEM, V264, P5818; CUATRECASAS P, 1970, J BIOL CHEM, V245, P3059; DEBANNE MT, 1976, BIOCHIM BIOPHYS ACTA, V428, P466; EKSTROM B, 1975, BIOCHEM BIOPH RES CO, V65, P1427, DOI 10.1016/S0006-291X(75)80388-3; EKSTROM B, 1977, J BIOL CHEM, V252, P8048; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; ESNARD F, 1981, BIOCHIMIE, V63, P767, DOI 10.1016/S0300-9084(81)80036-3; FERNANDEZLUNA JL, 1988, FEBS LETT, V236, P471, DOI 10.1016/0014-5793(88)80079-6; FREDRIKSON G, 1987, J IMMUNOL METHODS, V97, P65, DOI 10.1016/0022-1759(87)90106-2; GAUTHIER F, 1978, H-S Z PHYSIOL CHEM, V359, P987, DOI 10.1515/bchm2.1978.359.2.987; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GRUBB A, 1986, J BIOL CHEM, V261, P14313; Grubb A. O., 1983, SCAND J IMMUNOL S10, V17, P113; GRUBB AO, 1983, J BIOL CHEM, V258, P4698; HUANG JS, 1984, P NATL ACAD SCI-BIOL, V81, P342, DOI 10.1073/pnas.81.2.342; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; KASTERN W, 1986, J BIOL CHEM, V261, P5070; KAUMEYER JF, 1986, NUCLEIC ACIDS RES, V14, P7839, DOI 10.1093/nar/14.20.7839; KOHN J, 1982, BIOCHEM BIOPH RES CO, V107, P878, DOI 10.1016/0006-291X(82)90604-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; LOGDBERG L, 1981, SCAND J IMMUNOL, V13, P383, DOI 10.1111/j.1365-3083.1981.tb00148.x; LOGDBERG L, 1986, SCAND J IMMUNOL, V24, P575, DOI 10.1111/j.1365-3083.1986.tb02173.x; LONBERGHOLM K, 1987, J BIOL CHEM, V262, P438; MARCHALONIS JJ, 1969, BIOCHEM J, V113, P299, DOI 10.1042/bj1130299; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MENDEZ E, 1986, P NATL ACAD SCI USA, V83, P1472, DOI 10.1073/pnas.83.5.1472; NELLES LP, 1980, BIOCHIM BIOPHYS ACTA, V623, P46, DOI 10.1016/0005-2795(80)90006-9; NILSON B, 1986, J IMMUNOL METHODS, V91, P275, DOI 10.1016/0022-1759(86)90490-4; NILSON B, 1987, J IMMUNOL METHODS, V99, P39, DOI 10.1016/0022-1759(87)90029-9; OUCHTERLONY O, 1958, PROG ALLERGY, V5, P1, DOI 10.1159/000273347; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; SAITO A, 1985, J BIOCHEM-TOKYO, V98, P501, DOI 10.1093/oxfordjournals.jbchem.a135305; SOTTRUPJENSEN L, 1980, FEBS LETT, V121, P275, DOI 10.1016/0014-5793(80)80361-9; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; TEJLER L, 1976, BIOCHIM BIOPHYS ACTA, V439, P82, DOI 10.1016/0005-2795(76)90164-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANLEUVEN F, 1979, J BIOL CHEM, V254, P5155; VINCENT C, 1983, BIOCHEM BIOPH RES CO, V116, P180, DOI 10.1016/0006-291X(83)90398-4	44	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16150	16157						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697852				2022-12-27	WOS:A1990DZ95000021
J	FLORINI, JR; EWTON, DZ				FLORINI, JR; EWTON, DZ			HIGHLY SPECIFIC-INHIBITION OF IGF-I-STIMULATED DIFFERENTIATION BY AN ANTISENSE OLIGODEOXYRIBONUCLEOTIDE TO MYOGENIN MESSENGER-RNA - NO EFFECTS ON OTHER ACTIONS OF IGF-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note											FLORINI, JR (corresponding author), SYRACUSE UNIV,DEPT BIOL,SYRACUSE,NY 13244, USA.				NHLBI NIH HHS [HL 11551] Funding Source: Medline; NIA NIH HHS [AG 05557] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL011551, R37HL011551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG005557] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADASHI EY, 1984, ENDOCRINOLOGY, V115, P1227, DOI 10.1210/endo-115-3-1227; AGRAWAL S, 1989, P NATL ACAD SCI USA, V86, P7790, DOI 10.1073/pnas.86.20.7790; AMINI S, 1986, MOL CELL BIOL, V6, P2305, DOI 10.1128/MCB.6.7.2305; BRUNETTI A, 1990, J BIOL CHEM, V265, P5906; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; EWTON DZ, 1984, J CELL PHYSIOL, V120, P263, DOI 10.1002/jcp.1041200302; EWTON DZ, 1987, ENDOCRINOLOGY, V120, P115, DOI 10.1210/endo-120-1-115; FLORINI JR, 1984, IN VITRO CELL DEV B, V20, P942; FLORINI JR, 1979, IN VITRO CELL DEV B, V15, P983; FLORINI JR, 1989, AM J PHYSIOL, V256, pC701, DOI 10.1152/ajpcell.1989.256.4.C701; FLORINI JR, 1989, ANAL BIOCHEM, V182, P399, DOI 10.1016/0003-2697(89)90614-3; GEWIRTZ AM, 1989, SCIENCE, V245, P180, DOI 10.1126/science.2665077; GREEN PJ, 1986, ANNU REV BIOCHEM, V55, P569, DOI 10.1146/annurev.bi.55.070186.003033; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; JETTERN AM, 1988, EXP CELL RES, V167, P539; KATO Y, 1980, EXP CELL RES, V125, P157; KUROKOWA M, 1987, BIOCHEM BIOPH RES CO, V142, P775, DOI 10.1016/0006-291X(87)91481-1; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MASUI T, 1986, P NATL ACAD SCI USA, V83, P2438, DOI 10.1073/pnas.83.8.2438; MAURO T, 1988, ACTA ENDOCRINOL-COP, V117, P230; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; SANKAR S, 1989, EUR J BIOCHEM, V184, P39, DOI 10.1111/j.1432-1033.1989.tb14987.x; SCHMID C, 1984, FEBS LETT, V173, P48, DOI 10.1016/0014-5793(84)81015-7; SHAINBERG A, 1971, DEV BIOL, V25, P1, DOI 10.1016/0012-1606(71)90017-0; STEVENSON M, 1989, J GEN VIROL, V70, P2673, DOI 10.1099/0022-1317-70-10-2673; VANDERKROL AR, 1988, BIOTECHNIQUES, V6, P958; WICKSTROM EL, 1989, IN VITRO CELL DEV, V24, P297; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	30	88	95	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13435	13437						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696254				2022-12-27	WOS:A1990DU27500007
J	KWON, NS; NATHAN, CF; GILKER, C; GRIFFITH, OW; MATTHEWS, DE; STUEHR, DJ				KWON, NS; NATHAN, CF; GILKER, C; GRIFFITH, OW; MATTHEWS, DE; STUEHR, DJ			L-CITRULLINE PRODUCTION FROM L-ARGININE BY MACROPHAGE NITRIC-OXIDE SYNTHASE - THE UREIDO OXYGEN DERIVES FROM DIOXYGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									CORNELL UNIV,MED CTR,COLL MED,DIV HEMATOL ONCOL,BEATRICE & SAMUEL A SEAVER LAB,BOX 57,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,DEPT BIOCHEM,NEW YORK,NY 10021; CORNELL UNIV,MED CTR,COLL MED,DEPT MED,MASS SPECT FACIL,NEW YORK,NY 10021	Cornell University; Cornell University; Cornell University					NATIONAL CANCER INSTITUTE [R01CA043610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037116] Funding Source: NIH RePORTER; NCI NIH HHS [CA43610] Funding Source: Medline; NIDDK NIH HHS [DK37116] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMBER IJ, 1988, J LEUKOCYTE BIOL, V44, P58, DOI 10.1002/jlb.44.1.58; BILLIAR TR, 1989, J EXP MED, V169, P1467, DOI 10.1084/jem.169.4.1467; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BRENNEMAN AR, 1964, BIOCHEM BIOPH RES CO, V17, P177, DOI 10.1016/0006-291X(64)90141-X; BUBLITZ C, 1977, BIOCHEM MED METAB B, V17, P13, DOI 10.1016/0006-2944(77)90004-7; CURRAN RD, 1989, J EXP MED, V170, P1769, DOI 10.1084/jem.170.5.1769; DAVIS MD, 1989, J BIOL CHEM, V264, P8585; DIX TA, 1987, BIOCHEMISTRY-US, V26, P3354, DOI 10.1021/bi00386a016; FRIEDMAN PA, 1972, J BIOL CHEM, V247, P4165; GRANGER DL, 1988, J CLIN INVEST, V81, P1129, DOI 10.1172/JCI113427; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; HORMAN I, 1974, BIOMED MASS SPECTROM, V1, P115, DOI 10.1002/bms.1200010206; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; KAUFMAN S, 1959, J BIOL CHEM, V234, P2677; KAUFMAN S, 1963, P NATL ACAD SCI USA, V50, P1085, DOI 10.1073/pnas.50.6.1085; KWON NS, 1989, J BIOL CHEM, V264, P20496; KWON NS, 1990, FASEB J, V4, pA2323; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MASSEY V, 1975, ENZYMES, V12, P191; OGAWA T, 1987, BIOCHEM BIOPH RES CO, V148, P671, DOI 10.1016/0006-291X(87)90929-6; PALACIOS M, 1989, BIOCHEM BIOPH RES CO, V165, P802, DOI 10.1016/S0006-291X(89)80037-3; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; SCHMIDT HHHW, 1989, FEBS LETT, V244, P357, DOI 10.1016/0014-5793(89)80562-9; STUEHR DJ, 1985, P NATL ACAD SCI USA, V82, P7738, DOI 10.1073/pnas.82.22.7738; STUEHR DJ, 1990, BIOCHEM BIOPH RES CO, V168, P558, DOI 10.1016/0006-291X(90)92357-6; STUEHR DJ, 1989, BIOCHEM BIOPH RES CO, V161, P420, DOI 10.1016/0006-291X(89)92615-6; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; STUEHR DJ, 1990, FASEB J, V4, pA1854; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; WRIGHT CD, 1989, BIOCHEM BIOPH RES CO, V160, P813, DOI 10.1016/0006-291X(89)92506-0	34	237	243	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13442	13445						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696255				2022-12-27	WOS:A1990DU27500009
J	STOLZ, A; RAHIMIKIANI, M; AMEIS, D; CHAN, E; RONK, M; SHIVELY, JE				STOLZ, A; RAHIMIKIANI, M; AMEIS, D; CHAN, E; RONK, M; SHIVELY, JE			MOLECULAR-STRUCTURE OF RAT HEPATIC 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE - A MEMBER OF THE OXIDOREDUCTASE GENE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLICAL OXIDATION REDUCTION; ANTI-INFLAMMATORY DRUGS; LIVER CYTOSOL; DIHYDRODIOL DEHYDROGENASE; BILE-ACIDS; MICROSEQUENCE ANALYSIS; BINDING-PROTEIN; C-3 POSITION; BOVINE LUNG; INHIBITION	3-Alpha-hydroxysteroid dehydrogenase (3-alpha-HSD) (EC 1.1.1.50) is an important multifunctional oxidoreductase capable of metabolizing steroid hormones, polycyclic aromatic hydrocarbons, and prostaglandins. 3-alpha-HSD is also required for bile acid synthesis and has been suggested to play an important role in net bile acid transport across the hepatocyte (Stolz, A., Takikawa, H., Ookhtens, M., and Kaplowitz, N. (1989) Annu. Rev. Physiol. 51, 166-177). In order to characterize molecular forms and begin to determine its regulation, we now report the nucleotide sequence, tissue distribution, and homology to other members of the oxidoreductase superfamily. Rat hepatic 3-alpha-HSD cDNA encodes for a 322-amino acid protein with a predicted molecular weight of 37,022 expressed in a 2.4-kilobase (kb) message size. Northern blot analysis of total RNA revealed equivalent steady-state levels in liver and intestine in male rats with lower levels of expression in the colon and minimal expression in stomach, lung, and testis. Female liver contained approximately 2-3-fold greater steady-state levels of mRNA as compared to the male liver with equivalent intestinal expression. Two hybridizing bands, 2.4 and 1.4 kb, were identified in total RNA from the ovary. 3-alpha-HSD exhibits 75% amino acid sequence homology with bovine lung prostaglandin F synthetase and 50% homology with human aldose reductases. Amino acid sequence analysis with short chain alcohol dehydrogenases identified a possible NADP(H) cofactor-binding site at the amino terminus. The significant homology of 3-alpha-HSD with both prostaglandin F synthetase and aldose reductases suggest a subdivision of monomeric, NADPH reductases within the larger oxidoreductases superfamily.	LOS ANGELES OUTPATIENT VET ADM FACIL,LOS ANGELES,CA 90013; VET ADM WADSWORTH MED CTR,LOS ANGELES,CA 90073; UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA 90025; CITY HOPE NATL MED CTR,BECKMAN RES INT,DIV IMMUNOL,DUARTE,CA 91010	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; City of Hope; Beckman Research Institute of City of Hope	STOLZ, A (corresponding author), UNIV SO CALIF,SCH MED,DIV GASTROINTESTINAL & LIVER DIS,LOS ANGELES,CA 90033, USA.							BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BORRAS T, 1989, BIOCHEMISTRY-US, V28, P6133, DOI 10.1021/bi00441a001; CARPER D, 1987, FEBS LETT, V220, P209, DOI 10.1016/0014-5793(87)80905-5; CARPER DA, 1989, EXP EYE RES, V49, P377, DOI 10.1016/0014-4835(89)90048-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLARKE CF, 1987, MOL CELL BIOL, V7, P3138, DOI 10.1128/MCB.7.9.3138; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; HARA A, 1988, J BIOCHEM-TOKYO, V103, P1027, DOI 10.1093/oxfordjournals.jbchem.a122374; HAWKE DH, 1985, ANAL BIOCHEM, V147, P315, DOI 10.1016/0003-2697(85)90278-7; IVINS JK, 1987, CANCER RES, V47, P680; JARRELL J, 1984, J STEROID BIOCHEM, V21, P151, DOI 10.1016/0022-4731(84)90376-5; JARRELL J, 1985, BIOL REPROD, V33, P1207, DOI 10.1095/biolreprod33.5.1207; JARRELL J, 1982, J STEROID BIOCHEM, V16, P725, DOI 10.1016/0022-4731(82)90027-9; JOERNVALL H, 1987, EUR J BIOCHEM, V167, P195; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KRAUSE JE, 1980, J BIOL CHEM, V255, P1807; KRAUSE JE, 1981, J STEROID BIOCHEM, V14, P63, DOI 10.1016/0022-4731(81)90193-X; KRIEGER NR, 1989, J NEUROCHEM, V52, P1866, DOI 10.1111/j.1471-4159.1989.tb07269.x; KROOK M, 1990, BIOCHEMISTRY-US, V29, P738, DOI 10.1021/bi00455a021; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; NAKAGAWA M, 1989, CHEM PHARM BULL, V37, P2852; NAKAGAWA M, 1989, J BIOCHEM-TOKYO, V106, P633, DOI 10.1093/oxfordjournals.jbchem.a122908; PAN YCE, 1984, J CHROMATOGR, V297, P13, DOI 10.1016/S0021-9673(01)89024-5; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PENNING TM, 1987, BIOCHEM BIOPH RES CO, V148, P646, DOI 10.1016/0006-291X(87)90925-9; PENNING TM, 1986, STEROIDS, V47, P221; PENNING TM, 1984, BIOCHEM J, V222, P601, DOI 10.1042/bj2220601; PENNING TM, 1983, P NATL ACAD SCI-BIOL, V80, P4504, DOI 10.1073/pnas.80.14.4504; PENNING TM, 1985, J BIOL CHEM, V260, P5266; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIVELY JE, 1987, ANAL BIOCHEM, V163, P517, DOI 10.1016/0003-2697(87)90257-0; SMITHGALL TE, 1985, CANCER RES, V45, P4946; SMITHGALL TE, 1986, J BIOL CHEM, V261, P6184; STOLZ A, 1986, HEPATOLOGY, V6, P433, DOI 10.1002/hep.1840060319; STOLZ A, 1987, J CLIN INVEST, V79, P427, DOI 10.1172/JCI112829; STOLZ A, 1989, ANNU REV PHYSIOL, V51, P161, DOI 10.1146/annurev.ph.51.030189.001113; TAKIKAWA H, 1987, J CLIN INVEST, V80, P852, DOI 10.1172/JCI113143; TAKIKAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1043, P153, DOI 10.1016/0005-2760(90)90289-A; TAKIKAWA H, 1987, J CLIN INVEST, V80, P861, DOI 10.1172/JCI113144; VOGEL K, 1980, J BIOL CHEM, V255, P9621; Watanabe K, 1989, Prog Clin Biol Res, V290, P351; WATANABE K, 1985, J BIOL CHEM, V260, P7035; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669; WISTOW GJ, 1987, NATURE, V326, P622, DOI 10.1038/326622a0; WOERNER W, 1984, Febs Letters, V170, P263	52	73	74	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15253	15257						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714456				2022-12-27	WOS:A1991GB09700066
J	QUARONI, A; CALNEK, D; QUARONI, E; CHANDLER, JS				QUARONI, A; CALNEK, D; QUARONI, E; CHANDLER, JS			KERATIN EXPRESSION IN RAT INTESTINAL CRYPT AND VILLUS CELLS - ANALYSIS WITH A PANEL OF MONOCLONAL-ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; INTERMEDIATE FILAMENT PROTEIN; EPITHELIAL-CELLS; BRUSH-BORDER; TERMINAL DIFFERENTIATION; COMPOSITIONAL ANALYSIS; CYTOSKELETAL PROTEIN; POLYACRYLAMIDE GELS; MOLECULAR MARKERS; VISCERAL ENDODERM	Seven monoclonal antibodies were prepared against cytoskeletal components of rat intestinal brush borders. In the following paper (Chandler, J. S., Calnek, D., and Quaroni, A., J. Biol. Chem. 266, 11932-11938), three of them were shown to be specific for, respectively, keratin 8 (RK4), keratin 19 (RK7), and a newly identified type I keratin (keratin 21) (RK5). With these antibodies we have investigated the changes in keratin gene expression accompanying intestinal cell differentiation. Keratin 21 was detected exclusively in differentiated villus cells and in goblet, enteroendocrine, and Paneth cells in the crypts; in the proliferative crypt cells keratin 19 was predominant. Analysis of keratins expressed by cultured rat crypt cells (IEC cells) confirmed the absence of keratin 21 in undifferentiated intestinal cells. Changes in keratin's expression similar to those observed with cell differentiation in the adult intestinal mucosa were also demonstrated during early fetal intestinal development: the stratified epithelium present at 15-16 days of gestation contained predominantly keratin 19 with only a small amount of keratin 8; keratin 21 was first detected at 18-19 days of gestation, concomitant with the appearance of a well formed brush border and an apical cytoplasmic terminal web. These results suggest that keratin tonofilaments may play a role in the morphological and structural alterations accompanying intestinal cell differentiation in vivo.			QUARONI, A (corresponding author), CORNELL UNIV, DIV BIOL SCI, PHYSIOL SECT, 724 VET RES TOWER, ITHACA, NY 14853 USA.				NIDDK NIH HHS [DK 32656] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032656] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; BARIBAULT H, 1989, J CELL BIOL, V109, P1665, DOI 10.1083/jcb.109.4.1665; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BRETSCHER A, 1978, J CELL BIOL, V79, P839, DOI 10.1083/jcb.79.3.839; BRETSCHER A, 1978, EXP CELL RES, V116, P397, DOI 10.1016/0014-4827(78)90463-9; BRETSCHER A, 1981, COLD SPRING HARB SYM, V46, P871; CELIS JE, 1983, J CELL BIOL, V97, P1429, DOI 10.1083/jcb.97.5.1429; CHANDLER JS, 1991, J BIOL CHEM, V266, P11932; DUNN JS, 1967, J ANAT, V101, P57; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; EICHNER R, 1984, J CELL BIOL, V98, P1388, DOI 10.1083/jcb.98.4.1388; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; EZZELL RM, 1989, DEVELOPMENT, V106, P407; FATH KR, 1990, DEVELOPMENT, V109, P449; FRANKE WW, 1981, EXP CELL RES, V131, P299, DOI 10.1016/0014-4827(81)90234-2; FRANKE WW, 1981, J CELL BIOL, V90, P116, DOI 10.1083/jcb.90.1.116; FRANKE WW, 1981, J MOL BIOL, V153, P933, DOI 10.1016/0022-2836(81)90460-5; FRANKE WW, 1979, EUR J CELL BIOL, V19, P255; FUCHS E, 1985, ANN NY ACAD SCI, V455, P436, DOI 10.1111/j.1749-6632.1985.tb50427.x; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS EV, 1981, CELL, V27, P75, DOI 10.1016/0092-8674(81)90362-7; GALFRE G, 1977, NATURE, V266, P550, DOI 10.1038/266550a0; GLENNEY JR, 1983, CELL MOTIL CYTOSKEL, V3, P671, DOI 10.1002/cm.970030531; GLENNEY JR, 1982, CELL, V28, P843, DOI 10.1016/0092-8674(82)90063-0; HEINTZELMAN MB, 1990, DIFFERENTIATION, V43, P175, DOI 10.1111/j.1432-0436.1990.tb00444.x; HIROKAWA N, 1982, J CELL BIOL, V94, P425, DOI 10.1083/jcb.94.2.425; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; ICHINOSE Y, 1989, GENE, V80, P315; KIM KH, 1984, J CELL BIOL, V99, P1872, DOI 10.1083/jcb.99.5.1872; KIM KH, 1983, MOL CELL BIOL, V3, P495, DOI 10.1128/MCB.3.4.495; LANE EB, 1982, J CELL BIOL, V92, P665, DOI 10.1083/jcb.92.3.665; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MATHAN M, 1976, AM J ANAT, V146, P73, DOI 10.1002/aja.1001460104; MAUNOURY R, 1988, EMBO J, V7, P3321, DOI 10.1002/j.1460-2075.1988.tb03203.x; MESSER M, 1966, ANAL BIOCHEM, V14, P376, DOI 10.1016/0003-2697(66)90280-6; MOLL R, 1982, J CELL BIOL, V95, P285, DOI 10.1083/jcb.95.1.285; MOLL R, 1983, DIFFERENTIATION, V23, P256; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; MOOSEKER MS, 1975, J CELL BIOL, V67, P725, DOI 10.1083/jcb.67.3.725; MOOSEKER MS, 1985, ANNU REV CELL BIOL, V1, P209, DOI 10.1146/annurev.cellbio.1.1.209; NELSON WG, 1983, J CELL BIOL, V97, P244, DOI 10.1083/jcb.97.1.244; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OSBORN M, 1986, LAB INVEST, V55, P497; OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4; OUELLETTE AJ, 1989, J CELL BIOL, V108, P1687, DOI 10.1083/jcb.108.5.1687; QUARONI A, 1981, J NATL CANCER I, V67, P1353; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; QUARONI A, 1985, J CELL BIOL, V100, P1601, DOI 10.1083/jcb.100.5.1601; QUARONI A, 1985, DEV BIOL, V111, P267, DOI 10.1016/0012-1606(85)90482-8; QUARONI A, 1979, BIOCHEM J, V182, P203, DOI 10.1042/bj1820203; QUINLAN RA, 1985, ANN NY ACAD SCI, V455, P282, DOI 10.1111/j.1749-6632.1985.tb50418.x; REGAUER S, 1985, J CELL BIOL, V100, P997, DOI 10.1083/jcb.100.4.997; ROCHETTEEGLY C, 1987, DIFFERENTIATION, V35, P219, DOI 10.1111/j.1432-0436.1987.tb00172.x; SCHILLER DL, 1983, CELL BIOL INT REP, V7, P3, DOI 10.1016/0309-1651(83)90098-X; SHIBAYAMA T, 1987, J CELL BIOL, V105, P335, DOI 10.1083/jcb.105.1.335; SINGER PA, 1986, J BIOL CHEM, V261, P538; STEINERT PM, 1985, CELL, V42, P411, DOI 10.1016/0092-8674(85)90098-4; STEINERT PM, 1985, NATURE, V316, P767, DOI 10.1038/316767a0; STEVEN AC, 1985, ANN NY ACAD SCI, V455, P371, DOI 10.1111/j.1749-6632.1985.tb50423.x; SUN TT, 1978, J BIOL CHEM, V253, P2053; SUN TT, 1979, P NATL ACAD SCI USA, V76, P2813, DOI 10.1073/pnas.76.6.2813; TILNEY LG, 1971, P NATL ACAD SCI USA, V68, P2611, DOI 10.1073/pnas.68.10.2611; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIER JS, 1963, J CELL BIOL, V18, P599, DOI 10.1083/jcb.18.3.599; TRIER JS, 1981, PHYSL GASTROINTESTIN, V2, P925; TROYANOVSKY SM, 1989, J CELL SCI, V93, P419; VANMUIJEN GNP, 1984, AM J PATHOL, V114, P9; WEISER MM, 1973, J BIOL CHEM, V248, P2536; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0; WOODCOCKMITCHELL J, 1982, J CELL BIOL, V95, P580, DOI 10.1083/jcb.95.2.580; YEGER H, 1986, AM J CLIN PATHOL, V86, P697, DOI 10.1093/ajcp/86.6.697	75	67	67	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11923	11931						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711043				2022-12-27	WOS:A1991FT76200078
J	CALVO, JC; RODBARD, D; KATKI, A; CHERNICK, S; YANAGISHITA, M				CALVO, JC; RODBARD, D; KATKI, A; CHERNICK, S; YANAGISHITA, M			DIFFERENTIATION OF 3T3-L1 PREADIPOCYTES WITH 3-ISOBUTYL-1-METHYLXANTHINE AND DEXAMETHASONE STIMULATES CELL-ASSOCIATED AND SOLUBLE CHONDROITIN 4-SULFATE PROTEOGLYCANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DERMATAN SULFATE PROTEOGLYCAN; LIPOPROTEIN-LIPASE ACTIVITY; OVARIAN GRANULOSA-CELLS; ADIPOSE CONVERSION; INSULIN REGULATION; MESSENGER-RNA; CORE PROTEIN; FIBRONECTIN; FIBROBLASTS; ADIPOCYTES	The proteoglycans (cell-associated and culture media) in 3T3-L1 preadipocytes in culture were analyzed before and during differentiation into adipocytes. Cells were metabolically labeled with [S-35]sulfate and [H-3] glucosamine for 24 h and then extracted and analyzed. There was a 1.68 +/- 0.07-fold increase in the S-35 in medium proteoglycan during differentiation, whereas cell-associated proteoglycan radioactivity showed no increase. Analyses of radiolabeled molecules using ion-exchange chromatography, gel filtration, and high performance liquid chromatography after enzymatic or alkaline digestion indicated that all of the S-35 label was recovered as two major species of chondroitin 4-sulfate proteoglycans (CSPG-I and CSPG-II) and 7% as heparan sulfate proteoglycan. CSPG-I has a mass of almost-equal-to 970 kDa with multiple chondroitin sulfate chains (average of 50 kDa each) and a core protein of almost-equal-to 370 kDa including oligosaccharides. CSPG-II has a mass of 140 kDa with one or two chondroitin sulfate chains (average of 68 kDa each) and a core protein of 41 kDa including oligosaccharides. CSPG-I appears to be similar to versican, whereas CSPG-II is similar to decorin and/or biglycan, found in other fibroblastic cells. Cell differentiation was associated with a specific increase in CSPG-I (4.0 +/- 0.2-fold in media and 3.2 +/- 0.5-fold in the cell-associated form). This system should facilitate study of the functional roles of proteoglycans during growth and differentiation.	NICHHD,THEORET & PHYS BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	CALVO, JC (corresponding author), NIDR,BONE RES BRANCH,BLDG 30,RM 106,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							AILHAUD G, 1989, ENVIRON HEALTH PERSP, V80, P17, DOI 10.2307/3430728; AMRI EZ, 1984, EXP CELL RES, V152, P368, DOI 10.1016/0014-4827(84)90638-4; Bissell M. J., 1987, The mammary gland. Development, regulation, and function., P97; BRENNAN MJ, 1983, CANCER RES, V43, P4302; BRENNAN MJ, 1984, J BIOL CHEM, V259, P3742; CARLSON DM, 1968, J BIOL CHEM, V243, P616; CHERNICK SS, 1986, J LIPID RES, V27, P286; COLE BR, 1978, ELECTROPHORESIS 78, P79; COOK KS, 1985, P NATL ACAD SCI USA, V82, P6480, DOI 10.1073/pnas.82.19.6480; DANI C, 1986, BIOCHEM BIOPH RES CO, V138, P468, DOI 10.1016/0006-291X(86)90304-9; FISHER LW, 1983, J BIOL CHEM, V258, P6588; FISHER LW, 1989, J BIOL CHEM, V264, P4571; GLOSSL J, 1984, J BIOL CHEM, V259, P4144; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; HAUTANEN A, 1989, J BIOL CHEM, V264, P1437; HEINEGARD D, 1984, CONNECTIVE TISSUE BI, P277; KNOX P, 1979, J CELL SCI, V40, P77; KRUSIUS T, 1987, J BIOL CHEM, V262, P13120; KURIHARCUCH W, 1984, DIFFERENTIATION, V28, P173, DOI 10.1111/j.1432-0436.1984.tb00280.x; KURIHARCUCH W, 1983, J CELL PHYSIOL, V114, P39, DOI 10.1002/jcp.1041140107; KURIHARCUCH W, 1978, P NATL ACAD SCI USA, V75, P6107, DOI 10.1073/pnas.75.12.6107; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOHMANDER LS, 1980, J BIOL CHEM, V255, P6084; LOHMANDER LS, 1986, ARCH BIOCHEM BIOPHYS, V250, P211, DOI 10.1016/0003-9861(86)90719-8; MOTTA P, 1975, J MICROSC-PARIS, V22, P15; OERTER KE, 1990, ANAL BIOCHEM, V189, P235, DOI 10.1016/0003-2697(90)90114-O; OIKE Y, 1980, BIOCHEM J, V191, P193, DOI 10.1042/bj1910193; OTSU K, 1985, BIOCHEM J, V227, P37, DOI 10.1042/bj2270037; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; SPOONER PM, 1979, J BIOL CHEM, V254, P21; Toole B, 1982, CELL BIOL EXTRACELLU, P259; YAMAGUCHI Y, 1988, NATURE, V336, P244, DOI 10.1038/336244a0; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; YANAGISHITA M, 1989, J BIOL CHEM, V264, P17551; YANAGISHITA M, 1987, METHOD ENZYMOL, V138, P279; YANAGISHITA M, 1984, J BIOL CHEM, V259, P270; YANAGISHITA M, 1989, J BIOL CHEM, V264, P15714; YANAGISHITA M, 1984, J BIOL CHEM, V259, P260; ZEBROWER ME, 1986, ANAL BIOCHEM, V157, P93, DOI 10.1016/0003-2697(86)90201-0; ZIMMERMANN DR, 1989, EMBO J, V8, P2975, DOI 10.1002/j.1460-2075.1989.tb08447.x	46	45	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11237	11244						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710220				2022-12-27	WOS:A1991FQ77400083
J	DEFILIPPI, P; TRUFFA, G; STEFANUTO, G; ALTRUDA, F; SILENGO, L; TARONE, G				DEFILIPPI, P; TRUFFA, G; STEFANUTO, G; ALTRUDA, F; SILENGO, L; TARONE, G			TUMOR-NECROSIS-FACTOR-ALPHA AND INTERFERON-GAMMA MODULATE THE EXPRESSION OF THE VITRONECTIN RECEPTOR (INTEGRIN-BETA-3) IN HUMAN ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BETA; PLATELET GLYCOPROTEIN IIIA; ARG-GLY-ASP; ADHESION RECEPTORS; IMMUNE INTERFERON; PROTEIN-SYNTHESIS; VASCULAR ENDOTHELIUM; EXTRACELLULAR-MATRIX; SURFACE GLYCOPROTEIN; VONWILLEBRAND-FACTOR	In this paper we show that tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) alter the expression of extracellular matrix receptors (integrins) in cultured human endothelial cells. Endothelial cells express at their surface integrins of the beta-1 and beta-3 groups that include receptors for fibronectin, collagen, laminin, and vitronectin. After treatment for 72 h with a combination of TNF-alpha and IFN-gamma, the level of the vitronectin receptor (alpha-v-beta-3) at the cell surface decreases by 70%, whereas the amounts of the beta-1 integrins remain unchanged. The decreased expression of the alpha-v-beta-3 complex at the cell surface is due to a slective effect of TNF-alpha and IFN-gamma on the regulation of the beta-3 subunit synthesis at the translational level. In fact, although the steady state levels of the mRNA for the beta-3 subunit are comparable in control and treated cells, the overall synthesis of the beta-3 subunit is decreased by a factor of 70%. No significant alteration of the synthesis of the companion alpha-v subunit is detectable in cytokine-treated cells. As a consequence of the decreased expression of the receptor, cytokine-treated cells show decreased ability to adhere to vitronectin but adhere normally to fibronectin. These data show that two important inflammatory mediators, TNF-alpha and IFN-gamma, can modify the interaction of endothelial cells with the extracellular matrix by selectively altering the expression of specific cell surface integrin complexes.			DEFILIPPI, P (corresponding author), UNIV TURIN,DIPARTIMENTO GENET BIOL & CHIM MED,VIA SANTENA 5BIS,I-10126 TURIN,ITALY.		DEFILIPPI, Paola/L-2232-2014	Defilippi, Paola/0000-0001-6427-4906; Tarone, Guido/0000-0003-4805-086X				ALBELDA SM, 1989, J CLIN INVEST, V83, P1992, DOI 10.1172/JCI114109; BALLINGER DG, 1983, CELL, V33, P103, DOI 10.1016/0092-8674(83)90339-2; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BODARY SC, 1990, J BIOL CHEM, V265, P5938; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; BUSSOLINO F, 1988, J BIOL CHEM, V263, P11856; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHARO IF, 1987, J BIOL CHEM, V262, P9935; CHENG YF, 1989, J CELL PHYSIOL, V139, P275, DOI 10.1002/jcp.1041390209; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLLINS T, 1986, P NATL ACAD SCI USA, V83, P446, DOI 10.1073/pnas.83.2.446; CONFORTI G, 1989, BLOOD, V73, P1576; DAHLBACK K, 1987, HISTOCHEMISTRY, V87, P511, DOI 10.1007/BF00492465; DANIELSON PE, 1988, DNA CELL BIOL, V7, P2261; DEJANA E, 1988, BLOOD, V71, P566; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; GIANCOTTI FG, 1986, J CELL BIOL, V103, P429, DOI 10.1083/jcb.103.2.429; GIANCOTTI FG, 1985, EXP CELL RES, V156, P182, DOI 10.1016/0014-4827(85)90272-1; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; HEINO J, 1989, J BIOL CHEM, V264, P380; HEMLER ME, 1988, IMMUNOL TODAY, V9, P109, DOI 10.1016/0167-5699(88)91280-7; HEMLER ME, 1985, J BIOL CHEM, V260, P5246; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; IGNOTZ RA, 1989, J BIOL CHEM, V264, P389; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; JIRIK FR, 1989, J IMMUNOL, V142, P144; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPIERRE LA, 1988, J EXP MED, V167, P794, DOI 10.1084/jem.167.3.794; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LIBBY P, 1986, AM J PATHOL, V124, P179; MOCCHETTI I, 1987, NEUROPHARMACOLOGY, V26, P855, DOI 10.1016/0028-3908(87)90062-1; PATEL VP, 1984, SCIENCE, V224, P996, DOI 10.1126/science.6585955; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; POBER JS, 1988, AM J PATHOL, V133, P426; POBER JS, 1986, J IMMUNOL, V137, P1893; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; ROSENTHAL ET, 1980, CELL, V20, P487, DOI 10.1016/0092-8674(80)90635-2; ROSSINO P, 1990, EXP CELL RES, V189, P100, DOI 10.1016/0014-4827(90)90262-9; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; SEELENTAG WK, 1987, EMBO J, V6, P2261, DOI 10.1002/j.1460-2075.1987.tb02499.x; SHALABY MR, 1989, CELL IMMUNOL, V121, P372, DOI 10.1016/0008-8749(89)90036-1; SITIA R, 1987, EMBO J, V6, P3969, DOI 10.1002/j.1460-2075.1987.tb02739.x; SOOD AK, 1981, P NATL ACAD SCI-BIOL, V78, P616, DOI 10.1073/pnas.78.1.616; STOLPEN AH, 1986, AM J PATHOL, V123, P16; STOLPEN AH, 1988, J CELL BIOL, V107, P781, DOI 10.1083/jcb.107.2.781; TARONE G, 1990, J LIPID MEDIATOR, V2, pS45; TARONE G, 1982, J CELL BIOL, V94, P179, DOI 10.1083/jcb.94.1.179; THIAGARAJAN P, 1985, J CLIN INVEST, V75, P896, DOI 10.1172/JCI111789; VAQUERO C, 1982, BIOCHEM BIOPH RES CO, V107, P974, DOI 10.1016/0006-291X(82)90618-0; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; WAGNER DD, 1984, P NATL ACAD SCI-BIOL, V81, P471, DOI 10.1073/pnas.81.2.471	56	150	150	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7638	7645						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708389				2022-12-27	WOS:A1991FJ34200051
J	MCARTHUR, JG; STANNERS, CP				MCARTHUR, JG; STANNERS, CP			A GENETIC ELEMENT THAT INCREASES THE FREQUENCY OF GENE AMPLIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR-SURFACE ANTIGEN; CHORION GENE; INVERTED DUPLICATION; DNA AMPLIFICATION; ASPARAGINE SYNTHETASE; HAMSTER-CELLS; ANIMAL-CELLS; DROSOPHILA; LEUKEMIA; SEQUENCE	A repetitive mammalian genetic element, HSAG-1, has been shown to promote the amplification of the vector, pSV2-DHFR, containing the functional cDNA for dihydrofolate reductase (DHFR). LR-73 cells, a line of Chinese hamster ovary cells, were transfected with this recombinant construct or with the parent vector, then subjected to culture in selective medium containing steadily increasing concentrations of methotrexate, a drug which specifically inhibits DHFR. Cultures transfected with the HSAG-1-containing construct acquired drug resistance faster than those transfected with the parent vector. This acceleration of acquisition of drug resistance was due to an increased probability of the generation and subsequent selection of cellular variants with increased copy numbers of the vector. The effect has also been observed in CHO(DHFR-) and HeLa cell lines. Possible mechanisms for the effect of the HSAG-1 element on gene amplification are discussed.	MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,QUEBEC,CANADA; MCGILL UNIV,CTR CANC,MONTREAL H3G 1Y6,QUEBEC,CANADA	McGill University; McGill University								ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; BEITEL LK, 1986, NUCLEIC ACIDS RES, V14, P3391, DOI 10.1093/nar/14.8.3391; BEITEL LK, 1991, IN PRESS GENE AMST; CARTIER M, 1987, MOL CELL BIOL, V7, P1623, DOI 10.1128/MCB.7.5.1623; CHAMBERLAIN JW, 1986, NUCLEIC ACIDS RES, V14, P3409, DOI 10.1093/nar/14.8.3409; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DELIDAKIS C, 1989, EMBO J, V8, P891, DOI 10.1002/j.1460-2075.1989.tb03450.x; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GIULOTTO E, 1987, CELL, V48, P837, DOI 10.1016/0092-8674(87)90080-8; GRAHAM FL, 1980, INTRO MACROMOLECULES, P3; HYRIEN O, 1987, EMBO J, V6, P2401, DOI 10.1002/j.1460-2075.1987.tb02518.x; HYRIEN O, 1988, EMBO J, V7, P407, DOI 10.1002/j.1460-2075.1988.tb02828.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEGOUY E, 1989, SOMAT CELL MOLEC GEN, V15, P309, DOI 10.1007/BF01534970; Maniatis T., 1982, MOL CLONING; MCARTHUR JG, 1991, IN PRESS NUCLEIC ACI; MILBRANDT JD, 1983, MOL CELL BIOL, V3, P1266, DOI 10.1128/MCB.3.7.1266; ORRWEAVER TL, 1989, EMBO J, V8, P4153, DOI 10.1002/j.1460-2075.1989.tb08600.x; OTTO E, 1989, J BIOL CHEM, V264, P3390; PASSANANTI C, 1987, EMBO J, V6, P1697, DOI 10.1002/j.1460-2075.1987.tb02420.x; POLLARD JW, 1979, J CELL PHYSIOL, V98, P571, DOI 10.1002/jcp.1040980315; PONTE P, 1984, NUCLEIC ACIDS RES, V12, P1687, DOI 10.1093/nar/12.3.1687; RAO BS, 1990, GENE, V87, P233; RICE GC, 1987, P NATL ACAD SCI USA, V84, P9261, DOI 10.1073/pnas.84.24.9261; ROLFE M, 1988, CANCER CELL, V6, P325; RUIZ JC, 1988, MOL CELL BIOL, V8, P4302, DOI 10.1128/MCB.8.10.4302; SAGER R, 1985, P NATL ACAD SCI USA, V82, P7015, DOI 10.1073/pnas.82.20.7015; SCHIMKE RT, 1986, P NATL ACAD SCI USA, V83, P2157, DOI 10.1073/pnas.83.7.2157; SCHIMKE RT, 1988, J BIOL CHEM, V263, P5989; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SPRADLING AC, 1987, EMBO J, V6, P1045, DOI 10.1002/j.1460-2075.1987.tb04857.x; STANNERS CP, 1981, CELL, V27, P211, DOI 10.1016/0092-8674(81)90375-5; STANNERS CP, 1971, NATURE-NEW BIOL, V230, P52, DOI 10.1038/newbio230052a0; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; SUBRAMANI S, 1981, MOL CELL BIOL, V1, P854, DOI 10.1128/MCB.1.9.854; SWIMMER C, 1989, P NATL ACAD SCI USA, V86, P8823, DOI 10.1073/pnas.86.22.8823; TLSTY TD, 1989, P NATL ACAD SCI USA, V86, P9441, DOI 10.1073/pnas.86.23.9441; TRASK BJ, 1989, GENE DEV, V3, P1913, DOI 10.1101/gad.3.12a.1913; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; WAHL GM, 1989, CANCER RES, V49, P1333; WAHL GM, 1984, NATURE, V307, P516, DOI 10.1038/307516a0; WAYE MMY, 1979, SOMAT CELL GENET, V5, P625, DOI 10.1007/BF01542699; WEGNER M, 1989, NUCLEIC ACIDS RES, V17, P9909, DOI 10.1093/nar/17.23.9909; WEGNER M, 1989, NUCLEIC ACIDS RES, V17, P8783, DOI 10.1093/nar/17.21.8783	46	13	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					6000	6005						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706344				2022-12-27	WOS:A1991FD37000098
J	TANNICH, E; SCHOLZE, H; NICKEL, R; HORSTMANN, RD				TANNICH, E; SCHOLZE, H; NICKEL, R; HORSTMANN, RD			HOMOLOGOUS CYSTEINE PROTEINASES OF PATHOGENIC AND NONPATHOGENIC ENTAMOEBA-HISTOLYTICA - DIFFERENCES IN STRUCTURE AND EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURIFICATION; CDNA; DIFFERENTIATION; ELECTROPHORESIS; CULTIVATION; SEQUENCES; CLONING; PROBES; GENES; ACID	A cDNA clone derived from the gene encoding a cysteine proteinase of pathogenic Entamoeba histolytica was isolated using an antiserum to the purified enzyme. This clone was used to identify the homologous clone in a cDNA library from nonpathogenic E. histolytica. Sequence analysis and comparison of the predicted amino acid sequences revealed a sequence divergence of 16%. Southern blot analyses indicated that (i) pathogenic isolates may contain more genes coding for these or related enzymes than nonpathogenic isolates, (ii) the structure and organization of these genes are conserved within each group of amoebae, and (iii) none of the genes is found in both pathogenic and nonpathogenic E. histolytica, underlining the notion that the two groups are genetically distinct. Northern blot analyses suggested that the cysteine proteinase is expressed by pathogenic isolates in substantially higher amounts than by nonpathogenic isolates. Overexpression of this enzyme may be an important factor in the pathogenicity of E. histolytica.	UNIV OSNABRUCK,W-4500 OSNABRUCK,GERMANY	University Osnabruck	TANNICH, E (corresponding author), BERNARD NOCHT INST TROP MED,BERNARD NOCHT STR 74,W-2000 HAMBURG 36,GERMANY.							CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN LW, 1986, GENE, V48, P219, DOI 10.1016/0378-1119(86)90080-6; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DIAMOND LS, 1982, J PARASITOL, V68, P958, DOI 10.2307/3281016; EAKIN AE, 1990, MOL BIOCHEM PARASIT, V39, P1, DOI 10.1016/0166-6851(90)90002-4; EDMAN U, 1990, J EXP MED, V172, P879, DOI 10.1084/jem.172.3.879; EDMAN U, 1987, P NATL ACAD SCI USA, V84, P3024, DOI 10.1073/pnas.84.9.3024; GADASI H, 1983, INFECT IMMUN, V39, P528, DOI 10.1128/IAI.39.2.528-531.1983; GARFINKEL LI, 1989, INFECT IMMUN, V57, P926, DOI 10.1128/IAI.57.3.926-931.1989; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HUBER M, 1988, MOL BIOCHEM PARASIT, V31, P27, DOI 10.1016/0166-6851(88)90142-9; KEENE WE, 1986, J EXP MED, V163, P536, DOI 10.1084/jem.163.3.536; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; LOEW G, 1979, TETRAHEDRON, V32, P291; LUACES AL, 1988, BIOCHEM J, V250, P903, DOI 10.1042/bj2500903; LUSHBAUGH WB, 1985, EXP PARASITOL, V59, P328, DOI 10.1016/0014-4894(85)90088-8; LYNCH EC, 1982, EMBO J, V1, P801, DOI 10.1002/j.1460-2075.1982.tb01250.x; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MUNOZ MD, 1982, J EXP MED, V155, P42, DOI 10.1084/jem.155.1.42; PEARS CJ, 1985, NUCLEIC ACIDS RES, V13, P8853, DOI 10.1093/nar/13.24.8853; REED SL, 1989, J CLIN MICROBIOL, V27, P2772, DOI 10.1128/JCM.27.12.2772-2777.1989; ROSENBERG I, 1989, MOL BIOCHEM PARASIT, V33, P237, DOI 10.1016/0166-6851(89)90085-6; ROTHMAN JH, 1986, P NATL ACAD SCI USA, V83, P3248, DOI 10.1073/pnas.83.10.3248; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARGEAUNT PG, 1978, T ROY SOC TROP MED H, V72, P164, DOI 10.1016/0035-9203(78)90053-6; SARGEAUNT PG, 1978, T ROY SOC TROP MED H, V72, P519, DOI 10.1016/0035-9203(78)90174-8; SCHOLZE H, 1988, BIOMED BIOCHIM ACTA, V47, P115; SCHULTE W, 1989, J PROTOZOOL, V36, P538, DOI 10.1111/j.1550-7408.1989.tb01092.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRACHAN WD, 1988, LANCET, V1, P561; TANNICH E, 1989, P NATL ACAD SCI USA, V86, P5118, DOI 10.1073/pnas.86.13.5118; WADA K, 1987, EUR J BIOCHEM, V167, P13, DOI 10.1111/j.1432-1033.1987.tb13298.x; WALSH JA, 1986, REV INFECT DIS, V8, P228; YOUNG JDF, 1982, J EXP MED, V156, P1677, DOI 10.1084/jem.156.6.1677; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; [No title captured]	37	90	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4798	4803						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1705935				2022-12-27	WOS:A1991FC21700022
J	CHANG, CC; WU, JM				CHANG, CC; WU, JM			MODULATION OF ANTIVIRAL ACTIVITY OF INTERFERON AND 2',5'-OLIGOADENYLATE SYNTHETASE GENE-EXPRESSION BY MILD HYPERTHERMIA (39.5-DEGREES-C) IN CULTURED HUMAN-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; MESSENGER-RNA; HELA-CELLS; HEAT-SHOCK; RIBONUCLEIC-ACID; 2-5A SYNTHETASE; CYTO-TOXICITY; SEQUENCE; PROTEIN; FORMS	The antiviral/antiproliferative/antitumor properties of interferon (IFN) are potentiated by a febrile temperature (Heron, I., and Berg, K. (1978) Nature 274, 508-510; Fleischmann, W. R., Fleischmann, C. M., Jr., and Gindhart, T. D. (1986) Cancer Res. 46, 1722-1726; Groveman, D. S., Borden, E. C., Merritt, J. A., Robins, H. I., Steeves, R., and Bryan, G. T. (1984) Cancer Res. 44, 5517-5521). To investigate the role of 2',5'-oligoadenylate (2-5A) synthetase in linking temperature with these biological functions of IFN, antiviral activities and expression of the 2-5A synthetase gene were measured simultaneously in control and type I IFN-treated HL-60 and WISH cells at the selected elevated temperature of 39.5-degrees-C +/- 0.5-degrees-C (herein referred to as hyperthermia). In both cell lines, the IFN-mediated antiviral effect was enhanced 3-10-fold. Concurrently, enzymatic assays and immunoblot analyses with an anti-40-kDa synthetase antibody clearly gave a 2-3-fold increase of synthetase above that observed at the normal cell culture temperature (37-degrees-C). These results suggest that potentiation of 2-5A synthetase must partially account for the enhanced antiviral activity of IFN at the higher cell culture temperature. The supranormal elevation of 2-5A synthetase was accompanied by a parallel increase in the steady-state concentration of 2-5A synthetase mRNA, which is likely to contribute to the observed increase in enzyme level. Transient reporter gene expression studies using plasmid constructs carrying 2-5A synthetase gene promoter linked in tandem with chloramphenicol acetyltransferase showed that IFN-inducible chloramphenicol acetyltransferase activity was not influenced by hyperthermia, suggesting that transcription activation is an unlikely explanation for the observed 2-5A synthetase mRNA level increases. Messenger RNA stability assays showed that the half-life (t1/2) of 2-5A synthetase mRNA was extended from 2 to 4 h at 39.5-degrees-C. Under identical conditions, the t1/2 of poly(A)+ RNA remained unchanged whereas the t1/2 of beta-actin mRNA was reduced. Taken together, these results are consistent with the interpretation that selective stabilization of 2-5A synthetase mRNA at the elevated temperature is a major factor contributing to the potentiation of antiviral activity of IFN by hyperthermia.	NEW YORK MED COLL, DEPT BIOCHEM & MOLEC BIOL, VALHALLA, NY 10595 USA	New York Medical College								ANDREWS GK, 1987, MOL CELL BIOL, V7, P3452, DOI 10.1128/MCB.7.10.3452; BENECH P, 1985, EMBO J, V4, P2249, DOI 10.1002/j.1460-2075.1985.tb03922.x; BILLIAU A, 1979, ANTIMICROB AGENTS CH, V16, P56, DOI 10.1128/AAC.16.1.56; BORELLI TJ, 1983, BIOCHIM BIOPHYS ACTA, V760, P309, DOI 10.1016/0304-4165(83)90178-2; CHAN YL, 1984, J BIOL CHEM, V259, P224; CHEBATH J, 1987, J BIOL CHEM, V262, P3852; CHEBATH J, 1987, NATURE, V330, P587, DOI 10.1038/330587a0; De Maeyer E, 1988, INTERFERONS OTHER RE, P134; DEBENEDETTI A, 1986, J BIOL CHEM, V261, P338; DEFILIPPI P, 1986, FEBS LETT, V198, P326, DOI 10.1016/0014-5793(86)80430-6; DOUGHERTY JP, 1980, J BIOL CHEM, V255, P3813; DUBOIS MF, 1989, J BIOL CHEM, V264, P12165; ERNEST MJ, 1982, BIOCHEMISTRY-US, V21, P6761, DOI 10.1021/bi00269a022; FLEISCHMANN WR, 1986, CANCER RES, V46, P1722; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Gribaudo G, 1987, J Biol Regul Homeost Agents, V1, P143; GROVEMAN DS, 1984, CANCER RES, V44, P5517; GUBITS RM, 1988, ONCOGENE, V3, P163; HAMBURGER AW, 1985, CANCER RES, V45, P5369; HERON I, 1978, NATURE, V274, P508, DOI 10.1038/274508a0; HOVANESSIAN AG, 1979, P NATL ACAD SCI USA, V76, P3261, DOI 10.1073/pnas.76.7.3261; HOVANESSIAN AG, 1987, EMBO J, V6, P1273, DOI 10.1002/j.1460-2075.1987.tb02364.x; KLOSTERGAARD J, 1989, J BIOL RESP MODIF, V8, P262; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; Maniatis T., 1982, MOL CLONING; MELEFORS O, 1988, CELL, V52, P893, DOI 10.1016/0092-8674(88)90431-X; MERIGAN TC, 1978, NEW ENGL J MED, V299, P1449, DOI 10.1056/NEJM197812282992608; MERLIN G, 1983, P NATL ACAD SCI-BIOL, V80, P4904, DOI 10.1073/pnas.80.16.4904; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; RAJ NBK, 1981, P NATL ACAD SCI-BIOL, V78, P7426, DOI 10.1073/pnas.78.12.7426; RODGERS JR, 1985, METHOD ENZYMOL, V109, P572; RUGGIERO V, 1989, ANTIVIR RES, V11, P77, DOI 10.1016/0166-3542(89)90010-7; RUTHERFORD MN, 1988, EMBO J, V7, P751, DOI 10.1002/j.1460-2075.1988.tb02872.x; SADIS S, 1988, J CELL PHYSIOL, V135, P377, DOI 10.1002/jcp.1041350304; Sambrook J, 1989, MOL CLONING LABORATO; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHMEISSNER U, 1984, J MOL BIOL, V176, P39, DOI 10.1016/0022-2836(84)90381-4; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WALTLING D, 1985, EMBO J, V4, P431; WILLIAMS BRG, 1978, NATURE, V276, P88, DOI 10.1038/276088a0; WRESCHNER DH, 1988, EUR J BIOCHEM, V172, P333, DOI 10.1111/j.1432-1033.1988.tb13891.x; WU JM, 1987, FED PROC, V46, P1544	43	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4605	4612						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705557				2022-12-27	WOS:A1991FA69400090
J	KITANI, S; BERENSTEIN, E; MERGENHAGEN, S; TEMPST, P; SIRAGANIAN, RP				KITANI, S; BERENSTEIN, E; MERGENHAGEN, S; TEMPST, P; SIRAGANIAN, RP			A CELL-SURFACE GLYCOPROTEIN OF RAT BASOPHILIC LEUKEMIA-CELLS CLOSE TO THE HIGH-AFFINITY IGE RECEPTOR (FC-EPSILON-RI) - SIMILARITY TO HUMAN-MELANOMA DIFFERENTIATION ANTIGEN ME491	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTAMINE-RELEASE; MONOCLONAL-ANTIBODY; IMMUNOGLOBULIN-E; MAST-CELLS; TRANSFECTED CELLS; BINDING; VARIANTS; EXPRESSION; INHIBITION; HYBRIDOMAS	A monoclonal antibody (mAb), AD1, was isolated that recognized a cell surface protein on rat basophilic leukemia cells (RBL-2H3). At high concentration, this antibody inhibited IgE-mediated but not calcium ion-ophore-induced histamine release (49% inhibition at 100-mu-g/ml). The mAb AD1 did not inhibit the binding of IgE or of several antibodies directed to the high affinity IgE receptor (Fc-epsilon-RI). Likewise, IgE did not inhibit mAb AD1 binding. However, several anti-Fc-epsilon-RI antibodies did inhibit mAb AD1 binding as intact molecules but not as Fab fragments. Therefore, the sites on the cell surface to which mAb AD1 binds are close to Fc-epsilon-RI. The mAB AD1 immunoprecipitated a broad, 50-60-kDa band from I-125-surface-labeled RBL-2H3 cells that upon peptide N-glycosidase F treatment was transformed into a sharp 27-kDa band. A similar 27-kDa protein was immunoprecipitated from surface-radiolabeled cells after culture with tunicamycin. Thus, the protein recognized by mAb AD1 is highly glycosylated with predominatly N-linked oligosaccharides. The N-terminal sequence of 43 amino acids was found to be different from any subunit of Fc-epsilon-RI but nearly identical to that of the human melanoma-associated antigen ME491. Therefore, mAb AD1 binds to a surface glycoprotein on RBL-2H3 cells sterically close to the Fc-epsilon-RI but distinct from the recognized subunits of the receptor.	HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115	Harvard University; Harvard Medical School	KITANI, S (corresponding author), NIDR,IMMUNOL LAB,CLIN IMMUNOL SECT,BETHESDA,MD 20892, USA.		Wan, Daniel/F-4689-2010					ATKINSON B, 1985, HYBRIDOMA, V4, P243, DOI 10.1089/hyb.1985.4.243; BANIYASH M, 1987, J IMMUNOL, V138, P2999; BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENERBACK L, 1980, J IMMUNOL METHODS, V39, P135, DOI 10.1016/0022-1759(80)90302-6; GUO N, 1989, J BIOL CHEM, V264, P13267; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HOTTA H, 1988, CANCER RES, V48, P2955; ISHIZAKA T, 1984, PROG ALLERGY, V34, P188; KINET JP, 1989, CELL, V57, P351, DOI 10.1016/0092-8674(89)90910-0; KITANI S, 1988, J IMMUNOL, V140, P2585; LAMOYI E, 1983, J IMMUNOL METHODS, V56, P235, DOI 10.1016/0022-1759(83)90415-5; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; MORITA Y, 1981, J IMMUNOL, V127, P1339; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; SEGAL DM, 1981, J IMMUNOL, V126, P138; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; SIKORA LKJ, 1987, INT J CANCER, V39, P138, DOI 10.1002/ijc.2910390203; SIRAGANIAN RP, 1983, METHOD ENZYMOL, V92, P17; SIRAGANIAN RP, 1982, FED PROC, V41, P30; SIRAGANIAN RP, 1974, ANAL BIOCHEM, V57, P383, DOI 10.1016/0003-2697(74)90093-1; SIRAGANIAN RP, 1988, INFLAMMATION BASIC P, P513; SOTO EO, 1988, J IMMUNOL, V141, P4324; STRACKE ML, 1987, MOL IMMUNOL, V24, P347, DOI 10.1016/0161-5890(87)90176-3; STRACKE ML, 1987, IMMUNOL LETT, V14, P287, DOI 10.1016/0165-2478(87)90006-X; TEMPST P, 1989, ANAL BIOCHEM, V183, P290, DOI 10.1016/0003-2697(89)90482-X; VENNEGOOR C, 1985, INT J CANCER, V35, P287, DOI 10.1002/ijc.2910350302; WOLDEMUSSIE E, 1987, J IMMUNOL, V139, P2431	32	77	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1903	1909						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703158				2022-12-27	WOS:A1991EU49700081
J	MCGRANE, MM; YUN, JS; MOORMAN, AFM; LAMERS, WH; HENDRICK, GK; ARAFAH, BM; PARK, EA; WAGNER, TE; HANSON, RW				MCGRANE, MM; YUN, JS; MOORMAN, AFM; LAMERS, WH; HENDRICK, GK; ARAFAH, BM; PARK, EA; WAGNER, TE; HANSON, RW			METABOLIC EFFECTS OF DEVELOPMENTAL, TISSUE-SPECIFIC, AND CELL-SPECIFIC EXPRESSION OF A CHIMERIC PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) BOVINE GROWTH-HORMONE GENE IN TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER-REGULATORY REGION; MESSENGER-RNA; RAT-LIVER; GLUTAMINE-SYNTHETASE; PYRUVATE-KINASE; ADIPOSE-CELLS; FACTOR-I; INSULIN; TRANSCRIPTION; ELEMENTS	Transgenic mice were used to investigate sequences within the promoter of the gene for the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) from in rat (EC 4.1.1.32) (PEPCK) which are involved in tissue-specific and developmental regulation of gene expression. Segments of the PEPCK promoter between -2000 and -109 were linked to the structural gene for bovine growth hormone (bGH) and introduced into the germ line of mice by microinjection. Bovine growth hormone mRNA was found in tissues that express the endogenous PEPCK gene, mainly in the liver but to a lesser extent in the kidney, adipose tissue, small intestine, and mammary gland. In the liver the chimeric PEPCK/bGH(460) gene was expressed in periportal cells, which is consistent with the zonation of endogenous PEPCK. The PEPCK/bGH gene was not transcribed in the livers of fetal mice until immediately before birth; at birth the concentration of bGH mRNA increased 200-fold. Our results indicate that the region of the PEPCK promoter from -460 to +73 base pairs contains regulatory sequences required for tissue-specific and developmental regulation of PEPCK gene expression. Mice transgenic for PEPCK/bGH(460) were not hyperglycemic or hyperinsulinemic in response to elevated bGH, as were transgenic mice with the MT/bGH gene. The number of insulin receptors in skeletal muscle was no different in mice transgenic for MT/bGH when compared with mice transgenic for PEPCK/bGH(460) and control animals. However, mRNA abundance for the insulin-sensitive glucose transporter in skeletal muscle was decreased in mice transgenic for the MT/bGH gene. The differences in glucose homeostasis noted with the two types of transgenic mice may be the result of the relative site of expression, the different developmental pattern, or hormonal regulation of expression of the bGH gene.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT BIOCHEM,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT MED,CLEVELAND,OH 44106; OHIO UNIV,EDISON ANIM BIOTECHNOL CTR,ATHENS,OH 45107; UNIV AMSTERDAM,ANAT & EMBRYOL LAB,AMSTERDAM,NETHERLANDS; JOSLIN DIABET CTR,BOSTON,MA 02215	Case Western Reserve University; Case Western Reserve University; Ohio University; University of Amsterdam; Harvard University; Joslin Diabetes Center, Inc.	MCGRANE, MM (corresponding author), CASE WESTERN RESERVE UNIV,SCH MED,PEW CTR MOLEC NUTR,CLEVELAND,OH 44106, USA.		Lamers, Wouter H./D-2965-2012					ANDERSON JW, 1970, BIOCHIM BIOPHYS ACTA, V208, P165, DOI 10.1016/0304-4165(70)90066-8; BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; BALLARD FJ, 1967, J BIOL CHEM, V242, P2746; BALLARD FJ, 1963, BIOCHIM BIOPHYS ACTA, V71, P578, DOI 10.1016/0006-3002(63)91130-2; BARTKE A, 1988, J EXP ZOOL, V248, P121, DOI 10.1002/jez.1402480116; BAUMBACH WR, 1989, GENE DEV, V3, P1199, DOI 10.1101/gad.3.8.1199; BAXTER RC, 1982, ENDOCRINOLOGY, V111, P1020, DOI 10.1210/endo-111-3-1020; BECK P, 1965, J LAB CLIN MED, V66, P366; CAMERON CM, 1987, ENDOCRINOLOGY, V120, P1568, DOI 10.1210/endo-120-4-1568; CARLSON JA, 1988, J CLIN INVEST, V82, P26, DOI 10.1172/JCI113580; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CILIBERTO G, 1987, EMBO J, V6, P4017, DOI 10.1002/j.1460-2075.1987.tb02745.x; CIMBALA MA, 1982, J BIOL CHEM, V257, P7629; DAVIS LG, 1986, BASIC METHODS MOL BI, P143; DEGROOT CJ, 1987, BIOCHIM BIOPHYS ACTA, V908, P231, DOI 10.1016/0167-4781(87)90103-5; DENTE L, 1988, GENE DEV, V2, P259, DOI 10.1101/gad.2.2.259; DIMARCO PN, 1978, EUR J BIOCHEM, V87, P243; DOI T, 1988, AM J PATHOL, V131, P398; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; GARCIARUIZ JP, 1983, ENZYME, V30, P265; GARCIARUIZ JP, 1978, P NATL ACAD SCI USA, V75, P4189; GIEBELHAUS DH, 1985, DEV BIOL, V107, P407, DOI 10.1016/0012-1606(85)90322-7; GRANNER D, 1983, NATURE, V305, P549, DOI 10.1038/305549a0; GUDER WG, 1976, H-S Z PHYSIOL CHEM, V357, P1793, DOI 10.1515/bchm2.1976.357.2.1793; HANSEN I, 1986, AM J PHYSIOL, V250, pE269, DOI 10.1152/ajpendo.1986.250.3.E269; HANSON RW, 1972, AM J CLIN NUTR, V25, P1010; HATZOGLOU M, 1988, J BIOL CHEM, V263, P17798; HENNING HV, 1966, BIOCHEM Z, V344, P274; HERBOMEL P, 1989, MOL CELL BIOL, V9, P4750, DOI 10.1128/MCB.9.11.4750; JUNGERMANN K, 1978, TRENDS BIOCHEM SCI, V3, P198, DOI 10.1016/S0968-0004(78)91764-4; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; KAHN BB, 1989, J CLIN INVEST, V84, P404, DOI 10.1172/JCI114180; KAHN BB, 1989, J CLIN INVEST, V83, P199, DOI 10.1172/JCI113859; KELSEY GD, 1987, GENE DEV, V1, P161, DOI 10.1101/gad.1.2.161; KRUMLAUF R, 1985, MOL CELL BIOL, V5, P1639, DOI 10.1128/MCB.5.7.1639; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LAW MF, 1983, MOL CELL BIOL, V3, P2110, DOI 10.1128/MCB.3.11.2110; LIM IK, 1990, CANCER RES, V50, P1701; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGRANE MM, 1988, J BIOL CHEM, V263, P11443; MCKNIGHT GS, 1983, CELL, V34, P335; MESSING A, 1985, NATURE, V316, P461, DOI 10.1038/316461a0; MOORMAN AFM, 1988, J HISTOCHEM CYTOCHEM, V36, P751, DOI 10.1177/36.7.2898495; NORSTEDT G, 1984, CELL, V36, P805, DOI 10.1016/0092-8674(84)90030-8; PARK EA, 1990, IN PRESS MOL CELL BI; PETERSEN DD, 1988, MOL CELL BIOL, V8, P96, DOI 10.1128/MCB.8.1.96; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; QUAIFE CJ, 1989, ENDOCRINOLOGY, V124, P40, DOI 10.1210/endo-124-1-40; ROESLER WJ, 1989, J BIOL CHEM, V264, P9657; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SNELL K, 1979, BIOCHEM J, V103, P391; SWEENE I, 1987, DIABETES, V36, P288; SWIFT GH, 1989, GENE DEV, V3, P687, DOI 10.1101/gad.3.5.687; TREMP GL, 1989, J BIOL CHEM, V264, P19904; UTTER MF, 1954, J BIOL CHEM, V207, P787; VANDEZANDE L, 1988, NUCLEIC ACIDS RES, V16, P7726, DOI 10.1093/nar/16.15.7726; VANDEZANDE LPG, 1990, IN PRESS GENE AMST; WAGNER TE, 1981, P NATL ACAD SCI-BIOL, V78, P6376, DOI 10.1073/pnas.78.10.6376; WALS PA, 1988, J BIOL CHEM, V263, P4876; WEIGHART M, 1990, J REPROD FERTIL S, V41, P89; WELSH M, 1986, J BIOL CHEM, V261, P2915; WISE JK, 1973, J CLIN INVEST, V52, P2774, DOI 10.1172/JCI107473; WOYCHIK RP, 1982, NUCLEIC ACIDS RES, V10, P7197, DOI 10.1093/nar/10.22.7197; WYNSHAWBORIS A, 1986, J BIOL CHEM, V261, P9714; YOOWARREN H, 1983, P NATL ACAD SCI-BIOL, V80, P3656, DOI 10.1073/pnas.80.12.3656	67	145	145	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1990	265	36					22371	22379						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP556	1702419				2022-12-27	WOS:A1990EP55600051
J	SATO, R; KOMINE, Y; IMANAKA, T; TAKANO, T				SATO, R; KOMINE, Y; IMANAKA, T; TAKANO, T			MONOCLONAL-ANTIBODY EMR1A/212D RECOGNIZING SITE OF DEPOSITION OF EXTRACELLULAR LIPID IN ATHEROSCLEROSIS - ISOLATION AND CHARACTERIZATION OF A CDNA CLONE FOR THE ANTIGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											SATO, R (corresponding author), TEIKYO UNIV,FAC PHARMACEUT SCI,DEPT MICROBIOL & MOLEC PATHOL,SAGAMIKO,KANAGAWA 19901,JAPAN.			Imanaka, Tsuneo/0000-0003-4677-1356				BARNES DW, 1985, J CELL PHYSIOL, V125, P207, DOI 10.1002/jcp.1041250206; BHAAKDI S, 1982, J CELL BIOL, V94, P755; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; FOWLER S, 1979, LAB INVEST, V41, P372; FRYKLUND L, 1978, FEBS LETT, V87, P55, DOI 10.1016/0014-5793(78)80132-X; GEBB C, 1986, J BIOL CHEM, V261, P6698; GUETTIER C, 1989, VIRCHOWS ARCH A, V414, P309, DOI 10.1007/BF00734084; ILL CR, 1985, J BIOL CHEM, V260, P5610; JENNE D, 1985, EMBO J, V4, P3135; KIMURA J, 1986, VIRCHOWS ARCH A, V410, P159; KITAGAKIOGAWA H, 1990, BIOCHIM BIOPHYS ACTA, V1033, P49, DOI 10.1016/0304-4165(90)90193-Z; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; MIMURO J, 1989, J BIOL CHEM, V264, P936; MIMURO J, 1989, J BIOL CHEM, V264, P5058; MOTOJIMA K, 1989, BIOCHIM BIOPHYS ACTA, V1008, P116, DOI 10.1016/0167-4781(89)90178-4; NAKAGAMI K, 1989, AM J PATHOL, V135, P93; NICULESCU F, 1987, ATHEROSCLEROSIS, V65, P1, DOI 10.1016/0021-9150(87)90002-5; NICULESCU F, 1989, ATHEROSCLEROSIS, V78, P197, DOI 10.1016/0021-9150(89)90223-2; PREISSNER KT, 1989, BLOOD, V74, P1989; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO R, 1990, J BIOL CHEM, V265, P11880; SEIFERT PS, 1989, LAB INVEST, V60, P747; SMITH EB, 1976, ATHEROSCLEROSIS, V25, P71, DOI 10.1016/0021-9150(76)90049-6; SUZUKI S, 1987, J BIOL CHEM, V262, P14080; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; TAKANO T, 1986, ACTA HISTOCHEM CYTOC, V19, P135, DOI 10.1267/ahc.19.135; VLAICU R, 1985, ATHEROSCLEROSIS, V57, P163, DOI 10.1016/0021-9150(85)90030-9; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281; YUEN SW, 1988, USER B PROTEIN SEQUE	33	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21232	21236						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701177				2022-12-27	WOS:A1990EL02000079
J	ZHAO, H; LOESSBERG, PA; SACHS, G; MUALLEM, S				ZHAO, H; LOESSBERG, PA; SACHS, G; MUALLEM, S			REGULATION OF INTRACELLULAR CA-2+ OSCILLATION IN AR42J CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS,SW MED CTR,DEPT PHYSIOL,5323 HARRY HINES BLVD,DALLAS,TX 75235; VET ADM MED CTR BRENTWOOD,DEPT PHYSIOL,LOS ANGELES,CA 90073	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas					NIAMS NIH HHS [AR 39245] Funding Source: Medline; NIDDK NIH HHS [DK 38938] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038938] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BERRIDGE MJ, 1988, FASEB J, V2, P3074, DOI 10.1096/fasebj.2.15.2847949; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; CASE RM, 1989, CURR OPIN GASTROEN, V5, P665, DOI 10.1097/00001574-198910000-00012; CHANGYA L, 1989, FEBS LETT, V251, P43, DOI 10.1016/0014-5793(89)81425-5; DANOFF SK, 1988, BIOCHEM J, V254, P701, DOI 10.1042/bj2540701; EXTON JH, 1988, FASEB J, V2, P2670, DOI 10.1096/fasebj.2.11.2456243; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOOTMAN SR, 1987, PHYSL GASTROINTESTIN, P1129; HORSTMAN DA, 1988, J BIOL CHEM, V263, P15297; HUGHES AR, 1988, J BIOL CHEM, V263, P10314; JOSEPH SK, 1989, BIOCHEM J, V258, P261, DOI 10.1042/bj2580261; KAWAMOTO S, 1984, BIOCHEM BIOPH RES CO, V125, P258, DOI 10.1016/S0006-291X(84)80362-9; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; MATOZAKI T, 1989, AM J PHYSIOL, V257, pG594, DOI 10.1152/ajpgi.1989.257.4.G594; MATOZAKI T, 1990, J BIOL CHEM, V265, P6247; MERRITT JE, 1987, J BIOL CHEM, V262, P17362; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MUALLEM S, 1989, AM J PHYSIOL, V257, pG917, DOI 10.1152/ajpgi.1989.257.6.G917; MUALLEM S, 1988, AM J PHYSIOL, V255, pG229, DOI 10.1152/ajpgi.1988.255.2.G229; MUALLEM S, 1990, J BIOL CHEM, V265, P2011; MUALLEM S, 1989, ANNU REV PHYSIOL, V51, P83; MUALLEM S, 1988, AM J PHYSIOL, V255, pG221, DOI 10.1152/ajpgi.1988.255.2.G221; PANDOL SJ, 1987, J BIOL CHEM, V262, P16963; PANDOL SJ, 1986, J BIOL CHEM, V261, P4438; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; PETERSEN OH, 1986, AM J PHYSIOL, V251, pG1, DOI 10.1152/ajpgi.1986.251.1.G1; PRALONG WF, 1988, FEBS LETT, V242, P79, DOI 10.1016/0014-5793(88)80989-X; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; SALUJA AK, 1989, BIOCHEM BIOPH RES CO, V164, P8, DOI 10.1016/0006-291X(89)91675-6; SATO S, 1989, AM J PHYSIOL, V257, pG202, DOI 10.1152/ajpgi.1989.257.2.G202; STUENKEL EL, 1989, BIOCHEM BIOPH RES CO, V158, P863, DOI 10.1016/0006-291X(89)92802-7; SUNG CK, 1988, AM J PHYSIOL, V254, pG242, DOI 10.1152/ajpgi.1988.254.2.G242; SUPPATTAPONE S, 1988, P NATL ACAD SCI USA, V85, P8747; TSUNODA Y, 1990, AM J PHYSIOL, V258, pC147, DOI 10.1152/ajpcell.1990.258.1.C147; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; WILLIAMSON JR, 1989, ANNU REV PHYSIOL, V51, P107, DOI 10.1146/annurev.ph.51.030189.000543; WOODS NM, 1987, BIOCHEM J, V246, P619, DOI 10.1042/bj2460619; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8; WOODS NM, 1986, NATURE, V329, P719; YULE DI, 1988, FEBS LETT, V239, P358, DOI 10.1016/0014-5793(88)80951-7; ZHAO H, 1990, J BIOL CHEM, V265, P14822	43	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					20856	20862						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701171				2022-12-27	WOS:A1990EL02000023
J	BRENNAN, CA; PLATT, T				BRENNAN, CA; PLATT, T			MUTATIONS IN AN RNP1 CONSENSUS SEQUENCE OF RHO PROTEIN REDUCE RNA-BINDING AFFINITY BUT FACILITATE HELICASE TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINATION FACTOR-RHO; DEPENDENT TRANSCRIPTION TERMINATION; REPRESSOR-OPERATOR INTERACTION; CRO MESSENGER-RNA; ESCHERICHIA-COLI; NUCLEAR RIBONUCLEOPROTEIN; ATPASE ACTIVITY; 3' END; U1 RNA; DOMAIN	Escherichia coli rho protein facilitates transcription termination by a mechanism that involves rho binding to the nascent RNA, activation of rho's RNA-dependent ATPase activity, and release of the mRNA from the DNA template. The initial step, formation of a rho-RNA complex, is mediated primarily by an RNA binding domain included within the amino-terminal 151 amino acids of rho protein. We have now identified one specific portion of this region that is involved in RNA binding, by photocross-linking and by site-directed mutagenesis. UV irradiation of rho-RNA complexes results in covalent attachment of the RNA to a single peptide in rho that apparently spans amino acids 45-100. Within this peptide is a ribonucleoprotein (RNP1) consensus sequence, Gly-Phe-Gly-Phe, that is present in many RNA-binding proteins. Mutagenesis of the phenylalanine residues in this consensus to leucine or alanine results in mutant proteins that are defective for RNA binding and have altered ATPase and RNA-DNA helicase activities. The weakened affinity but inceased salt sensitivity of RNA binding by the mutant proteins suggests that they have lost more than just a set of nonionic interactions and are consistent with a change in the conformation of the RNA binding site. Whatever the changes, they appear localized primarily to the RNA binding domain because the mutants retain much of their RNA-dependent ATPase activity. We infer that the Phe residues themselves do not play a substantial role in the activation of ATP hydrolysis. Our results indicate that several different components of RNA interaction are required for rho activity and support a role for the RNP1 consensus region of rho in at least one specific aspect of RNA binding.	UNIV ROCHESTER,DEPT BIOCHEM,ROCHESTER,NY 14642	University of Rochester					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035658] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-35658] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; BEAR DG, 1985, P NATL ACAD SCI USA, V82, P1911, DOI 10.1073/pnas.82.7.1911; BRENNAN CA, 1990, J BIOL CHEM, V265, P5440; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; DOLAN JW, 1990, J BIOL CHEM, V265, P5747; DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18802; DOMBROSKI AJ, 1988, P NATL ACAD SCI USA, V85, P2538, DOI 10.1073/pnas.85.8.2538; DOMBROSKI AJ, 1990, J BACTERIOL, V172, P2477, DOI 10.1128/jb.172.5.2477-2484.1990; DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18810; FAUS I, 1989, BIOCHEMISTRY-US, V28, P3510, DOI 10.1021/bi00434a054; GALLOWAY JL, 1988, J BIOL CHEM, V263, P1761; GALLOWAY JL, 1986, REGULATION GENE EXPR, P155; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; HOWARD BH, 1976, J BIOL CHEM, V251, P2520; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LESSER DR, 1990, SCIENCE, V250, P776, DOI 10.1126/science.2237428; LOWERY C, 1977, J BIOL CHEM, V252, P1375; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; MERRILL BM, 1988, J BIOL CHEM, V263, P3307; MOSSING MC, 1985, J MOL BIOL, V186, P295, DOI 10.1016/0022-2836(85)90106-8; MOTT JE, 1985, P NATL ACAD SCI USA, V82, P88, DOI 10.1073/pnas.82.1.88; NAGAI K, 1990, NATURE, V348, P515, DOI 10.1038/348515a0; PINKHAM JL, 1983, NUCLEIC ACIDS RES, V11, P3531, DOI 10.1093/nar/11.11.3531; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; RECORD MT, 1977, BIOCHEMISTRY-US, V16, P4791, DOI 10.1021/bi00641a005; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; RICHARDSON JP, 1990, BIOCHIM BIOPHYS ACTA, V1048, P127, DOI 10.1016/0167-4781(90)90048-7; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; STEINMETZ EJ, 1990, J BIOL CHEM, V265, P18408; WITHERELL GW, 1989, BIOCHEMISTRY-US, V28, P71, DOI 10.1021/bi00427a011; WU AM, 1981, P NATL ACAD SCI-BIOL, V78, P2913, DOI 10.1073/pnas.78.5.2913	37	53	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17296	17305						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1716628				2022-12-27	WOS:A1991GF44500051
J	PARK, DH; PLAPP, BV				PARK, DH; PLAPP, BV			ISOENZYMES OF HORSE LIVER ALCOHOL-DEHYDROGENASE ACTIVE ON ETHANOL AND STEROIDS - CDNA CLONING, EXPRESSION, AND COMPARISON OF ACTIVE-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPUTER-GRAPHICS; KINETIC MECHANISM; ALPHA-SUBUNIT; RAT; SUBSTRATE; ISOZYMES; BINDING; CHAIN	Horse liver alcohol dehydrogenase occurs as isoenzymes: E is active on ethanol but not steroids; S is active on ethanol and steroids. The cDNAs for these isoenzymes were cloned; both were 1.8-kilobase long and contained complete coding sequences. Both enzymes were expressed in Escherichia coli, and the purified proteins had properties similar to those of the natural enzymes. The amino acid sequence deduced from the open reading frame of the E-type cDNA agreed with the amino acid sequence of the E isoenzyme determined by protein sequencing and x-ray crystallography. When compared with the E-type cDNA, the coding region of the S-type cDNA contains 24 substitutions and 3 deletions, giving rise to an amino acid sequence for the S isoenzyme that differs from that of the E isoenzyme at 10 positions: nine conservative substitutions and one deletion, of Asp-115. These changes can be accommodated in the three-dimensional structure of the E isoenzyme, and models of the E and S isoenzymes complexed with a 3-beta-hydroxy-5-beta-steroid were built. The modeling shows that Leu-116 apparently sterically hinders binding of steroids in the E isoenzyme, and deletion in the S isoenzyme of Asp-115 moves Leu-116 and relieves the hindrance. The human-gamma and rat liver enzymes are also active on steroids, but they have a different constellation of amino acid residues in the substrate pocket. Thus, there are multiple bases for the activity on steroids.			PARK, DH (corresponding author), UNIV IOWA, DEPT BIOCHEM, IOWA CITY, IA 52242 USA.		Plapp, Bryce V/F-6353-2010		NIAAA NIH HHS [AA06223] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA006223] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BLACKSHEAR PJ, 1984, METHOD ENZYMOL, V104, P237; Branden C.-I., 1975, ENZYMES, V11, P103; BRAUN T, 1987, FEBS LETT, V215, P233, DOI 10.1016/0014-5793(87)80152-7; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cleland W W, 1979, Methods Enzymol, V63, P103; CRABB DW, 1986, GENE, V48, P287, DOI 10.1016/0378-1119(86)90087-9; CRONHOLM T, 1975, ACTA CHEM SCAND B, V29, P571, DOI 10.3891/acta.chem.scand.29b-0571; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DWORSCHACK RT, 1977, BIOCHEMISTRY-US, V16, P111, DOI 10.1021/bi00620a018; EDENBERG HJ, 1985, P NATL ACAD SCI USA, V82, P2262, DOI 10.1073/pnas.82.8.2262; EKLUND H, 1990, EUR J BIOCHEM, V193, P303, DOI 10.1111/j.1432-1033.1990.tb19337.x; EKLUND H, 1987, EUR J BIOCHEM, V167, P185, DOI 10.1111/j.1432-1033.1987.tb13322.x; EKLUND H, 1976, J MOL BIOL, V102, P27, DOI 10.1016/0022-2836(76)90072-3; EKLUND H, 1982, J BIOL CHEM, V257, P4349; Eklund H., 1987, BIOL MACROMOL, V3, P73; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; HURLEY TD, 1990, J BIOL CHEM, V265, P16366; IKUTA T, 1986, P NATL ACAD SCI USA, V83, P634, DOI 10.1073/pnas.83.3.634; IKUTA T, 1985, P NATL ACAD SCI USA, V82, P2703, DOI 10.1073/pnas.82.9.2703; JONES TA, 1985, METHOD ENZYMOL, V115, P157; JORNVALL H, 1970, EUR J BIOCHEM, V16, P41, DOI 10.1111/j.1432-1033.1970.tb01050.x; JORNVALL H, 1970, EUR J BIOCHEM, V16, P25, DOI 10.1111/j.1432-1033.1970.tb01049.x; Maniatis T., 1982, MOL CLONING; MCEVILY AJ, 1988, BIOCHEMISTRY-US, V27, P4284, DOI 10.1021/bi00412a013; MEZEY E, 1983, ARCH BIOCHEM BIOPHYS, V225, P787, DOI 10.1016/0003-9861(83)90090-5; MEZEY E, 1982, HEPATOLOGY, V2, P359; OKUDA A, 1983, J BIOL CHEM, V258, P2899; PETTERSSON G, 1987, CRIT REV BIOCHEM MOL, V21, P349, DOI 10.3109/10409238609113616; PLAPP BV, 1970, J BIOL CHEM, V245, P1727; RYZEWSKI CN, 1980, BIOCHEMISTRY-US, V19, P4843, DOI 10.1021/bi00562a021; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STONE CL, 1989, J BIOL CHEM, V264, P11112; Sund H., 1963, ENZYMES, V7, P25; THEORELL H, 1963, BIOCHEM Z, V338, P537; VONBAHRLINDSTROM H, 1986, BIOCHEMISTRY-US, V25, P2465; WALLER G, 1965, ARCH BIOCHEM BIOPHYS, V111, P671, DOI 10.1016/0003-9861(65)90249-3	39	82	87	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13296	13302						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712777				2022-12-27	WOS:A1991FX13200078
J	MURPHY, PM; MCDERMOTT, D				MURPHY, PM; MCDERMOTT, D			FUNCTIONAL EXPRESSION OF THE HUMAN FORMYL PEPTIDE RECEPTOR IN XENOPUS OOCYTES REQUIRES A COMPLEMENTARY HUMAN FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; HUMAN INTERFERON-GAMMA; GTP-BINDING PROTEIN; MOLECULAR-CLONING; ALPHA-SUBUNIT; ALPHA-2-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTOR; CHEMOATTRACTANT RECEPTOR; SIGNAL-TRANSDUCTION	Human phagocytic cells express receptors for bacterial N-formyl peptides (formyl peptide receptor or FPR) which mediate chemotaxis, degranulation, and the respiratory burst. Although cDNA encoding a human phagocyte formyl peptide-binding protein has been reported recently (Boulay, F., Tardif, M., Brouchon, L., and Vignais, P. (1990) Biochem. Biophys. Res. Commun. 168, 1103-1109), functional coupling to signal transduction processes was not demonstrated. We describe corresponding full-length cDNA clones and prove that they encode the calcium-mobilizing human formyl peptide receptor by demonstrating functional reconstitution in the Xenopus oocyte. We further demonstrate that in contrast to all other cloned guanine nucleotide-binding regulatory protein (G-protein) coupled receptors expressed in this system, microinjection of FPR transcripts is not sufficient to confer ligand responsiveness to the oocyte: co-injection of phagocyte RNA encoding a complementary human factor that is not the alpha-subunit of the heterotrimeric G-proteins G(i1), G(i2), or G(i3) is also required. Whereas a 1.4-kilobase FPR transcript is expressed exclusively in differentiated phagocytic cells, the complementary factor activity localizes to a 3.5-kilobase RNA fraction and is expressed in both differentiated and undifferentiated myeloid cells as well as in liver. The deduced human FPR protein possesses seven hydrophobic putative membrane spanning segments, three sites for N-linked glycosylation, and a short 18-amino acid predicted third cytoplasmic loop. Surprisingly, the human FPR possesses only 28% amino acid identity with the rabbit FPR reported recently by Thomas and co-workers (Thomas, K. M., Pyun, H. Y., and Navarro, J. (1990) J. Biol. Chem. 265, 20061-20065). Moreover, the rabbit FPR does not require a complementary factor for calcium mobilization in the oocyte. Structural alignment reveals at most 20% amino acid identity of the human FPR with other G-protein coupled receptors, indicating a common ancestral gene. Functional reconstitution of the recombinant FPR will now permit precise delineation of its functional and regulatory domains. Moreover, discovery of a complementary factor for oocyte expression of the human FPR establishes a novel approach to the qualification by ligand screening of cDNA encoding other suspected G-protein coupled receptors.			MURPHY, PM (corresponding author), NIAID,CLIN INVEST LAB,BACTERIAL DIS SECT,BLDG 10,RM 11N110,BETHESDA,MD 20892, USA.		McDermott, David/AAP-2459-2021	McDermott, David/0000-0001-6978-0867				AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; ALLARD WJ, 1987, NUCLEIC ACIDS RES, V15, P10604, DOI 10.1093/nar/15.24.10604; BENOVIC JL, 1986, NATURE, V322, P869; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; BOULAY F, 1990, BIOCHEMISTRY-US, V29, P11123, DOI 10.1021/bi00502a016; BRAY P, 1987, P NATL ACAD SCI USA, V84, P5115, DOI 10.1073/pnas.84.15.5115; COCKCROFT S, 1984, BIOCHEM J, V221, P477, DOI 10.1042/bj2210477; COCKCROFT S, 1989, BIOCHEM J, V263, P715, DOI 10.1042/bj2630715; DAVIS LG, 1986, BASIC METHODS MOL BI, P139; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P389; DIDSBURY JR, 1987, FEBS LETT, V211, P160, DOI 10.1016/0014-5793(87)81428-X; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; GOLDSTEIN IM, 1988, INFLAMMATION BASIC P, P55; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; HLA T, 1990, J BIOL CHEM, V265, P9308; JONES DT, 1987, J BIOL CHEM, V262, P14241; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; JUNG V, 1987, P NATL ACAD SCI USA, V84, P4151, DOI 10.1073/pnas.84.12.4151; KING K, 1990, SCIENCE, V250, P121, DOI 10.1126/science.2171146; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; MALECH HL, 1985, J BIOL CHEM, V260, P2509; Maniatis T., 1982, MOL CLONING; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MURPHY PM, 1990, J BIOL CHEM, V265, P11615; MURPHY PM, 1990, FEBS LETT, V261, P353, DOI 10.1016/0014-5793(90)80590-F; MURPHY PM, 1990, J IMMUNOL, V145, P2227; MURPHY PM, 1987, FEBS LETT, V221, P81, DOI 10.1016/0014-5793(87)80356-3; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; ORCUTT BC, 1986, PIR ALI1284 NAT BIOM; PAI JK, 1988, J BIOL CHEM, V263, P12472; PINCKARD RN, 1988, INFLAMMATION BASIC P, P139; POLAKIS PG, 1988, J BIOL CHEM, V263, P4969; PRENTKI M, 1984, J BIOL CHEM, V259, P3777; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; ROTROSEN D, 1987, J IMMUNOL, V139, P3034; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO M, 1990, BINARY, V2, P187; SMITH CD, 1986, SCIENCE, V232, P97, DOI 10.1126/science.3006254; SNYDERMAN R, 1986, J LEUKOCYTE BIOL, V40, P785, DOI 10.1002/jlb.40.6.785; SNYDERMAN R, 1988, INFLAMMATION BASIC P, P309; THOMAS KM, 1990, J BIOL CHEM, V265, P20061; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	53	53	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12560	12567						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712023				2022-12-27	WOS:A1991FV18000072
J	GANGULY, A; BALDWIN, CT; STROBEL, D; CONWAY, D; HORTON, W; PROCKOP, DJ				GANGULY, A; BALDWIN, CT; STROBEL, D; CONWAY, D; HORTON, W; PROCKOP, DJ			HETEROZYGOUS MUTATION IN THE G+5 POSITION OF INTRON-33 OF THE PRO-ALPHA-2(I) GENE (COL1A2) THAT CAUSES ABERRANT RNA SPLICING AND LETHAL OSTEOGENESIS IMPERFECTA - USE OF CARBODIIMIDE METHODS THAT DECREASE THE EXTENT OF DNA SEQUENCING NECESSARY TO DEFINE AN UNUSUAL MUTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-BASE MUTATIONS; SYNDROME TYPE-VII; SYNDROME TYPE-IV; COLLAGEN GENE; III PROCOLLAGEN; BETA-THALASSEMIA; CHAIN; PATIENT; EXON; EXPRESSION	Cultured skin fibroblasts from a proband with osteogenesis imperfecta were found to synthesize normal and shortened alpha-2(I) chains of type I procollagen. A cDNA library was prepared using mRNA isolated from the proband's fibroblasts. Partial nucleotide sequencing of five clones demonstrated that two clones lacked the 54 base pairs (bp) of coding sequences found in exon 33 of the pro-alpha-2(I) gene (COL1A2). To reduce the amount of nucleotide sequencing required, heteroduplexes were prepared from two of the clones, one normal and the other lacking exon 33, and reacted with a water-soluble carbodiimide under conditions in which nonbase-paired G and T nucleotides are specifically modified by the reagent. Analysis of the heteroduplexes by immunoelectron microscopy suggested that the sequence variation near the codons of exon 33 was the only sequence difference in the cDNA clones. Amplification of cDNA from the proband by polymerase chain reaction gave products of two sizes, one of the expected size for the normal sequence and the other of the expected size for a product lacking the 54 bp in exon 33. To define the mutation in genomic DNA, a 1.6-kilobase region spanning exons 32 and 34 was amplified by the polymerase chain reaction and DNA heteroduplexes were prepared from the products. The heteroduplexes were treated with a water-soluble carbodiimide and then used as templates for primer extension under conditions in which extension terminates at the site of a carbodiimide-modified base. The results suggested a mismatch near the exon-intron boundary of exon 33 and a second mismatch near the 3' end of intron 33. Nucleotide sequencing of the polymerase chain reaction products revealed a single-base substitution in one allele that changed the moderately conserved G at position +5 of the 5' splice site of intron 33 to an A. In addition, there was an apparently neutral single-base substitution that placed both a G and T at position +661 of intron 33. The results provide only the third example of a mutation in the G at the +5 position of an intron that causes aberrant RNA splicing. Also, the results demonstrate that use of techniques involving carbodiimide modification of DNA heteroduplexes can reduce the amount of nucleotide sequencing necessary to define mutations in large and complex genes.	THOMAS JEFFERSON UNIV,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; UNIV TEXAS,HLTH SCI CTR,DEPT PEDIAT,HOUSTON,TX 77225	Jefferson University; University of Texas System; University of Texas Health Science Center Houston				Baldwin, Clinton/0000-0002-3275-9463	NIAMS NIH HHS [AR-38188] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038188] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ATWEH GF, 1987, BLOOD, V70, P147; BAKHSHI A, 1986, P NATL ACAD SCI USA, V83, P2689, DOI 10.1073/pnas.83.8.2689; BATEMAN JF, 1991, IN PRESS AM J MED GE; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; BONADIO J, 1990, J BIOL CHEM, V265, P2262; BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; CLADARAS C, 1987, J BIOL CHEM, V262, P2310; COLE WG, 1990, J BIOL CHEM, V265, P17070; CONSTANTINOU CD, 1987, EUR J BIOCHEM, V163, P247, DOI 10.1111/j.1432-1033.1987.tb10794.x; DEWET WJ, 1983, J BIOL CHEM, V258, P7721; FELBER BK, 1982, CELL, V29, P895, DOI 10.1016/0092-8674(82)90451-2; GANGULY A, 1990, NUCLEIC ACIDS RES, V18, P3933, DOI 10.1093/nar/18.13.3933; GANGULY A, 1989, GENOMICS, V4, P530, DOI 10.1016/0888-7543(89)90276-0; GANGULY A, 1990, AM JHUM GENET, V47, pA217; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HIDAKA Y, 1987, J CLIN INVEST, V80, P1409, DOI 10.1172/JCI113219; KONTUSAARI S, 1990, AM J HUM GENET, V47, P112; KUIVANIEMI H, 1988, J BIOL CHEM, V263, P11407; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; KULOZIK AE, 1988, BLOOD, V71, P457; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; MANNIATIS T, 1991, SCIENCE, V251, P33; MARVIT J, 1987, NUCLEIC ACIDS RES, V15, P5613, DOI 10.1093/nar/15.14.5613; METZ DH, 1969, BIOCHEMISTRY-US, V8, P2312, DOI 10.1021/bi00834a012; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P1926, DOI 10.1128/MCB.6.6.1926; NICHOLLS AC, 1991, IN PRESS AM J MED GE; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; RUFFNER DE, 1988, P NATL ACAD SCI USA, V85, P2125, DOI 10.1073/pnas.85.7.2125; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STRICKLIN GP, 1977, BIOCHEMISTRY-US, V16, P1607, DOI 10.1021/bi00627a013; STUDENCKI AB, 1984, DNA-J MOLEC CELL BIO, V3, P7, DOI 10.1089/dna.1.1984.3.7; THAKKERVARIA S, 1990, FASEB J, V4, pA2286; TREISMAN R, 1983, NATURE, V302, P591, DOI 10.1038/302591a0; TREISMAN R, 1982, CELL, V29, P903, DOI 10.1016/0092-8674(82)90452-4; TROMP G, 1988, P NATL ACAD SCI USA, V85, P5254, DOI 10.1073/pnas.85.14.5254; VASAN NS, 1991, AM J HUM GENET, V48, P305; WALLIS G A, 1989, American Journal of Human Genetics, V45, pA228; WEIL D, 1990, J BIOL CHEM, V265, P16007; WEIL D, 1989, J BIOL CHEM, V264, P16804; WEIL D, 1989, EMBO J, V8, P1705, DOI 10.1002/j.1460-2075.1989.tb03562.x; WEIL D, 1988, J BIOL CHEM, V263, P8561; WILLIAMS CJ, 1983, J BIOL CHEM, V258, P5915	48	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					12035	12040						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711048				2022-12-27	WOS:A1991FT76200093
J	BEYER, EC; STEINBERG, TH				BEYER, EC; STEINBERG, TH			EVIDENCE THAT THE GAP JUNCTION PROTEIN CONNEXIN-43 IS THE ATP-INDUCED PORE OF MOUSE MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RAT MAST-CELLS; EXTERNAL ATP; PERMEABILITY; MEMBRANE; LIVER; COMMUNICATION; CULTURE; CLONING; CONTACT; FLUXES	Extracellular ATP4- opens pores in the plasma membrane of mouse macrophages and the J774 macrophage-like cell line that allow molecules as large as fura-2 (831 daltons) to enter the cytoplasmic matrix of the cells. The functional similarity of the ATP-induced pores to gap junctions led us to examine whether these pores were related to members of the connexin family of gap junction proteins. Under conditions of high stringency, RNA isolated from J774 cells hybridized with cDNA for connexin-43 but not with cDNA for connexin-32, -26, or -46. RNA isolated from several variant J774 cell lines that do not permeabilize in response to extracellular ATP (ATPR cells) did not hybridize with connexin-43 cDNA. Immunoblots demonstrated that J774 cells, but not the variant ATPR B2 cell line, expressed connexin-43 protein. These studies demonstrate that mouse macrophages express the connexin-43 gap junction mRNA and protein and strongly suggest that in these cells connexin-43 forms "half-gap junctions" in response to extracellular ATP4-.	WASHINGTON UNIV,SCH MED,DEPT CELL BIOL & PHYSIOL,660 S EUCLID AVE,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PEDIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)			Beyer, Eric/V-1317-2019	Beyer, Eric/0000-0001-8044-1356	NATIONAL EYE INSTITUTE [R29EY008368, R01EY008368] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI000893] Funding Source: NIH RePORTER; NEI NIH HHS [EY08368] Funding Source: Medline; NHLBI NIH HHS [HL45466] Funding Source: Medline; NIAID NIH HHS [AI00893] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BEYER EC, 1988, GAP JUNCTIONS, P167; BUISMAN HP, 1988, P NATL ACAD SCI USA, V85, P7988, DOI 10.1073/pnas.85.21.7988; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCKCROFT S, 1979, NATURE, V279, P541, DOI 10.1038/279541a0; COCKCROFT S, 1980, BIOCHEM J, V188, P789, DOI 10.1042/bj1880789; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; DIVIRGILIO F, 1988, BIOCHEM J, V256, P959, DOI 10.1042/bj2560959; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; GREENBERG S, 1988, J BIOL CHEM, V263, P10337; HEPPEL LA, 1985, J MEMBRANE BIOL, V86, P189, DOI 10.1007/BF01870597; HULSER DF, 1972, EXP CELL RES, V74, P319, DOI 10.1016/0014-4827(72)90383-7; KITAGAWA T, 1986, BIOCHIM BIOPHYS ACTA, V860, P185, DOI 10.1016/0005-2736(86)90514-6; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; LARSON DM, 1990, CIRC RES, V66, P1074, DOI 10.1161/01.RES.66.4.1074; LEVY JA, 1976, EXP CELL RES, V103, P375, DOI 10.1016/0014-4827(76)90273-1; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; ORI M, 1980, CELL STRUCT FUNCT, V5, P259, DOI 10.1247/csf.5.259; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; POLACEK D, 1989, Journal of Cell Biology, V109, p19A; PORVAZNIK M, 1979, J CELL BIOL, V82, P555, DOI 10.1083/jcb.82.2.555; ROZENGURT E, 1977, J BIOL CHEM, V252, P4584; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; STEINBERG TH, 1987, J BIOL CHEM, V262, P3118; STEINBERG TH, 1987, J BIOL CHEM, V262, P8884; SUGIURA H, 1990, CIRC RES, V66, P1095, DOI 10.1161/01.RES.66.4.1095; WRIGHT SD, 1984, NATURE, V309, P359, DOI 10.1038/309359a0; ZANOVELLO P, 1990, J IMMUNOL, V145, P1545; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391; ZHENG LM, 1991, J CELL BIOL, V112, P279, DOI 10.1083/jcb.112.2.279	32	172	173	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					7971	7974						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1708769				2022-12-27	WOS:A1991FK44100003
J	PAGE, JD; COLMAN, RW				PAGE, JD; COLMAN, RW			LOCALIZATION OF DISTINCT FUNCTIONAL DOMAINS ON PREKALLIKREIN FOR INTERACTION WITH BOTH HIGH-MOLECULAR-WEIGHT KININOGEN AND ACTIVATED FACTOR-XII IN A 28-KDA FRAGMENT (AMINO-ACIDS 141-371)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PLASMA PREKALLIKREIN; FACTOR-DEPENDENT FIBRINOLYSIS; 4 TANDEM REPEATS; HAGEMAN-FACTOR; BLOOD-COAGULATION; HEAVY-CHAIN; KALLIKREIN; SEQUENCE; INACTIVATION; PURIFICATION	The predominant autolytic form of human kallikrein, beta-kallikrein, was used to localize the high molecular weight kininogen (HK) binding site on kallikrein as well as the substrate recognition site for activated factor XII on prekallikrein. Beta-kallikrein is formed by autolysis of the kallikrein heavy chain to give two fragments of approximately 18 and 28 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. A ligand binding technique established that the HK binding site on kallikrein resides on the 28-kDa fragment of the heavy chain. Limited NH2-terminal sequencing of this portion of beta-kallikrein showed that this fragment of the heavy chain consists of the COOH-terminal 231 amino acids of the heavy chain. A panel of five murine monoclonal antibodies to human prekallikrein (PK) were found to have epitopes on this same fragment of the heavy chain. None of the monoclonal antibodies were able to block binding of HK to PK. Three of the monoclonal antibodies (13G11, 13H11, and 6A6) were able to inhibit the activation of PK to kallikrein in both a plasma system and a purified system. The 28-kDa fragment of the PK heavy chain was purified and was able to compete with HK for binding to PK. The HK binding site and the site of recognitio of factor XII are separate and distinct on PK, and both are contained in the COOH-terminal 231 amino acids of the PK heavy chain.			PAGE, JD (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,THROMBOSIS RES CTR,3400 N BROAD ST,PHILADELPHIA,PA 19140, USA.							BAGDASARIAN A, 1973, IMMUNOL COMMUN, V2, P93, DOI 10.3109/08820137309022885; BAGLIA FA, 1990, J BIOL CHEM, V265, P4149; BOUMA BN, 1980, BIOCHEMISTRY-US, V19, P1151, DOI 10.1021/bi00547a018; BURGER D, 1986, J BIOL CHEM, V261, P324; CHUNG DW, 1986, BIOCHEMISTRY-US, V25, P2410, DOI 10.1021/bi00357a017; COCHRANE CG, 1973, J EXP MED, V138, P1564, DOI 10.1084/jem.138.6.1564; COLMAN RW, 1985, BLOOD, V65, P311; COLMAN RW, 1969, BIOCHEM BIOPH RES CO, V35, P273, DOI 10.1016/0006-291X(69)90278-2; COLMAN RW, 1969, J CLIN INVEST, V48, P23, DOI 10.1172/JCI105971; DELACADENA RA, 1987, J LAB CLIN MED, V109, P601; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; FUJIKAWA K, 1986, BIOCHEMISTRY-US, V25, P2417, DOI 10.1021/bi00357a018; HOCK J, 1990, J BIOL CHEM, V265, P12005; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; KELLERMANN J, 1986, EUR J BIOCHEM, V154, P471, DOI 10.1111/j.1432-1033.1986.tb09421.x; KERBIRIOU DM, 1979, J BIOL CHEM, V254, P2020; KLUFT C, 1978, J LAB CLIN MED, V91, P83; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOTTSPEICH F, 1985, EUR J BIOCHEM, V152, P307, DOI 10.1111/j.1432-1033.1985.tb09199.x; MANDLE R, 1977, J BIOL CHEM, V252, P6097; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; MANDLE RJ, 1979, BLOOD, V54, P850; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MEIER HL, 1977, J CLIN INVEST, V60, P18, DOI 10.1172/JCI108754; MORI K, 1981, J BIOCHEM-TOKYO, V89, P1465, DOI 10.1093/oxfordjournals.jbchem.a133339; NAGASE H, 1981, BIOCHEM J, V193, P187, DOI 10.1042/bj1930187; PIXLEY RA, 1987, ARCH BIOCHEM BIOPHYS, V256, P490, DOI 10.1016/0003-9861(87)90606-0; SCHAPIRA M, 1982, J CLIN INVEST, V69, P1199, DOI 10.1172/JCI110557; SCOTT CF, 1980, J CLIN INVEST, V65, P413, DOI 10.1172/JCI109684; SVENDSEN PJ, 1980, J BIOCHEM BIOPH METH, V3, P97; VANDERGRAAF F, 1982, J BIOL CHEM, V257, P4300; VELOSO D, 1987, BLOOD, V70, P1053; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WACHTFOGEL YT, 1983, J CLIN INVEST, V72, P1672, DOI 10.1172/JCI111126	34	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8143	8148						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1708772				2022-12-27	WOS:A1991FK44100032
J	CALI, JJ; RUSSELL, DW				CALI, JJ; RUSSELL, DW			CHARACTERIZATION OF HUMAN STEROL 27-HYDROXYLASE - A MITOCHONDRIAL CYTOCHROME-P-450 THAT CATALYZES MULTIPLE OXIDATION REACTIONS IN BILE-ACID BIOSYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER ALCOHOL-DEHYDROGENASE; DENSITY LIPOPROTEIN RECEPTOR; CEREBROTENDINOUS XANTHOMATOSIS; SIDE-CHAIN; BINDING; SEQUENCE; 26-HYDROXYLATION; ADRENODOXIN; 26-HYDROXYCHOLESTEROL; IDENTIFICATION	The enzyme sterol 27-hydroxylase catalyzes the first step in the oxidation of the side chain of sterol intermediates in the bile acid synthesis pathway. Human sterol 27-hydroxylase cDNAs were isolated from a liver cDNA library by cross-hybridization with a previously cloned rabbit cDNA probe. DNA sequence analysis of hybridization-positive clones predicted a human sterol 27-hydroxylase consisting of a 33-amino-acid mitochondrial signal sequence followed by a mature protein of 498 amino acids. RNA blotting experiments demonstrated sterol 27-hydroxylase mRNAs of approximately 1.8 to 2.2 kilobases in liver and fibroblast cells. The steady state levels of the mRNA did not change when cultured cells were grown in the presence or absence of sterols. Introduction of the sterol 27-hydroxylase cDNA into Simian COS cells resulted in the expression of active enzyme capable of catalyzing multiple oxidation reactions (R-CH3 --> R-CH2OH --> R-COOH) at carbon 27 of sterol intermediates of the bile acid synthesis pathway.			CALI, JJ (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.			Russell, David/0000-0002-0277-403X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKHTAR M, 1978, BIOCHEM J, V169, P449, DOI 10.1042/bj1690449b; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; ATSUTA Y, 1981, J BIOL CHEM, V256, P9144; BJORKHEM I, 1983, J CLIN INVEST, V71, P142, DOI 10.1172/JCI110742; BJORKHEM I, 1973, EUR J BIOCHEM, V36, P201, DOI 10.1111/j.1432-1033.1973.tb02902.x; BJORKHEM I, 1985, STEROLS BILE ACIDS, P231; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Carey M. C., 1982, LIVER BIOL PATHOBIOL, P429; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DAHLBACK H, 1988, BIOCHEM J, V252, P207, DOI 10.1042/bj2520207; DAHLBACK H, 1990, BIOCHEM BIOPH RES CO, V167, P391, DOI 10.1016/0006-291X(90)92034-W; DAHLBACK H, 1988, BIOCHEM BIOPH RES CO, V157, P30, DOI 10.1016/S0006-291X(88)80006-8; DANIELSSON H, 1960, ACTA CHEM SCAND, V14, P348, DOI 10.3891/acta.chem.scand.14-0348; DANIELSSON H, 1973, BILE ACIDS, P1; DOUGLAS MG, 1986, MICROBIOL REV, V50, P166, DOI 10.1128/MMBR.50.2.166-178.1986; ESSER V, 1988, J BIOL CHEM, V263, P13282; ESTERMAN AL, 1983, J LIPID RES, V24, P1304; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHER RT, 1989, J LIPID RES, V30, P1621; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; HANUKOGLU I, 1989, EUR J BIOCHEM, V180, P479, DOI 10.1111/j.1432-1033.1989.tb14671.x; JAVITT NB, 1990, J LIPID RES, V31, P1527; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LI YC, 1990, J BIOL CHEM, V265, P12012; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; NOLLER CR, 1965, CHEM ORGANIC COMPOUN, P1; NOSHIRO M, 1990, J BIOL CHEM, V265, P10036; OFTEBRO H, 1980, J CLIN INVEST, V65, P1418, DOI 10.1172/JCI109806; OGISHIMA T, 1989, J BIOL CHEM, V264, P10935; OKAMURA T, 1985, P NATL ACAD SCI USA, V82, P5705, DOI 10.1073/pnas.82.17.5705; OKUDA A, 1983, J BIOL CHEM, V258, P2899; OKUDA K, 1970, BIOCHIM BIOPHYS ACTA, V220, P141, DOI 10.1016/0005-2744(70)90001-X; POPJAK G, 1977, J AM CHEM SOC, V99, P931, DOI 10.1021/ja00445a041; PORTER TD, 1985, P NATL ACAD SCI USA, V82, P973, DOI 10.1073/pnas.82.4.973; POSTLIND H, 1989, BIOCHEM BIOPH RES CO, V159, P1135, DOI 10.1016/0006-291X(89)92227-4; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFER S, 1978, J BIOL CHEM, V253, P6386; SJOVALL J, 1985, BIOCHIM BIOPHYS ACTA, V836, P8, DOI 10.1016/0005-2760(85)90213-9; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; STEVENSON DE, 1988, J CHEM SOC PERK T 1, P2043, DOI 10.1039/p19880002043; SU P, 1990, DNA CELL BIOL, V9, P657, DOI 10.1089/dna.1990.9.657; SUNDSETH SS, 1990, J BIOL CHEM, V265, P15090; TULS J, 1989, J BIOL CHEM, V264, P16421; ULLAH AJH, 1990, J BIOL CHEM, V265, P1345; USUI E, 1990, FEBS LETT, V262, P135, DOI 10.1016/0014-5793(90)80172-F; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; WIKVALL K, 1984, J BIOL CHEM, V259, P3800; WOOD AW, 1988, J BIOL CHEM, V263, P17322; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; ZUBER MX, 1988, P NATL ACAD SCI USA, V85, P699, DOI 10.1073/pnas.85.3.699	54	294	303	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7774	7778						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708392				2022-12-27	WOS:A1991FJ34200073
J	DESTEFANO, JJ; BUISER, RG; MALLABER, LM; MYERS, TW; BAMBARA, RA; FAY, PJ				DESTEFANO, JJ; BUISER, RG; MALLABER, LM; MYERS, TW; BAMBARA, RA; FAY, PJ			POLYMERIZATION AND RNASE-H ACTIVITIES OF THE REVERSE TRANSCRIPTASES FROM AVIAN-MYELOBLASTOSIS, HUMAN IMMUNODEFICIENCY, AND MOLONEY MURINE LEUKEMIA VIRUSES ARE FUNCTIONALLY UNCOUPLED	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE; RIBONUCLEASE-H; ESCHERICHIA-COLI; TUMOR-VIRUSES; STRUCTURAL CHARACTERIZATION; MECHANISM; ENDONUCLEASE; EXPRESSION; RETROVIRUS; ANTIBODY	The functional interaction between the RNA-dependent DNA polymerase and the RNase H activities of reverse transcriptases (RTs) were examined using a 272 nucleotide long plasmid-derived RNA transcript primed in a specific location. Properties of the avian myeloblastosis virus (AMV) RT, the human immunodeficiency virus RT and the Moloney murine leukemia virus RT were examined. All three enzymes formed stable complexes with the primer-template with half-lives ranging from about 16 to 41 s. Each enzyme synthesized full-length primer extension products and cleaved the RNA template at least once during DNA synthesis. Polymerization was then assayed in the presence of challenger RNA that effectively sequestered RTs after one round of processive DNA synthesis. This assay allowed measurement of the number of endonucleolytic cleavages catalyzed by the RT during one encounter with the primer-template. Results indicated that each of the three RTs cut the transcript before dissociating from the primer-template, whether or not deoxynucleoside triphosphates were present to allow synthesis. During synthesis, the extent of RNA degradation differed among the RTs, with AMV-RT generating mostly large segments of RNA-DNA hybrid, and virtually no small RNA cleavage products. Human immunodeficiency virus and Moloney murine leukemia virus-RT generated more small degradation products than AMV-RT, but still left much of the potentially degradable hybrid undigested. Results demonstrate that the RNase H function is much less active than the polymerization function during processive DNA synthesis and that the activities are not strictly coupled.	UNIV ROCHESTER,DEPT BIOCHEM,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT MED,ROCHESTER,NY 14642; UNIV ROCHESTER,CTR CANC,ROCHESTER,NY 14642	University of Rochester; University of Rochester; University of Rochester					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027054] Funding Source: NIH RePORTER; NCI NIH HHS [CA 11193] Funding Source: Medline; NIAID NIH HHS [AI 27054] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BREWER LC, 1974, J VIROL, V14, P1494, DOI 10.1128/JVI.14.6.1494-1502.1974; FARMERIE WG, 1987, SCIENCE, V236, P305, DOI 10.1126/science.2436298; FERRIS AL, 1990, VIROLOGY, V175, P456, DOI 10.1016/0042-6822(90)90430-Y; GERARD GF, 1981, J VIROL, V37, P748, DOI 10.1128/JVI.37.2.748-754.1981; GERARD GF, 1981, BIOCHEMISTRY-US, V20, P256, DOI 10.1021/bi00505a005; GRANDGENETT D, 1985, J BIOL CHEM, V260, P8243; GRANDGENETT DP, 1974, J BIOL CHEM, V249, P5148; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HANSEN J, 1987, J BIOL CHEM, V262, P12393; HIZI A, 1990, VIROLOGY, V175, P575, DOI 10.1016/0042-6822(90)90444-V; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; HUBER HE, 1990, J BIOL CHEM, V265, P10565; HUBER HE, 1989, J BIOL CHEM, V264, P4669; KOTEWICZ ML, 1988, NUCLEIC ACIDS RES, V16, P265, DOI 10.1093/nar/16.1.265; KRUG MS, 1989, P NATL ACAD SCI USA, V86, P3539, DOI 10.1073/pnas.86.10.3539; LAI MHT, 1978, J VIROL, V25, P652, DOI 10.1128/JVI.25.2.652-663.1978; LEIS JP, 1973, P NATL ACAD SCI USA, V70, P466, DOI 10.1073/pnas.70.2.466; LEVIN JG, 1988, J VIROL, V62, P4376, DOI 10.1128/JVI.62.11.4376-4380.1988; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; MATSON SW, 1981, BIOCHIM BIOPHYS ACTA, V652, P29, DOI 10.1016/0005-2787(81)90205-7; MIZRAHI V, 1989, BIOCHEMISTRY-US, V28, P9088, DOI 10.1021/bi00449a020; MOELLING K, 1976, J VIROL, V18, P418, DOI 10.1128/JVI.18.2.418-425.1976; MOELLING K, 1971, NATURE, V234, P240; OYAMA F, 1989, J BIOL CHEM, V264, P18808; PRASAD VR, 1989, P NATL ACAD SCI USA, V86, P3104, DOI 10.1073/pnas.86.9.3104; ROTH MJ, 1985, J BIOL CHEM, V260, P9326; Sambrook J, 1989, MOL CLONING LABORATO; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; STARNES MC, 1989, J BIOL CHEM, V264, P7073; STARNES MC, 1988, J BIOL CHEM, V263, P5132; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; TISDALE M, 1988, J VIROL, V62, P3662, DOI 10.1128/JVI.62.10.3662-3667.1988; VARMUS H, 1984, RNA TUMOR VIRUSES, P369; VERMA IM, 1975, J VIROL, V15, P843, DOI 10.1128/JVI.15.4.843-854.1975; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504	36	131	132	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7423	7431						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708386				2022-12-27	WOS:A1991FJ34200020
J	SCHWOEBEL, E; PRASAD, S; TIMMONS, TM; COOK, R; KIMURA, H; NIU, EM; CHEUNG, P; SKINNER, S; AVERY, SE; WILKINS, B; DUNBAR, BS				SCHWOEBEL, E; PRASAD, S; TIMMONS, TM; COOK, R; KIMURA, H; NIU, EM; CHEUNG, P; SKINNER, S; AVERY, SE; WILKINS, B; DUNBAR, BS			ISOLATION AND CHARACTERIZATION OF A FULL-LENGTH CDNA-ENCODING THE 55-KDA RABBIT ZONA-PELLUCIDA PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERM RECEPTOR ACTIVITY; ALPHA-GLYCOPROTEIN; ANTIGEN PPZA; PORCINE; MOUSE; IDENTIFICATION; SEQUENCE; PIG; ZP3; HETEROIMMUNIZATION	A full-length cDNA (rc55) encoding the major rabbit zona pellucida (ZP) glycoprotein (55 kDa) has been cloned and sequenced. A lambda-gt11 expression library was constructed using poly(A)+ mRNA isolated from sexually immature rabbit ovaries which contain large numbers of developing follicles. The rc55 cDNA was identified using affinity purified polyclonal antibodies specific to ZP antigens which are shared among mammalian species. The deduced amino acid sequence of the full-length rc55 clone was matched to the NH2-terminal 25-amino acid sequence obtained for this protein. The predicted amino acid sequence consists of 540 amino acids including a putative signal peptide of 18-24 residues and six potential N-glycosylation sites. The cDNA hybridizes to a 2000-base species of mRNA from rabbit ovary which is not detected in other rabbit tissues. The message is present early in ovarian follicular development and is approximately 600-fold greater in sexually immature as compared with sexually mature rabbit ovaries. This cDNA was expressed as a cro-beta-galactosidase fusion protein using the pEX expression vector. Antibodies against native rabbit ZP, affinity-purified on the recombinant 55-kDa ZP protein, were found to recognize the native rabbit ZP glycoprotein, indicating partial conservation of native epitopes in the expressed recombinant protein.	BAYLOR UNIV, DEPT MICROBIOL & IMMUNOL, HOUSTON, TX 77030 USA	Baylor University	SCHWOEBEL, E (corresponding author), BAYLOR UNIV, DEPT CELL BIOL, HOUSTON, TX 77030 USA.							ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; BARKER WC, 1972, ATLAS PROTEIN SEQUEN, P101; BENSON S A, 1984, Biotechniques, V2, P126; CHAMBERLIN ME, 1989, DEV BIOL, V131, P207, DOI 10.1016/S0012-1606(89)80052-1; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dunbar B.S., 1983, P139; Dunbar B.S., 1984, Modern Cell Biology, V3, P77; DUNBAR BS, 1985, BIOL REPROD, V32, P619, DOI 10.1095/biolreprod32.3.619; DUNBAR BS, 1981, BIOL REPROD, V24, P1111; DUNBAR BS, 1987, J REPROD FERTIL, V81, P363, DOI 10.1530/jrf.0.0810363; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; FLORMAN HM, 1984, DEV BIOL, V106, P243, DOI 10.1016/0012-1606(84)90079-4; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; FUKUDA MN, 1981, J BIOL CHEM, V256, P3900; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JOVIN TM, 1973, BIOCHEMISTRY-US, V12, P871, DOI 10.1021/bi00729a014; KARP DR, 1982, J BIOL CHEM, V257, P7330; KINLOCH RA, 1988, P NATL ACAD SCI USA, V85, P6409, DOI 10.1073/pnas.85.17.6409; KOZAK M, 1983, MICROBIOL REV, V47, P1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAWRENCE CB, 1988, J BIOL BIOL, V4, P325; LIANG LF, 1990, MOL CELL BIOL, V10, P1507, DOI 10.1128/MCB.10.4.1507; LUNSFORD RD, 1990, GENOMICS, V6, P184, DOI 10.1016/0888-7543(90)90465-7; MAHIBROWN CA, 1985, BIOL REPROD, V32, P761, DOI 10.1095/biolreprod32.4.761; Maniatis T., 1982, MOL CLONING; MARESH GA, 1987, J EXP ZOOL, V244, P299, DOI 10.1002/jez.1402440214; MARESH GA, 1990, BIOL REPROD, V43, P965, DOI 10.1095/biolreprod43.6.965; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MILLAR SE, 1989, SCIENCE, V246, P935, DOI 10.1126/science.2479101; MOOS M, 1988, J BIOL CHEM, V263, P6005; NOONAN DM, 1988, J BIOL CHEM, V263, P16379; ORAND MG, 1985, J EXP ZOOL, V235, P423, DOI 10.1002/jez.1402350314; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RINGUETTE MJ, 1986, P NATL ACAD SCI USA, V83, P4341, DOI 10.1073/pnas.83.12.4341; RINGUETTE MJ, 1988, DEV BIOL, V127, P287, DOI 10.1016/0012-1606(88)90315-6; SACCO AG, 1989, BIOL REPROD, V41, P523, DOI 10.1095/biolreprod41.3.523; SACCO AG, 1981, BIOL REPROD, V25, P997, DOI 10.1095/biolreprod25.5.997; SACCO AG, 1983, FERTIL STERIL, V39, P350; SALZMANN GS, 1983, EMBO J, V2, P1451, DOI 10.1002/j.1460-2075.1983.tb01607.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SKINNER SM, 1987, J REPROD IMMUNOL, V12, P81, DOI 10.1016/0165-0378(87)90037-4; SKINNER SM, 1990, IMMUNOL ALLERGY CLIN, V10, P185; SKINNER SM, 1984, ENDOCRINOLOGY, V115, P2432; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; SWENSON CE, 1982, J EXP ZOOL, V219, P97, DOI 10.1002/jez.1402190112; TIMMONS TM, 1987, BIOL REPROD, V36, P1275, DOI 10.1095/biolreprod36.5.1275; TIMMONS TM, 1990, CONRAD W S, P277; TIMMONS TM, 1988, PERSPECTIVES IMMUNOR, P242; TIMMONS TM, 1990, METHOD ENZYMOL, V182, P679; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WASHENIK K, 1989, MAMMALIAN EGG COAT S, P49; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; WASSARMAN PM, 1990, DEVELOPMENT, V108, P1; WASSARMAN PM, 1984, MOL BIOL DEV, P213; WOOD DM, 1981, J EXP ZOOL, V217, P423, DOI 10.1002/jez.1402170314; WOOD DM, 1981, BIOL REPROD, V25, P439, DOI 10.1095/biolreprod25.2.439; Yanagimachi R., 1981, FERTILIZATION EMBRYO, P81; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; YUREWICZ EC, 1987, J BIOL CHEM, V262, P564; [No title captured]	64	75	83	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					7214	7219						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707882				2022-12-27	WOS:A1991FG72700088
J	AHN, NG; SEGER, R; BRATLIEN, RL; DILTZ, CD; TONKS, NK; KREBS, EG				AHN, NG; SEGER, R; BRATLIEN, RL; DILTZ, CD; TONKS, NK; KREBS, EG			MULTIPLE COMPONENTS IN AN EPIDERMAL GROWTH FACTOR-STIMULATED PROTEIN-KINASE CASCADE - INVITRO ACTIVATION OF A MYELIN BASIC-PROTEIN MICROTUBULE-ASSOCIATED PROTEIN-2 KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-THREONINE KINASE; S6 KINASE; TYROSINE KINASE; INSULIN; PHOSPHORYLATION; PURIFICATION; CELLS; EXPRESSION; ADIPOCYTES; RECEPTOR	Epidermal growth factor stimulates the activity of several cytosolic serine/threonine protein kinases in quiescent Swiss 3T3 cells. Two of these, which use myelin basic protein (MBP) as substrate, act as kinase kinases in that they are able to activate a separate peptide kinase activity in vitro by a mechanism involving protein phosphorylation. In this study, we have identified two activities from extracts of epidermal growth factor-treated cells that stimulate an ATP-dependent activation of both of the MBP kinases, derived in their inactive precursor forms from extracts of untreated cells. The resulting MBP kinase activities are stable to further purification and can be inactivated with either tyrosine or serine/threonine protein phosphatases and then reactivated to their original levels of activity. Thus, we propose that the in vitro activation involves protein phosphorylation, stimulated by the action of novel MBP kinase activating factors that represent intermediate components in a growth factor-stimulated kinase cascade.	UNIV WASHINGTON,DEPT PHARMACOL,SEATTLE,WA 98195; UNIV WASHINGTON,HOWARD HUGHES MED INST,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	AHN, NG (corresponding author), UNIV WASHINGTON,DEPT BIOCHEM,SEATTLE,WA 98195, USA.				NIDDK NIH HHS [DK42528] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042528] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHN NG, 1990, J BIOL CHEM, V265, P11487; AHN NG, 1990, J BIOL CHEM, V265, P11495; ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BASU M, 1984, NATURE, V311, P477, DOI 10.1038/311477a0; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRAUN S, 1984, J BIOL CHEM, V259, P2051; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COOPER JA, 1982, CELL, V31, P263, DOI 10.1016/0092-8674(82)90426-3; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; ELY CM, 1990, J CELL BIOL, V110, P731, DOI 10.1083/jcb.110.3.731; FERRELL JE, 1990, MOL CELL BIOL, V10, P3020, DOI 10.1128/MCB.10.6.3020; HANEKOM C, 1989, BIOCHEM J, V262, P449, DOI 10.1042/bj2620449; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HOSHI M, 1988, J BIOL CHEM, V263, P5396; HOSHI M, 1989, EUR J BIOCHEM, V184, P477, DOI 10.1111/j.1432-1033.1989.tb15040.x; JENO P, 1989, J BIOL CHEM, V264, P1293; JENO P, 1988, P NATL ACAD SCI USA, V85, P406, DOI 10.1073/pnas.85.2.406; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; MIYASAKA T, 1990, J BIOL CHEM, V265, P4730; MIYASAKA T, 1990, BIOCHEM BIOPH RES CO, V168, P1237, DOI 10.1016/0006-291X(90)91161-K; NEL AE, 1990, J IMMUNOL, V144, P2683; RAY LB, 1988, ARCH BIOCHEM BIOPHYS, V262, P307, DOI 10.1016/0003-9861(88)90193-2; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SANGHERA JS, 1990, J BIOL CHEM, V265, P52; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; SWEET LJ, 1990, MOL CELL BIOL, V10, P2413, DOI 10.1128/MCB.10.5.2413; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TONKS NK, 1990, J BIOL CHEM, V265, P10674; VILLALBA M, 1989, P NATL ACAD SCI USA, V86, P7848, DOI 10.1073/pnas.86.20.7848; ZIONCHECK TF, 1986, J BIOL CHEM, V261, P5637	35	473	475	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4220	4227						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705548				2022-12-27	WOS:A1991FA69400034
J	NAZAR, RN				NAZAR, RN			HIGHER-ORDER STRUCTURE OF THE RIBOSOMAL 5-S RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE RIBOSOMES; 5S RNA; ESCHERICHIA-COLI; SECONDARY STRUCTURES; TERTIARY STRUCTURE; PROTEIN COMPLEX; BINDING PROTEIN; REACTIVE SITES; ETHYLNITROSOUREA; IDENTIFICATION	The structure of the ribosomal 5 S RNA was examined using Fe(II)-EDTA, a solvent-based reagent that cleaves the phosphodiester backbone of both double- and single-stranded RNA but is restricted by the three-dimensional structure. In the yeast 5 S RNA, cleavages were significantly restricted in six specific regions of the molecule; restrictions in only two of these regions were clearly dependent on a high salt/magnesium ion environment. A comparison of four RNAs of diverse origin revealed strong similarities in the cleavage profiles supporting a highly conserved higher order structure. Taken together with previous studies these data provide a more detailed modeling of the three-dimensional structure.	UNIV GUELPH,DEPT MOLEC BIOL & GENET,GUELPH N1G 2W1,ONTARIO,CANADA	University of Guelph	NAZAR, RN (corresponding author), UNIV COLORADO,HOWARD HUGHES MED INST,DEPT CHEM & BIOCHEM,BOULDER,CO 80309, USA.							AUBERT M, 1973, BIOCHIMIE, V55, P135, DOI 10.1016/S0300-9084(73)80385-2; AZAD AA, 1979, NUCLEIC ACIDS RES, V7, P1913, DOI 10.1093/nar/7.7.1913; CELANDER DW, 1990, BIOCHEMISTRY-US, V29, P1355, DOI 10.1021/bi00458a001; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; Erdmann V A, 1976, Prog Nucleic Acid Res Mol Biol, V18, P45, DOI 10.1016/S0079-6603(08)60586-3; FABER NM, 1981, J MOL BIOL, V146, P223; FOX GE, 1975, NATURE, V256, P505, DOI 10.1038/256505a0; GARRETT RA, 1981, TRENDS BIOCHEM SCI, V6, P137, DOI 10.1016/0968-0004(81)90051-7; GARRETT RA, 1979, INT REV BIOCHEM, V25, P121; HANCOCK J, 1982, NUCLEIC ACIDS RES, V10, P1257, DOI 10.1093/nar/10.4.1257; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; LO AC, 1982, J BIOL CHEM, V257, P3516; LUOMA GA, 1978, P NATL ACAD SCI USA, V75, P4901, DOI 10.1073/pnas.75.10.4901; MCDOUGALL J, 1983, J BIOL CHEM, V258, P5256; MCDOUGALL J, 1987, NUCLEIC ACIDS RES, V15, P161, DOI 10.1093/nar/15.1.161; NAZAR RN, 1979, EUR J BIOCHEM, V102, P573, DOI 10.1111/j.1432-1033.1979.tb04274.x; NAZAR RN, 1982, CELL NUCLEUS, V11, P1; NAZAR RN, 1983, NUCLEIC ACIDS RES, V11, P3155, DOI 10.1093/nar/11.10.3155; NISHIKAW.K, 1974, FEBS LETT, V40, P106, DOI 10.1016/0014-5793(74)80904-X; NOLLER HF, 1979, J MOL BIOL, V132, P621, DOI 10.1016/0022-2836(79)90378-4; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; RAACKE ID, 1971, P NATL ACAD SCI USA, V68, P2357, DOI 10.1073/pnas.68.10.2357; TULLIUS TD, 1985, SCIENCE, V230, P679, DOI 10.1126/science.2996145; VANRYK DI, 1990, J BIOL CHEM, V265, P8377; VLASSOV VV, 1980, FEBS LETT, V120, P12, DOI 10.1016/0014-5793(80)81034-9; WAGNER R, 1978, NUCLEIC ACIDS RES, V5, P4065, DOI 10.1093/nar/5.11.4065; WEIDNER H, 1977, NATURE, V266, P193, DOI 10.1038/266193a0; WILDEMAN AG, 1982, J BIOL CHEM, V257, P1395; WILLICK GE, 1980, BIOCHEMISTRY-US, V19, P2738, DOI 10.1021/bi00553a031; YAGUCHI M, 1984, EUR J BIOCHEM, V139, P451, DOI 10.1111/j.1432-1033.1984.tb08026.x	30	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4562	4567						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705555				2022-12-27	WOS:A1991FA69400083
J	SHI, JP; SCHIMMEL, P				SHI, JP; SCHIMMEL, P			AMINOACYLATION OF ALANINE MINIHELICES - DISCRIMINATOR BASE MODULATES TRANSITION-STATE OF SINGLE TURNOVER REACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRANSFER RIBONUCLEIC-ACID; TRANSFER-RNA-SYNTHETASES; MAJOR DETERMINANT; IDENTITY; RECOGNITION; NUCLEOTIDES; DEACYLATION; PARAMETERS; POLYMERASE; BINDING	RNA hairpin minihelices that recreate the acceptor-T-psi-C stem of Escherichia coli alanine tRNA are charged specifically with alanine, provided that they encode the critical G3:U70 base pair that is the major determinant for the identity of an alanine tRNA. These model substrates were used to investigate the role in charging of N73, the unpaired nucleotide that is just three positions removed from the amino acid attachment site and which is sometimes referred to as the "discriminator" base. Previous work showed that, while substrates which encode G3:U70 are all charged by alanine tRNA synthetase regardless of the base at position 73, catalytic efficiency is substantially higher with substrates that have the wild-type A73. To identify a specific step in aminoacylation that is affected by substitutions of A73, we studied the single turnover charging of A73, U73, C73, and G73 minihelices, using preformed, enzyme-bound alanyl adenylate and saturating concentrations of the respective minihelices. Compared to the A73 substrate, the transfer of activated amino acid to bound RNA is sharply reduced for the substituted N73 minihelices. The low efficiency of transfer is not due to an abortive reaction in which the adenylate or a transiently charged RNA is hydrolyzed. Instead, under the conditions used, the active adenylate remains on the enzyme for extended periods and simply reacts slowly with bound N73 RNA. The results suggest that the nature of the discriminator base is a critical determinant of the transition state for the reaction of bound alanyl adenylate with RNA on the surface of the enzyme.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT)					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 15539] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CROTHERS DM, 1972, P NATL ACAD SCI USA, V69, P3063, DOI 10.1073/pnas.69.10.3063; DAVANLOO P, 1984, P NATL ACAD SCI-BIOL, V81, P2035, DOI 10.1073/pnas.81.7.2035; ELDRED EW, 1972, BIOCHEMISTRY-US, V11, P17, DOI 10.1021/bi00751a004; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; FERSHT AR, 1985, ENZYME STRUCTURE MEC, P355; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; FREIST W, 1989, BIOCHEMISTRY-US, V28, P6787, DOI 10.1021/bi00443a001; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; HOU YM, 1989, BIOCHEMISTRY-US, V28, P4942, DOI 10.1021/bi00438a005; HOU YM, 1989, BIOCHEMISTRY-US, V28, P6800, DOI 10.1021/bi00443a003; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; MCCLAIN WH, 1988, SCIENCE, V240, P793, DOI 10.1126/science.2452483; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PARK SJ, 1989, BIOCHEMISTRY-US, V28, P2740, DOI 10.1021/bi00432a056; PERRET V, 1990, NATURE, V344, P787, DOI 10.1038/344787a0; REGAN L, 1986, THESIS MIT; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SAMPSON JR, 1989, SCIENCE, V243, P1363; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SHI JP, 1990, BIOCHEMISTRY-US, V29, P3621, DOI 10.1021/bi00467a005; SPRINZL M, 1989, NUCLEIC ACIDS RES, V17, pR1, DOI 10.1093/nar/17.1.1; UEMURA H, 1982, NUCLEIC ACIDS RES, V10, P6531, DOI 10.1093/nar/10.20.6531; YARUS M, 1972, P NATL ACAD SCI USA, V69, P1915, DOI 10.1073/pnas.69.7.1915	26	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2705	2708						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704363				2022-12-27	WOS:A1991EX60000007
J	LIN, TH; QUINN, T; WALSH, M; GRANDGENETT, D; LEE, JC				LIN, TH; QUINN, T; WALSH, M; GRANDGENETT, D; LEE, JC			AVIAN-MYELOBLASTOSIS VIRUS REVERSE-TRANSCRIPTASE - EFFECT OF GLYCEROL ON ITS HYDRODYNAMIC PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT MUSCLE PHOSPHOFRUCTOKINASE; DIRECTED DNA-POLYMERASE; SARCOMA VIRUS; HYDRATION; VESICLES; ALPHA	Although reverse transcriptase has been the subject of intensive investigation, minimal information is available regarding the physical properties of the enzyme. The basic hydrodynamic properties of avian myeloblastosis virus reverse transcriptase in solution were measured by both sedimentation velocity and equilibrium measurements in two buffer systems. In a 0.3 M potassium phosphate buffer system, pH 7.8, the enzyme sedimented as a homogenous particle with a sedimentation coefficient of (7.1 +/- 0.3) S with a weight-average molecular weight, M(w), of (1.52 +/- 0.05) x 10(5). Since the enzyme consists of an alpha and beta subunit of equal molar ratio with M(w) of 6.3 x 10(4) and 9.4 x 10(4), respectively, it was concluded that the enzyme exists as an alpha beta heterodimer in this buffer system. In a Tris buffer system, pH 7.9, containing 0.46 M NaCl and 4% glycerol, the native enzyme also sedimented as a homogenous particle with an apparent sedimentation coefficient of (10.1 +/- 0.5) S, without considering the effect of glycerol on solvent-protein interaction. Based on the results of Gekko and Timasheff (Gekko, K., and Timasheff, S. N. (1981) Biochemistry 20, 4667-4676) and the polarity of the enzyme, it was estimated that there is significant solvent-protein interaction even at 4% glycerol leading to a value of -0.06 g/g in the preferential solvent interaction parameter. When the solvent effect was taken into consideration, the value for So20,w increased from 10.1 to 11.9 S, implying that the native enzyme dimerizes in the presence of 4% glycerol. The combined results of gel filtration and sedimentation velocity showed that the dimerization of the enzyme to form (alpha beta)2 is favored at 20-degrees-C with the alpha beta form predominanting at 4-degrees-C. The secondary structure of the reverse transcriptase was measured by circular dichroism. Results showed that the enzyme consists of (16 +/- 2) % alpha-helix, (24 +/- 2) % beta-sheet, (24 +/- 2) % beta-turn, and (36 +/- 4) % undefined structures.	ST LOUIS UNIV,SCH MED,INST MOLEC VIROL,ST LOUIS,MO 63104; ST LOUIS UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,ST LOUIS,MO 63104; BOSTON UNIV,SCH MED,HOUSEMAN MED RES CTR,INST BIOPHYS,DEPT MED,BOSTON,MA 02118; BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118	Saint Louis University; Saint Louis University; Boston University; Boston University					NATIONAL CANCER INSTITUTE [R01CA016312] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL026335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021489] Funding Source: NIH RePORTER; NCI NIH HHS [CA16312] Funding Source: Medline; NHLBI NIH HHS [HL26335] Funding Source: Medline; NIDDK NIH HHS [DK21489] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIGELOW CC, 1967, J THEOR BIOL, V16, P187, DOI 10.1016/0022-5193(67)90004-5; BULL HB, 1968, ARCH BIOCHEM BIOPHYS, V128, P488, DOI 10.1016/0003-9861(68)90055-6; CALHOUN DB, 1985, BIOCHEMISTRY-US, V24, P2095, DOI 10.1021/bi00329a043; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; COHEN G, 1968, BIOPOLYMERS, V6, P1077, DOI 10.1002/bip.1968.360060805; COHN EJ, 1943, PROTEINS AMINO ACIDS, P372; EDSALL JT, 1953, PROTEINS           B, V1, P549; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P2677; GERARD GF, 1980, MOL BIOL RNA TUMOR V, P345; GERARD GF, 1983, ENZYMES NUCLEIC ACID, V1, P1; GOLOMB M, 1979, J BIOL CHEM, V254, P1606; GRANDGENETT DP, 1973, P NATL ACAD SCI USA, V70, P230, DOI 10.1073/pnas.70.1.230; HESTERBERG LK, 1981, BIOCHEMISTRY-US, V20, P2974, DOI 10.1021/bi00513a040; HESTERBERG LK, 1980, BIOCHEMISTRY-US, V19, P2030, DOI 10.1021/bi00551a004; HIZI A, 1977, J BIOL CHEM, V252, P2281; KACIAN DL, 1971, BIOCHIM BIOPHYS ACTA, V246, P365, DOI 10.1016/0005-2787(71)90773-8; KUNTZ ID, 1971, J AM CHEM SOC, V93, P514, DOI 10.1021/ja00731a036; LEE JC, 1977, BIOCHEMISTRY-US, V16, P1754, DOI 10.1021/bi00627a037; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; MAO D, 1982, BIOCHEMISTRY-US, V21, P4960, DOI 10.1021/bi00263a020; NA GC, 1981, J MOL BIOL, V151, P165, DOI 10.1016/0022-2836(81)90226-6; NA GC, 1986, BIOCHEMISTRY-US, V25, P967, DOI 10.1021/bi00353a004; QUINN TP, 1988, J VIROL, V62, P2307, DOI 10.1128/JVI.62.7.2307-2312.1988; SCHACHMAN HK, 1966, BIOCHEMISTRY-US, V5, P2681, DOI 10.1021/bi00872a029; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; SOLTIS DA, 1988, P NATL ACAD SCI USA, V85, P3372, DOI 10.1073/pnas.85.10.3372; Svedberg T, 1940, THE ULTRACENTRIFUGE; TANFORD C, 1960, PHYSICAL CHEM MACROM, P364; TEMIN HM, 1972, ADV VIRUS RES, V17, P127; VARMUS H, 1984, RNA TUMOR VIRUSES, P369; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003	32	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1635	1640						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703151				2022-12-27	WOS:A1991EU49700044
J	MURRAY, R; SHIPP, E; FITZGERALD, GA				MURRAY, R; SHIPP, E; FITZGERALD, GA			PROSTAGLANDIN ENDOPEROXIDE THROMBOXANE-A2 RECEPTOR DESENSITIZATION - CROSS-TALK WITH ADENYLATE-CYCLASE IN HUMAN PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											MURRAY, R (corresponding author), VANDERBILT UNIV,DIV CLIN PHARMACOL,NASHVILLE,TN 37232, USA.		FitzGerald, Garret A/A-4222-2010		NHLBI NIH HHS [HL30400] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030400] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BEST LC, 1979, BIOCHIM BIOPHYS ACTA, V583, P344, DOI 10.1016/0304-4165(79)90458-6; BRASS LF, 1988, J BIOL CHEM, V263, P5348; BRASS LF, 1987, J CLIN INVEST, V79, P1269, DOI 10.1172/JCI112947; BRASS LF, 1986, J BIOL CHEM, V261, P6838; CARONI P, 1981, J BIOL CHEM, V256, P3263; CROUCH MF, 1989, J BIOL CHEM, V264, P584; CROUCH MF, 1988, J BIOL CHEM, V263, P3363; FEINSTEIN MB, 1983, BIOCHEM BIOPH RES CO, V113, P598, DOI 10.1016/0006-291X(83)91768-0; FITZGERALD DJ, 1988, J CLIN INVEST, V82, P1708, DOI 10.1172/JCI113784; FITZGERALD GA, 1984, NEW ENGL J MED, V310, P1075; GO M, 1988, BIOCHEM BIOPH RES CO, V153, P51; GORMAN RR, 1977, PROSTAGLANDINS, V13, P377, DOI 10.1016/0090-6980(77)90018-1; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMBERG M, 1974, P NATL ACAD SCI USA, V71, P345, DOI 10.1073/pnas.71.2.345; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; JAKOBS KH, 1985, EUR J BIOCHEM, V151, P425, DOI 10.1111/j.1432-1033.1985.tb09119.x; JEREMY JY, 1985, EUR J PHARMACOL, V107, P259, DOI 10.1016/0014-2999(85)90066-4; KAMBAYASHI J, 1981, THROMB RES, V22, P553, DOI 10.1016/0049-3848(81)90053-0; KASSIS S, 1985, J BIOL CHEM, V260, P8911; KATADA T, 1985, EUR J BIOCHEM, V151, P431, DOI 10.1111/j.1432-1033.1985.tb09120.x; KELLEHER DJ, 1984, P NATL ACAD SCI-BIOL, V81, P4316, DOI 10.1073/pnas.81.14.4316; LAPETINA EG, 1983, LIFE SCI, V32, P2069, DOI 10.1016/0024-3205(83)90094-2; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; MACINTYRE DE, 1985, FEBS LETT, V180, P160, DOI 10.1016/0014-5793(85)81063-2; MARCUS AJ, 1980, J CLIN INVEST, V73, P1105; MILLAR J, 1988, NATURE, V331, P492, DOI 10.1038/331492b0; MURAYAMA T, 1989, J BIOL CHEM, V264, P15186; MURRAY R, 1989, P NATL ACAD SCI USA, V86, P124, DOI 10.1073/pnas.86.1.124; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; POLLOCK WK, 1987, FEBS LETT, V210, P132, DOI 10.1016/0014-5793(87)81322-4; SALMON Y, 1974, ANAL BIOCHEM, V58, P541; SAUSSY DL, 1986, J BIOL CHEM, V261, P3025; SCHWERTSCHLAG US, 1988, J BIOL CHEM, V263, P13791; SEISS W, 1989, BIOCHEM J, V258, P57; SHEPHERD GL, 1983, BRIT J CLIN PHARMACO, V15, P77, DOI 10.1111/j.1365-2125.1983.tb01467.x; SIBLEY DR, 1984, BIOCHEM BIOPH RES CO, V121, P973, DOI 10.1016/0006-291X(84)90772-1; SNEDECOR GW, 1967, STATISTICAL METHODS, P3; STRASSER RH, 1986, P NATL ACAD SCI USA, V83, P6362, DOI 10.1073/pnas.83.17.6362; TAKAHARA K, 1990, J BIOL CHEM, V265, P6836; TROYER DA, 1988, BIOCHEM J, V251, P907, DOI 10.1042/bj2510907; WATSON SP, 1986, J BIOL CHEM, V261, P5368; WATSON SP, 1984, J BIOL CHEM, V259, P3199; WHEELERJONES CPD, 1989, BIOCHEM J, V263, P969, DOI 10.1042/bj2630969; WILLIAMS KA, 1987, BIOCHEM J, V243, P667, DOI 10.1042/bj2430667	46	74	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21670	21675						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1701435				2022-12-27	WOS:A1990EM45600048
J	ENYEART, JJ; BIAGI, BA; DAY, RN; SHEU, SS; MAURER, RA				ENYEART, JJ; BIAGI, BA; DAY, RN; SHEU, SS; MAURER, RA			BLOCKADE OF LOW AND HIGH THRESHOLD CA-2+ CHANNELS BY DIPHENYLBUTYLPIPERIDINE ANTIPSYCHOTICS LINKED TO INHIBITION OF PROLACTIN GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV IOWA,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242; UNIV ROCHESTER,SCH MED & DENT,DEPT PHARMACOL,ROCHESTER,NY 14642; OHIO STATE UNIV,DEPT PHYSIOL,COLUMBUS,OH 43210	University of Iowa; University of Rochester; Ohio State University	ENYEART, JJ (corresponding author), OHIO STATE UNIV,DEPT PHARMACOL,5188 GRAVES HALL,333 W 10TH AVE,COLUMBUS,OH 43210, USA.		Sheu, Shey-Shing/Y-4009-2019	Sheu, Shey-Shing/0000-0003-3838-3601	NHLBI NIH HHS [HL-33333] Funding Source: Medline; NIDDK NIH HHS [DK-40131, DK-36407] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK040131, R01DK036407] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMSTRONG CM, 1985, SCIENCE, V227, P65, DOI 10.1126/science.2578071; BANCROFT C, 1985, BIOCHEM ACTION HORM, V12, P173; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; COHEN CJ, 1987, J PHYSIOL-LONDON, V387, P195, DOI 10.1113/jphysiol.1987.sp016570; COTA G, 1986, J GEN PHYSIOL, V88, P83, DOI 10.1085/jgp.88.1.83; DAY RN, 1990, MOL ENDOCRINOL, V4, P736, DOI 10.1210/mend-4-5-736; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ENYEART JJ, 1987, J BIOL CHEM, V262, P3154; ENYEART JJ, 1985, AM J PHYSIOL, V248, pC510, DOI 10.1152/ajpcell.1985.248.5.C510; ENYEART JJ, 1987, AM J PHYSIOL, V253, pC162, DOI 10.1152/ajpcell.1987.253.1.C162; ENYEART JJ, 1990, MOL PHARMACOL, V37, P752; ENYEART JJ, 1990, MOL ENDOCRINOL, V41, P727; GALIZZI JP, 1986, P NATL ACAD SCI USA, V83, P7513, DOI 10.1073/pnas.83.19.7513; GICK GG, 1985, J BIOL CHEM, V260, P7614; GOULD RJ, 1983, P NATL ACAD SCI-BIOL, V80, P5122, DOI 10.1073/pnas.80.16.5122; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; HAMILL OP, 1981, PFLUEGERS ARCH, V398, P284; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; HINKLE PM, 1988, MOL ENDOCRINOL, V2, P1132, DOI 10.1210/mend-2-11-1132; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JACKSON AE, 1988, MOL ENDOCRINOL, V2, P1139, DOI 10.1210/mend-2-11-1139; KANAYA S, 1983, J MOL CELL CARDIOL, V15, P145, DOI 10.1016/0022-2828(83)90291-2; KIDOKORO Y, 1975, NATURE, V258, P741, DOI 10.1038/258741a0; LAVERRIERE JN, 1983, EMBO J, V2, P1493, DOI 10.1002/j.1460-2075.1983.tb01613.x; LEVIN RW, 1979, J PHARMACOL EXP THER, V208, P453; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MURDOCH GH, 1983, J BIOL CHEM, V258, P5329; MURDOCH GH, 1985, BIOCHEM ACTION HORM, V12, P36; OZAWA S, 1979, P NATL ACAD SCI USA, V76, P6017, DOI 10.1073/pnas.76.11.6017; PRESTON GM, 1990, MOL CELL BIOL, V10, P442, DOI 10.1128/MCB.10.2.442; SANGUINETTI MC, 1984, CIRC RES, V55, P336, DOI 10.1161/01.RES.55.3.336; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUZUKI S, 1989, P NATL ACAD SCI USA, V86, P7228, DOI 10.1073/pnas.86.18.7228; TANG CM, 1988, SCIENCE, V240, P213, DOI 10.1126/science.2451291; TARASKEVICH PS, 1980, NEUROSCIENCE, V5, P421, DOI 10.1016/0306-4522(80)90117-7; TASHJIAN AH, 1968, ENDOCRINOLOGY, V82, P342, DOI 10.1210/endo-82-2-342; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VEHARA A, 1985, J GEN PHYSIOL, V85, P621; WHITE BA, 1981, J BIOL CHEM, V256, P5942; YAARI Y, 1987, SCIENCE, V235, P680, DOI 10.1126/science.2433765	42	50	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16373	16379						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697857				2022-12-27	WOS:A1990DZ95000053
J	HATCH, CL; BONNER, WM				HATCH, CL; BONNER, WM			THE HUMAN HISTONE H2A.Z GENE - SEQUENCE AND REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											HATCH, CL (corresponding author), NCI,DIV CANC TREATMENT,MOLECUL PHARMACOL LAB,BLDG 37,RM 5C25,9000 ROCKVILLE PIKE,BETHESDA,MD 20892, USA.							ALLIS CD, 1986, J BIOL CHEM, V261, P1941; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; BRUSH D, 1985, MOL CELL BIOL, V5, P1307, DOI 10.1128/MCB.5.6.1307; CHALLONER PB, 1989, MOL CELL BIOL, V9, P902, DOI 10.1128/MCB.9.3.902; CHENG GH, 1989, P NATL ACAD SCI USA, V86, P7002, DOI 10.1073/pnas.86.18.7002; CHODOSH LA, 1988, CELL, V53, P25, DOI 10.1016/0092-8674(88)90484-9; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; DALTON S, 1989, NUCLEIC ACIDS RES, V17, P1745, DOI 10.1093/nar/17.4.1745; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; ERNST SG, 1987, NUCLEIC ACIDS RES, V15, P4629, DOI 10.1093/nar/15.11.4629; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FELGNER PL, 1989, BRL FOCUS, V11, P21; GABRIELLI F, 1981, EUR J BIOCHEM, V120, P363, DOI 10.1111/j.1432-1033.1981.tb05713.x; GHOSH PK, 1978, J MOL BIOL, V126, P813, DOI 10.1016/0022-2836(78)90022-0; GICK O, 1987, P NATL ACAD SCI USA, V84, P8937, DOI 10.1073/pnas.84.24.8937; GILMAN M, 1987, CURRENT PROTOCOLS MO; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GREEN GR, 1989, DEV BIOL, V134, P413, DOI 10.1016/0012-1606(89)90113-9; GREENBERG ME, 1987, CURRENT PROTOCOLS MO; HARVEY RP, 1983, P NATL ACAD SCI-BIOL, V80, P2819, DOI 10.1073/pnas.80.10.2819; HATCH CL, 1988, NUCLEIC ACIDS RES, V16, P1113, DOI 10.1093/nar/16.3.1113; HENTSCHEL CC, 1981, CELL, V25, P301, DOI 10.1016/0092-8674(81)90048-9; HUANG SY, 1986, P NATL ACAD SCI USA, V83, P3738, DOI 10.1073/pnas.83.11.3738; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; LEVINE M, 1989, CELL, V59, P405, DOI 10.1016/0092-8674(89)90024-X; Maniatis T., 1982, MOL CLONING; MANNIRONI C, 1989, NUCLEIC ACIDS RES, V17, P9113, DOI 10.1093/nar/17.22.9113; MARZLUFF WF, 1988, TRENDS BIOCHEM SCI, V13, P49, DOI 10.1016/0968-0004(88)90027-8; MAXSON R, 1983, ANNU REV GENET, V17, P239, DOI 10.1146/annurev.ge.17.120183.001323; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MCKNIGHT SL, 1984, CELL, V37, P253, DOI 10.1016/0092-8674(84)90321-0; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; MUELLER RD, 1985, J BIOL CHEM, V260, P5147; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; NEVINS JR, 1987, METHOD ENZYMOL, V152, P234; NICKEL BE, 1987, BIOCHEMISTRY-US, V26, P4427; PANTAZIS P, 1984, DIFFERENTIATION, V28, P186, DOI 10.1111/j.1432-0436.1984.tb00282.x; RIDSDALE JA, 1987, NUCLEIC ACIDS RES, V15, P1081, DOI 10.1093/nar/15.3.1081; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID CW, 1982, SCIENCE, V216, P1065, DOI 10.1126/science.6281889; SCHUMPERLI D, 1988, TRENDS GENET, V4, P187, DOI 10.1016/0168-9525(88)90074-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEIN G, 1989, P NATL ACAD SCI USA, V86, P1865, DOI 10.1073/pnas.86.6.1865; TRIPPUTI P, 1986, P NATL ACAD SCI USA, V83, P3185, DOI 10.1073/pnas.83.10.3185; VANDAAL A, 1990, J MOL EVOL, V30, P449, DOI 10.1007/BF02101116; VANDAAL A, 1988, NUCLEIC ACIDS RES, V16, P7487, DOI 10.1093/nar/16.15.7487; VANWIJNEN AJ, 1989, J BIOL CHEM, V264, P15034; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WELLS D, 1987, NUCLEIC ACIDS RES, V15, P2871, DOI 10.1093/nar/15.7.2871; WELLS D, 1985, P NATL ACAD SCI USA, V82, P2834, DOI 10.1073/pnas.82.9.2834; WEST MHP, 1980, BIOCHEMISTRY-US, V19, P3238, DOI 10.1021/bi00555a022; WHITE EM, 1988, NUCLEIC ACIDS RES, V16, P179, DOI 10.1093/nar/16.1.179; WU RS, 1982, J CELL BIOL, V93, P426, DOI 10.1083/jcb.93.2.426; WU RS, 1986, CRIT REV BIOCHEM MOL, V20, P201, DOI 10.3109/10409238609083735; WU RS, 1982, CELL, V31, P367, DOI 10.1016/0092-8674(82)90130-1; WU RS, 1981, CELL, V27, P321, DOI 10.1016/0092-8674(81)90415-3	70	58	60	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					15211	15218						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697587				2022-12-27	WOS:A1990DX40000081
J	LEE, DN; PHUNG, L; STEWART, J; LANDICK, R				LEE, DN; PHUNG, L; STEWART, J; LANDICK, R			TRANSCRIPTION PAUSING BY ESCHERICHIA-COLI RNA-POLYMERASE IS MODULATED BY DOWNSTREAM DNA-SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WASHINGTON UNIV,DEPT BIOL,ST LOUIS,MO 63130; WASHINGTON UNIV,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63130	Washington University (WUSTL); Washington University (WUSTL)					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038660, R37GM038660, R01GM038660] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-38660] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Ausubel FM, 1988, MOL REPROD DEV; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BURGESS RR, 1975, BIOCHEMISTRY-US, V14, P4634, DOI 10.1021/bi00692a011; Chamberlin M., 1976, RNA POLYMERASE, V6, P193; CHAN CL, 1989, J BIOL CHEM, V264, P20796; CONNOLLY BA, 1987, NUCLEIC ACIDS RES, V15, P3131, DOI 10.1093/nar/15.7.3131; CSORDASTOTH E, 1979, NUCLEIC ACIDS RES, V7, P2189, DOI 10.1093/nar/7.8.2189; Dahlberg JE, 1973, VIRUS RES, P533; DARLIX JL, 1975, NATURE, V256, P288, DOI 10.1038/256288a0; DARST SA, 1989, NATURE, V340, P730, DOI 10.1038/340730a0; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; FARNHAM PJ, 1980, CELL, V20, P739, DOI 10.1016/0092-8674(80)90320-7; FISHER R, 1983, J BIOL CHEM, V258, P9208; FISHER RF, 1983, J BIOL CHEM, V258, P8146; FISHER RF, 1985, J MOL BIOL, V182, P397, DOI 10.1016/0022-2836(85)90199-8; GILBERT W, 1973, COLD SPRING HARB SYM, V38, P845; GRAYHACK EJ, 1985, CELL, V42, P259, DOI 10.1016/S0092-8674(85)80121-5; GRIBSKOV M, 1983, GENE, V26, P109, DOI 10.1016/0378-1119(83)90180-4; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; KELLER EB, 1979, P NATL ACAD SCI USA, V76, P6186, DOI 10.1073/pnas.76.12.6186; KERPPOLA TK, 1990, BIOCHEMISTRY-US, V29, P269, DOI 10.1021/bi00453a037; KINGSTON RE, 1981, CELL, V27, P523, DOI 10.1016/0092-8674(81)90394-9; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LANDICK R, 1987, J MOL BIOL, V196, P363, DOI 10.1016/0022-2836(87)90697-8; LANDICK R, 1984, J BIOL CHEM, V259, P1550; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; LANDICK R, 1987, P NATL ACAD SCI USA, V84, P1507, DOI 10.1073/pnas.84.6.1507; LANDICK R, 1987, RNA POLYM REGULATION, P441; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LEVIN JR, 1987, J MOL BIOL, V196, P85, DOI 10.1016/0022-2836(87)90512-2; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; MAIZELS NM, 1973, P NATL ACAD SCI USA, V70, P3585, DOI 10.1073/pnas.70.12.3585; MITCHELL LG, 1989, ANAL BIOCHEM, V178, P239, DOI 10.1016/0003-2697(89)90631-3; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; REISBIG RR, 1981, BIOCHEMISTRY-US, V20, P1907, DOI 10.1021/bi00510a029; ROESSER JR, 1989, J BIOL CHEM, V264, P12284; ROESSER JR, 1988, J BIOL CHEM, V263, P14251; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMIDT MC, 1984, BIOCHEMISTRY-US, V23, P197, DOI 10.1021/bi00297a004; SHI YB, 1988, J MOL BIOL, V199, P277, DOI 10.1016/0022-2836(88)90314-2; STUDIER FW, 1981, J MOL BIOL, V153, P503, DOI 10.1016/0022-2836(81)90405-8; TELESNITSKY A, 1989, BIOCHEMISTRY-US, V28, P5210, DOI 10.1021/bi00438a044; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VONHIPPEL PH, 1986, P NATL ACAD SCI USA, V83, P1608; WINKLER ME, 1981, BIOCHEMISTRY-US, V20, P3738, DOI 10.1021/bi00516a011; YAGER TD, 1990, IN PRESS BIOCHEMISTR; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	53	69	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					15145	15153						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697586				2022-12-27	WOS:A1990DX40000072
J	LASH, JA; CRITSER, ES; PRESSLER, ML				LASH, JA; CRITSER, ES; PRESSLER, ML			CLONING OF A GAP JUNCTIONAL PROTEIN FROM VASCULAR SMOOTH-MUSCLE AND EXPRESSION IN 2-CELL MOUSE EMBRYOS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									INDIANA UNIV,SCH MED,DEPT PHYSIOL & BIOPHYS,INDIANAPOLIS,IN 46202; RICHARD L ROUDEBUSH VET ADM MED CTR,INDIANAPOLIS,IN 46202; METHODIST CTR REPROD & TRANSPLANTAT IMMUNOL,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System	LASH, JA (corresponding author), INDIANA UNIV,SCH MED,DEPT MED,KRANNERT INST CARDIOL,1001 W 10TH ST,INDIANAPOLIS,IN 46202, USA.				NHLBI NIH HHS [HLO1451, HLO1303] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K11HL001451, K08HL001303] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ausubel FM, 1988, MOL REPROD DEV; BARR L, 1965, J GEN PHYSIOL, V48, P797, DOI 10.1085/jgp.48.5.797; BARR L, 1968, J GEN PHYSIOL, V51, P347, DOI 10.1085/jgp.51.3.347; BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Bennett MVL, 1978, NEUROSCI RES PROG B, V16, P373; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BLENNERHASSETT MG, 1987, AM J PHYSIOL, V252, pC555, DOI 10.1152/ajpcell.1987.252.5.C555; BURT JM, 1988, AM J PHYSIOL, V254, pH1206, DOI 10.1152/ajpheart.1988.254.6.H1206; CAVENEY S, 1985, ANNU REV PHYSIOL, V47, P319; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; DAHL G, 1987, SCIENCE, V236, P1290, DOI 10.1126/science.3035715; DILLEY RJ, 1987, ATHEROSCLEROSIS, V63, P99, DOI 10.1016/0021-9150(87)90109-2; EBIHARA L, 1989, SCIENCE, V243, P1194, DOI 10.1126/science.2466337; GIMLICH RL, 1988, J CELL BIOL, V107, P1065, DOI 10.1083/jcb.107.3.1065; GREEN CR, 1988, PROC R SOC SER B-BIO, V233, P165, DOI 10.1098/rspb.1988.0016; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HERTZBERG EL, 1988, J BIOL CHEM, V263, P19105; KISTLER J, 1988, NATURE, V331, P721, DOI 10.1038/331721a0; KUMAR NM, 1986, J CELL BIOL, V103, P767, DOI 10.1083/jcb.103.3.767; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSON DM, 1987, MICROVASC RES, V34, P184, DOI 10.1016/0026-2862(87)90052-5; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; LOEWENSTEIN WR, 1987, CELL, V48, P725, DOI 10.1016/0092-8674(87)90067-5; MANJUNATH CK, 1985, AM J PHYSIOL, V248, pH783, DOI 10.1152/ajpheart.1985.248.6.H783; MAURER P, 1987, PFLUG ARCH EUR J PHY, V409, P394, DOI 10.1007/BF00583793; MCCLELLAND P, 1989, J BIOL CHEM, V264, P17428; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; NICHOLSON B, 1987, NATURE, V329, P732, DOI 10.1038/329732a0; NICHOLSON BJ, 1985, J BIOL CHEM, V260, P6514; NOMA A, 1987, J PHYSIOL-LONDON, V382, P193, DOI 10.1113/jphysiol.1987.sp016363; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; PEPPER MS, 1989, J CELL BIOL, V109, P3027, DOI 10.1083/jcb.109.6.3027; PERACCHIA C, 1985, AM J PHYSIOL, V248, pH765, DOI 10.1152/ajpheart.1985.248.6.H765; RANDRIAMAMPITA C, 1988, PFLUG ARCH EUR J PHY, V412, P462, DOI 10.1007/BF00582534; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; ROBL JM, 1986, BIOL REPROD, V34, P733, DOI 10.1095/biolreprod34.4.733; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; SWENSON KI, 1989, CELL, V57, P145, DOI 10.1016/0092-8674(89)90180-3; THYBERG J, 1985, CELL TISSUE RES, V239, P69, DOI 10.1007/BF00214904; UNWIN PNT, 1980, NATURE, V283, P545, DOI 10.1038/283545a0; WERNER R, 1989, P NATL ACAD SCI USA, V86, P5380, DOI 10.1073/pnas.86.14.5380; WHITE RL, 1985, AM J PHYSIOL, V249, pC447, DOI 10.1152/ajpcell.1985.249.5.C447; Whitten WK, 1971, ADV BIOSCI, V6, P129, DOI DOI 10.1016/B978-0-08-017571-3.50013-9; YANCEY SB, 1989, J CELL BIOL, V108, P2241, DOI 10.1083/jcb.108.6.2241; YOUNG JDE, 1987, CELL, V48, P733, DOI 10.1016/0092-8674(87)90071-7; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391; ZIMMER DB, 1987, J BIOL CHEM, V262, P7751	48	39	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13113	13117						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695901				2022-12-27	WOS:A1990DR20100056
J	JENA, BP; PADFIELD, PJ; INGEBRITSEN, TS; JAMIESON, JD				JENA, BP; PADFIELD, PJ; INGEBRITSEN, TS; JAMIESON, JD			PROTEIN TYROSINE PHOSPHATASE STIMULATES CA2+-DEPENDENT AMYLASE SECRETION FROM PANCREATIC ACINI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							DIFFERENT EXOCRINE GLANDS; HUMAN-PLACENTA; MAST-CELLS; POLYPEPTIDES OCCURS; GRANULE MEMBRANES; COMMON SPECTRUM; EXOCYTOSIS; BINDING	Eukaryotic cells respond to various stimuli by an increase or decrease in levels of phosphoproteins. Phosphotyrosine levels on eukaryotic cellular proteins are tightly regulated by the opposing actions of protein-tyrosine kinases and protein-tyrosine phosphatases (PTPases, EC 3.1.3.48). Studies on permeabilized mast cells suggest that the enabling reaction for exocytosis might involve protein dephosphorylation. In the present studies, a recombinant form of rat brain PTPase (rrbPTP-1) has been used to examine the potential role of PTPases in Ca2+-dependent amylase secretion from permeabilized rat pancreatic acini. Additionally, the concentrations and subcellular distributions of endogenous PTPase activity in rat pancreas were determined. The results from these experiments indicate that addition of exogenous PTPase stimulated Ca2+-dependent amylase secretion from pancreatic acinar cells and that endogenous PTPase activity was associated with the postgranule supernatant, zymogen granules, and in particular zymogen granule membranes. Our data suggest that protein tyrosine dephosphorylation is potentially involved in regulated secretion at a site(s) distal to receptor-mediated elevation of intracellular second messengers.	IOWA STATE UNIV SCI & TECHNOL,DEPT ZOOL & GENET,AMES,IA 50011	Iowa State University	JENA, BP (corresponding author), YALE UNIV,SCH MED,DEPT CELL BIOL,C222,SHM,333 CEDAR ST,NEW HAVEN,CT 06510, USA.				NCI NIH HHS [CA46128] Funding Source: Medline; NIDDK NIH HHS [DK17389] Funding Source: Medline; NIGMS NIH HHS [GM38415] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK017389, R01DK017389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038415] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONIW JF, 1976, EUR J BIOCHEM, V68, P44; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREW K, 1975, J BIOL CHEM, V250, P1434; BRUZZONE R, 1985, BIOCHEM J, V226, P621, DOI 10.1042/bj2260621; CAMERON RS, 1986, J CELL BIOL, V103, P1299, DOI 10.1083/jcb.103.4.1299; CHARBONNEAU H, 1989, P NATL ACAD SCI USA, V86, P5252, DOI 10.1073/pnas.86.14.5252; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; COCKCROFT S, 1987, J CELL BIOL, V105, P2745, DOI 10.1083/jcb.105.6.2745; FINDLAY L, 1958, BIOCHEM J, V69, P469; GOMPERTS BD, 1988, COLD SPRING HARB SYM, V53, P983, DOI 10.1101/SQB.1988.053.01.113; GOMPERTS BD, 1990, ANNU REV PHYSIOL, V52, P591; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; HOWELL TW, 1987, J CELL BIOL, V105, P191, DOI 10.1083/jcb.105.1.191; INGEBRITSEN TS, 1989, ADV PROT PHOSPHATASE, V5, P121; INGEBRITSEN TS, IN PRESS METHODS ENZ; Johnson R A, 1979, Adv Cyclic Nucleotide Res, V10, P135; PADFIELD PJ, 1991, BIOCHEM BIOPH RES CO, V174, P600, DOI 10.1016/0006-291X(91)91459-P; ROSENZWEIG SA, 1983, J CELL BIOL, V96, P1288, DOI 10.1083/jcb.96.5.1288; SOTTOCASA GL, 1967, J CELL BIOL, V32, P417; TATHAM PER, 1989, BIOSCIENCE REP, V9, P99, DOI 10.1007/BF01117516; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; TREADWAY JL, 1989, J BIOL CHEM, V264, P15136; VONZASTROW M, 1987, J CELL BIOL, V105, P2675, DOI 10.1083/jcb.105.6.2675; WAGNER PD, 1990, J BIOL CHEM, V265, P10352	26	56	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17744	17746						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717440				2022-12-27	WOS:A1991GG55300007
J	MARIN, O; DONELLADEANA, A; BRUNATI, AM; FISCHER, S; PINNA, LA				MARIN, O; DONELLADEANA, A; BRUNATI, AM; FISCHER, S; PINNA, LA			PEPTIDES REPRODUCING THE PHOSPHOACCEPTOR SITES OF PP60C-SRC AS SUBSTRATES FOR TPK-IIB, A SPLENIC TYROSINE KINASE DEVOID OF AUTOPHOSPHORYLATION ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASES; SYNTHETIC PEPTIDES; PARTICULATE-FRACTION; PHOSPHORYLATION; SPLEEN; SPECIFICITY; RECEPTOR; P56LCK; VIRUS	TPK-IIB, a spleen tyrosine protein kinase devoid of autophosphorylation activity (Brunati, A. M., and Pinna, L. A. (1988) Eur. J. Biochem. 172, 451-457), has been purified to near homogeneity and assayed for its ability to phosphorylate the synthetic peptides EDNEYTA and EPQYQPA reproducing the two conserved phosphoacceptor sites of pp60c-src (Tyr-416 and Tyr-527). While EPQYQPA was phosphorylated with low efficiency (K(m) = 16.7 mM, K(cat) = 14.4), EDNEYTA is an excellent substrate displaying a K(m) value of 58-mu-M and a K(cat) value of 31.2. The single substitution, in the latter peptide, of the glutamic acid adjacent to the tyrosine by alanine to give EDNAYTA caused a 6-fold increase in the K(m). The positive influence on the phosphorylation of the acidic residues at -3 and -4 relative to the tyrosine is indicated by comparison of the kinetic constants for peptides EDAAYAA (K(cat) = 4.6, K(m) 0.325 mM) and QNAAYAA (K(cat) 2.4, K(m) 1.7 mM). Furthermore, when residues in the peptide NEYTA were replaced by alanine, the phosphorylation of the peptides NAYTA and AAYAA, was almost negligible (in terms of K(cat)/K(m) ratio). However AEYTA, NEYAA and AEYAA were still phosphorylated, albeit less efficiently than NEYTA. The probability that these peptides will adopt a beta-turn is EDNAYTA = EDNEYTA, NAYTA > NEYTA, and no predicted beta-turn for AEYTA, NEYAA, and AEYAA. Therefore these results support the concept that an amino-terminal acidic residue(s) is strictly required by TPK-IIB, irrespective of peptide conformation, although a beta-turn may enhance the phosphorylation of those peptides that satisfy this requirement. Two other spleen tyrosine kinases, TPK-I/lyn and TPK-III, both related to the src family, also have a far greater preference for the peptide EDNEYTA over EPQYQPA. However, they can be distinguished from TPK-IIB by their lower affinity for the peptides ED-NEYTA and NEYTA and by their different specificity towards the substituted derivatives of NEYTA. TPK-I/lyn, accepts most of the substitutions that are detrimental to TPK-IIB, the triply substituted peptide AAYAA being actually preferred over the parent peptide NEYTA. The substitution of glutamic acid by alanine is also tolerated by TPK-III, although, in contrast to TPK-IIB, the phosphorylation efficiency is drastically decreased by the substitution of the asparagine at position -2. Taken together these data would indicate that the highly conserved phosphoacceptor site, homologous to pp60c-src Tyr-416, is optimally configured for the specificity requirements of TPK-IIB, suggesting that TPK-IIB or tyrosine protein kinases with similar specificity might be involved in the phosphorylation of the members of the src family.	UNIV PADUA,CTR STUDIO FISIOL MITOCONDRIALE NAZL RIC,I-35100 PADUA,ITALY; INSERM,U332,F-75005 PARIS,FRANCE	University of Padua; Institut National de la Sante et de la Recherche Medicale (Inserm)	MARIN, O (corresponding author), UNIV PADUA,DIPARTMENTO CHIM BIOL,I-35100 PADUA,ITALY.		Brunati, Anna Maria/I-8136-2018	Brunati, Anna Maria/0000-0002-3481-9503				BATZER AG, 1990, EUR J BIOCHEM, V194, P251, DOI 10.1111/j.1432-1033.1990.tb19450.x; BRUNATI AM, 1989, FEBS LETT, V254, P145, DOI 10.1016/0014-5793(89)81027-0; BRUNATI AM, 1988, EUR J BIOCHEM, V172, P451, DOI 10.1111/j.1432-1033.1988.tb13909.x; BRUNATI AM, 1991, BIOCHIM BIOPHYS ACTA, V1091, P123, DOI 10.1016/0167-4889(91)90232-M; CASNELLIE JE, 1984, ADV ENZYME REGUL, V22, P501, DOI 10.1016/0065-2571(84)90028-1; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; COLA C, 1989, BIOCHIM BIOPHYS ACTA, V1012, P191, DOI 10.1016/0167-4889(89)90095-5; Cooper J.A, 1990, PEPT PROT PHOSPH, P85; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; COURTNEIDGE SA, 1984, EMBO J, V3, P585, DOI 10.1002/j.1460-2075.1984.tb01852.x; DANIELIAN S, 1989, EUR J IMMUNOL, V19, P2183, DOI 10.1002/eji.1830191202; FOULKES JG, 1985, J BIOL CHEM, V260, P8070; GEAHLEN RL, 1990, PEPT PROT PHOSPH, P239; KEMP BE, 1975, P NATL ACAD SCI USA, V72, P3448, DOI 10.1073/pnas.72.9.3448; KMIECIK TE, 1988, MOL CELL BIOL, V8, P4541, DOI 10.1128/MCB.8.10.4541; MEGGIO F, 1976, ANAL BIOCHEM, V71, P283; OKADA M, 1989, J BIOL CHEM, V264, P20886; TINKER DA, 1988, J BIOL CHEM, V263, P5024; WONG TW, 1983, J BIOL CHEM, V258, P1022; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237	22	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17798	17803						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717442				2022-12-27	WOS:A1991GG55300016
J	LOWE, JB; KUKOWSKALATALLO, JF; NAIR, RP; LARSEN, RD; MARKS, RM; MACHER, BA; KELLY, RJ; ERNST, LK				LOWE, JB; KUKOWSKALATALLO, JF; NAIR, RP; LARSEN, RD; MARKS, RM; MACHER, BA; KELLY, RJ; ERNST, LK			MOLECULAR-CLONING OF A HUMAN FUCOSYL-TRANSFERASE GENE THAT DETERMINES EXPRESSION OF THE LEWIS-X AND VIM-2 EPITOPES BUT NOT ELAM-1-DEPENDENT CELL-ADHESION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-L-FUCOSE; D-GALACTOSIDE 2-ALPHA-L-FUCOSYLTRANSFERASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; MYELOGENOUS LEUKEMIA-CELLS; SIALYL-LEX DETERMINANT; HAMSTER OVARY CELLS; BLOOD GROUP-A; MONOCLONAL-ANTIBODY; EMBRYONIC ANTIGEN; MESSENGER-RNA	We have used the human Lewis blood group fucosyltransferase cDNA and cross-hybridization procedures to isolate a human gene that encodes a distinct fucosyltransferase. Its DNA sequence predicts a type II transmembrane protein whose sequence is identical to 133 of 231 amino acids at corresponding positions within the catalytic domain of the Lewis fucosyltransferase. When expressed by transfection in cultured cell lines, this gene determines expression of a fucosyltransferase capable of efficiently utilizing N-acetyllactosamine to form the Lewis x determinant (Gal-beta-1 --> 4[Fuc-alpha-1 --> 3]GlcNAc). By contrast, biochemical and flow cytometry analyses suggest that the enzyme cannot efficiently utilize the type II acceptor NeuNAc-alpha-2 --> 3Gal-beta-1 --> 4GlcNAc, to form the sialyl Lewis x determinant. In Chinese hamster ovary cells, however, the enzyme can determine expression of the alpha-2 --> 3-sialylated, alpha-1 --> 3-fucosylated structure known as VIM-2, a putative oligosaccharide ligand for ELAM-1. Cell adhesion assays using VIM-2-positive, sialyl Lewis x-negative transfected Chinese hamster ovary cells indicate that surface expression of the VIM-2 determinant is not sufficient to confer ELAM-1-dependent adhesive properties upon the cells. These results demonstrate that substantial structural similarities can exist between mammalian glycosyltransferases with closely related enzymatic properties, thus facilitating isolation of their cognate genes by cross-hybridization methods. The results further suggest that cell surface expression of the VIM-2 determinant is not necessarily sufficient to mediate ELAM-1-dependent cell adhesion.	UNIV MICHIGAN,SCH MED,DEPT PATHOL,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI 48109; SAN FRANCISCO STATE UNIV,DEPT CHEM & BIOCHEM,SAN FRANCISCO,CA 94132	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; California State University System; San Francisco State University	LOWE, JB (corresponding author), UNIV MICHIGAN,SCH MED,HOWARD HUGHES MED INST,MED SCI RES BLDG,RM 3510,1150 W MED CTR DR,ANN ARBOR,MI 48109, USA.				NATIONAL CANCER INSTITUTE [R01CA032826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038482] Funding Source: NIH RePORTER; NCI NIH HHS [CA32826] Funding Source: Medline; NIDDK NIH HHS [DK38482] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BENJAMIN C, 1990, BIOCHEM BIOPH RES CO, V171, P348, DOI 10.1016/0006-291X(90)91400-M; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; CAILLARD T, 1988, EXP CLIN IMMUNOGENET, V5, P15; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIA D, 1985, CANCER RES, V45, P435; COUILLIN P, 1991, CYTOGENET CELL GENET, V56, P108, DOI 10.1159/000133061; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; DERAPPE C, 1986, CARBOHYD RES, V150, P273, DOI 10.1016/0008-6215(86)80022-2; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ERNST LK, 1989, J BIOL CHEM, V264, P3436; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FUKUDA M, 1984, J BIOL CHEM, V259, P925; FUKUDA M, 1985, J BIOL CHEM, V260, P2957; FUKUDA MN, 1986, J BIOL CHEM, V261, P2376; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; GALTON J, 1985, 9TH P INT CONV IMM, P117; GOELZ SE, 1990, CELL, V63, P1349, DOI 10.1016/0092-8674(90)90430-M; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HOLMES EH, 1986, J BIOL CHEM, V261, P3737; HOWARD DR, 1987, J BIOL CHEM, V262, P16830; JOHNSON PH, 1981, BIOCHEM BIOPH RES CO, V100, P1611, DOI 10.1016/0006-291X(81)90703-8; JOZIASSE DH, 1989, J BIOL CHEM, V264, P14290; KOBATA A, 1972, METHOD ENZYMOL, V28, P262; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSEN RD, 1990, P NATL ACAD SCI USA, V87, P6674, DOI 10.1073/pnas.87.17.6674; LARSEN RD, 1990, J BIOL CHEM, V265, P7055; LARSEN RD, 1989, P NATL ACAD SCI USA, V86, P8227, DOI 10.1073/pnas.86.21.8227; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; MACHER BA, 1988, J BIOL CHEM, V263, P10186; Maniatis T., 1982, MOL CLONING; MELLIS SJ, 1983, ANAL BIOCHEM, V134, P442, DOI 10.1016/0003-2697(83)90320-2; MELLIS SJ, 1981, ANAL BIOCHEM, V114, P276, DOI 10.1016/0003-2697(81)90480-2; MOLLICONE R, 1990, EUR J BIOCHEM, V191, P169, DOI 10.1111/j.1432-1033.1990.tb19107.x; MONTREUIL J, 1960, B SOC CHIM BIOL, V42, P1399; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; OATES DC, 1977, SOMAT CELL GENET, V3, P561, DOI 10.1007/BF01539066; PALCIC MM, 1989, CARBOHYD RES, V190, P1, DOI 10.1016/0008-6215(89)84141-2; PATTERSON TA, 1987, NUCLEIC ACIDS RES, V15, P6298, DOI 10.1093/nar/15.15.6298; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; POTVIN B, 1990, J BIOL CHEM, V265, P1615; PRIEELS JP, 1981, J BIOL CHEM, V256, P456; RAJAN VP, 1989, J BIOL CHEM, V264, P11158; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SHAPER NL, 1988, J BIOL CHEM, V263, P10420; SMITH DF, 1990, J BIOL CHEM, V265, P6225; SMITH PL, 1988, SCIENCE, V242, P930, DOI 10.1126/science.2460923; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SYMINGTON FW, 1985, J IMMUNOL, V134, P2498; TETTEROO PAT, 1987, J BIOL CHEM, V262, P15984; TIEMEYER M, 1991, P NATL ACAD SCI USA, V88, P1138, DOI 10.1073/pnas.88.4.1138; VANKEUREN ML, 1986, AM J HUM GENET, V38, P793; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; Watkins W M, 1980, Adv Hum Genet, V10, P1; WEINSTEIN J, 1987, J BIOL CHEM, V262, P17735; YAMAMOTO F, 1990, J BIOL CHEM, V265, P19257; YAMAMOTO F, 1990, J BIOL CHEM, V265, P1146	65	290	295	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17467	17477						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1716630				2022-12-27	WOS:A1991GF44500074
J	REMILLARD, B; PETRILLO, R; MASLINSKI, W; TSUDO, M; STROM, TB; CANTLEY, L; VARTICOVSKI, L				REMILLARD, B; PETRILLO, R; MASLINSKI, W; TSUDO, M; STROM, TB; CANTLEY, L; VARTICOVSKI, L			INTERLEUKIN-2 RECEPTOR REGULATES ACTIVATION OF PHOSPHATIDYLINOSITOL 3-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							P70-75 BETA-SUBUNIT; PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; T-CELLS; MOLECULAR-CLONING; FUSION PROTEIN; LYMPHOCYTES-T; IL-2 RECEPTOR; ALPHA-CHAIN; RAT-LIVER	Interleukin-2 (IL-2) stimulates proliferation of T lymphocytes and is involved in the activation of both natural killer and lymphokine-activated killer precursor cells. The intracellular messengers which mediate IL-2-dependent events have not yet been identified. IL-2 receptor is not a protein-tyrosine kinase. Activation of a cellular protein-tyrosine kinase and direct association of a protein-tyrosine kinase activity with the IL-2 receptor occurs within minutes of IL-2 stimulation. We investigated the activation of phosphatidylinositol 3-kinase (PI 3-kinase) in IL-2-mediated signal transduction using the IL-2-dependent murine T-cell line, CTLL-2, and human phytohemagglutinin-stimulated peripheral blood lymphocytes (phytohemagglutinin blasts). Within a minute following stimulation of these cells with IL-2, PI 3-kinase activity could be detected in antiphosphotyrosine (anti-P-Tyr) antibody immunoprecipitates. IL-2 triggered a direct association of PI 3-kinase with the IL-2 receptor as detected in immunoprecipitates using anti-IL-2 receptor beta-chain antibody. In vivo labeled CTLL-2 cells have a time-dependent increase in D-3-phosphorylated polyphosphoinositides following stimulation with IL-2. This is the first group of second messengers identified in IL-2-mediated signal transduction.	TUFTS UNIV,ST ELIZABETHS HOSP,SCH MED,DEPT MED,BOSTON,MA 02135; TUFTS UNIV,ST ELIZABETHS HOSP,SCH MED,DEPT BIOMED RES,BOSTON,MA 02135; NEW ENGLAND DEACONESS HOSP,DEACONESS JOSLIN DIV NEPHROL,BOSTON,MA 02215; BETH ISRAEL HOSP,DEPT MED,BOSTON,MA 02215; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNITIKA CENT HOSP,DEPT MED,KYOTO,JAPAN; TUFTS UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02111	Tufts University; Tufts University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Tufts University			Cantley, Lewis C/D-1800-2014; Maslinski, Wlodzimierz/T-7078-2019	Cantley, Lewis C/0000-0002-1298-7653; Maslinski, Wlodzimierz/0000-0001-5597-9373; Varticovski, Lyuba/0000-0002-5105-9008	NIAID NIH HHS [AI22882, AI8512] Funding Source: Medline; NIGMS NIH HHS [R01 GM041890, GM36624] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036624, R01GM041890] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASAO H, 1990, J EXP MED, V171, P637, DOI 10.1084/jem.171.3.637; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BACHA P, 1988, J EXP MED, V167, P612, DOI 10.1084/jem.167.2.612; BENEDICT SH, 1987, J IMMUNOL, V139, P1694; BJORGE JD, 1990, P NATL ACAD SCI USA, V87, P3816, DOI 10.1073/pnas.87.10.3816; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; COSMAN D, 1984, NATURE, V312, P768, DOI 10.1038/312768a0; COUGHLIN SR, 1989, SCIENCE, V243, P1191; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; FARRAR WL, 1989, J BIOL CHEM, V264, P12562; FERRIS DK, 1989, J IMMUNOL, V143, P870; FUKUI Y, 1989, MOL CELL BIOL, V9, P1651, DOI 10.1128/MCB.9.4.1651; FUKUI Y, 1989, ONCOGENE RES, V4, P283; HATAKEYAMA M, 1987, J EXP MED, V166, P362, DOI 10.1084/jem.166.2.362; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KONDO S, 1987, NATURE, V327; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; MADDOCK EO, 1985, J IMMUNOL, V135, P4004; MERIDA I, 1990, J BIOL CHEM, V265, P5690; MILLS GB, 1986, J IMMUNOL, V136, P3019; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; REDONDO JM, 1988, J BIOL CHEM, V263, P17467; REEM GH, 1985, P NATL ACAD SCI USA, V82, P8663, DOI 10.1073/pnas.82.24.8663; ROBB RJ, 1984, J EXP MED, V160, P1126, DOI 10.1084/jem.160.4.1126; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SALTZMAN EM, 1990, J BIOL CHEM, V265, P10138; SALTZMAN EM, 1988, J BIOL CHEM, V263, P6956; SARAGOVI H, 1990, P NATL ACAD SCI USA, V87, P11, DOI 10.1073/pnas.87.1.11; SERUNIAN LA, 1989, J BIOL CHEM, V264, P17809; SHARON M, 1990, P NATL ACAD SCI USA, V87, P4869, DOI 10.1073/pnas.87.12.4869; SUGIMOTO Y, 1984, P NATL ACAD SCI-BIOL, V81, P2117, DOI 10.1073/pnas.81.7.2117; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694; TSUDO M, 1990, J IMMUNOL, V145, P599; VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X; VARTICOVSKI L, 1991, MOL CELL BIOL, V11, P1107, DOI 10.1128/MCB.11.2.1107; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; WALZ G, 1989, P NATL ACAD SCI USA, V86, P9485, DOI 10.1073/pnas.86.23.9485; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0	42	165	167	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14167	14170						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713578				2022-12-27	WOS:A1991FZ35100008
J	JOST, CJ; FUNDERBURGH, JL; MANN, M; HASSELL, JR; CONRAD, GW				JOST, CJ; FUNDERBURGH, JL; MANN, M; HASSELL, JR; CONRAD, GW			CELL-FREE TRANSLATION AND CHARACTERIZATION OF CORNEAL KERATAN SULFATE PROTEOGLYCAN CORE PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE GELS; QUANTITIES; CHICKEN; STROMA; ACID	Bovine corneal keratan sulfate proteoglycan (KSPG) contains two core proteins, 37 and 25 kDa, if fully deglycosylated, but 47 and 35 kDa, respectively, after endo-beta-galactosidase (Funderburgh, J. L., and Conrad, G. W. (1990) J. Biol Chem. 265, 8297-8303). Chicken corneal KSPG released a single core protein of 47 kDa after endo-beta-galactosidase, and of 35 and 36 kDa, if deglycosylated with N-glycanase or trifluoromethanesulfonic acid. Affinity purified rabbit antibodies against each KSPG recognized only the intact proteoglycan or its core proteins in immunoblots of unfractionated guanidine-HCl extracts of whole cornea after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Affinity purified antibody to a synthetic peptide duplicating the NH2-terminal sequence of the 37-kDa bovine core protein showed little reactivity with untreated corneal extract but reacted with the 47-kDa bovine protein in endo-beta-galactosidase-treated extracts. RNA was isolated from bovine and chick corneal stromas and used for in vitro translation. Antibody against bovine KSPG immunoprecipitated two proteins of 56-53 kDa and a protein of 41 kDa after translation of bovine RNA. Translation of chick RNA produced a double band of 38-39 kDa and a single band of 25 kDa precipitating with antibody against chicken KSPG. Homologous unlabeled KSPG competed for binding of antibodies to these translation products. These data suggest that in vertebrate corneas, the multiple KSPG core protein isoforms may arise as products of separate mRNAs, rather than from proteolytic processing of a large polypeptide precursor.	KANSAS STATE UNIV AGR & APPL SCI,DIV BIOL,ACKERT HALL,MANHATTAN,KS 66506; UNIV PITTSBURGH,INST EYE & EAR,DEPT OPHTHALMOL,PITTSBURGH,PA 15213	Kansas State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NATIONAL EYE INSTITUTE [R01EY008104, P30EY008098, R37EY008104, R01EY000952] Funding Source: NIH RePORTER; NEI NIH HHS [EY08098, EY00952, EY08104] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADAMS SL, 1987, METHOD ENZYMOL, V144, P84; AXELSSON I, 1975, BIOCHEM J, V145, P491, DOI 10.1042/bj1450491; BETTELHEIM FA, 1975, BIOCHIM BIOPHYS ACTA, V381, P203, DOI 10.1016/0304-4165(75)90202-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURK RR, 1983, METHOD ENZYMOL, V91, P247; CHAUDHURI TR, 1987, PREP BIOCHEM, V17, P93, DOI 10.1080/00327488708062478; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONRAD GW, 1982, J BIOL CHEM, V257, P464; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; EDMONDSON JM, 1988, BIOTECHNIQUES, V6, P868; FARRELL RA, 1973, J PHYSIOL-LONDON, V233, P589, DOI 10.1113/jphysiol.1973.sp010325; FUKUDA MN, 1981, J BIOL CHEM, V256, P3900; FUNDERBURGH JL, 1986, DEV BIOL, V116, P267, DOI 10.1016/0012-1606(86)90130-2; FUNDERBURGH JL, 1990, J BIOL CHEM, V265, P8297; FUNDERBURGH JL, 1991, IN PRESS J BIOL CHEM; HASCALL VC, 1972, J BIOL CHEM, V247, P4529; HASSELL JR, 1986, ANNU REV BIOCHEM, V55, P539, DOI 10.1146/annurev.bi.55.070186.002543; HASSELL JR, 1983, ARCH BIOCHEM BIOPHYS, V222, P362, DOI 10.1016/0003-9861(83)90532-5; Hay E.D., 1980, International Review of Cytology, V63, P263, DOI 10.1016/S0074-7696(08)61760-X; JAGUS R, 1987, METHOD ENZYMOL, V152, P267; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDBETTER SR, 1985, J BIOL CHEM, V260, P8106; MAURICE DM, 1968, BIOCH EYE, P51; MIDURA RJ, 1989, J BIOL CHEM, V264, P1423; OBEN M, 1987, BIOCHEM J, V248, P85; SALINOVICH O, 1986, ANAL BIOCHEM, V156, P341, DOI 10.1016/0003-2697(86)90263-0; SCOTT JE, 1985, BIOSCIENCE REP, V5, P765, DOI 10.1007/BF01119875; STEIN T, 1982, H-S Z PHYSIOL CHEM, V363, P825, DOI 10.1515/bchm2.1982.363.2.825; Stewart JM, 1984, SOLID PHASE PEPTIDE	29	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13336	13341						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712781				2022-12-27	WOS:A1991FX13200084
J	STRICKLAND, DK; ASHCOM, JD; WILLIAMS, S; BATTEY, F; BEHRE, E; MCTIGUE, K; BATTEY, JF; ARGRAVES, WS				STRICKLAND, DK; ASHCOM, JD; WILLIAMS, S; BATTEY, F; BEHRE, E; MCTIGUE, K; BATTEY, JF; ARGRAVES, WS			PRIMARY STRUCTURE OF ALPHA-2-MACROGLOBULIN RECEPTOR-ASSOCIATED PROTEIN - HUMAN HOMOLOG OF A HEYMANN NEPHRITIS ANTIGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-ENRICHED LIPOPROTEINS; SEQUENCE-ANALYSIS; APOLIPOPROTEIN-E; GEL-ELECTROPHORESIS; MOLECULAR-CLONING; SIGNAL SEQUENCES; MEDIATES UPTAKE; BINDING DOMAIN; LDL-RECEPTOR; DNA	The alpha-2-macroglobulin (alpha-2M) receptor complex as purified by affinity chromatography contains three polypeptides: a 515-kDa heavy chain, an 85-kDa light chain, and a 39-kDa associated protein. Previous studies have established that the 515/85-kDa components are derived from a 600-kDa precursor whose complete sequence has been determined by cDNA cloning (Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gassepohl, H., and Stanley, K. (1988) EMBO J. 7,4119-4127). We have now determined the primary structure of the human 39-kDa polypeptide, termed alpha-2M receptor-associated protein, by cDNA cloning. The deduced amino acid sequence contains a putative signal sequence that precedes the 323-residue mature protein. Comparative sequence analysis revealed that alpha-2M receptor-associated protein has 73% identity with a rat protein reported to be a pathogenic domain of Heymann nephritis antigen gp 330 and 77% identity to a mouse heparin-binding protein termed HBP-44. The high overall identity suggests that these molecules are interspecies homologues and indicates that the pathogenic domain, previously thought to be a portion of gp 330, is in fact a distinct protein. Further, the 120-residue carboxyl-terminal region of alpha-2M receptor-associated protein has 26% identity with a region of apolipoprotein E containing the low density lipoprotein receptor binding domain. Pulse-chase experiments revealed that the newly formed alpha-2M receptor-associated protein remains cell-associated, while surface labeling experiments followed by immunoprecipitation suggest that this protein is present on the cell surface forming a complex with the alpha-2M receptor heavy and light chains.	NINCDS,NEUROCHEM LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	STRICKLAND, DK (corresponding author), AMER RED CROSS,BIOCHEM LAB,15601 CRABBS BRANCH WAY,ROCKVILLE,MD 20855, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K04HL002113, R01HL030200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042581] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL30200, HL-02113] Funding Source: Medline; NIGMS NIH HHS [GM42581] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; ANDRES DA, 1990, J BIOL CHEM, V265, P5952; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BAXTER JH, 1960, J CLIN INVEST, V39, P455, DOI 10.1172/JCI104058; BJORK I, 1982, BIOCHEM J, V207, P347; CHEM WJ, 1990, J BIOL CHEM, V265, P3116; CHOPRA JS, 1971, LANCET, V1, P317; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; ENGVALL E, 1972, J IMMUNOL, V109, P129; FURUKAWA T, 1990, J BIOCHEM-TOKYO, V108, P297, DOI 10.1093/oxfordjournals.jbchem.a123197; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; HARPEL PC, 1973, J EXP MED, V138, P508, DOI 10.1084/jem.138.3.508; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; JENSEN PH, 1989, FEBS LETT, V255, P275, DOI 10.1016/0014-5793(89)81105-6; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; JOVAN J, 1990, NEW ENGL J MED, V323, P579; KANWAR YS, 1979, P NATL ACAD SCI USA, V76, P4493, DOI 10.1073/pnas.76.9.4493; KERJASCHKI D, 1982, P NATL ACAD SCI-BIOL, V79, P5557, DOI 10.1073/pnas.79.18.5557; KLUTHE R, 1967, VOX SANG, V12, P308, DOI 10.1111/j.1423-0410.1967.tb03107.x; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LITVINOVICH SV, 1991, J MOL BIOL, V217, P563, DOI 10.1016/0022-2836(91)90758-X; MILLAN JL, 1986, J BIOL CHEM, V261, P3112; MOESTRUP SK, 1989, J BIOL CHEM, V264, P15574; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; OKUDA S, 1990, J CLIN INVEST, V86, P453, DOI 10.1172/JCI114731; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PIETROMONACO S, 1990, P NATL ACAD SCI USA, V87, P1811, DOI 10.1073/pnas.87.5.1811; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RAYCHOWDHURY R, 1989, SCIENCE, V244, P1163, DOI 10.1126/science.2786251; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULTZE HE, 1959, CLIN CHIM ACTA, V4, P15, DOI 10.1016/0009-8981(59)90075-0; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SHIFFER M, 1967, BIOPHYS J, V7, P121; STRICKLAND DK, 1984, BIOCHEMISTRY-US, V23, P3115, DOI 10.1021/bi00309a002; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VANLEUVEN F, 1986, J BIOL CHEM, V261, P1369; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348; YANG JT, 1986, METHOD ENZYMOL, V130, P208; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	49	239	244	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13364	13369						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712782				2022-12-27	WOS:A1991FX13200088
J	LABBE, D; DUHAIME, JF; LANG, BF; MORAIS, R				LABBE, D; DUHAIME, JF; LANG, BF; MORAIS, R			THE TRANSCRIPTION OF DNA IN CHICKEN MITOCHONDRIA INITIATES FROM ONE MAJOR BIDIRECTIONAL PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; PRECISE ASSIGNMENT; STRAND PROMOTER; HEAVY-STRAND; START SITES; HELA-CELLS; 5' TERMINI; MOUSE L; IDENTIFICATION; REPLICATION	Transcription start sites of chicken mitochondrial DNA have been mapped in the control region by direct sequencing of in vitro capped mitochondrial RNA species, by primer extension and by S1 nuclease protection analysis. Transcription of the heavy strand initiates predominantly at a site 156 nucleotides upstream of the tRNA(Phe) gene, i.e. about 135 nucleotides further upstream than the corresponding sites in amphibia and mammals. On the opposite strand, transcription starts predominantly one nucleotide removed from the site in the heavy strand. The L-strand position start site is similar to that found in other vertebrates. The chicken mitochondrial DNA control region thus contains one major transcriptional promoter, whose bidirectional capacity is similar to the situation in amphibia but which contrasts to the mainly unidirectional capacity of mammalian promoters. In chicken mitochondria, the sequence comprising the start sites is A + T rich and contains an almost perfect inverted repeat which can be folded into a cruciform structure. The heavy and light strand initiation sites are flanked on their respective 3' ends by an octanucleotide sequence matching those surrounding the start sites in Xenopus laevis (5'-ACPuTTATA-3'). This motif is found associated with the H-strand start sites in mouse but is not present in human nor bovine mitochondrial DNA promoters.	UNIV MONTREAL,FAC MED,DEPT BIOCHIM,CP 6128,SUCCURSALE A,MONTREAL H3C 3J7,QUEBEC,CANADA	Universite de Montreal								ATTARDI G, 1985, INT REV CYTOL, V93, P93, DOI 10.1016/S0074-7696(08)61373-X; BHAT KS, 1989, BIOCHEMISTRY-US, V28, P763, DOI 10.1021/bi00428a052; BOGENHAGEN D, 1974, J BIOL CHEM, V249, P7991; BOGENHAGEN DF, 1986, J BIOL CHEM, V261, P8488; BOGENHAGEN DF, 1986, MOL CELL BIOL, V6, P2543, DOI 10.1128/MCB.6.7.2543; BOGENHAGEN DF, 1988, MOL CELL BIOL, V8, P2917, DOI 10.1128/MCB.8.7.2917; CANTATORE P, 1988, CURR GENET, V14, P477, DOI 10.1007/BF00521272; CHANG DD, 1986, MOL CELL BIOL, V6, P3262, DOI 10.1128/MCB.6.9.3262; CHANG DD, 1986, MOL CELL BIOL, V6, P1446, DOI 10.1128/MCB.6.5.1446; CHANG DD, 1984, CELL, V36, P635, DOI 10.1016/0092-8674(84)90343-X; CHANG DD, 1985, EMBO J, V4, P1559, DOI 10.1002/j.1460-2075.1985.tb03817.x; CHANG DD, 1986, MOL CELL BIOL, V6, P3253, DOI 10.1128/MCB.6.9.3253; CHANG DD, 1986, MOL CELL BIOL, V6, P294, DOI 10.1128/MCB.6.1.294; CHRISTIANSON T, 1982, J BIOL CHEM, V257, P6494; CLAYTON DA, 1984, ANNU REV BIOCHEM, V53, P573; DESJARDINS P, 1990, J MOL BIOL, V212, P599, DOI 10.1016/0022-2836(90)90225-B; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; GLAUS KR, 1980, ORG EXPRESSION MITOC, V2, P131; GROHMANN K, 1978, NUCLEIC ACIDS RES, V5, P637, DOI 10.1093/nar/5.3.637; KING TC, 1987, J BIOL CHEM, V262, P6204; LABBE D, 1990, J BIOL CHEM, V265, P2988; LEVENS D, 1981, J BIOL CHEM, V256, P5226; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; MONTOYA J, 1982, P NATL ACAD SCI-BIOL, V79, P7195, DOI 10.1073/pnas.79.23.7195; NAGLEY P, 1980, NUCLEIC ACIDS RES, V8, P2947, DOI 10.1093/nar/8.13.2947; OJALA D, 1981, J MOL BIOL, V150, P303, DOI 10.1016/0022-2836(81)90454-X; WEAVER RF, 1979, NUCLEIC ACIDS RES, V7, P1175, DOI 10.1093/nar/7.5.1175; YOZA BK, 1984, J BIOL CHEM, V259, P3909	28	75	76	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					10844	10850						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710214				2022-12-27	WOS:A1991FQ77400025
J	REINES, D				REINES, D			RNA POLYMERASE-II ELONGATION COMPLEX - ELONGATION COMPLEXES PURIFIED USING AN ANTI-RNA ANTIBODY DO NOT CONTAIN INITIATION FACTOR-ALPHA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' END FORMATION; C-MYC GENE; TRANSCRIPTION FACTOR; ACCURATE INITIATION; TERNARY COMPLEXES; PREMATURE TERMINATION; PREINITIATION COMPLEX; ESSENTIAL COMPONENT; CALF THYMUS; FACTOR-SII	Gene expression in eukaryotes can be regulated by controlling the efficiency of transcript elongation by RNA polymerase II. The composition of the elongation complex is, however, poorly understood. Previous work has identified DNA sequences which block RNA polymerase II transcription and factors which stimulate RNA chain elongation. Here, I have purified elongation complexes arrested at discrete template locations. Complexes were rapidly and efficiently precipitated from in vitro transcription reactions using a monoclonal antibody that binds RNA. The isolated complexes remained transcriptionally active. This technique enables the facile manipulation of transcription elongation complexes. Using this approach, I show that transcription initiation factor-alpha is not associated with a RNA polymerase II elongation complex. Since others have shown that alpha-associates stoichiometrically with DNA, RNA polymerase II, and other required factors in an initiation complex, this work suggests that alpha departs from the transcription complex after nucleotides are required but before extensive RNA chain synthesis. In this regard alpha resembles the bacterial promoter-recognition factor-sigma.			REINES, D (corresponding author), EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322, USA.		excellency, Your/R-2357-2019	excellency, Your/0000-0003-0832-6243	NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046331] Funding Source: NIH RePORTER; NCRR NIH HHS [S07-RR05364] Funding Source: Medline; NIGMS NIH HHS [R01 GM046331] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMAN S, 1983, NUCLEIC ACIDS RES, V11, P6041, DOI 10.1093/nar/11.17.6041; BENGAL E, 1989, J BIOL CHEM, V264, P18926; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; CARPOUSIS AJ, 1985, J MOL BIOL, V183, P165, DOI 10.1016/0022-2836(85)90210-4; CHAMBERLIN MJ, 1979, J BIOL CHEM, V254, P61; CONAWAY JW, 1989, J BIOL CHEM, V264, P2357; CONAWAY JW, 1990, SCIENCE, V248, P1550, DOI 10.1126/science.2193400; CONAWAY JW, 1990, J BIOL CHEM, V265, P7552; CONAWAY JW, 1987, J BIOL CHEM, V262, P8293; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; CONAWAY RC, 1990, J BIOL CHEM, V265, P7559; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; COPPOLA JA, 1984, J MOL BIOL, V178, P415, DOI 10.1016/0022-2836(84)90151-7; DEVEGVAR HEN, 1986, CELL, V47, P259; EILAT D, 1982, P NATL ACAD SCI-BIOL, V79, P3818, DOI 10.1073/pnas.79.12.3818; FIRE A, 1984, J BIOL CHEM, V259, P2509; FLORES O, 1989, J BIOL CHEM, V264, P8913; FLORES O, 1988, J BIOL CHEM, V263, P10812; GONZALEZ N, 1977, ARCH BIOCHEM BIOPHYS, V182, P404, DOI 10.1016/0003-9861(77)90521-5; HAHN S, 1989, CELL, V58, P1173, DOI 10.1016/0092-8674(89)90515-1; HANSEN UM, 1980, J BIOL CHEM, V255, P9564; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HERNANDEZ N, 1988, EMBO J, V7, P3125, DOI 10.1002/j.1460-2075.1988.tb03179.x; HORIKOSHI M, 1990, CELL, V61, P1171, DOI 10.1016/0092-8674(90)90681-4; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; LANGER L, 1981, P NATL ACAD SCI USA, V7, P6633; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; MADERIOUS A, 1984, P NATL ACAD SCI-BIOL, V81, P5931, DOI 10.1073/pnas.81.19.5931; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; Maniatis T., 1982, MOL CLONING; MANLEY JL, 1980, P NATL ACAD SCI-BIOL, V77, P3855, DOI 10.1073/pnas.77.7.3855; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MELVIN WT, 1977, BIOCHEM J, V168, P595, DOI 10.1042/bj1680595; MILLER H, 1989, MOL CELL BIOL, V9, P5340, DOI 10.1128/MCB.9.12.5340; PAULE MR, 1990, NATURE, V344, P819, DOI 10.1038/344819a0; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; RAPPAPORT J, 1987, J BIOL CHEM, V262, P5227; REINBERG D, 1987, J BIOL CHEM, V262, P3310; REINBERG D, 1987, J BIOL CHEM, V262, P3331; REINES D, 1987, J MOL BIOL, V196, P299, DOI 10.1016/0022-2836(87)90691-7; REINES D, 1989, J BIOL CHEM, V264, P10799; RESNEKOV O, 1989, J BIOL CHEM, V264, P9953; RESNEKOV O, 1989, P NATL ACAD SCI USA, V86, P12, DOI 10.1073/pnas.86.1.12; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SEKIMIZU K, 1976, BIOCHEMISTRY-US, V15, P5064, DOI 10.1021/bi00668a018; SKARNES WC, 1988, J MOL BIOL, V203, P153, DOI 10.1016/0022-2836(88)90099-X; SLUDER AE, 1989, J BIOL CHEM, V264, P8963; SOPTA M, 1985, J BIOL CHEM, V260, P353; SPENCER CA, 1990, ONCOGENE, V5, P777; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; STRANEY DC, 1985, CELL, V43, P449, DOI 10.1016/0092-8674(85)90175-8; THAYER GC, 1985, MOL GEN GENET, V199, P55, DOI 10.1007/BF00327509; TOLUNAY HE, 1984, P NATL ACAD SCI-BIOL, V81, P5916, DOI 10.1073/pnas.81.19.5916; VANDYKE MW, 1989, MOL CELL BIOL, V9, P342, DOI 10.1128/MCB.9.1.342; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; WAMPLER SL, 1990, J BIOL CHEM, V265, P21223; WEIL PA, 1979, CELL, V18, P469; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; ZHENG XM, 1987, CELL, V50, P361, DOI 10.1016/0092-8674(87)90490-9	67	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10510	10517						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709935				2022-12-27	WOS:A1991FP08600078
J	MONCECCHI, D; PASTUSZYN, A; SCALLEN, TJ				MONCECCHI, D; PASTUSZYN, A; SCALLEN, TJ			CDNA SEQUENCE AND BACTERIAL EXPRESSION OF MOUSE-LIVER STEROL CARRIER PROTEIN-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-TRANSFER PROTEIN; RAT-LIVER; CHOLESTEROL-BIOSYNTHESIS; ESCHERICHIA-COLI; ACID; PURIFICATION; MITOCHONDRIAL; DNA; PHOSPHOLIPIDS; LOCALIZATION	Sterol carrier protein-2 (SCP-2) is an intracellular protein of M(r) 13,096. In vitro studies have shown that it is involved in the transport and metabolism of cholesterol. This protein is believed to participate in these activities by forming a stoichiometric complex with the sterol. Because these activities occur in different intracellular locations, i.e. mitochondria, peroxisomes, and cytosol, it can be predicted that SCP-2 targets to these sites. In this report we show that a mouse cDNA (785 base pairs) encodes a precursor form of SCP-2 containing a N-terminal presequence and an additional C-terminal residue. These additional amino acid residues are found in proteins targeted to the mitochondria and peroxisomes, respectively. These signals are not found in SCP-2 purified from rat liver cytosol which is belived to be a cytosolic form. Northern analysis shows that there are four species of mRNA which hybridize to a SCP-2-specific probe at 1.0, 1.7, 2.2, and 2.9 kilobases. Southern analysis shows that the gene is distributed over a large amount of DNA or that there are multiple genes. We have cloned the cytosolic/peroxisomal form of mouse SCP-2 into the Escherichia coli expression vector pKK233-2 and have expressed and purified recombinant mouse SCP-2, M(r) 13,034. The purified recombinant SCP-2 is immunoreactive to rabbit anti-rat SCP-2 antibody. It also has biological activity equivalent to homogeneous rat liver SCP-2 in stimulating the microsomal conversion of 7-dehydrocholesterol to cholesterol and in the esterification of cholesterol by acyl-CoA cholesterol acyltransferase by rat liver microsomes.	UNIV NEW MEXICO,SCH MED,DEPT BIOCHEM,ALBUQUERQUE,NM 87131	University of New Mexico					NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK010628] Funding Source: NIH RePORTER; NCRR NIH HHS [S07 RR-05583-25] Funding Source: Medline; NIDDK NIH HHS [DK-10,628] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; BERENT S L, 1985, Biotechniques, V3, P208; BILLHEIMER JT, 1990, DNA CELL BIOL, V9, P159, DOI 10.1089/dna.1990.9.159; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BLOJ B, 1977, J BIOL CHEM, V252, P1613; BUTKO P, 1990, BIOCHEMISTRY-US, V29, P4070, DOI 10.1021/bi00469a007; CHANDERBHAN R, 1983, BIOCHEM BIOPH RES CO, V117, P702, DOI 10.1016/0006-291X(83)91654-6; CHANDERBHAN R, 1982, J BIOL CHEM, V257, P8928; CHANDERBHAN RF, 1986, ENDOCR RES, V12, P351, DOI 10.3109/07435808609035445; CHESTERTON CJ, 1988, J BIOL CHEM, V243, P1147; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GAVEY KL, 1981, J BIOL CHEM, V256, P2993; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; HENDRICK JP, 1989, P NATL ACAD SCI USA, V86, P4056, DOI 10.1073/pnas.86.11.4056; KELLER GA, 1989, J CELL BIOL, V108, P1355; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maniatis T., 1982, MOL CLONING; MONCECCHI D, 1987, FED PROC, V46, P1534; MORRIS HR, 1988, BIOCHEM BIOPH RES CO, V154, P476, DOI 10.1016/0006-291X(88)90711-5; NOLAND BJ, 1980, J BIOL CHEM, V255, P4282; NORGARD MV, 1980, J BIOL CHEM, V255, P7665; OSSENDORP BC, 1990, BIOCHEM BIOPH RES CO, V168, P631, DOI 10.1016/0006-291X(90)92367-9; PASTUSZYN A, 1987, J BIOL CHEM, V262, P13219; POORTHUIS BJHM, 1981, BIOCHIM BIOPHYS ACTA, V665, P256, DOI 10.1016/0005-2760(81)90010-2; REINHART MP, 1987, J BIOL CHEM, V262, P9649; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCALLEN TJ, 1985, J BIOL CHEM, V260, P4733; SCALLEN TJ, 1985, NEW COMPREHENSIVE BI, V12, P73; SCHROEDER F, 1990, J BIOL CHEM, V265, P151; SELTMAN H, 1985, BIOCHEM J, V230, P19, DOI 10.1042/bj2300019; Smith H O, 1980, Methods Enzymol, V65, P371; STRAUS D, 1985, P NATL ACAD SCI USA, V82, P2014, DOI 10.1073/pnas.82.7.2014; THOMPSON SL, 1987, J BIOL CHEM, V262, P17420; TRZASKOS JM, 1983, BIOCHIM BIOPHYS ACTA, V751, P52, DOI 10.1016/0005-2760(83)90256-4; TRZECIAK WH, 1987, J BIOL CHEM, V262, P3713; VAHOUNY GV, 1983, J BIOL CHEM, V258, P1731; VANDERKRIFT TP, 1985, BIOCHIM BIOPHYS ACTA, V812, P387, DOI 10.1016/0005-2736(85)90313-X; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; WESTERMAN J, 1985, BIOCHEM BIOPH RES CO, V127, P333, DOI 10.1016/S0006-291X(85)80163-7	42	59	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					9885	9892						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1709640				2022-12-27	WOS:A1991FM45900081
J	KILIC, F; BALL, EH				KILIC, F; BALL, EH			PARTIAL CLEAVAGE MAPPING OF THE CYTOSKELETAL PROTEIN VINCULIN - ANTIBODY AND TALIN BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT; ALPHA-ACTININ; SMOOTH-MUSCLE; POLYACRYLAMIDE GELS; FUNCTIONAL DOMAINS; CYSTEINE RESIDUES; OVERLAY TECHNIQUE; FOCAL ADHESIONS; HIGH-YIELD; KINASE-C	Vinculin is a 1066-amino acid protein found at several types of actin-membrane junction. To locate sites of interest in the primary structure, a map was derived using partial cleavage reactions. Of several different types of cleavage tested, the most useful was the 5-5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) reaction which cuts at cysteine residues. About 30 well defined fragments were obtained from vinculin, and several methods were used to locate these products in the sequence. Comparison of the peptides generated from whole vinculin with those from the 90-kDa amino-terminal proteolytic fragment revealed which originated there. The use of [C-14]cyanide in conjunction with DTNB showed which peptides contained the original amino terminus. Secondary cleavage with N-chlorosuccinimide, a tryptophan-specific reagent, helped locate fragments, although it led to apparent increases in molecular weight of the products. These experiments revealed the location of 10 of the major DTNB fragments on the sequence. This map was used to locate binding sites. The site of interaction between vinculin and the focal contact protein talin was mapped by binding labeled talin to the separated fragments. The binding site was found to be in the amino-terminal 325 amino acids. The binding site of a commercially obtained monoclonal antivinculin antibody was mapped using Western blotting of cleaved vinculin. It proved to bind in the central area of the molecule between amino acid residues 545 and 737. Thus the cysteine cleavage reaction products provide a map of general utility for locating features on the vinculin molecule.	UNIV WESTERN ONTARIO, DEPT BIOCHEM, LONDON N6A 5C1, ONTARIO, CANADA	Western University (University of Western Ontario)				Ball, Eric/0000-0003-2542-9156				BALL EH, 1986, J CELL BIOL, V103, P641, DOI 10.1083/jcb.103.2.641; BALL EH, 1988, BIOCHEMISTRY-US, V27, P6093, DOI 10.1021/bi00416a039; BECKERLE MC, 1987, CELL, V51, P569, DOI 10.1016/0092-8674(87)90126-7; BELKIN AM, 1987, FEBS LETT, V220, P291, DOI 10.1016/0014-5793(87)80832-3; BENDORI R, 1989, J CELL BIOL, V108, P2383, DOI 10.1083/jcb.108.6.2383; Bornstein P, 1977, Methods Enzymol, V47, P132; BURN P, 1987, SCIENCE, V235, P476, DOI 10.1126/science.3099391; BURRIDGE K, 1986, Cancer Reviews, V4, P18; BURRIDGE K, 1984, NATURE, V308, P744, DOI 10.1038/308744a0; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; COUTU MD, 1988, P NATL ACAD SCI USA, V85, P8535, DOI 10.1073/pnas.85.22.8535; DEGANI Y, 1974, BIOCHEMISTRY-US, V13, P1, DOI 10.1021/bi00698a001; EVANS RR, 1984, J BIOL CHEM, V259, P3916; FERAMISCO JR, 1980, J BIOL CHEM, V255, P1194; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GEIGER B, 1985, J CELL BIOL, V101, P1523, DOI 10.1083/jcb.101.4.1523; GEIGER B, 1987, J CELL SCI, P251; Geiger B, 1984, Cell Muscle Motil, V5, P195; GROESCH ME, 1990, CELL MOTIL CYTOSKEL, V15, P41, DOI 10.1002/cm.970150107; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; JACOBSON GR, 1973, J BIOL CHEM, V248, P6583; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; JONES P, 1989, J CELL BIOL, V109, P2917, DOI 10.1083/jcb.109.6.2917; KELLIE S, 1987, FEBS LETT, V213, P428, DOI 10.1016/0014-5793(87)81536-3; KELLIE S, 1986, EXP CELL RES, V165, P216, DOI 10.1016/0014-4827(86)90546-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2; MOLONY L, 1985, J CELL BIOCHEM, V29, P31, DOI 10.1002/jcb.240290104; NEFSKY B, 1989, P NATL ACAD SCI USA, V86, P3549, DOI 10.1073/pnas.86.10.3549; OTTO JJ, 1983, J CELL BIOL, V97, P1283, DOI 10.1083/jcb.97.4.1283; OTTO JJ, 1990, CELL MOTIL CYTOSKEL, V16, P1, DOI 10.1002/cm.970160102; PRICE GJ, 1989, BIOCHEM J, V259, P453, DOI 10.1042/bj2590453; ROHRSCHNEIDER LR, 1980, P NATL ACAD SCI-BIOL, V77, P3514, DOI 10.1073/pnas.77.6.3514; SHECHTER Y, 1976, BIOCHEMISTRY-US, V15, P5071, DOI 10.1021/bi00668a019; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; WACHSSTOCK DH, 1987, BIOCHEM BIOPH RES CO, V146, P554, DOI 10.1016/0006-291X(87)90564-X; WERTH DK, 1983, J BIOL CHEM, V258, P1423; WESTMEYER A, 1990, EMBO J, V9, P2071, DOI 10.1002/j.1460-2075.1990.tb07374.x; WILKINS JA, 1983, BIOCHEM BIOPH RES CO, V116, P1026, DOI 10.1016/S0006-291X(83)80245-9	41	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					8734	8740						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709157				2022-12-27	WOS:A1991FM03800018
J	SALMIVIRTA, M; ELENIUS, K; VAINIO, S; HOFER, U; CHIQUETEHRISMANN, R; THESLEFF, I; JALKANEN, M				SALMIVIRTA, M; ELENIUS, K; VAINIO, S; HOFER, U; CHIQUETEHRISMANN, R; THESLEFF, I; JALKANEN, M			SYNDECAN FROM EMBRYONIC TOOTH MESENCHYME BINDS TENASCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; HEPARAN-SULFATE PROTEOGLYCANS; SURFACE PROTEOGLYCAN; MEMBRANE PROTEOGLYCAN; MONOCLONAL-ANTIBODY; TISSUE INTERACTIONS; BASEMENT-MEMBRANE; MATRIX; RECEPTOR; ADHESION	Syndecan is a cell surface heparan sulfate-rich proteoglycan found on various epithelial cells but also in some embryonic mesenchymal tissues. We have immunoisolated syndecan from embryonic tooth mesenchyme that appeared as a 250-300-kDa molecule (K(av) = 0.3 in Sepharose 4B), containing only heparan sulfate side chains (M(r) = 35,000). Northern analysis of whole tooth germs and tooth mesenchymes also revealed high expression of syndecan mRNAs (2.6 and 3.4 kilobases). In the binding assay utilizing nitrocellulose as a solid phase to immobilize matrix molecules, syndecan immunoisolated from tooth mesenchyme revealed binding to tenascin, and this interaction was shown to be mediated via heparan sulfate side chains. In contrast, syndecan from mouse mammary epithelial cells showed only weak interaction with tenascin. We propose that syndecan and tenascin may represent interactions of a cell surface receptor and a matrix ligand involved in mesenchymal cell condensation and differentiation during early organogenesis.	UNIV HELSINKI, DEPT PEDODONT & ORTHODONT, SF-00280 HELSINKI, FINLAND; TURKU BIOTECHNOL CTR, SF-20521 TURKU, FINLAND; FRIEDRICH MIESCHER INST, CH-4002 BASEL, SWITZERLAND	University of Helsinki; Friedrich Miescher Institute for Biomedical Research	SALMIVIRTA, M (corresponding author), UNIV TURKU, DEPT MED BIOCHEM, SF-20520 TURKU 52, FINLAND.		Elenius, Klaus/AAI-7594-2021	Elenius, Klaus/0000-0001-5700-0827; Vainio, Seppo/0000-0001-9319-3566	NIDCR NIH HHS [DE09399-01] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009399] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AUFDERHEIDE E, 1988, J CELL BIOL, V107, P2341, DOI 10.1083/jcb.107.6.2341; BERNFIELD M, 1990, PHILOS T R SOC B, V327, P171, DOI 10.1098/rstb.1990.0052; BERNFIELD M, 1985, BASEMENT MEMBRANES, P343; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; BOURDON MA, 1985, J CELL BIOCHEM, V28, P183, DOI 10.1002/jcb.240280302; CHIQUET M, 1984, J CELL BIOL, V98, P1926, DOI 10.1083/jcb.98.6.1926; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; DAVID G, 1979, P NATL ACAD SCI USA, V76, P786, DOI 10.1073/pnas.76.2.786; EKBLOM P, 1986, ANNU REV CELL BIOL, V2, P27, DOI 10.1146/annurev.cb.02.110186.000331; ELENIUS K, 1990, J BIOL CHEM, V265, P17837; ERICKSON HP, 1988, ADV CELL BIOL, V2, P55; FRIEDLANDER DR, 1988, J CELL BIOL, V107, P2329, DOI 10.1083/jcb.107.6.2329; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; GEHLSEN KR, 1988, SCIENCE, V241, P1228, DOI 10.1126/science.2970671; GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0; GRUMET M, 1985, P NATL ACAD SCI USA, V82, P8075, DOI 10.1073/pnas.82.23.8075; HAYASHI K, 1988, LAB INVEST, V58, P68; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; JALKANEN M, 1987, MED BIOL, V65, P41; JALKANEN M, 1988, J CELL BIOL, V106, P953, DOI 10.1083/jcb.106.3.953; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; JALKANEN ST, 1986, EUR J IMMUNOL, V16, P1195, DOI 10.1002/eji.1830161003; KIEFER MC, 1990, P NATL ACAD SCI USA, V87, P6985, DOI 10.1073/pnas.87.18.6985; KODA JE, 1985, J BIOL CHEM, V260, P8157; Kollar E.J., 1978, P1; KOLLAR EJ, 1970, J EMBRYOL EXP MORPH, V24, P173; KRUSE J, 1985, NATURE, V316, P146, DOI 10.1038/316146a0; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; MACKIE EJ, 1988, J CELL BIOL, V107, P2757, DOI 10.1083/jcb.107.6.2757; MALI M, 1990, J BIOL CHEM, V265, P6884; MARTON LS, 1989, J BIOL CHEM, V264, P13145; MINA M, 1987, ARCH ORAL BIOL, V32, P123, DOI 10.1016/0003-9969(87)90055-0; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; RAPRAEGER A, 1985, J BIOL CHEM, V260, P4103; RAPRAEGER A, 1987, BIOL EXTRACELLULAR M, V2, P129; RAPRAEGER AC, 1983, J BIOL CHEM, V258, P3632; RUCH JV, 1983, J BIOL BUCCALE, V11, P173; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SLAVKIN HC, 1974, ORAL SCI REV, V4, P1; SOLURSH M, 1990, DEV BIOL, V140, P83, DOI 10.1016/0012-1606(90)90055-N; SPRING J, 1989, CELL, V59, P325, DOI 10.1016/0092-8674(89)90294-8; SUN XJ, 1989, J BIOL CHEM, V264, P11288; THESLEFF I, 1988, DEV BIOL, V129, P565, DOI 10.1016/0012-1606(88)90401-0; THESLEFF I, 1987, DEVELOPMENT, V101, P289; THESLEFF I, 1978, DIFFERENTIATION, V10, P71, DOI 10.1111/j.1432-0436.1978.tb00948.x; THESLEFF I, 1981, DIFFERENTIATION, V18, P75, DOI 10.1111/j.1432-0436.1981.tb01107.x; THESLEFF I, 1979, DEV BIOL, V70, P116, DOI 10.1016/0012-1606(79)90011-3; VAINIO S, 1989, J CELL BIOL, V108, P1945, DOI 10.1083/jcb.108.5.1945; VAINIO S, 1989, DEV BIOL, V134, P382, DOI 10.1016/0012-1606(89)90110-3; WEITZHANDLER M, 1988, J BIOL CHEM, V263, P6949	57	204	209	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7733	7739						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708391				2022-12-27	WOS:A1991FJ34200066
J	ENCIO, IJ; DETERAWADLEIGH, SD				ENCIO, IJ; DETERAWADLEIGH, SD			THE GENOMIC STRUCTURE OF THE HUMAN GLUCOCORTICOID RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROID-HORMONE RECEPTOR; MINERALOCORTICOID RECEPTOR; NUCLEAR RECEPTORS; RETINOIC ACID; GENE; TRANSCRIPTION; DNA; EXPRESSION; CDNA; ERBA	We have determined the structure of the human glucocorticoid receptor (hGR) gene after the isolation and characterization of cosmid clones mapping to discrete regions of the cDNA. The gene contains a total of 10 exons and has a minimum size of 80 kilobases. Exon 1 consists solely of 5'-untranslated sequence, and exon 2 encodes the amino-terminal portion of the receptor. The two putative zinc fingers are separately encoded by two exons, and a total of five exons combine to form the cortisol-binding domain. By restriction mapping and sequence analysis of cosmids located on the 3'-end of the gene, we have established that the two receptor isoforms, hGR-alpha and hGR-beta, originate from the same gene by alternative splicing. Each hGR isoform is encoded by nine exons, of which the first eight are identical, whereas the ninth exons are heterologous. Multiple GC boxes and no obvious TATA or CAAT elements have been found in the 5'-flanking region. S1 nuclease analysis yielded one major band, and the transcription start site is localized to the *C residue within TAC*C-CTC. Alignment of sequences around the splice junctions of hGR with those of other members of the steroid receptor superfamily revealed three different splice positions withing the DNA-binding domain. This comparison also permitted the prediction of the positions of the splice sites and the sizes of the putative exons in the human mineralocorticoid receptor.	NIMH,CLIN NEUROGENET BRANCH,BLDG 10,RM 3N218,9000 ROCKVILLE PIKE,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)				Encio, Ignacio/0000-0003-1732-1989				ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; ARRIZA JL, 1988, NEURON, V1, P887, DOI 10.1016/0896-6273(88)90136-5; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; DETHE H, 1987, NATURE, V330, P667, DOI 10.1038/330667a0; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DYNAN SW, 1988, NATURE, V316, P774; EVANS GA, 1987, METHOD ENZYMOL, V152, P604; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HUCKABY CS, 1987, P NATL ACAD SCI USA, V84, P8380, DOI 10.1073/pnas.84.23.8380; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; LUBAHN D, 1989, SCIENCE, V240, P327; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Maniatis T., 1982, MOL CLONING; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MISRAHI M, 1987, BIOCHEM BIOPH RES CO, V143, P740, DOI 10.1016/0006-291X(87)91416-1; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SWICK AG, 1989, NUCLEIC ACIDS RES, V17, P9291, DOI 10.1093/nar/17.22.9291; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; ZAHRAOUI A, 1987, EUR J BIOCHEM, V166, P63, DOI 10.1111/j.1432-1033.1987.tb13484.x	40	328	358	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					7182	7188						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707881				2022-12-27	WOS:A1991FG72700083
J	HOH, JH; JOHN, SA; REVEL, JP				HOH, JH; JOHN, SA; REVEL, JP			MOLECULAR-CLONING AND CHARACTERIZATION OF A NEW MEMBER OF THE GAP JUNCTION GENE FAMILY, CONNEXIN-31	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; INTER-CELLULAR JUNCTIONS; RAT-HEART; SUBSTRATE-SPECIFICITY; SYNTHETIC PEPTIDES; SEQUENCE-ANALYSIS; LIVER; PHOSPHORYLATION; COMMUNICATION; RNA	A new member of the connexin gene family has been identified and designated rat connexin-31 (Cx31) based on its predicted molecular mass of 30,960 daltons. Cx31 is 270 amino acids long and is coded for by a single copy gene. It is expressed as a 1.7-kilobase mRNA that is detected in placenta, Harderian gland, skin, and eye. Cx31 is highly conserved and can be detected in species as distantly related to rat as Xenopus laevis. It exhibits extensive sequence similarity to the previously identified connexins, 58, 50, and 40% amino acid identity to Cx26, Cx32, and Cx43, respectively. When conservation of predicted phosphorylation sites is used to adjust the alignment of Cx31 to other connexins, a unique alignment of three predicted protein kinase C phosphorylation sites near the carboxyl terminus of Cx31 with three sites at the carboxyl terminus of Cx43 is revealed.	CALTECH, DIV BIOL 156-29, PASADENA, CA 91125 USA	California Institute of Technology			Hoh, Jan H./P-8695-2019	John, Scott/0000-0002-1232-9140; Hoh, Jan/0000-0003-3842-9454	NCRR NIH HHS [RR07003] Funding Source: Medline; NHLBI NIH HHS [HL37109] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037109] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ausubel FM., 1988, CURRENT PROTOCOLS MO; BARR L, 1965, J GEN PHYSIOL, V48, P797, DOI 10.1085/jgp.48.5.797; BERDAN RC, 1988, CELL TISSUE RES, V251, P257, DOI 10.1007/BF00215833; BEYER EC, 1989, J CELL BIOL, V108, P595, DOI 10.1083/jcb.108.2.595; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; BEYER EC, 1987, J CELL BIOL, V105, P2621, DOI 10.1083/jcb.105.6.2621; BEYER EC, 1988, MODERN CELL BIOL, V7, P167; BUCANA CD, 1972, SCIENCE, V175, P205, DOI 10.1126/science.175.4018.205; BUULTJENS TEJ, 1988, CELL TISSUE RES, V251, P571, DOI 10.1007/BF00214005; CROW DS, 1990, MOL CELL BIOL, V10, P1754, DOI 10.1128/MCB.10.4.1754; Dayhoff MO, 1978, ATLAS PROTEIN SEQUEN, V5; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOOLITTLE RF, 1989, INT CONGR SER, V824, P73; EBIHARA L, 1989, SCIENCE, V243, P1194, DOI 10.1126/science.2466337; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FINBOW M, 1980, P NATL ACAD SCI-BIOL, V77, P970, DOI 10.1073/pnas.77.2.970; FLAGGNEWTON J, 1979, SCIENCE, V205, P404, DOI 10.1126/science.377490; GIMLICH RL, 1990, J CELL BIOL, V110, P597, DOI 10.1083/jcb.110.3.597; HENDERSON D, 1979, J MOL BIOL, V132, P193, DOI 10.1016/0022-2836(79)90391-7; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; KAM E, 1986, J INVEST DERMATOL, V87, P748, DOI 10.1111/1523-1747.ep12456937; KENSLER RW, 1980, J CELL BIOL, V86, P755, DOI 10.1083/jcb.86.3.755; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; KISTLER J, 1988, NATURE, V331, P721, DOI 10.1038/331721a0; KREIL G, 1984, METHOD ENZYMOL, V106, P218; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LARSON DM, 1990, CIRC RES, V66, P1074, DOI 10.1161/01.RES.66.4.1074; LASH JA, 1990, J BIOL CHEM, V265, P13113; LOEWENSTEIN WR, 1981, PHYSIOL REV, V61, P829, DOI 10.1152/physrev.1981.61.4.829; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; Maniatis T., 1982, MOL CLONING; MANJUNATH CK, 1984, AM J PHYSIOL, V246, pH865, DOI 10.1152/ajpheart.1984.246.6.H865; MANJUNATH CK, 1982, BIOCHEM J, V205, P189, DOI 10.1042/bj2050189; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; METZ J, 1978, CELL TISSUE RES, V192, P391; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; MILLER T, 1988, BIOSCIENCE REP, V8, P455, DOI 10.1007/BF01121644; MURATA M, 1985, P NATL ACAD SCI USA, V82, P3073, DOI 10.1073/pnas.82.10.3073; MURRAY AW, 1989, CELL INTERACTIONS GA, V1, P97; MUSIL LS, 1990, J MEMBRANE BIOL, V116, P163, DOI 10.1007/BF01868674; NICHOLSON B, 1987, NATURE, V329, P732, DOI 10.1038/329732a0; NICHOLSON BJ, 1981, P NATL ACAD SCI-BIOL, V78, P7594, DOI 10.1073/pnas.78.12.7594; NICHOLSON BJ, 1985, J BIOL CHEM, V260, P6514; PAUL DL, 1986, J CELL BIOL, V103, P123, DOI 10.1083/jcb.103.1.123; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; PITS JD, 1978, RECEPTORS RECOGNIT B, V2, P63; REVEL JP, 1967, J CELL BIOL, V33, pC7, DOI 10.1083/jcb.33.3.C7; ROBERTSON JD, 1963, J CELL BIOL, V19, P201, DOI 10.1083/jcb.19.1.201; RYERSE JS, 1989, CELL TISSUE RES, V256, P7; SAEZ JC, 1986, P NATL ACAD SCI USA, V83, P2473, DOI 10.1073/pnas.83.8.2473; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARGENT TD, 1979, P NATL ACAD SCI USA, V76, P3256, DOI 10.1073/pnas.76.7.3256; SHERIDAN JD, 1979, EXP CELL RES, V123, P111, DOI 10.1016/0014-4827(79)90427-0; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SPRAY DC, 1985, ANNU REV PHYSIOL, V47, P281, DOI 10.1146/annurev.ph.47.030185.001433; STRAUSS WM, 1988, CURRENT PROTOCOLS MO, V1; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TAKEDA A, 1987, FEBS LETT, V210, P169, DOI 10.1016/0014-5793(87)81330-3; TAKEDA A, 1989, J BIOCHEM-TOKYO, V106, P723, DOI 10.1093/oxfordjournals.jbchem.a122923; TRAUB O, 1989, J CELL BIOL, V108, P1039, DOI 10.1083/jcb.108.3.1039; WILBUR WJ, 1983, P NATL ACAD SCI-BIOL, V80, P726, DOI 10.1073/pnas.80.3.726; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x; WOODHOUSE MA, 1963, J ULTRA MOL STRUCT R, V9, P76, DOI 10.1016/S0022-5320(63)80037-4; YANCEY SB, 1989, J CELL BIOL, V108, P2241, DOI 10.1083/jcb.108.6.2241; ZHANG JT, 1989, J CELL BIOL, V109, P3391, DOI 10.1083/jcb.109.6.3391; ZIMMER DB, 1987, J BIOL CHEM, V262, P7751	70	98	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6524	6531						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706719				2022-12-27	WOS:A1991FE37300078
J	SIMONDS, WF; BUTRYNSKI, JE; GAUTAM, N; UNSON, CG; SPIEGEL, AM				SIMONDS, WF; BUTRYNSKI, JE; GAUTAM, N; UNSON, CG; SPIEGEL, AM			G-PROTEIN BETA-GAMMA DIMERS - MEMBRANE TARGETING REQUIRES SUBUNIT COEXPRESSION AND INTACT GAMMA C-A-A-X DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							ROD OUTER SEGMENTS; ALPHA-SUBUNITS; RAS PROTEINS; SIGNAL TRANSDUCTION; BINDING-PROTEINS; CYSTEINE RESIDUE; BOVINE BRAIN; EXPRESSION; GENES; SEPARATION	Attachment of heterotrimeric G-proteins to the inner face of the plasma membrane is fundamental to their role as signal transducers by allowing interaction with both receptors and effectors. Certain G-protein alpha-subunits are anchored to the membrane by covalent myristoylation. The beta-gamma-complex is required for G-protein interaction with receptors and is independently membrane associated through an unknown mechanism. A series of carboxyl-terminal modifications including isoprenylation which may contribute to membrane attachment has been identified recently in G-protein gamma-subunits. Expression and membrane targeting of beta and gamma-subunits were examined in COS cells. The expression of either subunit was found to require cotransfection with both beta and gamma-cDNAs. Mutation of the carboxyl-terminal cysteine residue of gamma shown to undergo isoprenylation and carboxymethyl-esterification preserved beta-gamma-expression but blocked isoprenylation and membrane attachment. These results implicate the carboxyl-terminal processing of G-protein gamma-subunits and beta-coexpression as necessary and sufficient for membrane targeting of the beta-gamma-complex.	CALTECH,DIV BIOL,PASADENA,CA 91125; ROCKEFELLER UNIV,NEW YORK,NY 10021	California Institute of Technology; Rockefeller University	SIMONDS, WF (corresponding author), NIDDKD,MOLEC PATHOPHYSIOL BRANCH,BETHESDA,MD 20892, USA.				NIGMS NIH HHS [GM34236, R37 GM034236] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034236, R01GM034236] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKLUND PS, 1990, J BIOL CHEM, V265, P15572; BIRNBAUMER L, 1990, ANNU REV PHARMACOL, V30, P675; BLUMER KJ, 1990, P NATL ACAD SCI USA, V87, P4363, DOI 10.1073/pnas.87.11.4363; BONIFACINO JS, 1990, SCIENCE, V247, P79, DOI 10.1126/science.2294595; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BUSS JE, 1987, P NATL ACAD SCI USA, V84, P7493, DOI 10.1073/pnas.84.21.7493; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CLEVELAND DW, 1980, CELL, V20, P94; COLE GM, 1990, MOL CELL BIOL, V10, P517; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DUNN SD, 1986, ANAL BIOCHEM, V157, P144, DOI 10.1016/0003-2697(86)90207-1; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; FINEGOLD AA, 1990, SCIENCE, V249, P165, DOI 10.1126/science.1695391; FONG HKW, 1986, P NATL ACAD SCI USA, V83, P2162, DOI 10.1073/pnas.83.7.2162; FUKADA Y, 1990, NATURE, V346, P658, DOI 10.1038/346658a0; FUNG BKK, 1990, FEBS LETT, V260, P313, DOI 10.1016/0014-5793(90)80132-3; FUNG BKK, 1983, J BIOL CHEM, V258, P495; GAUTAM N, 1990, P NATL ACAD SCI USA, V87, P7973, DOI 10.1073/pnas.87.20.7973; GAUTAM N, 1989, SCIENCE, V244, P971, DOI 10.1126/science.2499046; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOLDSMITH P, 1987, J BIOL CHEM, V262, P14683; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; JONES DT, 1987, J BIOL CHEM, V262, P14241; JONES TLZ, 1990, P NATL ACAD SCI USA, V87, P568, DOI 10.1073/pnas.87.2.568; KAMIYA Y, 1978, BIOCHEM BIOPH RES CO, V83, P1077, DOI 10.1016/0006-291X(78)91505-X; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; LAI RK, 1990, P NATL ACAD SCI USA, V87, P7673, DOI 10.1073/pnas.87.19.7673; LOCHRIE MA, 1988, BIOCHEMISTRY-US, V27, P4957, DOI 10.1021/bi00414a001; MALTESE WA, 1990, J BIOL CHEM, V265, P18071; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P5873, DOI 10.1073/pnas.87.15.5873; MUMBY SM, 1990, P NATL ACAD SCI USA, V87, P728, DOI 10.1073/pnas.87.2.728; NAVON SE, 1987, J BIOL CHEM, V262, P15746; POWERS S, 1986, CELL, V47, P413, DOI 10.1016/0092-8674(86)90598-2; ROBISHAW JD, 1989, J BIOL CHEM, V264, P15758; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHULTZ AM, 1987, BIOCHEM BIOPH RES CO, V146, P1234, DOI 10.1016/0006-291X(87)90780-7; SIMONDS WF, 1989, BIOCHEM BIOPH RES CO, V164, P46, DOI 10.1016/0006-291X(89)91680-X; SPIEGEL AM, 1987, MOL CELL ENDOCRINOL, V49, P1, DOI 10.1016/0303-7207(87)90058-X; STERNWEIS PC, 1986, J BIOL CHEM, V261, P631; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; VORBURGER K, 1989, EMBO J, V8, P4007, DOI 10.1002/j.1460-2075.1989.tb08583.x; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217; YAMANE HK, 1990, P NATL ACAD SCI USA, V87, P5868, DOI 10.1073/pnas.87.15.5868	48	205	206	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5363	5366						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706334				2022-12-27	WOS:A1991FD37000003
J	MYSZKA, DG; SWENSON, RP				MYSZKA, DG; SWENSON, RP			SYNTHESIS OF THE PHOTOAFFINITY PROBE 3-(P-AZIDOBENZYL)-4-HYDROXYCOUMARIN AND IDENTIFICATION OF THE DICOUMAROL BINDING-SITE IN RAT-LIVER NAD(P)H-QUINONE REDUCTASE (EC 1.6.99.2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DT-DIAPHORASE; VITAMIN-K; NAD(P)H DEHYDROGENASE; AFFINITY-CHROMATOGRAPHY; ISOLATED HEPATOCYTES; REACTION-MECHANISM; COUMARIN ACTION; CIBACRON BLUE; INHIBITION; WARFARIN	A photoaffinity analog of 4-hydroxycoumarin containing an azidobenzyl group at the 3-position and, if desired, carbon-14 or tritium radionuclides has been synthesized and characterized. This compound, 3-(p-azidobenzyl)-4-hydroxycoumarin, serves as an effective competitive inhibitor of the dicoumarol-sensitive NAD(P)H:quinone reductase (EC 1.6.99.2; DT-diaphorase) from rat liver, having an apparent inhibition constant of 6.6 x 10(-8) M, a value comparable to that observed for dicoumarol (1.7 x 10(-9) M), significantly lower than for Warfarin (3.5 x 10(-5) M) and well within the range required of an effective photoaffinity reagent. Irradiation of the reductase with ultraviolet light in the presence of the photoprobe resulted in the covalent labeling of up to 10% of the protein. Greater than 99% of the covalent incorporation is precluded by the addition of 15-mu-M dicoumarol, consistent with the specific labeling of the 4-hydroxycoumarin binding site of this enzyme by this photoaffinity reagent. Further evidence of a high degree of specificity is provided by the isolation and sequence analysis of the peptides covalently modified by this reagent. A single region within the protein was found to be labeled, with threonine 127 and tyrosine 128 being the only amino acid residues that were observed to be modified. These results, for the first time, define a portion of the 4-hydroxycoumarin binding site within a protein that has a well established sensitivity to this type of anticoagulant and, because dicoumarol serves as a competitive inhibitor for pyridine nucleotides in this enzyme, may also define a portion of this unusual pyridine nucleotide binding site. In addition, these results suggest that this reagent may be effective as a highly specific photoaffinity probe in the identification of other proteins that are similarly inhibited by 4-hydroxycoumarin derivatives, such as the microsomal enzymes associated with the vitamin K-dependent carboxylation system.	OHIO STATE UNIV,DEPT BIOCHEM,484 W 12TH AVE,COLUMBUS,OH 43210	Ohio State University								ALMEDA S, 1981, BIOCHEMISTRY-US, V20, P3731, DOI 10.1021/bi00516a010; Bayley H, 1977, Methods Enzymol, V46, P69; Bayley H., 1984, AZIDES NITRENES REAC, P433; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; DHOLAKIA JN, 1989, J BIOL CHEM, V264, P20638; ERNSTER L, 1960, BIOCHEM BIOPH RES CO, V2, P88, DOI 10.1016/0006-291X(60)90193-5; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; EVANS RK, 1989, BIOCHEMISTRY-US, V28, P713, DOI 10.1021/bi00428a045; FASCO MJ, 1982, J BIOL CHEM, V257, P4894; Hall JM, 1972, STRUCTURE FUNCTION O, P433; HANIU M, 1988, BIOCHEMISTRY-US, V27, P6877, DOI 10.1021/bi00418a033; HILDEBRANDT EF, 1982, BIOCHEMISTRY-US, V21, P2406, DOI 10.1021/bi00539a020; HOLLANDER PM, 1975, ARCH BIOCHEM BIOPHYS, V169, P560, DOI 10.1016/0003-9861(75)90200-3; HOSODA S, 1974, J BIOL CHEM, V249, P6416; HUANG MT, 1979, J BIOL CHEM, V254, P1223; HUEBNER CF, 1945, J AM CHEM SOC, V67, P99, DOI 10.1021/ja01217a035; IYANAGI T, 1987, CHEM SCRIPTA, V27A, P31; IYANAGI T, 1970, BIOCHIM BIOPHYS ACTA, V216, P282, DOI 10.1016/0005-2728(70)90220-3; JOHNSON BC, 1980, VITAMIN K METABOLISM, P455; KNOWLES JR, 1972, ACCOUNTS CHEM RES, V5, P155, DOI 10.1021/ar50052a006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIND C, 1982, ARCH BIOCHEM BIOPHYS, V216, P178, DOI 10.1016/0003-9861(82)90202-8; LIU XF, 1989, MOL PHARMACOL, V35, P818; MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7; Murray R. D. H., 1982, NATURAL COUMARINS OC; MYSZKA DG, 1990, BIOCHEM BIOPH RES CO, V172, P415, DOI 10.1016/0006-291X(90)90689-K; Porter A, 1984, LOOKING BACK, V24, P95, DOI DOI 10.1016/B978-0-12-633480-7.50007-9; POTTER RL, 1983, METHOD ENZYMOL, V91, P613; RASE B, 1976, ARCH BIOCHEM BIOPHYS, V172, P380, DOI 10.1016/0003-9861(76)90089-8; ROBERTSON JA, 1986, J BIOL CHEM, V261, P5794; RUOHO AE, 1984, MEMBRANES DETERGENTS, P119; RUSH J, 1990, J BIOL CHEM, V265, P4821; SHAH VR, 1960, J ORG CHEM, V25, P677, DOI 10.1021/jo01074a630; SHAILUBHAI K, 1990, J BIOL CHEM, V265, P14105; SHARKIS DH, 1989, BIOCHEM BIOPH RES CO, V161, P434, DOI 10.1016/0006-291X(89)92617-X; SUTTIE JW, 1985, ANNU REV BIOCHEM, V54, P459, DOI 10.1146/annurev.bi.54.070185.002331; THOR H, 1982, J BIOL CHEM, V257, P2419; TRAGER WF, 1970, J MED CHEM, V13, P1196, DOI 10.1021/jm00300a041; VELLACCIO F, 1980, ORGANIC CHEM, P731; WALLIN R, 1978, BIOCHEM J, V169, P95, DOI 10.1042/bj1690095; WALLIN R, 1981, BIOCHEM J, V194, P983, DOI 10.1042/bj1940983; WALLIN R, 1987, CHEM SCRIPTA, V27A, P193; WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003; YSERN X, 1989, J BIOL CHEM, V264, P7765	44	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4789	4797						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1705934				2022-12-27	WOS:A1991FC21700021
J	HERSHEY, AD; DYKEMA, PE; KRAUSE, JE				HERSHEY, AD; DYKEMA, PE; KRAUSE, JE			ORGANIZATION, STRUCTURE, AND EXPRESSION OF THE GENE ENCODING THE RAT SUBSTANCE-P RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CENTRAL NERVOUS-SYSTEM; AGONIST-PROMOTED DESENSITIZATION; NUCLEOTIDE REGULATORY PROTEINS; SITE-DIRECTED MUTAGENESIS; BETA-2-ADRENERGIC RECEPTOR; BINDING-SITES; LIGAND-BINDING; MOLECULAR CHARACTERIZATION	The gene for the rat substance P receptor has been cloned, its genomic structure determined, and the patterns of mRNA expression extensively analyzed. Unlike many genes encoding G protein-coupled receptors, the protein-coding region of this gene is divided into five exons consisting of 965, 195, 151, 197, and 2,010 base pairs. The substance P receptor gene extends more than 45 kilobases in length, and the splice sites for the exons occur at the borders of the sequences encoding putative membrane-spanning domains. The transcription initiation site has been defined by solution hybridization-nuclease protection and nucleotide sequence analyses, and lies downstream of a conventional TATA sequence. Substance P receptor mRNA levels in various tissues have been quantitated using solution hybridization-nuclease protection assays and were found to comprise from 0.00008 to 0.0016% of total RNA levels. Relatively high levels of substance P receptor mRNA are seen in the urinary bladder and the sublingual salivary gland, whereas moderate levels are observed for the submandibular salivary gland, striatum, hippocampus, midbrain, and olfactory bulb with lower levels in the remainder of the central nervous system and alimentary canal. These results are discussed in relation to the evolutionary role of multiple exons for a G protein-coupled receptor and with regard to the locations and mechanisms of substance P receptor gene expression.	WASHINGTON UNIV, SCH MED, DEPT ANAT & NEUROBIOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL)			Hershey, Andrew D./K-1245-2019	Hershey, Andrew D./0000-0002-1598-7536; Krause, James E./0000-0002-8094-1710	NINDS NIH HHS [NS21937] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R55NS021937, R01NS021937] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBERT PR, 1990, J BIOL CHEM, V265, P5825; BENOVIC JL, 1986, NATURE, V321, P869, DOI 10.1038/321869a0; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; BURKHOLDER AC, 1985, NUCLEIC ACIDS RES, V13, P8463, DOI 10.1093/nar/13.23.8463; CARTER MS, 1990, J NEUROSCI, V10, P2203; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUNG FZ, 1988, J BIOL CHEM, V263, P4052; DIXON RAF, 1987, EMBO J, V6, P3269, DOI 10.1002/j.1460-2075.1987.tb02645.x; DOHLMAN HG, 1988, BIOCHEMISTRY-US, V27, P1813, DOI 10.1021/bi00406a002; DOUGLASS J, 1984, ANNU REV BIOCHEM, V53, P665; FINDLAY JBC, 1981, NATURE, V293, P314, DOI 10.1038/293314a0; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KERDELHUE B, 1985, REGUL PEPTIDES, V10, P133, DOI 10.1016/0167-0115(85)90008-4; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KRAUSE JE, 1984, J NEUROSCI, V4, P775; KRAUSE JE, 1987, P NATL ACAD SCI USA, V84, P881, DOI 10.1073/pnas.84.3.881; KRAUSE JE, 1989, METHOD ENZYMOL, V168, P634; KUBO T, 1986, FEBS LETT, V209, P367, DOI 10.1016/0014-5793(86)81144-9; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LARSEN PJ, 1989, ENDOCRINOLOGY, V124, P2548, DOI 10.1210/endo-124-5-2548; LEE CM, 1983, MOL PHARMACOL, V23, P563; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LJUNGDAHL A, 1978, NEUROSCIENCE, V3, P861, DOI 10.1016/0306-4522(78)90116-1; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; MAGGI CA, 1987, J AUTON PHARMACOL, V7, P11, DOI 10.1111/j.1474-8673.1987.tb00130.x; MAGGI CA, 1986, J PHARMACOL EXP THER, V238, P341; MAGGI CA, 1988, J PHARMACOL EXP THER, V246, P308; MANTYH PW, 1989, J NEUROSCI, V9, P258; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; NAKAYAMA N, 1985, EMBO J, V4, P2643, DOI 10.1002/j.1460-2075.1985.tb03982.x; NATHANS J, 1984, P NATL ACAD SCI-BIOL, V81, P4851, DOI 10.1073/pnas.81.15.4851; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; OMALLEY KL, 1990, BIOCHEMISTRY-US, V29, P1367, DOI 10.1021/bi00458a003; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; PERNOW B, 1983, PHARMACOL REV, V35, P85; QUIRION R, 1983, NATURE, V303, P714, DOI 10.1038/303714a0; QUIRION R, 1986, J NEUROSCI, V6, P2187; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROGERS J, 1983, NATURE, V305, P101, DOI 10.1038/305101a0; RUBENSTEIN RC, 1987, J BIOL CHEM, V262, P16655; SAFFROY M, 1988, PEPTIDES, V9, P227, DOI 10.1016/0196-9781(88)90255-0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J., 1982, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHIGEMOTO R, 1990, J BIOL CHEM, V265, P623; SHULTS CW, 1984, PEPTIDES, V5, P1097, DOI 10.1016/0196-9781(84)90177-3; SIBLEY DR, 1986, P NATL ACAD SCI USA, V83, P9408, DOI 10.1073/pnas.83.24.9408; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; WANG JK, 1980, BIOCHEMISTRY-US, V19, P5111, DOI 10.1021/bi00563a027; WEISS ER, 1988, J BIOL CHEM, V263, P6150; WHEATLEY M, 1988, Trends in Pharmacological Sciences, P19; WONG SKF, 1988, J BIOL CHEM, V263, P7925; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	76	129	132	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4366	4374						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705552				2022-12-27	WOS:A1991FA69400055
J	JOHNSON, KW; SMITH, KA				JOHNSON, KW; SMITH, KA			MOLECULAR-CLONING OF A NOVEL HUMAN CDC2 CDC28-LIKE PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLE CONTROL GENES; CELL-CYCLE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURE; GLOBULAR PROTEINS; MITOTIC CONTROL; PHO SYSTEM; M-PHASE	A homology probing approach was utilized to isolate a new human protein kinase. Deoxyoligonucleotide probes recognizing a conserved subdomain in the COOH-terminal portion of protein kinases identified a cDNA clone encoding a putative kinase with predicted serine/threonine phosphorylation specificity. The full-length, 1.7-kilobase pair cDNA hybridizes to 1.7- and 3.4-kilobase mRNA transcripts in a number of tissues. The size of the encoded protein is 454 amino acids and consists of an NH2-terminal 130-residue segment, which may represent a regulatory region, followed by a 324-residue catalytic domain. Comparisons and alignments of the primary sequence and predicted secondary structure of the catalytic region to other known kinases reveal that the new kinase, denoted "CLK" (for CDC-like kinase), represents a prototype for a new family of human protein kinases bearing significant homology to the yeast cdc2/CDC28 kinases that regulate the cell cycle.	DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT MED,HANOVER,NH 03756	Dartmouth College								BEACH D, 1982, NATURE, V300, P706, DOI 10.1038/300706a0; BOOHER R, 1988, EMBO J, V7, P2321, DOI 10.1002/j.1460-2075.1988.tb03075.x; BOOHER R, 1987, EMBO J, V6, P3441, DOI 10.1002/j.1460-2075.1987.tb02667.x; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; CALIGIURI MA, 1990, J EXP MED, V171, P1509, DOI 10.1084/jem.171.5.1509; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; COURCHESNE WE, 1989, CELL, V58, P1107, DOI 10.1016/0092-8674(89)90509-6; CROSS F, 1989, ANNU REV CELL BIOL, V5, P341; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; ELION EA, 1990, CELL, V60, P649, DOI 10.1016/0092-8674(90)90668-5; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GOELET P, 1982, P NATL ACAD SCI-BIOL, V79, P5818, DOI 10.1073/pnas.79.19.5818; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GULLBERG M, 1986, J EXP MED, V163, P270, DOI 10.1084/jem.163.2.270; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; HINDLEY J, 1984, GENE, V31, P129, DOI 10.1016/0378-1119(84)90203-8; HINES J, 1989, CELL, V58, P833; HOLLEY LH, 1989, P NATL ACAD SCI USA, V86, P152, DOI 10.1073/pnas.86.1.152; HUNT T, 1989, NATURE, V342, P483, DOI 10.1038/342483a0; HUYNH TV, 1985, DNA CLONING PRACTICA; JOHNSON KW, 1990, J IMMUNOL, V145, P1144; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LANGAN TA, 1989, MOL CELL BIOL, V9, P3860, DOI 10.1128/MCB.9.9.3860; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEE M, 1988, TRENDS GENET, V4, P287, DOI 10.1016/0168-9525(88)90171-0; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LIM VI, 1974, J MOL BIOL, V88, P873, DOI 10.1016/0022-2836(74)90405-7; LORINCZ AT, 1984, NATURE, V307, P183, DOI 10.1038/307183a0; Maniatis T., 1982, MOL CLONING; MATUSHUSHIME H, 1990, MOL CELL BIOL, V10, P2261; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; MURRAY AW, 1989, NATURE, V342, P14, DOI 10.1038/342014a0; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; REED J, 1984, BIOCHEMISTRY-US, V23, P1357, DOI 10.1021/bi00302a004; REED S, 1981, P NATL ACAD SCI USA, V77, P2119; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; RICHARDSON HE, 1989, CELL, V59, P1127, DOI 10.1016/0092-8674(89)90768-X; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; SIMON M, 1986, EMBO J, V5, P2697, DOI 10.1002/j.1460-2075.1986.tb04553.x; SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; TOHE A, 1988, MOL GEN GENET, V214, P162, DOI 10.1007/BF00340196; UESONO Y, 1987, NUCLEIC ACIDS RES, V15, P10299, DOI 10.1093/nar/15.24.10299	52	76	80	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3402	3407						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704889				2022-12-27	WOS:A1991EY68200011
J	ARMSTRONG, PB; MANGEL, WF; WALL, JS; HAINFIELD, JF; VANHOLDE, KE; IKAI, A; QUIGLEY, JP				ARMSTRONG, PB; MANGEL, WF; WALL, JS; HAINFIELD, JF; VANHOLDE, KE; IKAI, A; QUIGLEY, JP			STRUCTURE OF ALPHA-2-MACROGLOBULIN FROM THE ARTHROPOD LIMULUS-POLYPHEMUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ALPHA-2-MACROGLOBULIN RECEPTOR; CRAYFISH PACIFASTACUS-LENIUSCULUS; PROTEINASE COMPLEX-FORMATION; THIOL-ESTER; ALPHA-MACROGLOBULIN; COVALENT BINDING; HALF-MOLECULES; INHIBITOR; PLASMA; HEMOLYMPH	A structural and functional homologue of vertebrate alpha-2-macroglobulin (alpha-2M) has been identified in the hemolymph and blood cells of the arthropod Limulus polyphemus, one of the oldest living fossil invertebrates (Quigley, J.P., and Armstrong, P.B. (1985) J. Biol. Chem. 260, 12715-12719). The subunit molecular mass is 185 kDa. The native molecular mass, determined by scanning transmission electron microscopy (STEM) under conditions in which the linear relationship between the STEM large angle detector signal and specimen mass thickness allows the determination of the total macromolecular mass, was 354 +/- 35 kDa. Sedimentation equilibrium measurements gave a value of 366 kDa, independent of solute concentration. Sedimentation velocity experiments indicated a homogeneous component with a frictional ratio of 1.41. Thus, the native structure appears to be a dimer, with a somewhat extended conformation. The behavior during gel permeation chromatography was anomolous, yielding an apparent molecular mass approximately half-way between that expected for the dimeric and tetrameric configurations. Transmission electron microscopy of negatively stained preparations revealed a dimeric butterfly-like structure that collapsed following reaction with chymotrypsin.	UNIV CALIF DAVIS,DEPT ZOOL,CELL BIOL LAB,DAVIS,CA 95616; BROOKHAVEN NATL LAB,DEPT BIOL,UPTON,NY 11973; OREGON STATE UNIV,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331; TOKYO INST TECHNOL,BIODYNAM LAB,YOKOHAMA,KANAGAWA 227,JAPAN; SUNY STONY BROOK,HLTH SCI CTR,DEPT PATHOL,STONY BROOK,NY 11794	University of California System; University of California Davis; United States Department of Energy (DOE); Brookhaven National Laboratory; Oregon State University; Tokyo Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	ARMSTRONG, PB (corresponding author), MARINE BIOL LAB,WOODS HOLE,MA 02543, USA.			Armstrong, Peter/0000-0001-5197-1999	NCRR NIH HHS [RR 01777] Funding Source: Medline; NIGMS NIH HHS [GM 35185] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035185] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG PB, 1985, J EXP ZOOL, V236, P1, DOI 10.1002/jez.1402360102; ARMSTRONG PB, 1987, BIOCHEM J, V248, P703, DOI 10.1042/bj2480703; ARMSTRONG PB, 1991, IN PRESS REC ADV ART; ARMSTRONG PB, 1985, BLOOD CELLS MARINE I, P253; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; FEINMAN RD, 1985, BIOCHEM J, V231, P417, DOI 10.1042/bj2310417; FEINMAN RD, 1983, CHEM BIOL ALPHA 2 MA; FELDMAN SR, 1984, ARCH BIOCHEM BIOPHYS, V235, P267, DOI 10.1016/0003-9861(84)90275-3; FELDMAN SR, 1986, BIOCHEMISTRY-US, V25, P721, DOI 10.1021/bi00351a032; GONIAS SL, 1983, BIOCHEMISTRY-US, V22, P536, DOI 10.1021/bi00272a003; GONIAS SL, 1983, BIOCHEMISTRY-US, V22, P4933, DOI 10.1021/bi00290a009; HALL M, 1989, FEBS LETT, V254, P111, DOI 10.1016/0014-5793(89)81019-1; HARPEL PC, 1973, J EXP MED, V138, P508, DOI 10.1084/jem.138.3.508; HERGENHAHN HG, 1985, COMP BIOCHEM PHYS B, V81, P833, DOI 10.1016/0305-0491(85)90075-6; HERGENHAHN HG, 1988, BIOCHEM J, V255, P801, DOI 10.1042/bj2550801; HOWARD JB, 1981, P NATL ACAD SCI-BIOL, V78, P2235, DOI 10.1073/pnas.78.4.2235; IKAI A, 1990, J BIOL CHEM, V265, P8280; JONES JM, 1972, BIOCHEM J, V127, P187, DOI 10.1042/bj1270187; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; OSADA T, 1986, J ULTRA MOL STRUCT R, V96, P136, DOI 10.1016/0889-1605(86)90014-5; QUIGLEY JP, 1983, J BIOL CHEM, V258, P7903; QUIGLEY JP, 1985, J BIOL CHEM, V260, P2715; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SALVESEN GS, 1980, BIOCHEM J, V187, P695, DOI 10.1042/bj1870695; SAND O, 1985, J BIOL CHEM, V260, P5723; Sottrup-Jensen L., 1987, PLASMA PROTEINS, V5, P191; SOTTRUPJENSEN L, 1981, FEBS LETT, V123, P145, DOI 10.1016/0014-5793(81)80039-7; SOTTRUPJENSEN L, 1981, FEBS LETT, V128, P127, DOI 10.1016/0014-5793(81)81097-6; SOTTRUPJENSEN L, 1980, FEBS LETT, V121, P275, DOI 10.1016/0014-5793(80)80361-9; SOTTRUPJENSEN L, 1990, COMP BIOCHEM PHYS B, V96, P621, DOI 10.1016/0305-0491(90)90066-3; SPYCHER SE, 1987, J BIOL CHEM, V262, P14606; STARKEY PM, 1982, BIOCHEM J, V205, P91, DOI 10.1042/bj2050091; Stocker W., 1986, Verhandlungen der Deutschen Zoologischen Gesellschaft, V79, P190; SWENSON RP, 1979, P NATL ACAD SCI USA, V76, P4313, DOI 10.1073/pnas.76.9.4313; SWENSON RP, 1979, J BIOL CHEM, V254, P4452; VANHOLDE KE, 1985, PHYSICAL BIOCH, P98; VANLEUVEN F, 1981, J BIOL CHEM, V256, P9023; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; WANG D, 1983, ARCH BIOCHEM BIOPHYS, V222, P117, DOI 10.1016/0003-9861(83)90508-8; WANG D, 1981, ARCH BIOCHEM BIOPHYS, V211, P500, DOI 10.1016/0003-9861(81)90483-5; WANG D, 1984, BIOCHEMISTRY-US, V23, P2807, DOI 10.1021/bi00307a042; WU K, 1981, J BIOL CHEM, V256, P409	45	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2526	2530						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703530				2022-12-27	WOS:A1991EV51500078
J	LEE, MYWT; JIANG, YQ; ZHANG, SJ; TOOMEY, NL				LEE, MYWT; JIANG, YQ; ZHANG, SJ; TOOMEY, NL			CHARACTERIZATION OF HUMAN DNA POLYMERASE-DELTA AND ITS IMMUNOCHEMICAL RELATIONSHIPS WITH DNA POLYMERASE-ALPHA AND POLYMERASE-EPSILON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DELTA AUXILIARY PROTEIN; CEREVISIAE CDC2 GENE; SACCHAROMYCES-CEREVISIAE; CALF THYMUS; MONOCLONAL-ANTIBODIES; REPLICATION INVITRO; HUMAN-FIBROBLASTS; REPAIR SYNTHESIS; ALPHA	DNA polymerase-delta was purified from human placenta and its polymerase catalytic subunit identified as a 125-kDa polypeptide by activity staining. This 125-kDa form of DNA polymerase-delta resembles that reported from calf thymus (Lee, M. Y. W. T., Tan, C.-K., Downey, K. M., and So, A. G. (1984) biochemistry 23, 1906-1913) and differs in molecular properties from a previously described form isolated from human placenta (Lee, M. Y. W. T., and Toomey, N. L. (1987) Biochemistry 26, 1076-1085) and now referred to as DNA polymerase-epsilon. The properties of DNA polymerase-delta were further investigated to determine its relationships with DNA polymerase-epsilon. The two enzymes differed in their response to proliferating cell nuclear antigen. Monoclonal antibodies against DNA polymerase-delta were raised and used to examine its immunochemical relationships with DNA polymerase-alpha and epsilon. These studies provided evidence that all three proteins are structurally distinct but share a common epitope(s). Immunofluorescence microscopy indicates that DNA polymerase-delta and possibly also DNA polymerase-epsilon are localized to the nucleus.			LEE, MYWT (corresponding author), UNIV MIAMI,SCH MED,DEPT MED,R-57,POB 016960,MIAMI,FL 33101, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031973] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 31973] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; BAUER GA, 1988, J BIOL CHEM, V263, P917; BOULET A, 1989, EMBO J, V8, P1849, DOI 10.1002/j.1460-2075.1989.tb03580.x; BUDD ME, 1989, J BIOL CHEM, V264, P6557; BURGERS PMJ, 1988, NUCLEIC ACIDS RES, V16, P6297, DOI 10.1093/nar/16.14.6297; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; BYRNES JJ, 1985, BIOCHEM BIOPH RES CO, V132, P628, DOI 10.1016/0006-291X(85)91179-9; BYRNES JJ, 1976, BIOCHEMISTRY-US, V15, P2817, DOI 10.1021/bi00658a018; CRUTE JJ, 1986, BIOCHEMISTRY-US, V25, P26, DOI 10.1021/bi00349a005; DRESLER SL, 1988, BIOCHEM PHARMACOL, V37, P1033, DOI 10.1016/0006-2952(88)90506-0; DRESLER SL, 1986, NUCLEIC ACIDS RES, V14, P7093, DOI 10.1093/nar/14.17.7093; FOCHER F, 1989, NUCLEIC ACIDS RES, V17, P1805, DOI 10.1093/nar/17.5.1805; FOCHER F, 1988, NUCLEIC ACIDS RES, V16, P6279, DOI 10.1093/nar/16.14.6279; GOSCIN LP, 1982, BIOCHEMISTRY-US, V21, P2513, DOI 10.1021/bi00539a034; HAMATAKE RK, 1990, J BIOL CHEM, V265, P4072; HAMMOND RA, 1987, BIOCHEMISTRY-US, V26, P6817, DOI 10.1021/bi00395a035; KNOPF CW, 1988, BIOCHIM BIOPHYS ACTA, V951, P298, DOI 10.1016/0167-4781(88)90100-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAVITT MC, 1989, P NATL ACAD SCI USA, V86, P4465, DOI 10.1073/pnas.86.12.4465; LEE MYW, 1988, DNA REPLICATION MUTA, P68; LEE MYWT, 1989, ARCH BIOCHEM BIOPHYS, V272, P1, DOI 10.1016/0003-9861(89)90187-2; LEE MYWT, 1987, BIOCHEMISTRY-US, V26, P1076, DOI 10.1021/bi00378a014; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LEE MYWT, 1985, NUCLEIC ACIDS RES, V13, P8623, DOI 10.1093/nar/13.23.8623; LEE MYWT, 1984, ANAL BIOCHEM, V138, P291; LEE MYWT, 1988, BIOCHEMISTRY-US, V27, P5188, DOI 10.1021/bi00414a036; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; MILLER MR, 1985, J BIOL CHEM, V260, P134; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; NISHIDA C, 1988, J BIOL CHEM, V263, P501; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SITNEY KC, 1989, CELL, V56, P599, DOI 10.1016/0092-8674(89)90582-5; SO AG, 1988, BIOCHEMISTRY-US, V27, P4591, DOI 10.1021/bi00413a001; SPANOS A, 1981, NUCLEIC ACIDS RES, V9, P1825, DOI 10.1093/nar/9.8.1825; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; TAN CK, 1986, J BIOL CHEM, V261, P2310; TANAKA S, 1982, J BIOL CHEM, V257, P8386; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x; WONG SW, 1989, J BIOL CHEM, V264, P5924; ZHANG SJ, 1987, ARCH BIOCHEM BIOPHYS, V252, P24, DOI 10.1016/0003-9861(87)90004-X	42	67	68	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2423	2429						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703528				2022-12-27	WOS:A1991EV51500063
J	RAFNAR, T; GRIFFITH, IJ; KUO, MC; BOND, JF; ROGERS, BL; KLAPPER, DG				RAFNAR, T; GRIFFITH, IJ; KUO, MC; BOND, JF; ROGERS, BL; KLAPPER, DG			CLONING OF AMB-A I (ANTIGEN-E), THE MAJOR ALLERGEN FAMILY OF SHORT RAGWEED POLLEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGENIC PROPERTIES; MONOCLONAL-ANTIBODIES; DENATURED ANTIGEN; ACID SEQUENCES; HAY-FEVER; T-CELLS; IMMUNOTHERAPY; CDNA; EXPRESSION; SITES	To determine the structure of Amb a I (previously called antigen E), the major allergen from short ragweed, cDNA from pollen was cloned into lambda-gt11 and lambda-gt10. One of the three distinct clones isolated from the lambda-gt11 library by screening with anti-denatured Amb a I antibodies was used to screen both libraries for other Amb a I sequences. Multiple clones were isolated and sequenced and proved to be highly homologous but nonidentical. The clones could be divided into three groups based on sequence similarity, and in accordance with the International Union of Immunological Societies-approved nomenclature (Marsh, D. G., Goodfriend, L., King, T. P., Lowenstein, H., and Platts-Mills, T. A. E. (1986) Bull. WHO 64, 767-770) they have been designated Amb a I.1, Amb a I.2, and Amb a I.3. Clones within a group have greater than 99% identity, and similarity among groups is 85-90% at the nucleotide level. The amino acid sequence of four peptides (isolated from antigen E obtained from the Research Resources Branch of the National Institutes of Health) containing 132 amino acids was identical to one of the clones (Amb a I.1). The presence of multiple naturally occurring isoelectric forms of Amb a I was demonstrated by two-dimensional gel electrophoresis and Western blotting. Southern blot analysis demonstrates the presence of multiple Amb a I-related sequences in the ragweed genome. Amb a I is therefore not a single molecule but rather a family of closely related proteins.	UNIV N CAROLINA,SCH MED,DEPT MICROBIOL & IMMUNOL,CHAPEL HILL,NC 27599; IMMULOG PHARMACEUT CORP,CAMBRIDGE,MA 02139	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine					NIAID NIH HHS [AI 14908] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014908] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDREWS PC, 1987, ANAL BIOCHEM, V161, P524, DOI 10.1016/0003-2697(87)90484-2; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; BUTTERFIELD JH, 1981, J ALLERGY CLIN IMMUN, V67, P272, DOI 10.1016/0091-6749(81)90021-X; Celis J, 1984, 2 DIMENSIONAL GEL EL; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DELISI C, 1985, P NATL ACAD SCI USA, V82, P7048, DOI 10.1073/pnas.82.20.7048; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DJURUP R, 1985, ALLERGY, V40, P469, DOI 10.1111/j.1398-9995.1985.tb00253.x; FANG KSY, 1988, P NATL ACAD SCI USA, V85, P895, DOI 10.1073/pnas.85.3.895; GRAMMER LC, 1982, J ALLERGY CLIN IMMUN, V69, P494, DOI 10.1016/0091-6749(82)90173-7; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANSON DD, 1989, PLANT CELL, V1, P173, DOI 10.1105/tpc.1.2.173; HUYUH TV, 1985, DNA CLONING, V1, P49; ISHIZAKA K, 1974, J IMMUNOL, V113, P70; ISHIZAKA K, 1975, J IMMUNOL, V114, P110; JUNGFORETAGENAB O, 1982, ISOELECTRIC FOCUSING, P127; KELLER C, 1984, NUCLEIC ACIDS RES, V12, P379, DOI 10.1093/nar/12.1Part1.379; KING TP, 1976, ADV IMMUNOL, V23, P77, DOI 10.1016/S0065-2776(08)60319-3; KING TP, 1964, BIOCHEMISTRY-US, V3, P458, DOI 10.1021/bi00891a026; KING TP, 1981, ARCH BIOCHEM BIOPHYS, V212, P127, DOI 10.1016/0003-9861(81)90351-9; KLAPPER DG, 1989, ADV BIOSCIENCES ALLE, V74, P149; KNOX RB, 1979, POLLEN ALLERGY, P56; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KUCHLER K, 1989, EUR J BIOCHEM, V184, P249, DOI 10.1111/j.1432-1033.1989.tb15014.x; LAGRIMINI LM, 1987, P NATL ACAD SCI USA, V84, P7542, DOI 10.1073/pnas.84.21.7542; LEVY S, 1987, GENE, V54, P167, DOI 10.1016/0378-1119(87)90484-7; LOWENSTEIN H, 1983, J IMMUNOL, V130, P727; LYCETT GW, 1983, FEBS LETT, V153, P43, DOI 10.1016/0014-5793(83)80116-1; Maniatis T, 1982, MOL CLONING LABORATO; MARSH DG, 1986, B WORLD HEALTH ORGAN, V64, P767; MARSH DG, 1975, ANTIGENS, V3, P271; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10335; NORMAN PS, 1968, J ALLERGY, V42, P93, DOI 10.1016/0021-8707(68)90139-1; NORMAN PS, 1984, J ALLERGY CLIN IMMUN, V73, P782, DOI 10.1016/0091-6749(84)90448-2; OLSON JR, 1986, J IMMUNOL, V136, P2109; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RIVIN CJ, 1982, MAINE BIOL RES; ROUX KH, 1990, BIOTECHNIQUES, V8, P48; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH JJ, 1988, MOL IMMUNOL, V25, P355, DOI 10.1016/0161-5890(88)90030-2; TERHORST C, 1977, P NATL ACAD SCI USA, V74, P4002, DOI 10.1073/pnas.74.9.4002; THOMAS WR, 1988, INT ARCH ALLER A IMM, V85, P127, DOI 10.1159/000234488; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; ZEISS CR, 1977, CLIN EXP IMMUNOL, V28, P250; ZEISS CR, 1973, J IMMUNOL, V110, P414	49	156	182	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1229	1236						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702434				2022-12-27	WOS:A1991ET17700084
J	SIEKIERKA, JJ; WIEDERRECHT, G; GREULICH, H; BOULTON, D; HUNG, SHY; CRYAN, J; HODGES, PJ; SIGAL, NH				SIEKIERKA, JJ; WIEDERRECHT, G; GREULICH, H; BOULTON, D; HUNG, SHY; CRYAN, J; HODGES, PJ; SIGAL, NH			THE CYTOSOLIC-BINDING PROTEIN FOR THE IMMUNOSUPPRESSANT FK-506 IS BOTH A UBIQUITOUS AND HIGHLY CONSERVED PEPTIDYL-PROLYL CIS-TRANS ISOMERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MERCK SHARP & DOHME LTD,DEPT BIOPHYS CHEM,RAHWAY,NJ 07065; MERCK SHARP & DOHME LTD,DEPT BASIC MED CHEM,RAHWAY,NJ 07065	Merck & Company; Merck & Company	SIEKIERKA, JJ (corresponding author), MERCK SHARP & DOHME LTD,DEPT IMMUNOL RES,POB 2000,R80W-107,RAHWAY,NJ 07065, USA.							BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; ELLIOTT JF, 1984, SCIENCE, V226, P1439, DOI 10.1126/science.6334364; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FISCHER G, 1990, BIOCHEMISTRY-US, V29, P2205, DOI 10.1021/bi00461a001; HAENDLER B, 1989, GENE, V83, P39, DOI 10.1016/0378-1119(89)90401-0; HARDING MW, 1986, J BIOL CHEM, V261, P8547; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; JUNE CH, 1987, MOL CELL BIOL, V7, P4472, DOI 10.1128/MCB.7.12.4472; KAY JE, 1990, TRANSPLANT P, V22, P96; KOLETSKY AJ, 1986, J IMMUNOL, V137, P1054; KRONKE M, 1984, P NATL ACAD SCI-BIOL, V81, P5214, DOI 10.1073/pnas.81.16.5214; LIGHTOWLERS MW, 1990, IN PRESS MOL BIOCH P; LIN CS, 1990, IN PRESS J CELL IMMU; MIZUSHIMA Y, 1987, J BIOCHEM-TOKYO, V102, P1193, DOI 10.1093/oxfordjournals.jbchem.a122158; RUPPRECHT KM, 1981, BIOCHEMISTRY-US, V20, P6570, DOI 10.1021/bi00526a008; SAWADA S, 1987, J IMMUNOL, V139, P1797; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIEKIERKA JJ, 1989, J IMMUNOL, V143, P1580; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; TANAKA H, 1987, J AM CHEM SOC, V109, P5031, DOI 10.1021/ja00250a050; TOCCI MJ, 1989, J IMMUNOL, V143, P718; TROPSCHUG M, 1989, NATURE, V342, P953, DOI 10.1038/342953a0; TROPSCHUG M, 1988, J BIOL CHEM, V263, P14433	27	124	135	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21011	21015						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701173				2022-12-27	WOS:A1990EL02000048
J	INOUE, T; TAMURA, TA; FURUICHI, T; MIKOSHIBA, K				INOUE, T; TAMURA, TA; FURUICHI, T; MIKOSHIBA, K			ISOLATION OF COMPLEMENTARY DNAS ENCODING A CEREBELLUM-ENRICHED NUCLEAR FACTOR-I FAMILY THAT ACTIVATES TRANSCRIPTION FROM THE MOUSE MYELIN BASIC-PROTEIN PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NATL INST BASIC BIOL,DIV BEHAV & NEUROBIOL,OKAZAKI,AICHI 444,JAPAN; OSAKA UNIV,INST PROT RES,DIV MACROMOLEC FUNCT,SUITA,OSAKA 565,JAPAN	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Osaka University			Inoue, Takafumi/AAM-9533-2020; Mikoshiba, Katsuhiko/N-7943-2015	Inoue, Takafumi/0000-0002-2728-0060; Furuichi, Teiichi/0000-0002-9676-1888				AMMENDOLA R, 1990, MOL CELL BIOL, V10, P387, DOI 10.1128/MCB.10.1.387; AOYAMA A, 1990, BIOCHEM BIOPH RES CO, V167, P648, DOI 10.1016/0006-291X(90)92074-A; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CARUSO M, 1990, EMBO J, V9, P947, DOI 10.1002/j.1460-2075.1990.tb08193.x; COLANTUONI V, 1987, EMBO J, V6, P631, DOI 10.1002/j.1460-2075.1987.tb04801.x; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; GOUNARI F, 1990, EMBO J, V9, P559, DOI 10.1002/j.1460-2075.1990.tb08143.x; GOYAL N, 1990, MOL CELL BIOL, V10, P1041, DOI 10.1128/MCB.10.3.1041; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HENNIGHAUSEN L, 1985, NATURE, V314, P289, DOI 10.1038/314289a0; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KATSUKI M, 1988, SCIENCE, V241, P593, DOI 10.1126/science.2456614; KENNEY S, 1984, SCIENCE, V226, P1337, DOI 10.1126/science.6095453; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; Maniatis T., 1982, MOL CLONING; MEISTERERNST M, 1989, BIOCHEMISTRY-US, V28, P8191, DOI 10.1021/bi00446a034; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MIKOSHIBA K, 1982, GENETIC APPROACHES D, P195; MIURA M, 1989, GENE, V75, P31; MORINAGA Y, 1984, BIO-TECHNOL, V2, P636, DOI 10.1038/nbt0784-636; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; NILSSON P, 1989, NUCLEIC ACIDS RES, V17, P4061, DOI 10.1093/nar/17.11.4061; NORTON WT, 1981, ADV NEUROBIOLOGY, P93; NOWOCK J, 1985, NUCLEIC ACIDS RES, V13, P2045, DOI 10.1093/nar/13.6.2045; OKANO H, 1987, J NEUROCHEM, V48, P470, DOI 10.1111/j.1471-4159.1987.tb04116.x; PAONESSA G, 1988, EMBO J, V7, P3115, DOI 10.1002/j.1460-2075.1988.tb03178.x; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUPP RAW, 1990, NUCLEIC ACIDS RES, V18, P2607, DOI 10.1093/nar/18.9.2607; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SHAUL Y, 1986, EMBO J, V5, P1967, DOI 10.1002/j.1460-2075.1986.tb04451.x; TAMURA T, 1990, J GEN VIROL, V71, P1829, DOI 10.1099/0022-1317-71-8-1829; TAMURA T, 1988, BIOCHEM BIOPH RES CO, V157, P419, DOI 10.1016/S0006-291X(88)80265-1; TAMURA T, 1988, NUCLEIC ACIDS RES, V16, P11441, DOI 10.1093/nar/16.24.11441; TAMURA TA, 1989, MOL CELL BIOL, V9, P3122, DOI 10.1128/MCB.9.7.3122; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3	38	95	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19065	19070						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699939				2022-12-27	WOS:A1990EF73900061
J	SACCHETTINI, JC; HAUFT, SM; VANCAMP, SL; CISTOLA, DP; GORDON, JI				SACCHETTINI, JC; HAUFT, SM; VANCAMP, SL; CISTOLA, DP; GORDON, JI			DEVELOPMENTAL AND STRUCTURAL STUDIES OF AN INTRACELLULAR LIPID-BINDING PROTEIN EXPRESSED IN THE ILEAL EPITHELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WASHINGTON UNIV, SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS, 660 S EUCLID AVE,BOX 8231, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PEDIAT, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)				Cistola, David/0000-0002-9586-8720	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292] Funding Source: NIH RePORTER; NCRR NIH HHS [RR05389-28, RR02004] Funding Source: Medline; NIDDK NIH HHS [DK30292] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BORGSTROM A, 1986, HISTOCHEMISTRY, V86, P101, DOI 10.1007/BF00492352; CABRAL DJ, 1986, J LIPID RES, V27, P334; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CISTOLA DP, 1986, BIOCHEMISTRY-US, V25, P2804, DOI 10.1021/bi00358a011; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; CISTOLA DP, 1987, J BIOL CHEM, V262, P10971; CISTOLA DP, 1989, J BIOL CHEM, V264, P2700; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P711, DOI 10.1021/bi00402a033; DEMMER LA, 1986, P NATL ACAD SCI USA, V83, P8102, DOI 10.1073/pnas.83.21.8102; DIETSCHY JM, 1968, J LIPID RES, V9, P297; DURONIO RJ, 1990, P NATL ACAD SCI USA, V87, P1506, DOI 10.1073/pnas.87.4.1506; ERLINGER S, 1987, PHYSL GASTROINTESTIN, P1569; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINSTEIN SI, 1983, NUCLEIC ACIDS RES, V11, P2927, DOI 10.1093/nar/11.9.2927; FERNANDOWARNAKULASURIYA GJP, 1983, J LIPID RES, V24, P1626; FROST SC, 1983, J LIPID RES, V24, P899; GANTZ I, 1989, J BIOL CHEM, V264, P20248; HAUFT SM, 1989, J BIOL CHEM, V264, P8419; Henning Susan J., 1987, PHYSL GASTROINTESTIN, V1, P285; HEUCKEROTH RO, 1987, J BIOL CHEM, V262, P9709; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; HOFMANN AF, 1984, HEPATOLOGY, V4, pS4, DOI 10.1002/hep.1840040803; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN MS, 1987, J BIOL CHEM, V262, P7118; LITTLE JM, 1980, AM J PHYSIOL, V239, pG319, DOI 10.1152/ajpgi.1980.239.4.G319; LOWE JB, 1987, J BIOL CHEM, V262, P5931; LOWE JB, 1984, J BIOL CHEM, V259, P2696; MOYER MS, 1986, GASTROENTEROLOGY, V90, P1188, DOI 10.1016/0016-5085(86)90384-7; OLINS PO, 1988, GENE, V73, P227, DOI 10.1016/0378-1119(88)90329-0; OLINS PO, 1989, J BIOL CHEM, V264, P16973; PAHLER A, 1985, FEBS LETT, V184, P185, DOI 10.1016/0014-5793(85)80603-7; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; RUBIN DC, 1989, P NATL ACAD SCI USA, V86, P1278, DOI 10.1073/pnas.86.4.1278; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; SACCHETTINI JC, 1990, IN PRESS CELL MOL BI; Sadler J R, 1974, Lab Pract, V23, P642; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SWEETSER DA, 1987, ANNU REV NUTR, V7, P337, DOI 10.1146/annurev.nu.07.070187.002005; SWEETSER DA, 1988, GENE DEV, V2, P1318, DOI 10.1101/gad.2.10.1318; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; SWEETSER DA, 1987, J BIOL CHEM, V262, P16060; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WALZ DA, 1988, J BIOL CHEM, V263, P14189; WHITE BA, 1982, J BIOL CHEM, V257, P8569; WIDER MD, 1984, ENDOCRINOLOGY, V115, P1484, DOI 10.1210/endo-115-4-1484; WINTER NS, 1990, J BIOL CHEM, V265, P10955	49	105	106	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19199	19207						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699943				2022-12-27	WOS:A1990EF73900080
J	SHIPMANAPPASAMY, P; COHEN, KS; PRYSTOWSKY, MB				SHIPMANAPPASAMY, P; COHEN, KS; PRYSTOWSKY, MB			INTERLEUKIN 2-INDUCED EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN IS REGULATED BY TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL MECHANISMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV PENN,DEPT PATHOL & LAB MED,547 CLIN RES BLDG,422 CURIE BLVD,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041226] Funding Source: NIH RePORTER; NCI NIH HHS [CA09140-12] Funding Source: Medline; NIGMS NIH HHS [GM41226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMENDRAL JM, 1987, P NATL ACAD SCI USA, V84, P1575, DOI 10.1073/pnas.84.6.1575; ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; BAUER GA, 1990, NUCLEIC ACIDS RES, V18, P261, DOI 10.1093/nar/18.2.261; BRAVO R, 1985, FEBS LETT, V182, P435, DOI 10.1016/0014-5793(85)80349-5; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; CHANG CD, 1990, MOL CELL BIOL, V10, P3289, DOI 10.1128/MCB.10.7.3289; CLEVENGER CV, 1985, CYTOMETRY, V6, P208, DOI 10.1002/cyto.990060306; COPPOCK DL, 1987, MOL CELL BIOL, V7, P2925, DOI 10.1128/MCB.7.8.2925; GLASEBROOK AL, 1980, J EXP MED, V151, P876, DOI 10.1084/jem.151.4.876; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; JASKULSKI D, 1988, SCIENCE, V240, P1544, DOI 10.1126/science.2897717; LEE SC, 1986, J CELL BIOL, V102, P1200, DOI 10.1083/jcb.102.4.1200; LIEBERMAN HB, 1988, MOL CELL BIOL, V8, P5280, DOI 10.1128/MCB.8.12.5280; LIPSON KE, 1989, P NATL ACAD SCI USA, V86, P6848, DOI 10.1073/pnas.86.18.6848; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; MATSUMOTO K, 1987, EMBO J, V6, P637, DOI 10.1002/j.1460-2075.1987.tb04802.x; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; OTTAVIO L, 1990, MOL CELL BIOL, V10, P303, DOI 10.1128/MCB.10.1.303; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P4901; PIECHACZYK M, 1985, CELL, V42, P589, DOI 10.1016/0092-8674(85)90116-3; PLUMB M, 1983, NUCLEIC ACIDS RES, V11, P2391, DOI 10.1093/nar/11.8.2391; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; PRUSSAK CE, 1989, J BIOL CHEM, V264, P4957; PRYSTOWSKY MB, 1986, LYMPHOKINE RES, V12, P22; REED JC, 1985, MOL CELL BIOL, V5, P3361, DOI 10.1128/MCB.5.12.3361; SABATH DE, 1986, P NATL ACAD SCI USA, V83, P4739, DOI 10.1073/pnas.83.13.4739; SABATH DE, 1990, J BIOL CHEM, V265, P12671; SABATH DE, 1990, GENE, V91, P185, DOI 10.1016/0378-1119(90)90087-8; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIPMAN PM, 1988, J CELL BIOCHEM, V38, P189, DOI 10.1002/jcb.240380306; TRAVALI S, 1989, J BIOL CHEM, V264, P7466; TSENG BY, 1989, MOL CELL BIOL, V9, P1940, DOI 10.1128/MCB.9.5.1940; WONG RL, 1987, CELL IMMUNOL, V110, P443, DOI 10.1016/0008-8749(87)90137-7; YAMAGUCHI M, 1990, MOL CELL BIOL, V10, P872, DOI 10.1128/MCB.10.3.872; Yanishevsky R M, 1981, Int Rev Cytol, V69, P223	37	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19180	19184						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699941				2022-12-27	WOS:A1990EF73900077
J	GENDLER, SJ; LANCASTER, CA; TAYLORPAPADIMITRIOU, J; DUHIG, T; PEAT, N; BURCHELL, J; PEMBERTON, L; LALANI, E; WILSON, D				GENDLER, SJ; LANCASTER, CA; TAYLORPAPADIMITRIOU, J; DUHIG, T; PEAT, N; BURCHELL, J; PEMBERTON, L; LALANI, E; WILSON, D			MOLECULAR-CLONING AND EXPRESSION OF HUMAN TUMOR-ASSOCIATED POLYMORPHIC EPITHELIAL MUCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											GENDLER, SJ (corresponding author), IMPERIAL CANC RES FUND,LINCOLNS INN FIELDS,POB 123,LONDON WC2A 3PX,ENGLAND.		Burchell, Joy/G-4560-2012	Lalani, El-Nasir/0000-0001-9733-459X; Burchell, Joy/0000-0003-0413-3823				ABE M, 1989, BIOCHEM BIOPH RES CO, V165, P644, DOI 10.1016/S0006-291X(89)80014-2; AMERONGEN AVN, 1983, CARBOHYD RES, V115, pC1; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; AUBERT JP, 1976, ARCH BIOCHEM BIOPHYS, V175, P410, DOI 10.1016/0003-9861(76)90528-2; AZEN E, 1984, P NATL ACAD SCI-BIOL, V81, P5561, DOI 10.1073/pnas.81.17.5561; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; BRIAND JP, 1981, J BIOL CHEM, V256, P2205; BURCHELL J, 1989, INT J CANCER, V44, P691, DOI 10.1002/ijc.2910440423; BURCHELL J, 1987, CANCER RES, V47, P5476; BURCHELL J, 1984, INT J CANCER, V34, P763, DOI 10.1002/ijc.2910340605; BURCHELL J, 1989, CANCER INVEST, V17, P53; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DENNY PA, 1982, CARBOHYD RES, V110, P305, DOI 10.1016/0008-6215(82)84012-3; EPENETOS AA, 1982, LANCET, V2, P1004; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER S, 1987, BREAST CANCER SCI CL, P112; GENDLER S, 1989, HUMAN TUMOR ANTIGENS, P11; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; GRANOWSKA M, 1984, NUCL MED COMMUN, V5, P485, DOI 10.1097/00006231-198408000-00002; GUM JR, 1989, J BIOL CHEM, V264, P6480; HANISCH FG, 1989, J BIOL CHEM, V264, P872; HANOVER JA, 1980, J BIOL CHEM, V255, P6713; HILKENS J, 1988, J BIOL CHEM, V263, P4215; HILKENS J, 1986, CANCER RES, V46, P2586; HULL SR, 1988, J CELL BIOCH S E, V12; JEFFREYS AJ, 1985, NATURE, V314, P64; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; LAN MS, 1990, J BIOL CHEM, V265, P15294; LINSLEY PS, 1988, J BIOL CHEM, V263, P8390; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; MANNING RF, 1980, J BIOL CHEM, V255, P9451; MERLO GR, 1989, CANCER RES, V49, P6966; MUSKAVITCH MAT, 1982, CELL, V29, P1041, DOI 10.1016/0092-8674(82)90467-6; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; OZAKI LS, 1983, CELL, V34, P815, DOI 10.1016/0092-8674(83)90538-X; SCHIMIZU M, 1982, J BIOCHEM-TOKYO, V91, P515; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; SORIMACHI H, 1988, J BIOL CHEM, V263, P17678; SWALLOW DM, 1987, NATURE, V328, P82, DOI 10.1038/328082a0; TIMTPE CW, 1988, J BIOL CHEM, V263, P1081; WRESCHNER DH, 1989, MAR P BIENN INT BREA; 1984, LANCET, V2, P1441	46	902	963	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					15286	15293						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697589				2022-12-27	WOS:A1990DX40000092
J	ENGELMANN, H; HOLTMANN, H; BRAKEBUSCH, C; AVNI, YS; SAROV, I; NOPHAR, Y; HADAS, E; LEITNER, O; WALLACH, D				ENGELMANN, H; HOLTMANN, H; BRAKEBUSCH, C; AVNI, YS; SAROV, I; NOPHAR, Y; HADAS, E; LEITNER, O; WALLACH, D			ANTIBODIES TO A SOLUBLE FORM OF A TUMOR-NECROSIS-FACTOR (TNF) RECEPTOR HAVE TNF-LIKE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL; HANOVER UNIV MED,DEPT MOLEC PHARMACOL,HANOVER,GERMANY; BEN GURION UNIV NEGEV,FAC HLTH SCI,VIROL UNIT,IL-84105 BEER SHEVA,ISRAEL; INTERPHARM LABS,NESS ZIONA,ISRAEL; WEIZMANN INST SCI,MONO YEDA RES & DEV CO LTD,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science; Ben Gurion University; Weizmann Institute of Science				Brakebusch, Cord/0000-0002-9342-1634				ADAMS DO, 1980, J IMMUNOL, V124, P286; ARAKAWA T, 1987, J BIOL CHEM, V262, P7484; BOLTAZZO GF, 1986, IMMUNOL REV, V94, P137; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CURRIE GA, 1978, NATURE, V273, P758, DOI 10.1038/273758a0; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; ESHHAR Z, 1980, J IMMUNOL, V124, P775; FINTER NB, 1969, J GEN VIROL, V5, P419, DOI 10.1099/0022-1317-5-3-419; Galfre G, 1981, Methods Enzymol, V73, P3; GEY GO, 1952, CANCER RES, V12, P264; GRANGER GA, 1968, J IMMUNOL, V101, P111; HAHN T, 1985, P NATL ACAD SCI USA, V82, P3814, DOI 10.1073/pnas.82.11.3814; HOHMANN HP, 1989, J BIOL CHEM, V264, P14927; HOLTMANN H, 1988, IMMUNOBIOLOGY, V178, P153; HOLTMANN H, 1989, BIOL CHEM H-S, V370, P780; HOLTMANN H, 1987, J IMMUNOL, V139, P1161; HOLTMANN H, 1988, IMMUNOBIOLOGY, V177, P7, DOI 10.1016/S0171-2985(88)80087-1; ISRAEL S, 1986, IMMUNOL LETT, V12, P217, DOI 10.1016/0165-2478(86)90007-6; KAEVER V, 1988, PROSTAGLANDINS, V35, P885, DOI 10.1016/0090-6980(88)90114-1; KAHN CR, 1978, P NATL ACAD SCI USA, V75, P4209, DOI 10.1073/pnas.75.9.4209; LEE SC, 1976, J IMMUNOL, V117, P283; Marrack P, 1986, Adv Immunol, V38, P1, DOI 10.1016/S0065-2776(08)60005-X; MOORE AE, 1955, CANCER RES, V15, P598; MUNCKPETERSEN C, 1989, EUR J IMMUNOL, V19, P1887; NARHI LO, 1987, BIOCHEM BIOPH RES CO, V147, P740, DOI 10.1016/0006-291X(87)90992-2; NISENOFF A, 1964, METHOD MED RES, V10, P134; OLSSON I, 1989, EUR J HAEMATOL, V42, P270, DOI 10.1111/j.1600-0609.1989.tb00111.x; ORTEGA E, 1988, EMBO J, V7, P4101, DOI 10.1002/j.1460-2075.1988.tb03304.x; PALOMBELLA VJ, 1987, J BIOL CHEM, V262, P1950; ROSENNAU W, 1980, INT J IMMUNOPHARMACO, V3, P1; RUDDLE NH, 1968, J EXP MED, V128, P1267, DOI 10.1084/jem.128.6.1267; RUFF MR, 1981, LYMPHOKINES, V2, P235; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; SECKINGER P, 1989, J BIOL CHEM, V264, P11966; SEGAL DM, 1977, P NATL ACAD SCI USA, V74, P2993, DOI 10.1073/pnas.74.7.2993; SHEMERAVNI Y, 1988, INFECT IMMUN, V56, P2503, DOI 10.1128/IAI.56.9.2503-2506.1988; SMITH RA, 1987, J BIOL CHEM, V262, P6951; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; TODARO GJ, 1966, SCIENCE, V153, P1252, DOI 10.1126/science.153.3741.1252; VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632; WALLACH D, 1984, J IMMUNOL, V132, P2464; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747	46	416	449	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14497	14504						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1696947				2022-12-27	WOS:A1990DV27800066
J	CHENG, HC; LITWIN, CME; HWANG, DM; WANG, JH				CHENG, HC; LITWIN, CME; HWANG, DM; WANG, JH			STRUCTURAL BASIS OF SPECIFIC AND EFFICIENT PHOSPHORYLATION OF PEPTIDES DERIVED FROM P34CDC2 BY A PP60SRC-RELATED PROTEIN TYROSINE KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CELL-CYCLE; M-PHASE; SEQUENCE; MECHANISM; MEMBRANES	Cys-cdc2(8-20), a synthetic peptide derived from p34cdc2, was previously reported to be a specific and efficient substrate of a pp60c-src-related tyrosine kinase isolated from bovine spleen (the spleen tyrosine kinase) (Litwin, C.M.E., Cheng, H.-C., and Wang, J.H. (1991) J. Biol. Chem. 266, 2557-2566). The longer peptide, cdc2(1-24), was found to be phosphorylated by the kinase with similar efficiency, and Tyr15 was the only amino acid residue phosphorylated. This indicated that the amino acid sequence of cdc2(8-20) peptide, EKI-GEGTYGVVYK, contained the structural features important for protein tyrosine kinase substrate activity. A stepwise procedure using synthetic peptides was employed to investigate such structural features. First, a computer search of protein sequences homologous to cdc2(8-20) uncovered five protein kinases containing homologous sequence with tyrosine at a position corresponding to Tyr15 of p34cdc2. Second, a peptide derived from ribosomal S6 protein kinase (rsk(436-456)) was synthesized. The rsk(436-456) peptide contained a segment, ETIGVGSYSVCKR, which is highly homologous to that of cdc2(8-20). It was found to be a very poor substrate of the spleen tyrosine kinase. Third, peptide analogs of cdc2(6-20) with single substitutions of amino acid residues Lys9, Glu12, Thr14, Gly16, Val18, and Tyr19 by amino acid residues at corresponding positions of rsk were synthesized and tested as spleen tyrosine kinase substrates. Only Glu12 and Thr14 substituted peptide analogs showed decreased substrate activities. (The substrate activity of a peptide is the ability of the peptide to serve as the substrate of the spleen tyrosine kinase. It was determined either by the kinetic parameters (K(m) and V(max)) of phosphorylation of the peptide or by the initial phosphorylation rate of the peptide by the spleen tyrosine kinase.) An analog with double substitution at Glu12 and Thr14 was found to be almost as poor a substrate as the rsk peptide. In addition, peptide analogs with Tyr15 substituted by Phe or D-Tyr had poor substrate activities as well as weak inhibitory activities. Thus, Glu12, Thr14, and Tyr15 residues of p34cdc2 contained structural components essential for the efficient phosphorylation of the peptides derived from p34cdc2 by the pp60c-src-related spleen tyrosine kinase.			CHENG, HC (corresponding author), UNIV CALGARY,FAC MED,DEPT MED BIOCHEM,MRC,SIGNAL TRANSDUCT GRP,CALGARY T2N 4N1,ALBERTA,CANADA.			Cheng, Heung-Chin/0000-0002-4965-7148				ALCORTA DA, 1989, MOL CELL BIOL, V9, P3850, DOI 10.1128/MCB.9.9.3850; BALDWIN GS, 1983, NATURE, V301, P435, DOI 10.1038/301435a0; BAUSE E, 1981, BIOCHEM J, V195, P639, DOI 10.1042/bj1950639; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRAUN S, 1984, J BIOL CHEM, V259, P2051; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; DONELLADEANA A, 1990, EUR J BIOCHEM, V194, P773, DOI 10.1111/j.1432-1033.1990.tb19468.x; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOUSE C, 1984, EUR J BIOCHEM, V140, P363, DOI 10.1111/j.1432-1033.1984.tb08109.x; HUNTER T, 1982, J BIOL CHEM, V257, P4843; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; HUNTER T, 1986, ENZYMES, V17, P192; KASUGA M, 1983, J BIOL CHEM, V258, P973; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KONG SK, 1987, J BIOL CHEM, V262, P2597; KREK W, 1990, J CELL BIOL, V111, P220; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; LITWIN CME, 1991, J BIOL CHEM, V266, P2557; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PIKE LJ, 1982, P NATL ACAD SCI-BIOL, V79, P1443, DOI 10.1073/pnas.79.5.1443; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; WHITEHOUSE S, 1983, J BIOL CHEM, V258, P3693; WONG TW, 1983, J BIOL CHEM, V258, P1022; YAMASHIRO D, 1973, J AM CHEM SOC, V95, P1310, DOI 10.1021/ja00785a049; YUAN CJ, 1990, J BIOL CHEM, V265, P16205	27	48	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17919	17925						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717444				2022-12-27	WOS:A1991GG55300034
J	FUKAYAMA, M; KANNO, T; BRODY, SL; KIRBY, M; CRYSTAL, RG				FUKAYAMA, M; KANNO, T; BRODY, SL; KIRBY, M; CRYSTAL, RG			RESPIRATORY-TRACT GENE-TRANSFER - TRANSPLANTATION OF GENETICALLY MODIFIED LYMPHOCYTES-T DIRECTLY TO THE RESPIRATORY EPITHELIAL SURFACE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; RETROVIRAL EXPRESSION; CELLS; THERAPY; GROWTH; MOUSE; LINE; TUMORIGENICITY; TRANSDUCTION; MIGRATION	To evaluate the strategy for potentially treating respiratory disorders with genetically modified T-lymphocytes, the interleukin-2 (IL-2)-dependent murine T-cell line, CTLL2, was genetically altered with the Escherichia coli beta-galactosidase (beta-gal) gene (lacZ) in vitro with a retroviral vector and the modified T-cells were transplanted directly to the respiratory epithelial surface of syngeneic C57Bl/6 mice. Southern and Northern analyses confirmed that the neomycin-selected modified T-cells contained and expressed the lacZ gene. The fate of the modified T-cells (CTLL2/lacZ) was followed by flow cytometry with T-cell surface marker Thy1.2 and fluorescent beta-gal analysis. One day after transplantation (7.5 x 10(5) CTLL2/lacZ T-cells/g of body weight), 95 +/- 3% of the Thy1.2+ T-cells recovered from respiratory epithelial lining fluid (ELF) were beta-gal+. Importantly, the modified T-cells remained in the lung for some time; at 3 days, Thy1.2+ beta-gal+ T-cells represented 63 +/- 12% of ELF Thy1.2+ T-cells and 59 +/- 6% of Thy1.2+ T-cells recovered from the whole lung. At 7 days, 33 +/- 8% of the Thy 1.2+ cells in ELF and 75 +/- 6% of the Thy1.2+ cells in whole lung were Thy1.2+ beta-gal+. In contrast, the proportion of the Thy1.2+ beta-gal+ T-cells in the spleen, the major extrapulmonary lymphatic organ, never rose above 3 +/- 1% of the total Thy1.2+ cells. The number of Thy1.2+ beta-gal+ T-cells in the lung could be modified by the systemic administration of IL-2, with whole lung Thy1.2+ beta-gal+ T-cells increasing 4.6-fold 3 days after transplantation, compared with non-IL-2-treated animals. These studies suggest that direct transplantation of genetically modified T-cells into the lung is feasible and represents a viable strategy for lung-specific gene transfer.	NHLBI, PULM BRANCH, BLDG 10, RM 6D03, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)								Anderson W French, 1990, Hum Gene Ther, V1, P331, DOI 10.1089/hum.1990.1.3-331; ANDERSON WF, 1984, SCIENCE, V226, P401, DOI 10.1126/science.6093246; AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BLANKENSTEIN T, 1990, EUR J IMMUNOL, V20, P935, DOI 10.1002/eji.1830200433; CULVER KW, 1990, UCLA SYM BI, V135, P129; CULVER KW, 1991, TRANSPLANT P, V23, P170; CULVER KW, 1990, HUM GENE THER, V1, P399, DOI 10.1089/hum.1990.1.4-399; DANNENBERG AM, 1981, METHODS STUDYING MON, P375; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GILLIS S, 1978, J IMMUNOL, V120, P2027; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; HAMBLIN AS, 1987, LYMPHOCYTES PRACTICA, P209; KANNO T, 1991, American Review of Respiratory Disease, V143, pA325; KANTOFF PW, 1986, P NATL ACAD SCI USA, V83, P6563, DOI 10.1073/pnas.83.17.6563; KASID A, 1990, P NATL ACAD SCI USA, V87, P473, DOI 10.1073/pnas.87.1.473; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; MILLER AD, 1990, BLOOD, V76, P271; NISHIHARA K, 1988, CANCER RES, V48, P4730; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; PABST R, 1989, IMMUNOL REV, V108, P83, DOI 10.1111/j.1600-065X.1989.tb00014.x; POZNANSKY M, 1991, J VIROL, V65, P532, DOI 10.1128/JVI.65.1.532-536.1991; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; ROTMAN B, 1961, P NATL ACAD SCI USA, V47, P1981, DOI 10.1073/pnas.47.12.1981; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; SPIESS PJ, 1987, JNCI-J NATL CANCER I, V79, P1067; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; STRAIR RK, 1990, BLOOD, V76, P1201; UYTTENHOVE C, 1991, J EXP MED, V173, P519, DOI 10.1084/jem.173.2.519; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; WILSON JM, 1990, SCIENCE, V248, P1413, DOI 10.1126/science.1972597; YAMADA G, 1987, EMBO J, V6, P2705, DOI 10.1002/j.1460-2075.1987.tb02563.x	36	16	16	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18339	18344						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717448				2022-12-27	WOS:A1991GG55300094
J	FABBRO, D; GRABOWSKI, GA				FABBRO, D; GRABOWSKI, GA			HUMAN ACID BETA-GLUCOSIDASE - USE OF INHIBITORY AND ACTIVATING MONOCLONAL-ANTIBODIES TO INVESTIGATE THE ENZYMES CATALYTIC MECHANISM AND SAPOSIN-A AND SAPOSIN-C BINDING-SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GLUCOCEREBROSIDASE GENE; GAUCHER DISEASE; NUCLEOTIDE-SEQUENCE; PROTEIN; CDNA; HETEROGENEITY; PURIFICATION; FIBROBLASTS; MUTATIONS; SPLEEN	Of 14 identified epitopes on human GCase (acid beta-glucosidase), monoclonal antibodies (MCABs) recognizing 3 produced inhibition and 1 resulted in activation of GCase. MCABs Fl and F2 completely, and MCAB 61 partially (approximately 70%), inhibited GCase activity. Substrates and active site-directed inhibitors (specific sphingolipid and 5-amino-5-deoxyglucose derivatives) protected the enzyme from inhibition by MCAB F1 and F2, but not that by MCAB 61. Conduritol B epoxide did not protect GCase from the inhibition by these MCABs when covalently bound to the active site. These results indicated highly specific binding requirements of MCABs Fl and F2 for residues in a complex active site. In comparison, kinetic analyses using GCase transition state analogues, N-alkyl-glucosylamines, and MCAB 61 demonstrated that this MCAB ''freezes'' the conformation of the enzyme and inhibits GCase by preventing formation of a conformer needed for maximal catalytic rates. The activating MCAB 122 mimicked the effects of saposin C and competed with this natural activator for residues on the enzyme. Interaction of saposin A and saposin C or MCAB 122 with GCase produced a synergistic effect leading to a marked sensitization of the enzyme to these activators. No such synergism or additivity was found for the maximal catalytic rate since it could be achieved by saturating amounts of any one or combinations of these activators. In the presence of MCAB 61, only 15 to 25% of the maximal activation of GCase was obtained by saposin C or MCAB 122, indicating that the major activation effects of these effectors derived from an induction of a GCase conformational change. These results demonstrate that saposins A and C mediate their activating effects by binding to distinct sites on GCase. Furthermore, major components of the mechanisms for catalysis and saposin C activation are due to conformational changes during the transition state. These findings have implications for understanding the perturbations of GCase function due to the missense mutations which cause Gaucher disease.			FABBRO, D (corresponding author), CUNY MT SINAI SCH MED,DEPT PEDIAT,DIV MED & MOLEC GENET,NEW YORK,NY 10029, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-71] Funding Source: Medline; NIDDK NIH HHS [R01 DK 36729] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACCOLLA RS, 1981, P NATL ACAD SCI USA, V78, P2465; BASU A, 1984, BIOCHEM J, V224, P515, DOI 10.1042/bj2240515; BASU A, 1985, J BIOL CHEM, V260, P3067; BERENT SL, 1981, BIOCHIM BIOPHYS ACTA, V664, P572, DOI 10.1016/0005-2760(81)90134-X; BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; CHRISTOMANOU H, 1986, BIOL CHEM H-S, V367, P879, DOI 10.1515/bchm3.1986.367.2.879; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; DJAVADIOHANIANCE L, 1984, BIOCHEMISTRY-US, V23, P97, DOI 10.1021/bi00296a016; ERICKSON JS, 1973, J LIPID RES, V14, P133; FABBRO D, 1988, THESIS CUNY NEW YORK; FIRON N, 1990, AM J HUM GENET, V46, P527; FUJIBAYASHI S, 1986, BIOCHIM BIOPHYS ACTA, V875, P554; FUJIBAYASHI S, 1986, J BIOL CHEM, V261, P5339; GATT S, 1966, BIOCHIM BIOPHYS ACTA, V113, P567, DOI 10.1016/S0926-6593(66)80014-0; GAVER RC, 1965, J AM OIL CHEM SOC, V42, P294, DOI 10.1007/BF02540132; GAVRIELIRORMAN E, 1989, GENOMICS, V5, P486; GLEW RH, 1988, LAB INVEST, V58, P5; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; GRACE ME, 1990, BIOCHEM BIOPH RES CO, V168, P771, DOI 10.1016/0006-291X(90)92388-G; GRACE ME, 1990, J BIOL CHEM, V265, P6827; GREENBERG P, 1990, BIOCHIM BIOPHYS ACTA, V1039, P12, DOI 10.1016/0167-4838(90)90220-A; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; INOUYE S, 1968, TETRAHEDRON, V23, P2125; Institute of Gaucher Disease, 2020, EP GAUCH DIS; KENNETT RH, 1980, MONOCLONAL ANTIBODIE; LATHAM T, 1990, AM J HUM GENET, V47, P79; LATHAM TE, 1991, DNA CELL BIOL, V10, P15, DOI 10.1089/dna.1991.10.15; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUBEN RA, 1980, MOL IMMUNOL, V17, P635, DOI 10.1016/0161-5890(80)90161-3; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; NAKANO T, 1989, J BIOCHEM-TOKYO, V105, P152, DOI 10.1093/oxfordjournals.jbchem.a122629; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; ONEILL RR, 1989, P NATL ACAD SCI USA, V86, P5049, DOI 10.1073/pnas.86.13.5049; OSIECKINEWMAN K, 1987, BIOCHIM BIOPHYS ACTA, V915, P87, DOI 10.1016/0167-4838(87)90128-2; OSIECKINEWMAN KM, 1986, ENZYME, V35, P147, DOI 10.1159/000469336; PETERS SP, 1977, J BIOL CHEM, V252, P563; PHILLIPS AP, 1984, J IMMUNOL METHODS, V74, P385, DOI 10.1016/0022-1759(84)90307-7; PIGMAN W, 1951, J AM CHEM SOC, V73, P1976, DOI 10.1021/ja01149a024; PRENCE E, 1985, ARCH BIOCHEM BIOPHYS, V236, P98, DOI 10.1016/0003-9861(85)90609-5; PRENCE EM, 1986, BIOCHEM J, V237, P655, DOI 10.1042/bj2370655; REINER O, 1989, J MOL NEUROSCI, V1, P225; SANO A, 1988, J BIOL CHEM, V263, P19597; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1986, J BIOL CHEM, V261, P50; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; VACCARO AM, 1985, EUR J BIOCHEM, V146, P315, DOI 10.1111/j.1432-1033.1985.tb08655.x; WIGDERSON M, 1989, AM J HUM GENET, V44, P365	56	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15021	15027						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714449				2022-12-27	WOS:A1991GB09700036
J	MEIJERS, JCM; CHUNG, DW				MEIJERS, JCM; CHUNG, DW			ORGANIZATION OF THE GENE CODING FOR HUMAN PROTEIN-C INHIBITOR (PLASMINOGEN-ACTIVATOR INHIBITOR-3) - ASSIGNMENT OF THE GENE TO CHROMOSOME-14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-1-ANTITRYPSIN GENES; TRANSCRIPTION FACTOR; NUCLEOTIDE-SEQUENCE; MESSENGER-RNA; HUMAN-PLASMA; ALPHA-1-ANTICHYMOTRYPSIN; PURIFICATION; SUPERFAMILY; OVALBUMIN; IDENTITY	Protein C inhibitor (plasminogen activator inhibitor-3) is a plasma glycoprotein and a member of the serine proteinase inhibitor superfamily. In the present study, the human gene for protein C inhibitor was isolated and characterized from three independent phage that contained overlapping inserts coding for the entire gene. The genomic DNA was isolated and studied by restriction mapping, polymerase chain reaction analysis, and DNA sequencing. The gene was 11.5 kilobases in length and consisted of five exons separated by four introns. In addition, 0.8 kilobases of DNA from the 5'-flanking region were sequenced. The exon-intron boundaries all observed the ''GT-AG'' rule. The gene for protein C inhibitor was assigned to chromosome 14 by polymerase chain reaction analysis of human/hamster hybrid cell lines. The organization of the gene for protein C inhibitor is similar to the genes coding for alpha-1-antitrypsin and alpha-1-antichymotrypsin. The genes for these two proteins are also localized on chromosome 14 suggesting a recent evolution of the genes for these three proteins from a common ancestor.			MEIJERS, JCM (corresponding author), UNIV WASHINGTON, DEPT BIOCHEM SJ-70, SEATTLE, WA 98195 USA.		Sessum, Rachel/F-7312-2015; Meijers, J.C.M./S-5981-2019	Sessum, Rachel/0000-0002-2444-7056; Meijers, J.C.M./0000-0002-4198-6780	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016919] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 16919] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAO JJ, 1987, BIOCHEMISTRY-US, V26, P7755, DOI 10.1021/bi00398a033; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BUCHER P, 1986, NUCLEIC ACIDS RES, V14, P10009, DOI 10.1093/nar/14.24.10009; FAIR DS, 1986, BLOOD, V67, P64; FRANCIS RB, 1984, THROMB HAEMOSTASIS, V52, P71; HEEB MJ, 1987, J BIOL CHEM, V262, P15813; HIROSAWA S, 1988, P NATL ACAD SCI USA, V85, P6836, DOI 10.1073/pnas.85.18.6836; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; KUHN LA, 1990, P NATL ACAD SCI USA, V87, P8506, DOI 10.1073/pnas.87.21.8506; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; LOSKUTOFF DJ, 1987, BIOCHEMISTRY-US, V26, P3763, DOI 10.1021/bi00387a004; MCDEVITT MA, 1984, CELL, V37, P993, DOI 10.1016/0092-8674(84)90433-1; MEIJERS JCM, 1988, BIOCHEMISTRY-US, V27, P4231, DOI 10.1021/bi00412a005; MEIJERS JCM, 1990, THROMB RES, V59, P389, DOI 10.1016/0049-3848(90)90142-Y; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MORITO F, 1985, BIOCHIM BIOPHYS ACTA, V844, P209, DOI 10.1016/0167-4889(85)90092-8; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; PROCHOWNIK EV, 1985, J BIOL CHEM, V260, P9608; PROSSER J, 1986, J MOL BIOL, V187, P145, DOI 10.1016/0022-2836(86)90224-X; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; RABIN M, 1986, SOMAT CELL MOLEC GEN, V12, P209, DOI 10.1007/BF01560668; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; STIEF TW, 1987, BIOL CHEM H-S, V368, P1427, DOI 10.1515/bchm3.1987.368.2.1427; SUZUKI K, 1989, THROMB HAEMOSTASIS, V61, P337; SUZUKI K, 1987, J BIOL CHEM, V262, P611; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; SUZUKI K, 1983, J BIOL CHEM, V258, P163; SUZUKI K, 1984, SEMIN THROMB HEMOST, V10, P154, DOI 10.1055/s-2007-1004418; SUZUKI K, 1985, PROTEIN C BIOCH MED, P43; WOO SLC, 1979, METHOD ENZYMOL, V68, P381; YE RD, 1989, J BIOL CHEM, V264, P5495; YOSHITAKE S, 1985, BIOCHEMISTRY-US, V24, P3736, DOI 10.1021/bi00335a049	37	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15028	15034						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714450				2022-12-27	WOS:A1991GB09700037
J	DAVIES, MV; PELLETIER, J; MEEROVITCH, K; SONENBERG, N; KAUFMAN, RJ				DAVIES, MV; PELLETIER, J; MEEROVITCH, K; SONENBERG, N; KAUFMAN, RJ			THE EFFECT OF POLIOVIRUS PROTEINASE 2APRO EXPRESSION ON CELLULAR-METABOLISM - INHIBITION OF DNA-REPLICATION, RNA POLYMERASE-II TRANSCRIPTION, AND TRANSLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION FACTOR-II; INFECTED HELA-CELLS; BINDING-PROTEIN; MESSENGER-RNAS; COMPLEX; PHOSPHORYLATION; IDENTIFICATION; INACTIVATION; PURIFICATION; PROTEOLYSIS	Infection of cells with poliovirus results in a rapid inhibition of host RNA and protein synthesis. Concordant with this shutoff, the p220 subunit of the cap-binding protein complex is cleaved, probably indirectly, by the poliovirus proteinase p2A (2A(pro)). To elucidate the mechanism of action of 2A(pro) in inhibiting protein synthesis in vivo, we studied the effect of transient expression of 2A(pro) in COS-1 monkey kidney cells. In cells transfected with a 2A(pro) expression plasmid, p220 was cleaved and the 2A(pro) mRNA was reduced 30-fold compared to an identical plasmid containing a translation termination codon within the 2A(pro) coding region. The reduced expression from the 2A(pro) vector results from a 4-fold reduction in DNA replication and 22-fold reduction in transcription by RNA polymerase II from the adenovirus major late promoter/SV40 enhancer utilized in this vector. In contrast, no decrease in transcription of the adenovirus virus-associated I RNA gene by RNA polymerase III was observed. The effect of 2A(pro) expression on cap-dependent mRNA translation was studied by producing a dicistronic beta-globin mRNA harboring the encephalomyocarditis virus leader and 2A(pro) coding region within the 3' end of the mRNA to mediate cap-independent translation of 2A(pro). Expression of this mRNA was also reduced 25-fold compared to an identical plasmid harboring a termination codon within the 2A(pro) coding region. Translation of the beta-globin marker gene from this mRNA was reduced 3-fold when corrected for mRNA level. These results suggest that p220 cleavage itself is not sufficient for complete inhibition of host translation and that an important effect of 2A(pro) expression on host protein synthesis is a reduction in RNA polymerase II transcription and to a lesser extent, DNA replication. This reduction could be a primary effect of 2A(pro), or a secondary effect caused by the inhibition of translation.	GENET INST, CAMBRIDGE, MA 02140 USA; MCGILL UNIV, DEPT BIOCHEM, MONTREAL H3A 2T5, QUEBEC, CANADA	McGill University								BALTIMORE D, 1962, P NATL ACAD SCI USA, V48, P1383, DOI 10.1073/pnas.48.8.1383; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BERNSTEIN HD, 1985, MOL CELL BIOL, V5, P2913, DOI 10.1128/MCB.5.11.2913; BONNEAU AM, 1987, J VIROL, V61, P986, DOI 10.1128/JVI.61.4.986-991.1987; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; CRAWFORD N, 1981, CELL, V27, P555, DOI 10.1016/0092-8674(81)90397-4; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; DERMAN E, 1981, CELL, V23, P731, DOI 10.1016/0092-8674(81)90436-0; DORNER AJ, 1984, J VIROL, V50, P507, DOI 10.1128/JVI.50.2.507-514.1984; DUNCAN R, 1985, J BIOL CHEM, V260, P5493; DUNCAN RF, 1987, MOL CELL BIOL, V7, P1293, DOI 10.1128/MCB.7.3.1293; ETCHISON D, 1984, J VIROL, V51, P832, DOI 10.1128/JVI.51.3.832-837.1984; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Favaloro J, 1980, Methods Enzymol, V65, P718; FRADKIN LG, 1987, MOL CELL BIOL, V7, P3880, DOI 10.1128/MCB.7.11.3880; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HIRT B, 1967, J MOL BIOL, V159, P189; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; KAUFMAN R J, 1990, Technique (Philadelphia), V2, P221; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P1233, DOI 10.1128/MCB.9.3.1233; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; KLIEWER S, 1988, MOL CELL BIOL, V8, P3175, DOI 10.1128/MCB.8.8.3175; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRAUSSLICH HG, 1987, J VIROL, V61, P2711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARD D, 1989, J VIROL, V63, P3858, DOI 10.1128/JVI.63.9.3858-3864.1989; LEE KAW, 1985, J VIROL, V55, P489, DOI 10.1128/JVI.55.2.489-493.1985; LEE KAW, 1985, J VIROL, V54, P515, DOI 10.1128/JVI.54.2.515-524.1985; LEIBOWITZ R, 1971, J VIROL, V8, P661, DOI 10.1128/JVI.8.5.661-668.1971; Maniatis T., 1982, MOL CLONING; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; OCHOA S, 1983, ARCH BIOCHEM BIOPHYS, V223, P325, DOI 10.1016/0003-9861(83)90598-2; ONEILL RE, 1989, J VIROL, V63, P5069, DOI 10.1128/JVI.63.12.5069-5075.1989; RACANIELLO VR, 1981, P NATL ACAD SCI-BIOL, V78, P4887, DOI 10.1073/pnas.78.8.4887; RANGEL LM, 1987, J VIROL, V61, P1002, DOI 10.1128/JVI.61.4.1002-1006.1987; REINBERG D, 1987, J BIOL CHEM, V262, P3322; RUBINSTEIN SJ, 1989, J VIROL, V63, P4689, DOI 10.1128/JVI.63.11.4689-4696.1989; SAFER B, 1988, MOL CELL BIOL, V8, P105, DOI 10.1128/MCB.8.1.105; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWADOGO M, 1988, J BIOL CHEM, V263, P11985; SONENBERG N, 1990, CURR TOP MICROBIOL, V161, P23; SUN XH, 1989, P NATL ACAD SCI USA, V86, P2143, DOI 10.1073/pnas.86.7.2143; TAHARA SM, 1981, J BIOL CHEM, V256, P7691; TOYODA H, 1986, CELL, V45, P761, DOI 10.1016/0092-8674(86)90790-7	49	63	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14714	14720						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713590				2022-12-27	WOS:A1991FZ35100093
J	FRANK, KB; NOLL, GJ; CONNELL, EV; SIM, IS				FRANK, KB; NOLL, GJ; CONNELL, EV; SIM, IS			KINETIC INTERACTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE WITH THE ANTIVIRAL TETRAHYDROIMIDAZO[4,5,1-JK]-[1,4]-BENZODIAZEPINE-2-(1H)-THIONE COMPOUND, R82150	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIDS-RELATED COMPLEX; PLACEBO-CONTROLLED TRIAL; PHASE-I TRIAL; NUCLEOTIDE-SEQUENCE; HIV-1 REPLICATION; DOUBLE-BLIND; 2',3'-DIDEOXYINOSINE DDI; AZIDOTHYMIDINE AZT; MITOCHONDRIAL-DNA; ZIDOVUDINE AZT	We examined the kinetic interaction of purified recombinant DNA-derived human immunodeficiency virus type 1 (HIV-1) reverse transcriptase with R82150, a member of the tetrahydroimidazo[4,5,1-jk]-[1,4]-benzodiazepin-2(1H)-thione family of compounds (Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Van Gelder, J., Woestenborghs, R., Heykants, J., Schellekens, K., Janssen, M. A. C., De Clercq, E., and Janssen, P. A. J. (1990) Nature 343, 470-474). R82150 inhibited noncompetitively the utilization of homopolymeric and heteropolymeric template-primers (K(I) range 280-300 nm). Inhibition of dNTP substrate incorporation was also noncompetitive (K(I) range 100-890 nM). In contrast, 100-mu-M R82150 did not inhibit human DNA polymerases-alpha, beta, or gamma. Gel electrophoresis was used to analyze the effect of inhibitors on extension of heteropolymeric template-primers by HIV-1 reverse transcriptase. ddCTP induced accumulation of partially extended primers which had been terminated at sites requiring incorporation of deoxycytidylate. Competing template-primers reduced accumulation of both fully and partially extended primers. In contrast, R82150 induced accumulation of shortened primers that were terminated at various sites that did not correspond to any one particular deoxynucleotide species. Our results suggest that R82150 does not interact with HIV-1 reverse transcriptase as an analog of either template-primer or deoxynucleoside triphosphate substrate, but may bind allosterically at a site unique to this replicase.			FRANK, KB (corresponding author), ROCHE RES CTR,DEPT VIROL,NUTLEY,NJ 07110, USA.							BARIL E, 1977, NUCLEIC ACIDS RES, V4, P2641, DOI 10.1093/nar/4.8.2641; CHEN CH, 1989, J BIOL CHEM, V264, P11934; CHEN MS, 1987, BIOCHEM PHARMACOL, V36, P4361, DOI 10.1016/0006-2952(87)90685-X; COOLEY TP, 1990, NEW ENGL J MED, V322, P1340, DOI 10.1056/NEJM199005103221902; COONEY DA, 1986, BIOCHEM PHARMACOL, V35, P2065, DOI 10.1016/0006-2952(86)90571-X; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; HUANG P, 1990, J BIOL CHEM, V265, P11914; JOHNSON MA, 1989, MOL PHARMACOL, V36, P291; KNOPF KW, 1976, BIOCHEMISTRY-US, V15, P4540, DOI 10.1021/bi00665a032; LAMBERT JS, 1990, NEW ENGL J MED, V322, P1333, DOI 10.1056/NEJM199005103221901; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; MANIATIS T, 1982, MOL CLONING LABORATO, P122; MERIGAN TC, 1989, ANN INTERN MED, V110, P189, DOI 10.7326/0003-4819-110-3-189; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; RABA M, 1979, EUR J BIOCHEM, V97, P305, DOI 10.1111/j.1432-1033.1979.tb13115.x; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1; STARNES MC, 1987, J BIOL CHEM, V262, P988; TU CPD, 1980, GENE, V10, P177, DOI 10.1016/0378-1119(80)90135-3; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; YARCHOAN R, 1989, SCIENCE, V245, P412, DOI 10.1126/science.2502840; YARCHOAN R, 1988, LANCET, V1, P76	27	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14232	14236						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713579				2022-12-27	WOS:A1991FZ35100020
J	LEASE, RA; YEE, T				LEASE, RA; YEE, T			EARLY EVENTS IN THE SYNTHESIS OF THE MULTICOPY SINGLE-STRANDED DNA-RNA BRANCHED COPOLYMER OF MYXOCOCCUS-XANTHUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REVERSE-TRANSCRIPTASE; ESCHERICHIA-COLI; LINKED MSDNA; BIOSYNTHESIS; BACTERIA; PRECURSOR	Myxobacteria and a variety of strains of Escherichia coli contain an unusual extrachromosomal element, a small single-stranded branched copolymer of DNA and RNA (msDNA). Interest in msDNA stems from the presence of a 2'-5' linkage between its DNA and RNA moieties and the possible involvement of reverse transcriptase in its synthesis. Two groups have proposed a model for the synthesis of msDNA that involves the following sequence of events: 1) synthesis of an RNA precursor; 2) addition of a dNTP in a 2'-5' linkage to the RNA precursor (branch priming); 3) synthesis by reverse transcriptase of complementary DNA on the primed RNA precursor; 4) concomitant processing of the RNA precursor by RNase H; and 5) further processing of the branched polymer. The branch priming hypothesis (step 2) was originally based on pulse-chase experiments using a lengthy pulse of 30-min duration. Our experiments with shorter pulse durations demonstrate a variety of intermediate forms not predicted by this model. Specifically, we find that early in synthesis, intermediate msDNA forms appear that are apparently not branch-linked to corresponding RNA moieties. The concomitant RNase H hypothesis (step 4) was based in part on intermediate trapping experiments using dideoxy NTPs to interrupt msDNA synthesis. These experiments showed an apparent complementary relationship between DNA length and RNA length in the trapped forms. In contrast, our experiments show that DNA elongation and RNA processing follow different kinetics. These results suggest an alternate model for synthesis of msDNA in which a conventionally primed DNA moiety is joined with the RNA moiety in a branch ligation event taking place several minutes after the synthesis of both moieties.			LEASE, RA (corresponding author), UNIV TEXAS,CELL & MOLEC BIOL PROGRAM,FO-31,RICHARDSON,TX 75083, USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007133] Funding Source: NIH RePORTER; NCRR NIH HHS [SO7 RR07133] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BRETSCHER AP, 1978, J BACTERIOL, V133, P763, DOI 10.1128/JB.133.2.763-768.1978; DHUNDALE A, 1987, CELL, V51, P1105, DOI 10.1016/0092-8674(87)90596-4; FURUICHI T, 1987, CELL, V48, P55, DOI 10.1016/0092-8674(87)90355-2; GREEN C, 1981, NUCLEIC ACIDS RES, V9, P1905, DOI 10.1093/nar/9.8.1905; HSU MY, 1989, J BIOL CHEM, V264, P6214; INOUYE S, 1989, CELL, V56, P709, DOI 10.1016/0092-8674(89)90593-X; LAMPSON BC, 1989, SCIENCE, V243, P1033, DOI 10.1126/science.2466332; LAMPSON BC, 1989, CELL, V56, P701, DOI 10.1016/0092-8674(89)90592-8; LIM D, 1989, MOL MICROBIOL, V3, P1141, DOI 10.1111/j.1365-2958.1989.tb00264.x; LIM D, 1989, CELL, V56, P891, DOI 10.1016/0092-8674(89)90693-4; SAMBROOK J, 1989, MOL CLONING LABORATO, V2; SUN J, 1989, P NATL ACAD SCI USA, V86, P7208, DOI 10.1073/pnas.86.18.7208; TEMIN HM, 1989, NATURE, V339, P254, DOI 10.1038/339254a0; VARMUS HE, 1989, CELL, V56, P721, DOI 10.1016/0092-8674(89)90673-9; VISWANATHAN M, 1989, J BIOL CHEM, V264, P13665; YEE T, 1991, BIOTECHNIQUES, V10, P786; YEE T, 1984, CELL, V38, P203, DOI 10.1016/0092-8674(84)90541-5	17	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14497	14503						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713583				2022-12-27	WOS:A1991FZ35100062
J	BORNSTEIN, P; OROURKE, K; WIKSTROM, K; WOLF, FW; KATZ, R; LI, P; DIXIT, VM				BORNSTEIN, P; OROURKE, K; WIKSTROM, K; WOLF, FW; KATZ, R; LI, P; DIXIT, VM			A 2ND, EXPRESSED THROMBOSPONDIN GENE (THBS2) EXISTS IN THE MOUSE GENOME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							1ST INTRON; ADHESIVE GLYCOPROTEIN; EXTRACELLULAR-MATRIX; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; ANGIOGENESIS; PROMOTER; GROWTH; REGION; HYBRIDIZATION	The diverse and occasionally conflicting properties described for the extracellular, cell surface-associated protein thrombospondin (TSP) have raised the possibility that functionally distinct forms of the protein exist in the same organism. We have isolated and characterized a partial cDNA clone for mouse TSP that is clearly homologous to, but distinct from, the coding sequence for mouse TSP deduced from a mouse genomic clone (Bornstein, P., Alfi, D., Devarayalu, L., Framson, P., and Li, P. (1990) J. Biol. Chem. 265, 16691-16698). This second TSP, which we term thrombospondin 2, is the product of a separate gene (Thbs2) and is expressed in a variety of mouse tissues in a pattern that differs from that for TSP1. Based on their translated amino acid sequences, it seems likely that TSP1 and TSP2 will be found to have both common and unique properties and that the functional consequences of TSP production will reflect the ratio of the levels of these two related proteins.	UNIV MICHIGAN, SCH MED, DEPT PATHOL, 1301 CATHERINE ST, BOX 0602, ANN ARBOR, MI 48109 USA; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle			dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE008229] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-393037, HL-18645] Funding Source: Medline; NIDCR NIH HHS [DE-08229] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BAGAVANDOSS P, 1990, BIOCHEM BIOPH RES CO, V170, P867, DOI 10.1016/0006-291X(90)92171-U; BORNSTEIN P, 1988, J BIOL CHEM, V263, P1603; BORNSTEIN P, 1990, J BIOL CHEM, V265, P16691; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEZARDIN P, 1986, EUR J BIOCHEM, V159, P569, DOI 10.1111/j.1432-1033.1986.tb09924.x; DIXIT VM, 1986, P NATL ACAD SCI USA, V83, P5449, DOI 10.1073/pnas.83.15.5449; DONOVIEL DB, 1990, J CELL PHYSIOL, V145, P16, DOI 10.1002/jcp.1041450104; DONOVIEL DB, 1988, J BIOL CHEM, V263, P18590; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HENNESSY SW, 1989, J CELL BIOL, V108, P729, DOI 10.1083/jcb.108.2.729; JAFFE E, 1990, GENOMICS, V7, P123, DOI 10.1016/0888-7543(90)90528-3; KOBAYASHI S, 1986, BIOCHEMISTRY-US, V25, P8418, DOI 10.1021/bi00374a014; LAHERTY CD, 1989, J BIOL CHEM, V264, P11222; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LAWLER J, 1986, BLOOD, V67, P1197; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415; MAJACK RA, 1987, CELL MEMBRANES METHO, V3, P55; MANIATIS T, 1982, MOL CLONING LAB MANU; MANSFIELD PJ, 1990, J CELL BIOL, V111, P3077, DOI 10.1083/jcb.111.6.3077; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; OSHEA KS, 1990, J CELL BIOL, V111, P2713, DOI 10.1083/jcb.111.6.2713; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PAUL L, 1989, Journal of Cell Biology, V109, p200A; PHAN SH, 1989, BIOCHEM BIOPH RES CO, V163, P56, DOI 10.1016/0006-291X(89)92098-6; PROCHOWNIK EV, 1989, J CELL BIOL, V109, P843, DOI 10.1083/jcb.109.2.843; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; RICH KA, 1990, SCIENCE, V249, P1574, DOI 10.1126/science.2120774; SILVERSTEIN RL, 1986, ARTERIOSCLEROSIS, V6, P245, DOI 10.1161/01.ATV.6.3.245; SUN XJ, 1989, J BIOL CHEM, V264, P11288; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; VARANI J, 1988, J CLIN INVEST, V81, P1537, DOI 10.1172/JCI113486; WOLF FW, 1990, GENOMICS, V6, P685, DOI 10.1016/0888-7543(90)90505-O	38	114	119	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					12821	12824						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712771				2022-12-27	WOS:A1991FX13200004
J	METHERALL, JE; RIDGWAY, ND; DAWSON, PA; GOLDSTEIN, JL; BROWN, MS				METHERALL, JE; RIDGWAY, ND; DAWSON, PA; GOLDSTEIN, JL; BROWN, MS			A 25-HYDROXYCHOLESTEROL-RESISTANT CELL-LINE DEFICIENT IN ACYL-COA-CHOLESTEROL ACYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEIN; COENZYME-A REDUCTASE; HUMAN FIBROBLASTS; PATHWAY; MUTANTS; BINDING; HOMEOSTASIS; SUPPRESSION; RECEPTORS; SYNTHASE	We describe a line of mutant Chinese hamster ovary cells, SRD-4 cells, that lacks acyl-coenzyme A:cholesterol acyltransferase (ACAT) activity and fails to synthesize cholesteryl esters when stimulated with 25-hydroxycholesterol or low density lipoprotein. The cells also have a partial defect in their ability to repress transcription of three sterol-regulated genes, 3-hydroxy-3-methylglutaryl-coenzyme A synthase, 3-hydroxy-3-methylglutaryl-coenzyme A reductase, and the low density lipoprotein receptor. The cells were selected by mutagenesis followed by growth in the presence of 25-hydroxycholesterol, which kills the parental cells by cholesterol depletion, owing to an inhibition of cholesterol synthesis and a stimulation of cholesterol esterification. Treatment of parental cells with compound 58-035 (3-(decyldimethylsilyl)-N-[2-(4-methylphenyl)-1-phenylethyl]propanamide), an inhibitor of ACAT, abolished cholesterol esterification but did not reproduce the defect in gene repression seen in the SRD-4 cells, and it only partially reproduced the resistance to the killing effect of 25-hydroxycholesterol. We conclude that the SRD-4 cells most likely have two independent defects, one in ACAT and the other in a factor that mediates sterol-dependent transcriptional repression. The SRD-4 cells thus resemble a line of hamster cells previously isolated (Cadigan, K. M., Heider, J. G., and Chang, T -Y. (1988) J. Biol. Chem. 263, 274-282), which has similar independent defects. The results raise the possibility that a partial resistance to sterol repression provides a growth advantage to cells that lack ACAT.			METHERALL, JE (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.			Ridgway, Neale/0000-0002-0441-6228	NATIONAL CANCER INSTITUTE [F32CA008398] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007524, P01HL020948] Funding Source: NIH RePORTER; NCI NIH HHS [CA-08398] Funding Source: Medline; NHLBI NIH HHS [HL-07524, HL 20948] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BALASUBRAMANIAM S, 1977, P NATL ACAD SCI USA, V74, P1421, DOI 10.1073/pnas.74.4.1421; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1978, J BIOL CHEM, V253, P1121; BROWN MS, 1975, J BIOL CHEM, V250, P4025; CADIGAN KM, 1989, J CELL BIOL, V108, P2201, DOI 10.1083/jcb.108.6.2201; CADIGAN KM, 1990, J CELL BIOL, V110, P295, DOI 10.1083/jcb.110.2.295; CADIGAN KM, 1988, J BIOL CHEM, V263, P274; CHANG TY, 1980, J BIOL CHEM, V255, P7787; CHANG TY, 1983, ENZYMES, V16, P523; CHEN HW, 1979, J BIOL CHEM, V254, P715; CHIN DJ, 1985, MOL CELL BIOL, V5, P634, DOI 10.1128/MCB.5.4.634; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; DAWSON PA, 1991, J BIOL CHEM, V266, P9128; FOLCH J, 1957, J BIOL CHEM, V226, P497; GAVEY KL, 1983, P NATL ACAD SCI-BIOL, V80, P2171, DOI 10.1073/pnas.80.8.2171; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; LISCUM L, 1987, J BIOL CHEM, V262, P17002; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; PENTCHEV PG, 1987, FASEB J, V1, P40, DOI 10.1096/fasebj.1.1.3609608; ROSS AC, 1984, J BIOL CHEM, V259, P815; SINENSKY M, 1982, J CELL PHYSIOL, V113, P314, DOI 10.1002/jcp.1041130220; SUCKLING KE, 1985, J LIPID RES, V26, P647	28	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12734	12740						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712025				2022-12-27	WOS:A1991FV18000097
J	BELLAS, RE; BENDORI, R; FARMER, SR				BELLAS, RE; BENDORI, R; FARMER, SR			EPIDERMAL GROWTH-FACTOR ACTIVATION OF VINCULIN AND BETA-1-INTEGRIN GENE-TRANSCRIPTION IN QUIESCENT SWISS 3T3 CELLS - REGULATION THROUGH A PROTEIN-KINASE C-INDEPENDENT PATHWAY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA PRODUCTION; ROUS-SARCOMA VIRUS; FACTOR-BETA; EXTRACELLULAR-MATRIX; DEPENDENT REGULATION; AKR-2B CELLS; ACTIN GENE; CULTURED FIBROBLASTS; FIBRONECTIN RECEPTOR; SURFACE RECEPTORS	Growth activation of quiescent Swiss 3T3 fibroblasts leads to a rapid induction of vinculin and beta-1-integrin gene expression. Addition of serum, epidermal growth factor (EGF), or platelet-derived growth factor to serum-starved, density-arrested cells resulted in a rapid increase in vinculin and beta-1-integrin mRNA levels and a corresponding increase in vinculin synthesis. The increase in vinculin and beta-1-integrin mRNA expression by serum or EGF was not blocked by the inhibition of protein synthesis by cycloheximide. The kinetics of induction of vinculin and beta-1-integrin mRNAs by EGF are different: vinculin mRNA levels reached a peak of expression 4-5-fold greater than that measured in quiescent cells by 2 h after addition of growth factor, whereas beta-1-integrin mRNA levels increased more slowly and to a lesser extent, reaching peaks of 2-3-fold induction at 5 h poststimulation. Down-regulation of protein kinase C by prolonged pretreatment of cells with phorbol 1,2-myristate 1,3-acetate had no effect on the ability of EGF or platelet-derived growth factor to activate vinculin or beta-1-integrin mRNA expression. Furthermore, direct activation of protein kinase C with 1,2-myristate 1,3-acetate did not induce the expression of vinculin or beta-1-integrin mRNA, but did activate c-fos expression. In vitro nuclear "run-on" transcription assays demonstrate a greater than 7-fold increase in vinculin and beta-1-integrin transcription at 40-60 min after addition of EGF when compared with levels in quiescent cells. This activation was rapid and transient, but appeared to occur later than the increase in c-fos and actin transcription. These results demonstrate that vinculin and beta-1-integrin, important components of the cell adhesion apparatus, are members of a group of immediate early growth-responsive genes, along with c-fos, c-myc, actin, and fibronectin. In addition, regulation of these cell adhesion genes occurs exclusively through a protein kinase C-independent pathway in serum-deprived, density-arrested Swiss 3T3 cells.	BOSTON UNIV,SCH MED,DEPT BIOCHEM,80 E CONCORD ST,BOSTON,MA 02118; WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL	Boston University; Weizmann Institute of Science				Farmer, Stephen/0000-0003-2483-2795	NCI NIH HHS [T32-CA09423] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009423] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; AQUINO A, 1988, CANCER RES, V48, P3324; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BELLAS R E, 1988, Journal of Cell Biology, V107, p79A; BENDORI R, 1987, EMBO J, V6, P2897, DOI 10.1002/j.1460-2075.1987.tb02593.x; BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161; BERRIDGE MJ, 1985, SCI AM, V253, P142, DOI 10.1038/scientificamerican1085-142; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BLACKSHEAR PJ, 1987, J BIOL CHEM, V262, P7774; BLATTI SP, 1988, P NATL ACAD SCI USA, V85, P1119, DOI 10.1073/pnas.85.4.1119; BOND JF, 1984, MOL CELL BIOL, V4, P1313, DOI 10.1128/MCB.4.7.1313; BOND JF, 1983, MOL CELL BIOL, V3, P1333, DOI 10.1128/MCB.3.8.1333; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; BURRIDGE K, 1986, Cancer Reviews, V4, P18; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; CARPENTER G, 1990, HDB EXPT PHARM, V95, P69; COLLINS MKL, 1984, J CELL PHYSIOL, V118, P133, DOI 10.1002/jcp.1041180205; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; DEAN DC, 1989, MOL CELL BIOL, V9, P1498, DOI 10.1128/MCB.9.4.1498; DEAN DC, 1990, J BIOL CHEM, V265, P3522; DEAN M, 1983, NATURE, V305, P443, DOI 10.1038/305443a0; DELISLE AJ, 1983, MOL CELL BIOL, V3, P1920, DOI 10.1128/MCB.3.11.1920; DHAWAN J, 1990, J BIOL CHEM, V265, P9015; ELDER PK, 1988, MOL CELL BIOL, V8, P480, DOI 10.1128/MCB.8.1.480; ELDER PK, 1984, P NATL ACAD SCI-BIOL, V81, P7476, DOI 10.1073/pnas.81.23.7476; FARMER SR, 1989, CELL SHAPE DETERMINA, P173; FARMER SR, 1986, CELL MOL BIOL CYTOSK, P131; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GENOVESE C, 1984, BIOCHEMISTRY-US, V23, P6210, DOI 10.1021/bi00320a049; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; GREENBERG ME, 1988, CURRENT PROTOCOLS MO; HIRAKI Y, 1988, J BIOL CHEM, V263, P13655; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; HOWE PH, 1990, J CELL PHYSIOL, V142, P39, DOI 10.1002/jcp.1041420106; HOWE PH, 1989, BIOCHEM J, V261, P879, DOI 10.1042/bj2610879; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; HYNES RO, 1989, J CELL BIOL, V109, P409, DOI 10.1083/jcb.109.1.409; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEOF EB, 1986, J CELL PHYSIOL, V127, P83, DOI 10.1002/jcp.1041270111; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MCCAFFREY P, 1987, J BIOL CHEM, V262, P1442; MCCAFFREY PG, 1987, BIOCHEM BIOPH RES CO, V146, P140, DOI 10.1016/0006-291X(87)90702-9; MOHUN T, 1987, EMBO J, V6, P667, DOI 10.1002/j.1460-2075.1987.tb04806.x; MURTHY US, 1988, BIOCHEM BIOPH RES CO, V152, P1228, DOI 10.1016/S0006-291X(88)80416-9; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OLASHAW NE, 1985, MEDIATORS CELL GROWT, P31; PACHTER JS, 1987, CELL, V51, P283, DOI 10.1016/0092-8674(87)90155-3; PASQUALE EB, 1986, P NATL ACAD SCI USA, V83, P5507, DOI 10.1073/pnas.83.15.5507; PELECH SL, 1986, BIOCHEMISTRY-US, V25, P8348, DOI 10.1021/bi00374a002; PELECH SL, 1987, J BIOL CHEM, V262, P11589; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROZENGURT E, 1982, J BIOL CHEM, V257, P3680; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RYSECK RP, 1989, EXP CELL RES, V180, P537, DOI 10.1016/0014-4827(89)90080-3; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; UNGAR F, 1986, NATURE, V319, P787, DOI 10.1038/319787a0; WERTH DK, 1983, J BIOL CHEM, V258, P1423	68	59	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					12008	12014						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711046				2022-12-27	WOS:A1991FT76200089
J	TSUKAMOTO, T; MATSUI, T; NAKATA, H; ITO, M; NATAZUKA, T; FUKASE, M; FUJITA, T				TSUKAMOTO, T; MATSUI, T; NAKATA, H; ITO, M; NATAZUKA, T; FUKASE, M; FUJITA, T			INTERLEUKIN-1 ENHANCES THE RESPONSE OF OSTEOBLASTS TO PLATELET-DERIVED GROWTH-FACTOR THROUGH THE ALPHA RECEPTOR-SPECIFIC UP-REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE CELLS; PDGF RECEPTOR; CDNA CLONING; A-CHAIN; B-CHAIN; BONE; HETERODIMER; ESTABLISHES; EXPRESSION; PART	Both platelet-derived growth factor (PDGF) and interleukin-1 (IL-1) are produced by activated macrophages and are thought to contribute to bone remodeling, but their precise roles remain to be clarified. The interaction between PDGF and IL-1 was, therefore, studied in normal osteoblast-like cells (MC3T3-E1). The expression of alpha- and beta-PDGF receptors on MC3T3-E1 cells was detected by RNA blot analysis and confirmed by immunoblot analysis. PDGF-induced chemotactic as well as mitogenic activities were synergistically enhanced by either IL-1-alpha or IL-1-beta (40 units/ml) pretreatment in serum-free medium, although IL-1 alone did not show any detectable chemotactic activities. This biological enhancement by IL-1 was accompanied by a selective increase of alpha-PDGF receptor expression, following the augmentation of alpha-receptor autophosphorylation and inositol phosphate hydrolysis induced by PDGF-AA. These findings suggest that PDGF and IL-1 are jointly involved in the bone-remodeling microenvironment as local coupling factors.			TSUKAMOTO, T (corresponding author), KOBE UNIV, SCH MED,DEPT MED,DIV 3,KUSUNOKI CHO, CHUO KU, KOBE 650, JAPAN.		Matsui, Toshimitsu/E-8065-2010	Matsui, Toshimitsu/0000-0002-2536-7584				BOIN PD, 1988, J BIOL CHEM, V263, P11052; CANALIS E, 1988, BONE, V9, P243, DOI 10.1016/8756-3282(88)90037-3; CHENG SL, 1987, J BONE MINER RES, V2, P467; CHENG SL, 1990, J BONE MINER RES, V8, P825; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; COLLINS T, 1985, NATURE, V316, P748, DOI 10.1038/316748a0; DEWHIRST FE, 1985, J IMMUNOL, V135, P2562; DINARELLO CA, 1986, J CLIN INVEST, V77, P1734, DOI 10.1172/JCI112495; FLEMING TP, 1989, P NATL ACAD SCI USA, V86, P8063, DOI 10.1073/pnas.86.20.8063; FLOEGE J, 1990, KIDNEY INT, V37, P859, DOI 10.1038/ki.1990.59; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; GRONWALD RGK, 1989, J BIOL CHEM, V264, P8120; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HAUSCHKA PV, 1988, CIBA F SYMP, V136, P207; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUI T, 1989, P NATL ACAD SCI USA, V86, P8314, DOI 10.1073/pnas.86.21.8314; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; NISTER M, 1988, CELL, V52, P791, DOI 10.1016/0092-8674(88)90421-7; OHMORI Y, 1988, BIOCHIM BIOPHYS ACTA, V970, P22, DOI 10.1016/0167-4889(88)90218-2; OPPENHEIM JJ, 1986, IMMUNOL TODAY, V7, P45, DOI 10.1016/0167-5699(86)90124-6; PARFITT AM, 1987, CLIN OBSTET GYNECOL, V30, P789, DOI 10.1097/00003081-198712000-00004; POSTLETHWAITE AE, 1979, J CLIN INVEST, V64, P1379, DOI 10.1172/JCI109595; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; SAPOLSKY R, 1987, SCIENCE, V238, P522, DOI 10.1126/science.2821621; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; UDAGAWA N, 1990, P NATL ACAD SCI USA, V87, P7260, DOI 10.1073/pnas.87.18.7260; WATROUS DA, 1989, SEMIN ARTHRITIS RHEU, V19, P45, DOI 10.1016/0049-0172(89)90086-3; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922	35	69	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10143	10147						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709926				2022-12-27	WOS:A1991FP08600025
J	CHEN, F; PUETT, D				CHEN, F; PUETT, D			DELINEATION VIA SITE-DIRECTED MUTAGENESIS OF THE CARBOXYL-TERMINAL REGION OF HUMAN CHORIOGONADOTROPIN-BETA REQUIRED FOR SUBUNIT ASSEMBLY AND BIOLOGICAL-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CHORIONIC-GONADOTROPIN; EQUINE GLYCOPROTEIN HORMONES; AMINO-ACID SEQUENCE; LEYDIG TUMOR-CELLS; LUTEINIZING-HORMONE; RECEPTOR-BINDING; DISULFIDE BONDS; EXPRESSION; FORM	The choriogonadotropin beta-subunit is unique in the human glycoprotein hormone family in containing a carboxyl-terminal extension, with four sites of O-glycosylation, that is not present in the other beta-subunits. We have used site-directed mutagenesis to define boundaries on the extent to which truncations can be made at the COOH terminus without abolishing subunit assembly and biological activity. Two COOH-terminal deletion mutant chains of human choriogonadotropin-beta, des(93-145) and des(101-145), were prepared and expressed in Chinese hamster ovary cells containing a stably integrated gene for bovine-alpha. The heterologous gonadotropin, bovine alpha-human choriogonadotropin des(101-145)beta, formed a heterodimer and, when assayed with transformed murine Leydig cells in vitro, competed with the binding of standard human choriogonadotropin and stimulated both cAMP and progesterone production, albeit with a reduced potency relative to bovine alpha-human choriogonadotropin beta-wild type. In contrast, human choriogonadotropin des(93-145)beta, expressed under identical conditions in the presence of bovine-alpha, failed to form heterodimer and thus exhibited no competitive binding and was without effect on cAMP and progesterone levels. Consequently, removal of the putative determinant loop region of the beta-subunit (residues 93-100), which is believed to be important in determining receptor specificity, abolishes association with alpha. Hence, in addition to its possible role as a receptor determinant, this region of the molecule appears to be critical for proper folding or subunit interaction. The truncated form of human choriogonadotropin-beta lacking residues 101-145 is the shortest form of the subunit yet described that retains biological activity. Moreover, these results demonstrate that the proposed disulfide between Cys-26 and Cys-110 is not requried for subunit assembly or for receptor binding and subsequent intracellular signaling.	UNIV MIAMI,SCH MED,DEPT BIOCHEM & MOLEC BIOL,REPROD SCI & ENDOCRINOL LABS,POB 016960,MIAMI,FL 33101	University of Miami					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033973] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK33973] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; ASCOLI M, 1987, ENDOCRINOLOGY, V120, P1161, DOI 10.1210/endo-120-3-1161; BEEBE JS, 1990, J BIOL CHEM, V265, P312; BOUSFIELD GR, 1987, J BIOL CHEM, V262, P8610; BOUSFIELD GR, 1989, ENDOCRINOLOGY, V124, P379, DOI 10.1210/endo-124-1-379; CATT KJ, 1973, NATURE-NEW BIOL, V244, P219, DOI 10.1038/newbio244219a0; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; CHEN F, 1990, 72ND END SOC M ATL, P216; ELDEIRY S, 1989, MOL ENDOCRINOL, V3, P1523, DOI 10.1210/mend-3-10-1523; ELDEIRY S, 1991, IN PRESS MOL CELL EN; FIDDES JC, 1984, RECENT PROG HORM RES, V40, P43; KAETZEL DM, 1985, P NATL ACAD SCI USA, V82, P7280, DOI 10.1073/pnas.82.21.7280; KEUTMANN HT, 1989, MOL ENDOCRINOL, V3, P526, DOI 10.1210/mend-3-3-526; MANIATIS T, 1982, MOL CLONING LABORATO, P88; MATZUK MM, 1990, ENDOCRINOLOGY, V126, P376, DOI 10.1210/endo-126-1-376; MISE T, 1981, J BIOL CHEM, V256, P6587; MOORE WT, 1980, CHORIONIC GONADOTROP, P89; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; PUETT D, 1978, ACTA ENDOCRINOL-COP, V89, P612; RUDDON RW, 1989, ENDOCRINOLOGY, V124, P862, DOI 10.1210/endo-124-2-862; RUDDON RW, 1987, J BIOL CHEM, V262, P12533; RYAN RJ, 1987, RECENT PROG HORM RES, V43, P383; RYAN RJ, 1988, FASEB J, V2, P2661, DOI 10.1096/fasebj.2.11.2456242; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STRICKLAND TW, 1985, LUTEINIZING HORMONE, P1; SUGANUMA N, 1989, J BIOL CHEM, V264, P19302; SUGINO H, 1987, J BIOL CHEM, V262, P8603; TALMADGE K, 1983, DNA, V2, P1948	28	50	51	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					6904	6908						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707877				2022-12-27	WOS:A1991FG72700043
J	GOSHORN, SC; RETZEL, E; JEMMERSON, R				GOSHORN, SC; RETZEL, E; JEMMERSON, R			COMMON STRUCTURAL FEATURES AMONG MONOCLONAL-ANTIBODIES BINDING THE SAME ANTIGENIC REGION OF CYTOCHROME-C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; HEAVY-CHAIN; 3-DIMENSIONAL STRUCTURE; SOMATIC RECOMBINATION; GLOBULAR-PROTEINS; CRYSTAL-STRUCTURE; 2.8-A RESOLUTION; IMMUNOGLOBULIN; MOUSE; SEQUENCES	To examine if there are common physicochemical features among antibodies binding the same antigenic region of a protein, B cell hybridomas were prepared against the two major antigenic regions on mammalian cytochromes c, and the nucleotide sequences encoding the monoclonal antibody (mAb) heavy (H) and light (L) chains were determined and compared. Although the genetic elements used were somewhat diverse, similarities among mAbs to a given antigenic region were observed. In particular, mAbs binding in a region situated at a bend in the antigen around residues 44 and 47 had longer complementarity-determining regions (4-5 additional amino acid residues in L1 and 1-2 in H3) than mAbs binding the other region around residues 60 and 62 located on a relatively flat surface. These observations indicate that the topography of an antigenic site and the lengths of certain complementarity-determining regions are important physiochemical properties determining, at least in part, which antibodies (B cells) will participate in an immune response to a particular site on a protein antigen.	UNIV MINNESOTA,SCH MED,DEPT MICROBIOL,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities					NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NCI NIH HHS [5T32-CA-09138] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BENJAMIN DC, 1984, ANNU REV IMMUNOL, V2, P67, DOI 10.1146/annurev.iy.02.040184.000435; BORDEN D, 1976, HDB BIOCHEMISTRY MOL, V3, P268; BOULOT G, 1980, J CRYST GROWTH, V90, P213; Brautigan D L, 1978, Methods Enzymol, V53, P128; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; BRUGGEMANN M, 1986, EMBO J, V5, P1561, DOI 10.1002/j.1460-2075.1986.tb04397.x; CARBONE FR, 1985, J IMMUNOL, V135, P2609; CARLSON SS, 1977, BIOCHEMISTRY-US, V16, P1437, DOI 10.1021/bi00626a031; CATON AJ, 1986, EMBO J, V5, P1577, DOI 10.1002/j.1460-2075.1986.tb04399.x; CHANG CH, 1985, BIOCHEMISTRY-US, V24, P4890, DOI 10.1021/bi00339a025; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; CLARKE SH, 1990, J IMMUNOL, V144, P2795; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; DARSLEY MJ, 1985, EMBO J, V4, P393, DOI 10.1002/j.1460-2075.1985.tb03641.x; DIAMOND B, 1984, P NATL ACAD SCI-BIOL, V81, P5841, DOI 10.1073/pnas.81.18.5841; EDMUNDSO.AB, 1974, BIOCHEMISTRY-US, V13, P3816, DOI 10.1021/bi00715a031; EISEN HN, 1964, HARVEY LECT, P1; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; JEMMERSON R, 1987, P NATL ACAD SCI USA, V84, P9180, DOI 10.1073/pnas.84.24.9180; JEMMERSON R, 1988, J IMMUNOL, V140, P1762; JEMMERSON R, 1987, J IMMUNOL, V138, P213; KAARTINEN M, 1983, NATURE, V304, P320, DOI 10.1038/304320a0; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KEARNEY JF, 1979, J IMMUNOL, V123, P1548; KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; LIVANT D, 1986, CELL, V47, P461, DOI 10.1016/0092-8674(86)90603-3; LOUIE GV, 1988, J MOL BIOL, V199, P295, DOI 10.1016/0022-2836(88)90315-4; MANSER T, 1987, IMMUNOL REV, V96, P141, DOI 10.1111/j.1600-065X.1987.tb00513.x; MARQUART M, 1980, J MOL BIOL, V141, P369, DOI 10.1016/0022-2836(80)90252-1; MEEK K, 1989, P NATL ACAD SCI USA, V86, P4664, DOI 10.1073/pnas.86.12.4664; MELTZER SJ, 1990, BIOTECHNIQUES, V8, P142; MESSING J, 1983, METHOD ENZYMOL, V101, P20; OCHI H, 1983, J MOL BIOL, V166, P407, DOI 10.1016/S0022-2836(83)80092-8; PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938; POTTER M, 1982, MOL IMMUNOL, V19, P1619, DOI 10.1016/0161-5890(82)90273-5; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUL FA, 1978, J BIOL CHEM, V253, P585; SHARON J, 1990, P NATL ACAD SCI USA, V87, P4814, DOI 10.1073/pnas.87.12.4814; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SINHA ND, 1984, NUCLEIC ACIDS RES, V12, P4539, DOI 10.1093/nar/12.11.4539; Siskind G W, 1969, Adv Immunol, V10, P1, DOI 10.1016/S0065-2776(08)60414-9; SORGER SB, 1990, J IMMUNOL, V144, P1127; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; TAKANO T, 1981, J MOL BIOL, V153, P79, DOI 10.1016/0022-2836(81)90528-3; TULIP WR, 1989, COLD SH Q B, V54, P257; WANG BC, 1979, J MOL BIOL, V129, P657, DOI 10.1016/0022-2836(79)90475-3	52	42	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2134	2142						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703527				2022-12-27	WOS:A1991EV51500022
J	GARG, UC; HASSID, A				GARG, UC; HASSID, A			NITRIC-OXIDE DECREASES CYTOSOLIC FREE CALCIUM IN BALB/C 3T3 FIBROBLASTS BY A CYCLIC GMP-INDEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							VASCULAR SMOOTH-MUSCLE; NITROVASODILATOR-INDUCED RELAXATION; CULTURED ENDOTHELIAL-CELLS; MESANGIAL CELLS; GENERATING VASODILATORS; RELAXING FACTOR; MITOGENESIS; AMP; ATRIOPEPTIN; INHIBITION	The purpose of this study was to investigate the effects of NO on cystosolic calcium levels in Balb/c 3T3 fibroblasts that were previously shown to lack soluble guanylate cyclase activity. Authentic NO as well as two NO-generating vasodilators, S-nitroso-N-acetyl-penicillamine and isosorbide dinitrate, decreased cytosolic calcium in these fibroblasts. The effect of NO and S-nitroso-N-acetylpenicillamine was concentration-dependent and, for the most part, reversible. Since S-nitroso-N-acetylpenicillamine did not increase either cGMP or cAMP, NO did not increase cGMP, and 8-bromo-cGMP did not alter cytosolic free calcium, we conclude that NO decreases cytosolic free calcium by a cyclic nucleotide-independent mechanism in Balb/c 3T3 fibroblasts.	NEW YORK MED COLL,DEPT PHARMACOL,VALHALLA,NY 10595	New York Medical College			Garg, Uttam/ABC-8189-2020		NHLBI NIH HHS [HL33769] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033769] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		APPEL RG, 1987, FEBS LETT, V224, P396, DOI 10.1016/0014-5793(87)80491-X; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; BRUNE B, 1989, J BIOL CHEM, V264, P8455; CORNWELL TL, 1989, J BIOL CHEM, V264, P1146; FELBEL J, 1988, J BIOL CHEM, V263, P16764; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GARG UC, 1989, AM J PHYSIOL, V257, pF60, DOI 10.1152/ajprenal.1989.257.1.F60; HASSID A, 1987, AM J PHYSIOL, V253, pF1077; HASSID A, 1986, AM J PHYSIOL, V251, pF1018; HASSID A, 1986, J PHARMACOL EXP THER, V239, P334; HASSID A, 1986, AM J PHYSIOL, V251, pC681, DOI 10.1152/ajpcell.1986.251.5.C681; IGNARRO LJ, 1984, J PHARMACOL EXP THER, V228, P682; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JOHNSON A, 1988, BIOCHEM BIOPH RES CO, V152, P893, DOI 10.1016/S0006-291X(88)80123-2; KELM M, 1988, BIOCHEM BIOPH RES CO, V154, P236, DOI 10.1016/0006-291X(88)90675-4; LUCKHOFF A, 1987, HYPERTENSION, V9, P295, DOI 10.1161/01.HYP.9.3.295; MORGANBOYD R, 1987, AM J PHYSIOL, V253, pC588, DOI 10.1152/ajpcell.1987.253.4.C588; MURAD F, 1988, BIOCHEM SOC T, V16, P490, DOI 10.1042/bst0160490; NAPOLI SA, 1980, J PHARMACOL EXP THER, V212, P469; NESBITT JA, 1976, J BIOL CHEM, V251, P2344; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281	26	114	116	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					9	12						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702429				2022-12-27	WOS:A1991EQ33900003
J	HSU, YM; GUIDOTTI, G				HSU, YM; GUIDOTTI, G			EFFECTS OF HYPOKALEMIA ON THE PROPERTIES AND EXPRESSION OF THE (NA+,K+)-ATPASE OF RAT SKELETAL-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+,K+-ATPASE ALPHA-SUBUNIT; NA,K-ATPASE BETA-SUBUNIT; ATPASE MESSENGER-RNAS; 2 MOLECULAR-FORMS; (NA+ + K+)-ATPASE; LOW EXTERNAL K+; SOLEUS MUSCLE; NA+-K+; DIFFERENTIAL EXPRESSION; UNTRANSLATED REGION	Rats maintained on a low potassium diet develop hypokalemia, which is associated with an approximately 80% decrease in the number of (Na+, K+)-ATPase molecules in skeletal muscle sarcolemma (Norgaard, A., Kjeldsen, K., and Clausen,T. (1981) Nature 293, 739-741); the skeletal muscles of the hypokalemic rats become paralyzed after exposure to insulin in low [K+] media (Otsuka, M., and Ohtsuki, I. (1970) Am. J. Physiol. 219, 1178-1182). We have been interested in the interactions between the insulin receptor and the alpha-2 isoform of the (Na+, K+)-ATPase as a mechanism for the insulin activation of (Na+, K+)- pumping and decided to use the hypokalemic rats to obtain additional information on this question. We show here that the amount of the alpha-2 isoform is the skeletal muscles of hypokalemic rats is greatly decreased as determined by immunoblotting and (Na+, K+)-ATPase activity; the effect of hypokalemia on the amount of the alpha-1 isoform is small. The mechanism of the decrease in the alpha-2 isoform is not known, but it is not due to transcriptional regulation of the alpha-2 gene because the amounts of the transcripts for this polypeptide are increased in the rats on the low potassium diet. The (Na+, K+)-pump that remains in the skeletal muscles of rats on a low potassium diet for a period of 2 weeks is still activated by insulin; under these conditions, however, insulin does not bring about a decrease in the intracellular [Na+] in contrast to the situation with normal muscle.			HSU, YM (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138, USA.				NHLBI NIH HHS [HL 08893] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BARCHI RL, 1979, BIOCHIM BIOPHYS ACTA, V550, P59, DOI 10.1016/0005-2736(79)90115-9; BOWEN JW, 1987, AM J PHYSIOL, V252, pC179, DOI 10.1152/ajpcell.1987.252.2.C179; CANTLEY L, 1986, TRENDS NEUROSCI, V9, P1, DOI 10.1016/0166-2236(86)90002-0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLAUSEN T, 1987, AM J PHYSIOL, V252, pE492, DOI 10.1152/ajpendo.1987.252.4.E492; CLAUSEN T, 1977, J PHYSIOL-LONDON, V265, P19, DOI 10.1113/jphysiol.1977.sp011703; EMANUEL JR, 1987, P NATL ACAD SCI USA, V84, P9030, DOI 10.1073/pnas.84.24.9030; ENDO T, 1987, CELL, V49, P515, DOI 10.1016/0092-8674(87)90454-5; EVERTS ME, 1988, AM J PHYSIOL, V255, pE604, DOI 10.1152/ajpendo.1988.255.5.E604; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HABER RS, 1988, AM J PHYSIOL, V255, pE912, DOI 10.1152/ajpendo.1988.255.6.E912; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; HERRERA VLM, 1988, SCIENCE, V241, P221, DOI 10.1126/science.2838907; HSU YM, 1989, BIOCHEMISTRY-US, V28, P569, DOI 10.1021/bi00428a023; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; JOSEPHSON L, 1977, BIOCHEMISTRY-US, V16, P4572, DOI 10.1021/bi00640a006; KAO I, 1975, SCIENCE, V188, P740, DOI 10.1126/science.1124397; KIM D, 1984, CIRC RES, V55, P39, DOI 10.1161/01.RES.55.1.39; KJELDSEN K, 1988, BIOCHEM J, V249, P481, DOI 10.1042/bj2490481; KOHN PG, 1971, BIOCHIM BIOPHYS ACTA, V225, P277, DOI 10.1016/0005-2736(71)90221-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAYZER RB, 1982, ANN NEUROL, V11, P547, DOI 10.1002/ana.410110602; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LYTTON J, 1985, J BIOL CHEM, V260, P1177; LYTTON J, 1985, J BIOL CHEM, V260, P75; MARTINVASALLO P, 1989, J BIOL CHEM, V264, P4613; MARVER D, 1986, J MEMBRANE BIOL, V94, P205, DOI 10.1007/BF01869716; MCDONOUGH AA, 1988, AM J PHYSIOL, V254, pC323, DOI 10.1152/ajpcell.1988.254.2.C323; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; NORGAARD A, 1981, NATURE, V293, P739, DOI 10.1038/293739a0; OFFERIJNS FGJ, 1958, J PHYSIOL-LONDON, V141, P377, DOI 10.1113/jphysiol.1958.sp005981; ORLOWSKI J, 1988, J BIOL CHEM, V263, P17817; ORLOWSKI J, 1988, J BIOL CHEM, V263, P10436; OTSUKA M, 1970, AM J PHYSIOL, V219, P1178, DOI 10.1152/ajplegacy.1970.219.5.1178; POLLACK LR, 1981, J CELL PHYSIOL, V106, P85, DOI 10.1002/jcp.1041060110; PRESSLEY TA, 1986, J GEN PHYSIOL, V87, P591, DOI 10.1085/jgp.87.4.591; PRESSLEY TA, 1988, AM J PHYSIOL, V255, pC252, DOI 10.1152/ajpcell.1988.255.2.C252; RESH MD, 1980, J BIOL CHEM, V255, P938; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SWEADNER KJ, 1979, J BIOL CHEM, V254, P6060; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347; TAMKUN MM, 1986, J BIOL CHEM, V261, P1009; TAORMINO JP, 1990, J BIOL CHEM, V265, P4116; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERREY F, 1987, J CELL BIOL, V104, P1231, DOI 10.1083/jcb.104.5.1231; WOLITZKY BA, 1986, J BIOL CHEM, V261, P9990; YOUNG RM, 1987, BIOCHEM BIOPH RES CO, V145, P52, DOI 10.1016/0006-291X(87)91286-1; YOUNG RM, 1987, J BIOL CHEM, V262, P4905; ZAMOFING D, 1988, J MEMBRANE BIOL, V104, P69, DOI 10.1007/BF01871903	50	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					427	433						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702427				2022-12-27	WOS:A1991EQ33900062
J	MOLDAY, LL; COOK, NJ; KAUPP, UB; MOLDAY, RS				MOLDAY, LL; COOK, NJ; KAUPP, UB; MOLDAY, RS			THE CGMP-GATED CATION CHANNEL OF BOVINE ROD PHOTORECEPTOR CELLS IS ASSOCIATED WITH A 240-KDA PROTEIN EXHIBITING IMMUNOCHEMICAL CROSS-REACTIVITY WITH SPECTRIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV BRITISH COLUMBIA, DEPT BIOCHEM, VANCOUVER V6T 1W5, BC, CANADA; MAX PLANCK INST BIOPHYS, MOLEK MEMBRANBIOL ABT, W-6000 FRANKFURT 71, GERMANY; FORSCHUNGSZENTRUM JULICH, INST BIOL INFORMATIONSVERARBEITUNG, W-5170 JULICH 1, GERMANY	University of British Columbia; Max Planck Society; Helmholtz Association; Research Center Julich					NATIONAL EYE INSTITUTE [R01EY002422] Funding Source: NIH RePORTER; NEI NIH HHS [EY 02422] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENNETT V, 1983, METHOD ENZYMOL, V96, P313; CLACK JW, 1988, P NATL ACAD SCI USA, V85, P9806, DOI 10.1073/pnas.85.24.9806; COOK NJ, 1986, PHOTOBIOCH PHOTOBIOP, V13, P331; COOK NJ, 1988, J BIOL CHEM, V263, P11382; COOK NJ, 1986, J BIOL CHEM, V261, P7033; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; COOK NJ, 1989, J BIOL CHEM, V264, P6996; CUATRECASAS P, 1970, J BIOL CHEM, V245, P3059; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; HAEST CWM, 1982, BIOCHIM BIOPHYS ACTA, V694, P331, DOI 10.1016/0304-4157(82)90001-6; HANKE W, 1988, P NATL ACAD SCI USA, V85, P94, DOI 10.1073/pnas.85.1.94; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATESIC D, 1987, NATURE, V326, P600, DOI 10.1038/326600a0; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; MOLDAY RS, 1987, J CELL BIOL, V105, P2589, DOI 10.1083/jcb.105.6.2589; MORROW JS, 1989, J CELL BIOL, V108, P455, DOI 10.1083/jcb.108.2.455; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; SMITH HG, 1975, EXP EYE RES, V20, P211, DOI 10.1016/0014-4835(75)90134-7; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; WOHLFART P, 1989, J BIOL CHEM, V264, P20934; WONG S, 1986, BIOCHEMISTRY-US, V25, P6294, DOI 10.1021/bi00368a069; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; YAU KW, 1985, NATURE, V317, P252, DOI 10.1038/317252a0	26	77	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18690	18695						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1698790				2022-12-27	WOS:A1990EE20100100
J	MCCARTHY, TL; CENTRELLA, M; CANALIS, E				MCCARTHY, TL; CENTRELLA, M; CANALIS, E			CYCLIC-AMP INDUCES INSULIN-LIKE GROWTH FACTOR-I SYNTHESIS IN OSTEOBLAST-ENRICHED CULTURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									ST FRANCIS HOSP,DEPT MED,ENDOCRINE SECT,HARTFORD,CT 06105; UNIV CONNECTICUT,CTR HLTH,FARMINGTON,CT 06032	Saint Francis Hospital & Medical Center; University of Connecticut	MCCARTHY, TL (corresponding author), ST FRANCIS HOSP,RES LAB,114 WOODLAND ST,HARTFORD,CT 06105, USA.				NIAMS NIH HHS [AR21707, AR39201] Funding Source: Medline; NIDDK NIH HHS [DK42424] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039201, R01AR021707, R37AR021707, R29AR039201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042424] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CANALIS E, 1988, ENDOCRINOLOGY, V122, P22, DOI 10.1210/endo-122-1-22; CANALIS E, 1988, J CLIN INVEST, V81, P277, DOI 10.1172/JCI113318; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CHASE LR, 1970, J BIOL CHEM, V245, P1520; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIVITELLI R, 1989, ENDOCRINOLOGY, V124, P2928, DOI 10.1210/endo-124-6-2928; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; HOCK JM, 1988, ENDOCRINOLOGY, V122, P254, DOI 10.1210/endo-122-1-254; HOWARD GA, 1981, P NATL ACAD SCI-BIOL, V78, P3204, DOI 10.1073/pnas.78.5.3204; LINKHART TA, 1989, ENDOCRINOLOGY, V125, P1484, DOI 10.1210/endo-125-3-1484; Maniatis T., 1982, MOL CLONING; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P301, DOI 10.1210/endo-124-1-301; MCCARTHY TL, 1988, J BONE MINER RES, V3, P401; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P1247, DOI 10.1210/endo-124-3-1247; MCCUSKER RH, 1988, J CELL PHYSIOL, V137, P505, DOI 10.1002/jcp.1041370316; MOCHAN E, 1986, ARTHRITIS RHEUM, V29, P1078, DOI 10.1002/art.1780290904; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MURPHY LJ, 1987, ENDOCRINOLOGY, V121, P684, DOI 10.1210/endo-121-2-684; RASMUSSEN H, 1986, NEW ENGL J MED, V314, P1094; RASMUSSEN H, 1986, NEW ENGL J MED, V314, P1164; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SLOVIK DM, 1981, J CLIN INVEST, V68, P1261, DOI 10.1172/JCI110372; STEMPIEN MM, 1986, DNA-J MOLEC CELL BIO, V5, P357, DOI 10.1089/dna.1986.5.357; Sussenbach J S, 1989, Prog Growth Factor Res, V1, P33, DOI 10.1016/0955-2235(89)90040-9; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; WONG GL, 1975, P NATL ACAD SCI USA, V72, P3169; WU CH, 1986, J BIOL CHEM, V261, P482; WYNE KL, 1989, J BIOL CHEM, V264, P981; YAMAGUCHI DT, 1987, J BIOL CHEM, V262, P7711; ZHANG YH, 1988, J BIOL CHEM, V263, P6177	34	136	136	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15353	15356						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1697590				2022-12-27	WOS:A1990DY96400002
J	BLAKE, MJ; GERSHON, D; FARGNOLI, J; HOLBROOK, NJ				BLAKE, MJ; GERSHON, D; FARGNOLI, J; HOLBROOK, NJ			DISCORDANT EXPRESSION OF HEAT-SHOCK PROTEIN MESSENGER-RNAS IN TISSUES OF HEAT-STRESSED RATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TECHNION ISRAEL INST TECHNOL,DEPT BIOL,IL-32000 HAIFA,ISRAEL	Technion Israel Institute of Technology	BLAKE, MJ (corresponding author), NIA,MOLEC GENET LAB,BALTIMORE,MD 21224, USA.							ARRIGO AP, 1988, EXP CELL RES, V175, P169, DOI 10.1016/0014-4827(88)90264-9; ARRIGO AP, 1987, J BIOL CHEM, V262, P15359; BARBE MF, 1988, SCIENCE, V241, P1817, DOI 10.1126/science.3175623; CAIRO G, 1985, HEPATOLOGY, V5, P357, DOI 10.1002/hep.1840050303; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COSGROVE JW, 1983, P NATL ACAD SCI-BIOL, V80, P569, DOI 10.1073/pnas.80.2.569; CURRIE RW, 1983, CAN J BIOCHEM CELL B, V61, P438, DOI 10.1139/o83-059; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORNACE AJ, 1989, EXP CELL RES, V182, P61, DOI 10.1016/0014-4827(89)90279-6; FRANKEL HM, 1959, J APPL PHYSIOL, V14, P997, DOI 10.1152/jappl.1959.14.6.997; GIBBS DM, 1985, BRAIN RES, V335, P360, DOI 10.1016/0006-8993(85)90494-9; HICKEY E, 1986, NUCLEIC ACIDS RES, V14, P4127, DOI 10.1093/nar/14.10.4127; HOLMGREN R, 1981, P NATL ACAD SCI-BIOL, V78, P3775, DOI 10.1073/pnas.78.6.3775; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MORIMOTO RI, 1989, STRESS INDUCED PROTE, P83; NOWAK TS, 1990, J NEUROCHEM, V54, P451, DOI 10.1111/j.1471-4159.1990.tb01893.x; NOWAK TS, 1988, J NEUROCHEM, V50, P285, DOI 10.1111/j.1471-4159.1988.tb13262.x; OMALLEY K, 1985, MOL CELL BIOL, V5, P3476, DOI 10.1128/MCB.5.12.3476; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; SORGER PK, 1987, NATURE, V329, P81, DOI 10.1038/329081a0; SORGER PK, 1987, EMBO J, V6, P3035, DOI 10.1002/j.1460-2075.1987.tb02609.x; UNEY JB, 1988, FEBS LETT, V235, P215, DOI 10.1016/0014-5793(88)81265-1; WU BJ, 1986, P NATL ACAD SCI USA, V83, P629, DOI 10.1073/pnas.83.3.629; YOST HJ, 1986, CELL, V45, P185, DOI 10.1016/0092-8674(86)90382-X; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	26	178	183	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					15275	15279						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697588				2022-12-27	WOS:A1990DX40000090
J	HEEB, MJ; GRUBER, A; GRIFFIN, JH				HEEB, MJ; GRUBER, A; GRIFFIN, JH			IDENTIFICATION OF DIVALENT METAL ION-DEPENDENT INHIBITION OF ACTIVATED PROTEIN-C BY ALPHA-2-MACROGLOBULIN AND ALPHA-2-ANTIPLASMIN IN BLOOD AND COMPARISONS TO INHIBITION OF FACTOR-XA, THROMBIN, AND PLASMIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE PLASMA; PRIMATE MODEL; PURIFICATION; COAGULATION; INVIVO; ALPHA-1-ANTITRYPSIN; DEFICIENCY; MECHANISM; INACTIVATION; ASSAYS	The half-life of activated protein C (APC) was 31 min in citrated blood and 18 min in whole blood. Immunoblotting analysis of citrated blood identified APC-protein C inhibitor (APC-PCI) and APC-alpha-1-antitrypsin complexes. Whole blood contained two additional APC-inhibitor complexes, one stimulated by Ca2+ and another by Mg2+. The former was identified as APC-alpha-2-macroglobulin (APC-alpha-2M) while the latter was not identified. APC-alpha-2-antiplasmin complexes (APC-alpha-2AP) were identified, comigrating with APC-PCI complexes. Purified alpha-2M and alpha-2AP inhibited APC in the presence of Ca2+ (k2 = 99 and 100 M-1 s-1, respectively. Inhibition of APC and Factor Xa by alpha-2M and inhibition of APC by alpha-2AP was stimulated by Ca2+, Mn2+, and Mg2+. Inhibition of thrombin by alpha-2M and of plasmin by alpha-2AP was not altered by EDTA or Ca2+, suggesting divalent metal ions affect APC and Factor Xa rather than the inhibitors. k2 values for the APC inhibitors and their plasma concentrations suggest that PCI and alpha-1-antitrypsin are the more important APC inhibitors and that alpha-2M and alpha-2AP are metal ion-dependent auxiliary inhibitors. Inhibitors can account for the in vivo half-life of APC.	Scripps Res Inst, RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA; Scripps Res Inst, RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute				Griffin, John/0000-0002-4302-2547	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-31950] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AMPHLETT GW, 1981, BIOCHEMISTRY-US, V20, P2156, DOI 10.1021/bi00511a013; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BRANSON HE, 1983, LANCET, V2, P1165; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; EMEKLI NB, 1980, HAEMATOLOGICA, V65, P644; EMERICK SC, 1987, PHARM TOXICOLOGY PRO, P351; ESPANA F, 1989, THROMB RES, V55, P369, DOI 10.1016/0049-3848(89)90069-8; ESPANA F, 1991, BLOOD, V77, P1754; FEINMAN RD, 1985, BIOCHEM J, V231, P417, DOI 10.1042/bj2310417; FELDMAN S R, 1986, Seminars in Thrombosis and Hemostasis, V12, P223, DOI 10.1055/s-2007-1003556; FENTON JW, 1974, THROMB RES, V4, P809, DOI 10.1016/0049-3848(74)90024-3; FUCHS HE, 1983, J CLIN INVEST, V72, P2041, DOI 10.1172/JCI111169; GEIGER M, 1989, THROMB HAEMOSTASIS, V61, P86; GLADSON CL, 1989, BLOOD, V74, P173; GONIAS SL, 1982, J CLIN INVEST, V70, P412, DOI 10.1172/JCI110631; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; GRUBER A, 1989, BLOOD, V73, P639; HEEB MJ, 1990, CIRCULATION, V82, P769; HEEB MJ, 1990, J BIOL CHEM, V265, P2365; HEEB MJ, 1987, J BIOL CHEM, V262, P15813; HEEB MJ, 1989, BLOOD, V73, P446; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; HEEB MJ, 1988, THROMB RES, V52, P33, DOI 10.1016/0049-3848(88)90038-2; HEEB MJ, 1989, BLOOD, V73, P455; HOOGENDOORN H, 1990, BLOOD, V75, P2164; JOHNSON AE, 1983, J BIOL CHEM, V258, P5554; KISIEL W, 1979, J CLIN INVEST, V64, P761, DOI 10.1172/JCI109521; KISIEL W, 1977, BIOCHEMISTRY-US, V16, P5824, DOI 10.1021/bi00645a029; LIJNEN HR, 1986, PROTEINASE INHIBITOR, P457; MARLAR RA, 1989, THROMB RES, V54, P177, DOI 10.1016/0049-3848(89)90225-9; MARLAR RA, 1982, BLOOD, V59, P1067; MEIJERS JCM, 1987, BIOCHEMISTRY-US, V26, P5932, DOI 10.1021/bi00392a053; MILES LA, 1982, BLOOD, V59, P1246; OKAJIMA K, 1990, THROMB HAEMOSTASIS, V63, P48; SAITO H, 1979, P NATL ACAD SCI USA, V76, P2013, DOI 10.1073/pnas.76.4.2013; STENFLO J, 1976, J BIOL CHEM, V251, P355; SUZUKI K, 1983, J BIOL CHEM, V258, P163; TAYLOR FB, 1987, J CLIN INVEST, V79, P918, DOI 10.1172/JCI112902; VANDERMEER FJM, 1989, THROMB HAEMOSTASIS, V62, P756; WALKER FJ, 1979, BIOCHIM BIOPHYS ACTA, V571, P333, DOI 10.1016/0005-2744(79)90103-7; WIMAN B, 1977, EUR J BIOCHEM, V78, P19, DOI 10.1111/j.1432-1033.1977.tb11709.x	42	79	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17606	17612						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1716632				2022-12-27	WOS:A1991GF44500093
J	UCKUN, FM; SCHIEVEN, GL; DIBIRDIK, I; CHANDANLANGLIE, M; TUELAHLGREN, L; LEDBETTER, JA				UCKUN, FM; SCHIEVEN, GL; DIBIRDIK, I; CHANDANLANGLIE, M; TUELAHLGREN, L; LEDBETTER, JA			STIMULATION OF PROTEIN TYROSINE PHOSPHORYLATION, PHOSPHOINOSITIDE TURNOVER, AND MULTIPLE PREVIOUSLY UNIDENTIFIED SERINE THREONINE-SPECIFIC PROTEIN-KINASES BY THE PAN-B-CELL RECEPTOR CD40/BP50 AT DISCRETE DEVELOPMENTAL STAGES OF HUMAN B-CELL ONTOGENY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; LIGAND-INDUCED DESENSITIZATION; MEDIATED CA-2+ MOBILIZATION; PHOSPHOLIPASE-C-GAMMA; LYMPHOCYTE-B; MONOCLONAL-ANTIBODY; SIGNAL TRANSDUCTION; ANTIGEN RECEPTOR; PC12 CELLS; SURFACE MOLECULES	CD40/Bp50 B-cell receptor has been implicated as having an important function for the regulation of human B-cell growth and maturation as well as antigen-driven selection of tonsillar B-cells in germinal centers. The purpose of the present study was to examine the biochemical events triggered by the engagement of the CD40 receptor in human B-lineage lymphoid cells corresponding to discrete developmental stages of human B-cell ontogeny. The engagement of the CD40 receptor on pro-B-, pre-pre-B-, pre-B-, or activated mature B-cells but not on resting mature B-cells with the agonistic anti-CD40 monoclonal antibody G28-5 resulted in enhanced tyrosine phosphorylation of four distinct phosphoproteins with molecular masses of 67, 72, 96, and 113 kDa and induced a rapid increase in the production of inositol 1,4,5-trisphosphate. Further, we have identified five electrophoretically distinct renaturable CD40-regulated serine/threonine-specific protein kinases (PK120, PK93, PK76, PK55, and PK48) that showed markedly increased in vitro activity after CD40 stimulation. Protein kinase C inhibitor 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7) abrogated the stimulation of the in vitro activity of PK120, PK93, PK55, and PK48 and attenuated the stimulation of the in vitro activity of PK76 in response to the engagement of the CD40 receptor but did not influence the enhanced tyrosine phosphorylation of cellular substrates after CD40 stimulation. Notably, genistein and herbimycin A, two potent inhibitors of tyrosine-specific protein kinases, not only abrogated the CD40-induced enhanced tyrosine phosphorylation on the 67-, 72-, 96-, and 113-kDa substrates, but they also inhibited the CD40-induced stimulation of phosphoinositide turnover as well as the CD40-induced increase of the in vitro activity of renaturable serine/threonine-specific protein kinases. Taken together, these results demonstrate the following: (a) The CD40 receptor is active in signal transduction at multiple stages of B-cell ontogeny including the pro-B-, pre-pre-B-, and pre-B-cell stages before surface immunoglobulin expression as well as the later stages of B-cell differentiation in germinal centers; (b) The transmembrane signal triggered by engagement of the CD40 receptor is intimately linked to a functional protein tyrosine kinase/protein tyrosine phosphatase regulatory pathway, activates phospholipase C in immature B-cell precursors, early B-cells, and activated buoyant tonsillar B-cells but not in sIgM+ dense tonsillar B-cells with functional antigen receptors; (c) Tyrosine phosphorylation is an important and perhaps mandatory step in the generation of the CD40 receptor-linked transmembrane signal; (d) CD40 ligation induces activation by covalent modification of multiple previously unidentified serine/threonine-specific protein kinases.	UNIV MINNESOTA, HLTH SCI CTR, DEPT THERAPEUT RADIOL RADIAT ONCOL, CANC & LEUKEMIA BIOL SECT, MINNEAPOLIS, MN 55455 USA; UNIV MINNESOTA, HLTH SCI CTR, DEPT PEDIAT, DIV HEMATOL ONCOL BONE MARROW TRANSPLANTAT, MINNEAPOLIS, MN 55455 USA; UNIV WASHINGTON, DEPT MICROBIOL, SEATTLE, WA 98195 USA; BRISTOL MYERS SQUIBB PHARMACEUT RES INST, SEATTLE, WA 98121 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; Bristol-Myers Squibb				Uckun, Fatih M./0000-0001-9334-183X	NCI NIH HHS [R01-CA-51425] Funding Source: Medline; NIGMS NIH HHS [P01 GM-42508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM042508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; BACKER JM, 1989, J BIOL CHEM, V264, P1694; BANCHEREAU J, 1991, SCIENCE, V251, P70, DOI 10.1126/science.1702555; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BIJSTERBOSCH MK, 1985, CELL, V41, P999, DOI 10.1016/S0092-8674(85)80080-5; CAIRNS J, 1988, EUR J IMMUNOL, V18, P349, DOI 10.1002/eji.1830180305; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; CAMBIER JC, 1990, J IMMUNOL, V145, P13; CAMBIER JC, 1987, IMMUNOL REV, V95, P37, DOI 10.1111/j.1600-065X.1987.tb00499.x; CAMPBELL KS, 1990, EMBO J, V9, P441, DOI 10.1002/j.1460-2075.1990.tb08129.x; CLARK EA, 1989, ADV CANCER RES, V52, P81; CLARK EA, 1990, J IMMUNOL, V145, P1400; CLEMENT LT, 1986, J IMMUNOL, V136, P2375; COCHET C, 1984, J BIOL CHEM, V259, P2553; COGGESHALL KM, 1984, J IMMUNOL, V133, P3382; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; DEAN NM, 1989, ANAL BIOCHEM, V183, P199, DOI 10.1016/0003-2697(89)90468-5; DEFRANCO AL, 1987, ANNU REV CELL BIOL, V3, P143; DHAR A, 1990, MOL PHARMACOL, V37, P519; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; EARP HS, 1985, J BIOL CHEM, V260, P4351; EARP HS, 1984, P NATL ACAD SCI-BIOL, V81, P2347, DOI 10.1073/pnas.81.8.2347; EVANS JPM, 1990, BLOOD, V75, P88; FERRELL JE, 1989, J BIOL CHEM, V264, P20723; FRELINGER JA, 1975, SCIENCE, V188, P268, DOI 10.1126/science.1118728; GETTYS TW, 1990, RECEPTOR PHOSPHORYLA, P39; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; GORDON J, 1987, EUR J IMMUNOL, V17, P1535, DOI 10.1002/eji.1830171026; GORDON J, 1988, J IMMUNOL, V140, P1425; GRUNBERGER G, 1984, P NATL ACAD SCI-BIOL, V81, P2762, DOI 10.1073/pnas.81.9.2762; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HARRISON ML, 1984, J BIOL CHEM, V259, P9348; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; JUNE CH, 1990, P NATL ACAD SCI USA, V87, P7722, DOI 10.1073/pnas.87.19.7722; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KIM UH, 1991, J BIOL CHEM, V266, P1359; KNAPP W, 1989, IMMUNOL TODAY, V10, P253, DOI 10.1016/0167-5699(89)90135-7; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KURNICK JT, 1979, SCAND J IMMUNOL, V10, P563, DOI 10.1111/j.1365-3083.1979.tb01391.x; LANE PJL, 1990, J IMMUNOL, V144, P3684; LANE PJL, 1991, J IMMUNOL, V146, P715; LEDBETTER JA, 1988, P NATL ACAD SCI USA, V85, P1897, DOI 10.1073/pnas.85.6.1897; LEDBETTER JA, 1987, J IMMUNOL, V138, P788; LEDBETTER JA, 1991, BLOOD, V77, P1271; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MATSUDA Y, 1987, J BIOL CHEM, V262, P2832; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MORRISON DK, 1990, MOL CELL BIOL, V10, P2359, DOI 10.1128/MCB.10.5.2359; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; NAKAYAMA T, 1989, NATURE, V341, P651, DOI 10.1038/341651a0; NEL AE, 1985, J IMMUNOL, V135, P3448; NISHIBE S, 1989, J BIOL CHEM, V264, P10335; PADEH S, 1991, J CLIN INVEST, V87, P1114, DOI 10.1172/JCI115074; PATEL MD, 1987, J BIOL CHEM, V262, P5831; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SHARON M, 1989, J IMMUNOL, V143, P2530; SHAWVER LK, 1989, J BIOL CHEM, V264, P1046; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SORENSEN P, 1989, J BIOL CHEM, V264, P19253; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; UCKUN FM, 1991, P NATL ACAD SCI USA, V88, P3589, DOI 10.1073/pnas.88.9.3589; UCKUN FM, 1990, BLOOD, V76, P2449; UCKUN FM, 1988, P NATL ACAD SCI USA, V85, P8603, DOI 10.1073/pnas.85.22.8603; UCKUN FM, 1987, BLOOD, V70, P1020; UCKUN FM, 1989, J CLIN INVEST, V84, P1595, DOI 10.1172/JCI114337; UCKUN FM, 1990, BLOOD, V76, P1908; UCKUN FM, 1988, BLOOD, V71, P13; VALENTINE MA, 1989, J BIOL CHEM, V264, P11282; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	77	151	154	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17478	17485						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1716631				2022-12-27	WOS:A1991GF44500075
J	ALEXANDROPOULOS, K; JOSEPH, CK; SPANGLER, R; FOSTER, DA				ALEXANDROPOULOS, K; JOSEPH, CK; SPANGLER, R; FOSTER, DA			EVIDENCE THAT A G-PROTEIN TRANSDUCES SIGNALS INITIATED BY THE PROTEIN-TYROSINE KINASE-V-FPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PERTUSSIS TOXIN; SARCOMA-VIRUS; PLATELET PROTEIN; BINDING PROTEIN; HUMAN-MONOCYTES; PHORBOL ESTERS; TRANSFORMATION; PHOSPHORYLATION; EXPRESSION; ACTIVATION	The protein-tyrosine kinase (PTK) v-Fps induces protein kinase C (PKC)-dependent expression of the transformation-related 9E3 gene in chicken embryo fibroblasts (Spangler, R., Joseph, C., Qureshi, S. A., Berg, K., and Foster, D. A. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 7017-7021). We present evidence here that a GTP-binding protein (G-protein) is a component of this PKC-dependent signaling pathway. 1) A GTP analogue that stimulates G-protein-mediated signals induced 9E3 gene expression. 2) A GDP analogue that inhibits signaling through G-proteins inhibited expression of 9E3 and phosphorylation of a 67-kDa PKC substrate induced by v-Fps. The GDP analogue had no effect on phosphorylation of the PKC substrate or the expression of 9E3 induced by direct activation of PKC with phorbol ester. 3) Increased v-Fps PTK activity led to increased GTP binding to a 50-kDa protein. The molecular weight of this GTP-binding protein is consistent with the molecular weight of alpha-subunits of G-proteins of the heterotrimeric class. The data suggest that a G-protein functions upstream from PKC in a signaling pathway that connects v-Fps PTK activity to increased 9E3 gene expression.	CUNY HUNTER COLL,DEPT BIOL SCI,695 PK AVE,NEW YORK,NY 10021; CUNY HUNTER COLL,INST BIOMOLEC STRUCT & FUNCT,NEW YORK,NY 10021	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Hunter College (CUNY)					NATIONAL CANCER INSTITUTE [R29CA046677, R01CA046677] Funding Source: NIH RePORTER; NCI NIH HHS [CA46677] Funding Source: Medline; NCRR NIH HHS [RRO-3037-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BEDARD PA, 1987, P NATL ACAD SCI USA, V84, P6715, DOI 10.1073/pnas.84.19.6715; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURCH RM, 1987, P NATL ACAD SCI USA, V84, P6374, DOI 10.1073/pnas.84.18.6374; DRUCKER BJ, 1989, NEW ENGL J MED, V321, P1383; ERUSALIMSKY JD, 1988, J BIOL CHEM, V263, P19188; FAIN JN, 1988, FASEB J, V2, P2569, DOI 10.1096/fasebj.2.10.2838362; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GAWLER D, 1987, FEBS LETT, V216, P94, DOI 10.1016/0014-5793(87)80763-9; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOMPERTS BD, 1983, NATURE, V306, P64, DOI 10.1038/306064a0; HANAFUSA T, 1981, J VIROL, V38, P347, DOI 10.1128/JVI.38.1.347-355.1981; HURST KM, 1990, BIOCHEM J, V272, P749, DOI 10.1042/bj2720749; IMAMURA K, 1990, EMBO J, V9, P2423, DOI 10.1002/j.1460-2075.1990.tb07418.x; IMAMURA K, 1988, J BIOL CHEM, V263, P14093; JOHNSON RM, 1986, P NATL ACAD SCI USA, V83, P2032, DOI 10.1073/pnas.83.7.2032; KRUPINSKI J, 1988, J BIOL CHEM, V263, P12333; LAPETINA EG, 1987, P NATL ACAD SCI USA, V84, P2261, DOI 10.1073/pnas.84.8.2261; LUTTRELL L, 1990, J BIOL CHEM, V265, P16873; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NORTHUP JK, 1982, J BIOL CHEM, V257, P1416; QURESHI SA, 1991, MOL CELL BIOL, V11, P102, DOI 10.1128/MCB.11.1.102; SAGARA J, 1986, CANCER RES, V46, P5291; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; SPANGLER R, 1989, P NATL ACAD SCI USA, V86, P7017, DOI 10.1073/pnas.86.18.7017; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; SUGANO S, 1987, CELL, V49, P321, DOI 10.1016/0092-8674(87)90284-4; VEDIA LMMY, 1988, P NATL ACAD SCI USA, V85, P5899, DOI 10.1073/pnas.85.16.5899	29	19	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15583	15586						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714894				2022-12-27	WOS:A1991GB97700008
J	PETTITT, J; KINGSTON, IB				PETTITT, J; KINGSTON, IB			THE COMPLETE PRIMARY STRUCTURE OF A NEMATODE ALPHA-2(IV) COLLAGEN AND THE PARTIAL STRUCTURAL ORGANIZATION OF ITS GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE COLLAGEN; AMINO-ACID-SEQUENCE; SHORT-CHAIN COLLAGEN; IV COLLAGEN; CAENORHABDITIS-ELEGANS; ALPHA-1(IV) CHAIN; ASCARIS-SUUM; INVERTEBRATE COLLAGENS; EXTENSIVE HOMOLOGY; MOUSE ALPHA-1(IV)	We have isolated and characterized cDNA and genomic DNA clones which encode an alpha-2(IV) collagen chain from the parasitic nematode Ascaris suum. In addition we have determined, by nucleic acid sequence analysis, the structural organization of approximately two-thirds of the gene. This analysis has shown that the gene contains at least 15 introns, and those that have been characterized range in size from 141 to 854 base pairs. The derived protein sequence contains 1763 amino acids and includes a putative 26-amino acid signal sequence. The collagenous triple-helical region contains 17 interruptions, many of which occur in the same positions as those in the human alpha-1(IV) and alpha-2(IV) chains. Comparison of the genomic DNA sequence with the cDNA sequence has revealed the presence of a sequence within the gene which appears to be an intact and normal exon that is not represented in our cDNA sequence. The presence of this putative exon raises the possibility that the A. suum alpha-2(IV) collagen gene may undergo alternative splicing.			PETTITT, J (corresponding author), UNIV CAMBRIDGE,DEPT PATHOL,TENNIS COURT RD,CAMBRIDGE CB2 1QP,ENGLAND.			Pettitt, Jonathan/0000-0001-7988-6833	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMS E, 1978, SCIENCE, V202, P591, DOI 10.1126/science.212833; ANDERSON S, 1983, P NATL ACAD SCI USA, V80, P6839; BABEL W, 1984, EUR J BIOCHEM, V143, P545, DOI 10.1111/j.1432-1033.1984.tb08404.x; BAIRATI A, 1985, BIOL INVERTEBRATE LO, V93; BANKIER AT, 1987, METHOD ENZYMOL, V155, P51; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; BLUMBERG B, 1987, J BIOL CHEM, V262, P5947; BRAZEL D, 1987, EUR J BIOCHEM, V168, P529, DOI 10.1111/j.1432-1033.1987.tb13450.x; BRAZEL D, 1988, EUR J BIOCHEM, V172, P35, DOI 10.1111/j.1432-1033.1988.tb13852.x; COX GN, 1990, ACTA TROP, V47, P269, DOI 10.1016/0001-706X(90)90028-X; COX GN, 1989, GENE, V76, P331, DOI 10.1016/0378-1119(89)90173-X; EMMONS SW, 1988, NEMATODE CAENORHABDI, P47; EXPOSITO JY, 1990, EUR J BIOCHEM, V190, P401, DOI 10.1111/j.1432-1033.1990.tb15589.x; GUO XD, 1991, NATURE, V349, P707, DOI 10.1038/349707a0; GUO XD, 1989, J BIOL CHEM, V264, P17574; HARALSON MA, 1985, BIOCHEMISTRY-US, V24, P5792, DOI 10.1021/bi00342a016; HOSTIKKA SL, 1988, J BIOL CHEM, V263, P19488; HOSTIKKA SL, 1987, FEBS LETT, V216, P281, DOI 10.1016/0014-5793(87)80706-8; HUNG CH, 1980, J BIOL CHEM, V255, P4964; INDIK Z, 1987, P NATL ACAD SCI USA, V84, P940; KINGSTON IB, 1990, ACTA TROP, V47, P283, DOI 10.1016/0001-706X(90)90029-Y; KINGSTON IB, 1991, PARASITOL TODAY, V7, P11, DOI 10.1016/0169-4758(91)90077-2; KINGSTON IB, 1989, MOL BIOCHEM PARASIT, V37, P137, DOI 10.1016/0166-6851(89)90110-2; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; KUHN K, 1981, FEBS LETT, V125, P123, DOI 10.1016/0014-5793(81)81012-5; KUHN K, 1989, CYTOSKELETAL EXTRACE, P69; KURKINEN M, 1985, NATURE, V317, P177, DOI 10.1038/317177a0; KURKINEN M, 1987, J BIOL CHEM, V262, P8496; LANGEVELD JPM, 1988, J BIOL CHEM, V263, P10481; LUNSTRUM GP, 1988, J BIOL CHEM, V263, P18318; MORRISON KE, 1991, J BIOL CHEM, V266, P34; MURRAY LW, 1982, METHOD ENZYMOL, V82, P65; MUTHUKUMARAN G, 1989, J BIOL CHEM, V264, P6310; NISHIMURA I, 1989, J BIOL CHEM, V264, P20033; NOELKEN ME, 1986, J BIOL CHEM, V261, P4706; OUAZANA R, 1985, BIOL INVERTEBRATE A, V93, P217; PECZON BD, 1975, BIOCHEMISTRY-US, V14, P4069, DOI 10.1021/bi00689a023; PELHAM HRB, 1982, TECHNIQUES LIPID MEM, V4; PIHLAJANIEMI T, 1990, J BIOL CHEM, V265, P13758; PIHLAJANIEMI T, 1987, P NATL ACAD SCI USA, V84, P940, DOI 10.1073/pnas.84.4.940; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAKURAI Y, 1986, J BIOL CHEM, V261, P6654; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUS J, 1989, J BIOL CHEM, V264, P6318; SCHUPPAN D, 1982, EUR J BIOCHEM, V123, P505; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; SIEBOLD B, 1987, EUR J BIOCHEM, V168, P569, DOI 10.1111/j.1432-1033.1987.tb13455.x; SOININEN R, 1986, EMBO J, V5, P2821, DOI 10.1002/j.1460-2075.1986.tb04574.x; SOININEN R, 1986, P NATL ACAD SCI USA, V83, P1568, DOI 10.1073/pnas.83.6.1568; SOININEN R, 1989, J BIOL CHEM, V264, P13565; SOININEN R, 1987, FEBS LETT, V225, P188; STADEN R, 1986, NUCLEIC ACIDS RES, V14, P217, DOI 10.1093/nar/14.1.217; TIKKA L, 1988, P NATL ACAD SCI USA, V85, P7491, DOI 10.1073/pnas.85.20.7491; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; TIMPL R, 1979, FEBS LETT, V101, P265, DOI 10.1016/0014-5793(79)81022-4; TRUEB B, 1982, J BIOL CHEM, V257, P5239; VENKATESAN M, 1986, P NATL ACAD SCI USA, V83, P3351, DOI 10.1073/pnas.83.10.3351; WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x; WOOD L, 1988, FEBS LETT, V227, P5, DOI 10.1016/0014-5793(88)81402-9; YAMADA Y, 1980, CELL, V22, P887, DOI 10.1016/0092-8674(80)90565-6	61	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					16149	16156						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714907				2022-12-27	WOS:A1991GB97700093
J	MOESTRUP, SK; GLIEMANN, J				MOESTRUP, SK; GLIEMANN, J			ANALYSIS OF LIGAND RECOGNITION BY THE PURIFIED ALPHA-2-MACROGLOBULIN RECEPTOR (LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN) - EVIDENCE THAT HIGH-AFFINITY OF ALPHA-2-MACROGLOBULIN-PROTEINASE COMPLEX IS ACHIEVED BY BINDING TO ADJACENT RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL END; ALPHA-MACROGLOBULIN; MONOCLONAL-ANTIBODIES; APOLIPOPROTEIN-E; RAT PLASMA; CULTURED FIBROBLASTS; GROWTH-FACTOR; IDENTIFICATION; PURIFICATION; SITE	The molecular basis for binding of alpha-macroglobulin-proteinase complexes to the human two-chain 500/85-kDa (alpha/beta) alpha-2-macroglobulin (alpha-2M) receptor (alpha-2MR)/low density lipoprotein receptor-related protein was analyzed. Ligand blotting experiments showed that a 40-kDa protein, present in the affinity-purified alpha-2MR preparation, is bound to the alpha-2MR-alpha-chain and released by heparin. Removal of the 40-kDa protein resulted in a 3-5-fold increase in binding of alpha-2M-trypsin. Nitrocellulose-immobilized pure two-chain alpha-2MR was incubated with human alpha-2-M-trypsin, containing four identical subunits, and two monovalent ligands: rat alpha-1-inhibitor-3-chymotrypsin and the 18-kDa receptor binding fragment of the alpha-2-M subunit. Binding Of alpha-2-M-trypsin to the alpha-chain of immobilized alpha-2MR was composed of a high (K(d) = 40 pM at 4-degrees-C) and a low (K(d) = 2 nM) affinity component. Alpha-1-Inhibitor-3-chymotrypsin bound to the same sites but with one component (K(d) = 0.4 nM). Competition-inhibition experiments and dissociation experiments, using ligands with different valences, as well as experiments with alpha-2MR immobilized at different densities, led to the following model. The low (K(d) = 2 nm) affinity of alpha-2-M-proteinase is prevalent when only one of the four domains binds to alpha-2MR, i.e. when the receptor density is low or when neighboring receptors are occupied. The high (K(d) = 40 pM) affinity is achieved by binding of at least two domains to adjacent receptors.			MOESTRUP, SK (corresponding author), AARHUS UNIV,INST PHYSIOL,DK-8000 AARHUS,DENMARK.		Moestrup, Søren Kragh/AAD-1735-2019; Moestrup, Søren Kragh/A-1403-2014	Moestrup, Søren Kragh/0000-0003-3862-2107				ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BORTH W, 1990, J IMMUNOL, V145, P3747; BORTH W, 1986, IMMUNOLOGY, V57, P367; DAVIDSEN O, 1985, BIOCHIM BIOPHYS ACTA, V846, P85, DOI 10.1016/0167-4889(85)90113-2; DELAIN E, 1988, J BIOL CHEM, V263, P2981; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; DICKSON RB, 1981, FEBS LETT, V126, P265, DOI 10.1016/0014-5793(81)80257-8; DICKSON RB, 1981, J BIOL CHEM, V256, P3454; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; ENGHILD JJ, 1989, BIOCHEMISTRY-US, V28, P1406, DOI 10.1021/bi00429a069; ESNARD F, 1985, FEBS LETT, V182, P125, DOI 10.1016/0014-5793(85)81168-6; FELDMAN SR, 1983, BIOCHEM BIOPH RES CO, V114, P757, DOI 10.1016/0006-291X(83)90845-8; GERKE V, 1986, CELL, V47, P973, DOI 10.1016/0092-8674(86)90812-3; GLIEMANN J, 1987, FEBS LETT, V221, P55, DOI 10.1016/0014-5793(87)80351-4; GLIEMANN J, 1986, BIOCHIM BIOPHYS ACTA, V885, P49, DOI 10.1016/0167-4889(86)90037-6; HANOVER JA, 1983, J BIOL CHEM, V258, P370; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; IKAI A, 1990, FEBS LETT, V260, P291, DOI 10.1016/0014-5793(90)80126-4; JAMES K, 1990, IMMUNOL TODAY, V11, P163, DOI 10.1016/0167-5699(90)90067-J; JENSEN PH, 1988, PLACENTA, V9, P463, DOI 10.1016/0143-4004(88)90019-7; JENSEN PH, 1989, FEBS LETT, V255, P275, DOI 10.1016/0014-5793(89)81105-6; KAPLAN J, 1979, J BIOL CHEM, V254, P7323; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LONBERGHOLM K, 1987, J BIOL CHEM, V262, P438; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MATSUDA T, 1989, J IMMUNOL, V142, P148; MOESTRUP SK, 1990, EXP CELL RES, V190, P195, DOI 10.1016/0014-4827(90)90185-D; MOESTRUP SK, 1990, J BIOL CHEM, V265, P12623; MOESTRUP SK, 1989, J BIOL CHEM, V264, P15574; MOESTRUP SK, 1987, BIOCHIM BIOPHYS ACTA, V930, P297, DOI 10.1016/0167-4889(87)90002-4; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; PETERSEN CM, 1987, SCAND J CLIN LAB INV, V47, P55; PETERSEN CM, 1990, IMMUNOL TODAY, V11, P431; PETERSEN CM, 1981, EUR J CLIN INVEST, V756, P230; SOTTRUPJENSEN L, 1980, FEBS LETT, V121, P275, DOI 10.1016/0014-5793(80)80361-9; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; STEWARD MW, 1983, ANTIBODY AFFINITY TH, P122; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694; VANLEUVEN F, 1979, J BIOL CHEM, V254, P5155; VANLEUVEN F, 1981, J BIOL CHEM, V256, P9016; VANLEUVEN F, 1986, J BIOL CHEM, V261, P6933	49	203	207	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					14011	14017						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713212				2022-12-27	WOS:A1991FY02700087
J	KELLER, SR; KITAGAWA, K; AEBERSOLD, R; LIENHARD, GE; GARNER, CW				KELLER, SR; KITAGAWA, K; AEBERSOLD, R; LIENHARD, GE; GARNER, CW			ISOLATION AND CHARACTERIZATION OF THE 160,000-DA PHOSPHOTYROSYL PROTEIN, A PUTATIVE PARTICIPANT IN INSULIN SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GROWTH FACTOR-I; TYROSINE KINASE-ACTIVITY; 3T3-L1 ADIPOCYTES; RECEPTOR KINASE; RAT ADIPOCYTES; HEPATOMA-CELLS; PHOSPHORYLATION; SUBSTRATE; STIMULATE; COMMON	The 160,000-Da protein (pp160) which is rapidly phosphorylated on tyrosine in response to insulin and thus is a putative participant in signaling from the insulin receptor has been purified to homogeneity from 3T3-L1 adipocytes. Isolation of this protein was accomplished by chromatography on an immobilized monoclonal antibody against phosphotyrosine, followed by gel electrophoresis. Sufficient protein was obtained to allow the determination of the sequences of several peptides, which in turn enabled the development of anti-peptide antibodies that specifically recognize pp160. Immunoblotting of 3T3-L1 adipocyte lysates, together with the purified pp160 as a standard, indicate that an insulin-treated 3T3-L1 adipocyte possesses about 230,000 copies of tyrosine-phosphorylated ppl60 and that this amount is approximately 25% of the total pp160 in the cell. The number of tyrosine-phosphorylated pp160s per cell is approximately the same as that of insulin receptor beta-subunits. These results provide further evidence for a role of pp160 in insulin signaling. Moreover, the availability of purified protein and knowledge of peptide sequences will allow the elucidation of the structure and function of this protein.	TEXAS TECH UNIV,HLTH SCI CTR,DEPT BIOCHEM & MOLEC BIOL,LUBBOCK,TX 79430; DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT BIOCHEM,HANOVER,NH 03756; UNIV BRITISH COLUMBIA,CTR BIOMED RES,VANCOUVER V6T 1W5,BC,CANADA; UNIV BRITISH COLUMBIA,DEPT BIOCHEM,VANCOUVER V6T 1W5,BC,CANADA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Dartmouth College; University of British Columbia; University of British Columbia					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025336, R01DK042816, R55DK025336] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 25336, DK 42816] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BRINDLE NPJ, 1990, BIOCHEM J, V268, P615, DOI 10.1042/bj2680615; BURDETT E, 1990, AM J PHYSIOL, V258, pC99, DOI 10.1152/ajpcell.1990.258.1.C99; CHOU CK, 1987, J BIOL CHEM, V262, P1842; CONDORELLI G, 1989, J BIOL CHEM, V264, P12633; DELVECCHIO RL, 1989, BIOCHIM BIOPHYS ACTA, V986, P41, DOI 10.1016/0005-2736(89)90270-8; ENDEMANN G, 1990, J BIOL CHEM, V265, P396; FROST SC, 1985, J BIOL CHEM, V260, P2646; GIBBS EM, 1986, J BIOL CHEM, V261, P6597; IZUMI T, 1987, J BIOL CHEM, V262, P1282; KADOWAKI T, 1987, J BIOL CHEM, V262, P7342; KAHN CR, 1988, J CLIN INVEST, V82, P1152; KASUGA M, 1990, DIABETES CARE, V13, P317, DOI 10.2337/diacare.13.3.317; MADOFF DH, 1988, BIOCHEM J, V252, P7, DOI 10.1042/bj2520007; MARGOLIS RN, 1990, BIOCHEM BIOPH RES CO, V166, P562, DOI 10.1016/0006-291X(90)90845-E; MOMOMURA K, 1988, BIOCHEM BIOPH RES CO, V155, P1181, DOI 10.1016/S0006-291X(88)81264-6; MOONEY RA, 1989, ENDOCRINOLOGY, V124, P422, DOI 10.1210/endo-124-1-422; PANG DT, 1985, ARCH BIOCHEM BIOPHYS, V242, P176, DOI 10.1016/0003-9861(85)90491-6; PASQUALE EB, 1988, J CELL PHYSIOL, V137, P146, DOI 10.1002/jcp.1041370118; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; RUDERMAN NB, 1990, P NATL ACAD SCI USA, V87, P1411, DOI 10.1073/pnas.87.4.1411; SHEMER J, 1987, J BIOL CHEM, V262, P15476; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TASHIROHASHIMOTO Y, 1989, J BIOL CHEM, V264, P6879; TOBE K, 1990, DIABETES, V39, P528, DOI 10.2337/diabetes.39.5.528; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; WHITE MF, 1987, J BIOL CHEM, V262, P9769; WHITE MF, 1988, CELL, V54, P641, DOI 10.1016/S0092-8674(88)80008-4; WHITEMF, 1986, NATURE, V318, P183; WITTERS LA, 1988, BIOCHEM BIOPH RES CO, V153, P992, DOI 10.1016/S0006-291X(88)81326-3; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	34	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					12817	12820						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712770				2022-12-27	WOS:A1991FX13200003
J	YUI, Y; HATTORI, R; KOSUGA, K; EIZAWA, H; HIKI, K; KAWAI, C				YUI, Y; HATTORI, R; KOSUGA, K; EIZAWA, H; HIKI, K; KAWAI, C			PURIFICATION OF NITRIC-OXIDE SYNTHASE FROM RAT MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ARGININE; RELAXING FACTOR; SMOOTH-MUSCLE; OXIDATION; SYNTHETASE; CALMODULIN; NITRATE	Nitric oxide (NO) synthase (EC 1.14.23) has been purified to apparent homogeneity from rat macrophages. The purification procedure involves affinity chromatography with adenosine 2',5'-diphosphate-agarose and gel filtration chromatography on a Superose 12 HR 10/30 column. The apparent molecular weight is 300,000 by gel filtration. On polyacrylamide gel electrophoresis in sodium dodecyl sulfate, the enzyme migrates as a single protein band with M(r) = 150,000. The purified enzyme is colorless, and an absorption maximum is observed at 280 nm. The half-life of the enzyme activity is 6 h at pH 7.4 and 4-degrees-C. The enzyme activity required the presence of NADPH, (6R)-5,6,7,8-tetrahydro-L-biopterin, and dithiothreitol. Although the cerebellar and endothelial enzyme require Ca2+ and calmodulin, these are not required by the macrophage enzyme. The macrophage nitric oxide synthase (an inducible enzyme) seems to be different from the cerebellar and endothelial enzyme (a constitutive enzyme).	KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 3,KYOTO 606,JAPAN	Kyoto University								BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; CURRAN RD, 1989, J EXP MED, V170, P1769, DOI 10.1084/jem.170.5.1769; Hibbs J B Jr, 1986, Methods Enzymol, V132, P508; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; KOSUGA K, 1990, BIOCHEM BIOPH RES CO, V172, P705, DOI 10.1016/0006-291X(90)90731-2; KWOKN NS, 1989, J BIOL CHEM, V264, P20496; KWON NS, 1990, J BIOL CHEM, V265, P13442; MAKI Y, 1969, J BIOL CHEM, V244, P2942; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RIMELE TJ, 1988, J PHARMACOL EXP THER, V245, P102; SCHMIDT HHHW, 1991, P NATL ACAD SCI USA, V88, P365, DOI 10.1073/pnas.88.2.365; STUEHR DJ, 1990, BIOCHEM BIOPH RES CO, V168, P558, DOI 10.1016/0006-291X(90)92357-6; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; YUI Y, 1989, BIOCHEM BIOPH RES CO, V164, P544, DOI 10.1016/0006-291X(89)91753-1	16	232	237	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12544	12547						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712021				2022-12-27	WOS:A1991FV18000069
J	OLSEN, SR; UHLER, MD				OLSEN, SR; UHLER, MD			ISOLATION AND CHARACTERIZATION OF CDNA CLONES FOR AN INHIBITOR PROTEIN OF CAMP-DEPENDENT PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; LOBSTER TAIL MUSCLE; CATALYTIC SUBUNIT; GENE-EXPRESSION; DNA; PURIFICATION; CELLS; IDENTIFICATION; TRANSLATION; HOLOENZYME	Synthetic oligonucleotides were designed to amplify DNA sequences related to the heat-stable protein kinase inhibitor (PKI) isolated from rabbit skeletal muscle. Using these oligonucleotides, a 167-base pair fragment was isolated and shown to code for a portion of the mouse protein kinase inhibitor gene. This amplified DNA sequence was used to isolate three cDNA clones from a mouse brain cDNA library. A composite sequence was derived from these clones and contained a 228-nucleotide open reading frame encoding a protein of 76 amino acids. In addition, the sequence contained 29 nucleotides of 5'-untranslated and 2022 nucleotides of 3'-untranslated regions of the mouse PKI mRNA. Northern blot analysis of various mouse tissues indicated that the 3.8-kilobase pair mRNA is present at high levels in skeletal muscle and brain but is present at lower levels in heart, testis, and liver. RNase protection experiments also suggested that skeletal muscle and brain represent tissues of highest expression and that similar nucleotide sequences are found in the skeletal muscle, brain, and testicular transcripts. Southern blot analysis indicated a single prominent species of genomic DNA sequence related to the mouse PKI cDNA clones but a minor species was also detected.	UNIV MICHIGAN,MENTAL HLTH RES INST,GRAD PROGRAM CELLULAR & MOLEC BIOL,205 WASHTENAW PL,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038788, R01GM038788] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-38788] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASHBY CD, 1973, J BIOL CHEM, V248, P1255; ASHBY CD, 1972, J BIOL CHEM, V247, P6637; BEALE EG, 1977, J BIOL CHEM, V252, P6322; BEALE EG, 1977, ENDOCRINOLOGY, V101, P1621, DOI 10.1210/endo-101-5-1621; CECH TR, 1983, CELL, V34, P713, DOI 10.1016/0092-8674(83)90527-5; CHENG HC, 1985, BIOCHEM J, V231, P655, DOI 10.1042/bj2310655; CHIRGWIN J, 1979, BIOCHEMISTRY-US, V19, P5294; Davis R W, 1980, Methods Enzymol, V65, P404; DAY RN, 1989, J BIOL CHEM, V264, P431; DONNELLY TE, 1973, J BIOL CHEM, V248, P199; DONNELLY TE, 1973, J BIOL CHEM, V248, P190; FANNING TG, 1987, BIOCHIM BIOPHYS ACTA, V910, P203, DOI 10.1016/0167-4781(87)90112-6; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRAZ C, 1979, BIOCHIMIE, V61, P645, DOI 10.1016/S0300-9084(79)80162-5; GARRETT JE, 1989, MOL CELL BIOL, V9, P4381, DOI 10.1128/MCB.9.10.4381; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; GROVE JR, 1989, J BIOL CHEM, V264, P19506; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MCPHERSON JM, 1979, BIOCHEMISTRY-US, V18, P4835, DOI 10.1021/bi00589a011; OLSEN SR, 1989, J BIOL CHEM, V264, P18662; POSNER JB, 1965, J BIOL CHEM, V240, P982; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P4379, DOI 10.1073/pnas.82.13.4379; SCOTT JD, 1985, P NATL ACAD SCI USA, V82, P5732, DOI 10.1073/pnas.82.17.5732; SKALA JP, 1974, BIOCHEM J, V138, P195, DOI 10.1042/bj1380195; SZMIGIELSKI A, 1977, J BIOL CHEM, V252, P3848; TASH JS, 1981, ENDOCRINOLOGY, V108, P427, DOI 10.1210/endo-108-2-427; TURPEN T H, 1986, Biotechniques, V4, P14; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; WALSH DA, 1971, J BIOL CHEM, V246, P1977; WHITEHOUSE S, 1983, J BIOL CHEM, V258, P3682; WHITEHOUSE S, 1980, ARCH BIOCHEM BIOPHYS, V203, P734, DOI 10.1016/0003-9861(80)90233-7; ZINN K, 1983, CELL, V34, P865, DOI 10.1016/0092-8674(83)90544-5	35	60	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11158	11162						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710219				2022-12-27	WOS:A1991FQ77400071
J	CORVERA, S; JASPERS, S; PASCERI, M				CORVERA, S; JASPERS, S; PASCERI, M			ACUTE INHIBITION OF INSULIN-STIMULATED GLUCOSE-TRANSPORT BY THE PHOSPHATASE INHIBITOR, OKADAIC ACID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; PLASMA-MEMBRANE; TRANSFERRIN RECEPTORS; 3T3-L1 ADIPOCYTES; RAT ADIPOCYTES; PROTEIN; PHOSPHORYLATION; REDISTRIBUTION; TRANSLOCATION; CELL	Insulin is thought to exert its effects on cellular function through the phosphorylation or dephosphorylation of specific regulatory substrates. We have analyzed the effects of okadaic acid, a potent inhibitor of type 1 and 2A protein phosphatases, on the ability of insulin to stimulate glucose transport in rat adipocytes. Insulin and okadaic acid caused a 20-25- and a 3-6-fold increase, respectively, in the rate of 2-deoxyglucose accumulation by adipose cells. When added to cells previously treated with okadaic acid, insulin failed to stimulate 2-deoxyglucose accumulation beyond the levels observed with okadaic acid alone. Treatment of cells with okadaic acid did not inhibit the effect of insulin to stimulate tyrosine autophosphorylation of its receptor. These results indicate that okadaic acid potently inhibits the effects of insulin to stimulate glucose uptake and/or utilization at a step after receptor activation. To clarify the mechanism of inhibition by okadaic acid, the intrinsic activity of the plasma membrane glucose transporters was analyzed by measuring the rate of uptake of 3-O-methylglucose by adipose cells, and the concentration of adipocyte/skeletal muscle isoform of the glucose transporter (GLUT-4) in plasma membranes isolated from these cells. Insulin caused a 15-20-fold stimulation of 3-O-methylglucose uptake and a 2-3-fold increase in the levels of GLUT-4 detected by immunoblotting of isolated plasma membranes; okadaic acid caused a 2-fold increase in 3-O-methylglucose uptake, and a 1.5-fold increase in plasma membrane GLUT-4. Pretreatment of cells with okadaic acid blocked the effect of insulin to stimulate 3-O-methylglucose uptake and to increase the plasma membrane concentration of GLUT-4 beyond the levels observed with okadaic acid alone. These results indicate that the effect of okadaic acid to inhibit the effect of insulin on glucose uptake is exerted at a step prior to the recruitment of glucose transporters to the cell surface, and suggest that a phosphatase activity may be critical for this process.	UNIV MASSACHUSETTS,SCH MED,DEPT CELL BIOL,WORCESTER,MA 01655; UNIV MASSACHUSETTS,SCH MED,DEPT BIOCHEM & MOLEC BIOL,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	CORVERA, S (corresponding author), UNIV MASSACHUSETTS,SCH MED,PROGRAM MOLEC MED,WORCESTER,MA 01655, USA.				NIDDK NIH HHS [DK-40330] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040330] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; BOLLAG GE, 1986, P NATL ACAD SCI USA, V83, P5822, DOI 10.1073/pnas.83.16.5822; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; CORVERA S, 1990, J BIOL CHEM, V265, P2413; CORVERA S, 1989, J BIOL CHEM, V264, P10133; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DAVIS RJ, 1986, J BIOL CHEM, V261, P8708; HAAVIK J, 1989, FEBS LETT, V251, P36, DOI 10.1016/0014-5793(89)81424-3; HAYSTEAD TAJ, 1990, EUR J BIOCHEM, V187, P199, DOI 10.1111/j.1432-1033.1990.tb15295.x; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; MCKEEL DW, 1970, J CELL BIOL, V44, P417, DOI 10.1083/jcb.44.2.417; OKA Y, 1986, J BIOL CHEM, V261, P9090; RODBELL M, 1964, J BIOL CHEM, V239, P375; SAKAI R, 1989, P NATL ACAD SCI USA, V86, P9946, DOI 10.1073/pnas.86.24.9946; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TANNER LI, 1987, J BIOL CHEM, V262, P8975	20	56	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					9271	9275						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709166				2022-12-27	WOS:A1991FM03800091
J	RUFFJAMISON, S; CAMPOSGONZALEZ, R; GLENNEY, JR				RUFFJAMISON, S; CAMPOSGONZALEZ, R; GLENNEY, JR			HEAVY AND LIGHT CHAIN VARIABLE REGION SEQUENCES AND ANTIBODY PROPERTIES OF ANTI-PHOSPHOTYROSINE ANTIBODIES REVEAL BOTH COMMON AND DISTINCT FEATURES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; ROUS-SARCOMA VIRUS; CONTAINING PROTEINS; AFFINITY-CHROMATOGRAPHY; MONOCLONAL-ANTIBODIES; TRANSFORMED CELLS; TYROSINE KINASES; IMMUNOGLOBULIN; PHOSPHORYLATION; RECEPTOR	Phosphotyrosine and similar analogs have been used to elicit antibodies that have found widespread use in the study of cellular tyrosine phosphorylation. In order to better understand the anti-phosphotyrosine immune response and to elucidate the details of the specific association between a tyrosine phosphate and an antibody combining site, we have undertaken a detailed comparison of antibody stability, specificity, apparent affinity, and primary structure for eight different antiphosphotyrosine antibodies derived from immunizations with three different antigens. Two of these, 2G8 and 1G2, were derived from an immunization using azobenzylphosphonate conjugated to carrier, and five others, Py2, Py20, Py42, Py54, and Py69, were the products of an immunization with phosphotyrosine conjugated to carrier. Each of these anti-hapten antibodies was an IgG. One antibody, 129, an IgM, was the result of an immunization with a mixture of tyrosine-phosphorylated proteins which had been purified from growth factor treated cells. We found that antibody binding was significantly inhibited by millimolar levels of divalent cations or high concentrations of monovalent salt, with the exception of the antibody 129 where binding was significantly enhanced by both. Under optimal conditions, the highest apparent affinities for phosphotyrosine were observed for antibodies Py69 and Py20 (10(-6)-10(-7) M) and the lowest for 129 and 1G2 (10(-3)-10(-4). The heavy and light chain variable regions of seven of these antibodies were cloned and sequenced and a predominant anti-phosphotyrosine response was observed. The light chains of these antibodies could be assigned to one of two major VK groups, VK10 and VK19, with sequence identity between the different light chains of each class ranging from 65 to 100% at the amino acid level. Similar sequence identity was found among the heavy chain sequences (89-98% identity at the amino acid level) with the exception of one antibody, 2G8, which was only distantly related to the others (61-64% amino acid identity). These heavy chains belong to the same heavy chain family, J558. Two of the antibodies, Py20 and Py69, were clearly derived from the same progenitor cell since both share a highly unusual apparent V-D-D-JH organization. However, a significant level of somatic mutation has occurred between the two antibodies resulting in subtle changes in their apparent affinity and specificity.	UNIV KENTUCKY,COLL MED,DEPT BIOCHEM,LUCILLE P MARKEY CANC CTR,LEXINGTON,KY 40536	University of Kentucky								ALKOLKAR PN, 1987, J IMMUNOL, V138, P4472; BRODEUR PH, 1984, EUR J IMMUNOL, V14, P922, DOI 10.1002/eji.1830141012; CABILLY S, 1985, GENE, V40, P157, DOI 10.1016/0378-1119(85)90037-X; CAMPOSGONZALEZ R, 1991, IN PRESS GROWTH FACT; CHAING YL, 1989, BIOTECHNIQUES, V7, P360; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOTHIA C, 1987, J MOL BIOL, V196, P910; COMOGLIO PM, 1984, EMBO J, V3, P483, DOI 10.1002/j.1460-2075.1984.tb01834.x; COOPER JA, 1983, CURR TOP MICROBIOL, V107, P125; COOPER JA, 1981, MOL CELL BIOL, V1, P394, DOI 10.1128/MCB.1.5.394; DECLUE JE, 1987, MOL CELL BIOL, V7, P371, DOI 10.1128/MCB.7.1.371; FRACKELTON AR, 1983, MOL CELL BIOL, V3, P1343, DOI 10.1128/MCB.3.8.1343; GLENNEY JR, 1988, J IMMUNOL METHODS, V109, P277, DOI 10.1016/0022-1759(88)90253-0; HAMLYN PH, 1981, NUCLEIC ACIDS RES, V9, P4485, DOI 10.1093/nar/9.18.4485; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; IVERSON BL, 1990, SCIENCE, V249, P659, DOI 10.1126/science.2116666; KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201; LEAHY DJ, 1988, P NATL ACAD SCI USA, V85, P3661, DOI 10.1073/pnas.85.11.3661; MEEK KD, 1989, J EXP MED, V170, P39, DOI 10.1084/jem.170.1.39; OGAWA R, 1988, JPN J CANCER RES, V79, P297, DOI 10.1111/j.1349-7006.1988.tb01589.x; OHTSUKA M, 1984, INT J CANCER, V34, P855, DOI 10.1002/ijc.2910340618; PANG DT, 1985, ARCH BIOCHEM BIOPHYS, V242, P176, DOI 10.1016/0003-9861(85)90491-6; PASQUALE EB, 1986, P NATL ACAD SCI USA, V83, P5507, DOI 10.1073/pnas.83.15.5507; POTTER M, 1982, MOL IMMUNOL, V19, P1619, DOI 10.1016/0161-5890(82)90273-5; ROSS AH, 1981, NATURE, V294, P654, DOI 10.1038/294654a0; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; SCHIFF C, 1975, EUR J BIOCHEM, V59, P525, DOI 10.1111/j.1432-1033.1975.tb02479.x; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; SENGUPTA A, 1988, P NATL ACAD SCI USA, V85, P8062, DOI 10.1073/pnas.85.21.8062; SIEGELMAN M, 1981, P NATL ACAD SCI-BIOL, V78, P7679, DOI 10.1073/pnas.78.12.7679; STROHAL R, 1987, NUCLEIC ACIDS RES, V15, P2771, DOI 10.1093/nar/15.6.2771; SUN LK, 1987, P NATL ACAD SCI USA, V84, P214, DOI 10.1073/pnas.84.1.214; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; WANG JYJ, 1985, MOL CELL BIOL, V5, P3640, DOI 10.1128/MCB.5.12.3640; WANG JYJ, 1988, ANAL BIOCHEM, V172, P1, DOI 10.1016/0003-2697(88)90403-4; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZIPPEL R, 1986, BIOCHIM BIOPHYS ACTA, V881, P54, DOI 10.1016/0304-4165(86)90096-6	39	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6607	6613						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706720				2022-12-27	WOS:A1991FE37300089
J	STUEHR, DJ; KWON, NS; NATHAN, CF; GRIFFITH, OW; FELDMAN, PL; WISEMAN, J				STUEHR, DJ; KWON, NS; NATHAN, CF; GRIFFITH, OW; FELDMAN, PL; WISEMAN, J			N-OMEGA-HYDROXY-L-ARGININE IS AN INTERMEDIATE IN THE BIOSYNTHESIS OF NITRIC-OXIDE FROM L-ARGININE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; NITROGEN-OXIDES; MACROPHAGE OXIDATION; MURINE MACROPHAGES; RELAXING FACTOR; NITRATE; ACTIVATION; CYTOKINES; COFACTOR; RELEASE	Authentic N-omega-hydroxy-L-arginine was synthesized and used to determine whether it is an intermediate in nitric oxide (.NO) synthesis from L-arginine by macrophage .NO synthase. The apparent K(m) (6.6-mu-M) and V(max) (99 nmol x min-1 x mg-1) observed with N-omega-hydroxy-L-arginine were similar to those observed with L-arginine (K(m) = 2.3-mu-M; V(max) = 54-mu-mol x min-1 x mg-1). N-omega-Hydroxy-D-arginine was not a substrate. Stable isotope studies showed that .NO synthase exclusively oxidized the hydroxylated nitrogen of N-omega-hydroxy-L-arginine, forming .NO and L-citrulline. As with L-arginine, O2 was the source of the ureido oxygen in L-citrulline from N-omega-hydroxy-L-arginine. In the presence of excess N-omega-hydroxy-L-arginine, .NO synthase generated a metabolite of L-[C-14]arginine that cochromatographed with authentic N-omega-hydroxy-L-arginine. The labeled metabolite exhibited identical chromatographic behavior in three solvent systems and generated the same product (L-citrulline) upon alkaline hydrolysis as authentic N-omega-hydroxy-L-arginine. Experiments were then run to identify which redox cofactor (NADPH or tetrahydrobiopterin) participated in the enzymatic synthesis of N-omega-hydroxy-L-arginine. Both cofactors were required for synthesis of .NO from either N-omega-hydroxy-L-arginine or L-arginine. However, with L-arginine, the synthesis of 1 mol of .NO was coupled to the oxidation of 1.52 +/- 0.02 mol of NADPH; whereas with N-omega-hydroxy-L-arginine, only 0.53 +/- 0.04 mol of NADPH was oxidized per mol of .NO formed. These results support a mechanism in which N-omega-hydroxy-L-arginine is generated as an intermediate in .NO synthesis through an NADPH-dependent hydroxylation of L-arginine.	CORNELL UNIV, MED CTR,COLL MED,DEPT MED,DIV HEMATOL ONCOL, BEATRICE & SAMUEL A SEAVER LAB, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA; GLAXO RES INST, DEPT MED CHEM, RES TRIANGLE PK, NC 27709 USA; GLAXO RES INST, DEPT BIOCHEM, RES TRIANGLE PK, NC 27709 USA	Cornell University; Cornell University; GlaxoSmithKline; GlaxoSmithKline					NATIONAL CANCER INSTITUTE [R01CA043610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037116] Funding Source: NIH RePORTER; NCI NIH HHS [CA43610] Funding Source: Medline; NIDDK NIH HHS [DK37116] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMBER IJ, 1988, J LEUKOCYTE BIOL, V44, P58, DOI 10.1002/jlb.44.1.58; BILLIAR TR, 1990, BIOCHEM BIOPH RES CO, V168, P1034, DOI 10.1016/0006-291X(90)91133-D; BILLIAR TR, 1989, J EXP MED, V169, P1467, DOI 10.1084/jem.169.4.1467; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BUBLITZ C, 1977, BIOCHEM MED METAB B, V17, P13, DOI 10.1016/0006-2944(77)90004-7; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; COLLETTE J, 1956, J AM CHEM SOC, V78, P3819, DOI 10.1021/ja01596a070; CRAINE JE, 1972, J BIOL CHEM, V247, P6082; CURRAN RD, 1989, J EXP MED, V170, P1769, DOI 10.1084/jem.170.5.1769; DING AH, 1988, J IMMUNOL, V141, P2407; FEELISCH M, 1987, EUR J PHARMACOL, V139, P19, DOI 10.1016/0014-2999(87)90493-6; FELDMAN PL, 1991, TETRAHEDRON LETT, V32, P875, DOI 10.1016/S0040-4039(00)92109-9; FUKUTO JM, 1990, BIOCHEM BIOPH RES CO, V168, P458, DOI 10.1016/0006-291X(90)92343-X; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GILAV E, 1980, J AM CHEM SOC, V102, P5115, DOI 10.1021/ja00535a059; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; GROSS SS, 1990, BIOCHEM BIOPH RES CO, V170, P96, DOI 10.1016/0006-291X(90)91245-N; HAUSCHILDT S, 1990, BIOCHEM J, V270, P351, DOI 10.1042/bj2700351; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; HIBBS JB, 1990, INT CONGR SER, V897, P189; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; IYENGAR R, 1987, P NATL ACAD SCI USA, V84, P6369, DOI 10.1073/pnas.84.18.6369; KAUFMAN S, 1959, J BIOL CHEM, V234, P2677; KELM M, 1988, BIOCHEM BIOPH RES CO, V154, P236, DOI 10.1016/0006-291X(88)90675-4; KILBOURN RG, 1990, J NATL CANCER I, V82, P772, DOI 10.1093/jnci/82.9.772; KNOWLES RG, 1990, BIOCHEM J, V269, P207, DOI 10.1042/bj2690207; KWON NS, 1989, J BIOL CHEM, V264, P20496; KWON NS, 1990, J BIOL CHEM, V265, P13442; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; MAYER B, 1989, BIOCHEM BIOPH RES CO, V164, P678, DOI 10.1016/0006-291X(89)91513-1; NATHAN CF, 1991, IN PRESS CURR OPINIO; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P5193, DOI 10.1073/pnas.87.13.5193; SCHMIDT HHHW, 1989, BIOCHEM BIOPH RES CO, V165, P284, DOI 10.1016/0006-291X(89)91067-X; SCHMIDT HHHW, 1991, P NATL ACAD SCI USA, V88, P365, DOI 10.1073/pnas.88.2.365; SCHMIDT HHHW, 1988, EUR J PHARMACOL, V154, P213, DOI 10.1016/0014-2999(88)90101-X; STUEHR DJ, 1990, BIOCHEM BIOPH RES CO, V168, P558, DOI 10.1016/0006-291X(90)92357-6; STUEHR DJ, 1987, J IMMUNOL, V139, P518; STUEHR DJ, 1991, FASEB J, V5, P98, DOI 10.1096/fasebj.5.1.1703974; STUEHR DJ, 1991, IN PRESS ADV ENZYMOL; TAYEH MA, 1989, J BIOL CHEM, V264, P19654	43	526	548	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6259	6263						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706713				2022-12-27	WOS:A1991FE37300041
J	TRUNEH, A; BUCK, D; CASSATT, DR; JUSZCZAK, R; KASSIS, S; RYU, SE; HEALEY, D; SWEET, R; SATTENTAU, Q				TRUNEH, A; BUCK, D; CASSATT, DR; JUSZCZAK, R; KASSIS, S; RYU, SE; HEALEY, D; SWEET, R; SATTENTAU, Q			A REGION IN DOMAIN-1 OF CD4 DISTINCT FROM THE PRIMARY GP120 BINDING-SITE IS INVOLVED IN HIV-INFECTION AND VIRUS-MEDIATED FUSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; RETROVIRUS HTLV-III/LAV; T4 MOLECULE; SOLUBLE CD4; MONOCLONAL-ANTIBODIES; ANTIGEN; EXPRESSION; PROTEIN; RECEPTOR; SEQUENCES	The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 resides within the amino-terminal domain (D1) of CD4. Mutational and antibody epitope analyses have implicated the region encompassing residues 40-60 in D1 as the primary binding site for gp120. Outside of this region, a single residue substitution at position 87 abrogates syncytium formation without affecting gp120 binding. We describe two groups of CD4 monoclonal antibodies (mAbs) which recognize distinct epitopes associated with these regions in D1. These mAbs distinguish between the gp120 binding event and virus infection and virus-induced cell fusion. One cluster of mAbs, which bind at or near the high affinity gp120 binding site, blocked gp120 binding to CD4 and, as expected, also blocked HIV infection of CD4+ cells and virus-induced syncytium formation. A second cluster of mAbs, which recognize the CDR-3 like loop, did not block gp120 binding as demonstrated by their ability to form ternary complexes with CD4 and gp120. Yet, these mAbs strongly inhibited HIV infection of CD4+ cells and HIV-envelope/CD4-mediated syncytium formation. The structure of D1 has recently been solved at atomic resolution and in its general features resembles IgV-kappa regions as predicted from sequence homology and mAb epitopes. In the D1 structure, the regions recognized by these two groups of antibodies correspond to the C'C" (Ig CDR2) and FG (Ig CDR3) hairpin loops, respectively, which are solvent-exposed-beta turns protruding in two different directions on a face of D1 distal to the D2 domain. This face is straddled by the longer BC (Ig CDR1) loop which bisects the plain formed by C'C" and FG. This structure is consistent with C'C" and FG forming two distinct epitope clusters within D1. We conclude that the initial interaction between gp120 and CD4 is not sufficient for HIV infection and syncytium formation and that CD4 plays a critical role in the subsequent virus-cell and cell-cell membrane fusion events. We propose that the initial binding of CD4 to gp120 induces conformational changes in gp120 leading to subsequent interactions of the FG loop with other regions in gp120 or with the fusogenic gp41 portion of the envelope gp160 glycoprotein.	SMITHKLINE BEECHAM PHARMACEUT,DEPT MOLEC GENET,KING OF PRUSSIA,PA 19406; BECTON DICKINSON MONOCLONAL CTR INC,SAN JOSE,CA 95131; COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,HOWARD HUGHES MED INST,NEW YORK,NY 10032; UNIV COLL & MIDDLESEX SCH MED,ACAD DEPT GENITOURINARY MED,RETROVIRAL IMMUNOL GRP,LONDON SW1,ENGLAND	GlaxoSmithKline; Becton Dickinson; Columbia University; Columbia University; Howard Hughes Medical Institute; University of London; University College London	TRUNEH, A (corresponding author), SMITHKLINE BEECHAM PHARMACEUT,DEPT CELL SCI,709 SWEDELAND RD,KING OF PRUSSIA,PA 19406, USA.		Truneh, Alem/ABB-7891-2020	Cassatt, David/0000-0002-1742-864X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI026462] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 26462] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; ASHKENAZI A, 1990, P NATL ACAD SCI USA, V87, P7150, DOI 10.1073/pnas.87.18.7150; BRODSKY MH, 1990, J IMMUNOL, V144, P3078; CAMERINI D, 1990, CELL, V60, P747, DOI 10.1016/0092-8674(90)90089-W; CLARK SJ, 1987, P NATL ACAD SCI USA, V84, P1649, DOI 10.1073/pnas.84.6.1649; CLAYTON LK, 1988, NATURE, V335, P363, DOI 10.1038/335363a0; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; EIDEN LE, 1990, ANN M LABORATORY TUM; Estess P, 1990, CURRENT RES PROTEIN, P499; FISHER RA, 1988, NATURE, V331, P76, DOI 10.1038/331076a0; GAY D, 1987, NATURE, V328, P626, DOI 10.1038/328626a0; GILMOUR JEM, 1989, AIDS, V3, P717, DOI 10.1097/00002030-198911000-00005; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; KIRSH R, 1990, AIDS RES HUM RETROV, V6, P1209, DOI 10.1089/aid.1990.6.1209; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; LIFSON JD, 1988, SCIENCE, V241, P712, DOI 10.1126/science.2969619; MADDON PJ, 1987, P NATL ACAD SCI USA, V84, P9155, DOI 10.1073/pnas.84.24.9155; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; MCDOUGAL JS, 1986, J IMMUNOL, V137, P2937; MCDOUGAL JS, 1985, J IMMUNOL, V135, P3151; MIZUKAMI T, 1988, P NATL ACAD SCI USA, V85, P9273, DOI 10.1073/pnas.85.23.9273; MOORE JP, 1990, AIDS, V4, P297, DOI 10.1097/00002030-199004000-00003; MOORE JP, 1990, SCIENCE, V250, P1139, DOI 10.1126/science.2251501; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; SATTENTAU QJ, 1989, J EXP MED, V170, P1319, DOI 10.1084/jem.170.4.1319; SATTENTAU QJ, 1986, SCIENCE, V234, P1120, DOI 10.1126/science.2430333; SLECKMAN BP, 1987, NATURE, V328, P351, DOI 10.1038/328351a0; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; SPENCE RP, 1989, J GEN VIROL, V70, P2853, DOI 10.1099/0022-1317-70-11-2853; TRAUNECKER A, 1988, NATURE, V331, P84, DOI 10.1038/331084a0	35	86	91	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5942	5948						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706342				2022-12-27	WOS:A1991FD37000091
J	CHIKIRA, M; SATO, T; ANTHOLINE, WE; PETERING, DH				CHIKIRA, M; SATO, T; ANTHOLINE, WE; PETERING, DH			ORIENTATION OF NON-BLUE CUPRIC COMPLEXES ON DNA FIBERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-SPIN-RESONANCE; BLEOMYCIN; BINDING; COPPER; CONFORMATION; DESIGN; OXYGEN; SITE; IRON; ION	Three different orientations of non-blue, type 2 cupric complexes on DNA fibers are obtained from EPR data. The cupric complex of bleomycin, CuBlm, binds as described previously (Shields, H., McGlumphy, C., and Hamrick, P. J., Jr. (1982) Biochim. Biophys. Acta 697, 113-120), except possibly with more restricted motion. The square plane of CuBlm makes an angle of about 65-degrees with the fiber axis. The tridentate complex 2-formylpyridine monothiosemicarbazonato Cu2+ binds with its planar structure perpendicular to the fiber axis. In contrast, other tridentate cupric complexes of tripeptides, CuGHK and CuGHG, bind with the square plane parallel to the fiber axis. The bound forms of Cu(GHK) and Cu(GHG) are determined mostly by the GH moiety in the complex; the contribution of lysine in defining the orientation of the copper moiety is minimal. Thus, the structure of the ligand determines the orientation of these complexes on DNA.	MED COLL WISCONSIN,NATL BIOMED ELECTRON SPIN RESONANCE CTR,MILWAUKEE,WI 53226; MED COLL WISCONSIN,DEPT RADIAT BIOL & BIOPHYS,MILWAUKEE,WI 53226; UNIV WISCONSIN,DEPT CHEM,MILWAUKEE,WI 53201; CHUO UNIV,FAC SCI & ENGN,DEPT APPL CHEM,TOKYO 112,JAPAN	Medical College of Wisconsin; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Milwaukee; Chuo University			Chikira, Makoto/C-6199-2011		NATIONAL CANCER INSTITUTE [R01CA022184] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001008] Funding Source: NIH RePORTER; NCI NIH HHS [CA-22184] Funding Source: Medline; NCRR NIH HHS [RR-01008] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANTHOLINE WE, 1984, J BIOL CHEM, V259, P4437; ANTHOLINE WE, 1979, BIOCHEM BIOPH RES CO, V91, P528, DOI 10.1016/0006-291X(79)91554-7; ANTHOLINE WE, 1975, J MED CHEM, V19, P339; AUST S D, 1985, Journal of Free Radicals in Biology and Medicine, V1, P3, DOI 10.1016/0748-5514(85)90025-X; BURGER RM, 1981, J BIOL CHEM, V256, P1636; CHIKIRA M, 1989, J BIOL CHEM, V264, P21478; DABROWIAK JC, 1978, BIOCHIM BIOPHYS ACTA, V517, P517, DOI 10.1016/0005-2787(78)90218-6; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; Dickerson R. E., 1986, MECHANISMS DNA DAMAG, P245; FRONCISZ W, 1982, J MAGN RESON, V47, P515, DOI 10.1016/0022-2364(82)90221-9; IITAKA Y, 1978, J ANTIBIOT, V31, P1070, DOI 10.7164/antibiotics.31.1070; LEVY MJ, 1988, BIOCHEMISTRY-US, V27, P2647, DOI 10.1021/bi00408a002; MACK DP, 1988, J AM CHEM SOC, V110, P7572, DOI 10.1021/ja00230a067; MARTIN RB, 1987, MET IONS BIOL SYST, V21, P57; PICKART L, 1980, J CELL PHYSIOL, V102, P129, DOI 10.1002/jcp.1041020205; SEALY RC, 1985, MODERN PHYSICAL METH, P109; SHIELDS H, 1982, BIOCHIM BIOPHYS ACTA, V697, P113, DOI 10.1016/0167-4781(82)90051-3; SHIELDS H, 1984, BIOCHIM BIOPHYS ACTA, V800, P277, DOI 10.1016/0304-4165(84)90406-9; SHINAR E, 1983, J BIOL CHEM, V258, P4778; SHINDO H, 1980, BIOCHEMISTRY-US, V19, P518, DOI 10.1021/bi00544a020; SOLAIMAN D, 1980, J INORG BIOCHEM, V12, P201, DOI 10.1016/S0162-0134(00)80202-0; SUGIURA Y, 1980, J AM CHEM SOC, V102, P5216, DOI 10.1021/ja00536a016; SUGIURA Y, 1979, J INORG BIOCHEM, V11, P171, DOI 10.1016/S0162-0134(00)80181-6; YAMAMOTO K, 1989, J BIOL CHEM, V264, P15435	24	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2859	2863						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704368				2022-12-27	WOS:A1991EX60000032
J	PARKER, WB; WHITE, EL; SHADDIX, SC; ROSS, LJ; BUCKHEIT, RW; GERMANY, JM; SECRIST, JA; VINCE, R; SHANNON, WM				PARKER, WB; WHITE, EL; SHADDIX, SC; ROSS, LJ; BUCKHEIT, RW; GERMANY, JM; SECRIST, JA; VINCE, R; SHANNON, WM			MECHANISM OF INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE AND HUMAN DNA POLYMERASE-ALPHA, POLYMERASE-BETA, AND POLYMERASE-GAMMA BY THE 5'-TRIPHOSPHATES OF CARBOVIR, 3'-AZIDO-3'-DEOXYTHYMIDINE, 2',3'-DIDEOXYGUANOSINE, AND 3'-DEOXYTHYMIDINE - A NOVEL RNA TEMPLATE FOR THE EVALUATION OF ANTIRETROVIRAL DRUGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR PHARMACOLOGY; INSERTION FIDELITY; MITOCHONDRIAL-DNA; INVITRO; CELLS; 2',3'-DIDEOXYCYTIDINE; TRIPHOSPHATE; ELONGATION; TOXICITY; ANALOGS	Carbovir (the carbocyclic analog of 2',3'-didehydro-2',3'-dideoxyguanosine) is a potent inhibitor of human immunodeficiency virus type 1 (HIV-1) replication. Assays were developed to assess the mechanism of inhibition by the 5'-triphosphate of carbovir of HIV-1 reverse transcriptase using either RNA or DNA templates that contain all four natural nucleotides. Carbovir-TP was a potent inhibitor of HIV-1 reverse transcriptase using either template with K(i) values similar to that observed by AZT-TP, ddGTP, and ddTTP. The kinetic constants for incorporation of these nucleotide analogs into DNA by HIV-1 reverse transcriptase using either template were similar to the values seen for their respective natural nucleotides. In addition, the incorporation of either carbovir-TP or AZT-TP in the presence of dGTP or dTTP, respectively, indicated that the mechanism of inhibition by these two nucleotide analogs was due to their incorporation into the DNA resulting in chain termination. Carbovir-TP was not a potent inhibitor of DNA polymerase alpha, beta, or gamma, or DNA primase. Given the potent activity of carbovir-TP against HIV-1 reverse transcriptase and its lack of activity against human DNA polymerases, we believe that further evaluation of this compound as a potential drug for the treatment of HIV-1 infection is warranted.	SO RES INST,KETTERING MEYER LAB,BIRMINGHAM,AL 35205; UNIV MINNESOTA,COLL PHARM,DEPT MED CHEM,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities					NATIONAL CANCER INSTITUTE [R01CA023263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029157] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA-23263] Funding Source: Medline; NIAID NIH HHS [R01 AI29157] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGARWAL RP, 1989, AIDS RES HUM RETROV, V5, P541, DOI 10.1089/aid.1989.5.541; BALZARINI J, 1988, BIOCHEM PHARMACOL, V37, P897, DOI 10.1016/0006-2952(88)90178-5; BARIL E, 1977, NUCLEIC ACIDS RES, V4, P2641, DOI 10.1093/nar/4.8.2641; BOOSALIS MS, 1989, J BIOL CHEM, V264, P11360; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; BROSIUS J, 1981, J MOL BIOL, V148, P107, DOI 10.1016/0022-2836(81)90508-8; CHEN CH, 1989, J BIOL CHEM, V264, P11934; CHEN MS, 1987, BIOCHEM PHARMACOL, V36, P4361, DOI 10.1016/0006-2952(87)90685-X; CHENG YC, 1987, J BIOL CHEM, V262, P2187; CLOYD MW, 1990, VIROLOGY, V174, P103, DOI 10.1016/0042-6822(90)90059-Z; DIXON M, 1979, ENZYMES, P345; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; HALDANE JBS, 1932, ALLGEMEINE CHEM ENZY, P119; HAO Z, 1988, MOL PHARMACOL, V34, P431; HAO Z, 1990, MOL PHARMACOL, V37, P157; HENTOSH P, 1990, J BIOL CHEM, V265, P4033; HO HT, 1989, ANTIMICROB AGENTS CH, V33, P844, DOI 10.1128/AAC.33.6.844; HUANG P, 1990, J BIOL CHEM, V265, P11914; JOHNSON MA, 1988, J BIOL CHEM, V263, P15354; KEDAR PS, 1990, BIOCHEMISTRY-US, V29, P3603, DOI 10.1021/bi00467a003; KONIG H, 1989, ANTIMICROB AGENTS CH, V33, P2109, DOI 10.1128/AAC.33.12.2109; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1990, ANTIMICROB AGENTS CH, V34, P436, DOI 10.1128/AAC.34.3.436; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; MATTHES E, 1987, BIOCHEM BIOPH RES CO, V148, P78, DOI 10.1016/0006-291X(87)91078-3; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; MITSUYA H, 1987, P NATL ACAD SCI USA, V84, P2033, DOI 10.1073/pnas.84.7.2033; OHNO Y, 1989, CANCER RES, V49, P2077; OHNO Y, 1988, CANCER RES, V48, P1494; ONO K, 1986, BIOCHEM BIOPH RES CO, V140, P498, DOI 10.1016/0006-291X(86)90760-6; ONO K, 1989, MOL PHARMACOL, V35, P578; PARKER WB, 1988, MOL PHARMACOL, V34, P485; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; REID R, 1988, J BIOL CHEM, V263, P3398; RICCHETTI M, 1990, EMBO J, V9, P1583, DOI 10.1002/j.1460-2075.1990.tb08278.x; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; ROOKE R, 1989, AIDS, V3, P411, DOI 10.1097/00002030-198907000-00001; ROSE LM, 1990, P AM ASSOC CANC RES, V31, P2270; SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1; SOMMADOSSI JP, 1988, ANTIMICROB AGENTS CH, V32, P997, DOI 10.1128/AAC.32.7.997; SOMMADOSSI JP, 1989, MOL PHARMACOL, V36, P9; STARNES MC, 1987, J BIOL CHEM, V262, P988; STCLAIR MH, 1987, ANTIMICROB AGENTS CH, V31, P1972, DOI 10.1128/AAC.31.12.1972; TOWNSEND AJ, 1987, MOL PHARMACOL, V32, P330; VAZQUESPADUA MA, 1989, P AM ASSOC CANC RES, V30, P2386; VINCE R, 1990, BIOCHEM BIOPH RES CO, V168, P912, DOI 10.1016/0006-291X(90)91115-9; VINCE R, 1988, BIOCHEM BIOPH RES CO, V156, P1046, DOI 10.1016/S0006-291X(88)80950-1; WHITE EL, 1989, BIOCHEM BIOPH RES CO, V161, P393, DOI 10.1016/0006-291X(89)92611-9; WHITE EL, 1982, CANCER RES, V42, P2260; YAGURA T, 1983, J BIOCHEM-TOKYO, V91, P607; YONG WH, 1990, AIDS, V4, P199, DOI 10.1097/00002030-199003000-00004	54	148	156	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1754	1762						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703154				2022-12-27	WOS:A1991EU49700063
J	ANDERSEN, B; KENNEDY, GC; NILSON, JH				ANDERSEN, B; KENNEDY, GC; NILSON, JH			A CIS-ACTING ELEMENT LOCATED BETWEEN THE CAMP RESPONSE ELEMENTS AND CCAAT BOX AUGMENTS CELL-SPECIFIC EXPRESSION OF THE GLYCOPROTEIN HORMONE ALPHA-SUBUNIT GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CASE WESTERN RESERVE UNIV,DEPT PHARMACOL,CLEVELAND,OH 44106; CLEVELAND METROPOLITAN GEN HOSP,CLEVELAND,OH 44109; CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106	Case Western Reserve University; MetroHealth System; Case Western Reserve University					NCI NIH HHS [P30-CA-43703] Funding Source: Medline; NIDDK NIH HHS [DK-28559] Funding Source: Medline; PHS HHS [WO-4162] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028559] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN B, 1990, MOL ENDOCRINOL, V4, P573, DOI 10.1210/mend-4-4-573; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BOKAR JA, 1988, J BIOL CHEM, V263, P19740; BOKAR JA, 1989, MOL CELL BIOL, V9, P5113, DOI 10.1128/MCB.9.11.5113; BURNSIDE J, 1988, GENE, V70, P67, DOI 10.1016/0378-1119(88)90105-9; CHODOSH LA, 1987, CURRENT PTOTOCOLS MO, V2; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DEUTSCH PJ, 1987, J BIOL CHEM, V262, P12169; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORDON DF, 1988, DNA-J MOLEC CELL BIO, V7, P679, DOI 10.1089/dna.1988.7.679; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; JAMESON JL, 1989, J BIOL CHEM, V264, P16190; JAMESON JL, 1988, J BIOL CHEM, V263, P9879; JAMESON JL, 1989, MOL ENDOCRINOL, V3, P763, DOI 10.1210/mend-3-5-763; KENNEDY GC, 1990, J BIOL CHEM, V265, P6279; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; MUELLER PR, 1989, SCIENCE, V246, P780, DOI 10.1126/science.2814500; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; SCHAFFNER W, 1989, TRENDS GENET, V5, P37, DOI 10.1016/0168-9525(89)90017-6; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	25	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21874	21880						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1701437				2022-12-27	WOS:A1990EM45600076
J	ALCIVAR, AA; HAKE, LE; HARDY, MP; HECHT, NB				ALCIVAR, AA; HAKE, LE; HARDY, MP; HECHT, NB			INCREASED LEVELS OF JUNB AND C-JUN MESSENGER-RNAS IN MALE GERM-CELLS FOLLOWING TESTICULAR CELL-DISSOCIATION - MAXIMAL STIMULATION IN PREPUBERAL ANIMALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TUFTS UNIV,DEPT BIOL,MEDFORD,MA 02155; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DIV REPROD BIOL,BALTIMORE,MD 21205	Tufts University; Johns Hopkins University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD011878] Funding Source: NIH RePORTER; NICHD NIH HHS [HD11878] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALCIVAR AA, 1989, DEV BIOL, V135, P263, DOI 10.1016/0012-1606(89)90178-4; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; BERNSTEIN P, 1989, TRENDS BIOCHEM SCI, V14, P373, DOI 10.1016/0968-0004(89)90011-X; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BISHOP JM, 1983, ANNU REV BIOCHEM, V52, P301, DOI 10.1146/annurev.bi.52.070183.001505; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; FUJIMOTO H, 1988, Molecular Reproduction and Development, V1, P27, DOI 10.1002/mrd.1080010106; HAKE LE, 1990, DEVELOPMENT, V110, P249; HATTORI K, 1988, P NATL ACAD SCI USA, V85, P9148, DOI 10.1073/pnas.85.23.9148; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; KLEENE KC, 1989, DEVELOPMENT, V106, P367; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LI L, 1990, J BIOL CHEM, V265, P1556; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MAKINO R, 1984, NATURE, V310, P697, DOI 10.1038/310697a0; MEIJER D, 1987, EMBO J, V6, P4041, DOI 10.1002/j.1460-2075.1987.tb02749.x; Meistrich M L, 1977, Methods Cell Biol, V15, P15, DOI 10.1016/S0091-679X(08)60207-1; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NISHIMURA T, 1988, ONCOGENE, V3, P659; OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200; PONZETTO C, 1985, MOL CELL BIOL, V5, P1791, DOI 10.1128/MCB.5.7.1791; PONZETTO C, 1989, SERONO S PUBL, V53, P251; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; PROPST F, 1988, ONCOGENE, V2, P227; PROPST F, 1988, TRENDS GENET, V4, P183, DOI 10.1016/0168-9525(88)90073-X; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYDER K, 1989, P NATL ACAD SCI USA, V86, P1500, DOI 10.1073/pnas.86.5.1500; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SHACKLEFORD GM, 1987, CELL, V50, P89, DOI 10.1016/0092-8674(87)90665-9; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHERMAN L, 1984, NUCLEIC ACIDS RES, V12, P9349, DOI 10.1093/nar/12.24.9349; SORRENTINO V, 1988, P NATL ACAD SCI USA, V85, P2191, DOI 10.1073/pnas.85.7.2191; STEWART TA, 1984, SCIENCE, V226, P707, DOI 10.1126/science.6494906; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; WOLFES H, 1989, SCIENCE, V245, P740, DOI 10.1126/science.2475907; XANTHOPOULOS KG, 1989, P NATL ACAD SCI USA, V86, P4117, DOI 10.1073/pnas.86.11.4117	43	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20160	20165						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700782				2022-12-27	WOS:A1990EJ52500022
J	CORNELIUS, P; MARLOWE, M; LEE, MD; PEKALA, PH				CORNELIUS, P; MARLOWE, M; LEE, MD; PEKALA, PH			THE GROWTH FACTOR-LIKE EFFECTS OF TUMOR-NECROSIS-FACTOR-ALPHA - STIMULATION OF GLUCOSE-TRANSPORT ACTIVITY AND INDUCTION OF GLUCOSE TRANSPORTER AND IMMEDIATE EARLY GENE-EXPRESSION IN 3T3-L1 PREADIPOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									E CAROLINA UNIV,SCH MED,DEPT BIOCHEM,GREENVILLE,NC 27858	University of North Carolina; East Carolina University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032892] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32892] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ASANO T, 1989, J BIOL CHEM, V264, P3416; AUSTGULEN R, 1988, SCAND J IMMUNOL, V26, P621; BALY DL, 1987, J BIOL CHEM, V262, P21; BALY DL, 1988, BIOCHIM BIOPHYS ACTA, V947, P571, DOI 10.1016/0304-4157(88)90008-1; Bergmeyer H, 1974, METHODS ENZYM ANAL, V1, P473; BERNLOHR DA, 1984, P NATL ACAD SCI-BIOL, V81, P5468, DOI 10.1073/pnas.81.17.5468; BERNLOHR DA, 1985, J BIOL CHEM, V260, P5563; BEUTLER B, 1985, J EXP MED, V161, P984, DOI 10.1084/jem.161.5.984; BEUTLER B, 1986, NATURE, V320, P584, DOI 10.1038/320584a0; BIRNBAUM MJ, 1987, SCIENCE, V235, P1495, DOI 10.1126/science.3029870; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; BUTLER DM, 1988, J RHEUMATOL, V15, P1463; CALDERHEAD DM, 1988, J BIOL CHEM, V263, P12171; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLANCY BM, 1990, J BIOL CHEM, V265, P12434; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; CORNELIUS P, 1988, BIOCHEM J, V249, P765, DOI 10.1042/bj2490765; CORNELIUS P, 1989, J CELL BIOL, V107, P718; CURRAN T, 1982, J VIROL, V44, P674, DOI 10.1128/JVI.44.2.674-682.1982; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; EY PL, 1986, METHOD ENZYMOL, V121, P497; FARESE RV, 1985, ENDOCRINOLOGY, V116, P2650, DOI 10.1210/endo-116-6-2650; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FILETTI S, 1987, ENDOCRINOLOGY, V120, P2576, DOI 10.1210/endo-120-6-2576; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; FROST SC, 1985, J BIOL CHEM, V260, P2646; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; FUSHIKI T, 1989, AM J PHYSIOL, V256, pE580, DOI 10.1152/ajpendo.1989.256.5.E580; GOULD GW, 1990, TRENDS BIOCHEM SCI, V15, P18, DOI 10.1016/0968-0004(90)90125-U; GOULD GW, 1989, J BIOL CHEM, V264, P2180; GRECOPEROTTO R, 1987, BIOCHEM J, V247, P63, DOI 10.1042/bj2470063; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; HATANAKA M, 1974, BIOCHIM BIOPHYS ACTA, V355, P77, DOI 10.1016/0304-419X(74)90008-0; HELSON L, 1975, NATURE, V258, P731, DOI 10.1038/258731a0; HIRAKI Y, 1988, J BIOL CHEM, V263, P13655; HUBERMAN JA, 1981, CELL, V23, P647, DOI 10.1016/0092-8674(81)90426-8; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; JONES TLZ, 1989, J BIOL CHEM, V264, P7874; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KALB VF, 1977, ANAL BIOCHEM, V82, P362, DOI 10.1016/0003-2697(77)90173-7; KITAGAWA T, 1989, BIOCHIM BIOPHYS ACTA, V980, P100, DOI 10.1016/0005-2736(89)90205-8; KLETZIEN RF, 1974, J BIOL CHEM, V249, P3375; KLETZIEN RF, 1974, J BIOL CHEM, V249, P3366; KLIP A, 1982, BIOCHIM BIOPHYS ACTA, V687, P265, DOI 10.1016/0005-2736(82)90555-7; KLIP A, 1983, ARCH BIOCHEM BIOPHYS, V221, P175, DOI 10.1016/0003-9861(83)90134-0; KOHASE M, 1987, MOL CELL BIOL, V7, P273, DOI 10.1128/MCB.7.1.273; KOHASE M, 1987, J CELL PHYSIOL, V132, P271, DOI 10.1002/jcp.1041320211; KOHASE M, 1986, CELL, V45, P659, DOI 10.1016/0092-8674(86)90780-4; KOSAKI A, 1988, DIABETES, V37, P1583, DOI 10.2337/diabetes.37.11.1583; KULL FC, 1984, P NATL ACAD SCI-BIOL, V81, P7932, DOI 10.1073/pnas.81.24.7932; KULL FC, 1985, P NATL ACAD SCI USA, V82, P5756, DOI 10.1073/pnas.82.17.5756; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LE JM, 1987, J IMMUNOL, V138, P2137; LIN JX, 1987, J BIOL CHEM, V262, P11908; LINIAL M, 1985, SCIENCE, V230, P1126, DOI 10.1126/science.2999973; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACKALL J, 1979, ANAL BIOCHEM, V95, P270, DOI 10.1016/0003-2697(79)90216-1; MANIATIS T, 1982, MOL CLONING LABORATO, P383; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; OBRIEN TG, 1982, J CELL PHYSIOL, V110, P63, DOI 10.1002/jcp.1041100111; OLD LJ, 1985, SCIENCE, V230, P630, DOI 10.1126/science.2413547; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; PALOMBELLA VJ, 1987, J BIOL CHEM, V262, P1950; PAPE ME, 1988, MOL ENDOCRINOL, V2, P395, DOI 10.1210/mend-2-5-395; PEDRALINOY G, 1979, BIOCHEM BIOPH RES CO, V88, P1194, DOI 10.1016/0006-291X(79)91106-9; PEKALA P, 1983, J EXP MED, V157, P1360, DOI 10.1084/jem.157.4.1360; PILCH PF, 1990, ENDOCRINOLOGY, V126, P3, DOI 10.1210/endo-126-1-3; REID TR, 1989, J BIOL CHEM, V264, P4583; RIFAS L, 1984, P NATL ACAD SCI-BIOL, V81, P4558, DOI 10.1073/pnas.81.14.4558; ROLLINS BJ, 1988, J BIOL CHEM, V263, P16523; RUFF MR, 1981, INFECT IMMUN, V31, P380, DOI 10.1128/IAI.31.1.380-385.1981; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SIMPSON IA, 1986, ANNU REV BIOCHEM, V55, P1059, DOI 10.1146/annurev.biochem.55.1.1059; SPEIGELMAN BM, 1983, J BIOL CHEM, V258, P10083; STUMPO DJ, 1986, P NATL ACAD SCI USA, V83, P9453, DOI 10.1073/pnas.83.24.9453; SUGARMAN BJ, 1985, SCIENCE, V230, P943, DOI 10.1126/science.3933111; SUZUKI K, 1988, J BIOL CHEM, V263, P12247; SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; TOYODA N, 1987, J BIOL CHEM, V262, P2737; VANSNICK J, 1988, EUR J IMMUNOL, V18, P193; VILCEK J, 1986, J EXP MED, V163, P632, DOI 10.1084/jem.163.3.632; WALKER PS, 1990, J BIOL CHEM, V265, P1516; WALSH C, 1979, ENZYMATIC REACTION M, P224; WALSH DA, 1971, J BIOL CHEM, V246, P1977; WHEELER TJ, 1985, ANNU REV PHYSIOL, V47, P503, DOI 10.1146/annurev.ph.47.030185.002443; WILLIAMS SA, 1988, J BIOL CHEM, V263, P19513; WILLIAMSON BD, 1983, P NATL ACAD SCI-BIOL, V80, P5397, DOI 10.1073/pnas.80.17.5397; YAMADA K, 1986, J CELL PHYSIOL, V127, P211, DOI 10.1002/jcp.1041270204; ZHANG YH, 1988, J BIOL CHEM, V263, P6177; ZUCALI JR, 1988, J IMMUNOL, V140, P840	97	144	144	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20506	20516						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700789				2022-12-27	WOS:A1990EJ52500070
J	GOY, MF				GOY, MF			ACTIVATION OF MEMBRANE GUANYLATE-CYCLASE BY AN INVERTEBRATE PEPTIDE-HORMONE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											GOY, MF (corresponding author), UNIV N CAROLINA, DEPT PHYSIOL, CHAPEL HILL, NC 27599 USA.				NINDS NIH HHS [NS21290, NS25915] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS025915, R23NS021290] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1; BERGSTRAND H, 1977, MOL PHARMACOL, V13, P38; CASNELLI.JE, 1974, P NATL ACAD SCI USA, V71, P1891, DOI 10.1073/pnas.71.5.1891; CRAVEN PA, 1978, J BIOL CHEM, V253, P8433; FISCHMEISTER R, 1987, J PHYSIOL-LONDON, V387, P453, DOI 10.1113/jphysiol.1987.sp016584; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; GAMMON CM, 1989, J NEUROCHEM, V53, P95, DOI 10.1111/j.1471-4159.1989.tb07299.x; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GOLDBERG ND, 1977, ANNU REV BIOCHEM, V46, P823, DOI 10.1146/annurev.bi.46.070177.004135; GOY MF, 1984, J NEUROSCI, V4, P611; GOY MF, 1989, J NEUROSCI, V9, P369; GOY MF, 1987, J NEUROCHEM, V48, P954, DOI 10.1111/j.1471-4159.1987.tb05610.x; GOY MF, 1987, NEUR ABSTR, V13, P1257; GRIFFITH TM, 1988, J AM COLL CARDIOL, V12, P797, DOI 10.1016/0735-1097(88)90324-5; GRUETTER CA, 1979, J CYCLIC NUCL PROT, V5, P211; HAMET P, 1986, J HYPERTENS, V4, pS49; HANSBROUGH JR, 1981, J BIOL CHEM, V256, P1447; HUBERMAN A, 1986, COMP BIOCHEM PHYS B, V85, P197, DOI 10.1016/0305-0491(86)90243-9; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KEGEL G, 1989, FEBS LETT, V255, P10, DOI 10.1016/0014-5793(89)81051-8; KELLER R, 1985, AM ZOOL, V25, P207; KELLER R, 1973, GEN COMP ENDOCR, V20, P572, DOI 10.1016/0016-6480(73)90089-0; KUO JF, 1970, J BIOL CHEM, V245, P2493; KUO JF, 1982, HDB EXP PHARM, V58, P393; LEITMAN DC, 1987, ENDOCRIN METAB CLIN, V16, P79, DOI 10.1016/S0889-8529(18)30496-1; LEITMAN DC, 1987, BIOCHEM J, V244, P69, DOI 10.1042/bj2440069; LINCOLN TM, 1984, ADV CYCLIC NUCL PROT, V17, P285; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martell A.E., 1974, CRITICAL STABILITY C, V1, P204; MARTELL AE, 1975, CRITICAL STABILITY C, V2, P290; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; NAIRN AC, 1983, FED PROC, V42, P3107; NAMBI P, 1981, ENDOCRINOLOGY, V108, P2025, DOI 10.1210/endo-108-5-2025; NEWCOMB RW, 1983, J COMP PHYSIOL, V153, P207, DOI 10.1007/BF00689624; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PAVLOFF MS, 1990, J NEUROCHEM, V55, P788, DOI 10.1111/j.1471-4159.1990.tb04561.x; RAPOPORT RM, 1982, P NATL ACAD SCI-BIOL, V79, P6470, DOI 10.1073/pnas.79.21.6470; SAPER CB, 1985, SCIENCE, V227, P1047, DOI 10.1126/science.2858127; SCHULZ S, 1989, FASEB J, V3, P2026, DOI 10.1096/fasebj.3.9.2568301; SEDLMEIER D, 1981, GEN COMP ENDOCR, V45, P82, DOI 10.1016/0016-6480(81)90172-6; SEIDAH NG, 1984, P NATL ACAD SCI-BIOL, V81, P2640, DOI 10.1073/pnas.81.9.2640; SONG DL, 1988, FEBS LETT, V232, P125, DOI 10.1016/0014-5793(88)80400-9; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; SUZUKI N, 1984, J BIOL CHEM, V259, P4874; TANAKA I, 1984, BIOCHEM BIOPH RES CO, V124, P663, DOI 10.1016/0006-291X(84)91606-1; TREMBLAY J, 1988, ADV SEC MESS PHOSPH, V22, P319; WALDMAN SA, 1985, BIOCHIM BIOPHYS ACTA, V845, P298, DOI 10.1016/0167-4889(85)90191-0; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WOOD JN, 1989, J NEUROCHEM, V53, P1203, DOI 10.1111/j.1471-4159.1989.tb07416.x	50	53	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20220	20227						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700784				2022-12-27	WOS:A1990EJ52500030
J	KAPUS, A; SZASZI, K; KALDI, K; LIGETI, E; FONYO, A				KAPUS, A; SZASZI, K; KALDI, K; LIGETI, E; FONYO, A			RUTHENIUM RED INHIBITS MITOCHONDRIAL NA+ AND K+ UNIPORTS INDUCED BY MAGNESIUM REMOVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note											KAPUS, A (corresponding author), SEMMELWEIS UNIV MED,DEPT PHYSIOL,PUSKIN U9,POB 259,H-1444 BUDAPEST 8,HUNGARY.		Káldi, Krisztina/X-4080-2019; Szaszi, Katalin/J-7522-2012	Kaldi, Krisztina/0000-0002-5724-0182; Szaszi, Katalin/0000-0002-2490-8422				BERNARDI P, 1990, EUR J BIOCHEM, V188, P91, DOI 10.1111/j.1432-1033.1990.tb15375.x; BERNARDI P, 1989, J BIOL CHEM, V264, P18902; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; BRIERLEY GP, 1990, BIOCHEMISTRY-US, V29, P408, DOI 10.1021/bi00454a015; BRIERLEY GP, 1989, BIOCHEMISTRY-US, V28, P4347, DOI 10.1021/bi00436a034; BRIERLEY GP, 1988, J BIOENERG BIOMEMBR, V20, P193, DOI 10.1007/BF00768394; CARAFOLI E, 1984, BIOENERGETICS, P269; CROMPTON M, 1976, EUR J BIOCHEM, V69, P453, DOI 10.1111/j.1432-1033.1976.tb10930.x; DIWAN JJ, 1986, J BIOENERG BIOMEMBR, V18, P123, DOI 10.1007/BF00743481; DIWAN JJ, 1988, BIOCHEM BIOPH RES CO, V153, P224, DOI 10.1016/S0006-291X(88)81212-9; EAVIS AD, 1990, J BIOL CHEM, V265, P2538; FONYO A, 1979, PHARMACOL THERAPEUT, V7, P627, DOI 10.1016/0163-7258(79)90045-7; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; JUNG DW, 1977, ARCH BIOCHEM BIOPHYS, V183, P452, DOI 10.1016/0003-9861(77)90380-0; KAKAR SS, 1989, J BIOL CHEM, V264, P5846; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; KAPUS A, 1989, FEBS LETT, V251, P49, DOI 10.1016/0014-5793(89)81426-7; KAPUS A, 1988, BIOCHIM BIOPHYS ACTA, V944, P383, DOI 10.1016/0005-2736(88)90509-3; KRAMER R, 1989, BIOCHIM BIOPHYS ACTA, V974, P1, DOI 10.1016/S0005-2728(89)80160-4; LUFT JH, 1971, ANAT REC, V171, P347, DOI 10.1002/ar.1091710302; LUKACS GL, 1987, BIOCHEM J, V248, P609, DOI 10.1042/bj2480609; LUKACS GL, 1985, BIOCHIM BIOPHYS ACTA, V809, P160, DOI 10.1016/0005-2728(85)90058-1; MARTIN WH, 1984, J BIOL CHEM, V259, P2062; MOORE CL, 1971, BIOCHEM BIOPH RES CO, V42, P298, DOI 10.1016/0006-291X(71)90102-1; NAKASHIMA RA, 1982, J BIOL CHEM, V257, P9252; NICHOLLS D, 1982, BIOCHIM BIOPHYS ACTA, V683, P57, DOI 10.1016/0304-4173(82)90013-1; NIGGLI V, 1978, EXPERIENTIA, V34, P1136, DOI 10.1007/BF01922914; REED KC, 1974, BIOCHEM J, V140, P143, DOI 10.1042/bj1400143; SANDRI G, 1979, BIOCHIM BIOPHYS ACTA, V558, P214, DOI 10.1016/0005-2736(79)90061-0; SANDRI G, 1976, BIOCHEM BIOPH RES CO, V68, P1272, DOI 10.1016/0006-291X(76)90334-X; SETTLEMIRE CT, 1968, BIOCHIM BIOPHYS ACTA, V162, P487, DOI 10.1016/0005-2728(68)90055-8; VAGHY PL, 1982, J BIOL CHEM, V257, P6000; VASINGTON FD, 1972, BIOCHIM BIOPHYS ACTA, V256, P43, DOI 10.1016/0005-2728(72)90161-2; VINOGRADOV A, 1973, J BIOL CHEM, V248, P5527; WEHRLE JP, 1976, ARCH BIOCHEM BIOPHYS, V174, P312, DOI 10.1016/0003-9861(76)90350-7	35	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18063	18066						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1698784				2022-12-27	WOS:A1990EE20100006
J	CHEN, ZJ; NILES, EG; PICKART, CM				CHEN, ZJ; NILES, EG; PICKART, CM			ISOLATION OF A CDNA-ENCODING A MAMMALIAN MULTIUBIQUITINATING ENZYME (E225K) AND OVEREXPRESSION OF THE FUNCTIONAL ENZYME IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN CARRIER PROTEIN; REPAIR GENE RAD6; CONJUGATING ENZYMES; DNA-POLYMERASE; DEGRADATION; PURIFICATION; CHAIN; ACID; E2; PROTEOLYSIS	The ubiquitin (Ub)-conjugating enzyme E2(25K) catalyzes the synthesis of multi-Ub chains in which successive Ub units are linked by an isopeptide bond involving the epsilon-amino group of Lys-48 of Ub(n), and the COOH-terminal Gly residue of Ub(n+1) (Chen, Z., and Pickart, C. M. (1990) J. Biol. Chem., 265, 21835-21842). We now describe the Polymerase chain reaction (PCR)-based cloning of an E2(25K)-encoding cDNA from a bovine thymus library, using degenerate oligonucleotide primers based on the sequences of two E2(25K) peptides. The cDNA encodes a 200-residue protein whose sequence bears similarities of 66 and 59%, respectively, to the sequences of the Ub-conjugating enzymes encoded by the UBC1 and UBC4/UBC5 genes of the yeast Saccharomyces cerevisiae. These three yeast E2s play key roles in Ub-dependent proteolysis (Seufert, W., McGrath, J. P., and Jentsch, S. (1990) EMBO J. 9, 4535-4541). Comparison of the amino acid sequence of E2(25K) with other known E2 sequences strongly suggests that Cys-92, one of two E2(25K) Cys residues, forms the Ub thiol ester adduct that is an intermediate in E2-catalyzed multiubiquitination. The E2(25K)-encoding cDNA was overexpressed in Escherichia coli, and the recombinant E2(25K) protein was purified to electrophoretic homogeneity; enzymatic assays showed that its multiubiquitinating activity was quantitatively identical with that of the native protein. The availability of a cloned cDNA will allow us to assess the physiological role of E2(25K).	SUNY BUFFALO,DEPT BIOCHEM,140 FARBER HALL,BUFFALO,NY 14214	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo			Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028824] Funding Source: NIH RePORTER; NIAID NIH HHS [AI28824] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BACHMAIR A, 1990, EMBO J, V9, P4543, DOI 10.1002/j.1460-2075.1990.tb07906.x; BENSON S A, 1984, Biotechniques, V2, P66; BERLETH ES, 1990, BIOCHEM BIOPH RES CO, V171, P705, DOI 10.1016/0006-291X(90)91203-5; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; Frohman M.A., 1990, PCR PROTOCOLS GUIDE, P28; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GREGORI L, 1990, J BIOL CHEM, V265, P8354; HAAS A, 1990, J BIOL CHEM, V265, P21664; HAAS AL, 1988, J BIOL CHEM, V263, P13268; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1984, P NATL ACAD SCI-BIOL, V81, P1619, DOI 10.1073/pnas.81.6.1619; HOUGH R, 1986, J BIOL CHEM, V261, P2391; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; KLEMPERER NS, 1989, BIOCHEMISTRY-US, V28, P6035, DOI 10.1021/bi00440a047; KUDO M, 1991, EXP CELL RES, V192, P110, DOI 10.1016/0014-4827(91)90164-P; MAYER AN, 1989, BIOCHEMISTRY-US, V28, P166, DOI 10.1021/bi00427a024; MCGRATH JP, 1991, EMBO J, V10, P27; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PICKART CM, 1985, J BIOL CHEM, V260, P1573; PICKART CM, 1989, ARCH BIOCHEM BIOPHYS, V272, P114, DOI 10.1016/0003-9861(89)90201-4; PICKART CM, 1988, J BIOL CHEM, V263, P15076; PICKART CM, 1988, J BIOL CHEM, V263, P12028; PICKART CM, 1988, UBIQUITIN, P77; Prakash S, 1990, EUKARYOTIC NUCLEUS, P275; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER R, 1990, EMBO J, V9, P1431, DOI 10.1002/j.1460-2075.1990.tb08259.x; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; SHATZMAN AR, 1987, METHOD ENZYMOL, V152, P661; SULLIVAN ML, 1989, P NATL ACAD SCI USA, V86, P9861, DOI 10.1073/pnas.86.24.9861; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695	45	71	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15698	15704						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714895				2022-12-27	WOS:A1991GB97700030
J	COOL, DR; LEIBACH, FH; BHALLA, VK; MAHESH, VB; GANAPATHY, V				COOL, DR; LEIBACH, FH; BHALLA, VK; MAHESH, VB; GANAPATHY, V			EXPRESSION AND CYCLIC AMP-DEPENDENT REGULATION OF A HIGH-AFFINITY SEROTONIN TRANSPORTER IN THE HUMAN PLACENTAL CHORIOCARCINOMA CELL-LINE (JAR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE VESICLES; HUMAN-BLOOD-PLATELETS; <H-3>IMIPRAMINE BINDING-SITES; PROTEIN KINASE-C; 5-HYDROXYTRYPTAMINE TRANSPORTER; ENDOTHELIAL-CELLS; SOLUBILIZATION; CULTURE; SYSTEM; PURIFICATION	The JAR human placental choriocarcinoma cell line transports serotonin, accumulating the monoamine inside the cell against a concentration gradient. The transport is energized by an NaCl gradient. Tricyclic (imipramine and desipramine) and non-tricyclic (paroxetine and fluoxetine) antidepressants inhibit the transporter markedly, but reserpine and 5-hydroxy-tryptophan do not. Ouabain, gramicidin, and nigericin, which reduce or abolish the transmembrane Na+ gradient, and phloridzin, which interferes with glucose transport into the cells, inhibit the transport. Preincubation of the cells with glucose-free medium also causes similar inhibition. The activity of the serotonin transporter in this cell line is stimulated in response to overnight (16-h) incubation with increasing concentrations of cholera toxin (0.1-1,000 ng/ml). Under these conditions the stimulation is maximal at 10 ng/ml cholera toxin (3.1 +/- 0.2-fold). Cholera toxin increases the cAMP content of these cells by several hundredfold within 2 h. Isobutylmethylxanthine (100-mu-M), dibutyryl cAMP (100-mu-M), and forskolin (100-mu-M) mimic the action of cholera toxin, eliciting a 1.6-2.5-fold stimulation of the serotonin transporter activity. The stimulatory effect of cholera toxin is antagonized significantly by simultaneous incubation of the cells with 50-mu-M N-(2-aminoethyl)-5-isoquinolinesulfonamide, a protein kinase inhibitor. The effect of cholera toxin on serotonin transport is specific because, under similar conditions, cholera toxin inhibits 3-O-methyl-D-glucose transport and does not influence taurine transport in this cell line. There is also no significant change in the protein content of the cells after cholera toxin treatment. Kinetic analysis reveals that cholera toxin causes an increase in the maximal velocity (7.89 +/- 0.67 to 17.55 +/- 1.06 pmol/mg of protein/5 min) and a decrease in the Michaelis-Menten constant (0.52 +/- 0.09 to 0.29 +/- 0.04-mu-M). These data show that the JAR human placental choriocarcinoma cell line expresses a high affinity serotonin transporter that is sensitive to inhibition by antidepressants and that the activity of the transporter is under cAMP-dependent regulation.	MED COLL GEORGIA,DEPT BIOCHEM & MOLEC BIOL,AUGUSTA,GA 30912; MED COLL GEORGIA,DEPT PHYSIOL & ENDOCRINOL,AUGUSTA,GA 30912	University System of Georgia; Augusta University; University System of Georgia; Augusta University					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022103, R01HD024451] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24451, HD22103] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BALKOVETZ DF, 1989, J BIOL CHEM, V264, P2195; BENOIT J, 1988, AM J OBSTET GYNECOL, V158, P328, DOI 10.1016/0002-9378(88)90148-2; BHALLA VK, 1980, FUNCTIONAL CORRELATE, P419; BIESSEN EAL, 1990, BIOCHEMISTRY-US, V29, P3349, DOI 10.1021/bi00465a029; BUCCARON MH, 1990, P NATL ACAD SCI USA, V87, P1922, DOI 10.1073/pnas.87.5.1922; CESURA AM, 1983, EUR J PHARMACOL, V96, P235, DOI 10.1016/0014-2999(83)90312-6; CHANG ASS, 1989, P NATL ACAD SCI USA, V86, P9611, DOI 10.1073/pnas.86.23.9611; COOL DR, 1990, BIOCHEMISTRY-US, V29, P1818, DOI 10.1021/bi00459a022; COOL DR, 1990, AM J PHYSIOL, V259, pC196, DOI 10.1152/ajpcell.1990.259.2.C196; COOL DR, 1990, BIOCHEM PHARMACOL, V40, P2161, DOI 10.1016/0006-2952(90)90249-K; DAVIS A, 1984, EXPERIENTIA, V40, P782, DOI 10.1007/BF01951960; DAVIS A, 1983, EUR J PHARMACOL, V86, P353, DOI 10.1016/0014-2999(83)90184-X; DEVITRY F, 1986, NEUROCHEM INT, V9, P43, DOI 10.1016/0197-0186(86)90030-6; FEINMAN MA, 1986, J CLIN ENDOCR METAB, V63, P1211, DOI 10.1210/jcem-63-5-1211; GANAPATHY V, 1989, J PHARMACOL EXP THER, V251, P9; GRAHAM D, 1988, NEURONAL SEROTONIN, P367; HABERT E, 1986, EUR J PHARMACOL, V122, P197, DOI 10.1016/0014-2999(86)90103-2; HARMAN I, 1987, ENDOCRINOLOGY, V121, P59, DOI 10.1210/endo-121-1-59; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HILIBRAND AS, 1987, NEUROCHEM INT, V10, P185, DOI 10.1016/0197-0186(87)90126-4; HOLLENBERG NK, 1988, ANNU REV PHARMACOL, V28, P41; HOUSTON DS, 1986, DRUGS, V31, P149, DOI 10.2165/00003495-198631020-00004; IENI JR, 1985, EUR J PHARMACOL, V112, P261, DOI 10.1016/0014-2999(85)90506-0; KELLEY LK, 1983, BIOCHIM BIOPHYS ACTA, V734, P91, DOI 10.1016/0005-2736(83)90079-2; KEYES SR, 1982, J BIOL CHEM, V257, P1172; KLETZIEN RF, 1975, ANAL BIOCHEM, V68, P537, DOI 10.1016/0003-2697(75)90649-1; KULANTHAIVEL P, 1989, BIOCHIM BIOPHYS ACTA, V985, P139, DOI 10.1016/0005-2736(89)90358-1; KULANTHAIVEL P, 1991, BIOCHEM J, V277, P53, DOI 10.1042/bj2770053; LEE SL, 1986, AM J PHYSIOL, V250, pC761, DOI 10.1152/ajpcell.1986.250.5.C761; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARCUSSON JO, 1990, PSYCHOPHARMACOLOGY, V102, P145, DOI 10.1007/BF02245915; MELLERUP ET, 1985, EUROPEAN J PHARM, V106, P411; MIYAMOTO Y, 1988, FEBS LETT, V231, P263, DOI 10.1016/0014-5793(88)80744-0; MYERS CL, 1989, AM J PHYSIOL, V257, pL253, DOI 10.1152/ajplung.1989.257.4.L253; NELSON PJ, 1982, J BIOL CHEM, V257, P6151; OREILLY CA, 1988, J BIOL CHEM, V263, P6115; REITH MEA, 1989, BIOCHEM PHARMACOL, V38, P2091, DOI 10.1016/0006-2952(89)90062-2; ROSS SB, 1982, BIOL SEROTONERGIC TR, P159; RUDNICK G, 1977, J BIOL CHEM, V252, P2170; SEUWEN K, 1990, BIOCHEM PHARMACOL, V39, P985, DOI 10.1016/0006-2952(90)90276-Q; Sneddon J M, 1973, Prog Neurobiol, V1, P151, DOI 10.1016/0301-0082(73)90019-1; STERNBACH Y, 1990, J BIOL CHEM, V265, P3961; TAKUWA N, 1989, AM J PHYSIOL, V257, pF431, DOI 10.1152/ajprenal.1989.257.3.F431; TALVENHEIMO J, 1980, J BIOL CHEM, V255, P8606; WENNOGLE LP, 1985, EMBO J, V4, P971, DOI 10.1002/j.1460-2075.1985.tb03726.x	45	149	149	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15750	15757						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714897				2022-12-27	WOS:A1991GB97700038
J	ESCRIBANO, J; GRUBB, A; CALERO, M; MENDEZ, E				ESCRIBANO, J; GRUBB, A; CALERO, M; MENDEZ, E			THE PROTEIN-HC CHROMOPHORE IS LINKED TO THE CYSTEINE RESIDUE AT POSITION-34 OF THE POLYPEPTIDE-CHAIN BY A REDUCTION-RESISTANT BOND AND CAUSES THE CHARGE HETEROGENEITY OF PROTEIN-HC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-FORMING GLYCOPROTEIN; RETINOL-BINDING PROTEIN; ALPHA-TRYPSIN INHIBITOR; AMINO-ACID-SEQUENCE; IGA COMPLEX; HUMAN ALPHA-1-MICROGLOBULIN; BETA-LACTOGLOBULIN; HUMAN-PLASMA; BODY-FLUIDS; HOMOLOGY	Protein HC, an extremely charge-heterogeneous lipocalin, carries a yellow-brown fluorescent chromophore of unknown structure covalently bound at an unidentified site of its polypeptide chain. Two chromophore-carrying peptides with 60% of the chromophore material (defined as material absorbing light at 330 nm) were isolated from pepsin-digested native human protein HC by reversed-phase high performance liquid chromatography. Sequence analysis of these peptides indicated that the chromophore was bound to the cysteine residue at position 34 of the protein HC polypeptide chain. Sequence analysis of a native chromophore-tripeptide complex, isolated from pronase digests of the pepsin-produced peptides, identified the sequence Thr33-X34-Pro35, corroborating the position of the chromophore linkage. Quantitative amino acid analysis of the hydrolyzed, performic acid-oxidized, chromophore-tripeptide complex demonstrated approximately equal amounts of threonine, cysteic acid, and proline in the complex. Reduction and carboxymethylation of the native chromophore-tripeptide complex did not remove the chromophore from the peptide. The absorption spectrum of the chromophore-tripeptide complex was similar to that of native protein HC, implying that all of the heterogeneity of protein HC resides in its chromophore.	CTR ESPECIAL RAMON & CAJAL, SERV ENDOCRINOL, CARRETERA COLMENAR, KM 9-1, MADRID 34, SPAIN; UNIV LUND HOSP, DEPT CLIN CHEM, S-22185 LUND, SWEDEN	Lund University; Skane University Hospital			Calero, Miguel/H-5691-2015; Escribano, Julio/D-9742-2015	Calero, Miguel/0000-0001-5366-3324; Escribano, Julio/0000-0002-8919-8134; Grubb, Anders/0000-0002-0125-3662				DIARRAMEHRPOUR M, 1989, EUR J BIOCHEM, V179, P147, DOI 10.1111/j.1432-1033.1989.tb14532.x; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; EKSTROM B, 1975, BIOCHEM BIOPH RES CO, V65, P1427, DOI 10.1016/S0006-291X(75)80388-3; EKSTROM B, 1977, J BIOL CHEM, V252, P8048; ESCRIBANO J, 1988, J CHROMATOGR, V444, P165, DOI 10.1016/S0021-9673(01)94019-1; ESCRIBANO J, 1990, FEBS LETT, V266, P167, DOI 10.1016/0014-5793(90)81531-R; ESCRIBANO J, 1988, BIOCHEM BIOPH RES CO, V155, P1424, DOI 10.1016/S0006-291X(88)81300-7; FERNANDEZLUNA JL, 1988, J CLIN PATHOL, V41, P1176, DOI 10.1136/jcp.41.11.1176; GAVILANES JG, 1984, BIOCHEMISTRY-US, V23, P1234, DOI 10.1021/bi00301a033; GRUBB A, 1986, J BIOL CHEM, V261, P14313; GRUBB AO, 1983, J BIOL CHEM, V258, P4698; HAEFLIGER JA, 1987, BIOCHEM BIOPH RES CO, V149, P750, DOI 10.1016/0006-291X(87)90431-1; HUNT LT, 1987, BIOCHEM BIOPH RES CO, V149, P282, DOI 10.1016/0006-291X(87)91636-6; KAUMEYER JF, 1986, NUCLEIC ACIDS RES, V14, P7839, DOI 10.1093/nar/14.20.7839; LOPEZ C, 1981, BIOCHEM BIOPH RES CO, V103, P919, DOI 10.1016/0006-291X(81)90898-6; MENDEZ E, 1986, P NATL ACAD SCI USA, V83, P1472, DOI 10.1073/pnas.83.5.1472; MENDEZ E, 1982, ARCH BIOCHEM BIOPHYS, V213, P240, DOI 10.1016/0003-9861(82)90458-1; MOHAMED HB, 1989, IMMUNOBIOLOGY, V180, P221; MOORE S, 1963, J BIOL CHEM, V238, P235; OTIN CL, 1984, ARCH BIOCHEM BIOPHYS, V228, P544, DOI 10.1016/0003-9861(84)90021-3; PAPIZ MZ, 1986, NATURE, V324, P383, DOI 10.1038/324383a0; PERVAIZ S, 1985, SCIENCE, V228, P335, DOI 10.1126/science.2580349; PERVAIZ S, 1987, FASEB J, V1, P209, DOI 10.1096/fasebj.1.3.3622999; PEVSNER J, 1988, SCIENCE, V241, P336, DOI 10.1126/science.3388043; SEON BK, 1978, BIOCHEMISTRY-US, V17, P2815, DOI 10.1021/bi00607a018; TAKAGI K, 1980, J CLIN PATHOL, V33, P786, DOI 10.1136/jcp.33.8.786; TAKAGI K, 1980, CLIN CHIM ACTA, V108, P277; TAKAGI T, 1981, BIOCHEM BIOPH RES CO, V98, P997, DOI 10.1016/0006-291X(81)91209-2; TEJLER L, 1976, BIOCHIM BIOPHYS ACTA, V439, P82, DOI 10.1016/0005-2795(76)90164-1; TRABONI C, 1986, NUCLEIC ACIDS RES, V14, P6340, DOI 10.1093/nar/14.15.6340; TRUEDSSON L, 1988, SCAND J IMMUNOL, V27, P201, DOI 10.1111/j.1365-3083.1988.tb02340.x	31	41	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15758	15763						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714898				2022-12-27	WOS:A1991GB97700039
J	KERR, D; KHALILI, K				KERR, D; KHALILI, K			A RECOMBINANT CDNA DERIVED FROM HUMAN BRAIN ENCODES A DNA-BINDING PROTEIN THAT STIMULATES TRANSCRIPTION OF THE HUMAN NEUROTROPIC VIRUS JCV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; NUCLEAR-PROTEIN; RNA-POLYMERASE; PROMOTER; ENHANCER; EXPRESSION; REGION; CELLS; GENE; INVITRO	The human neurotropic virus JCV contains a 98-base pair repeat enhancer/promoter sequence that confers glial-specific transcription to the viral early and late promoters. The central region of this repeat, designated the B-domain, binds to a glial-derived nuclear protein that stimulates transcription of the viral promoter in vitro. We now report the isolation of a recombinant cDNA clone, termed glial factor-1 (GF1), from a brain expression library that encodes a novel protein which interacts with the JCV B-domain. Results from RNA studies indicate that the GF1 transcript is more abundant in brain than in other tissues and that the level of GF1 RNAs increases progressively during brain development. Cotransfection of the recombinant GF1 expressor plasmid with JCV promoters indicates that GF1 stimulates transcription of the JCV late promoter and to a lesser extent the JCV early promoter predominantly in cells of human glial origin. Thus, GF1 is a sequence-specific DNA binding protein that may play a role in determining the glial-specific expression of JCV.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Jefferson University			KERR, Douglas A/B-9270-2008		NCI NIH HHS [CA47996] Funding Source: Medline; PHS HHS [A128272] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA047996] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHMED S, 1990, J BIOL CHEM, V265, P13899; AHMED S, 1990, NUCLEIC ACIDS RES, V18, P7417, DOI 10.1093/nar/18.24.7417; ANSTROM KE, 1985, BRAIN, V81, P98; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; CASTAIGNE P, 1974, REV NEUROL-FRANCE, V130, P379; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; FEIGENBAUM L, 1987, P NATL ACAD SCI USA, V84, P3695, DOI 10.1073/pnas.84.11.3695; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; GIARUSSO MH, 1978, J NEUROL SCI, V35, P391, DOI 10.1016/0022-510X(78)90019-9; GORMAN CM, 1982, MOL CELL BIOL, V2, P1046; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROSVELD GC, 1981, CELL, V25, P215, DOI 10.1016/0092-8674(81)90246-4; HENNIGHAUSEN L, 1985, NATURE, V314, P289, DOI 10.1038/314289a0; JOHNSON PF, 1987, GENE DEV, V1, P133, DOI 10.1101/gad.1.2.133; JOHNSON RT, 1983, POLYOMAVIRUSES HUMAN, P183; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KENNEY S, 1984, SCIENCE, V226, P1337, DOI 10.1126/science.6095453; KHALILI K, 1988, EMBO J, V7, P1205, DOI 10.1002/j.1460-2075.1988.tb02932.x; KHOURY G, 1983, CELL, V33, P313, DOI 10.1016/0092-8674(83)90410-5; LASHGARI MS, 1989, VIROLOGY, V170, P292, DOI 10.1016/0042-6822(89)90381-4; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; PADGETT BL, 1977, INFECT IMMUN, V15, P656, DOI 10.1128/IAI.15.2.656-662.1977; PADGETT BL, 1971, LANCET, V1, P1257; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; ROBSON B, 1976, J MOL BIOL, V107, P327, DOI 10.1016/S0022-2836(76)80008-3; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; SMALL JA, 1986, CELL, V46, P13, DOI 10.1016/0092-8674(86)90855-X; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TADA H, 1989, J VIROL, V63, P463, DOI 10.1128/JVI.63.1.463-466.1989; TADA H, 1991, VIROLOGY, V180, P327, DOI 10.1016/0042-6822(91)90037-C; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WALKER DL, 1978, HDB CLIN NEUROLOGY, P307; ZUREIN GM, 1969, PROG MED VIROL, V11, P185	41	45	46	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15876	15881						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714899				2022-12-27	WOS:A1991GB97700055
J	THOMAS, KM; TAYLOR, L; NAVARRO, J				THOMAS, KM; TAYLOR, L; NAVARRO, J			THE INTERLEUKIN-8 RECEPTOR IS ENCODED BY A NEUTROPHIL-SPECIFIC CDNA CLONE, F3R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PEPTIDE	Interleukin-8 (IL-8) is one of the most potent chemotactic agents for neutrophils and has been implicated as a major mediator of inflammation. The IL-8 receptor is expressed exclusively in neutrophils and belongs to the family of G-protein-coupled receptors. In a recent paper we reported the characterization of a cDNA clone, F3R, isolated from a neutrophil cDNA library and showed that it encodes a G-protein-coupled receptor which is exclusively expressed in neutrophils. We also suggested, based on expression studies in Xenopus oocytes, that the F3R protein product is an isoform of the (fMLP) receptor (Thomas, K. M., Pyun, H. Y., and Navarro, J. (1990) J. Biol. Chem. 265, 20061-20064). In this work, the F3R receptor cDNA is expressed in monkey kidney cells (COS-7) and is shown to encode the IL-8 receptor. F3R cDNA does not encode for a fMLP receptor isoform. We show conclusively that the F3R-transfected COS-7 cells express the IL-8 receptor at a density equivalent to that observed in neutrophils. The pharmacological profile of the F3R-transfected cells is the same as that of neutrophils. The apparent K(d) values for binding of I-125-IL-8 to neutrophils and F3R-transfected COS-7 cell membranes were 1.2 and 1.4 nM, respectively. Antipeptide antibodies against a partial sequence of the F3R protein product specifically immunoprecipitate the IL-8 receptor from transfected cells as well as neutrophils. The molecular characterization of the IL-8 receptor should provide the basis for further studies on the identification of the binding domain of this inflammatory receptor.	BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118	Boston University	THOMAS, KM (corresponding author), BOSTON UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02118, USA.			Navarro, Javier/0000-0001-7098-4373	NIAMS NIH HHS [AR39602, K04 AR 01810] Funding Source: Medline; NIA NIH HHS [AG00115] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039602, K04AR001810] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DELARCO JE, 1981, J CELL PHYSIOL, V109, P143, DOI 10.1002/jcp.1041090116; FARGIN A, 1988, NATURE, V335, P358, DOI 10.1038/335358a0; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; KUNKEL SL, 1991, EXP LUNG RES, V17, P17, DOI 10.3109/01902149109063278; LEONARD EJ, 1990, AM J RESP CELL MOL, V2, P479, DOI 10.1165/ajrcmb/2.6.479; MOSER B, 1991, J BIOL CHEM, V266, P10666; THOMAS KM, 1990, J BIOL CHEM, V265, P20061; WILLIAMSON K, 1988, BIOCHEMISTRY-US, V27, P5371, DOI 10.1021/bi00414a062	10	85	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					14839	14841						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714446				2022-12-27	WOS:A1991GB09700003
J	PHILBRICK, JB; DINER, BA; ZILINSKAS, BA				PHILBRICK, JB; DINER, BA; ZILINSKAS, BA			CONSTRUCTION AND CHARACTERIZATION OF CYANOBACTERIAL MUTANTS LACKING THE MANGANESE-STABILIZING POLYPEPTIDE OF PHOTOSYSTEM-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-EVOLVING COMPLEX; PHOTOSYNTHETIC WATER OXIDATION; CHARGE ACCUMULATION STATES; KDA EXTRINSIC PROTEIN; NUCLEOTIDE-SEQUENCE; 33-KDA PROTEIN; CHLAMYDOMONAS-REINHARDTII; BINDING PROTEIN; OXIDIZING SIDE; D1 POLYPEPTIDE	Mutants of the cyanobacterium Synechocystis sp. Pasteur Culture Collection (PCC) 6803 that specifically lack the extrinsic 33-kDa manganese-stabilizing polypeptide of the photosystem II oxygen-evolving complex have been constructed by two independent methods. Cartridge mutagenesis was used to insertionally inactivate the psbO gene of one mutant and completely delete the psbO gene of the other mutant. These mutants have no detectable manganese-stabilizing polypeptide, but they do accumulate steady-state levels of the intrinsic photosystem II polypeptides D1, D2, and CP-43 that are comparable to wild-type, as determined by immunoblot analysis. Measurement of the evolution of the relative quantum yields of chlorophyll fluorescence following actinic flash excitation indicates that though the concentration of reaction centers in mutant cells is comparable to that of wild-type cells, approximately 40% of these centers harbor a fluorescence-quenching species other than P680+. The mutants are capable of photoautotrophic growth at a slower rate than that of wild-type. Under conditions of Ca2+ depletion where wild-type growth is unaffected, the mutants are unable to grow at all. The manganese-stabilizing protein, therefore, enhances the binding of Ca2+ or protects the reaction center at low Ca2+ concentrations. The mutants evolve oxygen at approximately 70% of the wild-type rate, but are completely photoinactivated by high light intensities. Our results indicate that the manganese-stabilizing polypeptide is not absolutely required for photosystem II assembly or function in cyanobacteria, but its absence does lead to an enhanced sensitivity to photoinhibition.	RUTGERS STATE UNIV, COOK COLL, DEPT BIOCHEM & MICROBIOL, NEW BRUNSWICK, NJ 08903 USA; DUPONT CO, DEPT CR&D, EXPTL STN, WILMINGTON, DE 19880 USA	Rutgers State University New Brunswick; DuPont								ANDERSSON B, 1984, FEBS LETT, V168, P113, DOI 10.1016/0014-5793(84)80217-3; BLUBAUGH DJ, 1990, BIOCHEMISTRY-US, V29, P5109, DOI 10.1021/bi00473a016; BLUBAUGH DJ, 1990, CURRENT RES PHOTOSYN, V1, P503; BORTHAKUR D, 1989, PLANT MOL BIOL, V13, P427, DOI 10.1007/BF00015555; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; BRAND JJ, 1988, METHOD ENZYMOL, V167, P280; BRUDVIG GW, 1989, ANNU REV BIOPHYS BIO, V18, P25, DOI 10.1146/annurev.biophys.18.1.25; BURNAP R, 1989, PHOTOSYNTH RES, V22, P123, DOI 10.1007/BF00035442; BURNAP RL, 1991, BIOCHEMISTRY-US, V30, P440, DOI 10.1021/bi00216a020; CAMM EL, 1987, PHOTOSYNTH RES, V13, P69, DOI 10.1007/BF00032266; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLEMAN WJ, 1987, BIOCHIM BIOPHYS ACTA, V894, P453, DOI 10.1016/0005-2728(87)90124-1; CRITCHLEY C, 1985, BIOCHIM BIOPHYS ACTA, V811, P33, DOI 10.1016/0304-4173(85)90004-7; DEBUS RJ, 1988, BIOCHEMISTRY-US, V27, P9071, DOI 10.1021/bi00426a001; DEBUS RJ, 1988, P NATL ACAD SCI USA, V85, P427, DOI 10.1073/pnas.85.2.427; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; GHANOTAKIS DF, 1990, ANNU REV PLANT PHYS, V41, P255, DOI 10.1146/annurev.pp.41.060190.001351; GHANOTAKIS DF, 1984, BIOCHIM BIOPHYS ACTA, V767, P524, DOI 10.1016/0005-2728(84)90051-3; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; GHANOTAKIS DF, 1984, FEBS LETT, V170, P169, DOI 10.1016/0014-5793(84)81393-9; Hallick RB, 1989, PLANT MOL BIOL REP, V7, P266, DOI [10.1007/BF02668635, DOI 10.1007/BF02668635]; HANSSON O, 1990, PHOTOSYNTH RES, V23, P131, DOI 10.1007/BF00035006; HOMANN PH, 1988, BIOCHIM BIOPHYS ACTA, V934, P1, DOI 10.1016/0005-2728(88)90113-2; HUNZIKER D, 1987, BIOCHIM BIOPHYS ACTA, V890, P6, DOI 10.1016/0005-2728(87)90062-4; JOLIOT P, 1980, J CHIM PHYS PCB, V77, P209, DOI 10.1051/jcp/1980770209; KELLEY PM, 1978, BIOCHIM BIOPHYS ACTA, V502, P198, DOI 10.1016/0005-2728(78)90042-7; KO K, 1990, PLANT MOL BIOL, V14, P217, DOI 10.1007/BF00018562; KUWABARA T, 1985, BIOCHIM BIOPHYS ACTA, V806, P283, DOI 10.1016/0005-2728(85)90107-0; KUWABARA T, 1987, P NATL ACAD SCI USA, V84, P8230, DOI 10.1073/pnas.84.23.8230; MacKinney G, 1941, J BIOL CHEM, V140, P315; MAYFIELD SP, 1989, PLANT MOL BIOL, V12, P683, DOI 10.1007/BF00044159; MAYFIELD SP, 1987, EMBO J, V6, P313, DOI 10.1002/j.1460-2075.1987.tb04756.x; METZ JG, 1989, BIOCHEMISTRY-US, V28, P6960, DOI 10.1021/bi00443a028; MIYAO M, 1985, FEBS LETT, V180, P303, DOI 10.1016/0014-5793(85)81091-7; MIYAO M, 1986, PHOTOSYNTH RES, V10, P489, DOI 10.1007/BF00118315; MIYAO M, 1987, BIOCHIM BIOPHYS ACTA, V890, P151, DOI 10.1016/0005-2728(87)90016-8; ONO T, 1986, BIOCHIM BIOPHYS ACTA, V850, P380, DOI 10.1016/0005-2728(86)90194-5; ONO T, 1984, FEBS LETT, V166, P381, DOI 10.1016/0014-5793(84)80117-9; PAKRASI HB, 1989, PLANT CELL, V1, P591, DOI 10.2307/3868946; PETER GF, 1989, METHODS PLANT BIOCH, V5; PHILBRICK JB, 1988, MOL GEN GENET, V212, P418, DOI 10.1007/BF00330845; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; SINCLAIR J, 1984, BIOCHIM BIOPHYS ACTA, V764, P247, DOI 10.1016/0005-2728(84)90034-3; SIVARAJA M, 1989, BIOCHEMISTRY-US, V28, P9459, DOI 10.1021/bi00450a032; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; STEWART AC, 1985, BIOCHIM BIOPHYS ACTA, V808, P353, DOI 10.1016/0005-2728(85)90145-8; TYAGI A, 1987, MOL GEN GENET, V207, P288, DOI 10.1007/BF00331591; VASS I, 1987, BIOCHIM BIOPHYS ACTA, V892, P224, DOI 10.1016/0005-2728(87)90178-2; VASS I, 1987, FEBS LETT, V211, P215, DOI 10.1016/0014-5793(87)81439-4; VERMAAS W, 1990, BIOCHEMISTRY-US, V29, P5325, DOI 10.1021/bi00474a017; VERMAAS WFJ, 1988, P NATL ACAD SCI USA, V85, P8477, DOI 10.1073/pnas.85.22.8477; VERMAAS WFJ, 1986, P NATL ACAD SCI USA, V83, P9474, DOI 10.1073/pnas.83.24.9474; WALES R, 1989, PLANT MOL BIOL, V12, P439, DOI 10.1007/BF00017583	53	146	148	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13370	13376						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712783				2022-12-27	WOS:A1991FX13200089
J	DOLPHIN, C; SHEPHARD, EA; POVEY, S; PALMER, CNA; ZIEGLER, DM; AYESH, R; SMITH, RL; PHILLIPS, IR				DOLPHIN, C; SHEPHARD, EA; POVEY, S; PALMER, CNA; ZIEGLER, DM; AYESH, R; SMITH, RL; PHILLIPS, IR			CLONING, PRIMARY SEQUENCE, AND CHROMOSOMAL MAPPING OF A HUMAN FLAVIN-CONTAINING MONOOXYGENASE (FMO1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTION AMINE OXIDASE; SOMATIC-CELL HYBRIDS; FISH-ODOR SYNDROME; LIVER-MICROSOMES; SUBSTRATE-SPECIFICITY; PRIMARY ALKYLAMINES; N-OXIDATION; PIG-LIVER; DISTINCT; RABBIT	cDNA clones that code for a pig and human flavin-containing monooxygenase (FMO) have been isolated. The full-length sequence of the human cDNAs revealed that they encode a polypeptide of 532 amino acid residues containing putative FAD- and NADP-binding sites. The deduced amino acid sequence has 88 and 86% identity, respectively, with the pig and rabbit "hepatic" forms of FMO, but is only 58% similar to the rabbit "pulmonary" FMO, and thus represents the human ortholog of the "hepatic" form of FMO. However, as this FMO is present in low abundance in human adult liver, the general term "hepatic" for this form of the enzyme is misleading, and thus we propose the name FMO1 to describe this human FMO and its mammalian orthologs. Northern blot analysis demonstrated that human FMO1 mRNA is more abundant in fetal than in adult liver, indicating that in man the enzyme is subject to developmental regulation. Southern blot hybridization of human genomic DNA suggests that the protein is encoded by a single gene, which has been designated FMO1 and mapped to chromosome 1.	UNIV LONDON,QUEEN MARY & WESTFIELD COLL,DEPT BIOCHEM,MILE END RD,LONDON E1 4NS,ENGLAND; UNIV LONDON UNIV COLL,DEPT BIOCHEM & MOLEC BIOL,LONDON WC1E 6BT,ENGLAND; GALTON LAB,MRC,HUMAN BIOCHEM GENET UNIT,LONDON NW1 2HE,ENGLAND; UNIV TEXAS,DEPT CHEM & BIOCHEM,CLAYTON FDN BIOCHEM INST,AUSTIN,TX 78712; UNIV LONDON,ST MARYS HOSP,SCH MED,DEPT PHARMACOL & TOXICOL,LONDON W2 1PG,ENGLAND	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; University of Texas System; University of Texas Austin; Imperial College London; University of London			Phillips, Ian R/A-7337-2008; Palmer, Colin NA/C-7053-2008	Palmer, Colin NA/0000-0002-6415-6560	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALWAIZ M, 1987, XENOBIOTICA, V17, P551, DOI 10.3109/00498258709043962; ALWAIZ M, 1987, CLIN PHARMACOL THER, V42, P588, DOI 10.1038/clpt.1987.201; ALWAIZ M, 1987, LANCET, V1, P634; ANDREWS PW, 1985, ANN HUM GENET, V49, P31, DOI 10.1111/j.1469-1809.1985.tb01673.x; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOYD Y, 1987, CLIN GENET, V31, P84; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DENHARDT DT, 1966, BIOCHEM BIOPH RES CO, V23, P641, DOI 10.1016/0006-291X(66)90447-5; EDWARDS YH, 1985, ANN HUM GENET, V49, P101, DOI 10.1111/j.1469-1809.1985.tb01681.x; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fourney R.M., 1988, FOCUS, V10, P5; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GASSER R, 1990, BIOCHEMISTRY-US, V29, P119, DOI 10.1021/bi00453a014; GOLD MS, 1973, XENOBIOTICA, V3, P179, DOI 10.3109/00498257309151512; HARRIS H, 1976, HDB ELECTROPHORESIS; HARRIS H, 1977, HDB ELECTROPHORESI S; HIGGINS T, 1972, BIOCHEM MED METAB B, V6, P392, DOI 10.1016/0006-2944(72)90025-7; HLAVICA P, 1977, BIOCHEM J, V164, P487, DOI 10.1042/bj1640487; HUMBERT JR, 1970, LANCET, V2, P770; HUYNH TY, 1985, DNA CLONING PRACTICA, P109; KIELTY CM, 1982, ANN HUM GENET, V46, P307, DOI 10.1111/j.1469-1809.1982.tb01582.x; KIMURA T, 1983, BIOCHEM BIOPH RES CO, V110, P640, DOI 10.1016/0006-291X(83)91197-X; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAWTON MP, 1990, J BIOL CHEM, V265, P5855; LEMOINE A, 1990, ARCH BIOCHEM BIOPHYS, V276, P336, DOI 10.1016/0003-9861(90)90729-I; MASTERS BSS, 1971, ARCH BIOCHEM BIOPHYS, V145, P358, DOI 10.1016/0003-9861(71)90048-8; MASTERS BSS, 1971, J BIOL CHEM, V246, P4143; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; OZOLS J, 1990, J BIOL CHEM, V265, P10289; OZOLS J, 1989, BIOCHEM BIOPH RES CO, V163, P49, DOI 10.1016/0006-291X(89)92097-4; POULSEN LL, 1986, MOL PHARMACOL, V30, P680; RANE A, 1973, CLIN PHARMACOL THER, V15, P32; SABOURIN PJ, 1984, INT J BIOCHEM, V16, P713, DOI 10.1016/0020-711X(84)90180-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHELLEY ED, 1984, JAMA-J AM MED ASSOC, V251, P253, DOI 10.1001/jama.251.2.253; SHEPHARD EA, 1989, ANN HUM GENET, V53, P23, DOI 10.1111/j.1469-1809.1989.tb01119.x; SOLOMON E, 1979, ANN HUM GENET, V42, P273, DOI 10.1111/j.1469-1809.1979.tb00661.x; TYNES RE, 1986, ARCH BIOCHEM BIOPHYS, V251, P654, DOI 10.1016/0003-9861(86)90375-9; TYNES RE, 1985, ARCH BIOCHEM BIOPHYS, V240, P77, DOI 10.1016/0003-9861(85)90010-4; TYNES RE, 1985, BIOCHEM BIOPH RES CO, V126, P1069, DOI 10.1016/0006-291X(85)90294-3; WILLIAMS DE, 1984, BIOCHEM BIOPH RES CO, V125, P116, DOI 10.1016/S0006-291X(84)80342-3; WONG Z, 1987, ANN HUM GENET, V51, P260; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; ZIEGLER DM, 1988, DRUG METAB REV, V19, P1, DOI 10.3109/03602538809049617; ZIEGLER DM, 1990, TRENDS PHARMACOL SCI, V11, P321, DOI 10.1016/0165-6147(90)90235-Z	47	94	95	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12379	12385						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712018				2022-12-27	WOS:A1991FV18000045
J	MORRIS, GL; CHENG, HC; COLYER, J; WANG, JH				MORRIS, GL; CHENG, HC; COLYER, J; WANG, JH			PHOSPHOLAMBAN REGULATION OF CARDIAC SARCOPLASMIC-RETICULUM (CA2+-MG2+)-ATPASE - MECHANISM OF REGULATION AND SITE OF MONOCLONAL-ANTIBODY INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CALCIUM-TRANSPORT; CA-2+ PUMP; SMOOTH-MUSCLE; PHOSPHORYLATION; STIMULATION; ATPASE; SEQUENCE; CLEAVAGE; VESICLES	Monoclonal antibodies raised against canine cardiac sarcoplasmic reticulum phospholamban were used to study the structure-function relationship between phospholamban and the sarcoplasmic reticulum (SR) (Ca2+-Mg2+)-ATPase (Suzuki, T., and Wang, J. H. (1986) J. Biol. Chem. 261, 7018-7023). Additional monoclonal antibodies are characterized further. When five of these monoclonal antibodies were assessed for their ability to affect SR Ca2+ uptake three of these antibodies had no effect on SR Ca2+ uptake, whereas the other two monoclonals were able to stimulate SR Ca2+ uptake to levels similar to those caused by phosphorylation of phospholamban at different calcium concentrations. Using synthetic peptides corresponding to various portions of phospholamban in a competitive binding assay, it was possible to map the epitope site of monoclonals which stimulate the (Ca2+-Mg2+)-ATPase activity to phospholamban residues 7-16. These results implicate phospholamban residues 7-16 in the regulation of the (Ca2+-Mg2+)-ATPase.	UNIV CALGARY,DEPT MED BIOCHEM,CELL REGULAT GRP,CALGARY T2N 4N1,ALBERTA,CANADA	University of Calgary				Cheng, Heung-Chin/0000-0002-4965-7148				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; CHIESI M, 1989, FEBS LETT, V244, P240; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; FUJII J, 1989, J BIOL CHEM, V264, P12950; FUJII J, 1987, J CLIN INVEST, V79, P301, DOI 10.1172/JCI112799; Hudson L, 1989, PRACTICAL IMMUNOLOGY, P348; HUGGINS JP, 1989, BIOCHEM J, V260, P829, DOI 10.1042/bj2600829; JAMES P, 1989, NATURE, V342, P90, DOI 10.1038/342090a0; KIM HW, 1990, J BIOL CHEM, V265, P1702; KIRCHBERGER MA, 1982, J BIOL CHEM, V257, P5685; KIRCHBERGER MA, 1986, BIOCHEMISTRY-US, V25, P5484, DOI 10.1021/bi00367a021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEPEUCH CJ, 1979, BIOCHEMISTRY-US, V18, P5150, DOI 10.1021/bi00590a019; MARTONOSI A, 1964, J BIOL CHEM, V239, P648; MITCHELL AR, 1976, J AM CHEM SOC, V98, P7357, DOI 10.1021/ja00439a041; MOVSESIAN MA, 1984, J BIOL CHEM, V259, P8029; PETERS KA, 1977, BIOCHEMISTRY-US, V16, P5691, DOI 10.1021/bi00645a007; RAEYMAEKERS L, 1988, BIOCHEM J, V252, P269, DOI 10.1042/bj2520269; ROGERS TB, 1990, J BIOL CHEM, V265, P4302; SIMMERMAN HKB, 1989, BIOCHIM BIOPHYS ACTA, V997, P322, DOI 10.1016/0167-4838(89)90203-3; SIMMERMAN HKB, 1986, J BIOL CHEM, V261, P3333; SUZUKI T, 1987, BIOCHEM CELL BIOL, V65, P302, DOI 10.1139/o87-039; SUZUKI T, 1986, J BIOL CHEM, V261, P7018; TADA M, 1975, J BIOL CHEM, V250, P2640; TADA M, 1979, J BIOL CHEM, V254, P319; TADA M, 1989, BIOESSAYS, V10, P157, DOI 10.1002/bies.950100505; TADA M, 1978, PHYSIOL REV, V58, P1; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEGENER AD, 1989, J BIOL CHEM, V264, P11468; WEGENER AD, 1986, J BIOL CHEM, V261, P5154; XU ZC, 1989, J BIOL CHEM, V264, P16644	33	80	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11270	11275						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710223				2022-12-27	WOS:A1991FQ77400087
J	STRYER, L				STRYER, L			VISUAL EXCITATION AND RECOVERY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ROD OUTER SEGMENTS; CYCLIC-GMP PHOSPHODIESTERASE; RETINAL RODS; CGMP PHOSPHODIESTERASE; INHIBITORY SUBUNIT; ACTIVATED CHANNEL; FUNCTIONAL EXPRESSION; MOLECULAR MECHANISM; NUCLEOTIDE CASCADE; LIGHT ADAPTATION				STRYER, L (corresponding author), STANFORD UNIV, MED CTR, SCH MED, SHERMAN FAIRCHILD CTR, DEPT CELL BIOL, STANFORD, CA 94305 USA.				NEI NIH HHS [EY-02005] Funding Source: Medline; NIGMS NIH HHS [GM-24032] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002005, R37EY002005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024032, R37GM024032] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARSHAVSKY VY, 1991, BIOPHYS J, V59, pA407; BAEHR W, 1979, J BIOL CHEM, V254, P1669; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1987, INVEST OPHTH VIS SCI, V28, P34; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; BLUMER KJ, 1988, COLD SPRING HARB SYM, V53, P591, DOI 10.1101/SQB.1988.053.01.068; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BROWN RL, 1989, P NATL ACAD SCI USA, V86, P4922, DOI 10.1073/pnas.86.13.4922; CASEY PJ, 1988, COLD SPRING HARB SYM, V53, P203, DOI 10.1101/SQB.1988.053.01.026; CERVETTO L, 1989, NATURE, V337, P740, DOI 10.1038/337740a0; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; COOK NJ, 1988, J BIOL CHEM, V263, P11382; COOPER A, 1981, FEBS LETT, V123, P324, DOI 10.1016/0014-5793(81)80319-5; DETERRE P, 1986, Proteins Structure Function and Genetics, V1, P188, DOI 10.1002/prot.340010210; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DRATZ EA, 1987, BIOCHEM BIOPH RES CO, V146, P379, DOI 10.1016/0006-291X(87)90540-7; DRATZ EA, 1983, TRENDS BIOCHEM SCI, V8, P128, DOI 10.1016/0968-0004(83)90235-9; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FOWLES C, 1989, BIOCHEMISTRY-US, V28, P9385, DOI 10.1021/bi00450a020; FUNG BKK, 1989, BIOCHEMISTRY-US, V28, P3133, DOI 10.1021/bi00434a003; FUNG BKK, 1990, BIOCHEMISTRY-US, V29, P2657, DOI 10.1021/bi00463a006; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; HAYWARD G, 1981, SCIENCE, V211, P942, DOI 10.1126/science.7466366; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; HO YK, 1989, CURR TOP CELL REGUL, V30, P171; HURLEY JB, 1982, J BIOL CHEM, V257, P1094; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; JONES DT, 1989, SCIENCE, V244, P790, DOI 10.1126/science.2499043; KARPEN JW, 1988, COLD SPRING HARB SYM, V53, P325, DOI 10.1101/SQB.1988.053.01.039; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KAUPP UB, 1988, COLD SPRING HARB SYM, V53, P407, DOI 10.1101/SQB.1988.053.01.048; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LANCET D, 1988, COLD SPRING HARB SYM, V53, P343, DOI 10.1101/SQB.1988.053.01.041; LEFKOWITZ RJ, 1988, COLD SPRING HARB SYM, V53, P507, DOI 10.1101/SQB.1988.053.01.058; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; LUDWIG J, 1990, FEBS LETT, V270, P24, DOI 10.1016/0014-5793(90)81226-E; MILLER JL, 1986, BIOCHEMISTRY-US, V25, P4983, DOI 10.1021/bi00366a002; MILLER WH, 1990, INVEST OPHTH VIS SCI, V31, P1664; MONCRIEF ND, 1990, J MOL EVOL, V30, P522, DOI 10.1007/BF02101108; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NUMA S, 1988, COLD SPRING HARB SYM, V53, P295, DOI 10.1101/SQB.1988.053.01.036; PALCZEWSKI K, 1989, BIOCHEMISTRY-US, V28, P415, DOI 10.1021/bi00428a001; POLANS AS, 1991, J CELL BIOL, V112, P981, DOI 10.1083/jcb.112.5.981; PUPILLO M, 1988, COLD SPRING HARB SYM, V53, P657, DOI 10.1101/SQB.1988.053.01.075; STRYER L, 1987, CHEM SCRIPTA, V27B, P161; STRYER L, 1988, COLD SPRING HARB SYM, V53, P283, DOI 10.1101/SQB.1988.053.01.035; VUONG T M, 1991, Biophysical Journal, V59, p348A; VUONG TM, 1990, NATURE, V346, P71, DOI 10.1038/346071a0; VUONG TM, 1984, NATURE, V311, P659, DOI 10.1038/311659a0; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; WENSEL T G, 1986, Proteins Structure Function and Genetics, V1, P90, DOI 10.1002/prot.340010114; WENSEL TG, 1990, BIOCHEMISTRY-US, V29, P2155, DOI 10.1021/bi00460a028; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; YAMAGATA K, 1990, NEURON, V4, P469, DOI 10.1016/0896-6273(90)90059-O; YAMAZAKI A, 1990, J BIOL CHEM, V265, P11539; YAU KW, 1985, NATURE, V313, P579, DOI 10.1038/313579a0; YAU KW, 1979, NATURE, V279, P806, DOI 10.1038/279806a0; ZIMMERMAN AL, 1985, P NATL ACAD SCI USA, V82, P8813, DOI 10.1073/pnas.82.24.8813	67	427	440	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					10711	10714						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710212				2022-12-27	WOS:A1991FQ77400001
J	HEYDRICK, SJ; LARDEUX, BR; MORTIMORE, GE				HEYDRICK, SJ; LARDEUX, BR; MORTIMORE, GE			UPTAKE AND DEGRADATION OF CYTOPLASMIC RNA BY HEPATIC LYSOSOMES - QUANTITATIVE RELATIONSHIP TO RNA TURNOVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED-RAT-LIVER; AMINO-ACID DEPRIVATION; PROTEIN-DEGRADATION; AUTOPHAGY; PROTEOLYSIS; INSULIN; PH; COMPARTMENTATION; PERMEABILITY; FRACTIONS	Past evidence has suggested that the lysosomal pathway is an important site of cytoplasmic RNA degradation in the hepatic parenchymal cell (Lardeux, B. R., Heydrick, S. J., and Mortimore, G. E. (1987) J. Biol. Chem. 262, 14507-14519). We now provide additional support for this notion by quantitating degradable RNA in lysosomes and correlating its pool size with hepatic RNA degradation. Rat livers, previously labeled with [6-C-14]orotic acid, were perfused with graded levels of amino acids over the full range of induced autophagy; RNA degradation was determined from [C-14]cytidine release. Close correspondence between the marker beta-acetylglucosaminidase and the breakdown of RNA to cytidine in subcellular fractions indicated that the lysosome was the main site of catabolism, a conclusion supported by the fact that degradation was enhanced when external pH was lowered from 7 to 6. Although [C-14]cytidine was also released in homogenates by the action of neutral ribonucleases on cytosolic RNA, this source was eliminated by unlabeled exogenous RNA. The size of the degradable RNA pool in lysosomes, determined from the total release of cytidine in homogenates, correlated directly with rates of hepatic RNA degradation over the full range of basal and induced degradation. A direct correlation was also seen between RNA degradation and cytidine pools within lysosomal particles. Because cytosolic cytidine was not taken up by lysosomes under these conditions, the pool could only have arisen from the breakdown of intralysosomal RNA. As determined by cytidine production, these findings support the view that the lysosomal-vacuolar system is the main, if not sole, site of induced and basal RNA degradation in liver.	PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT CELLULAR & MOLEC PHYSIOL,HERSHEY,PA 17033	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health					NIDDK NIH HHS [DK 21624] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021624] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLBERG J, 1982, LAB INVEST, V47, P523; BALAVOINE S, 1990, EUR J BIOCHEM, V19, P617; BARTHOLEYNS J, 1975, EUR J BIOCHEM, V57, P205, DOI 10.1111/j.1432-1033.1975.tb02292.x; BAUDHUIN P, 1975, EUR J BIOCHEM, V57, P213, DOI 10.1111/j.1432-1033.1975.tb02293.x; BURTON R, 1975, BIOCHEM SOC T, V3, P1251, DOI 10.1042/bst0031251; CLIFFORD AJ, 1972, BIOCHIM BIOPHYS ACTA, V277, P443, DOI 10.1016/0005-2787(72)90087-1; FOUCHIER F, 1983, ACTA ENDOCRINOL-COP, V103, P53, DOI 10.1530/acta.0.1030053; GOLDMAN R, 1973, FEBS LETT, V33, P233, DOI 10.1016/0014-5793(73)80200-5; HIRSCH CA, 1966, J BIOL CHEM, V241, P5936; KHAN MN, 1981, P NATL ACAD SCI-BIOL, V78, P4980, DOI 10.1073/pnas.78.8.4980; KIMBALL SR, 1987, BIOCHEM CELL BIOL, V65, P27, DOI 10.1139/o87-004; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LARDEUX B, 1983, ANAL BIOCHEM, V131, P160, DOI 10.1016/0003-2697(83)90148-3; LARDEUX BR, 1987, J BIOL CHEM, V262, P14514; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; MORTIMORE GE, 1988, J BIOL CHEM, V263, P2506; MORTIMORE GE, 1972, J BIOL CHEM, V247, P2776; MORTIMORE GE, 1973, BIOCHEM BIOPH RES CO, V54, P89, DOI 10.1016/0006-291X(73)90892-9; MORTIMORE GE, 1984, FED PROC, V43, P1289; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; MORTIMORE GE, 1981, J BIOL CHEM, V256, P7659; NEELY AN, 1974, BIOCHIM BIOPHYS ACTA, V338, P458, DOI 10.1016/0304-4165(74)90307-9; NYGARD O, 1975, CHEM-BIOL INTERACT, V11, P589, DOI 10.1016/0009-2797(75)90033-2; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; PAPADOPOULOS T, 1986, LAB INVEST, V54, P100; PETERS TJ, 1972, J EXP MED, V136, P117; PFEIFER U, 1973, VIRCHOWS ARCH B, V12, P195; PISONI RL, 1989, J BIOL CHEM, V264, P4850; POSO AR, 1984, P NATL ACAD SCI-BIOL, V81, P4270, DOI 10.1073/pnas.81.14.4270; POULSON R, 1977, RIBONUCLEIC ACIDS, P340; REIJNGOUD DJ, 1976, BIOCHIM BIOPHYS ACTA, V448, P290, DOI 10.1016/0005-2736(76)90243-1; ROTH JS, 1967, METHOD CANCER RES, V3, P153; SAMESHIMA M, 1981, MOL CELL BIOL, V1, P75, DOI 10.1128/MCB.1.1.75; SCHWORER CM, 1981, J BIOL CHEM, V256, P7652; Sierakowska H, 1977, Prog Nucleic Acid Res Mol Biol, V20, P59; SURMACZ CA, 1987, BIOCHEM J, V242, P453, DOI 10.1042/bj2420453; TSURUGI K, 1974, EUR J BIOCHEM, V45, P119, DOI 10.1111/j.1432-1033.1974.tb03536.x; VANDYCK JM, 1968, EUR J BIOCHEM, V7, P15; WARD WF, 1978, J BIOL CHEM, V253, P3581	39	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					8790	8796						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709158				2022-12-27	WOS:A1991FM03800027
J	SEIFFERT, D; LOSKUTOFF, DJ				SEIFFERT, D; LOSKUTOFF, DJ			EVIDENCE THAT TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR BINDS TO THE SOMATOMEDIN-B DOMAIN OF VITRONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL CELLS; GROWTH FACTOR-BETA; EXTRACELLULAR-MATRIX; HUMAN-PLASMA; MONOCLONAL-ANTIBODIES; POLYACRYLAMIDE GELS; HUMAN-PLATELETS; S-PROTEIN; PURIFICATION; PAI-1	The interaction between type 1 plasminogen activator inhibitor (PAI-1) and fragments of vitronectin (Vn) was investigated. The PAI-1-binding domain was not destroyed when Vn ws cleaved by treatment with either acid or CNBr. Acid-cleaved Vn was fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and analyzed by PAI-1 ligand binding. The smallest fragment (M(r) 40,000) that retained PAI-1 binding function was sequenced and shown to contain the NH2 terminus of the molecule. Further cleavage of this fragment by treatment with CNBr generated a M(r) 35,000 fragment (Pro52-Asp239) that did not interact with PAI-1, and a M(r) 6,000 NH2-terminal fragment (Asp1-Met51) that spanned the somatomedin B domain and contained the RGD (cell binding) sequence. The purified M(r) 6,000 fragment competed with immobilized Vn for PAI-1 binding, and formed complexes with activated PAI-1. These complexes could be immuno-precipitated by antibodies to PAI-1. Synthetic peptides containing the RGD sequence had no effect on the binding of this fragment to PAI-1. These results suggest that the cell-binding and PAI-1-binding sequences of Vn occupy distinct regions in the NH2-terminal somatomedin B domain of the molecule.	Scripps Res Inst, RES INST, COMM VASC BIOL IMM14, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA	Scripps Research Institute					NHLBI NIH HHS [HL31950] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASTRUP T, 1978, PROGR CHEM FIBRINOLY, P1; BOOTH NA, 1985, J CLIN PATHOL, V38, P825, DOI 10.1136/jcp.38.7.825; COLLEN D, 1980, THROMB HAEMOSTASIS, V43, P77; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; ERICKSON LA, 1986, BLOOD, V68, P1298; FRYKLUND L, 1974, BIOCHEM BIOPH RES CO, V61, P950, DOI 10.1016/0006-291X(74)90247-2; HARLOW E, 1988, ANTIBODIES LABORATOR; HEKMAN CM, 1988, ARCH BIOCHEM BIOPHYS, V262, P199, DOI 10.1016/0003-9861(88)90182-8; HEKMAN CM, 1988, BIOCHEMISTRY-US, V27, P2911, DOI 10.1021/bi00408a037; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HELDIN CH, 1981, SCIENCE, V213, P1122, DOI 10.1126/science.6973821; HOLLENBERG MD, 1977, LIFE SCI, V21, P943, DOI 10.1016/0024-3205(77)90260-0; IZUMI M, 1988, CELL STRUCT FUNCT, V13, P217, DOI 10.1247/csf.13.217; KAREY KP, 1989, ANAL BIOCHEM, V178, P255, DOI 10.1016/0003-2697(89)90634-9; KNUDSEN BS, 1987, J CLIN INVEST, V80, P1082, DOI 10.1172/JCI113164; KOOISTRA T, 1986, BIOCHEM J, V239, P497, DOI 10.1042/bj2390497; KRUITHOF EKO, 1987, BLOOD, V70, P1645; KRUITHOF EKO, 1986, THROMB HAEMOSTASIS, V55, P201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIHO M, 1986, J CELL BIOL, V103, P2403, DOI 10.1083/jcb.103.6.2403; LAIHO M, 1987, J BIOL CHEM, V262, P17467; LEVIN EG, 1987, BLOOD, V70, P1090; LEVIN EG, 1987, J CELL BIOL, V105, P2543, DOI 10.1083/jcb.105.6.2543; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIMURO J, 1987, BLOOD, V70, P721; MIMURO J, 1989, J BIOL CHEM, V264, P936; MIMURO J, 1989, J BIOL CHEM, V264, P5058; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; PANNEKOEK H, 1989, THROMB HAEMOSTASIS, V62, P11; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PREISSNER KT, 1985, BIOCHEM J, V231, P349, DOI 10.1042/bj2310349; PREISSNER KT, 1989, BLOOD, V74, P1989; RHEINWALD JG, 1987, J CELL BIOL, V104, P263, DOI 10.1083/jcb.104.2.263; SAKSELA O, 1985, BIOCHIM BIOPHYS ACTA, V823, P35, DOI 10.1016/0304-419X(85)90014-9; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; SARA VR, 1979, SOMATOMEDINS GROWTH, P225; SCHLEEF RR, 1985, THROMB HAEMOSTASIS, V53, P170; SEIFFERT D, 1990, J CELL BIOL, V111, P1283, DOI 10.1083/jcb.111.3.1283; SEIFFERT D, 1990, FIBRINOLYSIS, V4, P197, DOI 10.1016/0268-9499(90)90014-B; SPRENGERS ED, 1986, THROMB HAEMOSTASIS, V55, P325; SPRENGERS ED, 1987, BLOOD, V69, P381; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANMOURIK JA, 1984, J BIOL CHEM, V259, P14914; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2; WUN TC, 1989, J BIOL CHEM, V264, P7862; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	52	149	152	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2824	2830						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704366				2022-12-27	WOS:A1991EX60000027
J	KOMURO, I; KATOH, Y; KAIDA, T; SHIBAZAKI, Y; KURABAYASHI, M; HOH, E; TAKAKU, F; YAZAKI, Y				KOMURO, I; KATOH, Y; KAIDA, T; SHIBAZAKI, Y; KURABAYASHI, M; HOH, E; TAKAKU, F; YAZAKI, Y			MECHANICAL LOADING STIMULATES CELL HYPERTROPHY AND SPECIFIC GENE-EXPRESSION IN CULTURED RAT CARDIAC MYOCYTES - POSSIBLE ROLE OF PROTEIN-KINASE-C ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN MESSENGER-RNAS; ALPHA-ACTIN; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; PHORBOL ESTER; INDUCTION; MOUSE; TRANSCRIPTION; INHIBITORS; ONCOGENE	To examine the molecular mechanisms by which mechanical stimuli induce cardiac hypertrophy and specific gene expression, we cultured rat neonatal cardiocytes in deformable dishes and imposed an in vitro mechanical load by stretching the adherent cells. Myocyte stretching increased total cell RNA content and mRNA levels of c-fos and skeletal alpha-actin. Nuclear run-off transcription assay revealed that this increase in c-fos mRNA level by stretching at least partially reflects changes in the transcriptional status. The transfected chloramphenicol acetyltransferase gene linked to upstream sequences of the fos gene indicated that sequences containing a serum response element were required for efficient transcription by stretching and that sequences containing a cAMP/calcium response element might not be involved in the c-fos mRNA by stretching was suppressed by protein kinase C inhibitors at the transcriptional level and inhibited markedly by down-regulation of protein kinase C. Moreover, myocyte stretching increased inositol phosphate levels, and activation of protein kinase C by phorbol esters stimulated the expression of c-fos and skeletal alpha-actin genes. These findings suggest that mechanical stimuli (myocyte stretching) might directly induce cardiac hypertrophy and specific gene expression possibly via protein kinase C activation.	UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo								AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; BHAGYALAKSHMI A, 1989, BIOCHEM BIOPH RES CO, V158, P31, DOI 10.1016/S0006-291X(89)80172-X; BISHOPRIC NH, 1987, J CLIN INVEST, V80, P1194, DOI 10.1172/JCI113179; DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379; FULLER SJ, 1989, FEBS LETT, V247, P209, DOI 10.1016/0014-5793(89)81336-5; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HENRICH CJ, 1988, J MOL CELL CARDIOL, V20, P1081, DOI 10.1016/0022-2828(88)90588-3; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; KOMURO I, 1990, J BIOL CHEM, V265, P3595; MANN DL, 1989, CIRC RES, V64, P1079, DOI 10.1161/01.RES.64.6.1079; MINTY AJ, 1982, CELL, V30, P185, DOI 10.1016/0092-8674(82)90024-1; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHIBANUMA M, 1987, EUR J BIOCHEM, V164, P15, DOI 10.1111/j.1432-1033.1987.tb10985.x; SIMPSON PC, 1985, CLIN RES, V33, pA229; STARKSEN NF, 1986, P NATL ACAD SCI USA, V83, P8348, DOI 10.1073/pnas.83.21.8348; VANDENBURGH H, 1979, SCIENCE, V203, P265, DOI 10.1126/science.569901; VANDENBURGH HH, 1990, AM J PHYSIOL, V259, pC232, DOI 10.1152/ajpcell.1990.259.2.C232; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; VONHARSDORF R, 1989, CIRC RES, V65, P494, DOI 10.1161/01.RES.65.2.494; ZAK R, 1974, CIRC RES, V35, P17	27	413	418	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1265	1268						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702436				2022-12-27	WOS:A1991ET17700089
J	SILVANOVICH, A; ASTWOOD, J; ZHANG, L; OLSEN, E; KISIL, F; SEHON, A; MOHAPATRA, S; HILL, R				SILVANOVICH, A; ASTWOOD, J; ZHANG, L; OLSEN, E; KISIL, F; SEHON, A; MOHAPATRA, S; HILL, R			NUCLEOTIDE-SEQUENCE ANALYSIS OF 3 CDNAS CODING FOR POA-P IX ISOALLERGENS OF KENTUCKY BLUEGRASS POLLEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; LOLIUM-PERENNE POLLEN; IMMUNOCHEMICAL CHARACTERIZATION; ALLERGEN; PROTEIN; DNA; PURIFICATION; CLONING; GENE	Grass pollen allergens are one of the major causes of type I allergic reactions (allergic rhinoconjunctivitis, allergic bronchial asthma, and hayfever) in temperate climates afflicting 15-20% of a genetically predisposed population. Workers have found considerable physico-and immunochemical heterogeneity within the grass pollen allergens which has made them difficult to purify for both therapeutic uses and further biochemical study. We recently reported the construction of a cDNA library in lambda-gt11 using mRNA extracted from dehydrated Kentucky bluegrass (KBG, Poa pratensis). Here, we present the nucleotide and deduced amino acid sequences for three KBG pollen allergen cDNA clones, KBG 41, 60, and 31, which were isolated from the above library using a pool of six sera from grass pollen allergic patients. These clones exhibit an exceptionally high degree of sequence similarity to one another, only minor similarity to other known allergens, and no homologies to other known proteins or genes. The predicted molecular mass for the cloned proteins range from 28.3 to 37.8 kDa with pI values of 9.6-10.2. All three clones appear to possess leader peptides and lack asparagine sequons required for N-glycosylation. Therefore, the molecular mass of the post-translationally modified proteins were calculated to be 28.4-34.9 kDa, which is consistent with the size of the polypeptides revealed in Western blots of pollen proteins using an antiserum to a recombinant peptide encoded by the partial cDNA clone KBG 8.3. Northern blotting analysis indicates that expression of the genes corresponding to these clones is confined to pollen tissue. The results suggest that the clones code for a group of proteins that represent a new and previously uncharacterized group of grass pollen isoallergens, which have been hereby designated as Poa p IX.	UNIV MANITOBA,DEPT IMMUNOL,730 WILLIAM AVE,WINNIPEG R3E 0W3,MANITOBA,CANADA; UNIV MANITOBA,DEPT PLANT SCI,WINNIPEG R3E 0W3,MANITOBA,CANADA; UNIV MANITOBA,MED RES COUNCIL,ALLERGY RES GRP,WINNIPEG R3E 0W3,MANITOBA,CANADA	University of Manitoba; University of Manitoba; University of Manitoba			Mohapatra, Shyam/C-2500-2012					ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; ANSARI AA, 1989, BIOCHEMISTRY-US, V28, P8665, DOI 10.1021/bi00447a058; ANSARI AA, 1989, J BIOL CHEM, V264, P11181; ATTASSI AA, 1990, EPITOPES ATOPIC ALLE, P33; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; CHUA KY, 1988, J EXP MED, V167, P175, DOI 10.1084/jem.167.1.175; CHUA KY, 1988, INT ARCH ALLER A IMM, V85, P127; COTTAM GP, 1986, BIOCHEM J, V234, P305, DOI 10.1042/bj2340305; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; EKRAMODDOULLAH AKM, 1983, MOL IMMUNOL, V20, P465, DOI 10.1016/0161-5890(83)90027-5; ESCH RE, 1989, MOL IMMUNOL, V26, P557, DOI 10.1016/0161-5890(89)90007-2; FANG KSY, 1988, P NATL ACAD SCI USA, V85, P895, DOI 10.1073/pnas.85.3.895; FRAGA S, 1982, CAN J CHEM, V60, P2606, DOI 10.1139/v82-374; GUO LH, 1984, GENE, V29, P251, DOI 10.1016/0378-1119(84)90186-0; IPSEN H, 1983, J ALLERGY CLIN IMMUN, V72, P150, DOI 10.1016/0091-6749(83)90523-7; KAPLAN AP, 1985, ALLERGY; KASLOW DC, 1986, NUCLEIC ACIDS RES, V14, P6767, DOI 10.1093/nar/14.16.6767; KLAPPER DG, 1980, BIOCHEMISTRY-US, V19, P5729, DOI 10.1021/bi00566a010; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEITERMANN K, 1984, J ALLERGY CLIN IMMUN, V74, P147, DOI 10.1016/0091-6749(84)90278-1; LIN ZW, 1988, INT ARCH ALLER A IMM, V87, P294, DOI 10.1159/000234688; LUTCKE HA, 1987, EMBO J, V6, P43, DOI 10.1002/j.1460-2075.1987.tb04716.x; MARSH DG, 1986, B WORLD HEALTH ORGAN, V64, P767; MATTHIESEN F, 1990, EPITOPES ATOPIC ALLE, P9; MOHAPATRA S, 1990, IN PRESS 1ST P PAN S; MOHAPATRA SS, 1990, INT ARCH ALLER A IMM, V91, P362, DOI 10.1159/000235142; MOHAPATRA SS, 1990, EPITOPES ATOPIC ALLE, P61; MOLE LE, 1975, BIOCHEMISTRY-US, V14, P1216, DOI 10.1021/bi00677a019; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; THOMAS WR, 1990, EPITOPES ATOPIC ALLE, P77; TOVEY ER, 1989, J EXP MED, V170, P1457, DOI 10.1084/jem.170.4.1457; UNANUE ER, 1985, NATURE, V317, P359; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4	37	104	114	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1204	1210						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702432				2022-12-27	WOS:A1991ET17700081
J	BAUMANN, H; JAHREIS, GP; MORELLA, KK				BAUMANN, H; JAHREIS, GP; MORELLA, KK			INTERACTION OF CYTOKINE-RESPONSE AND GLUCOCORTICOID-RESPONSE ELEMENTS OF ACUTE-PHASE PLASMA-PROTEIN GENES - IMPORTANCE OF GLUCOCORTICOID RECEPTOR LEVEL AND CELL TYPE FOR REGULATION OF THE ELEMENTS FROM RAT ALPHA-1-ACID GLYCOPROTEIN AND BETA-FIBRINOGEN GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; HEPATOCYTE-STIMULATING FACTOR; ALPHA-1-ACID GLYCOPROTEIN; DOWN-REGULATION; MESSENGER-RNA; TRANSGENIC MICE; CULTURED-CELLS; NUCLEAR FACTOR; EXPRESSION; TRANSCRIPTION	Dexamethasone increased the transcriptional activity of several acute-phase plasma protein genes in cytokine-treated HepG2 cells, suggesting the presence of functional glucocorticoid receptors (GR). The level of GR was, however, insufficient for stimulation of transiently transfected gene constructs containing glucocorticoid-response elements (GRE). By complementation of HepG2 cells with a GR expression vector, a cell system was generated that allowed analysis of the interaction between GRE and cytokine-response elements of the rat-alpha-1-acid glycoprotein gene and identification of the principal regulatory elements of the rat-beta-fibrinogen gene. Although the expression of plasmid-derived GR mRNA was reduced by dexamethasone treatment, the concentration of GR was sufficient for full, short-term stimulation of GRE-containing vectors. By comparing the pattern of regulation of the cloned GRES in HepG2 and mouse L-cells, an equivalent, cell-type independent dexamethasone response was monitored for the alpha-1-acid glycoprotein element but a response limited to HepG2 cells was found for the beta-fibrinogen element. The data indicate that, although substantial differences exist in the organization and composition of the regulatory elements of the two genes, the overall function is, nevertheless, remarkably similar.			BAUMANN, H (corresponding author), NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT MOLEC & CELLULAR BIOL,BUFFALO,NY 14263, USA.				NCI NIH HHS [CA26222] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ARCONE R, 1988, NUCLEIC ACIDS RES, V16, P3195, DOI 10.1093/nar/16.8.3195; BAUER J, 1989, FED EUR BIOCH SOC, V249, P2730; BAUMANN H, 1989, IN VITRO CELL DEV B, V25, P115; BAUMANN H, 1987, J IMMUNOL, V139, P4122; BAUMANN H, 1988, J BIOL CHEM, V263, P17390; BAUMANN H, 1989, ANN NY ACAD SCI, V557, P280; BAUMANN H, 1986, MOL CELL BIOL, V6, P2551, DOI 10.1128/MCB.6.7.2551; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; CHALEPAKIS G, 1988, CELL, V53, P371, DOI 10.1016/0092-8674(88)90157-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CILIBERTO G, 1987, EMBO J, V6, P4017, DOI 10.1002/j.1460-2075.1987.tb02745.x; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7939; DENTE L, 1985, NUCLEIC ACIDS RES, V13, P3941, DOI 10.1093/nar/13.11.3941; DENTE L, 1988, GENE DEV, V2, P259, DOI 10.1101/gad.2.2.259; DEWEY MJ, 1990, J IMMUNOL, V144, P4392; DONG Y, 1988, MOL ENDOCRINOL, V2, P1256, DOI 10.1210/mend-2-12-1256; DOWER SK, 1986, NATURE, V324, P266, DOI 10.1038/324266a0; EDBROOKE MR, 1989, MOL CELL BIOL, V9, P1908, DOI 10.1128/MCB.9.5.1908; FEY G, 1990, PROGR LIVER DIS, P89; FOWLKES DM, 1984, P NATL ACAD SCI-BIOL, V81, P2313, DOI 10.1073/pnas.81.8.2313; GANTER U, 1989, EMBO J, V8, P3773, DOI 10.1002/j.1460-2075.1989.tb08554.x; GEIGER T, 1988, J BIOL CHEM, V263, P7141; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; HATTORI M, 1990, P NATL ACAD SCI USA, V87, P2364, DOI 10.1073/pnas.87.6.2364; HILL RE, 1984, NATURE, V311, P175, DOI 10.1038/311175a0; HOECK W, 1989, J BIOL CHEM, V264, P14396; HUBER P, 1990, J BIOL CHEM, V265, P5695; KALINYAK JE, 1987, J BIOL CHEM, V262, P10441; KLEIN ES, 1987, J BIOL CHEM, V262, P520; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KOJ A, 1985, ACUTE PHASE RESPONSE, P00145; KUHN NJ, 1984, NUCLEIC ACIDS RES, V12, P6073, DOI 10.1093/nar/12.15.6073; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LI SP, 1990, J BIOL CHEM, V265, P4136; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MARINKOVIC S, 1990, MOL CELL BIOL, V10, P1573, DOI 10.1128/MCB.10.4.1573; MCINTYRE WR, 1985, J BIOL CHEM, V260, P418; MIESFELD R, 1986, CELL, V46, P389, DOI 10.1016/0092-8674(86)90659-8; MORRONE G, 1988, J BIOL CHEM, V263, P12554; OKRET S, 1986, P NATL ACAD SCI USA, V83, P5899, DOI 10.1073/pnas.83.16.5899; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; OTTO JM, 1987, J CELL BIOL, V105, P1067, DOI 10.1083/jcb.105.3.1067; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; POLI V, 1989, P NATL ACAD SCI USA, V86, P8202, DOI 10.1073/pnas.86.21.8202; PROWSE KR, 1990, J BIOL CHEM, V265, P10201; PROWSE KR, 1988, MOL CELL BIOL, V8, P42, DOI 10.1128/MCB.8.1.42; RAUGEI G, 1983, NUCLEIC ACIDS RES, V11, P5811, DOI 10.1093/nar/11.17.5811; REINKE R, 1985, J BIOL CHEM, V260, P4397; RON D, 1990, MOL CELL BIOL, V10, P1023, DOI 10.1128/MCB.10.3.1023; RORIES C, 1989, ANNU REV PHYSIOL, V51, P653, DOI 10.1146/annurev.physiol.51.1.653; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; SCHWEERS LA, 1990, J BIOL CHEM, V265, P7590; SIERRA F, 1983, NUCLEIC ACIDS RES, V11, P7069, DOI 10.1093/nar/11.20.7069; TSAI SY, 1989, CELL, V57, P443, DOI 10.1016/0092-8674(89)90919-7; WONG GG, 1988, J IMMUNOL, V140, P3040; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	65	99	99	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1990	265	36					22275	22281						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP556	1702418				2022-12-27	WOS:A1990EP55600036
J	FEAGIN, JE				FEAGIN, JE			RNA EDITING IN KINETOPLASTID MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review											FEAGIN, JE (corresponding author), SEATTLE BIOMED RES INST,SEATTLE,WA 98109, USA.							ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; BAKALARA N, 1989, J BIOL CHEM, V264, P18679; BENNE R, 1989, BIOCHIM BIOPHYS ACTA, V1007, P131, DOI 10.1016/0167-4781(89)90031-6; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BENNE R, 1990, TRENDS GENET, V6, P177, DOI 10.1016/0168-9525(90)90173-4; BENNE R, 1985, ACHIEVEMENTS PERSPEC, V1, P325; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; CAMPBELL DA, 1989, MOL BIOCHEM PARASIT, V36, P197, DOI 10.1016/0166-6851(89)90192-8; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; FEAGIN JE, 1988, MOL CELL BIOL, V8, P1259, DOI 10.1128/MCB.8.3.1259; FEAGIN JE, 1988, MOL BIOL RNA; HARRIS ME, 1990, J BIOL CHEM, V265, P11368; JASMER DP, 1986, MOL BIOCHEM PARASIT, V18, P257, DOI 10.1016/0166-6851(86)90084-8; JASMER DP, 1986, MOL BIOCHEM PARASIT, V18, P321, DOI 10.1016/0166-6851(86)90089-7; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; POLLARD VW, 1990, IN PRESS CELL; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; SHAW JM, 1989, P NATL ACAD SCI USA, V86, P6220, DOI 10.1073/pnas.86.16.6220; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; SIMPSON L, 1987, J BIOL CHEM, V262, P6182; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051; SLOOF P, 1987, NUCLEIC ACIDS RES, V15, P51, DOI 10.1093/nar/15.1.51; STUART K, 1989, EXP PARASITOL, V68, P486, DOI 10.1016/0014-4894(89)90135-5; STUART K, 1989, GENE, V82, P155, DOI 10.1016/0378-1119(89)90040-1; STUART KD, 1987, BIOESSAYS, V6, P178, DOI 10.1002/bies.950060408; STURM NR, 1990, CELL, V61, P879, DOI 10.1016/0092-8674(90)90198-N; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M; VANDERSPEK H, 1990, EMBO J, V9, P257, DOI 10.1002/j.1460-2075.1990.tb08103.x; VANDERSPEK H, 1988, EMBO J, V7, P2509, DOI 10.1002/j.1460-2075.1988.tb03098.x; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; VIDAL S, 1990, EMBO J, V9, P2017, DOI 10.1002/j.1460-2075.1990.tb08330.x; VOLLOCH V, 1990, NATURE, V343, P482, DOI 10.1038/343482a0; WEISSMANN C, 1990, NATURE, V343, P697, DOI 10.1038/343697a0	40	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19373	19376						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1700976				2022-12-27	WOS:A1990EJ18800001
J	WILLIAMS, KJ; LOEB, LA; FRY, M				WILLIAMS, KJ; LOEB, LA; FRY, M			SYNTHESIS OF DNA BY HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE IS PREFERENTIALLY BLOCKED AT TEMPLATE OLIGO(DEOXYADENOSINE) TRACTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV WASHINGTON,DEPT PATHOL,JOSEPH GOTTSTEIN MEM CANC RES LAB,SEATTLE,WA 98195; TECHNION ISRAEL INST TECHNOL,FAC MED,RAPPAPORT INST RES MED SCI,HAIFA,ISRAEL; TECHNION ISRAEL INST TECHNOL,BIOCHEM UNIT,HAIFA,ISRAEL	University of Washington; University of Washington Seattle; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology					NCI NIH HHS [R35-CA-39903] Funding Source: Medline; PHS HHS [68-0570] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA039903] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGRAWAL S, 1989, P NATL ACAD SCI USA, V86, P7790, DOI 10.1073/pnas.86.20.7790; BEBENEK K, 1989, J BIOL CHEM, V264, P16948; COFFIN JM, 1986, CELL, V46, P1, DOI 10.1016/0092-8674(86)90851-2; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; HAHN BH, 1986, SCIENCE, V232, P1548, DOI 10.1126/science.3012778; HUBER HE, 1989, J BIOL CHEM, V264, P4669; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; Maniatis T., 1982, MOL CLONING; MODROW S, 1987, J VIROL, V61, P570, DOI 10.1128/JVI.61.2.570-578.1987; MONTEFIORI DC, 1989, P NATL ACAD SCI USA, V86, P7191, DOI 10.1073/pnas.86.18.7191; MYERS G, 1989, HUMAN RETROVIRUSES A; OYAMA F, 1989, J BIOL CHEM, V264, P18808; PERRINO FW, 1989, P NATL ACAD SCI USA, V86, P8343, DOI 10.1073/pnas.86.21.8343; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; TAKEUCHI Y, 1988, J VIROL, V62, P3900, DOI 10.1128/JVI.62.10.3900-3902.1988; TEMIN HM, 1988, CANCER RES, V48, P1697; WABL M, 1985, P NATL ACAD SCI USA, V82, P479, DOI 10.1073/pnas.82.2.479; WEISMANSHOMER P, 1989, BIOCHEM BIOPH RES CO, V164, P1149, DOI 10.1016/0006-291X(89)91789-0; WILLEY RL, 1986, P NATL ACAD SCI USA, V83, P5038, DOI 10.1073/pnas.83.14.5038	24	39	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18682	18689						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1698789				2022-12-27	WOS:A1990EE20100099
J	BENESCH, RE; KWONG, S				BENESCH, RE; KWONG, S			THE STABILITY OF THE HEME-GLOBIN LINKAGE IN SOME NORMAL, MUTANT, AND CHEMICALLY MODIFIED HEMOGLOBINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											BENESCH, RE (corresponding author), COLUMBIA UNIV COLL PHYS & SURG,DEPT BIOCHEM & MOLEC BIOPHYS,NEW YORK,NY 10032, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL005791, R37HL005791] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-05791] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONINI E, 1981, METHOD ENZYMOL, V76, P5; ARNONE A, 1977, J MOL BIOL, V115, P627, DOI 10.1016/0022-2836(77)90107-3; BEAVEN GH, 1974, EUR J BIOCHEM, V41, P539, DOI 10.1111/j.1432-1033.1974.tb03295.x; Benesch R, 1981, Methods Enzymol, V76, P147; BENESCH RE, 1972, BIOCHEMISTRY-US, V11, P3576, DOI 10.1021/bi00769a013; BENESCH RE, 1988, BIOCHEM BIOPH RES CO, V156, P9, DOI 10.1016/S0006-291X(88)80798-8; BUNN HF, 1967, J BIOL CHEM, V243, P465; Cassoly R, 1981, Methods Enzymol, V76, P121; DRABKIN DL, 1961, IUB S SER, V19, P142; EDELSTEI.SJ, 1970, J BIOL CHEM, V245, P4372; ENOKI Y, 1968, J MOL BIOL, V31, P613, DOI 10.1016/0022-2836(68)90432-4; GRATZER WB, 1960, PHYSICAL CHEM STUDIE; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; INGRAM VM, 1961, NATURE, V190, P1079, DOI 10.1038/1901079a0; KEIPERT PE, 1989, TRANSFUSION, V29, P768, DOI 10.1046/j.1537-2995.1989.29990070179.x; SHARMA VS, 1980, J MOL BIOL, V144, P267, DOI 10.1016/0022-2836(80)90090-X; TYUMA I, 1966, BIOCHEMISTRY-US, V5, P2957, DOI 10.1021/bi00873a027; WINTERHALTER KH, 1971, BIOCHEMISTRY-US, V10, P3790, DOI 10.1021/bi00796a023; ZWART A, 1984, CLIN CHEM, V30, P373	20	60	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					14881	14885						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697581				2022-12-27	WOS:A1990DX40000035
J	WIMSATT, DK; HOHL, CM; BRIERLEY, GP; ALTSCHULD, RA				WIMSATT, DK; HOHL, CM; BRIERLEY, GP; ALTSCHULD, RA			CALCIUM ACCUMULATION AND RELEASE BY THE SARCOPLASMIC-RETICULUM OF DIGITONIN-LYSED ADULT MAMMALIAN VENTRICULAR CARDIOMYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									OHIO STATE UNIV, MED CTR,DEPT PHYSIOL CHEM,5170 GRAVES HALL, 333 W 10TH AVE, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University					NHLBI NIH HHS [HL-36240] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036240] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALSCHULD RA, 1985, J BIOL CHEM, V260, P14325; ALTSCHULD RA, 1987, J BIOL CHEM, V262, P13527; ANTONIU B, 1985, BIOCHIM BIOPHYS ACTA, V816, P9, DOI 10.1016/0005-2736(85)90387-6; BEEKMAN RE, 1989, BIOCHEM J, V259, P229, DOI 10.1042/bj2590229; BEEKMAN RE, 1988, BIOCHIM BIOPHYS ACTA, V969, P18, DOI 10.1016/0167-4889(88)90083-3; BESCH HR, 1985, FED PROC, V44, P2960; BRANDT NR, 1985, BIOCHEM BIOPH RES CO, V128, P739, DOI 10.1016/0006-291X(85)90109-3; CARAFOLI E, 1985, J MOL CELL CARDIOL, V17, P203, DOI 10.1016/S0022-2828(85)80003-1; CHAMBERLAIN BK, 1984, J BIOL CHEM, V259, P7547; CHAMBERLAIN BK, 1984, J BIOL CHEM, V259, P7540; CHIESI M, 1988, BIOCHEM BIOPH RES CO, V154, P1, DOI 10.1016/0006-291X(88)90641-9; CHIESI M, 1981, J CELL BIOL, V91, P728, DOI 10.1083/jcb.91.3.728; CHU A, 1983, J BIOL CHEM, V258, P543; DELABASTIE D, 1990, CIRC RES, V66, P554, DOI 10.1161/01.RES.66.2.554; ELZ JS, 1984, J MOL CELL CARDIOL, V16, pR6, DOI 10.1016/S0022-2828(84)80672-0; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FABIATO A, 1982, FED PROC, V41, P2238; FEHER JJ, 1988, J MOL CELL CARDIOL, V20, P1107, DOI 10.1016/0022-2828(88)90591-3; FEHER JJ, 1985, BIOCHIM BIOPHYS ACTA, V813, P77, DOI 10.1016/0005-2736(85)90347-5; FEHER JJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P171, DOI 10.1016/0003-9861(88)90382-7; FEHER JJ, 1985, BIOCHIM BIOPHYS ACTA, V818, P373, DOI 10.1016/0005-2736(85)90012-4; GARFINKEL L, 1986, J MOL CELL CARDIOL, V18, P1003, DOI 10.1016/S0022-2828(86)80289-9; GEISBUHLER T, 1984, CIRC RES, V54, P536, DOI 10.1161/01.RES.54.5.536; GRIESE M, 1988, J MOL CELL CARDIOL, V20, P1189, DOI 10.1016/0022-2828(88)90598-6; GRODEN DL, 1989, CIRCULATION S2, V80, P504; HANSFORD RG, 1987, J PHYSIOL-LONDON, V390, P453, DOI 10.1113/jphysiol.1987.sp016711; HARIGAYA S, 1969, CIRC RES, V25, P781, DOI 10.1161/01.RES.25.6.781; HARRISON SM, 1987, BIOCHIM BIOPHYS ACTA, V925, P133, DOI 10.1016/0304-4165(87)90102-4; HASSELBACH W, 1987, FEBS LETT, V221, P119, DOI 10.1016/0014-5793(87)80364-2; HASSELBACH W, 1983, ANNU REV PHYSIOL, V45, P325, DOI 10.1146/annurev.ph.45.030183.001545; HAWORTH RA, 1987, AM J PHYSIOL, V253, pH1484, DOI 10.1152/ajpheart.1987.253.6.H1484; HOHL CM, 1990, PROG CLIN BIOL RES, V327, P735; HOHL CM, 1989, AM J PHYSIOL, V257, pC948, DOI 10.1152/ajpcell.1989.257.5.C948; HOHL CM, 1983, ARCH BIOCHEM BIOPHYS, V221, P197, DOI 10.1016/0003-9861(83)90136-4; HOSTE AM, 1988, PFLUG ARCH EUR J PHY, V411, P558, DOI 10.1007/BF00582378; HUNTER DR, 1983, CIRC RES, V53, P703, DOI 10.1161/01.RES.53.5.703; HYMEL L, 1988, BIOCHEM BIOPH RES CO, V152, P308, DOI 10.1016/S0006-291X(88)80715-0; INUI M, 1987, J BIOL CHEM, V262, P15637; INUI M, 1988, J BIOL CHEM, V263, P10843; KHYM JX, 1975, CLIN CHEM, V21, P1245; KIMURA S, 1989, AM J PHYSIOL, V256, pH1006; KRANIAS EG, 1985, BIOCHIM BIOPHYS ACTA, V844, P193, DOI 10.1016/0167-4889(85)90090-4; Kun E, 1979, Methods Enzymol, V55, P115; LAI FA, 1988, BIOCHEM BIOPH RES CO, V151, P441, DOI 10.1016/0006-291X(88)90613-4; LATTANZIO FA, 1987, J BIOL CHEM, V262, P2711; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; LI Q, 1989, AM J PHYSIOL, V257, pC427, DOI 10.1152/ajpcell.1989.257.3.C427; LI Q, 1989, AM J PHYSIOL, V257, pC957, DOI 10.1152/ajpcell.1989.257.5.C957; LI Q, 1988, AM J PHYSIOL, V255, pC162, DOI 10.1152/ajpcell.1988.255.2.C162; LI QA, 1987, BIOCHEM BIOPH RES CO, V147, P120; LIMAS C, 1987, CIRC RES, V61, P824, DOI 10.1161/01.RES.61.6.824; LIMAS CJ, 1978, AM J PHYSIOL, V235, pH745, DOI 10.1152/ajpheart.1978.235.6.H745; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McCune S A, 1989, Nutrition, V5, P52; MCGREW SG, 1989, BIOCHEMISTRY-US, V28, P1686, DOI 10.1021/bi00430a039; MEISSNER G, 1984, J BIOL CHEM, V259, P2365; MEISSNER G, 1987, J BIOL CHEM, V262, P3065; MEISSNER G, 1986, J BIOL CHEM, V261, P6300; MEISSNER G, 1988, MOL CELL BIOCHEM, V82, P59; MICHALAK M, 1988, BIOCHEM J, V253, P631, DOI 10.1042/bj2530631; MITCHELL MR, 1985, J PHYSIOL-LONDON, V364, P113, DOI 10.1113/jphysiol.1985.sp015734; OHNISHI ST, 1979, J BIOCHEM, V86, P1147, DOI 10.1093/oxfordjournals.jbchem.a132609; ORCHARD CH, 1985, J GEN PHYSIOL, V86, P637, DOI 10.1085/jgp.86.5.637; PAGE E, 1973, AM J CARDIOL, V31, P172, DOI 10.1016/0002-9149(73)91030-8; POWELL T, 1976, BIOCHEM BIOPH RES CO, V72, P327, DOI 10.1016/0006-291X(76)90997-9; RAPUNDALO ST, 1989, CIRC RES, V64, P104, DOI 10.1161/01.RES.64.1.104; ROGERS TB, 1990, J BIOL CHEM, V265, P4302; ROHRER D, 1988, J BIOL CHEM, V263, P6941; ROUSSEAU E, 1987, AM J PHYSIOL, V253, pC364, DOI 10.1152/ajpcell.1987.253.3.C364; ROUSSEAU E, 1989, AM J PHYSIOL, V256, pH328, DOI 10.1152/ajpheart.1989.256.2.H328; SCHAFFER SW, 1989, AM J PHYSIOL, V256, pE25, DOI 10.1152/ajpendo.1989.256.1.E25; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6894; SHIGEKAWA M, 1985, J BIOL CHEM, V260, P1679; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; SPURGEON HA, 1990, AM J PHYSIOL, V258, pH574, DOI 10.1152/ajpheart.1990.258.2.H574; SUTKO JL, 1985, FED PROC, V44, P2984; SUTKO JL, 1979, J PHARMACOL EXP THER, V209, P37; WATERHOUSE AL, 1987, J MED CHEM, V30, P710, DOI 10.1021/jm00387a022; WHITMER JT, 1988, CIRC RES, V62, P81, DOI 10.1161/01.RES.62.1.81; WIER WG, 1986, J PHYSIOL-LONDON, V376, P507, DOI 10.1113/jphysiol.1986.sp016167; WIER WG, 1990, ANNU REV PHYSIOL, V52, P467; WIER WG, 1985, FED PROC, V44, P2989; ZADOK R, 1984, HUM PATHOL, V15, P902	84	60	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					14849	14857						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697580				2022-12-27	WOS:A1990DX40000030
J	POWERS, MF; BEAVIS, AD				POWERS, MF; BEAVIS, AD			TRIORGANOTINS INHIBIT THE MITOCHONDRIAL INNER MEMBRANE ANION CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; HEART SUBMITOCHONDRIAL PARTICLES; ORGANOTIN COMPOUNDS; TRIPHENYLTIN COMPOUNDS; DIBUTYLCHLOROMETHYLTIN CHLORIDE; OXIDATIVE-PHOSPHORYLATION; TRIETHYLTIN BROMIDE; LIGHT-SCATTERING; CAT HEMOGLOBIN; ION CHANNEL	The inner membrane of liver and heart mitochondria possesses an anion uniport pathway, known as the inner membrane anion channel (IMAC). IMAC is inhibited by matrix Mg2+, matrix H+, N,N'-dicyclohexylcarbodiimide, mercurials and amphiphilic amines such as propranolol. Most of these agents react with a number of different mitochondrial proteins and, therefore, more selective inhibitors have been sought. In this paper, we report the discovery of a new class of inhibitors, triorganotin compounds, which block IMAC completely. One of the most potent, tributyltin (TBT) inhibits malonate uniport via IMAC 95% at 0.9 nmol/mg. The only other mitochondrial protein reported to react with triorganotins, the F1F0ATPase, is inhibited by about 0.75 nmol/mg. The potency of inhibition of IMAC increases with hydrophobicity in the sequence trimethyltin << triethyltin << tripropyltin < triphenyltin < tributyltin; which suggests that the binding site is accessible from the lipid bilayer. It has long been established that triorganotins are anionophores able to catalyze Cl-/OH- exchange; however, TBT is able to inhibit Cl- and NO3- transport via IMAC at doses below those required to catalyze rapid rates of Cl-/OH- exchange. Consistent with previous reports, the data indicate that about 0.8 nmol of TBT per mg of mitochondrial protein is tightly bound and not available to mediate Cl-/OH- exchange. We have also shown that the mercurials, p-chloromercuribenzene sulfonate and mersalyl, which only partially inhibit Cl- and NO3- transport can increase the IC50 for TBT 10-fold. This effect appears to result from a reaction at a previously unidentified mercurial reactive site. The inhibitory dose is also increased by raising the pH and inhibition by TBT can be reversed by S2- and dithiols but not by monothiols.			POWERS, MF (corresponding author), MED COLL OHIO,DEPT PHARMACOL,TOLEDO,OH 43699, USA.				NHLBI NIH HHS [HL-36573] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALDRIDGE WN, 1970, BIOCHEM J, V118, P171, DOI 10.1042/bj1180171; ALDRIDGE WN, 1955, BIOCHEM J, V61, P406, DOI 10.1042/bj0610406; BEAVIS AD, 1987, J BIOL CHEM, V262, P15085; BEAVIS AD, 1990, BIOPHYS J, V57, pA179; BEAVIS AD, 1988, J BIOL CHEM, V263, P7574; BEAVIS AD, 1989, EUR J BIOCHEM, V185, P511, DOI 10.1111/j.1432-1033.1989.tb15143.x; BEAVIS AD, 1989, J BIOL CHEM, V264, P17148; BEAVIS AD, 1985, J BIOL CHEM, V260, P3424; BEAVIS AD, 1989, J BIOL CHEM, V264, P1508; BEAVIS AD, 1991, BIOCHIM BIOPHYS ACTA, V1063, P111, DOI 10.1016/0005-2736(91)90360-K; BEECHEY RB, 1966, BIOCHEM BIOPH RES CO, V23, P75, DOI 10.1016/0006-291X(66)90271-3; BRIERLEY GP, 1984, J BIOL CHEM, V259, P4672; BYINGTON KH, 1974, TOXICOL APPL PHARM, V27, P230, DOI 10.1016/0041-008X(74)90194-X; BYINGTON KH, 1971, BIOCHEM BIOPH RES CO, V42, P16, DOI 10.1016/0006-291X(71)90355-X; COSTA LG, 1985, TOXICOL APPL PHARM, V79, P471, DOI 10.1016/0041-008X(85)90144-9; DIWAN JJ, 1982, J BIOENERG BIOMEMBR, V14, P15, DOI 10.1007/BF00744076; DIWAN JJ, 1983, J BIOENERG BIOMEMBR, V15, P277, DOI 10.1007/BF00744525; DOCTOR SV, 1982, TOXICOLOGY, V25, P213, DOI 10.1016/0300-483X(82)90031-2; ELFERINK JGR, 1986, BIOCHEM PHARMACOL, V35, P3727, DOI 10.1016/0006-2952(86)90657-X; ELLIOT BM, 1977, BIOCHEM J, V103, P583; ELLIOTT BM, 1979, BIOCHEM J, V177, P461, DOI 10.1042/bj1770461; EMANUEL EL, 1984, BIOCHIM BIOPHYS ACTA, V766, P209, DOI 10.1016/0005-2728(84)90233-0; FARROW BG, 1978, EUR J BIOCHEM, V86, P85, DOI 10.1111/j.1432-1033.1978.tb12287.x; FONYO A, 1978, J BIOENERG BIOMEMBR, V10, P171, DOI 10.1007/BF00743106; GARLID KD, 1985, J BIOL CHEM, V260, P3434; GARLID KD, 1986, BIOCHIM BIOPHYS ACTA, V853, P187, DOI 10.1016/0304-4173(87)90001-2; GARLID KD, 1986, J BIOL CHEM, V261, P1529; KIEHL R, 1980, BIOCHEMISTRY-US, V19, P541, DOI 10.1021/bi00544a023; KINNALLY KW, 1989, J BIOENERG BIOMEMBR, V21, P497, DOI 10.1007/BF00762521; POWERS M F, 1991, Biophysical Journal, V59, p596A; ROSE MS, 1972, BIOCHEM J, V127, P51, DOI 10.1042/bj1270051; ROSE MS, 1968, BIOCHEM J, V106, P821, DOI 10.1042/bj1060821; ROSE MS, 1969, BIOCHEM J, V111, P129, DOI 10.1042/bj1110129; SELWYN MJ, 1970, EUR J BIOCHEM, V14, P120, DOI 10.1111/j.1432-1033.1970.tb00268.x; SELWYN MJ, 1972, BIOCHEM J, V130, pP65, DOI 10.1042/bj1300065P; SELWYN MJ, 1976, ORGANOTIN COMPOUNDS, P204; SIEBENLIST KR, 1986, BIOCHEM J, V233, P471, DOI 10.1042/bj2330471; SIEBENLIST KR, 1983, BIOCHEMISTRY-US, V22, P4642, DOI 10.1021/bi00289a005; SOLOMON R, 1989, TOXICOL APPL PHARM, V100, P307, DOI 10.1016/0041-008X(89)90316-5; SONE N, 1964, J BIOCHEM-TOKYO, V56, P151, DOI 10.1093/oxfordjournals.jbchem.a127972; SORGATO MC, 1987, NATURE, V330, P498, DOI 10.1038/330498a0; SORGATO MC, 1989, J BIOENERG BIOMEMBR, V21, P485, DOI 10.1007/BF00762520; UREN SC, 1983, MAR POLLUT BULL, V14, P303, DOI 10.1016/0025-326X(83)90540-4; VANDERKERK GJM, 1976, ORGANOTIN COMPOUNDS, P1; WATLING AS, 1970, FEBS LETT, V10, P139, DOI 10.1016/0014-5793(70)80437-9; WULF RG, 1975, ARCH BIOCHEM BIOPHYS, V167, P176, DOI 10.1016/0003-9861(75)90454-3	46	75	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17250	17256						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1716627				2022-12-27	WOS:A1991GF44500044
J	ODA, Y; KUO, MD; HUANG, SS; HUANG, JS				ODA, Y; KUO, MD; HUANG, SS; HUANG, JS			THE PLASMA-CELL MEMBRANE GLYCOPROTEIN, PC-1, IS A THREONINE-SPECIFIC PROTEIN-KINASE STIMULATED BY ACIDIC FIBROBLAST GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; FACTOR RECEPTOR; PURIFICATION; LIVER; BONDS	A P-32-labeled protein that co-purified with acidic fibroblast growth factor (aFGF) receptor from bovine liver proved to be a distinct membrane protein, which itself has kinase activity that is stimulated by aFGF. The protein was designated MAFP for major aFGF-stimulated phosphoprotein. MAFP was purified from bovine liver using immunoaffinity chromatography with monoclonal antibody to MAFP following Triton X-100 extraction of plasma membranes and wheat germ lectin-Sepharose 4B column chromatography. The purified MAFP showed molecular masses of 130 kDa and 260 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing and nonreducing conditions, respectively. Purified MAFP elicited aFGF-stimulated Thr-specific autophosphorylation activity and phosphorylation activity toward protein substrates (myelin basic protein and histone). Amino acid sequence analyses of 16 peptide fragments of MAFP, produced by endoproteinase Lys-C digestion followed by reduction and S-pyridylethylation, showed approximately 80-100% homology with the cDNA-deduced amino acid sequences of human and mouse plasma cell membrane glycoprotein, PC-1 (Buckley, M. F., Loveland, K. A., McKinstry, W. J., Garson, 0. M., and Goding, J. W. (1990) J. Biol. Chem. 265, 17506-17511), suggesting that MAFP is the bovine version of PC-1. The amino acid sequences of bovine MAFP, human and mouse PC-1 reveal a putative ATP binding site in their extracellular domains. These results suggest that MAFP(PC-1) is an ectoprotein kinase. In addition to the kinase activity, MAFP(PC-1) was also found to possess alkaline nucleotide phosphodiesterase activity. It is now clear that several of the unique properties previously attributed to the aFGF receptor kinase are actually properties of this novel Thr-specific ectoprotein kinase, which co-purifies with the aFGF receptor and is responsive to stimulation by aFGF.	ST LOUIS UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOL,1402 S GRAND BLVD,ST LOUIS,MO 63104	Saint Louis University					NCI NIH HHS [CA38808] Funding Source: Medline; NHLBI NIH HHS [HL41782] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038808] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041782] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BUCKLEY MF, 1990, J BIOL CHEM, V265, P17506; EVANS WH, 1973, BIOCHEM J, V135, P819, DOI 10.1042/bj1350819; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; HIROSE M, 1988, ANAL BIOCHEM, V168, P193, DOI 10.1016/0003-2697(88)90028-0; HUANG JS, 1986, J BIOL CHEM, V261, P1600; HUANG SS, 1986, J BIOL CHEM, V261, P9568; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KUO MD, 1990, J BIOL CHEM, V265, P16455; LOKESHWAR VB, 1990, J BIOL CHEM, V265, P1665; RAZZELL WE, 1963, METHOD ENZYMOL, V6, P236, DOI 10.1016/0076-6879(63)06169-3; REBBE NF, 1991, P NATL ACAD SCI USA, V88, P5192, DOI 10.1073/pnas.88.12.5192; SKUBITZ KM, 1991, BIOCHEM BIOPH RES CO, V174, P49, DOI 10.1016/0006-291X(91)90483-N; SU L, 1985, ANN REV PHYSL, V47, P665; TAKAHASHI T, 1970, J EXP MED, V131, P1325, DOI 10.1084/jem.131.6.1325; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; VONDRIEL IR, 1987, J BIOL CHEM, V262, P4882; WOLD F, 1981, ANNU REV BIOCHEM, V50, P783, DOI 10.1146/annurev.bi.50.070181.004031	17	55	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16791	16795						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715869				2022-12-27	WOS:A1991GD63500086
J	SPICER, AP; PARRY, G; PATTON, S; GENDLER, SJ				SPICER, AP; PARRY, G; PATTON, S; GENDLER, SJ			MOLECULAR-CLONING AND ANALYSIS OF THE MOUSE HOMOLOG OF THE TUMOR-ASSOCIATED MUCIN, MUC1, REVEALS CONSERVATION OF POTENTIAL O-GLYCOSYLATION SITES, TRANSMEMBRANE, AND CYTOPLASMIC DOMAINS AND A LOSS OF MINISATELLITE-LIKE POLYMORPHISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-ASSOCIATED ANTIGEN; EPITHELIAL-CELL LINE; XENOPUS-LAEVIS; MONOCLONAL-ANTIBODIES; INTEGUMENTARY MUCIN; SEQUENCE-ANALYSIS; GENE; EXPRESSION; PROTEIN; CDNA	We present here the full-length cDNA sequence and genomic structure of the mouse homologue of the tumor-associated mucin, MUC1. This mucin (previously called polymorphic epithelial mucin) is present at the apical surface of most glandular epithelial cells. The mouse gene, Muc-1, encodes an integral membrane protein with 40% of its coding capacity made up of serine, threonine, and proline, a composition typical of a highly O-glycosylated protein. The mucin core protein consists of an amino-terminal signal sequence, a tandem repeat domain encoding 16 repeats of 20-21 amino acids, and unique sequence containing transmembrane and cytoplasmic domains. Homology with the human protein is only 34% in the tandem repeat domain, mainly showing conservation of serines and threonines, presumed sites of O-linked carbohydrate attachment. Homology rises to 87% in the transmembrane and cytoplasmic domains, suggesting that these regions may be functionally important. The pattern of expression of the mouse mucin is very similar to that of its human counterpart and accordingly the two promoter regions share high homology, 74%, although previously identified potential hormone-responsive elements are not conserved. Interestingly, the mouse homologue, unlike its human counterpart does not exhibit a variable number tandem repeat polymorphism. We present evidence that suggests that the mouse gene was at one time polymorphic but has mutated away from this state.	IMPERIAL CANC RES FUND,MOLEC EPITHELIAL CELL BIOL LAB,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND; LAWRENCE BERKELEY LAB,DIV CELL & MOLEC BIOL,BERKELEY,CA 94720; CTR MOLEC GENET,SCH MED,DEPT NEUROSCI,LA JOLLA,CA 92093	Cancer Research UK; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory								ABE M, 1989, BIOCHEM BIOPH RES CO, V165, P644, DOI 10.1016/S0006-291X(89)80014-2; ALBERTS B, 1989, MOL BIOL CELL, P220; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; BURCHELL J, 1983, J IMMUNOL, V131, P508; BURCHELL J, 1989, INT J CANCER, V44, P691, DOI 10.1002/ijc.2910440423; BYRD JC, 1989, BIOCHEM J, V261, P617, DOI 10.1042/bj2610617; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; GRIFFITHS B, 1990, ANN HUM GENET, V54, P277, DOI 10.1111/j.1469-1809.1990.tb00383.x; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; GUM JR, 1989, J BIOL CHEM, V264, P6480; HAUSER F, 1990, EXP CELL RES, V189, P157, DOI 10.1016/0014-4827(90)90230-8; HOFFMANN W, 1988, J BIOL CHEM, V263, P7686; HOGAN B, 1986, MANIPULATING MOUSE E, P174; JARMAN AP, 1989, TRENDS GENET, V5, P367, DOI 10.1016/0168-9525(89)90171-6; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; KHORRAMI A, 1989, GLYCOCONJUGATE J, V6, P428; KIOUSSIS D, 1987, EMBO J, V6, P355, DOI 10.1002/j.1460-2075.1987.tb04762.x; LAN MS, 1990, J BIOL CHEM, V265, P15294; LANCASTER CA, 1990, BIOCHEM BIOPH RES CO, V173, P1019, DOI 10.1016/S0006-291X(05)80888-5; LIGTENBERG MJL, 1990, J BIOL CHEM, V265, P5573; Maniatis T., 1982, MOL CLONING; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; MOSS L, 1988, J CELL PHYSIOL, V137, P310, DOI 10.1002/jcp.1041370215; PARRY G, 1990, EXP CELL RES, V188, P302, DOI 10.1016/0014-4827(90)90174-9; PATTON S, 1986, LIPIDS, V21, P170, DOI 10.1007/BF02534441; PATTON S, 1990, J DAIRY SCI, V73, P3567, DOI 10.3168/jds.S0022-0302(90)79057-1; PATTON S, 1989, BIOCHIM BIOPHYS ACTA, V980, P333, DOI 10.1016/0005-2736(89)90321-0; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; PROBST JC, 1990, BIOCHEMISTRY-US, V29, P6240, DOI 10.1021/bi00478a018; SCHIMIZU M, 1982, J BIOCHEM-TOKYO, V91, P515; SIDDIQUI J, 1988, P NATL ACAD SCI USA, V85, P2320, DOI 10.1073/pnas.85.7.2320; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; SWALLOW DM, 1987, NATURE, V328, P82, DOI 10.1038/328082a0; TAYLORPAPADIMITRIOU J, 1981, INT J CANCER, V28, P17, DOI 10.1002/ijc.2910280104; TIMPTE CS, 1988, J BIOL CHEM, V263, P1081; TSARFATY I, 1990, GENE, V93, P313, DOI 10.1016/0378-1119(90)90242-J; VAIDYA AB, 1978, VIROLOGY, V90, P12, DOI 10.1016/0042-6822(78)90328-8; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WRESCHNER DH, 1990, EUR J BIOCHEM, V189, P463, DOI 10.1111/j.1432-1033.1990.tb15511.x; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; ZOTTER S, 1988, Cancer Reviews, V11-12, P55	48	208	225	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15099	15109						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714452				2022-12-27	WOS:A1991GB09700048
J	HOSTOMSKA, Z; MATTHEWS, DA; DAVIES, JF; NODES, BR; HOSTOMSKY, Z				HOSTOMSKA, Z; MATTHEWS, DA; DAVIES, JF; NODES, BR; HOSTOMSKY, Z			PROTEOLYTIC RELEASE AND CRYSTALLIZATION OF THE RNASE-H DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; RIBONUCLEASE-H; EXPRESSION; PURIFICATION; PROTEASE; ENDONUCLEASE; MUTAGENESIS; MUTATIONS; RESIDUES; PROTEINS	The RNase H domain of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase was released from recombinant DHFR-RNase H fusion protein by the action of HIV-1 protease and crystallized as large trigonal prisms that diffract x-rays to at least 2.4-angstrom resolution. The protease cleavage occurred 18 residues away from the Phe440-Tyr441 site reported to be processed during maturation of the reverse transcriptase heterodimer. Mutagenesis of the protease-sensitive region (residues 430-440), which is part of the crystallized domain, indicates that any alteration of the wild-type sequence results in increased proteolysis of the p66 subunit. A model of asymmetric processing in HIV-1 reserve transcriptase which involves partial unfolding of the RNase H domain is proposed based on these results and the recently reported three-dimensional structure of this domain.			HOSTOMSKA, Z (corresponding author), AGOURON PHARMACEUT INC,LA JOLLA,CA 92037, USA.				NIGMS NIH HHS [GM-39599] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM039599] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNOLD E, 1990, ADV VIRUS RES, V39, P1; BECERRA SP, 1990, FEBS LETT, V270, P76, DOI 10.1016/0014-5793(90)81238-J; DAVIES JF, 1991, SCIENCE, V252, P88, DOI 10.1126/science.1707186; DEIBEL MR, 1990, AIDS RES HUM RETROV, V6, P329, DOI 10.1089/aid.1990.6.329; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; FERRIS AL, 1990, VIROLOGY, V175, P456, DOI 10.1016/0042-6822(90)90430-Y; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; GRAVES MC, 1990, BIOCHEM BIOPH RES CO, V168, P30, DOI 10.1016/0006-291X(90)91670-N; HENDERSON LE, 1988, J VIROL, V62, P2587, DOI 10.1128/JVI.62.8.2587-2595.1988; HIZI A, 1990, VIROLOGY, V175, P575, DOI 10.1016/0042-6822(90)90444-V; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; HOSTOMSKY Z, 1989, BIOCHEM BIOPH RES CO, V161, P1056, DOI 10.1016/0006-291X(89)91350-8; HOSTOMSKY Z, 1991, P NATL ACAD SCI USA, V88, P1148, DOI 10.1073/pnas.88.4.1148; JACOBOMOLINA A, 1990, J CELL BIOCHEM, V14, P105; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KATAYANAGI K, 1990, NATURE, V347, P306, DOI 10.1038/347306a0; KRAUSSLICH HG, 1989, P NATL ACAD SCI USA, V86, P807, DOI 10.1073/pnas.86.3.807; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEGRICE SFJ, 1989, J BIOL CHEM, V264, P14902; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MITSUYA H, 1990, SCIENCE, V249, P1533, DOI 10.1126/science.1699273; MIZRAHI V, 1989, ARCH BIOCHEM BIOPHYS, V273, P347, DOI 10.1016/0003-9861(89)90493-1; MIZRAHI V, 1990, NUCLEIC ACIDS RES, V18, P5359, DOI 10.1093/nar/18.18.5359; OYAMA F, 1989, J BIOL CHEM, V264, P18808; PRASAD VR, 1989, P NATL ACAD SCI USA, V86, P3104, DOI 10.1073/pnas.86.9.3104; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989; SCHATZ O, 1989, FEBS LETT, V257, P311, DOI 10.1016/0014-5793(89)81559-5; SCHATZ O, 1990, GENE REGULATION AIDS, P293; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TISDALE M, 1990, J CELL BIOCHEM     S, V14, P179; TOMASSELLI AG, 1990, J BIOL CHEM, V265, P408; UNGE T, 1990, AIDS RES HUM RETROV, V6, P1297, DOI 10.1089/aid.1990.6.1297; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648	37	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14697	14702						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713588				2022-12-27	WOS:A1991FZ35100090
J	MULLER, B; RESTLE, T; KUHNEL, H; GOODY, RS				MULLER, B; RESTLE, T; KUHNEL, H; GOODY, RS			EXPRESSION OF THE HETERODIMERIC FORM OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 REVERSE-TRANSCRIPTASE IN ESCHERICHIA-COLI AND CHARACTERIZATION OF THE ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-SEQUENCE; POLYACRYLAMIDE GELS; HIV-1; PROTEINS; AIDS; IDENTIFICATION; PURIFICATION; MACROPHAGES; PROTEASE; ISOLATE	A system for the expression of recombinant human immunodeficiency virus type 2 (HIV-2) reverse transcriptase (RT) in Escherichia coli has been developed, which allows purification of the heterodimeric form of the enzyme as well as the separate purification of the two subunits. It is shown that equilibrium formation between monomeric and homodimeric forms of the recombinant 66- and 51-kDa subunits is considerably more rapid than in the case of the corresponding homodimeric forms of HIV-1 RT. In accordance with our previously published studies on HIV-1 RT (Restle, T., Muller, B., and Goody, R. S. (1990) J. Biol. Chem. 2 65, 8986-8988) RNA-dependent DNA polymerase activity of the HIV-2 RT preparations can be exactly correlated to their dimer content. No significant heterodimer formation can be observed upon coexpression of the 66-kDa subunit of HIV-2 RT with the 51-kDa subunit of HIV-1 RT in the same cell, indicating differences in the dimerization domains of the two proteins. Recombinant HIV-2 RT is not recognized by a set of 23 monoclonal antibodies raised against HIV-1 RT, although it shows weak cross-reactivity with sera from HIV-1-infected patients.	GEORG SPEYER HAUS,CHEMOTHERAPEUT FORSCHUNGSINST,W-6000 FRANKFURT 70,GERMANY	Octapharma	MULLER, B (corresponding author), MAX PLANCK INST MED RES,BIOPHYS ABT,JAHNSTR 29,W-6900 HEIDELBERG 1,GERMANY.		Goody, Roger S/J-8845-2014	Goody, Roger S/0000-0002-0772-0444; Muller, Barbara/0000-0001-5726-5585				AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; CERTA U, 1986, EMBO J, V5, P3051, DOI 10.1002/j.1460-2075.1986.tb04605.x; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; DEVICO AL, 1989, AIDS RES HUM RETROV, V5, P51, DOI 10.1089/aid.1989.5.51; GRAVES MC, 1990, BIOCHEM BIOPH RES CO, V168, P30, DOI 10.1016/0006-291X(90)91670-N; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; KUHNEL H, 1990, NUCLEIC ACIDS RES, V18, P6142, DOI 10.1093/nar/18.20.6142; KUHNEL H, 1989, P NATL ACAD SCI USA, V86, P2383, DOI 10.1073/pnas.86.7.2383; LEGRICE SFJ, 1988, J VIROL, V62, P2525, DOI 10.1128/JVI.62.7.2525-2529.1988; LEGRICE SFJ, 1989, J BIOL CHEM, V264, P14902; LEWIS N, 1990, J VIROL, V64, P1690, DOI 10.1128/JVI.64.4.1690-1697.1990; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; MALIM MH, 1989, P NATL ACAD SCI USA, V86, P8222, DOI 10.1073/pnas.86.21.8222; Maniatis T., 1982, MOL CLONING; MIZRAHI V, 1989, ARCH BIOCHEM BIOPHYS, V273, P347, DOI 10.1016/0003-9861(89)90493-1; MULLER B, 1989, J BIOL CHEM, V264, P13975; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RESTLE T, 1990, J BIOL CHEM, V265, P8986; ROWLEY GL, 1990, BIOCHEM BIOPH RES CO, V167, P673, DOI 10.1016/0006-291X(90)92078-E; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SHIBATA R, 1990, J VIROL, V64, P742, DOI 10.1128/JVI.64.2.742-747.1990; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; WU JC, 1990, ARCH BIOCHEM BIOPHYS, V277, P306, DOI 10.1016/0003-9861(90)90584-L	25	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14709	14713						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713589				2022-12-27	WOS:A1991FZ35100092
J	HOOVER, D; FRIEDMANN, M; REEVES, R; MAGNUSON, NS				HOOVER, D; FRIEDMANN, M; REEVES, R; MAGNUSON, NS			RECOMBINANT HUMAN PIM-1 PROTEIN EXHIBITS SERINE THREONINE KINASE-ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE ONCOGENE PIM-1; TRANSGENIC MICE; GENE-PRODUCT; ACTIVATION; INVITRO; REGION; LYMPHOMAGENESIS; IDENTIFICATION; SEQUENCES; DELETION	The protein predicted by the sequence of the human pim-1 proto-oncogene shares extensive homology with known serine/threonine protein kinases, and yet the human Pim-1 enzyme has previously been reported to exhibit protein tyrosine kinase activity both in vitro and in vivo. Recently a new class of protein kinases has been identified which exhibits both protein-serine/threonine and protein-tyrosine kinase activities. We therefore investigated the possibility that the human Pim-1 kinase likewise possesses such bifunctional enzymatic phosphorylating activities. A full-length human pim-1 cDNA was subcloned into the bacterial vector pGEX-2T and the Pim-1 protein expressed as a fusion product with bacterial glutathione S-transferase (GST). The hybrid GST-Pim-1 fusion protein was affinity purified on a glutathione-Sepharose column prior to treatment with thrombin for cleavage of the Pim-1 protein from the transferase. Pim-1 was purified and the identity of recombinant protein confirmed by amino-terminal sequence analysis. Pim-1 was tested for kinase activity with a variety of proteins and peptides known to be substrates for either mammalian protein-serine/threonine or protein-tyrosine kinases and was found to phosphorylate serine/threonine residues exclusively in vitro. Both the Pim-1-GST fusion protein and the isolated Pim-1 protein exhibited only serine/threonine phosphorylating activity under all in vitro conditions tested. Pim-1 phosphorylated purified mammalian histone H1 with a K(m) of approximately 51-mu-m. Additionally, Pim-1 exhibited low levels of serine/threonine autophosphorylating activity. These observations place the human Pim-1 in a small select group of cytoplasmic transforming oncogenic kinases, including the protein kinase C, the Raf/Mil, and the Mos subfamilies, exhibiting serine/threonine phosphorylating activity.	WASHINGTON STATE UNIV,DEPT MICROBIOL,PULLMAN,WA 99164; WASHINGTON STATE UNIV,PROGRAM GENET & CELL BIOL,PULLMAN,WA 99164; WASHINGTON STATE UNIV,DEPT BIOCHEM & BIOPHYS,PULLMAN,WA 99164	Washington State University; Washington State University; Washington State University					PHS HHS [R01-A126356] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ausubel FM., 1988, CURRENT PROTOCOLS MO; BEEMON K, 1978, J VIROL, V28, P551, DOI 10.1128/JVI.28.2.551-566.1978; BENDAVID Y, 1991, EMBO J, V10, P317, DOI 10.1002/j.1460-2075.1991.tb07952.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREUER M, 1989, NATURE, V340, P61, DOI 10.1038/340061a0; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COOPER GM, 1990, ONCOGENES, P1; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; COOPER JA, 1984, J BIOL CHEM, V259, P7835; CUYPERS HT, 1984, CELL, V37, P141; DAILEY D, 1990, MOL CELL BIOL, V10, P6244, DOI 10.1128/MCB.10.12.6244; DOMEN J, 1987, ONCOGENE RES, V1, P103; ELTON TS, 1985, ANAL BIOCHEM, V144, P403, DOI 10.1016/0003-2697(85)90133-2; FEATHERSTONE C, 1991, NATURE, V349, P808, DOI 10.1038/349808a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; HUNTER T, 1991, CELL, V64, P249, DOI 10.1016/0092-8674(91)90637-E; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; MEEKER TC, 1987, J CELL BIOCHEM, V35, P105, DOI 10.1002/jcb.240350204; MUCENSKI ML, 1988, J VIROL, V62, P839, DOI 10.1128/JVI.62.3.839-846.1988; REEVES R, 1990, GENE, V90, P303, DOI 10.1016/0378-1119(90)90195-W; ROSKOSKI R, 1983, METHOD ENZYMOL, V99, P3; Sambrook J, 1989, MOL CLONING LABORATO; SELTEN G, 1986, CELL, V46, P603, DOI 10.1016/0092-8674(86)90886-X; SELTEN G, 1985, EMBO J, V4, P1793, DOI 10.1002/j.1460-2075.1985.tb03852.x; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; STANTON VP, 1987, MOL CELL BIOL, V7, P1171, DOI 10.1128/MCB.7.3.1171; TAHIRA T, 1987, NUCLEIC ACIDS RES, V15, P4809, DOI 10.1093/nar/15.12.4809; TELERMAN A, 1988, MOL CELL BIOL, V8, P1498, DOI 10.1128/MCB.8.4.1498; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; ZAKUTHOURI R, 1987, GENE, V54, P105, DOI 10.1016/0378-1119(87)90352-0; ZICK Y, 1985, EUR J BIOCHEM, V148, P177, DOI 10.1111/j.1432-1033.1985.tb08822.x	33	85	87	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					14018	14023						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713213				2022-12-27	WOS:A1991FY02700088
J	CHANDLER, JS; CALNEK, D; QUARONI, A				CHANDLER, JS; CALNEK, D; QUARONI, A			IDENTIFICATION AND CHARACTERIZATION OF RAT INTESTINAL KERATINS - MOLECULAR-CLONING OF CDNAS ENCODING CYTOKERATIN-8, CYTOKERATIN-19, AND A NEW 49-KDA TYPE-I CYTOKERATIN (CYTOKERATIN-21) EXPRESSED BY DIFFERENTIATED INTESTINAL EPITHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; INTERMEDIATE FILAMENT PROTEINS; S-CARBOXYMETHYLKERATIN-A; MOUSE EPIDERMAL KERATIN; ALPHA-HELICAL SEGMENTS; MESSENGER-RNAS; SECONDARY STRUCTURE; BOVINE KERATIN; POLYPEPTIDES; INVITRO	In the previous paper (Quaroni, A., Calnek, D., Quaroni, E., and Chandler, J. S. (1991) J. Biol. Chem. 266, 11923-11931) we describe the use of a panel of "antikeratin' monoclonal antibodies to study cytokeratin distribution in rat intestinal epithelium. In the present paper we describe the use of three antikeratin monoclonal antibodies to identify and recover cDNA clones expressing immunologically specific fusion proteins from a rat intestinal cDNA library. DNA sequence analysis identified each cDNA encoded epitope including the carboxyl-terminal portions of cytokeratins 8 and 19 (as cataloged by Moll, R., Franke, W. W., and Schiller, D. L. (1982) Cell 31, 11-24) recognized by antibodies RK4 and RK7, respectively. In addition, antibody RK5 was used to recover a cDNA clone (pRK5) encoding a portion of a 48-kDa keratin-related protein with unique tissue and cellular distribution, designated cytokeratin 21. Translation of cDNA-selected mRNAs yielded individual proteins which could be resolved and identified by their specific immunoreactivities. The pRK5 cDNA was used to recover a larger (approximately 1.3 kilobase pairs) cDNA clone (KB2) from an independent cDNA library for DNA sequence analysis and for the recovery of additional overlapping cDNA clones. The resulting cDNA sequence (1519 base pairs) contains the complete coding region of cytokeratin 21 (49,387 daltons). The predicted amino acid sequence of cytokeratin 21 confirms its identity as a novel type I cytokeratin expressed predominantly in the intestinal epithelium.	CORNELL UNIV,DIV BIOL SCI,PHYSIOL SECT,724 VET RES TOWER,ITHACA,NY 14853	Cornell University					NIDDK NIH HHS [DK 32656] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032656] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; BADER BL, 1986, EMBO J, V5, P1865, DOI 10.1002/j.1460-2075.1986.tb04438.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COOPER D, 1985, LAB INVEST, V52, P243; CREWTHER WG, 1978, BIOCHEM J, V173, P365, DOI 10.1042/bj1730365; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; ECKERT RL, 1984, P NATL ACAD SCI-BIOL, V81, P4321, DOI 10.1073/pnas.81.14.4321; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; FRANKE WW, 1981, J CELL BIOL, V90, P116, DOI 10.1083/jcb.90.1.116; FRANKE WW, 1981, J MOL BIOL, V153, P933, DOI 10.1016/0022-2836(81)90460-5; FRANKE WW, 1979, EUR J CELL BIOL, V19, P255; FUCHS E, 1979, CELL, V17, P573, DOI 10.1016/0092-8674(79)90265-4; FUCHS EV, 1981, CELL, V27, P75, DOI 10.1016/0092-8674(81)90362-7; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GAUSCUEL O, 1988, CABIOS, V4, P357; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1983, EMBO J, V2, P1295, DOI 10.1002/j.1460-2075.1983.tb01584.x; GOUGH KH, 1978, BIOCHEM J, V173, P373, DOI 10.1042/bj1730373; HANUKOGLU I, 1982, CELL, V31, P243, DOI 10.1016/0092-8674(82)90424-X; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; HATZFELD M, 1987, J MOL BIOL, V197, P237, DOI 10.1016/0022-2836(87)90122-7; HOFFMANN W, 1984, EMBO J, V3, P1301, DOI 10.1002/j.1460-2075.1984.tb01966.x; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; ICHINOSE Y, 1989, GENE, V80, P315; JORCANO JL, 1984, J MOL BIOL, V176, P21, DOI 10.1016/0022-2836(84)90380-2; JORCANO JL, 1984, J MOL BIOL, V179, P257, DOI 10.1016/0022-2836(84)90468-6; JORCANO JL, 1984, DIFFERENTIATION, V28, P155, DOI 10.1111/j.1432-0436.1984.tb00278.x; KIM KH, 1983, MOL CELL BIOL, V3, P495, DOI 10.1128/MCB.3.4.495; LEUBE RE, 1986, DIFFERENTIATION, V33, P69, DOI 10.1111/j.1432-0436.1986.tb00412.x; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAGIN TM, 1983, EMBO J, V2, P1387, DOI 10.1002/j.1460-2075.1983.tb01596.x; MAGIN TM, 1986, DIFFERENTIATION, V30, P254, DOI 10.1111/j.1432-0436.1986.tb00788.x; Maniatis T., 1982, MOL CLONING; MCLACHLAN AD, 1978, J MOL BIOL, V124, P297, DOI 10.1016/0022-2836(78)90163-8; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; MORITA T, 1988, GENE, V68, P109; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; OSHIMA RG, 1986, DIFFERENTIATION, V33, P61, DOI 10.1111/j.1432-0436.1986.tb00411.x; PUSTELL J, 1984, NUCLEIC ACIDS RES, V12, P643, DOI 10.1093/nar/12.1Part2.643; PUSTELL J, 1982, NUCLEIC ACIDS RES, V10, P4465; QUAXJEUKEN YEFM, 1983, P NATL ACAD SCI-BIOL, V80, P3548, DOI 10.1073/pnas.80.12.3548; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROOP DR, 1983, P NATL ACAD SCI-BIOL, V80, P716, DOI 10.1073/pnas.80.3.716; ROSENBERG M, 1988, MOL CELL BIOL, V8, P722, DOI 10.1128/MCB.8.2.722; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHILLER DL, 1982, EMBO J, V1, P761, DOI 10.1002/j.1460-2075.1982.tb01243.x; SCHWEIZER J, 1980, EUR J BIOCHEM, V112, P243, DOI 10.1111/j.1432-1033.1980.tb07200.x; SELDEN RF, 1987, CURRENT PROTOCOLS MO; SEMAT A, 1988, DIFFERENTIATION, V35, P40; SHARP SB, 1989, GENE, V80, P293, DOI 10.1016/0378-1119(89)90293-X; SINGER PA, 1986, J BIOL CHEM, V261, P538; STEINERT PM, 1983, J INVEST DERMATOL, V81, pS86, DOI 10.1111/1523-1747.ep12540757; STEINERT PM, 1985, J BIOL CHEM, V260, P7142; STEINERT PM, 1983, NATURE, V302, P794, DOI 10.1038/302794a0; STEINERT PM, 1984, P NATL ACAD SCI-BIOL, V81, P5709, DOI 10.1073/pnas.81.18.5709; SUN TT, 1985, ANN NY ACAD SCI, V455, P307, DOI 10.1111/j.1749-6632.1985.tb50419.x; UARONI A, 1991, J BIOL CHEM, V266, P11923; WU YJ, 1982, CELL, V31, P693, DOI 10.1016/0092-8674(82)90324-5	61	37	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11932	11938						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711044				2022-12-27	WOS:A1991FT76200079
J	MICHALOWSKI, CB; LOFFELHARDT, W; BOHNERT, HJ				MICHALOWSKI, CB; LOFFELHARDT, W; BOHNERT, HJ			AN ORF323 WITH HOMOLOGY TO CRTE, SPECIFYING PREPHYTOENE PYROPHOSPHATE DEHYDROGENASE, IS ENCODED BY CYANELLE DNA IN THE EUKARYOTIC ALGA CYANOPHORA-PARADOXA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS GENE-CLUSTER; CAROTENOID BIOSYNTHESIS; RHODOBACTER-CAPSULATUS; NUCLEOTIDE-SEQUENCE; PHYTOENE DESATURASE; HIGHER-PLANTS; STR OPERON; GENOME; ORGANIZATION; PLASTIDS	Carotenoids are essential constituents of the light-harvesting and light-protective systems of photosynthetic organisms. The biochemistry of carotenoid biosynthesis in eukaryotes is known, whereas evidence for the genes specifying this biosynthetic pathway is scant. We report here the nucleotide sequence and expression of a gene likely encoding crtE (prephytoene pyrophosphate dehydrogenase). The reaction product of this enzyme is phytoene, a C40 carotenoid precursor common to all organisms. The gene is found in the cyanelle (plastid) DNA of an eukaryotic alga, Cyanophora paradoxa. The expression into protein of cyanelle crtE has been demonstrated in vitro. The identity and similarity scores of CrtE from cyanelles with the corresponding protein from the photosynthetic bacterium Rhodobacter capsulatus are 28.6 and 68.5%, respectively.	UNIV VIENNA, INST ALLGEMEINE BIOCHEM, A-1090 VIENNA, AUSTRIA; UNIV VIENNA, LUDWIG BOLTZMANN FORSCHUNGSSTELLE BIOCHEM, A-1090 VIENNA, AUSTRIA; UNIV ARIZONA, DEPT BIOCHEM, TUCSON, AZ 85721 USA; UNIV ARIZONA, DEPT MOLEC & CELLULAR BIOL, TUCSON, AZ 85721 USA; UNIV ARIZONA, DEPT PLANT SCI, TUCSON, AZ 85721 USA	University of Vienna; Ludwig Boltzmann Institute; University of Vienna; University of Arizona; University of Arizona; University of Arizona			Bohnert, Hans J/A-7104-2009					ARMSTRONG GA, 1990, J BIOL CHEM, V265, P8329; ARMSTRONG GA, 1989, MOL GEN GENET, V216, P254, DOI 10.1007/BF00334364; ARMSTRONG GA, 1990, P NATL ACAD SCI USA, V87, P9975, DOI 10.1073/pnas.87.24.9975; BEYER P, 1985, EUR J BIOCHEM, V153, P341, DOI 10.1111/j.1432-1033.1985.tb09308.x; BRAMLEY PM, 1985, ADV LIPID RES, V21, P243; Britton G., 1988, Plant pigments., P133; BRYANT DA, 1990, FEBS LETT, V259, P273, DOI 10.1016/0014-5793(90)80026-F; CAMARA B, 1989, CUR TOP PL, V2, P141; COSTES C, 1979, FEBS LETT, V103, P17, DOI 10.1016/0014-5793(79)81241-7; DOGBO O, 1988, P NATL ACAD SCI USA, V85, P7054, DOI 10.1073/pnas.85.19.7054; DOGBO O, 1987, PLANT SCI LIMERICK, V49, P75; Douce R, 1984, Subcell Biochem, V10, P1; DOUCE R, 1990, ANNU REV CELL BIOL, V6, P173, DOI 10.1146/annurev.cb.06.110190.001133; GIULIANO G, 1988, MOL GEN GENET, V213, P78, DOI 10.1007/BF00333401; JANSSEN I, 1989, CURR GENET, V15, P335, DOI 10.1007/BF00419913; KLEINIG H, 1989, ANNU REV PLANT PHYS, V40, P39, DOI 10.1146/annurev.pp.40.060189.000351; KRAUS M, 1990, PLANT MOL BIOL, V15, P561, DOI 10.1007/BF00017831; KUNTZ M, 1984, MOL GEN GENET, V194, P508, DOI 10.1007/BF00425566; KUNTZ M, 1988, NUCLEIC ACIDS RES, V16, P8733, DOI 10.1093/nar/16.17.8733; LUTKEBRINKHAUS F, 1982, PLANTA, V156, P176, DOI 10.1007/BF00395433; MICHALOWSKI CB, 1990, MOL GEN GENET, V224, P222, DOI 10.1007/BF00271555; MICHALOWSKI CB, 1991, PLANT PHYSIOL, V95, P329, DOI 10.1104/pp.95.1.329; NEUMANNSPALLART C, 1990, FEBS LETT, V268, P55, DOI 10.1016/0014-5793(90)80971-K; NEUMULLER M, 1983, Z NATURFORSCH C, V38, P984; SANDMANN G, 1989, BIOCHEM BIOPH RES CO, V163, P916, DOI 10.1016/0006-291X(89)92309-7; SCHMIDT A, 1990, GENE, V91, P113, DOI 10.1016/0378-1119(90)90170-V; SCHMIDT A, 1989, EUR J BIOCHEM, V184, P375, DOI 10.1111/j.1432-1033.1989.tb15029.x; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; SPURGEON SL, 1980, BIOCH PLANTS, V4, P420; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; SUGIURA M, 1989, ANNU REV CELL BIOL, V5, P51, DOI 10.1146/annurev.cb.05.110189.000411; UMESONO K, 1988, J MOL BIOL, V203, P299, DOI 10.1016/0022-2836(88)90002-2	32	22	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11866	11870						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711042				2022-12-27	WOS:A1991FT76200069
J	SATO, S; ANIMASHAUN, T; HUGHES, RC				SATO, S; ANIMASHAUN, T; HUGHES, RC			CARBOHYDRATE-BINDING SPECIFICITY OF TETRACARPIDIUM-CONOPHORUM LECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCANASE-RELEASED OLIGOSACCHARIDES; RICINUS-COMMUNIS AGGLUTININ; AFFINITY-CHROMATOGRAPHY; IMMUNOGLOBULIN-G; FC-FRAGMENT; N-GLYCANS; GLYCOPROTEINS; GLYCOPEPTIDES; COMPLEX; CELLS	The carbohydrate-binding specificity of a novel plant lectin isolated from the seeds of Tetracarpidium conophorum (Nigerian walnut) has been studied by quantitative hapten inhibition assays and by determining the behavior of a number of oligosaccharides and glycopeptides on lectin-Sepharose affinity columns. The Tetracarpidium lectin shows preference for simple, unbranched oligosaccharides containing a terminal Gal-beta-1 --> 4GlcNAc sequence over a Gal-beta-1 --> 3GlcNAc sequence and substitution by sialic acid or fucose of the terminal galactose residue, the subterminal N-acetylglucosamine or more distally located sugar residues of oligosaccharides reduce binding activity. Branched complex-type glycans containing either Gal-beta-1 --> 4GlcNAc or Gal-beta-1 --> 3GlcNAc termini bind with higher affinity than simpler oligosaccharides. The lectin shows highest affinity for a tri-antennary glycan carrying Gal-beta-1 --> 4GlcNAc substituents on C-2 and C-4 of Man-alpha-1 --> 3 and C-2 of Man-alpha-1 --> 6 core residues. Bi-and tri-glycans lacking this branching pattern bind more weakly. Tetra-antennary glycans and mono- and dibranched hybrid-type glycans also bind weakly to the immobilized lectin. Therefore, Tetracarpidium lectin complements the binding specificities of well-known lectins such as Datura stramonium agglutinin, Phaseolus vulgaris agglutinin, and lentil lectin and will be a useful additional tool for the identification and separation of complex-type glycans.	NATL INST MED RES,RIDGEWAY,MILL HILL,LONDON NW7 1AA,ENGLAND	MRC National Institute for Medical Research								ANIMASHAUN T, 1989, J CELL BIOCH A S, V13, P117; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; BAYARD GSB, 1975, FEBS LETT, V50, P296; CARVER JP, 1984, BIOL CARBOHYDRATES, V2, P289; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1235; DEBRAY H, 1986, CARBOHYD RES, V151, P359, DOI 10.1016/S0008-6215(00)90355-0; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; FALASCA A, 1980, BIOCHIM BIOPHYS ACTA, V632, P95, DOI 10.1016/0304-4165(80)90252-4; GLEESON PA, 1985, BIOCHEMISTRY-US, V24, P493, DOI 10.1021/bi00323a037; GREEN ED, 1987, J BIOL CHEM, V262, P12018; GREEN ED, 1987, J BIOL CHEM, V262, P12030; HUGHES RC, 1985, BIOCHEM J, V226, P487, DOI 10.1042/bj2260487; HUGHES RC, 1983, BIOCHEM J, V211, P575, DOI 10.1042/bj2110575; LEGER D, 1989, BIOCHEM J, V257, P231, DOI 10.1042/bj2570231; MERKLE RK, 1987, METHOD ENZYMOL, V138, P232; MIZUOCHI T, 1982, J IMMUNOL, V129, P2016; MIZUOCHI T, 1979, J BIOL CHEM, V254, P6419; NARASIMHAN S, 1984, GLYCOCONJUGATES J, V1, P51; Olsnes S., 1982, MOL ACTION TOXINS VI, P51; SCHMID K, 1953, J AM CHEM SOC, V75, P60, DOI 10.1021/ja01097a017; SUTTON BJ, 1983, BIOCHEM SOC T, V11, P130, DOI 10.1042/bst0110130; TAKASAKI S, 1986, BIOCHEMISTRY-US, V25, P5706; Togun R.A., 1988, LECTINS BIOL BIOCH C, V6, P369; YAMAMOTO K, 1981, BIOCHEM J, V195, P701, DOI 10.1042/bj1950701; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602; YAMASHITA K, 1988, J BIOL CHEM, V263, P17482; YOSHIMA H, 1981, J BIOL CHEM, V256, P8476	27	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11485	11494						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711034				2022-12-27	WOS:A1991FT76200015
J	FABER, PW; VANROOIJ, HCJ; VANDERKORPUT, HAGM; BAARENDS, WM; BRINKMANN, AO; GROOTEGOED, JA; TRAPMAN, J				FABER, PW; VANROOIJ, HCJ; VANDERKORPUT, HAGM; BAARENDS, WM; BRINKMANN, AO; GROOTEGOED, JA; TRAPMAN, J			CHARACTERIZATION OF THE HUMAN ANDROGEN RECEPTOR TRANSCRIPTION UNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RIBONUCLEIC-ACID; GLUCOCORTICOID RECEPTOR; COMPLEMENTARY-DNA; MAMMALIAN-CELLS; GENE; EXPRESSION; SEQUENCE; CLONING; CDNA; ORGANIZATION	A full length human androgen receptor (hAR) cDNA was constructed from cDNA and genomic clones. Structurally the 10.6-kilobase (kb) hAR cDNA consists of a long 5'-untranslated region (5'-UTR, 1.1 kb), a previously described open reading frame (ORF, 2.7 kb) (Trapman, J., Klaassen, P., Kuiper, G. G. J. M., van der Korput, J. A. G. M., Faber, P. W., van Rooij, H. C. J., Geurts van Kessel, A., Voorhorst, M. M., Mulder, E., and Brinkmann, A. O. (1988) Biochem. Biophys. Res. Commun. 153, 241-248; Faber, P. W., Kuiper, G. G. J. M., van Rooij, H. C. J., van der Korput, J. A. G. M., Brinkmann, A. O., and Trapman, J. (1989) Mol. Cell. Endocrinol. 61, 257-262), and a very long 3'-untranslated region (3'-UTR, 6.8 kb). The complete 5'- and 3'-UTRs were found to be encoded by the previously reported first and eight protein coding exons of the hAR gene, respectively (Kuiper, G. G. J. M., Faber, P. W., van Rooij, H. C. J., van der Korput, J. A. G. M., Ris-Stalpers, C., Klaassen, P., Trapman, J., and Brinkmann, A. O. (1989) J. Mol. Endocrinol. 2, Rl-R4). Two major sites of transcription initiation were identified in a 13-base pair region. DNA fragments spanning these transcription initiation sites conferred promoter activity upon a promoterless chloramphenicol acetyltransferase reporter gene construct. Two equally effective, functional polyadenylation signals (ATTAAA and CATAAA) at a mutual distance of 221 base pairs were detected. The ATTAAA hexamer sequence gave rise to multiple sites of poly(A) addition, whereas only one position was used following the CATAAA hexamer. In LNCaP prostatic carcinoma cells an alternatively spliced hAR mRNA species was identified which lacks 3 kb of the 3'-UTR.	ERASMUS UNIV, DEPT BIOCHEM 2, 3000 DR ROTTERDAM, NETHERLANDS	Erasmus University Rotterdam	FABER, PW (corresponding author), ERASMUS UNIV, DEPT PATHOL, POB 1738, 3000 DR ROTTERDAM, NETHERLANDS.							ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BAARENDS WM, 1990, MOL CELL ENDOCRINOL, V74, P75, DOI 10.1016/0303-7207(90)90207-O; Battey, 1986, BASIC METHODS MOL BI; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BLOK LJ, 1989, MOL CELL ENDOCRINOL, V63, P267, DOI 10.1016/0303-7207(89)90104-4; BROWN TR, 1988, P NATL ACAD SCI USA, V85, P8151, DOI 10.1073/pnas.85.21.8151; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Coffey D S, 1987, Prog Clin Biol Res, V239, P1; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FABER PW, 1989, MOL CELL ENDOCRINOL, V61, P257, DOI 10.1016/0303-7207(89)90137-8; FAVOLORO J, 1980, METHOD ENZYMOL, V65, P718; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GRIFFIN JE, 1989, METABOLIC BASIS INHE; HOLLENBERG SM, 1985, NATURE, V318, P635, DOI 10.1038/318635a0; HUCKABY CS, 1987, P NATL ACAD SCI USA, V84, P8380, DOI 10.1073/pnas.84.23.8380; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; JELTSCH JM, 1990, J BIOL CHEM, V265, P3967; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; KUIPER GGJM, 1989, J MOL ENDOCRINOL, V2, pR1, DOI 10.1677/jme.0.002R001; LUBAHN DB, 1989, P NATL ACAD SCI USA, V86, P9534, DOI 10.1073/pnas.86.23.9534; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; LUBAHN DB, 1988, SCIENCE, V240, P327, DOI 10.1126/science.3353727; Maniatis T., 1982, MOL CLONING; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MEANS AL, 1990, MOL CELL BIOL, V10, P653, DOI 10.1128/MCB.10.2.653; MISRAHI M, 1988, NUCLEIC ACIDS RES, V16, P5459, DOI 10.1093/nar/16.12.5459; MOORADIAN AD, 1987, ENDOCR REV, V8, P1, DOI 10.1210/edrv-8-1-1; OMALLEY B, 1990, MOL ENDOCRINOL, V4, P363, DOI 10.1210/mend-4-3-363; PINSKY L, 1987, ADV HUM GENET, V16, P299; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P22, DOI 10.1210/mend-4-1-22; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAVAGE NL, 1982, P NATL ACAD SCI-BIOL, V79, P223, DOI 10.1073/pnas.79.2.223; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; SIMONSEN CC, 1983, MOL CELL BIOL, V3, P2250, DOI 10.1128/MCB.3.12.2250; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; TRAPMAN J, 1988, BIOCHEM BIOPH RES CO, V153, P241, DOI 10.1016/S0006-291X(88)81214-2; WIEDEMANN LM, 1984, MOL CELL BIOL, V4, P2518, DOI 10.1128/MCB.4.11.2518; ZAHRAOUI A, 1987, EUR J BIOCHEM, V166, P63, DOI 10.1111/j.1432-1033.1987.tb13484.x	50	87	93	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					10743	10749						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710213				2022-12-27	WOS:A1991FQ77400009
J	RISKE, F; HAKIMI, J; MALLAMACI, M; GRIFFIN, M; PILSON, B; TOBKES, N; LIN, P; DANHO, W; KOCHAN, J; CHIZZONITE, R				RISKE, F; HAKIMI, J; MALLAMACI, M; GRIFFIN, M; PILSON, B; TOBKES, N; LIN, P; DANHO, W; KOCHAN, J; CHIZZONITE, R			HIGH-AFFINITY HUMAN IGE RECEPTOR (FC-EPSILON-RI) - ANALYSIS OF FUNCTIONAL DOMAINS OF THE ALPHA-SUBUNIT WITH MONOCLONAL-ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASOPHILIC LEUKEMIA-CELLS; IMMUNOGLOBULIN-E; TRANSFECTED CELLS; MAST-CELLS; GENE-PRODUCTS; EXPRESSION; BINDING; PURIFICATION; COMPLEXES; PROTEINS	The binding of IgE to the high affinity Fc-epsilon receptor (Fc-epsilon-RI) on mast cells and basophils is mediated by the alpha-subunit of the tetrameric receptor complex. Based on sequence homologies, the 50-kDa alpha-subunit is a member of the immunoglobulin superfamily of proteins and has two predicted disulfide-bonded loops. Monoclonal antibodies specific for the human alpha-subunit have been identified and separated into two major classes: inhibitory and noninhibitory antibodies. Inhibitory antibodies (i.e. 15A5) block I-125-IgE binding to a recombinant chimeric alpha-subunit (ch-alpha-protein) expressed on Chinese hamster ovary cells and immunoprecipitate I-125-labeled purified ch-alpha-protein. Noninhibitory antibodies (i.e. 22E7) immunoprecipitate both I-125-labeled ch-alpha-protein and the soluble complex of I-125-IgE cross-linked to ch-alpha-protein but do not block I-125-IgE binding to the ch-alpha-protein expressed on Chinese hamster ovary cells. Both classes of antibodies bind to natural Fc-epsilon-RI present on human basophils and induce histamine release from these cells. Inhibitory antibody 15A5 specifically binds to a peptide corresponding to amino acids 125-140 of the putative second domain of the alpha-subunit sequence. All the inhibitory antibodies compete with I-125-15A5 for binding to the ch-alpha-protein, indicating that these antibodies recognize inhibitory epitopes that are either identical or sterically overlapping. Noninhibitory antibodies (i.e. 22E7) do not block I-125-15A5 binding to the ch-alpha-protein. These data suggest that antibodies binding to the predicted second domain of the alpha-subunit can inhibit IgE binding to the alpha-subunit, while antibodies binding at a distance from this site do not inhibit IgE binding. These inhibitory antibodies may block IgE binding to the ch-alpha-protein by direct overlap, steric inhibition, or induced conformational changes of the receptor contact points for IgE.	HOFFMANN LA ROCHE INC,ROCHE RES CTR,DEPT MOLEC GENET,NUTLEY,NJ 07110; HOFFMANN LA ROCHE INC,ROCHE RES CTR,DEPT IMMUNOPHARMACOL,NUTLEY,NJ 07110; HOFFMANN LA ROCHE INC,ROCHE RES CTR,DEPT PEPTIDE RES,NUTLEY,NJ 07110; HOFFMANN LA ROCHE INC,ROCHE RES CTR,DEPT PROT BIOCHEM,NUTLEY,NJ 07110	Roche Holding; Roche Holding; Roche Holding; Roche Holding								ALCARAZ G, 1984, J BIOL CHEM, V259, P4922; BANIYASH M, 1987, J IMMUNOL, V138, P2999; BARANY G, 1980, PEPTIDES ANAL SYNTHE, V2, P1; BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; Bayer E A, 1979, Methods Enzymol, V62, P308; BAZIN H, 1974, IMMUNOLOGY, V26, P713; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHIZZONITE R, 1989, P NATL ACAD SCI USA, V86, P8029, DOI 10.1073/pnas.86.20.8029; CONRAD DH, 1976, IMMUNOCHEMISTRY, V13, P329, DOI 10.1016/0019-2791(76)90343-8; Galfre G, 1981, Methods Enzymol, V73, P3; GROTH SFD, 1980, J IMMUNOL METHODS, V35, P1; GUYRE PM, 1989, J IMMUNOL, V143, P1650; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; HARLOW E, 1988, ANTIBODIES LABORATOR, P332; HELM B, 1989, P NATL ACAD SCI USA, V86, P9465, DOI 10.1073/pnas.86.23.9465; HOLOWKA D, 1980, J RECEPTOR RES, V1, P41, DOI 10.3109/10799898009039254; HOLOWKA D, 1982, MOL IMMUNOL, V19, P219, DOI 10.1016/0161-5890(82)90334-0; ISHIZAKA K, 1985, METHOD ENZYMOL, V116, P76; KILIAN PL, 1986, J IMMUNOL, V136, P4509; KINET JP, 1988, P NATL ACAD SCI USA, V85, P6483, DOI 10.1073/pnas.85.17.6483; KINET JP, 1987, BIOCHEMISTRY-US, V26, P4605, DOI 10.1021/bi00389a002; KOCHAN J, 1988, NUCLEIC ACIDS RES, V16, P3584, DOI 10.1093/nar/16.8.3584; KRENIK KD, 1989, J IMMUNOL METHODS, V117, P91, DOI 10.1016/0022-1759(89)90122-1; KULCZYCKI A, 1976, J IMMUNOL, V117, P661; KULCZYCKI A, 1974, J EXP MED, V139, P600, DOI 10.1084/jem.139.3.600; KUSTER H, 1990, J BIOL CHEM, V265, P6448; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONARD EJ, 1984, J LEUKOCYTE BIOL, V35, P169; MCCONAHEY PJ, 1986, INT ARCH ALLER A IMM, V29, P185; METZGER H, 1986, ANNU REV IMMUNOL, V4, P419, DOI 10.1146/annurev.iy.04.040186.002223; MILLER L, 1989, SCIENCE, V244, P334, DOI 10.1126/science.2523561; MIROLI AA, 1987, J IMMUNOL METHODS, V97, P185, DOI 10.1016/0022-1759(87)90458-3; NORDAN RP, 1987, J IMMUNOL, V139, P813; PEREZMONTFORT R, 1983, BIOCHEMISTRY-US, V22, P5733, DOI 10.1021/bi00294a009; PEREZMONTFORT R, 1983, BIOCHEMISTRY-US, V22, P5722, DOI 10.1021/bi00294a007; RA C, 1989, J BIOL CHEM, V264, P15323; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHIMIZU A, 1988, P NATL ACAD SCI USA, V85, P1907, DOI 10.1073/pnas.85.6.1907; STRACKE ML, 1987, MOL IMMUNOL, V24, P347, DOI 10.1016/0161-5890(87)90176-3; URDAL DL, 1988, J BIOL CHEM, V263, P2870	41	209	220	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11245	11251						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710221				2022-12-27	WOS:A1991FQ77400084
J	MANGANEL, M; TURNER, RJ				MANGANEL, M; TURNER, RJ			RAPID SECRETAGOGUE-INDUCED ACTIVATION OF NA+/H+ EXCHANGE IN RAT PAROTID ACINAR-CELLS - POSSIBLE INTERRELATIONSHIP BETWEEN VOLUME REGULATION AND STIMULUS-SECRETION COUPLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANDIBULAR SALIVARY-GLAND; AGONIST-INDUCED ACTIVATION; CYTOSOLIC FREE CALCIUM; PROTEIN-KINASE-C; ION-TRANSPORT; INTRACELLULAR PH; SUBSTANCE-P; MECHANISMS; CHANNELS; ACETYLCHOLINE	We demonstrate a rapid activation of the Na+/H+ exchanger in intact rat parotid acini in response to muscarinic (carbachol; K1/2 = 0.4-mu-M) and alpha-adrenergic (epinephrine; K1/2 = 0.1-mu-M) stimulation. This rapid activation is apparently distinct from the relatively "slow" activation of the exchanger (t1/2 greater-than-or-equal-to 5 min) reported previously (Manganel, M., and Turner, R. J. (1989) J. Membr. Biol. 111, 191-198). This rapid activation is not produced by treatmednt of acini with active diacylglycerol analogues nor prevented by protein kinase inhibitors, arguing against the involvement of protein kinase C-dependent processes. Stimulation of the exchanger is, however, produced by concentrations of ionomycin which yield intracellular calcium levels in the physiologic (secretagogue-induced) range. In addition, chelation of intracellular calcium with 1,2-bis(O-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid blocks the effect of carbachol, but calmodulin antagonists are without effect. The possibility that the rapid activation of the Na+/H+ exchanger may be associated with cell shrinkage arising from carbachol-induced calcium mobilization is explored. In support of this suggestion we present evidence that: (i) the Na+/H+ exchanger is stimulated by shrinkage of these cells, (ii) the carbachol dose dependence of Na+/H+ exchange activation correlates well with that of shrinkage (but not with that of intracellular calcium levels), and (iii) maneuvers which blunt carbachol- or calcium-induced shrinkage also blunt activation of the exchanger. We suggest that this osmoregulatory response may play an important role in maintaining ionic homeostasis during the acinar fluid secretory process.	NIDR,CLIN INVEST & PATIENT CARE BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)								AMBUDKAR IS, 1988, PFLUG ARCH EUR J PHY, V412, P75, DOI 10.1007/BF00583733; BAUM B J, 1987, P123; BROWN PD, 1989, J PHYSIOL-LONDON, V414, P415, DOI 10.1113/jphysiol.1989.sp017696; BURGEN ASV, 1956, J PHYSIOL-LONDON, V132, P20, DOI 10.1113/jphysiol.1956.sp005500; DEPONT JJH, 1982, ELECTROLYTE WATER TR, P11; EVELOFF JL, 1987, AM J PHYSIOL, V252, pF1, DOI 10.1152/ajprenal.1987.252.1.F1; FOSKETT JK, 1989, SCIENCE, V244, P1582, DOI 10.1126/science.2500708; GRINSTEIN S, 1986, BIOCHEM BIOPH RES CO, V134, P8, DOI 10.1016/0006-291X(86)90519-X; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; GRINSTEIN S, 1986, J BIOL CHEM, V261, P8009; GRINSTEIN S, 1990, ANNU REV PHYSIOL, V52, P399; IZUTSU KT, 1987, J DENT RES, V66, P537, DOI 10.1177/00220345870660022501; LAU KR, 1989, AM J PHYSIOL, V256, pC288, DOI 10.1152/ajpcell.1989.256.2.C288; LEWIS SA, 1990, NEWS PHYSIOL SCI, V5, P112; MANGANEL M, 1989, J MEMBRANE BIOL, V111, P191, DOI 10.1007/BF01871782; MANGANEL M, 1990, J BIOL CHEM, V265, P4284; MARTINEZ JR, 1987, J DENT RES, V66, P638, DOI 10.1177/00220345870660S206; MELVIN JE, 1988, J BIOL CHEM, V263, P19564; MELVIN JE, 1987, BIOCHEM BIOPH RES CO, V145, P754, DOI 10.1016/0006-291X(87)91029-1; MERRITT JE, 1987, J BIOL CHEM, V262, P14912; MERRITT JE, 1987, J BIOL CHEM, V262, P17362; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MURAKAMI M, 1989, PFLUG ARCH EUR J PHY, V414, P385, DOI 10.1007/BF00585047; NAUNTOFTE B, 1986, AM J PHYSIOL, V251, pC175, DOI 10.1152/ajpcell.1986.251.2.C175; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; PETERSEN OH, 1988, ANNU REV PHYSIOL, V50, P65; PIRANI D, 1987, PFLUG ARCH EUR J PHY, V408, P178, DOI 10.1007/BF00581349; POULSEN JH, 1988, MOL MECHANISMS SECRE, P152; PUTNEY JW, 1986, ANNU REV PHYSIOL, V48, P75, DOI 10.1146/annurev.ph.48.030186.000451; PUTNEY JW, 1976, J PHARMACOL EXP THER, V198, P375; SOLTOFF SP, 1989, J GEN PHYSIOL, V93, P285, DOI 10.1085/jgp.93.2.285; WONG PYD, 1989, PFLUG ARCH EUR J PHY, V413, P414, DOI 10.1007/BF00584492; YOUNG JA, 1987, J DENT RES, V66, P531, DOI 10.1177/00220345870660022401; [No title captured]	34	46	50	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10182	10188						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709927				2022-12-27	WOS:A1991FP08600031
J	ZOU, LL; RICHARDSON, JP				ZOU, LL; RICHARDSON, JP			ENHANCEMENT OF TRANSCRIPTION TERMINATION FACTOR RHO ACTIVITY WITH POTASSIUM GLUTAMATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRO MESSENGER-RNA; PROTEIN-DNA INTERACTIONS; LAMBDA-PR PROMOTER; ESCHERICHIA-COLI; DEPENDENT TERMINATION; GENE-EXPRESSION; 3' END; BINDING; SITES; IDENTIFICATION	The efficiencies of rho action as a termination factor during transcription in vitro of several DNA templates were determined as a function of the concentration and type of electrolyte ions. The termination efficiencies with lambda-tR1 and the promoter proximal lacZ intragenic terminators were significantly higher with 0.1-0.2 M potassium glutamate as the major electrolyte than with the optimal concentrations of KCl (approximately 0.05 M) or potassium acetate (approximately 0.15 M). Similar high efficiencies were obtained with salts of other acidic amino acids but not with a salt of N-acetylglutamic acid or with a mixture of 0.15 M potassium acetate and 0.15 M glycine, and termination was inhibited completely when 0.12 M KCl was present along with 0.12 M potassium glutamate. The salts that give high termination efficiencies have two properties in common; they consist of anions that are also zwitterions, and they are weak chelators of Mg2+ ions. The increase in termination efficiency with potassium glutamate can be ascribed mainly to a facilitation of the reactions of rho with RNA that are coupled to ATP hydrolysis, as the rate of ATP hydrolysis with isolated transcripts as cofactors was about five times higher with 0.15 M potassium glutamate than with 0.05 M KCl, whereas the rates of chain elongation, the general stability of the transcription complexes, and the binding affinity of rho with the transcripts were all very similar under the two conditions. Further analysis revealed that the activation of ATP hydrolysis is an outcome of a shift in the optimum magnesium salt concentration from 0.5 mM with 0.05 M KCl to 4 mM with 0.15 M potassium glutamate. Since glutamate is a relatively weak counterion for cationic groups in proteins, potassium glutamate can be used at 0.15 M without inhibiting the binding of rho to RNA. At that concentration, it serves to buffer the level of free Mg2+ available to stabilize RNA secondary structures that are known to impede rho action on RNA. The two special properties of glutamate together create conditions that allow rho to terminate transcription in vitro at an efficiency that matches the in vivo efficiency with use of a physiological level of K+ ions.	INDIANA UNIV,DEPT CHEM,BLOOMINGTON,IN 47405	Indiana University System; Indiana University Bloomington					NIAID NIH HHS [AI 10142] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI010142, R01AI010142] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; ANDREWS C, 1985, J BIOL CHEM, V260, P5826; ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; CHEN CYA, 1986, CELL, V46, P1023, DOI 10.1016/0092-8674(86)90701-4; CHEN CYA, 1987, J BIOL CHEM, V262, P11292; DOVE WF, 1962, J MOL BIOL, V5, P467, DOI 10.1016/S0022-2836(62)80119-3; EPSTEIN W, 1965, J GEN PHYSIOL, V49, P221, DOI 10.1085/jgp.49.2.221; FAUS I, 1989, BIOCHEMISTRY-US, V28, P3510, DOI 10.1021/bi00434a054; FAUS I, 1990, J MOL BIOL, V212, P53, DOI 10.1016/0022-2836(90)90304-5; FINGER LR, 1982, J MOL BIOL, V156, P203, DOI 10.1016/0022-2836(82)90467-3; FINGER LR, 1981, BIOCHEMISTRY-US, V20, P1640, DOI 10.1021/bi00509a036; FRIEDMAN DI, 1987, ANNU REV GENET, V21, P453; GALLUPPI G, 1976, RNA POLYMERASE, P657; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; LAU LF, 1982, P NATL ACAD SCI-BIOL, V79, P6171, DOI 10.1073/pnas.79.20.6171; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; LUMB RF, 1953, J PHYS CHEM-US, V57, P690, DOI 10.1021/j150508a021; LYNCH DC, 1974, BIOCHEMISTRY-US, V13, P1841, DOI 10.1021/bi00706a012; MORGAN WD, 1983, J BIOL CHEM, V258, P9565; MORGAN WD, 1983, J BIOL CHEM, V258, P9553; O'Sullivan W J, 1979, Methods Enzymol, V63, P294; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; RECORD MT, 1977, BIOCHEMISTRY-US, V16, P4791, DOI 10.1021/bi00641a005; RICHARDSON JP, 1970, COLD SPRING HARB SYM, V35, P127, DOI 10.1101/SQB.1970.035.01.019; RICHARDSON JP, 1966, J MOL BIOL, V21, P115, DOI 10.1016/0022-2836(66)90083-0; RICHARDSON JP, 1981, BIOCHEMISTRY-US, V20, P1133, DOI 10.1021/bi00508a014; RICHARDSON JP, 1980, BIOCHEMISTRY-US, V19, P4293, DOI 10.1021/bi00559a022; RICHARDSON JP, 1990, BIOCHIM BIOPHYS ACTA, V1048, P127, DOI 10.1016/0167-4781(90)90048-7; RICHEY B, 1987, J BIOL CHEM, V262, P7157; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; ROSENBERG M, 1979, ANNU REV GENET, V13, P319, DOI 10.1146/annurev.ge.13.120179.001535; RUTESHOUSER EC, 1989, J MOL BIOL, V208, P23, DOI 10.1016/0022-2836(89)90085-5; SHARP JA, 1984, J BIOL CHEM, V259, P2268; STORK JB, 1977, J BIOL CHEM, V252, P7850; TSURUSHITA N, 1989, J MOL BIOL, V210, P23, DOI 10.1016/0022-2836(89)90288-X; Westall J, 1976, MINEQL COMPUTER PROG; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; ZOU L, 1990, THESIS INDIANA U BLO	40	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10201	10209						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709928				2022-12-27	WOS:A1991FP08600034
J	QUINN, CL; STEPHENSON, BT; SWITZER, RL				QUINN, CL; STEPHENSON, BT; SWITZER, RL			FUNCTIONAL-ORGANIZATION AND NUCLEOTIDE-SEQUENCE OF THE BACILLUS-SUBTILIS PYRIMIDINE BIOSYNTHETIC OPERON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; ESCHERICHIA-COLI K-12; GENE ENCODING DIHYDROOROTASE; SITE-DIRECTED MUTAGENESIS; ASPARTATE-TRANSCARBAMYLASE; SACCHAROMYCES-CEREVISIAE; DICTYOSTELIUM-DISCOIDEUM; SALMONELLA-TYPHIMURIUM; TRYPTOPHAN OPERON; MULTIFUNCTIONAL ENZYME	A 12.5-kilobase segment of Bacillus subtilis chromosomal DNA containing the entire pyrimidine biosynthetic (pyr) gene cluster has been cloned and sequenced. The sequenced DNA has seven cistrons encoding the six enzymes of de novo pyrimidine nucleotide biosynthesis and two open reading frames of unknown function. Based on the sequence and mapping of transcripts, the genes in this cluster appear to be transcribed on one large polycistronic message in the order ORF1, pyrB, pyrC, pyrAA, pyrAB, ORF2, pyrD, pyrF, pyrE. The deduced amino acid sequences for six pyrimidine biosynthetic enzymes from B. subtilis and comparisons with the corresponding sequences from numerous other species are presented. The 3' ends of the reading frames overlap the 5' ends of the downstream open reading frames for all cistrons in the cluster except ORF1 and pyrB, which are separated by a 145-base pair intercistronic region. The start of transcription was mapped by primer extension to a G residue 158 nucleotides upstream from the translation initiation codon of ORF1. This site is preceded by a typical B. subtilis sigma-A-dependent promoter. A promoter indicator plasmid was used to show that this region carried a promoter from which transcription was regulated by pyrimidines. Transcription from this promoter was not detected in primer extension experiments using mRNA prepared from B. subtilis cells grown in the presence of excess uracil. No transcripts initiating from the intercistronic space between ORF1 and pyrB were detected with S1 nuclease mapping; however, a transcription terminator was detected in this region that reduced but did not fully block transcriptional readthrough. This terminator was not regulated by pyrimidines in the growth medium under the conditions tested. The region immediately following the promoter and 5' to ORF1 has a potential transcription terminator sequence. The roles, if any, of these transcription terminators in the regulation of pyr operon expression are yet to be determined. However, deletion of the terminator immediately following the promoter abolished pyrimidine regulation of transcription in the indicator plasmid.	UNIV ILLINOIS,DEPT BIOCHEM,1209 W CALIF,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI011121] Funding Source: NIH RePORTER; NIAID NIH HHS [AI11121] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKSOY S, 1984, J BACTERIOL, V157, P363, DOI 10.1128/JB.157.2.363-367.1984; AMURO N, 1985, J BIOL CHEM, V260, P4844; ASASHI S, 1989, AGR BIOL CHEM TOKYO, V53, P97; BAND L, 1984, GENE, V27, P55, DOI 10.1016/0378-1119(84)90238-5; BAUGHMAN G, 1983, CELL, V34, P979, DOI 10.1016/0092-8674(83)90555-X; BOND RW, 1983, J BACTERIOL, V153, P253, DOI 10.1128/JB.153.1.253-258.1983; BONEKAMP F, 1984, EMBO J, V3, P2857, DOI 10.1002/j.1460-2075.1984.tb02220.x; BURBULYS D, 1991, CELL, V64, P545, DOI 10.1016/0092-8674(91)90238-T; CHAVIRA R, 1984, ANAL BIOCHEM, V136, P446, DOI 10.1016/0003-2697(84)90242-2; CONTENTE S, 1979, MOL GEN GENET, V167, P251, DOI 10.1007/BF00267416; DAS A, 1984, NUCLEIC ACIDS RES, V12, P4657; DEMONTIGNY J, 1989, MOL GEN GENET, V215, P455, DOI 10.1007/BF00427043; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; DOI RH, 1986, MICROBIOL REV, V50, P227, DOI 10.1128/MMBR.50.3.227-243.1986; EBBOLE DJ, 1988, J BIOL CHEM, V263, P10894; EBBOLE DJ, 1987, J BIOL CHEM, V262, P8274; EVANS DR, 1985, MULTIDOMAIN PROTEINS, P283; FAURE M, 1989, EUR J BIOCHEM, V179, P345, DOI 10.1111/j.1432-1033.1989.tb14560.x; FREUND JN, 1987, J MOL BIOL, V193, P1, DOI 10.1016/0022-2836(87)90621-8; GUYONVARCH A, 1988, MOL GEN GENET, V212, P134, DOI 10.1007/BF00322456; Hanahan D., 1985, TECHNIQUES TRANSFORM, P109; HENNER DJ, 1985, GENE, V34, P169, DOI 10.1016/0378-1119(85)90125-8; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; JACQUET M, 1985, BIOCHIMIE, V67, P583, DOI 10.1016/S0300-9084(85)80197-8; JACQUET M, 1988, MOL GEN GENET, V211, P441, DOI 10.1007/BF00425698; JONES ME, 1980, ANNU REV BIOCHEM, V49, P253, DOI 10.1146/annurev.bi.49.070180.001345; KAWAMURA F, 1984, J BACTERIOL, V160, P442, DOI 10.1128/JB.160.1.442-444.1984; KILSTRUP M, 1988, EUR J BIOCHEM, V176, P421, DOI 10.1111/j.1432-1033.1988.tb14299.x; LAPILATO J, 1986, MOL GEN GENET, V205, P285; LARSEN JN, 1985, EUR J BIOCHEM, V151, P59, DOI 10.1111/j.1432-1033.1985.tb09068.x; LERNER CG, 1987, J BACTERIOL, V169, P2202, DOI 10.1128/jb.169.5.2202-2206.1987; LERNER CG, 1986, J BIOL CHEM, V261, P1156; LIU CG, 1989, J BACTERIOL, V171, P3337, DOI 10.1128/jb.171.6.3337-3342.1989; LUSTY CJ, 1983, J BIOL CHEM, V258, P4466; MAURIZI MR, 1978, J BACTERIOL, V135, P943, DOI 10.1128/JB.135.3.943-951.1978; MCLAUGHLIN JR, 1981, J BIOL CHEM, V256, P1283; Miller J. H., 1972, EXPT MOL GENETICS, P431; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NEUHARD J, 1986, EUR J BIOCHEM, V157, P335, DOI 10.1111/j.1432-1033.1986.tb09673.x; NEWBURY SF, 1986, GENE, V43, P51, DOI 10.1016/0378-1119(86)90007-7; NYUNOYA H, 1983, P NATL ACAD SCI-BIOL, V80, P4629, DOI 10.1073/pnas.80.15.4629; ODONOVAN GA, 1970, BACTERIOL REV, V34, P278, DOI 10.1128/MMBR.34.3.278-343.1970; OPPENHEIM DS, 1980, GENETICS, V95, P785; OZKAYNAK E, 1987, BIOTECHNIQUES, V5, P770; PAULUS TJ, 1982, J BACTERIOL, V149, P775, DOI 10.1128/JB.149.2.775-778.1982; PAULUS TJ, 1979, J BACTERIOL, V137, P82, DOI 10.1128/JB.137.1.82-91.1979; PIETTE J, 1984, P NATL ACAD SCI-BIOL, V81, P4134, DOI 10.1073/pnas.81.13.4134; PIGGOT PJ, 1985, MICROBIOL REV, V49, P158, DOI 10.1128/MMBR.49.2.158-179.1985; POST LE, 1990, J BIOL CHEM, V265, P7742; POTVIN BW, 1975, J BACTERIOL, V123, P604, DOI 10.1128/JB.123.2.604-615.1975; POULSEN P, 1983, EUR J BIOCHEM, V135, P223, DOI 10.1111/j.1432-1033.1983.tb07641.x; RADFORD A, 1988, GENOME, V30, P501, DOI 10.1139/g88-084; REDDY P, 1985, P NATL ACAD SCI USA, V82, P5656, DOI 10.1073/pnas.82.17.5656; ROLAND KL, 1985, J BACTERIOL, V163, P991, DOI 10.1128/JB.163.3.991-999.1985; ROSE M, 1984, GENE, V29, P113, DOI 10.1016/0378-1119(84)90172-0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUMPERLI D, 1982, CELL, V30, P856; SIMMER JP, 1990, P NATL ACAD SCI USA, V87, P174, DOI 10.1073/pnas.87.1.174; STRAUCH M, 1990, P NATL ACAD SCI USA, V87, P1801, DOI 10.1073/pnas.87.5.1801; SUTTLE DP, 1988, P NATL ACAD SCI USA, V85, P1754, DOI 10.1073/pnas.85.6.1754; THEISEN M, 1987, EUR J BIOCHEM, V164, P613, DOI 10.1111/j.1432-1033.1987.tb11171.x; TINOCO I, 1973, NATURE-NEW BIOL, V246, P40, DOI 10.1038/newbio246040a0; TURCQ B, 1987, GENE, V53, P201, DOI 10.1016/0378-1119(87)90008-4; TURNBOUGH CL, 1987, J BIOL CHEM, V262, P10239; ULMANEN I, 1985, J BACTERIOL, V162, P176, DOI 10.1128/JB.162.1.176-182.1985; VANDEYAR MA, 1986, J BACTERIOL, V167, P530, DOI 10.1128/jb.167.2.530-534.1986; WANG LF, 1986, THESIS U CALIFORNIA; WASHABAUGH MW, 1984, J BIOL CHEM, V259, P3293; WILSON HR, 1987, J BACTERIOL, V169, P3051, DOI 10.1128/jb.169.7.3051-3058.1987; WONG SC, 1990, J BACTERIOL, V172, P630, DOI 10.1128/jb.172.2.630-642.1990; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; ZALKIN H, 1988, J BIOL CHEM, V263, P1595	72	122	134	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					9113	9127						15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709162				2022-12-27	WOS:A1991FM03800070
J	PEPPEL, K; BAGLIONI, C				PEPPEL, K; BAGLIONI, C			DEADENYLATION AND TURNOVER OF INTERFERON-BETA MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MESSENGER-RNA DEGRADATION; C-FOS; SEQUENCE; CELLS; IDENTIFICATION; POLY(A); REGION; MOUSE	The pathway of degradation of human interferon-beta (IFN-beta) mRNA was examined in murine C127 cells that carry an expression vector for this mRNA. The IFN-beta mRNA decayed with a half-life of approximately 45 min in actinomycin D-treated cells and became gradually shorter. This mRNA was superinduced in cycloheximide-treated cells, but it also became gradually shorter. However, apparently full-length species of IFN-beta mRNA accumulated after prolonged incubation with cycloheximide. The shortened IFN-beta mRNA species were partially deadenylated and less stable than full-length species. These findings suggest that at least two nuclease activities are involved in degrading IFN-beta mRNA; one deadenylates this mRNA and decays in cycloheximide-treated cells, while the other apparently breaks down deadenylated mRNA.	SUNY ALBANY,DEPT BIOL SCI,1400 WASHINGTON AVE,ALBANY,NY 12222	State University of New York (SUNY) System; State University of New York (SUNY) Albany					NCI NIH HHS [CA-29895] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA029895] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRAWERMAN G, 1981, CRC CR REV BIOCH MOL, V10, P1, DOI 10.3109/10409238109114634; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; DERYNCK R, 1980, NATURE, V285, P542, DOI 10.1038/285542a0; DIMAIO D, 1982, P NATL ACAD SCI-BIOL, V79, P4030, DOI 10.1073/pnas.79.13.4030; ERNST TJ, 1989, J BIOL CHEM, V264, P5700; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; KINDY MS, 1986, J BIOL CHEM, V261, P2865; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; Maniatis T., 1982, MOL CLONING; PERRY RP, 1973, J MOL BIOL, V79, P681, DOI 10.1016/0022-2836(73)90071-5; RAJI NBK, 1981, P NATL ACAD SCI USA, V78, P7426; ROSENTHAL ET, 1987, DEV BIOL, V121, P237, DOI 10.1016/0012-1606(87)90155-2; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHYU AB, 1989, GENE DEV, V3, P60, DOI 10.1101/gad.3.1.60; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0	17	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					6663	6666						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707871				2022-12-27	WOS:A1991FG72700002
J	RAN, S; BENOS, DJ				RAN, S; BENOS, DJ			ISOLATION AND FUNCTIONAL RECONSTITUTION OF A 38-KDA CHLORIDE CHANNEL PROTEIN FROM BOVINE TRACHEAL MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROSIS AIRWAY EPITHELIA; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; BINDING; ACETYLCHOLINE; TRANSPORT	Secretion of chloride ions via apically located anion-selective channels in epithelia regulates fluid formation and cytosolic Cl- homeostasis. In order to understand the biochemical basis of Cl- channel function, we attempted to isolate this transporter from bovine tracheal apical membranes. Initially, peripheral polypeptides were removed from apically enriched vesicles by washing with alkaline buffer (pH 10.8) containing 2 mM CHAPS. The resulting pellet contained 50-60% of the original protein and displayed 2-fold enhanced Cl- channel activity compared to untreated vesicles. The pellet was treated with Triton X-100, and the solubilized proteins were separated on the cationic exchanger CM-cellufine. Washing the resin with a pH 8.0-8.3 buffer eluted a fraction with enriched Cl- channel activity. This fraction contained < 5% of the total solubilized protein. A subsequent separation was performed using the anionic exchanger AM-cellufine. The highest activity was found in the fractions eluted by 80-120 mM KCl. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis showed a major 38,000-Da protein band. This band was electroeluted from the gel under nondenaturing and nonreducing conditions and reconstituted into phosphatidylcholine liposomes. KCl-loaded vesicles containing the purified 38-kDa protein transported up to 5 nmol of I-125-/mg of protein/5 min. This value was 15-fold higher than the uptake measured in vesicles reconstituted with total solubilized membrane proteins and 4-fold higher compared to the CM-cellufine-enriched fraction. The observed I-125- uptake was 90% inhibited by 100-mu-M 4,4-bis(isothiocyano)-2,2'-stilbenedisulfonate or 10-mu-M valinomycin. In summary, we have developed a biochemical protocol for the isolation of a 38 kDa protein mediating potential-dependent and 4,4-bis(isothiocyano)-2,2'-stilbenedisulfonate-sensitive Cl- channel activity.			RAN, S (corresponding author), UNIV ALABAMA,DEPT PHYSIOL & BIOPHYS,BIRMINGHAM,AL 35294, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK042017] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42017] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLANCY J P, 1989, FASEB Journal, V3, pA562; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; DUBINSKY WP, 1986, AM J PHYSIOL, V251, pC713, DOI 10.1152/ajpcell.1986.251.5.C713; FARACH MC, 1983, J BIOL CHEM, V258, P4166; FINKELSTEIN A, 1968, J GEN PHYSIOL, V52, pS145; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GOGELEIN H, 1988, BIOCHIM BIOPHYS ACTA, V947, P521, DOI 10.1016/0304-4157(88)90006-8; HJELMELAND LM, 1983, ANAL BIOCHEM, V130, P72, DOI 10.1016/0003-2697(83)90651-6; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; LANGRIDGESMITH JE, 1983, BIOCHIM BIOPHYS ACTA, V731, P318, DOI 10.1016/0005-2736(83)90024-X; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LIEDTKE CM, 1989, ANNU REV PHYSIOL, V51, P143, DOI 10.1146/annurev.physiol.51.1.143; NEUBIG RR, 1979, P NATL ACAD SCI USA, V76, P690, DOI 10.1073/pnas.76.2.690; PARTEARROYO MA, 1988, BIOCHEM INT, V16, P259; QUINTON PM, 1983, NATURE, V301, P421, DOI 10.1038/301421a0; REDDY MM, 1989, AM J PHYSIOL, V257, pC727, DOI 10.1152/ajpcell.1989.257.4.C727; ROBERTSON RN, 1977, FEBS LETT, V76, P16, DOI 10.1016/0014-5793(77)80111-7; ROSENBER.B, 1968, CHEM PHYS LIPIDS, V2, P47, DOI 10.1016/0009-3084(68)90034-0; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; TORRIANI A, 1968, METHOD ENZYMOL, V23, P212; VAINSTEIN A, 1984, BIOCHIM BIOPHYS ACTA, V773, P181, DOI 10.1016/0005-2736(84)90081-6; VALDIVIA HH, 1988, SCIENCE, V242, P1441, DOI 10.1126/science.2462280; VENGLARIK CJ, 1990, AM J PHYSIOL, V259, pC358; WIDDICOMBE JH, 1980, AM J PHYSIOL, V239, pC112, DOI 10.1152/ajpcell.1980.239.3.C112; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226; YODA A, 1970, BIOCHEM BIOPH RES CO, V40, P880, DOI 10.1016/0006-291X(70)90985-X	27	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4782	4788						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1705933				2022-12-27	WOS:A1991FC21700020
J	MONTROSERAFIZADEH, C; GUGGINO, WB; MONTROSE, MH				MONTROSERAFIZADEH, C; GUGGINO, WB; MONTROSE, MH			CELLULAR-DIFFERENTIATION REGULATES EXPRESSION OF CL- TRANSPORT AND CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MESSENGER-RNA IN HUMAN INTESTINAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; CHLORIDE CHANNELS; ENTEROCYTIC DIFFERENTIATION; FLUOROGENIC SUBSTRATE; AIRWAY EPITHELIA; LINE; HT29; IDENTIFICATION; AMINOPEPTIDASE; ACTIVATION	The gene defective in cystic fibrosis has recently been shown to code for a membrane protein designated the "cystic fibrosis transmembrane conductance regulator" (CFTR) protein. While it has been shown that detectable levels of the mRNA for the normal CFTR protein are present in epithelial cells from different tissues, factors which regulate CFTR expression have not been identified. A clonal cell line originating from a human colon adenocarcinoma (HT29-18) differentiates to multiple epithelial cell types when deprived of glucose in the culture medium. In these studies, mRNA isolated from these cells was examined by hybridization to a 1.45-kilobase cDNA probe which encodes transmembrane portions of the CFTR protein between exons 13 and 19. Cellular differentiation of HT29-18 causes a 9-18-fold increase in CFTR mRNA abundance versus the mRNA for the structural proteins actin and tubulin. Cellular differentiation also causes a 5-fold increase in second messenger-regulated Cl- transport which is sensitive to a Cl- channel blocker (diphenylamine 2-carboxylate). Subclones of HT29-18 which are committed to differentiate to either a mucin-secreting (HT29-18-N2) or an "enterocyte-like" (HT29-18-C1) phenotype have also been examined. In both subclones, elevated levels of CFTR mRNA are observed when compared with undifferentiated HT29-18 cells. However, during cellular differentiation, the regulation of CFTR mRNA abundance and membrane enzyme expression by the subclones is different from HT29-18. The results show that elevated CFTR mRNA occurs in multiple differentiated intestinal epithelial cell types, despite a phenotype-specific regulation of membrane protein expression. This suggests that CFTR expression plays a role in the differentiated functions of multiple epithelial phenotypes and that both cellular differentiation and cellular phenotypes are factors which regulate CFTR expression.	JOHNS HOPKINS UNIV,SCH MED,DEPT MED,515 HUNTERIAN,725 N WOLFE ST,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University								AUGERON C, 1984, CANCER RES, V44, P3961; BERSCHNEIDER HM, 1988, FASEB J, V2, P2625, DOI 10.1096/fasebj.2.10.2838365; BUBIEN JK, 1990, SCIENCE, V248, P1416, DOI 10.1126/science.2162561; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; DISTEFANO A, 1985, PFLUG ARCH EUR J PHY, V405, pS95, DOI 10.1007/BF00581787; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; DUDOUET B, 1987, J CELL BIOL, V105, P359, DOI 10.1083/jcb.105.1.359; EDMONDS M, 1971, P NATL ACAD SCI USA, V68, P1336, DOI 10.1073/pnas.68.6.1336; FANTINI J, 1986, J CELL SCI, V83, P235; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HALL JL, 1983, MOL CELL BIOL, V3, P854, DOI 10.1128/MCB.3.5.854; HUET C, 1987, J CELL BIOL, V105, P345, DOI 10.1083/jcb.105.1.345; HWANG TC, 1989, SCIENCE, V244, P1351, DOI 10.1126/science.2472005; KANAOKA Y, 1977, CHEM PHARM BULL, V25, P362; KATO T, 1978, BIOCHEM MED METAB B, V19, P351, DOI 10.1016/0006-2944(78)90035-2; KIM HD, 1988, BIOCHIM BIOPHYS ACTA, V946, P397, DOI 10.1016/0005-2736(88)90415-4; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; Neutra M.R., 1987, PHYSL GASTROINTESTIN, V2, P975; PHILLIPS TE, 1988, GASTROENTEROLOGY, V94, P1390, DOI 10.1016/0016-5085(88)90678-6; PINTO M, 1982, BIOL CELL, V44, P193; PONDER BAJ, 1985, NATURE, V313, P689, DOI 10.1038/313689a0; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; SCHOUMACHER RA, 1987, NATURE, V330, P752, DOI 10.1038/330752a0; SOOD R, 1990, PEDIATR PULM S, V5, P194; TAYLOR CJ, 1987, LANCET, V2, P107, DOI 10.1016/S0140-6736(87)92781-4; TRUGNAN G, 1987, J CELL BIOL, V104, P1199, DOI 10.1083/jcb.104.5.1199; WELSH MJ, 1987, J CLIN INVEST, V80, P1523, DOI 10.1172/JCI113237; WELSH MJ, 1986, PFLUG ARCH EUR J PHY, V407, pS116, DOI 10.1007/BF00584940; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226	31	46	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4495	4499						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705554				2022-12-27	WOS:A1991FA69400074
J	TOMPKINS, TA; MOSCARELLO, MA				TOMPKINS, TA; MOSCARELLO, MA			A 57-KDA PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-C FROM BOVINE BRAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN BASIC-PROTEIN; SIGNAL TRANSDUCTION; RAT-BRAIN; PURIFICATION; MESSENGER; FORMS; ACID; STIMULATION; HYDROLYSIS; TURNOVER	A phosphatidylinositol-specific phospholipase C (PI-PLC) has been isolated from bovine brain (purification factor of 5.6 X 10(4)). By sodium dodecyl sulfate-polyacrylamide gel electrophoresis, it had a M(r) of 57,000. Neither amino nor neutral sugars were detected in the purified enzyme. The pH optimum was 7.0-7.5, and the activity decreased only slightly at pH 8.0. When phosphatidylinositol was used as a substrate, the optimum Ca2+ requirement was 4 mM, and K(m) was 260-mu-M. When phosphatidylinositol 4,5-bisphosphate was used, the optimum Ca2+ requirement was 10(-7) M, and the K(m) was reduced to 90-mu-M. Lipid specificity studies showed that equal amounts of inositol phosphate and diacylglycerol were released from phosphatidylinositol but 4 times as much inositol 1,4,5-trisphosphate was released from phosphatidylinositol 4,5-bisphosphate. Other lipids, phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin, were not substrates. Failure to detect phosphatidic acid confirmed the absence of a phospholipase D activity in the purified enzyme. Myelin basic protein (MBP) stimulated the PI-PLC activity between 2- and 3-fold. Histone had a small effect only, whereas bovine serum albumin and cytochrome C had no effect. Phosphorylation of MBP reduced the stimulatory effect. Protein-protein interactions between MBP and PI-PLC have been demonstrated both immunologically and by sucrose density gradients. A stoichiometry of 1:1 has been suggested by the latter method. A number of peptides have been prepared by chemical, enzymatic, and synthetic methods. Peptides containing the MBP sequences consisting of residues 24-33 and 114-122 stimulated the PI-PLC but were less effective than the intact protein.	HOSP SICK CHILDREN,DEPT BIOCHEM,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)								BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BERRIDGE MJ, 1986, CANCER SURV, V5, P413; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BOGGS JM, 1981, BIOCHEMISTRY-US, V20, P1065, DOI 10.1021/bi00508a004; BOULIAS C, 1989, BIOCHEM BIOPH RES CO, V162, P282, DOI 10.1016/0006-291X(89)91993-1; BOULIAS C, 1989, T AM SOC NEUROCHEM, V20, P336; BRADY GW, 1985, BIOCHEM BIOPH RES CO, V126, P1121; CHAN KC, 1988, BIOCHEM BIOPH RES CO, V152, P1468, DOI 10.1016/S0006-291X(88)80451-0; COHEN SA, 1988, ANAL BIOCHEM, V174, P1, DOI 10.1016/0003-2697(88)90512-X; DESHMUKH DS, 1981, J NEUROCHEM, V36, P591; EICHBERG J, 1964, BIOCHEM J, V96, P644; FUKUI T, 1988, J BIOL CHEM, V263, P17730; GERFEN CR, 1988, P NATL ACAD SCI USA, V85, P3208, DOI 10.1073/pnas.85.9.3208; HOFMANN SL, 1982, J BIOL CHEM, V257, P6461; HOFMANN SL, 1982, J BIOL CHEM, V257, P4359; HOMMA Y, 1988, J BIOL CHEM, V263, P6592; IRVINE RF, 1986, PHOSPHOINOSITIDES RE, P97; KAHN DW, 1988, J NEUROCHEM, V50, P1542, DOI 10.1111/j.1471-4159.1988.tb03042.x; KEOUGH KMW, 1970, J NEUROCHEM, V17, P1, DOI 10.1111/j.1471-4159.1970.tb00495.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAROCCA JN, 1987, BRAIN RES, V436, P357, DOI 10.1016/0006-8993(87)91679-9; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; LOW MG, 1983, BIOCHEM J, V215, P325, DOI 10.1042/bj2150325; LOWDEN JA, 1966, CAN J BIOCHEM CELL B, V44, P567, DOI 10.1139/o66-068; MAJERUS PW, 1986, SCIENCE, V234, P1519, DOI 10.1126/science.3024320; MARKWELL MAK, 1978, BIOCHEMISTRY-US, V17, P4807, DOI 10.1021/bi00615a031; MORRIS AJ, 1990, J BIOL CHEM, V265, P13501; MOSCARELLO MA, 1989, DYNAMIC INTERACTION, P25; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; NORTON WT, 1980, SEARCH CAUSE MULTIPL, P64; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; PUTNEY JW, 1989, FASEB J, V3, P1899, DOI 10.1096/fasebj.3.8.2542110; RAMWANI JJ, 1989, BIOCHEMISTRY-US, V28, P6538, DOI 10.1021/bi00442a002; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; ROSS CA, 1989, P NATL ACAD SCI USA, V86, P2923, DOI 10.1073/pnas.86.8.2923; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SALTIEL AR, 1987, BIOCHEM J, V241, P759, DOI 10.1042/bj2410759; TAKENAWA T, 1981, J BIOL CHEM, V256, P6769; WOOD DD, 1989, J BIOL CHEM, V264, P5121	40	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4228	4236						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705549				2022-12-27	WOS:A1991FA69400035
J	LITWIN, CME; CHENG, HC; WANG, JH				LITWIN, CME; CHENG, HC; WANG, JH			PURIFICATION AND CHARACTERIZATION OF A PP60C-SRC-RELATED TYROSINE KINASE THAT EFFECTIVELY PHOSPHORYLATES A SYNTHETIC PEPTIDE DERIVED FROM P34CDC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE; POLYACRYLAMIDE GELS; SPLEEN; NITROCELLULOSE; IDENTIFICATION; SUBSTRATE; CELLS; LSTRA; GENE	A protein tyrosine kinase has been purified from the particulate fraction of bovine spleen to a specific activity of 0.217-mu-mol/min/mg at 100-mu-M ATP and 3 mM [Val5] angiotensin II. Both angiotensin phosphorylation activity and immunoreactivity towards an antibody preparation raised against a synthetic peptide containing the autophosphorylation site of pp60c-src, Cys-src(403-421), were monitored during the purification. The purified sample displayed three closely spaced protein bands with molecular weights of 50-55 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. All bands could be phosphorylated exclusively on tyrosine residues under autophosphorylation conditions. All reacted on immunoblots with an antibody raised against a synthetic peptide corresponding to the consensus autophosphorylation site of members of the pp603-src family of tyrosine kinases. Tryptic phosphopeptide maps of the three proteins were essentially indistinguishable. The results suggest that the purified enzyme preparation contained mainly three closely related pp60c-src-family protein tyrosine kinases or a pp60src-family protein tyrosine kinase modified posttranslationally to give three closely spaced protein bands on sodium dodecyl sulfate gel. Neither of these proteins appears to be pp60c-src or p56lck. The spleen protein tyrosine kinase was found to phosphorylate a p34cdc2 kinase peptide, Cys-cdc2(8-20), which contained the regulatory tyrosine residue Tyr-15 about 20 times better than [Val5]angiotensin II or Cys-src(403-421) peptide at a peptide substrate concentration of 1mM. In contrast, epidermal growth factor receptor kinase partially purified from A431 cells did not show preference for Cys-cdc2(8-20) as its substrate. Although Cys-cdc2(8-20) contained two tyrosine residues, only the tyrosine corresponding to Tyr-15 in p34cdc2 was phosphorylated by the spleen tyrosine kinase. The observation suggests that the primary structure surrounding Tyr-15 of p34cdc2 contains substrate structural determinants specific for the spleen tyrosine kinase.	UNIV CALGARY, FAC MED,DEPT MED BIOCHEM,CELL REGULAT GRP, 3330 HOSP DR NW, CALGARY T2N 4N1, ALBERTA, CANADA	University of Calgary				Cheng, Heung-Chin/0000-0002-4965-7148				AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; AKIYAMA T, 1985, BIOCHEM BIOPH RES CO, V131, P442, DOI 10.1016/0006-291X(85)91822-4; CASNELLIE JE, 1982, P NATL ACAD SCI-BIOL, V79, P282, DOI 10.1073/pnas.79.2.282; CASNELLIE JE, 1984, P NATL ACAD SCI-BIOL, V81, P6676, DOI 10.1073/pnas.81.21.6676; DRAETTA G, 1988, NATURE, V336, P738, DOI 10.1038/336738a0; DYMECKI SM, 1990, SCIENCE, V247, P332, DOI 10.1126/science.2404338; FAVA RA, 1984, J BIOL CHEM, V259, P2636; FENNER C, 1975, ANAL BIOCHEM, V63, P595, DOI 10.1016/0003-2697(75)90386-3; FLOCKHART DA, 1982, CRC CR REV BIOCH MOL, V12, P133, DOI 10.3109/10409238209108705; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; HARRINGTON MG, 1990, METHOD ENZYMOL, V182, P488; HUNTER T, 1982, J BIOL CHEM, V257, P4843; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KAMPS MP, 1988, ONCOGENE, V2, P305; KONG SK, 1988, J BIOL CHEM, V263, P14523; KONG SK, 1987, J BIOL CHEM, V262, P2597; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MILES LEM, 1968, NATURE, V219, P186, DOI 10.1038/219186a0; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PIKE LJ, 1984, J BIOL CHEM, V259, P9913; SWARUP G, 1983, J BIOL CHEM, V258, P341; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; WONG TW, 1983, J BIOL CHEM, V258, P1022; WONG TW, 1984, J BIOL CHEM, V259, P8505; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; ZIOCHECK TF, 1986, J BIOL CHEM, V261, P15637	30	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2557	2566						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703531				2022-12-27	WOS:A1991EV51500083
J	FOURNIE, JJ; MULLINS, RJ; BASTEN, A				FOURNIE, JJ; MULLINS, RJ; BASTEN, A			ISOLATION AND STRUCTURAL CHARACTERISTICS OF A MONOCLONAL ANTIBODY-DEFINED CROSS-REACTIVE PHOSPHOLIPID ANTIGEN FROM MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-LEPRAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST ATOM BOMBARDMENT; MASS-SPECTROMETRY; LEPROSY; KANSASII; LIPOARABINOMANNAN; SERODIAGNOSIS; GLYCOLIPIDS; RESPONSES; PROTEINS; LIPIDS	A low molecular weight antigen of Mycobacterium leprae and other mycobacteria was previously defined in our laboratory by means of IgG2a monoclonal antibody termed L4. The antigen had an apparent molecular mass of 4.5-6 kDa on sodium dodecyl sulfate-polyacrylamide gel electrophoresis and was assumed to be a glycoprotein on the basis of its staining with periodic acid Schiff and sensitivity to periodate treatment. In the present work, the cross-reactive and phospholipidic nature of the antigen, present in Mycobacterium tuberculosis as well as in M. leprae sonicates, was demonstrated and this enabled us to undertake its purification from crude M. tuberculosis phospholipidic extracts. The L4-reactive antigen from M. tuberculosis called L4-PIM, was purified by means of silicic acid high pressure liquid chromatography. Its characterization by gas chromatography and FAB-MS showed the antigen to be the common mycobacterial dimannosylated phosphatidylinositol (PIM2), the structure of which had been previously established by others (Lee, Y. C., and Ballou, C. E. (1964) J. Biol. Chem. 239, 1316-1327; Lee, Y. C., and Ballou, C. E. (1965) J. Biochem. (Tokyo) 4, 1395-1404). Delineation of the L4 epitope on M. tuberculosis L4-PIM revealed the involvement of the axial 2-hydroxyl of the alpha-D-mannosyl residues, without any detectable contribution from the myo-inositol. Consequently, L4 was shown to react with PIM5, the structure of which contains twice the number of epitopes as does PIM2. By using both immunostained thin layer chromatography and indirect enzyme-linked immunosorbent assay, similar L4-PIM epitopes were demonstrated in M. leprae sonicate, thereby explaining the cross-reactive nature of the L4-monoclonal antibody. Antibodies of IgG class directed against M. tuberculosis L4-PIM were detectable in sera from patients with leprosy, but no evidence of T cell reactivity to L4-PIM was obtained. The demonstration of a correlation of anti-L4-PIM IgG and anti-disacharide-conjugated bovine serum albumin IgM antibody titers in the sera of leprosy patients indicates that measurement of antibodies directed against L4-PIM may have the potential to be used as a complementary assay to the disaccharide-conjugated bovine serum albumin test for diagnosis and monitoring of patients undergoing leprosy therapy.	UNIV SYDNEY,CENTENARY INST CANC MED & CELL BIOL,SYDNEY,NSW 2006,AUSTRALIA	University of Sydney; Centenary Institute			Fournie, Jean-Jacques/J-7805-2013	Fournie, Jean-Jacques/0000-0001-6542-6908; Mullins, Raymond/0000-0002-0267-1591				BAUMGART K, 1987, T ROY SOC TROP MED H, V81, P1030, DOI 10.1016/0035-9203(87)90388-9; BRENNAN P, 1967, J BIOL CHEM, V242, P3046; BRENNAN PJ, 1970, LIPIDS, V6, P401; BRITTON WJ, 1985, J IMMUNOL, V135, P4171; BRITTON WJ, 1986, INT J LEPROSY, V54, P545; BROWNBACK PE, 1988, INFECT IMMUN, V56, P1044, DOI 10.1128/IAI.56.5.1044-1050.1988; CHO SN, 1983, INFECT IMMUN, V41, P1077, DOI 10.1128/IAI.41.3.1077-1083.1983; ELLNER JJ, 1979, CLIN EXP IMMUNOL, V35, P250; ENGERS HD, 1985, INFECT IMMUN, V48, P603; FOURNIE JJ, 1987, J BIOL CHEM, V262, P3180; FOURNIE JJ, 1989, INFECT IMMUN, V57, P3653, DOI 10.1128/IAI.57.11.3653-3659.1989; FUJIWARA T, 1984, INFECT IMMUN, V43, P252; GARSIA RJ, 1989, INFECT IMMUN, V57, P204, DOI 10.1128/IAI.57.1.204-212.1989; GAYLORD H, 1987, INFECT IMMUN, V55, P2860, DOI 10.1128/IAI.55.11.2860-2863.1987; GILLERON M, 1990, EUR J BIOCHEM, V189, P167, DOI 10.1111/j.1432-1033.1990.tb15473.x; GILLERON M, 1988, J CARBOHYD CHEM, V7, P733, DOI 10.1080/07328308808058941; Goren M, 1979, TUBERCULOSIS, P63; GOREN MB, 1982, AM REV RESPIR DIS, V125, P50; HUNTER SW, 1982, J BIOL CHEM, V257, P5072; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; HUSSON RN, 1987, P NATL ACAD SCI USA, V84, P1679, DOI 10.1073/pnas.84.6.1679; JENSEN NJ, 1988, MASS SPECTROM REV, V7, P41, DOI 10.1002/mas.1280070103; KAPLAN MH, 1980, J INFECT DIS, V142, P825, DOI 10.1093/infdis/142.6.825; KHULLER GK, 1971, IMMUNOCHEMISTRY, V8, P251, DOI 10.1016/0019-2791(71)90479-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YC, 1964, J BIOL CHEM, V239, P1316; LEE YC, 1965, BIOCHEMISTRY-US, V4, P1395, DOI 10.1021/bi00883a026; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P2007; MORENO C, 1988, CLIN EXP IMMUNOL, V74, P206; MUNSTER H, 1986, BIOMED ENVIRON MASS, V13, P423, DOI 10.1002/bms.1200130808; PANGBORN MC, 1966, J LIPID RES, V7, P627; REGGIARDO Z, 1980, J IMMUNOL METHODS, V34, P55, DOI 10.1016/0022-1759(80)90224-0; REGGIARDO Z, 1975, AM J EPIDEMIOL, V100, P469; REGGIARDO Z, 1975, AM J EPIDEMIOL, V100, P477; RIDELL M, 1986, LETT APPL MICROBIOL, V2, P89, DOI 10.1111/j.1472-765X.1986.tb01522.x; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; RIVIERE M, 1987, J BIOL CHEM, V262, P14879; SASAKI A, 1975, J BIOCHEM-TOKYO, V78, P547, DOI 10.1093/oxfordjournals.jbchem.a130939; Sasaki A, 1974, C R Seances Soc Biol Fil, V168, P626; SHERMAN WR, 1985, BIOMED MASS SPECTROM, V12, P409, DOI 10.1002/bms.1200120810; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; VERMA JN, 1983, ADV LIPID RES, V20, P257; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; YOUNG DB, 1984, INFECT IMMUN, V43, P183, DOI 10.1128/IAI.43.1.183-188.1984	44	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1211	1219						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702433				2022-12-27	WOS:A1991ET17700082
J	OLSEN, AS; GEDDIS, AE; PROCKOP, DJ				OLSEN, AS; GEDDIS, AE; PROCKOP, DJ			HIGH-LEVELS OF EXPRESSION OF A MINIGENE VERSION OF THE HUMAN PRO-ALPHA-1(I) COLLAGEN GENE IN STABLY TRANSFECTED MOUSE FIBROBLASTS - EFFECTS OF DELETING PUTATIVE REGULATORY SEQUENCES IN THE 1ST INTRON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL CONTROL; DNA-SEQUENCES; RETROVIRUS; ELEMENTS; IDENTIFICATION; CONTRIBUTE; INSERTION; PROMOTER; MUTATION; ENHANCER	A minigene version of the human gene for the pro-alpha(I) chain of type I procollagen (COL1A1) was prepared that contained -2.3 kilobases of the 5'-flanking sequence, the first 5 exons and introns, the last 6 exons and introns, and about 2 kilobases of the 3'-flanking sequence. The gene was then used for stable transfection experiments with mouse NIH 3T3 fibroblasts. Because the products of the minigene were shorter, it was possible to compare expression of the minigene with expression of the endogenous pro-alpha-1(I) gene by Northern and Western blot analyses. The results demonstrated that the construct contained enough of the gene to obtain high levels of expression in many of the stably transfected cells. Since previous observations suggested that the first intron of the pro-alpha-1(I) gene contained important cis-regulatory elements, two versions of the minigene were prepared in which most of the first intron was deleted. Comparison of expression of the minigene with expression of two deleted versions of the same gene established that 85% of the total sequences in the first intron are not essential for high levels of expression of the gene in stably transfected mouse fibroblasts.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, INST MOLEC MED, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA	Jefferson University					NIAMS NIH HHS [AR-38188] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038188] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARSH GS, 1984, J BIOL CHEM, V259, P4906; BORNSTEIN P, 1988, J BIOL CHEM, V263, P1603; BORNSTEIN P, 1988, MOL CELL BIOL, V8, P4851, DOI 10.1128/MCB.8.11.4851; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU ML, 1982, NUCLEIC ACIDS RES, V10, P5925, DOI 10.1093/nar/10.19.5925; FINER MH, 1987, J BIOL CHEM, V262, P13323; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARBERS K, 1984, P NATL ACAD SCI-BIOL, V81, P1504, DOI 10.1073/pnas.81.5.1504; HARTUNG S, 1986, NATURE, V320, P365, DOI 10.1038/320365a0; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HORTON W, 1987, P NATL ACAD SCI USA, V84, P8864, DOI 10.1073/pnas.84.24.8864; KILLENPD, 1988, J BIOL CHEM, V263, P12310; KRATOCHWIL K, 1989, CELL, V57, P807, DOI 10.1016/0092-8674(89)90795-2; LAW MF, 1983, MOL CELL BIOL, V3, P2110, DOI 10.1128/MCB.3.11.2110; RIPPE RA, 1989, MOL CELL BIOL, V9, P2224, DOI 10.1128/MCB.9.5.2224; ROSSI P, 1987, P NATL ACAD SCI USA, V84, P5590, DOI 10.1073/pnas.84.16.5590; ROSSOUW CMS, 1987, J BIOL CHEM, V262, P15151; SCHNIEKE A, 1987, P NATL ACAD SCI USA, V84, P764, DOI 10.1073/pnas.84.3.764; SHERWOOD AL, 1990, BIOCHEM J, V265, P895, DOI 10.1042/bj2650895; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0	21	52	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1117	1121						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702430				2022-12-27	WOS:A1991ET17700069
J	KOUNS, WC; WALL, CD; WHITE, MM; FOX, CF; JENNINGS, LK				KOUNS, WC; WALL, CD; WHITE, MM; FOX, CF; JENNINGS, LK			A CONFORMATION-DEPENDENT EPITOPE OF HUMAN PLATELET GLYCOPROTEIN-IIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TENNESSEE,CTR HLTH SCI,DEPT MED,956 COURT AVE,RM A303,MEMPHIS,TN 38163; UNIV TENNESSEE,CTR HLTH SCI,DEPT BIOCHEM,MEMPHIS,TN 38163	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL038171] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 38171] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEER J, 1989, J BIOL CHEM, V264, P17564; BENNETT JS, 1982, J BIOL CHEM, V257, P8049; BENNETT JS, 1983, P NATL ACAD SCI-BIOL, V80, P2417, DOI 10.1073/pnas.80.9.2417; BENNETT JS, 1988, J BIOL CHEM, V263, P12948; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHARO IF, 1986, P NATL ACAD SCI USA, V83, P8351, DOI 10.1073/pnas.83.21.8351; CHARO IF, 1989, BLOOD, V74, pA134; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; DSOUZA SE, 1988, J BIOL CHEM, V263, P3943; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; DSOUZA SE, 1989, BLOOD S, V74, pA90; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FUJIMOTO T, 1982, J CLIN INVEST, V69, P1212, DOI 10.1172/JCI110560; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; GEORGE JN, 1984, NEW ENGL J MED, V311, P1084, DOI 10.1056/NEJM198410253111705; GINSBERG M, 1985, J BIOL CHEM, V260, P3931; GINSBERG MH, 1990, J CELL BIOCH A S, V14, P139; GOGSTAD G, 1983, BLOOD, V60, P663; HOLMSEN H, 1966, ANAL BIOCHEM, V17, P456, DOI 10.1016/0003-2697(66)90181-3; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; JENNINGS LK, 1985, BLOOD, V65, P1112; JENNINGS LK, 1986, BLOOD, V68, P173; JENNINGS LK, 1989, BLOOD, V74, pA169; KLOCZEWIAK M, 1982, BIOCHEM BIOPH RES CO, V107, P181, DOI 10.1016/0006-291X(82)91686-2; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; KOUNS WC, 1989, BLOOD, V74, pA91; KOUNS WC, 1989, BLOOD, V74, pA92; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOFTUS JC, 1989, BLOOD, V74, pA58; NACHMAN RL, 1982, J CLIN INVEST, V69, P263, DOI 10.1172/JCI110448; NEWMAN PJ, 1985, BLOOD, V65, P227; OHTA Y, 1987, FEBS LETT, V222, P305, DOI 10.1016/0014-5793(87)80391-5; PAINTER RG, 1985, J CELL BIOL, V100, P652, DOI 10.1083/jcb.100.2.652; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PEERSCHKE EI, 1981, BLOOD, V57, P663; PHILLIPS DR, 1972, BIOCHEMISTRY-US, V11, P4582, DOI 10.1021/bi00774a025; PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985; PLOW EF, 1985, P NATL ACAD SCI USA, V82, P8057, DOI 10.1073/pnas.82.23.8057; PLOW EF, 1981, J BIOL CHEM, V256, P9477; PYETELA R, 1986, SCIENCE, V231, P1559; SANTORO SA, 1987, CELL, V48, P867, DOI 10.1016/0092-8674(87)90083-3; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; WARDELL MR, 1989, J BIOL CHEM, V264, P15656; WORTHINGTON RE, 1990, BRIT J HAEMATOL, V74, P216, DOI 10.1111/j.1365-2141.1990.tb02568.x	49	157	161	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20594	20601						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700791				2022-12-27	WOS:A1990EJ52500082
J	VERDI, JM; CAMPAGNONI, AT				VERDI, JM; CAMPAGNONI, AT			TRANSLATIONAL REGULATION BY STEROIDS - IDENTIFICATION OF A STEROID MODULATORY ELEMENT IN THE 5'-UNTRANSLATED REGION OF THE MYELIN BASIC-PROTEIN MESSENGER-RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALIF LOS ANGELES, MENTAL RETARDAT RES CTR, DEV BIOL GRP, 760 WESTWOOD PLAZA, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles					NINDS NIH HHS [NS 23022, NS 23322] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023022, R01NS023322] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALI M, 1987, SCIENCE, V235, P467, DOI 10.1126/science.3798121; BEATO M, 1987, J STEROID BIOCHEM, V27, P9, DOI 10.1016/0022-4731(87)90288-3; BENJAMINS JA, 1984, OLIGODENDROGLIA, P87; CAMPAGNONI AT, 1988, MOL NEUROBIOL, V2, P41, DOI 10.1007/BF02935632; CAPAGNONI AT, 1987, J NEUROSCI RES, V17, P102, DOI 10.1002/jnr.490170203; DAWSON G, 1979, J BIOL CHEM, V254, P163; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; EVANS RM, 1989, NEURON, V2, P1105, DOI 10.1016/0896-6273(89)90177-3; HOF L, 1990, T AM SOC NEUROCHEM, V21, P234; KELLY R, 1987, MOL CELL BIOL, V7, P799, DOI 10.1128/MCB.7.2.799; KITAMURA K, 1990, J NEUROCHEM, V54, P2032, DOI 10.1111/j.1471-4159.1990.tb04908.x; KUMAR S, 1989, P NATL ACAD SCI USA, V86, P6807, DOI 10.1073/pnas.86.17.6807; LABATE ME, 1986, ENDOCRINOLOGY, V119, P140, DOI 10.1210/endo-119-1-140; LIANG T, 1975, P NATL ACAD SCI USA, V72, P706, DOI 10.1073/pnas.72.2.706; LIAO S, 1980, J BIOL CHEM, V255, P5545; MEYUHAS O, 1987, MOL CELL BIOL, V7, P2691, DOI 10.1128/MCB.7.8.2691; Morell P, 1984, OLIGODENDROGLIA, P47; PAEK I, 1987, MOL CELL BIOL, V7, P1496, DOI 10.1128/MCB.7.4.1496; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; PALMITER RD, 1971, BIOCHEMISTRY-US, V10, P4399, DOI 10.1021/bi00800a008; PENNEQUIN P, 1978, EUR J BIOCHEM, V90, P51, DOI 10.1111/j.1432-1033.1978.tb12573.x; PRESTON SL, 1984, J NEUROCHEM, V42, P262, DOI 10.1111/j.1471-4159.1984.tb09727.x; RANNELS SR, 1978, AM J PHYSIOL, V235, pE134, DOI 10.1152/ajpendo.1978.235.2.E134; ROTH HJ, 1985, J NEUROCHEM, V45, P572, DOI 10.1111/j.1471-4159.1985.tb04025.x; SACEDA M, 1988, MOL ENDOCRINOL, V2, P1157, DOI 10.1210/mend-2-12-1157; SCHNEIDER E, 1978, MOL GEN GENET, V160, P121, DOI 10.1007/BF00267473; SHAPIRO DJ, 1987, BIOESSAYS, V6, P221, DOI 10.1002/bies.950060507; VERDI JM, 1989, J NEUROCHEM, V52, P321, DOI 10.1111/j.1471-4159.1989.tb10935.x	28	84	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20314	20320						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700788				2022-12-27	WOS:A1990EJ52500044
J	WARING, P				WARING, P			DNA FRAGMENTATION INDUCED IN MACROPHAGES BY GLIOTOXIN DOES NOT REQUIRE PROTEIN-SYNTHESIS AND IS PRECEDED BY RAISED INOSITOL TRIPHOSPHATE LEVELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											WARING, P (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DIV CELL BIOL,POB 334,CANBERRA,ACT 2601,AUSTRALIA.							ALNEMRI ES, 1989, J BIOL CHEM, V264, P4104; BAXTER GD, 1989, BIOCHEM BIOPH RES CO, V162, P30, DOI 10.1016/0006-291X(89)91957-8; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BRAITHWAITE AW, 1987, MOL IMMUNOL, V24, P47, DOI 10.1016/0161-5890(87)90110-6; CHANG MP, 1989, SCIENCE, V246, P1165, DOI 10.1126/science.2531465; CLOUSTON WM, 1985, MED HYPOTHESES, V18, P399, DOI 10.1016/0306-9877(85)90107-0; COHEN JJ, 1985, ADV EXP MED BIOL, V184, P493; COHEN JJ, 1984, J IMMUNOL, V132, P38; COMPTON MM, 1987, J BIOL CHEM, V262, P8288; DEALTRY GB, 1987, EUR J IMMUNOL, V17, P689, DOI 10.1002/eji.1830170517; DON MM, 1977, AUST J EXP BIOL MED, V55, P407, DOI 10.1038/icb.1977.38; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; EICHNER RD, 1983, INT J BIOCHEM, V15, P1485, DOI 10.1016/0020-711X(83)90084-8; EICHNER RD, 1988, J BIOL CHEM, V263, P3772; GRIFFITHS GD, 1987, J PATHOL, V151, P221, DOI 10.1002/path.1711510310; HOWAT AJ, 1988, J PATHOL, V154, P29, DOI 10.1002/path.1711540105; Kerr J.F.R., 1987, P93; KERR JFR, 1984, RECENT ADV HISTOPATH, P1; LAFFERTY KJ, 1980, AUST J EXP BIOL MED, V58, P533, DOI 10.1038/icb.1980.55; LIU Y, 1989, EUR J IMMUNOL, V19, P1153, DOI 10.1002/eji.1830190628; MCCONKEY DJ, 1988, SCIENCE, V242, P256, DOI 10.1126/science.3262923; MCCONKEY DJ, 1989, ARCH BIOCHEM BIOPHYS, V269, P365, DOI 10.1016/0003-9861(89)90119-7; MULLBACHER A, 1984, P NATL ACAD SCI-BIOL, V81, P3835, DOI 10.1073/pnas.81.12.3835; MULLBACHER A, 1985, J GEN MICROBIOL, V131, P1251; MULLBACHER A, 1987, DRUGS FUTURE, V12, P565; ORRENIUS S, 1989, TRENDS PHARMACOL SCI, V10, P281, DOI 10.1016/0165-6147(89)90029-1; PAEZ E, 1987, MECH VIRAL TOXICITY, P59; PATER MM, 1974, NATURE, V250, P786, DOI 10.1038/250786a0; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; PILDER S, 1984, J VIROL, V52, P664, DOI 10.1128/JVI.52.2.664-671.1984; RUBIN BY, 1988, CANCER RES, V48, P6006; SELLINS KS, 1987, J IMMUNOL, V139, P3199; TOMEI LD, 1988, BIOCHEM BIOPH RES CO, V155, P324, DOI 10.1016/S0006-291X(88)81088-X; VORIS BP, 1981, J BIOL CHEM, V256, P1319; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; WARING P, 1988, J BIOL CHEM, V263, P18493; WARING P, 1987, AUST J CHEM, V40, P991, DOI 10.1071/CH9870991; WARING P, 1988, MED RES REV, V8, P499, DOI 10.1002/med.2610080404; WARING P, 1990, IN PRESS INT J IMMUN; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	41	198	204	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14476	14480						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1696946				2022-12-27	WOS:A1990DV27800063
J	ELDAR, H; ZISMAN, Y; ULLRICH, A; LIVNEH, E				ELDAR, H; ZISMAN, Y; ULLRICH, A; LIVNEH, E			OVEREXPRESSION OF PROTEIN KINASE-C ALPHA-SUBTYPE IN SWISS 3T3 FIBROBLASTS CAUSES LOSS OF BOTH HIGH AND LOW AFFINITY RECEPTOR NUMBERS FOR EPIDERMAL GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									WEIZMANN INST SCI,DEPT CLIN IMMUNOL,IL-76100 REHOVOT,ISRAEL; GENENTECH INC,S SAN FRANCISCO,CA 94080; MAX PLANCK INST BIOCHEM,W-8033 MARTINSRIED,GERMANY	Weizmann Institute of Science; Roche Holding; Genentech; Max Planck Society			Eldar-Finkelman, Hagit/AAF-8329-2019	Eldar-Finkelman, Hagit/0000-0002-8460-9686				ASHENDEL CL, 1983, CANCER RES, V43, P4333; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BJORGE JD, 1987, J BIOL CHEM, V262, P6615; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT SJ, 1987, CELL, V49, P57, DOI 10.1016/0092-8674(87)90755-0; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; COUSSENS L, 1986, SCIENCE, V233, P859, DOI 10.1126/science.3755548; COUSSENS L, 1987, DNA-J MOLEC CELL BIO, V6, P389, DOI 10.1089/dna.1987.6.389; EARP HS, 1986, J BIOL CHEM, V261, P4777; HOUSEY GM, 1987, P NATL ACAD SCI USA, V84, P1065, DOI 10.1073/pnas.84.4.1065; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; KISHIMOTO A, 1980, J BIOL CHEM, V255, P2273; KNOPF JL, 1986, CELL, V46, P491, DOI 10.1016/0092-8674(86)90874-3; KRAUSS RS, 1989, ONCOGENE, V4, P991; KRIS RM, 1985, CELL, V40, P619, DOI 10.1016/0092-8674(85)90210-7; KUDLOW JE, 1986, J BIOL CHEM, V261, P4134; LEACH KL, 1983, P NATL ACAD SCI-BIOL, V80, P4208, DOI 10.1073/pnas.80.14.4208; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LIN CR, 1984, SCIENCE, V224, P843, DOI 10.1126/science.6326261; LIVNEH E, 1987, EMBO J, V6, P2669, DOI 10.1002/j.1460-2075.1987.tb02558.x; LIVNEH E, 1988, MOL CELL BIOL, V8, P2302, DOI 10.1128/MCB.8.6.2302; MAKOWSKE M, 1986, J BIOL CHEM, V261, P3389; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MERLINO GT, 1984, SCIENCE, V224, P417, DOI 10.1126/science.6200934; MOSES HL, 1981, CANCER RES, V41, P2842; NEIDEL JE, 1983, P NATL ACAD SCI USA, V80, P36; NISHIZUKA Y, 1984, SCIENCE, V225, P1365, DOI 10.1126/science.6147898; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OBRIAN CA, 1984, BIOCHEM BIOPH RES CO, V124, P296, DOI 10.1016/0006-291X(84)90951-3; OHNO S, 1987, NATURE, V325, P161, DOI 10.1038/325161a0; ONO Y, 1986, FEBS LETT, V203, P111, DOI 10.1016/0014-5793(86)80724-4; ONO Y, 1987, SCIENCE, V236, P1116, DOI 10.1126/science.3576226; ONO Y, 1986, FEBS LETT, V206, P347, DOI 10.1016/0014-5793(86)81010-9; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; PERSONS DA, 1988, CELL, V52, P447, DOI 10.1016/S0092-8674(88)80037-0; RIEDEL H, 1988, P NATL ACAD SCI USA, V85, P1477, DOI 10.1073/pnas.85.5.1477; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; TAKAI Y, 1979, J BIOL CHEM, V254, P3692; TODARO GJ, 1976, NATURE, V264, P26, DOI 10.1038/264026a0; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; WAKSHULL E, 1985, CANCER RES, V45, P2070; WIGLER M, 1979, CELL, V16, P777, DOI 10.1016/0092-8674(79)90093-X; YAMAMOTO T, 1986, CANCER RES, V46, P414	51	94	96	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13290	13296						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695906				2022-12-27	WOS:A1990DR20100080
J	HOSTETLER, KY; CARSON, DA; RICHMAN, DD				HOSTETLER, KY; CARSON, DA; RICHMAN, DD			PHOSPHATIDYLAZIDOTHYMIDINE - MECHANISM OF ANTIRETROVIRAL ACTION IN CEM CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-III; AIDS-RELATED LYMPHADENOPATHY; FOLLICULAR DENDRITIC CELLS; HTLV-III/LAV; MONONUCLEAR PHAGOCYTES; REVERSE-TRANSCRIPTASE; LANGERHANS CELLS; BRAIN-TISSUE; INFECTION; PARTICLES	Dimyristoylphosphatidylazidothymidine has been shown to inhibit human immunodeficiency virus (HIV) replication in CEM or U937 cells infected with the LAV-1 strain in vitro, but its metabolism and mechanism of antiretroviral activity have not been determined (Hostetler, K. Y., Stuhmiller, L. M., Lenting, H. B. M., van den Bosch, H., and Richman, D. D., J. Biol. Chem. (1990) 265, 6112-6117). We synthesized phosphatidylazidothymidine labeled with tritium in the 5'-position of dideoxyribose and incubated the phospholipid prodrug with CEM cells for 24 h. The radioactive products were analyzed by high pressure liquid chromatography and thin layer chromatography. Phosphatidylazidothymidine is deacylated by cellular phospholipases A to lysophosphatidylazidothymidine, which is subsequently hydrolyzed to glycero-3-phospho-5'-azidothymidine by lysophospholipases. Phosphodiesteratic cleavage of glycero-3-phospho-5'-azidothymidine occurs with formation of azidothymidine (AZT) or AZT-5'-monophosphate. Anabolic phosphorylation leads to the formation of AZT-diphosphate and AZT-triphosphate. To evaluate the possibility of direct inhibition of HIV reverse transcriptase by phosphatidyl-AZT, lysophosphatidyl-AZT or glycero-3-phospho-5'-AZT, we synthesized these compounds and found them to lack the ability to inhibit HIV recombinant reverse transcriptase in vitro. AZT-triphosphate was > 10,000 times more potent in inhibiting reverse transcriptase activity. Thus, phosphatidyl-AZT exerts its antiviral activity by metabolic conversion to AZT-triphosphate. Phospholipid prodrugs of this type may be useful in treating the macrophage reservoir of HIV infection.	VICAL INC,SAN DIEGO,CA 92121; UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92093; VET ADM MED CTR,SAN DIEGO,CA 92161	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	HOSTETLER, KY (corresponding author), UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093, USA.			Hostetler, Karl/0000-0002-1155-2885	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI030457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024979] Funding Source: NIH RePORTER; NHLBI NIH HHS [HB-67019] Funding Source: Medline; NIAID NIH HHS [AI-30457] Funding Source: Medline; NIGMS NIH HHS [GM-24979] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMSTRONG JA, 1984, LANCET, V2, P370; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BECKER J, 1988, VIRCHOWS ARCH A, V412, P413, DOI 10.1007/BF00750575; CAO Y, 1990, J CELL BIOCHEM, V14, P98; CHANG YY, 1967, J BIOL CHEM, V242, P516; CHAYT KJ, 1986, JAMA-J AM MED ASSOC, V256, P2356, DOI 10.1001/jama.256.17.2356; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FOLCH J, 1957, J BIOL CHEM, V226, P497; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; GABUZDA DH, 1986, ANN NEUROL, V20, P289, DOI 10.1002/ana.410200304; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; GENDELMAN HE, 1989, AIDS, V3, P475, DOI 10.1097/00002030-198908000-00001; HO DD, 1986, J CLIN INVEST, V77, P1712, DOI 10.1172/JCI112491; HOSTETLER KY, 1990, J BIOL CHEM, V265, P6112; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; LARDER B, 1987, EMBO J, V6, P3133, DOI 10.1002/j.1460-2075.1987.tb02623.x; LETOURNEAU A, 1986, HUM PATHOL, V17, P1047, DOI 10.1016/S0046-8177(86)80089-2; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; LEWIS SH, 1990, LANCET, V335, P565, DOI 10.1016/0140-6736(90)90349-A; McGuigan C, 1990, ANTIVIR CHEM CHEMOTH, V1, P25, DOI 10.1177/095632029000100105; MELTZER MS, 1990, ANNU REV IMMUNOL, V8, P169, DOI 10.1146/annurev.iy.08.040190.001125; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; NICHOLSON JKA, 1986, J IMMUNOL, V137, P323; RAPPERSBERGER K, 1988, INTERVIROLOGY, V29, P185; STARK E, 1988, J NEUROL NEUROSUR PS, V51, P977, DOI 10.1136/jnnp.51.7.977; STOLER MH, 1986, JAMA-J AM MED ASSOC, V256, P2381; TENNERRACZ K, 1986, AM J PATHOL, V123, P9; TENNERRACZ K, 1985, LANCET, V1, P105; TSCHACHLER E, 1987, J INVEST DERMATOL, V88, P233, DOI 10.1111/1523-1747.ep12525402; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089; ZIZA JM, 1985, NEW ENGL J MED, V313, P183	33	26	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11714	11717						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711037				2022-12-27	WOS:A1991FT76200047
J	ANN, DK; MOUTSATSOS, IK; NAKAMURA, T; LIN, HH; MAO, PL; LEE, MJ; CHIN, S; LIEM, RKH; WANG, E				ANN, DK; MOUTSATSOS, IK; NAKAMURA, T; LIN, HH; MAO, PL; LEE, MJ; CHIN, S; LIEM, RKH; WANG, E			ISOLATION AND CHARACTERIZATION OF THE RAT CHROMOSOMAL GENE FOR A POLYPEPTIDE (PS1) ANTIGENICALLY RELATED TO STATIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-DIPLOID CELLS; NONPROLIFERATING CELLS; PROTEIN-SYNTHESIS; TOPOISOMERASE-II; BINDING PROTEIN; MESSENGER-RNAS; DNA-SYNTHESIS; SENESCENT; SEQUENCES; MARKER	Increasing evidence shows the existence of nonproliferation-specific gene(s) whose expression is mostly present in growth-arrested cells. One member of this gene family has been identified by previous work as a nuclear protein of 57,000 Da, termed statin. Logical extensions of statin research are to identify the genomic and cDNA clones encoding for statin and to study the regulation of statin gene expression. During the search for the statin gene, we have identified a cDNA clone and a genomic clone named S1 and S10, respectively, by screening a rat brain lambda-gt11 expression library with the statin antibody and subsequently using S1 cDNA as a probe to screen a rat genomic cosmid library. Here, we report the cloning and sequencing of the S1 cDNA and S10 genomic clones. Primary sequence analyses indicate that the derived amino acid sequence of S1 shares high homology (> 92.6%) with human elongation factor 1-alpha (EF-1-alpha), whereas the 5'- and 3'-untranslated regions are < 20% homologous. Despite the unusually high degree of similarity between S1 and human EF-1-alpha at the amino acid sequence level, their protein products are different and immunologically distinct. The in vitro transcription and translation product of S1 (pS1), a 49,000-Da polypeptide, reacts only with the monoclonal antibody against statin; this antibody exhibits no antigenic reaction to the EF-1-alpha protein. Northern blot analysis shows that the S1 message is most abundant in G0 phase of 3T3 mouse fibroblasts, but becomes significantly reduced in G1 and S phase cells. EF-1-alpha messages do not show such dramatic changes during cell cycle phase transition. These findings suggest that the expression of the identified S1 cDNA clone is specific for nonproliferating cells and that the in vitro translation product of the S1 cDNA is recognized by the statin antibody. Genomic Southern blots indicate that S1 cDNA is encoded by a single copy gene in the rat genome and is a unique member of the EF-1-alpha/S1 supermultigene family. DNA sequence analysis demonstrates that the rat S1 transcription unit is 12 kilobase pairs in length and contains seven introns. The organization of exons is virtually identical between S1 and human EF-1-alpha. In contrast, neither a TATA box nor a CAAT box is located in the proximal 5'-flanking regions from positions -1 to -1359 of the S1 gene, where we could expect to find the regulatory region containing the elements controlling gene expression; no evident sequence homology to the human EF-1-alpha gene is detected in this region. Furthermore, EF-1-alpha and S1 share no sequence homology in the regions of the seven introns, and the two genes differ in length by 5 kilobases. The lack of homologies in the 5'- and 3'-untranslated regions and the 5'-upstream region supports the idea that the S1 gene is distinct and regulated differently from the EF-1-alpha gene.	SIR MORTIMER B DAVIS JEWISH HOSP,LADY DAVIS INST MED RES,BLOOMFIELD CTR RES AGING,MONTREAL H3T 1E2,QUEBEC,CANADA; UNIV MINNESOTA,SCH MED,DEPT PHARMACOL,MINNEAPOLIS,MN 55455; MCGILL UNIV,DEPT MED,MONTREAL H3T 1E2,QUEBEC,CANADA; MCGILL UNIV,DEPT ANAT,MONTREAL H3T 1E2,QUEBEC,CANADA; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032	Lady Davis Institute; McGill University; University of Minnesota System; University of Minnesota Twin Cities; McGill University; McGill University; Columbia University					NIA NIH HHS [AG 0744] Funding Source: Medline; NIDCR NIH HHS [5R29-DE09175] Funding Source: Medline; NINDS NIH HHS [NS15182] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE009175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS015182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K07AG000744] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANN DK, 1988, J BIOL CHEM, V263, P10887; ANN DK, 1988, J BIOL CHEM, V263, P3546; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DILELLA AG, 1987, METHOD ENZYMOL, V152, P199; DJE MK, 1990, NUCLEIC ACIDS RES, V18, P3489, DOI 10.1093/nar/18.12.3489; DRESCHERLINCOLN CK, 1984, EXP CELL RES, V153, P208, DOI 10.1016/0014-4827(84)90462-2; GROSVELD FG, 1982, NUCLEIC ACIDS RES, V10, P6715, DOI 10.1093/nar/10.21.6715; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; HECK MMS, 1986, J CELL BIOL, V103, P2569, DOI 10.1083/jcb.103.6.2569; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOVEMANN B, 1988, NUCLEIC ACIDS RES, V16, P3175, DOI 10.1093/nar/16.8.3175; JUAN CC, 1988, P NATL ACAD SCI USA, V85, P8910, DOI 10.1073/pnas.85.23.8910; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LU X, 1989, Nucleic Acids Research, V17, P442, DOI 10.1093/nar/17.1.442; LUMPKIN CK, 1986, SCIENCE, V232, P393, DOI 10.1126/science.2421407; MADSEN HO, 1990, NUCLEIC ACIDS RES, V18, P1513, DOI 10.1093/nar/18.6.1513; MATSUMURA T, 1980, EXP CELL RES, V125, P453, DOI 10.1016/0014-4827(80)90139-1; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCLEAN MJ, 1988, J BIOL CHEM, V263, P7370; MEISLER MH, 1986, MOL CELLULAR BASIS D, P249; MOLDAVE K, 1985, ANNU REV BIOCHEM, V54, P1109, DOI 10.1146/annurev.biochem.54.1.1109; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590; NIELSEN PJ, 1980, J CELL PHYSIOL, V104, P269, DOI 10.1002/jcp.1041040302; OHTA K, 1990, J BIOL CHEM, V265, P3240; PEREIRASMITH OM, 1985, EXP CELL RES, V160, P297, DOI 10.1016/0014-4827(85)90177-6; RABINOVITCH PS, 1980, EXP CELL RES, V130, P101, DOI 10.1016/0014-4827(80)90046-4; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SESTER U, 1989, EXP CELL RES, V182, P550, DOI 10.1016/0014-4827(89)90258-9; SOLBIN LI, 1988, EUR J BIOCHEM, V173, P305; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEIN GH, 1981, P NATL ACAD SCI-BIOL, V78, P3025, DOI 10.1073/pnas.78.5.3025; TSAIPFLUGFELDER M, 1988, P NATL ACAD SCI USA, V85, P7177, DOI 10.1073/pnas.85.19.7177; USTSUKI T, 1989, J BIOL CHEM, V264, P5791; VANNOORT JM, 1984, P NATL ACAD SCI-BIOL, V81, P3969; WANG E, 1989, EXP GERONTOL, V24, P485, DOI 10.1016/0531-5565(89)90055-7; WANG E, 1986, EXP CELL RES, V167, P135, DOI 10.1016/0014-4827(86)90211-9; WANG E, 1985, J HISTOCHEM CYTOCHEM, V33, P587, DOI 10.1177/33.6.3889143; WANG E, 1985, J CELL BIOL, V101, P1695, DOI 10.1083/jcb.101.5.1695; WANG E, 1985, J CELL BIOL, V100, P545, DOI 10.1083/jcb.100.2.545; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; 1989, MANUAL MOL BIOL INFO	47	49	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10429	10437						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709933				2022-12-27	WOS:A1991FP08600067
J	PULIDO, R; ELICES, MJ; CAMPANERO, MR; OSBORN, L; SCHIFFER, S; GARCIAPARDO, A; LOBB, R; HEMLER, ME; SANCHEZMADRID, F				PULIDO, R; ELICES, MJ; CAMPANERO, MR; OSBORN, L; SCHIFFER, S; GARCIAPARDO, A; LOBB, R; HEMLER, ME; SANCHEZMADRID, F			FUNCTIONAL EVIDENCE FOR 3 DISTINCT AND INDEPENDENTLY INHIBITABLE ADHESION ACTIVITIES MEDIATED BY THE HUMAN INTEGRIN VLA-4 - CORRELATION WITH DISTINCT ALPHA-4 EPITOPES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-SITE; FIBRONECTIN RECEPTOR; VITRONECTIN RECEPTOR; MONOCLONAL-ANTIBODY; PLASMA FIBRONECTIN; CELL DISTRIBUTION; T-CELLS; IDENTIFICATION; SUBUNIT; LFA-1	The human integrin VLA (very late activation antigens)-4 (CD49d/CD29), the leukocyte receptor for both the CS-1 region of plasma fibronectin (Fn) and the vascular cell surface adhesion molecule-1 (VCAM-1), also mediates homotypic aggregation upon triggering with specic anti-VLA-4 monoclonal antibody (mAb). Epitope mapping of this integrin of the human B-cell line Ramos, performed with a wide panel of anti-VLA-4 mAb by both cross-competitive cell binding and protease sensitivity assays, revealed the existence of three topographically distinct epitopes on the alpha-4 chain, referred to as epitopes A-C. By testing this panel of anti-VLA-4 mAb for inhibition of cecell binding to both a 38-kDa Fn fragment containing CS-1 and to VCAM-1, as well as for induction and inhibition of VLA-4 mediated homotypic cell adhesion, we have found overlapping but different functiional properties associated with each epitope. Anti-alpha-4 mAb recognizing epitope B inhibited cell attachment to both Fn and VCAM-1, whereas mAb against epitope A did not block VCAM-1 binding and only partially inhibited binding to Fn. In contrast, mAb directed to epitope C did not affect cell adhesion to either of the two VLA-4 ligands. All mAb directed to site A, as well as a subgroup of mAb recognizing epitope B (called B2), were able to induce cell aggregation, but this effect was not exerted by mAb specific to site C and by a subgroup against epitope B (called B1). Moreover, although anti-epitope C and anti-epitope B1 mAb did not trigger aggregation, those mAb blocked aggregation induced by anti-epitope A or B2 mAb. In addition, anti-epitope A mAb blocked B2-induced aggregation, and conversely, anti-epitope B2 mAb blocked A-induced aggregation. Further evidence for multiple VLA-4 functions is that anti-Fn and anti-VCAM-1 antibodies inhibited binding to Fn or to VCAM-1, respectively, but did not affect VLA-4-mediated aggregation. In summary, we have demonstrated that there are at least three different VLA-4-mediated adhesion functions, we have defined three distinct VLA-4 epitopes, and we have correlated these epitopes with the different functions of VLA-4.	CTR INVEST BIOL,E-28006 MADRID,SPAIN; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR BIOL,BOSTON,MA 02115; BIOGEN INC,CAMBRIDGE,MA 02142	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Biogen	PULIDO, R (corresponding author), UNIV AUTONOMA MADRID,HOSP PRINCESA,SECC INMUNOL,DIEGO DE LEON 62,E-28006 MADRID,SPAIN.		Sanchez-Madrid, Francisco/M-7889-2016; Campanero, Miguel R/A-4052-2013; Garcia Pardo, Angeles/G-5987-2015	Sanchez-Madrid, Francisco/0000-0001-5303-0762; Campanero, Miguel R/0000-0003-1410-8621; Garcia Pardo, Angeles/0000-0001-5577-2954; Pulido, Rafael/0000-0001-9100-248X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038903] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38903] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEDNARCZYK JL, 1990, J IMMUNOL, V144, P777; BODARY SC, 1990, J BIOL CHEM, V265, P5938; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; CAMPANERO MR, 1990, J CELL BIOL, V110, P2157, DOI 10.1083/jcb.110.6.2157; CLAYBERGER C, 1987, J IMMUNOL, V138, P1510; DSOUZA SE, 1990, J BIOL CHEM, V265, P3440; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FIGDOR CG, 1990, IMMUNOL TODAY, V11, P277, DOI 10.1016/0167-5699(90)90112-M; GARCIAPARDO A, 1990, J IMMUNOL, V144, P3361; GARCIAPARDO A, 1987, BIOCHEM J, V241, P923, DOI 10.1042/bj2410923; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; GULINO D, 1990, J BIOL CHEM, V265, P9575; HEMLER ME, 1988, IMMUNOL TODAY, V9, P109, DOI 10.1016/0167-5699(88)91280-7; HEMLER ME, 1990, IMMUNOL REV, V114, P45, DOI 10.1111/j.1600-065X.1990.tb00561.x; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; HEMLER ME, 1989, J BIOL CHEM, V264, P6529; HEMLER ME, 1984, J IMMUNOL, V132, P3011; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; KAJIJI S, 1989, EMBO J, V8, P673, DOI 10.1002/j.1460-2075.1989.tb03425.x; MATSUYAMA T, 1989, J EXP MED, V170, P1133, DOI 10.1084/jem.170.4.1133; MCINTYRE BW, 1989, J BIOL CHEM, V264, P13745; OSBORN L, 1990, CELL, V62, P3, DOI 10.1016/0092-8674(90)90230-C; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; SANCHEZMADRID F, 1986, EUR J IMMUNOL, V16, P1343, DOI 10.1002/eji.1830161106; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; SCHWARTZ BR, 1990, J CLIN INVEST, V85, P2019, DOI 10.1172/JCI114668; SHIMIZU Y, 1990, IMMUNOL REV, V114, P109, DOI 10.1111/j.1600-065X.1990.tb00563.x; SMITH JW, 1990, J BIOL CHEM, V265, P2168; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; TAKADA Y, 1989, EMBO J, V8, P1361, DOI 10.1002/j.1460-2075.1989.tb03516.x; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321	35	253	285	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10241	10245						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709929				2022-12-27	WOS:A1991FP08600039
J	SALEHZADA, T; SILHOL, M; LEBLEU, B; BISBAL, C				SALEHZADA, T; SILHOL, M; LEBLEU, B; BISBAL, C			POLYCLONAL ANTIBODIES AGAINST RNASE-L - SUBCELLULAR-LOCALIZATION OF THIS ENZYME IN MOUSE CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-TREATED CELLS; DOUBLE-STRANDED-RNA; BIOLOGICAL-ACTIVITY; PROTEIN-SYNTHESIS; 2-5A SYNTHETASE; INTACT-CELLS; HELA-CELLS; PPP(A2'P)NA-DEPENDENT RNASE; 2-5A-DEPENDENT RNASE; JLS-V9R CELLS	RNase L activated by 2-5A (a series of 2'-5'-linked adenylic oligoribonucleotides) is a key enzyme of the interferon system. To study RNase L (endonuclease L) in intact cells independently of intracellular 2-5A and of its activity, we have developed polyclonal antibodies against RNase L. RNase L from mouse spleen was purified on a column of 2-5A-Sepharose and used to immunize rabbits in co-injection with polyadenylic-polyuridylic acid as adjuvant. Antibodies were purified by chromatography on Affi-Gel blue and 2-5A-Sepharose-immobilized RNase L. These polyclonal antibodies immunoprecipitate the 80- and 40-kDa forms of RNase L in mouse spleen. In Western blot, only the 80-kDa form of RNase L is recognized by these antibodies. These purified antibodies were used to localize RNase L in the cytoplasm of intact mouse NIH 3T3 cells by immunofluorescence. The cytoplasmic localization of RNase L was confirmed by its 2-5A binding activity after cellular fractionation.	UNIV MONTPELLIER 2,BIOCHIM PROT LAB,CNRS,URA 1191,PL E BATAILLON,F-34095 MONTPELLIER 5,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier			Bisbal, Catherine/I-6984-2016	Bisbal, Catherine/0000-0003-1086-020X				BAGLIONI C, 1978, NATURE, V273, P684, DOI 10.1038/273684a0; BAGLIONI C, 1981, J BIOL CHEM, V256, P3253; BANDYOPADHYAY R, 1990, MOL CELL BIOL, V10, P2060, DOI 10.1128/MCB.10.5.2060; BAYARD B, 1986, BIOCHEMISTRY-US, V25, P3730, DOI 10.1021/bi00360a038; BISBAL C, 1989, EUR J BIOCHEM, V179, P595, DOI 10.1111/j.1432-1033.1989.tb14588.x; BISBAL C, 1987, BIOCHEMISTRY-US, V26, P5172, DOI 10.1021/bi00390a041; DARNELL J, 1986, MOL CELL BIOL, P327; DEFILIPPI P, 1986, FEBS LETT, V198, P326, DOI 10.1016/0014-5793(86)80430-6; EPPSTEIN DA, 1985, J BIOL CHEM, V260, P3666; FLOYDSMITH G, 1982, J BIOL CHEM, V257, P8584; GALABRU J, 1985, J GEN VIROL, V66, P711, DOI 10.1099/0022-1317-66-4-711; HAUGH MC, 1983, EUR J BIOCHEM, V132, P77, DOI 10.1111/j.1432-1033.1983.tb07327.x; HOVANESSIAN AG, 1987, EMBO J, V6, P1273, DOI 10.1002/j.1460-2075.1987.tb02364.x; IMAI J, 1984, BIOCHEMISTRY-US, V23, P766, DOI 10.1021/bi00299a028; JACOBSEN H, 1983, P NATL ACAD SCI-BIOL, V80, P4954, DOI 10.1073/pnas.80.16.4954; JACOBSEN H, 1983, VIROLOGY, V125, P496, DOI 10.1016/0042-6822(83)90222-2; JAMOULLE JC, 1984, BIOCHEMISTRY-US, V23, P3063, DOI 10.1021/bi00308a033; KARIKO K, 1987, BIOCHEMISTRY-US, V26, P7136, DOI 10.1021/bi00396a040; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KNIGHT M, 1980, NATURE, V288, P189, DOI 10.1038/288189a0; KRAUSE D, 1985, J BIOL CHEM, V260, P9501; KRISHNAN I, 1981, MOL CELL BIOL, V1, P932, DOI 10.1128/MCB.1.10.932; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE CG, 1985, BIOCHEMISTRY-US, V24, P551, DOI 10.1021/bi00324a001; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; MECHTI N, 1988, BIOCHIMIE, V70, P869, DOI 10.1016/0300-9084(88)90227-1; MINKS MA, 1979, NUCLEIC ACIDS RES, V6, P767, DOI 10.1093/nar/6.2.767; NILSEN TW, 1979, P NATL ACAD SCI USA, V76, P2600, DOI 10.1073/pnas.76.6.2600; NILSEN TW, 1981, J BIOL CHEM, V256, P7806; RATNER L, 1978, BIOCHEM BIOPH RES CO, V81, P947, DOI 10.1016/0006-291X(78)91443-2; SILVERMAN RH, 1985, ANAL BIOCHEM, V144, P450, DOI 10.1016/0003-2697(85)90141-1; SILVERMAN RH, 1981, EUR J BIOCHEM, V115, P79; SILVERMAN RH, 1985, INTERFERON, V3, P177; SILVERMAN RH, 1983, BIOL INTERFERON SYST, P189; SLATTERY E, 1979, P NATL ACAD SCI USA, V76, P4778, DOI 10.1073/pnas.76.10.4778; STARK GR, 1979, NATURE, V278, P471, DOI 10.1038/278471a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WATLING D, 1985, EMBO J, V4, P431, DOI 10.1002/j.1460-2075.1985.tb03647.x; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; WILLIAMS BRG, 1978, EUR J BIOCHEM, V92, P455, DOI 10.1111/j.1432-1033.1978.tb12767.x; WOLESENICK JJ, 1976, AM J ANAT, V147, P303; WRESCHNER DH, 1982, EUR J BIOCHEM, V124, P261; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; WU JM, 1985, BIOSCIENCE REP, V5, P1041, DOI 10.1007/BF01119625	45	15	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5808	5813						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706339				2022-12-27	WOS:A1991FD37000071
J	OCONNELL, PJ; GERKIS, V; DAPICE, AJF				OCONNELL, PJ; GERKIS, V; DAPICE, AJF			VARIABLE O-GLYCOSYLATION OF CD13 (AMINOPEPTIDASE-N)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ANTIGEN GP150; MONOCLONAL-ANTIBODIES; EXPRESSION; DIFFERENTIATION; CLONING; CELLS	The monoclonal antibody AG6 was raised against HUVE cells and was confirmed as recognizing CD13 (aminopeptidase N) by its reactivity with the CD13 cDNA transfectant pipz"4". However, in sequential immunoprecipitation studies with another anti-CD13 monoclonal, WM15, neither was able to completely remove the molecules recognized by the other. As both monoclonals recognize the same cDNA transfectant, the differences cannot be in the amino acid sequence, suggesting that the CD13 subpopulations have glycosylation differences. Neither neuraminidase and endoglycosidase H treatment of the immunoprecipitates, nor tunicamycin and monensin treatment of proliferating cells differentiated the molecular subpopulations. The epitopes are protein and not carbohydrate as both monoclonals were able to precipitate deglycosylated CD13 from tunicamycin- and monensin-treated cells and o-glycanase-treated purified CD13. Sequential immunoprecipitation studies with WM15 and AG6 of pipz"4" and purified o-glycanase-treated CD13 showed that the subpopulations were due to the O-linked oligosaccharides. Sequential immunoprecipitations with seven other CD13 monoclonals show that there are at least five subpopulations of CD13. It is postulated that the differences between the subpopulations are due to differential utilization of glycosylation sites or subtle differences in oligosaccharide composition causing variable masking of protein epitopes. Similar observations with the integrin group of molecules suggests that this may be an example of a more general phenomenon among glycoproteins.	ST VINCENTS HOSP,DEPT CLIN IMMUNOL,41 VICTORIA PARADE,FITZROY,VIC 3065,AUSTRALIA	St Vincent's Hospital Melbourne								FAVALORO EJ, 1988, BRIT J HAEMATOL, V69, P163, DOI 10.1111/j.1365-2141.1988.tb07618.x; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; GODING JW, 1983, MONOCLONAL ANTIBODIE, P145; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; LOOK AT, 1985, J CLIN INVEST, V75, P569, DOI 10.1172/JCI111733; LOOK AT, 1986, J CLIN INVEST, V78, P914, DOI 10.1172/JCI112680; LOOK AT, 1989, J CLIN INVEST, V83, P1299, DOI 10.1172/JCI114015; LOOK AT, 1987, LEUKOCYTE TYPING 3, P626; MACHAMER CE, 1984, P NATL ACAD SCI-BIOL, V81, P1287, DOI 10.1073/pnas.81.5.1287; RUSS GR, 1985, J CLIN INVEST, V76, P1965, DOI 10.1172/JCI112195; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; SKUBITZ KM, 1987, J IMMUNOL, V139, P1631; STOCKINGER H, 1984, J NATL CANCER I, V73, P1; TETTEROO PAT, 1984, EUR J IMMUNOL, V14, P1089, DOI 10.1002/eji.1830141205; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659	15	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4593	4597						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705556				2022-12-27	WOS:A1991FA69400088
J	OHASHI, T; HONG, CM; WEILER, S; TOMICH, JM; AERTS, JMFG; TAGER, JM; BARRANGER, JA				OHASHI, T; HONG, CM; WEILER, S; TOMICH, JM; AERTS, JMFG; TAGER, JM; BARRANGER, JA			CHARACTERIZATION OF HUMAN GLUCOCEREBROSIDASE FROM DIFFERENT MUTANT ALLELES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID BETA-GLUCOSIDASE; GAUCHER DISEASE TYPE-1; B EPOXIDE DERIVATIVES; GENETIC-HETEROGENEITY; MONOCLONAL-ANTIBODIES; NUCLEOTIDE-SEQUENCE; ACTIVATOR PROTEIN; CDNA; FIBROBLASTS; MUTATIONS	Human cDNA was mutagenized to duplicate six naturally occurring mutations in the gene for glucocerebrosidase. The mutant genes were expressed in NIH 3T3 cells. The abnormal human enzymes were purified by immunoaffinity chromatography and characterized. The Asn370 --> Ser mutant protein differed from normal enzyme in its inhibition by both conduritol B epoxide and glucosphingosine demonstrating that the 370 mutant enzyme has an abnormal catalytic site. In addition, the 370 mutant enzyme is less activated by saposin C, but more stimulated by phosphatidylserine than the wild type enzyme. The Arg463 --> Cys mutant protein was normal with respect to conduritol B epoxide and glucosphingosine inhibition, but was less activated by both saposin C and phosphatidylserine. The Arg120 --> Gln mutant protein was catalytically inactive. The Leu444 --> Pro, the pseudopattern, and the Pro415 --> Arg mutants appear to have reduced amounts of enzyme protein in cells. The studies demonstrated that mutations in the gene for glucocerebrosidase have different effects on the catalytic activity and stability of the enzyme.	UNIV SO CALIF,LOS ANGELES,CA 90024; UNIV AMSTERDAM,EC SLATER INST BIOCHEM RES,1012 WX AMSTERDAM,NETHERLANDS	University of Southern California; University of Amsterdam			Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; TOMICH, JOHN M./0000-0001-7848-8307; Ohashi, Toya/0000-0002-9932-0631				AERTS JMF, 1991, BIOCHIM BIOPHYS ACTA, V1041, P55; AERTS JMFG, 1988, EXP CELL RES, V177, P391, DOI 10.1016/0014-4827(88)90472-7; AERTS JMFG, 1986, ANAL BIOCHEM, V154, P655, DOI 10.1016/0003-2697(86)90043-6; AERTS JMFG, 1990, BIOCHEM J, V269, P93, DOI 10.1042/bj2690093; AUSUBEL FM, 1989, CURRENT PROTOCOLS MO, P491; BARNEVELD RA, 1983, EUR J BIOCHEM, V134, P585, DOI 10.1111/j.1432-1033.1983.tb07606.x; Barranger J. A., 1989, METABOLIC BASIS INHE, P1677; BERENT SL, 1981, BIOCHIM BIOPHYS ACTA, V664, P572, DOI 10.1016/0005-2760(81)90134-X; BEUTLER E, 1984, P NATL ACAD SCI-BIOL, V81, P6506, DOI 10.1073/pnas.81.20.6506; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHRISTOMANOU H, 1989, KLIN WOCHENSCHR, V67, P999, DOI 10.1007/BF01716064; CHRISTOMANOU H, 1986, BIOL CHEM H-S, V367, P879, DOI 10.1515/bchm3.1986.367.2.879; FABBRO D, 1987, AM J HUM GENET, V40, P15; FIRON N, 1990, AM J HUM GENET, V46, P527; GINNS EI, 1982, P NATL ACAD SCI-BIOL, V79, P5607, DOI 10.1073/pnas.79.18.5607; GINNS EI, 1984, BIOCHEM BIOPH RES CO, V123, P574, DOI 10.1016/0006-291X(84)90268-7; GRABOWSKI GA, 1984, ARCH BIOCHEM BIOPHYS, V231, P144, DOI 10.1016/0003-9861(84)90371-0; GRABOWSKI GA, 1989, ENZYME, V41, P131, DOI 10.1159/000469068; GRABOWSKI GA, 1985, AM J HUM GENET, V37, P499; GRABOWSKI GA, 1985, AM J MED GENET, V21, P529, DOI 10.1002/ajmg.1320210316; GRABOWSKI GA, 1986, J BIOL CHEM, V261, P8263; GRACE ME, 1990, 41ST AM SOC HUM GEN; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; JONSSON LMV, 1987, EUR J BIOCHEM, V164, P171, DOI 10.1111/j.1432-1033.1987.tb11008.x; KOHN DB, 1989, GENE TRANSFER GENE T, P397; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1986, J BIOL CHEM, V261, P50; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; Wenger D, 1981, LYSOSOMES LYSOSOMAL, P157; WIGDERSON M, 1989, AM J HUM GENET, V44, P365; WILLEMSEN R, 1987, J NEUROL, V234, P44, DOI 10.1007/BF00314009; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415	42	79	82	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3661	3667						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704891				2022-12-27	WOS:A1991EY68200049
J	JOHNSTON, GI; BLISS, GA; NEWMAN, PJ; MCEVER, RP				JOHNSTON, GI; BLISS, GA; NEWMAN, PJ; MCEVER, RP			STRUCTURE OF THE HUMAN GENE ENCODING GRANULE MEMBRANE PROTEIN-140, A MEMBER OF THE SELECTIN FAMILY OF ADHESION RECEPTORS FOR LEUKOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV OKLAHOMA,HLTH SCI CTR,ST FRANCIS MED RES INST,DEPT MED,825 NE 13TH ST,OKLAHOMA CITY,OK 73104; OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,OKLAHOMA CITY,OK 73104; BLOOD CTR SE WISCONSIN INC,MILWAUKEE,WI 53233	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; Versiti Blood Center of Wisconsin			Johnston, Geoffrey/AAB-5278-2022		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K04HL001733, R01HL040926, R01HL034364] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 01733, HL 40926, HL 34364] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BERMAN CL, 1986, J CLIN INVEST, V78, P130, DOI 10.1172/JCI112542; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOWEN BR, 1989, J CELL BIOL, V109, P421, DOI 10.1083/jcb.109.1.421; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; DRICKAMER K, 1987, J BIOL CHEM, V262, P2582; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; HAMBURGER SA, 1990, BLOOD, V75, P550; HATTORI R, 1989, J BIOL CHEM, V264, P7768; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JUTILA MA, 1989, J IMMUNOL, V143, P3318; KISHIMOTO TK, 1989, SCIENCE, V245, P1238, DOI 10.1126/science.2551036; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; KRANGEL MS, 1985, EMBO J, V4, P1205, DOI 10.1002/j.1460-2075.1985.tb03761.x; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LEUNG JO, 1985, J BIOL CHEM, V260, P2523; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; NEWMAN PJ, 1988, J CLIN INVEST, V82, P739, DOI 10.1172/JCI113656; ORD DC, 1990, J BIOL CHEM, V265, P7760; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; SIEGELMAN MH, 1989, P NATL ACAD SCI USA, V86, P5562, DOI 10.1073/pnas.86.14.5562; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; SUTER U, 1987, NUCLEIC ACIDS RES, V15, P7295, DOI 10.1093/nar/15.18.7295; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; TEDDER TF, 1990, J IMMUNOL, V144, P532; WALTERHOUSE DO, 1988, BLOOD S, V72, pA344; WATSON ML, 1990, J EXP MED, V172, P263, DOI 10.1084/jem.172.1.263; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0	34	188	209	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21381	21385						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701178				2022-12-27	WOS:A1990EL02000101
J	THOMPSON, LD; DANIELS, CJ				THOMPSON, LD; DANIELS, CJ			RECOGNITION OF EXON-INTRON BOUNDARIES BY THE HALOBACTERIUM-VOLCANII TRANSFER-RNA INTRON ENDONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									OHIO STATE UNIV,DEPT MICROBIOL,COLUMBUS,OH 43210	University System of Ohio; Ohio State University			Thompson, Lester D. R./J-8404-2016	Thompson, Lester D. R./0000-0003-3714-1432				BALDI MI, 1986, CELL, V47, P965, DOI 10.1016/0092-8674(86)90811-1; BHATTACHARYYA A, 1989, NUCLEIC ACIDS RES, V17, P6821, DOI 10.1093/nar/17.17.6821; BONNARD G, 1984, MOL GEN GENET, V194, P330, DOI 10.1007/BF00383536; CECH TR, 1986, ANNU REV BIOCHEM, V55, P599, DOI 10.1146/annurev.biochem.55.1.599; CECH TR, 1986, CELL, V44, P207, DOI 10.1016/0092-8674(86)90751-8; CULBERTSON MR, 1989, YEAST, V5, P405, DOI 10.1002/yea.320050602; DANIELS CJ, 1985, J BIOL CHEM, V260, P3132; DANIELS CJ, 1985, MOL GEN GENET, V198, P270, DOI 10.1007/BF00383005; DANIELS CJ, 1986, MICROBIOLOGY 1986, P349; DATTA PK, 1989, CAN J MICROBIOL, V35, P189, DOI 10.1139/m89-029; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; GAMULIN V, 1983, NUCLEIC ACIDS RES, V11, P8537, DOI 10.1093/nar/11.24.8537; GANDINIATTARDI D, 1985, EMBO J, V4, P3289; GREER CL, 1987, MOL CELL BIOL, V7, P76, DOI 10.1128/MCB.7.1.76; HO CK, 1988, NATURE, V333, P24, DOI 10.1038/333024a0; HSIEH CH, 1989, P NATL ACAD SCI USA, V86, P4833, DOI 10.1073/pnas.86.13.4833; JOHNSON JD, 1980, P NATL ACAD SCI-BIOL, V77, P2564, DOI 10.1073/pnas.77.5.2564; KAINE BP, 1987, J MOL EVOL, V25, P248, DOI 10.1007/BF02100018; KAINE BP, 1983, P NATL ACAD SCI-BIOL, V80, P3309, DOI 10.1073/pnas.80.11.3309; KJEMS J, 1989, CAN J MICROBIOL, V35, P210, DOI 10.1139/m89-033; KJEMS J, 1989, J BIOL CHEM, V264, P17834; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LOCKARD RE, 1978, NUCLEIC ACIDS RES, V5, P37, DOI 10.1093/nar/5.1.37; MATHISON L, 1989, MOL CELL BIOL, V9, P4220, DOI 10.1128/MCB.9.10.4220; MATTOCCIA E, 1988, CELL, V55, P731, DOI 10.1016/0092-8674(88)90231-0; NISHIKURA K, 1982, EMBO J, V1, P263, DOI 10.1002/j.1460-2075.1982.tb01157.x; PEEBLES CL, 1979, CELL, V18, P27, DOI 10.1016/0092-8674(79)90350-7; PERLMAN PS, 1990, INTERVENING SEQUENCE, P112; REYES VM, 1987, ANAL BIOCHEM, V166, P90, DOI 10.1016/0003-2697(87)90551-3; REYES VM, 1988, CELL, V55, P719, DOI 10.1016/0092-8674(88)90230-9; RICE JA, 1989, BIOCHEMISTRY-US, V28, P4512, DOI 10.1021/bi00436a058; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; STANGE N, 1988, EMBO J, V7, P3823, DOI 10.1002/j.1460-2075.1988.tb03267.x; STEINMETZ A, 1982, NUCLEIC ACIDS RES, V10, P3027, DOI 10.1093/nar/10.10.3027; STROBEL MC, 1986, MOL CELL BIOL, V6, P2663, DOI 10.1128/MCB.6.7.2663; SUMNERSMITH M, 1984, MOL GEN GENET, V197, P447, DOI 10.1007/BF00329941; SZEKELY E, 1988, J BIOL CHEM, V263, P13839; THOMPSON LD, 1988, J BIOL CHEM, V263, P17951; THOMPSON LD, 1989, CAN J MICROBIOL, V35, P36, DOI 10.1139/m89-006; WICH G, 1978, EMBO J, V6, P523; WILLIS I, 1984, EMBO J, V3, P1573, DOI 10.1002/j.1460-2075.1984.tb02013.x; WU HN, 1987, BIOCHEMISTRY-US, V26, P8221, DOI 10.1021/bi00399a030	45	73	75	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18104	18111						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1698785				2022-12-27	WOS:A1990EE20100016
J	KAGEYAMA, R; SASAI, Y; NAKANISHI, S				KAGEYAMA, R; SASAI, Y; NAKANISHI, S			MOLECULAR CHARACTERIZATION OF TRANSCRIPTION FACTORS THAT BIND TO THE CAMP RESPONSIVE REGION OF THE SUBSTANCE-P PRECURSOR GENE - CDNA CLONING OF A NOVEL C/EBP-RELATED FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR CREB; CYCLIC-AMP; LEUCINE ZIPPER; ACTIVATOR PROTEIN; SOMATOSTATIN GENE; DNA; PHOSPHORYLATION; ENHANCER; FAMILY; EXPRESSION	A cAMP response element (CRE) plays an important role in the cAMP-mediated gene regulation. Several factors that recognize a CRE have been characterized, and it has been shown that they need either covalent modification by protein kinase A or a cofactor such as the adenovirus Ela to function as an activator. In this study we show that the substance P precursor gene expression is regulated by protein kinase A and identify the CRE sequence in its promoter region. We find that a novel factor and ATF2 bind to the region containing the CRE of the substance P precursor gene. The sequence analysis indicates that the novel protein, designated CELF, has a significant homology to C/EBP gene family proteins in the carboxyl-terminal part containing the basic region and the leucine zipper motif. Ubiquitous expression of CELF suggests that this factor is utilized by various genes. Cell-free transcription analyses indicate that CELF is a constitutive transcriptional activator without apparent phosphorylation by protein kinase A. These results demonstrate that multiple factors are responsible for transcriptional control of the substance P precursor gene through the CRE region.			KAGEYAMA, R (corresponding author), KYOTO UNIV,FAC MED,DEPT IMMUNOL,KYOTO 606,JAPAN.							AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; BLACK IB, 1987, SCIENCE, V236, P1263, DOI 10.1126/science.2884727; CHODOSH LA, 1986, MOL CELL BIOL, V6, P4723, DOI 10.1128/MCB.6.12.4723; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; DECROMBRUGGHE B, 1984, SCIENCE, V224, P831, DOI 10.1126/science.6372090; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; IVASHKIV LB, 1990, MOL CELL BIOL, V10, P1609, DOI 10.1128/MCB.10.4.1609; KAGEYAMA R, 1988, J BIOL CHEM, V263, P6329; KAGEYAMA R, 1989, CELL, V59, P815, DOI 10.1016/0092-8674(89)90605-3; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; LEE KAW, 1987, EMBO J, V6, P1345, DOI 10.1002/j.1460-2075.1987.tb02374.x; LINDSAY RM, 1989, NATURE, V337, P362, DOI 10.1038/337362a0; LIU F, 1990, CELL, V61, P1217, DOI 10.1016/0092-8674(90)90686-9; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MCKNIGHT SL, 1989, GENE DEV, V3, P2021, DOI 10.1101/gad.3.12b.2021; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MONTMINY MR, 1990, TRENDS NEUROSCI, V13, P184, DOI 10.1016/0166-2236(90)90045-C; NAWA H, 1990, NEURON, V4, P269, DOI 10.1016/0896-6273(90)90101-K; NAWA H, 1984, NATURE, V312, P729, DOI 10.1038/312729a0; NAWA H, 1983, NATURE, V306, P32, DOI 10.1038/306032a0; OTSUKA M, 1972, P JPN ACAD, V48, P342, DOI 10.2183/pjab1945.48.342; PERNOW B, 1983, PHARMACOL REV, V35, P85; POLI V, 1990, CELL, V63, P643, DOI 10.1016/0092-8674(90)90459-R; RIABOWOL KT, 1988, NATURE, V336, P83, DOI 10.1038/336083a0; ROMAN C, 1990, GENE DEV, V4, P1404, DOI 10.1101/gad.4.8.1404; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649	44	105	107	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15525	15531						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714459				2022-12-27	WOS:A1991GB09700104
J	MATSUBARA, H; LIMAN, ER; HESS, P; KOREN, G				MATSUBARA, H; LIMAN, ER; HESS, P; KOREN, G			PRETRANSLATIONAL MECHANISMS DETERMINE THE TYPE OF POTASSIUM CHANNELS EXPRESSED IN THE RAT SKELETAL AND CARDIAC MUSCLES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELAYED RECTIFIER PROPERTIES; XENOPUS OOCYTES; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; DROSOPHILA; SHAKER; CDNA; FAMILY; BRAIN; GENES	We have cloned a cDNA (RMK2) coding for a Shaker type delayed rectifier K+ channel from a rat skeletal muscle cDNA library. The clone encodes a putative protein of 602 amino acids, identical with a rat brain K+ channel K(v)1 (Swanson, R., Marshall, R., Smith, J. S., Williams, J. B., Boyle, M. B., Folander, K., Luneau, C. J., Antanavage, J., Oliva, C., Burhow, S. A., Bennet, C., Stein, R. B., and Kaczmarek, L. K. (1990) Neuron 4, 929-939). Northern blot analysis showed that RMK2 is expressed in skeletal and cardiac muscle. RNase protection analysis showed that the 3'-noncoding regions of the brain, cardiac, and skeletal muscle RMK2 transcripts are identical. Cloning of the gene confirmed that the protein is encoded by a single exon (Swanson et al. (1990) Neuron 4, 929-939). We expressed RMK2 in Xenopus oocytes and showed that it encodes noninactivating delayed rectifier K+ channels, resistant to block by external tetraethylammonium, with a small unitary conductance of 8.0 picosiemens. Coinjection of RMK2 and RCK1 (RMK1) (Baumann, A., Grupe, A., Ackermann, A., and Pongs, O. (1988) EMBO J. 7, 2457-2463; Koren, G., Liman, E. R., Logothetis, D. E., Nadal-Ginard, B., and Hess, P. (1990) Neuron 4, 39-51) into Xenopus oocytes resulted in the expression of currents that have tetraethylammonium inhibition curves that differ from the linear combination of inhibition curves of the two types expressed individually. Thus, RMK2 and RCK1 (RMK1) can form heteromultimers. RNA blot hybridization analysis revealed that the RMK2 transcript is developmentally regulated in a different manner in the rat skeletal muscle, ventricle, and atrium.	BRIGHAM & WOMENS HOSP,DIV CARDIOL,75 FRANCIS ST,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School			Liman, Emily/AAC-7383-2021	liman, emily/0000-0003-4765-5496				BAUMANN A, 1988, EMBO J, V7, P2457, DOI 10.1002/j.1460-2075.1988.tb03092.x; BERGER SL, 1987, METHODS ENZYMOLOGY G; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CHANDY KG, 1990, SCIENCE, V247, P973, DOI 10.1126/science.2305265; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOLANDER K, 1990, P NATL ACAD SCI USA, V87, P2975, DOI 10.1073/pnas.87.8.2975; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; KAMB A, 1987, CELL, V50, P405, DOI 10.1016/0092-8674(87)90494-6; KOREN G, 1990, NEURON, V4, P39, DOI 10.1016/0896-6273(90)90442-I; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; Maniatis T., 1982, MOL CLONING; MCCORMACK T, 1990, P NATL ACAD SCI USA, V87, P5227, DOI 10.1073/pnas.87.13.5227; MCKINNON D, 1989, J BIOL CHEM, V264, P8230; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PONGS O, 1988, EMBO J, V7, P1087, DOI 10.1002/j.1460-2075.1988.tb02917.x; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; STUEHMER W, 1989, EMBO (European Molecular Biology Organization) Journal, V8, P3235; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; SWANSON R, 1990, NEURON, V4, P929, DOI 10.1016/0896-6273(90)90146-7; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; TSENGCRANK JCL, 1990, FEBS LETT, V268, P63, DOI 10.1016/0014-5793(90)80973-M; YOKOYAMA S, 1989, FEBS LETT, V259, P37, DOI 10.1016/0014-5793(89)81488-7; YUE DT, 1988, PFLUG ARCH EUR J PHY, V413, P127, DOI 10.1007/BF00582522	28	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13324	13328						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712780				2022-12-27	WOS:A1991FX13200082
J	SINNETT, D; RICHER, C; DERAGON, JM; LABUDA, D				SINNETT, D; RICHER, C; DERAGON, JM; LABUDA, D			ALU RNA SECONDARY STRUCTURE CONSISTS OF 2 INDEPENDENT 7-SL RNA-LIKE FOLDING UNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							SIGNAL RECOGNITION PARTICLE; REPEATED DNA-SEQUENCES; 7SL-RNA COMPONENT; FAMILY; EVOLUTION; RETROPOSONS; RECOMBINATION; PSEUDOGENES; POLYMERASE; INSERTION	The amplification of genomic Alu elements by retroposition, i.e. by reintegration of reverse-transcribed RNA, suggests that Alu RNA plays an important role in this process. We report enzymatic studies of the secondary structure of Alu RNAs transcribed in vitro from two recently retroposed Alu elements. These experiments show that the dimeric organization of an Alu sequence is reflected in its RNA folding. Alu subunits fold independently, conserving secondary structure motifs of their progenitor 7 SL RNA molecule. Energy minimization analysis indicates that this folding pattern is also characteristic of different Alu and Alu-like sequences and has been conserved since primate divergence. By analogy to 7 SL RNA, the Alu RNA folding may be important for specific interactions with proteins. This could indicate a physiological function for Alu transcripts. However, this can be also seen as a structural adaptation leading to efficient retroposition of these sequence elements.	UNIV MONTREAL, HOP ST JUSTINE,DEPT PEDIAT,SERV GENET MED, 3175 CHEMIN COTE STE CATHERINE, MONTREAL H3T 1C5, QUEBEC, CANADA	Universite de Montreal			sinnett, daniel/S-4589-2017; Deragon, Jean-Marc/C-5174-2008	sinnett, daniel/0000-0003-3625-6676; Deragon, Jean-Marc/0000-0002-2476-4932				BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; BRITTEN RJ, 1986, SCIENCE, V231, P1393, DOI 10.1126/science.3082006; BRITTEN RJ, 1989, P NATL ACAD SCI USA, V86, P3718, DOI 10.1073/pnas.86.10.3718; DALESSIO JM, 1982, GEL ELECTROPHORESIS, P173; DANIELS GR, 1983, NUCLEIC ACIDS RES, V11, P7579, DOI 10.1093/nar/11.21.7579; DANIELS GR, 1983, NUCLEIC ACIDS RES, V11, P7595, DOI 10.1093/nar/11.21.7595; DEININGER PL, 1988, MOL CELL BIOL, V8, P4566, DOI 10.1128/MCB.8.10.4566; DERAGON JM, 1990, EMBO J, V9, P3363, DOI 10.1002/j.1460-2075.1990.tb07537.x; GUNDELFINGER ED, 1984, EMBO J, V3, P2325, DOI 10.1002/j.1460-2075.1984.tb02134.x; HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; LABUDA D, 1991, IN PRESS J MOL EVOL, V32; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; QUENTIN Y, 1989, J MOL EVOL, V28, P299, DOI 10.1007/BF02103425; RINEHART FP, 1981, BIOCHEMISTRY-US, V20, P3003, DOI 10.1021/bi00514a003; ROGERS JH, 1985, INT REV CYTOL, V93, P187, DOI 10.1016/S0074-7696(08)61375-3; ROUYER F, 1987, CELL, V51, P417, DOI 10.1016/0092-8674(87)90637-4; RYAN SC, 1989, P NATL ACAD SCI USA, V86, P9360, DOI 10.1073/pnas.86.23.9360; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SINNETT D, 1990, GENOMICS, V7, P331, DOI 10.1016/0888-7543(90)90166-R; TRABUCHET G, 1987, J MOL EVOL, V25, P288, DOI 10.1007/BF02603112; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; ULLU E, 1984, MOL CELL BIOL, V6, P2041; WATSON JB, 1987, MOL CELL BIOL, V7, P3324, DOI 10.1128/MCB.7.9.3324; WEINER AM, 1986, ANNU REV BIOCHEM, V55, P631, DOI 10.1146/annurev.bi.55.070186.003215; WILLARD C, 1987, J MOL EVOL, V26, P180, DOI 10.1007/BF02099850; ZUKER M, 1989, METHOD ENZYMOL, V180, P262	31	97	98	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					8675	8678						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709156				2022-12-27	WOS:A1991FM03800008
J	KNAPP, B; NAU, U; HUNDT, E; KUPPER, HA				KNAPP, B; NAU, U; HUNDT, E; KUPPER, HA			DEMONSTRATION OF ALTERNATIVE SPLICING OF A PRE-MESSENGER-RNA EXPRESSED IN THE BLOOD STAGE FORM OF PLASMODIUM-FALCIPARUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; SEQUENCES; ANTIGEN; ERYTHROCYTE; PRODUCTS; SURFACE; PROTEIN; INVITRO; SITES; EXON	By screening of a lambda-gt11 library from Plasmodium falciparum genomic DNA with an antiserum raised against a 41-kDa protein band, which was shown to confer protective immunity to monkeys, the phage clone 41-3 was identified. The entire 41-3 gene was isolated, and its coding regions were determined by amplification and sequencing of 41-3 specific mRNA fragments. The 41-3 gene has a complex structure consisting of nine exons, encoding 375 amino acids in total with a calculated molecular weight of 43,400. Provided that the N-terminal hydrophobic residues function as signal sequence which is cleaved off, the molecular weight of the 41-3 protein decreases to 41,200 and could therefore be considered to be a component of the protective M(r) = 41,000 protein band. Indeed, a 41-kDa protein could be detected by Western blot analysis using antisera raised against different recombinant expression products of the 41-3 gene. We furthermore demonstrate an alternative splice process for the mRNA precursor transcribed from the 41-3 gene to yield at least three distinct mRNAs. The major splice product carries all exons E1 to E9, whereas at least two minor 41-3 mRNA species can be identified which show deletions in the region between exons E5 and E7. The possible role of this differential splice process for the parasite is discussed.			KNAPP, B (corresponding author), BEHRINGWERKE AG,IMMUNOL ONCOL GRP,RES DEPT,W-3550 MARBURG,GERMANY.							AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; BREITBART RE, 1985, CELL, V41, P67, DOI 10.1016/0092-8674(85)90062-5; CERTA U, 1988, SCIENCE, V240, P1036, DOI 10.1126/science.3285469; CHIARIOTTI L, 1988, MOL ENDOCRINOL, V2, P1115, DOI 10.1210/mend-2-11-1115; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EDWARDS RH, 1986, NATURE, V319, P784, DOI 10.1038/319784a0; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; HELFMAN DM, 1988, GENE DEV, V2, P1627, DOI 10.1101/gad.2.12a.1627; HERRERA S, 1990, P NATL ACAD SCI USA, V87, P4017, DOI 10.1073/pnas.87.10.4017; KNAPP B, 1989, MOL BIOCHEM PARASIT, V32, P73, DOI 10.1016/0166-6851(89)90131-X; KNAPP B, 1991, MOL BIOCHEM PARASIT, V44, P1, DOI 10.1016/0166-6851(91)90215-R; KNAPP B, 1989, MOL BIOCHEM PARASIT, V37, P47, DOI 10.1016/0166-6851(89)90101-1; KNAPP B, 1990, MOL BIOCHEM PARASIT, V40, P1, DOI 10.1016/0166-6851(90)90074-V; KNAPP B, 1988, BEHRING I MITT, V82, P349; LACROIX D, 1990, GENE, V86, P201, DOI 10.1016/0378-1119(90)90280-5; MCCUTCHAN TF, 1984, SCIENCE, V225, P625, DOI 10.1126/science.6330899; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; MORGAN BA, 1986, EMBO J, V5, P3335, DOI 10.1002/j.1460-2075.1986.tb04648.x; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; NABESHIMA YI, 1984, NATURE, V308, P333, DOI 10.1038/308333a0; NORTON PA, 1990, NUCLEIC ACIDS RES, V18, P4089, DOI 10.1093/nar/18.14.4089; PERRIN LH, 1985, J CLIN INVEST, V75, P1718, DOI 10.1172/JCI111881; SAITTA B, 1990, J BIOL CHEM, V265, P6473; Sambrook J, 1989, MOL CLONING LABORATO; SAUL A, 1990, MOL BIOCHEM PARASIT, V42, P55, DOI 10.1016/0166-6851(90)90112-Y; SHARMA PM, 1990, J BIOL CHEM, V265, P9006; SIMMONS D, 1987, EMBO J, V6, P485, DOI 10.1002/j.1460-2075.1987.tb04779.x; STREBEL K, 1986, J VIROL, V57, P983, DOI 10.1128/JVI.57.3.983-991.1986; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; TSE WT, 1990, GENE, V88, P293, DOI 10.1016/0378-1119(90)90047-U; WEBER JL, 1988, EXP PARASITOL, V66, P143, DOI 10.1016/0014-4894(88)90087-2; WEBER JL, 1987, GENE, V52, P103, DOI 10.1016/0378-1119(87)90399-4; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	34	27	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					7148	7154						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707880				2022-12-27	WOS:A1991FG72700079
J	HWANG, SR; TABITA, FR				HWANG, SR; TABITA, FR			COTRANSCRIPTION, DEDUCED PRIMARY STRUCTURE, AND EXPRESSION OF THE CHLOROPLAST-ENCODED RBCL AND RBCS GENES OF THE MARINE DIATOM CYLINDROTHECA SP STRAIN-N1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; AMINO-ACID-SEQUENCE; OXYGENASE SMALL SUBUNIT; SITE-DIRECTED MUTANTS; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE; 1,5-BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; NUCLEOTIDE-SEQUENCE; ACTIVE-SITE; RHODOSPIRILLUM-RUBRUM	The primary structure of ribulose-1,5-bisphosphate carboxylase/oxygenase from the marine diatom Cylindrotheca sp. strain N1 has been determined. Unlike higher plants and green algae, the genes encoding the large and the small subunits of ribulose-1,5-bisphosphate carboxylase/oxygenase are chloroplast-encoded and closely associated (Hwang and Tabita, 1989). The rbcL and rbcS genes in strain N1 are cotranscribed and are separated by an intergenic region of 46 nucleotide base pairs. Ribosome binding sites and a potential promoter sequence were highly homologous to previously determined chloroplast sequences. Comparison of the deduced primary structure of the diatom large and small subunits indicated significant homology to previously determined sequences from bacteria; there was much less homology to large and small subunits from cyanobacteria, green algae, and higher plants. Although high levels of recombinant diatom large subunits could be expressed in Escherichia coli, the protein synthesized was primarily insoluble and incapable of forming an active hexadecameric enzyme. Edman degradation studies indicated that the amino terminus of the large subunit isolated from strain N1 was blocked, suggesting that the mechanism responsible for processing and subsequent assembly of large and small subunits resembles the situation found with other eucaryotic ribulose-1,5-bisphosphate carboxylase/oxygenase proteins, despite the distinctive procaryotic gene arrangement and sequence homology.	OHIO STATE UNIV,DEPT MICROBIOL,484 W 12TH AVE,COLUMBUS,OH 43210; OHIO STATE UNIV,CTR BIOTECHNOL,COLUMBUS,OH 43210	Ohio State University; Ohio State University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024497] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24497] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AN GH, 1987, BIOESSAYS, V7, P211, DOI 10.1002/bies.950070505; ANDERSEN K, 1987, J BACTERIOL, V169, P4547, DOI 10.1128/jb.169.10.4547-4558.1987; ANDERSSON I, 1989, NATURE, V337, P229, DOI 10.1038/337229a0; AVNI A, 1989, EMBO J, V8, P1915, DOI 10.1002/j.1460-2075.1989.tb03594.x; BERRY JO, 1988, P NATL ACAD SCI USA, V85, P4190, DOI 10.1073/pnas.85.12.4190; BOCZAR BA, 1989, P NATL ACAD SCI USA, V86, P4996, DOI 10.1073/pnas.86.13.4996; BRIAT JF, 1986, BIOCHIMIE, V68, P981, DOI 10.1016/S0300-9084(86)80041-4; CHAPMAN MS, 1988, SCIENCE, V241, P71, DOI 10.1126/science.3133767; CHEN Z, 1988, P NATL ACAD SCI USA, V85, P4696, DOI 10.1073/pnas.85.13.4696; CHEN ZX, 1989, J BIOL CHEM, V264, P3051; CLAIRE S, 1988, CURR GENET, V14, P461; DOUGLAS SE, 1989, PLANT MOL BIOL, V13, P13, DOI 10.1007/BF00027331; DRON M, 1982, J MOL BIOL, V162, P775, DOI 10.1016/0022-2836(82)90547-2; ELLIS RJ, 1979, TRENDS BIOCHEM SCI, V4, P241, DOI 10.1016/0968-0004(79)90212-3; ELLIS RJ, 1981, ANNU REV PLANT PHYS, V32, P111, DOI 10.1146/annurev.pp.32.060181.000551; ESTELLE M, 1985, J BIOL CHEM, V260, P9523; ESTEP MF, 1978, J PHYCOL, V14, P183, DOI 10.1111/j.1529-8817.1978.tb02446.x; GILMARTIN PM, 1990, PLANT CELL, V2, P369, DOI 10.1105/tpc.2.5.369; GINGRICH JC, 1985, J BIOL CHEM, V260, P6156; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; GUTTERIDGE S, 1986, FEBS LETT, V196, P263, DOI 10.1016/0014-5793(86)80260-5; GUTTERIDGE S, 1988, PLANT PHYSIOL BIOCH, V26, P675; GUTTERIDGE S, 1987, OXFORD SURVEYS PLANT, V4, P95; HARTMAN FC, 1989, J BIOL CHEM, V264, P11784; HERNDON CS, 1984, J BIOL CHEM, V269, P3102; HOUTZ RL, 1989, P NATL ACAD SCI USA, V86, P1855, DOI 10.1073/pnas.86.6.1855; HUDSON GS, 1990, J BIOL CHEM, V265, P808; HWANG SR, 1989, PLANT MOL BIOL, V13, P69, DOI 10.1007/BF00027336; IGARASHI Y, 1985, BIOCHEMISTRY-US, V24, P3957, DOI 10.1021/bi00336a024; JORDAN DB, 1983, ARCH BIOCHEM BIOPHYS, V227, P425, DOI 10.1016/0003-9861(83)90472-1; JORDAN DB, 1981, NATURE, V291, P513, DOI 10.1038/291513a0; KETTLEBOROUGH CA, 1987, EUR J BIOCHEM, V170, P335, DOI 10.1111/j.1432-1033.1987.tb13704.x; LARIMER FW, 1987, J BIOL CHEM, V262, P15327; LEBRUN M, 1987, NUCLEIC ACIDS RES, V15, P4360, DOI 10.1093/nar/15.10.4360; LORIMER GH, 1981, BIOCHEMISTRY-US, V20, P1236, DOI 10.1021/bi00508a028; LORIMER GH, 1980, BIOCHEMISTRY-US, V19, P5321, DOI 10.1021/bi00564a027; Maniatis T., 1982, MOL CLONING; MARTIN PG, 1979, AUST J PLANT PHYSIOL, V6, P401; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCINTOSH L, 1980, NATURE, V288, P556, DOI 10.1038/288556a0; MCKNIGHT TD, 1986, GENE, V48, P23, DOI 10.1016/0378-1119(86)90348-3; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; NARGANG F, 1984, MOL GEN GENET, V193, P220, DOI 10.1007/BF00330671; NEWMAN J, 1990, J BIOL CHEM, V265, P15154; NEWMAN SM, 1989, PLANT PHYSIOL, V91, P939, DOI 10.1104/pp.91.3.939; NIERZWICKIBAUER SA, 1984, P NATL ACAD SCI-BIOL, V81, P5961, DOI 10.1073/pnas.81.19.5961; OLIVER JL, 1990, NUCLEIC ACIDS RES, V18, P65, DOI 10.1093/nar/18.1.65; RAMAGE RT, 1988, TECHNIQUES NEW DEV P, P307; REITH M, 1986, P NATL ACAD SCI USA, V83, P8599, DOI 10.1073/pnas.83.22.8599; SAILLAND A, 1986, PLANT MOL BIOL, V7, P213, DOI 10.1007/BF00021333; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHINOZAKI K, 1982, GENE, V20, P91, DOI 10.1016/0378-1119(82)90090-7; SHINOZAKI K, 1983, NUCLEIC ACIDS RES, V11, P6957, DOI 10.1093/nar/11.20.6957; SHINOZAKI K, 1983, P NATL ACAD SCI-BIOL, V80, P4050, DOI 10.1073/pnas.80.13.4050; SMITH HB, 1990, J BIOL CHEM, V265, P1243; SMITH HB, 1988, J BIOL CHEM, V263, P4921; SOPER TS, 1989, J PROTEIN CHEM, V8, P239, DOI 10.1007/BF01024947; STARNES SM, 1985, FEMS MICROBIOL LETT, V28, P165; TABITA FR, 1988, MICROBIOL REV, V52, P155, DOI 10.1128/MMBR.52.2.155-189.1988; TERZAGHI BE, 1986, BIOCHEM J, V235, P839, DOI 10.1042/bj2350839; VALENTIN K, 1989, CURR GENET, V16, P203, DOI 10.1007/BF00391478; VIALE AM, 1989, J BACTERIOL, V171, P2391, DOI 10.1128/jb.171.5.2391-2400.1989; WAGNER SJ, 1988, FEMS MICROBIOL LETT, V55, P217, DOI 10.1111/j.1574-6968.1988.tb13937.x; WASMANN CC, 1989, P NATL ACAD SCI USA, V86, P1188; XIE Y, 1988, NUCLEIC ACIDS RES, V16, P7749, DOI 10.1093/nar/16.15.7749; ZURAWSKI G, 1981, NUCLEIC ACIDS RES, V9, P3251, DOI 10.1093/nar/9.14.3251	66	51	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6271	6279						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706714				2022-12-27	WOS:A1991FE37300043
J	PERIN, MS; FRIED, VA; STONE, DK; XIE, XS; SUDHOF, TC				PERIN, MS; FRIED, VA; STONE, DK; XIE, XS; SUDHOF, TC			STRUCTURE OF THE 116-KDA POLYPEPTIDE OF THE CLATHRIN-COATED VESICLE SYNAPTIC VESICLE PROTON PUMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; CHROMAFFIN-GRANULE MEMBRANES; TRANSLOCATING COMPLEX; ENDOCYTIC VESICLES; NEUROSPORA-CRASSA; SENSITIVE ATPASE; TONOPLAST ATPASE; CDNA SEQUENCE; SUBUNIT; PROTEIN	A 116-kDa polypeptide has recently been found to be a common component of vacuolar proton pumps isolated from a variety of sources. The 116-kDa subunit of the proton pump was purified from clathrin-coated vesicles of bovine brain, and internal sequences were obtained from proteolytic peptides. Oligonucleotide probes designed from these peptide sequences were utilized in polymerase chain reactions to isolate partial bovine cDNA clones for the protein. Sequences from these were then utilized to isolate rat brain cDNA clones containing the full-length coding region. RNA blots indicate the presence of an abundant 3.9-kilobase message for the 116-kDa subunit in brain, and primer extension analysis demonstrates that the cloned sequence is full-length. The rat cDNA sequences predict synthesis of a protein of 96,267 Da. Analysis of the deduced amino acid sequence of the 116-kDa subunit suggests that it consists of two fundamental domains: a hydrophilic amino-terminal half that is composed of > 30% charged residues, and a hydrophobic carboxyl-terminal half that contains at least six transmembrane regions. The structural properties of the 116-kDa proton pump polypeptide agree well with its proposed function in coupling ATP hydrolysis by the cytoplasmic subunits to proton translocation by the intramembranous components of the pump.	UNIV TEXAS, SW MED CTR,DEPT MOLEC GENET,5323 HARRY HINES BLVD, RM Q4 226, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, HOWARD HUGHES MED INST, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT PHYSIOL, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA; ST JUDE CHILDRENS RES HOSP, DEPT BIOCHEM, MEMPHIS, TN 38101 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040616] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL39644-02] Funding Source: Medline; NIDDK NIH HHS [DK33627] Funding Source: Medline; NIGMS NIH HHS [GM40616] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADACHI I, 1990, J BIOL CHEM, V265, P967; ARAI H, 1988, J BIOL CHEM, V263, P8796; BOWMAN BJ, 1988, J BIOL CHEM, V263, P14002; BOWMAN EJ, 1983, J BIOL CHEM, V258, P5238; BOWMAN EJ, 1986, P NATL ACAD SCI USA, V83, P48, DOI 10.1073/pnas.83.1.48; CIDON S, 1989, J BIOL CHEM, V264, P8281; CIDON S, 1986, J BIOL CHEM, V261, P9222; DEAN GE, 1984, J BIOL CHEM, V259, P9569; FORGAC M, 1983, P NATL ACAD SCI-BIOL, V80, P1300, DOI 10.1073/pnas.80.5.1300; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; GALLOWAY CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3334, DOI 10.1073/pnas.80.11.3334; GLICKMAN J, 1983, J CELL BIOL, V97, P1303, DOI 10.1083/jcb.97.4.1303; HARIKUMAR P, 1983, J BIOL CHEM, V258, P403; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HIRSCH S, 1988, P NATL ACAD SCI USA, V85, P3004, DOI 10.1073/pnas.85.9.3004; KANE PM, 1989, J BIOL CHEM, V264, P19236; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MANDALA S, 1986, J BIOL CHEM, V261, P2850; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MANOLSON MF, 1985, J BIOL CHEM, V260, P2273; MANOLSON MF, 1988, J BIOL CHEM, V263, P17987; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; PARRY RV, 1989, J BIOL CHEM, V264, P20025; PERCY JM, 1985, BIOCHEM J, V231, P557, DOI 10.1042/bj2310557; PERIN MS, 1988, EMBO J, V7, P2697, DOI 10.1002/j.1460-2075.1988.tb03123.x; RANDALL SK, 1986, J BIOL CHEM, V261, P1364; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNEIDER DL, 1981, J BIOL CHEM, V256, P3858; SHELTONINLOES BB, 1986, BIOCHEMISTRY-US, V25, P3164, DOI 10.1021/bi00359a014; STONE DK, 1989, J BIOENERG BIOMEMBR, V21, P605, DOI 10.1007/BF00808116; STONE DK, 1983, J BIOL CHEM, V258, P4059; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; SUDHOF TC, 1989, P NATL ACAD SCI USA, V86, P6067, DOI 10.1073/pnas.86.16.6067; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; SUN SZ, 1987, J BIOL CHEM, V262, P14790; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; XIE XS, 1986, J BIOL CHEM, V261, P2492; XIE XS, 1988, J BIOL CHEM, V263, P9859; XIE XS, 1989, J BIOL CHEM, V264, P1710; XIE XS, 1988, J BIOL CHEM, V263, P13994; YAMASHIRO DJ, 1983, J CELL BIOL, V97, P929, DOI 10.1083/jcb.97.3.929; ZHANG F, 1983, BIOCHEM BIOPH RES CO, V114, P620, DOI 10.1016/0006-291X(83)90825-2	46	107	110	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3877	3881						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704894				2022-12-27	WOS:A1991EY68200079
J	ZIEGLER, A; HAGMANN, J; KIEFER, B; NAGAMINE, Y				ZIEGLER, A; HAGMANN, J; KIEFER, B; NAGAMINE, Y			CA-2+ POTENTIATES CAMP-DEPENDENT EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE THROUGH A CALMODULIN AND PROTEIN KINASE-C-INDEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									FRIEDRICH MIESCHER INST, POB 2543, CH-4002 BASEL, SWITZERLAND	Friedrich Miescher Institute for Biomedical Research				Ziegler, Annemarie/0000-0003-0018-7031				ALTUS MS, 1987, BIOCHEM J, V242, P387, DOI 10.1042/bj2420387; ANDRUS L, 1988, J BIOL CHEM, V263, P6183; ARDAILLOU R, 1975, NEPHRON, V15, P250, DOI 10.1159/000180515; BAEUERLE PA, 1988, CELL, V53, P211, DOI 10.1016/0092-8674(88)90382-0; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BAKER EJ, 1986, MOL CELL BIOL, V6, P54, DOI 10.1128/MCB.6.1.54; BEAVO JA, 1982, HDB EXPT PHARM, V581, P363; BELL JD, 1985, J BIOL CHEM, V260, P2625; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; BRAWERMAN G, 1987, CELL, V48, P5, DOI 10.1016/0092-8674(87)90346-1; BREWER G, 1989, MOL CELL BIOL, V9, P1996, DOI 10.1128/MCB.9.5.1996; CHEUNG WY, 1982, SCI AM, V246, P62, DOI 10.1038/scientificamerican0682-62; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cohen P, 1978, Curr Top Cell Regul, V14, P117; COHEN P, 1982, NATURE, V296, P613, DOI 10.1038/296613a0; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DAYER JM, 1981, J CELL BIOL, V91, P195, DOI 10.1083/jcb.91.1.195; DEGEN JL, 1985, J BIOL CHEM, V260, P2426; DEUTSCH PJ, 1988, P NATL ACAD SCI USA, V85, P7922, DOI 10.1073/pnas.85.21.7922; DOUCET A, 1982, AM J PHYSIOL, V242, pF346, DOI 10.1152/ajprenal.1982.242.4.F346; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDMAN PA, 1981, AM J PHYSIOL, V240, pF558, DOI 10.1152/ajprenal.1981.240.6.F558; GOLDRING SR, 1978, BIOCHEM BIOPH RES CO, V83, P434, DOI 10.1016/0006-291X(78)91009-4; GRANELLIPIPERNO A, 1977, J EXP MED, V146, P1693, DOI 10.1084/jem.146.6.1693; GSTRAUNTHALER GJA, 1988, RENAL PHYSIOL BIOCH, V11, P1; Helmreich E J, 1976, Curr Top Cell Regul, V10, P41; HEMMINGS BA, 1986, FEBS LETT, V196, P126, DOI 10.1016/0014-5793(86)80226-5; HERON JF, 1981, CALCIFIED TISSUE INT, V33, P41, DOI 10.1007/BF02409411; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; HESKETH TR, 1983, J BIOL CHEM, V258, P4876; HIDAKA H, 1980, MOL PHARMACOL, V17, P66; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; JANS DA, 1987, BIOCHEM J, V243, P413, DOI 10.1042/bj2430413; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KAKIUCHI S, 1970, BIOCHEM BIOPH RES CO, V41, P1104, DOI 10.1016/0006-291X(70)90199-3; KARIN M, 1989, TRENDS GENET, V5, P65, DOI 10.1016/0168-9525(89)90027-9; KHANDJIAN EW, 1986, MOL BIOL REP, V11, P107, DOI 10.1007/BF00364822; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; LEVIN EG, 1983, P NATL ACAD SCI-BIOL, V80, P6804, DOI 10.1073/pnas.80.22.6804; LI Y, 1989, ONCOGENE, V4, P795; LIU CM, 1978, J BIOL CHEM, V253, P5892; MALTER JS, 1989, SCIENCE, V246, P664, DOI 10.1126/science.2814487; NAGAMINE Y, 1983, CELL, V32, P1181, DOI 10.1016/0092-8674(83)90301-X; NAGAMINE Y, 1984, NUCLEIC ACIDS RES, V12, P9525, DOI 10.1093/nar/12.24.9525; NAKAGAWA J, 1988, J BIOL CHEM, V263, P2460; NARINDRASORASAK S, 1987, J BIOL CHEM, V262, P10497; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; RANNELS SR, 1980, J BIOL CHEM, V255, P7085; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; RESENDEZ E, 1985, MOL CELL BIOL, V5, P1212, DOI 10.1128/MCB.5.6.1212; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P553, DOI 10.1146/annurev.bi.49.070180.002533; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIRAKAWA F, 1989, MOL CELL BIOL, V9, P2424, DOI 10.1128/MCB.9.6.2424; SIBLEY DR, 1986, ARCH BIOCHEM BIOPHYS, V244, P373, DOI 10.1016/0003-9861(86)90126-8; SMITH CD, 1986, SCIENCE, V232, P97, DOI 10.1126/science.3006254; STIMAC E, 1984, MOL CELL BIOL, V4, P2082, DOI 10.1128/MCB.4.10.2082; TALMAGE RV, 1983, BONE MINERAL RES ANN, V1, P74; TAMM I, 1978, ADV VIRUS RES, V22, P188; TAYLOR CW, 1986, TRENDS PHARMACOL SCI, V7, P238, DOI 10.1016/0165-6147(86)90331-7; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; WALSH DA, 1979, BIOCH ACTIONS HORMON; Weiss B, 1980, Ann N Y Acad Sci, V356, P319, DOI 10.1111/j.1749-6632.1980.tb29621.x; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; WODNARFILIPOWICZ A, 1990, P NATL ACAD SCI USA, V87, P777, DOI 10.1073/pnas.87.2.777; Wolff D J, 1979, Adv Cyclic Nucleotide Res, V11, P27; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0	71	35	35	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21194	21201						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701176				2022-12-27	WOS:A1990EL02000074
J	ENJALBERT, A; GUILLON, G; MOUILLAC, B; AUDINOT, V; RASOLONJANAHARY, R; KORDON, C; BOCKAERT, J				ENJALBERT, A; GUILLON, G; MOUILLAC, B; AUDINOT, V; RASOLONJANAHARY, R; KORDON, C; BOCKAERT, J			DUAL MECHANISMS OF INHIBITION BY DOPAMINE OF BASAL AND THYROTROPIN-RELEASING HORMONE-STIMULATED INOSITOL PHOSPHATE PRODUCTION IN ANTERIOR-PITUITARY-CELLS - EVIDENCE FOR AN INHIBITION NOT MEDIATED BY VOLTAGE-DEPENDENT CA-2+ CHANNELS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CNRS,INSERM,F-34094 MONTPELLIER 5,FRANCE	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	ENJALBERT, A (corresponding author), CTR PAUL BROCA,INSERM,U159,2TER RUE ALESIA,F-75014 PARIS,FRANCE.		MOUILLAC, Bernard/M-3896-2014	MOUILLAC, Bernard/0000-0002-3906-8673				ALBERT PR, 1987, J BIOL CHEM, V262, P6577; BERRIDGE MJ, 1983, BIOCHEM J, V212, P473, DOI 10.1042/bj2120473; CANONICO PL, 1986, J ENDOCRINOL, V110, P389, DOI 10.1677/joe.0.1100389; CANONICO PL, 1983, ENDOCRINOLOGY, V113, P7, DOI 10.1210/endo-113-1-7; CLAUSTRE Y, 1988, EUR J PHARMACOL, V149, P149, DOI 10.1016/0014-2999(88)90054-4; CRONIN MJ, 1983, AM J PHYSIOL, V244, pE499, DOI 10.1152/ajpendo.1983.244.5.E499; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; DELAESCALERA GM, 1988, ENDOCRINOLOGY, V123, P1682, DOI 10.1210/endo-123-3-1682; DELAHUNTY TM, 1988, BIOCHEM J, V255, P69, DOI 10.1042/bj2550069; ENJALBERT A, 1989, HORM RES, V31, P6, DOI 10.1159/000181079; ENJALBERT A, 1983, MOL PHARMACOL, V23, P576; ENJALBERT A, 1988, ENDOCRINOLOGY, V123, P406, DOI 10.1210/endo-123-1-406; ENJALBERT A, 1986, J BIOL CHEM, V261, P4071; GIANNATTASIO G, 1981, LIFE SCI, V28, P1605, DOI 10.1016/0024-3205(81)90315-5; GIROS B, 1989, NATURE, V342, P926; HOLZ RW, 1982, J NEUROCHEM, V39, P635, DOI 10.1111/j.1471-4159.1982.tb07940.x; HOPKINS CR, 1973, J CELL BIOL, V59, P276, DOI 10.1083/jcb.59.2.276; HOSEY MM, 1988, J MEMBRANE BIOL, V104, P81, DOI 10.1007/BF01870922; ISRAEL JM, 1985, ENDOCRINOLOGY, V117, P1448, DOI 10.1210/endo-117-4-1448; ISRAEL JM, 1987, J PHYSIOL-LONDON, V390, P1, DOI 10.1113/jphysiol.1987.sp016682; JARVIS WD, 1988, ENDOCRINOLOGY, V123, P2793, DOI 10.1210/endo-123-6-2793; JOURNOT L, 1987, J BIOL CHEM, V262, P15106; KLIP A, 1987, J BIOL CHEM, V262, P9141; LITOSCH I, 1989, BIOCHEM J, V261, P245, DOI 10.1042/bj2610245; MALGAROLI A, 1987, J BIOL CHEM, V262, P13920; MARTIN TFJ, 1986, J BIOL CHEM, V261, P2918; MCDONALD WM, 1984, MOL CELL ENDOCRINOL, V36, P201, DOI 10.1016/0303-7207(84)90037-6; MEMO M, 1986, J NEUROCHEM, V47, P1689, DOI 10.1111/j.1471-4159.1986.tb13075.x; MONSMA FJ, 1989, NATURE, V342, P926, DOI 10.1038/342926a0; MOUILLAC B, 1989, BIOCHEM BIOPH RES CO, V159, P953, DOI 10.1016/0006-291X(89)92201-8; NISWENDER GD, 1969, P SOC EXP BIOL MED, V130, P793, DOI 10.3181/00379727-130-33657; OHARA K, 1988, MOL PHARMACOL, V33, P290; PETCOFF DW, 1987, EUR J PHARMACOL, V137, P269, DOI 10.1016/0014-2999(87)90234-2; REBECCHI MJ, 1983, BIOCHEM J, V216, P287, DOI 10.1042/bj2160287; SCHOFIELD JG, 1983, FEBS LETT, V159, P79, DOI 10.1016/0014-5793(83)80420-7; SENOGLES SE, 1987, J BIOL CHEM, V262, P4860; SIMMONDS SH, 1985, NEUROSCI LETT, V60, P267, DOI 10.1016/0304-3940(85)90588-9; TAM SW, 1980, J BIOL CHEM, V255, P6595; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; VALLAR L, 1988, J BIOL CHEM, V263, P10127; WESS J, 1989, FEBS LETT, V258, P133, DOI 10.1016/0014-5793(89)81633-3; YATANI A, 1988, J BIOL CHEM, V263, P9887	42	55	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					18816	18822						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699937				2022-12-27	WOS:A1990EF73900022
J	BASU, A; BASU, S; MODAK, MJ				BASU, A; BASU, S; MODAK, MJ			SITE-DIRECTED MUTAGENESIS OF MOLONEY MURINE LEUKEMIA-VIRUS REVERSE-TRANSCRIPTASE - DEMONSTRATION OF LYSINE-103 IN THE NUCLEOTIDE BINDING-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT BIOCHEM & MOLEC BIOL,NEWARK,NJ 07103	Rutgers State University New Brunswick; Rutgers State University Medical Center								ABBOTTS J, 1988, J BIOL CHEM, V263, P15094; BASU A, 1988, J BIOL CHEM, V263, P1648; BASU A, 1989, J BIOL CHEM, V264, P8746; BASU A, 1987, BIOCHEMISTRY-US, V27, P6710; BASU S, 1988, BIOCHEMISTRY-US, V27, P6710, DOI 10.1021/bi00418a011; DICKSON C, 1982, MOL BIOL TUMOR VIRUS, P513; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; FARMERIE WG, 1987, SCIENCE, V236, P305, DOI 10.1126/science.2436298; GERARD GF, 1975, J VIROL, V15, P785, DOI 10.1128/JVI.15.4.785-797.1975; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; HANSEN J, 1987, J BIOL CHEM, V262, P12393; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; HUBER HE, 1989, J BIOL CHEM, V264, P4669; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KOPCHICK JJ, 1978, P NATL ACAD SCI USA, V75, P2016, DOI 10.1073/pnas.75.4.2016; KOTEWICZ ML, 1988, NUCLEIC ACIDS RES, V116, P165; KOTEWICZ ML, 1985, GENE AMST, V35, P149; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; MODAK MJ, 1981, BIOCHIM BIOPHYS ACTA, V654, P227, DOI 10.1016/0005-2787(81)90176-3; MODAK MJ, 1977, J BIOL CHEM, V252, P11; MODAK MJ, 1976, BIOCHEMISTRY-US, V15, P3620, DOI 10.1021/bi00661a033; MODAK MJ, 1977, J VIROL, V22, P243, DOI 10.1128/JVI.22.1.243-246.1977; ROTH MJ, 1985, J BIOL CHEM, V260, P9326; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SRIVASTAVA A, 1980, J BIOL CHEM, V255, P917; TANESE N, 1986, J VIROL, V59, P743, DOI 10.1128/JVI.59.3.743-745.1986; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; VARMUS H, 1984, RNA TUMOR VIRUSES, P369; VERMA IM, 1975, J VIROL, V15, P843, DOI 10.1128/JVI.15.4.843-854.1975; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504	32	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					17162	17166						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1698772				2022-12-27	WOS:A1990EA85700071
J	PEI, J; RINGERTZ, NR				PEI, J; RINGERTZ, NR			CADMIUM INDUCES TRANSCRIPTION OF PROTOONCOGENES C-JUN AND C-MYC IN RAT L6 MYOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											PEI, J (corresponding author), KAROLINSKA INST,MED NOBEL INST,DEPT MED CELL GENET,BOX 60400,S-10401 STOCKHOLM 60,SWEDEN.							ALAM J, 1989, J BIOL CHEM, V264, P6371; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; Goyer RA, 1986, CASARETT DOULLS TOXI, P592; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HAY N, 1989, GENE DEV, V3, P293, DOI 10.1101/gad.3.3.293; KARIN M, 1984, NATURE, V308, P513, DOI 10.1038/308513a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Leonard A., 1984, MUTAGENICITY CARCINO, P59; LI GC, 1985, J CELL PHYSIOL, V122, P91, DOI 10.1002/jcp.1041220114; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; MISRA S, 1989, BIOCHIM BIOPHYS ACTA, V1007, P325, DOI 10.1016/0167-4781(89)90155-3; NELSON MT, 1986, J GEN PHYSIOL, V87, P201, DOI 10.1085/jgp.87.2.201; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; RAHM M, 1990, J CELL PHYSIOL, V142, P352, DOI 10.1002/jcp.1041420218; RAHM M, 1989, J CELL PHYSIOL, V139, P237, DOI 10.1002/jcp.1041390204; RINGERTZ NR, 1978, EXP CELL RES, V113, P233, DOI 10.1016/0014-4827(78)90363-4; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHONTHAL A, 1989, ONCOGENE, V4, P629; SEJERSEN T, 1986, J CELL PHYSIOL, V127, P274, DOI 10.1002/jcp.1041270213; SMITH JB, 1989, J BIOL CHEM, V264, P7115; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; SUBRAMANIAM M, 1989, NATURE, V340, P64, DOI 10.1038/340064a0; SUNDERMAN FW, 1978, FED PROC, V37, P40; SUSZKIW J, 1984, BRAIN RES, V323, P31, DOI 10.1016/0006-8993(84)90262-2; TAKIMOTO M, 1989, J BIOL CHEM, V264, P8992; TERRACIO L, 1986, ARCH TOXICOL, V58, P141, DOI 10.1007/BF00340973; TERRACIO L, 1988, ARCH TOXICOL, V61, P450, DOI 10.1007/BF00293691; TSIEN RW, 1983, ANNU REV PHYSIOL, V45, P341, DOI 10.1146/annurev.ph.45.030183.002013; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; VALLEE BL, 1972, ANNU REV BIOCHEM, V41, P91, DOI 10.1146/annurev.bi.41.070172.000515; VOGT PK, 1988, ONCOGENE, V3, P3; VOGT PK, 1989, TRENDS BIOCHEM SCI, V14, P172, DOI 10.1016/0968-0004(89)90268-5; VOGT PK, 1990, IN PRESS ADV CANCER; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477	40	142	144	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14061	14064						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1696944				2022-12-27	WOS:A1990DV27800002
J	DEVINEBEACH, K; LASHGARI, MS; KHALILI, K				DEVINEBEACH, K; LASHGARI, MS; KHALILI, K			MYELIN BASIC-PROTEIN GENE-TRANSCRIPTION - IDENTIFICATION OF PROXIMAL AND DISTAL CIS-ACTING REGULATORY ELEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Jefferson University								AGRAWAL HC, 1982, BIOCHEM J, V201, P39, DOI 10.1042/bj2010039; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; BARBARESE E, 1977, P NATL ACAD SCI USA, V74, P3360, DOI 10.1073/pnas.74.8.3360; BARBARESE E, 1981, P NATL ACAD SCI-BIOL, V78, P1953, DOI 10.1073/pnas.78.3.1953; BARBARESE E, 1978, J NEUROCHEM, V31, P779, DOI 10.1111/j.1471-4159.1978.tb00110.x; BRAUN PE, 1984, MYELIN, P97; CARSON JH, 1983, DEV BIOL, V96, P485, DOI 10.1016/0012-1606(83)90185-9; COMPAGNONI CW, 1978, ARCH BIOCHEM BIOPHYS, V190, P188; DEFERRA F, 1985, CELL, V43, P721, DOI 10.1016/0092-8674(85)90245-4; DEROSBO NK, 1984, NEUROCHEM RES, V9, P1359, DOI 10.1007/BF00964663; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUNKLEY PR, 1974, BIOCHEM J, V141, P243, DOI 10.1042/bj1410243; FEIGENBAUM L, 1987, P NATL ACAD SCI USA, V84, P3695, DOI 10.1073/pnas.84.11.3695; FOLKS D, 1980, CELL, V22, P405; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRISQUE RJ, 1980, J VIROL, V35, P265, DOI 10.1128/JVI.35.1.265-269.1980; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; KAMHOLZ J, 1986, P NATL ACAD SCI USA, V83, P4962, DOI 10.1073/pnas.83.13.4962; KHALILI K, 1986, J VIROL, V60, P935, DOI 10.1128/JVI.60.3.935-942.1986; LAIMINS LA, 1982, P NATL ACAD SCI-BIOL, V79, P6453, DOI 10.1073/pnas.79.21.6453; Lees M., 1984, MYELIN, P197; MANIATIS T, 1982, MOL CLONING LABORATO, P324; MARTENSO.RE, 1971, J NEUROCHEM, V18, P2427, DOI 10.1111/j.1471-4159.1971.tb00198.x; Martenson R. E., 1980, BIOCH BRAIN, P49; MARTENSON RE, 1972, BIOCHIM BIOPHYS ACTA, V263, P193, DOI 10.1016/0005-2795(72)90172-9; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MIURA M, 1989, GENE, V75, P31; NEWMAN SL, 1987, J NEUROCHEM S, V48, P27; QUEEN C, 1983, CELL, V33, P741, DOI 10.1016/0092-8674(83)90016-8; ROTH HJ, 1987, J NEUROSCI RES, V17, P321, DOI 10.1002/jnr.490170402; ROTH HJ, 1985, J NEUROCHEM, V45, P572, DOI 10.1111/j.1471-4159.1985.tb04025.x; ROTH HJ, 1986, J NEUROSCI RES, V16, P227, DOI 10.1002/jnr.490160120; TADA H, 1989, J VIROL, V63, P463, DOI 10.1128/JVI.63.1.463-466.1989; TAKAHASHI N, 1985, CELL, V42, P139, DOI 10.1016/S0092-8674(85)80109-4; YU YT, 1982, J NEUROCHEM, V39, P1559, DOI 10.1111/j.1471-4159.1982.tb07988.x; ZELLER WK, 1984, P NATL ACAD SCI USA, V86, P18	40	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13830	13835						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696259				2022-12-27	WOS:A1990DU27500066
J	BOTTERI, FM; BALLMERHOFER, K; RAJPUT, B; NAGAMINE, Y				BOTTERI, FM; BALLMERHOFER, K; RAJPUT, B; NAGAMINE, Y			DISRUPTION OF CYTOSKELETAL STRUCTURES RESULTS IN THE INDUCTION OF THE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									FRIEDRICH MIESCHER INST, CH-4002 BASEL, SWITZERLAND	Friedrich Miescher Institute for Biomedical Research				Ballmer-Hofer, Kurt/0000-0002-3800-9129				ABULAFIA R, 1984, J MOL BIOL, V172, P467, DOI 10.1016/S0022-2836(84)80018-2; ALTUS MS, 1987, BIOCHEM J, V242, P387, DOI 10.1042/bj2420387; ANDRUS L, 1988, J BIOL CHEM, V263, P6183; BENZEEV A, 1986, TRENDS BIOCHEM SCI, V11, P478, DOI 10.1016/0968-0004(86)90251-3; BENZEEV A, 1984, BIOCHIM BIOPHYS ACTA, V780, P197, DOI 10.1016/0304-419X(85)90003-4; BIRCHMEIER W, 1984, TRENDS BIOCHEM SCI, V9, P192, DOI 10.1016/0968-0004(84)90137-3; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BORISY GG, 1967, J CELL BIOL, V34, P525, DOI 10.1083/jcb.34.2.525; BREATHNACH R, 1987, NUCLEIC ACIDS RES, V15, P1139, DOI 10.1093/nar/15.3.1139; CARLSON KE, 1986, MOL PHARMACOL, V30, P463; CERVERA M, 1981, CELL, V23, P113, DOI 10.1016/0092-8674(81)90276-2; CHERKSEY BD, 1980, P NATL ACAD SCI-BIOL, V77, P6401, DOI 10.1073/pnas.77.11.6401; CHIN JR, 1985, J BIOL CHEM, V260, P2367; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CROSSIN KL, 1981, CELL, V23, P61, DOI 10.1016/0092-8674(81)90270-1; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; DEGEN JL, 1985, J BIOL CHEM, V260, P2426; DELLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P6497, DOI 10.1073/pnas.79.21.6497; DIERKSVENTLING C, 1989, INT J CANCER, V44, P865, DOI 10.1002/ijc.2910440520; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FLANAGAN MD, 1980, J BIOL CHEM, V255, P835; FLEISCHMANN G, 1984, P NATL ACAD SCI-BIOL, V81, P6958, DOI 10.1073/pnas.81.22.6958; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; GRAVES RA, 1984, MOL CELL BIOL, V4, P351, DOI 10.1128/MCB.4.2.351; HARTWIG JH, 1979, J MOL BIOL, V134, P539, DOI 10.1016/0022-2836(79)90366-8; HEARING VJ, 1988, CANCER RES, V48, P1270; HEMMINGS BA, 1986, FEBS LETT, V196, P126, DOI 10.1016/0014-5793(86)80226-5; HERMAN B, 1986, J CELL PHYSIOL, V126, P115, DOI 10.1002/jcp.1041260116; HULL RN, 1977, THROMB RES, V10, P669, DOI 10.1016/0049-3848(77)90049-4; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; HYNES RO, 1978, CELL, V15, P875, DOI 10.1016/0092-8674(78)90272-6; INSEL PA, 1978, NATURE, V273, P471, DOI 10.1038/273471a0; JARVINEN M, 1987, EUR J CELL BIOL, V44, P238; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; MANESS PF, 1982, CELL, V30, P253, DOI 10.1016/0092-8674(82)90031-9; MATRISIAN LM, 1986, MOL CELL BIOL, V6, P1679, DOI 10.1128/MCB.6.5.1679; MIRAYLOPEZ R, 1983, CANCER RES, V43, P5467; MIRONOV NM, 1986, EXP CELL RES, V167, P391, DOI 10.1016/0014-4827(86)90179-5; NAGAMINE Y, 1983, CELL, V32, P1181, DOI 10.1016/0092-8674(83)90301-X; NAGAMINE Y, 1984, NUCLEIC ACIDS RES, V12, P9525, DOI 10.1093/nar/12.24.9525; ORNELLES DA, 1986, MOL CELL BIOL, V6, P1650, DOI 10.1128/MCB.6.5.1650; PEARSON D, 1987, BIOCHEM BIOPH RES CO, V143, P329, DOI 10.1016/0006-291X(87)90669-3; POLLACK R, 1975, CELL, V6, P495, DOI 10.1016/0092-8674(75)90038-0; QUIGLEY JP, 1987, P NATL ACAD SCI USA, V84, P2776, DOI 10.1073/pnas.84.9.2776; RAJPUT B, 1987, SOMAT CELL MOLEC GEN, V13, P581, DOI 10.1007/BF01534500; RAJPUT B, 1985, SCIENCE, V230, P672, DOI 10.1126/science.3840278; RASENICK MM, 1981, NATURE, V294, P560, DOI 10.1038/294560a0; RAZ A, 1983, SCIENCE, V221, P1307, DOI 10.1126/science.6612347; REEVES R, 1983, J BIOL CHEM, V258, P679; ROSE SM, 1984, J BIOL CHEM, V259, P8534; ROTEM N, 1987, MOL CELL BIOL, V7, P622, DOI 10.1128/MCB.7.2.622; SAHYOUN NE, 1981, P NATL ACAD SCI-BIOL, V78, P6158, DOI 10.1073/pnas.78.10.6158; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; SEILERTUYNS A, 1981, J MOL BIOL, V151, P607, DOI 10.1016/0022-2836(81)90426-5; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; STIMAC E, 1984, MOL CELL BIOL, V4, P2082, DOI 10.1128/MCB.4.10.2082; TAYLOR EW, 1965, J CELL BIOL, V25, P145, DOI 10.1083/jcb.25.1.145; WERB Z, 1978, P NATL ACAD SCI USA, V75, P1839, DOI 10.1073/pnas.75.4.1839; WERB Z, 1986, J CELL BIOL, V102, P697, DOI 10.1083/jcb.102.3.697; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WILSON EL, 1980, CANCER RES, V40, P933	64	85	85	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13327	13334						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695907				2022-12-27	WOS:A1990DR20100085
J	CRABB, JW; GAUR, VP; GARWIN, GG; MARX, SV; CHAPLINE, C; JOHNSON, CM; SAARI, JC				CRABB, JW; GAUR, VP; GARWIN, GG; MARX, SV; CHAPLINE, C; JOHNSON, CM; SAARI, JC			TOPOLOGICAL AND EPITOPE MAPPING OF THE CELLULAR RETINALDEHYDE-BINDING PROTEIN FROM RETINA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE RETINA; ANTIGENIC DETERMINANTS; MONOCLONAL-ANTIBODIES; VITAMIN-A; SEQUENCE; LOCALIZATION; ADSORPTION; MEMBRANES; SURFACE; CELLS	Cellular retinaldehyde-binding protein (CRALBP) carries 11-cis-retinol or 11-cis-retinaldehyde as endogenous ligands and may function as a substrate carrier protein that modulates interaction of these retinoids with visual cycle enzymes. As a first approach to identifying functional domains and protein recognition sites in CRALBP, a low resolution topological and epitope map has been developed using monoclonal and polyclonal antibodies and limited proteolysis. Fifteen peptides of 8-31 residues spanning 99% of the 316-residue bovine CRALBP were synthesized and used to prepare 13 anti-peptide polyclonal antibodies. Using a competitive ELISA procedure, peptide epitopes were classified as either accessible or inaccessible in the native protein based on the extent of their recognition by these site-specific antibodies. Use of the synthetic peptides to map the epitopes of a polyclonal antibody to intact CRALBP confirmed that the amino terminus and carboxyl terminus are immunodominate regions and hence likely to be exposed, at least in part. Limited tryptic proteolysis of native CRALBP produced three major fragments which were shown by microsequence and Western analysis to be derived from sequential loss of short peptides from the amino terminus. None of these major fragments reacted with four monoclonal antibodies (mAbs) to intact CRALBP although each mAb immunoprecipitated native CRALBP. These results and the lack of mAb recognition of any of the synthetic peptides indicates that the amino terminus of the protein is exposed and contains part of an assembly epitope recognized by the mAbs. Overall this study indicates that residues 1-30, 100-124, and 257-285 contain highly exposed segments in the native protein and therefore constitute potential interaction domains for CRALBP and visual cycle enzymes. Residues 30-99 and 176-229 are inaccessible in the native structure and may be involved with retinoid binding. These results provide a basis for a systematic higher resolution mutagenesis study directed toward correlating CRALBP structural domains with function.	W ALTON JONES CELL SCI CTR,PROT CHEM FACIL,LAKE PLACID,NY 12946; UNIV WASHINGTON,SCH MED,DEPT OPHTHALMOL,SEATTLE,WA 98195; UNIV WASHINGTON,SCH MED,DEPT BIOCHEM,SEATTLE,WA 98195	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NATIONAL EYE INSTITUTE [P30EY001730, R01EY003523] Funding Source: NIH RePORTER; NEI NIH HHS [EY01730, EY02317, EY03523] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMIT AG, 1985, NATURE, V313, P156, DOI 10.1038/313156a0; ANDERSON AB, 1987, PROTEINS INTERFACES, P306; BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; BUNTMILAM AH, 1983, J CELL BIOL, V97, P703, DOI 10.1083/jcb.97.3.703; CHAPLINE C, 1989, 3RD S PROT SOC SEATT; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CRABB JW, 1988, J BIOL CHEM, V263, P18678; CRABB JW, 1988, J BIOL CHEM, V263, P18688; CRABB JW, 1991, FASEB J, V5, pA1173; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DOWLING JE, 1960, NATURE, V163, P144; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FAZEKAS S, 1980, J IMMUNOL METHODS, V35, P1; GAUR VP, 1988, J NEUROCYTOL, V17, P683, DOI 10.1007/BF01260995; GAUR VP, 1990, EXP EYE RES, V50, P505, DOI 10.1016/0014-4835(90)90039-W; GEYSEN HM, 1986, CIBA F SYMP, V119, P130; HARFORD J, 1984, NATURE, V311, P673, DOI 10.1038/311673a0; HOLLANDER Z, 1986, MOL IMMUNOL, V23, P927, DOI 10.1016/0161-5890(86)90122-7; INTRES R, 1990, Investigative Ophthalmology and Visual Science, V31, P113; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURENT BC, 1987, CHEM SCRIPTA, V27, P185; LION F, 1975, BIOCHIM BIOPHYS ACTA, V384, P282; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P226, DOI 10.1073/pnas.83.2.226; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RICHARDS FM, 1959, J BIOL CHEM, V234, P1459; Saari J.C., 1990, Progress in Retinal Research, V9, P363, DOI 10.1016/0278-4327(90)90011-6; SAARI J C, 1990, Investigative Ophthalmology and Visual Science, V31, P111; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1982, J BIOL CHEM, V257, P13329; SAARI JC, 1987, J BIOL CHEM, V262, P7618; SAARI JC, 1982, BIOCHIM BIOPHYS ACTA, V716, P266, DOI 10.1016/0304-4165(82)90277-X; SARIN VK, 1981, ANAL BIOCHEM, V117, P147, DOI 10.1016/0003-2697(81)90704-1; SORIA J, 1985, J COLLOID INTERF SCI, V107, P204, DOI 10.1016/0021-9797(85)90163-8; STANKER LH, 1985, J IMMUNOL METHODS, V76, P157, DOI 10.1016/0022-1759(85)90488-0; WEST KA, 1990, CURRENT RES PROTEIN, P37	41	40	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16674	16683						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715867				2022-12-27	WOS:A1991GD63500070
J	VONHEIJNE, G; LILJESTROM, P; MIKUS, P; ANDERSSON, H; NY, T				VONHEIJNE, G; LILJESTROM, P; MIKUS, P; ANDERSSON, H; NY, T			THE EFFICIENCY OF THE UNCLEAVED SECRETION SIGNAL IN THE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 PROTEIN CAN BE ENHANCED BY POINT MUTATIONS THAT INCREASE ITS HYDROPHOBICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MONOCYTES-MACROPHAGES; HAMSTER OVARY CELLS; ESCHERICHIA-COLI; DIRECTED MUTAGENESIS; EUKARYOTIC CELLS; CLONING; GENE; PEPTIDE; DNA; IDENTIFICATION	Plasminogen-activator inhibitor type 2 (PAI-2) is a specific inhibitor of plasminogen activators that belongs to the serine protease inhibitor superfamily (SERPINS). PAI-2 exists in two molecular forms: an intracellular, non-glycosylated form and a secreted, glycosylated form. Like ovalbumin, PAI-2 contains an uncleaved internal secretion signal. By deletion analysis, we have mapped the secretion signal to two mildly hydrophobic regions near the NH2 terminus. We also show that both of these regions become more efficient translocation signals when their hydrophobicities are increased. The PAI-2 secretion signal provides a unique example of a signal that, by virtue of its poor efficiency, allows the synthesis of both an extracellular and an intracellular form of the protein.	UMEA UNIV,DEPT APPL CELL & MOLEC BIOL,S-90187 UMEA,SWEDEN	Umea University	VONHEIJNE, G (corresponding author), KAROLINSKA INST,DEPT MOLEC BIOL,NOVUM,S-14152 HUDDINGE,SWEDEN.		von Heijne, Gunnar/F-5576-2011; von Heijne, Gunnar/AAH-9389-2019	von Heijne, Gunnar/0000-0002-4490-8569; 				ANDREASEN PA, 1990, MOL CELL ENDOCRINOL, V68, P1, DOI 10.1016/0303-7207(90)90164-4; ASTEDT B, 1987, Fibrinolysis, V1, P203, DOI 10.1016/0268-9499(87)90037-3; BACHMANN F, 1987, THROMB DIATH HAEMO, P227; BATY D, 1981, GENE, V16, P79, DOI 10.1016/0378-1119(81)90063-9; BELIN D, 1989, EMBO J, V8, P3287, DOI 10.1002/j.1460-2075.1989.tb08489.x; BENSON S A, 1984, Biotechniques, V2, P66; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHAMBERLAIN JP, 1979, ANAL BIOCHEM, V98, P132, DOI 10.1016/0003-2697(79)90716-4; CHAPMAN HA, 1982, CELL, V28, P653, DOI 10.1016/0092-8674(82)90220-3; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHUNG CT, 1988, NUCLEIC ACIDS RES, V16, P3580, DOI 10.1093/nar/16.8.3580; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; ERICKSON BW, 1976, PROTEINS, P255; GARCIA PD, 1988, J CELL BIOL, V106, P1093, DOI 10.1083/jcb.106.4.1093; GENTON C, 1987, J CELL BIOL, V104, P705, DOI 10.1083/jcb.104.3.705; GRUNDSTROM T, 1985, NUCLEIC ACIDS RES, V13, P3305, DOI 10.1093/nar/13.9.3305; HSUEH AJW, 1988, MEIOTIC INHIBITION M, P227; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAWRENCE D, 1989, EUR J BIOCHEM, V186, P523, DOI 10.1111/j.1432-1033.1989.tb15238.x; LILJESTROM P, 1991, J VIROL, V65, P147; Loskutoff DJ, 1988, PROGR HEMOSTASIS THR, P87; NY T, 1989, FIBRINOLYSIS, V3, P189, DOI 10.1016/0268-9499(89)90045-3; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; SAKSELA O, 1985, BIOCHIM BIOPHYS ACTA, V823, P35, DOI 10.1016/0304-419X(85)90014-9; Sambrook J, 1989, MOL CLONING LABORATO; Silhavy T. J., 1984, EXPT GENE FUSIONS; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; SU TZ, 1988, GENE, V69, P81, DOI 10.1016/0378-1119(88)90380-0; TABE L, 1984, J MOL BIOL, V180, P645, DOI 10.1016/0022-2836(84)90031-7; VASSALLI JD, 1984, J EXP MED, V159, P1653, DOI 10.1084/jem.159.6.1653; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; VONHEIJNE G, 1984, EMBO J, V3, P2315, DOI 10.1002/j.1460-2075.1984.tb02132.x; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; WOHLWEND A, 1987, J EXP MED, V165, P320, DOI 10.1084/jem.165.2.320; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YE RD, 1988, J BIOL CHEM, V263, P4869; YE RD, 1987, J BIOL CHEM, V262, P3718; ZETTLMEISSL G, 1987, BIO-TECHNOL, V5, P720, DOI 10.1038/nbt0787-720	40	81	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15240	15243						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714455				2022-12-27	WOS:A1991GB09700064
J	REARDON, JE; FURFINE, ES; CHENG, N				REARDON, JE; FURFINE, ES; CHENG, N			HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE - EFFECT OF PRIMER LENGTH ON TEMPLATE-PRIMER BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; T-LYMPHOTROPIC RETROVIRUS; PLUS-STRAND DNA; RNASE-H; MONOCLONAL-ANTIBODIES; ENZYME FUNCTION; SARCOMA VIRUS; CALF THYMUS; C-TERMINUS; MECHANISM	Poly(rA).oligo(dT)n binding to human immunodeficiency virus type-1 reverse transcriptase heterodimer (p66-p5l) was primer length-dependent. The estimated K(d) for (n = 10-14) was 20-30 nm and for (n = 16-20) was 0.11-0.14 nm. Gel electrophoretic analysis of the patterns of primer extension was consistent with an abrupt change in the K(d) between a primer length of 14 and 16 nucleotides. Further, the rate constant for dissociation of the reverse transcriptase-template-primer complex was determined from steady state kinetics and enzyme-template-primer trapping experiments to be independent of primer length. Thus, the abrupt change in K(d) was most likely due to a change in the rate constant for formation of the reverse transcriptase-template-primer complex. A similar shift in the K(d) for template-primer binding was observed with poly (dA).oligo(dT)n. Reverse transcriptase homodimer (p66) catalyzed the incorporation of dTMP into poly(rA).oligo(dT)n with the same primer length dependence observed for the heterodimer. In contrast, binding of the p51 homodimer to poly(rA).oligo(dT)n, was independent of primer length. Thus, the RNase H domain may contribute to reverse transcriptase heterodimer or p66 homodimer binding to template-primers in which the primer length is greater than 14 nucleotides.	WELLCOME RES LABS, DIV VIROL, RES TRIANGLE PK, NC 27709 USA	Wellcome Research Laboratories	REARDON, JE (corresponding author), WELLCOME RES LABS, DIV EXPTL THERAPY, RES TRIANGLE PK, NC 27709 USA.							BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BATHURST IC, 1990, BIOCHEM BIOPH RES CO, V171, P589, DOI 10.1016/0006-291X(90)91187-W; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; CHAMPOUX JJ, 1984, J VIROL, V49, P686, DOI 10.1128/JVI.49.3.686-691.1984; CHENG N, 1991, BIOCHEM BIOPH RES CO, V174, P785, DOI 10.1016/0006-291X(91)91486-V; Cleland W W, 1979, Methods Enzymol, V63, P103; COLLETT MS, 1978, NATURE, V272, P181, DOI 10.1038/272181a0; DAS SK, 1979, J BIOL CHEM, V254, P1227; DOWNEY KM, 1988, CANCER CELLS EUKARYO, V6, P403; FISHER PA, 1981, BIOCHEMISTRY-US, V20, P4560, DOI 10.1021/bi00519a008; FURFINE ES, 1991, J BIOL CHEM, V266, P406; FURMAN PA, 1979, J VIROL, V32, P72, DOI 10.1128/JVI.32.1.72-77.1979; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; HOHN KT, 1987, BIOCHEMISTRY-US, V26, P2870, DOI 10.1021/bi00384a031; HOPKINS S, 1989, BIOCHEM BIOPH RES CO, V163, P106, DOI 10.1016/0006-291X(89)92105-0; HUBER HE, 1989, J BIOL CHEM, V264, P4669; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; LARDER B, 1987, EMBO J, V6, P3133, DOI 10.1002/j.1460-2075.1987.tb02623.x; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; MAJUMDAR C, 1988, J BIOL CHEM, V263, P15657; ODONNELL ME, 1987, J BIOL CHEM, V262, P4260; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; REARDON JE, 1990, J BIOL CHEM, V265, P20302; RESNICK R, 1984, J VIROL, V51, P813, DOI 10.1128/JVI.51.3.813-821.1984; REY MA, 1984, BIOCHEM BIOPH RES CO, V121, P126, DOI 10.1016/0006-291X(84)90696-X; SMITH JK, 1984, J VIROL, V52, P314, DOI 10.1128/JVI.52.2.314-319.1984; SMITH JK, 1984, J VIROL, V49, P200, DOI 10.1128/JVI.49.1.200-204.1984; TAN CK, 1987, NUCLEIC ACIDS RES, V15, P2269, DOI 10.1093/nar/15.5.2269; TISDALE M, 1988, J VIROL, V62, P3662, DOI 10.1128/JVI.62.10.3662-3667.1988; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; WANG TSF, 1982, BIOCHEMISTRY-US, V21, P1597, DOI 10.1021/bi00536a021	33	44	44	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					14128	14134						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713216				2022-12-27	WOS:A1991FY02700102
J	MEHTA, KD; CHEN, WJ; GOLDSTEIN, JL; BROWN, MS				MEHTA, KD; CHEN, WJ; GOLDSTEIN, JL; BROWN, MS			THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IN XENOPUS-LAEVIS .1. 5 DOMAINS THAT RESEMBLE THE HUMAN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL RECEPTOR; CHOLESTEROL HOMEOSTASIS; MEDIATED ENDOCYTOSIS; CYTOPLASMIC DOMAIN; SEQUENCE; CLONING; ACID; HYPERCHOLESTEROLEMIA; IDENTIFICATION; VITELLOGENIN	All five functional domains of the low density lipoprotein (LDL) receptor were assembled in their modern form more than 350 million years ago, as revealed from the sequence of two cloned cDNAs from the frog Xenopus laevis. The two cDNAs appear to represent duplicated copies of the LDL receptor gene that arose when the entire genome of Xenopus duplicated approximately 30 million years ago. Both frog LDL receptors bound Xenopus LDL with high affinity and human LDL with lower affinity when expressed in monkey COS cells. The receptors also showed high affinity for rabbit beta-migrating very low density lipoprotein and canine apoE-HDL(c), both of which contain apolipoprotein E. Each of the seven cysteine-rich repeats in the ligand binding domain of the Xenopus receptors resembles its counterpart in the human, indicating that these repeats had already acquired their independent structures by the time of amphibian development. The cytoplasmic tail of both Xenopus receptors is 86% identical to the human, including the FDNPVY sequence necessary for internalization in coated pits. The attainment of a fully developed receptor structure in Xenopus suggests that earlier forms of the receptor may exist in animals that are older than amphibians. An accompanying paper demonstrates that expression of both Xenopus receptor genes is controlled by a sterol regulatory element that closely resembles the human sequence (Mehta, K. D., Brown, M. S., Bilheimer, D. W., and Goldstein, J. L. (1991) J. Biol. Chem. 266, 10415-10419).	UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	MEHTA, KD (corresponding author), UNIV TEXAS,SW MED CTR,DEPT MOLEC GENET,DALLAS,TX 75235, USA.				NHLBI NIH HHS [HL 20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BARAKAT HA, 1985, J LIPID RES, V26, P1252; BISBEE CA, 1977, SCIENCE, V195, P785, DOI 10.1126/science.65013; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS CG, 1986, J BIOL CHEM, V261, P2828; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; DOOLITTLE RF, 1984, PLASMA PROTEINS, V4, P317; GIL G, 1988, P NATL ACAD SCI USA, V85, P8963, DOI 10.1073/pnas.85.23.8963; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; INNERARITY TL, 1986, ARTERIOSCLEROSIS, V6, P114, DOI 10.1161/01.ATV.6.1.114; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; LEE LY, 1989, NUCLEIC ACIDS RES, V17, P1259, DOI 10.1093/nar/17.3.1259; LEHRMAN MA, 1987, J BIOL CHEM, V262, P3354; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; Maxam A M, 1980, Methods Enzymol, V65, P499; MEHTA KD, 1991, J BIOL CHEM, V266, P10415; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; RUSSELL DW, 1984, CELL, V37, P577, DOI 10.1016/0092-8674(84)90388-X; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SAMBROOK J, 1989, MOL CLONING LABORATO, V1; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; STIFANI S, 1990, J BIOL CHEM, V265, P882; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; VANDRIEL IR, 1987, J BIOL CHEM, V262, P16127; WALLACE RA, 1968, CAN J BIOCHEM CELL B, V46, P953, DOI 10.1139/o68-142; WILEY HS, 1979, ANAL BIOCHEM, V97, P145, DOI 10.1016/0003-2697(79)90338-5; YAMAMOTO T, 1986, SCIENCE, V232, P1230, DOI 10.1126/science.3010466; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	37	76	80	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10406	10414						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709931				2022-12-27	WOS:A1991FP08600064
J	DUBOIS, MF; HOVANESSIAN, AG; BENSAUDE, O				DUBOIS, MF; HOVANESSIAN, AG; BENSAUDE, O			HEAT-SHOCK-INDUCED DENATURATION OF PROTEINS - CHARACTERIZATION OF THE INSOLUBILIZATION OF THE INTERFERON-INDUCED P68 KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THERMAL SENSITIVITY; CELL-CYCLE; MONOCLONAL-ANTIBODIES; ABNORMAL PROTEINS; GENE-EXPRESSION; MAMMALIAN-CELLS; HELA-CELLS; C-MYC; STRESS; THERMOTOLERANCE	Heat-shock stress causes inactivation and aggregation of various cellular proteins which become further insoluble. Previous studies have shown that the interferon-induced p68 kinase activity was greatly reduced in extracts of heat-shocked HeLa cells, and that the loss of activity was due to a decreased solubility of the enzyme. Here we show that the p68 kinase which is normally evenly distributed in the cytoplasm, aggregates as a thick ring around the nucleus in heat-shocked cells. The 70-kDa constitutive heat-shock proteins are major insolubilized proteins during stress and we find them to colocalize with the p68 kinase after stress. Treatments of cells with drugs which disrupt the cytoskeleton, such as colcemid and cytochalasin E, do not hinder the enzyme insolubilization during heat-shock. On the contrary, heat-protectors such as glycerol and deuterium oxide (D2O) keep the p68 kinase under a soluble and active form during heat-shock stress. Similarly, an attenuation of the insolubilization of this enzyme is observed in cells rendered thermotolerant by a previous heat-shock, suggesting that heat-shock proteins may also contribute to the protection. During the recovery period at normal temperature after heat-shock, resolubilization occurs and most of the enzyme is again recovered under an active soluble form.	INST PASTEUR,UNITE VIROL & IMMUNOL CELLULAIRE,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	DUBOIS, MF (corresponding author), ECOLE NORM SUPER,BIOL MOLEC STRESS GRP,46 RUE ULM,F-75230 PARIS 05,FRANCE.			Bensaude, Olivier/0000-0002-0259-6608				ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; AZZAM EI, 1982, RADIAT RES, V90, P644, DOI 10.2307/3575742; BENSAUDE O, 1991, IN PRESS HEAT SHOCK; BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; CALDERWOOD SK, 1983, BIOCHIM BIOPHYS ACTA, V756, P1, DOI 10.1016/0304-4165(83)90016-8; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; CARPER SW, 1987, CANCER RES, V47, P5249; DUBOIS MF, 1987, ANN INST PASTEUR VIR, V138, P345, DOI 10.1016/S0769-2617(87)80021-7; DUBOIS MF, 1990, VIROLOGY, V179, P591, DOI 10.1016/0042-6822(90)90126-C; DUBOIS MF, 1989, J BIOL CHEM, V264, P12165; DUNCAN R, 1984, J BIOL CHEM, V259, P1882; DUNCAN RF, 1989, J CELL BIOL, V109, P1467, DOI 10.1083/jcb.109.4.1467; EDINGTON BV, 1989, J CELL PHYSIOL, V139, P219, DOI 10.1002/jcp.1041390202; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; FINLEY D, 1984, CELL, V37, P43, DOI 10.1016/0092-8674(84)90299-X; GAITANARIS GA, 1990, CELL, V61, P1013, DOI 10.1016/0092-8674(90)90066-N; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; HENLE KJ, 1981, RADIAT RES, V88, P392, DOI 10.2307/3575671; HIGHTOWER LE, 1980, J CELL PHYSIOL, V102, P407, DOI 10.1002/jcp.1041020315; HOVANESSIAN AG, 1987, EMBO J, V6, P1273, DOI 10.1002/j.1460-2075.1987.tb02364.x; KASHLEV MV, 1989, MOL GEN GENET, V216, P469, DOI 10.1007/BF00334392; LANDRY J, 1983, CAN J BIOCHEM CELL B, V61, P428, DOI 10.1139/o83-058; LAURENT AG, 1985, P NATL ACAD SCI USA, V82, P4341, DOI 10.1073/pnas.82.13.4341; LENGYEL P, 1982, ANNU REV BIOCHEM, V51, P251, DOI 10.1146/annurev.bi.51.070182.001343; LEPOCK JR, 1988, J CELL PHYSIOL, V137, P14, DOI 10.1002/jcp.1041370103; LI GC, 1982, RADIAT RES, V92, P541, DOI 10.2307/3575926; LI GC, 1982, P NATL ACAD SCI-BIOL, V79, P3218, DOI 10.1073/pnas.79.10.3218; LI GC, 1985, CHANGES EUKARYOTIC G, P227; LIN PS, 1981, J CELL PHYSIOL, V108, P439, DOI 10.1002/jcp.1041080318; LITTLEWOOD TD, 1987, J CELL SCI, V88, P65; LUSCHER B, 1988, MOL CELL BIOL, V8, P2504; LUTZ Y, 1988, EXP CELL RES, V175, P109, DOI 10.1016/0014-4827(88)90259-5; MAGUN BE, 1981, RADIAT RES, V86, P133, DOI 10.2307/3575605; MASSICOTTENOLAN P, 1981, RADIAT RES, V87, P284, DOI 10.2307/3575584; MATTEI D, 1989, EUR J IMMUNOL, V19, P1823, DOI 10.1002/eji.1830191010; MIVECHI NF, 1985, RADIAT RES, V103, P337, DOI 10.2307/3576756; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; RAAPHORST GP, 1982, J THERM BIOL, V7, P147, DOI 10.1016/0306-4565(82)90004-3; RIABOWOL KT, 1988, SCIENCE, V242, P433, DOI 10.1126/science.3175665; ROTI JLR, 1986, RADIAT RES, V107, P250, DOI 10.2307/3576812; SCIANDRA JJ, 1984, CANCER RES, V44, P5188; STONE DE, 1990, MOL CELL BIOL, V10, P1622, DOI 10.1128/MCB.10.4.1622; STRAUS D, 1990, GENE DEV, V4, P2202, DOI 10.1101/gad.4.12a.2202; SUBJECK JR, 1982, HEAT SHOCK BACTERIA, P405; WELCH WJ, 1985, MOL CELL BIOL, V5, P1571, DOI 10.1128/MCB.5.7.1571; WELCH WJ, 1988, J CELL BIOL, V106, P1117, DOI 10.1083/jcb.106.4.1117; WOLFFE AP, 1984, EMBO J, V3, P2763, DOI 10.1002/j.1460-2075.1984.tb02207.x; YOST HJ, 1986, CELL, V45, P185, DOI 10.1016/0092-8674(86)90382-X	50	73	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					9707	9711						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1709639				2022-12-27	WOS:A1991FM45900058
J	KIEFER, MC; MASIARZ, FR; BAUER, DM; ZAPF, J				KIEFER, MC; MASIARZ, FR; BAUER, DM; ZAPF, J			IDENTIFICATION AND MOLECULAR-CLONING OF 2 NEW 30-KDA INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS ISOLATED FROM ADULT HUMAN SERUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRAPANCREATIC TUMOR HYPOGLYCEMIA; IGF-I; INVARIANT CHAIN; MESSENGER-RNA; RAT SERUM; SEQUENCE; EXPRESSION; ACID; DNA; PURIFICATION	Three insulin-like growth factor binding proteins (IGFBP) with apparent molecular masses of 24, 28-30, and 30 kDa, nonreduced, have been isolated from human serum. The 15 NH2-terminal amino acids of the 24-kDa binding protein are identical with those of the 30-kDa BP. The apparent molecular mass of the latter is reduced to 24 kDa by N-glycanase, suggesting that the 30-kDa BP is the glycosylated form of the isolated 24-kDa BP. The complete amino acid sequences derived from the cloned cDNAs represent two new IGFBPs. They are tentatively termed IGFBP-4 and -5. The prepeptide sequences of BP-4 and -5 contain 27 and 21, the mature proteins 213 and 237 amino acids, respectively (M(r) = 22,610 and 25,980). The NH2- and COOH-terminal thirds of BP-4 and -5 display pronounced homology to the other three human BPs. 16 of the 16-20 cysteines and 37 of the 213-289 amino acids (12.8-17.1%) are conserved in all five mature BPs. 10 amino acid positions located in the NH2-terminal region and shared by BP-1, -2, -3, and -5 are different in BP-4. These differences may account for the preferential affinity of BP-4 for IGF II. A most intriguing homology exists between the COOH-terminal quarter of the five IGFBPs, 10 repetitive domains of human thyroglobulin, a gastrointestinal tumor-associated antigen, and the invariant chain of the class II histocompatibility antigen. The cDNAs of five human IGFBPs are now available. They will allow their expression and production in sufficient quantities for in vivo studies to unravel their role in growth and metabolism.	UNIV HOSP ZURICH,DEPT MED,METAB UNIT,CH-8091 ZURICH,SWITZERLAND; CHIRON CORP,EMERYVILLE,CA 94608	University of Zurich; University Zurich Hospital; Novartis								AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARR PJ, 1986, BIOTECHNIQUES, V4, P428; BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6898, DOI 10.1073/pnas.86.18.6898; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BINKERT C, 1989, EMBO J, V8, P2497, DOI 10.1002/j.1460-2075.1989.tb08386.x; BLAT C, 1989, J BIOL CHEM, V264, P12449; BLUM WF, 1989, ENDOCRINOLOGY, V125, P766, DOI 10.1210/endo-125-2-766; BREWER MT, 1988, BIOCHEM BIOPH RES CO, V152, P1289, DOI 10.1016/S0006-291X(88)80425-X; BRINKMAN A, 1988, EMBO J, V7, P2417, DOI 10.1002/j.1460-2075.1988.tb03087.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FREEMAN GJ, 1983, P NATL ACAD SCI-BIOL, V80, P4094, DOI 10.1073/pnas.80.13.4094; HAMMERLING GJ, 1990, IMMUNOL TODAY, V11, P337; HARDOUIN S, 1987, EUR J BIOCHEM, V170, P121, DOI 10.1111/j.1432-1033.1987.tb13676.x; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; HUHTALA ML, 1986, BIOCHEM BIOPH RES CO, V141, P263, DOI 10.1016/S0006-291X(86)80363-1; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; JULKUNEN M, 1988, FEBS LETT, V236, P295, DOI 10.1016/0014-5793(88)80041-3; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; LEE YL, 1988, MOL ENDOCRINOL, V2, P404, DOI 10.1210/mend-2-5-404; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; LUTHMAN H, 1989, EUR J BIOCHEM, V180, P259, DOI 10.1111/j.1432-1033.1989.tb14641.x; MALTHIERY Y, 1987, EUR J BIOCHEM, V165, P491, DOI 10.1111/j.1432-1033.1987.tb11466.x; Maniatis T., 1982, MOL CLONING; MARTIN JL, 1990, J BIOL CHEM, V265, P4124; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; NILSON BL, 1984, ANAL BIOCHEM, V141, P311; Rochat H, 1979, Adv Cytopharmacol, V3, P325; ROGHANI M, 1989, FEBS LETT, V255, P253, DOI 10.1016/0014-5793(89)81101-9; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIMONAKA M, 1989, BIOCHEM BIOPH RES CO, V165, P189, DOI 10.1016/0006-291X(89)91053-X; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WANG JF, 1988, BIOCHEM BIOPH RES CO, V157, P718, DOI 10.1016/S0006-291X(88)80309-7; WOOD WI, 1988, MOL ENDOCRINOL, V2, P1176, DOI 10.1210/mend-2-12-1176; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZAPF J, 1988, BIOCHEM BIOPH RES CO, V156, P1187, DOI 10.1016/S0006-291X(88)80758-7; ZAPF J, 1990, J CLIN INVEST, V86, P952, DOI 10.1172/JCI114797; ZAPF J, 1990, J BIOL CHEM, V265, P14892; ZAPF J, 1975, ARCH BIOCHEM BIOPHYS, V168, P638, DOI 10.1016/0003-9861(75)90296-9	45	112	121	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					9043	9049						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709161				2022-12-27	WOS:A1991FM03800060
J	SAKAGUCHI, K; YANAGISHITA, M; TAKEUCHI, Y; AURBACH, GD				SAKAGUCHI, K; YANAGISHITA, M; TAKEUCHI, Y; AURBACH, GD			IDENTIFICATION OF HEPARAN-SULFATE PROTEOGLYCAN AS A HIGH-AFFINITY RECEPTOR FOR ACIDIC FIBROBLAST GROWTH-FACTOR (AFGF) IN A PARATHYROID CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBENDOTHELIAL EXTRACELLULAR-MATRIX; CAPILLARY ENDOTHELIAL-CELLS; PROTEIN-TYROSINE KINASE; NUCLEOTIDE-SEQUENCE; BOVINE BRAIN; GLYCOSAMINOGLYCAN CHAINS; PROTEOLYTIC DEGRADATION; MEMBRANE PROTEOGLYCAN; ANGIOGENIC PROTEIN; BINDING-SITES	We have characterized two high affinity acidic fibroblast growth factor (aFGF) receptors in a rat parathyroid cell line (PT-r). Affinity labeling with I-125-aFGF showed that these two receptors, apparent molecular masses, 150 and 130 kDa, respectively, display higher affinity for aFGF than for bFGF. The 150-kDa receptor bears a heparan sulfate chain(s), demonstrated by a decrease in size of 15-20 kDa with heparitinase digestion after affinity labeling. Heparitinase digestion before affinity labeling markedly reduced the intensity of the 150 kDa species. Scatchard analysis showed two different high affinity binding sites (K(d) of 3.9 pM with 180 sites/cell and K(d) of 110 pM with 5800 sites/cell). The higher affinity site was completely eliminated by digestion with heparitinase before adding labeled aFGF; the lower affinity site was unaffected. In ion exchange chromatography after metabolic labeling of the cells with [H-3]glucosamine and affinity labeling with I-125-aFGF, the larger receptor-ligand complex, 165 kDa, eluted with approximately 0.5 M NaCl, typical eluting conditions for heparan sulfate proteoglycans. Both of the receptor-ligand complexes were smaller on sodium dodecyl sulfate-polyacrylamide gel electrophoresis than two major heparan sulfate proteoglycans, HSPG I and II, which we characterized in this cell line previously (Yanagishita, M., Brandi, M. L., and Sakaguchi, K. (1989) J. Biol. Chem. 264, 15714-15720). Both receptors have similar N-linked oligosaccharide and sialic acid contents, shown by analysis of affinity-labeled receptors upon digestion with glycopeptidase F and with neuraminidase. All together, these results suggest that PT-r cells bear two distinct high affinity receptors for aFGF, a 150-kDa receptor which is a heparan sulfate proteoglycan and another that is a glycoprotein. The heparan sulfate glycosaminoglycan moiety of the 150- kDa receptor is critical for high affinity binding of aFGF. These findings contrast with current concepts derived from other systems, suggesting that heparan sulfate glycosaminoglycans/proteoglycans function as a reservoir source for FGF or as a group of low affinity binding sites.	NIDR, BONE RES BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	SAKAGUCHI, K (corresponding author), NIDDK, METAB DIS BRANCH, BLDG 10, RM 9C101, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA.							ABRAHAM JA, 1986, SCIENCE, V233, P545, DOI 10.1126/science.2425435; ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; BURRUS LW, 1989, J BIOL CHEM, V264, P18647; CASTELLOT JJ, 1987, SEMIN THROMB HEMOST, V13, P489, DOI 10.1055/s-2007-1003525; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1989, J BIOL CHEM, V264, P12025; COLE GJ, 1989, NEURON, V2, P1157, DOI 10.1016/0896-6273(89)90182-7; COURTY J, 1988, J BIOL CHEM, V263, P11217; DAMON DH, 1989, J CELL PHYSIOL, V138, P221, DOI 10.1002/jcp.1041380202; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; DOEGE K, 1987, J BIOL CHEM, V262, P17757; FEIGE JJ, 1988, J BIOL CHEM, V263, P14023; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FRIESEL R, 1986, J BIOL CHEM, V261, P7581; GOLDSTEIN LA, 1989, CELL, V56, P1063, DOI 10.1016/0092-8674(89)90639-9; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; HALBERG DF, 1988, J BIOL CHEM, V263, P9486; HAUTANEN A, 1989, J BIOL CHEM, V264, P1437; HUANG JS, 1986, J BIOL CHEM, V261, P1600; ISHIHARA M, 1987, J BIOL CHEM, V262, P4708; ISHIHARA M, 1986, J BIOL CHEM, V261, P3575; JAYE M, 1987, J BIOL CHEM, V262, P16612; JAYE M, 1986, SCIENCE, V233, P541, DOI 10.1126/science.3523756; KAN M, 1988, J BIOL CHEM, V263, P11306; KISS I, 1987, P NATL ACAD SCI USA, V84, P6399, DOI 10.1073/pnas.84.18.6399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDOUX D, 1989, BIOCHEM BIOPH RES CO, V159, P290, DOI 10.1016/0006-291X(89)92436-4; LEE PL, 1989, SCIENCE, V245, P57, DOI 10.1126/science.2544996; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; LINKER A, 1984, CARBOHYD RES, V127, P75, DOI 10.1016/0008-6215(84)85107-1; LOBB R, 1986, J BIOL CHEM, V261, P1924; LOBB RR, 1988, BIOCHEMISTRY-US, V27, P2572, DOI 10.1021/bi00407a045; MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; MARICS I, 1989, ONCOGENE, V4, P335; MOENNER M, 1986, P NATL ACAD SCI USA, V83, P5024, DOI 10.1073/pnas.83.14.5024; MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; MUNSON PJ, 1984, COMPUTERS ENDOCRINOL, P117; NEAME PJ, 1987, J BIOL CHEM, V262, P17768; NEUFELD G, 1986, J BIOL CHEM, V261, P5631; NEUFELD G, 1985, J BIOL CHEM, V260, P3860; OLWIN BB, 1986, BIOCHEMISTRY-US, V25, P3487, DOI 10.1021/bi00360a001; PASQUALE EB, 1989, P NATL ACAD SCI USA, V86, P5449, DOI 10.1073/pnas.86.14.5449; RANTER N, 1988, P NATL ACAD SCI USA, V85, P6992; REID HH, 1990, P NATL ACAD SCI USA, V87, P1596, DOI 10.1073/pnas.87.4.1596; RIZZINO A, 1986, IN VITRO CELL DEV B, V22, P749; ROSENGART TK, 1988, BIOCHEM BIOPH RES CO, V152, P432, DOI 10.1016/S0006-291X(88)80732-0; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; RUTA M, 1989, P NATL ACAD SCI USA, V86, P8722, DOI 10.1073/pnas.86.22.8722; RUTA M, 1988, ONCOGENE, V3, P9; SAKAGUCHI K, 1987, P NATL ACAD SCI USA, V84, P3269, DOI 10.1073/pnas.84.10.3269; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SCHMIDT G, 1987, J CELL BIOL, V104, P1683, DOI 10.1083/jcb.104.6.1683; SCHREIBER AB, 1985, P NATL ACAD SCI USA, V82, P6138, DOI 10.1073/pnas.82.18.6138; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; SHING Y, 1984, SCIENCE, V223, P1296, DOI 10.1126/science.6199844; SOMMER A, 1989, J CELL PHYSIOL, V138, P215, DOI 10.1002/jcp.1041380129; STAMENKOVIC I, 1989, CELL, V56, P1057, DOI 10.1016/0092-8674(89)90638-7; THOMPSON JA, 1988, SCIENCE, V241, P1349, DOI 10.1126/science.2457952; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; VIGNY M, 1988, J CELL PHYSIOL, V137, P321, DOI 10.1002/jcp.1041370216; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; YANAGISHITA M, 1989, J BIOL CHEM, V264, P15714; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	74	82	82	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					7270	7278						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707883				2022-12-27	WOS:A1991FG72700097
J	KUROSAKA, A; YANO, A; ITOH, N; KURODA, Y; NAKAGAWA, T; KAWASAKI, T				KUROSAKA, A; YANO, A; ITOH, N; KURODA, Y; NAKAGAWA, T; KAWASAKI, T			THE STRUCTURE OF A NEURAL SPECIFIC CARBOHYDRATE EPITOPE OF HORSERADISH-PEROXIDASE RECOGNIZED BY ANTI-HORSERADISH PEROXIDASE ANTISERUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; GRASSHOPPER EMBRYOS; STEM BROMELAIN; SUGAR CHAINS; GLYCOPROTEINS; MOIETY; DROSOPHILA; LECTINS; GLYCOPEPTIDES; SURFACE	Antiserum raised against horseradish peroxidase (HRP) recognizes a neural specific carbohydrate antigen in Drosophila and other insects. The epitopic activity of the carbohydrate moiety of HRP recognized by anti-HRP antiserum was measured by a newly developed enzyme linked immunosorbent assay, in which HRP glycopeptides conjugated with bovine serum albumin were coated onto the wells and then reacted with goat anti-HRP antiserum. HRP sugar moieties released by almond glycopeptidase A digestion of HRP pepsin digests were subjected to pyridylamination. Pyridylamino oligosaccharides were separated into seven fractions by reverse-phase high performance liquid chromatography. The major fraction, which comprised about 80% of the total sugars, reacted strongly with anti-HRP antiserum. The carbohydrate structure of this fraction was determined by sugar composition analysis and 600-MHz H-1 NMR spectroscopy as follows: Man-alpha-1 --> 6(Man-alpha-1 --> 3)(Xyl-beta-l --> 2)Man-beta-1 --> 4GlcNAc-beta-1 --> 4(Fuc-alpha-1 --> 3)GlcNAc. Analyses of reactivity with anti-HRP antiserum of various oligosaccharide derivatives obtained from the major fraction by exoglycosidase digestion and partial acid hydrolysis indicated that alpha-1 --> 6-linked mannose and alpha-1 --> 3-linked fucose are predominantly involved in the epitopic structure.	KYOTO SANGYO UNIV,FAC SCI,DEPT PHYS,KITA KU,KYOTO 603,JAPAN; KYOTO UNIV,FAC PHARMACEUT SCI,DEPT BIOL CHEM,KYOTO 606,JAPAN; KYOTO UNIV,FAC PHARMACEUT SCI,DEPT ANALYT CHEM,KYOTO 606,JAPAN	Kyoto Sangyo University; Kyoto University; Kyoto University	KUROSAKA, A (corresponding author), KYOTO SANGYO UNIV,FAC ENGN,DEPT BIOTECHNOL,KAMIGAMO MOTOYAMA,KITA KU,KYOTO 603,JAPAN.							ASHFORD D, 1987, EUR J BIOCHEM, V166, P311, DOI 10.1111/j.1432-1033.1987.tb13516.x; BASTIANI MJ, 1987, CELL, V48, P745, DOI 10.1016/0092-8674(87)90072-9; BERMAN E, 1981, J BIOL CHEM, V256, P6657; BOUWSTRA JB, 1990, EUR J BIOCHEM, V190, P113, DOI 10.1111/j.1432-1033.1990.tb15553.x; GERFEN CR, 1984, BRAIN RES, V290, P219, DOI 10.1016/0006-8993(84)90940-5; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; HASE S, 1986, J BIOCHEM-TOKYO, V100, P1; HEWITT F, 1937, BIOCHEM J, V31, P360; HOTTA T, 1985, Journal of Applied Biochemistry, V7, P98; ISHIHARA H, 1979, J BIOL CHEM, V254, P715; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; KADMON G, 1990, J CELL BIOL, V110, P193, DOI 10.1083/jcb.110.1.193; KALADAS PM, 1983, MOL IMMUNOL, V20, P727, DOI 10.1016/0161-5890(83)90050-0; KALIL RE, 1989, SCI AM, V261, P38; KAMERLING JP, 1990, 15TH INT CARB S YOK, P1; KATZ F, 1988, EMBO J, V7, P3471, DOI 10.1002/j.1460-2075.1988.tb03222.x; KIMURA Y, 1988, J BIOCHEM-TOKYO, V103, P944, DOI 10.1093/oxfordjournals.jbchem.a122391; KIMURA Y, 1987, J BIOCHEM-TOKYO, V101, P1051, DOI 10.1093/oxfordjournals.jbchem.a121947; KITAGAKIOGAWA H, 1986, EUR J BIOCHEM, V161, P779, DOI 10.1111/j.1432-1033.1986.tb10507.x; SNOW PM, 1987, J NEUROSCI, V7, P4137; STIEBER A, 1989, BRAIN RES, V495, P131, DOI 10.1016/0006-8993(89)91226-2; TAKAHASHI N, 1986, BIOCHEMISTRY-US, V25, P388, DOI 10.1021/bi00350a018; TOMIYA N, 1988, ANAL BIOCHEM, V171, P73, DOI 10.1016/0003-2697(88)90126-1; VANKUIK JA, 1986, GLYCOCONJUGATE J, V3, P27, DOI 10.1007/BF01108609; YASUDA Y, 1970, BIOCHEMISTRY-US, V9, P25, DOI 10.1021/bi00803a004	26	175	177	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4168	4172						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705547				2022-12-27	WOS:A1991FA69400026
J	JOHANSSON, HE; DEGROOT, N; HOCHBERG, AA; HENTZE, MW				JOHANSSON, HE; DEGROOT, N; HOCHBERG, AA; HENTZE, MW			EFFECT OF HEPARIN CONTAINED IN PREPARATIONS OF SMALL CYTOPLASMIC RNAS ON CELL-FREE TRANSLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RIBONUCLEOPROTEIN PARTICLES; FREE PROTEIN-SYNTHESIS; HUMAN TERM PLACENTA; PURIFICATION; INHIBITOR; COMPLEX; INVITRO; MUSCLE	It has been reported that small cytoplasmic RNA (scRNA) from human placenta inhibits translation of most mRNAs in both wheat germ extracts and reticulocyte lysates (Lorberboum, H., Digweed, M., Erdmann, V. A., Servadio, Y., Weinstein, D., De Groot, N., and Hochberg, A. A. (1986) Eur. J. Biochem. 155, 279-287). We have investigated the mechanism by which scRNA preparations inhibit mRNA translation in vitro. We demonstrate that the inhibitory agent(s) is not sensitive to treatment with various ribonucleases but that translational inhibition is sensitive to incubation with 1 N NaOH at 95-degrees-C or to treatment with heparinase. Based on these findings and on the ability of heparin to inhibit cell-free translation by itself, we conclude that the presence of heparin in preparations of scRNA from human placenta is responsible for effects which have previously been attributed to inhibitory RNA molecules. Since heparin is also frequently used in the isolation of translationally inhibitory scRNAs from other sources, we suggest that the sensitivity of these preparations to ribonucleases and heparinase should be examined.	EUROPEAN MOLEC BIOL LAB,MEYERHOFSTR 1,POSTFACH 102209,W-6900 HEIDELBERG,GERMANY; HEBREW UNIV JERUSALEM,INST LIFE SCI,IL-91904 JERUSALEM,ISRAEL	European Molecular Biology Laboratory (EMBL); Hebrew University of Jerusalem			Johansson, Hans E./C-5113-2017; Hentze, Matthias/V-3980-2017	Johansson, Hans E./0000-0001-9495-6107; Hentze, Matthias/0000-0002-4023-7876				AKHAYAT O, 1987, EUR J BIOCHEM, V170, P23, DOI 10.1111/j.1432-1033.1987.tb13663.x; ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; CASTANO JG, 1986, CELL, V46, P377, DOI 10.1016/0092-8674(86)90658-6; Clemens M, 1984, TRANSCRIPTION TRANSL, P231; DREYFUSS G, 1988, J CELL BIOL, V106, P1419, DOI 10.1083/jcb.106.5.1419; ELLER MS, 1984, ARCH BIOCHEM BIOPHYS, V232, P526, DOI 10.1016/0003-9861(84)90570-8; FALKENBURG PE, 1988, NATURE, V331, P190, DOI 10.1038/331190a0; JAIN SK, 1979, BIOCHEMISTRY-US, V18, P745, DOI 10.1021/bi00572a002; KLOPPSTECH K, 1987, EUR J BIOCHEM, V167, P501, DOI 10.1111/j.1432-1033.1987.tb13365.x; KUHN B, 1982, EUR J BIOCHEM, V126, P181, DOI 10.1111/j.1432-1033.1982.tb06764.x; LORBERBOUM H, 1986, EUR J BIOCHEM, V155, P279, DOI 10.1111/j.1432-1033.1986.tb09487.x; LORBERBOUM H, 1982, BIOCHEM INT, V5, P407; MANS RJ, 1961, ARCH BIOCHEM BIOPHYS, V94, P48, DOI 10.1016/0003-9861(61)90009-1; MCCARTHY TL, 1983, BIOCHEMISTRY-US, V22, P935, DOI 10.1021/bi00273a035; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; REDDY R, 1983, PROG NUCLEIC ACID RE, V30, P127; ROBERTS BE, 1973, P NATL ACAD SCI USA, V70, P2330, DOI 10.1073/pnas.70.8.2330; Sambrook J, 1989, MOL CLONING LABORATO; SARKAR S, 1981, J BIOL CHEM, V256, P5077; Steitz J. A., 1988, STRUCTURE FUNCTION M, P115; WALDEN WE, 1988, P NATL ACAD SCI USA, V85, P9503, DOI 10.1073/pnas.85.24.9503; WALDMAN AA, 1973, BIOCHEMISTRY-US, V14, P2706; YANG VC, 1985, J BIOL CHEM, V260, P1849	23	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1921	1925						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703159				2022-12-27	WOS:A1991EU49700084
J	NASHED, EM; PERDOMO, GR; PADLAN, EA; KOVAC, P; MATSUDA, T; KABAT, EA; GLAUDEMANS, CPJ				NASHED, EM; PERDOMO, GR; PADLAN, EA; KOVAC, P; MATSUDA, T; KABAT, EA; GLAUDEMANS, CPJ			BINDING CHARACTERISTICS OF IGA-16.4.12E, A MONOCLONAL-ANTIBODY WITH SPECIFICITY FOR THE NONREDUCING TERMINAL EPITOPE OF ALPHA-(1-]6)-DEXTRANS - COMPARISONS BETWEEN IGA HYBRIDOMA-16.4.12E AND MYELOMA-W3129	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NIDDKD, BETHESDA, MD 20892 USA; NIH, OFF DIRECTOR, BETHESDA, MD 20892 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA; COLUMBIA UNIV COLL PHYS & SURG, DEPT GENET & DEV, NEW YORK, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; Columbia University; Columbia University					PHS HHS [1R01 A1-19042] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BENNETT LG, 1979, CARBOHYD RES, V72, P315, DOI 10.1016/S0008-6215(00)83958-0; BERMAN HM, 1968, ACTA CRYSTALL B-STRU, VB 24, P897, DOI 10.1107/S0567740868003389; BOCK K, 1982, ANNU REP NMR SPECTRO, V13, P1; BORDEN P, 1987, P NATL ACAD SCI USA, V84, P2440, DOI 10.1073/pnas.84.8.2440; CARD PJ, 1983, J ORG CHEM, V48, P393, DOI 10.1021/jo00151a027; CARDILLO G, 1983, CHEM IND-LONDON, P643; CAREY FA, 1970, CARBOHYD RES, V12, P463, DOI 10.1016/S0008-6215(00)80628-X; CISAR J, 1975, J EXP MED, V142, P435, DOI 10.1084/jem.142.2.435; CISAR J, 1974, J EXP MED, V139, P159, DOI 10.1084/jem.139.1.159; COLSON P, 1974, J AM CHEM SOC, V96, P8081, DOI 10.1021/ja00833a038; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CSUK R, 1988, ADV CARBOHYD CHEM BI, V46, P73, DOI 10.1016/S0065-2318(08)60165-1; GAREGG PJ, 1979, ACTA CHEM SCAND B, V33, P116, DOI 10.3891/acta.chem.scand.33b-0116; GLAUDEMANS CPJ, 1989, ANGEW CHEM INT EDIT, V28, P1669, DOI 10.1002/anie.198916691; GLAUDEMANS CPJ, 1988, ACS SYM SER, V374, P78; GLAUDEMANS CPJ, 1987, MOL IMMUNOL, V24, P371, DOI 10.1016/0161-5890(87)90179-9; GLAUDEMANS CPJ, 1984, BIOCHEMISTRY-US, V23, P6732, DOI 10.1021/bi00321a069; GLAUDEMANS CPJ, 1989, CARBOHYD RES, V190, P267, DOI 10.1016/0008-6215(89)84130-8; GLAUDEMANS CPJ, 1963, J ORG CHEM, V28, P3004, DOI 10.1021/jo01046a016; Glaudemans CPJ, 1980, METHODS CARBOHYDR CH, V8, P145; HELFERICH B, 1924, BER B, V59, P79; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; HUGHES IW, 1949, J CHEM SOC, P2846, DOI 10.1039/jr9490002846; ITTAH Y, 1981, CARBOHYD RES, V95, P189, DOI 10.1016/S0008-6215(00)85575-5; JOLLEY ME, 1974, CARBOHYD RES, V33, P377, DOI 10.1016/S0008-6215(00)82819-0; JONES TA, 1978, J APPL CRYSTALLOGR, V16, P548; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KARIPEDES A, 1974, J AM CHEM SOC, V106, P1494; KOVAC P, 1973, CARBOHYD RES, V31, P323, DOI 10.1016/S0008-6215(00)86196-0; KOVAC P, 1988, J CARBOHYD CHEM, V7, P317, DOI 10.1080/07328308808058928; KOVAC P, 1988, CARBOHYD RES, V175, P201, DOI 10.1016/0008-6215(88)84143-0; KOVAC P, 1988, CARBOHYD RES, V184, P87, DOI 10.1016/0008-6215(88)80008-9; KOVAC P, 1987, CARBOHYD RES, V169, P23, DOI 10.1016/0008-6215(87)80239-2; KRONZER FJ, 1973, CARBOHYD RES, V27, P379, DOI 10.1016/S0008-6215(00)81320-8; LEMIEUX RU, 1984, MOL IMMUNOL, V21, P751, DOI 10.1016/0161-5890(84)90161-5; MATSUDA T, 1989, J IMMUNOL, V142, P863; MUNAVU RM, 1976, J ORG CHEM, V41, P1832, DOI 10.1021/jo00872a033; PADLAN EA, 1988, P NATL ACAD SCI USA, V85, P6885, DOI 10.1073/pnas.85.18.6885; PRINS DA, 1946, HELV CHIM ACTA, V29, P1, DOI 10.1002/hlca.19460290101; QUIOCHO FA, 1984, NATURE, V310, P381, DOI 10.1038/310381a0; RASMUSSEN JR, 1981, J ORG CHEM, V46, P4843, DOI 10.1021/jo00337a004; REED LA, 1981, J CHEM SOC CHEM COMM, P760, DOI 10.1039/c39810000760; SATOW Y, 1986, J MOL BIOL, V190, P593, DOI 10.1016/0022-2836(86)90245-7; SHICHIDA Y, 1987, BIOCHEMISTRY-US, V26, P4422, DOI 10.1021/bi00388a035; SINHA SK, 1980, CARBOHYD RES, V81, P239, DOI 10.1016/S0008-6215(00)85655-4; STILL WC, 1978, J ORG CHEM, V43, P2923, DOI 10.1021/jo00408a041; STREET IP, 1986, BIOCHEMISTRY-US, V25, P6021, DOI 10.1021/bi00368a028; SUH S W, 1986, Proteins Structure Function and Genetics, V1, P74, DOI 10.1002/prot.340010112; TEMERIUSZ A, 1982, CARBOHYD RES, V108, P298, DOI 10.1016/S0008-6215(00)81801-7; TSUCHIYA T, 1978, TETRAHEDRON LETT, P3365; VANBOECKEL CAA, 1985, TETRAHEDRON, V41, P4557, DOI 10.1016/S0040-4020(01)82350-4; VANBOECKEL CAA, 1985, TETRAHEDRON, V41, P4545, DOI 10.1016/S0040-4020(01)82349-8; VIS E, 1954, HELV CHIM ACTA, V37, P378, DOI 10.1002/hlca.19540370147; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; WALSH C, 1983, ADV ENZYMOL RAMB, V55, P197; WEIGERT M, 1974, J EXP MED, V139, P137, DOI 10.1084/jem.139.1.137; WONG TC, 1984, J ORG CHEM, V49, P4358, DOI 10.1021/jo00197a006; ZIEGLER T, 1990, CARBOHYD RES, V204, P167, DOI 10.1016/0008-6215(90)84033-Q	58	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20699	20707						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700793				2022-12-27	WOS:A1990EJ52500098
J	REARDON, JE; MILLER, WH				REARDON, JE; MILLER, WH			HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE - SUBSTRATE AND INHIBITOR KINETICS WITH THYMIDINE 5'-TRIPHOSPHATE AND 3'-AZIDO-3'-DEOXYTHYMIDINE 5'-TRIPHOSPHATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											REARDON, JE (corresponding author), WELLCOME RES LABS,DIV EXPTL THERAPY,3030 CORNWALLIS RD,RES TRIANGLE PK,NC 27709, USA.							BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; BRYANT FR, 1983, BIOCHEMISTRY-US, V22, P3537, DOI 10.1021/bi00284a001; CHENG YC, 1987, J BIOL CHEM, V262, P2187; Cleland W W, 1979, Methods Enzymol, V63, P103; FURMAN PA, 1979, J VIROL, V32, P72, DOI 10.1128/JVI.32.1.72-77.1979; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; FYFE JA, 1982, MOL PHARMACOL, V21, P432; HANDLON AL, 1988, PHARMACEUT RES, V5, P297, DOI 10.1023/A:1015926720740; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; HUBER HE, 1989, J BIOL CHEM, V264, P4669; KEDAR PS, 1990, BIOCHEMISTRY-US, V29, P3603, DOI 10.1021/bi00467a003; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; LARDER B, 1987, EMBO J, V6, P3133, DOI 10.1002/j.1460-2075.1987.tb02623.x; MAJUMDAR C, 1988, J BIOL CHEM, V263, P15657; MANIATIS T, 1982, MOL CLONING LABORATO, P133; MATTHES E, 1987, BIOCHEM BIOPH RES CO, V148, P78, DOI 10.1016/0006-291X(87)91078-3; Maxam A M, 1980, Methods Enzymol, V65, P499; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; ONO K, 1986, BIOCHEM BIOPH RES CO, V140, P498, DOI 10.1016/0006-291X(86)90760-6; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; REY MA, 1984, BIOCHEM BIOPH RES CO, V121, P126, DOI 10.1016/0006-291X(84)90696-X; STARNES MC, 1988, VIRUS GENES, V2, P241; STCLAIR MH, 1987, ANTIMICROB AGENTS CH, V31, P1972, DOI 10.1128/AAC.31.12.1972; TISDALE M, 1988, J VIROL, V62, P3662, DOI 10.1128/JVI.62.10.3662-3667.1988; VRANG L, 1988, ANTIMICROB AGENTS CH, V32, P1733, DOI 10.1128/AAC.32.11.1733; WHITE EL, 1989, BIOCHEM BIOPH RES CO, V161, P393, DOI 10.1016/0006-291X(89)92611-9; YARCHOAN R, 1986, LANCET, V1, P575	27	136	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20302	20307						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700787				2022-12-27	WOS:A1990EJ52500042
J	CARROLL, MP; CLARKLEWIS, I; RAPP, UR; MAY, WS				CARROLL, MP; CLARKLEWIS, I; RAPP, UR; MAY, WS			INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR MEDIATE RAPID PHOSPHORYLATION AND ACTIVATION OF CYTOSOLIC-C-RAF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									JOHNS HOPKIN ONCOL CTR, 424 N BOND ST, BALTIMORE, MD 21231 USA; UNIV BRITISH COLUMBIA, BIOMED RES CTR, VANCOUVER V6T 1W5, BC, CANADA; NCI, VIRAL CARCINOGENESIS LAB, FREDERICK, MD 21701 USA	Johns Hopkins University; Johns Hopkins Medicine; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)					NATIONAL CANCER INSTITUTE [R01CA044649, R01CA047993] Funding Source: NIH RePORTER; NCI NIH HHS [CA 44649, CA 47993] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARRETT CB, 1990, MOL CELL BIOL, V10, P310, DOI 10.1128/MCB.10.1.310; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CHEN WS, 1987, NATURE, V328, P820, DOI 10.1038/328820a0; CLARKLEWIS I, 1988, J IMMUNOL, V141, P881; CLARKLEWIS I, 1986, SCIENCE, V231, P134, DOI 10.1126/science.3079915; CLEVELAND JL, 1989, MOL CELL BIOL, V9, P5685, DOI 10.1128/MCB.9.12.5685; CLEVELAND JL, 1986, J CELL BIOCHEM, V30, P195, DOI 10.1002/jcb.240300303; COOK WD, 1985, CELL, V41, P677, DOI 10.1016/S0092-8674(85)80048-9; DEXTER TM, 1980, J EXP MED, V152, P1036, DOI 10.1084/jem.152.4.1036; EK B, 1982, NATURE, V295, P419, DOI 10.1038/295419a0; ESCOBEDO JA, 1988, MOL CELL BIOL, V8, P5126, DOI 10.1128/MCB.8.12.5126; FIELDS AP, 1988, J BIOL CHEM, V263, P8253; FIELDS AP, 1989, J BIOL CHEM, V264, P21896; GOMEZCAMBRONERO J, 1989, P NATL ACAD SCI USA, V86, P3569, DOI 10.1073/pnas.86.10.3569; GRIFFIN JD, 1986, BLOOD, V67, P1448; HUNTER T, 1987, CELL, V49, P1, DOI 10.1016/0092-8674(87)90745-8; ISFORT R, 1988, J BIOL CHEM, V263, P19203; ISFORT RJ, 1988, P NATL ACAD SCI USA, V85, P7982, DOI 10.1073/pnas.85.21.7982; ITOH N, 1990, SCIENCE, V247, P324, DOI 10.1126/science.2404337; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; KIPREOS ET, 1987, P NATL ACAD SCI USA, V84, P1345, DOI 10.1073/pnas.84.5.1345; KOYASU S, 1987, EMBO J, V6, P3979, DOI 10.1002/j.1460-2075.1987.tb02740.x; KRAFT AS, 1986, P NATL ACAD SCI USA, V83, P1334, DOI 10.1073/pnas.83.5.1334; MAXWELL SA, 1985, VIROLOGY, V143, P321, DOI 10.1016/0042-6822(85)90119-9; MCCLAIN DA, 1990, J BIOL CHEM, V265, P1678; METCALF D, 1986, BLOOD, V67, P257; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; PRYWES R, 1985, J VIROL, V54, P114, DOI 10.1128/JVI.54.1.114-122.1985; RAPP UR, 1985, J VIROL, V55, P23, DOI 10.1128/JVI.55.1.23-33.1985; RAPP UR, 1988, HDB ONCOGENES, P213; RAPP UR, 1987, ONCOGENES CANCER, P55; SARIBAN E, 1987, BLOOD, V69, P1437; SCHULTZ AM, 1988, ONCOGENE, V2, P187; SCHULTZ AM, 1985, VIROLOGY, V146, P78, DOI 10.1016/0042-6822(85)90054-6; SHERR CJ, 1990, BLOOD, V75, P1; SIEFF CA, 1987, J CLIN INVEST, V79, P1549, DOI 10.1172/JCI112988; SORENSEN P, 1989, J BIOL CHEM, V264, P19253; TAYLOR GR, 1989, EMBO J, V8, P2029, DOI 10.1002/j.1460-2075.1989.tb03611.x; USHIRO H, 1980, J BIOL CHEM, V255, P8363; WALKER F, 1985, CELL, V43, P269, DOI 10.1016/0092-8674(85)90032-7; WATSON JD, 1987, J IMMUNOL, V139, P123; WEINBERG RA, 1985, SCIENCE, V230, P770, DOI 10.1126/science.2997917; WHEELER EF, 1987, MOL CELL BIOL, V7, P1673, DOI 10.1128/MCB.7.5.1673; WHETTON AD, 1988, P NATL ACAD SCI USA, V85, P3284, DOI 10.1073/pnas.85.10.3284	46	181	184	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19812	19817						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1700980				2022-12-27	WOS:A1990EJ18800069
J	KURABAYASHI, M; KOMURO, I; SHIBASAKI, Y; TSUCHIMOCHI, H; TAKAKU, F; YAZAKI, Y				KURABAYASHI, M; KOMURO, I; SHIBASAKI, Y; TSUCHIMOCHI, H; TAKAKU, F; YAZAKI, Y			FUNCTIONAL IDENTIFICATION OF THE TRANSCRIPTIONAL REGULATORY ELEMENTS WITHIN THE PROMOTER REGION OF THE HUMAN VENTRICULAR MYOSIN ALKALI LIGHT CHAIN GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV SO CALIF,SCH MED,DEPT BIOCHEM,LOS ANGELES,CA 90033; UNIV TOKYO,FAC MED,DEPT INTERNAL MED 3,BUNKYO KU,TOKYO 113,JAPAN	University of Southern California; University of Tokyo								ARNOLD HH, 1988, NUCLEIC ACIDS RES, V16, P2411, DOI 10.1093/nar/16.6.2411; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BALDWIN TJ, 1988, J CELL BIOL, V107, P2271, DOI 10.1083/jcb.107.6.2271; BALDWIN TJ, 1989, NATURE, V341, P716, DOI 10.1038/341716a0; BERGSMA DJ, 1986, MOL CELL BIOL, V6, P2462, DOI 10.1128/MCB.6.7.2462; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BILLETER R, 1988, MOL CELL BIOL, V8, P1361, DOI 10.1128/MCB.8.3.1361; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BOUVAGNET PF, 1987, MOL CELL BIOL, V7, P4377, DOI 10.1128/MCB.7.12.4377; BOXER LM, 1989, MOL CELL BIOL, V9, P515, DOI 10.1128/MCB.9.2.515; BUCKINGHAM ME, 1983, EUKARYOTIC GENES THE, P365; CHOW KL, 1990, MOL CELL BIOL, V10, P528, DOI 10.1128/MCB.10.2.528; COHEN A, 1988, NUCLEIC ACIDS RES, V16, P10037, DOI 10.1093/nar/16.21.10037; CRIBBS LL, 1989, J BIOL CHEM, V264, P10672; DAVIDSON I, 1986, NATURE, V323, P544, DOI 10.1038/323544a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONOGHUE M, 1988, GENE DEV, V2, P1779, DOI 10.1101/gad.2.12b.1779; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; FODOR WL, 1989, J BIOL CHEM, V264, P2143; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GUSTAFSON TA, 1988, MOL CELL BIOL, V8, P4110, DOI 10.1128/MCB.8.10.4110; HAMADA H, 1984, MOL CELL BIOL, V4, P2610, DOI 10.1128/MCB.4.12.2610; HORLICK RA, 1989, MOL CELL BIOL, V9, P2396, DOI 10.1128/MCB.9.6.2396; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; KLARSFELD A, 1987, MOL CELL BIOL, V7, P951, DOI 10.1128/MCB.7.2.951; KONIECZNY SF, 1987, MOL CELL BIOL, V7, P3065, DOI 10.1128/MCB.7.9.3065; KURABAYASHI M, 1988, J BIOL CHEM, V263, P13930; LAIMINS LA, 1982, P NATL ACAD SCI-BIOL, V79, P6453, DOI 10.1073/pnas.79.21.6453; Maniatis T., 1982, MOL CLONING; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MAR JH, 1988, J CELL BIOL, V107, P573, DOI 10.1083/jcb.107.2.573; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; Miller J. H, 1972, EXPT MOL GENETICS; MINTY A, 1986, MOL CELL BIOL, V6, P2137, DOI 10.1128/MCB.6.6.2137; MINTY A, 1986, MOL CELL BIOL, V6, P2125, DOI 10.1128/MCB.6.6.2125; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MIWA T, 1987, MOL CELL BIOL, V7, P2803, DOI 10.1128/MCB.7.8.2803; MUSCAT GEO, 1987, MOL CELL BIOL, V7, P4089, DOI 10.1128/MCB.7.11.4089; ONEILL MC, 1974, DEV BIOL, V37, P117, DOI 10.1016/0012-1606(74)90173-0; PIETTE J, 1989, EMBO J, V6, P3611; ROBBINS PD, 1986, MOL CELL BIOL, V6, P1283, DOI 10.1128/MCB.6.4.1283; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMPSON P, 1982, CIRC RES, V51, P787, DOI 10.1161/01.RES.51.6.787; STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896; STRAUSS F, 1984, CELL, V37, P889, DOI 10.1016/0092-8674(84)90424-0; TRASK RV, 1988, J BIOL CHEM, V263, P17142; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; WANG Y, 1988, NEURON, V1, P527, DOI 10.1016/0896-6273(88)90183-3; WEIHER H, 1983, SCIENCE, V219, P626, DOI 10.1126/science.6297005; YU YT, 1989, MOL CELL BIOL, V9, P1839, DOI 10.1128/MCB.9.5.1839; YUTZEY KE, 1989, MOL CELL BIOL, V9, P1397, DOI 10.1128/MCB.9.4.1397	54	21	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19271	19278						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699944				2022-12-27	WOS:A1990EF73900090
J	WHITFIELD, CD; JEFFERSON, LM				WHITFIELD, CD; JEFFERSON, LM			ELEVATED MITOCHONDRIAL RNA IN A CHINESE-HAMSTER MUTANT DEFICIENT IN THE MITOCHONDRIALLY ENCODED SUBUNITS OF NADH DEHYDROGENASE AND CYTOCHROME-C-OXIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									HOWARD UNIV, CTR CANC, WASHINGTON, DC 20059 USA	Howard University	WHITFIELD, CD (corresponding author), HOWARD UNIV, COLL MED, DEPT BIOCHEM, WASHINGTON, DC 20059 USA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; ATTARDI G, 1983, METHOD ENZYMOL, V97, P435; BHAT KS, 1984, BIOCHEMISTRY-US, V23, P1695, DOI 10.1021/bi00303a018; BHAT KS, 1985, BIOCHEMISTRY-US, V24, P5818, DOI 10.1021/bi00342a020; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BREEN GAM, 1986, J BIOL CHEM, V261, P1680; CARR SM, 1987, EVOLUTION, V41, P176, DOI 10.1111/j.1558-5646.1987.tb05780.x; CHOMYN A, 1986, SCIENCE, V234, P614, DOI 10.1126/science.3764430; CHOMYN A, 1985, NATURE, V314, P592, DOI 10.1038/314592a0; CHU EHY, 1974, GENETICS, V78, P115; CHU EHY, 1972, P NATL ACAD SCI USA, V69, P3459, DOI 10.1073/pnas.69.11.3459; DARLEYUSMAR VM, 1981, COMP BIOCHEM PHYS B, V68, P445, DOI 10.1016/0305-0491(81)90154-1; DITTA G, 1977, NATURE, V268, P64, DOI 10.1038/268064a0; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; DOHERTY PJ, 1985, MOL CELL BIOL, V5, P466, DOI 10.1128/MCB.5.3.466; FOX TD, 1986, TRENDS GENET, V2, P97, DOI 10.1016/0168-9525(86)90192-7; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GRAHAM DE, 1984, J VIROL, V49, P819, DOI 10.1128/JVI.49.3.819-827.1984; HARE JF, 1982, J BIOL CHEM, V257, P3575; HUTTON JJ, 1985, ANN NY ACAD SCI, V451, P227, DOI 10.1111/j.1749-6632.1985.tb27113.x; KOERNER TJ, 1987, J BIOL CHEM, V262, P3690; KUZELA S, 1988, BIOCHIM BIOPHYS ACTA, V936, P372, DOI 10.1016/0005-2728(88)90013-8; LIPSKY NG, 1981, J BIOL CHEM, V256, P8652; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALCZEWSKI RM, 1984, J BIOL CHEM, V259, P1103; MALCZEWSKI RM, 1982, J BIOL CHEM, V257, P8137; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MICHAELIS G, 1982, MITOCHONDRIAL GENES, P311; MILLER DL, 1983, BIOCHEMISTRY-US, V22, P1709, DOI 10.1021/bi00276a029; MYERS AM, 1987, J BIOL CHEM, V262, P3388; NASS MMK, 1983, GENE, V21, P249, DOI 10.1016/0378-1119(83)90008-2; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; RUSSELL SM, 1980, BIOCHEM J, V192, P321, DOI 10.1042/bj1920321; SCHULZE M, 1989, MOL GEN GENET, V216, P37, DOI 10.1007/BF00332228; SODERBERG K, 1979, SOMAT CELL GENET, V5, P225, DOI 10.1007/BF01539163; SUN NC, 1975, P NATL ACAD SCI USA, V72, P469, DOI 10.1073/pnas.72.2.469; VANETTEN RA, 1982, MITOCHONDRIAL GENES, P73; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; Wallace DC, 1982, TECHNIQUES SOMATIC C, P159; WHITFIELD C, 1986, MOL CELL BIOL, V6, P1422, DOI 10.1128/MCB.6.5.1422; ZHENG X, 1989, NEUROLOGY, V39, P1203, DOI 10.1212/WNL.39.9.1203	43	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					18852	18859						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699938				2022-12-27	WOS:A1990EF73900028
J	HUBER, A; SMITH, DP; ZUKER, CS; PAULSEN, R				HUBER, A; SMITH, DP; ZUKER, CS; PAULSEN, R			OPSIN OF CALLIPHORA PERIPHERAL PHOTORECEPTORS R1-6 - HOMOLOGY WITH DROSOPHILA RH1 AND POSTTRANSLATIONAL PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV REGENSBURG, INST ZOOL, W-8400 REGENSBURG, GERMANY; HOWARD HUGHES MED INST, LA JOLLA, CA USA; UNIV CALIF SAN DIEGO, LA JOLLA, CA 92093 USA	University of Regensburg; Howard Hughes Medical Institute; University of California System; University of California San Diego			Huber, Armin/GYU-6322-2022	Huber, Armin/0000-0003-3977-089X				BENTROP J, 1986, EUR J BIOCHEM, V161, P61, DOI 10.1111/j.1432-1033.1986.tb10124.x; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BLUMENFELD A, 1985, P NATL ACAD SCI USA, V82, P7116, DOI 10.1073/pnas.82.20.7116; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; CHU FK, 1986, J BIOL CHEM, V261, P172; COWMAN AF, 1986, CELL, V44, P705, DOI 10.1016/0092-8674(86)90836-6; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; DEVARY O, 1987, P NATL ACAD SCI USA, V84, P6939, DOI 10.1073/pnas.84.19.6939; FEILER R, 1988, NATURE, V333, P737, DOI 10.1038/333737a0; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; FLIESLER SJ, 1985, P NATL ACAD SCI USA, V82, P1116, DOI 10.1073/pnas.82.4.1116; FLIESLER SJ, 1985, J CELL BIOL, V100, P574, DOI 10.1083/jcb.100.2.574; FUKUDA MN, 1979, J BIOL CHEM, V254, P8201; Hardie R.C., 1985, Progress in Sensory Physiology, V5, P1; HARGRAVE PA, 1982, PROGR RETINAL RES, P1; HIRANI S, 1987, ANAL BIOCHEM, V162, P485, DOI 10.1016/0003-2697(87)90424-6; ITO M, 1988, CHEM PHARM BULL, V36, P78; JOHNSON EC, 1986, J GEN PHYSIOL, V88, P651, DOI 10.1085/jgp.88.5.651; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANIATIS T, 1982, MOL CLONING LABORATO, P187; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PAK WL, 1988, PHOTOCHEM PHOTOBIOL, V47, P877, DOI 10.1111/j.1751-1097.1988.tb01670.x; Paulsen R., 1986, Progress in Zoology, V33, P299; PAULSEN R, 1979, BIOCHIM BIOPHYS ACTA, V557, P385, DOI 10.1016/0005-2736(79)90336-5; PAULSEN R, 1984, J COMP PHYSIOL, V155, P47, DOI 10.1007/BF00610930; PAULSEN R, 1984, J COMP PHYSIOL, V155, P39, DOI 10.1007/BF00610929; PAYNE R, 1986, PHOTOBIOCH PHOTOBIOP, V13, P373; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SCHWEMER J, 1984, J COMP PHYSIOL, V154, P535, DOI 10.1007/BF00610167; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; STAVENGA DG, 1984, PHOTORECEPTION VISIO, P12; TANIMURA T, 1986, PHOTOCHEM PHOTOBIOL, V43, P225, DOI 10.1111/j.1751-1097.1986.tb09519.x; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; VOGT K, 1983, Z NATURFORSCH C, V38, P329; WILDEN U, 1986, P NATL ACAD SCI USA, V83, P1174, DOI 10.1073/pnas.83.5.1174; ZEIGER J, 1989, VISION RES, V29, P519, DOI 10.1016/0042-6989(89)90038-2; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	47	70	71	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17906	17910						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698782				2022-12-27	WOS:A1990EC76600083
J	ORLANDO, RA; CHERESH, DA				ORLANDO, RA; CHERESH, DA			ARGININE-GLYCINE-ASPARTIC ACID BINDING LEADING TO MOLECULAR STABILIZATION BETWEEN INTEGRIN ALPHA-V-BETA-3 AND ITS LIGAND	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARG-GLY-ASP; HUMAN-ENDOTHELIAL CELLS; SYNTHETIC PEPTIDES; VITRONECTIN RECEPTOR; EXTRACELLULAR-MATRIX; VONWILLEBRAND-FACTOR; HAMSTER FIBROBLASTS; ADHESION RECEPTORS; MELANOMA-CELLS; BETA-SUBUNIT	Cell adhesion is characterized by an integrin-mediated ligand binding event followed by reorganization of the actin-cytoskeleton leading to cell spreading and/or migration. In this report we examine the role of integrin alpha-v-beta-3 in mediating cell attachment to vitronectin or a RGD-containing peptide in the presence of cytochalasin B to prevent actin polymerization. Under these conditions cell attachment to a RGD-containing peptide can be dissociated by excess soluble ligand whereas cells attached to vitronectin cannot. These results suggest that alpha-v-beta-3-mediated cell attachment to vitronectin results in a highly stabilized interaction that is independent of the actin-cytoskeleton. To investigate the molecular nature of this interaction alpha-v-beta-3 was purified to homogeneity, and its binding properties toward various ligands were measured in a solid-phase receptor assay. The data indicate that alpha-v-beta-3 binds to vitronectin or fibronectin in a nondissociable manner whereas a RGD-containing peptide derived from vitronectin binds specifically but is completely dissociable with a K(d) of 9.4 x 10(-7) M. Moreover, chemical modification of alpha-v-beta-3 with limited glutaraldehyde treatment allowed vitronectin to bind in a RGD-dependent and dissociable manner, suggesting that receptor conformational changes or specific amino acid residues proximal to the ligand binding site(s) are involved in the stabilization event. Thus, in the absence of cytoskeletal proteins or other cellular components, integrin alpha-v-beta-3-ligand binding involves recognition of the RGD sequence leading to a highly stabilized protein-protein association.	SCRIPPS CLIN & RES FDN, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	Scripps Research Institute					NCI NIH HHS [CA50286, CA45726] Funding Source: Medline; NIAID NIH HHS [T32 AI 07244-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA050286, R01CA045726, R01CA050286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; BARSHAVIT R, 1991, J CELL BIOL, V112, P335, DOI 10.1083/jcb.112.2.335; BOUCAUT JC, 1984, J CELL BIOL, V99, P1822, DOI 10.1083/jcb.99.5.1822; BURRIDGE K, 1987, J CELL SCI, P211; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CARTER WG, 1981, J CELL BIOL, V88, P138, DOI 10.1083/jcb.88.1.138; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHEN JM, 1987, CELL, V48, P193, DOI 10.1016/0092-8674(87)90423-5; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; DAVIDPFEUTY T, 1985, EUR J CELL BIOL, V36, P195; DEJANA E, 1988, J CELL BIOL, V107, P1215, DOI 10.1083/jcb.107.3.1215; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; GEHLSEN KR, 1988, J CELL BIOL, V106, P925, DOI 10.1083/jcb.106.3.925; GRINNELL F, 1974, ARCH BIOCHEM BIOPHYS, V165, P524, DOI 10.1016/0003-9861(74)90278-1; HUGHES RC, 1979, EXP CELL RES, V121, P307, DOI 10.1016/0014-4827(79)90009-0; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MARGUERIE GA, 1980, J BIOL CHEM, V255, P154; MCCARTHY JB, 1984, J CELL BIOL, V98, P1474, DOI 10.1083/jcb.98.4.1474; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PEERSCHKE EIB, 1985, AM J PHYSIOL, V248, pC466, DOI 10.1152/ajpcell.1985.248.5.C466; PHILLIPS DR, 1988, BLOOD, V71, P831; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; RAUB TJ, 1989, EXP CELL RES, V184, P407, DOI 10.1016/0014-4827(89)90340-6; RUOSLAHTI E, 1989, CANCER CELL-MON REV, V1, P119; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SINGER II, 1982, J CELL BIOL, V92, P398, DOI 10.1083/jcb.92.2.398; SINGER II, 1988, J CELL BIOL, V106, P2171, DOI 10.1083/jcb.106.6.2171; SMITH JW, 1990, J BIOL CHEM, V265, P2168; SMITH JW, 1990, J BIOL CHEM, V265, P11008; SMITH JW, 1988, J BIOL CHEM, V263, P18726; TUSZYNSKI GP, 1984, J BIOL CHEM, V259, P5247; VIRTANEN I, 1982, NATURE, V298, P660, DOI 10.1038/298660a0; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WEILAND GA, 1981, LIFE SCI, V29, P313, DOI 10.1016/0024-3205(81)90324-6; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WILEY HS, 1982, J BIOL CHEM, V257, P4222; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	41	100	105	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19543	19550						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717468				2022-12-27	WOS:A1991GK66700063
J	JI, IH; JI, TH				JI, IH; JI, TH			ASP383 IN THE 2ND TRANSMEMBRANE DOMAIN OF THE LUTROPIN RECEPTOR IS IMPORTANT FOR HIGH-AFFINITY HORMONE BINDING AND CAMP PRODUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; SITE-DIRECTED MUTAGENESIS; MOLECULAR CHARACTERIZATION; FUNCTIONAL CDNA; CLONING; EXPRESSION; GENE; AGONIST; SODIUM; CHORIOGONADOTROPIN	The lutropin (LH), follitropin, and thyrotropin receptors belong to the superfamily of G-protein coupled receptors and have some unique structural features. These glycoprotein hormone receptors comprise a C-terminal half and an N-terminal half of similar size. The C-terminal half is equivalent to the entire structure of other G-protein coupled receptors and has seven transmembrane domains, three cytoplasmic loops, three exoplasmic loops, and a C terminus. In contrast, the hydrophilic N-terminal half is exoplasmic and unique to the glycoprotein hormone receptors. This large N-terminal half of the LH receptor has recently been shown to be capable of binding the hormone. Therefore, these glycoprotein hormone receptors are structurally and functionally different from other G-protein coupled receptors. In an attempt to define the role of the membrane-associated C-terminal half of the LH receptor, we have prepared several mutant receptors in which an Asp or Glu in the seven transmembrane domains has been converted to Asn or Gln, respectively. These include Asp383 --> Asn in the second transmembrane domain, Glu410 --> Gln in the third transmembrane domain, and Asp556 --> Asn in the sixth transmembrane domain. All these mutant receptors were successfully expressed in Cos 7A cells. The Glu410 --> Gln and Asp556 --> Asn mutants maintained normal affinities for hormone binding and cAMP production, but the Asp383 --> Asn mutant showed significantly lower affinities. Although Asp383 of the LH receptor is conserved in all G-protein coupled receptors cloned to date except the substance P receptor, which has Glu in the place of the Asp residue, this is the first observation of the critical role of the Asp in hormone binding and subsequent stimulation of cAMP production.			JI, IH (corresponding author), UNIV WYOMING,DEPT MOLEC BIOL,LARAMIE,WY 82071, USA.				NICHD NIH HHS [HD-18702] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018702] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; BLUME AJ, 1979, P NATL ACAD SCI USA, V76, P5626, DOI 10.1073/pnas.76.11.5626; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CHAZENBALK GD, 1990, J BIOL CHEM, V265, P20970; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; FRASER CM, 1988, P NATL ACAD SCI USA, V85, P5478, DOI 10.1073/pnas.85.15.5478; FRAZIER AL, 1990, MOL ENDOCRINOL, V4, P1264, DOI 10.1210/mend-4-8-1264; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; JACOBS KH, 1981, ADV CYCLIC NUCLEOTID, V14, P173; JI I, 1991, J BIOL CHEM, V266, P13076; JI I, 1990, P NATL ACAD SCI USA, V87, P4396, DOI 10.1073/pnas.87.11.4396; JI I, 1981, P NATL ACAD SCI-BIOL, V78, P5465, DOI 10.1073/pnas.78.9.5465; JI I, 1990, GLYCOPROTEIN HORMONE, P355; JI IH, 1985, J BIOL CHEM, V260, P2815; JI IH, 1991, ENDOCRINOLOGY, V128, P2648, DOI 10.1210/endo-128-5-2648; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KLEIN PS, 1988, SCIENCE, V241, P1467, DOI 10.1126/science.3047871; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KORANA HG, 1988, J BIOL CHEM, V263, P7439; KOSTERLITZ HW, 1988, J RECEPTOR RES, V8, P363, DOI 10.3109/10799898809048998; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; MACFARLAND KC, 1989, SCIENCE, V245, P494; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MINEGISH T, 1990, BIOCHEM BIOPH RES CO, V172, P1049, DOI 10.1016/0006-291X(90)91552-4; MINUTH M, 1986, N-S ARCH PHARMACOL, V333, P124, DOI 10.1007/BF00506514; MISRAHI M, 1990, BIOCHEM BIOPH RES CO, V166, P394, DOI 10.1016/0006-291X(90)91958-U; Nagao M, 1989, Nihon Naibunpi Gakkai Zasshi, V65, P1357; NAKAYAMA N, 1985, EMBO J, V4, P2643, DOI 10.1002/j.1460-2075.1985.tb03982.x; NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OKADA Y, 1989, PLACENTAL PROTEIN HO, P269; PAPPIN DJC, 1984, BIOCHEM J, V217, P605, DOI 10.1042/bj2170605; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; PERT CB, 1974, MOL PHARMACOL, V10, P868; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; SHELDEN RF, 1987, CURRENT PROTOCOLS MO; SHIGEMOTO R, 1990, J BIOL CHEM, V265, P623; SHIN J, 1986, J BIOL CHEM, V261, P7501; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; STRADER CD, 1988, J BIOL CHEM, V263, P10267; STRADER CD, 1989, FASEB J, V3, P1825, DOI 10.1096/fasebj.3.7.2541037; STRADER CD, 1989, J BIOL CHEM, V264, P16470; TSAIMORRIS CH, 1990, J BIOL CHEM, V265, P19385; XIE YB, 1990, J BIOL CHEM, V265, P21411; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	49	69	70	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					14953	14957						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714448				2022-12-27	WOS:A1991GB09700026
J	REEVE, JR; EYSSELEIN, VE; EBERLEIN, GA; CHEW, P; HO, FJ; HUEBNER, VD; SHIVELY, JE; LEE, TD; LIDDLE, RA				REEVE, JR; EYSSELEIN, VE; EBERLEIN, GA; CHEW, P; HO, FJ; HUEBNER, VD; SHIVELY, JE; LEE, TD; LIDDLE, RA			CHARACTERIZATION OF CANINE INTESTINAL CHOLECYSTOKININ-58 LACKING ITS CARBOXYL-TERMINAL NONAPEPTIDE - EVIDENCE FOR SIMILAR POSTTRANSLATIONAL PROCESSING IN BRAIN AND GUT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; MICROSEQUENCE ANALYSIS; BOVINE CHOLECYSTOKININ-58; HORMONAL POLYPEPTIDES; FLANKING PEPTIDE; N-TERMINUS; PIG BRAIN; PREPROCHOLECYSTOKININ; PURIFICATION; OCTAPEPTIDES	An antibody raised against a synthetic cholecystokinin (CCK) analog, (1-27)-(CCK)-33, corresponding to the midregion of CCK-58, detected immunoreactivity in intestinal extracts which eluted between the positions of CCK-33/39 and CCK-58 on high performance liquid chromatography. This peak, lacking carboxyl-terminal cholecystokinin immunoreactivity, was purified by reverse phase and cation-exchange chromatographies. Amino acid, mass spectral, and microsequence analysis established that it was the amino-terminal desnonapeptide fragment of cholecystokinin-58, (1-49)-CCK-58. It was demonstrated further that CCK-58 has less biological activity than CCK-8, suggesting that the amino terminus either sterically hindered the ability of CCK-58 to exert its biological activity or that its amino terminus acted at another site to inhibit release of amylase from rat pancreatic acini. The desnonapeptide of CCK-58 by itself had no biological activity, nor did it affect CCK-8-stimulated amylase release from isolated rat pancreatic acini, suggesting that the amino terminus shields the carboxyl terminus from expressing its biological activity. Its presence in intestine suggests that it is released into the circulation where it could be detected by midregion antibodies. The presence of high proportions of (1-49)-CCK-58 indicates that most CCK-8 is directly derived from CCK-58. Its occurrence in brain and intestine indicates similar processing for procholecystokinin in both tissues.	UNIV CALIF LOS ANGELES, DEPT MED, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, LOS ANGELES CTY HARBOR MED CTR, CTR INFLAMMATORY BOWEL DIS, TORRANCE, CA 90509 USA; CALIF BIOTECHNOL INC, MT VIEW, CA 94043 USA; CITY HOPE NATL MED CTR, BECKMAN RES INT, DIV IMMUNOL, DUARTE, CA 91010 USA; MT ZION HOSP & MED CTR, DEPT MED, SAN FRANCISCO, CA 94120 USA; MT ZION HOSP & MED CTR, CELL BIOL LAB, SAN FRANCISCO, CA 94120 USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; City of Hope; Beckman Research Institute of City of Hope; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; University of California System; University of California San Francisco; University of California System; University of California San Francisco	REEVE, JR (corresponding author), VET ADM HOSP WADSWORTH, CTR ULCER RES & EDUC, BLDG 115, RM 115, LOS ANGELES, CA 90073 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK038626, R01DK033850, R01DK038626, R01DK033155] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 33155, DK 33850, DK 38626] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADRIAN TE, 1986, FEBS LETT, V196, P5, DOI 10.1016/0014-5793(86)80203-4; BENOIT R, 1987, SCIENCE, V238, P1126, DOI 10.1126/science.2891188; BRADBURY AF, 1982, NATURE, V298, P686, DOI 10.1038/298686a0; CANTOR P, 1989, AM J PHYSIOL, V256, pG53, DOI 10.1152/ajpgi.1989.256.1.G53; DEBAS HT, 1973, DIGESTION, V9, P469, DOI 10.1159/000197476; DESCHENES RJ, 1984, P NATL ACAD SCI-BIOL, V81, P726, DOI 10.1073/pnas.81.3.726; DOCKRAY GJ, 1978, NATURE, V274, P711, DOI 10.1038/274711a0; EBERLEIN GA, 1988, PEPTIDES, V9, P993, DOI 10.1016/0196-9781(88)90079-4; ENG J, 1984, PEPTIDES, V5, P1203, DOI 10.1016/0196-9781(84)90188-8; ENG J, 1983, P NATL ACAD SCI-BIOL, V80, P6381, DOI 10.1073/pnas.80.20.6381; ENG J, 1990, REGUL PEPTIDES, V30, P15, DOI 10.1016/0167-0115(90)90131-F; EYSSELEIN VE, 1988, REGUL PEPTIDES, V22, P205, DOI 10.1016/0167-0115(88)90033-X; EYSSELEIN VE, 1984, REGUL PEPTIDES, V9, P173, DOI 10.1016/0167-0115(84)90070-3; EYSSELEIN VE, 1990, AM J PHYSIOL, V258, pG253, DOI 10.1152/ajpgi.1990.258.2.G253; EYSSELEIN VE, 1982, PEPTIDES, V3, P687, DOI 10.1016/0196-9781(82)90171-1; EYSSELEIN VE, 1983, AM J PHYSIOL, V245, pG313, DOI 10.1152/ajpgi.1983.245.2.G313; EYSSELEIN VE, 1990, AM J PHYSIOL, V258, pG951, DOI 10.1152/ajpgi.1990.258.6.G951; EYSSELEIN VE, 1984, P NATL ACAD SCI-BIOL, V81, P6565, DOI 10.1073/pnas.81.21.6565; EYSSELEIN VE, 1987, J BIOL CHEM, V262, P214; FAN ZW, 1987, BRAIN RES BULL, V18, P757, DOI 10.1016/0361-9230(87)90211-5; FRIEDMAN JM, 1989, GENOMICS, V5, P463, DOI 10.1016/0888-7543(89)90010-4; GARDNER JD, 1986, EXOCRINE PANCREAS BI, P109; GUBLER U, 1984, P NATL ACAD SCI-BIOL, V81, P4307, DOI 10.1073/pnas.81.14.4307; HAWKE D, 1982, ANAL BIOCHEM, V120, P302, DOI 10.1016/0003-2697(82)90351-7; JUNG DH, 1980, CLIN CHIM ACTA, V100, P7, DOI 10.1016/0009-8981(80)90179-5; LIDDLE RA, 1986, PEPTIDES, V7, P723, DOI 10.1016/0196-9781(86)90085-9; LIDDLE RA, 1984, GASTROENTEROLOGY, V87, P542; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MILLER LJ, 1984, J NEUROCHEM, V43, P835, DOI 10.1111/j.1471-4159.1984.tb12806.x; MUTT V, 1968, EUR J BIOCHEM, V6, P156, DOI 10.1111/j.1432-1033.1968.tb00433.x; MUTT V, 1976, CLIN ENDOCRINOL, V5, pS175, DOI 10.1111/j.1365-2265.1976.tb03825.x; MUTT V, 1974, EUR J BIOCHEM, V42, P581, DOI 10.1111/j.1432-1033.1974.tb03373.x; MUTT V, 1971, BIOCHEM J, V125, pP57, DOI 10.1042/bj1250057P; NIEHRS C, 1990, J BIOL CHEM, V265, P8525; REEVE JR, 1984, PEPTIDES, V5, P959, DOI 10.1016/0196-9781(84)90123-2; REEVE JR, 1986, J BIOL CHEM, V261, P6392; REHFELD JF, 1986, J BIOL CHEM, V261, P5832; ROSENQUIST GL, 1980, GASTROINTESTINAL HOR, P769; SHIVELY J, 1987, AM J PHYSIOL, V252, pG272, DOI 10.1152/ajpgi.1987.252.2.G272; SHIVELY JE, 1987, ANAL BIOCHEM, V163, P517, DOI 10.1016/0003-2697(87)90257-0; SOLOMON TE, 1984, AM J PHYSIOL, V247, pG105, DOI 10.1152/ajpgi.1984.247.1.G105; TAKAHASHI Y, 1985, P NATL ACAD SCI USA, V82, P1931, DOI 10.1073/pnas.82.7.1931; TATEMOTO K, 1984, FEBS LETT, V174, P289, DOI 10.1016/0014-5793(84)81175-8; TURKELSON CM, 1988, PEPTIDES, V9, P1255, DOI 10.1016/0196-9781(88)90189-1; TURKELSON CM, 1990, GASTROENTEROLOGY, V99, P646, DOI 10.1016/0016-5085(90)90950-6; VARRO A, 1986, FEBS LETT, V204, P386, DOI 10.1016/0014-5793(86)80849-3; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; ZHOU ZZ, 1985, PEPTIDES, V6, P337, DOI 10.1016/0196-9781(85)90059-2	48	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					13770	13776						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713209				2022-12-27	WOS:A1991FY02700051
J	MIZUTA, TR; SUZUKI, N; SHIMIZU, A; HONJO, T				MIZUTA, TR; SUZUKI, N; SHIMIZU, A; HONJO, T			DUPLICATED VARIABLE REGION GENES ACCOUNT FOR DOUBLE ISOTYPE EXPRESSION IN A HUMAN LEUKEMIC B-CELL LINE THAT GIVES RISE TO SINGLE ISOTYPE-EXPRESSING CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN GENES; CLASS-SWITCH RECOMBINATION; CIRCULAR DNA; EPSILON-GENES; GAMMA-GENES; C-EPSILON; IMMUNOGLOBULIN; DELETION; REARRANGEMENT; MOUSE	The SSK41 cell is an immunoglobulin IgM+ human neoplastic B-cell line that switches to IgG+ cells (SSK-gamma) spontaneously. We isolated a derivative of SSK41 (SSKWB) that expressed both IgM and IgG. Studies on the Ig heavy chain gene organization have shown that the SSKWB cell had two identical VDJ genes on the same chromosome; one linked to the C-mu-gene and the other to the C-gamma-1 gene, both of which are transcribed to produce mu- and gamma-mRNAs with the same VDJ sequence. We also isolated the two switch variants derived from the SSKWB cell by cell sorter: 1G (IgG+) and 11M (IgM+). The 1G cells contained two populations; one had a similar genetic organization as SSK-gamma and expressed only IgG1, and the other carried the same genetic organization as the SSKWB cell but produced aberrantly spliced mu-chain mRNA, in which the hydrophobic signal sequence exon is directly joined to the C-mu/exon . Te 11M cell deleted the VDJ-C-gamma-1, segment of the SSKWB cell and expressed IgM. These results raise the interesting possibility of another mechanism for class switching.	KYOTO UNIV,CTR MOLEC BIOL & GENET SAKYO KU,KYOTO 606,JAPAN	Kyoto University	MIZUTA, TR (corresponding author), KYOTO UNIV,FAC MED,DEPT MED CHEM,SAKYO KU,KYOTO 606,JAPAN.		Honjo, Tasuku/N-4470-2016					ALEXANDER EL, 1977, J IMMUNOL, V119, P1084; ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x; BLACKBURN EH, 1984, ANNU REV BIOCHEM, V53, P163, DOI 10.1146/annurev.bi.53.070184.001115; CHEN YW, 1986, J EXP MED, V164, P562, DOI 10.1084/jem.164.2.562; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CORY S, 1980, NATURE, V285, P450, DOI 10.1038/285450a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GERSTEIN RM, 1990, CELL, V63, P537, DOI 10.1016/0092-8674(90)90450-S; GIBSON TJ, 1987, GENE, V53, P275, DOI 10.1016/0378-1119(87)90016-3; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; HISAJIMA H, 1983, P NATL ACAD SCI-BIOL, V80, P2995, DOI 10.1073/pnas.80.10.2995; HOLLIDAY R, 1989, TRENDS GENET, V5, P355, DOI 10.1016/0168-9525(89)90150-9; HONJO T, 1983, ANNU REV IMMUNOL, V1, P499, DOI 10.1146/annurev.iy.01.040183.002435; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919; KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8; KEYEUX G, 1989, GENOMICS, V5, P431, DOI 10.1016/0888-7543(89)90006-2; LUTZKER S, 1988, MOL CELL BIOL, V8, P1849, DOI 10.1128/MCB.8.4.1849; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; MAX EE, 1982, CELL, V29, P691, DOI 10.1016/0092-8674(82)90185-4; NIKAIDO T, 1982, J BIOL CHEM, V257, P7322; NISHIDA Y, 1982, P NATL ACAD SCI-BIOL, V79, P3833, DOI 10.1073/pnas.79.12.3833; Noma Y, 1984, Mol Biol Med, V2, P337; OBATA M, 1981, P NATL ACAD SCI-BIOL, V78, P2437, DOI 10.1073/pnas.78.4.2437; PERLMUTTER AP, 1984, P NATL ACAD SCI-BIOL, V81, P7189, DOI 10.1073/pnas.81.22.7189; PERNIS B, 1976, COLD SPRING HARB SYM, V41, P175; RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0; RADBRUCH A, 1983, EMBO J, V2, P1929, DOI 10.1002/j.1460-2075.1983.tb01681.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SHIMIZU A, 1989, P NATL ACAD SCI USA, V86, P8020, DOI 10.1073/pnas.86.20.8020; SHIMIZU A, 1984, CELL, V36, P801, DOI 10.1016/0092-8674(84)90029-1; Sideras P, 1989, Int Immunol, V1, P631, DOI 10.1093/intimm/1.6.631; SMITH GR, 1983, CELL, V34, P709, DOI 10.1016/0092-8674(83)90525-1; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; TAKAHASHI N, 1982, CELL, V29, P671, DOI 10.1016/0092-8674(82)90183-0; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; UEDA S, 1982, EMBO J, V1, P1539, DOI 10.1002/j.1460-2075.1982.tb01352.x; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; YAOITA Y, 1980, BIOMED RES-TOKYO, V1, P164, DOI 10.2220/biomedres.1.164; YAOITA Y, 1982, NATURE, V297, P697, DOI 10.1038/297697a0; YAOITA Y, 1980, NATURE, V286, P850, DOI 10.1038/286850a0	47	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12514	12521						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712020				2022-12-27	WOS:A1991FV18000066
J	CLAUDE, A; ARENAS, J; HURWITZ, J				CLAUDE, A; ARENAS, J; HURWITZ, J			THE ISOLATION AND CHARACTERIZATION OF AN RNA HELICASE FROM NUCLEAR EXTRACTS OF HELA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC INITIATION-FACTORS; MESSENGER-RNA; UNWINDING ACTIVITY; DEPENDENT ATPASE; PROTEIN; YEAST; BINDING; SUPERFAMILY; CEREVISIAE; PRECURSORS	An RNA helicase, isolated from nuclear extracts of HeLa cells, displaced duplex RNA in the presence of any one of the eight common nucleoside triphosphates. The unwinding reaction was supported most efficiently by ATP and GTP and poorly by dCTP and dTTP. The enzyme activity, purified 300-fold, contained two major protein bands of 80 and 55 kDa when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. All fractions that contained RNA helicase activity also possessed single-stranded RNA-dependent nucleoside triphosphatase activity. Purified RNA helicase fractions displaced a hybrid of U4/U6 RNAs with the same efficiency as it displaced other duplex RNA structures. In contrast, the RNA helicase did not displace duplex RNA/DNA and DNA/DNA structures. Evidence is presented that suggests that this RNA helicase can displace duplex RNA by translocating in both the 3' to 5' and the 5' to 3' directions. The properties of the RNA helicase described here differ from the deaminase RNA unwinding activity described in Xenopus oocytes (Bass, B. L., and Weintraub, H. (1987) Cell 48, 607-613) and from the p68 HeLa RNA helicase (Hirling, H., Scheffner, M., Restle, T., and Stahl, H. (1989) Nature 339, 562-564).	CALTECH, DIV BIOL 14775, PASADENA, CA 91125 USA	California Institute of Technology	CLAUDE, A (corresponding author), SLOAN KETTERING MEM CANC CTR, MEM SLOAN KETTERING CANC CTR, PROGRAM MOLEC BIOL, NEW YORK, NY 10021 USA.							ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; BROW DA, 1988, NATURE, V334, P213, DOI 10.1038/334213a0; BURGESS S, 1990, CELL, V60, P705, DOI 10.1016/0092-8674(90)90086-T; CHANG TH, 1990, P NATL ACAD SCI USA, V87, P1571, DOI 10.1073/pnas.87.4.1571; CHEN JH, 1990, NUCLEIC ACIDS RES, V18, P6447, DOI 10.1093/nar/18.21.6447; CHENG SC, 1987, GENE DEV, V1, P1014, DOI 10.1101/gad.1.9.1014; DALBADIEMCFARLAND G, 1990, P NATL ACAD SCI USA, V87, P4236, DOI 10.1073/pnas.87.11.4236; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; HODGMAN TC, 1988, NATURE, V333, P22, DOI 10.1038/333022b0; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIN S, 1989, GENE, V82, P357, DOI 10.1016/0378-1119(89)90063-2; LAIN S, 1990, NUCLEIC ACIDS RES, V18, P7003, DOI 10.1093/nar/18.23.7003; LAIN S, 1991, J VIROL, V65, P1, DOI 10.1016/0042-6822(91)90641-N; LAMOND AI, 1988, P NATL ACAD SCI USA, V85, P411, DOI 10.1073/pnas.85.2.411; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LINDER P, 1988, NUCLEIC ACIDS RES, V16, P10359, DOI 10.1093/nar/16.21.10359; LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; NISHI K, 1988, NATURE, V336, P496, DOI 10.1038/336496a0; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PIKIELNY CW, 1986, NATURE, V324, P341, DOI 10.1038/324341a0; PRUZAN R, 1990, J BIOL CHEM, V265, P2804; RAY BK, 1985, J BIOL CHEM, V260, P7651; ROZEN F, 1990, MOL CELL BIOL, V10, P1134, DOI 10.1128/MCB.10.3.1134; SCHEFFNER M, 1989, CELL, V57, P955, DOI 10.1016/0092-8674(89)90334-6; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; SILICIANO PG, 1987, CELL, V50, P585, DOI 10.1016/0092-8674(87)90031-6; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x	34	32	32	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10358	10367						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709930				2022-12-27	WOS:A1991FP08600058
J	ZECHNER, R; MOSER, R; NEWMAN, TC; FRIED, SK; BRESLOW, JL				ZECHNER, R; MOSER, R; NEWMAN, TC; FRIED, SK; BRESLOW, JL			APOLIPOPROTEIN-E GENE-EXPRESSION IN MOUSE 3T3-L1 ADIPOCYTES AND HUMAN ADIPOSE-TISSUE AND ITS REGULATION BY DIFFERENTIATION AND LIPID-CONTENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEINS; TUMOR NECROSIS FACTOR; E MESSENGER-RNA; CHOLESTEROL TRANSPORT; PERIPHERAL-TISSUES; RECEPTOR-BINDING; TRANSGENIC MICE; E BIOSYNTHESIS; HIGH-AFFINITY; CELLS	Apolipoprotein E (apoE) is an important constituent of plasma lipoproteins and a ligand for several lipoprotein receptors. It is produced mainly in the liver but also in several peripheral tissues like brain, adrenal glands, kidney, and macrophages. Some of these tissues also coexpress lipoprotein lipase (LPL), an important enzyme in the metabolism of lipids and lipoproteins. This suggested a possible coordinate expression of these genes and led us to analyze whether adipocytes, a major source of LPL, could also synthesize apoE. Northern blotting experiments showed that apoE mRNA is found in differentiated mouse 3T3-L1 adipocytes as well as biopsies of human adipose tissue maintained in organ culture but not in undifferentiated 3T3-L1 preadipocytes. [S-35]Methionine pulse-labeling experiments revealed that apoE protein is produced in human adipose tissue and differentiated mouse 3T3-L1 adipocytes but not in preadipocytes. In biosynthetic labeling experiments, most apoE was found to be cell associated even after prolonged chase periods. Heparin treatment of the cultured cells did not enhance apoE secretion. During differentiation of 3T3-L1 cells, the onset of apoE gene expression was later than that of LPL. The apoE mRNA and intracellular apoE protein concentrations increased linearly with time of differentiation, at least through day 11, whereas LPL showed highest expression at day 7 and then declined. The increase in apoE mRNA correlated with the cellular lipid content. Inhibition of lipid accumulation in differentiated cells by biotin deprivation decreased apoE expression. Cholesterol-loading experiments suggested that apoE mRNA expression is regulated by the intracellular free cholesterol content of 3T3-L1 adipocytes. In contrast, the LPL mRNA level was not influenced by biotin deprivation or cholesterol loading. Human recombinant tumor necrosis factor, a potent inhibitor of LPL gene transcription, had no effect on adipocyte apoE mRNA levels. Therefore, although apoE and LPL are both expressed in adipocytes in a differentiation-dependent manner, the time course of their expression differs as do their responses to cellular lipid content and tumor necrosis factor. We conclude that these genes are not coordinately regulated in adipocytes.	ROCKEFELLER UNIV,BIOCHEM GENET & METAB LAB,1230 YORK AVE,NEW YORK,NY 10021; GRAZ UNIV,INST MED BIOCHEM,A-8010 GRAZ,AUSTRIA; ROCKEFELLER UNIV,HUMAN BEHAV & METAB LAB,NEW YORK,NY 10021	Rockefeller University; University of Graz; Rockefeller University			Breslow, Jan L/B-7544-2008	Zechner, Rudolf/0000-0001-5483-1182; Fried, Susan K./0000-0003-1101-9332	NHLBI NIH HHS [HL36461, HL32435, HL33714] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032435, R01HL033714, R37HL036461] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUWERX JH, 1988, BIOCHEMISTRY-US, V27, P2651, DOI 10.1021/bi00408a003; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V149, P545, DOI 10.1016/0006-291X(87)90402-5; BASHEERUDDIN K, 1987, P NATL ACAD SCI USA, V84, P709, DOI 10.1073/pnas.84.3.709; BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; BOYLES JK, 1989, J CLIN INVEST, V83, P1015, DOI 10.1172/JCI113943; BRESLOW JL, 1985, ANNU REV BIOCHEM, V54, P699, DOI 10.1146/annurev.biochem.54.1.699; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAS HK, 1985, J BIOL CHEM, V260, P6240; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DAVIS LG, 1986, BASIC METHODS MOL BI, P143; DAWSON PA, 1988, J BIOL CHEM, V263, P3372; DRISCOLL DM, 1984, J LIPID RES, V25, P1368; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; FENJVES ES, 1989, P NATL ACAD SCI USA, V86, P8803, DOI 10.1073/pnas.86.22.8803; FRIED SK, 1989, J LIPID RES, V30, P1917; HAMILTON RL, 1990, J LIPID RES, V31, P1589; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; KIM MH, 1989, J LIPID RES, V30, P663; KOSTNER GM, 1974, EUR J BIOCHEM, V45, P611, DOI 10.1111/j.1432-1033.1974.tb03587.x; KRAFT HG, 1989, J CLIN INVEST, V83, P137, DOI 10.1172/JCI113849; KRAUSE BR, 1984, J LIPID RES, V25, P97; KREMPLER F, 1987, J CLIN INVEST, V80, P401, DOI 10.1172/JCI113086; KURIHARCUCH W, 1978, CELL, V14, P53, DOI 10.1016/0092-8674(78)90300-8; LINLEE YC, 1981, BIOCHEMISTRY-US, V20, P6474, DOI 10.1021/bi00525a028; MAJACK RA, 1988, J CELL BIOL, V107, P1207, DOI 10.1083/jcb.107.3.1207; MAZZONE T, 1987, J BIOL CHEM, V262, P11657; MURAKAMI M, 1988, J CLIN INVEST, V82, P177, DOI 10.1172/JCI113568; NEWMAN TC, 1985, J BIOL CHEM, V260, P2452; PAIK YK, 1988, J BIOL CHEM, V263, P13340; PRICE SR, 1986, ARCH BIOCHEM BIOPHYS, V251, P738, DOI 10.1016/0003-9861(86)90384-X; REUE KL, 1984, J BIOL CHEM, V259, P2100; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SCHMITZ G, 1985, EMBO J, V4, P613, DOI 10.1002/j.1460-2075.1985.tb03674.x; SEMENKOVICH CF, 1989, J LIPID RES, V30, P423; SHERRILL BC, 1980, J BIOL CHEM, V255, P1804; SIMONET WS, 1990, J BIOL CHEM, V265, P10809; SMITH JD, 1988, J BIOL CHEM, V263, P8300; SMITH JD, 1990, J BIOL CHEM, V265, P14709; TAJIMA S, 1985, BIOCHEM BIOPH RES CO, V126, P526, DOI 10.1016/0006-291X(85)90637-0; TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1, DOI 10.1152/ajpcell.1984.246.1.C1; UTERMANN G, 1985, ADV EXP MED BIOL, V54, P173; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; WYNE KL, 1989, J BIOL CHEM, V264, P981; ZANNIS VI, 1986, J BIOL CHEM, V261, P3415; ZANNIS VI, 1984, J BIOL CHEM, V259, P5495; ZANNIS VI, 1982, CIRCULATION, V66, P170; ZECHNER R, 1988, MOL CELL BIOL, V8, P2394, DOI 10.1128/MCB.8.6.2394; ZECHNER R, 1990, BIOCHIM BIOPHYS ACTA, V1044, P20, DOI 10.1016/0005-2760(90)90213-H	49	117	118	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10583	10588						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709937				2022-12-27	WOS:A1991FP08600087
J	ASANO, K; KATO, A; MORIWAKI, H; HAMA, C; SHIBA, K; MIZOBUCHI, K				ASANO, K; KATO, A; MORIWAKI, H; HAMA, C; SHIBA, K; MIZOBUCHI, K			POSITIVE AND NEGATIVE REGULATIONS OF PLASMID COLIB-P9 REPZ GENE-EXPRESSION AT THE TRANSLATIONAL LEVEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; CLONING VEHICLES; DNA; REPLICATION; SYSTEM; CONSTRUCTION; PSEUDOKNOT; PRODUCT; INVITRO	Expression of the repZ gene involved in DNA replication of the ColIb-P9 plasmid depends on translation of a transcribed repZ leader sequence (repY) and is negatively regulated by Inc RNA, the product of the inc gene and a countertranscript to RepZ mRNA. To further understand the regulatory loop of repZ expression, we isolated and characterized replication-defective ColIb-P9 mutants that affected the level of repZ expression. Here we report that mutations occurring in two complementary sequences, one (5'GGCG3') in the inc region and one in the repY region, reduce the level of repZ expression without affecting transcription. The mutations in one complementary sequence were suppressed by compensatory base changes in the other sequence, restoring the ability of repZ expression. These results indicated that interaction by base pairing between the two complementary sequences of RepZ mRNA was essential for repZ translation. The two sequences, separated by 107 bases from each other, have a potential to form a novel pseudoknot in the RepZ mRNA leader. We also found that some mutations in the 5'GGCG3' sequence altered the specificity of Inc RNA, thereby reducing significantly its regulatory activity. Thus, this single specific sequence is involved in both positive and negative regulations for repZ expression. Possible regulatory mechanisms of repZ expression are discussed.	UNIV TOKYO,FAC SCI,DEPT BIOPHYS & BIOCHEM,TOKYO 113,JAPAN	University of Tokyo			Shiba, Kiyotaka/I-9588-2014	Shiba, Kiyotaka/0000-0001-6459-0204				APPLEYARD RK, 1954, GENETICS, V39, P429; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CASE CC, 1989, EMBO J, V8, P4297, DOI 10.1002/j.1460-2075.1989.tb08616.x; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; GEGENHEIMER P, 1981, MICROBIOL REV, V45, P502, DOI 10.1128/MMBR.45.4.502-541.1981; GOLD L, 1988, ANNU REV BIOCHEM, V57, P199, DOI 10.1146/annurev.bi.57.070188.001215; HAMA C, 1990, J BACTERIOL, V172, P1983, DOI 10.1128/jb.172.4.1983-1991.1990; HAMA C, 1990, J BIOL CHEM, V265, P10666; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LACATENA RM, 1981, NATURE, V294, P623, DOI 10.1038/294623a0; LIGHT J, 1983, EMBO J, V2, P93, DOI 10.1002/j.1460-2075.1983.tb01387.x; LINDAHL L, 1986, ANNU REV GENET, V20, P267; Maniatis T., 1982, MOL CLONING; MAYFORD M, 1989, EMBO J, V8, P4307, DOI 10.1002/j.1460-2075.1989.tb08617.x; MCPHEETERS DS, 1988, J MOL BIOL, V201, P517, DOI 10.1016/0022-2836(88)90634-1; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller J.H., 1972, EXPT MOL GENETICS; NARAYANAN CS, 1987, J BIOL CHEM, V262, P1756; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; NOVICK RP, 1989, CELL, V59, P395, DOI 10.1016/0092-8674(89)90300-0; PHILIPPE C, 1990, J MOL BIOL, V211, P415, DOI 10.1016/0022-2836(90)90362-P; PLEIJ CWA, 1985, NUCLEIC ACIDS RES, V13, P1717, DOI 10.1093/nar/13.5.1717; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBA K, 1990, J BACTERIOL, V172, P1992, DOI 10.1128/jb.172.4.1992-1997.1990; Silhavy T. J., 1984, EXPT GENE FUSIONS; STAUDENBAUER WL, 1976, MOL GEN GENET, V145, P273, DOI 10.1007/BF00325823; TANG CK, 1989, CELL, V57, P531, DOI 10.1016/0092-8674(89)90123-2; TOMIZAWA J, 1981, P NATL ACAD SCI-BIOL, V78, P1421, DOI 10.1073/pnas.78.3.1421; TOMIZAWA J, 1990, J MOL BIOL, V212, P683, DOI 10.1016/0022-2836(90)90230-J; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WAGNER EGH, 1987, EMBO J, V6, P515, DOI 10.1002/j.1460-2075.1987.tb04783.x; WOMBLE DD, 1984, J BACTERIOL, V160, P28, DOI 10.1128/JB.160.1.28-35.1984; WULCZYN FG, 1989, CELL, V57, P1201, DOI 10.1016/0092-8674(89)90057-3	39	51	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3774	3781						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704893				2022-12-27	WOS:A1991EY68200066
J	THOMAS, KM; PYUN, HY; NAVARRO, J				THOMAS, KM; PYUN, HY; NAVARRO, J			MOLECULAR-CLONING OF THE FMET-LEU-PHE RECEPTOR FROM NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									BOSTON UNIV,SCH MED,DEPT BIOCHEM,BOSTON,MA 02118	Boston University	THOMAS, KM (corresponding author), BOSTON UNIV,SCH MED,DEPT PHYSIOL,BOSTON,MA 02118, USA.			Navarro, Javier/0000-0001-7098-4373	NIAMS NIH HHS [R01 AR39602, K04 AR01810] Funding Source: Medline; NIA NIH HHS [AG00115] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039602, K04AR001810] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cb.04.110188.002201; BONITZ SG, 1980, J BIOL CHEM, V255, P1927; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; BOULAY F, 1990, BIOCHEM BIOPH RES CO, V168, P1103, DOI 10.1016/0006-291X(90)91143-G; CHAPLINSKI TJ, 1982, J CLIN INVEST, V70, P953, DOI 10.1172/JCI110707; COATS WD, 1990, J BIOL CHEM, V265, P5964; COLMAN A, 1986, TRANSCRIPTION TRANSL; DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; LAD PM, 1985, P NATL ACAD SCI USA, V82, P869, DOI 10.1073/pnas.82.3.869; LIBERT F, 1989, SCIENCE, V244, P569, DOI 10.1126/science.2541503; MALECH HL, 1985, J BIOL CHEM, V260, P2509; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MOLSKI TFP, 1984, BIOCHEM BIOPH RES CO, V124, P644, DOI 10.1016/0006-291X(84)91603-6; MURPHY PM, 1990, FEBS LETT, V261, P353, DOI 10.1016/0014-5793(90)80590-F; NEIDEL JE, 1980, CURRENT TOPICS CELL, V17, P137; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; RIZZOLO LJ, 1976, BIOCHEMISTRY-US, V15, P3433, DOI 10.1021/bi00661a006; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIFFMANN E, 1975, J IMMUNOL, V114, P1831; SNYDERMAN R, 1981, SCIENCE, V213, P830, DOI 10.1126/science.6266014; VERGHESE MW, 1985, BIOCHEM BIOPH RES CO, V127, P450, DOI 10.1016/S0006-291X(85)80181-9; WILLIAMSON K, 1988, BIOCHEMISTRY-US, V27, P5371, DOI 10.1021/bi00414a062; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102	25	100	113	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20061	20064						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700779				2022-12-27	WOS:A1990EJ52500003
J	WAGA, S; MIZUNO, S; YOSHIDA, M				WAGA, S; MIZUNO, S; YOSHIDA, M			CHROMOSOMAL PROTEIN HMG1 REMOVES THE TRANSCRIPTIONAL BLOCK CAUSED BY THE CRUCIFORM IN SUPERCOILED DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TOHOKU UNIV,DEPT AGR CHEM,BIOCHEM LAB,SENDAI,MIYAGI 980,JAPAN	Tohoku University				Waga, Shou/0000-0003-4986-8735				BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BIDNEY DL, 1978, BIOCHEM BIOPH RES CO, V85, P1211, DOI 10.1016/0006-291X(78)90671-X; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BRAHMS JG, 1985, J MOL BIOL, V181, P455, DOI 10.1016/0022-2836(85)90419-X; EINCK L, 1985, EXP CELL RES, V156, P295, DOI 10.1016/0014-4827(85)90539-7; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; HAMADA H, 1985, BIOCHEMISTRY-US, V24, P1428, DOI 10.1021/bi00327a022; ISACKSON PJ, 1979, J BIOL CHEM, V254, P5569; JAVAHERIAN K, 1979, NUCLEIC ACIDS RES, V6, P3569, DOI 10.1093/nar/6.11.3569; Johns EW, 1975, CIBA F S, V28, P95; KAPLAN DJ, 1988, NUCLEIC ACIDS RES, V16, P10375, DOI 10.1093/nar/16.21.10375; KELLER W, 1975, P NATL ACAD SCI USA, V72, P4876, DOI 10.1073/pnas.72.12.4876; LACATENA RM, 1981, NATURE, V294, P623, DOI 10.1038/294623a0; LARSEN A, 1982, CELL, V29, P609, DOI 10.1016/0092-8674(82)90177-5; LILLEY DMJ, 1980, P NATL ACAD SCI-BIOL, V77, P6468, DOI 10.1073/pnas.77.11.6468; MAKIGUCHI K, 1984, J BIOCHEM-TOKYO, V95, P423, DOI 10.1093/oxfordjournals.jbchem.a134623; MANIATIS T, 1975, BIOCHEMISTRY-US, V14, P3787, DOI 10.1021/bi00688a010; MANIATIS T, 1982, MOL CLONING LABORATO, P93; MATHIS DJ, 1980, NUCLEIC ACIDS RES, V12, P2577; MORITA M, 1979, EUR J BIOCHEM, V97, P435, DOI 10.1111/j.1432-1033.1979.tb13131.x; PANAYOTATOS N, 1981, NATURE, V289, P466, DOI 10.1038/289466a0; PAONESSA G, 1987, NUCLEIC ACIDS RES, V15, P9077, DOI 10.1093/nar/15.21.9077; PECK LJ, 1985, CELL, V40, P129, DOI 10.1016/0092-8674(85)90316-2; SCHMITT B, 1984, EUR J BIOCHEM, V144, P127, DOI 10.1111/j.1432-1033.1984.tb08440.x; SHASTRI K, 1982, NUCLEIC ACIDS RES, V10, P5059, DOI 10.1093/nar/10.16.5059; SHIRAKAWA H, 1990, BIOCHEMISTRY-US, V29, P4419, DOI 10.1021/bi00470a022; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TREMETHICK DJ, 1986, J BIOL CHEM, V261, P6986; TREMETHICK DJ, 1988, NUCLEIC ACIDS RES, V16, P11107, DOI 10.1093/nar/16.23.11107; TSUDA K, 1988, BIOCHEMISTRY-US, V27, P6159, DOI 10.1021/bi00416a050; WAGA S, 1989, BIOCHIM BIOPHYS ACTA, V1007, P209, DOI 10.1016/0167-4781(89)90041-9; WAGA S, 1988, BIOCHEM BIOPH RES CO, V153, P334, DOI 10.1016/S0006-291X(88)81227-0; WEINTRAUB H, 1983, CELL, V32, P1191, DOI 10.1016/0092-8674(83)90302-1; YOSHIDA M, 1984, J BIOCHEM-TOKYO, V95, P117, DOI 10.1093/oxfordjournals.jbchem.a134573; YOSHIDA M, 1987, J BIOCHEM-TOKYO, V101, P175, DOI 10.1093/oxfordjournals.jbchem.a121888	36	47	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19424	19428						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1700977				2022-12-27	WOS:A1990EJ18800013
J	SOTTRUPJENSEN, L; HANSEN, HF; PEDERSEN, HS; KRISTENSEN, L				SOTTRUPJENSEN, L; HANSEN, HF; PEDERSEN, HS; KRISTENSEN, L			LOCALIZATION OF EPSILON-LYSYL-GAMMA-GLUTAMYL CROSS-LINKS IN 5 HUMAN ALPHA-2-MACROGLOBULIN-PROTEINASE COMPLEXES - NATURE OF THE HIGH-MOLECULAR-WEIGHT CROSS-LINKED PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TECH UNIV DENMARK, DEPT BIOCHEM & NUTR, DK-2800 LYNGBY, DENMARK	Technical University of Denmark	SOTTRUPJENSEN, L (corresponding author), AARHUS UNIV, DEPT MOLEC BIOL, DK-8000 AARHUS, DENMARK.							BARKHOLT V, 1989, ANAL BIOCHEM, V177, P318, DOI 10.1016/0003-2697(89)90059-6; BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; BOISSET N, 1989, J BIOL CHEM, V264, P12046; BORTH W, 1989, J BIOL CHEM, V264, P5818; BROWN JR, 1966, BIOCHEM J, V101, P214, DOI 10.1042/bj1010214; CHEN BJ, 1990, BIOCHEMISTRY-US, V29, P3361, DOI 10.1021/bi00465a031; CHRISTENSEN U, 1984, BIOCHEMISTRY-US, V23, P6619, DOI 10.1021/bi00321a052; CHRISTENSEN U, 1989, BIOCHEMISTRY-US, V28, P9324, DOI 10.1021/bi00450a012; DELAIN E, 1988, J BIOL CHEM, V263, P2981; DELL A, 1982, BIOCHEM BIOPH RES CO, V106, P1456, DOI 10.1016/0006-291X(82)91277-3; Edman P, 1970, Mol Biol Biochem Biophys, V8, P211; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; GETTINS P, 1988, BIOCHEMISTRY-US, V27, P2905, DOI 10.1021/bi00408a036; GONIAS SL, 1988, J BIOL CHEM, V263, P10903; GRIFFIN M, 1982, ANAL BIOCHEM, V124, P406, DOI 10.1016/0003-2697(82)90057-4; HARRISON RA, 1981, P NATL ACAD SCI-BIOL, V78, P7388, DOI 10.1073/pnas.78.12.7388; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; HOWARD JB, 1986, J BIOL CHEM, V261, P60; HOWARD JB, 1981, P NATL ACAD SCI-BIOL, V78, P2235, DOI 10.1073/pnas.78.4.2235; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; JENSEN PEH, 1986, J BIOL CHEM, V261, P5863; JONSSON GP, 1986, ANAL CHEM, V58, P1084, DOI 10.1021/ac00297a023; KHAN SA, 1982, J BIOL CHEM, V257, P1864; LAW SKA, 1984, BIOCHEMISTRY-US, V23, P3267, DOI 10.1021/bi00309a022; MARKLAND FS, 1967, J BIOL CHEM, V242, P5198; MEIJERS JCM, 1987, BIOCHEMISTRY-US, V26, P5932, DOI 10.1021/bi00392a053; MELOUN B, 1966, BIOCHIM BIOPHYS ACTA, V130, P543, DOI 10.1016/0304-4165(66)90258-3; MENDEZ E, 1975, ANAL BIOCHEM, V68, P47, DOI 10.1016/0003-2697(75)90677-6; MIKES O, 1966, BIOCHEM BIOPH RES CO, V24, P346, DOI 10.1016/0006-291X(66)90162-8; NISHIGAI M, 1985, BIOCHIM BIOPHYS ACTA, V831, P236, DOI 10.1016/0167-4838(85)90040-8; OSADA T, 1988, J ULTRA MOL STRUCT R, V101, P62, DOI 10.1016/0889-1605(88)90082-1; PIZZO SV, 1986, BIOL CHEM H-S, V367, P1177, DOI 10.1515/bchm3.1986.367.2.1177; POCHON F, 1987, FEBS LETT, V217, P101, DOI 10.1016/0014-5793(87)81251-6; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SALVESEN GS, 1980, BIOCHEM J, V187, P695, DOI 10.1042/bj1870695; SCHRAMM HJ, 1982, H-S Z PHYSIOL CHEM, V363, P803, DOI 10.1515/bchm2.1982.363.2.803; SHOTTON D M, 1970, Nature (London), V225, P802, DOI 10.1038/225802a0; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; SINHA S, 1987, P NATL ACAD SCI USA, V84, P2228, DOI 10.1073/pnas.84.8.2228; SOTTRUPJENSEN L, 1983, ANN NY ACAD SCI, V421, P188, DOI 10.1111/j.1749-6632.1983.tb18109.x; SOTTRUPJENSEN L, 1981, FEBS LETT, V128, P127, DOI 10.1016/0014-5793(81)81097-6; SOTTRUPJENSEN L, 1980, FEBS LETT, V121, P275, DOI 10.1016/0014-5793(80)80361-9; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8318; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P393; SOTTRUPJENSEN L, 1982, BIOCHEM BIOPH RES CO, V107, P93, DOI 10.1016/0006-291X(82)91674-6; SOTTRUPJENSEN L, 1981, FEBS LETT, V128, P123, DOI 10.1016/0014-5793(81)81096-4; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; STUCHBURY T, 1975, BIOCHEM J, V151, P417, DOI 10.1042/bj1510417; SVENSON A, 1977, FEBS LETT, V73, P171, DOI 10.1016/0014-5793(77)80974-5; TACK BF, 1980, P NATL ACAD SCI-BIOL, V77, P5764, DOI 10.1073/pnas.77.10.5764; Tarr G E, 1977, Methods Enzymol, V47, P335; TITANI K, 1972, NATURE-NEW BIOL, V238, P35, DOI 10.1038/newbio238035a0; TITANI K, 1975, BIOCHEMISTRY-US, V14, P1358, DOI 10.1021/bi00678a003; VANDERGRAAF F, 1984, BIOCHEMISTRY-US, V23, P1760, DOI 10.1021/bi00303a027; WALLER EK, 1983, BIOCHEM J, V215, P123, DOI 10.1042/bj2150123; WANG D, 1984, BIOCHEMISTRY-US, V23, P2807, DOI 10.1021/bi00307a042; WANG D, 1983, ANN NY ACAD SCI, V421, P90, DOI 10.1111/j.1749-6632.1983.tb18095.x; WELLS JA, 1983, NUCLEIC ACIDS RES, V11, P7911, DOI 10.1093/nar/11.22.7911; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0; WU K, 1981, J BIOL CHEM, V256, P409	63	76	77	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17727	17737						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698779				2022-12-27	WOS:A1990EC76600058
J	FUJIWARA, T; TANAKA, K; ORINO, E; YOSHIMURA, T; KUMATORI, A; TAMURA, T; CHUNG, CH; NAKAI, T; YAMAGUCHI, K; SHIN, S; KAKIZUKA, A; NAKANISHI, S; ICHIHARA, A				FUJIWARA, T; TANAKA, K; ORINO, E; YOSHIMURA, T; KUMATORI, A; TAMURA, T; CHUNG, CH; NAKAI, T; YAMAGUCHI, K; SHIN, S; KAKIZUKA, A; NAKANISHI, S; ICHIHARA, A			PROTEASOMES ARE ESSENTIAL FOR YEAST PROLIFERATION - CDNA CLONING AND GENE DISRUPTION OF 2 MAJOR SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TOKUSHIMA,INST ENZYME RES,TOKUSHIMA 770,JAPAN; OTSUKA PHARMACEUT CO LTD,TOKUSHIMA 77101,JAPAN; KYOWA HAKKO KOGYO CO LTD,TOKYO 194,JAPAN; SEOUL NATL UNIV,COLL NAT SCI,DEPT ZOOL,SEOUL 151742,SOUTH KOREA; KYOTO UNIV,FAC MED,INST IMMUNOL,KYOTO 606,JAPAN; MEIJI INST HLTH SCI,ODAWARA 250,JAPAN	Tokushima University; Otsuka Pharmaceutical; Kyowa Kirin Ltd; Seoul National University (SNU); Kyoto University			Tamura, Tomohiro/M-4732-2018	Tamura, Tomohiro/0000-0003-2409-6556				AKHAYAT O, 1987, P NATL ACAD SCI USA, V84, P1595, DOI 10.1073/pnas.84.6.1595; ARRIGO AP, 1987, J MOL EVOL, V25, P141, DOI 10.1007/BF02101756; ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; CASTANO JG, 1986, CELL, V46, P377, DOI 10.1016/0092-8674(86)90658-6; Cryer D R, 1975, Methods Cell Biol, V12, P39; DAHLMANN B, 1985, BIOCHEM J, V228, P161, DOI 10.1042/bj2280161; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; DESA CM, 1986, J MOL BIOL, V187, P479, DOI 10.1016/0022-2836(86)90328-1; DESA MFG, 1988, J CELL SCI, V89, P151; DRISCOLL J, 1990, J BIOL CHEM, V265, P4789; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; FALKENBURG PE, 1988, NATURE, V331, P190, DOI 10.1038/331190a0; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FUJIWARA T, 1989, BIOCHEMISTRY-US, V28, P7332, DOI 10.1021/bi00444a028; GAUTIER J, 1988, J CELL SCI, V90, P543; GLASS JR, 1987, J CELL PHYSIOL, V130, P133, DOI 10.1002/jcp.1041300119; GRAINGER JL, 1989, J CELL BIOL, V109, P675, DOI 10.1083/jcb.109.2.675; HAASS C, 1989, EMBO J, V8, P2373, DOI 10.1002/j.1460-2075.1989.tb08366.x; HAASS C, 1989, EXP CELL RES, V180, P243, DOI 10.1016/0014-4827(89)90228-0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KLEINSCHMIDT JA, 1988, FEBS LETT, V239, P35, DOI 10.1016/0014-5793(88)80540-4; KUEHN L, 1990, FEBS LETT, V261, P274, DOI 10.1016/0014-5793(90)80570-9; KUMATORI A, 1990, FEBS LETT, V264, P279, DOI 10.1016/0014-5793(90)80267-M; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSCHER B, 1988, MOL CELL BIOL, V8, P2504; Maniatis T., 1982, MOL CLONING; MATTHEWS W, 1989, P NATL ACAD SCI USA, V86, P2597, DOI 10.1073/pnas.86.8.2597; MCGUIRE MJ, 1988, ARCH BIOCHEM BIOPHYS, V262, P273, DOI 10.1016/0003-9861(88)90189-0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; ORLOWSKI M, 1989, BIOCHEMISTRY-US, V28, P9270, DOI 10.1021/bi00450a006; PAL JK, 1988, J CELL SCI, V90, P555; RIVETT AJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P1, DOI 10.1016/0003-9861(89)90558-4; RIVETT AJ, 1989, J BIOL CHEM, V264, P12215; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHERRER K, 1990, MOL BIOL REP, V14, P1, DOI 10.1007/BF00422709; Sherman F., 1981, METHODS YEAST GENETI; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAMURA T, 1990, FEBS LETT, V264, P91, DOI 10.1016/0014-5793(90)80773-C; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V164, P1253, DOI 10.1016/0006-291X(89)91804-4; TANAKA K, 1986, J BIOL CHEM, V261, P5204; TANAKA K, 1988, FEBS LETT, V236, P159, DOI 10.1016/0014-5793(88)80306-5; TANAKA K, 1988, J MOL BIOL, V203, P985, DOI 10.1016/0022-2836(88)90123-4; TANAKA K, 1988, J BIOL CHEM, V263, P16209; TANAKA K, 1986, J BIOL CHEM, V261, P5197; TANAKA K, 1990, BIOCHEMISTRY-US, V29, P3777, DOI 10.1021/bi00467a026; TANAKA K, 1989, J CELL PHYSIOL, V139, P34, DOI 10.1002/jcp.1041390107; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSUKAHARA T, 1989, FEBS LETT, V255, P179, DOI 10.1016/0014-5793(89)81086-5; WATANABE N, 1989, NATURE, V342, P505, DOI 10.1038/342505a0; WEINBERGER C, 1985, SCIENCE, V228, P740, DOI 10.1126/science.2581314; WILK S, 1983, J NEUROCHEM, V40, P842, DOI 10.1111/j.1471-4159.1983.tb08056.x; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	53	135	138	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16604	16613						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697860				2022-12-27	WOS:A1990DZ95000085
J	RUF, J; WACKER, H; JAMES, P; MAFFIA, M; SEILER, P; GALAND, G; VONKIECKEBUSCH, A; SEMENZA, G; MANTEI, N				RUF, J; WACKER, H; JAMES, P; MAFFIA, M; SEILER, P; GALAND, G; VONKIECKEBUSCH, A; SEMENZA, G; MANTEI, N			RABBIT SMALL INTESTINAL TREHALASE - PURIFICATION, CDNA CLONING, EXPRESSION, AND VERIFICATION OF GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									SWISS FED INST TECHNOL,DEPT BIOCHEM 2,CH-8092 ZURICH,SWITZERLAND; SWISS FED INST TECHNOL,DEPT BIOCHEM 3,CH-8092 ZURICH,SWITZERLAND; UNITE ENSEIGNEMENT RECH SCI EXACTES & NAT,PHYSIOL ANIM LAB,F-51062 REIMS,FRANCE	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich			MAFFIA, MICHELE/AAC-2943-2020					AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BALL EH, 1986, ANAL BIOCHEM, V155, P23, DOI 10.1016/0003-2697(86)90218-6; BERGOZ R, 1971, GASTROENTEROLOGY, V60, P909; CAMPBELL BJ, 1984, J BIOL CHEM, V259, P4586; CARAS IW, 1989, J CELL BIOL, V108, P1387, DOI 10.1083/jcb.108.4.1387; CHEN CC, 1987, BIOCHEM J, V247, P715, DOI 10.1042/bj2470715; COGOLI A, 1975, J BIOL CHEM, V250, P7802; COLMAN A, 1984, TRANSCRIPTION TRANSL, P271; COURTOIS JE, 1966, B SOC CHIM BIOL, V48, P277; Defaye J., 1980, MECHANISMS SACCHARID, P331; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DOERING TL, 1990, J BIOL CHEM, V265, P611; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; GALAND G, 1984, BIOCHIM BIOPHYS ACTA, V789, P10, DOI 10.1016/0167-4838(84)90054-2; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; GUTIERREZ C, 1989, MOL GEN GENET, V217, P347, DOI 10.1007/BF02464903; HANOZET G, 1981, J BIOL CHEM, V256, P3703; HAUSER H, 1980, BIOCHIM BIOPHYS ACTA, V602, P567, DOI 10.1016/0005-2736(80)90335-1; HEDIGER MA, 1987, P NATL ACAD SCI USA, V84, P2634, DOI 10.1073/pnas.84.9.2634; HEHRE EJ, 1982, BIOCHEMISTRY-US, V21, P3090, DOI 10.1021/bi00256a009; HOEFSLOOT LH, 1988, EMBO J, V7, P1697, DOI 10.1002/j.1460-2075.1988.tb02998.x; HOOPER NM, 1990, BIOCHEM J, V265, P429, DOI 10.1042/bj2650429; HOOPER NM, 1987, BIOCHEM J, V247, P85, DOI 10.1042/bj2470085; HOOPER NM, 1989, BIOCHEM J, V261, P811, DOI 10.1042/bj2610811; HUNZIKER W, 1986, CELL, V46, P227, DOI 10.1016/0092-8674(86)90739-7; KALF GF, 1958, J BIOL CHEM, V230, P691; KHANDJIAN EW, 1986, MOL BIOL REP, V11, P107, DOI 10.1007/BF00364822; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; LOW MG, 1989, FASEB J, V3, P1600, DOI 10.1096/fasebj.3.5.2522071; MADZAROV.J, 1973, GASTROENTEROLOGY, V65, P130; Maniatis T., 1982, MOL CLONING; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; MELTON DA, 1987, METHOD ENZYMOL, V152, P288; MOOS M, 1988, J BIOL CHEM, V263, P6005; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKANO M, 1985, J BIOCHEM-TOKYO, V97, P1329, DOI 10.1093/oxfordjournals.jbchem.a135185; NAKANO M, 1989, CARBOHYD RES, V194, P139, DOI 10.1016/0008-6215(89)85013-X; NAKANO M, 1977, J BIOCHEM, V81, P1041, DOI 10.1093/oxfordjournals.jbchem.a131526; NORRANDER J, 1983, GENE, V26, P101, DOI 10.1016/0378-1119(83)90040-9; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SASAJIMA K, 1975, BIOCHIM BIOPHYS ACTA, V403, P139, DOI 10.1016/0005-2744(75)90017-0; SEMENZA G, 1974, EUR J BIOCHEM, V41, P149, DOI 10.1111/j.1432-1033.1974.tb03255.x; SEMENZA G, 1987, MAMMALIAN ECTOENZYME, P265; SOREQ H, 1982, P NATL ACAD SCI-BIOL, V79, P830, DOI 10.1073/pnas.79.3.830; SOREQ H, 1985, CRC CR REV BIOCH MOL, V18, P199, DOI 10.3109/10409238509085134; STRUHL K, 1985, Biotechniques, V3, P452; TAKESUE Y, 1986, FEBS LETT, V201, P5, DOI 10.1016/0014-5793(86)80560-9; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; YOKOTA K, 1986, BIOCHIM BIOPHYS ACTA, V881, P405, DOI 10.1016/0304-4165(86)90033-4	57	71	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					15034	15039						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697585				2022-12-27	WOS:A1990DX40000058
J	LAZAROWSKI, ER; WINEGAR, DA; NOLAN, RD; OBERDISSE, E; LAPETINA, EG				LAZAROWSKI, ER; WINEGAR, DA; NOLAN, RD; OBERDISSE, E; LAPETINA, EG			EFFECT OF PROTEIN KINASE-A ON INOSITIDE METABOLISM AND RAP-1 G-PROTEIN IN HUMAN ERYTHROLEUKEMIA-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									BURROUGHS WELLCOME CO,DIV CELL BIOL,RES TRIANGLE PK,NC 27709	Burroughs Wellcome Fund								BALLA T, 1988, J BIOL CHEM, V263, P4083; BATTY IR, 1985, BIOCHEM J, V232, P211, DOI 10.1042/bj2320211; BOOYSE FM, 1976, BIOCHIM BIOPHYS ACTA, V422, P60, DOI 10.1016/0005-2744(76)90008-5; CLARKE NG, 1981, BIOCHEM J, V195, P301, DOI 10.1042/bj1950301; COCKCROFT S, 1987, BIOCHEM J, V241, P409, DOI 10.1042/bj2410409; CONNOLLY TM, 1987, J BIOL CHEM, V262, P2146; CUNHAMELO JR, 1988, J BIOL CHEM, V263, P14245; DANIEL JL, 1987, BIOCHEM J, V246, P109, DOI 10.1042/bj2460109; EDWARDS RJ, 1987, BRIT J PHARMACOL, V90, P501, DOI 10.1111/j.1476-5381.1987.tb11199.x; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HASLAM RJ, 1979, BIOCHEM J, V178, P397, DOI 10.1042/bj1780397; HOSHIJIMA M, 1988, BIOCHEM BIOPH RES CO, V157, P851, DOI 10.1016/S0006-291X(88)80953-7; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; LACAL JC, 1986, P NATL ACAD SCI USA, V83, P5400, DOI 10.1073/pnas.83.15.5400; LAPETINA E G, 1986, P271; LAPETINA EG, 1989, P NATL ACAD SCI USA, V86, P3131, DOI 10.1073/pnas.86.9.3131; LAPETINA EG, 1986, FEBS LETT, V195, P111, DOI 10.1016/0014-5793(86)80141-7; LAZAROWSKI ER, 1989, BIOCHEM BIOPH RES CO, V161, P972, DOI 10.1016/0006-291X(89)91338-7; LAZAROWSKI ER, 1989, BIOCHEM BIOPH RES CO, V158, P440, DOI 10.1016/S0006-291X(89)80067-1; MICHEL MC, 1989, J BIOL CHEM, V264, P4986; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OBERDISSE E, 1990, J BIOL CHEM, V265, P726; OHMORI T, 1988, BIOCHEM BIOPH RES CO, V157, P670, DOI 10.1016/S0006-291X(88)80302-4; PIZON V, 1988, ONCOGENE, V3, P201; SALAMA SE, 1984, BIOCHEM J, V218, P285, DOI 10.1042/bj2180285; STEPHENS L, 1989, BIOCHEM J, V259, P267, DOI 10.1042/bj2590267; TABILIO A, 1984, EMBO J, V3, P453, DOI 10.1002/j.1460-2075.1984.tb01827.x; TAKAI Y, 1982, J BIOCHEM-TOKYO, V91, P403, DOI 10.1093/oxfordjournals.jbchem.a133700; TRAYNORKAPLAN AE, 1988, NATURE, V334, P353, DOI 10.1038/334353a0; WATSON SP, 1984, J BIOL CHEM, V259, P3199; WHITE TE, 1990, P NATL ACAD SCI USA, V87, P758, DOI 10.1073/pnas.87.2.758; WHITMAN M, 1988, Biochimica et Biophysica Acta, V948, P327; WREGGETT KA, 1987, BIOCHEM J, V245, P933, DOI 10.1042/bj2450933	33	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13118	13123						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695902				2022-12-27	WOS:A1990DR20100057
J	MACHIDA, CA; BUNZOW, JR; SEARLES, RP; VANTOL, H; TESTER, B; NEVE, KA; TEAL, P; NIPPER, V; CIVELLI, O				MACHIDA, CA; BUNZOW, JR; SEARLES, RP; VANTOL, H; TESTER, B; NEVE, KA; TEAL, P; NIPPER, V; CIVELLI, O			MOLECULAR-CLONING AND EXPRESSION OF THE RAT BETA-1-ADRENERGIC RECEPTOR GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									OREGON HLTH SCI UNIV,VOLLUM INST ADV BIOMED RES,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201; VET ADM MED CTR,PORTLAND,OR 97201; OREGON REG PRIMATE RES CTR,DIV NEUROSCI,BEAVERTON,OR 97006	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; Oregon National Primate Research Center			Civelli, Olivier/A-8392-2012		NCRR NIH HHS [RR00163] Funding Source: Medline; NHLBI NIH HHS [HL42358] Funding Source: Medline; NIMH NIH HHS [MH45372] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042358, R29HL042358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045372] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBERT PR, 1990, J BIOL CHEM, V265, P5825; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BONNER TI, 1989, TRENDS NEUROSCI, V12, P148, DOI 10.1016/0166-2236(89)90054-4; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUNG FZ, 1987, FEBS LETT, V211, P200, DOI 10.1016/0014-5793(87)81436-9; COLLINS S, 1988, J BIOL CHEM, V263, P9067; COLLINS S, 1989, P NATL ACAD SCI USA, V86, P4853, DOI 10.1073/pnas.86.13.4853; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; EMORINE LJ, 1987, P NATL ACAD SCI USA, V84, P6995, DOI 10.1073/pnas.84.20.6995; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FRIELLE T, 1988, TRENDS NEUROSCI, V11, P321, DOI 10.1016/0166-2236(88)90095-1; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P46; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P8415, DOI 10.1073/pnas.85.22.8415; HADCOCK JR, 1988, P NATL ACAD SCI USA, V85, P5021, DOI 10.1073/pnas.85.14.5021; HAUSDORFF WP, 1990, J BIOL CHEM, V265, P1388; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; MACHIDA CA, 1989, DNA-J MOLEC CELL BIO, V8, P447, DOI 10.1089/dna.1.1989.8.447; MCGONIGLE P, 1986, MOL PHARMACOL, V30, P329; NAKADA MT, 1989, BIOCHEM J, V260, P53, DOI 10.1042/bj2600053; NEVE KA, 1986, J PHARMACOL EXP THER, V238, P46; NEVE KA, 1989, MOL PHARMACOL, V36, P446; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; RAINBOW TC, 1984, P NATL ACAD SCI-BIOL, V81, P1585, DOI 10.1073/pnas.81.5.1585; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SIBLEY DR, 1987, CELL, V48, P913, DOI 10.1016/0092-8674(87)90700-8; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STILES GL, 1984, PHYSIOL REV, V64, P661, DOI 10.1152/physrev.1984.64.2.661	36	141	148	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					12960	12965						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695899				2022-12-27	WOS:A1990DR20100036
J	BEAR, CE; DUGUAY, F; NAISMITH, AL; KARTNER, N; HANRAHAN, JW; RIORDAN, JR				BEAR, CE; DUGUAY, F; NAISMITH, AL; KARTNER, N; HANRAHAN, JW; RIORDAN, JR			CL- CHANNEL ACTIVITY IN XENOPUS OOCYTES EXPRESSING THE CYSTIC-FIBROSIS GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							TRANSMEMBRANE CONDUCTANCE REGULATOR; CHLORIDE CHANNEL; TRANSPORT; PROTEINS; CELLS	The expression of the cystic fibrosis (CF) gene on its introduction into nonepithelial somatic cells has recently been shown to result in the appearance of distinctive low conductance chloride channels stimulated by cyclic AMP (Kartner, N., Hanrahan, J. W., Jensen, T. J., Naismith, A. L., Sun, S., Ackerley, C. A., Reyes, E. F., Tsui, L.-C., Rommens, J. M., Bear, C. E., and Riordan, J. R. (1991) Cell 64, 681-691; Anderson, M. P., Rich, D. P., Gregory, R. J., Smith, A. E., and Welsh, M. J. (1991) Science 251, 679-682). Since Xenopus oocytes provide a powerful system for ion channel characterization, we have examined whole cell and single channel currents in them after injection of cRNA to program the synthesis of the cystic fibrosis transmembrane conductance regulator (CFTR). This has enabled the direct demonstration that the cyclic AMP activation is mediated by protein kinase A and that CFTR is without effect on the endogenous calcium-activated chloride channels of the oocyte, which have been well characterized previously and widely used as reporters of the expression of G-protein-coupled receptors. These findings strengthen the argument that the CF gene codes for a novel regulated chloride channel rather than a regulatory protein which can modulate separate chloride channel molecules.	UNIV TORONTO,DEPT PHYSIOL,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT BIOCHEM & CLIN BIOCHEM,TORONTO M5S 1A1,ONTARIO,CANADA; MCGILL UNIV,DEPT PHYSIOL,MONTREAL H3G 1Y6,QUEBEC,CANADA	University of Toronto; University of Toronto; McGill University	BEAR, CE (corresponding author), HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA.		Hanrahan, John/AGG-1926-2022	Hanrahan, John/0000-0001-9080-2039				ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; GRAY MA, 1989, AM J PHYSIOL, V257, pC240, DOI 10.1152/ajpcell.1989.257.2.C240; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; Hille B, 1984, IONIC CHANNELS EXCIT; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; LESTER HA, 1988, SCIENCE, V241, P1057, DOI 10.1126/science.2457947; LODISH HF, 1990, NATURE, V348, P489, DOI 10.1038/348489a0; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RINGE D, 1990, NATURE, V346, P312, DOI 10.1038/346312a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1991, IN PRESS BIOESSAYS; RIORDAN JR, 1991, IDENTIFICATION CF CY; TABCHARANI JA, 1990, FEBS LETT, V270, P157, DOI 10.1016/0014-5793(90)81257-O; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593	18	171	172	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19142	19145						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717461				2022-12-27	WOS:A1991GK66700005
J	FEYEN, JHM; EVANS, DB; BINKERT, C; HEINRICH, GF; GEISSE, S; KOCHER, HP				FEYEN, JHM; EVANS, DB; BINKERT, C; HEINRICH, GF; GEISSE, S; KOCHER, HP			RECOMBINANT HUMAN [CYS281]INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-2 INHIBITS BOTH BASAL AND INSULIN-LIKE GROWTH FACTOR-I-STIMULATED PROLIFERATION AND COLLAGEN-SYNTHESIS IN FETAL-RAT CALVARIAE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST-ENRICHED CULTURES; IGF-I; PARATHYROID-HORMONE; CARRIER PROTEINS; ORGAN-CULTURE; BONE; CELLS; ESTRADIOL; EXPRESSION; CORTISOL	It is recognized that insulin-like growth factors (IGFs) are bound to specific high-affinity insulin-like growth factor-binding proteins (IGFBPs). The role of IGFBPs in bone metabolism is not well established. The effect of recombinant human [Cys281]IGFBP-2 ([Cys281]rhIGFBP-2) on bone formation in 21-day-old fetal rat calvariae was investigated. [Cys281]rhIGFBP-2 was expressed in and purified from conditioned medium of a clonal Chinese hamster ovary cell line. IGFI-stimulated cell proliferation was inhibited dose dependently by [CyS281]rhIGFBP-2, with half-maximal inhibition observed at 2 x 10(-8) M. Suppression of the IGF-I-stimulated DNA synthesis was observed at an apparent dose ratio of 1:10. [Cys281]rhlGFBP-2 (10(-6) M) also inhibited the basal incorporation of [H-3]thymidine into DNA by up to 45%. Insulin-stimulated cell proliferation was not affected in the presence of the binding protein. In addition, [Cys281]rhlGFBP-2 inhibited bone collagen synthesis under basal and IGF-I-stimulated conditions. In contrast, [CyS281]rhIGFBP-2 did not alter the parathyroid hormone-stimulated bone cell proliferation rate. In conclusion, binding of hIGF-I to rhlGFBP-2 results in an inhibition of the actions of free IGF-I on bone cell replication and matrix synthesis. Parathyroid hormone-stimulated cell proliferation is not mediated by an increase in free IGFs.	SANDOZ PHARMA LTD,DEPT BIOTECHNOL,CH-4002 BASEL,SWITZERLAND	Novartis; Sandoz	FEYEN, JHM (corresponding author), SANDOZ PHARMA LTD,DEPT ENDOCRINOL,PRECLIN RES 360-406,CH-4002 BASEL,SWITZERLAND.							BAGLEY CJ, 1989, BIOCHEM J, V259, P665, DOI 10.1042/bj2590665; Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0; BINGHAM PJ, 1974, CALC TISS RES, V14, P31, DOI 10.1007/BF02060281; BINKERT C, 1989, EMBO J, V8, P2497, DOI 10.1002/j.1460-2075.1989.tb08386.x; BLUM WF, 1989, ENDOCRINOLOGY, V125, P766, DOI 10.1210/endo-125-2-766; BURCH WM, 1990, J CLIN ENDOCR METAB, V70, P173, DOI 10.1210/jcem-70-1-173; BVENBERG WA, 1990, MOL CELL ENDOCRINOL, V74, P45; CANALIS E, 1988, ENDOCRINOLOGY, V122, P22, DOI 10.1210/endo-122-1-22; CANALIS E, 1990, ENDOCRINOLOGY, V126, P1806, DOI 10.1210/endo-126-4-1806; CANALIS E, 1989, J CLIN INVEST, V83, P60, DOI 10.1172/JCI113885; CENTRELLA M, 1990, ENDOCRINOLOGY, V126, P39, DOI 10.1210/endo-126-1-39; CHEN TL, 1991, ENDOCRINOLOGY, V128, P73, DOI 10.1210/endo-128-1-73; CHENU C, 1990, BONE, V11, P81, DOI 10.1016/8756-3282(90)90054-3; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; DUNPHY MJ, 1987, J CHROMATOGR-BIOMED, V420, P394, DOI 10.1016/0378-4347(87)80195-0; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; ERNST M, 1988, P NATL ACAD SCI USA, V85, P2307, DOI 10.1073/pnas.85.7.2307; ERNST M, 1990, ENDOCRINOLOGY, V127, P807, DOI 10.1210/endo-127-2-807; ERNST M, 1988, BIOCHEM BIOPH RES CO, V151, P142, DOI 10.1016/0006-291X(88)90570-0; ERNST M, 1987, CALCIFIED TISSUE INT, V40, P27, DOI 10.1007/BF02555725; GRAY TK, 1989, BIOCHEM BIOPH RES CO, V158, P407, DOI 10.1016/S0006-291X(89)80062-2; HOCK JM, 1988, ENDOCRINOLOGY, V122, P254, DOI 10.1210/endo-122-1-254; KNAUER DJ, 1980, P NATL ACAD SCI-BIOL, V77, P7252, DOI 10.1073/pnas.77.12.7252; KREAM BE, 1985, ENDOCRINOLOGY, V116, P296, DOI 10.1210/endo-116-1-296; LINKHART TA, 1989, ENDOCRINOLOGY, V125, P1484, DOI 10.1210/endo-125-3-1484; MCCARTHY TL, 1990, J BIOL CHEM, V265, P15353; MCCARTHY TL, 1990, ENDOCRINOLOGY, V126, P1569, DOI 10.1210/endo-126-3-1569; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P301, DOI 10.1210/endo-124-1-301; MCCARTHY TL, 1989, ENDOCRINOLOGY, V124, P1247, DOI 10.1210/endo-124-3-1247; MCCARTHY TL, 1989, CONNECT TISSUE RES, V20, P277, DOI 10.3109/03008208909023897; MOHAN S, 1988, BIOCHIM BIOPHYS ACTA, V966, P44, DOI 10.1016/0304-4165(88)90127-4; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; RITVOS O, 1988, ENDOCRINOLOGY, V122, P2150, DOI 10.1210/endo-122-5-2150; SCHMID C, 1989, FEBS LETT, V244, P328, DOI 10.1016/0014-5793(89)80556-3; SCHMID C, 1989, BIOCHEM BIOPH RES CO, V160, P788, DOI 10.1016/0006-291X(89)92502-3; SCHMID C, 1984, FEBS LETT, V173, P48, DOI 10.1016/0014-5793(84)81015-7; SCHMID C, 1990, 3RD P INT S OST DENM, P40; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STRACKE H, 1984, ACTA ENDOCRINOL-COP, V107, P16, DOI 10.1530/acta.0.1070016; TOLLEFSEN SE, 1991, J CLIN INVEST, V87, P1241, DOI 10.1172/JCI115125; URLAUB G, 1980, P NATL ACAD SCI-BIOL, V77, P4216, DOI 10.1073/pnas.77.7.4216; VANDORSSELAER A, 1990, BIOMED ENVIRON MASS, V19, P692, DOI 10.1002/bms.1200191108; WALTON PE, 1989, P SOC EXP BIOL MED, V190, P315; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623	44	90	94	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19469	19474						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717466				2022-12-27	WOS:A1991GK66700053
J	PEPINSKY, RB; CHEN, LL; MEIER, W; WALLNER, BP				PEPINSKY, RB; CHEN, LL; MEIER, W; WALLNER, BP			THE INCREASED POTENCY OF CROSS-LINKED LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-3 (LFA-3) MULTIMERS IS A DIRECT CONSEQUENCE OF CHANGES IN VALENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE LIGAND; ALTERNATIVE PATHWAY; CD2; RECEPTOR; ADHESION; GLYCOPROTEIN; MOLECULES; BINDING; RECOGNITION; ACTIVATION	We have used chemically cross-linked dimers, trimers, and tetramers of lymphocyte function-associated antigen-3 (LFA-3) to study the role of multivalency in the interaction of the protein with its receptor, CD2. The cross-linked adducts showed enhanced activity in systems where LFA-3 has been shown to (i) block LFA-3/CD2 interactions in a rosetting assay and (ii) provide through the CD2 on peripheral blood lymphocytes a trigger for T-cell proliferation. The level of increase was directly related to the valency state of the multimers. In the rosetting assay, the dimers, trimers, and tetramers, by weight, exhibited 15-, 150-, and 430-fold increases in activity over monomeric LFA-3. In the proliferation assay, the tetramer produced a 6-fold increase in thymidine incorporation at 0.06-mu-g/ml, the trimer was 100 times less active than the tetramer, and the dimer and monomer were inactive. The LFA-3 multimers were generated using a three-step cross-linking chemistry that was targeted at the carbohydrates on LFA-3. With this procedure over 60% of the starting protein was converted into multimers with no effect on function. The cross-linking approach should be applicable to other surface antigens, providing a simple method for analyzing multivalent interactions.			PEPINSKY, RB (corresponding author), BIOGEN INC,CAMBRIDGE,MA 02142, USA.							DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DENNING SM, 1988, J IMMUNOL, V141, P2980; DUSTIN ML, 1987, J EXP MED, V165, P677, DOI 10.1084/jem.165.3.677; DUSTIN ML, 1987, NATURE, V329, P846, DOI 10.1038/329846a0; DUSTIN ML, 1989, J EXP MED, V169, P503, DOI 10.1084/jem.169.2.503; EDIDIN M, 1991, J CELL BIOL, V112, P1143, DOI 10.1083/jcb.112.6.1143; HUNIG T, 1987, NATURE, V326, P298, DOI 10.1038/326298a0; KAUFMAN RJ, 1982, J MOL BIOL, V159, P601, DOI 10.1016/0022-2836(82)90103-6; KOYASU S, 1990, P NATL ACAD SCI USA, V87, P2603, DOI 10.1073/pnas.87.7.2603; KRENSKY AM, 1984, J IMMUNOL, V132, P2180; KRENSKY AM, 1983, J IMMUNOL, V131, P611; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; MEUER SC, 1984, ANNU REV IMMUNOL, V2, P23, DOI 10.1146/annurev.immunol.2.1.23; PLUNKETT ML, 1987, J EXP MED, V165, P664, DOI 10.1084/jem.165.3.664; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; SHAW S, 1986, NATURE, V323, P262, DOI 10.1038/323262a0; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; VOLLGER LW, 1987, J IMMUNOL, V138, P358; WALLNER BP, 1987, J EXP MED, V166, P923, DOI 10.1084/jem.166.4.923; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2	22	25	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18244	18249						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717445				2022-12-27	WOS:A1991GG55300080
J	CAMIRAND, A; HEYSEN, A; GRONDIN, B; HERSCOVICS, A				CAMIRAND, A; HEYSEN, A; GRONDIN, B; HERSCOVICS, A			GLYCOPROTEIN-BIOSYNTHESIS IN SACCHAROMYCES-CEREVISIAE - ISOLATION AND CHARACTERIZATION OF THE GENE ENCODING A SPECIFIC PROCESSING ALPHA-MANNOSIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEINS; ENDOPLASMIC-RETICULUM; NUCLEOTIDE-SEQUENCE; GCN4 PROTEIN; YEAST; GLYCOSYLATION; TRANSCRIPTION; ACID; DNA; PURIFICATION	We have isolated the gene from Saccharomyces cerevisiae encoding an alpha-mannosidase of unique specificity which catalyzes the removal of one mannose residue from Man9GlcNAc to produce a single isomer of Man8GlcNAc (Jelinek-Kelly, S., and Herscovics, A. (1988) J. Biol. Chem. 263, 14757-14763). Amino acid sequence information was obtained and corresponding degenerate oligonucleotide primers were synthesized for polymerase chain reactions on yeast genomic DNA. The labeled polymerase chain reaction products were used to screen a S. cerevisiae genomic library in YEp24, and positive clones of different lengths with similar restriction maps were isolated. A 4.6-kilobase fragment which hybridized with the probes was sequenced. It contained a 1650-base pair open reading frame encoding peptide sequences corresponding to the amino acid sequences of the purified alpha-mannosidase. The gene, designated MNS1, encodes a 549-amino acid polypeptide of calculated molecular size 63,017 Da produced by an mRNA species of approximately 1.7 kilobases. The protein possesses a putative noncleavable signal sequence near its N-terminal region which probably acts as a transmembrane domain. It has three potential N-glycosylation sites and a calcium-binding consensus sequence. Its amino acid sequence is homologous to the recently isolated cDNA from rabbit liver alpha-1,2 mannosidase which can transform Man9GlcNAc to Man5GlcNAc (Moremen, K. W., Schutzbach, J. S., Forsee, W. T., Neame, P., Bishoff, J., Lodish, H. F., and Robbins, P. W. (1990) Glycoconjugate J. 7, 401). Overexpression of the MNS1 gene caused an 8-10-fold increase in specific alpha-mannosidase activity. Disruption of the MNS1 gene resulted in undetectable specific alpha-mannosidase activity but no apparent effect on growth. These results demonstrate that MNS1 is the structural gene for the specific alpha-mannosidase and that its activity is not essential for viability.	MCGILL UNIV, MCGILL CANC CTR, 3655 DRUMMOND ST, MONTREAL H3G 1Y6, QUEBEC, CANADA	McGill University					NIGMS NIH HHS [GM-31265] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBERSOLD RH, 1987, P NATL ACAD SCI USA, V84, P6970, DOI 10.1073/pnas.84.20.6970; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; BISCHOFF J, 1986, J BIOL CHEM, V261, P4766; BISCHOFF J, 1986, J BIOL CHEM, V261, P4758; BROWN PH, 1986, J BIOL CHEM, V261, P2575; BYRD JC, 1982, J BIOL CHEM, V257, P4657; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CIGAN AM, 1987, GENE, V59, P1; DOBSON MJ, 1982, NUCLEIC ACIDS RES, V10, P2625, DOI 10.1093/nar/10.8.2625; DONAHUE TF, 1983, CELL, V32, P89, DOI 10.1016/0092-8674(83)90499-3; ESMON B, 1984, J BIOL CHEM, V259, P322; FAYE G, 1981, P NATL ACAD SCI-BIOL, V78, P2258, DOI 10.1073/pnas.78.4.2258; GODELAINE D, 1981, J BIOL CHEM, V256, P161; HERNANDEZ LM, 1989, J BIOL CHEM, V264, P13648; HERSCOVICS A, 1987, ANAL BIOCHEM, V166, P85, DOI 10.1016/0003-2697(87)90550-1; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; JELINEKKELLY S, 1988, J BIOL CHEM, V263, P14757; KILKER RD, 1981, J BIOL CHEM, V256, P5299; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUKURUZINSKA MA, 1987, ANNU REV BIOCHEM, V56, P915, DOI 10.1146/annurev.biochem.56.1.915; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MANIATIS T, 1982, MOL CLONING LABORATO, P310; MARCK C, 1988, NUCLEIC ACIDS RES, V16, P1829, DOI 10.1093/nar/16.5.1829; MARSDEN BJ, 1990, BIOCHEM CELL BIOL, V68, P587, DOI 10.1139/o90-084; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MONTGOMERY DL, 1980, P NATL ACAD SCI-BIOL, V77, P541, DOI 10.1073/pnas.77.1.541; MOREMEN K, 1988, PROTEIN TRANSFER ORG, P209; MOREMEN KW, 1989, P NATL ACAD SCI USA, V86, P5276, DOI 10.1073/pnas.86.14.5276; MOREMEN KW, 1990, GLYCOCONJUGATE J, V7, P401; OHTSUKA E, 1985, J BIOL CHEM, V260, P2605; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RIZZOLO LJ, 1988, J BIOL CHEM, V263, P9520; ROMERO PA, 1989, J BIOL CHEM, V264, P1946; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUNIER B, 1982, J BIOL CHEM, V257, P4155; SCHUTZBACH JS, 1990, J BIOL CHEM, V265, P2546; SELDEN RF, 1987, CURRENT PROTOCOLS MO; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P2951, DOI 10.1093/nar/10.9.2951; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TRECO DA, 1989, CURRENT PROTOCOLS MO; VONHEIJNE G, 1988, BIOCHIM BIOPHYS ACTA, V947, P307, DOI 10.1016/0304-4157(88)90013-5; WEIS JH, 1987, CURRENT PROTOCOLS MO; YOSHIHISA T, 1989, BIOCHEM BIOPH RES CO, V163, P908, DOI 10.1016/0006-291X(89)92308-5; ZARET KS, 1982, CELL, V28, P563, DOI 10.1016/0092-8674(82)90211-2	52	113	115	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15120	15127						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714453				2022-12-27	WOS:A1991GB09700050
J	MCSWINEKENNICK, RL; MCKEEGAN, EM; JOHNSON, MD; MORIN, MJ				MCSWINEKENNICK, RL; MCKEEGAN, EM; JOHNSON, MD; MORIN, MJ			PHORBOL DIESTER-INDUCED ALTERATIONS IN THE EXPRESSION OF PROTEIN-KINASE-C ISOZYMES AND THEIR MESSENGER-RNAS - ANALYSIS IN WILD-TYPE AND PHORBOL DIESTER-RESISTANT HL-60 CELL CLONES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3 DISTINCT TYPES; ESTER RECEPTOR; LEUKEMIA-CELLS; TRANSCRIPTIONAL REGULATION; TUMOR PROMOTION; DOWN-REGULATION; LYMPHOCYTES-T; EGF RECEPTOR; DIFFERENTIATION; GROWTH	In an HL-60 cell subline (PR-17) which was greater than 100-fold resistant to the differentiating and cytostatic activities of phorbol 12-myristate 13-acetate (PMA), the protein kinase C phenotype was found to be nearly identical to that of wild-type HL-60 cells. A measurable decrease (30%) in the specific activities of crude preparations of PR-17 cell protein kinase C was observed when the enzyme was measured with histone as the phosphate acceptor substrate, but other aspects of the protein kinase C phenotype (intracellular concentrations and binding affinities of phorbol diester receptors, translocation of activated enzyme from cytosolic to particulate subcellular fractions, relative expression of the alpha and beta-isozyme proteins) were equivalent in both PMA-resistant PR-17 cells and in wild-type HL-60 cells. Direct analysis of the behavior of the alpha and beta-isozymes after the exposure of each cell type to 100 nM PMA for 12 h revealed that the activities and intracellular concentrations of both isozymes were downregulated to an equivalent extent in both wild-type and PMA-resistant cells. These results suggest that the cellular basis for the resistance to the effects of PMA was present ''down-stream'' from the activation and down-regulation of protein kinase C and was perhaps a nuclear component. Among the genes which were likely to be differentially regulated when each of the two cell lines were treated with PMA were those for the protein kinase C isozymes themselves. In wild-type HL-60 cells, the intracellular concentrations of mRNA for each of the beta-isozymes were increased (up to 5-fold) 48 h after the initiation of PMA treatment; further studies indicate that an activator of protein kinase C could influence the expression of HL-60 cell protein kinase C genes in an isozyme-specific manner. Comparable PMA-induced alterations in mRNA levels were not observed in PMA-resistant cells, even under conditions of significant activation and subsequent down-regulation of protein kinase C protein. Taken together, these data suggest that activation and down-regulation of the isozymes of protein kinase C may not represent absolute determinants of the PMA-induced differentiation of HL-60 cells, but that specific alterations in the levels of the mRNA for the beta-isozymes of protein kinase C, or of other genes which may be regulated by the activated kinase isozymes, are important to the induction of leukemia cell differentiation by PMA.	NORTHWESTERN UNIV,SCH MED,DEPT PHARMACOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT PATHOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,CTR CANC,CHICAGO,IL 60611	Northwestern University; Northwestern University; Northwestern University					NCI NIH HHS [T32 CA-09560, CA-44589] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009560, R29CA044589] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; ASHENDEL CL, 1983, CANCER RES, V43, P4333; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BERNSTEIN LR, 1989, SCIENCE, V244, P566, DOI 10.1126/science.2541502; BEYERS AD, 1988, J IMMUNOL, V141, P3463; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CANNISTRA SA, 1990, P NATL ACAD SCI USA, V87, P93, DOI 10.1073/pnas.87.1.93; CHEN KH, 1990, J BIOL CHEM, V265, P19961; COREY SJ, 1989, J BIOL CHEM, V264, P14165; DATTA R, 1991, CELL GROWTH DIFFER, V2, P43; DAVIS GE, 1990, CANCER RES, V50, P1113; DUGAICZYK A, 1983, BIOCHEMISTRY-US, V22, P1605, DOI 10.1021/bi00276a013; EARP HS, 1986, J BIOL CHEM, V261, P4777; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FIELDS AP, 1989, J BIOL CHEM, V264, P21896; GAILANI D, 1989, CANCER RES, V49, P5329; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; HATA A, 1989, FEBS LETT, V252, P144, DOI 10.1016/0014-5793(89)80907-X; HIDAKA H, 1988, J BIOL CHEM, V263, P4523; HOMMA Y, 1988, CANCER RES, V48, P2744; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; HSIAO WLW, 1989, MOL CELL BIOL, V9, P2641, DOI 10.1128/MCB.9.6.2641; HUANG KP, 1986, P NATL ACAD SCI USA, V83, P8535, DOI 10.1073/pnas.83.22.8535; IDO M, 1987, FEBS LETT, V219, P215, DOI 10.1016/0014-5793(87)81219-X; ISAKOV N, 1990, J BIOL CHEM, V265, P2091; ISFORT R, 1988, J BIOL CHEM, V263, P19203; ISSANDOU M, 1988, CANCER RES, V48, P6943; JAKEN S, 1987, P NATL ACAD SCI USA, V84, P4418, DOI 10.1073/pnas.84.13.4418; JOHNSON MD, 1987, MOL CELL BIOL, V7, P2821, DOI 10.1128/MCB.7.8.2821; JOHNSON MD, 1987, ENVIRON HEALTH PERSP, V76, P89, DOI 10.2307/3430469; KOLESNICK RN, 1988, J BIOL CHEM, V263, P6534; KREUTTER D, 1985, J BIOL CHEM, V260, P5979; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MAKOWSKE M, 1988, J BIOL CHEM, V263, P3402; Maniatis T., 1982, MOL CLONING; MARTELL RE, 1987, J BIOL CHEM, V262, P5570; MEGIDISH T, 1989, NATURE, V342, P807, DOI 10.1038/342807a0; MELLONI E, 1987, P NATL ACAD SCI USA, V84, P5282, DOI 10.1073/pnas.84.15.5282; MILLS GB, 1988, CELL, V55, P91, DOI 10.1016/0092-8674(88)90012-8; MORIN MJ, 1987, J BIOL CHEM, V262, P11758; NIEDEL JE, 1983, P NATL ACAD SCI-BIOL, V80, P36, DOI 10.1073/pnas.80.1.36; NISHIKAWA M, 1990, CANCER RES, V50, P621; NISHIZUKA Y, 1989, CANCER, V63, P1892, DOI 10.1002/1097-0142(19890515)63:10<1892::AID-CNCR2820631005>3.0.CO;2-Z; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; OBEID LM, 1990, J BIOL CHEM, V265, P2370; OHNO S, 1987, NATURE, V325, P161, DOI 10.1038/325161a0; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; Posada J A, 1989, Cancer Commun, V1, P285; QUINO A, 1990, BIOCHEM BIOPH RES CO, V166, P723; REDONDO JM, 1988, J BIOL CHEM, V263, P17467; ROGUE P, 1990, J BIOL CHEM, V265, P4161; ROSOFF PM, 1988, CELL, V54, P73, DOI 10.1016/0092-8674(88)90181-X; SANDO JJ, 1983, P NATL ACAD SCI-BIOL, V80, P2642, DOI 10.1073/pnas.80.9.2642; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; SEKIGUCHI K, 1987, BIOCHEM BIOPH RES CO, V145, P797, DOI 10.1016/0006-291X(87)91035-7; SHAW G, 1983, CELL, V44, P659; SHERMAN ML, 1990, J BIOL CHEM, V265, P3320; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X; VANDENBARK GR, 1984, J NATL CANCER I, V73, P1013; WADA H, 1989, BIOCHEM BIOPH RES CO, V165, P533, DOI 10.1016/0006-291X(89)91102-9; WALKER F, 1985, CELL, V43, P269, DOI 10.1016/0092-8674(85)90032-7; WHETTON AD, 1988, P NATL ACAD SCI USA, V85, P3284, DOI 10.1073/pnas.85.10.3284; YAMAMOTO S, 1985, J BIOL CHEM, V260, P4230; YOSHIDA Y, 1988, J BIOL CHEM, V263, P9868	68	49	51	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15135	15143						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714454				2022-12-27	WOS:A1991GB09700052
J	CAIN, CC; WILSON, RB; MURPHY, RF				CAIN, CC; WILSON, RB; MURPHY, RF			ISOLATION BY FLUORESCENCE-ACTIVATED CELL SORTING OF CHINESE-HAMSTER OVARY CELL-LINES WITH PLEIOTROPIC, TEMPERATURE-CONDITIONAL DEFECTS IN RECEPTOR RECYCLING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; RABBIT ALVEOLAR MACROPHAGES; TRANSFERRIN RECEPTOR; MEDIATED ENDOCYTOSIS; IMMUNOELECTRON MICROSCOPY; SURFACE-RECEPTORS; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; KINASE-ACTIVITY; RAT-LIVER	We have isolated several Chinese hamster ovary cell lines with temperature-sensitive defects in the recycling of receptors after endocytosis. These cell lines were selected using fluorescence-activated cell sorting for retention of a pulse of labeled transferrin after a chase in the presence of unlabeled transferrin. One of these cell lines, TfT1.11, was selected for further characterization. In TfT1.11 the trapping of transferrin within the cells is paralleled by a loss of cell surface transferrin receptors. Within 4 h after the shift from 33 to 41-degrees-C the surface binding of transferrin is reduced to 18% of parental cells at 41-degrees-C. The trapping of transferrin and the loss of transferrin receptor from the cell surface are caused by a temperature-conditional 5.5-fold decrease in the initial rate of transferrin recycling. TfT1.11 cells also rapidly lose 89% of their ability to take up alpha-2-macroglobulin after the temperature shift to 41-degrees-C. These data indicate that the TfT1.11 cell line has a pleiotropic defect in receptor recycling.	CARNEGIE MELLON UNIV,DEPT BIOL SCI,4400 5TH AVE,PITTSBURGH,PA 15213; CARNEGIE MELLON UNIV,CTR FLUORESCENCE RES BIOMED SCI,PITTSBURGH,PA 15213	Carnegie Mellon University; Carnegie Mellon University			Mastick, Cynthia/G-9841-2017	Mastick, Cynthia/0000-0003-4769-5412	NIGMS NIH HHS [GM32508, GM13179] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032508, F32GM013179] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; BUYS SS, 1987, J BIOL CHEM, V262, P12970; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; COLBAUGH PA, 1989, J CELL BIOL, V108, P2211, DOI 10.1083/jcb.108.6.2211; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; DAVIS RJ, 1987, J BIOL CHEM, V262, P13126; DAVIS RJ, 1987, J BIOL CHEM, V262, P16041; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; DUNN WA, 1984, J CELL BIOL, V98, P2148, DOI 10.1083/jcb.98.6.2148; FELDER S, 1990, CELL, V61, P623, DOI 10.1016/0092-8674(90)90474-S; FUCHS R, 1989, P NATL ACAD SCI USA, V86, P539, DOI 10.1073/pnas.86.2.539; GEUZE HJ, 1983, CELL, V32, P277, DOI 10.1016/0092-8674(83)90518-4; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; GONZALEZNORIEGA A, 1980, J CELL BIOL, V85, P839, DOI 10.1083/jcb.85.3.839; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HEARING J, 1989, J CELL BIOL, V108, P339, DOI 10.1083/jcb.108.2.339; HONEGGER AM, 1987, CELL, V51, P199, DOI 10.1016/0092-8674(87)90147-4; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; KAPLAN J, 1980, CELL, V19, P197, DOI 10.1016/0092-8674(80)90401-8; KAPLAN J, 1981, J BIOL CHEM, V256, P7705; KAPLAN J, 1979, J BIOL CHEM, V254, P7329; KLAUSNER RD, 1984, J CELL BIOL, V98, P1098, DOI 10.1083/jcb.98.3.1098; KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263; KURECKI T, 1979, ANAL BIOCHEM, V99, P415, DOI 10.1016/S0003-2697(79)80026-3; LINDERMAN JJ, 1988, J THEOR BIOL, V132, P203, DOI 10.1016/S0022-5193(88)80157-7; LIPSON KE, 1988, J BIOL CHEM, V263, P10495; MARNELL MH, 1984, INFECT IMMUN, V44, P145, DOI 10.1128/IAI.44.1.145-150.1984; MCGRAW TE, 1988, J CELL BIOL, V106, P1061, DOI 10.1083/jcb.106.4.1061; MCKINLEY DN, 1988, J CELL PHYSIOL, V136, P389, DOI 10.1002/jcp.1041360302; MELLMAN I, 1984, J CELL BIOL, V98, P1163, DOI 10.1083/jcb.98.4.1163; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MERION M, 1983, P NATL ACAD SCI-BIOL, V80, P5315, DOI 10.1073/pnas.80.17.5315; MUELLER SC, 1986, J CELL BIOL, V102, P932, DOI 10.1083/jcb.102.3.932; MURPHY RF, 1979, NUCLEIC ACIDS RES, V6, P3911, DOI 10.1093/nar/6.12.3911; OKEEFE DO, 1988, SOMAT CELL MOLEC GEN, V14, P473, DOI 10.1007/BF01534713; PEARSE BMF, 1988, EMBO J, V7, P3331, DOI 10.1002/j.1460-2075.1988.tb03204.x; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; ROEDERER M, 1988, EUR J CELL BIOL, V48, P37; ROFF CF, 1986, J CELL BIOL, V103, P2283, DOI 10.1083/jcb.103.6.2283; SCHARTZ AL, 1982, J BIOL CHEM, V257, P4230; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SIPE DM, 1987, P NATL ACAD SCI USA, V84, P7119, DOI 10.1073/pnas.84.20.7119; SOUTHWICK PL, 1990, CYTOMETRY, V11, P418, DOI 10.1002/cyto.990110313; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; STOORVOGEL W, 1989, J CELL BIOL, V108, P2137, DOI 10.1083/jcb.108.6.2137; TANNER LI, 1989, J CELL BIOL, V108, P1537, DOI 10.1083/jcb.108.4.1537; TANNER LI, 1987, J BIOL CHEM, V262, P8975; WAGNER M, 1990, CYTOMETRY S, V4, P75; WARD DM, 1989, J BIOL CHEM, V264, P8164	52	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11746	11752						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711039				2022-12-27	WOS:A1991FT76200052
J	HAVILAND, DL; HAVILAND, JC; FLEISCHER, DT; WETSEL, RA				HAVILAND, DL; HAVILAND, JC; FLEISCHER, DT; WETSEL, RA			STRUCTURE OF THE MURINE 5TH COMPLEMENT COMPONENT (C5) GENE - A LARGE, HIGHLY INTERRUPTED GENE WITH A VARIANT DONOR SPLICE SITE AND ORGANIZATIONAL HOMOLOGY WITH THE 3RD AND 4TH COMPLEMENT COMPONENT GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ALPHA-2-MACROGLOBULIN GENE; SEQUENCE-ANALYSIS; MOLECULAR-BASIS; MOUSE; CHAIN; DEFICIENCY; PROMOTER; BIOSYNTHESIS; INDUCTION; PRO-C5	To understand fifth complement component (C5) gene regulation, splicing, and C5 protein deficiency at the molecular level, the organization of the murine C5 gene was determined. The C5 structural gene is present as a single copy in the mouse genome as demonstrated by Southern blot analysis. Accordingly, three cosmid clones were isolated from a genomic library that was prepared from mouse strain B10.D2/nSnJ. These clones overlapped and contained the structural gene encoding the complete C5 alpha-chain and 90% of the beta-chain. The 5'-flanking region of the C5 gene was obtained from a clone isolated from a genomic lambda-MOPC-41 library. Unique restriction fragments were prepared from the genomic clones and subcloned, and the exons were sequenced. All introns were sized by sequencing or Southern analysis. The C5 structural gene was found to be a highly interrupted gene of approximately 78 kilobases containing 42 exons and 41 introns. The exons ranged in length from 58 to 247 base pairs, with an average length of 131 base pairs. The introns ranged in size from 100 base pairs to 4 kilobases with an average length of 1.5 kilobases. The C5 alpha-chain was encoded by 49 kilobases containing 26 exons; the beta-chain was encoded by 29 kilobases containing 16 exons. The C5a coding sequence was split between two exons. All intron/exon junctions followed the normal consensus rule except at intron 35 in which the 5'-donor GT was substituted by GC. The 2-base-pair gene deletion and HindIII and PvuII restriction fragment length polymorphisms associated with murine C5 deficiency were localized to exon 7, exon 16, and intron 20, respectively. Comparison of the intron-exon junctions of the murine C5, human C3, and mouse C4 genes indicated that these genes are nearly identical in structural organization. However, the rat alpha-2-macroglobulin gene showed only moderate genomic organizational similarity to the murine C5 gene. A major and a minor transcriptional initiation site in the C5 gene were identified by primer extensions and confirmed by RNase protection assays. Sequence analysis of the 5'-flanking region (760 base pairs) revealed a TATA-like and CAAT box upstream of the major transcriptional initiation site at positions -274 and -303, respectively, suggesting an atypical promoter. The 5'-flanking region also contained sequences identical with several cis-acting motifs known to bind the liver-specific nuclear protein LF-A1 and the nuclear protein NF-kappa-B. In addition, cis sequences that are thought to be involved in IL-6 and dexamethasone-mediated gene expression were found upstream of the transcriptional initiation site.	WASHINGTON UNIV,SCH MED,DEPT PEDIAT,BOX 8116,400 S KINGSHIGHWAY BLVD,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)			Haviland, David/ABH-4952-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R55AI025011, R01AI025011, R01AI024836] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37951] Funding Source: Medline; NIAID NIH HHS [AI24836, AI25011] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARNUM SR, 1989, J BIOL CHEM, V264, P8471; DEUSTACHIO P, 1986, J IMMUNOL, V137, P3990; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FONG KY, 1990, GENOMICS, V7, P579, DOI 10.1016/0888-7543(90)90202-6; HARDON EM, 1988, EMBO J, V7, P1711, DOI 10.1002/j.1460-2075.1988.tb03000.x; HATTORI M, 1989, GENE, V77, P333, DOI 10.1016/0378-1119(89)90081-4; HAVILAND DL, 1991, J IMMUNOL, V146, P362; KINGSTON RE, 1989, CURRENT PROTOCOLS MO; KUNZ D, 1989, NUCLEIC ACIDS RES, V17, P1121, DOI 10.1093/nar/17.3.1121; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LUNDWALL AB, 1985, J BIOL CHEM, V260, P2108; Maniatis T, 1989, DECONTAMINATION DILU; MONT SM, 1982, NUCLEIC ACIDS RES, V10, P459; NILSSON UR, 1975, J IMMUNOL, V114, P815; OGATA RT, 1989, J BIOL CHEM, V264, P16565; OLIVIERO S, 1987, EMBO J, V6, P1905, DOI 10.1002/j.1460-2075.1987.tb02450.x; OOI YM, 1979, J IMMUNOL, V123, P2494; PATEK PQ, 1978, NATURE, V276, P510, DOI 10.1038/276510a0; PATEL F, 1979, J IMMUNOL, V123, P2408; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; RYFFEL GU, 1989, NUCLEIC ACIDS RES, V17, P939, DOI 10.1093/nar/17.3.939; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEIDMAN JG, 1978, NATURE, V276, P790, DOI 10.1038/276790a0; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; SOTTRUPJENSEN L, 1986, PLASMA PROTEINS, V5, P191; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TACK BF, 1979, BIOCHEMISTRY-US, V18, P1490, DOI 10.1021/bi00575a016; TSUCHIYA Y, 1987, GENE, V57, P73; VIK DP, 1991, BIOCHEMISTRY-US, V30, P1080, DOI 10.1021/bi00218a029; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; WETSEL RA, 1987, BIOCHEMISTRY-US, V26, P737, DOI 10.1021/bi00377a013; WETSEL RA, 1988, BIOCHEMISTRY-US, V27, P1474, DOI 10.1021/bi00405a012; WETSEL RA, 1991, IN PRESS BIOCH MOL B; WHEAT WH, 1987, J EXP MED, V165, P1442, DOI 10.1084/jem.165.5.1442; ZAHEDI K, 1989, J IMMUNOL, V143, P2880	38	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11818	11825						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711041				2022-12-27	WOS:A1991FT76200062
J	EFRAT, S; SURANA, M; FLEISCHER, N				EFRAT, S; SURANA, M; FLEISCHER, N			GLUCOSE INDUCES INSULIN GENE-TRANSCRIPTION IN A MURINE PANCREATIC BETA-CELL LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II 5'-FLANKING REGION; TRANSGENIC MICE; MESSENGER-RNA; CA-2+ CHANNELS; HIT CELLS; EXPRESSION; SEQUENCES; ENHANCER; ISLETS; METABOLISM	The ability of insulin secretagogues to stimulate insulin gene transcription was analyzed in the murine insulinoma cell line beta-TC3, which had been derived from a transgenic mouse expressing SV40 T antigen under control of the rat insulin II gene regulatory region. Glucose induced a 3-fold increase in the transcription of both the endogenous mouse insulin genes and the transgene. This effect was inhibited by D600, a calcium channel blocker, which also inhibited glucose-induced insulin secretion in these cells. This suggests that similar signals may be involved in glucose-stimulated insulin secretion and insulin gene transcription. Agents that increase intracellular levels of cAMP did not have a significant effect on the transcription of either the insulin genes or the transgene. Stimulation of transcription of the RIP-Tag transgene by glucose suggests that the 695-base pair fragment of the insulin gene regulatory region that is included in the transgene contains the cis elements required for response to the glucose-induced signal.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,CTR DIABET RES & TRAINING,BRONX,NY 10461	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	EFRAT, S (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MOLEC PHARMACOL,BRONX,NY 10461, USA.			Efrat, Shimon/0000-0001-5987-232X	NIDDK NIH HHS [DK20541] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARKHAMMAR P, 1987, J BIOL CHEM, V262, P5448; AXEN KV, 1983, J CLIN INVEST, V72, P13, DOI 10.1172/JCI110951; BOYD AE, 1989, INSULIN SECRETION, P93; BRUNSTEDT J, 1982, BIOCHEM BIOPH RES CO, V106, P1383, DOI 10.1016/0006-291X(82)91267-0; CROWE DT, 1989, MOL CELL BIOL, V9, P1784, DOI 10.1128/MCB.9.4.1784; DAMBRA R, 1990, ENDOCRINOLOGY, V126, P2815, DOI 10.1210/endo-126-6-2815; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; EFRAT S, 1987, MOL CELL BIOL, V7, P192, DOI 10.1128/MCB.7.1.192; EFRAT S, 1989, TRANSFORMING PROTEIN, P89; FLEISCHER N, 1989, INTRACELLULAR SIGNAL, P107; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; GOLD G, 1989, INSULIN SECRETION, P25; HALBAN PA, 1983, BIOCHEM J, V212, P439, DOI 10.1042/bj2120439; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; HENQUIN JC, 1984, ENDOCRINOLOGY, V115, P1125, DOI 10.1210/endo-115-3-1125; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; OHLSSON H, 1986, CELL, V45, P35, DOI 10.1016/0092-8674(86)90535-0; OHLSSON H, 1988, P NATL ACAD SCI USA, V85, P4228, DOI 10.1073/pnas.85.12.4228; PHILIPPE J, 1990, J BIOL CHEM, V265, P1465; RAJAN AS, 1989, DIABETES, V38, P874, DOI 10.2337/diabetes.38.7.874; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SMITH PA, 1989, NATURE, V342, P550, DOI 10.1038/342550a0; WALKER MD, 1990, NUCLEIC ACIDS RES, V18, P1159, DOI 10.1093/nar/18.5.1159; WELSH M, 1986, DIABETES, V35, P228, DOI 10.2337/diabetes.35.2.228; WHELAN J, 1989, MOL CELL BIOL, V9, P3253, DOI 10.1128/MCB.9.8.3253; WHELAN J, 1990, MOL CELL BIOL, V10, P1564, DOI 10.1128/MCB.10.4.1564	28	88	90	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11141	11143						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710218				2022-12-27	WOS:A1991FQ77400068
J	ENGLISH, BK; WEAVER, WM; WILSON, CB				ENGLISH, BK; WEAVER, WM; WILSON, CB			DIFFERENTIAL REGULATION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR GENES IN HUMAN LYMPHOCYTES-T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; HUMAN-ENDOTHELIAL CELLS; HUMAN B-CELLS; FACTOR CACHECTIN; MESSENGER-RNA; FACTOR-ALPHA; IMMUNE INTERFERON; FACTOR-BETA; GROWTH-FACTOR; TNF-ALPHA	Lymphotoxin (LT) and tumor necrosis factor (TNF) are related cytokines that share many biological effects. The genes for LT and TNF are adjacent to each other on chromosome 6 in man, but previous data indicate that the kinetics of their production differ markedly. To explain the mechanisms for this difference, we compared the regulation of these two genes in human T lymphocytes, isolated from peripheral blood, after stimulation with the mitogens concanavalin A and phorbol myristate acetate. Differences in the kinetics of protein secretion were paralleled by differences in cognate mRNA accumulation. TNF mRNA accumulated rapidly after stimulation, peaked by 6 h, and returned to unstimulated (base-line) levels by 24 h. In contrast, LT mRNA accumulated slowly after stimulation, usually peaked at approximately 18 h, and remained increased above base-line levels at 48-72 h. By nuclear transcription run-on assays, increased transcription of TNF mRNA and LT mRNA was demonstrated after stimulation. However, TNF transcription peaked earlier and appeared to be 4-10 times greater than that of the LT gene. In contrast, the half-life of LT mRNA was 8-10-fold longer than that of TNF mRNA as demonstrated by actinomycin D pulse-chase experiments. Cycloheximide did not block LT or TNF mRNA accumulation, indicating that new protein synthesis was not required for induction of either gene. These results suggest strongly that the LT and TNF genes are regulated differently in human T lymphocytes after mitogen stimulation. TNF mRNA accumulates rapidly primarily because of increased transcription and decreases rapidly related to its brief half-life. In contrast, LT mRNA accumulates more slowly but persists much longer; the accumulation of this mRNA appears to be controlled largely by post-transcriptional mechanisms.	UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; CHILDRENS HOSP & MED CTR,DIV IMMUNOL,SEATTLE,WA 98105; CHILDRENS HOSP & MED CTR,DIV RHEUMATOL & INFECT DIS,SEATTLE,WA 98105	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital					NHLBI NIH HHS [HL39157] Funding Source: Medline; NIAID NIH HHS [AI16760] Funding Source: Medline; NICHD NIH HHS [HD18184] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018184, R37HD018184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL039157] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGGARWAL BB, 1985, J BIOL CHEM, V260, P2345; AGGARWAL BB, 1985, J BIOL CHEM, V260, P2334; BEUTLER B, 1985, NATURE, V316, P552, DOI 10.1038/316552a0; BEUTLER B, 1986, SCIENCE, V232, P977, DOI 10.1126/science.3754653; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BROUDY VC, 1987, J IMMUNOL, V138, P4298; BROWNING J, 1989, J IMMUNOL, V143, P1859; BURCHETT SK, 1988, J IMMUNOL, V140, P3473; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; CLIFF A, 1987, CELL, V50, P555; COLLART MA, 1986, J EXP MED, V164, P2113, DOI 10.1084/jem.164.6.2113; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CUTURI MC, 1987, J EXP MED, V165, P1581, DOI 10.1084/jem.165.6.1581; DEGLIANTONI G, 1985, J EXP MED, V162, P1512, DOI 10.1084/jem.162.5.1512; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; ENGLISH BK, 1988, PEDIATR RES, V24, P717; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FISCHER H, 1990, J IMMUNOL, V144, P4663; GRANGER GA, 1968, NATURE, V218, P1253, DOI 10.1038/2181253a0; GRAY PW, 1984, NATURE, V312, P721, DOI 10.1038/312721a0; GREEN LM, 1986, J IMMUNOL, V137, P3488; HERRIN DL, 1988, BIOTECHNIQUES, V6, P196; JONGENEEL CV, 1989, J CELL BIOCHEM, V13, P230; KEHRL JH, 1987, J EXP MED, V166, P786, DOI 10.1084/jem.166.3.786; KEHRL JH, 1987, SCIENCE, V238, P1144, DOI 10.1126/science.3500512; KRONKE M, 1985, J EXP MED, V161, P1593, DOI 10.1084/jem.161.6.1593; LEWIS DB, 1986, J EXP MED, V163, P1018, DOI 10.1084/jem.163.4.1018; LOCKSLEY RM, 1987, J IMMUNOL, V139, P1891; MANIATIS T, 1982, MOL CLONING LABORATO, P187; MESTAN J, 1986, NATURE, V323, P816, DOI 10.1038/323816a0; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; NELSON JA, 1986, MOL CELL BIOL, V6, P452, DOI 10.1128/MCB.6.2.452; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; PAYA CV, 1988, J IMMUNOL, V141, P1989; PENNICA D, 1984, NATURE, V312, P724, DOI 10.1038/312724a0; PERLMUTTER DH, 1986, J CLIN INVEST, V78, P1349, DOI 10.1172/JCI112721; PERUSSIA B, 1987, J IMMUNOL, V138, P765; PETERS PM, 1986, J IMMUNOL, V137, P2592; PIGUET PF, 1987, IMMUNOBIOLOGY, V175, P27; RUDDLE NH, 1967, SCIENCE, V157, P1060, DOI 10.1126/science.157.3792.1060; SARIBAN E, 1988, J CLIN INVEST, V81, P1506, DOI 10.1172/JCI113482; SCHEURICH P, 1987, J IMMUNOL, V138, P1786; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; SHALABY MR, 1985, J IMMUNOL, V135, P2069; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHAW J, 1987, MOL IMMUNOL, V24, P409, DOI 10.1016/0161-5890(87)90014-9; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SPIES T, 1986, P NATL ACAD SCI USA, V83, P8699, DOI 10.1073/pnas.83.22.8699; STEFFEN M, 1988, J IMMUNOL, V140, P2621; SUNG SSJ, 1988, J EXP MED, V168, P1539, DOI 10.1084/jem.168.5.1539; SUNG SSJ, 1988, J EXP MED, V167, P937, DOI 10.1084/jem.167.3.937; TANIGUCHI T, 1988, ANNU REV IMMUNOL, V6, P439, DOI 10.1146/annurev.iy.06.040188.002255; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRINCHIERI G, 1986, J EXP MED, V164, P1206, DOI 10.1084/jem.164.4.1206; TURNER M, 1988, BIOCHEM BIOPH RES CO, V153, P1144, DOI 10.1016/S0006-291X(88)81347-0; WILSON CB, 1979, CLIN EXP IMMUNOL, V36, P511; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0	60	43	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					7108	7113						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707879				2022-12-27	WOS:A1991FG72700073
J	MCGOWAN, JL; KESSLER, SP; ANDERSON, DC; GALLOWAY, DR				MCGOWAN, JL; KESSLER, SP; ANDERSON, DC; GALLOWAY, DR			IMMUNOCHEMICAL ANALYSIS OF PSEUDOMONAS-AERUGINOSA EXOTOXIN-A - ANALYSIS OF THE HIS426 DETERMINANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; DIPHTHERIA-TOXIN; GLUTAMIC ACID-553; ACTIVE-SITE; PROTEIN; EXPRESSION; HOMOLOGY; SEQUENCE; DOMAINS; PEPTIDE	This study describes a combined immunochemical and genetic approach defining a site on Pseudomonas aeruginosa exotoxin A (ETA) which is critical to the ADP-ribosyltransferase (ADPRT) activity of the toxin. The sequential epitope of a monoclonal antibody (TC-1) which binds to domain III (residues 405-613), containing the ADPRT activity of ETA, has been defined using a series of synthetic peptides. This epitope spans residues 422-432 which composes the major alpha-helical segment of domain III and includes His426 which has previously been shown to be essential for ADPRT activity (Wozniak, D. J., Hsu, L.-Y., and Galloway, D. R. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 8880-8884). The critical His426 residue which projects into a major cleft becomes exposed when the ETA protein is in an ADPRT-active configuration. Since the TC-1 mAb does not block the binding of NAD+, it is possible that the alpha-helix site containing the TC-1 epitope and the His426 residue is associated with the interaction between ETA and its elongation factor 2 substrate.	OHIO STATE UNIV, DEPT MICROBIOL, COLUMBUS, OH 43210 USA	University System of Ohio; Ohio State University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K04AI000876] Funding Source: NIH RePORTER; NIAID NIH HHS [AI123429-04, AI00876-02] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLURED VS, 1986, P NATL ACAD SCI USA, V83, P1320, DOI 10.1073/pnas.83.5.1320; ANDERSON DC, 1988, J IMMUNOL, V141, P607; BARBIERI JT, 1989, J BACTERIOL, V171, P4362, DOI 10.1128/JB.171.8.4362-4369.1989; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRANDHUBER BJ, 1988, PROTEINS, V3, P146, DOI 10.1002/prot.340030303; CARROLL SF, 1987, J BIOL CHEM, V262, P8707; CARROLL SF, 1988, MOL MICROBIOL, V2, P293, DOI 10.1111/j.1365-2958.1988.tb00031.x; CHAUDHARY VK, 1990, P NATL ACAD SCI USA, V87, P308, DOI 10.1073/pnas.87.1.308; CHUNG DW, 1977, INFECT IMMUN, V16, P832, DOI 10.1128/IAI.16.3.832-841.1977; CRYZ SJ, 1980, P NATL ACAD SCI-BIOL, V77, P7199, DOI 10.1073/pnas.77.12.7199; DOUGLAS CM, 1987, J BACTERIOL, V169, P4967, DOI 10.1128/jb.169.11.4967-4971.1987; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GALLOWAY DR, 1984, INFECT IMMUN, V44, P262, DOI 10.1128/IAI.44.2.262-267.1984; GALLOWAY DR, 1989, J BIOL CHEM, V264, P14869; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; HWANG J, 1987, CELL, V48, P129, DOI 10.1016/0092-8674(87)90363-1; HWANG JL, 1989, J BIOL CHEM, V264, P2379; Iglewski B H, 1979, Methods Enzymol, V60, P780; JOHNSON S, 1987, P AM SOC MICROBIOLOG, pB52; KANDEL J, 1974, J BIOL CHEM, V249, P2088; LEPPLA SH, 1976, INFECT IMMUN, V14, P1077, DOI 10.1128/IAI.14.4.1077-1086.1976; LUKAC M, 1988, BIOCHEMISTRY-US, V27, P7629, DOI 10.1021/bi00420a009; OHMAN DE, 1980, INFECT IMMUN, V28, P899; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TARTOF K, 1989, FOCUS, V9, P12; VOLLER A, 1976, B WORLD HEALTH ORGAN, V53, P55; WILLIS RC, 1974, ARCH BIOCHEM BIOPHYS, V161, P64, DOI 10.1016/0003-9861(74)90235-5; WOZNIAK DJ, 1988, P NATL ACAD SCI USA, V85, P8880, DOI 10.1073/pnas.85.23.8880; WOZNIAK DJ, 1987, NUCLEIC ACIDS RES, V15, P2123, DOI 10.1093/nar/15.5.2123	29	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4911	4916						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1705936				2022-12-27	WOS:A1991FC21700038
J	OWENSBY, DA; MORTON, PA; WUN, TC; SCHWARTZ, AL				OWENSBY, DA; MORTON, PA; WUN, TC; SCHWARTZ, AL			BINDING OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 TO EXTRACELLULAR-MATRIX OF HEP-G2 CELLS - EVIDENCE THAT THE BINDING-PROTEIN IS VITRONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL CELLS; LINE HEP-G2; ASIALOGLYCOPROTEIN RECEPTOR; POLYACRYLAMIDE GELS; ANTITHROMBIN-III; SPREADING FACTOR; SARCOMA-CELLS; HUMAN-PLASMA; PURIFICATION; COMPLEX	Catabolism of plasminogen activators by Hep G2 cells is mediated by a specific receptor which recognizes complexes of these serine proteases with their physiological inhibitor, plasminogen activator inhibitor type-1 (PAI-1). This catabolic process is initiated by interaction of exogenous plasminogen activators with bioactive PAI-1, which is secreted and localizes in an active form to the extracellular matrix (ECM) of Hep G2 cells. We now report that vitronectin (VN) mediates the specific binding of PAI-1 to the ECM of these cells. Purified bovine or human VN competes for specific binding of PAI-1 to Hep G2 ECM, and ligand blotting reveals specific binding of PAI-1 to ECM-associated VN. Hep G2 cells secrete both VN and PAI-1, and pulse-chase studies strongly suggest that these proteins associate only following secretion. Although Hep G2 cell-derived VN does not significantly bind to ECM in vitro, 30-40% of endogenous PAI-1 binds to the ECM, even in the presence of human serum, suggesting that ECM-associated VN is entirely derived from bovine serum. PAI-1 was localized by indirect immunofluorescence to ECM beneath cells and at cell margins, whereas VN exhibited a uniform distribution throughout the growth substratum. VN associated with the ECM may confer retention and bioactivity to PAI-1, potentially facilitating both pericellular regulation of plasmin generation and the rapid hepatic clearance of plasminogen activators.	WASHINGTON UNIV, ST LOUIS CHILDRENS HOSP, SCH MED, EDWARD MALLINCKRODT DEPT PEDIAT & PHARMACOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, ST LOUIS CHILDRENS HOSP,SCH MED,DEPT MED, DIV CARDIOVASC, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, ST LOUIS CHILDRENS HOSP, SCH MED, DIV HEMATOL ONCOL, ST LOUIS, MO 63110 USA; MONSANTO CO, CHESTERFIELD, MO 63198 USA	St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Monsanto					NHLBI NIH HHS [HL 17646, 5-T32-HL-07081-15] Funding Source: Medline; NIGMS NIH HHS [GM 38284] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL017646, T32HL007081, P50HL017646] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARNES DW, 1985, J CELL PHYSIOL, V125, P207, DOI 10.1002/jcp.1041250206; COLUCCI M, 1985, J CLIN INVEST, V75, P818, DOI 10.1172/JCI111777; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; DEBLAS AL, 1983, ANAL BIOCHEM, V133, P214, DOI 10.1016/0003-2697(83)90245-2; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HEKMAN CM, 1988, BIOCHEMISTRY-US, V27, P2911, DOI 10.1021/bi00408a037; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; ILL CR, 1985, J BIOL CHEM, V260, P5610; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KNUDSEN BS, 1987, J CLIN INVEST, V80, P1082, DOI 10.1172/JCI113164; KNUDSEN BS, 1988, J BIOL CHEM, V263, P9476; KOOISTRA T, 1986, BIOCHEM J, V239, P497, DOI 10.1042/bj2390497; KRUITHOF E K O, 1988, Fibrinolysis, V2, P59; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIHO M, 1987, J BIOL CHEM, V262, P17467; LAMBERS JWJ, 1987, J BIOL CHEM, V262, P17492; LEVIN EG, 1986, BLOOD, V67, P1309; LEVIN EG, 1987, BLOOD, V70, P1090; LEVIN EG, 1987, J CELL BIOL, V105, P2543, DOI 10.1083/jcb.105.6.2543; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; LUCORE CL, 1988, CIRCULATION, V77, P660, DOI 10.1161/01.CIR.77.3.660; MIMURO J, 1987, BLOOD, V70, P721; MIMURO J, 1989, J BIOL CHEM, V264, P936; MIMURO J, 1989, J BIOL CHEM, V264, P5058; MORTON PA, 1990, J BIOL CHEM, V265, P14093; MORTON PA, 1989, J BIOL CHEM, V264, P7228; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; OWENSBY DA, 1988, J BIOL CHEM, V263, P10587; OWENSBY DA, 1989, J BIOL CHEM, V264, P18180; PERLMUTTER DH, 1990, J BIOL CHEM, V265, P16713; PERLMUTTER DH, 1990, J BIOL CHEM, V87, P3753; PIZZO SV, 1989, AM J MED, V87, pS10, DOI 10.1016/0002-9343(89)80524-8; POLLANEN J, 1987, J CELL BIOL, V104, P1085, DOI 10.1083/jcb.104.4.1085; PREISSNER KT, 1989, BLOOD, V74, P1989; PREISSNER KT, 1988, THROMB HAEMOSTASIS, V60, P399; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; SALONEN EM, 1984, FEBS LETT, V172, P29, DOI 10.1016/0014-5793(84)80866-2; SCHLEEF RR, 1990, J CELL BIOL, V110, P155, DOI 10.1083/jcb.110.1.155; SCHWARTZ AL, 1983, J BIOL CHEM, V258, P1249; SCHWARTZ AL, 1981, J BIOL CHEM, V256, P8878; SHIFMAN MA, 1982, J BIOL CHEM, V257, P3243; SPRENGERS ED, 1985, J LAB CLIN MED, V105, P751; SPRENGERS ED, 1987, BLOOD, V69, P381; STEPHENS RW, 1989, J CELL BIOL, V108, P1987, DOI 10.1083/jcb.108.5.1987; SUZUKI S, 1986, P NATL ACAD SCI USA, V83, P8614, DOI 10.1073/pnas.83.22.8614; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WIMAN B, 1984, J BIOL CHEM, V259, P3644; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2; WIMAN B, 1988, THROMB HAEMOSTASIS, V59, P392; WUN TC, 1989, J BIOL CHEM, V264, P7862; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	57	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4334	4340						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705551				2022-12-27	WOS:A1991FA69400051
J	NILSEN, BM; SLETTEN, K; PAULSEN, BS; ONEILL, M; VANHALBEEK, H				NILSEN, BM; SLETTEN, K; PAULSEN, BS; ONEILL, M; VANHALBEEK, H			STRUCTURAL-ANALYSIS OF THE GLYCOPROTEIN ALLERGEN ART UPSILON-II FROM THE POLLEN OF MUGWORT (ARTEMISIA-VULGARIS L)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; VENOM PHOSPHOLIPASE-A2; CARBOHYDRATE; SEQUENCE; SPECTROSCOPY; PURIFICATION; BIOSYNTHESIS; ANTIBODIES; EMPHASIS; POSITION	The glycoprotein allergen Art v II, from the pollen of mugwort (Artemisia vulgaris L.) was treated with peptide:N-glycosidase F (PNGase F) to release asparagine-linked oligosaccharides. The oligosaccharides were isolated by gel permeation chromatography and their structures determined by 500-MHz H-1 NMR spectroscopy, fast atom bombardment-mass spectrometry, and high-pH anion-exchange chromatography. The high-mannose oligosaccharides Man5GlcNAc2, Man6GlcNAc2, Man7GlcNAc2, Man8GlcNAc2, and Man9GlcNA2 were present in the ratios 2:49:19:24:6 and accounted for all the asparagine-linked oligosaccharides released from Art v II by PNGase F. The NH2-terminal amino acid sequences of Art v II and of four peptides generated by cyanogen bromide (CNBr) cleavage of deglycosylted Art v II were determined. The first 30 amino acid residues of Art v II did not contain any potential N-glycosylation sites. One potential N-glycosylation site was identified in one of the CNBr fragments. The native protein conformation was shown by enzyme-linked immunosorbent assay inhibition assays to be essential for the binding of rabbit IgG to Art v II and for the binding of human IgE to the major IgE-binding epitope(s) in this allergen. At least one minor IgE-binding epitope still bound IgE after denaturation of the allergen. Removal of the high-mannose chains from denatured Art v II had no significant effect on the binding of human IgE to the minor IgE-binding epitope(s).	UNIV OSLO,DEPT BIOCHEM,OSLO 3,NORWAY; UNIV GEORGIA,COMPLEX CARBOHYDRATE RES CTR,ATHENS,GA 30602; UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602	University of Oslo; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	NILSEN, BM (corresponding author), UNIV OSLO,DEPT PHARM,OSLO 3,NORWAY.				NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR-05351] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ARGADE SP, 1988, ARCH BIOCHEM BIOPHYS, V266, P227, DOI 10.1016/0003-9861(88)90254-8; AXELSEN NH, 1983, SCAND J IMMUNOL S10, V17, P103; CHAMBERS RE, 1971, BIOCHEM J, V125, P1009, DOI 10.1042/bj1251009; CHAPMAN MD, 1988, J IMMUNOL, V140, P812; DELAHOZ F, 1990, MOL IMMUNOL, V27, P651, DOI 10.1016/0161-5890(90)90008-N; DELL A, 1986, BIOCHEM BIOPH RES CO, V135, P1126, DOI 10.1016/0006-291X(86)91045-4; DIENER C, 1988, Allergie und Immunologie (Leipzig), V34, P3; Dische Z, 1962, METHODS CARBOHYDRATE, P478; ELBEIN AD, 1990, METHODS PLANT BIOCH, V2, P79; FAYE L, 1989, PHYSIOL PLANTARUM, V75, P309, DOI 10.1111/j.1399-3054.1989.tb06187.x; GREEN ED, 1988, J BIOL CHEM, V263, P18253; HAASNOOT CAG, 1983, J MAGN RESON, V52, P153, DOI 10.1016/0022-2364(83)90268-8; HAAVIK S, 1985, INT ARCH ALLER A IMM, V78, P197, DOI 10.1159/000233884; HARBOE M, 1983, SCAND J IMMUNOL S10, V17, P353; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; IPSEN H, 1985, ALLERGY, V40, P289, DOI 10.1111/j.1398-9995.1985.tb00234.x; Kobata A., 1984, BIOL CARBOHYDRATES, V2, P87; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MUTSAERS JHGM, 1985, EUR J BIOCHEM, V147, P569; NEESER JR, 1985, GLYCOCONJ J, V0002; NILSEN BM, 1990, MOL IMMUNOL, V27, P1047, DOI 10.1016/0161-5890(90)90128-M; NILSEN BM, 1986, INT ARCH ALLER A IMM, V80, P113, DOI 10.1159/000234037; PAULSEN BS, 1985, INT ARCH ALLER A IMM, V78, P206; SLETTEN K, 1974, EUR J BIOCHEM, V41, P117, DOI 10.1111/j.1432-1033.1974.tb03251.x; SPELLMAN MW, 1989, J BIOL CHEM, V264, P14100; SPIEKSMA FTM, 1980, CLIN ALLERGY, V10, P319, DOI 10.1111/j.1365-2222.1980.tb02114.x; STURM A, 1987, J BIOL CHEM, V262, P13392; SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TARENTINO AL, 1987, METHOD ENZYMOL, V138, P770; VANHALBEEK H, 1985, GLYCOCONJUGATE J, V2, P235; VLIEGENTHART JFG, 1983, ADV CARBOHYD CHEM BI, V41, P209, DOI 10.1016/S0065-2318(08)60059-1; WEBER A, 1987, ALLERGY, V42, P464, DOI 10.1111/j.1398-9995.1987.tb00364.x; WEBER A, 1986, COMP BIOCHEM PHYS B, V83, P321, DOI 10.1016/0305-0491(86)90374-3	35	48	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2660	2668						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703533				2022-12-27	WOS:A1991EV51500097
J	TISCHLER, AS; RUZICKA, LA; DOBNER, PR				TISCHLER, AS; RUZICKA, LA; DOBNER, PR			A PROTEIN-KINASE INHIBITOR, STAUROSPORINE, MIMICS NERVE GROWTH-FACTOR INDUCTION OF NEUROTENSIN NEUROMEDIN-N GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR FACTOR CREB; PC12 CELLS; CYCLIC-AMP; POTENT INHIBITOR; C-FOS; FACTOR RECEPTOR; PHOSPHORYLATION; BINDING; JUN; TRANSCRIPTION	Nerve growth factor (NGF) cooperates with glucocorticoids, activators of adenylate cyclase, and lithium to induce the expression of the gene encoding the neuropeptides neurotensin and neuromedin N (NT/N gene) in PC 12 pheochromocytoma cells. High level expression requires simultaneous treatment with three or all four inducers. To examine the mechanism underlying this complex synergism, we have examined the effects of protein kinase inhibitors and other agents which influence intracellular signal transduction on NT/N gene expression. Two structurally similar bacterial alkaloids, staurosporine and K-252a, inhibit several protein kinases in vitro, including protein kinase C and cyclic nucleotide-dependent kinases. K-252a has been reported to specifically inhibit the effects of NGF on PC12 pheochromocytoma cells. Surprisingly, staurosporine in combination with other inducers markedly potentiated NT/N gene expression. In contrast, K-252a had no effect on NT/N gene expression when added simultaneously with other inducers. Expression of the NT/N gene was also potentiated by the phorbol ester 12-O-tetradecanoylphorbol-13-acetate, which directly activates protein kinase C, and by bradykinin, which stimulates phosphatidylinositol turnover in PC12 cells, and these effects were not blocked by staurosporine. Staurosporine was generally more effective in stimulating NT/N gene expression when used in inducer combinations that did not include NGF. These results, taken together with recent evidence that staurosporine is also able to induce neurite outgrowth from PC12 cells, suggest that the effects of staurosporine and NGF may converge, in part, on a common intracellular target.	UNIV MASSACHUSETTS,MED CTR,DEPT MOLEC GENET & MICROBIOL,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester	TISCHLER, AS (corresponding author), TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111, USA.			Tischler, Arthur/0000-0002-9726-5739	NATIONAL CANCER INSTITUTE [R01CA027808] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R23HL033307, R01HL033307] Funding Source: NIH RePORTER; NCI NIH HHS [CA-27808] Funding Source: Medline; NHLBI NIH HHS [HL-33307] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGELETT.RH, 1971, P NATL ACAD SCI USA, V68, P2417, DOI 10.1073/pnas.68.10.2417; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BLOCK T, 1983, J NEUROCHEM, V40, P1654, DOI 10.1111/j.1471-4159.1983.tb08139.x; BREWER G, 1988, MOL CELL BIOL, V8, P1697, DOI 10.1128/MCB.8.4.1697; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; CURRAN T, 1987, BIOESSAYS, V7, P255, DOI 10.1002/bies.950070606; CURRAN T, 1985, SCIENCE, V229, P1265, DOI 10.1126/science.4035354; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; CURRAN T, 1986, P NATL ACAD SCI USA, V83, P8521, DOI 10.1073/pnas.83.22.8521; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DOBNER PR, 1988, J BIOL CHEM, V263, P13983; END D, 1983, J BIOL CHEM, V258, P6549; FASOLATO C, 1988, J BIOL CHEM, V263, P17350; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HASHIMOTO S, 1986, J NEUROCHEM, V46, P1599, DOI 10.1111/j.1471-4159.1986.tb01782.x; HASHIMOTO S, 1989, J NEUROCHEM, V53, P1675, DOI 10.1111/j.1471-4159.1989.tb09230.x; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KASE H, 1986, J ANTIBIOT, V39, P1059, DOI 10.7164/antibiotics.39.1059; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; KISLAUSKIS E, 1990, NEURON, V4, P783, DOI 10.1016/0896-6273(90)90205-T; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; KOIZUMI S, 1989, FEBS LETT, V253, P55, DOI 10.1016/0014-5793(89)80928-7; KOIZUMI S, 1988, J NEUROSCI, V8, P715; KRUIJER W, 1985, P NATL ACAD SCI USA, V82, P7330, DOI 10.1073/pnas.82.21.7330; LAZAROVICI P, 1989, J NEUROSCI RES, V23, P1, DOI 10.1002/jnr.490230102; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MORIOKA H, 1985, AGR BIOL CHEM TOKYO, V49, P1959, DOI 10.1080/00021369.1985.10867017; NAKANO H, 1987, J ANTIBIOT, V40, P706, DOI 10.7164/antibiotics.40.706; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OMURA S, 1977, J ANTIBIOT, V30, P275, DOI 10.7164/antibiotics.30.275; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; ROWLAND EA, 1987, J BIOL CHEM, V262, P7504; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TISCHLER AS, 1990, J NEUROCHEM, V55, P1159, DOI 10.1111/j.1471-4159.1990.tb03120.x; TISCHLER AS, 1986, J NEUROSCI, V6, P1719; TOGARI A, 1985, J BIOL CHEM, V260, P3804; TOGARI A, 1985, J NEUROSCI, V5, P302; VANBELLE H, 1981, CELL CALCIUM, V2, P483, DOI 10.1016/0143-4160(81)90007-5; VOLANTE C, 1989, J CELL BIOL, V109, P2395; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	55	36	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1141	1146						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702431				2022-12-27	WOS:A1991ET17700073
J	MUNOZCANOVES, P; VIK, DP; TACK, BF				MUNOZCANOVES, P; VIK, DP; TACK, BF			MAPPING OF A RETINOIC ACID-RESPONSIVE ELEMENT IN THE PROMOTER REGION OF THE COMPLEMENT FACTOR-H GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									SCRIPPS CLIN & RES FDN,DEPT IMMUNOL,IMM-17A,10666 N TORREY PINES RD,LA JOLLA,CA 92037	Scripps Research Institute			Munoz-Canoves, Pura/B-3889-2015		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI029742, P01AI017354] Funding Source: NIH RePORTER; NIAID NIH HHS [AI17354, AI29742] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BEDO G, 1989, NATURE, V339, P231, DOI 10.1038/339231a0; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BRENT GA, 1989, J BIOL CHEM, V264, P178; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; DAY RN, 1989, MOL ENDOCRINOL, V3, P931, DOI 10.1210/mend-3-6-931; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEHRING MR, 1987, J BIOL CHEM, V262, P446; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GLICK AB, 1989, CELL REGUL, V1, P87, DOI 10.1091/mbc.1.1.87; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; KRISTENSEN T, 1986, P NATL ACAD SCI USA, V83, P3963, DOI 10.1073/pnas.83.11.3963; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; MUNOZCANOVES P, 1989, BIOCHEMISTRY-US, V28, P9891, DOI 10.1021/bi00452a002; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; VASIOS GW, 1989, P NATL ACAD SCI USA, V86, P9099, DOI 10.1073/pnas.86.23.9099; VIK DP, 1989, CURR TOP MICROBIOL I, V153, P147; WANG XF, 1985, CELL, V43, P659, DOI 10.1016/0092-8674(85)90238-7; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0	30	68	71	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20065	20068						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700780				2022-12-27	WOS:A1990EJ52500004
J	BERK, BC; TAUBMAN, MB; CRAGOE, EJ; FENTON, JW; GRIENDLING, KK				BERK, BC; TAUBMAN, MB; CRAGOE, EJ; FENTON, JW; GRIENDLING, KK			THROMBIN SIGNAL TRANSDUCTION MECHANISMS IN RAT VASCULAR SMOOTH-MUSCLE CELLS - CALCIUM AND PROTEIN KINASE-C-DEPENDENT AND KINASE-C-INDEPENDENT PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12208; CHILDRENS HOSP MED CTR,DEPT CARDIOL,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOVASC,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115; UNION UNIV,ALBANY,NY 12208	State University of New York (SUNY) System; Wadsworth Center; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Union College	BERK, BC (corresponding author), EMORY UNIV,SCH MED,DEPT MED,DIV CARDIOVASC,PO DRAWER LL,ATLANTA,GA 30322, USA.			Griendling, Kathy/0000-0002-9456-8582; Berk, Bradford/0000-0002-2767-4115	NHLBI NIH HHS [HL-13160, HL-07042, HL-108321] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL007042, R01HL013160] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASADA Y, 1988, ATHEROSCLEROSIS, V70, P1, DOI 10.1016/0021-9150(88)90093-7; BARSHAVIT R, 1990, CELL REGUL, V1, P453, DOI 10.1091/mbc.1.6.453; BARSHAVIT R, 1983, J CELL BIOL, V96, P282, DOI 10.1083/jcb.96.1.282; BARSHAVIT R, 1986, J CELL BIOCHEM, V32, P261, DOI 10.1002/jcb.240320403; BERK B C, 1989, FASEB Journal, V3, pA611; BERK BC, 1987, J BIOL CHEM, V262, P5065; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; BERK BC, 1987, J BIOL CHEM, V262, P5057; BERK BC, 1988, CIRCULATION S2, V78, P231; BROCK TA, 1988, J CELL PHYSIOL, V136, P54, DOI 10.1002/jcp.1041360107; CARNEY DH, 1984, J CELL BIOCHEM, V26, P181, DOI 10.1002/jcb.240260306; CARNEY DH, 1985, CELL, V42, P479, DOI 10.1016/0092-8674(85)90105-9; CHAMBARD JC, 1986, EXP CELL RES, V164, P282, DOI 10.1016/0014-4827(86)90029-7; CRAGOE EJ, 1967, J MED CHEM, V10, P66, DOI 10.1021/jm00313a014; DANIEL TO, 1986, J BIOL CHEM, V261, P9579; EXTON JH, 1990, J BIOL CHEM, V265, P1; FENTON JW, 1987, CONTROL ANIMAL CELL, V2, P133; GARRELS JI, 1979, J BIOL CHEM, V254, P7961; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GRIENDLING KK, 1988, J BIOL CHEM, V263, P10620; GRIENDLING KK, 1989, J BIOL CHEM, V264, P8237; GRIENDLING KK, 1986, J BIOL CHEM, V261, P5901; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; HARLAN JM, 1986, J CELL BIOL, V103, P1129, DOI 10.1083/jcb.103.3.1129; HUANG CL, 1987, J BIOL CHEM, V262, P14134; HUANG CL, 1987, NATURE, V329, P849, DOI 10.1038/329849a0; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; KANOH H, 1989, BIOCHEM J, V258, P455, DOI 10.1042/bj2580455; LIOTTA LA, 1981, CANCER RES, V41, P4629; LOUGH J, 1975, LAB INVEST, V33, P130; MAGNALDO I, 1988, BIOCHEM J, V253, P711, DOI 10.1042/bj2530711; NAFTILAN AJ, 1989, J CLIN INVEST, V83, P1419, DOI 10.1172/JCI114032; NAGAI R, 1988, P NATL ACAD SCI USA, V85, P1047, DOI 10.1073/pnas.85.4.1047; NEER EJ, 1984, J BIOL CHEM, V259, P4222; RABEN DM, 1987, J CELL PHYSIOL, V130, P466, DOI 10.1002/jcp.1041300322; SOCORRO L, 1990, BIOCHEM J, V265, P799, DOI 10.1042/bj2650799; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; VANHOUTTE PM, 1986, ANNU REV PHYSIOL, V48, P307; WALZ DA, 1985, P SOC EXP BIOL MED, V180, P518	40	128	128	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					17334	17340						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1698774				2022-12-27	WOS:A1990EA85700095
J	FLIEGEL, L; NEWTON, E; BURNS, K; MICHALAK, M				FLIEGEL, L; NEWTON, E; BURNS, K; MICHALAK, M			MOLECULAR-CLONING OF CDNA-ENCODING A 55-KDA MULTIFUNCTIONAL THYROID-HORMONE BINDING-PROTEIN OF SKELETAL-MUSCLE SARCOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV ALBERTA, FAC MED, CARDIOVASC DIS RES GRP, 417 HERITAGE MED RES CTR, EDMONTON T6G 2S2, ALBERTA, CANADA; UNIV ALBERTA, DEPT PEDIAT, EDMONTON T6G 2S2, ALBERTA, CANADA; UNIV ALBERTA, DEPT BIOCHEM, EDMONTON T6G 2S2, ALBERTA, CANADA	University of Alberta; University of Alberta; University of Alberta								BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BOADO RJ, 1988, BIOCHEM BIOPH RES CO, V155, P1297, DOI 10.1016/S0006-291X(88)81282-8; BRANDL CJ, METHOD ENZYMOL, V157, P289; CAMPBELL KP, 1981, J BIOL CHEM, V256, P4626; CAMPBELL KP, 1986, SARCOPLASMIC RETICUL, V1, P65; CHENG SY, 1987, J BIOL CHEM, V262, P11221; CHENG SY, 1986, P NATL ACAD SCI USA, V83, P947, DOI 10.1073/pnas.83.4.947; CHOU PY, 1979, BIOPHYS J, V26, P367, DOI 10.1016/S0006-3495(79)85259-5; CROZE EM, 1984, J CELL PHYSIOL, V119, P46, DOI 10.1002/jcp.1041190109; EARNSHAW WC, 1987, J CELL BIOL, V105, P1479, DOI 10.1083/jcb.105.4.1479; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; FLIEGEL L, 1989, BIOCHEM CELL BIOL, V67, P696, DOI 10.1139/o89-104; FLIEGEL L, 1987, P NATL ACAD SCI USA, V84, P1167, DOI 10.1073/pnas.84.5.1167; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; FLIEGEL L, 1989, BIOCHIM BIOPHYS ACTA, V982, P1, DOI 10.1016/0005-2736(89)90166-1; FLIEGEL L, 1988, SARCOMERIC NONSARCOM, P601; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEETHAHABIB M, 1988, CELL, V54, P1053, DOI 10.1016/0092-8674(88)90120-1; HASUMURA S, 1986, BIOCHEMISTRY-US, V25, P7881, DOI 10.1021/bi00372a014; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Hillson DA, 1979, BIOCHEM SOC T, V7, P573, DOI 10.1042/bst0070573; HOFMANN SL, 1989, J BIOL CHEM, V264, P18083; HORIUCHI R, 1982, P NATL ACAD SCI-BIOL, V79, P5527, DOI 10.1073/pnas.79.18.5527; HORIUCHI R, 1989, EUR J BIOCHEM, V183, P529, DOI 10.1111/j.1432-1033.1989.tb21081.x; HSU MP, 1989, BIOCHEMISTRY-US, V28, P6440, DOI 10.1021/bi00441a042; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; Kivirikko KI, 1980, ENZYMOLOGY POSTTRANS, P53; KOIVU J, 1987, BIOCHEM J, V247, P237, DOI 10.1042/bj2470237; KOIVU J, 1987, J BIOL CHEM, V262, P6447; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBERER E, 1989, J BIOL CHEM, V264, P3484; LEBERER E, 1989, P NATL ACAD SCI USA, V86, P6047, DOI 10.1073/pnas.86.16.6047; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacLennan D., 1983, CALCIUM CELL FUNCT, V4, P151; Maniatis T., 1982, MOL CLONING; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAZZARELLA RA, 1990, J BIOL CHEM, V265, P1094; MICHALAK M, 1990, J BIOL CHEM, V265, P5869; MICHALAK M, 1985, ENZYMES BIOL MEMBR, V3, P115; MITCHELL RD, 1988, J BIOL CHEM, V263, P1376; MORRIS JI, 1988, BIOCHIM BIOPHYS ACTA, V949, P169, DOI 10.1016/0167-4781(88)90080-2; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; OBATA T, 1988, J BIOL CHEM, V263, P782; OSTWALD TJ, 1974, J BIOL CHEM, V249, P974; PARKKONEN T, 1988, BIOCHEM J, V256, P1005, DOI 10.1042/bj2561005; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOENMAKERS CHH, 1989, BIOCHEM BIOPH RES CO, V162, P857, DOI 10.1016/0006-291X(89)92389-9; SCOTT BT, 1988, J BIOL CHEM, V263, P8958; SMITH MJ, 1989, EMBO J, V8, P3581, DOI 10.1002/j.1460-2075.1989.tb08530.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSIBRIS J, 1988, J CELL BIOL, V107, P691; VANCE JE, 1988, J BIOL CHEM, V263, P5898; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WETTERAU JR, 1989, CIRCULATION, V80, P4; YAMAUCHI K, 1987, BIOCHEM BIOPH RES CO, V146, P1485, DOI 10.1016/0006-291X(87)90817-5	60	49	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15496	15502						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1697592				2022-12-27	WOS:A1990DY96400026
J	ENSOR, CM; YANG, JY; OKITA, RT; TAI, HH				ENSOR, CM; YANG, JY; OKITA, RT; TAI, HH			CLONING AND SEQUENCE-ANALYSIS OF THE CDNA FOR HUMAN PLACENTAL NAD+-DEPENDENT 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV KENTUCKY,COLL PHARM,DIV MED CHEM & PHARMACEUT,LEXINGTON,KY 40536; MED COLL WISCONSIN,DEPT BIOCHEM,MILWAUKEE,WI 53226	University of Kentucky; Medical College of Wisconsin				Ensor, Mark/0000-0003-3065-688X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021765] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032727] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-03326] Funding Source: Medline; NHLBI NIH HHS [HL-32727] Funding Source: Medline; NICHD NIH HHS [HD-21765] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALAM NA, 1976, ENDOCRINOLOGY, V98, P859, DOI 10.1210/endo-98-4-859; ANGGARD E, 1966, ACTA PHYSIOL SCAND, V66, P509, DOI 10.1111/j.1748-1716.1966.tb03231.x; ANGGARD E, 1964, J BIOL CHEM, V239, P4097; ANGGARD E, 1971, ACTA PHYSIOL SCAND, V81, P396, DOI 10.1111/j.1748-1716.1971.tb04914.x; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BEDWANI JR, 1975, BRIT J PHARMACOL, V53, P547, DOI 10.1111/j.1476-5381.1975.tb07393.x; BERGHOLTE JM, 1986, ARCH BIOCHEM BIOPHYS, V245, P308, DOI 10.1016/0003-9861(86)90221-3; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FLOWER RJ, 1974, PHARMACOL RES COMMUN, V26, P33; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JARABAK J, 1988, PROSTAG OTH LIPID M, V36, P205, DOI 10.1016/0090-6980(88)90307-3; JARABAK J, 1988, PROSTAGLANDINS, V35, P403, DOI 10.1016/0090-6980(88)90131-1; KROOK M, 1990, BIOCHEMISTRY-US, V29, P738, DOI 10.1021/bi00455a021; MAK OT, 1982, BIOSCIENCE REP, V2, P503, DOI 10.1007/BF01115248; MAK OT, 1990, IN PRESS BIOCH BIOPH; Maniatis T, 1989, DECONTAMINATION DILU; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOORE PK, 1980, NATURE, V288, P269, DOI 10.1038/288269a0; RICHARDSON CC, 1965, P NATL ACAD SCI USA, V54, P158, DOI 10.1073/pnas.54.1.158; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEGEL W, 1974, PROSTAGLANDINS, V5, P417, DOI 10.1016/S0090-6980(74)80011-0; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TAI CL, 1990, BIOCHEM J, V267, P75, DOI 10.1042/bj2670075; TAI HH, 1974, BIOCHEM BIOPH RES CO, V57, P457, DOI 10.1016/0006-291X(74)90953-X; TAI HH, 1976, BIOCHEM BIOPH RES CO, V68, P814, DOI 10.1016/0006-291X(76)91218-3; TAI HH, 1976, BIOCHEMISTRY-US, V15, P4586, DOI 10.1021/bi00666a007; TANAKA T, 1986, BIOCHEM BIOPH RES CO, V135, P1058, DOI 10.1016/0006-291X(86)91035-1; THALERDAO H, 1974, FEBS LETT, V48, P204, DOI 10.1016/0014-5793(74)80468-0	30	88	95	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					14888	14891						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697582				2022-12-27	WOS:A1990DX40000037
J	BALL, RL; TANNER, KD; CARPENTER, G				BALL, RL; TANNER, KD; CARPENTER, G			EPIDERMAL GROWTH-FACTOR POTENTIATES CYCLIC-AMP ACCUMULATION IN A-431 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VANDERBILT UNIV,MED CTR,SCH MED,DEPT MED,NASHVILLE,TN 37232	Vanderbilt University	BALL, RL (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232, USA.				NCI NIH HHS [CA43720] Funding Source: Medline; NHLBI NIH HHS [HLO7256] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA043720] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELL JD, 1985, J BIOL CHEM, V260, P2625; BILLESTRUP N, 1986, P NATL ACAD SCI USA, V83, P6854, DOI 10.1073/pnas.83.18.6854; BOURNE HR, 1987, NATURE, V330, P517, DOI 10.1038/330517a0; BURGER MM, 1972, NATURE-NEW BIOL, V239, P161, DOI 10.1038/newbio239161a0; BUSS JE, 1982, P NATL ACAD SCI-BIOL, V79, P2574, DOI 10.1073/pnas.79.8.2574; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Carpenter G, 1990, PEPTIDE GROWTH FACTO, V95, P69; CARPENTER G, 1981, HDB EXP PHARM, V57, P89; CASSEL D, 1977, P NATL ACAD SCI USA, V74, P3307, DOI 10.1073/pnas.74.8.3307; Chlapowski F J, 1975, Adv Cyclic Nucleotide Res, V6, P245; DELAVIERKLUTCHKO C, 1984, FEBS LETT, V169, P151, DOI 10.1016/0014-5793(84)80308-7; FISCH TM, 1987, MOL CELL BIOL, V7, P3490, DOI 10.1128/MCB.7.10.3490; Friedman D L, 1976, Adv Cyclic Nucleotide Res, V7, P69; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GREEN H, 1978, CELL, V15, P801, DOI 10.1016/0092-8674(78)90265-9; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GROVE RI, 1984, DEV BIOL, V106, P427, DOI 10.1016/0012-1606(84)90242-2; HAIGLER H, 1978, P NATL ACAD SCI USA, V75, P3317, DOI 10.1073/pnas.75.7.3317; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HEN R, 1989, P NATL ACAD SCI USA, V86, P4785, DOI 10.1073/pnas.86.12.4785; HO AK, 1988, J BIOL CHEM, V263, P9292; HOLLENBERG MD, 1973, P NATL ACAD SCI USA, V70, P2964, DOI 10.1073/pnas.70.10.2964; IMAGAWA W, 1988, J CELL PHYSIOL, V135, P509, DOI 10.1002/jcp.1041350320; JOHNSON GS, 1972, J NATL CANCER I, V48, P1377; KATADA T, 1982, J BIOL CHEM, V257, P3739; KING CS, 1986, J BIOL CHEM, V261, P73; KRAM R, 1973, P NATL ACAD SCI USA, V70, P1432, DOI 10.1073/pnas.70.5.1432; KRAMER GL, 1977, BIOCHEMISTRY-US, V16, P3316, DOI 10.1021/bi00634a006; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LEVITZKI A, 1986, PHYSIOL REV, V66, P819, DOI 10.1152/physrev.1986.66.3.819; MCCORMICK F, 1989, NATURE, V340, P678, DOI 10.1038/340678a0; MEEKER RB, 1982, MOL PHARMACOL, V22, P310; PARSONS WJ, 1988, MOL PHARMACOL, V34, P37; RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216; ROZENGURT E, 1981, P NATL ACAD SCI-BIOL, V78, P4392, DOI 10.1073/pnas.78.7.4392; ROZENGURT E, 1982, J CELL PHYSIOL, V112, P243, DOI 10.1002/jcp.1041120213; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SAWYER ST, 1981, BIOCHEMISTRY-US, V20, P6280, DOI 10.1021/bi00524a057; SEAMON K, 1981, J BIOL CHEM, V256, P9799; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SHIRAKAWA F, 1988, P NATL ACAD SCI USA, V85, P8201, DOI 10.1073/pnas.85.21.8201; SNYDER SH, 1981, P NATL ACAD SCI-BIOL, V78, P3260, DOI 10.1073/pnas.78.5.3260; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; SU YF, 1976, J CYCLIC NUCL PROT, V2, P257; TAYLORPAPADIMITRIOU J, 1980, J CELL PHYSIOL, V102, P317, DOI 10.1002/jcp.1041020306; TREISMAN R, 1986, CELL, V46, P567, DOI 10.1016/0092-8674(86)90882-2; VALLAR L, 1987, NATURE, V330, P566, DOI 10.1038/330566a0; VERMA IM, 1987, CELL, V51, P513, DOI 10.1016/0092-8674(87)90115-2; WAHL M, 1988, J BIOL CHEM, V263, P7581; WAHL MI, 1987, BIOCHEM BIOPH RES CO, V142, P688, DOI 10.1016/0006-291X(87)91469-0; WELLS JN, 1981, J MED CHEM, V24, P954, DOI 10.1021/jm00140a008; WELLS JN, 1975, MOL PHARMACOL, V11, P775; WHITELEY B, 1986, J CELL BIOL, V103, P1355, DOI 10.1083/jcb.103.4.1355; WILLEY JC, 1985, J CELL PHYSIOL, V124, P207, DOI 10.1002/jcp.1041240206; YOSHIMASA T, 1987, NATURE, V327, P67, DOI 10.1038/327067a0	55	60	60	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					12836	12845						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695898				2022-12-27	WOS:A1990DR20100018
J	CORMACK, RS; MACKIE, GA				CORMACK, RS; MACKIE, GA			MAPPING RIBOSOMAL PROTEIN-S20-16-S RIBOSOMAL-RNA INTERACTIONS BY MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; EQUILIBRIUM BINDING; ACID INTERACTIONS; PROTEINS S4; 16-S RNA; S20; SEQUENCE; REGIONS; GENE; SITE	Specific ribonucleotides within the 5' domain of Escherichia coli 16 S rRNA were altered by deletion and/or substitution by site-directed mutagenesis of cloned DNA to assess the importance of these particular residues in defining the binding site for ribosomal protein S20. Gel filtration and sucrose gradient centrifugation were employed to measure the binding of ribosomal protein S20 to synthetic transcripts spanning the 5' domain of 16 S rRNA containing various alterations. In several cases, the apparent association constants for these interactions were also determined. Three essential results were obtained. First, RNA transcripts containing residues 1-402 are sufficient for high affinity S20 binding. Second, bulges at residues 250-251 and 278-280 in a stem-loop structure extending from residues 240 to 286 are critical for S20 binding, arguing that the "260 stem" directly interacts with S20 at these sites. Third, mutations in a hairpin structure spanning residues 316-337 demonstrate a strong requirement for both the specific A321*G332 bulge and for unpaired residues in the loop itself for proper S20 binding. Our results document the importance of unpaired residues in maintaining the interaction between S20 and 16 S rRNA.	UNIV WESTERN ONTARIO, DEPT BIOCHEM, LONDON N6A 5C1, ONTARIO, CANADA	Western University (University of Western Ontario)								DONLY BC, 1988, NUCLEIC ACIDS RES, V16, P997, DOI 10.1093/nar/16.3.997; DONLY BC, 1988, THESIS U W ONTARIO; DRAPER DE, 1979, BIOCHEMISTRY-US, V18, P753, DOI 10.1021/bi00572a003; DRAPER DE, 1988, METHOD ENZYMOL, V164, P203; EHRESMANN B, 1977, FEBS LETT, V78, P261, DOI 10.1016/0014-5793(77)80319-0; EHRESMANN C, 1980, EUR J BIOCHEM, V103, P439, DOI 10.1111/j.1432-1033.1980.tb05967.x; FELLNER P, 1969, EUR J BIOCHEM, V11, P12, DOI 10.1111/j.1432-1033.1969.tb00733.x; GARRETT RA, 1972, MOL GEN GENET, V114, P112, DOI 10.1007/BF00332782; GUTELL RR, 1990, P NATL ACAD SCI USA, V87, P3119; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACKIE GA, 1981, J BIOL CHEM, V256, P8177; MACKIE GA, 1978, J MOL BIOL, V121, P17, DOI 10.1016/0022-2836(78)90260-7; MACKIE GA, 1977, BIOCHEMISTRY-US, V16, P4497, DOI 10.1021/bi00639a026; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; PARSONS GD, 1988, J BACTERIOL, V170, P2485, DOI 10.1128/jb.170.6.2485-2492.1988; SAPAG A, 1990, BIOCHIM BIOPHYS ACTA, V1050, P34, DOI 10.1016/0167-4781(90)90137-Q; SCHULTE C, 1974, BIOCHEMISTRY-US, V13, P1032, DOI 10.1021/bi00702a031; SPICER E, 1977, NUCLEIC ACIDS RES, V4, P491, DOI 10.1093/nar/4.2.491; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; STERN S, 1986, J MOL BIOL, V192, P101, DOI 10.1016/0022-2836(86)90467-5; STERN S, 1988, J MOL BIOL, V200, P291, DOI 10.1016/0022-2836(88)90241-0; UNGEWICKELL E, 1975, EUR J BIOCHEM, V51, P165, DOI 10.1111/j.1432-1033.1975.tb03917.x; WITTMANN HG, 1986, STRUCTURE FUNCTION G, P1; WOESE CR, 1983, MICROBIOL REV, V47, P621, DOI 10.1128/MMBR.47.4.621-669.1983; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; Zimmermann R. A., 1980, RIBOSOMES STRUCTURE, P135; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	28	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18525	18529						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717450				2022-12-27	WOS:A1991GJ47200021
J	ZIZI, M; FISHER, RS; GRILLO, FG				ZIZI, M; FISHER, RS; GRILLO, FG			FORMATION OF CATION CHANNELS IN PLANAR LIPID BILAYERS BY BREFELDIN-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GOLGI; RECONSTITUTION; PROTEINS; MEMBRANE; EXCHANGE	Brefeldin A (BFA) is a novel agent with the unique property of effecting a rapid increase of Golgi cisternae volume and subsequent loss of a recognizable Golgi apparatus in treated cells. Although a receptor-mediated mechanism has been proposed, the molecular basis of BFA action remains unknown (Lippincott-Schwartz, J., Glickman, J., Donaldson, J. G., Robbins, J., Kreis, T. E., Seamon, K. B., Sheetz, M. P., and Klausner, R. D. (1991) J. Cell Biol. 112, 567-577). Since a variety of ionophores distort Golgi architecture by initially causing osmotic swelling of the cisternae (Mollenhauer, H. H., Morre, D. J., and Rowe, L. D. (1990) Biochim. Biophys. Acta 1031, 225-246), Golgi membrane permeabilization by BFA seemed possible. We examined the effects of BFA on the conductance of planar lipid bilayers bathed in several aqueous salt solutions. Addition of BFA (1-mu-g/ml) quickly augmented alkali cation conductance (K+ > Na+ >> Li+) but not anion conductance of the bilayer. Lower concentrations (1 ng/ml) indicated that BFA formed discrete, cation-selective channels in these bilayers. Given that Golgi cisternae volume increases immediately upon treatment with BFA, these findings suggest that alteration of ion gradients or Golgi membrane potential followed by an influx of water may be the mechanism by which BFA initiates disruption of Golgi structural integrity. Subsequent functional perturbations may then ensue either as a consequence of these initial structural changes or by a combination of several distinct mechanisms.	WALTER REED ARMY MED CTR, DEPT NEPHROL, WASHINGTON, DC 20307 USA	United States Department of Defense; United States Army; Walter Reed National Military Medical Center								DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; HARRI E, 1963, HELV CHIM ACTA, V46, P1235, DOI 10.1002/hlca.19630460419; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; MIRAMOSER F, 1976, EUR J CLIN INVEST, V6, P103, DOI 10.1111/j.1365-2362.1976.tb00499.x; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; ORCI L, 1991, CELL, V64, P1183; RABAN M, 1991, TETRAHEDRON LETT, V32, P35, DOI 10.1016/S0040-4039(00)71211-1; SCHEIN SJ, 1976, J MEMBRANE BIOL, V30, P99, DOI 10.1007/BF01869662; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; SOMLYO AP, 1975, J CELL BIOL, V66, P425, DOI 10.1083/jcb.66.2.425; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; WHETSELL WO, 1969, J CELL BIOL, V42, P490, DOI 10.1083/jcb.42.2.490	16	17	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18443	18445						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717449				2022-12-27	WOS:A1991GJ47200009
J	COY, DH; JIANG, NY; KIM, SH; MOREAU, JP; LIN, JT; FRUCHT, H; QIAN, JM; WANG, LW; JENSEN, RT				COY, DH; JIANG, NY; KIM, SH; MOREAU, JP; LIN, JT; FRUCHT, H; QIAN, JM; WANG, LW; JENSEN, RT			COVALENTLY CYCLIZED AGONIST AND ANTAGONIST ANALOGS OF BOMBESIN AND RELATED PEPTIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; RECEPTOR ANTAGONISTS; ANTIMITOTIC ACTIVITY; PANCREATIC ACINAR; POTENT	During a search for possible cyclization points in shortened, potent bombesin agonists and antagonists, it was found that the joining of amino acid residues in positions 6 and 14 by various means resulted in retention of significant binding affinity for rat pancreatic acini and murine Swiss 3T3 cells. In one series of analogues, Cys residues in these positions were used for bridging via a disulfide bond. (D)-C-Q-W-A-V-G-H-L-C-NH2 retained significant binding affinity for rat pancreatic acini cells and was a full amylase releasing agonist (EC50 187 nM). Potency was markedly increased by substituting D-Ala for Gly (EC50 67 nM compared to 10 nM for its linear counterpart) and was decreased by substituting L-Cys for D-Cys in this analogue (EC50 214 nM), thus strongly suggesting stabilization of peptide folding by the D residues. Elimination of the COOH-terminal amino acid produces competitive antagonists in the linear analogues; however, (D)-C-Q-W-A-V-G-H-C-NH2 Was devoid of activity. Likewise, cyclization to position 13 with the 14 amino acids intact to give (D)-C-Q-W-A-V-G-H-C-L-NH2 resulted in an almost inactive peptide. On the other hand, as in the linear series, the reduced peptide bond analogue, (D)-C-Q-W-A-V-(D)-A-H-L-psi(CH2NH)-C-NH2, was a receptor antagonist (IC50 5.7 mM), albeit much weaker than the corresponding linear analogues, but with no residual agonist activity. Direct head-to-tail cyclization was also tried. Both cyclo[(D)-F-Q-W-A-V-G-H-L-L] (EC50 346 mM) and the shorter cyclo[Q-W-A-V-G-H-L-L] (EC50 1236 mM) were full agonists. Elimination of the COOH-terminal residue in cyclo[(D)-p-Cl-F-Q-W-A-V-(D)-A-H-L-] produced an agonist (EC50 716 nM) rather than an antagonist. These results provide support for the proposal that both bombesin agonists and antagonists adopt a folded conformation at their receptor (s). Furthermore, the retention of appreciable potencies using several cyclization strategies and chain lengths suggests that further optimization of these structures both in terms of potency and ring size is possible. Since these peptides have increased conformational restriction, they should begin to serve as useful substrates for NMR and molecular modeling studies aimed at comparing the obviously subtle differences between agonist and antagonist structures.	BIOMEASURE INC, HOPKINTON, MA 01748 USA; NIH, DIGEST DIS BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA	COY, DH (corresponding author), TULANE UNIV, SCH MED, DEPT MED, PEPTIDE RES LABS, NEW ORLEANS, LA 70112 USA.				NATIONAL CANCER INSTITUTE [R55CA045153, R01CA045153] Funding Source: NIH RePORTER; NCI NIH HHS [CA-45153] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CAMBLE R, 1989, LIFE SCI, V45, P1521, DOI 10.1016/0024-3205(89)90417-7; CESKA M, 1969, CLIN CHIM ACTA, V26, P437, DOI 10.1016/0009-8981(69)90071-0; CESKA M, 1969, CLIN CHIM ACTA, V26, P781; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COY D, 1990, EUR J PHARMACOL, V190, P31, DOI 10.1016/0014-2999(90)94109-B; COY DH, 1988, J BIOL CHEM, V263, P5056; COY DH, 1989, J BIOL CHEM, V264, P14691; DIBELLO C, 1989, BIOCHEM BIOPH RES CO, V161, P987, DOI 10.1016/0006-291X(89)91340-5; DIBELLO C, 1989, BIOPOLYMERS, V28, P421, DOI 10.1002/bip.360280139; DICKINSON KEJ, 1988, BIOCHEM BIOPH RES CO, V157, P1154, DOI 10.1016/S0006-291X(88)80994-X; GARDNER JD, 1977, J PHYSIOL-LONDON, V270, P439, DOI 10.1113/jphysiol.1977.sp011961; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEIMBROOK DC, 1989, J BIOL CHEM, V264, P11258; HEINZERIAN P, 1987, AM J PHYSIOL, V252, pG439, DOI 10.1152/ajpgi.1987.252.3.G439; JENSEN RT, 1988, AM J PHYSIOL, V254, pG883, DOI 10.1152/ajpgi.1988.254.6.G883; JENSEN RT, 1982, J BIOL CHEM, V257, P5554; JENSEN RT, 1991, TRENDS PHARMACOL SCI, V12, P13, DOI 10.1016/0165-6147(91)90483-9; KNIGHT M, 1990, 11TH P PEPT S, P185; MOSBERG HI, 1982, BIOCHEM BIOPH RES CO, V106, P506, DOI 10.1016/0006-291X(82)91139-1; RIVIER JE, 1978, BIOCHEMISTRY-US, V17, P1766, DOI 10.1021/bi00602a030; RIVIER JE, 1990, 11TH P AM PEPT S, P33; ROZENGURT E, 1988, ANN NY ACAD SCI, V547, P277, DOI 10.1111/j.1749-6632.1988.tb23896.x; SAEED ZA, 1989, PEPTIDES, V10, P597, DOI 10.1016/0196-9781(89)90149-6; SASAKI Y, 1987, PEPTIDES, V8, P119, DOI 10.1016/0196-9781(87)90174-4; VEBER DF, 1984, LIFE SCI, V34, P1371, DOI 10.1016/0024-3205(84)90009-2; VONSCHRENCK T, 1990, AM J PHYSIOL, V259, pG468, DOI 10.1152/ajpgi.1990.259.3.G468; WANG LH, 1990, BIOCHEMISTRY-US, V29, P616, DOI 10.1021/bi00455a004; WANG LH, 1990, J BIOL CHEM, V265, P15695	28	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16441	16447						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715866				2022-12-27	WOS:A1991GD63500035
J	LODISH, HF; KONG, N				LODISH, HF; KONG, N			CYCLOSPORINE-A INHIBITS AN INITIAL STEP IN FOLDING OF TRANSFERRIN WITHIN THE ENDOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							CIS-TRANS ISOMERASE; CYTOSOLIC-BINDING-PROTEIN; HEPATOMA SECRETORY PROTEINS; PEPTIDYL-PROLYL ISOMERASE; GOLGI-COMPLEX; IMMUNOSUPPRESSANT FK506; FK506-BINDING PROTEIN; COMPLEMENTARY-DNA; CYCLOPHILIN; MATURATION	As resolved by electrophoresis in non-reducing SDS gels, transferrin newly made in Hep G2 cells migrates as a very diffuse set of species. During a subsequent 1-h chase all transferrin polypeptides are converted to a single, rapidly migrating species. These changes in gel mobility are due to alterations in the pattern of disulfide bonding, are not caused by carbohydrate processing, and occur while the protein is in the rough endoplasmic reticulum. Cyclosporin A causes an approximately 10-min lag in transferrin folding, after which folding resumes at the normal rate. Cyclosporin A also retards transferrin maturation from the endoplasmic reticulum and its secretion, at concentrations that do not affect secretion of other hepatoma proteins. Neither FK506 nor rapamycin affect transferrin folding. We conclude that an initial stage in transferrin folding is accelerated by an endoplasmic reticulum peptidyl-proline isomerase that is inhibited by cyclosporin A.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA	Massachusetts Institute of Technology (MIT)	LODISH, HF (corresponding author), WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035012] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35012] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAI N, 1989, J IMMUNOL, V142, P274; ELLIOTT JF, 1984, SCIENCE, V226, P1439, DOI 10.1126/science.6334364; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FRIES E, 1984, EMBO J, V3, P147, DOI 10.1002/j.1460-2075.1984.tb01775.x; HAENDLER B, 1987, EMBO J, V6, P947, DOI 10.1002/j.1460-2075.1987.tb04843.x; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; HARDING MW, 1986, J BIOL CHEM, V261, P8547; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; LEDFORD BE, 1983, J BIOL CHEM, V258, P3304; LODISH HF, 1990, J BIOL CHEM, V265, P10893; LODISH HF, 1988, J BIOL CHEM, V263, P2107; LODISH HF, 1987, J CELL BIOL, V104, P221, DOI 10.1083/jcb.104.2.221; LODISH HF, 1983, NATURE, V304, P80, DOI 10.1038/304080a0; LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720; MAKI N, 1990, P NATL ACAD SCI USA, V87, P5440, DOI 10.1073/pnas.87.14.5440; MATTILA PS, 1990, EMBO J, V9, P4425, DOI 10.1002/j.1460-2075.1990.tb07893.x; MORGAN EH, 1985, J BIOL CHEM, V260, P4793; OWEN MJ, 1980, J BIOL CHEM, V255, P9678; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PFEFFER SR, 1987, ANNU REV BIOCHEM, V56, P829, DOI 10.1146/annurev.biochem.56.1.829; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; SCHEELE G, 1985, J BIOL CHEM, V260, P926; SCHNEUWLY S, 1989, P NATL ACAD SCI USA, V86, P5390, DOI 10.1073/pnas.86.14.5390; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SCHWARTZ AL, 1981, J BIOL CHEM, V256, P8878; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; SIEKIERKA JJ, 1990, J BIOL CHEM, V265, P21011; Stamnes MA, 1990, CURR OPIN CELL BIOL, V2, P1104, DOI 10.1016/0955-0674(90)90163-9; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STANDAERT RF, 1990, NATURE, V346, P671, DOI 10.1038/346671a0; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; STROUS JAM, 1980, CELL, V22, P709, DOI 10.1016/0092-8674(80)90547-4; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; ZILBERSTEIN A, 1980, CELL, V21, P417, DOI 10.1016/0092-8674(80)90478-X	36	168	175	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					14835	14838						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714445				2022-12-27	WOS:A1991GB09700002
J	COHEN, KA; HOPKINS, J; INGRAHAM, RH; PARGELLIS, C; WU, JC; PALLADINO, DEH; KINKADE, P; WARREN, TC; ROGERS, S; ADAMS, J; FARINA, PR; GROB, PM				COHEN, KA; HOPKINS, J; INGRAHAM, RH; PARGELLIS, C; WU, JC; PALLADINO, DEH; KINKADE, P; WARREN, TC; ROGERS, S; ADAMS, J; FARINA, PR; GROB, PM			CHARACTERIZATION OF THE BINDING-SITE FOR NEVIRAPINE (BI-RG-587), A NONNUCLEOSIDE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Nevirapine (BI-RG-587) is a potent and specific non-nucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase. The compound is non-competitive with respect to template, primer, and nucleoside triphosphates indicating that BI-RG-587 does not act directly at the catalytic site. The binding site for this inhibitor was investigated by employing an azido photoaffinity analogue, BI-RJ-70, to covalently label the enzyme. The resulting photoadduct was subjected to enzymatic digestion by trypsin and endoproteinase lys-C and a single, highly labeled peptide was identified as residues 174-199. Sequencing of this peptide identified Tyr-181 and Tyr-188 as labeled residues.	BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT MED CHEM,RIDGEFIELD,CT 06877; BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT BIOCHEM,RIDGEFIELD,CT 06877	Boehringer Ingelheim; Boehringer Ingelheim	COHEN, KA (corresponding author), BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT ANALYT SCI,90 E RIDGE,POB 368,RIDGEFIELD,CT 06877, USA.							ARGOS P, 1988, NUCLEIC ACIDS RES, V16, P9909, DOI 10.1093/nar/16.21.9909; Bayley H, 1977, Methods Enzymol, V46, P69; BAYLEY H, 1983, LABORATORY TECHNIQUE, V12, P2; DAQUILA RT, 1989, J ACQ IMMUN DEF SYND, V2, P579; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; GUILLORY RJ, 1989, PHARMACOL THERAPEUT, V41, P1, DOI 10.1016/0163-7258(89)90100-9; HARGRAVE KD, 1991, IN PRESS J MED CHEM; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; LAU SYM, 1984, J CHROMATOGR, V317, P129, DOI 10.1016/S0021-9673(01)91653-X; LIU KP, 1990, J NEUROCHEM, V54, P963, DOI 10.1111/j.1471-4159.1990.tb02344.x; MERLUZZI VJ, 1990, SCIENCE, V250, P1411, DOI 10.1126/science.1701568; PALLADINO DEH, 1991, J CHROMATOGR SCI, V29, P91, DOI 10.1093/chromsci/29.3.91; RUSH J, 1990, J BIOL CHEM, V265, P4821; STONE KL, 1986, J CHROMATOGR, V359, P203, DOI 10.1016/0021-9673(86)80074-7; WEBSTER TA, 1989, MOL BIOL EVOL, V6, P317; WU JC, 1991, BIOCHEMISTRY-US, V30, P2022, DOI 10.1021/bi00222a003	17	119	124	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14670	14674						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713587				2022-12-27	WOS:A1991FZ35100085
J	FLETCHER, BS; LIM, RW; VARNUM, BC; KUJUBU, DA; KOSKI, RA; HERSCHMAN, HR				FLETCHER, BS; LIM, RW; VARNUM, BC; KUJUBU, DA; KOSKI, RA; HERSCHMAN, HR			STRUCTURE AND EXPRESSION OF TIS21, A PRIMARY RESPONSE GENE INDUCED BY GROWTH-FACTORS AND TUMOR PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRADECANOYL PHORBOL ACETATE; LEFT-HANDED DNA; SWISS 3T3 CELLS; C-FOS GENE; MOUSE FIBROBLASTS; G0/G1 TRANSITION; PROTO-ONCOGENE; MESSENGER-RNA; LYMPHOCYTE MITOGENS; NUCLEOTIDE-SEQUENCE	The TIS21 gene is a primary response gene that is induced rapidly and transiently in 3T3 cells by the tumor promoter and mitogen tetradecanoyl phorbol acetate. The predicted open reading frame of the TIS21 cDNA encodes a protein of 158 amino acids with no obvious similarity to any known protein. Antiserum prepared to TIS21 recombinant protein produced in Escherichia coli precipitates a 17-kDa protein from Swiss 3T3 cells. The 2040-nucleotide 3'-untranslated region of the cDNA includes an unusual T18 sequence. The TIS21 gene has a single 1.4-kilobase intron which interrupts the open reading frame and is otherwise identical to the cDNA sequence. The 5'-flanking sequence of the TIS21 gene contains TATA and CAAT box-type sequences, three potential Sp1 sites, two putative cyclic AMP response elements, two potential AP1 binding elements, and an AP2 element. A possible Z-DNA structure of 29 AC repeats is present 660 nucleotides from the start of transcription. Expression from a luciferase reporter construct containing a 460-nucleotide fragment of the TIS21 promoter is induced by tetradecanoyl phorbol acetate, forskolin, epidermal growth factor, and serum, despite the absence of a consensus serum response element.	UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,BIOMED & ENVIRONM SCI LAB,LOS ANGELES,CA 90024; AMGEN INC,AMGEN CTR,THOUSAND OAKS,CA 91320	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Amgen	FLETCHER, BS (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,INST MOLEC BIOL,LOS ANGELES,CA 90024, USA.				NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, R01GM024797] Funding Source: NIH RePORTER; NCI NIH HHS [CA16042] Funding Source: Medline; NIGMS NIH HHS [GM24797, GMO 8042-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ANDERSEN RD, 1986, MOL CELL BIOL, V6, P302, DOI 10.1128/MCB.6.1.302; ARENANDER AT, 1989, J NEUROSCI RES, V24, P107, DOI 10.1002/jnr.490240115; ARENANDER AT, 1989, J NEUROSCI RES, V23, P247, DOI 10.1002/jnr.490230302; BANKER D, 1989, J CELL PHYSIOL, V139, P42, DOI 10.1002/jcp.1041390108; BURNETTE WN, 1988, BIO-TECHNOL, V6, P699, DOI 10.1038/nbt0688-699; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; GILMAN MZ, 1988, GENE DEV, V2, P394, DOI 10.1101/gad.2.4.394; GOMPERTS M, 1990, ONCOGENE, V5, P1081; GREENBERG ME, 1987, MOL CELL BIOL, V7, P1217, DOI 10.1128/MCB.7.3.1217; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GROSS-BELLARD MM, 1973, EUR J BIOCHEM, V36, P32, DOI 10.1111/j.1432-1033.1973.tb02881.x; HANIFORD DB, 1985, NUCLEIC ACIDS RES, V13, P4343, DOI 10.1093/nar/13.12.4343; HARPOLD MM, 1979, CELL, V17, P1025, DOI 10.1016/0092-8674(79)90341-6; HARTZELL S, 1989, MOL CELL BIOL, V9, P2567, DOI 10.1128/MCB.9.6.2567; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HERSCHMAN HR, 1973, NATURE-NEW BIOL, V241, P242, DOI 10.1038/newbio241242a0; HERSCHMAN HR, IN PRESS CURRENT TOP; HIRAKI Y, 1988, J BIOL CHEM, V263, P13655; JAWORSKI A, 1987, SCIENCE, V238, P773, DOI 10.1126/science.3313728; JIMENEZRUIZ A, 1991, P NATL ACAD SCI USA, V88, P31, DOI 10.1073/pnas.88.1.31; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; KAWAHARA RS, 1989, J BIOL CHEM, V264, P679; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; KILPATRICK MW, 1984, J BIOL CHEM, V259, P7268; KLYSIK J, 1982, J BIOL CHEM, V257, P152; KLYSIK J, 1981, NATURE, V290, P672, DOI 10.1038/290672a0; KRUIJER W, 1984, NATURE, V312, P711, DOI 10.1038/312711a0; KUJUBU DA, 1987, ONCOGENE, V1, P257; LAI WS, 1990, J BIOL CHEM, V265, P16556; LAMPH WW, 1988, NATURE, V334, P629, DOI 10.1038/334629a0; LAU LF, 1985, EMBO J, V4, P3145, DOI 10.1002/j.1460-2075.1985.tb04057.x; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LIM RW, 1987, ONCOGENE, V1, P263; LIM RW, 1989, MOL CELL BIOL, V9, P1790, DOI 10.1128/MCB.9.4.1790; Maxam A M, 1980, Methods Enzymol, V65, P499; MCLEAN MJ, 1986, P NATL ACAD SCI USA, V83, P5884, DOI 10.1073/pnas.83.16.5884; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MULLER R, 1984, NATURE, V312, P716, DOI 10.1038/312716a0; MURPHY KE, 1986, NUCLEIC ACIDS RES, V14, P7325, DOI 10.1093/nar/14.18.7325; NAYLOR LH, 1990, NUCLEIC ACIDS RES, V18, P1595, DOI 10.1093/nar/18.6.1595; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; OQUENDO P, 1989, J BIOL CHEM, V264, P4133; QUANTIN B, 1988, NATURE, V334, P538, DOI 10.1038/334538a0; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; RYDER K, 1988, P NATL ACAD SCI USA, V85, P8464, DOI 10.1073/pnas.85.22.8464; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; RYSECK RP, 1988, NATURE, V334, P535, DOI 10.1038/334535a0; RYSECK RP, 1989, EXP CELL RES, V180, P266, DOI 10.1016/0014-4827(89)90230-9; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; RYSECK RP, 1989, EXP CELL RES, V180, P537, DOI 10.1016/0014-4827(89)90080-3; Sambrook J, 1989, MOL CLONING LABORATO; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; SEMENZA GL, 1984, J BIOL CHEM, V259, P6045; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; THOMAS P, 1980, P NATL ACAD SCI USA, V747, P5201; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; van der Eb A J, 1980, Methods Enzymol, V65, P826; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; VARNUM BC, 1989, ONCOGENE, V4, P119; VARNUM BC, 1989, MOL CELL BIOL, V9, P3580, DOI 10.1128/MCB.9.8.3580; VARNUM BC, 1989, ONCOGENE, V4, P1263; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; YAMAMOTO KR, 1976, ANNU REV BIOCHEM, V45, P721, DOI 10.1146/annurev.bi.45.070176.003445	75	161	170	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14511	14518						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713584				2022-12-27	WOS:A1991FZ35100064
J	MAZZONI, MR; MALINSKI, JA; HAMM, HE				MAZZONI, MR; MALINSKI, JA; HAMM, HE			STRUCTURAL-ANALYSIS OF ROD GTP-BINDING PROTEIN, GT - LIMITED PROTEOLYTIC DIGESTION PATTERN OF GT WITH 4 PROTEASES DEFINES MONOCLONAL-ANTIBODY EPITOPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-GMP PHOSPHODIESTERASE; TRANSDUCING G-PROTEINS; AMINO-ACID SEQUENCE; ALPHA-SUBUNIT; OUTER SEGMENTS; PERTUSSIS-TOXIN; ADP-RIBOSYLATION; BETA-GAMMA; VERTEBRATE PHOTORECEPTORS; 3-DIMENSIONAL STRUCTURE	The epitope of monoclonal antibody (mAb 4A), which recognizes the alpha-subunit of the rod G protein, G(t), has been suggested to be both at the carboxyl terminus (Deretic, D., and Hamm, H. E. (1987) J. Biol. Chem. 262, 10839-10847) and the amino terminus (Navon, S. E., and Fung, B. K.-K. (1988) J. Biol. Chem. 263, 489-496) of the molecule. To characterize further the mAb 4A binding site on alpha-t and to resolve the discrepancy between these results limited proteolytic digestion of G(t) or alpha-t using four proteases with different substrate specificities has been performed. Endoproteinase Arg-C, which cleaves the peptide bond at the carboxylic side of arginine residues, cleaved the majority of alpha-t into two fragments of 34 and 5 kDa. The alpha-t 34-kDa fragment in the holoprotein, but not alpha-t-guanosine 5'-O-(3-thiotriphosphate), was converted further to a 23-kDa fragment. A small fraction of alpha-t-GDP was cleaved into 23- and 15-kDa fragments. Endoproteinase Lys-C, which selectively cleaves at lysine residues, progressively removed 17 and then 8 residues from the amino terminus, forming 38- and 36-kDa fragments. Staphylococcus aureus V8 protease is known to remove 21 amino acid residues from the amino-terminal region of alpha-t, with the formation of a 38-kDa fragment. L-1-Tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin cleaved alpha-t progressively into fragments of known amino acid sequences (38, then 32 and 5, then 21 and 12 kDa) and a transient 34 kDa fragment. The binding of mAb 4A to proteolytic fragments was analyzed by Western blot and immunoprecipitation. The major fragments recognized by mAb 4A on Western blots were the 34- and 23-kDa fragments obtained by endoproteinase Arg-C and tryptic digestion. Under conditions that allowed sequencing of the 15- and 5-kDa fragments neither the 34- nor the 23-kDa fragments could be sequenced by Edman degradation, indicating that they contained a blocked amino terminus. The smallest fragment that retained mAb 4A binding was the 23-kDa fragment containing Met1 to Arg204. Thus the main portion of the mAb 4A antigenic site was located within this fragment, indicating that the carboxyl-terminal residues from Lys205 to Phe350 were not required for recognition by the antibody. Additionally, the antibody did not bind the 38- and 36-kDa or other fragments containing the carboxyl terminus, showing that the amino-terminal residues from Met1 to Lys17 were essential for antibody binding to alpha-t.	UNIV ILLINOIS,COLL MED,DEPT PHYSIOL & BIOPHYS,BOX 6998,CHICAGO,IL 60680	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital			Hamm, Heidi E/G-2374-2014; Mazzoni, Maria Rosa/AAA-2366-2022	Mazzoni, Maria Rosa/0000-0003-2612-432X				AMIT AG, 1986, SCIENCE, V233, P747, DOI 10.1126/science.2426778; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CERIONE RA, 1988, J BIOL CHEM, V263, P9345; CORREZE C, 1987, J BIOL CHEM, V262, P15182; COTE TE, 1984, J BIOL CHEM, V259, P8693; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; DERETIC D, 1987, J BIOL CHEM, V262, P10839; DHANASEKARAN N, 1988, J BIOL CHEM, V263, P17942; FUNG BKK, 1983, J BIOL CHEM, V258, P503; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; FUNG BKK, 1983, J BIOL CHEM, V258, P495; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hamm H E, 1990, Biochem Soc Symp, V56, P35; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HAMM HE, 1989, J BIOL CHEM, V264, P11475; HAMM HE, 1987, J BIOL CHEM, V262, P10831; HAMM HE, 1984, J GEN PHYSIOL, V84, P265, DOI 10.1085/jgp.84.2.265; HAMM HE, 1991, BIOPHYS J, V59, P347; HINGORANI VN, 1988, J BIOL CHEM, V263, P6916; HINGORANI VN, 1988, J BIOL CHEM, V263, P19804; HO YK, 1989, CURR TOP CELL REGUL, V30, P171; HURLEY JB, 1984, SCIENCE, V226, P860, DOI 10.1126/science.6436980; HURLEY JB, 1987, ANNU REV PHYSIOL, V49, P793; JANIN J, 1990, J BIOL CHEM, V265, P16027; KLEUSS C, 1987, J CHROMATOGR, V407, P281, DOI 10.1016/S0021-9673(01)92625-1; KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0; KUROSE H, 1983, J BIOL CHEM, V258, P4870; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; LOCHRIE MA, 1985, SCIENCE, V228, P96, DOI 10.1126/science.3856323; MAZZONI MR, 1989, BIOCHEMISTRY-US, V28, P9873, DOI 10.1021/bi00451a047; MCKENZIE FR, 1988, BIOCHEM J, V249, P653, DOI 10.1042/bj2490653; MEDYNSKI DC, 1985, P NATL ACAD SCI USA, V82, P4311, DOI 10.1073/pnas.82.13.4311; NAVON SE, 1988, J BIOL CHEM, V263, P489; NAVON SE, 1987, J BIOL CHEM, V262, P15746; NEER EJ, 1988, J BIOL CHEM, V263, P8996; NEER EJ, 1990, G PROTEINS, P41; OSAWA S, 1990, MOL CELL BIOL, V10, P2931, DOI 10.1128/MCB.10.6.2931; OSAWA S, 1990, CELL, V63, P697, DOI 10.1016/0092-8674(90)90136-3; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; RAMDAS L, 1990, Investigative Ophthalmology and Visual Science, V31, P216; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SIMONDS WF, 1989, P NATL ACAD SCI USA, V86, P7809, DOI 10.1073/pnas.86.20.7809; STRYER L, 1986, ANNU REV CELL BIOL, V2, P391, DOI 10.1146/annurev.cb.02.110186.002135; STRYER L, 1983, METHOD ENZYMOL, V96, P617; SULLIVAN KA, 1987, NATURE, V330, P758, DOI 10.1038/330758a0; SUNYER T, 1989, MOL ENDOCRINOL, V3, P1115, DOI 10.1210/mend-3-7-1115; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UI M, 1986, P163; VANDOP C, 1984, J BIOL CHEM, V259, P23; WEST RE, 1985, J BIOL CHEM, V260, P4428; WHEELER GL, 1977, P NATL ACAD SCI USA, V74, P4238, DOI 10.1073/pnas.74.10.4238; WITT PL, 1984, J GEN PHYSIOL, V84, P251, DOI 10.1085/jgp.84.2.251; YATANI A, 1988, SCIENCE, V241, P828, DOI 10.1126/science.2457252; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P4316, DOI 10.1073/pnas.82.13.4316	58	91	94	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					14072	14081						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713215				2022-12-27	WOS:A1991FY02700095
J	SELKIRK, ME; YAZDANBAKHSH, M; FREEDMAN, D; BLAXTER, ML; COOKSON, E; JENKINS, RE; WILLIAMS, SA				SELKIRK, ME; YAZDANBAKHSH, M; FREEDMAN, D; BLAXTER, ML; COOKSON, E; JENKINS, RE; WILLIAMS, SA			A PROLINE-RICH STRUCTURAL PROTEIN OF THE SURFACE SHEATH OF LARVAL BRUGIA FILARIAL NEMATODE PARASITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; PAHANGI MICROFILARIAE; CAENORHABDITIS-ELEGANS; COLLAGEN GENE; MALAYI; BINDING; PHOSPHOPROTEIN; IDENTIFICATION; GLYCOPROTEIN; EGGSHELL	Both cDNA and genomic DNA sequences have been isolated which encode a proline-rich precursor protein of the sheath from microfilariae, the first stage larvae of the filarial nematode parasites Brugia pahangi and Brugia malayi. This 22-kDa protein is soluble only under reducing conditions and is extensively cross-linked by both disulfide and nonreducible bonds. Immunogold electron microscopy shows that the protein is localized exclusively in the sheath, a vestigial remnant of the eggshell, which is retained by and encloses the mature microfilaria. Analysis by Western blotting confirms that the protein is expressed only in microfilariae and adult female worms, although transcripts are detectable only in adult females. The deduced amino acid sequence contains a short N-terminal hydrophobic putative leader sequence, a central repetitive domain that contains 14 copies of a degenerate 5-amino acid repeat with the consensus sequence Met-Pro-Pro-Gln-Gly, and a C-terminal proline-rich domain flanked by clusters of cysteine residues. These clusters can be aligned with cysteine residues implicated in cross-linking of a family of cuticular collagens originally identified in Caenorhabditis elegans but which extends to other nematodes.	SMITH COLL, DEPT BIOL SCI, NORTHAMPTON, MA 01063 USA; LONDON SCH HYG & TROP MED, ELECTRON MICROSCOPY UNIT, LONDON WC1E 6BT, ENGLAND	Smith College; University of London; London School of Hygiene & Tropical Medicine	SELKIRK, ME (corresponding author), IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOCHEM, WELLCOME RES CTR PARASIT INFECT, LONDON SW7 2AZ, ENGLAND.		Blaxter, Mark/O-2535-2019; Yazdanbakhsh, Maria/AAI-3996-2020; Blaxter, Mark L/B-4113-2010	Yazdanbakhsh, Maria/0000-0002-7666-1441; Blaxter, Mark L/0000-0003-2861-949X; Selkirk, Murray/0000-0002-6274-6014; Williams, Steven/0000-0002-4881-7496	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANN DK, 1988, J BIOL CHEM, V263, P10887; Anya A.O., 1976, Advances Parasit, V14, P267, DOI 10.1016/S0065-308X(08)60516-3; BENNICK A, 1978, CARIES RES, V12, P159, DOI 10.1159/000260326; BENNICK A, 1976, BIOCHEM J, V155, P163, DOI 10.1042/bj1550163; BOEDTKER H, 1956, J AM CHEM SOC, V78, P4267, DOI 10.1021/ja01598a024; BRESSAN GM, 1987, BIOCHEMISTRY-US, V26, P1497, DOI 10.1021/bi00380a001; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHITWOOD BG, 1950, INTRO NEMATOLOGY; CLEMENTS S, 1985, J BIOL CHEM, V260, P3471; CORDINGLEY JS, 1987, PARASITOL TODAY, V3, P341, DOI 10.1016/0169-4758(87)90118-9; Croll NA., 1977, BIOL NEMATODES, P152; DEVANEY E, 1985, TROPENMED PARASITOL, V36, P25; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FUHRMAN JA, 1985, MOL BIOCHEM PARASIT, V17, P93, DOI 10.1016/0166-6851(85)90130-6; FURMAN A, 1983, ACTA TROP, V40, P45; GAO B, 1986, P NATL ACAD SCI USA, V83, P8634, DOI 10.1073/pnas.83.22.8634; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAEDA N, 1985, J BIOL CHEM, V260, P1123; MAIZELS RM, 1989, MOL BIOCHEM PARASIT, V32, P213, DOI 10.1016/0166-6851(89)90072-8; Maniatis T., 1982, MOL CLONING; MCGREEVY PB, 1980, AM J TROP MED HYG, V29, P553, DOI 10.4269/ajtmh.1980.29.553; MCLAREN DJ, 1972, PARASITOLOGY, V65, P317, DOI 10.1017/S0031182000045108; MCPHAIL GD, 1987, J PATHOL, V151, P231, DOI 10.1002/path.1711510311; Neville A.C., 1975, BIOL ARTHROPOD CUTIC; OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3; OVCHINNIKOV YA, 1988, FEBS LETT, V232, P69, DOI 10.1016/0014-5793(88)80388-0; PARTONO F, 1987, T ROY SOC TROP MED H, V81, P657, DOI 10.1016/0035-9203(87)90445-7; PERRINE KG, 1988, MOL BIOCHEM PARASIT, V30, P97, DOI 10.1016/0166-6851(88)90137-5; PINDER M, 1988, J IMMUNOL, V141, P2480; ROGERS R, 1976, J HELMINTHOL, V50, P251, DOI 10.1017/S0022149X00026675; Rogers WP, 1962, NATURE PARASITISM; SAYERS G, 1984, PARASITOLOGY, V89, P425, DOI 10.1017/S0031182000056675; SCHRAERMEYER U, 1987, Z PARASITENKD, V73, P557; SELKIRK ME, 1989, J IMMUNOL, V143, P299; SELKIRK ME, 1990, MOL BIOCHEM PARASIT, V42, P31, DOI 10.1016/0166-6851(90)90110-8; SELKIRK ME, 1989, MOL BIOCHEM PARASIT, V32, P229, DOI 10.1016/0166-6851(89)90073-X; SHAMANSKY LM, 1989, MOL BIOCHEM PARASIT, V37, P73, DOI 10.1016/0166-6851(89)90104-7; SIMPSON MG, 1972, PARASITOLOGY, V64, P61, DOI 10.1017/S0031182000044656; STEINERT PM, 1983, NATURE, V302, P794, DOI 10.1038/302794a0; TARR GE, 1973, LIPIDS, V8, P7, DOI 10.1007/BF02533232; TARR GE, 1973, COMP BIOCHEM PHYSIOL, V46, P167, DOI 10.1016/0305-0491(73)90058-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; WHARTON D, 1980, PARASITOLOGY, V81, P447, DOI 10.1017/S003118200005616X; WHARTON DA, 1979, INT J PARASITOL, V9, P127, DOI 10.1016/0020-7519(79)90102-4; WHARTON DA, 1978, TISSUE CELL, V10, P427, DOI 10.1016/S0040-8166(16)30338-X; WONG MM, 1969, T ROY SOC TROP MED H, V63, P796, DOI 10.1016/0035-9203(69)90123-0; WONG RSC, 1979, J BIOL CHEM, V254, P4800; WONG RSC, 1980, J BIOL CHEM, V255, P5943; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; ZAMAN V, 1987, Z PARASITENKD, V73, P281	52	38	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11002	11008						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710216				2022-12-27	WOS:A1991FQ77400048
J	KRONBACH, T; JOHNSON, EF				KRONBACH, T; JOHNSON, EF			AN INHIBITORY MONOCLONAL-ANTIBODY BINDS IN CLOSE PROXIMITY TO A DETERMINANT FOR SUBSTRATE BINDING IN CYTOCHROME-P450IIC5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC PROGESTERONE 21-HYDROXYLASE; COUMARIN HYDROXYLASE-ACTIVITY; SITE-SPECIFIC ANTIBODIES; GENETIC-REGULATION; CRYSTAL-STRUCTURE; LIVER; IDENTIFICATION; ISOENZYME; PROTEINS; MICE	We used the expression of chimeric proteins and point mutants to identify amino acids of the hepatic progesterone 21-hydroxylase P450IIC5 which are part of an epitope recognized by an inhibitory monoclonal antibody and which affect substrate binding. Three amino acids of P450IIC5 at positions 113, 115, and 118 were introduced into P450IIC4, which is 95% identical to P450IIC5. The resultant chimeric protein acquired binding of the monoclonal antibody 1F11, which is highly specific and inhibitory for P450IIC5. Point mutants in P450IIC4 showed that two of the three changes, T115S and N118K, contribute to the epitope recognized by this antibody. The T115S mutant bound the antibody weakly (K(d) > 30 nM) whereas the N118K mutant bound the antibody as tightly as P450IIC5 (K(d) less-than-or-equal-to 0.7 nM). Thus, residues 115 and 118 are located on the surface of these enzymes, and the Lys/Asn difference at amino acid 118 is largely responsible for the high degree of discrimination which this antibody exhibits between P450IIC5 and P450IIC4. The valine to alanine mutation at position 113 conferred to P450IIC4 a lower apparent K(m) for progesterone 21-hydroxylation. Because antibody binding was not affected by this mutation, it is tempting to speculate that this residue is buried in the protein where it exerts its effect on the catalytic activity by interaction with the substrate or alters the positions of residues of the active site. The close proximity of the epitope at positions 115 and 118 to Ala113 suggests that the inhibitory monoclonal antibody interferes with substrate binding.	Scripps Res Inst, RES INST,DEPT MOLEC & EXPTL MED,DIV BIOCHEM,BCR-7, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA	Scripps Research Institute					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00833] Funding Source: Medline; NIGMS NIH HHS [GM31001] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AOYAMA T, 1989, J BIOL CHEM, V264, P21327; ATKINS WM, 1988, J BIOL CHEM, V263, P18842; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DELEMOSCHIARANDINI C, 1987, J CELL BIOL, V104, P209, DOI 10.1083/jcb.104.2.209; DIETER HH, 1982, SCIENCE, V217, P741, DOI 10.1126/science.6808664; DIETER HH, 1982, BIOCHEM BIOPH RES CO, V105, P515, DOI 10.1016/0006-291X(82)91465-6; EDWARDS RJ, 1989, BIOCHEM SOC T, V17, P1022, DOI 10.1042/bst0171022; FREY AB, 1985, J BIOL CHEM, V260, P5253; Gotoh O., 1989, FRONTIERS BIOTRANSFO, V1, P195; JOHNSON EF, 1987, J BIOL CHEM, V262, P5918; KRONBACH T, 1989, P NATL ACAD SCI USA, V86, P8262, DOI 10.1073/pnas.86.21.8262; KRONBACH T, 1987, ANAL BIOCHEM, V162, P24, DOI 10.1016/0003-2697(87)90006-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; MILES JS, 1990, GENOMICS, V7, P445, DOI 10.1016/0888-7543(90)90182-T; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NEGISHI M, 1990, 8TH P INT S MICR DRU, P15; NELSON DR, 1989, BIOCHEMISTRY-US, V28, P656, DOI 10.1021/bi00428a036; POULOS TL, 1987, J MOL BIOL, V195, P687, DOI 10.1016/0022-2836(87)90190-2; POULOS TL, 1986, BIOCHEMISTRY-US, V25, P5314, DOI 10.1021/bi00366a049; REUBI I, 1984, BIOCHEMISTRY-US, V23, P4598, DOI 10.1021/bi00315a013; REUBI I, 1984, J BIOL CHEM, V259, P5887; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WOOD AW, 1979, J BIOL CHEM, V254, P5641; WOOD AW, 1979, J BIOL CHEM, V254, P5647	26	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6215	6220						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706711				2022-12-27	WOS:A1991FE37300035
J	NILSSON, B; BERMANMARKS, C; KUNTZ, ID; ANDERSON, S				NILSSON, B; BERMANMARKS, C; KUNTZ, ID; ANDERSON, S			SECRETION INCOMPETENCE OF BOVINE PANCREATIC TRYPSIN-INHIBITOR EXPRESSED IN ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTOSE-BINDING PROTEIN; BETA-LACTAMASE; SALMONELLA-TYPHIMURIUM; PROLINE RESIDUES; SIGNAL SEQUENCE; TRANSLOCATION; MEMBRANES; PATHWAY; EXPORT; PURIFICATION	There is increasing evidence that protein folding and protein export are competing processes in prokaryotic cells. Virtually all secretion studies reported to date, however, have employed proteins that are relatively uncharacterized in terms of their folding behavior and three-dimensional structure. In contrast, the structural and biochemical parameters governing the folding of bovine pancreatic trypsin inhibitor (BPTI) and several of its mutants have been studied intensively. We therefore undertook a study of the secretion behavior in Escherichia coli of recombinant BPTI and its mutants. Wild-type BPTI and two well-characterized folding mutants (C14A, C38A)BPTI and (C30A, C51A)BPTI (missing the 14-38 and 30-51 disulfide bonds, respectively), were investigated by analyzing their expression fused to an E. coli signal sequence or to two synthetic IgG-binding domains of staphylococcal protein A. Both disulfide mutants are destabilized relative to wild-type BPTI and exhibit markedly altered folding kinetics: one (C14A, C38A) folds more slowly than wild-type BPTI and the other (C30A, C51A) unfolds more rapidly. Both mutants were observed to be exported 3-10 times more efficiently than the wild-type molecule. Moreover, the levels of unprocessed preprotein in the cytoplasm were severalfold higher for the wild-type fusion than for the fusion to the two folding mutants. Intracellular degradation of the BPTI moiety was also observed. These results are consistent with traffic of intracellular BPTI preproteins on at least three routes along the secretory pathway: (a) facile secretion of unfolded material, (b) intracellular folding leading to secretion blockage, and (c) degradation followed by export of truncated molecules. A novel feature of these findings is the implication that disulfide bonds can form in the bacterial cytoplasm and lead to secretion incompetence.	GENENTECH INC,DEPT CARDIOVASC RES,S SAN FRANCISCO,CA 94080; UNIV CALIF SAN FRANCISCO,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94143	Roche Holding; Genentech; University of California System; University of California San Francisco								BAKER K, 1987, J MOL BIOL, V198, P693, DOI 10.1016/0022-2836(87)90210-5; BONNER WM, 1984, METHOD ENZYMOL, V104, P460; CARTER P, 1987, METHOD ENZYMOL, V154, P382; CHANG CN, 1987, GENE, V55, P189, DOI 10.1016/0378-1119(87)90279-4; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; COVER WH, 1987, J BACTERIOL, V169, P1794, DOI 10.1128/jb.169.5.1794-1800.1987; CREIGHTON TE, 1977, J MOL BIOL, V113, P275, DOI 10.1016/0022-2836(77)90142-5; CREIGHTON TE, 1984, J MOL BIOL, V179, P497, DOI 10.1016/0022-2836(84)90077-9; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; de Boer HA., 1986, MAXIMIZING GENE EXPR, P225; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EILERS M, 1988, CELL, V52, P481, DOI 10.1016/0092-8674(88)90458-8; FUH G, 1990, J BIOL CHEM, V265, P3111; GLEASON FK, 1988, FEMS MICROBIOL LETT, V54, P271, DOI 10.1111/j.1574-6968.1988.tb02747.x; GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0; GOLDENBERG DP, 1988, BIOCHEMISTRY-US, V27, P2481, DOI 10.1021/bi00407a034; HARISCH G, 1979, EXPERIENTIA, V35, P719, DOI 10.1007/BF01968201; HELLEBUST H, 1990, IN PRESS J BACTERIOL; HOLLECKER M, 1983, J MOL BIOL, V168, P409, DOI 10.1016/S0022-2836(83)80026-6; HURLE MR, 1990, BIOCHEMISTRY-US, V29, P4410, DOI 10.1021/bi00470a021; HURT EC, 1987, TRENDS BIOCHEM SCI, V12, P369, DOI 10.1016/0968-0004(87)90171-X; JULLIEN M, 1981, J MOL BIOL, V145, P265, DOI 10.1016/0022-2836(81)90343-0; KOSEN PA, 1983, BIOCHEMISTRY-US, V22, P2433, DOI 10.1021/bi00279a020; KOSHLAND D, 1980, CELL, V20, P749, DOI 10.1016/0092-8674(80)90321-9; KOSHLAND D, 1982, CELL, V30, P893, DOI 10.1016/0092-8674(82)90294-X; KOSHLAND D, 1982, CELL, V30, P903, DOI 10.1016/0092-8674(82)90295-1; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZDUNSKI AM, 1989, FEMS MICROBIOL LETT, V63, P265, DOI 10.1111/j.1574-6968.1989.tb03400.x; LEVITT M, 1981, J MOL BIOL, V145, P251, DOI 10.1016/0022-2836(81)90342-9; LOWENADLER B, 1987, GENE, V58, P87, DOI 10.1016/0378-1119(87)90032-1; MAHER PA, 1986, P NATL ACAD SCI USA, V83, P9001, DOI 10.1073/pnas.83.23.9001; MARKS CB, 1986, J BIOL CHEM, V261, P7115; MARKS CB, 1987, SCIENCE, V235, P1370, DOI 10.1126/science.2435002; MARKS CB, 1987, PROTEIN STRUCTURE FO, V2, P335; MOKS T, 1987, BIOCHEMISTRY-US, V26, P5239, DOI 10.1021/bi00391a005; MOKS T, 1986, EUR J BIOCHEM, V156, P637, DOI 10.1111/j.1432-1033.1986.tb09625.x; MOSES E, 1983, J MOL BIOL, V170, P765, DOI 10.1016/S0022-2836(83)80130-2; NILSSON B, 1990, PROTEIN FOLDING : DECIPHERING THE SECOND HALF OF THE GENETIC CODE, P117; NILSSON B, 1990, METHOD ENZYMOL, V185, P144; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; NILSSON B, 1990, IN PRESS METHODS ENZ; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; PHILLIPS GJ, 1990, NATURE, V344, P882, DOI 10.1038/344882a0; POLITT S, 1983, J BACTERIOL, V153, P27; RANDALL LL, 1983, CELL, V33, P231, DOI 10.1016/0092-8674(83)90352-5; RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; ROTHMAN JE, 1986, NATURE, V322, P209, DOI 10.1038/322209a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAUER RT, 1986, BIOCHEMISTRY-US, V25, P5992, DOI 10.1021/bi00368a024; VIERA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; VONWILCKENBERGMANN B, 1986, EMBO J, V5, P3219, DOI 10.1002/j.1460-2075.1986.tb04632.x; WENG QP, 1988, J BACTERIOL, V170, P126, DOI 10.1128/jb.170.1.126-131.1988; WICKNER WT, 1985, SCIENCE, V230, P400, DOI 10.1126/science.4048938; WLODAWER A, 1987, J MOL BIOL, V193, P145, DOI 10.1016/0022-2836(87)90633-4; ZIMMERMANN R, 1986, TRENDS BIOCHEM SCI, V11, P512, DOI 10.1016/0968-0004(86)90085-X	59	35	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2970	2977						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704370				2022-12-27	WOS:A1991EX60000048
J	ZHANG, ZY; VANETTEN, RL				ZHANG, ZY; VANETTEN, RL			PRE-STEADY-STATE AND STEADY-STATE KINETIC-ANALYSIS OF THE LOW-MOLECULAR-WEIGHT PHOSPHOTYROSYL PROTEIN PHOSPHATASE FROM BOVINE HEART	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATIC-ACID-PHOSPHATASE; INORGANIC-PHOSPHATE; EXCHANGE-REACTIONS; PURIFICATION; ENZYME; LIVER; PHOSPHORYLATION; INTERMEDIATE; DEPENDENCE; PROGRAM	The complete time course of the hydrolysis of p-nitrophenyl phosphate catalyzed by the low molecular weight (acid) phosphotyrosyl protein phosphatase from bovine heart was elucidated and analyzed in detail. Burst titration kinetics were demonstrated for the first time with this class of enzyme. At pH 7.0, 4.5-degrees-C, a transient pre-steady-state "burst" of p-nitrophenol was formed with a rate constant of 48 S-1. The burst was effectively stoichiometric and corresponded to a single enzyme active site/molecule. The burst was followed by a slow steady-state turnover of the phosphoenzyme intermediate with a rate constant of 1.2 S-1. Product inhibition studies indicated an ordered uni-bi kinetic scheme for the hydrolysis. Partition experiments conducted for several substrates revealed a constant product ratio. V(max) was constant for these substrates, and the overall rate of hydrolysis was increased greatly in the presence of alcohol acceptors. An enzyme-catalyzed O-18 exchange between inorganic phosphate and water was detected and occurred with k(cat) = 4.47 x 10(-3) S-1 at pH 5.0, 37-degrees-C. These results were all consistent with the existence of a phosphoenzyme intermediate in the catalytic pathway and with the breakdown of the intermediate being the rate-limiting step. The true Michaelis binding constant K8 = 6.0 mM, the apparent K(m) = 0.38 mM, and the rate constants for phosphorylation (k2 = 540 S-1) and dephosphorylation (k3 = 36.5 S-1) were determined under steady-state conditions with p-nitrophenyl phosphate at pH 5.0 and 37-degrees-C in the presence of phosphate acceptors. The energies of activation for the enzyme-catalyzed hydrolysis at pH 5.0 and 7.0 were 13.6 and 14.1 kcal/mol, respectively. The activation energy for the enzyme-catalyzed medium O-18 exchange between phosphate and water was 20.2 kcal/mol Using the available equilibrium and rate constants, an energetic diagram was constructed for the enzyme-catalyzed reaction.	PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus					NCRR NIH HHS [RR 01077] Funding Source: Medline; NIGMS NIH HHS [GM 27003] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027003] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENDER ML, 1964, J AM CHEM SOC, V86, P3697, DOI 10.1021/ja01072a019; BENDER ML, 1967, J CHEM EDUC, V44, P84, DOI 10.1021/ed044p84; BEREZIN IV, 1971, BIOCHEMISTRY-USSR+, V36, P108; BLACK MJ, 1983, ANAL BIOCHEM, V135, P233, DOI 10.1016/0003-2697(83)90756-X; BOIVIN P, 1987, INT J BIOCHEM, V19, P613, DOI 10.1016/0020-711X(87)90227-8; BOURNE N, 1984, J ORG CHEM, V49, P1200, DOI 10.1021/jo00181a011; COHN M, 1978, P NATL ACAD SCI USA, V75, P200, DOI 10.1073/pnas.75.1.200; EARGLE DH, 1977, ANAL BIOCHEM, V81, P186, DOI 10.1016/0003-2697(77)90612-1; FALLER LD, 1989, BIOCHEMISTRY-US, V28, P6908, DOI 10.1021/bi00443a020; FERSHT A, 1985, ENZYME STRUCTURE MEC, P101; HACKNEY DD, 1978, P NATL ACAD SCI USA, V75, P3133, DOI 10.1073/pnas.75.7.3133; HALL AD, 1986, BIOCHEMISTRY-US, V25, P4784, DOI 10.1021/bi00365a010; IGARASHI M, 1970, BIOCHIM BIOPHYS ACTA, V220, P85, DOI 10.1016/0005-2744(70)90231-7; KNACK I, 1981, H-S Z PHYSIOL CHEM, V362, P1119, DOI 10.1515/bchm2.1981.362.2.1119; LAIDLER PM, 1982, ARCH BIOCHEM BIOPHYS, V216, P512, DOI 10.1016/0003-9861(82)90240-5; LAWRENCE GL, 1981, ARCH BIOCHEM BIOPHYS, V206, P122, DOI 10.1016/0003-9861(81)90073-4; LUTZ RA, 1985, CLIN CHEM, V31, P656; OSTROWSKI W, 1973, BIOCHEMISTRY-US, V12, P3893, DOI 10.1021/bi00744a016; RISLEY JM, 1978, J LABELLED COMPD RAD, V15, P533, DOI 10.1002/jlcr.2580150162; Rudolph F B, 1979, Methods Enzymol, V63, P411; SAINI MS, 1981, J BIOL CHEM, V256, P453; TAGA EM, 1982, ARCH BIOCHEM BIOPHYS, V214, P505, DOI 10.1016/0003-9861(82)90054-6; VANETTEN RL, 1977, BIOCHIM BIOPHYS ACTA, V484, P386, DOI 10.1016/0005-2744(77)90094-8; VANETTEN RL, 1977, ARCH BIOCHEM BIOPHYS, V183, P250, DOI 10.1016/0003-9861(77)90438-6; VANETTEN RL, 1982, ANN NY ACAD SCI, V390, P27; VANETTEN RL, 1978, P NATL ACAD SCI USA, V75, P4784; VANETTEN RL, 1972, 164TH NAT M AM CHEM; WAHEED A, 1988, BIOCHEMISTRY-US, V27, P4265, DOI 10.1021/bi00412a010; ZHANG ZY, 1990, ARCH BIOCHEM BIOPHYS, V282, P39, DOI 10.1016/0003-9861(90)90084-C	29	140	141	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1516	1525						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703150				2022-12-27	WOS:A1991EU49700028
J	JIN, P; SEJERSEN, T; RINGERTZ, NR				JIN, P; SEJERSEN, T; RINGERTZ, NR			RECOMBINANT PLATELET-DERIVED GROWTH FACTOR-BB STIMULATES GROWTH AND INHIBITS DIFFERENTIATION OF RAT L6 MYOBLASTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENT DIMERIC FORMS; PDGF RECEPTOR; MYOGENIC DIFFERENTIATION; SKELETAL-MUSCLE; MESSENGER-RNAS; CDNA CLONING; EXPRESSION; CHAIN; ESTABLISHES; ISOFORMS	We previously found that L6 myoblasts and skeletal muscle isolated from developing rats express the platelet-derived growth factor (PDGF) beta-receptor gene (Jin, P., Rahm, M., Claesson-Welsh, L., Heldin, C.-H., and Sejersen, T. (1990) J. Cell Biol. 110, 1665-1672). We now report that recombinant human PDGF-BB is a mitogen for L6 myoblasts and also a potent inhibitor of myogenic differentiation. Treatment of L6J1 myoblasts with PDGF-BB increased the rate of DNA synthesis and stimulated cell proliferation. In differentiation medium (Dulbecco's modified Eagle's medium/0.5% fetal calf serum or Dulbecco's modified Eagle's medium/insulin), PDGF-BB prevented fusion of confluent myoblasts and suppressed biochemical differentiation in L6J1 cells. Inhibition of myoblast differentiation was, however, reversible. Withdrawal of PDGF-BB from the medium allowed myoblast fusion to occur. Northern blot hybridization showed that the PDGF beta-receptor mRNA was down-regulated to an undetectable level when confluent cultures of L6J1 myoblasts in growth medium (Dulbecco's modified Eagle's medium/5% fetal calf serum) were shifted to differentiation medium. Receptor binding assays further indicated that binding of PDGF-BB to its receptors on L6J1 myoblasts declined rapidly before creatine kinase activity rose. Our results provide the first demonstration that PDGF-BB is a potent regulator of myogenesis of L6 rat myoblasts and suggest that it may regulate muscle differentiation in vivo.			JIN, P (corresponding author), KAROLINSKA INST,MED NOBEL INST,DEPT MED CELL GENET,S-10401 STOCKHOLM 60,SWEDEN.							BOLTON AE, 1973, BIOCHEM J, V133, P529, DOI 10.1042/bj1330529; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; COUGHLIN SR, 1989, SCIENCE, V243, P1191; DEUEL T F, 1988, Biofactors, V1, P213; EWTON DZ, 1981, DEV BIOL, V86, P31, DOI 10.1016/0012-1606(81)90312-2; FLORINI JR, 1984, IN VITRO CELL DEV B, V20, P942; FLORINI JR, 1987, MUSCLE NERVE, V10, P577, DOI 10.1002/mus.880100702; FLORINI JR, 1989, AM J PHYSIOL, V256, pC701, DOI 10.1152/ajpcell.1989.256.4.C701; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAMMACHER A, 1988, J BIOL CHEM, V263, P16493; HAMMACHER A, 1988, EUR J BIOCHEM, V176, P179, DOI 10.1111/j.1432-1033.1988.tb14266.x; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HELDIN CH, 1985, MOL CELL ENDOCRINOL, V39, P169, DOI 10.1016/0303-7207(85)90061-9; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; JIN P, 1990, J CELL BIOL, V110, P1665, DOI 10.1083/jcb.110.5.1665; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Maniatis T., 1982, MOL CLONING; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MINTY AJ, 1981, J BIOL CHEM, V256, P1008; OLWIN BB, 1988, J CELL BIOL, V107, P761, DOI 10.1083/jcb.107.2.761; Ostman A, 1989, GROWTH FACTORS, V1, P271, DOI 10.3109/08977198908998003; PEARSON ML, 1982, MUSCLE DEV MOL CELLU, P559; RINGERTZ NR, 1978, EXP CELL RES, V113, P233, DOI 10.1016/0014-4827(78)90363-4; ROSS R, 1986, CELL, V46, P155, DOI 10.1016/0092-8674(86)90733-6; STROOBANT P, 1984, EMBO J, V3, P2963, DOI 10.1002/j.1460-2075.1984.tb02241.x; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; WEYDERT A, 1983, J BIOL CHEM, V258, P3867; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	34	54	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					1245	1249						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702435				2022-12-27	WOS:A1991ET17700086
J	HAFFAR, BM; HOCART, SJ; COY, DH; MANTEY, S; CHIANG, HCV; JENSEN, RT				HAFFAR, BM; HOCART, SJ; COY, DH; MANTEY, S; CHIANG, HCV; JENSEN, RT			REDUCED PEPTIDE-BOND PSEUDOPEPTIDE ANALOGS OF SECRETIN - A NEW CLASS OF SECRETIN RECEPTOR ANTAGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOACTIVE INTESTINAL PEPTIDE; PANCREATIC ACINAR-CELLS; GUINEA-PIG PANCREAS; TYROSINE-HYDROXYLASE; ADENOSINE 3',5'-CYCLIC-MONOPHOSPHATE; STRUCTURAL REQUIREMENTS; BIOLOGICAL-ACTIVITY; ADENYLATE-CYCLASE; DISPERSED ACINI; AMYLASE RELEASE	The ability to assess the importance of secretin in various physiological processes is limited by the lack of specific potent antagonists. Recently, reduced peptide bond (psi) analogues of bombesin or substance P in which the -CONH- Bond is replaced by -CH2NH- are reported to be receptor antagonists. To attempt to develop a new class of secretin receptor antagonists, we have adopted a similar strategy with secretin and sequentially altered the eight NH2-terminal peptide bonds, the biological active portion of secretin. In guinea pig pancreatic acini, secretin caused a 75-fold increase in cyclic AMP (cAMP). Secretin inhibited I-125-secretin binding with a half-maximal effect at 7 nM. Each of the psi-analogues inhibited I-125-secretin binding. [psi-4,5]Secretin was the most potent, causing the half-maximal inhibition at 4-mu-M, and was 2-fold more potent than the [psi-1,2]secretin; 7-fold more than [psi-3,4]secretin, [psi-5,6]secretin, and [psi-8,9]secretin; 9-fold more than [psi-7,8]secretin; 13-fold more potent[psi-6,7]secretin, and 17-fold more than [psi-2,3]secretin. Secretin caused a half-maximal increase in cAMP at 1 nM. At concentrations up to 10-mu-M, ]psi-2,3[secretin, [psi-4,5]secretin, and [psi-8,0]secretin did not alter cAMP whereas [psi-1,2]secretin and [psi-6,7]secretin caused a detectable increase in cAMP at 10 nM, [psi-7,8]secretin at 300 nM, [psi-5,6]secretin at 1-mu-M, and [psi-3,4]secretin at 10-mu-M. The [psi-4,5], [psi-2,3], and [psi8,9] analogues of secretin each inhibited 1 nM secretin-stimulated cAMP as well as [psi-3,4]secretin, which functioned as a partial agonist. [psi-4,5]Secretin was the most potent, causing half-maximal inhibition at 3-mu-M whereas [psi-8,9]secretin was 6-fold less potent, and [psi-2,3]secretin and [psi-3,4]secretin were 17-fold less potent. [psi-4,5]Secretin inhibited secretin-stimulated cAMP and binding of I-125-secretin in a competitive manner. [psi-4,5]Secretin did not interact with cholecystokinin, bombesin, calcitonin gene-related peptide, or cholinergic receptors but did interact with receptors for vasoactive intestinal peptide, causing half-maximal inhibition at 72-mu-M and thus had a 18-fold higher affinity for secretin than vasoactive intestinal peptide receptors. These results indicate that reduced peptide bond analogues of the NH2 terminus of secretin represent a new class of secretin receptor antagonists. It is likely that in the future even more potent members of this class can be developed which may be useful to investigate the role of secretin in various physiological processes.	TULANE UNIV,MED CTR,DEPT MED,PEPTIDE RES LABS,NEW ORLEANS,LA 70112; NIDDKD,DIGEST DIS BRANCH,BETHESDA,MD 20892	Tulane University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)					NIDDK NIH HHS [DK-30167] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030167] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BABU GN, 1983, BRAIN RES BULL, V11, P25, DOI 10.1016/0361-9230(83)90053-9; BARBEZAT GO, 1972, P SOC EXP BIOL MED, V139, P211; BARON DN, 1958, EXPERIENTIA, V14, P30, DOI 10.1007/BF02159660; Bayliss WM, 1902, J PHYSIOL-LONDON, V28, P325; BODANSZKY A, 1972, J AM CHEM SOC, V94, P3600, DOI 10.1021/ja00765a057; BODANSZKY M, 1967, J AM CHEM SOC, V89, P6753, DOI 10.1021/ja01001a063; BODANSZKY M, 1979, HORMONE RECEPTORS DI, P15; BUSSOLATI G, 1971, HISTOCHEMISTRY, V26, P218, DOI 10.1007/BF00305655; CALKER BV, 1980, P NATL ACAD SCI USA, V77, P6907; CESKA M, 1969, CLIN CHIM ACTA, V26, P445, DOI 10.1016/0009-8981(69)90072-2; CESKA M, 1969, CLIN CHIM ACTA, V26, P437, DOI 10.1016/0009-8981(69)90071-0; CHANG TM, 1980, DIGEST DIS SCI, V25, P529, DOI 10.1007/BF01315215; CHARLTON CG, 1986, PEPTIDES, V7, P865, DOI 10.1016/0196-9781(86)90107-5; CHARLTON CG, 1983, PEPTIDES, V4, P739, DOI 10.1016/0196-9781(83)90029-3; CHATELAIN P, 1980, PFLUG ARCH EUR J PHY, V389, P21, DOI 10.1007/BF00587924; CHEY WY, 1970, GASTROENTEROLOGY, V58, P820; Chey WY, 1989, HDB PHYSL 6, V2, P359; CHRISTOPHE JP, 1976, J BIOL CHEM, V251, P4629; CLORE GM, 1988, EUR J BIOCHEM, V171, P479, DOI 10.1111/j.1432-1033.1988.tb13814.x; COY DH, 1988, J BIOL CHEM, V263, P5056; COY DH, 1989, J BIOL CHEM, V264, P14691; FELIX AM, 1988, INT J PEPT PROT RES, V32, P441; FREMEAU RT, 1986, J NEUROCHEM, V46, P1947; FUXE K, 1979, FED PROC, V38, P2333; GARDNER JD, 1977, J PHYSIOL-LONDON, V270, P439, DOI 10.1113/jphysiol.1977.sp011961; GARDNER JD, 1979, BIOCHIM BIOPHYS ACTA, V583, P491, DOI 10.1016/0304-4165(79)90066-7; GARDNER JD, 1989, HDB PHYSL NEURAL END, P171; GRONENBORN AM, 1987, FEBS LETT, V215, P88, DOI 10.1016/0014-5793(87)80119-9; GUNNES P, 1989, SCAND J CLIN LAB INV, V49, P701, DOI 10.3109/00365518909091547; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HOCART SJ, 1990, IN PRESS J MED CHEM; HUBEL KA, 1972, GASTROENTEROLOGY, V62, P318; IP NY, 1985, J NEUROSCI, V5, P1947; JAEGER E, 1979, HORMONE RECEPTORS DI, P25; JENSEN RT, 1983, AM J PHYSIOL, V245, pG186, DOI 10.1152/ajpgi.1983.245.2.G186; JENSEN RT, 1988, AM J PHYSIOL, V254, pG883, DOI 10.1152/ajpgi.1988.254.6.G883; JENSEN RT, 1982, J BIOL CHEM, V257, P5554; JENSEN RT, 1981, FED PROC, V40, P2486; JENSEN RT, 1981, AM J PHYSIOL, V241, pG498, DOI 10.1152/ajpgi.1981.241.6.G498; JONES RS, 1971, GASTROENTEROLOGY, V60, P64; MARTINEZ J, 1985, J MED CHEM, V28, P1874, DOI 10.1021/jm00150a020; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; MUTT V, 1965, BIOCHEMISTRY-US, V4, P2358, DOI 10.1021/bi00887a014; MUTT V, 1979, LIFE SCI, V25, P1703, DOI 10.1016/0024-3205(79)90472-7; ODONOHUE TL, 1981, P NATL ACAD SCI-BIOL, V78, P5221, DOI 10.1073/pnas.78.8.5221; PEIKIN SR, 1978, AM J PHYSIOL, V235, pE743, DOI 10.1152/ajpendo.1978.235.6.E743; PETERSEN H, 1978, AM J PHYSIOL, V234, pE286, DOI 10.1152/ajpendo.1978.234.3.E286; POLAK JM, 1971, SCAND J GASTROENTERO, V6, P739, DOI 10.3109/00365527109179946; PROPST F, 1979, J NEUROCHEM, V32, P1495, DOI 10.1111/j.1471-4159.1979.tb11090.x; QIAN JM, 1989, J BIOL CHEM, V264, P16667; RAMIREZ M, 1970, AM J DIG DIS, V15, P539, DOI 10.1007/BF02238114; ROBBERECHT P, 1976, J BIOL CHEM, V251, P4635; ROBINSON RM, 1982, BIOPOLYMERS, V21, P1217, DOI 10.1002/bip.360210615; RODRIGUEZ M, 1986, INT J PEPT PROT RES, V27, P293; ROSSELIN G, 1986, PEPTIDES, V7, P89, DOI 10.1016/0196-9781(86)90170-1; SASAKI Y, 1987, PEPTIDES, V8, P119, DOI 10.1016/0196-9781(87)90174-4; SASAKI Y, 1987, J MED CHEM, V30, P1162, DOI 10.1021/jm00390a008; SCHILD HO, 1949, BRIT J PHARM CHEMOTH, V4, P277, DOI 10.1111/j.1476-5381.1949.tb00548.x; SCHWARZSCHILD MA, 1989, J NEUROSCI, V9, P160; SOLOMON TE, 1978, AM J PHYSIOL, V236, pE714; STENING GF, 1969, GASTROENTEROLOGY, V56, P468; VATN MH, 1974, SCAND J GASTROENTERO, V9, P313; WALSH JH, 1987, PHYSL GASTROINTESTIN, P181; ZHOU ZC, 1987, PEPTIDES, V8, P633, DOI 10.1016/0196-9781(87)90037-4; ZHOU ZC, 1989, AM J PHYSIOL, V256, pG283, DOI 10.1152/ajpgi.1989.256.2.G283	65	41	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					316	322						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702423				2022-12-27	WOS:A1991EQ33900047
J	BLITHE, DL				BLITHE, DL			N-LINKED OLIGOSACCHARIDES ON FREE-ALPHA INTERFERE WITH ITS ABILITY TO COMBINE WITH HUMAN CHORIONIC GONADOTROPIN-BETA SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											BLITHE, DL (corresponding author), NICHHD, DEV ENDOCRINOL BRANCH, BETHESDA, MD 20892 USA.							ARUMUGHAM RG, 1983, J BIOL CHEM, V258, P1883; ASHITAKA Y, 1974, ENDOCRINOL JAPON, V21, P547; BEEBE JS, 1990, ENDOCRINOLOGY, V126, P384, DOI 10.1210/endo-126-1-384; BEEBE JS, 1989, ENDOCRINOLOGY, V124, P1613, DOI 10.1210/endo-124-4-1613; BEGEOT M, 1984, SCIENCE, V226, P566, DOI 10.1126/science.6208610; BENVENISTE R, 1979, ENDOCRINOLOGY, V105, P581, DOI 10.1210/endo-105-3-581; BLITHE DL, 1987, ENDOCRINOLOGY, V121, P1215, DOI 10.1210/endo-121-4-1215; BLITHE DL, 1985, ENDOCRINOLOGY, V117, P2218, DOI 10.1210/endo-117-5-2218; BLITHE DL, 1990, ENDOCRINOLOGY, V126, P2788, DOI 10.1210/endo-126-6-2788; COLE LA, 1984, BIOCHEM BIOPH RES CO, V122, P1260, DOI 10.1016/0006-291X(84)91228-2; COLE LA, 1983, ENDOCRINOLOGY, V113, P1176, DOI 10.1210/endo-113-3-1176; CORLESS CL, 1987, J BIOL CHEM, V262, P14197; CORLESS CL, 1985, ENDOCRINOLOGY, V117, P1699, DOI 10.1210/endo-117-4-1699; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1235; ENDO Y, 1979, J BIOCHEM-TOKYO, V85, P669; HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9; HUNT LA, 1981, J VIROL, V39, P646, DOI 10.1128/JVI.39.2.646-650.1981; HUSSA RO, 1981, LIGAND REV S2, V3, P6; KANG MS, 1983, J VIROL, V46, P60, DOI 10.1128/JVI.46.1.60-69.1983; KAWANO T, 1988, ARCH BIOCHEM BIOPHYS, V267, P787, DOI 10.1016/0003-9861(88)90088-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSTBADER J, 1987, J BIOL CHEM, V262, P14204; MIZUOCHI T, 1983, J BIOL CHEM, V258, P4126; NISHIMURA R, 1985, ENDOCRINOL JAPON, V32, P463; PARSONS TF, 1984, J BIOL CHEM, V259, P2662; PETERS BP, 1989, ENDOCRINOLOGY, V124, P1602, DOI 10.1210/endo-124-4-1602; PETERS BP, 1984, J BIOL CHEM, V259, P5123; REICHERT LE, 1973, ENDOCRINOLOGY, V93, P938, DOI 10.1210/endo-93-4-938; SWAMINATHAN N, 1970, BIOCHEM BIOPH RES CO, V40, P422, DOI 10.1016/0006-291X(70)91026-0; TAKAHASHI N, 1978, J BIOCHEM-TOKYO, V84, P1467, DOI 10.1093/oxfordjournals.jbchem.a132270; TALIADOUROS GS, 1982, J CLIN ENDOCR METAB, V54, P1002, DOI 10.1210/jcem-54-5-1002; TARENTINO AL, 1974, J BIOL CHEM, V249, P818; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; VAITUKAITIS J, 1971, J CLIN ENDOCR METAB, V33, P988, DOI 10.1210/jcem-33-6-988; VAITUKAITIS JL, 1972, AM J OBSTET GYNECOL, V113, P751, DOI 10.1016/0002-9378(72)90553-4; WEINTRAUB BD, 1975, J CLIN INVEST, V56, P1043, DOI 10.1172/JCI108151	36	40	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21951	21956						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1701438				2022-12-27	WOS:A1990EM45600087
J	SUGG, EE; GARCIA, ML; REUBEN, JP; PATCHETT, AA; KACZOROWSKI, GJ				SUGG, EE; GARCIA, ML; REUBEN, JP; PATCHETT, AA; KACZOROWSKI, GJ			SYNTHESIS AND STRUCTURAL CHARACTERIZATION OF CHARYBDOTOXIN, A POTENT PEPTIDYL INHIBITOR OF THE HIGH CONDUCTANCE CA-2+-ACTIVATED K+ CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									MERCK SHARP & DOHME LTD,DEPT EXPLORATORY CHEM,RAHWAY,NJ 07065; MERCK SHARP & DOHME LTD,DEPT MEMBRANE BIOCHEM & BIOPHYS,RAHWAY,NJ 07065	Merck & Company; Merck & Company								ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; ATHERTON E, 1985, J CHEM SOC CHEM COMM, V3, P165; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; DRYLAND A, 1986, J CHEM SOC PERK T 1, P125, DOI 10.1039/p19860000125; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERMANN A, 1987, J GEN PHYSIOL, V90, P27, DOI 10.1085/jgp.90.1.27; JONES TR, 1990, IN PRESS J PHARM EXP; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LUCCHESI K, 1989, J MEMBRANE BIOL, V109, P269, DOI 10.1007/BF01870284; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8087, DOI 10.1021/bi00446a019; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PETERSEN OH, 1984, NATURE, V307, P693, DOI 10.1038/307693a0; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; SANDS SB, 1989, J GEN PHYSIOL, V93, P1061, DOI 10.1085/jgp.93.6.1061; SCHNEIDER MJ, 1989, FEBS LETT, V250, P433, DOI 10.1016/0014-5793(89)80771-9; SCHWEITZ H, 1989, BIOCHEMISTRY-US, V28, P9708, DOI 10.1021/bi00451a025; SLAUGHTER RS, 1989, BIOCHEMISTRY-US, V28, P3995, DOI 10.1021/bi00435a055; SMITH C, 1986, J BIOL CHEM, V261, P4607; STRONG PN, 1989, BRIT J PHARMACOL, V98, P817, DOI 10.1111/j.1476-5381.1989.tb14610.x; SUGG EE, 1990, PEPTIDES CHEM STRUCT, P1069; VALDIVIA HH, 1988, FEBS LETT, V226, P280, DOI 10.1016/0014-5793(88)81439-X; VAZQUEZ J, 1990, J BIOL CHEM, V265, P15564; VAZQUEZ J, 1989, J BIOL CHEM, V264, P20902; WILLIAMS DL, 1988, P NATL ACAD SCI USA, V85, P9360, DOI 10.1073/pnas.85.23.9360; WINQUIST RJ, 1989, J PHARMACOL EXP THER, V248, P149	31	65	67	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					18745	18748						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699936				2022-12-27	WOS:A1990EF73900009
J	MACNAUL, KL; CHARTRAIN, N; LARK, M; TOCCI, MJ; HUTCHINSON, NI				MACNAUL, KL; CHARTRAIN, N; LARK, M; TOCCI, MJ; HUTCHINSON, NI			DISCOORDINATE EXPRESSION OF STROMELYSIN, COLLAGENASE, AND TISSUE INHIBITOR OF METALLOPROTEINASES-1 IN RHEUMATOID HUMAN SYNOVIAL FIBROBLASTS - SYNERGISTIC EFFECTS OF INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA ON STROMELYSIN EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MERCK SHARP & DOHME LTD,DEPT MOLEC IMMUNOL,R80W112,POB 2000,RAHWAY,NJ 07065; MERCK SHARP & DOHME LTD,DEPT BIOCHEM & MOLEC PATHOL,RAHWAY,NJ 07065	Merck & Company; Merck & Company								BAYNE EK, 1986, J EXP MED, V163, P1267, DOI 10.1084/jem.163.5.1267; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOONE TC, 1990, P NATL ACAD SCI USA, V87, P2800, DOI 10.1073/pnas.87.7.2800; CAMPBELL EJ, 1987, J BIOL CHEM, V262, P15862; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHIN J, 1988, J CLIN INVEST, V82, P420, DOI 10.1172/JCI113614; CHIN JR, 1985, J BIOL CHEM, V260, P2367; CLARK SD, 1987, J CLIN INVEST, V80, P1280, DOI 10.1172/JCI113203; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; DAYER JM, 1976, P NATL ACAD SCI USA, V73, P945, DOI 10.1073/pnas.73.3.945; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; FRISCH SM, 1987, P NATL ACAD SCI USA, V84, P2600, DOI 10.1073/pnas.84.9.2600; GADHER SJ, 1987, RHEUMATOL INT, V7, P13, DOI 10.1007/BF00267337; GOWEN M, 1983, NATURE, V306, P378, DOI 10.1038/306378a0; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HARRIS ED, 1989, TXB RHEUMATOLOGY, P905; HEMBRY RM, 1985, J CELL SCI, V73, P105; HERRON GS, 1986, J BIOL CHEM, V261, P2814; HUTCHINSON NI, 1986, VIROLOGY, V155, P160, DOI 10.1016/0042-6822(86)90176-5; KINGSTON RE, 1987, CURRENT PROTOCOLS MO; KULL FC, 1985, P NATL ACAD SCI USA, V82, P5756, DOI 10.1073/pnas.82.17.5756; LARK M, UNPUB; MACNAUL KL, UNPUB J IMMUNOL; Maniatis T., 1982, MOL CLONING; MCCACHREN SS, 1989, ARTHRITIS RHEUM, V32, P1539, DOI 10.1002/anr.1780321207; MIZEL SB, 1981, P NATL ACAD SCI-BIOL, V78, P2474, DOI 10.1073/pnas.78.4.2474; MULLER D, 1988, BIOCHEM J, V253, P187, DOI 10.1042/bj2530187; MURPHY G, 1985, J BIOL CHEM, V260, P3079; OKADA Y, 1986, J BIOL CHEM, V261, P14245; OKADA Y, 1989, FEBS LETT, V244, P473, DOI 10.1016/0014-5793(89)80586-1; PEACOCK SL, 1981, BIOCHIM BIOPHYS ACTA, V655, P243, DOI 10.1016/0005-2787(81)90014-9; PETTIPHER ER, 1986, P NATL ACAD SCI USA, V83, P8749, DOI 10.1073/pnas.83.22.8749; QUINONES S, 1989, J BIOL CHEM, V264, P8339; SAKLATVALA J, 1984, BIOCHEM J, V224, P461, DOI 10.1042/bj2240461; SAKLATVALA J, 1986, NATURE, V322, P547, DOI 10.1038/322547a0; SAUS J, 1988, J BIOL CHEM, V263, P6742; SELLERS A, 1978, BIOCHEM J, V171, P493, DOI 10.1042/bj1710493; SINGER RH, 1986, BIOTECHNIQUES, V4, P230; STETLERSTEVENSON WG, 1989, J BIOL CHEM, V264, P17374; TOCCI MJ, 1987, J IMMUNOL, V138, P1109; VANCE BA, 1989, J CELL BIOL, V108, P2037, DOI 10.1083/jcb.108.6.2037; WERB Z, 1989, J CELL BIOL, V109, P877, DOI 10.1083/jcb.109.2.877; WILHELM SM, 1987, P NATL ACAD SCI USA, V84, P6725, DOI 10.1073/pnas.84.19.6725	44	422	428	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					17238	17245						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1698773				2022-12-27	WOS:A1990EA85700082
J	NAKANE, M; ARAI, K; SAHEKI, S; KUNO, T; BUECHLER, W; MURAD, F				NAKANE, M; ARAI, K; SAHEKI, S; KUNO, T; BUECHLER, W; MURAD, F			MOLECULAR-CLONING AND EXPRESSION OF CDNAS CODING FOR SOLUBLE GUANYLATE-CYCLASE FROM RAT LUNG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TOKYO METROPOLITAN INST NEUROSCI, FUCHU, TOKYO 183, JAPAN; EHIME UNIV, SCH MED, SHIGENOBU, EHIME 79102, JAPAN; KOBE UNIV, SCH MED, KOBE 650, JAPAN	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Ehime University; Kobe University	NAKANE, M (corresponding author), ABBOTT LABS, D47R, AP9A, 119, ABBOTT PK, IL 60064 USA.				NHLBI NIH HHS [HL-28474] Funding Source: Medline; NIDDK NIH HHS [DK-30787] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030787] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BRANDWEIN H, 1981, P NATL ACAD SCI-BIOL, V78, P4241, DOI 10.1073/pnas.78.7.4241; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; CHINKERS M, 1989, SCIENCE, V245, P1392, DOI 10.1126/science.2571188; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISMAN TD, 1975, J BIOL CHEM, V250, P374; CRAVEN PA, 1979, J BIOL CHEM, V254, P8213; DEGUCHI T, 1976, J NEUROCHEM, V27, P1027, DOI 10.1111/j.1471-4159.1976.tb00304.x; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; GARBERS DL, 1978, J BIOL CHEM, V253, P1898; GARBERS DL, 1989, J BIOL CHEM, V264, P9103; GERZER R, 1982, BIOCHEM BIOPH RES CO, V108, P678, DOI 10.1016/0006-291X(82)90883-X; GERZER R, 1981, FEBS LETT, V132, P71, DOI 10.1016/0014-5793(81)80429-2; GUERRANT RL, 1980, J INFECT DIS, V142, P220, DOI 10.1093/infdis/142.2.220; HUGHES JM, 1978, NATURE, V271, P755, DOI 10.1038/271755a0; HUYNH TV, 1985, GENETIC ENG, V7, P29; HUYNH TV, 1985, DNA CLONING PRACTICA, P98; KAMISAKI Y, 1986, J BIOL CHEM, V261, P7236; KIM DW, 1990, IN PRESS GENE AMST; KIMURA H, 1975, J BIOL CHEM, V250, P4810; KOESLING D, 1988, FEBS LETT, V239, P29, DOI 10.1016/0014-5793(88)80539-8; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; LEWICKI JA, 1983, J BIOL CHEM, V258, P3509; LEWICKI JA, 1980, J CYCLIC NUCL PROT, V6, P283; LOWE DG, 1989, EMBO J, V8, P1377, DOI 10.1002/j.1460-2075.1989.tb03518.x; Maniatis T., 1982, MOL CLONING; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; NAKANE M, 1982, FEBS LETT, V140, P89, DOI 10.1016/0014-5793(82)80527-9; NAKANE M, 1990, FASEB Journal, V4, pA872; NAKANE M, 1988, BIOCHEM BIOPH RES CO, V157, P1139, DOI 10.1016/S0006-291X(88)80992-6; NAKANE M, 1989, 7TH INT C CYCL NUCL, P121; OYEN O, 1988, FEBS LETT, V229, P391, DOI 10.1016/0014-5793(88)81163-3; RAPOPORT RM, 1983, J CYCLIC NUCL PROT, V9, P281; SAHEKI S, 1990, BIOCHIM BIOPHYS ACTA, V1051, P306, DOI 10.1016/0167-4889(90)90139-5; SINGH S, 1988, NATURE, V334, P708, DOI 10.1038/334708a0; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; THORPE DS, 1989, J BIOL CHEM, V264, P6545; WALDMAN SA, 1984, J BIOL CHEM, V259, P4332; WINQUIST RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7661, DOI 10.1073/pnas.81.23.7661; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	44	201	208	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					16841	16845						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1698769				2022-12-27	WOS:A1990EA85700025
J	PIHLAJANIEMI, T; TAMMINEN, M				PIHLAJANIEMI, T; TAMMINEN, M			THE ALPHA-1 CHAIN OF TYPE-XIII COLLAGEN CONSISTS OF 3 COLLAGENOUS AND 4 NONCOLLAGENOUS DOMAINS, AND ITS PRIMARY TRANSCRIPT UNDERGOES COMPLEX ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV OULU,DEPT MED BIOCHEM,SF-90220 OULU,FINLAND	University of Oulu	PIHLAJANIEMI, T (corresponding author), UNIV OULU,BIOCTR,COLLAGEN RES UNIT,SF-90220 OULU,FINLAND.			Pihlajaniemi, Taina/0000-0002-1664-9045				BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.bi.56.070187.002343; BROWN CC, 1987, J CELL BIOL, V105, P1007, DOI 10.1083/jcb.105.2.1007; BURGESON RE, 1988, ANNU REV CELL BIOL, V4, P551, DOI 10.1146/annurev.cb.04.110188.003003; CHU ML, 1987, EUR J BIOCHEM, V168, P309, DOI 10.1111/j.1432-1033.1987.tb13422.x; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; DEWET JR, 1984, DNA-J MOLEC CELL BIO, V3, P437, DOI 10.1089/dna.1.1984.3.437; DIXIT R, 1988, CONNECT TISSUE RES, V17, P71, DOI 10.3109/03008208808992795; DUBLET B, 1989, J BIOL CHEM, V264, P13150; GELIEBTER J, 1987, FOCUS, V9, P5; GORDON MK, 1987, P NATL ACAD SCI USA, V84, P6040, DOI 10.1073/pnas.84.17.6040; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; KAPOOR R, 1986, BIOCHEMISTRY-US, V25, P3930, DOI 10.1021/bi00361a029; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LOZANO G, 1985, P NATL ACAD SCI USA, V82, P4050, DOI 10.1073/pnas.82.12.4050; MAJACK RA, 1985, J CELL BIOL, V100, P613, DOI 10.1083/jcb.100.2.613; Maniatis T., 1982, MOL CLONING LABORATO, pA840 A851; MARTIN GR, 1985, TRENDS BIOCHEM SCI, V10, P285, DOI 10.1016/0968-0004(85)90089-1; Mayne R., 1987, STRUCTURE FUNCTION C; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILLER EJ, 1987, METHOD ENZYMOL, V144, P3; NINOMIYA Y, 1984, P NATL ACAD SCI-BIOL, V81, P3014, DOI 10.1073/pnas.81.10.3014; OLSEN BR, 1985, ANN NY ACAD SCI, V460, P141, DOI 10.1111/j.1749-6632.1985.tb51162.x; PIHLAJANIEMI T, 1987, P NATL ACAD SCI USA, V84, P940, DOI 10.1073/pnas.84.4.940; PIHLAJANIEMI T, 1987, METHOD ENZYMOL, V145, P213; PROCKOP DJ, 1989, ARTHRITIS ALLIED CON, P222; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TIKKA L, 1988, P NATL ACAD SCI USA, V85, P7491, DOI 10.1073/pnas.85.20.7491; VANDERREST M, 1985, J BIOL CHEM, V260, P220; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; YAMAGUCHI N, 1989, J BIOL CHEM, V264, P16022; YAMAUCHI M, 1986, BIOCHEMISTRY-US, V25, P1997, DOI 10.1021/bi00356a024	31	59	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					16922	16928						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1698771				2022-12-27	WOS:A1990EA85700037
J	PITTET, D; DIVIRGILIO, F; POZZAN, T; MONOD, A; LEW, DP				PITTET, D; DIVIRGILIO, F; POZZAN, T; MONOD, A; LEW, DP			CORRELATION BETWEEN PLASMA-MEMBRANE POTENTIAL AND 2ND MESSENGER GENERATION IN THE PROMYELOCYTIC CELL-LINE HL-60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV PADUA,IST PATOL GEN,I-35131 PADUA,ITALY; UNIV FERRARA,IST PATOL GEN,I-44100 FERRARA,ITALY; UNIV PADUA,CNR,CTR RIC STUDIO FISIOL MITOCONDRI,I-35131 PADUA,ITALY	University of Padua; University of Ferrara; Consiglio Nazionale delle Ricerche (CNR); University of Padua	PITTET, D (corresponding author), UNIV GENEVA,HOP CANTONAL,DIV INFECT DIS,CH-1211 GENEVA 4,SWITZERLAND.		Di Virgilio, Francesco/J-3754-2018; DI VIRGILIO, Francesco/O-4634-2019	Di Virgilio, Francesco/0000-0003-3566-1362; DI VIRGILIO, Francesco/0000-0003-3566-1362				ANDERSSON T, 1986, MOL PHARMACOL, V30, P437; ANDERSSON T, 1986, BIOCHEM J, V240, P333, DOI 10.1042/bj2400333; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BESTERMAN JM, 1984, J CELL BIOL, V99, P340, DOI 10.1083/jcb.99.1.340; DETOGNI P, 1983, BIOCHIM BIOPHYS ACTA, V755, P506, DOI 10.1016/0304-4165(83)90256-8; DIVIRGILIO F, 1987, J BIOL CHEM, V262, P4574; DIVIRGILIO F, 1990, CURR TOP MEMBR TRANS, V35, P179; DUNHAM PB, 1974, J CELL BIOL, V63, P215, DOI 10.1083/jcb.63.1.215; JACOB J, 1988, FEBS LETT, V231, P139, DOI 10.1016/0014-5793(88)80718-X; KORCHAK HM, 1978, P NATL ACAD SCI USA, V75, P3818, DOI 10.1073/pnas.75.8.3818; LADOUX A, 1984, FEBS LETT, V176, P467, DOI 10.1016/0014-5793(84)81220-X; LADOUX A, 1986, DIFFERENTIATION, V33, P142, DOI 10.1111/j.1432-0436.1986.tb00419.x; LEW PD, 1986, J BIOL CHEM, V261, P3121; MELDOLESI J, 1987, EXP CELL RES, V171, P271, DOI 10.1016/0014-4827(87)90161-3; MERRITT JE, 1989, J BIOL CHEM, V264, P1522; MOHR FC, 1987, J CELL BIOL, V104, P783, DOI 10.1083/jcb.104.3.783; MOTTOLA C, 1982, J CELL BIOL, V93, P129, DOI 10.1083/jcb.93.1.129; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PITTET D, 1987, J BIOL CHEM, V262, P10072; PITTET D, 1989, J BIOL CHEM, V264, P7251; ROBERTS RL, 1984, J IMMUNOL, V132, P2000; SELIGMANN BE, 1980, J CLIN INVEST, V66, P493, DOI 10.1172/JCI109880; SHAAFI RI, 1981, ADV INFLAMMAT RES, V2, P115; SHAPIRO HM, 1979, P NATL ACAD SCI USA, V76, P5728, DOI 10.1073/pnas.76.11.5728; TSIEN RY, 1982, NATURE, V295, P68, DOI 10.1038/295068a0; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; WALLACE BA, 1988, SCIENCE, V241, P182, DOI 10.1126/science.2455344	27	31	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14256	14263						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1696945				2022-12-27	WOS:A1990DV27800030
J	SAWAMURA, D; LI, KH; CHU, ML; UITTO, J				SAWAMURA, D; LI, KH; CHU, ML; UITTO, J			HUMAN BULLOUS PEMPHIGOID ANTIGEN (BPAG1) - AMINO-ACID-SEQUENCES DEDUCED FROM CLONED CDNAS PREDICT BIOLOGICALLY IMPORTANT PEPTIDE SEGMENTS AND PROTEIN DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASEMENT-MEMBRANE; HUMAN-SKIN; HUMAN KERATINOCYTES; HEMIDESMOSOMES; LOCALIZATION; EXPRESSION; AUTOANTIBODIES; JUNCTION; DNA	Bullous pemphigoid antigens are defined as the autoantigens in a blistering skin disease, bullous pemphigoid. One of them, a 230-kDa protein (BPAG1), is associated with hemidesmosomes, attachment complexes at the basal keratinocyte-lamina lucida interface within the dermal-epidermal basement membrane zone. The precise functions and cellular compartmentalization of BPAG1 are unknown. In this study, a human keratinocyte lambda-gt11 cDNA library was screened for clones corresponding to BPAG1. The composite of overlapping cDNAs delineated 8,930 base pairs of nucleotide sequences that contained an open reading frame encoding 2,649 amino acids. Analysis of the deduced amino acid sequences predicted a putative signal peptide of 43 amino acids and the presence of a membrane-associated sequence of 17 amino acids. Several potential sites for N-glycosylation, as well as for protein kinase C or cAMP- and cGMP-dependent protein kinase-mediated phosphorylation were identified. Three peptide segments were predicted to be highly antigenic, potentially serving as epitopes for the formation of autoantibodies. Eight repeat segments of 38 residues each with a high degree of homology with sequences in desmoplakin I, a component of desmosomal cytoplasmic plaques, were detected in the carboxyl-terminal end of the molecule. In addition, the presence of three subdomains characterized by heptad repeats predicted an alpha-helical coiled coil dimer structure in the central portion of the protein. These data suggest that BPAG1 may be a membrane-associated protein that plays a role in the attachment of basal keratinocytes to the underlying basement membrane.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL,233 S 10TH ST,BLSB 450,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON INST MOLEC MED,MOLEC DERMATOL SECT,PHILADELPHIA,PA 19107	Jefferson University; Jefferson University; Jefferson University					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923, T32AR007561] Funding Source: NIH RePORTER; NIAMS NIH HHS [T32AR7561, P01AR38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BERNARD P, 1989, J INVEST DERMATOL, V92, P171, DOI 10.1111/1523-1747.ep12276689; BRIGGAMAN RA, 1982, J INVEST DERMATOL, V78, P1, DOI 10.1111/1523-1747.ep12497841; DIAZ LA, 1978, BRIT J DERMATOL, V98, P631, DOI 10.1111/j.1365-2133.1978.tb03581.x; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FINE JD, 1988, ARCH DERMATOL, V124, P713, DOI 10.1001/archderm.124.5.713; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; HOLUBAR K, 1975, J INVEST DERMATOL, V64, P220, DOI 10.1111/1523-1747.ep12510658; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; IKEDA S, 1990, J INVEST DERMATOL, V94, P336, DOI 10.1111/1523-1747.ep12874466; JONES JCR, 1986, CELL MOTIL CYTOSKEL, V6, P560, DOI 10.1002/cm.970060604; LABIB RS, 1986, J IMMUNOL, V136, P1231; LEVER WF, 1965, PEMPHIGUS PEMPHIGOID, P15; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; MUELLER S, 1989, J INVEST DERMATOL, V92, P33, DOI 10.1111/1523-1747.ep13070476; MUTASIM DF, 1989, J INVEST DERMATOL, V92, P225, DOI 10.1111/1523-1747.ep12276753; MUTASIM DF, 1985, J INVEST DERMATOL, V84, P47, DOI 10.1111/1523-1747.ep12274684; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; NORTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; OLSEN DR, 1988, J INVEST DERMATOL, V90, P734, DOI 10.1111/1523-1747.ep12560934; PARRY DAD, 1977, J MOL BIOL, V113, P449, DOI 10.1016/0022-2836(77)90153-X; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; RAO JKM, 1986, BIOCHIM BIOPHYS ACTA, V869, P197, DOI 10.1016/0167-4838(86)90295-5; REGNIER M, 1985, J INVEST DERMATOL, V85, P187, DOI 10.1111/1523-1747.ep12276656; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SAWAMURA D, 1990, GENOMICS, V8, P722, DOI 10.1016/0888-7543(90)90261-R; SAWAMURA D, 1991, J INVEST DERMATOL, V96, P908, DOI 10.1111/1523-1747.ep12475433; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; STANLEY JR, 1984, J INVEST DERMATOL, V82, P108, DOI 10.1111/1523-1747.ep12259224; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; TAKAHASHI Y, 1985, J INVEST DERMATOL, V85, P309, DOI 10.1111/1523-1747.ep12276893; THIVOLET CH, 1984, J INVEST DERMATOL, V82, P329, DOI 10.1111/1523-1747.ep12260634; TIMPL R, 1986, INT REV EXP PATHOL, V29, P1; TSURUMI C, 1990, BIOCHEM BIOPH RES CO, V169, P136, DOI 10.1016/0006-291X(90)91444-W; UITTO J, 1989, J INVEST DERMATOL, V92, pS61; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4783; WESTGATE GE, 1985, J INVEST DERMATOL, V84, P218, DOI 10.1111/1523-1747.ep12265229	42	210	211	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17784	17790						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717441				2022-12-27	WOS:A1991GG55300014
J	GUTIERREZ, LM; BRAWLEY, RM; HOSEY, MM				GUTIERREZ, LM; BRAWLEY, RM; HOSEY, MM			DIHYDROPYRIDINE-SENSITIVE CALCIUM CHANNELS FROM SKELETAL-MUSCLE .1. ROLES OF SUBUNITS IN CHANNEL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CA-2+ CHANNEL; TRANSVERSE TUBULES; 1,4-DIHYDROPYRIDINE RECEPTOR; BINDING; PHOSPHORYLATION; PURIFICATION; PEPTIDE; PROTEIN; CELLS; RECONSTITUTION	Dihydropyridine-sensitive Ca2+ channels from skeletal muscle are hetero-oligomeric proteins. Little is known about the functional roles of the various subunits, except that the alpha-1 subunit is the essential channel unit. We have reconstituted both partially purified holomeric channels and the separated subunits into liposomes and measured their properties using an assay based on the Ca2+ indicator dye fluo-3. The holomeric channels exhibited Ca2+ influx that was sensitive to membrane potential achieved by the addition of valinomycin in the presence of a K+ gradient. Dissipation of the K+ gradient resulted in the loss of the valinomycin-sensitive Ca2+ flux. In addition, the reconstituted channels were: 1) activated by the dihydropyridine Ca2+ channel activator Bay K 8644 in a dose-dependent manner with a K(d) of 20 nM; 2) inhibited by various types of Ca2+ channel inhibitors including the dihydropyridine (+)-PN 200-110, the phenylalkylamine verapamil, and the benzothiazepine d-cis-diltiazem; and 3) modulated in a stereoselective manner by the enantiomers of the dihydropyridine S-202-791. The purified channels used in this work possessed an alpha-1 subunit of 165 kDa and did not appear to contain a larger alpha-1 subunit of approximately 210 kDa, suggesting that channel activity with properties similar to those observed in intact cells can be supported with an alpha-1 subunit of 165 kDa. Reconstituted channels that were 85% depleted in the alpha-2/delta subunits showed a significant decrease in the initial rate of Ca2+ influx induced by valinomycin, but retained responsiveness to Bay K 8644 and (+)-PN 200-110. When the separated alpha-2 and delta-subunits were added back to the alpha-1 subunit-containing preparation, the channels exhibited their normal rate of Ca2+ influx. These results demonstrated that the dihydropyridine-sensitive Ca2+ channels from skeletal muscle require the presence of the alpha-2.delta complex in stoichiometric amounts to exhibit full activity.	NORTHWESTERN UNIV,SCH MED,DEPT PHARMACOL,303 E CHICAGO AVE,CHICAGO,IL 60611	Northwestern University			Gutierrez, Luis/K-8633-2014	Gutierrez, Luis/0000-0002-0512-7858	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL023306, R01HL023306] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL23306] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BORSOTTO M, 1985, J BIOL CHEM, V260, P4255; BORSOTTO M, 1984, BIOCHEM BIOPH RES CO, V122, P1357, DOI 10.1016/0006-291X(84)91241-5; CHANG CF, 1991, J BIOL CHEM, V266, P16395; CHANG CF, 1990, BIOCHEM BIOPH RES CO, V172, P751, DOI 10.1016/0006-291X(90)90738-9; CHANG FC, 1988, J BIOL CHEM, V263, P18929; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; COGNARD C, 1986, P NATL ACAD SCI USA, V83, P517, DOI 10.1073/pnas.83.2.517; CURTIS BM, 1986, BIOCHEMISTRY-US, V25, P3077, DOI 10.1021/bi00359a002; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; FERRY DR, 1983, N-S ARCH PHARMACOL, V323, P292, DOI 10.1007/BF00512466; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; FOSSET M, 1983, J BIOL CHEM, V258, P6086; GLOSSMANN H, 1983, N-S ARCH PHARMACOL, V323, P1, DOI 10.1007/BF00498821; HAMILTON SL, 1987, MOL PHARMACOL, V31, P221; HAMILTON SL, 1989, BIOCHEMISTRY-US, V28, P7820, DOI 10.1021/bi00445a044; HORNE WA, 1988, P NATL ACAD SCI USA, V85, P3718, DOI 10.1073/pnas.85.11.3718; HOSEY MM, 1987, BIOCHEM BIOPH RES CO, V147, P1137; ILDEFONSE M, 1985, BIOCHEM BIOPH RES CO, V129, P904, DOI 10.1016/0006-291X(85)91977-1; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KIM HS, 1990, J BIOL CHEM, V265, P11828; KOKUBUN S, 1986, MOL PHARMACOL, V30, P571; KRAMER S, 1989, J BIOL CHEM, V264, P13273; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAI Y, 1990, J BIOL CHEM, V265, P20839; LEUNG AT, 1987, J BIOL CHEM, V262, P7943; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; MOCZYDLOWSKI EG, 1983, BIOCHIM BIOPHYS ACTA, V732, P412, DOI 10.1016/0005-2736(83)90058-5; MUNDINAWEILENMANN C, 1991, J BIOL CHEM, V266, P4067; OCALLAHAN CM, 1988, BIOCHEMISTRY-US, V27, P6071, DOI 10.1021/bi00416a036; PEREZREYES E, 1989, NATURE, V340, P233, DOI 10.1038/340233a0; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; SCHILLING WP, 1984, J MEMBRANE BIOL, V79, P163, DOI 10.1007/BF01872120; SIEBER M, 1987, EUR J BIOCHEM, V167, P117, DOI 10.1111/j.1432-1033.1987.tb13311.x; SMITH JS, 1987, BIOCHEMISTRY-US, V26, P7182, DOI 10.1021/bi00396a046; STRIESSNIG J, 1987, FEBS LETT, V212, P247, DOI 10.1016/0014-5793(87)81354-6; SUGDEN PH, 1976, BIOCHEM J, V159, P409, DOI 10.1042/bj1590409; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TALVENHEIMO JA, 1987, BIOPHYS J, V52, P891, DOI 10.1016/S0006-3495(87)83283-6; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; TANABE T, 1990, NATURE, V344, P451, DOI 10.1038/344451a0; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; VAGHY PL, 1987, J BIOL CHEM, V262, P14337; WILLIAMS JS, 1985, BIOCHEM BIOPH RES CO, V131, P13, DOI 10.1016/0006-291X(85)91763-2	44	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16387	16394						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715865				2022-12-27	WOS:A1991GD63500026
J	SKINNER, RH; BRADLEY, S; BROWN, AL; JOHNSON, NJE; RHODES, S; STAMMERS, DK; LOWE, PN				SKINNER, RH; BRADLEY, S; BROWN, AL; JOHNSON, NJE; RHODES, S; STAMMERS, DK; LOWE, PN			USE OF THE GLU-GLU-PHE C-TERMINAL EPITOPE FOR RAPID PURIFICATION OF THE CATALYTIC DOMAIN OF NORMAL AND MUTANT RAS GTPASE-ACTIVATING PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							NEUROFIBROMATOSIS TYPE-1 GENE; P21 GTPASE; GAP; INTERACTS; CLONING; PRODUCT	The C-terminal catalytic domain (residues 704-1047) of the human ras GTPase-activating protein (GAP) has been engineered so as to incorporate the tripeptide, Glu-Glu-Phe, at its C terminus. This motif is recognized by the commercially available YL1/2 monoclonal antibody to alpha-tubulin and has previously been used for the immunoaffinity purification of HIV enzymes engineered to contain this epitope (Stammers, D. K., Tisdale, M., Court, S., Parmar, V., Bradley, C., and Ross, C. K. (1991) FEBS Lett. 283, 298-302). The engineered GAP catalytic domain (GAP-344) was obtained in high yield and purity from Escherichia coli extracts by means of a single affinity column of immobilized YL1/2, eluted under mild conditions with the dipeptide, Asp-Phe. The protein had similar activity to that previously described for full-length GAP, suggesting that the addition of the epitope did not grossly affect the activity. R903K and L902I mutants of GAP-344 were constructed, and the immunoaffinity purification procedure allowed their rapid characterization. The R903K mutant had less than 3% the activity of the normal protein, whereas the L902I substitution had less than 0.5% of normal activity, suggesting an important role for Leu-902 and Arg-903, residues absolutely conserved among GAP-related proteins. This work exemplifies the general utility of the C-terminal Glu-Glu-Phe motif for the rapid purification of proteins whose function is not altered by C-terminal modification.	WELLCOME RES LABS,DEPT CELL BIOL,LANGLEY COURT,BECKENHAM BR3 3BS,KENT,ENGLAND; WELLCOME RES LABS,DEPT MOLEC SCI,BECKENHAM BR3 3BS,KENT,ENGLAND	GlaxoSmithKline; Wellcome Research Laboratories; GlaxoSmithKline; Wellcome Research Laboratories								ADARI H, 1988, SCIENCE, V240, P518, DOI 10.1126/science.2833817; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BUCHBERG AM, 1990, NATURE, V347, P291, DOI 10.1038/347291a0; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; GILMAN M, 1987, CURRENT PROTOCOLS MO; HALENBECK R, 1990, J BIOL CHEM, V265, P21922; HALL A, 1990, CELL, V61, P921, DOI 10.1016/0092-8674(90)90054-I; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; LOWE PN, 1991, J BIOL CHEM, V266, P1672; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; MCCORMICK F, 1990, ONCOGENE, V5, P1281; SASSENFELD HM, 1990, TRENDS BIOTECHNOL, V8, P88, DOI 10.1016/0167-7799(90)90145-N; SCHABER MD, 1989, PROTEINS, V6, P306, DOI 10.1002/prot.340060313; STAMMERS DK, 1991, FEBS LETT, V283, P298, DOI 10.1016/0014-5793(91)80613-8; TANAKA K, 1991, P NATL ACAD SCI USA, V88, P468, DOI 10.1073/pnas.88.2.468; TRAHEY M, 1988, SCIENCE, V242, P1697, DOI 10.1126/science.3201259; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; WEHLAND J, 1984, EMBO J, V3, P1295, DOI 10.1002/j.1460-2075.1984.tb01965.x; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; XU GF, 1990, CELL, V62, P599, DOI 10.1016/0092-8674(90)90024-9	24	63	140	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14163	14166						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713577				2022-12-27	WOS:A1991FZ35100007
J	CHEUNG, RK; DOSCH, HM				CHEUNG, RK; DOSCH, HM			THE TYROSINE KINASE LCK IS CRITICALLY INVOLVED IN THE GROWTH TRANSFORMATION OF HUMAN LYMPHOCYTES-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							EPSTEIN-BARR-VIRUS; LYMPHOPROLIFERATIVE DISORDERS; GENE-EXPRESSION; CELL-LINES; T-CELLS; PROTEIN; ACTIVATION; TRANSCRIPTS; DNA; EBV	Epstein-Barr virus (EBV) exposure of human B lymphocytes induces rapid, Ca2+-dependent tyrosine phosphorylation of two cytosolic proteins, one likely the CD21 EBV receptor and another unknown species of 55-60 kDa. We now identify the latter protein as the tyrosine kinase lck (p56lck). In T cells many activation events reduce the high constitutive p56lck expression levels typical for that lineage, and they induce the appearance of a 60-kDa lck species. We now demonstrate that in B cells exposed to EBV the at best low constitutive p56lck expression levels are rapidly and transiently up-regulated without generation of 60-kDa lck. lck-specific antisense oligonucleotides block p56lck induction and prevent subsequent B cell activation and immortalization whereas B cell activation by nononcogenic agents was unaffected. We propose that p56lck superinduction is a transformation prerequisite which signals entry into the oncogenic growth transformation process.	HOSP SICK CHILDREN, RES INST, 555 UNIV AVE, TORONTO M5G 1X8, ONTARIO, CANADA; UNIV TORONTO, DEPT PEDIAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT IMMUNOL, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto								BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BRUSAMOLINO E, 1989, HAEMATOLOGICA, V74, P605; CANNON MJ, 1990, J CLIN INVEST, V85, P1333, DOI 10.1172/JCI114573; DOHERTY PJ, 1989, ANAL BIOCHEM, V177, P7, DOI 10.1016/0003-2697(89)90003-1; DOSCH HM, 1985, J IMMUNOL, V135, P3808; DOSCH HM, 1990, INT IMMUNOL, V2, P833, DOI 10.1093/intimm/2.9.833; GARVIN AM, 1988, MOL CELL BIOL, V8, P3058, DOI 10.1128/MCB.8.8.3058; HIBI T, 1986, EUR J IMMUNOL, V16, P139, DOI 10.1002/eji.1830160206; HIBI T, 1986, J IMMUNOL, V136, P3211; HUI MF, 1989, J IMMUNOL, V143, P2470; KOGA Y, 1986, EUR J IMMUNOL, V16, P1643, DOI 10.1002/eji.1830161229; KOGA Y, 1988, CANCER RES, V48, P856; LEEDER JS, 1989, ANAL BIOCHEM, V177, P364, DOI 10.1016/0003-2697(89)90067-5; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MACKENZIE T, 1989, J EXP MED, V169, P407, DOI 10.1084/jem.169.2.407; MARCUSSEKURA CJ, 1988, ANAL BIOCHEM, V172, P289, DOI 10.1016/0003-2697(88)90447-2; MARTH JD, 1989, J IMMUNOL, V142, P2430; MARTH JD, 1988, MOL CELL BIOL, V8, P540, DOI 10.1128/MCB.8.2.540; MOSIER DE, 1989, CURR TOP MICROBIOL, V152, P195; NALESNIK MA, 1988, AM J PATHOL, V133, P173; PERLMUTTER RM, 1988, J CELL BIOCHEM, V38, P117, DOI 10.1002/jcb.240380206; Purtilo D T, 1985, IARC Sci Publ, P231; RALPH RK, 1990, BIOESSAYS, V12, P121, DOI 10.1002/bies.950120305; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SHUTTLEWORTH J, 1988, EMBO J, V7, P427, DOI 10.1002/j.1460-2075.1988.tb02830.x; STEIN CA, 1988, CANCER RES, V48, P2659; TAKADERA T, 1989, MOL CELL BIOL, V9, P2173, DOI 10.1128/MCB.9.5.2173; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VEILLETTE A, 1988, MOL CELL BIOL, V8, P4353, DOI 10.1128/MCB.8.10.4353; VEILLETTE A, 1987, ONCOGENE RES, V1, P357; VORONOVA AF, 1987, MOL CELL BIOL, V7, P4407, DOI 10.1128/MCB.7.12.4407; 1989, CURR TOP MICROBIOL I, V152, P1	33	58	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					8667	8670						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709155				2022-12-27	WOS:A1991FM03800006
J	SKINNER, MP; LUCAS, CM; BURNS, GF; CHESTERMAN, CN; BERNDT, MC				SKINNER, MP; LUCAS, CM; BURNS, GF; CHESTERMAN, CN; BERNDT, MC			GMP-140 BINDING TO NEUTROPHILS IS INHIBITED BY SULFATED GLYCANS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GRANULE MEMBRANE-PROTEIN; WEIBEL-PALADE BODIES; ACTIVATED PLATELETS; ENDOTHELIAL-CELLS; MONOCLONAL-ANTIBODY; ADHESION; RECEPTOR; CARBOHYDRATE; MOLECULES; LYMPHOCYTES	GMP-140 is a 140-kDa granule membrane glycoprotein localized to the alpha-granules of platelets and the Weibel-Palade bodies of endothelial cells. Expression of GMP-140 on the activated cell surface has been shown to mediate the adhesion of thrombin-activated platelets to neutrophils and monocytes and the transient adhesion of neutrophils to endothelium. In contrast, fluid-phase GMP-140 strongly inhibits the CD18-dependent adhesion of tumor necrosis factor alpha-activated neutrophils to endothelium suggesting that GMP-140 can also serve an anti-adhesive function. In the present report, it is demonstrated that fluid-phase GMP-140 which exists predominantly as a tetramer binds to a single class of high affinity receptor on neutrophils and HL60 cells. Binding of I-125-labeled GMP-140 to neutrophils and HL60 cells and the rosetting of neutrophils and HL60 cells by thrombin-activated platelets were inhibited by EDTA, excess unlabeled fluid-phase GMP-140, Fab fragments of an affinity-purified rabbit anti-GMP-140 antibody, and by the murine anti-GMP-140 monoclonal antibody, AK 4. Both neutrophil and HL60 GMP-140 binding and platelet rosetting were strongly inhibited by heparin, fucoidin, and dextran sulfate 500,000, were partially inhibited by dextran sulfate 5,000 and lambda- and kappa-carrageenan, but were not inhibited by chondroitins 4- and 6-sulfate. Since this sulfated glycan specificity is identical to that previously reported by us for GMP-140, the present results suggest that the sulfated glycan binding site and the neutrophil receptor binding site on GMP-140 are either identical or proximal.	UNIV SYDNEY,WESTMEAD HOSP,THROMBOSIS & CARDIOVASC DIS RES CTR,DEPT MED,WESTMEAD,NSW 2145,AUSTRALIA; UNIV NEWCASTLE,ROYAL NEWCASTLE HOSP,DEPT CANC RES,NEWCASTLE,NSW 2300,AUSTRALIA; UNIV NEW S WALES,PRINCE WALES HOSP,DEPT HAEMATOL,RANDWICK,NSW 2031,AUSTRALIA	University of Sydney; University of Newcastle; University of New South Wales Sydney			Berndt, Michael C/D-5580-2012					BERNDT MC, 1985, EUR J BIOCHEM, V151, P637, DOI 10.1111/j.1432-1033.1985.tb09152.x; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BIGNOLD LP, 1987, J IMMUNOL METHODS, V96, P29, DOI 10.1016/0022-1759(87)90363-2; BONFANTI R, 1989, BLOOD, V73, P1109; BOOTH WJ, 1985, THROMB RES, V39, P29, DOI 10.1016/0049-3848(85)90119-7; BOWEN BR, 1990, J CELL BIOL, V110, P147, DOI 10.1083/jcb.110.1.147; COLE GJ, 1986, NATURE, V320, P445, DOI 10.1038/320445a0; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; FOX JEB, 1988, J BIOL CHEM, V263, P4882; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GAMBLE JR, 1990, SCIENCE, V249, P414; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; HAMBURGER SA, 1990, BLOOD, V75, P550; HATTORI R, 1989, J BIOL CHEM, V264, P7768; HSULIN SC, 1984, J BIOL CHEM, V259, P9121; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LEDERMAN S, 1989, J IMMUNOL, V143, P1149; MCEVER RP, 1984, J BIOL CHEM, V259, P9799; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; PARISH CR, 1988, J IMMUNOL, V141, P3498; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SKINNER MP, 1989, BIOCHEM BIOPH RES CO, V164, P1373, DOI 10.1016/0006-291X(89)91821-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STENBERG PE, 1985, J CELL BIOL, V101, P880, DOI 10.1083/jcb.101.3.880; STOOLMAN LM, 1989, CELL, V56, P907, DOI 10.1016/0092-8674(89)90620-X; STOOLMAN LM, 1984, J CELL BIOL, V99, P1535, DOI 10.1083/jcb.99.4.1535; YEDNOCK TA, 1987, J CELL BIOL, V104, P713, DOI 10.1083/jcb.104.3.713; YEDNOCK TA, 1987, J CELL BIOL, V104, P725, DOI 10.1083/jcb.104.3.725	33	187	197	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5371	5374						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706335				2022-12-27	WOS:A1991FD37000005
J	PELLEGRINO, MG; LI, GR; POTASH, MJ; VOLSKY, DJ				PELLEGRINO, MG; LI, GR; POTASH, MJ; VOLSKY, DJ			CONTRIBUTION OF MULTIPLE ROUNDS OF VIRAL ENTRY AND REVERSE TRANSCRIPTION TO EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - A QUANTITATIVE KINETIC-STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD4 ANTIGEN; INFECTIVITY; INVITRO; RNA; REPLICATION; CELLS; HIV; RECEPTOR; MEMBRANE; FUSION	Human immunodeficiency virus 1 (HIV-1) infection in vitro has been analyzed by the kinetics of expression of HIV-1 RNA and antigens during treatment with antiviral agents. Intracellular HIV-1 RNA rose from input values of 15 molecules per cell to 28 molecules per cell within 3 h after infection and reached a peak of 13,125 in 5 days. The first detectable increase in levels of HIV-1 capsid protein production was 1 day after infection. Virus infection was interrupted at different time points by the introduction of either 2',3'-dideoxycytidine, 3'-azido-3'-deoxythymidine, or suramin to block reverse transcription, or recombinant soluble CD4 to block binding and re-entry of progeny virus. Two results are noteworthy. First, the three inhibitors of reverse transcription blocked viral expression when added up to 48 h after infection. Second, the extent of infection, although postponed, is not greatly altered by culture of infected cells in recombinant soluble CD4. These data imply that reinfection with progeny virus, while necessary for rapid virus expression, is not required for the establishment of productive HIV-1 infection.	ST LUKES ROOSEVELT HOSP,MOLEC VIROL LAB,NEW YORK,NY 10019; COLUMBIA UNIV COLL PHYS & SURG,NEW YORK,NY 10032	Mount Sinai St. Luke's; Mount Sinai West; Columbia University				Pesola, Marko/0000-0002-3916-346X	NATIONAL CANCER INSTITUTE [U01CA037465, R01CA037465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI025902, U01AI027397] Funding Source: NIH RePORTER; NCI NIH HHS [CA37465-04] Funding Source: Medline; NIAID NIH HHS [AI-27397, AI-25902] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BABA M, 1988, P NATL ACAD SCI USA, V85, P6132, DOI 10.1073/pnas.85.16.6132; BALZARINI J, 1986, INT J CANCER, V37, P451, DOI 10.1002/ijc.2910370318; BYRN RA, 1989, J VIROL, V63, P4370, DOI 10.1128/JVI.63.10.4370-4375.1989; CASAREALE D, 1987, VIROLOGY, V156, P40, DOI 10.1016/0042-6822(87)90434-X; Coffin J. M., 1990, VIROLOGY, P1437; DAGLEISH AG, 1984, NATURE, V312, P763; FOLEY GE, 1965, CANCER, V18, P522, DOI 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J; HASELTINE WA, 1988, J ACQ IMMUN DEF SYND, V1, P217; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; MITSUYA H, 1986, P NATL ACAD SCI USA, V83, P1911, DOI 10.1073/pnas.83.6.1911; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; NARA PL, 1989, P NATL ACAD SCI USA, V86, P7139, DOI 10.1073/pnas.86.18.7139; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; PELLEGRINO MG, 1987, BIOTECHNIQUES, V5, P452; SAKAI K, 1986, ANN INST PASTEUR VIR, V137E, P311, DOI 10.1016/S0769-2617(86)80222-2; SCHOLS D, 1989, P NATL ACAD SCI USA, V86, P3322, DOI 10.1073/pnas.86.9.3322; SHAW GM, 1984, SCIENCE, V226, P1165, DOI 10.1126/science.6095449; SINANGIL F, 1988, FEBS LETT, V239, P88, DOI 10.1016/0014-5793(88)80551-9; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; SOMASUNDARAN M, 1988, SCIENCE, V242, P1554, DOI 10.1126/science.3201245; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; THOMPSON J, 1989, ANAL BIOCHEM, V181, P371, DOI 10.1016/0003-2697(89)90257-1; VOLSKY DJ, 1990, J VIROL METHODS, V28, P257, DOI 10.1016/0166-0934(90)90119-Z	24	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1783	1788						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703155				2022-12-27	WOS:A1991EU49700066
J	JEFFERSON, AB; SCHULMAN, H				JEFFERSON, AB; SCHULMAN, H			PHOSPHORYLATION OF MICROTUBULE-ASSOCIATED PROTEIN-2 IN GH3 CELLS - REGULATION BY CAMP AND BY CALCIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYROTROPIN-RELEASING-HORMONE; VASOACTIVE INTESTINAL PEPTIDE; PITUITARY-TUMOR CELLS; KINASE KINASE-II; CYCLIC-AMP; SPHINGOSINE INHIBITION; SECRETORY GRANULES; DEPENDENT KINASES; HUMAN-PLATELETS; BRAIN-TISSUES	The rat pituitary cell line GH3 contains a high molecular weight microtubule-associated protein with properties characteristic of microtubule-associated protein-2 (MAP-2). The 280-kDa protein is selectively immunoprecipitated by antibodies to authentic bovine brain MAP-2 and is phosphorylated at appropriate sites by cAMP-dependent protein kinase (cAMP kinase) and multifunctional Ca2+/calmodulin-dependent protein kinase (CaM kinase). Although MAP-2 is a minor cellular constituent, it can be immunoprecipitated from [P-32]P(i)-labeled GH3 cells and shown to contain a high level of basal phosphorylation. Vasoactive intestinal peptide, forskolin, 3-isobutyl-1-methylxanthene, or cholera toxin, treatments which increase cellular cAMP levels, or dibutyryl cAMP stimulate phosphorylation of specific sites on MAP-2 without significantly increasing its high state of basal phosphorylation. Phosphopeptide mapping reveals that the sites phosphorylated by cAMP kinase in vitro are the same sites whose phosphorylation in situ increases following stimulation of GH3 with agents that activate cAMP kinase. Increasing intracellular Ca2+ levels in GH3 cells also stimulates phosphorylation of MAP-2 but at sites distinct from those phosphorylated following treatment with cAMP inducing agonists. Phosphopeptide mapping indicates that the sites phosphorylated by CaM kinase in vitro are the same sites whose phosphorylation in situ increases following Ca2+-mediated stimulation. We conclude that activation of cAMP- and Ca2+-based signaling pathways leads to phosphorylation of MAP-2 in GH3 cells and that cAMP kinase and CaM kinase mediate phosphorylation by these pathways, respectively.	STANFORD UNIV,MED CTR,SCH MED,DEPT PHARMACOL,STANFORD,CA 94305	Stanford University					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030179, R01GM030179] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30179] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIZAWA T, 1985, ENDOCRINOLOGY, V116, P909, DOI 10.1210/endo-116-3-909; AKIYAMA T, 1986, J BIOL CHEM, V261, P4797; ALBERT PR, 1984, J BIOL CHEM, V259, P5350; ALETTA JM, 1988, J CELL BIOL, V106, P1573, DOI 10.1083/jcb.106.5.1573; Beavo J A, 1974, Methods Enzymol, V38, P299; BENNETT MK, 1983, J BIOL CHEM, V258, P2735; BERSHADSKY AD, 1981, P NATL ACAD SCI-BIOL, V78, P3610, DOI 10.1073/pnas.78.6.3610; BLOOM GS, 1985, BIOCHEMISTRY-US, V24, P4185, DOI 10.1021/bi00336a055; BLOOM GS, 1983, J CELL BIOL, V96, P1523, DOI 10.1083/jcb.96.6.1523; BROSTROM MA, 1983, MOL PHARMACOL, V23, P399; BURNS RG, 1986, ANN NY ACAD SCI, V466, P340, DOI 10.1111/j.1749-6632.1986.tb38405.x; BURNS RG, 1984, EUR J BIOCHEM, V141, P599, DOI 10.1111/j.1432-1033.1984.tb08235.x; CACERES A, 1984, J NEUROSCI, V4, P394; DECAMILLI P, 1984, NEUROSCIENCE, V11, P761, DOI 10.1016/0306-4522(84)90193-3; DEERY WJ, 1983, J CELL BIOL, V96, P1631, DOI 10.1083/jcb.96.6.1631; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; DRUST DS, 1982, J BIOL CHEM, V257, P3306; FABBRO D, 1985, J CYCLIC NUCL PROT, V10, P31; GOLDENRING JR, 1985, J NEUROCHEM, V45, P900, DOI 10.1111/j.1471-4159.1985.tb04078.x; GOURDJI D, 1979, FEBS LETT, V104, P165, DOI 10.1016/0014-5793(79)81107-2; HANNUN YA, 1986, J BIOL CHEM, V261, P2604; HANNUN YA, 1987, J BIOL CHEM, V262, P13620; HUBER G, 1984, J NEUROSCI, V4, P151; JEFFERSON AB, 1988, J BIOL CHEM, V263, P15241; KOSIK KS, 1988, J NEUROCHEM, V51, P587, DOI 10.1111/j.1471-4159.1988.tb01079.x; LOU LL, 1986, P NATL ACAD SCI USA, V83, P9497, DOI 10.1073/pnas.83.24.9497; LOU LL, 1989, J NEUROSCI, V9, P2020; MILLER P, 1982, P NATL ACAD SCI-BIOL, V79, P5562, DOI 10.1073/pnas.79.18.5562; MURTHY ASN, 1983, EUR J BIOCHEM, V137, P37, DOI 10.1111/j.1432-1033.1983.tb07792.x; PASCHAL BM, 1987, NATURE, V330, P181, DOI 10.1038/330181a0; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RICHTER-LANDSBERG C, 1983, Developmental Neuroscience, V6, P32, DOI 10.1159/000112330; SCHREURS J, 1984, BIOCHEM PHARMACOL, V33, P3375, DOI 10.1016/0006-2952(84)90108-4; SCHULMAN H, 1984, J CELL BIOL, V99, P11, DOI 10.1083/jcb.99.1.11; SCHULMAN H, 1984, MOL CELL BIOL, V4, P1175, DOI 10.1128/MCB.4.6.1175; SCHULMAN H, 1978, P NATL ACAD SCI USA, V75, P5432, DOI 10.1073/pnas.75.11.5432; SEFTON BM, 1978, J VIROL, V28, P957, DOI 10.1128/JVI.28.3.957-971.1978; SELDEN SC, 1983, J BIOL CHEM, V258, P7064; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SHERLINE P, 1977, J CELL BIOL, V72, P380, DOI 10.1083/jcb.72.2.380; SLETHOLT K, 1987, BIOSCIENCE REP, V7, P93, DOI 10.1007/BF01121872; SLOBODA RG, 1975, P NATL ACAD SCI USA, V72, P171; SOBEL A, 1983, J BIOL CHEM, V258, P312; SUPRENANT KA, 1982, J CELL BIOL, V93, P164, DOI 10.1083/jcb.93.1.164; TAN KN, 1984, J BIOL CHEM, V259, P418; Tashjian A H Jr, 1979, Methods Enzymol, V58, P527; THEURKAUF WE, 1983, J BIOL CHEM, V258, P7883; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; TSUYAMA S, 1987, J BIOL CHEM, V262, P10886; TSUYAMA S, 1986, J BIOL CHEM, V261, P4110; UCHIDA T, 1984, J BIOL CHEM, V259, P2311; VALLANO ML, 1985, P NATL ACAD SCI USA, V82, P3202, DOI 10.1073/pnas.82.10.3202; VALLEE R, 1980, P NATL ACAD SCI-BIOL, V77, P3206, DOI 10.1073/pnas.77.6.3206; Vallee R B, 1984, Cell Muscle Motil, V5, P289; WALSH MP, 1984, BIOCHEM J, V224, P117, DOI 10.1042/bj2240117; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; WOOD CL, 1985, REGUL PEPTIDES, V12, P237, DOI 10.1016/0167-0115(85)90065-5; YAMAMOTO H, 1985, J NEUROCHEM, V44, P759, DOI 10.1111/j.1471-4159.1985.tb12880.x; YAMAMOTO H, 1983, J NEUROCHEM, V41, P1119, DOI 10.1111/j.1471-4159.1983.tb09060.x; YAMAUCHI T, 1983, BIOCHEM BIOPH RES CO, V110, P287, DOI 10.1016/0006-291X(83)91293-7; YAMAUCHI T, 1982, BIOCHEM BIOPH RES CO, V109, P975, DOI 10.1016/0006-291X(82)92035-6	61	26	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					346	354						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702424				2022-12-27	WOS:A1991EQ33900051
J	KURDOWSKA, A; TRAVIS, J				KURDOWSKA, A; TRAVIS, J			ACUTE PHASE PROTEIN STIMULATION BY ALPHA-1-ANTICHYMOTRYPSIN-CATHEPSIN-G COMPLEXES - EVIDENCE FOR THE INVOLVEMENT OF INTERLEUKIN-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV GEORGIA,DEPT BIOCHEM,ATHENS,GA 30602; JAGIELLONIAN UNIV,INST MOLEC BIOL,PL-31120 KRAKOW,POLAND	University System of Georgia; University of Georgia; Jagiellonian University					NHLBI NIH HHS [HL-26148, HL-37090] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL037090, R01HL137090, R01HL037090, R01HL026148] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BANDA MJ, 1988, J EXP MED, V167, P1608, DOI 10.1084/jem.167.5.1608; BAUGH RJ, 1976, BIOCHEMISTRY-US, V15, P836, DOI 10.1021/bi00649a017; BAUMANN H, 1989, IN VITRO CELL DEV B, V25, P115; BAUMANN H, 1987, J IMMUNOL, V139, P4122; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; HELFGOTT DC, 1987, J EXP MED, V166, P1300, DOI 10.1084/jem.166.5.1300; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KOHASE M, 1987, MOL CELL BIOL, V7, P273, DOI 10.1128/MCB.7.1.273; Koj A, 1988, Adv Exp Med Biol, V240, P171; KOJ A, 1984, BIOCHEM J, V224, P505, DOI 10.1042/bj2240505; Koj A, 1985, ACUTE PHASE RESPONSE, P139; KRESS LF, 1986, J CELL BIOCHEM, V32, P51, DOI 10.1002/jcb.240320106; MAGIELSKAZERO D, 1987, BRIT J EXP PATHOL, V68, P485; MAY LT, 1989, BIOCHEM BIOPH RES CO, V159, P991, DOI 10.1016/0006-291X(89)92206-7; MORII M, 1983, J BIOL CHEM, V258, P2749; PERLMUTTER DH, 1988, J CLIN INVEST, V81, P1774, DOI 10.1172/JCI113519; PIZZO SV, 1988, BIOCHIM BIOPHYS ACTA, V967, P158, DOI 10.1016/0304-4165(88)90005-0; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; RAY A, 1988, BIOCHEMISTRY-US, V27, P6701; REDINI F, 1988, BIOCHEM BIOPH RES CO, V155, P786, DOI 10.1016/S0006-291X(88)80564-3; SIPE JD, 1985, ACUTE PHASE RESPONSE, P3; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P393; TABIIBZADEH SS, 1989, J IMMUNOL, V412, P3134; TRAVIS J, 1978, BIOCHEMISTRY-US, V17, P5647, DOI 10.1021/bi00619a010	25	60	62	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21023	21026						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701174				2022-12-27	WOS:A1990EL02000050
J	SUWANICHKUL, A; CUBBAGE, ML; POWELL, DR				SUWANICHKUL, A; CUBBAGE, ML; POWELL, DR			THE PROMOTER OF THE HUMAN GENE FOR INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 - BASAL PROMOTER ACTIVITY IN HEP-G2 CELLS DEPENDS UPON LIVER FACTOR-B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									BAYLOR UNIV, DIABET RES CTR, DEPT PEDIAT, 8080 N STADIUM, HOUSTON, TX 77054 USA	Baylor University					NIDDK NIH HHS [DK-38778] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAUMHUETER S, 1988, EMBO J, V7, P2485, DOI 10.1002/j.1460-2075.1988.tb03095.x; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; BAXTER RC, 1987, J CLIN ENDOCR METAB, V65, P423, DOI 10.1210/jcem-65-3-423; BREWER MT, 1988, BIOCHEM BIOPH RES CO, V152, P1289, DOI 10.1016/S0006-291X(88)80425-X; BRINKMAN A, 1988, BIOCHEM BIOPH RES CO, V157, P898, DOI 10.1016/S0006-291X(88)80959-8; BRINKMAN A, 1988, EMBO J, V7, P2417, DOI 10.1002/j.1460-2075.1988.tb03087.x; BURCH WM, 1990, J CLIN ENDOCR METAB, V70, P173, DOI 10.1210/jcem-70-1-173; BUSBY WH, 1988, J BIOL CHEM, V263, P14203; BUSBY WH, 1988, J CLIN ENDOCR METAB, V67, P1225, DOI 10.1210/jcem-67-6-1225; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONOVER CA, 1990, J CLIN ENDOCR METAB, V70, P1062, DOI 10.1210/jcem-70-4-1062; COTTERILL AM, 1988, J CLIN ENDOCR METAB, V67, P882, DOI 10.1210/jcem-67-5-882; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; CUBBAGE ML, 1989, MOL ENDOCRINOL, V3, P846, DOI 10.1210/mend-3-5-846; DERCOLE AJ, 1987, J DEV PHYSIOL, V9, P481; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; DROP SLS, 1984, J CLIN ENDOCR METAB, V59, P908, DOI 10.1210/jcem-59-5-908; DROP SLS, 1984, J CLIN ENDOCR METAB, V59, P899, DOI 10.1210/jcem-59-5-899; ELGIN R, 1986, P NATL ACAD SCI USA, V84, P3254; FAZLEABAS AT, 1989, ENDOCRINOLOGY, V124, P2321, DOI 10.1210/endo-124-5-2321; FEUERMAN MH, 1989, MOL CELL BIOL, V9, P4204, DOI 10.1128/MCB.9.10.4204; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; FRAUMAN AG, 1989, ENDOCRINOLOGY, V124, P2289, DOI 10.1210/endo-124-5-2289; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARDOUIN S, 1987, EUR J BIOCHEM, V170, P121, DOI 10.1111/j.1432-1033.1987.tb13676.x; HARDOUIN S, 1989, J CLIN ENDOCR METAB, V69, P1291, DOI 10.1210/jcem-69-6-1291; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; JOSEESTANYOL M, 1988, J BIOL CHEM, V263, P10865; JULKUNEN M, 1988, FEBS LETT, V236, P295, DOI 10.1016/0014-5793(88)80041-3; KOISTINEN R, 1986, ENDOCRINOLOGY, V118, P1375, DOI 10.1210/endo-118-4-1375; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEE YL, 1988, MOL ENDOCRINOL, V2, P404, DOI 10.1210/mend-2-5-404; LEWITT MS, 1990, ENDOCRINOLOGY, V126, P1527, DOI 10.1210/endo-126-3-1527; LEWITT MS, 1989, J CLIN ENDOCR METAB, V69, P246, DOI 10.1210/jcem-69-2-246; LUTHMAN H, 1989, EUR J BIOCHEM, V180, P259, DOI 10.1111/j.1432-1033.1989.tb14641.x; Maxam A M, 1980, Methods Enzymol, V65, P499; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; MULLER N, 1986, J ORG CHEM, V51, P263, DOI 10.1021/jo00352a032; MYERS RM, 1986, SCIENCE, V232, P613, DOI 10.1126/science.3457470; OOI GT, 1990, MOL ENDOCRINOL, V4, P321, DOI 10.1210/mend-4-2-321; POVOA G, 1984, EUR J BIOCHEM, V144, P199, DOI 10.1111/j.1432-1033.1984.tb08449.x; POWELL DR, 1989, INT CONGR SER, V881, P3; POWELL DR, 1987, J CHROMATOGR-BIOMED, V420, P163, DOI 10.1016/0378-4347(87)80168-8; RECHLER MM, 1985, ANNU REV PHYSIOL, V47, P425; RITVOS O, 1988, ENDOCRINOLOGY, V122, P2150, DOI 10.1210/endo-122-5-2150; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SUIKKARI AM, 1989, J CLIN ENDOCR METAB, V68, P135, DOI 10.1210/jcem-68-1-135; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; ZHANG DE, 1990, J BIOL CHEM, V265, P3382	55	72	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					21185	21193						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701175				2022-12-27	WOS:A1990EL02000073
J	PREISSNER, KT; GRULICHHENN, J; EHRLICH, HJ; DECLERCK, P; JUSTUS, C; COLLEN, D; PANNEKOEK, H; MULLERBERGHAUS, G				PREISSNER, KT; GRULICHHENN, J; EHRLICH, HJ; DECLERCK, P; JUSTUS, C; COLLEN, D; PANNEKOEK, H; MULLERBERGHAUS, G			STRUCTURAL REQUIREMENTS FOR THE EXTRACELLULAR INTERACTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH ENDOTHELIAL-CELL MATRIX-ASSOCIATED VITRONECTIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, DEPT MOLEC BIOL, 1006 AK AMSTERDAM, NETHERLANDS; CATHOLIC UNIV LEUVEN, CTR THROMBOSIS & VASC RES, B-3000 LOUVAIN, BELGIUM	KU Leuven	PREISSNER, KT (corresponding author), MAX PLANCK GESELL, CLIN RES UNIT BLOOD COAGULAT & THROMBOSIS, W-6300 GIESSEN, GERMANY.		Declerck, Paul J/A-2330-2017	Declerck, Paul J/0000-0003-1259-9105				BAETSCHER M, 1986, J CELL BIOL, V103, P369, DOI 10.1083/jcb.103.2.369; BROEKHUIJSEN MP, 1986, GENE, V49, P189, DOI 10.1016/0378-1119(86)90279-9; CHMIELEWSKA J, 1987, Fibrinolysis, V1, P67, DOI 10.1016/0268-9499(87)90012-9; DECLERCK PJ, 1988, BLOOD, V71, P220; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GEBB C, 1986, J BIOL CHEM, V261, P6698; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HEKMAN CM, 1988, BIOCHEMISTRY-US, V27, P2911, DOI 10.1021/bi00408a037; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HILDEBRAND A, 1989, J BIOL CHEM, V264, P15429; IZUMI M, 1988, CELL STRUCT FUNCT, V13, P217, DOI 10.1247/csf.13.217; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JAFFE EA, 1978, J EXP MED, V147, P1779, DOI 10.1084/jem.147.6.1779; Jaffe EA, 1984, BIOL ENDOTHELIAL CEL, P1; JENNE D, 1985, EMBO J, V4, P3153, DOI 10.1002/j.1460-2075.1985.tb04058.x; KEIJER J, 1990, IN PRESS FIBRINOLYSI; KLAGSBRUN M, 1987, METHOD ENZYMOL, V147, P95; KNUDSEN BS, 1987, J CLIN INVEST, V80, P1082, DOI 10.1172/JCI113164; KRUITHOF EKO, 1986, THROMB HAEMOSTASIS, V55, P201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE DA, 1987, J BIOL CHEM, V262, P16343; LEVIN EG, 1987, BLOOD, V70, P1090; LEVIN EG, 1987, J CELL BIOL, V105, P2543, DOI 10.1083/jcb.105.6.2543; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOSKUTOFF DJ, 1983, P NATL ACAD SCI-BIOL, V80, P2956, DOI 10.1073/pnas.80.10.2956; MAHN I, 1975, HAEMOSTASIS, V4, P40; Maniatis T., 1982, MOL CLONING; MIMURO J, 1987, BLOOD, V70, P721; MIMURO J, 1989, J BIOL CHEM, V264, P936; MIMURO J, 1989, J BIOL CHEM, V264, P5058; NEYFAKH AA, 1983, EXP CELL RES, V149, P387, DOI 10.1016/0014-4827(83)90351-8; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; PARKER CJ, 1989, BRIT J HAEMATOL, V71, P245, DOI 10.1111/j.1365-2141.1989.tb04262.x; POLLANEN J, 1987, J CELL BIOL, V104, P1085, DOI 10.1083/jcb.104.4.1085; PREISSNER KT, 1988, BLOOD, V71, P1581; PREISSNER KT, 1985, BIOCHEM J, V231, P349, DOI 10.1042/bj2310349; PREISSNER KT, 1989, BLOOD, V74, P1989; PREISSNER KT, 1987, J BIOL CHEM, V262, P12247; PREISSNER KT, 1987, BIOCHEM J, V243, P105, DOI 10.1042/bj2430105; PREISSNER KT, 1989, BLUT, V59, P419, DOI 10.1007/BF00349063; PREISSNER KT, 1988, HAEMOSTASIS, V18, P271; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; SANE DC, 1990, J BIOL CHEM, V265, P3543; SCHLEEF RR, 1988, HAEMOSTASIS, V18, P328; SUZUKI S, 1985, EMBO J, V4, P2519, DOI 10.1002/j.1460-2075.1985.tb03965.x; TOMASINI BR, 1988, BLOOD, V72, P903; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSCHOPP TB, 1974, J LAB CLIN MED, V83, P296; VANMOURIK JA, 1984, J BIOL CHEM, V259, P14914; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2; WIMAN B, 1988, THROMB HAEMOSTASIS, V59, P392; WUN TC, 1989, J BIOL CHEM, V264, P7862; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	57	122	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18490	18498						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1698787				2022-12-27	WOS:A1990EE20100071
J	SUGA, H; SHIRABE, K; YAMAMOTO, T; TASUMI, M; UMEDA, M; NISHIMURA, C; NAKAZAWA, A; NAKANISHI, M; ARATA, Y				SUGA, H; SHIRABE, K; YAMAMOTO, T; TASUMI, M; UMEDA, M; NISHIMURA, C; NAKAZAWA, A; NAKANISHI, M; ARATA, Y			STRUCTURAL-ANALYSES OF A CHANNEL-FORMING FRAGMENT OF COLICIN-E1 INCORPORATED INTO LIPID VESICLES - FOURIER-TRANSFORM INFRARED AND TRYPTOPHAN FLUORESCENCE STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTIFICIAL MEMBRANE-VESICLES; SITE-DIRECTED MUTAGENESIS; ACIDIC PH REQUIREMENT; SECONDARY STRUCTURE; ESCHERICHIA-COLI; SELF-DECONVOLUTION; ION CHANNEL; E1 CHANNEL; PROTEINS; PEPTIDE	Structural changes upon binding to the membrane of a COOH-terminal channel-forming thermolytic fragment of colicin E1 have been studied by means of a variety of spectroscopic techniques. Circular dichroism measurements show that the thermolytic fragment predominantly takes a helical structure in aqueous and detergent solutions. Fourier transform infrared spectroscopic measurements indicate that the content of the beta-structure is significantly increased when the thermolytic fragment is bound to vesicles. On the basis of the result of tryptophan fluorescence measurements, we have concluded that each of the three tryptophan residues of the thermolytic fragment exists in different environments, i.e. one is buried in the lipid bilayer, one exists on the cis side of the vesicles, and one exists near the surface of the lipid bilayer. The Fourier transform infrared and fluorescence data have been used along with the crystal structure of colicin A, which is highly homologous to colicin El in structure and function, to propose a model of the thermolytic fragment bound to the lipid vesicles.	UNIV TOKYO, FAC PHARMACEUT SCI, BUNKYO KU, TOKYO 113, JAPAN; MED COLL OITA, DEPT BIOCHEM, OITA 87956, JAPAN; UNIV TOKYO, FAC SCI, DEPT CHEM, BUNKYO KU, TOKYO 113, JAPAN; YAMAGUCHI UNIV, SCH MED, DEPT BIOCHEM, UBE, YAMAGUCHI 755, JAPAN	University of Tokyo; Oita University; University of Tokyo; Yamaguchi University			SUGA, Hinako/I-8095-2014	SUGA, Hinako/0000-0002-9158-6224				BISHOP LJ, 1985, J BACTERIOL, V164, P237, DOI 10.1128/JB.164.1.237-244.1985; BRUNDEN KR, 1984, J BIOL CHEM, V259, P7682; BULLOCK JO, 1983, J BIOL CHEM, V258, P9908; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CABIAUX V, 1989, J BIOL CHEM, V264, P4928; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; CLEVELAND MV, 1983, P NATL ACAD SCI-BIOL, V80, P3706, DOI 10.1073/pnas.80.12.3706; DANKERT JR, 1982, J BIOL CHEM, V257, P3857; DAVIDSON VL, 1984, J BIOL CHEM, V259, P594; DAVIDSON VL, 1985, P NATL ACAD SCI USA, V82, P1386, DOI 10.1073/pnas.82.5.1386; GOULD JM, 1977, J BIOL CHEM, V252, P5491; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; JACOB F, 1952, ANN I PASTEUR PARIS, V83, P295; JAKES KS, 1990, J BIOL CHEM, V265, P6984; JONES RN, 1983, APPL SPECTROSC, V37, P59, DOI 10.1366/0003702834634271; KLEFFEL B, 1985, EMBO J, V4, P1589, DOI 10.1002/j.1460-2075.1985.tb03821.x; KOUYAMA T, 1989, EUR J BIOCHEM, V182, P517, DOI 10.1111/j.1432-1033.1989.tb14858.x; LAZDUNSKI CJ, 1988, BIOCHIM BIOPHYS ACTA, V947, P445, DOI 10.1016/0304-4157(88)90003-2; LIU Q R, 1986, Proteins Structure Function and Genetics, V1, P218, DOI 10.1002/prot.340010304; MASSOTTE D, 1989, BIOCHEMISTRY-US, V28, P7713, DOI 10.1021/bi00445a029; MICHEL H, 1988, BIOCHEMISTRY-US, V27, P1, DOI 10.1021/bi00401a001; OHNOIWASHITA Y, 1982, J BIOL CHEM, V257, P6446; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; PETERSON AA, 1987, J MEMBRANE BIOL, V99, P197, DOI 10.1007/BF01995700; SHIMADA I, 1987, J COLLOID INTERF SCI, V120, P523, DOI 10.1016/0021-9797(87)90379-1; SHIRABE K, 1989, J BIOL CHEM, V264, P1951; SHIVER JW, 1987, J BIOL CHEM, V262, P14273; SHIVER JW, 1988, BIOCHEMISTRY-US, V27, P8421, DOI 10.1021/bi00422a019; SHIVER JW, 1989, METHOD ENZYMOL, V172, P439; SUGAWARA Y, 1984, J MOL SPECTROSC, V108, P206, DOI 10.1016/0022-2852(84)90179-6; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; WASACZ FM, 1987, BIOCHEMISTRY-US, V26, P1464, DOI 10.1021/bi00379a038; XU S, 1988, P NATL ACAD SCI USA, V85, P7531, DOI 10.1073/pnas.85.20.7531; YAMADA M, 1984, EUR J BIOCHEM, V140, P249, DOI 10.1111/j.1432-1033.1984.tb08095.x; YAMADA M, 1982, P NATL ACAD SCI-BIOL, V79, P2827, DOI 10.1073/pnas.79.9.2827; YAMADA M, 1986, MOL GEN GENET, V202, P24, DOI 10.1007/BF00330511; YAMAMOTO T, 1988, CAN J SPECTROSC, V33, P133	37	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					13537	13543						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713207				2022-12-27	WOS:A1991FY02700015
J	TISCHER, E; MITCHELL, R; HARTMAN, T; SILVA, M; GOSPODAROWICZ, D; FIDDES, JC; ABRAHAM, JA				TISCHER, E; MITCHELL, R; HARTMAN, T; SILVA, M; GOSPODAROWICZ, D; FIDDES, JC; ABRAHAM, JA			THE HUMAN GENE FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR - MULTIPLE PROTEIN FORMS ARE ENCODED THROUGH ALTERNATIVE EXON SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-A-CHAIN; TUMOR-CELL LINES; PERMEABILITY FACTOR; TRANSCRIPTION FACTOR; MITOGEN; EXPRESSION; SEQUENCE; DNA; PROMOTER; ORGANIZATION	Vascular endothelial growth factor (VEGF) is an apparently endothelial cell-specific mitogen that is structurally related to platelet-derived growth factor. By Northern blot and protein analyses, we show that VEGF is produced by cultured vascular smooth muscle cells. Analysis of VEGF transcripts in these cells by polymerase chain reaction and cDNA cloning revealed three different forms of the VEGF coding region, as had been reported in HL60 cells. The three forms of the human VEGF protein chain predicted from these coding regions are 189, 165, and 121 amino acids in length. Comparison of cDNA nucleotide sequences with sequences derived from human VEGF genomic clones indicates that the VEGF gene is split among eight exons and that the various VEGF coding region forms arise from this gene by alternative splicing: the 165-amino-acid form of the protein is missing the residues encoded by exon 6, whereas the 121-amino-acid form is missing the residues encoded by exons 6 and 7. Analysis of the VEGF gene promoter region revealed a single major transcription start, which lies near a cluster of potential Sp1 factor binding sites. The promoter region also contains several potential binding sites for the transcription factors AP-1 and AP-2; consistent with the presence of these sites, Northern blot analysis demonstrated that the level of VEGF transcripts is elevated in cultured vascular smooth muscle cells after treatment with the phorbol ester 12-O-tetradecanoyl-phorbol-13-acetate.	CALIF BIOTECHNOL INC,2450 BAYSHORE PKWY,MT VIEW,CA 94043; UNIV CALIF SAN FRANCISCO,SCH MED,CANC RES INST,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco					NHLBI NIH HHS [HL44832-01] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL044832] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAHAM JA, 1986, EMBO J, V5, P2523, DOI 10.1002/j.1460-2075.1986.tb04530.x; BECKMANN MP, 1988, SCIENCE, V241, P1346, DOI 10.1126/science.2842868; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BETSHOLTZ C, 1990, NATURE, V344, P299, DOI 10.1038/344299a0; BIENZ M, 1986, CELL, V45, P753, DOI 10.1016/0092-8674(86)90789-0; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; CONN G, 1990, P NATL ACAD SCI USA, V87, P1323, DOI 10.1073/pnas.87.4.1323; CONN G, 1990, P NATL ACAD SCI USA, V87, P2628, DOI 10.1073/pnas.87.7.2628; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; CONNOLLY DT, 1989, J BIOL CHEM, V264, P20017; CORDEN J, 1980, SCIENCE, V209, P1406, DOI 10.1126/science.6251548; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; GIDONI D, 1984, NATURE, V312, P409, DOI 10.1038/312409a0; GOSPODAROWICZ D, 1990, UCLA SYM BI, V114, P15; GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311; GOSPODAROWICZ D, 1988, EUR J CELL BIOL, V46, P144; GOSPODAROWICZ D, 1977, J CELL PHYSIOL, V91, P377, DOI 10.1002/jcp.1040910307; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Levy AP, 1989, GROWTH FACTORS, V2, P9, DOI 10.3109/08977198909069077; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; PLOUET J, 1989, EMBO J, V8, P3801, DOI 10.1002/j.1460-2075.1989.tb08557.x; RAO CD, 1986, P NATL ACAD SCI USA, V83, P2392, DOI 10.1073/pnas.83.8.2392; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; SENGER DR, 1986, CANCER RES, V46, P5629; STERNFELD MD, 1988, J CELL PHYSIOL, V136, P297, DOI 10.1002/jcp.1041360212; TISCHER E, 1989, BIOCHEM BIOPH RES CO, V165, P1198, DOI 10.1016/0006-291X(89)92729-0; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	42	1765	1913	0	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11947	11954						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711045				2022-12-27	WOS:A1991FT76200081
J	RUBENSTEIN, DS; ENGHILD, JJ; PIZZO, SV				RUBENSTEIN, DS; ENGHILD, JJ; PIZZO, SV			LIMITED PROTEOLYSIS OF THE ALPHA-MACROGLOBULIN RAT ALPHA-1-INHIBITOR-3 - IMPLICATIONS FOR A DOMAIN-STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING DOMAIN; SODIUM DODECYL-SULFATE; HUMAN ALPHA-2-MACROGLOBULIN; GEL-ELECTROPHORESIS; PROTEINASE BINDING; PLASMA FIBRONECTIN; MESSENGER-RNA; SEQUENCE; LOCALIZATION; PROTEASE	Rat alpha-1-inhibitor-3 is a 180-kDa monomeric proteinase inhibitor found in high concentration in rat plasma. By several criteria it has been shown to be a member of the family of alpha-macroglobulin proteinase inhibitors often exemplified by the tetrameric human alpha-2-macroglobulin. We have used limited proteolysis of rat alpha-1-inhibitor-3 to probe the domain structure of this family of proteins. Proteinases of different specificities, including trypsin, chymotrypsin, thermolysin, and Staphylococcus aureus V8 proteinase, were employed and a common fragmentation pattern was observed when the reaction products were examined by sodium dodecyl sulfate polyacrylamide gel electrophoresis. These fragments were electrotransferred to polyvinylidene difluoride membranes and subjected to NH2-terminal amino acid sequence analysis in order to position them within the context of the primary structure. The fragmentation pattern may define the domain structure of alpha-1-inhibitor-3 and serve as a model for the domain organization of the family of alpha-macroglobulin proteinase inhibitors.	DUKE UNIV,MED CTR,DEPT PATHOL,POB 3712,DURHAM,NC 27710	Duke University				Enghild, Jan Johannes/0000-0001-9292-9172	NATIONAL CANCER INSTITUTE [P01CA029589] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL024066, R37HL024066] Funding Source: NIH RePORTER; NCI NIH HHS [CA-29589] Funding Source: Medline; NHLBI NIH HHS [HL-24066] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIELLO LP, 1988, J BIOL CHEM, V263, P4013; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BOISSET N, 1989, J BIOL CHEM, V264, P12046; BOND JS, 1989, PROTEOLYTIC ENZYMES, P232; BRACIAK TA, 1988, J BIOL CHEM, V263, P3999; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; DRAPEAU GR, 1972, J BIOL CHEM, V247, P6720; DUNN JT, 1967, J BIOL CHEM, V242, P5556; EDELMAN GM, 1973, SCIENCE, V180, P830, DOI 10.1126/science.180.4088.830; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; EDELMAN GM, 1970, BIOCHEMISTRY-US, V9, P3197, DOI 10.1021/bi00818a012; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; ENGHILD JJ, 1989, BIOCHEMISTRY-US, V28, P1406, DOI 10.1021/bi00429a069; ESNARD F, 1985, FEBS LETT, V182, P125, DOI 10.1016/0014-5793(85)81168-6; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001; GEIGER T, 1987, J BIOL CHEM, V262, P4973; GONIAS SL, 1981, BIOCHIM BIOPHYS ACTA, V678, P268, DOI 10.1016/0304-4165(81)90216-6; GONIAS SL, 1989, J BIOL CHEM, V264, P9565; HARPEL PC, 1979, J BIOL CHEM, V254, P8669; HILL RL, 1966, P NATL ACAD SCI USA, V56, P1762, DOI 10.1073/pnas.56.6.1762; HUDSON NW, 1987, BIOCHEM J, V248, P837, DOI 10.1042/bj2480837; JENSEN PEH, 1986, J BIOL CHEM, V261, P5863; LAMBIN P, 1979, ANAL BIOCHEM, V98, P160, DOI 10.1016/0003-2697(79)90721-8; LAMBIN P, 1978, ANAL BIOCHEM, V85, P114, DOI 10.1016/0003-2697(78)90281-6; MARSHALL RD, 1964, BIOCHEMISTRY-US, V3, P1596, DOI 10.1021/bi00898a036; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NISONOFF A, 1960, ARCH BIOCHEM BIOPHYS, V88, P241, DOI 10.1016/0003-9861(60)90229-0; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; OTT U, 1982, EUR J BIOCHEM, V123, P63, DOI 10.1111/j.1432-1033.1982.tb06499.x; PIZZO SV, 1986, BIOCHEM J, V238, P217, DOI 10.1042/bj2380217; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; RUBEN GC, 1988, J BIOL CHEM, V263, P2861; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; Salvesen G, 1989, PROTEOLYTIC ENZYMES, P83; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P3967; SEKIGUCHI K, 1981, J BIOL CHEM, V256, P6452; Sottrup-Jensen L., 1987, PLASMA PROTEINS, V5, P191; SOTTRUPJENSEN L, 1981, FEBS LETT, V123, P145, DOI 10.1016/0014-5793(81)80039-7; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; SOTTRUPJENSEN L, 1984, J BIOL CHEM, V259, P8318; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; VANLEUVEN F, 1986, J BIOL CHEM, V261, P1369	47	19	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 15	1991	266	17					11252	11261						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FQ774	1710222				2022-12-27	WOS:A1991FQ77400085
J	KELLY, JD; HALDEMAN, BA; GRANT, FJ; MURRAY, MJ; SEIFERT, RA; BOWENPOPE, DF; COOPER, JA; KAZLAUSKAS, A				KELLY, JD; HALDEMAN, BA; GRANT, FJ; MURRAY, MJ; SEIFERT, RA; BOWENPOPE, DF; COOPER, JA; KAZLAUSKAS, A			PLATELET-DERIVED GROWTH-FACTOR (PDGF) STIMULATES PDGF RECEPTOR SUBUNIT DIMERIZATION AND INTERSUBUNIT TRANS-PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; FACTOR-I RECEPTOR; INSULIN-RECEPTOR; SIGNAL TRANSDUCTION; FACTOR-A; INTERMOLECULAR AUTOPHOSPHORYLATION; DIFFERENT ISOFORMS; PROTEIN-KINASE; CDNA CLONING; EXPRESSION	High affinity binding of platelet-derived growth factor (PDGF) has been proposed to involve the interaction of the dimeric PDGF ligand with two receptor subunits, designated alpha and beta. We have cloned and expressed a human PDGF receptor cDNA which differs in sequence from the beta-subunit and which has the PDGF binding properties and monoclonal antibody recognition, predicted for the alpha-subunit. Scatchard analysis indicated that PDGF-AA and PDGF-AB bound to transfected alpha-subunits with affinities of K(d) = 0.06 and 0.05 nM, respectively. PDGF-BB bound with a significantly lower affinity (K(d) = 0.4 nM). Nevertheless, this affinity is still great enough to mediate substantial PDGF-BB binding at physiological concentrations and would be considered to be "high affinity." We have used wild-type and kinase-inactive human beta-subunits to show that PDGF binding promotes receptor subunit dimerization in intact cells. In addition, we found that PDGF stimulates tyrosine phosphorylation of the kinase-inactive beta-subunit when it is expressed with alpha-subunits. The kinase-inactive beta-subunits were phosphorylated at tyrosine 857 and 751, the major phosphorylation sites of the wild-type beta-subunit, indicating either that intra- and intermolecular phosphorylation occurs on the same sites, or that a significant fraction of receptor tyrosine phosphorylation is intermolecular.	UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195; ZYMOGENET,SEATTLE,WA 98103; FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	University of Washington; University of Washington Seattle; Zymogenet Inc.; Fred Hutchinson Cancer Center					NCI NIH HHS [CA28151] Funding Source: Medline; NHLBI NIH HHS [HL-18645] Funding Source: Medline; NIGMS NIH HHS [GM-35501] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA028151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035501] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALLOTTI R, 1989, EMBO J, V8, P3303, DOI 10.1002/j.1460-2075.1989.tb08491.x; BISHAYEE S, 1989, J BIOL CHEM, V264, P11699; BISHAYEE S, 1986, P NATL ACAD SCI USA, V83, P6756, DOI 10.1073/pnas.83.18.6756; BOWENPOPE DF, 1989, J BIOL CHEM, V264, P2502; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; COLLINS T, 1987, NATURE, V328, P621, DOI 10.1038/328621a0; COOPER JA, 1988, P NATL ACAD SCI USA, V85, P4232, DOI 10.1073/pnas.85.12.4232; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FANTL WJ, 1989, MOL CELL BIOL, V9, P4473, DOI 10.1128/MCB.9.10.4473; Ferns GAA, 1990, GROWTH FACTORS, V3, P315, DOI 10.3109/08977199009003674; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; HART CE, 1987, J BIOL CHEM, V262, P10780; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HART CE, 1990, BIOCHEMISTRY-US, V29, P166, DOI 10.1021/bi00453a022; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HONEGGER AM, 1989, P NATL ACAD SCI USA, V86, P925, DOI 10.1073/pnas.86.3.925; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; KAZLAUSKAS A, 1990, EMBO J, V9, P3279, DOI 10.1002/j.1460-2075.1990.tb07527.x; KAZLAUSKAS A, 1988, EMBO J, V7, P3727, DOI 10.1002/j.1460-2075.1988.tb03256.x; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KAZLAUSKAS A, 1989, CELL, V58, P1121, DOI 10.1016/0092-8674(89)90510-2; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; LEE KH, 1990, MOL CELL BIOL, V10, P2237, DOI 10.1128/MCB.10.5.2237; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MATSUI T, 1989, P NATL ACAD SCI USA, V86, P8314, DOI 10.1073/pnas.86.21.8314; MILLER AD, 1986, SOMAT CELL MOLEC GEN, V12, P175, DOI 10.1007/BF01560664; NISTER M, 1988, CELL, V52, P791, DOI 10.1016/0092-8674(88)90421-7; OHTSUKA M, 1990, MOL CELL BIOL, V10, P1664, DOI 10.1128/MCB.10.4.1664; RONNSTRAND L, 1987, J BIOL CHEM, V262, P2929; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; SHURTLEFF SA, 1990, EMBO J, V9, P2415, DOI 10.1002/j.1460-2075.1990.tb07417.x; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; WHITE MF, 1984, J BIOL CHEM, V259, P255; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YU KT, 1984, J BIOL CHEM, V259, P5277	46	174	186	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					8987	8992						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709159				2022-12-27	WOS:A1991FM03800052
J	ZHANG, XK; DONG, JM; CHIU, JF				ZHANG, XK; DONG, JM; CHIU, JF			REGULATION OF ALPHA-FETOPROTEIN GENE-EXPRESSION BY ANTAGONISM BETWEEN AP-1 AND THE GLUCOCORTICOID RECEPTOR AT THEIR OVERLAPPING BINDING-SITE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE REGULATION; MESSENGER-RNA; ALPHA-1-FETOPROTEIN GENE; MAMMALIAN-CELLS; AUTO-REGULATION; PROTO-ONCOGENE; RAT-LIVER; HORMONE; TRANSCRIPTION; REPRESSION	We show here that the alpha-fetoprotein gene (AFP) promoter can be regulated by AP-1 activity using transient transfection assays. AFP promoter activity induced by c-jun/c-fos can be repressed by cotransfected glucocorticoid receptor. The DNA sequence conferring AP-1 activity was located in the proximal promoter region. Gel retardation assays using the AFP proximal promoter identified an AP-1-like sequence which can bind to bacterially expressed c-jun protein. This AP-1-like element, when cloned into the tk promoter, responds to the AP-1 activity of c-jun/c-fos products in both CV-1 and F-9 cells. The element overlaps with a consensus glucocorticoid-responsive element which was shown to confer negative modulation of AFP promoter activity. A 23-base pair DNA element containing the overlapping glucocorticoid-responsive element and AP-1 sites can be positively regulated by glucocorticoid receptor in the absence of c-jun/c-fos products. When plasmids expressing glucocorticoid receptor, c-jun and c-fos are cotransfected together, they repress each other. Thus, these data demonstrate that negative regulation of the AFP gene by glucocorticoid may be due to the interference of AP-1 activity by glucocorticoid receptor either by direct competition for DNA binding or via protein-protein interaction. They provide another example of transcriptional regulation of developing-associated genes between two major signal transduction pathways in response to extracellular stimuli. This supports the model that expression of alpha-fetoprotein is regulated during development by the effect on transcription of antagonism between glucocorticoid receptor and fos/jun.	UNIV VERMONT, COLL MED, DEPT BIOCHEM, BURLINGTON, VT 05405 USA	University of Vermont					NATIONAL CANCER INSTITUTE [R01CA025098] Funding Source: NIH RePORTER; NCI NIH HHS [CA25098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abelev G I, 1971, Adv Cancer Res, V14, P295, DOI 10.1016/S0065-230X(08)60523-0; AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BELANGER L, 1975, NATURE, V256, P657, DOI 10.1038/256657a0; BELANGER L, 1979, CANCER RES, V39, P2141; CAKE MH, 1975, BIOCHEMICAL ACTIONS, V3, P317; CAMPER SA, 1989, GENE DEV, V3, P537, DOI 10.1101/gad.3.4.537; CHARRON J, 1986, P NATL ACAD SCI USA, V83, P8903, DOI 10.1073/pnas.83.23.8903; CHIU JF, 1981, NUCLEIC ACIDS RES, V9, P6917, DOI 10.1093/nar/9.24.6917; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; COMMER P, 1979, BIOCHEM BIOPH RES CO, V89, P1294, DOI 10.1016/0006-291X(79)92149-1; COOK JR, 1986, J BIOL CHEM, V261, P4663; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; DONG JM, 1989, MOL CELL ENDOCRINOL, V66, P109, DOI 10.1016/0303-7207(89)90054-3; DROUIN J, 1989, MOL CELL BIOL, V9, P5305, DOI 10.1128/MCB.9.12.5305; DYNAN WS, 1989, CELL, V58, P1, DOI 10.1016/0092-8674(89)90393-0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; GITLIN D, 1967, J CLIN INVEST, V46, P1010, DOI 10.1172/JCI105590; GODOWSKI PJ, 1988, SCIENCE, V241, P812, DOI 10.1126/science.3043662; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; GUERTIN M, 1983, BIOCHEMISTRY-US, V22, P4296, DOI 10.1021/bi00287a021; GUERTIN M, 1988, MOL CELL BIOL, V8, P1398, DOI 10.1128/MCB.8.4.1398; HENNING SJ, 1978, AM J PHYSIOL, V235, pE451, DOI 10.1152/ajpendo.1978.235.5.E451; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KARIN M, 1990, MOL ASPECTS CELLULAR, V6; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; KONIG H, 1989, EMBO J, V8, P2559, DOI 10.1002/j.1460-2075.1989.tb08394.x; LUCIBELLO FC, 1990, EMBO J, V9, P2827, DOI 10.1002/j.1460-2075.1990.tb07471.x; LUCIBELLO FC, 1989, CELL, V59, P999, DOI 10.1016/0092-8674(89)90756-3; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MCKNIGHT S, 1986, CELL, V46, P795, DOI 10.1016/0092-8674(86)90061-9; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MORDACQ JC, 1989, GENE DEV, V3, P760, DOI 10.1101/gad.3.6.760; MORELLO D, 1990, MOL CELL BIOL, V10, P3185, DOI 10.1128/MCB.10.6.3185; NAKAO K, 1990, MOL CELL BIOL, V10, P1461, DOI 10.1128/MCB.10.4.1461; PETROPOULOS C, 1983, J BIOL CHEM, V258, P4901; PIETTE J, 1987, EMBO J, V6, P1331, DOI 10.1002/j.1460-2075.1987.tb02372.x; POLIARD A, 1990, J BIOL CHEM, V265, P2137; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SCOTTO KW, 1989, GENE DEV, V3, P651, DOI 10.1101/gad.3.5.651; TURCOTTE B, 1990, MOL CELL BIOL, V10, P5002, DOI 10.1128/MCB.10.9.5002; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZHANG XK, 1988, CANCER LETT, V41, P147, DOI 10.1016/0304-3835(88)90111-5; ZHANG XK, 1987, BIOCHEM BIOPH RES CO, V142, P932, DOI 10.1016/0006-291X(87)91503-8; ZHANG XK, 1990, ONCOGENE, V5, P909	55	104	105	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8248	8254						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1708774				2022-12-27	WOS:A1991FK44100048
J	EDELBERG, JM; REILLY, CF; PIZZO, SV				EDELBERG, JM; REILLY, CF; PIZZO, SV			THE INHIBITION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 - THE EFFECTS OF FIBRINOGEN, HEPARIN, VITRONECTIN, AND LIPOPROTEIN(A)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS; HUMAN-PLASMA; MYOCARDIAL-INFARCTION; CONDITIONED MEDIUM; KINETIC-ANALYSIS; PAI-1; PURIFICATION; BINDING; UROKINASE; PROTEIN	Plasminogen activator inhibitor-1 (PAI-1) regulates fibrinolysis by inhibiting tissue type plasminogen activator (t-PA). Fibrinogen, heparin, and vitronectin enhance the rate of inhibition of t-PA by PAI-1. Kinetic studies indicate that both fibrinogen and heparin increase the second-order inhibition constant by a maximum of approximately 4-fold, whereas vitronectin increases the rate constant by a maximum of approximately 6-fold. The dissociation constants of fibrinogen, heparin, and vitronectin for the inhibition reaction were 200 nM, 20 nM, and 600 pM, respectively. In addition, PAI-1 inhibition of t-PA may be regulated by the presence of lipoprotein(a) (Lp(a)). Previous studies demonstrated that Lp(a) competes with plasminogen for the active site of fibrinogen- and heparin-bound tPA. Kinetic studies described here demonstrate that Lp(a) prevents the inhibition of t-PA by PAI-1 in the presence of fibrinogen and heparin, but has no effect on the reaction in the presence of vitronectin or in the absence of either fibrinogen or heparin. The data suggest that fibrinogen and heparin may enhance the rate of inhibition through an interaction with t-PA, and that vitronectin may enhance the inhibition through an interaction with PAI-1. In addition, these experiments indicate that Lp(a) may regulate fibrinolysis by competing with PAI-1 and plasminogen for fibrinogen- and heparin-bound t-PA. These data suggest that PAI-1 inhibition of t-PA in vivo is primarily mediated via interaction with fibrinogen, heparin, vitronectin, and Lp(a), and therefore, the functional levels of PAI-1 activity in the vasculature may be regulated by the presence of these components.	DUKE UNIV,MED CTR,DEPT PATHOL,BOX 3712,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710; MERCK SHARP & DOHME LTD,DEPT PHARMACOL,W POINT,PA 19486	Duke University; Duke University; Merck & Company					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043339] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-31939, HL-43339] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALESSI MC, 1988, EUR J BIOCHEM, V175, P531, DOI 10.1111/j.1432-1033.1988.tb14225.x; ANDRADEGORDON P, 1986, BIOCHEMISTRY-US, V25, P4033, DOI 10.1021/bi00362a007; BACHMANN F, 1984, SEMIN THROMB HEMOST, V10, P6, DOI 10.1055/s-2007-1004403; BOOTH NA, 1985, THROMB RES, V38, P261, DOI 10.1016/0049-3848(85)90154-9; BOOTH NA, 1985, J CLIN PATHOL, V38, P825, DOI 10.1136/jcp.38.7.825; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; CHMIELEWSKA J, 1988, BIOCHEM J, V251, P327, DOI 10.1042/bj2510327; CHMIELEWSKA J, 1987, Fibrinolysis, V1, P67, DOI 10.1016/0268-9499(87)90012-9; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; EDELBERG JM, 1990, THROMB RES, V57, P155, DOI 10.1016/0049-3848(90)90203-O; EDELBERG JM, 1990, BIOCHEMISTRY-US, V29, P5906, DOI 10.1021/bi00477a004; EDELBERG JM, 1989, BIOCHEMISTRY-US, V28, P2375; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; EMEIS JJ, 1983, BIOCHEM BIOPH RES CO, V110, P393; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; FERSHT A, 1984, ENZYME STRUCTURE MEC, P176; GARDELL SJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P467, DOI 10.1016/0003-9861(90)90286-8; GONZALEZGRONOW M, 1984, BIOCHEMISTRY-US, V23, P190, DOI 10.1021/bi00297a003; HAMSTEN A, 1987, LANCET, V2, P3; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; HEKMAN CM, 1988, ARCH BIOCHEM BIOPHYS, V262, P199, DOI 10.1016/0003-9861(88)90182-8; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HOYALERTS M, 1982, J BIOL CHEM, V257, P2912; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; KRUITHOF EKO, 1984, BLOOD, V64, P907; LAMBERS JWJ, 1987, J BIOL CHEM, V262, P17492; LAUG WE, 1985, THROMB HAEMOSTASIS, V53, P165; LEVIN EG, 1983, P NATL ACAD SCI-BIOL, V80, P6804, DOI 10.1073/pnas.80.22.6804; LINDAHL TL, 1989, THROMB HAEMOSTASIS, V62, P748; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P240, DOI 10.1161/01.ATV.10.2.240; LOSKUTOFF DJ, 1983, P NATL ACAD SCI-BIOL, V80, P2956, DOI 10.1073/pnas.80.10.2956; MASSON C, 1988, BIOCHEM J, V256, P237, DOI 10.1042/bj2560237; NIEUWENHUIZEN W, 1983, BIOCHIM BIOPHYS ACTA, V755, P531, DOI 10.1016/0304-4165(83)90261-1; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; PARAMO JA, 1985, BRIT MED J, V291, P573, DOI 10.1136/bmj.291.6495.573; RANBY M, 1982, BIOCHIM BIOPHYS ACTA, V704, P461, DOI 10.1016/0167-4838(82)90068-1; REILLY TM, 1990, J BIOL CHEM, V265, P9570; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; SCANU AM, 1990, J CLIN INVEST, V85, P1709, DOI 10.1172/JCI114625; SPRENGERS ED, 1986, BIOCHIM BIOPHYS ACTA, V883, P233, DOI 10.1016/0304-4165(86)90313-2; SPRENGERS ED, 1985, J LAB CLIN MED, V105, P751; SPRENGERS ED, 1987, BLOOD, V69, P381; STEIN PL, 1989, J BIOL CHEM, V264, P15441; THORSEN S, 1984, BIOCHIM BIOPHYS ACTA, V802, P111, DOI 10.1016/0304-4165(84)90040-0; THORSEN S, 1988, EUR J BIOCHEM, V175, P33, DOI 10.1111/j.1432-1033.1988.tb14162.x; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; VANMOURIK JA, 1984, J BIOL CHEM, V259, P14914; WAGNER OF, 1989, J CLIN INVEST, V84, P647, DOI 10.1172/JCI114211; WILCZYNSKA M, 1990, THROMB HAEMOSTASIS, V63, P246; WIMAN B, 1985, J LAB CLIN MED, V105, P265; WOJTA J, 1989, J BIOL CHEM, V264, P7957; WUN TC, 1989, J BIOL CHEM, V264, P7862	53	41	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7488	7493						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708387				2022-12-27	WOS:A1991FJ34200028
J	IGBAVBOA, U; PFEIFFER, DR				IGBAVBOA, U; PFEIFFER, DR			REGULATION OF REVERSE UNIPORT ACTIVITY IN MITOCHONDRIA BY EXTRAMITOCHONDRIAL DIVALENT-CATIONS - DEPENDENCE ON A SOLUBLE INTERMEMBRANE SPACE COMPONENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; CA-2+ RELEASE; MECHANISMS; EGTA	We previously reported that uncoupling Ca2+-loaded mitochondria in the presence of [ethylenebis(oxyethylenenitrilo)]tetraacetic acid (EGTA) produces a partial expression of the permeability transition. From this and related observations, it was proposed that the absence of external free Ca2+ is inhibitory to reverse activity of the Ca2+ uniporter (Igbavboa, U., and Pfeiffer, D. R. (1988) J. Biol. Chem. 263, 1405-1412). By using Sr2+ - instead of Ca2+-loaded mitochondria, the transition is avoided upon treatment with EGTA plus uncoupler, and inhibition of reverse uniport activity can be observed directly. In the presence of physiological Mg2+ concentrations, reverse uniport of Sr2+ is eliminated by external EGTA following a brief period of rapid activity. It is proposed that binding of Mg2+ rather than Sr2+ (Ca2+) at an external site is responsible for the inhibition. Regulation at the external site is modified by the size of the Sr2+ load. EGTA, in the presence of Mg2+, does not inhibit the reverse uniport-dependent release of Sr2+ from mitoplasts. The inhibitory effect can be recovered by adding back the soluble components obtained as the intermembrane space fraction following removal of the outer membrane. The soluble factor could be a regulatory subunit which contains the external cation binding site. Adjustments to uniporter activity due to regulation by the binding site and/or the soluble factor may be slow and may be significant in determining how mitochondria respond to rapid Ca2+ transients in vivo.	UNIV MINNESOTA,HORMEL INST,801 16TH AVE NE,AUSTIN,MN 55912	University of Minnesota System					NHLBI NIH HHS [HL08214] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL008214] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BROEKEMEIER KM, 1985, J BIOL CHEM, V260, P105; BROEKEMEIER KM, 1989, BIOCHEM BIOPH RES CO, V163, P561, DOI 10.1016/0006-291X(89)92174-8; CARAFOLI E, 1987, ANNU REV BIOCHEM, V56, P395, DOI 10.1146/annurev.bi.56.070187.002143; EXTON JH, 1988, FASEB J, V2, P2670, DOI 10.1096/fasebj.2.11.2456243; Greenawalt J W, 1979, Methods Enzymol, V55, P88; Gunter T E, 1988, Adv Exp Med Biol, V232, P1; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Hansford R G, 1988, Adv Exp Med Biol, V232, P230; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; IGBAVBOA U, 1988, FASEB J, V2, P775; KRONER H, 1986, BIOL CHEM H-S, V367, P483, DOI 10.1515/bchm3.1986.367.1.483; KRONER H, 1987, BIOL CHEM HOPPESEYLE, V369, P149; McCormack J G, 1988, Adv Exp Med Biol, V232, P249; MCCORMACK JG, 1989, MOL CELL BIOCHEM, V89, P121; PFEIFFER DR, 1978, J BIOL CHEM, V253, P4165; RICHELMI P, 1989, TOXICOLOGY, V57, P29, DOI 10.1016/0300-483X(89)90032-2; RILEY WW, 1986, J BIOL CHEM, V261, P28; RILEY WW, 1985, J BIOL CHEM, V260, P2416; THOMAS CE, 1989, HEPATOLOGY, V10, P35; WINGROVE DE, 1986, J BIOL CHEM, V261, P5159; WINGROVE DE, 1986, J BIOL CHEM, V261, P5166	21	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4283	4287						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705550				2022-12-27	WOS:A1991FA69400043
J	DEUTSCH, C; PRICE, M; LEE, S; KING, VF; GARCIA, ML				DEUTSCH, C; PRICE, M; LEE, S; KING, VF; GARCIA, ML			CHARACTERIZATION OF HIGH-AFFINITY BINDING-SITES FOR CHARYBDOTOXIN IN HUMAN LYMPHOCYTES-T - EVIDENCE FOR ASSOCIATION WITH THE VOLTAGE-GATED K+ CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; ADENYLATE-CYCLASE ACTIVATION; POTASSIUM CHANNELS; CONDUCTANCE; PROLIFERATION; FORSKOLIN; INHIBITOR; CELLS	Charybdotoxin (ChTX) inhibits with high affinity a voltage-gated K+ channel that is present in human T lymphocytes. In this system, I-125-ChTX binds specifically and reversibly to a single class of sites which display a K(d) of 8-14 pM, as measured by either equilibrium or kinetic binding protocols. The maximum density of sites, 542 sites/cell, correlates well with the density of K+ channel as determined by electrophysiological experiments. Binding of I-125-ChTX is modulated by the ionic strength of the incubation media and by Ca2+. Increasing concentrations of either K+, Na+, or Ca2+ cause inhibition of toxin binding. Inhibition of binding by Ca2+ is due, primarily, to an effect on toxin dissociation rates. Increasing the pH of the external media from 6.8 to 8.5 enhances toxin binding, due to an increase in affinity with no significant effect on the maximum density of receptor sites. Different agents that block the voltage-gated K+ channel in human T lymphocytes, inhibit toxin binding. Mitogen-stimulated T cells display 2.5-3-fold increase in toxin binding as compared with unstimulated control cells. These data, taken together, suggest that I-125-ChTX binding sites identified in this study, represent the predominant voltage-gated K+ channel present in peripheral human T lymphocytes. Therefore, I-125-ChTX is a useful probe for elucidating the physiological role of this type of K+ channel.	MERCK INST THERAPEUT RES, DEPT MEMBRANE BIOCHEM & BIOPHYS, RAHWAY, NJ 07065 USA	Merck & Company	DEUTSCH, C (corresponding author), UNIV PENN, DEPT PHYSIOL, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041467] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 41467] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; CAHALAN MD, 1985, J PHYSIOL-LONDON, V358, P197, DOI 10.1113/jphysiol.1985.sp015548; CHANDY KG, 1984, J EXP MED, V160, P369, DOI 10.1084/jem.160.2.369; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DECOURSEY TE, 1984, NATURE, V307, P465, DOI 10.1038/307465a0; DEUTSCH C, 1990, BIOPHYS J, V57, pA116; DEUTSCH C, 1982, J CELL PHYSIOL, V113, P73, DOI 10.1002/jcp.1041130113; DEUTSCH C, 1986, J PHYSIOL-LONDON, V372, P405, DOI 10.1113/jphysiol.1986.sp016016; DEUTSCH C, 1982, BIOCHIM BIOPHYS ACTA, V721, P262, DOI 10.1016/0167-4889(82)90078-7; DEUTSCH C, 1989, J PHYSIOL-LONDON, V413, P399, DOI 10.1113/jphysiol.1989.sp017660; DEUTSCH C, 1988, RENAL PHYSIOL BIOCH, V11, P260; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; GRINSTEIN S, 1984, AM J PHYSIOL, V246, pC204, DOI 10.1152/ajpcell.1984.246.3.C204; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; KRAUSE D, 1988, PFLUG ARCH EUR J PHY, V412, P133, DOI 10.1007/BF00583742; LEE SC, 1988, AM J PHYSIOL, V254, pC286, DOI 10.1152/ajpcell.1988.254.2.C286; LEE SC, 1990, BIOPHYS J, V57, P49, DOI 10.1016/S0006-3495(90)82506-6; LEE SC, 1986, J CELL BIOL, V102, P1200, DOI 10.1083/jcb.102.4.1200; MATTESON DR, 1984, NATURE, V307, P468, DOI 10.1038/307468a0; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; SANDS SB, 1989, J GEN PHYSIOL, V93, P1061, DOI 10.1085/jgp.93.6.1061; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; VAZQUEZ J, 1990, J BIOL CHEM, V265, P15564; VAZQUEZ J, 1989, J BIOL CHEM, V264, P20902; WEILAND GA, 1981, LIFE SCI, V29, P313, DOI 10.1016/0024-3205(81)90324-6; WHITE MM, 1988, MOL PHARMACOL, V34, P427	27	74	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3668	3674						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704892				2022-12-27	WOS:A1991EY68200050
J	COLLINS, T; WILLIAMS, A; JOHNSTON, GI; KIM, J; EDDY, R; SHOWS, T; GIMBRONE, MA; BEVILACQUA, MP				COLLINS, T; WILLIAMS, A; JOHNSTON, GI; KIM, J; EDDY, R; SHOWS, T; GIMBRONE, MA; BEVILACQUA, MP			STRUCTURE AND CHROMOSOMAL LOCATION OF THE GENE FOR ENDOTHELIAL-LEUKOCYTE ADHESION MOLECULE-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NODE HOMING RECEPTOR; NF-KAPPA-B; ACTIVATED PLATELETS; NUCLEOTIDE-SEQUENCE; INTERACTION DOMAINS; MEMBRANE-PROTEIN; HUMAN HOMOLOG; GROWTH-FACTOR; HUMAN GENOME; DNA	Endothelial-leukocyte adhesion molecule 1 is a cell surface glycoprotein expressed by cytokine-activated endothelium that mediates the adhesion of blood neutrophils. Endothelial-leukocyte adhesion molecule 1 is a member of the selectin family of cell adhesion molecules each of which contain an amino-terminal lectin-like domain, followed by an epidermal growth factor-like domain and a variable number of short consensus repeats similar to those found in complement binding proteins. Genomic clones encoding the ELAM gene were isolated and the organization of the ELAM gene was determined. The gene, which is present in a single copy in the human genome, contains 14 exons spanning about 13 kilobases of DNA. The positions of exon-intron boundaries correlate with the putative functional subdivisions of the protein. Introns are found at similar positions in all of the six complement regulatory repeats, suggesting that these elements arose by internal gene duplication. A consensus TATAA element is located upstream of the transcriptional start site. The ELAM promoter contains an inverted CCAAT box and consensus NF-kB- and AP-1-binding sites. The ELAM gene was assigned to the q12 > qter region of human chromosome 1 by analysis of human-mouse hybrid cell lines. Two other members of the selectin gene family, the leukocyte adhesion molecule 1 (LAM-1, TQ1, LEC-CAM 1, or Leu-8) and the granule membrane protein 140 (GMP-140, PADGEM, OR CD62) have been localized to the long arm of chromosome 1, as have the structurally related complement binding proteins, suggesting that these genes may share a common evolutionary history.	UNIV OKLAHOMA, HLTH SCI CTR,DEPT MED,OKLAHOMA MED RES FDN, CARDIOVASC BIOL RES PROGRAM, OKLAHOMA CITY, OK 73104 USA; ROSWELL PK MEM INST, DEPT HUMAN GENET, BUFFALO, NY 14163 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Roswell Park Cancer Institute	COLLINS, T (corresponding author), BRIGHAM & WOMENS HOSP, DEPT PATHOL, DIV VASC RES, BOSTON, MA 02115 USA.		Johnston, Geoffrey/AAB-5278-2022		NHLBI NIH HHS [P01 HL-36028, HL-35716] Funding Source: Medline; NIGMS NIH HHS [GM20454] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL035716, R01HL035716, P01HL036028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020454] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADRIAN GS, 1986, GENE, V49, P167, DOI 10.1016/0378-1119(86)90277-5; AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BOWEN BR, 1989, J CELL BIOL, V109, P421, DOI 10.1083/jcb.109.1.421; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; COTRAN RS, 1986, J EXP MED, V164, P661, DOI 10.1084/jem.164.2.661; COTRAN RS, 1987, AM J PATHOL, V129, P407; DRICKAMER K, 1987, J BIOL CHEM, V262, P2582; DUBY A, 1987, CURRENT PROTOCOLS MO; EDBROOKE MR, 1989, MOL CELL BIOL, V9, P1908, DOI 10.1128/MCB.9.5.1908; EMORINE L, 1983, NATURE, V304, P447, DOI 10.1038/304447a0; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOSTER DC, 1985, P NATL ACAD SCI USA, V82, P4673, DOI 10.1073/pnas.82.14.4673; GAMBLE JR, 1990, SCIENCE, V249, P414; GENG JG, 1990, NATURE, V343, P757, DOI 10.1038/343757a0; GILBERT W, 1985, SCIENCE, V228, P823, DOI 10.1126/science.4001923; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; HESSION C, 1990, P NATL ACAD SCI USA, V87, P1673, DOI 10.1073/pnas.87.5.1673; HSULIN SC, 1984, J BIOL CHEM, V259, P9121; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JOHNSTON GI, 1988, BLOOD S, V72, P327; KISS I, 1989, J BIOL CHEM, V264, P8126; KRISTENSEN T, 1987, BIOCHEMISTRY-US, V26, P4668, DOI 10.1021/bi00389a012; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420; MANIATIS T, 1978, CELL, V15, P687, DOI 10.1016/0092-8674(78)90036-3; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MARTIN ME, 1988, P NATL ACAD SCI USA, V85, P5839, DOI 10.1073/pnas.85.16.5839; MCLAUCHLAN J, 1985, NUCLEIC ACIDS RES, V13, P1347, DOI 10.1093/nar/13.4.1347; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; ORD DC, 1990, J BIOL CHEM, V265, P7760; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; POBER JS, 1988, AM J PATHOL, V133, P426; POLTE T, 1990, NUCLEIC ACIDS RES, V18, P1083, DOI 10.1093/nar/18.4.1083; REYCAMPOS J, 1988, J EXP MED, V167, P664, DOI 10.1084/jem.167.2.664; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAMBROOL J, 1989, MOL CLONING LABORATO; SHAKHOV AN, 1990, J EXP MED, V171, P35, DOI 10.1084/jem.171.1.35; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; SHOWS T, 1984, SOMAT CELL MOLEC GEN, V10, P315, DOI 10.1007/BF01535253; SHOWS TB, 1983, ISOZYMES-CURR T BIOL, V10, P323; SHOWS TB, 1978, CYTOGENET CELL GENET, V21, P99, DOI 10.1159/000130882; SHOWS TB, 1982, ADV HUM GENET, V12, P341; SIEGELMAN MH, 1989, P NATL ACAD SCI USA, V86, P5562, DOI 10.1073/pnas.86.14.5562; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SMITH MW, 1988, J MOL EVOL, V27, P45, DOI 10.1007/BF02099729; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; SUDHOF TC, 1985, SCIENCE, V228, P893, DOI 10.1126/science.3873704; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; VOGT P, 1990, ADV CANCER RES, V85, P1; WATSON ML, 1990, J EXP MED, V172, P263, DOI 10.1084/jem.172.1.263; WEIS JH, 1987, J IMMUNOL, V138, P312; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0	68	179	219	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2466	2473						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703529				2022-12-27	WOS:A1991EV51500069
J	SCOCCA, JR; KRAG, SS				SCOCCA, JR; KRAG, SS			SEQUENCE OF A CDNA THAT SPECIFIES THE URIDINE-DIPHOSPHATE N-ACETYL-D-GLUCOSAMINE - DOLICHOL PHOSPHATE N-ACETYLGLUCOSAMINE-1-PHOSPHATE TRANSFERASE FROM CHINESE-HAMSTER OVARY CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											SCOCCA, JR (corresponding author), JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT BIOCHEM, BALTIMORE, MD 21218 USA.				NIGMS NIH HHS [GM36570] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036570] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBRIGHT CF, 1989, P NATL ACAD SCI USA, V86, P7366, DOI 10.1073/pnas.86.19.7366; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BARNES G, 1984, MOL CELL BIOL, V4, P2381, DOI 10.1128/MCB.4.11.2381; BIRNSTIEL ML, 1985, CELL, V41, P349, DOI 10.1016/S0092-8674(85)80007-6; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHISHOLM D, 1989, BIOTECHNIQUES, V7, P21; CLARK GF, 1983, J BIOL CHEM, V258, P4263; CRISCUOLO BA, 1982, J CELL BIOL, V94, P586, DOI 10.1083/jcb.94.3.586; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEETHAHABIB M, 1988, CELL, V54, P1053, DOI 10.1016/0092-8674(88)90120-1; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; HARTOG KO, 1987, NUCLEIC ACIDS RES, V15, P3627, DOI 10.1093/nar/15.8.3627; HAYES GR, 1983, J BIOL CHEM, V258, P5095; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; KEAN EL, 1986, ARCH BIOCHEM BIOPHYS, V250, P146, DOI 10.1016/0003-9861(86)90711-3; KINK JA, 1987, P NATL ACAD SCI USA, V84, P1253, DOI 10.1073/pnas.84.5.1253; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KRAG SS, 1985, CURR TOP MEMBR TRANS, V24, P181; KUKURUZINSKA MA, 1987, P NATL ACAD SCI USA, V84, P2145, DOI 10.1073/pnas.84.8.2145; KUO SC, 1974, BIOCHEM BIOPH RES CO, V58, P287, DOI 10.1016/0006-291X(74)90925-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; LEHRMAN MA, 1988, J BIOL CHEM, V263, P19796; Maniatis T., 1982, MOL CLONING; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; OHANLON TP, 1989, J BIOL CHEM, V264, P17389; PLOUHAR PL, 1983, J BIOL CHEM, V258, P2988; RAPOPORT TA, 1985, CURR TOP MEMBR TRANS, V24, P1; RICHARDS GM, 1974, ANAL BIOCHEM, V57, P369, DOI 10.1016/0003-2697(74)90091-8; RINE J, 1983, P NATL ACAD SCI-BIOL, V80, P6750, DOI 10.1073/pnas.80.22.6750; RIORDAN JR, 1985, NATURE, V316, P817, DOI 10.1038/316817a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOCCA JR, 1988, BIOCHEM BIOPH RES CO, V156, P1063, DOI 10.1016/S0006-291X(88)80740-X; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SHAILUBHAI K, 1988, J BIOL CHEM, V263, P15964; SHAPER NL, 1988, J BIOL CHEM, V263, P10420; TAKATSUKI A, 1975, AGR BIOL CHEM TOKYO, V39, P2089, DOI 10.1080/00021369.1975.10861914; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; TONEGUZZO F, 1988, BIOTECHNIQUES, V6, P460; VOLPE JJ, 1987, DEV BRAIN RES, V33, P277, DOI 10.1016/0165-3806(87)90160-X; VONHEIJNE G, 1985, CURR TOP MEMBR TRANS, V24, P151; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; WALDMAN BC, 1987, J CELL PHYSIOL, V131, P302, DOI 10.1002/jcp.1041310303; WANG LM, 1988, BIOTECHNIQUES, V6, P839; WELPLY JK, 1985, DEV BIOL, V107, P252, DOI 10.1016/0012-1606(85)90393-8	50	52	57	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20621	20626						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700792				2022-12-27	WOS:A1990EJ52500086
J	TOKIDA, Y; ARATANI, Y; MORITA, A; KITAGAWA, Y				TOKIDA, Y; ARATANI, Y; MORITA, A; KITAGAWA, Y			PRODUCTION OF 2 VARIANT LAMININ FORMS BY ENDOTHELIAL-CELLS AND SHIFT OF THEIR RELATIVE LEVELS BY ANGIOSTATIC STEROIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NAGOYA UNIV, SCH AGR, INST BIOCHEM REGULAT, CHIKUSA KU, NAGOYA 46401, JAPAN; KIRIN BREWERY CO LTD, PHARMACEUT LAB, TAKASAKI, GUNMA 37012, JAPAN	Nagoya University; Kirin Brewery Company Limited								ARATANI Y, 1988, FEBS LETT, V235, P129, DOI 10.1016/0014-5793(88)81247-X; ARATANI Y, 1987, FEBS LETT, V218, P47, DOI 10.1016/0014-5793(87)81015-3; ARATANI Y, 1988, J BIOL CHEM, V263, P16163; CAMPBELL JH, 1986, ANNU REV PHYSIOL, V48, P295, DOI 10.1146/annurev.ph.48.030186.001455; CHUNG AE, 1979, CELL, V16, P277, DOI 10.1016/0092-8674(79)90005-9; CHUNG AE, 1977, BIOCHEM BIOPH RES CO, V79, P859, DOI 10.1016/0006-291X(77)91190-1; COOPER AR, 1981, EUR J BIOCHEM, V119, P189, DOI 10.1111/j.1432-1033.1981.tb05593.x; DURKIN ME, 1988, BIOCHEMISTRY-US, V27, P5198, DOI 10.1021/bi00414a038; EDGAR D, 1988, J CELL BIOL, V106, P1299, DOI 10.1083/jcb.106.4.1299; ENGEL J, 1981, J MOL BIOL, V150, P97, DOI 10.1016/0022-2836(81)90326-0; Fawcett DW, 1986, TXB HISTOLOGY, P367; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; FORM DM, 1986, LAB INVEST, V55, P521; FURCHT LT, 1986, LAB INVEST, V55, P505; GOSPODAROWICZ D, 1976, P NATL ACAD SCI USA, V73, P4120, DOI 10.1073/pnas.73.11.4120; GROSS J, 1981, P NATL ACAD SCI-BIOL, V78, P1176, DOI 10.1073/pnas.78.2.1176; HAUDENSCHILD CC, 1984, BIOL ENDOTHELIAL CEL, P74; HERBST TJ, 1988, J CELL BIOL, V106, P1365, DOI 10.1083/jcb.106.4.1365; HOGAN BLM, 1980, DEV BIOL, V80, P289, DOI 10.1016/0012-1606(80)90405-4; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; KLEINMAN HK, 1985, J CELL BIOCHEM, V27, P317, DOI 10.1002/jcb.240270402; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; MACARAK EJ, 1983, J CELL PHYSIOL, V116, P76, DOI 10.1002/jcp.1041160112; MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153; MADRI JA, 1982, AM J PATHOL, V106, P180; MARTIN GR, 1987, ANNU REV CELL BIOL, V3, P57, DOI 10.1146/annurev.cellbio.3.1.57; MCGUIRE PG, 1987, LAB INVEST, V57, P94; MIKI K, 1988, EXP CELL RES, V179, P344, DOI 10.1016/0014-4827(88)90273-X; MIKI K, 1987, J BIOCHEM-TOKYO, V102, P385, DOI 10.1093/oxfordjournals.jbchem.a122065; MONTELL DJ, 1988, CELL, V53, P463, DOI 10.1016/0092-8674(88)90166-3; MONTESANO R, 1983, J CELL BIOL, V97, P1648, DOI 10.1083/jcb.97.5.1648; MORITA A, 1985, BIOCHEM J, V229, P259, DOI 10.1042/bj2290259; MORITA A, 1985, J CELL PHYSIOL, V125, P263, DOI 10.1002/jcp.1041250214; MORITA A, 1984, J BIOCHEM-TOKYO, V95, P743, DOI 10.1093/oxfordjournals.jbchem.a134665; OHNO M, 1986, CONNECT TISSUE RES, V15, P199, DOI 10.3109/03008208609167143; PALM SL, 1983, J CELL BIOL, V96, P1218, DOI 10.1083/jcb.96.5.1218; PRATT BM, 1985, ANN NY ACAD SCI, V460, P274, DOI 10.1111/j.1749-6632.1985.tb51175.x; REPESH LA, 1982, J HISTOCHEM CYTOCHEM, V30, P351, DOI 10.1177/30.4.6174568; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; SASAKI M, 1987, J BIOL CHEM, V262, P17111; SASAKI M, 1987, P NATL ACAD SCI USA, V84, P935, DOI 10.1073/pnas.84.4.935; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SHOLLEY MM, 1977, LAB INVEST, V36, P18; STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1; TIMPL R, 1979, J BIOL CHEM, V254, P9933; TIMPL R, 1986, INT REV EXP PATHOL, V29, P1	47	106	108	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18123	18129						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1698786				2022-12-27	WOS:A1990EE20100019
J	COUTURIER, S; ERKMAN, L; VALERA, S; RUNGGER, D; BERTRAND, S; BOULTER, J; BALLIVET, M; BERTRAND, D				COUTURIER, S; ERKMAN, L; VALERA, S; RUNGGER, D; BERTRAND, S; BOULTER, J; BALLIVET, M; BERTRAND, D			ALPHA-5, ALPHA-3, AND NON-ALPHA-3 - 3 CLUSTERED AVIAN GENES ENCODING NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR-RELATED SUBUNITS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV GENEVA,DEPT BIOCHEM,SCI 2,30 QUAI ERNEST ANSERMET,CH-1211 GENEVA 4,SWITZERLAND; UNIV GENEVA,SCH MED,DEPT PHYSIOL,CH-1211 GENEVA 4,SWITZERLAND; UNIV GENEVA,DEPT ANIM BIOL,CH-1211 GENEVA 4,SWITZERLAND; SALK INST BIOL STUDIES,MOLEC NEUROBIOL LAB,SAN DIEGO,CA 92138	University of Geneva; University of Geneva; University of Geneva; Salk Institute								BALLIVET M, 1983, COLD SPRING HARB SYM, V48, P83, DOI 10.1101/SQB.1983.048.01.011; BALLIVET M, 1988, NEURON, V1, P847, DOI 10.1016/0896-6273(88)90132-8; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BERTRAND D, 1990, P NATL ACAD SCI USA, V87, P1993, DOI 10.1073/pnas.87.5.1993; BERTRAND D, 1986, INT J BIOMED COMPUT, V18, P193, DOI 10.1016/0020-7101(86)90016-4; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; BOULTER J, 1986, NATURE, V319, P368, DOI 10.1038/319368a0; BOULTER J, 1990, J BIOL CHEM, V265, P4472; BOYD RT, 1988, NEURON, V1, P495; BUONANNO A, 1989, J BIOL CHEM, V264, P7611; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DENERIS ES, 1989, J BIOL CHEM, V264, P6268; DOWNING JEG, 1987, P NATL ACAD SCI USA, V84, P7739, DOI 10.1073/pnas.84.21.7739; DREANO M, 1986, GENE, V49, P1, DOI 10.1016/0378-1119(86)90380-X; DUVOISIN RM, 1989, NEURON, V3, P487, DOI 10.1016/0896-6273(89)90207-9; EPPIG JJ, 1976, IN VITRO CELL DEV B, V12, P173; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERAMISCO JR, 1982, J BIOL CHEM, V257, P1024; GIRAUDAT J, 1986, P NATL ACAD SCI USA, V83, P2719, DOI 10.1073/pnas.83.8.2719; GIRAUDAT J, 1987, BIOCHEMISTRY-US, V26, P2410, DOI 10.1021/bi00383a003; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HALVORSEN SW, 1990, J NEUROSCI, V10, P1711; HEIDMANN O, 1986, SCIENCE, V234, P866, DOI 10.1126/science.3022377; HUCHO F, 1986, EUR J BIOCHEM, V158, P211, DOI 10.1111/j.1432-1033.1986.tb09740.x; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KAO PN, 1986, J BIOL CHEM, V261, P8085; KHANDJIAN EW, 1986, MOL BIOL REP, V11, P107, DOI 10.1007/BF00364822; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEONARD RJ, 1988, SCIENCE, V242, P1578, DOI 10.1126/science.2462281; LOENEN WAM, 1980, GENE, V10, P249, DOI 10.1016/0378-1119(80)90054-2; Maniatis T., 1982, MOL CLONING; MARGIOTTA JF, 1987, P NATL ACAD SCI USA, V84, P8155, DOI 10.1073/pnas.84.22.8155; MARGIOTTA JF, 1987, J NEUROSCI, V7, P3612; MARGIOTTA JF, 1989, DEV BIOL, V135, P326, DOI 10.1016/0012-1606(89)90183-8; MATTER JM, 1990, EMBO J, V9, P1021, DOI 10.1002/j.1460-2075.1990.tb08205.x; MESSING J, 1982, GENE, V19, P269, DOI 10.1016/0378-1119(82)90016-6; MOSS BL, 1989, NEURON, V3, P597, DOI 10.1016/0896-6273(89)90270-5; NATHANSON NM, 1987, ANNU REV NEUROSCI, V10, P195, DOI 10.1146/annurev.ne.10.030187.001211; NEF P, 1984, P NATL ACAD SCI-BIOL, V81, P7975, DOI 10.1073/pnas.81.24.7975; NEF P, 1988, EMBO J, V7, P595, DOI 10.1002/j.1460-2075.1988.tb02852.x; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; ROLE LW, 1988, P NATL ACAD SCI USA, V85, P2825, DOI 10.1073/pnas.85.8.2825; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOEPFER R, 1989, FEBS LETT, V257, P393, DOI 10.1016/0014-5793(89)81580-7; SCHOEPFER R, 1988, NEURON, V1, P241, DOI 10.1016/0896-6273(88)90145-6; SHIBAHARA S, 1985, EUR J BIOCHEM, V146, P15, DOI 10.1111/j.1432-1033.1985.tb08614.x; SHIEH BH, 1987, J CELL BIOL, V104, P1337, DOI 10.1083/jcb.104.5.1337; SIMMONS LK, 1990, NEURON, V4, P393, DOI 10.1016/0896-6273(90)90051-G; Sober HA, 1970, HDB BIOCH; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STERNBERG N, 1977, GENE, V1, P255, DOI 10.1016/0378-1119(77)90049-X; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; VOELLMY R, 1982, P NATL ACAD SCI-BIOL, V79, P1776, DOI 10.1073/pnas.79.6.1776; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; WADA K, 1988, SCIENCE, V240, P330, DOI 10.1126/science.2832952; WHITING P, 1987, FEBS LETT, V219, P459, DOI 10.1016/0014-5793(87)80272-7; WHITING P, 1987, FEBS LETT, V213, P55, DOI 10.1016/0014-5793(87)81464-3; WHITING PJ, 1987, J NEUROSCI, V7, P4005	60	183	187	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17560	17567						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698777				2022-12-27	WOS:A1990EC76600035
J	DIMATTIA, GE; GELLERSEN, B; DUCKWORTH, ML; FRIESEN, HG				DIMATTIA, GE; GELLERSEN, B; DUCKWORTH, ML; FRIESEN, HG			HUMAN PROLACTIN GENE-EXPRESSION - THE USE OF AN ALTERNATIVE NONCODING EXON IN DECIDUA AND THE IM-9-P3 LYMPHOBLAST CELL-LINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									INST HORMONE & FERTIL RES, W-2000 HAMBURG 54, GERMANY		DIMATTIA, GE (corresponding author), UNIV MANITOBA, FAC MED, DEPT PHYSIOL, WINNIPEG R3E 0W3, MANITOBA, CANADA.							ADLER HT, 1988, J VIROL, V62, P4113, DOI 10.1128/JVI.62.11.4113-4122.1988; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BENYAJATI C, 1983, CELL, V33, P125, DOI 10.1016/0092-8674(83)90341-0; BONHOFF A, 1990, Cytotechnology, V3, P43, DOI 10.1007/BF00365265; Brenner R.M., 1988, PHYSL REPROD, P303; CHAPITIS J, 1988, AM J OBSTET GYNECOL, V158, P846, DOI 10.1016/0002-9378(88)90083-X; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEMENTS J, 1983, ENDOCRINOLOGY, V112, P1133, DOI 10.1210/endo-112-3-1133; COOKE NE, 1981, J BIOL CHEM, V256, P4007; DALY DC, 1983, AM J OBSTET GYNECOL, V145, P672, DOI 10.1016/0002-9378(83)90572-0; DAVIS LG, 1986, BASIC METHODS MOL BI, P62; DAY RN, 1989, MOL ENDOCRINOL, V3, P3, DOI 10.1210/mend-3-1-3; DIMATTIA GE, 1988, ENDOCRINOLOGY, V122, P2508, DOI 10.1210/endo-122-6-2508; DUCKWORTH ML, 1988, MOL ENDOCRINOL, V2, P912, DOI 10.1210/mend-2-10-912; DUCKWORTH ML, 1986, J BIOL CHEM, V261, P879; ELSHOLTZ HP, 1986, SCIENCE, V234, P1552, DOI 10.1126/science.3491428; FAHEY JL, 1971, ANN NY ACAD SCI, V190, P221, DOI 10.1111/j.1749-6632.1971.tb13537.x; FRAIN M, 1989, CELL, V59, P145, DOI 10.1016/0092-8674(89)90877-5; GELLERSEN B, 1989, MOL CELL ENDOCRINOL, V64, P127, DOI 10.1016/0303-7207(89)90073-7; GOLANDER A, 1978, SCIENCE, V202, P311, DOI 10.1126/science.694535; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUTIERREZHARTMANN A, 1987, P NATL ACAD SCI USA, V84, P5211, DOI 10.1073/pnas.84.15.5211; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HUANG JR, 1987, ENDOCRINOLOGY, V121, P2011; HUYNH TV, 1985, DNA CLONING PRACTICA, P47; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JACKSON AE, 1988, MOL ENDOCRINOL, V2, P1139, DOI 10.1210/mend-2-11-1139; JULKUNEN M, 1988, P NATL ACAD SCI USA, V85, P8845, DOI 10.1073/pnas.85.23.8845; KIM KE, 1988, MOL ENDOCRINOL, V2, P1374, DOI 10.1210/mend-2-12-1374; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LEMAIGRE FP, 1989, DNA-J MOLEC CELL BIO, V8, P149, DOI 10.1089/dna.1.1989.8.149; LINZER DIH, 1985, P NATL ACAD SCI USA, V82, P4356, DOI 10.1073/pnas.82.13.4356; MANIATIS T, 1982, MOL CLONING LABORATO, P113; MASLAR IA, 1980, J CLIN ENDOCR METAB, V51, P78, DOI 10.1210/jcem-51-1-78; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; MASLAR IA, 1986, ENDOCRINOLOGY, V118, P2102, DOI 10.1210/endo-118-5-2102; Maxam A M, 1980, Methods Enzymol, V65, P499; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; RIDDICK DH, 1978, LIFE SCI, V23, P1913, DOI 10.1016/0024-3205(78)90557-X; RIDDICK DH, 1985, PROLACTIN BASIC CLIN, P463; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SARTOR O, 1989, MOL CELL BIOL, V9, P2983, DOI 10.1128/MCB.9.7.2983; SCHULER LA, 1987, P NATL ACAD SCI USA, V84, P5650, DOI 10.1073/pnas.84.16.5650; SCHUSTER WA, 1988, EMBO J, V7, P1721, DOI 10.1002/j.1460-2075.1988.tb03001.x; SHARP ZD, 1989, NUCLEIC ACIDS RES, V17, P2705, DOI 10.1093/nar/17.7.2705; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TAKAHASHI H, 1984, J BIOCHEM-TOKYO, V95, P1491, DOI 10.1093/oxfordjournals.jbchem.a134757; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TRUONG AT, 1984, EMBO J, V3, P429, DOI 10.1002/j.1460-2075.1984.tb01824.x; VISVADER J, 1989, MOL CELL BIOL, V9, P1336, DOI 10.1128/MCB.9.3.1336; VORONOVA AF, 1987, MOL CELL BIOL, V7, P4407, DOI 10.1128/MCB.7.12.4407; WALTERS CA, 1983, AM J OBSTET GYNECOL, V147, P639, DOI 10.1016/0002-9378(83)90441-6; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YOUNG RA, 1981, CELL, V23, P451, DOI 10.1016/0092-8674(81)90140-9	56	124	124	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16412	16421						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697858				2022-12-27	WOS:A1990DZ95000058
J	THOMAS, MK; FRANCIS, SH; CORBIN, JD				THOMAS, MK; FRANCIS, SH; CORBIN, JD			CHARACTERIZATION OF A PURIFIED BOVINE LUNG CGMP-BINDING CGMP PHOSPHODIESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									VANDERBILT UNIV, DEPT MOLEC PHYSIOL & BIOPHYS, NASHVILLE, TN 37232 USA; VANDERBILT UNIV, HOWARD HUGHES MED INST, NASHVILLE, TN 37232 USA	Vanderbilt University; Howard Hughes Medical Institute; Vanderbilt University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM041269] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK15988] Funding Source: Medline; NIGMS NIH HHS [GM41269, GM07347] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; COOK NJ, 1987, P NATL ACAD SCI USA, V84, P585, DOI 10.1073/pnas.84.2.585; COQUIL JF, 1983, BIOCHIM BIOPHYS ACTA, V743, P359, DOI 10.1016/0167-4838(83)90394-1; COQUIL JF, 1985, BIOCHEM BIOPH RES CO, V127, P226, DOI 10.1016/S0006-291X(85)80148-0; COQUIL JF, 1980, BIOCHIM BIOPHYS ACTA, V631, P148, DOI 10.1016/0304-4165(80)90063-X; CORBIN JD, 1988, METHOD ENZYMOL, V159, P74; ERNEUX C, 1984, ADV CYCLIC NUCL PROT, V16, P107; FRANCIS SH, 1980, J BIOL CHEM, V255, P620; FRANCIS SH, 1988, METHOD ENZYMOL, V159, P722; FRANCIS SH, 1985, CURR TOP CELL REGUL, V26, P247; GETTYS TW, 1987, J BIOL CHEM, V262, P333; GETTYS TW, 1988, J BIOL CHEM, V263, P10359; GOLDBERG ND, 1977, ANNU REV BIOCHEM, V46, P823, DOI 10.1146/annurev.bi.46.070177.004135; GOLDBERG ND, 1983, J BIOL CHEM, V258, P9213; GRANT PG, 1988, P NATL ACAD SCI USA, V85, P9071, DOI 10.1073/pnas.85.23.9071; HAMET P, 1978, J CYCLIC NUCL PROT, V4, P281; HAMET P, 1984, ADV CYCLIC NUCL PROT, V16, P119; HAMET P, 1988, METHOD ENZYMOL, V159, P710; HURWITZ RL, 1984, ADV CYCLIC NUCL PROT, V16, P89; KESBEKE F, 1985, EUR J BIOCHEM, V151, P179, DOI 10.1111/j.1432-1033.1985.tb09083.x; KRAMER GL, 1977, BIOCHEMISTRY-US, V16, P3316, DOI 10.1021/bi00634a006; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINCOLN TM, 1983, ADV CYCL NUCL RES<D>, V15, P139; LINCOLN TM, 1976, P NATL ACAD SCI USA, V73, P2559, DOI 10.1073/pnas.73.8.2559; LUGNIER C, 1986, BIOCHEM PHARMACOL, V35, P1743, DOI 10.1016/0006-2952(86)90333-3; MACPHEE CH, 1988, J BIOL CHEM, V263, P10353; MACPHEE CH, 1986, P NATL ACAD SCI USA, V83, P6660, DOI 10.1073/pnas.83.17.6660; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIOT F, 1985, EUR J BIOCHEM, V149, P59, DOI 10.1111/j.1432-1033.1985.tb08893.x; MONKEN CE, 1989, J BIOL CHEM, V5255, P7067; PANG DC, 1988, DRUG DEVELOP RES, V12, P85, DOI 10.1002/ddr.430120203; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; STROOP SD, 1989, J BIOL CHEM, V264, P13718; TAYLOR SS, 1988, FASEB J, V2, P2677, DOI 10.1096/fasebj.2.11.3294077; THOMAS MK, 1990, J BIOL CHEM, V265, P14971; TREMBLAY J, 1988, ADV SEC MESS PHOSPH, V22, P319; VANHAASTERT PJM, 1984, J CELL BIOL, V98, P709, DOI 10.1083/jcb.98.2.709; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; WALSETH TF, 1979, BIOCHIM BIOPHYS ACTA, V562, P11, DOI 10.1016/0005-2787(79)90122-9; WALSETH TF, 1985, FED PROC, V44, P1854; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; WEISHAAR RE, 1986, J CYCLIC NUCL PROT, V11, P463; WEISHAAR RE, 1986, BIOCHEM PHARMACOL, V35, P787, DOI 10.1016/0006-2952(86)90247-9; WELLS JN, 1981, J MED CHEM, V24, P954, DOI 10.1021/jm00140a008; WELLS JN, 1975, BIOCHIM BIOPHYS ACTA, V384, P430, DOI 10.1016/0005-2744(75)90044-3; WOLFE L, 1987, J BIOL CHEM, V262, P16906; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; YAMAMOTO T, 1984, BIOCHEMISTRY-US, V23, P670, DOI 10.1021/bi00299a013; YAMAZAKI A, 1980, J BIOL CHEM, V255, P1619	54	204	207	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					14964	14970						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697584				2022-12-27	WOS:A1990DX40000048
J	HANICJOYCE, PJ; GRAY, MW				HANICJOYCE, PJ; GRAY, MW			PROCESSING OF TRANSFER-RNA PRECURSORS IN A WHEAT MITOCHONDRIAL EXTRACT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									DALHOUSIE UNIV, DEPT BIOCHEM, HALIFAX B3H 4H7, NS, CANADA	Dalhousie University				Gray, Michael/0000-0001-7125-2625				AKABOSHI E, 1980, BIOCHEM BIOPH RES CO, V96, P831, DOI 10.1016/0006-291X(80)91430-8; ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BONEN L, 1980, NUCLEIC ACIDS RES, V8, P319, DOI 10.1093/nar/8.2.319; CASTANO JG, 1986, CELL, V46, P377, DOI 10.1016/0092-8674(86)90658-6; CHEN JY, 1988, J BIOL CHEM, V263, P13677; CLEWELL DB, 1969, P NATL ACAD SCI USA, V62, P1159, DOI 10.1073/pnas.62.4.1159; DEUTSCHER MP, 1984, CRC CR REV BIOCH MOL, V17, P45, DOI 10.3109/10409238409110269; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; DONISKELLER H, 1980, NUCLEIC ACIDS RES, V8, P3133, DOI 10.1093/nar/8.14.3133; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; FALCONET D, 1984, EMBO J, V3, P297, DOI 10.1002/j.1460-2075.1984.tb01799.x; FRENDEWEY D, 1985, J BIOL CHEM, V260, P449; GARBER RL, 1979, CELL, V18, P817, DOI 10.1016/0092-8674(79)90134-X; GARDINER K, 1980, J BIOL CHEM, V255, P7507; GOLD HA, 1986, CELL, V44, P243, DOI 10.1016/0092-8674(86)90758-0; GRAY MW, 1982, MICROBIOL REV, V46, P1; GRAY MW, 1983, FEBS LETT, V161, P323, DOI 10.1016/0014-5793(83)81034-5; GREENBERG BM, 1986, PLANT MOL BIOL, V6, P89, DOI 10.1007/BF00027302; GREENBERG BM, 1984, PLANT MOL BIOL, V3, P97, DOI 10.1007/BF00040034; GRUISSEM W, 1983, CELL, V35, P815, DOI 10.1016/0092-8674(83)90114-9; GUALBERTO JM, 1989, NUCLEIC ACIDS RES, V17, P3586, DOI 10.1093/nar/17.9.3586; GUALBERTO JM, 1988, MOL GEN GENET, V215, P118, DOI 10.1007/BF00331312; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P4885, DOI 10.1093/nar/17.12.4885; JOYCE PBM, 1988, NUCLEIC ACIDS RES, V16, P1210, DOI 10.1093/nar/16.3.1210; JOYCE PBM, 1989, BIOCHIM BIOPHYS ACTA, V1008, P355, DOI 10.1016/0167-4781(89)90028-6; JOYCE PBM, 1988, PLANT MOL BIOL, V11, P833, DOI 10.1007/BF00019523; JOYCE PBM, 1988, PLANT MOL BIOL, V10, P251, DOI 10.1007/BF00027402; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P7865, DOI 10.1093/nar/17.19.7865; JOYCE PBM, 1989, NUCLEIC ACIDS RES, V17, P5461, DOI 10.1093/nar/17.14.5461; KLINE L, 1981, J BIOL CHEM, V256, P5058; KOLODNER R, 1975, BIOCHIM BIOPHYS ACTA, V402, P372, DOI 10.1016/0005-2787(75)90273-7; KRUPP G, 1986, EMBO J, V5, P1697, DOI 10.1002/j.1460-2075.1986.tb04413.x; LEE JY, 1989, MOL CELL BIOL, V9, P2536, DOI 10.1128/MCB.9.6.2536; LONSDALE DM, 1989, BIOCH PLANTS COMPREH, V15, P229; MACKAY RM, 1980, EUR J BIOCHEM, V112, P561; MANAM S, 1987, J BIOL CHEM, V262, P10272; MARECHAL L, 1987, CURR GENET, V12, P91, DOI 10.1007/BF00434662; MARIONPOLL A, 1988, PLANT MOL BIOL, V11, P45, DOI 10.1007/BF00016013; MARTIN NC, 1985, J BIOL CHEM, V260, P1479; MILLER DL, 1983, CELL, V34, P911, DOI 10.1016/0092-8674(83)90548-2; MULLIGAN RM, 1988, MOL GEN GENET, V211, P373, DOI 10.1007/BF00425688; MULLIGAN RM, 1988, P NATL ACAD SCI USA, V85, P7998, DOI 10.1073/pnas.85.21.7998; NOMURA T, 1988, EMBO J, V7, P3539, DOI 10.1002/j.1460-2075.1988.tb03230.x; PALLESCHI C, 1984, EMBO J, V3, P1389, DOI 10.1002/j.1460-2075.1984.tb01982.x; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; RAMBACH A, 1977, P NATL ACAD SCI USA, V74, P5041, DOI 10.1073/pnas.74.11.5041; RUNEBERGROOS P, 1987, PLANT MOL BIOL, V9, P237, DOI 10.1007/BF00166460; SCHNARE MN, 1985, CURR GENET, V9, P389, DOI 10.1007/BF00421610; SEDEROFF RR, 1984, ADV GENET, V22, P1, DOI 10.1016/S0065-2660(08)60038-3; SIMONCSITS A, 1977, NATURE, V269, P833, DOI 10.1038/269833a0; STARK BC, 1978, P NATL ACAD SCI USA, V75, P3717, DOI 10.1073/pnas.75.8.3717; STERN DB, 1982, NATURE, V299, P698, DOI 10.1038/299698a0; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; YAMAGUCHISHINOZAKI K, 1987, FEBS LETT, V215, P132, DOI 10.1016/0014-5793(87)80127-8; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZASLOFF M, 1982, J BIOL CHEM, V257, P7857	59	56	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13782	13791						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696257				2022-12-27	WOS:A1990DU27500060
J	ARAKAWA, T; YPHANTIS, DA; LARY, JW; NARHI, LO; LU, HS; PRESTRELSKI, SJ; CLOGSTON, CL; ZSEBO, KM; MENDIAZ, EA; WYPYCH, J; LANGLEY, KE				ARAKAWA, T; YPHANTIS, DA; LARY, JW; NARHI, LO; LU, HS; PRESTRELSKI, SJ; CLOGSTON, CL; ZSEBO, KM; MENDIAZ, EA; WYPYCH, J; LANGLEY, KE			GLYCOSYLATED AND UNGLYCOSYLATED RECOMBINANT-DERIVED HUMAN STEM-CELL FACTORS ARE DIMERIC AND HAVE EXTENSIVE REGULAR SECONDARY STRUCTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE RECEPTOR; C-KIT RECEPTOR; GROWTH-FACTOR; MUTANT MICE; SI-LOCUS; W-LOCUS; LIGAND; PROTEINS; MOUSE; IDENTIFICATION	We have recently described the identification, isolation, and characterization of a factor, termed stem cell factor (SCF), which acts on primitive hematopoietic progenitors of the marrow. A soluble form of the factor was isolated from the conditioned medium of a rat cell line (Zsebo, K. M., Wypych, J., McNiece, I. K., Lu, H. S., Smith, K. A., Karkare, S. B., Sachdev, R. K., Yuschenkoff, V. N., Birkett, N. C., Williams, L. R., Satyagal, V. N., Tung, W., Bosselman, R. A., Mendiaz, E. A., and Langley, K. E. (1990) Cell 63, 195-201) and rat and human cDNAs have been cloned (Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I. K., Jacobsen, F. W., Mendiaz, E. A., Birkett, N. C., Smith, K. A., Johnson, M. J., Parker, V. P., Flores, J. C., Patel, A. C., Fisher, E. F., Erjavec, H. O., Herrera, C. J., Wypych, J., Sachdev, R. K., Pope, J. A., Leslie, I., Wen, D., Lin, C.-H., Cupples, R. L., and Zsebo, K. M. (1990) Cell 63, 203-211). The cDNAs encode amino acids C-terminal to those found in the isolated natural form, including a putative transmembrane domain. This paper describes the structural characterization of soluble forms of recombinant human SCF purified from Escherichia coli (unglycosylated) and from Chinese hamster ovary (CHO) cells (glycosylated). Fluorescence emission spectra indicate that the single Trp residue is present in a hydrophobic environment. Circular dichroism and infrared spectroscopy indicate considerable secondary structure, including both alpha-helix and beta-sheet. Molecular weight determinations by sedimentation equilibrium show that the molecules are dimeric (noncovalently associated), and gel filtration analyses are consistent with this conclusion. The CHO cell-derived SCF is about 30% carbohydrate by weight, with both N-linked and O-linked sugar. The presence or absence of the carbohydrate does not influence the results of the various structural analyses.	AMGEN INC,AMGEN CTR,THOUSAND OAKS,CA 91320; UNIV CONNECTICUT,ANALYT ULTRACENTRIFUGE FACIL,STORRS,CT 06269; UNIV CONNECTICUT,DEPT MOLEC & CELL BIOL,STORRS,CT 06269; UNIV CRETE,DEPT BIOL,HERAKLION,GREECE; UNIV CRETE,INST MOLEC BIOL & BIOTECHNOL,HERAKLION,GREECE	Amgen; University of Connecticut; University of Connecticut; University of Crete; University of Crete								ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; ANDREWS P, 1964, BIOCHEM J, V91, P222, DOI 10.1042/bj0910222; ANDREWS RG, 1991, IN PRESS BLOOD, V78; BERNSTEIN ID, 1991, BLOOD, V77, P2316; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHANG CT, 1978, ANAL BIOCHEM, V91, P13, DOI 10.1016/0003-2697(78)90812-6; Cohn E. J., 1943, PROTEINS AMINO ACIDS; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; CORREIA JC, 1981, THESIS U CONNECTICUT; CORREIA JJ, 1980, FED PROC, V39, P1604; DAS SK, 1982, J BIOL CHEM, V257, P13679; DECLERCK YA, 1991, J BIOL CHEM, V266, P3893; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; FUJITA J, 1989, P NATL ACAD SCI USA, V86, P2888, DOI 10.1073/pnas.86.8.2888; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; JOHNSSON A, 1982, BIOCHEM BIOPH RES CO, V104, P66, DOI 10.1016/0006-291X(82)91941-6; KAUPPINEN JK, 1981, APPL SPECTROSC, V35, P271, DOI 10.1366/0003702814732634; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARY J, 1990, BIOPHYS J, V57, pA377; LAURENT TC, 1964, J CHROMATOGR, V14, P317, DOI 10.1016/S0021-9673(00)86637-6; Lee J C, 1979, Methods Enzymol, V61, P26; LEVISCHAFFER F, 1985, J IMMUNOL, V135, P3454; LU HS, 1991, J BIOL CHEM, V266, P8102; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; MCCULLOC.EA, 1965, BLOOD-J HEMATOL, V26, P399, DOI 10.1182/blood.V26.4.399.399; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; MCNIECE IK, 1991, J IMMUNOL, V146, P3785; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; NOCKA K, 1990, EMBO J, V9, P3287, DOI 10.1002/j.1460-2075.1990.tb07528.x; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PRESTRELSKI SJ, 1991, INT J PEPT PROT RES, V37, P508; PRESTRELSKI SJ, 1991, BIOCHEMISTRY-US, V30, P133, DOI 10.1021/bi00215a020; QUI F, 1988, EMBO J, V7, P1003; REITH AD, 1990, GENE DEV, V4, P390, DOI 10.1101/gad.4.3.390; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; TRAUBE J, 1899, SAMML CHEM CHEM TECH, V4, P255; VANHOLDE KE, 1958, J PHYS CHEM-US, V62, P734, DOI 10.1021/j150564a025; Westphal U, 1975, Methods Enzymol, V36, P91; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; YPHANTIS DA, 1960, ANN NY ACAD SCI, V88, P586, DOI 10.1111/j.1749-6632.1960.tb20055.x; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	53	91	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18942	18948						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717457				2022-12-27	WOS:A1991GJ47200082
J	ARM, JP; GURISH, MF; REYNOLDS, DS; SCOTT, HC; GARTNER, CS; AUSTEN, KF; KATZ, HR				ARM, JP; GURISH, MF; REYNOLDS, DS; SCOTT, HC; GARTNER, CS; AUSTEN, KF; KATZ, HR			MOLECULAR-CLONING OF GP49, A CELL-SURFACE ANTIGEN THAT IS PREFERENTIALLY EXPRESSED BY MOUSE MAST-CELL PROGENITORS AND IS A NEW MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINIDASE-F; SULFATE-E-PROTEOGLYCAN; CONNECTIVE-TISSUE-TYPE; PROTEIN-KINASE-C; BONE-MARROW; MONOCLONAL-ANTIBODIES; CARBOXYPEPTIDASE-A; SEQUENCE-ANALYSIS; W/WV MICE; DIFFERENTIATION	gp49 is a M(r) 49,000 glycoprotein expressed on the surface of mouse bone marrow-derived mast cells, which are progenitors for the major in vivo mast cell subclasses, typified by intestinal mucosal mast cells and serosal mast cells. The amino-terminal amino acid sequence of gp49 was determined after isolation of the solubilized membrane protein by affinity chromatography with the B23.1 anti-gp49 monoclonal antibody. Redundant oligonucleotides were used to isolate a full-length 1.3-kilobase cDNA from a mouse mast cell library. The predicted amino acid sequence contains a signal peptide of 23 residues, an extracellular domain of 215 residues with three potential sites of N-linked glycosylation, a transmembrane domain of 23 residues, and a cytoplasmic tail of 42 residues. Hybridization of the gp49 cDNA was limited to mRNA extracted from those cell types that also bound the B23.1 monoclonal antibody as assessed by cytofluorographic analyses. The predicted extracellular domain of gp49 contains two regions of 48 and 51 amino acids, each flanked by cysteine residues. Both regions meet criteria for being C2-type domains of the immunoglobulin superfamily based upon the alignment of consensus amino acids and their predicted secondary structure organization. Thus, gp49, a membrane glycoprotein preferentially expressed by the progenitor mast cell population, is a new member of the immunoglobulin superfamily.	BRIGHAM & WOMENS HOSP, DEPT RHEUMATOL & IMMUNOL, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital	ARM, JP (corresponding author), HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI023401, T32AI007306, R37AI022531, R01AI022531] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-07306, AI-22531, AI-23401] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; AVRAHAM S, 1989, P NATL ACAD SCI USA, V86, P3763, DOI 10.1073/pnas.86.10.3763; BADLEY JE, 1988, BIOTECHNIQUES, V6, P114; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; DAYHOFF MO, 1983, METHOD ENZYMOL, V91, P524; ELDER JH, 1982, P NATL ACAD SCI-BIOL, V79, P4540, DOI 10.1073/pnas.79.15.4540; GALLI SJ, 1982, J CELL BIOL, V95, P435, DOI 10.1083/jcb.95.2.435; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GELIEBTER J, 1986, P NATL ACAD SCI USA, V83, P3371, DOI 10.1073/pnas.83.10.3371; GURISH MF, 1989, CIBA F SYMP, V147, P36; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P227; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; KATZ HR, 1981, J RETICULOENDOTH SOC, V30, P439; KATZ HR, 1985, J IMMUNOL, V134, P2617; KATZ HR, 1989, J IMMUNOL, V142, P919; KATZ HR, 1990, J IMMUNOL, V145, P3412; KATZ HR, 1983, P NATL ACAD SCI-BIOL, V80, P5916, DOI 10.1073/pnas.80.19.5916; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; LEBLANC PA, 1982, J RETICULOENDOTH SOC, V32, P219; LEBLANC PA, 1984, CELL IMMUNOL, V83, P242, DOI 10.1016/0008-8749(84)90303-4; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; OTSU K, 1987, J EXP MED, V165, P615, DOI 10.1084/jem.165.3.615; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; RAZIN E, 1983, J EXP MED, V157, P189, DOI 10.1084/jem.157.1.189; RAZIN E, 1984, J IMMUNOL, V132, P1479; RAZIN E, 1982, J BIOL CHEM, V257, P7229; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; REYNOLDS DS, 1988, J BIOL CHEM, V263, P12783; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SERAFIN WE, 1987, J IMMUNOL, V139, P3771; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WILLIAMS AF, 1987, IMMUNOL TODAY, V8, P298, DOI 10.1016/0167-5699(87)90016-8; Wise R J, 1984, Mol Biol Med, V2, P307; WOODGETT JR, 1986, EUR J BIOCHEM, V161, P177, DOI 10.1111/j.1432-1033.1986.tb10139.x	41	75	79	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15966	15973						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714901				2022-12-27	WOS:A1991GB97700067
J	LEE, ME; TEMIZER, DH; CLIFFORD, JA; QUERTERMOUS, T				LEE, ME; TEMIZER, DH; CLIFFORD, JA; QUERTERMOUS, T			CLONING OF THE GATA-BINDING PROTEIN THAT REGULATES ENDOTHELIN-1 GENE-EXPRESSION IN ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROID TRANSCRIPTION FACTOR; DNA-BINDING; MAMMALIAN-CELLS; SEQUENCE; PEPTIDE; LOCALIZATION; PROMOTER; LINEAGES; CDNA	Previously, we have identified two regions (A and B) of the endothelin-1 promoter that are important for the expression of this gene in cultured vascular endothelial cells. The cis-acting sequence in one of these regions (Region A) includes the core binding motif GATA, raising the possibility that this region of DNA mediates binding of a member of the GATA-binding protein family. In this report, we describe the use of polymerase chain reaction in conjunction with cDNA cloning to characterize the GATA-binding protein expressed in endothelial cells. The nucleotide sequence of endothelial cell cDNA clones is highly homologous to that of the chicken GATA-2 (NF-E lb) gene, indicating that our clones encode the human GATA-2 gene transcript. By RNA blot analysis, this gene is expressed in cultured cell lines derived from a number of different tissues. Transactivation experiments utilizing human GATA-2 eukaryotic expression vectors indicate that the GATA-2 protein interacts with the endothelin-1 GATA sequence to increase transcription of reporter genes in both BAEC and HeLa cells. These data provide the first evidence for a non-erythroid target gene regulated by GATA-2 and indicate that GATA-2 may have a more broad role in transcriptional regulation than the erythroid-specific GATA-1 protein.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	LEE, ME (corresponding author), MASSACHUSETTS GEN HOSP,GEN MED SERV,CARDIAC UNIT,JACKSON 14,BOSTON,MA 02114, USA.			Quertermous, Thomas/0000-0002-7645-9067				BADR KF, 1989, J CLIN INVEST, V83, P336, DOI 10.1172/JCI113880; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; EVANS T, 1991, MOL CELL BIOL, V11, P843, DOI 10.1128/MCB.11.2.843; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FU YH, 1990, MOL CELL BIOL, V10, P1056, DOI 10.1128/MCB.10.3.1056; FUKUDA Y, 1988, BIOCHEM BIOPH RES CO, V155, P167, DOI 10.1016/S0006-291X(88)81064-7; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; GROBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745; HAWASAKI ES, 1990, PCR PROTOCOLS, P21; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HOMURA I, 1988, FEBS LETT, V238, P249; HOZAK M, 1986, CELL, V44, P283; HUDLA B, 1990, EMBO J, V9, P1355; LEE ME, 1990, J BIOL CHEM, V265, P10446; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORISHITA R, 1989, BIOCHEM BIOPH RES CO, V160, P628, DOI 10.1016/0006-291X(89)92479-0; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; RAKUGI H, 1988, BIOCHEM BIOPH RES CO, V155, P1244, DOI 10.1016/S0006-291X(88)81273-7; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; STOJILKOVIC SS, 1990, SCIENCE, V248, P1663, DOI 10.1126/science.2163546; TAKUWA N, 1989, J BIOL CHEM, V264, P7856; TRAINOR CD, 1990, NATURE, V343, P92, DOI 10.1038/343092a0; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; ZON LI, 1990, P NATL ACAD SCI USA, V87, P668, DOI 10.1073/pnas.87.2.668	32	229	239	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					16188	16192						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714909				2022-12-27	WOS:A1991GB97700098
J	LOPEZ, LC; YOUAKIM, A; EVANS, SC; SHUR, BD				LOPEZ, LC; YOUAKIM, A; EVANS, SC; SHUR, BD			EVIDENCE FOR A MOLECULAR DISTINCTION BETWEEN GOLGI AND CELL-SURFACE FORMS OF BETA-1,4-GALACTOSYLTRANSFERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE BETA-1,4-GALACTOSYLTRANSFERASE; MESSENGER-RNAS; GALACTOSYLTRANSFERASE; EXPRESSION; CDNA; TRANSLATION; GENE; BIOSYNTHESIS; POLYPEPTIDES; INVERTASE	Beta-1,4-Galactosyltransferase (GalTase) is present on the plasma membrane of many cell types in addition to its traditional location within the Golgi compartment. Recently, the GalTase gene has been shown to encode two proteins that are identical throughout their length except that one has an additional 13-amino acid extension in its amino-terminal cytoplasmic domain. We present evidence here suggesting that the longer GalTase protein, containing this unique 13-amino acid peptide, is preferentially targeted to the plasma membrane, and the shorter GalTase protein resides primarily within the Golgi compartment. S1 nuclease protection assays of RNA from a variety of cells and tissues show that the relative abundance of the short and long GalTase mRNAs correlates with GalTase-specific activities in the Golgi and plasma membranes, respectively. Furthermore, transfection of cDNAs encoding either the long or short GalTase protein into F9 embryonal carcinoma cells suggests that the long GalTase protein is preferentially expressed on the cell surface. These results propose a molecular distinction between the Golgi and cell surface forms of GalTase as well as a novel mechanism for targeting glycoproteins to the cell surface.	UNIV TEXAS,MD ANDERSON CANC CTR,DEPT BIOCHEM & MOLEC BIOL,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center					NICHD NIH HHS [HD22590] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD022590] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADRA CN, 1987, GENE, V60, P65, DOI 10.1016/0378-1119(87)90214-9; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; BELTZER JP, 1986, J BIOL CHEM, V261, P5160; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRETAUDIERE JP, 1984, METHOD ENZYMAT AN, V4, P75; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Ebner K. E., 1975, SUBUNIT ENZYMES BIOC, P137; ECKSTEIN DJ, 1989, J CELL BIOL, V108, P2507, DOI 10.1083/jcb.108.6.2507; ECKSTEIN DJ, 1990, J CELL BIOL, V111, P423; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HOLLIS GF, 1989, BIOCHEM BIOPH RES CO, V162, P1069, DOI 10.1016/0006-291X(89)90782-1; HUMPHREYSBEHER MG, 1987, J BIOL CHEM, V262, P11706; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; KUKOWSKALATALLO JF, 1990, GENE DEV, V4, P1288, DOI 10.1101/gad.4.8.1288; LOPEZ LC, 1989, MOL CELL BIOL, V9, P2370, DOI 10.1128/MCB.9.6.2370; MASIBAY AS, 1989, P NATL ACAD SCI USA, V86, P5733, DOI 10.1073/pnas.86.15.5733; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; NILSSON T, 1989, CELL, V58, P707, DOI 10.1016/0092-8674(89)90105-0; PERLMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P781, DOI 10.1073/pnas.79.3.781; ROSEMAN S, 1970, CHEM PHYS LIPIDS, V5, P270, DOI 10.1016/0009-3084(70)90024-1; ROTH S, 1973, Q REV BIOL, V48, P541, DOI 10.1086/407816; RUSSO RN, 1990, J BIOL CHEM, V265, P3324; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPER NL, 1985, J CELL BIOCHEM, V28, P229, DOI 10.1002/jcb.240280305; SHAPER NL, 1988, J BIOL CHEM, V263, P10420; SHUR BD, 1982, J BIOL CHEM, V257, P6871; SHUR BD, 1989, BIOCHIM BIOPHYS ACTA, V988, P389, DOI 10.1016/0304-4157(89)90012-9; STROUS GJ, 1988, BIOCHEM BIOPH RES CO, V151, P314, DOI 10.1016/0006-291X(88)90595-5; STULTS NL, 1989, J BIOL CHEM, V264, P19956; WANG X, 1990, Glycobiology, V1, P25, DOI 10.1093/glycob/1.1.25	33	99	101	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15984	15991						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714903				2022-12-27	WOS:A1991GB97700070
J	RODEWALD, HR; ARULANANDAM, ARN; KOYASU, S; REINHERZ, EL				RODEWALD, HR; ARULANANDAM, ARN; KOYASU, S; REINHERZ, EL			THE HIGH-AFFINITY FC-EPSILON RECEPTOR-GAMMA SUBUNIT (FC-EPSILON-RI-GAMMA) FACILITATES T-CELL RECEPTOR EXPRESSION AND ANTIGEN MAJOR HISTOCOMPATIBILITY COMPLEX-DRIVEN SIGNALING IN THE ABSENCE OF CD3-ZETA AND CD3-ETA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZETA-CHAIN; SURFACE EXPRESSION; MOLECULAR-CLONING; TRANSFECTED CELLS; IGE RECEPTOR; BETA-CHAIN; GENE; CHROMOSOME-11; ISOFORMS; FAMILY	The T cell receptor (TCR) is a molecular complex formed by at least seven transmembrane proteins: the antigen/major histocompatibility complex recognition unit (Ti-alpha-beta heterodimer) and the invariant CD3 chains (gamma, delta, epsilon, zeta, and eta). In addition to targeting partially assembled Ti-alpha-beta-CD3-gamma-delta-epsilon TCR complexes to the cell surface, CD3-zeta appears to be essential for interleukin-2 production after TCR stimulation with antigen/major histocompatibility complex. The gamma-chain of the high affinity Fc receptor for IgE (Fc-epsilon-RI-gamma) has significant structural homology to CD3-zeta and the related CD3-eta subunit. To identify the functional significance of sequence homologies between CD3-zeta and Fc-epsilon-RI-gamma in T cells, we have transfected a Fc-epsilon-RI-gamma cDNA into a T cell hybridoma lacking CD3-zeta and CD3-eta proteins. Herein we show that a Fc-epsilon-RI-gamma-gamma homodimer associates with TCR components to up-regulate TCR surface expression. A TCR composed of Ti-alpha-beta-CD3-gamma-delta-epsilon-Fc-epsilon-RI-gamma-gamma is sufficient to restore the coupling of TCR antigen recognition to the interleukin-2 induction pathway, demonstrating the functional significance of structural homology between the above receptor subunits. These results, in conjunction with the recent finding that CD3-zeta, CD3-eta, and Fc-epsilon-RI-gamma are coexpressed in certain T cells as subunits of an unusual TCR isoform, suggest that Fc-epsilon-RI-gamma is likely to play a role in T cell lineage function.	HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	RODEWALD, HR (corresponding author), HARVARD UNIV,SCH MED,DANA FARBER CANC INST,IMMUNOBIOL LAB,BOSTON,MA 02115, USA.		Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038	NIAID NIH HHS [AI21226, AI 19807] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019807, R01AI021226, R37AI019807, R56AI019807] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALCOVER A, 1990, J BIOL CHEM, V265, P4131; ARULANANDAM ARN, 1991, J EXP MED, V173, P859, DOI 10.1084/jem.173.4.859; ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BANIYASH M, 1989, J BIOL CHEM, V264, P13252; BAUER A, 1991, P NATL ACAD SCI USA, V88, P3842, DOI 10.1073/pnas.88.9.3842; BLANK U, 1989, NATURE, V337, P187, DOI 10.1038/337187a0; CLAYTON LK, 1990, J EXP MED, V172, P1243, DOI 10.1084/jem.172.4.1243; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; DAVIS MM, 1988, NATURE, V334, P95; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANK SJ, 1990, SCIENCE, V249, P174, DOI 10.1126/science.2371564; GILLIS S, 1978, J IMMUNOL, V120, P2027; GOLD DP, 1987, P NATL ACAD SCI USA, V84, P1664, DOI 10.1073/pnas.84.6.1664; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; HIBBS ML, 1989, SCIENCE, V246, P1608, DOI 10.1126/science.2531918; HOWARD FD, 1990, P NATL ACAD SCI USA, V87, P7015, DOI 10.1073/pnas.87.18.7015; HUPP K, 1989, J IMMUNOL, V143, P3787; JIN YJ, 1990, P NATL ACAD SCI USA, V87, P3319, DOI 10.1073/pnas.87.9.3319; JOHN S, 1989, EUR J IMMUNOL, V19, P335, DOI 10.1002/eji.1830190218; KINET JP, 1989, CELL, V57, P351, DOI 10.1016/0092-8674(89)90910-0; KRISSANSEN GW, 1987, IMMUNOGENETICS, V26, P258, DOI 10.1007/BF00346520; KUSTER H, 1990, J BIOL CHEM, V265, P6448; LAEMMLI UK, 1970, NATURE, V227, P3680; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MEUER SC, 1984, ANNU REV IMMUNOL, V2, P23, DOI 10.1146/annurev.immunol.2.1.23; MORLEY BJ, 1988, J EXP MED, V168, P1971, DOI 10.1084/jem.168.6.1971; ORLOFF DG, 1990, NATURE, V347, P189, DOI 10.1038/347189a0; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; RA C, 1989, J BIOL CHEM, V264, P15323; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Sambrook J, 1989, MOL CLONING LABORATO; SAMELSON LE, 1983, P NATL ACAD SCI-BIOL, V80, P6972, DOI 10.1073/pnas.80.22.6972; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; VANDENELSEN P, 1985, NATURE, V314, P542, DOI 10.1038/314542a0; VANDENELSEN P, 1985, P NATL ACAD SCI USA, V82, P2920, DOI 10.1073/pnas.82.9.2920; WEISSMAN AM, 1988, SCIENCE, V239, P1018, DOI 10.1126/science.3278377; WEISSMAN AM, 1989, EMBO J, V8, P3651, DOI 10.1002/j.1460-2075.1989.tb08539.x; YOUNG JDE, 1987, P NATL ACAD SCI USA, V84, P9175, DOI 10.1073/pnas.84.24.9175	40	48	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15974	15978						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714902				2022-12-27	WOS:A1991GB97700068
J	KUJUBU, DA; FLETCHER, BS; VARNUM, BC; LIM, RW; HERSCHMAN, HR				KUJUBU, DA; FLETCHER, BS; VARNUM, BC; LIM, RW; HERSCHMAN, HR			TIS10, A PHORBOL ESTER TUMOR PROMOTER-INDUCIBLE MESSENGER-RNA FROM SWISS 3T3 CELLS, ENCODES A NOVEL PROSTAGLANDIN SYNTHASE CYCLOOXYGENASE HOMOLOG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; TRANSFORMED MOUSE BALB-3T3; ENDOPEROXIDE SYNTHASE; HUMAN MYELOPEROXIDASE; THYROID PEROXIDASE; COMPLEMENTARY-DNA; ARACHIDONIC-ACID; GENE; SEQUENCE; EXPRESSION	TIS10 is a primary response gene whose cDNA was cloned as a result of its rapid, superinducible expression in Swiss 3T3 cells in response to 12-O-tetradecanoylphorbol-13-acetate. The 5'-untranslated region of the 3.9-kilobase TIS10 message contains only 124 nucleotides, whereas the 3'-untranslated region is almost 2 kilobases in length. Within this long 3' region, there are multiple repeats of the sequence ATTTA, a sequence often present in rapidly degraded mRNA species. Primer extension revealed that the TIS10 cDNA begins 16 base pairs downstream of the transcription start site for the TIS10 gene. The TIS10 cDNA encodes a predicted protein of 604 amino acids. A computer search identified striking similarities between the predicted TIS10 protein product and the murine, sheep, and human prostaglandin synthase/cyclooxygenase proteins. The TIS10 protein has many of the same conserved amino acids that are thought to be important for cyclooxygenase function. TIS10 mRNA is undetectable by Northern analysis in quiescent 3T3 cells. The TIS10 gene is rapidly and transiently induced by forskolin and serum, as well as by 12-O-tetradecanoylphorbol-13-acetate, in Swiss 3T3 cells. These agents elicit far more dramatic changes in TIS10 mRNA levels than in cyclooxygenase mRNA levels. The expression of the TIS10 gene appears to be highly cell type-restricted in cultured cell lines; of 12 cell lines tested under superinducing conditions, only the rodent embryonic Swiss 3T3 and Rat1 cell lines expressed TIS10 gene.	UNIV CALIF LOS ANGELES,SCH MED,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,BIOMED & ENVIRONM SCI LAB,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	KUJUBU, DA (corresponding author), UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024, USA.				NIGMS NIH HHS [GM24797, GMO 8042-08] Funding Source: Medline; PHS HHS [1K11 01815] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024797, T32GM008042] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ARENANDER AT, 1989, J NEUROSCI RES, V23, P247, DOI 10.1002/jnr.490230302; BANKER D, 1989, J CELL PHYSIOL, V139, P42, DOI 10.1002/jcp.1041390108; BUTLERGRALLA E, 1983, BIOCHEM BIOPH RES CO, V111, P194, DOI 10.1016/S0006-291X(83)80135-1; CHEN AC, 1989, P NATL ACAD SCI USA, V86, P1608, DOI 10.1073/pnas.86.5.1608; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; DEWITT DL, 1988, P NATL ACAD SCI USA, V85, P1412, DOI 10.1073/pnas.85.5.1412; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; HAN JW, 1990, P NATL ACAD SCI USA, V87, P3373, DOI 10.1073/pnas.87.9.3373; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; HERSCHMAN HR, 1991, IN PRESS CURRENT TOP; HERSCHMAN HR, 1988, GROWTH FACTORS TUMOR, V58, P295; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; HONG SCL, 1976, J BIOL CHEM, V251, P776; JOHNSON KR, 1987, NUCLEIC ACIDS RES, V15, P2013, DOI 10.1093/nar/15.5.2013; KIMURA S, 1987, P NATL ACAD SCI USA, V84, P5555, DOI 10.1073/pnas.84.16.5555; KIMURA S, 1988, PROTEINS, V3, P113, DOI 10.1002/prot.340030206; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KUJUBU DA, 1987, ONCOGENE, V1, P257; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LIM RW, 1987, ONCOGENE, V1, P263; LIM RW, 1989, MOL CELL BIOL, V9, P1790, DOI 10.1128/MCB.9.4.1790; LIN AH, 1989, J BIOL CHEM, V264, P17379; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MAIER JAM, 1990, J BIOL CHEM, V265, P10805; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MERLIE JP, 1988, J BIOL CHEM, V263, P3550; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MORISHITA K, 1987, J BIOL CHEM, V262, P3844; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; OHUCHI K, 1978, J BIOL CHEM, V253, P4783; Pace-Asciak CR, 1983, ENZYMES LIPID ENZYMO, VXVI, P543; PASH JM, 1988, FASEB J, V2, P2613, DOI 10.1096/fasebj.2.10.2968288; PONG SS, 1977, J BIOL CHEM, V252, P1408; RAZ A, 1989, P NATL ACAD SCI USA, V86, P1657, DOI 10.1073/pnas.86.5.1657; RAZ A, 1988, J BIOL CHEM, V263, P3022; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SAMBROOK J, 1989, MOL CLONING LABORATO; SCHREWE H, 1990, MOL CELL BIOL, V10, P2738, DOI 10.1128/MCB.10.6.2738; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TIPPETTS MT, 1989, MOL CELL BIOL, V8, P4570; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; VARNUM BC, 1989, ONCOGENE, V4, P119; VARNUM BC, 1989, MOL CELL BIOL, V9, P3580, DOI 10.1128/MCB.9.8.3580; VARNUM BC, 1989, ONCOGENE, V4, P1263; WONG WYL, 1989, MOL ENDOCRINOL, V3, P1714, DOI 10.1210/mend-3-11-1714; WRIGHT JJ, 1990, SCIENCE, V248, P588, DOI 10.1126/science.2110381; YAMAMOTO KR, 1976, ANNU REV BIOCHEM, V45, P721, DOI 10.1146/annurev.bi.45.070176.003445; YOKOYAMA C, 1988, FEBS LETT, V231, P347, DOI 10.1016/0014-5793(88)80847-0; YOKOYAMA C, 1989, BIOCHEM BIOPH RES CO, V165, P888, DOI 10.1016/S0006-291X(89)80049-X	55	1681	1730	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					12866	12872						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712772				2022-12-27	WOS:A1991FX13200014
J	TANAKA, T; PARRY, DAD; KLAUSKOVTUN, V; STEINERT, PM; STANLEY, JR				TANAKA, T; PARRY, DAD; KLAUSKOVTUN, V; STEINERT, PM; STANLEY, JR			COMPARISON OF MOLECULARLY CLONED BULLOUS PEMPHIGOID ANTIGEN TO DESMOPLAKIN-I CONFIRMS THAT THEY DEFINE A NEW FAMILY OF CELL-ADHESION JUNCTION PLAQUE PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL COILED COILS; SECONDARY-STRUCTURE; DESMOSOMAL PLAQUE; ALPHA-TROPOMYOSIN; AMINO-ACID; SEQUENCE; LOCALIZATION; CDNA; HEMIDESMOSOMES; ANTIBODY	Bullous pemphigoid is a subepidermal blistering disease in which patients have autoantibodies against the plaque of the hemidesmosome. Starting with a previously isolated 2-kilobase (kb) cDNA for bullous pemphigoid antigen (BPA), we used primer extension of keratinocyte mRNA to isolate overlapping cDNAs with a combined open reading frame of 6.3 kb, encoding most (243 kDa) of the BPA, but lacking the far amino terminus. Analysis of this amino acid sequence revealed a carboxyl-terminal domain containing two regions of 174 and 176 residues with high sequence identity. Most of the amino-terminal two-thirds of BPA is predicted to be in an alpha-helical conformation in which two chains would aggregate into a coiled-coil rod structure. BPA and desmoplakin I, a desmosome plaque protein, show remarkable sequence and structural homology. In its carboxyl-terminal domain, desmoplakin I also has 176 residue repeats with 40% sequence identity to those in BPA. The repeats in both molecules have a regular linear distribution of acidic and basic residues with a period of 9.5, the same as that found in the 1B segment of keratin filaments, suggesting a means of ionic interaction between keratin and these plaque proteins. Also, desmoplakin I, like BPA, is predicted to have a rod domain, which in both proteins has similar regular charge periodicities, suggesting a means of ionic self-aggregation. These findings extend those of Green et al. (Green, K. J., Parry, D. A. D., Steinert, P. S., Virata, L. A., Wagner, R. M., Angst, B. D., and Nilles, L. A. (1990) J. Biol. Chem. 265,2603-2612) which show that BPA and desmoplakin I represent the first members of a new family of adhesion junction plaque proteins.	NCI, DERMATOL BRANCH, BLDG 10, RM 12N238, BETHESDA, MD 20892 USA; NIAMSK, SKIN BIOL LAB, BETHESDA, MD 20892 USA; MASSEY UNIV, DEPT PHYS & BIOPHYS, PALMERSTON NORTH, NEW ZEALAND	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Massey University								AMAGAI M, 1990, J INVEST DERMATOL, V95, P252, DOI 10.1111/1523-1747.ep12484863; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; COHEN C, 1986, TRENDS BIOCHEM SCI, V11, P245, DOI 10.1016/0968-0004(86)90186-6; COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102; CONWAY JF, 1990, INT J BIOL MACROMOL, V12, P328, DOI 10.1016/0141-8130(90)90023-4; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; FRANKE WW, 1981, DIFFERENTIATION, V20, P17; FRASER RDB, 1976, 16TH P INT ORN C CAN, P443; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIBBS AJ, 1970, EUR J BIOCHEM, V16, P1, DOI 10.1111/j.1432-1033.1970.tb01046.x; GORBSKY G, 1981, J CELL BIOL, V90, P243, DOI 10.1083/jcb.90.1.243; GREEN KJ, 1990, J BIOL CHEM, V265, P2603; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; JONES JCR, 1986, CELL MOTIL CYTOSKEL, V6, P560, DOI 10.1002/cm.970060604; LABIB RS, 1986, J IMMUNOL, V136, P1231; Maniatis T., 1982, MOL CLONING; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MILLER K, 1987, EMBO J, V6, P885, DOI 10.1002/j.1460-2075.1987.tb04834.x; MUELLER H, 1983, J MOL BIOL, V163, P647, DOI 10.1016/0022-2836(83)90116-X; MUELLER S, 1989, J INVEST DERMATOL, V92, P33, DOI 10.1111/1523-1747.ep13070476; MUTASIM DF, 1985, J INVEST DERMATOL, V84, P47, DOI 10.1111/1523-1747.ep12274684; PARRY DAD, 1975, J MOL BIOL, V98, P519, DOI 10.1016/S0022-2836(75)80084-2; PARRY DAD, 1985, INT J BIOL MACROMOL, V7, P203, DOI 10.1016/0141-8130(85)90003-0; REGNIER M, 1985, J INVEST DERMATOL, V85, P187, DOI 10.1111/1523-1747.ep12276656; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; STANLEY JR, 1981, CELL, V24, P897, DOI 10.1016/0092-8674(81)90115-X; TANAKA T, 1990, J INVEST DERMATOL, V94, P617, DOI 10.1111/1523-1747.ep12876200; WESTGATE GE, 1985, J INVEST DERMATOL, V84, P218, DOI 10.1111/1523-1747.ep12265229; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	31	155	157	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12555	12559						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712022				2022-12-27	WOS:A1991FV18000071
J	BARACCHINI, E; BREMER, H				BARACCHINI, E; BREMER, H			CONTROL OF RIBOSOMAL-RNA SYNTHESIS IN ESCHERICHIA-COLI AT INCREASED RRN GENE DOSAGE - ROLE OF GUANOSINE TETRAPHOSPHATE AND RIBOSOME FEEDBACK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-RATE CONTROL; RNA-SYNTHESIS; RIBONUCLEIC-ACID; TRANSCRIPTION; STRINGENT; REPLICATION; BACTERIA; PROMOTER; STRAINS; PPGPP	The effects of extra, plasmid-borne rRNA genes on the synthesis rate of rRNA in Escherichia coli were examined by measuring the fraction of total RNA synthesis that is rRNA and tRNA (r(s)/r(t)), the cytoplasmic concentration of guanosine tetraphosphate (ppGpp), and the absolute rates of RNA and protein synthesis. Experiments were carried out in different growth media and with two different strains of E. coli, B/r and K-12. The results indicated: 1) increased rrn gene dosage from either intact or defective rrn genes reduced bacterial growth rates and ribosome activity (protein synthesis rate/average ribosome), and increased r(s)/r(t). 2) Extra intact, but not extra defective, plasmid-borne rrn genes caused the level of ppGpp to be increased in comparison to the pBR322-carrying control strain. 3) As a function of ppGpp, r(s)/r(t) was increased with either intact or defective rrn genes. 4) The rRNA synthesis rate/rrn gene was reduced in the presence of extra rrn genes; this reduction in gene activity was greater with intact than with defective rrn genes. An analysis of these results showed that they are consistent with the ppGpp hypothesis of rRNA control but not with a feedback effector role of translating ribosomes.	UNIV TEXAS,CELL BIOL PROGRAM,RICHARDSON,TX 75083; UNIV TEXAS,MOLEC BIOL PROGRAM,RICHARDSON,TX 75083; UNIV TEXAS,RICHARDSON,TX 75080	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Dallas								BARACCHINI E, 1988, J BIOL CHEM, V263, P2597; BARACCHINI E, 1987, ANAL BIOCHEM, V167, P245, DOI 10.1016/0003-2697(87)90160-6; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; BREMER H, 1977, J THEOR BIOL, V69, P645, DOI 10.1016/0022-5193(77)90373-3; Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527; BRUNSCHEDE H, 1977, J BACTERIOL, V129, P1020, DOI 10.1128/JB.129.2.1020-1033.1977; CHURCHWARD G, 1982, J BACTERIOL, V150, P572, DOI 10.1128/JB.150.2.572-581.1982; COLE JR, 1987, J MOL BIOL, V198, P383, DOI 10.1016/0022-2836(87)90288-9; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; CSONKA LN, 1979, GENETICS, V93, P321; DENNIS PP, 1972, J BIOL CHEM, V247, P204; DICKSON RR, 1989, J BACTERIOL, V171, P4862, DOI 10.1128/jb.171.9.4862-4870.1989; HELMSTETTER CE, 1967, J MOL BIOL, V24, P417, DOI 10.1016/0022-2836(67)90228-8; HERNANDEZ VJ, 1991, J BIOL CHEM, V266, P5991; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; JINKSROBERTSON S, 1983, CELL, V33, P865, DOI 10.1016/0092-8674(83)90029-6; KJELDGAARD NO, 1958, J GEN MICROBIOL, V19, P607, DOI 10.1099/00221287-19-3-607; LAZZARINI RA, 1971, J BIOL CHEM, V246, P4381; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; LITTLE R, 1983, J BACTERIOL, V154, P787, DOI 10.1128/JB.154.2.787-792.1983; LITTLE R, 1982, ANAL BIOCHEM, V126, P381, DOI 10.1016/0003-2697(82)90531-0; LITTLE R, 1984, J BACTERIOL, V159, P863, DOI 10.1128/JB.159.3.863-869.1984; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; RYALS J, 1982, J BACTERIOL, V151, P1425, DOI 10.1128/JB.151.3.1425-1432.1982; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SCHLEIF R, 1967, J MOL BIOL, V27, P41, DOI 10.1016/0022-2836(67)90350-6; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; VANOOYEN AJJ, 1975, NATURE, V254, P530, DOI 10.1038/254530a0; XIAO H, 1991, J BIOL CHEM, V266, P5980; ZACHARIAS M, 1989, EMBO J, V8, P3357, DOI 10.1002/j.1460-2075.1989.tb08498.x	33	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11753	11760						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711040				2022-12-27	WOS:A1991FT76200053
J	TOSTESON, MT; TOSI, PF; NICOLAU, C; TOSTESON, DC				TOSTESON, MT; TOSI, PF; NICOLAU, C; TOSTESON, DC			CD4+ LIPID BILAYERS - A MODEL FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 COAT PROTEIN-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note								gpl20, the coat glycoprotein of the human immunodeficiency virus type 1 (HIV1) binds to a molecule on the surface of a class of T-lymphocytes, CD4, which is also the receptor for major histocompatibility complex class Il (MHCII). To study the events that follow the interaction of gpl20 with CD4, we have incorporated CD4 into lipid bilayers and recorded the electrical changes which occur after the addition of gpI20. Interaction of gpl20 to CD4-containing bilayers induces multistate ion-permeable channels with a maximum conductance of 380-400 picosiemens. When CD4+ bilayers were preexposed to either MHCII or to OKT4A antibody, no channels were formed after the addition of gpl20. These results indicate that CD4+-containing bilayers bind gpl20, MHCII, and OKT4A, that binding of gpl20 produces ion-permeable channels, and that CD4+ bilayers can be used to assay for gp120 in the solution bathing the bilayer.	TEXAS A&M UNIV SYST,INST BIOSCI & TECHNOL,CELL BIOL SECT,COLLEGE STN,TX 77843	Texas A&M University System; Texas A&M University College Station	TOSTESON, MT (corresponding author), HARVARD UNIV,SCH MED,DEPT CELLULAR & MOLEC PHYSIOL,MEMBRANE TRANSPORT LAB,BOSTON,MA 02115, USA.							DREYER EB, 1990, SCIENCE, V248, P364, DOI 10.1126/science.2326646; EVANS LA, 1989, BIOCHIM BIOPHYS ACTA, V989, P237; HUSSEY RE, 1988, NATURE, V331, P78, DOI 10.1038/331078a0; KIEBEREMMONS T, 1989, BIOCHIM BIOPHYS ACTA, V989, P281; KORNFELD H, 1988, NATURE, V335, P445, DOI 10.1038/335445a0; LAMARRE D, 1989, SCIENCE, V245, P743, DOI 10.1126/science.2549633; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; ROSENSTEIN Y, 1990, J IMMUNOL, V144, P526; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; TOSTESON MT, 1989, P NATL ACAD SCI USA, V86, P707, DOI 10.1073/pnas.86.2.707; WEBB NR, 1989, P NATL ACAD SCI USA, V86, P7731, DOI 10.1073/pnas.86.20.7731	12	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11433	11435						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711033				2022-12-27	WOS:A1991FT76200008
J	EDER, PS; WALDER, JA				EDER, PS; WALDER, JA			RIBONUCLEASE-H FROM K562 HUMAN ERYTHROLEUKEMIA-CELLS - PURIFICATION, CHARACTERIZATION, AND SUBSTRATE-SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CALF THYMUS; RNASE-H; SEROLOGICAL ANALYSIS; DEFECTIVE-MUTANTS; DNA; REPLICATION; YEAST; CLEAVAGE; PROTEINS	The major ribonuclease H from K562 human erythroleukemia cells has been purified more than 4,000-fold. This RNase H, now termed RNase H1, is an endoribonuclease whose products contain 5'-phosphoryl and 3'-hydroxyl termini. The enzyme has a native molecular weight of 89,000 based on its sedimentation and diffusion coefficients. Human RNase H1 has an absolute requirement for a divalent cation. Maximal activity is obtained with either 10 mM Mg2+, 5 mM Co2+, or 0.5 mM Mn2+. The pH optimum is between 8.0 and 8.5 in the presence of 10 mM Mg2+. The isoelectric point is 6.4. RNase H1 lacks double-stranded and single-stranded RNase and DNase activities, and it will not hydrolyze the DNA moiety of an RNA.DNA heteroduplex. Unlike the Escherichia coli enzyme, which requires a heteroduplex that contains at least four consecutive ribonucleotides for activity, human RNase H1 can hydrolyze a DNA.RNA.DNA/DNA heteroduplex that contains a single ribonucleotide. Cleavage occurs at the 5' phosphodiester of this residue. This substrate specificity suggests that human RNase H1 could play a role in ribonucleotide excision from genomic DNA during replication.	UNIV IOWA,DEPT BIOCHEM,IOWA CITY,IA 52242; INTEGRATED DNA TECHNOL,CORALVILLE,IA 52241	University of Iowa					NHLBI NIH HHS [HL 33555] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033555] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERTS B, 1983, MOL BIOL CELL, P230; BERG P, 1963, S INFORMATIONAL MACR, P467; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSEN W, 1977, EUR J BIOCHEM, V74, P203, DOI 10.1111/j.1432-1033.1977.tb11382.x; BUSEN W, 1975, EUR J BIOCHEM, V52, P179, DOI 10.1111/j.1432-1033.1975.tb03985.x; BUSEN W, 1980, J BIOL CHEM, V255, P9434; CHERIATHUNDAM E, 1982, ARCH BIOCHEM BIOPHYS, V219, P110, DOI 10.1016/0003-9861(82)90139-4; Crouch R. J., 1982, NUCLEASES, P211; DEVLIN TM, 1986, TXB BIOCH, P492; DIFRANCESCO RA, 1985, J BIOL CHEM, V260, P4764; HOGREFE HH, 1990, J BIOL CHEM, V265, P5561; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; KANAYA S, 1984, P NATL ACAD SCI-BIOL, V81, P3447, DOI 10.1073/pnas.81.11.3447; KANAYA S, 1983, J BIOL CHEM, V258, P1276; KARWAN R, 1986, FEBS LETT, V206, P189, DOI 10.1016/0014-5793(86)80978-4; KARWAN R, 1983, BIOCHEMISTRY-US, V22, P5500, DOI 10.1021/bi00293a008; KELLER W, 1972, P NATL ACAD SCI USA, V69, P1560, DOI 10.1073/pnas.69.6.1560; KITAHARA N, 1982, J BIOCHEM, V92, P855, DOI 10.1093/oxfordjournals.jbchem.a133999; KOGOMA T, 1986, J BACTERIOL, V166, P361, DOI 10.1128/jb.166.2.361-363.1986; KRYNETSKAYA NF, 1986, NUCLEOS NUCLEOT, V5, P33, DOI 10.1080/07328318608081904; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; MASON WS, 1987, ADV VIRUS RES, V32, P35, DOI 10.1016/S0065-3527(08)60474-1; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NAITO S, 1984, P NATL ACAD SCI-BIOL, V81, P550, DOI 10.1073/pnas.81.2.550; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; ROEWEKAMP W, 1974, EUR J BIOCHEM, V43, P405, DOI 10.1111/j.1432-1033.1974.tb03426.x; SARNGADHARAN MG, 1975, J BIOL CHEM, V250, P365; SAWAI Y, 1983, BIOCHEM BIOPH RES CO, V110, P470, DOI 10.1016/0006-291X(83)91173-7; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; TANFORD C, 1961, PHYSICAL CHEM MACROM, P326; VANDESANDE JH, 1972, J BIOL CHEM, V247, P6140; VONWIRTH H, 1989, EUR J BIOCHEM, V184, P321, DOI 10.1111/j.1432-1033.1989.tb15022.x; WALDER RY, 1988, P NATL ACAD SCI USA, V85, P5011, DOI 10.1073/pnas.85.14.5011; WINTERSBERGER U, 1991, IN PRESS PHARM THER; WYERS F, 1976, EUR J BIOCHEM, V69, P377, DOI 10.1111/j.1432-1033.1976.tb10921.x	36	100	119	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6472	6479						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706718				2022-12-27	WOS:A1991FE37300071
J	ABBOTTS, J; JAJU, M; WILSON, SH				ABBOTTS, J; JAJU, M; WILSON, SH			THERMODYNAMICS OF A-G MISMATCH POLY(DG) SYNTHESIS BY HUMAN IMMUNODEFICIENCY VIRUS-1 REVERSE-TRANSCRIPTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; STEADY-STATE KINETICS; ESCHERICHIA-COLI; DEOXYRIBONUCLEIC-ACID; FIDELITY; MECHANISM; HIV-1; PROCESSIVITY; KLENOW; BETA	Human immunodeficiency virus 1 (HIV-1) reverse transcriptase has been found to conduct error-prone synthesis on DNA and RNA templates. We find here that tolerance of an A:G mispair with poly(rA) as template is particularly strong, such that extensive poly(dG) synthesis is conducted. This type of extensive misincorporation is not observed with several reference DNA polymerases. Surprisingly, HIV reverse transcriptase processivity and k(cat) for dGMP misincorporation and normal dTMP incorporation are about the same. However, the K(m) value for dGTP in poly(dG) synthesis is approximately 1000-fold higher than the K(m) for dTTP in poly(dT) synthesis. Comparison of thermodynamic parameters for dGMP misincorporation and normal dNMP incorporation indicates a lower energy of activation for dGMP misincorporation than for normal dNMP incorporation. Entropy of activation (DELTA-S*) for normal dTMP incorporation is positive (approximately 10 cal/kmol), whereas DELTA-S* for dGMP misincorporation is negative (-36 cal/kmol). Since differences in DELTA-S* are usually considered to reflect differences in solvation for the transition state complex, these results are consistent with the interpretation that the active site of HIV reverse transcriptase is flexible enough to misincorporate dGMP without the usual dispersion of water molecules.	NCI, BIOCHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Wilson, Samuel H/E-6644-2019	Wilson, Samuel H/0000-0002-1702-5293				BEBENEK K, 1989, J BIOL CHEM, V264, P16948; BOHN EW, 1974, CANCER RES, V34, P1977; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; COFFIN JM, 1986, CELL, V46, P1, DOI 10.1016/0092-8674(86)90851-2; DAS SK, 1977, J BIOL CHEM, V252, P8708; DETERA SD, 1982, J BIOL CHEM, V257, P9770; Dixon M., 1964, ENZYMES, V2nd; ELDEIRY WS, 1988, BIOCHEMISTRY-US, V27, P546, DOI 10.1021/bi00402a007; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1983, J MOL BIOL, V165, P655, DOI 10.1016/S0022-2836(83)80272-1; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; GARVEY N, 1990, Proceedings of the American Association for Cancer Research Annual Meeting, V31, P307; HILLEBRAND GG, 1984, NUCLEIC ACIDS RES, V12, P3155, DOI 10.1093/nar/12.7.3155; HILLEBRAND GG, 1985, J BIOL CHEM, V260, P3116; HUBER HE, 1989, J BIOL CHEM, V264, P4669; KEDAR PS, 1990, BIOCHEMISTRY-US, V29, P3603, DOI 10.1021/bi00467a003; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; LAI MD, 1988, BIOCHEMISTRY-US, V27, P1722, DOI 10.1021/bi00405a051; Laidler K J, 1979, Methods Enzymol, V63, P234; LOEB LA, 1982, ANNU REV BIOCHEM, V51, P429, DOI 10.1146/annurev.bi.51.070182.002241; MAJUMDAR C, 1988, J BIOL CHEM, V263, P15657; MATSUKAGE A, 1975, BIOCHEMISTRY-US, V14, P1006, DOI 10.1021/bi00676a020; Maxam A M, 1980, Methods Enzymol, V65, P499; McClure W R, 1980, Methods Enzymol, V64, P277; MCCLURE WR, 1975, J BIOL CHEM, V250, P4073; MIZRAHI V, 1985, BIOCHEMISTRY-US, V24, P4010, DOI 10.1021/bi00336a031; MIZUTANI S, 1976, BIOCHEMISTRY-US, V15, P1510, DOI 10.1021/bi00652a023; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; SAAG MS, 1988, NATURE, V334, P440, DOI 10.1038/334440a0; SCHRIER BK, 1973, ANAL BIOCHEM, V56, P196, DOI 10.1016/0003-2697(73)90184-X; STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205; TAKEUCHI Y, 1988, J VIROL, V62, P3900, DOI 10.1128/JVI.62.10.3900-3902.1988; TANABE K, 1979, BIOCHEMISTRY-US, V18, P3401, DOI 10.1021/bi00582a029; TINOCO I, 1978, PHYSICAL CHEM, pCH7; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; WANG TSF, 1980, BIOCHEMISTRY-US, V19, P1782, DOI 10.1021/bi00550a009; WILLIAMS KJ, 1990, J BIOL CHEM, V265, P18682	42	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3937	3943						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704895				2022-12-27	WOS:A1991EY68200087
J	YUI, Y; HATTORI, R; KOSUGA, K; EIZAWA, H; HIKI, K; OHKAWA, S; OHNISHI, K; TERAO, S; KAWAI, C				YUI, Y; HATTORI, R; KOSUGA, K; EIZAWA, H; HIKI, K; OHKAWA, S; OHNISHI, K; TERAO, S; KAWAI, C			CALMODULIN-INDEPENDENT NITRIC-OXIDE SYNTHASE FROM RAT POLYMORPHONUCLEAR NEUTROPHILS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							RELAXING FACTOR; SMOOTH-MUSCLE; L-ARGININE; GENERATION; COFACTOR	Recently, the purification of nitric oxide synthase (EC 1.14.23) from rat cerebellum has been reported, and the enzyme is a calmodulin-requiring enzyme (Bredt, D. S., and Snyder, S. H. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 682-685). In this paper, nitric oxide synthase has been purified to near homogeneity from the cytosol fraction of rat polymorphonuclear neutrophils. The purification procedure involves affinity chromatography with adenosine 2',5'-diphosphate-agarose and an anion exchange column, DEAE-Bio-Gel A. On polyacrylamide gel electrophoresis in sodium dodecyl sulfate, the enzyme migrated as a single protein band with M(r) = 150,000. The molecular weight was estimated to be 150,000 by gel filtration on a Superose 12 HR 10/30. The purified enzyme was unstable with a half-life of 3 h at pH 7.4 and 4-degrees-C. The enzyme activity required the presence of Ca2+, NADPH, FAD, and (6R)-5,6,7,8-tetrahydro-L-biopterin. Calmodulin antagonists (W5, W7, W13, and trifluoperazine dihydrochloride) did not inhibit the enzyme activity, and the addition of calmodulin was also ineffective for the increase in the enzyme activity. The neutrophil enzyme appears to be a calmodulin-independent type of nitric oxide synthase.	TAKEDA CHEM IND LTD,CHEM RES LABS,OSAKA 532,JAPAN	Takeda Chemical Industries	YUI, Y (corresponding author), KYOTO UNIV,FAC MED,DEPT INTERNAL MED,DIV 3,KYOTO 606,JAPAN.							BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; GROSS SS, 1990, BIOCHEM BIOPH RES CO, V170, P96, DOI 10.1016/0006-291X(90)91245-N; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; IGNARRO LJ, 1990, ANNU REV PHARMACOL, V30, P535, DOI 10.1146/annurev.pa.30.040190.002535; KOSUGA K, 1990, BIOCHEM BIOPH RES CO, V172, P705, DOI 10.1016/0006-291X(90)90731-2; KWON NS, 1989, J BIOL CHEM, V264, P20496; MARTELL AE, 1977, CRITICAL STABILITY C, P269; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; RIMELE TJ, 1988, J PHARMACOL EXP THER, V245, P102; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; YUI Y, 1989, BIOCHEM BIOPH RES CO, V164, P544, DOI 10.1016/0006-291X(89)91753-1	15	197	201	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3369	3371						3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704888				2022-12-27	WOS:A1991EY68200004
J	LESLEY, SA; BROW, MAD; BURGESS, RR				LESLEY, SA; BROW, MAD; BURGESS, RR			USE OF INVITRO PROTEIN-SYNTHESIS FROM POLYMERASE CHAIN REACTION-GENERATED TEMPLATES TO STUDY INTERACTION OF ESCHERICHIA-COLI TRANSCRIPTION FACTORS WITH CORE RNA-POLYMERASE AND FOR EPITOPE MAPPING OF MONOCLONAL-ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL SIGMA-FACTORS; NUCLEOTIDE-SEQUENCE; METABOLIC FUNCTIONS; GENE-PRODUCT; NTRA RPON; AMPLIFICATION; INVOLVEMENT; EXPRESSION; PROMOTERS; GLNA	The interaction of two Escherichia coli transcription factors (sigma-54 and sigma-32) with the core RNA polymerase was studied here. We examined the core binding ability of various fragments of these two transcription factors using a novel method for the in vitro synthesis of truncated proteins in a coupled transcription-translation (S-30) system. The method uses DNA templates generated by the polymerase chain reaction to direct synthesis of precisely truncated fragments of the encoded protein. Primers for the polymerase chain reaction contain transcription and translation signals so that the resulting product can be incubated in the S-30 directly. The synthesized proteins were used for mapping of both functional domains and epitopes of monoclonal antibodies to sigma-54 and sigma-32.	UNIV WISCONSIN,MCARDLE LAB CANC RES,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison				Burgess, Richard/0000-0001-9545-3165	NATIONAL CANCER INSTITUTE [P30CA007175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028575] Funding Source: NIH RePORTER; NCI NIH HHS [CA07175] Funding Source: Medline; NIGMS NIH HHS [GM28575] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARTZ SW, 1975, P NATL ACAD SCI USA, V72, P3453, DOI 10.1073/pnas.72.9.3453; BIEK DP, 1986, J BACTERIOL, V167, P594, DOI 10.1128/jb.167.2.594-603.1986; BIRKMANN A, 1987, MOL GEN GENET, V210, P535, DOI 10.1007/BF00327209; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; CHEN HZ, 1983, J BACTERIOL, V154, P650, DOI 10.1128/JB.154.2.650-655.1983; CHROBOCZEK J, 1985, EUR J BIOCHEM, V149, P565, DOI 10.1111/j.1432-1033.1985.tb08962.x; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; FUJITA N, 1987, MOL GEN GENET, V210, P5, DOI 10.1007/BF00337751; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; GROSS CA, 1979, P NATL ACAD SCI USA, V76, P5789, DOI 10.1073/pnas.76.11.5789; GROSSMAN AD, 1984, CELL, V38, P383, DOI 10.1016/0092-8674(84)90493-8; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HIRSCHMAN J, 1985, P NATL ACAD SCI USA, V82, P7525, DOI 10.1073/pnas.82.22.7525; HUNT TP, 1985, P NATL ACAD SCI USA, V82, P8453, DOI 10.1073/pnas.82.24.8453; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; JOVANOVICH S, 1983, THESIS U CALIFORNIA; KOHLER T, 1989, J BACTERIOL, V171, P4326; KUSTU S, 1986, REGULATION GENE EXPR, P139; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; LESLEY SA, 1989, THESIS U WISCONSIN M; LESLEY SA, 1987, J BIOL CHEM, V262, P5405; MACKOW ER, 1990, P NATL ACAD SCI USA, V87, P518, DOI 10.1073/pnas.87.2.518; MAGASANIK B, 1982, ANNU REV GENET, V16, P135, DOI 10.1146/annurev.ge.16.120182.001031; MERRICK M, 1987, MOL GEN GENET, V210, P323, DOI 10.1007/BF00325701; MERRICK MJ, 1985, NUCLEIC ACIDS RES, V13, P7607, DOI 10.1093/nar/13.21.7607; NINFA AJ, 1989, J BACTERIOL, V171, P383, DOI 10.1128/jb.171.1.383-391.1989; OLINS PO, 1988, GENE, V73, P227, DOI 10.1016/0378-1119(88)90329-0; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; POPHAM DL, 1989, THESIS U CALIFORNIA; RONSON CW, 1987, J BACTERIOL, V169, P2424, DOI 10.1128/jb.169.6.2424-2431.1987; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SARKAR G, 1989, SCIENCE, V244, P331, DOI 10.1126/science.2565599; STOFLET ES, 1988, SCIENCE, V239, P491, DOI 10.1126/science.3340835; STRAGIER P, 1985, FEBS LETT, V187, P11, DOI 10.1016/0014-5793(85)81203-5; STRAUS DB, 1987, NATURE, V329, P348, DOI 10.1038/329348a0; STRICKLAND MS, 1988, BIOCHEMISTRY-US, V27, P5755, DOI 10.1021/bi00415a054; TOWBIN H, 1979, P NATL ACAD SCI USA, V80, P1194; YANG HL, 1980, P NATL ACAD SCI-BIOL, V77, P7029, DOI 10.1073/pnas.77.12.7029; ZUBAY G, 1973, ANNU REV GENET, V7, P267, DOI 10.1146/annurev.ge.07.120173.001411	41	117	160	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2632	2638						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703532				2022-12-27	WOS:A1991EV51500093
J	PAGEL, JM; HATFIELD, GW				PAGEL, JM; HATFIELD, GW			INTEGRATION HOST FACTOR-MEDIATED EXPRESSION OF THE ILVGMEDA OPERON OF ESCHERICHIA-COLI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR IHF; NUCLEOTIDE-SEQUENCE; ATTENUATOR REGION; PHASE VARIATION; ILVGEDA OPERON; PLASMID PSC101; RNA-POLYMERASE; BINDING-SITES; LEADER REGION; PROTEIN	The structural genes of the ilvGMEDA operon of Escherichia coli are preceded by two promoters, ilvP(G)1 and ilvP(G)2, and a leader-attenuator region. Alkylation protection and hydroxyl radical footprinting techniques have been used to demonstrate that integration host factor (IHF) interacts with the nucleotides in a consensus-like DNA sequence located immediately downstream of the RNA polymerase transcriptional pause site in the leader-attenuator region. In the presence of purified IHF protein, in vitro transcriptional pausing of RNA polymerase at the leader-attenuator pause site is increased 2-fold and, concomitantly, a 2-fold increase in transcriptional termination at the attenuator is observed. Strains containing chromosomal transcriptional fusions of various segments of the ilvGMEDA promoter-attenuator region to the galK gene were used to show that IHF also decreases the in vivo basal level of transcriptional readthrough at the attenuator 2-fold. The binding of IHF to another target site in the ilvP(G)1 promoter region represses transcription from this promoter and causes a 4-fold stimulation of transcription initiation from the downstream ilvP(G)2 promoter 4-fold. This IHF-mediated control of transcription initiation from the upstream promoter region is independent of the regulation of transcription termination effected by IHF interaction at the attenuator site. Thus, IHF is capable of regulating the expression of the ilvGMEDA operon in opposing manners; it can activate transcription initiation of this operon from the ilvP(G)2 promoter 4-fold and increase the termination of this transcription at the downstream attenuator 2-fold.	UNIV CALIF IRVINE,CALIF COLL MED,DEPT MICROBIOL & MOLEC GENET,IRVINE,CA 92717	University of California System; University of California Irvine					NIGMS NIH HHS [GM24330, GM0714] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024330] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS CW, 1984, J BIOL CHEM, V259, P7399; ADAMS CW, 1985, J BIOL CHEM, V260, P8538; BACHMANN BJ, 1983, MICROBIOL REV, V47, P180, DOI 10.1128/MMBR.47.2.180-230.1983; BEAR SE, 1984, J VIROL, V52, P966, DOI 10.1128/JVI.52.3.966-972.1984; BIEK DP, 1989, J BACTERIOL, V171, P2066, DOI 10.1128/jb.171.4.2066-2074.1989; BIEK DP, 1989, J BACTERIOL, V171, P2056, DOI 10.1128/jb.171.4.2056-2065.1989; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN CL, 1989, J BIOL CHEM, V264, P20796; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P1293, DOI 10.1073/pnas.70.5.1293; COHEN SN, 1977, J BACTERIOL, V132, P734, DOI 10.1128/JB.132.2.734-737.1977; COLE JR, 1986, P NATL ACAD SCI USA, V83, P4129, DOI 10.1073/pnas.83.12.4129; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; DEMPSEY WB, 1987, J BACTERIOL, V169, P4391, DOI 10.1128/jb.169.9.4391-4392.1987; DORMAN CJ, 1987, J BACTERIOL, V169, P3840, DOI 10.1128/jb.169.8.3840-3843.1987; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; EISENSTEIN BI, 1987, P NATL ACAD SCI USA, V84, P6506, DOI 10.1073/pnas.84.18.6506; FILUTOWICZ M, 1988, NUCLEIC ACIDS RES, V16, P3829, DOI 10.1093/nar/16.9.3829; FLAMM EL, 1985, J MOL BIOL, V183, P117, DOI 10.1016/0022-2836(85)90206-2; FRIDEN P, 1984, J MOL BIOL, V172, P573, DOI 10.1016/S0022-2836(84)80024-8; FRIEDMAN DI, 1984, J BACTERIOL, V157, P484, DOI 10.1128/JB.157.2.484-489.1984; FRIEDMAN DI, 1988, CELL, V55, P545, DOI 10.1016/0092-8674(88)90213-9; GAMAS P, 1986, MOL GEN GENET, V204, P85, DOI 10.1007/BF00330192; GAMAS P, 1987, J MOL BIOL, V195, P261, DOI 10.1016/0022-2836(87)90648-6; GAMAS P, 1987, MOL GEN GENET, V207, P302, DOI 10.1007/BF00331593; GARDNER JF, 1982, J BIOL CHEM, V257, P3896; GILADI H, 1990, J MOL BIOL, V213, P109, DOI 10.1016/S0022-2836(05)80124-X; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; GUTTERSON NI, 1983, P NATL ACAD SCI-BIOL, V80, P4894, DOI 10.1073/pnas.80.16.4894; HATFIELD GW, 1987, TRANSLATIONAL REGULA, P447; HAUSER CA, 1985, J BIOL CHEM, V260, P1765; HAWLEY DK, 1980, P NATL ACAD SCI-BIOL, V77, P6381, DOI 10.1073/pnas.77.11.6381; HECK JD, 1988, J BIOL CHEM, V263, P857; HOYT MA, 1982, CELL, V31, P565, DOI 10.1016/0092-8674(82)90312-9; KRAUSE HM, 1986, J BIOL CHEM, V261, P3744; KUR J, 1989, GENE, V81, P1, DOI 10.1016/0378-1119(89)90331-4; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; LANDICK R, 1987, ESCHERICHIA COLI SAL, P1276; LAWTHER RP, 1987, NUCLEIC ACIDS RES, V15, P2137, DOI 10.1093/nar/15.5.2137; LAWTHER RP, 1980, P NATL ACAD SCI-BIOL, V77, P1862, DOI 10.1073/pnas.77.4.1862; MAHAJNA J, 1986, J BACTERIOL, V165, P167, DOI 10.1128/jb.165.1.167-174.1986; Maxam A M, 1980, Methods Enzymol, V65, P499; MCKENNEY K, 1982, GENE AMPLIFICATION A, P383; MECHULAM Y, 1987, J MOL BIOL, V197, P453, DOI 10.1016/0022-2836(87)90558-4; MILLER G, 1988, MOL GEN GENET, V212, P157, DOI 10.1007/BF00322459; MILLER HI, 1984, COLD SPRING HARB SYM, V49, P691, DOI 10.1101/SQB.1984.049.01.078; Miller J.H., 1972, EXPT MOL GENETICS; NARGANG FE, 1980, P NATL ACAD SCI-BIOL, V77, P1823, DOI 10.1073/pnas.77.4.1823; NASH HA, 1987, J BACTERIOL, V169, P4124, DOI 10.1128/jb.169.9.4124-4127.1987; ORTUNO MJ, 1987, NUCLEIC ACIDS RES, V15, P1521, DOI 10.1093/nar/15.4.1521; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PEREIRA RF, 1988, NUCLEIC ACIDS RES, V16, P5973, DOI 10.1093/nar/16.13.5973; PRENTKI P, 1987, EMBO J, V6, P2479, DOI 10.1002/j.1460-2075.1987.tb02529.x; ROBERTSON CA, 1988, J BIOL CHEM, V263, P3554; ROSE JK, 1972, J MOL BIOL, V69, P103, DOI 10.1016/0022-2836(72)90026-5; Sambrook J, 1989, MOL CLONING LABORATO; SIEBENLIST U, 1980, P NATL ACAD SCI-BIOL, V77, P122, DOI 10.1073/pnas.77.1.122; Silhavy T. J., 1984, EXPT GENE FUSIONS; SINGER M, 1989, MICROBIOL REV, V53, P1; STENZEL TT, 1987, CELL, V49, P709, DOI 10.1016/0092-8674(87)90547-2; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; THOMPSON RJ, 1988, NUCLEIC ACIDS RES, V16, P3313, DOI 10.1093/nar/16.8.3313; TSUI P, 1988, J MOL BIOL, V203, P817, DOI 10.1016/0022-2836(88)90212-4; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; TURNBOUGH CL, 1983, P NATL ACAD SCI-BIOL, V80, P368, DOI 10.1073/pnas.80.2.368; UMBARGER HE, 1987, ESCHERICHIA COLI SAL, P302; UMBARGER HE, 1983, AMINO ACIDS BIOSYNTH, P245; VANRIJN PA, 1988, NUCLEIC ACIDS RES, V16, P4595, DOI 10.1093/nar/16.10.4595; WEK RC, 1986, NUCLEIC ACIDS RES, V14, P2763, DOI 10.1093/nar/14.6.2763; WEK RC, 1988, J MOL BIOL, V203, P643, DOI 10.1016/0022-2836(88)90199-4; WINKELMAN JW, 1990, J BIOL CHEM, V265, P10055; WINKELMAN JW, 1990, THESIS U CALIFORNIA; XIN W, 1988, NUCLEIC ACIDS RES, V16, P2015, DOI 10.1093/nar/16.5.2015; YANG CC, 1989, CELL, V57, P869, DOI 10.1016/0092-8674(89)90801-5; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	75	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1985	1996						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703160				2022-12-27	WOS:A1991EU49700092
J	TAVARE, JM; CLACK, B; ELLIS, L				TAVARE, JM; CLACK, B; ELLIS, L			2-DIMENSIONAL PHOSPHOPEPTIDE ANALYSIS OF THE AUTOPHOSPHORYLATION CASCADE OF A SOLUBLE INSULIN-RECEPTOR TYROSINE KINASE - THE TYROSINES PHOSPHORYLATED ARE TYPICAL OF THOSE OBSERVED FOLLOWING PHOSPHORYLATION OF THE HETEROTETRAMERIC INSULIN-RECEPTOR IN INTACT-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; CYTOPLASMIC DOMAIN; INVITRO; SITES; IDENTIFICATION; PURIFICATION; ACTIVATION; EXPRESSION; PROTEINS; RESIDUES	A soluble derivative of the human insulin receptor cytoplasmic domain, as expressed in insect cells via a Baculovirus vector, is an active protein-tyrosine kinase. In the present study, we find that three forms of the enzyme (48, 43, and 38 kDa) can be partially purified by MonoQ fast protein liquid chromatography. Two-dimensional thin layer phosphopeptide mapping reveals that the 48-kDa enzyme undergoes a rapid autophosphorylation on the same tyrosines (residues 1158, 1162, 1163, 1328, and 1334) that have previously been shown to be major autophosphorylation sites on the native insulin receptor beta-subunit in intact cells. Furthermore, the 48- and 43-kDa proteins are phosphorylated on serine residues by a serine kinase(s) that copurifies through MonoQ fast protein liquid chromatography. Tyrosine autophosphorylation sites 1328 and 1334 and virtually all serine phosphorylation sites are absent in the 38-kDa kinase. Partial tryptic proteolysis of the 48-kDa kinase generates a core 38-kDa enzyme that undergoes autophosphorylation almost exclusively on tyrosines 1158, 1162, and 1163. Phosphorylation of these tyrosine residues occurs in a cascade manner analogous to that found in the intact insulin receptor beta-subunit.	UNIV TEXAS,SW MED CTR,SW MED SCH,HOWARD HUGHES MED INST,5323 HARRY HINES BLVD,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV BRISTOL,SCH MED SCI,DEPT BIOCHEM,BRISTOL BS8 1TD,AVON,ENGLAND	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Bristol								BALLOTTI R, 1987, BIOCHEM J, V241, P99, DOI 10.1042/bj2410099; COBB MH, 1989, J BIOL CHEM, V264, P18701; COOPER JA, 1983, METHOD ENZYMOL, V99, P387; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELLIS L, 1988, J VIROL, V62, P1634, DOI 10.1128/JVI.62.5.1634-1639.1988; HERRERA R, 1988, J BIOL CHEM, V263, P5560; HERRERA R, 1986, J BIOL CHEM, V261, P1980; KAHN CR, 1985, MOL BASIS INSULIN AC, P67; KLEIN HH, 1986, J BIOL CHEM, V261, P4691; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEWIS RE, 1990, J BIOL CHEM, V265, P947; PANG DT, 1985, J BIOL CHEM, V260, P7131; PERLMAN R, 1989, J BIOL CHEM, V264, P8946; ROSEN OM, 1983, P NATL ACAD SCI-BIOL, V80, P3237, DOI 10.1073/pnas.80.11.3237; SMITH DM, 1988, BIOCHEM J, V250, P509, DOI 10.1042/bj2500509; TAVARE JM, 1988, BIOCHEM J, V252, P607, DOI 10.1042/bj2520607; TAVARE JM, 1988, BIOCHEM J, V253, P783, DOI 10.1042/bj2530783; TORNQVIST HE, 1987, J BIOL CHEM, V262, P10212; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VILLALBA M, 1989, P NATL ACAD SCI USA, V86, P7848, DOI 10.1073/pnas.86.20.7848; WHITE MF, 1988, J BIOL CHEM, V263, P2969; WHITE MF, 1985, J BIOL CHEM, V260, P9470; YU YT, 1984, J BIOL CHEM, V259, P5277; YU YT, 1986, J BIOL CHEM, V261, P4715; ZICK Y, 1989, CRIT REV BIOCHEM MOL, V24, P217, DOI 10.3109/10409238909082554	26	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1390	1395						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703148				2022-12-27	WOS:A1991EU49700009
J	DONAHUE, JP; TURNBOUGH, CL				DONAHUE, JP; TURNBOUGH, CL			CHARACTERIZATION OF TRANSCRIPTIONAL INITIATION FROM PROMOTERS P1 AND P2 OF THE PYRBI OPERON OF ESCHERICHIA-COLI K12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294	University of Alabama System; University of Alabama Birmingham					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029466] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29466] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALPER MD, 1978, J BACTERIOL, V133, P149, DOI 10.1128/JB.133.1.149-157.1978; CASEHEL M, 1987, ESCHERICHIA COLI SAL, V2, P1410; CHAMBERLIN MJ, 1974, ANNU REV BIOCHEM, V43, P721, DOI 10.1146/annurev.bi.43.070174.003445; CLEMMESEN K, 1985, MOL GEN GENET, V201, P247, DOI 10.1007/BF00425666; CSONKA LN, 1981, J BACTERIOL, V145, P299, DOI 10.1128/JB.145.1.299-305.1981; EDLIN G, 1968, J MOL BIOL, V37, P257, DOI 10.1016/0022-2836(68)90266-0; FISHER R, 1983, J BIOL CHEM, V258, P9208; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; HAMMING J, 1980, NUCLEIC ACIDS RES, V8, P3947, DOI 10.1093/nar/8.17.3947; JENSEN KF, 1988, EUR J BIOCHEM, V175, P587, DOI 10.1111/j.1432-1033.1988.tb14232.x; JENSEN KF, 1986, J BACTERIOL, V166, P857, DOI 10.1128/jb.166.3.857-865.1986; KAJITANI M, 1984, J BIOL CHEM, V259, P1951; KUPPER H, 1975, P NATL ACAD SCI USA, V72, P4754, DOI 10.1073/pnas.72.12.4754; LEE F, 1977, P NATL ACAD SCI USA, V74, P4365, DOI 10.1073/pnas.74.10.4365; LEVIN HL, 1985, P NATL ACAD SCI USA, V82, P4643, DOI 10.1073/pnas.82.14.4643; LEVIN HL, 1989, J BIOL CHEM, V264, P14638; LIU CG, 1989, J BACTERIOL, V171, P3337, DOI 10.1128/jb.171.6.3337-3342.1989; LUSE DS, 1981, NUCLEIC ACIDS RES, V9, P4339, DOI 10.1093/nar/9.17.4339; Maxam A M, 1980, Methods Enzymol, V65, P499; MIZUSHIMASUGANO J, 1983, MOL GEN GENET, V189, P185, DOI 10.1007/BF00337802; NAVRE M, 1983, P NATL ACAD SCI-BIOL, V80, P1207, DOI 10.1073/pnas.80.5.1207; OOSTRA BA, 1977, MOL GEN GENET, V152, P1, DOI 10.1007/BF00264932; ROLAND KL, 1988, P NATL ACAD SCI USA, V85, P7149, DOI 10.1073/pnas.85.19.7149; ROLAND KL, 1985, J BACTERIOL, V163, P991, DOI 10.1128/JB.163.3.991-999.1985; ROOF WD, 1982, MOL GEN GENET, V187, P391, DOI 10.1007/BF00332617; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; TRAVERS A, 1976, MOL GEN GENET, V147, P225, DOI 10.1007/BF00267575; TRAVERS A, 1974, CELL, V3, P97, DOI 10.1016/0092-8674(74)90112-3; TRAVERS AA, 1983, CELL, V35, P265, DOI 10.1016/0092-8674(83)90229-5; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; TURNBOUGH CL, 1983, J BACTERIOL, V153, P998, DOI 10.1128/JB.153.2.998-1007.1983; TURNBOUGH CL, 1983, P NATL ACAD SCI-BIOL, V80, P368, DOI 10.1073/pnas.80.2.368; TURNBOUGH CL, 1987, J BIOL CHEM, V262, P10239; VALENTINHANSEN P, 1982, EMBO J, V1, P317, DOI 10.1002/j.1460-2075.1982.tb01167.x; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	36	26	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19091	19099						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699940				2022-12-27	WOS:A1990EF73900065
J	ELENIUS, K; SALMIVIRTA, M; INKI, P; MALI, M; JALKANEN, M				ELENIUS, K; SALMIVIRTA, M; INKI, P; MALI, M; JALKANEN, M			BINDING OF HUMAN SYNDECAN TO EXTRACELLULAR-MATRIX PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TURKU, DEPT MED BIOCHEM, SF-20520 TURKU 52, FINLAND	University of Turku			Elenius, Klaus/AAI-7594-2021	Elenius, Klaus/0000-0001-5700-0827				BALE MD, 1989, BLOOD, V74, P2698; BERNFIELD M, 1990, PHILOS T R SOC B, V327, P171, DOI 10.1098/rstb.1990.0052; BISWAS C, 1988, J CELL PHYSIOL, V136, P147, DOI 10.1002/jcp.1041360119; BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143; CAREY DJ, 1989, J CELL BIOL, V108, P1891, DOI 10.1083/jcb.108.5.1891; CHARONIS AS, 1988, J CELL BIOL, V107, P1253, DOI 10.1083/jcb.107.3.1253; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVID G, 1979, P NATL ACAD SCI USA, V76, P786, DOI 10.1073/pnas.76.2.786; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; Gallagher JT, 1989, CURR OPIN CELL BIOL, V1, P1201, DOI 10.1016/S0955-0674(89)80072-9; GOWDA DC, 1986, J BIOL CHEM, V261, P4926; HAYASHI K, 1987, J HISTOCHEM CYTOCHEM, V35, P1079, DOI 10.1177/35.10.2957423; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HYNES RO, 1989, J CELL BIOL, V109, P409, DOI 10.1083/jcb.109.1.409; ISHIHARA M, 1987, J BIOL CHEM, V262, P4708; JALKANEN M, 1988, J CELL BIOL, V106, P953, DOI 10.1083/jcb.106.3.953; JALKANEN M, 1987, J CELL BIOL, V105, P3087, DOI 10.1083/jcb.105.6.3087; JALKANEN M, 1985, J CELL BIOL, V101, P976, DOI 10.1083/jcb.101.3.976; JALKANEN M, 1989, J CELL BIOL, V109, P320; KITAGAWA T, 1976, J BIOCHEM-TOKYO, V79, P233, DOI 10.1093/oxfordjournals.jbchem.a131053; KJELLEN L, 1980, J BIOL CHEM, V255, P407; KODA JE, 1985, J BIOL CHEM, V260, P8157; MALI M, 1990, J BIOL CHEM, V265, P6884; MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046; RAPRAEGER A, 1986, J CELL BIOL, V103, P2683, DOI 10.1083/jcb.103.6.2683; RAPRAEGER A, 1985, J BIOL CHEM, V260, P4103; RAPRAEGER AC, 1983, J BIOL CHEM, V258, P3632; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SANDERSON RD, 1988, P NATL ACAD SCI USA, V85, P9562, DOI 10.1073/pnas.85.24.9562; SAUNDERS S, 1988, J CELL BIOL, V106, P423, DOI 10.1083/jcb.106.2.423; SAUNDERS S, 1989, J CELL BIOL, V108, P1547, DOI 10.1083/jcb.108.4.1547; SAUNDERS S, 1989, J CELL BIOL, V109, P5; SCOTT JE, 1988, BIOCHEM J, V252, P313, DOI 10.1042/bj2520313; STAHLI C, 1983, METHOD ENZYMOL, V92, P242; SUN XJ, 1989, J BIOL CHEM, V264, P11288; SUTHERLAND AE, 1989, J CELL BIOL, V109, P193; THESLEFF I, 1988, DEV BIOL, V129, P565, DOI 10.1016/0012-1606(88)90401-0; VAINIO S, 1989, DEV BIOL, V134, P382, DOI 10.1016/0012-1606(89)90110-3; WEITZHANDLER M, 1988, J BIOL CHEM, V263, P6949; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	45	130	135	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17837	17843						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698781				2022-12-27	WOS:A1990EC76600073
J	PFAFFLE, P; JACKSON, V				PFAFFLE, P; JACKSON, V			STUDIES ON RATES OF NUCLEOSOME FORMATION WITH DNA UNDER STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											PFAFFLE, P (corresponding author), MED COLL WISCONSIN,DEPT BIOCHEM,MILWAUKEE,WI 53226, USA.				PHS HHS [35829] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; BLASQUEZ V, 1986, J MOL BIOL, V191, P97, DOI 10.1016/0022-2836(86)90425-0; CAMERINIOTERO RD, 1976, CELL, V8, P333, DOI 10.1016/0092-8674(76)90145-8; CAMERINIOTERO RD, 1977, NUCLEIC ACIDS RES, V4, P1159, DOI 10.1093/nar/4.5.1159-a; CAMPBELL JL, 1986, ANNU REV BIOCHEM, V55, P733, DOI 10.1146/annurev.bi.55.070186.003505; CLARKE MF, 1985, J BIOL CHEM, V260, P2394; COTTEN M, 1987, EMBO J, V6, P3945, DOI 10.1002/j.1460-2075.1987.tb02736.x; COTTEN M, 1985, NUCLEIC ACIDS RES, V13, P401, DOI 10.1093/nar/13.2.401; DABAN JR, 1982, J MOL BIOL, V156, P771, DOI 10.1016/0022-2836(82)90141-3; DELANGE RJ, 1971, ANNU REV BIOCHEM, V40, P279, DOI 10.1146/annurev.bi.40.070171.001431; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; DREW HR, 1985, J MOL BIOL, V186, P773, DOI 10.1016/0022-2836(85)90396-1; EARNSHAW WC, 1980, CELL, V21, P373, DOI 10.1016/0092-8674(80)90474-2; GARNER MM, 1987, P NATL ACAD SCI USA, V84, P2620, DOI 10.1073/pnas.84.9.2620; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; GERMOND JE, 1976, NUCLEIC ACIDS RES, V3, P3173, DOI 10.1093/nar/3.11.3173; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HOVATTER KR, 1987, P NATL ACAD SCI USA, V84, P1162, DOI 10.1073/pnas.84.5.1162; ISENBERG I, 1979, ANN REV BIOCH, V49, P1115; JACKSON V, 1990, BIOCHEMISTRY-US, V29, P719, DOI 10.1021/bi00455a019; JORCANO JL, 1979, BIOCHEMISTRY-US, V18, P768, DOI 10.1021/bi00572a005; KLEINSCHMIDT J, 1986, EMBO J, V5, P3547, DOI 10.1002/j.1460-2075.1986.tb04681.x; KLEINSCHMIDT JA, 1985, J BIOL CHEM, V260, P1166; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; LIU LF, 1981, P NATL ACAD SCI-BIOL, V78, P3487, DOI 10.1073/pnas.78.6.3487; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; LOSA R, 1987, CELL, V50, P801, DOI 10.1016/0092-8674(87)90338-2; Maniatis T., 1982, MOL CLONING; MANNING GS, 1989, J BIOMOL STRUCT DYN, V6, P877, DOI 10.1080/07391102.1989.10506519; MANNING GS, 1985, CELL BIOPHYS, V7, P57, DOI 10.1007/BF02788639; MCGHEE JD, 1982, J MOL BIOL, V158, P685, DOI 10.1016/0022-2836(82)90254-6; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; OUDET P, 1975, CELL, V4, P281, DOI 10.1016/0092-8674(75)90149-X; PFAFFLE P, 1990, J BIOL CHEM, V265, P16830; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; STEIN A, 1985, BIOCHEMISTRY-US, V24, P1783, DOI 10.1021/bi00328a032; STEIN A, 1979, J MOL BIOL, V130, P103, DOI 10.1016/0022-2836(79)90421-2; STEIN A, 1980, NUCLEIC ACIDS RES, V8, P4803, DOI 10.1093/nar/8.20.4803; STEIN A, 1979, P NATL ACAD SCI USA, V76, P5000, DOI 10.1073/pnas.76.10.5000; STEIN A, 1977, P NATL ACAD SCI USA, V74, P2780, DOI 10.1073/pnas.74.7.2780; STILLMAN B, 1986, CELL, V45, P555, DOI 10.1016/0092-8674(86)90287-4; TAN RKZ, 1989, J MOL BIOL, V205, P573, DOI 10.1016/0022-2836(89)90227-1; TATCHELL K, 1977, BIOCHEMISTRY-US, V16, P5295, DOI 10.1021/bi00643a021; WASYLYK B, 1979, NUCLEIC ACIDS RES, V7, P705, DOI 10.1093/nar/7.3.705; WATSON DK, 1982, BIOCHEMISTRY-US, V21, P248, DOI 10.1021/bi00531a008; WHITLOCK JP, 1978, J BIOL CHEM, V253, P3857; WRAY W, 1981, ANAL BIOCHEM, V118, P197, DOI 10.1016/0003-2697(81)90179-2; WU HY, 1988, CELL, V53, P433, DOI 10.1016/0092-8674(88)90163-8; YAGER TD, 1989, BIOCHEMISTRY-US, V28, P2271, DOI 10.1021/bi00431a045; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2	53	50	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					16821	16829						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1698768				2022-12-27	WOS:A1990EA85700023
J	REHNMARK, S; NECHAD, M; HERRON, D; CANNON, B; NEDERGAARD, J				REHNMARK, S; NECHAD, M; HERRON, D; CANNON, B; NEDERGAARD, J			ALPHA-ADRENERGIC AND BETA-ADRENERGIC INDUCTION OF THE EXPRESSION OF THE UNCOUPLING PROTEIN THERMOGENIN IN BROWN ADIPOCYTES DIFFERENTIATED IN CULTURE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV STOCKHOLM,WENNER GREN INST,S-10691 STOCKHOLM,SWEDEN; UNIV PARIS 06,PHYSIOL COMPAREE LAB,CNRS,UA 307,F-75252 PARIS,FRANCE; UNIV STOCKHOLM,ARRHENIUS LABS F3,S-10691 STOCKHOLM,SWEDEN	Stockholm University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Stockholm University			Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Cannon, Barbara/B-3089-2016	Cannon, Barbara/0000-0001-6594-2363; Nedergaard, Jan/0000-0003-2070-1587; Herron, David/0000-0001-8750-3150				ARCH JRS, 1989, P NUTR SOC, V48, P215, DOI 10.1079/PNS19890032; ARCH JRS, 1984, NATURE, V309, P163, DOI 10.1038/309163a0; BIANCO AC, 1987, J CLIN INVEST, V79, P295, DOI 10.1172/JCI112798; BIANCO AC, 1988, J BIOL CHEM, V263, P18168; BOUILLAUD F, 1984, J BIOL CHEM, V259, P1583; BURGI U, 1986, AM J PHYSIOL, V251, pE503, DOI 10.1152/ajpendo.1986.251.5.E503; CANNON B, 1985, ESSAYS BIOCHEM, V20, P110; CIGOLINI M, 1986, J ANAT, V145, P207; CONNOLLY E, 1986, J BIOL CHEM, V261, P4377; CUNNINGHAM SA, 1987, BIOCHEM J, V245, P485, DOI 10.1042/bj2450485; CZECH MP, 1974, J BIOL CHEM, V249, P5421; FOREST C, 1987, EXP CELL RES, V168, P218, DOI 10.1016/0014-4827(87)90430-7; FOREST C, 1987, EXP CELL RES, V168, P233, DOI 10.1016/0014-4827(87)90431-9; FOSTER DO, 1984, THERMAL PHYSL, P201; FREEMAN KB, 1989, BIOCHEM CELL BIOL, V67, P147, DOI 10.1139/o89-022; GRANNEMAN JG, 1988, J PHARMACOL EXP THER, V245, P1075; GRECOPEROTTO R, 1987, BIOCHEM J, V247, P63, DOI 10.1042/bj2470063; HEMON P, 1976, BIOL NEONATE, V28, P241, DOI 10.1159/000240823; HERRON D, 1989, AM J PHYSIOL, V257, pC920, DOI 10.1152/ajpcell.1989.257.5.C920; HOUSTEK J, 1988, BIOCHIM BIOPHYS ACTA, V935, P19, DOI 10.1016/0005-2728(88)90103-X; HOUSTEK J, 1989, IN PRESS BIOCH BIOPH; JACOBSSON A, 1987, FEBS LETT, V224, P353, DOI 10.1016/0014-5793(87)80483-0; JACOBSSON A, 1986, BIOSCIENCE REP, V6, P621, DOI 10.1007/BF01114756; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; KENAKIN TP, 1984, BRIT J PHARMACOL, V81, P131, DOI 10.1111/j.1476-5381.1984.tb10753.x; KUUSELA P, 1986, LIFE SCI, V38, P589, DOI 10.1016/0024-3205(86)90052-4; LANDS AM, 1967, NATURE, V214, P597, DOI 10.1038/214597a0; LEVIN BE, 1986, J PHARMACOL EXP THER, V236, P681; MA SWY, 1984, CAN J PHYSIOL PHARM, V62, P943, DOI 10.1139/y84-158; MASSINGHAM R, 1979, CLIN SCI          S5, V57, P185; MOHELL N, 1987, AM J PHYSIOL, V253, pC301, DOI 10.1152/ajpcell.1987.253.2.C301; MOHELL N, 1989, BIOCHEM J, V261, P401, DOI 10.1042/bj2610401; MOHELL N, 1983, EUR J PHARMACOL, V93, P183, DOI 10.1016/0014-2999(83)90136-X; MOHELL N, 1989, COMP BIOCH PHYSL C, V94; NECHAD M, 1983, BIOL CELL, V48, P167; NECHAD M, 1987, AM J PHYSIOL, V253, pC889, DOI 10.1152/ajpcell.1987.253.6.C889; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; NECHAD M, 1983, EXP CELL RES, V149, P105, DOI 10.1016/0014-4827(83)90384-1; NEDERGAARD J, 1979, EUR J BIOCHEM, V95, P139, DOI 10.1111/j.1432-1033.1979.tb12948.x; Nedergaard J., 1986, BROWN ADIPOSE TISSUE, P152; OBREGON MJ, 1989, BIOCHEM J, V259, P341, DOI 10.1042/bj2590341; OBREGON MJ, 1987, BIOCHEM BIOPH RES CO, V148, P9, DOI 10.1016/0006-291X(87)91069-2; PORRAS A, 1989, BIOCHEM BIOPH RES CO, V163, P541, DOI 10.1016/0006-291X(89)92171-2; RAASMAJA A, 1989, ENDOCRINOLOGY, V125, P2502, DOI 10.1210/endo-125-5-2502; REHNMARK S, 1989, EXP CELL RES, V182, P75, DOI 10.1016/0014-4827(89)90280-2; RICQUIER D, 1984, FEBS LETT, V178, P240, DOI 10.1016/0014-5793(84)80608-0; RICQUIER D, 1986, J BIOL CHEM, V261, P13905; RICQUIER D, 1986, BROWN ADIPOSE TISSUE, P86; RIDLEY RG, 1986, BIOSCIENCE REP, V6, P87, DOI 10.1007/BF01145183; ROTHWELL NJ, 1985, AM J PHYSIOL, V248, pE397, DOI 10.1152/ajpendo.1985.248.4.E397; SEYDOUX J, 1984, FEBS LETT, V166, P141, DOI 10.1016/0014-5793(84)80060-5; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; SUGIHARA H, 1983, EXP CLIN ENDOCRINOL, V82, P309, DOI 10.1055/s-0029-1210291; SUNDIN U, 1981, BIOL NEONATE, V39, P141; SUNDIN U, 1980, COMP BIOCHEM PHYS B, V65, P463, DOI 10.1016/0305-0491(80)90298-9; SVOBODA P, 1979, EUR J BIOCHEM, V102, P203, DOI 10.1111/j.1432-1033.1979.tb06281.x; TAN S, 1983, INT J OBESITY, V7, P409	57	191	201	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16464	16471						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697859				2022-12-27	WOS:A1990DZ95000065
J	FUKUNAGA, R; ISHIZAKAIKEDA, E; NAGATA, S				FUKUNAGA, R; ISHIZAKAIKEDA, E; NAGATA, S			PURIFICATION AND CHARACTERIZATION OF THE RECEPTOR FOR MURINE GRANULOCYTE COLONY-STIMULATING FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											FUKUNAGA, R (corresponding author), OSAKA BIOSCI INST, 6-2-4 FURUEDAI, SUITA, OSAKA 565, JAPAN.		Nagata, Shigekazu/AAG-3203-2019; Fukunaga, Rikiro/CAG-2891-2022	Nagata, Shigekazu/0000-0001-9758-8426; 				AGUET M, 1987, J EXP MED, V165, P988, DOI 10.1084/jem.165.4.988; BEGLEY CG, 1987, LEUKEMIA, V1, P1; BERDEL WE, 1989, BLOOD, V73, P80; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; BUSSOLINO F, 1989, NATURE, V337, P471, DOI 10.1038/337471a0; CALVO JC, 1983, BIOCHEM J, V212, P259, DOI 10.1042/bj2120259; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUKUNAGA R, 1984, P NATL ACAD SCI-BIOL, V81, P5086, DOI 10.1073/pnas.81.16.5086; FUKUNAGA R, 1990, CELL, V61, P341, DOI 10.1016/0092-8674(90)90814-U; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; JACOBS S, 1985, METHOD ENZYMOL, V109, P399; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUDA S, 1989, BLOOD, V74, P2343; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MITANI M, 1986, J BIOL CHEM, V261, P1309; NAGATA S, 1986, EMBO J, V5, P575, DOI 10.1002/j.1460-2075.1986.tb04249.x; NAGATA S, 1986, NATURE, V319, P415, DOI 10.1038/319415a0; NAGATA S, 1990, HDB EXPT PHARM, P699; NECESSARY PC, 1984, J BIOL CHEM, V259, P6942; NICOLA NA, 1985, NATURE, V314, P625, DOI 10.1038/314625a0; NICOLA NA, 1983, J BIOL CHEM, V258, P9017; NICOLA NA, 1986, J BIOL CHEM, V261, P2384; NICOLA NA, 1985, J CELL PHYSIOL, V124, P313, DOI 10.1002/jcp.1041240222; NICOLA NA, 1986, J CELL PHYSIOL, V128, P501, DOI 10.1002/jcp.1041280320; NICOLA NA, 1989, ANNU REV BIOCHEM, V58, P45; NMORSTYN G, 1989, TRENDS PHARMSCI, V10, P154; NOMURA H, 1986, EMBO J, V5, P871, DOI 10.1002/j.1460-2075.1986.tb04297.x; OCHS D, 1983, ANAL BIOCHEM, V135, P470, DOI 10.1016/0003-2697(83)90714-5; OHEDA M, 1988, J BIOCHEM-TOKYO, V103, P544, DOI 10.1093/oxfordjournals.jbchem.a122305; PARK LS, 1989, BLOOD, V74, P56; SANTOLI D, 1987, J IMMUNOL, V139, P3348; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; TSUCHIYA M, 1986, P NATL ACAD SCI USA, V83, P7633, DOI 10.1073/pnas.83.20.7633; TSUCHIYA M, 1987, EMBO J, V6, P611, DOI 10.1002/j.1460-2075.1987.tb04798.x; URDAL DL, 1988, J BIOL CHEM, V263, P2870; UZUMAKI H, 1989, P NATL ACAD SCI USA, V86, P9323, DOI 10.1073/pnas.86.23.9323; WEINSTEIN Y, 1986, P NATL ACAD SCI USA, V83, P5010, DOI 10.1073/pnas.83.14.5010; ZHANG QY, 1989, P NATL ACAD SCI USA, V86, P8294, DOI 10.1073/pnas.86.21.8294	39	164	173	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					14008	14015						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696260				2022-12-27	WOS:A1990DU27500092
J	FARRAR, MA; FERNANDEZLUNA, J; SCHREIBER, RD				FARRAR, MA; FERNANDEZLUNA, J; SCHREIBER, RD			IDENTIFICATION OF 2 REGIONS WITHIN THE CYTOPLASMIC DOMAIN OF THE HUMAN INTERFERON-GAMMA RECEPTOR REQUIRED FOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; MURINE PERITONEAL-MACROPHAGES; IFN-GAMMA; EXPRESSION; CELLS; CDNA; CLONING; PURIFICATION; MOUSE; DNA	Functionally active human interferon-gamma (IFN-gamma) receptors require the presence of at least two polypeptides: the IFN-gamma receptor and an accessory molecule encoded by a gene on human chromosome 21. Here we have used a murine L cell line that stably contains human chromosome 21 (SCC16-5) to determine whether the receptor's cytoplasmic domain is important for receptor function. SCC16-5 stably transfected with the full-length human IFN-gamma receptor cDNA bound, internalized, and responded to human IFN-gamma. In contrast, SCC16-5 expressing human IFN-gamma receptors lacking a cytoplasmic domain bound human IFN-gamma but did not internalize or respond to it. Using a family of IFN-gamma receptor deletion mutants, two functionally important regions within the intracellular domain were identified: (a) a membrane proximal region (residues 256-303) required for ligand processing and biologic responsiveness and (b) the carboxyl-terminal 39 amino acids (residues 434-472) needed exclusively for biologic responses.	WASHINGTON UNIV,SCH MED,DEPT PATHOL,BOX 8118,660 S EUCLID AVE,ST LOUIS,MO 63110	Washington University (WUSTL)			Farrar, Michael A/M-7802-2013; Schreiber, Robert D/A-1276-2013; Schreiber, Robert/Q-7550-2019	Schreiber, Robert D/0000-0001-6311-0432; Farrar, Michael/0000-0002-5569-0366	NCI NIH HHS [CA43059] Funding Source: Medline; NIAID NIH HHS [AI24854] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043059, R37CA043059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI024854] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AGUET M, 1987, J EXP MED, V165, P988, DOI 10.1084/jem.165.4.988; BASU MT, 1988, P NATL ACAD SCI USA, V85, P6282, DOI 10.1073/pnas.85.17.6282; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; CALDERON J, 1988, P NATL ACAD SCI USA, V85, P4837, DOI 10.1073/pnas.85.13.4837; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; CELADA A, 1985, J CLIN INVEST, V76, P2196, DOI 10.1172/JCI112228; CELADA A, 1986, J IMMUNOL, V137, P2373; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; COFANO F, 1990, J BIOL CHEM, V265, P4064; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; FAN XD, 1988, P NATL ACAD SCI USA, V85, P5122, DOI 10.1073/pnas.85.14.5122; FIDLER IJ, 1985, J IMMUNOL, V135, P4289; FISCHER T, 1990, Cytokine, V2, P157, DOI 10.1016/1043-4666(90)90010-Q; FOUNTOULAKIS M, 1990, J BIOL CHEM, V265, P1368; FUHLBRIGGE RC, 1988, P NATL ACAD SCI USA, V85, P5649, DOI 10.1073/pnas.85.15.5649; GRAY PW, 1989, P NATL ACAD SCI USA, V86, P8497, DOI 10.1073/pnas.86.21.8497; HAMILTON TA, 1985, J BIOL CHEM, V260, P1378; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HEMMI S, 1989, P NATL ACAD SCI USA, V86, P9901, DOI 10.1073/pnas.86.24.9901; HERSHEY GKK, 1989, J BIOL CHEM, V264, P11981; HERSHEY GKK, 1990, J BIOL CHEM, V265, P17868; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HORII Y, 1989, J IMMUNOL, V143, P3949; JANSSEN JWG, 1986, CYTOMETRY, V7, P411, DOI 10.1002/cyto.990070504; JUNG V, 1990, J BIOL CHEM, V265, P1827; JUNG V, 1987, P NATL ACAD SCI USA, V84, P4151, DOI 10.1073/pnas.84.12.4151; KOIDE Y, 1988, P NATL ACAD SCI USA, V85, P3120, DOI 10.1073/pnas.85.9.3120; KUMAR CS, 1989, J BIOL CHEM, V264, P17939; LANGER JA, 1988, IMMUNOL TODAY, V9, P393, DOI 10.1016/0167-5699(88)91241-8; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; MAO C, 1990, J IMMUNOL, V145, P3949; MUNRO S, 1989, P NATL ACAD SCI USA, V86, P9248, DOI 10.1073/pnas.86.23.9248; PRPIC V, 1989, SCIENCE, V244, P469, DOI 10.1126/science.2541500; REHBERG E, 1982, J BIOL CHEM, V257, P1497; SANCEAU J, 1987, P NATL ACAD SCI USA, V84, P2906, DOI 10.1073/pnas.84.9.2906; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHEEHAN KCF, 1988, J IMMUNOL, V140, P4231; SMITH MR, 1990, J IMMUNOL, V144, P1777; SOMERS SD, 1986, J IMMUNOL, V136, P4199; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317; TRINCHIERI G, 1985, IMMUNOL TODAY, V6, P131, DOI 10.1016/0167-5699(85)90080-5; UCER U, 1986, CANCER RES, V46, P5339; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VANDAMME J, 1987, J EXP MED, V165, P914, DOI 10.1084/jem.165.3.914; VILCEK J, 1985, LYMPHOKINES, V11, P1	48	91	93	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19626	19635						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717469				2022-12-27	WOS:A1991GK66700073
J	BRASSEUR, R				BRASSEUR, R			DIFFERENTIATION OF LIPID-ASSOCIATING HELICES BY USE OF 3-DIMENSIONAL MOLECULAR HYDROPHOBICITY POTENTIAL CALCULATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; APOLIPOPROTEIN-A-I; DENSITY LIPOPROTEINS; PLASMA-LIPOPROTEINS; PROTEIN; RECEPTOR; MODEL; RESOLUTION; PROFILES; MEMBRANE	Several types of lipid-associating helices exist: transmembrane helices such as in receptor proteins, pore-forming helices in ion channel proteins, fusion-inducing peptides in viral proteins, and amphipathic helices such as in plasma apolipoproteins. In order to propose a classification of these helices according to their molecular properties, we introduce the concept of molecular hydrophobicity potential for such helical segments. The calculation of this parameter for alpha-helices enables the visualization of the hydrophobic and hydrophilic envelopes around the peptide and their three-dimensional representation by molecular graphics. We have used this parameter to differentiate between pore-forming helices with a hydrophobic envelope larger than the hydrophilic component, membrane-spanning helices surrounded almost entirely by an hydrophobic envelope, fusiogenic peptides with an hydrophobicity gradient both around the helix and along the axis, and finally, amphipathic helices with a predominantly hydrophilic envelope. The structure of the lipid-protein complexes is determined by a number of different interactions: the hydrophobic interaction of the apolar faces of the helices with lipids, the polar interaction of the hydrophilic sides of different helices with each other, and the interaction of hydrophilic residues with the aqueous solvent. The relative magnitude of the hydrophobic and hydrophilic envelopes accounts for the differences in the structure of the lipid-protein complexes. Purely hydrophobic interactions stabilize transmembrane helical segments, while hydrophobic interactions with the lipid phase and with each other are involved in the stabilization of the pore-forming helices. In contrast, both hydrophobic interactions with the lipids and hydrophilic interactions with the aqueous phase contribute to the arrangement of amphipathic helices around the edges of the discoidal lipid-apoprotein complexes.			BRASSEUR, R (corresponding author), UNIV LIBRE BRUXELLES,CHIM PHYS MACROMOLEC INTERFACES LAB,CP 206-2,BLVD DU TRIOMPHE,B-1050 BRUSSELS,BELGIUM.							ANANTHARAMAIAH GM, 1990, ARTERIOSCLEROSIS, V10, P95, DOI 10.1161/01.ATV.10.1.95; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BRASSEUR R, 1988, BIOCHIM BIOPHYS ACTA, V943, P95, DOI 10.1016/0005-2736(88)90350-1; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BRASSEUR R, 1988, J BIOL CHEM, V263, P12571; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1029, P267, DOI 10.1016/0005-2736(90)90163-I; BRASSEUR R, 1988, AIDS RES HUM RETROV, V4, P83, DOI 10.1089/aid.1988.4.83; Brasseur R, 1988, Virus Genes, V1, P325; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; DELEERS M, 1989, BIOCHEM PHARMACOL, V38, P2441, DOI 10.1016/0006-2952(89)90087-7; DELOOF H, 1986, P NATL ACAD SCI USA, V83, P2295; DRICKAMER K, 1981, J BIOL CHEM, V256, P5827; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; EISENBERG D, 1984, P NATL ACAD SCI-BIOL, V81, P140, DOI 10.1073/pnas.81.1.140; FAUCHERE JL, 1988, J MOL GRAPHICS, V6, P203, DOI 10.1016/S0263-7855(98)80004-0; FURET P, 1988, J MOL GRAPHICS, V6, P182, DOI 10.1016/S0263-7855(98)80001-5; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GHOSE AK, 1986, J COMPUT CHEM, V7, P565, DOI 10.1002/jcc.540070419; Hansch C, 1979, SUBSTITUENT CONSTANT; JONAS A, 1988, J LIPID RES, V29, P1349; JONAS A, 1989, J BIOL CHEM, V264, P4818; LE L, 1988, VIRUS GENES, V4, P333; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; MAHLEY RW, 1984, J LIPID RES, V25, P1277; MARTIN I, 1991, BIOCHEM BIOPH RES CO, V175, P872, DOI 10.1016/0006-291X(91)91646-T; MEYERS G, 1988, HUMAN RETROVIRUSES A; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; POWNALL HJ, 1984, BIOCHIM BIOPHYS ACTA, V793, P149, DOI 10.1016/0005-2760(84)90316-3; REKKER RF, 1979, EUR J MED CHEM, V14, P479; ROSSENEU M, 1991, P M DRUGS AFFECTING, P179; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; Tanford C., 1973, HYDROPHOBIC EFFECT; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0	38	197	205	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					16120	16127						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714906				2022-12-27	WOS:A1991GB97700089
J	BREITMAN, ML; TSUDA, M; USUKURA, J; KIKUCHI, T; ZUCCONI, A; KHOO, W; SHINOHARA, T				BREITMAN, ML; TSUDA, M; USUKURA, J; KIKUCHI, T; ZUCCONI, A; KHOO, W; SHINOHARA, T			EXPRESSION OF S-ANTIGEN IN RETINA, PINEAL-GLAND, LENS, AND BRAIN IS DIRECTED BY 5'-FLANKING SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ADRENERGIC-RECEPTOR; 48-KDA PROTEIN; ALPHA-TRANSDUCIN; RHODOPSIN-KINASE; BOVINE RETINA; ARRESTIN; BINDING; DROSOPHILA; GENE; CDNA	S-antigen (S-Ag) is an abundant protein of the retina and pineal gland that elicits experimental autoimmune uveitis and pinealocytis in several animal species. To study the elements regulating the expression of S-Ag, we generated transgenic mice expressing the chloramphenicol acetyl transferase (CAT) gene under the control of a 1.3-kilobase pair 5'-flanking segment of the mouse S-Ag gene. While all of the transgenic mice expressed CAT activity in the retina, in some animals CAT activity was also detected in the pineal gland, lens, and brain. Immunoblotting, polymerase chain reaction-mediated detection of RNA, and immunocytostaining of transgenic tissues with antibodies to CAT and S-Ag established that the profile of expression of the transgene corresponded to that of S-Ag; both proteins were detectable in retinal photoreceptor cells, pinealocytes, lens fiber and epithelial cells, the cerebellum, and the cerebral cortex. These results indicate that S-Ag is expressed in a wider spectrum of the cell types than previously recognized and that a 1.3-kilobase pair S-Ag promoter segment contains sufficient information to direct appropriate tissue-specific gene expression in transgenic mice.	MT SINAI HOSP,SAMUEL LUNENFELD RES INST,DIV MOLEC & DEV BIOL,600 UNIV AVE,TORONTO M5G 1X5,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA; NAGOYA UNIV,SCH MED,DEPT ANAT,NAGOYA,AICHI 466,JAPAN; NEI,RETINAL CELL & MOLEC BIOL LAB,BETHESDA,MD 20892	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Nagoya University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)				Usukura, Jiro/0000-0003-2286-5403; Shinohara, Toshimichi/0000-0002-7197-9039				ABE T, 1989, FEBS LETT, V247, P307, DOI 10.1016/0014-5793(89)81358-4; ABE T, 1990, EXP EYE RES, V51, P111, DOI 10.1016/0014-4835(90)90178-W; BENNETT N, 1988, BIOCHEMISTRY-US, V27, P1710, DOI 10.1021/bi00405a049; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; BREITMAN ML, 1987, SCIENCE, V238, P1563, DOI 10.1126/science.3685993; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; Collin J.P., 1986, PINEAL RETINAL RELAT, P15; DONOSO LA, 1986, CURR EYE RES, V5, P995, DOI 10.3109/02713688608995181; Faure J P, 1980, Curr Top Eye Res, V2, P215; FAURE JP, 1990, CURR EYE RES, V9, P163, DOI 10.3109/02713689008999437; FUKADA Y, 1990, FEBS LETT, V261, P419, DOI 10.1016/0014-5793(90)80606-J; Gilliland G., 1990, PCR PROTOCOLS GUIDE, P60; GLITSCHER W, 1989, FEBS LETT, V256, P101, DOI 10.1016/0014-5793(89)81726-0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; HOGAN B, 1986, MANIPULATING MOUSE E; HUPPERTZ B, 1990, J BIOL CHEM, V265, P9470; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; KALSOW CM, 1977, INVEST OPHTH VIS SCI, V16, P181; KAPPERS JA, 1981, PINEAL ORGAN PHOTOBI, P3; KORF HW, 1985, CELL TISSUE RES, V239, P81, DOI 10.1007/BF00214906; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; KUHN H, 1984, FEBS LETT, V176, P473, DOI 10.1016/0014-5793(84)81221-1; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Maizel JV, 1971, METHOD VIROL, V5, P179; MIRSHAHI M, 1989, FEBS LETT, V258, P240, DOI 10.1016/0014-5793(89)81663-1; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; SHINOHARA T, 1987, P NATL ACAD SCI USA, V84, P6975, DOI 10.1073/pnas.84.20.6975; SHINOHARA T, 1988, PROGR RETINAL RES, V8, P51; SMITH DP, 1990, P NATL ACAD SCI USA, V87, P1003, DOI 10.1073/pnas.87.3.1003; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRYER L, 1988, COLD SPRING HARB SYM, V53, P283, DOI 10.1101/SQB.1988.053.01.035; TSUDA M, 1988, GENE, V73, P11, DOI 10.1016/0378-1119(88)90308-3; TSUDA M, 1991, IN PRESS EUR J BIOCH; USUKURA J, 1987, EXP EYE RES, V45, P501, DOI 10.1016/S0014-4835(87)80061-1; WACKER WB, 1977, J IMMUNOL, V119, P1949; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YAMAKI K, 1988, FEBS LETT, V234, P39, DOI 10.1016/0014-5793(88)81298-5; YAMAKI K, 1987, BIOCHEM BIOPH RES CO, V142, P904, DOI 10.1016/0006-291X(87)91499-9; YAMAKI K, 1990, J BIOL CHEM, V265, P20757; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; ZUCKERMAN R, 1986, FEBS LETT, V207, P35, DOI 10.1016/0014-5793(86)80008-4	41	40	40	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15505	15510						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714458				2022-12-27	WOS:A1991GB09700101
J	QUINONES, MA; MUNDSCHAU, LJ; RAKE, JB; FALLER, DV				QUINONES, MA; MUNDSCHAU, LJ; RAKE, JB; FALLER, DV			DISSOCIATION OF PLATELET-DERIVED GROWTH-FACTOR (PDGF) RECEPTOR AUTOPHOSPHORYLATION FROM OTHER PDGF-MEDIATED 2ND MESSENGER EVENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIRSTEN SARCOMA-VIRUS; PHOSPHOLIPASE-C-GAMMA; EJ-RAS ONCOGENE; NIH-3T3 CELLS; TYROSINE PHOSPHORYLATION; KINASE-ACTIVITY; PROTEIN-KINASE; CDNA CLONING; CYCLIC-AMP; EXPRESSION	Activated p21ras alters the platelet-derived growth factor (PDGF) signal transduction pathway in fibroblasts by inhibiting autophosphorylation of the receptor as well as by inhibiting the induction of the growth-related genes c-myc, c-fos, and JE. To elucidate the cause and effect relationships between receptor autophosphorylation and other second messenger events in the PDGF signaling pathway we created revertants of v-ras transformed cells by two methods: 1) the use of cAMP analogues, and 2) the introduction of a gene, Krev-1, which has been reported previously to revert ras transformed cells to normal morphology. Analysis of the revertants shows that the PDGF-mediated tyrosine phosphorylation of the 180-kDa PDGF receptor remains inhibited; however, the PDGF-mediated activation of phospholipase C and the induction of the growth-related genes c-myc, c-fos, and JE have been restored. These data suggest the presence of parallel pathways for PDGF signal transduction which are not dependent on autophosphorylation of the PDGF receptor.	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,44 BINNEY ST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School				Kasman, Laura/0000-0002-8661-2918				ANDERSON WB, 1974, J BIOL CHEM, V249, P7041; BADING H, 1990, CELL GROWTH DIFFER, V1, P113; BENJAMIN CW, 1988, P NATL ACAD SCI USA, V85, P4345, DOI 10.1073/pnas.85.12.4345; BENJAMIN CW, 1987, P NATL ACAD SCI USA, V84, P546, DOI 10.1073/pnas.84.2.546; BOWENPOPE DF, 1989, J BIOL CHEM, V264, P2502; CARCHMAN RA, 1974, CELL, V1, P59, DOI 10.1016/0092-8674(74)90156-1; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; CLAESSONWELSH L, 1988, MOL CELL BIOL, V8, P3476, DOI 10.1128/MCB.8.8.3476; ERUSALIMSKY JD, 1988, J BIOL CHEM, V263, P19188; ESCOBEDO JA, 1988, SCIENCE, V240, P1532, DOI 10.1126/science.2836953; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FORGUELAFITTE ME, 1989, CANCER RES, V49, P6566; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; JACKOWSKI S, 1986, J BIOL CHEM, V261, P4978; KACZMAREK L, 1985, SCIENCE, V228, P1313, DOI 10.1126/science.4001943; KAKKIS E, 1989, NATURE, V339, P718, DOI 10.1038/339718a0; KAPLAN DR, 1986, P NATL ACAD SCI USA, V83, P3624, DOI 10.1073/pnas.83.11.3624; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAWATA M, 1988, J BIOL CHEM, V263, P18965; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LICHTMAN AH, 1987, J IMMUNOL, V138, P3276; LICHTMAN AH, 1986, NATURE, V324, P489, DOI 10.1038/324489a0; Maniatis T., 1982, MOL CLONING LAB MANU, P250; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; OFFERMANN MK, 1989, MOL CELL BIOL, V9, P1969, DOI 10.1128/MCB.9.5.1969; OLINGER PL, 1989, J CELL PHYSIOL, V139, P335, DOI 10.1002/jcp.1041390216; PARRIES G, 1987, P NATL ACAD SCI USA, V84, P2648, DOI 10.1073/pnas.84.9.2648; PIZON V, 1988, ONCOGENE, V3, P201; RAKE JB, 1991, J BIOL CHEM, V266, P5348; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SIEFERT RA, 1989, J BIOL CHEM, V264, P8771; SUCHY BK, 1989, CANCER RES, V49, P6781; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; ZAJAC-KAYE M, 1990, J BIOL CHEM, V265, P4547; ZULLO JN, 1988, MOL CELL BIOL, V8, P5080, DOI 10.1128/MCB.8.12.5080	43	27	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					14055	14063						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713214				2022-12-27	WOS:A1991FY02700093
J	CIRCOLO, A; WELGUS, HG; PIERCE, GF; KRAMER, J; STRUNK, RC				CIRCOLO, A; WELGUS, HG; PIERCE, GF; KRAMER, J; STRUNK, RC			DIFFERENTIAL REGULATION OF THE EXPRESSION OF PROTEINASES ANTIPROTEINASES IN FIBROBLASTS - EFFECTS OF INTERLEUKIN-1 AND PLATELET-DERIVED GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; HUMAN MONONUCLEAR PHAGOCYTES; HUMAN-SKIN COLLAGENASE; HUMAN SYNOVIAL-CELLS; FACTOR-B GENE; STIMULATES COLLAGENASE; CONNECTIVE TISSUES; FACTOR-ALPHA; COMPLEMENT; INHIBITOR	We have previously reported that polypeptide growth factors had an anti-inflammatory effect by decreasing the cytokine-enhanced expression of factor B (FB), an activator of the alternative complement pathway, in human fibroblasts. To further characterize the role of cytokines and growth factors in the inflammatory/repair continuum, we have studied the effects of interleukin-1 (IL-1) and platelet-derived growth factor (PDGF) on the expression of metalloproteinases/antiproteinases of the extracellular matrix in cultured human fibroblasts. Co-incubation of IL-1 and PDGF synergistically increased the expression of stromelysin and interstitial collagenase to 23-fold (for both proteins) over background, while PDGF decreased the IL-1-enhanced expression of FB by 82%. PDGF, but not IL-1, alone or in combination, increased the synthesis of tissue inhibitor of metalloproteinases. RNA blot analysis indicated that the changes in protein synthesis were regulated at a pretranslational level. Cycloheximide treatment indicated that the effects of PDGF on the metalloproteinases/antiproteinases were not protein-dependent, in contrast to results obtained for FB. The effect of the three dimeric forms of PDGF (AA, AB, and BB) on the synthesis of metalloproteinases and FB was also analyzed. The effects were qualitatively similar for each of the dimeric forms; however, the BB and AB isoforms had considerably greater effects than PDGF-AA. It has been reported that the PDGF receptors found in human fibroblasts have higher binding affinity for the BB and AB isoforms of the growth factor. The results presented in this paper are in accord with the possibility that differences in the biological activity of the three isoforms of PDGF are due to differences in the number or affinity of the binding sites of the target cells, rather than to different activation pathways of the receptor. Thus, PDGF increased cytokine effects on metalloproteinases, while decreasing cytokine effects on complement activator FB. The net effect of these changes may be to decrease inflammation and enhance remodeling early in repair and to enhance matrix stability later in the repair process.	WASHINGTON UNIV,SCH MED,DEPT PEDIAT,400 S KINGSHIGHWAY BLVD,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,ST LOUIS CHILDRENS HOSP,MED CTR,DIV PULM MED,ST LOUIS,MO 63110; WASHINGTON UNIV,ST LOUIS CHILDRENS HOSP,MED CTR,DIV ALLERGY IMMUNOL,ST LOUIS,MO 63110; WASHINGTON UNIV,JEWISH HOSP ST LOUIS,MED CTR,DIV DERMATOL,ST LOUIS,MO 63110; AMGEN INC,DEPT EXPTL PATHOL,THOUSAND OAKS,CA 91320	Washington University (WUSTL); Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL); Amgen					NHLBI NIH HHS [HL-37591] Funding Source: Medline; NIAID NIH HHS [AI-24836] Funding Source: Medline; NIDDK NIH HHS [DK-26609] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL037591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026609] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALVAREZ OM, 1986, DERMATOLOGY GENERAL, P321; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BAUER EA, 1985, P NATL ACAD SCI USA, V82, P4132, DOI 10.1073/pnas.82.12.4132; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; CARMICHAEL DF, 1986, P NATL ACAD SCI USA, V83, P2407, DOI 10.1073/pnas.83.8.2407; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CIRCOLO A, 1990, J BIOL CHEM, V265, P5066; COLE FS, 1985, J IMMUNOL, V134, P2610; CONCA W, 1989, J CLIN INVEST, V83, P1753, DOI 10.1172/JCI114077; DAVIES P, 1976, IMMUNOBIOLOGY MACROP, P4427; DAYER JM, 1985, J EXP MED, V162, P2163, DOI 10.1084/jem.162.6.2163; DAYER JM, 1986, J CLIN INVEST, V77, P645, DOI 10.1172/JCI112350; DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; EDWARDS DR, 1987, EMBO J, V6, P1899, DOI 10.1002/j.1460-2075.1987.tb02449.x; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; HAMMACHER A, 1989, EMBO J, V8, P2489, DOI 10.1002/j.1460-2075.1989.tb08385.x; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; KATZ Y, 1989, J IMMUNOL, V142, P3862; KERR LD, 1988, SCIENCE, V242, P1424, DOI 10.1126/science.2462278; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; MACNAUL KL, 1990, J BIOL CHEM, V265, P17238; MIYAJIMA A, 1988, FASEB J, V2, P2462, DOI 10.1096/fasebj.2.9.2836253; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; MURPHY G, 1985, BIOESSAYS, V2, P55, DOI 10.1002/bies.950020204; MURPHY G, 1985, J BIOL CHEM, V260, P3079; MUSTOE TA, 1991, J CLIN INVEST, V87, P694, DOI 10.1172/JCI115048; NONAKA M, 1989, MOL CELL BIOCHEM, V89, P1; PIERCE GF, 1988, J EXP MED, V167, P974, DOI 10.1084/jem.167.3.974; PIERCE GF, 1991, J CELL BIOCHEM, V45, P319, DOI 10.1002/jcb.240450403; PIERCE GF, 1991, IN PRESS AM J PATHOL; POSTLETHWAITE AE, 1988, J CELL BIOL, V106, P311, DOI 10.1083/jcb.106.2.311; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SHERRY B, 1988, J CELL BIOL, V107, P1269, DOI 10.1083/jcb.107.4.1269; SRICKEN GP, 1983, J BIOL CHEM, V258, P12252; STRICKLIN GP, 1977, BIOCHEMISTRY-US, V16, P1607, DOI 10.1021/bi00627a013; THOMAS PS, 1980, P NATL ACAD SCI USA, V77, P5102; TZENG DY, 1984, BLOOD, V64, P1123; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; WELGUS HG, 1983, J BIOL CHEM, V258, P2259; WILHELM SM, 1987, P NATL ACAD SCI USA, V84, P6725, DOI 10.1073/pnas.84.19.6725; WOODS DE, 1982, P NATL ACAD SCI-BIOL, V79, P5661, DOI 10.1073/pnas.79.18.5661; WU LC, 1987, CELL, V48, P331, DOI 10.1016/0092-8674(87)90436-3	45	76	77	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12283	12288						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712016				2022-12-27	WOS:A1991FV18000030
J	HALL, SW; HUMPHRIES, JE; GONIAS, SL				HALL, SW; HUMPHRIES, JE; GONIAS, SL			INHIBITION OF CELL-SURFACE RECEPTOR-BOUND PLASMIN BY ALPHA-2-ANTIPLASMIN AND ALPHA-2-MACROGLOBULIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-ENDOTHELIAL CELLS; RAT HEPATOCYTES; UROKINASE RECEPTORS; BINDING; ACTIVATOR; ENZYME; EXPRESSION; KINETICS; COMPLEX; GLYCOPROTEIN	The purpose of this investigation was to characterize the reaction of alpha-2-antiplasmin (alpha-2-AP) and alpha-2-macroglobulin (alpha-2-M) with human plasmin bound to rat C6 glioma cells and human umbilical vein endothelial cells (HUVECs). Binding of plasmin (0.1-mu-M) to C6 cells at 4-degrees-C did not cause cell detachment, decrease viability or change cell morphology. The K(D) and B(max) for the binding of diisopropyl phosphoryl plasmin (DIP-plasmin) to C6 cells were 0.9-mu-M and 2.6 x 10(6) sites/cell. The dissociation rate constants (k(off)) for I-125-plasmin were 9.7 x 10(-4) and 4.0 x 10(-4) s-1 at 4-degrees-C in the presence and absence of 0.3-mu-M DIP-plasmin, respectively. Similar constants were determined for I-125-plasminogen and I-125-DIP-plasmin. Neither alpha-2-AP nor alpha-2-M affected the dissociation of DIP-plasmin. C6 cell-associated I-125-plasmin reacted slowly with alpha-2-AP; however, the inhibition rate constants exceeded the k(off). Alpha-2-AP-plasmin complex formed after the plasmin dissociated into solution (reaction pathway 1) and by direct reaction of alpha-2-AP with cell-associated enzyme (reaction pathway 2). High concentrations of alpha-2-AP favored pathway 2. C6 cell-associated plasmin was also protected from inhibition by alpha-2-M. While the same pathways were probably involved in this reaction, alpha-2-M was less effective than alpha-2-AP as an inhibitor of nondissociated plasmin (pathway 2). When C6 cell-bound plasmin reacted with alpha-2AP, alpha-2-AP-plasmin complex was recovered primarily in the medium, suggesting dissociation of complexes formed on the cell surface. Plasmin-receptor dissociation and inhibition experiments were performed at 22-degrees and 37-degrees-C, confirming the conclusions of the 4-degrees-C studies. Comparable results were also obtained using HUVEC cultures. These studies demonstrate that cell-associated plasmin is protected from inhibition by alpha-2-M as well as alpha-2-AP. At least two reaction pathways may be demonstrated for the inhibition of plasmin that is initially receptor-bound; however, neither pathway is highly effective, accounting for the "plasmin-protective" activity of the cell surface.	UNIV VIRGINIA,HLTH SCI CTR,DEPT PATHOL,BOX 214,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT BIOCHEM,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,HLTH SCI CTR,DEPT INTERNAL MED,CHARLOTTESVILLE,VA 22908	University of Virginia; University of Virginia; University of Virginia					NHLBI NIH HHS [HL45786] Funding Source: Medline; NIADDK NIH HHS [1T32AMO7509] Funding Source: Medline; NIGMS NIH HHS [GM 07267] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [T32AM007509] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANONICK PK, 1990, THROMB RES, V59, P449, DOI 10.1016/0049-3848(90)90406-3; ANONICK PK, 1989, BIOCHEM J, V264, P745, DOI 10.1042/bj2640745; AOKI N, 1984, SEMIN THROMB HEMOST, V10, P24, DOI 10.1055/s-2007-1004405; BAUER PI, 1984, BIOCHEM J, V218, P119, DOI 10.1042/bj2180119; BEHRENDT N, 1990, J BIOL CHEM, V265, P6453; CAMACHO M, 1989, FEBS LETT, V245, P21, DOI 10.1016/0014-5793(89)80183-8; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; ELLIS V, 1990, J BIOL CHEM, V265, P9904; ELLIS V, 1989, J BIOL CHEM, V264, P2185; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; GONIAS SL, 1988, BIOCHEM J, V255, P725; GONIAS SL, 1989, BLOOD, V74, P729; HAJJAR KA, 1987, J CLIN INVEST, V80, P1712, DOI 10.1172/JCI113262; HALL SW, 1989, BRAIN RES, V495, P373, DOI 10.1016/0006-8993(89)90231-X; HALL SW, 1989, BIOCHEM BIOPH RES CO, V164, P1288, DOI 10.1016/0006-291X(89)91809-3; HALL SW, 1990, J CELL BIOCHEM, V43, P213, DOI 10.1002/jcb.240430303; HEUMANN D, 1989, BIOCHEM BIOPH RES CO, V165, P14, DOI 10.1016/0006-291X(89)91027-9; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; KNUDSEN BS, 1986, J BIOL CHEM, V261, P765; LAURENT P, 1989, BIOCHIM BIOPHYS ACTA, V994, P285, DOI 10.1016/0167-4838(89)90306-3; LIOTTA LA, 1981, CANCER RES, V41, P4629; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MARKUS G, 1988, ENZYME, V40, P158, DOI 10.1159/000469158; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; MIGNATTI P, 1986, CELL, V47, P487, DOI 10.1016/0092-8674(86)90613-6; MILES L A, 1988, Fibrinolysis, V2, P61, DOI 10.1016/0268-9499(88)90369-4; MILES LA, 1985, J BIOL CHEM, V260, P4303; MILES LA, 1989, BIOCHEMISTRY-US, V28, P9337, DOI 10.1021/bi00450a014; MILES LA, 1988, BLOOD, V72, P628; MILES LA, 1988, J BIOL CHEM, V263, P11928; OGRADY RL, 1981, INT J CANCER, V28, P509, DOI 10.1002/ijc.2910280418; PETERSON GL, 1979, ANAL BIOCHEM, V100, P201, DOI 10.1016/0003-2697(79)90222-7; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; ROLDAN AL, 1990, EMBO J, V9, P467, DOI 10.1002/j.1460-2075.1990.tb08132.x; SILVERSTEIN RL, 1985, J CLIN INVEST, V75, P2065, DOI 10.1172/JCI111926; SILVERSTEIN RL, 1984, J CLIN INVEST, V74, P1625, DOI 10.1172/JCI111578; SIVERSTEIN RL, 1988, J CLIN INVEST, V82, P1948; SOTTRUPJENSEN L, 1978, PROGR CHEM FIBRINOLY, V3, P191; STEINER JP, 1987, BIOCHEMISTRY-US, V26, P8487, DOI 10.1021/bi00399a068; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WIMAN B, 1978, EUR J BIOCHEM, V84, P573, DOI 10.1111/j.1432-1033.1978.tb12200.x; WIMAN B, 1980, BIOCHEM J, V191, P229, DOI 10.1042/bj1910229	43	140	142	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12329	12336						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712017				2022-12-27	WOS:A1991FV18000037
J	MOLINA, H; BRENNER, C; JACOBI, S; GORKA, J; CAREL, JC; KINOSHITA, T; HOLERS, VM				MOLINA, H; BRENNER, C; JACOBI, S; GORKA, J; CAREL, JC; KINOSHITA, T; HOLERS, VM			ANALYSIS OF EPSTEIN-BARR VIRUS-BINDING SITES ON COMPLEMENT RECEPTOR 2 (CR2/CD21) USING HUMAN-MOUSE CHIMERAS AND PEPTIDES - AT LEAST 2 DISTINCT SITES ARE NECESSARY FOR LIGAND-RECEPTOR INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; EBV/C3D RECEPTOR; FRAGMENT C3D; TYPE-1 CR-1; CELLS; ACTIVATION; CD21; EBV; IDENTIFICATION; EXPRESSION	The predicted amino acid sequence of human complement receptor 2 (CR2, CD21, C3d,g/Epstein-Barr virus receptor) and its genetic murine homologue are approximately 70% identical. The sequence of each consists of a linear array of 60-70 amino acid repeats designated short consensus repeats (SCRs). Although they share significant sequence identity, a major difference in the activities of these two proteins has been believed to be the ability of human, but not mouse, CR2 to mediate Epstein-Barr virus (EBV) infection of B lymphocytes. In order to formally address this question and to directly compare the activities of the CR2 protein of each species, we have expressed recombinant mouse CR2 (rMCR2) in a human K562 erythroleukemia cell line background. We have found that rMCR2 reacts with two previously described rat anti-MCR2 monoclonal antibodies (mAbs), 7G6 and 7E9, but not mAb 8C12, which recognizes only mouse complement receptor 1. rMCR2 rosettes with erythrocytes bearing mouse and human C3d,g and binds glutaraldehyde cross-linked human C3d,g with a similar K(d) as human CR2 (HCR2). rMCR2 does not bind EBV. By using this observation and constructing chimeras bearing portions of MCR2 on a HCR2 background, we have been able to define unique sequences in HCR2 SCRs 1 and 2 important in the interaction with both mAb OKB7, which blocks EBV binding and infection, and with EBV. In addition, by using blocking peptides derived from HCR2 sequence, we have identified a second distinct region in SCR2 important in EBV binding. Therefore, within the first two SCRs of HCR2 are multiple distinct sites of interaction with EBV and with mAb OKB7.	WASHINGTON UNIV, SCH MED,HOWARD HUGHES MED INST,DEPT MED, DIV RHEUMATOL,MED LABS, ST LOUIS, MO 63110 USA; OSAKA UNIV, SCH MED, DEPT BACTERIOL, OSAKA, JAPAN; HOP ST VINCENT DE PAUL, INSERM, U188, F-75674 PARIS 14, FRANCE	Howard Hughes Medical Institute; Washington University (WUSTL); Osaka University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Carel, Jean-Claude/AAZ-7691-2020; Kinoshita, Taroh/C-7353-2009	Carel, Jean-Claude/0000-0002-0424-6767; 				AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; AHEARN JM, 1988, P NATL ACAD SCI USA, V85, P9307, DOI 10.1073/pnas.85.23.9307; ARVIEUX J, 1988, IMMUNOLOGY, V65, P229; BAREL M, 1989, P NATL ACAD SCI USA, V86, P10054, DOI 10.1073/pnas.86.24.10054; BOHNSACK JF, 1988, J IMMUNOL, V141, P2569; CAREL JC, 1990, J BIOL CHEM, V265, P12293; CAREL JC, 1989, J IMMUNOL, V143, P923; CARTER RH, 1988, J IMMUNOL, V141, P457; COOPER NR, 1988, ANNU REV IMMUNOL, V6, P85; DYKMAN TR, 1983, J EXP MED, V157, P2160, DOI 10.1084/jem.157.6.2160; FINGEROTH JD, 1990, J IMMUNOL, V144, P3458; GORKA J, 1989, Peptide Research, V2, P376; HEYMAN B, 1990, J EXP MED, V172, P665, DOI 10.1084/jem.172.2.665; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; KINOSHITA T, 1990, INT IMMUNOL, V2, P651, DOI 10.1093/intimm/2.7.651; KINOSHITA T, 1988, J IMMUNOL, V140, P3066; KINOSHITA T, 1985, J IMMUNOL, V134, P2564; KURTZ CB, 1990, J IMMUNOL, V144, P3581; LOWELL CA, 1989, J EXP MED, V170, P1931, DOI 10.1084/jem.170.6.1931; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MOLINA H, 1990, J IMMUNOL, V145, P2974; NEMEROW GR, 1987, J VIROL, V61, P1416, DOI 10.1128/JVI.61.5.1416-1420.1987; PETZER AL, 1988, IMMUNOLOGY, V63, P47; SHAPIRO IM, 1981, BIOCHIM BIOPHYS ACTA, V676, P19, DOI 10.1016/0304-4165(81)90004-0; TANNER J, 1987, CELL, V50, P203, DOI 10.1016/0092-8674(87)90216-9; TSOKOS GC, 1990, J IMMUNOL, V144, P1640; VOLSKY DJ, 1980, P NATL ACAD SCI-BIOL, V77, P5453, DOI 10.1073/pnas.77.9.5453; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0	28	84	87	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12173	12179						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712014				2022-12-27	WOS:A1991FV18000013
J	BROOKE, RG; SINGHAL, R; HINKLE, DC; DUMAS, LB				BROOKE, RG; SINGHAL, R; HINKLE, DC; DUMAS, LB			PURIFICATION AND CHARACTERIZATION OF THE 180-KILODALTON AND 86-KILODALTON SUBUNITS OF THE SACCHAROMYCES-CEREVISIAE DNA PRIMASE-DNA POLYMERASE PROTEIN COMPLEX - THE 180-KILODALTON SUBUNIT HAS BOTH DNA-POLYMERASE AND 3'-]5'-EXONUCLEASE ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE ESSENTIAL GENE; DROSOPHILA-MELANOGASTER; ENZYMOLOGICAL CHARACTERIZATION; IMMUNOAFFINITY PURIFICATION; POLYPEPTIDE STRUCTURE; KB-CELLS; YEAST; ALPHA; FIDELITY; EMBRYOS	The yeast Saccharomyces cerevisiae catalytic DNA polymerase I 180-kDa subunit and the tightly associated 86-kDa polypeptide have been purified using immunoaffinity chromatography, permitting further characterization of the DNA polymerase activity of the DNA primase-DNA polymerase protein complex. The subunits were purified to apparent homogeneity from separate overproducing yeast strains using monoclonal antibodies specifically recognizing each subunit. When the individual subunits were recombined in vitro a p86p180 physical complex formed spontaneously, as judged by immunoprecipitation of 180-kDa polypeptide and DNA polymerase activity with the anti-86-kDa monoclonal antibody. The 86-kDa subunit stabilized the DNA polymerase activity of the 180-kDa catalytic subunit at 30-degrees-C, the physiological temperature. The apparent DNA polymerase processivity of 50-60 nucleotides on poly(dA).oligo(dT)12 or poly(dT).oligo(A)8-12 template-primer was not affected by the presence of the 86-kDa subunit but was reduced by increased Mg2+ concentration. The K(m) of the catalytic 180-kDa subunit for dATP or DNA primer terminus was unaffected by the presence of the 86-kDa subunit. The isolated 180-kDa polypeptide was sufficient to catalyze all the DNA synthesis that had been observed previously in the DNA primase-DNA polymerase protein complex. The 180-kDa subunit possessed a 3' --> 5'-exonuclease activity that catalyzed degradation of polynucleotides, but degradation of oligonucleotide substrates of chain lengths up to 50 was not detected. This exonuclease activity was unaffected by the presence of the 86-kDa subunit. Despite the striking physical similarity of the DNA primase-DNA polymerase protein complex in all eukaryotes examined, the data presented here indicate differences in the enzymatic properties detected in preparations of the DNA polymerase subunits isolated from S. cerevisiae as compared with the properties of preparations from Drosophila cells. In particular, the 3' --> 5'-exonuclease activity associated with the yeast catalytic DNA polymerase subunit was not masked by the 86-kDa subunit.	NORTHWESTERN UNIV,DEPT BIOCHEM MOLEC BIOL & CELL BIOL,EVANSTON,IL 60208; UNIV ROCHESTER,DEPT BIOL,ROCHESTER,NY 14627	Northwestern University; University of Rochester					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029686] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 23448, GM 29686] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAUER GA, 1988, J BIOL CHEM, V263, P917; BERNAD A, 1989, CELL, V59, P219, DOI 10.1016/0092-8674(89)90883-0; BIALEK G, 1989, EMBO J, V8, P1833, DOI 10.1002/j.1460-2075.1989.tb03578.x; BORSTPAUWELS GWFH, 1981, BIOCHIM BIOPHYS ACTA, V650, P88, DOI 10.1016/0304-4157(81)90002-2; BROOKS M, 1989, J BIOL CHEM, V264, P3602; CHANG LMS, 1984, J BIOL CHEM, V259, P4679; CHANG LMS, 1977, J BIOL CHEM, V252, P1873; COTTERILL S, 1987, J BIOL CHEM, V262, P16100; COTTERILL S, 1987, J BIOL CHEM, V262, P16105; COTTERILL SM, 1987, P NATL ACAD SCI USA, V84, P5635, DOI 10.1073/pnas.84.16.5635; FISCHER PA, 1979, JBC, V254, P11033; FISHER PA, 1979, J BIOL CHEM, V254, P6128; FOIANI M, 1989, MOL CELL BIOL, V9, P3081, DOI 10.1128/MCB.9.7.3081; FRY M, 1986, ANIMAL CELL DNA POLY, P157; GRIEP MA, 1989, J BIOL CHEM, V264, P11294; HOLMES AM, 1986, J BIOL CHEM, V261, P1924; JOHNSON LM, 1985, CELL, V43, P369, DOI 10.1016/0092-8674(85)90042-X; KAGUNI LS, 1988, BIOCHIM BIOPHYS ACTA, V950, P87, DOI 10.1016/0167-4781(88)90001-2; KUNKEL TA, 1989, MOL CELL BIOL, V9, P4447, DOI 10.1128/MCB.9.10.4447; KUNKEL TA, 1988, J BIOL CHEM, V263, P4450; LEIRMO S, 1987, BIOCHEMISTRY-US, V26, P2095, DOI 10.1021/bi00382a006; LOEB LA, 1986, PROG NUCLEIC ACID RE, V33, P27; LUCCHINI G, 1987, EMBO J, V6, P737, DOI 10.1002/j.1460-2075.1987.tb04815.x; MILLER MA, 1988, NUCLEIC ACIDS RES, V16, P7961, DOI 10.1093/nar/16.16.7961; PAUSCH MH, 1988, CANCER CELL, V6, P359; PIZZAGALLI A, 1988, P NATL ACAD SCI USA, V85, P3772, DOI 10.1073/pnas.85.11.3772; PLEVANI P, 1987, NUCLEIC ACIDS RES, V15, P7975; PLEVANI P, 1984, J BIOL CHEM, V259, P7532; PLEVANI P, 1985, J BIOL CHEM, V260, P7102; PRUSSAK CE, 1987, J BIOL CHEM, V262, P6018; RANDERATH K, 1964, J CHROMATOGR, V16, P111, DOI 10.1016/S0021-9673(01)82445-6; Record M T Jr, 1985, Adv Biophys, V20, P109; REYLAND ME, 1988, J BIOL CHEM, V263, P6518; REYLAND ME, 1987, J BIOL CHEM, V262, P10824; SABATINO RD, 1988, BIOCHEMISTRY-US, V27, P2998, DOI 10.1021/bi00408a050; SINGH H, 1984, J BIOL CHEM, V259, P7936; SINGH H, 1986, J BIOL CHEM, V261, P8564; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUZUKI M, 1985, J BIOCHEM-TOKYO, V98, P581, DOI 10.1093/oxfordjournals.jbchem.a135314; VISHWANATHA JK, 1986, J BIOL CHEM, V261, P6619; WAHL AF, 1984, BIOCHEMISTRY-US, V23, P1895, DOI 10.1021/bi00304a001; WONG SW, 1986, J BIOL CHEM, V261, P7958	42	40	41	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3005	3015						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704371				2022-12-27	WOS:A1991EX60000053
J	TILLY, BC; KANSEN, M; VANGAGELDONK, PGM; VANDENBERGHE, N; GALJAARD, H; BIJMAN, J; DEJONGE, HR				TILLY, BC; KANSEN, M; VANGAGELDONK, PGM; VANDENBERGHE, N; GALJAARD, H; BIJMAN, J; DEJONGE, HR			G-PROTEINS MEDIATE INTESTINAL CHLORIDE CHANNEL ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROSIS AIRWAY EPITHELIA; CYSTIC-FIBROSIS; CELL-LINE; KINASE-C; K+-CHANNEL; TRANSPORT; SECRETION; NUCLEOTIDES; CONDUCTANCE; INHIBITION	The localization of several GTP-binding regulatory proteins in the apical membrane of intestinal epithelial cells has prompted us to investigate a possible role for G-proteins as modulators of apical Cl- channels. In membrane vesicles isolated from rat small intestine or human HT29-cl.19A colon carcinoma cells, the entrapment of guanosine 5'-O-(3-thiophosphate (GTP-gamma-S) led to a large increase in Cl- conductance, as evidenced by an increased I--125 uptake and faster SPQ quenching. The enhancement was observed in the presence, but not in the absence of the K+ ionophore valinomycin, indicating that the increased Cl- permeability is not secondary to the opening of K+ channels. The effect of GTP-gamma-S was counteracted by guanosine 5'-O-(2-thiophosphate (GDP-beta-S) and appeared to be independent of cytosolic messengers, including ATP, cAMP, and Ca2+, suggesting that protein phosphorylation and/or phospholipase C activation is not involved. Patch clamp analysis of apical membrane patches of HT29-cl.19A colonocytes revealed a GTP-gamma-S-activated, inwardly rectifying, anion-selective channel with a unitary conductance of 20 +/- 4 pS. No spontaneous channel openings were observed in the absence of GTP-gamma-S, while the open time probability (P(o)) increases dramatically to 0.81 +/- 0.09 upon addition with GTP-gamma-S. Since the electrophysiological characteristics and regulatory properties of this channel are markedly different from those of the more widely studied cAMP/protein kinase A-operated channel, we propose the existence of a separate Cl--selective ion channel in the apical border of intestinal epithelial cells. Our results suggest an alternative regulatory pathway in transepithelial salt transport and a possible site for anomalous channel regulation as observed in cystic fibrosis patients.	ERASMUS UNIV,FAC MED,DEPT CELL BIOL & GENET,3000 DR ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam	TILLY, BC (corresponding author), ERASMUS UNIV,FAC MED,DEPT BIOCHEM 1,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.			van Gageldonk, Pieter/0000-0003-2753-9674				AUGERON C, 1984, CANCER RES, V44, P3961; BARROWMAN MM, 1986, NATURE, V319, P504, DOI 10.1038/319504a0; BERSCHNEIDER HM, 1988, FASEB J, V2, P2625, DOI 10.1096/fasebj.2.10.2838365; CORNWELL MM, 1987, FASEB J, V1, P51, DOI 10.1096/fasebj.1.1.2886389; DEJONGE HR, 1989, BIOCHEM SOC T, V17, P816, DOI 10.1042/bst0170816; DEJONGE HR, 1985, CIBA F SYMP, V112, P116; DEJONGE HR, 1987, PEDIATR PULM S, V1, P54; DEMAREST JR, 1989, SCIENCE, V245, P402, DOI 10.1126/science.2474200; DOMINGUEZ P, 1987, P NATL ACAD SCI USA, V84, P6965, DOI 10.1073/pnas.84.20.6965; DUNN SMJ, 1989, BIOCHEMISTRY-US, V28, P2551, DOI 10.1021/bi00432a031; FIELD M, 1989, NEW ENGL J MED, V321, P879; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; FRIZZELL RA, 1987, TRENDS NEUROSCI, V10, P190, DOI 10.1016/0166-2236(87)90144-5; GARTY H, 1983, J BIOL CHEM, V258, P3094; GIRALDEZ F, 1988, BIOCHIM BIOPHYS ACTA, V942, P353, DOI 10.1016/0005-2736(88)90037-5; HALM DR, 1988, AM J PHYSIOL, V254, pC505, DOI 10.1152/ajpcell.1988.254.4.C505; HAYSLETT JP, 1987, PFLUG ARCH EUR J PHY, V410, P487, DOI 10.1007/BF00586530; HWANG TC, 1989, SCIENCE, V244, P1351, DOI 10.1126/science.2472005; ILLSLEY NP, 1987, BIOCHEMISTRY-US, V26, P1215, DOI 10.1021/bi00379a002; KANAHO Y, 1988, J BIOL CHEM, V263, P17584; KIM D, 1989, NATURE, V337, P557, DOI 10.1038/337557a0; KURACHI Y, 1989, NATURE, V337, P555, DOI 10.1038/337555a0; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LIGHT DB, 1989, J CLIN INVEST, V84, P352, DOI 10.1172/JCI114162; MOHRMANN M, 1987, AM J PHYSIOL, V253, pF372, DOI 10.1152/ajprenal.1987.253.2.F372; QUINTON PM, 1983, NEW ENGL J MED, V308, P185; RIORDAN JR, 1989, CIENCE, V245, P1066; SACHS G, 1988, COMP BIOCHEM PHYS A, V90, P727, DOI 10.1016/0300-9629(88)90691-3; SCHWIEBERT EM, 1990, J BIOL CHEM, V265, P7725; TAYLOR CJ, 1988, GUT, V29, P957, DOI 10.1136/gut.29.7.957; VAANDRAGER AB, 1990, AM J PHYSIOL, V259, pG410, DOI 10.1152/ajpgi.1990.259.3.G410; VANDOMMELEN FS, 1986, BIOCHEM J, V236, P771, DOI 10.1042/bj2360771; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC1045, DOI 10.1152/ajpcell.1989.256.5.C1045; WORRELL RT, 1989, AM J PHYSIOL, V256, pC1111, DOI 10.1152/ajpcell.1989.256.6.C1111; YATANI A, 1987, SCIENCE, V238, P1288, DOI 10.1126/science.2446390; YATANI A, 1987, SCIENCE, V235, P442	38	66	66	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1991	266	4					2036	2040						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV515	1703525				2022-12-27	WOS:A1991EV51500007
J	WALES, R; RICHARDSON, PT; ROBERTS, LM; WOODLAND, HR; LORD, JM				WALES, R; RICHARDSON, PT; ROBERTS, LM; WOODLAND, HR; LORD, JM			MUTATIONAL ANALYSIS OF THE GALACTOSE BINDING ABILITY OF RECOMBINANT RICIN-B CHAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-CHAIN; COMMUNIS AGGLUTININ; ESCHERICHIA-COLI; XENOPUS-OOCYTES; ENZYME-ACTIVITY; ANTIBODY-RICIN; EXPRESSION; GLYCOSYLATION; IMMUNOTOXINS; CELLS	Ricin B chain (RTB) is an N-glycosylated galactose-specific lectin which folds into two globular domains. Each domain binds one galactoside. The x-ray crystallographic structure has shown that the two binding sites are structurally similar and contain key binding residues which hydrogen bond to the sugar, and a conserved tripeptide, Asp-Val-Arg. We have used oligonucleotide site-directed mutagenesis to change either the binding residues or the homologous tripeptide in one or other or in both of the sites. The 5' signal sequence and RTB coding region were excised from preproricin cDNA and fused in frame to generate preRTB cDNA. Transcripts synthesized in vitro from wild-type or mutant preRTB cloned into the Xenopus transcription vector pSP64T using SP6 RNA polymerase, were microinjected into Xenopus oocytes. The recombinant products were segregated into the oocyte rough endoplasmic reticulum and core-glycosylated, and the N-terminal signal peptide was removed. Mutating sugar binding sites individually did not abrogate the lectin activity of RTB. When both sites were changed simultaneously, RTB was produced which was soluble and stable but no longer able to bind galactose. Changing the Asn residues of the two RTB N-glycosylation sites to Gln showed that oligosaccharide side chains were essential for both the stability and biological activity of recombinant RTB.			WALES, R (corresponding author), UNIV WARWICK,DEPT BIOL SCI,COVENTRY CV4 7AL,W MIDLANDS,ENGLAND.							AIKAWA J, 1990, J BIOL CHEM, V265, P13955; ANDERSON CW, 1983, METHOD ENZYMOL, V101, P635; BLAKEY DC, 1986, BIOESSAYS, V4, P292, DOI 10.1002/bies.950040615; COLMAN A, 1981, EUR J BIOCHEM, V113, P339, DOI 10.1111/j.1432-1033.1981.tb05072.x; DEAN JW, 1990, J BIOL CHEM, V265, P12553; ELLIS RJ, 1990, SCIENCE, V250, P954, DOI 10.1126/science.250.4983.954; FISCHER T, 1990, J BIOL CHEM, V265, P1710; HOUSTON LL, 1982, J BIOL CHEM, V257, P4147; HOUSTON LL, 1982, J BIOL CHEM, V257, P1532; HUSSAIN K, 1989, FEBS LETT, V244, P383, DOI 10.1016/0014-5793(89)80568-X; KRETZ KA, 1990, P NATL ACAD SCI USA, V87, P2541, DOI 10.1073/pnas.87.7.2541; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LAMBERT JM, 1991, BIOCHEMISTRY-US, V30, P3234, DOI 10.1021/bi00227a011; LORD JM, 1985, EUR J BIOCHEM, V146, P411, DOI 10.1111/j.1432-1033.1985.tb08667.x; MCINTOSH DP, 1983, FEBS LETT, V164, P17, DOI 10.1016/0014-5793(83)80009-X; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; NEVILLE DM, 1982, IMMUNOL REV, V62, P75, DOI 10.1111/j.1600-065X.1982.tb00390.x; OHARE M, 1987, FEBS LETT, V216, P73, DOI 10.1016/0014-5793(87)80759-7; Olsnes S., 1982, MOL ACTION TOXINS VI, P51; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PIATAK M, 1988, J BIOL CHEM, V263, P4837; RICHARDSON PT, 1988, BIO-TECHNOL, V6, P565, DOI 10.1038/nbt0588-565; RICHARDSON PT, 1988, BIOCHIM BIOPHYS ACTA, V950, P385, DOI 10.1016/0167-4781(88)90135-2; RICHARDSON PT, 1990, IN PRESS CARBOHYDRAT; ROBERTS LM, 1981, EUR J BIOCHEM, V119, P31, DOI 10.1111/j.1432-1033.1981.tb05573.x; ROTHMAN E, 1989, CELL, V49, P591; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; SEMENKOVICH CF, 1990, J BIOL CHEM, V265, P5429; TAKEUCHI M, 1990, J BIOL CHEM, V265, P12127; THORPE PE, 1984, EUR J BIOCHEM, V140, P63, DOI 10.1111/j.1432-1033.1984.tb08067.x; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; VILLAFRANCA JE, 1981, J BIOL CHEM, V256, P554; VITETTA ES, 1986, J IMMUNOL, V136, P1880; VITETTA ES, 1984, J EXP MED, V160, P341, DOI 10.1084/jem.160.1.341; VITETTA ES, 1990, BIOCHIM BIOPHYS ACTA, V1049, P151, DOI 10.1016/0167-4781(90)90035-Z; VITETTA ES, 1985, ANNU REV IMMUNOL, V3, P197; YOULE RJ, 1982, J BIOL CHEM, V257, P1598; YOULE RJ, 1987, J BIOL CHEM, V262, P4676; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	39	77	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19172	19179						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717462				2022-12-27	WOS:A1991GK66700012
J	CAGLIERO, E; ROTH, T; ROY, S; MAIELLO, M; LORENZI, M				CAGLIERO, E; ROTH, T; ROY, S; MAIELLO, M; LORENZI, M			EXPRESSION OF GENES RELATED TO THE EXTRACELLULAR-MATRIX IN HUMAN ENDOTHELIAL-CELLS - DIFFERENTIAL MODULATION BY ELEVATED GLUCOSE-CONCENTRATIONS, PHORBOL ESTERS, AND CAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN KINASE-C; PLASMINOGEN-ACTIVATOR INHIBITOR; GROWTH-FACTOR-BETA; STREPTOZOTOCIN-DIABETIC RATS; BASEMENT-MEMBRANE COLLAGEN; FACTOR MESSENGER-RNA; PANCREATIC-ISLETS; MOLECULAR-CLONING; FIBRONECTIN; PROMOTER	To identify agents and mechanisms responsible for the thickened basement membranes characteristic of diabetic angiopathy we examined the effects of high glucose (30 mM) on the expression of genes related to extracellular matrix composition and turnover and investigated whether the changes induced by high glucose were mimicked and sustained by activation of protein kinase C or A. In human umbilical vein endothelial cells high glucose increased fibronectin, collagen IV, tissue plasminogen activator (tPA), and plasminogen activator-inhibitor 1 (PAI-1) mRNA levels 2-fold but did not affect type IV and interstitial collagenase expression. Acute treatment with phorbol esters resulted in increased collagen IV, tPA, PAI- 1, and interstitial collagenase mRNAs; the type IV collagenase mRNA levels were instead suppressed to 50% of control. Upon longer exposure to phorbol esters (48 h) suppression of fibronectin and PAI-1 mRNAs also occurred. Intracellular elevation of cAMP led to over-expression of fibronectin and type IV collagenase and potentiated the effects of phorbol esters on collagen IV, tPA, and interstitial collagenase expression. The mRNA changes induced by high glucose occurred in the absence of protein kinase C activation or cAMP elevation. These studies indicate that events other than activation of protein kinase C or A bridge high ambient glucose to changes in endothelial cell gene expression that may contribute to diabetic angiopathy.	HARVARD UNIV,SCH MED,DEPT OPHTHALMOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	CAGLIERO, E (corresponding author), EYE RES INST,20 STANFORD ST,BOSTON,MA 02114, USA.				NEI NIH HHS [EY09122] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009122] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; AUWERX J, 1988, ARTERIOSCLEROSIS, V8, P68, DOI 10.1161/01.ATV.8.1.68; BALLESTER R, 1985, J BIOL CHEM, V260, P5194; BOERI D, 1989, DIABETES, V38, P212, DOI 10.2337/diabetes.38.2.212; BOSMA PJ, 1988, J BIOL CHEM, V263, P9129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINCKERHOFF CE, 1987, J CLIN INVEST, V79, P542, DOI 10.1172/JCI112845; CAGLIERO E, 1991, DIABETES, V40, P102, DOI 10.2337/diabetes.40.1.102; CAGLIERO E, 1991, INVEST OPHTH VIS SCI, V32, P1439; CAGLIERO E, 1988, J CLIN INVEST, V82, P735, DOI 10.1172/JCI113655; CARVALLO P, 1989, MOL ENDOCRINOL, V3, P1935, DOI 10.1210/mend-3-12-1935; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN MP, 1982, AM J PHYSIOL, V242, pF385, DOI 10.1152/ajprenal.1982.242.4.F385; COLLIER IE, 1988, J BIOL CHEM, V263, P6579; CRAVEN PA, 1989, J CLIN INVEST, V83, P1667, DOI 10.1172/JCI114066; CROSSMAN DC, 1990, J BIOL CHEM, V265, P9782; DEAN DC, 1988, J CELL BIOL, V106, P2159, DOI 10.1083/jcb.106.6.2159; DEAN DC, 1989, MOL CELL BIOL, V9, P1498, DOI 10.1128/MCB.9.4.1498; DEGEN SJF, 1986, J BIOL CHEM, V261, P6972; ENGERMAN RL, 1989, DIABETES, V38, P1203, DOI 10.2337/diabetes.38.10.1203; FENG P, 1990, J BIOL CHEM, V265, P2022; FINI ME, 1990, J CELL SCI, V97, P373; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; LEVIN EG, 1989, J BIOL CHEM, V264, P16030; LORENZI M, 1985, DIABETES, V34, P621, DOI 10.2337/diabetes.34.7.621; LOSKUTOFF DJ, 1986, J CELL BIOCHEM, V32, P273, DOI 10.1002/jcb.240320404; MACKIE K, 1986, J CELL PHYSIOL, V128, P367, DOI 10.1002/jcp.1041280304; MARTINEZHERNANDEZ A, 1983, LAB INVEST, V48, P656; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MOSCATELLI D, 1988, BIOCHIM BIOPHYS ACTA, V948, P67, DOI 10.1016/0304-419X(88)90005-4; NELLES L, 1987, J BIOL CHEM, V262, P10855; NISHIZUKA Y, 1989, JAMA-J AM MED ASSOC, V262, P1826, DOI 10.1001/jama.262.13.1826; OLDBERG A, 1983, J BIOL CHEM, V258, P193; OSTERBY R, 1990, DIABETES MELLITUS TH, P220; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; PARVING HH, 1976, DIABETES, V25, P884; POSCHL E, 1988, EMBO J, V7, P2687, DOI 10.1002/j.1460-2075.1988.tb03122.x; POULSOM R, 1988, J BIOL CHEM, V263, P10072; RICCIO A, 1988, NUCLEIC ACIDS RES, V16, P2805, DOI 10.1093/nar/16.7.2805; ROSENSTOCK J, 1986, AM J MED, V81, P1012, DOI 10.1016/0002-9343(86)90398-0; ROY S, 1990, P NATL ACAD SCI USA, V87, P404, DOI 10.1073/pnas.87.1.404; SAKSELA O, 1987, J CELL BIOL, V105, P957, DOI 10.1083/jcb.105.2.957; SANTELL L, 1988, J BIOL CHEM, V263, P16802; STEFFES MW, 1989, DIABETES, V38, P1077, DOI 10.2337/diabetes.38.9.1077; STEFFES MW, 1985, NEW ENGL J MED, V312, P1282, DOI 10.1056/NEJM198505163122003; THAMS P, 1988, BIOCHEM J, V253, P229, DOI 10.1042/bj2530229; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; WOLF BA, 1990, J CLIN INVEST, V85, P482, DOI 10.1172/JCI114463	51	88	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14244	14250						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713580				2022-12-27	WOS:A1991FZ35100022
J	BUISER, RG; DESTEFANO, JJ; MALLABER, LM; FAY, PJ; BAMBARA, RA				BUISER, RG; DESTEFANO, JJ; MALLABER, LM; FAY, PJ; BAMBARA, RA			REQUIREMENTS FOR THE CATALYSIS OF STRAND TRANSFER SYNTHESIS BY RETROVIRAL DNA-POLYMERASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIAN-SARCOMA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; REVERSE-TRANSCRIPTASE; ESCHERICHIA-COLI; RNASE-H; LINEAR DNA; GENOME; AIDS; PROCESSIVITY; RIBONUCLEASE	We have examined the properties of reverse transcriptases (RTs) required for strand transfer synthesis on poly(rA). In this process, a primer is elongated on one template and then switches to other templates for additional elongation until it is much longer than the templates on which it was made. Models of retrovirus replication require the RT to catalyze two distinct strand transfers. Additionally, they propose that the RT ribonuclease H (RNase H) activity is involved in both transfers. RTs from human immunodeficiency virus (HIV), avian myeloblastosis virus, and murine leukemia virus differ in molecular mass and subunit composition. However, they all catalyzed strand transfer synthesis on (rA)300, generating characteristically long products. An RNase H-deficient enzyme, HIV-RT(RD), catalyzed strand transfer synthesis to the same degree as native HIV-RT, indicating that a functional RNase H activity is not required. Additionally, N-ethylmaleimide, which inhibits RNase H but not polymerase activity of HIV-RT, did not diminish strand transfer synthesis. Highly processive DNA synthesis by each RT was found to be required for the strand transfer reaction. RNase H- murine leukemic virus RT has a structural modification that not only eradicates RNase H, but also makes the polymerase much less processive for DNA synthesis. However, conditions that allow this modified enzyme to bind repeatedly to the same primer during synthesis, i.e. conditions that simulate higher processivity, allow strand transfer synthesis. Catalysis of strand transfer synthesis is not a property of all DNA polymerases, since the Klenow fragment of Escherichia coli DNA polymerase I is unable to catalyze this reaction even if high processivity is simulated. These results suggest that strand transfer synthesis relies on an unidentified functional activity present in RTs.	UNIV ROCHESTER, MED CTR, DEPT BIOCHEM, BOX 607, 601 ELMWOOD AVE, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, MED CTR, DEPT MED, ROCHESTER, NY 14642 USA; UNIV ROCHESTER, MED CTR, CTR CANC, ROCHESTER, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester					NCI NIH HHS [CA 11198] Funding Source: Medline; NIAID NIH HHS [AI 27054] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA011198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027054] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAMBARA RA, 1978, J BIOL CHEM, V253, P413; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; COLLETT MS, 1978, NATURE, V272, P181, DOI 10.1038/272181a0; COLLETT MS, 1978, J VIROL, V26, P498, DOI 10.1128/JVI.26.2.498-509.1978; FARMERIE WG, 1987, SCIENCE, V236, P305, DOI 10.1126/science.2436298; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; GERARD GF, 1980, MOL BIOL RNA TUMOR V, P345; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; HIZI A, 1991, J BIOL CHEM, V266, P6230; HUBER HE, 1989, J BIOL CHEM, V264, P4669; HUGHES SH, 1978, CELL, V15, P1397, DOI 10.1016/0092-8674(78)90064-8; KOTEWICZ ML, 1988, NUCLEIC ACIDS RES, V16, P265, DOI 10.1093/nar/16.1.265; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; LOWRY DR, 1985, VIROLOGY, P235; MAJORS JE, 1981, NATURE, V289, P253, DOI 10.1038/289253a0; OMER CA, 1982, CELL, V30, P797, DOI 10.1016/0092-8674(82)90284-7; OMER CA, 1981, J VIROL, V38, P398, DOI 10.1128/JVI.38.1.398-402.1981; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; ROTH MJ, 1985, J BIOL CHEM, V260, P9326; SABATINO RD, 1988, BIOCHEMISTRY-US, V27, P2998, DOI 10.1021/bi00408a050; Sambrook J, 1989, MOL CLONING LABORATO; SHANK PR, 1978, CELL, V15, P1383, DOI 10.1016/0092-8674(78)90063-6; STARNES MC, 1989, J BIOL CHEM, V264, P7073; SWANSTROM R, 1981, J BIOL CHEM, V256, P1115; TAYLOR JM, 1980, COLD SPRING HARB SYM, V44, P1091, DOI 10.1101/SQB.1980.044.01.117; TEMIN HM, 1981, CELL, V27, P1, DOI 10.1016/0092-8674(81)90353-6; VARMUS HE, 1985, RNA TUMOR VIRUSES, V2, P75; VERMA IM, 1975, J VIROL, V15, P843, DOI 10.1128/JVI.15.4.843-854.1975; VERMA IM, 1981, ENYZMES, V14, P78; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504	31	33	33	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13103	13109						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712774				2022-12-27	WOS:A1991FX13200050
J	FISCHMANN, TO; BENTLEY, GA; BHAT, TN; BOULOT, G; MARIUZZA, RA; PHILLIPS, SEV; TELLO, D; POLJAK, RJ				FISCHMANN, TO; BENTLEY, GA; BHAT, TN; BOULOT, G; MARIUZZA, RA; PHILLIPS, SEV; TELLO, D; POLJAK, RJ			CRYSTALLOGRAPHIC REFINEMENT OF THE 3-DIMENSIONAL STRUCTURE OF THE FABD1.3-LYSOZYME COMPLEX AT 2.5-A RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-LYSOZYME ANTIBODY; FAB FRAGMENT; D1.3; BINDING; FV	The three-dimensional crystal structure of the complex between the Fab from the monoclonal anti-lysozyme antibody D1.3 and the antigen, hen egg white lysozyme, has been refined by crystallographic techniques using x-ray intensity data to 2.5-angstrom resolution. The antibody contacts the antigen with residues from all its complementarity determining regions. Antigen residues 18-27 and 117-125 form a discontinuous antigenic determinant making hydrogen bonds and van der Waals interactions with the antibody. Water molecules at or near the antigen-antibody interface mediate some contacts between antigen and antibody. The fine specificity of antibody D1.3, which does not bind (K(a) < 10(5) M-1) avian lysozymes where Gln121 in the amino acid sequence is occupied by His, can be explained on the basis of the refined model.	UNIV LEEDS,DEPT BIOCHEM & MOLEC BIOL,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND	University of Leeds	FISCHMANN, TO (corresponding author), INST PASTEUR,DEPT IMMUNOL,F-75724 PARIS 15,FRANCE.		Bentley, Graham/B-3623-2011	Phillips, Simon/0000-0001-8922-0250	NIAID NIH HHS [AI 25369] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025369] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIT AG, 1986, SCIENCE, V228, P1280; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; BHAT TN, 1979, INT J PEPT PROT RES, V13, P170; BHAT TN, 1984, J APPL CRYSTALLOGR, V11, P268; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; BOULOT G, 1987, J MOL BIOL, V194, P577, DOI 10.1016/0022-2836(87)90685-1; BOULOT G, 1990, J MOL BIOL, V213, P617, DOI 10.1016/S0022-2836(05)80248-7; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CHOTHIA C, 1986, SCIENCE, V233, P755, DOI 10.1126/science.3090684; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P648; HARPER M, 1987, MOL IMMUNOL, V24, P97, DOI 10.1016/0161-5890(87)90081-2; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MARIUZZA RA, 1983, J MOL BIOL, V170, P1055, DOI 10.1016/S0022-2836(83)80206-X; Pflugrath J. W., 1984, Methods and Applications in Crystallographic Computing. International Summer School on Crystallographic Computing, P404; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; SOBOTTKA SE, 1990, J APPL CRYSTALLOGR, V23, P199, DOI 10.1107/S002188989000098X; TULIP WR, 1989, COLD SH Q B, V54, P257; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0	26	183	189	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					12915	12920						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712773				2022-12-27	WOS:A1991FX13200022
J	NAKADA, H; NUMATA, Y; INOUE, M; TANAKA, N; KITAGAWA, H; FUNAKOSHI, I; FUKUI, S; YAMASHINA, I				NAKADA, H; NUMATA, Y; INOUE, M; TANAKA, N; KITAGAWA, H; FUNAKOSHI, I; FUKUI, S; YAMASHINA, I			ELUCIDATION OF AN ESSENTIAL STRUCTURE RECOGNIZED BY AN ANTI-GALNAC ALPHA-SER(THR) MONOCLONAL-ANTIBODY (MLS-128)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-GROUP; TN-ANTIGEN; HUMAN FIBRONECTIN; GLYCOPROTEINS; EPITOPE; MUCIN; GLYCOLIPIDS; TRANSFERASE; CANCER	To determine the epitopic structure for an anti-GalNAc-alpha-Ser(Thr) (anti-Tn) monoclonal antibody, MLS 128, asialo-ovine submaxillary mucin was digested with various proteases, and the digests were fractionated by immunoaffinity column chromatography and high performance liquid chromatography. From the tryptic digest, a glycopeptide, GP-I, and five other glycopeptides, GP-1-5, were obtained as bound and unbound fractions, respectively, of the immunoaffinity column. By solid phase radioimmunoassaying, it was found that GP-I was strongly immunoreactive, whereas GP-1-5 were poorly immunoreactive. On treatment with V8 protease, GP-I was converted to two glycopeptides, one with poor reactivity and the other with intermediate reactivity. From the thermolysin digest, the smallest fragment, GP-II, was isolated, which was as strongly immunoreactive as GP-I. GP-II corresponded to a part of GP-I, its sequence being Leu-Ser*-Glu-Ser*-Thr*-Thr*-Gln-Leu-Pro-Gly, where asterisks denote amino acids to which an alpha-GalNAc residue is attached. Other anti-Tn monoclonal antibodies, NCC-LU-35 and CA 3239, showed essentially the same reactivity to these glycopeptides as MLS 128 did. The glycopeptides (GP-1-5), which exhibited poor immunoreactivity, contained various GalNAc-containing structures, such as GaINAc-Ser, GalNAc-Thr, GalNAc-Ser-(GalNAc)Ser, and GalNAc-Thr-(GalNAc)-Thr. These results indicate that a glycopeptide including a cluster structure, Ser*-Thr*-Thr*, is an essential part of the epitope recognized by anti-Tn antibodies.	KYOTO SANGYO UNIV, FAC ENGN, DEPT BIOTECHNOL, KITA KU, KYOTO 603, ENGLAND; SHIONOGI PHARMACEUT CO, SETTSU 566, JAPAN; KYOTO UNIV, FAC PHARMACEUT SCI, DEPT BIOL CHEM, SAKYO KU, KYOTO 606, JAPAN	Shionogi & Company Limited; Kyoto University			Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079				BERGER EG, 1978, FEBS LETT, V93, P105, DOI 10.1016/0014-5793(78)80815-1; CARTRON JP, 1978, EUR J BIOCHEM, V92, P111, DOI 10.1111/j.1432-1033.1978.tb12728.x; DAHR W, 1974, VOX SANG, V27, P29, DOI 10.1111/j.1423-0410.1974.tb02386.x; DAUSSET J, 1959, BLOOD, V14, P1079, DOI 10.1182/blood.V14.10.1079.1079; DAY ED, 1972, ADV IMMUNOCHEMISTRY, P267; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FUKUI S, 1988, JPN J CANCER RES, V79, P1119, DOI 10.1111/j.1349-7006.1988.tb01535.x; GARDELL S, 1953, ACTA CHEM SCAND, V7, P207, DOI 10.3891/acta.chem.scand.07-0207; GOPALAKRISHNAN PV, 1974, J IMMUNOL, V113, P769; HAKOMORI S, 1985, CANCER RES, V45, P2405; HILL HD, 1977, J BIOL CHEM, V252, P3799; HIROHASHI S, 1985, P NATL ACAD SCI USA, V82, P7039, DOI 10.1073/pnas.82.20.7039; KJELDSEN T, 1988, CANCER RES, V48, P2214; KUROSAKA A, 1988, J BIOL CHEM, V263, P8724; KUROSAKA A, 1987, FEBS LETT, V215, P137, DOI 10.1016/0014-5793(87)80128-X; MATSUURA H, 1989, J BIOL CHEM, V264, P10472; MATSUURA H, 1988, J BIOL CHEM, V263, P3314; NUMATA Y, 1990, BIOCHEM BIOPH RES CO, V170, P981, DOI 10.1016/0006-291X(90)90488-9; SPRINGER GF, 1976, NATURWISSENSCHAFTEN, V63, P488, DOI 10.1007/BF00624592; SPRINGER GF, 1985, CANCER, V55, P561, DOI 10.1002/1097-0142(19850201)55:3<561::AID-CNCR2820550315>3.0.CO;2-1; SPRINGER GF, 1984, SCIENCE, V224, P1198, DOI 10.1126/science.6729450; STEIN R, 1989, CANCER RES, V49, P32; TAKAHASHI HK, 1988, CANCER RES, V48, P4361; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9	24	84	85	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12402	12405						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712019				2022-12-27	WOS:A1991FV18000048
J	MODIANO, JF; KOLP, R; LAMB, RJ; NOWELL, PC				MODIANO, JF; KOLP, R; LAMB, RJ; NOWELL, PC			PROTEIN-KINASE-C REGULATES BOTH PRODUCTION AND SECRETION OF INTERLEUKIN-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYMPHOCYTE-T ACTIVATION; CELL GROWTH-FACTOR; ANTIGEN RECEPTOR COMPLEX; MONOCLONAL-ANTIBODY; SIGNAL TRANSDUCTION; GENE-EXPRESSION; PHORBOL ESTER; CLONED CDNA; RAT-BRAIN; CALCIUM	Inhibiting protein kinase C (PKC) activity abrogated interleukin 2 (IL2) production by mitogen-stimulated human T lymphocytes. This effect was due partially to a 50% decrease in IL2 gene expression. However, when PKC inhibitors were added after IL2 gene transcription had already proceeded for 3-4 h, the IL2 in the culture supernatants was still reduced by 30-80%, and intracellular IL2 was increased by up to 50%. The inhibition of PKC affected the expression of IL2 receptors by these cells differently; it had little effect on gene expression or on the membrane-bound form of the receptor, but it decreased soluble receptors in the supernatants by 50-80%. These data indicate that in addition to its previously defined role in gene expression, PKC can also regulate extracellular secretion of proteins critical for T cell proliferation.	UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104	University of Pennsylvania			MODIANO, JAIME/K-3583-2019	MODIANO, JAIME/0000-0001-6398-7648	NATIONAL CANCER INSTITUTE [P01CA015822, R35CA042232] Funding Source: NIH RePORTER; NCI NIH HHS [CA-42232, CA-15822] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAKER PE, 1979, J EXP MED, V149, P273, DOI 10.1084/jem.149.1.273; BERRY N, 1989, J IMMUNOL, V143, P1407; BEYERS AD, 1988, J IMMUNOL, V141, P3463; BRANDT SJ, 1987, CELL, V49, P57, DOI 10.1016/0092-8674(87)90755-0; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; FARRAR WL, 1986, J IMMUNOL, V136, P1266; FRIEDRICH B, 1988, EUR J IMMUNOL, V18, P489, DOI 10.1002/eji.1830180327; GARDNER P, 1989, CELL, V59, P15, DOI 10.1016/0092-8674(89)90865-9; HIGASHIHARA M, 1985, BIOCHEM BIOPH RES CO, V133, P306, DOI 10.1016/0006-291X(85)91876-5; HOLBROOK NJ, 1984, P NATL ACAD SCI-BIOL, V81, P1634, DOI 10.1073/pnas.81.6.1634; HUANG FL, 1987, BIOCHEM BIOPH RES CO, V149, P946, DOI 10.1016/0006-291X(87)90500-6; IMBODEN J, 1987, J IMMUNOL, V138, P1322; IMBODEN JB, 1985, J EXP MED, V161, P446, DOI 10.1084/jem.161.3.446; ISAKOV N, 1987, IMMUNOL REV, V95, P89, DOI 10.1111/j.1600-065X.1987.tb00501.x; ISAKOV N, 1987, J IMMUNOL, V138, P3100; KAIBUCHI K, 1983, J BIOL CHEM, V258, P6701; KAJIKAWA N, 1983, BIOCHEM BIOPH RES CO, V116, P743, DOI 10.1016/0006-291X(83)90587-9; KERN JA, 1986, J IMMUNOL, V137, P764; KIKKAWA U, 1983, METHOD ENZYMOL, V99, P288; KIKKAWA U, 1986, PROG BRAIN RES, V69, P29; KUNG HF, 1989, MOL CELL BIOCHEM, V89, P29; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDBETTER JA, 1986, J IMMUNOL, V136, P3945; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; MANGER B, 1987, J IMMUNOL, V139, P2755; MILLS GB, 1989, J CELL PHYSIOL, V141, P310, DOI 10.1002/jcp.1041410212; MIRE AR, 1986, BIOCHEM BIOPH RES CO, V137, P128, DOI 10.1016/0006-291X(86)91185-X; MOCHLYROSEN D, 1987, P NATL ACAD SCI USA, V84, P4660, DOI 10.1073/pnas.84.13.4660; MODIANO JF, 1988, J CELL PHYSIOL, V135, P451, DOI 10.1002/jcp.1041350312; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; NAKADATE T, 1988, BIOCHEM PHARMACOL, V37, P1541, DOI 10.1016/0006-2952(88)90016-0; NEL AE, 1987, J IMMUNOL, V138, P3519; NELSON DL, 1986, J CLIN IMMUNOL, V6, P114, DOI 10.1007/BF00918743; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PONTREMOLI S, 1986, J BIOL CHEM, V261, P8309; RABIN H, 1981, J IMMUNOL, V127, P1852; ROBB RJ, 1981, J EXP MED, V154, P1455, DOI 10.1084/jem.154.5.1455; ROBB RJ, 1987, J IMMUNOL, V139, P855; ROBB RJ, 1984, P NATL ACAD SCI-BIOL, V81, P6486, DOI 10.1073/pnas.81.20.6486; RUBIN LA, 1985, J IMMUNOL, V135, P3172; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHACKELFORD DA, 1986, J BIOL CHEM, V261, P8334; SIMONIAN NA, 1990, IN PRESS J EXP MED; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; SUBRAMANIAM A, 1988, CELL IMMUNOL, V116, P439, DOI 10.1016/0008-8749(88)90243-2; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; SZAMEL M, 1989, J IMMUNOL, V143, P2806; TAMAOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397, DOI 10.1016/0006-291X(86)90008-2; TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0; TANIGUCHI T, 1986, IMMUNOL REV, V92, P121, DOI 10.1111/j.1600-065X.1986.tb01497.x; TRUNEH A, 1985, NATURE, V313, P318, DOI 10.1038/313318a0; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X; WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337; WILKINSON M, 1988, NUCLEIC ACIDS RES, V16, P10933, DOI 10.1093/nar/16.22.10933; YAMAMOTO Y, 1986, J BIOCHEM-TOKYO, V100, P333, DOI 10.1093/oxfordjournals.jbchem.a121719; ZURGIL N, 1985, FEBS LETT, V185, P257, DOI 10.1016/0014-5793(85)80918-2	58	25	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10552	10561						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709936				2022-12-27	WOS:A1991FP08600083
J	WILLIAMS, WV; KIEBEREMMONS, T; WEINER, DB; RUBIN, DH; GREENE, MI				WILLIAMS, WV; KIEBEREMMONS, T; WEINER, DB; RUBIN, DH; GREENE, MI			CONTACT RESIDUES AND PREDICTED STRUCTURE OF THE REOVIRUS TYPE 3-RECEPTOR INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIRECEPTOR ANTIBODY; MAMMALIAN REOVIRUS; CELL RECEPTORS; HEMAGGLUTININ; ATTACHMENT; BINDING; GLYCOPROTEINS; INHIBITION; IDIOTYPE; DOMAINS	Sequence similarity between the reovirus type 3 hemagglutinin (HA3) and a anti-idiotypic monoclonal antibody (87.92.6) has been shown to define the site of interaction with a neutralizing (idiotypic) monoclonal antibody (9B.G5) and the cellular receptor for the virus. A synthetic peptide (V(L) peptide) derived from the anti-idiotypic sequence inhibits viral binding to the receptor. In this study, variants of the V(L) peptide were utilized to probe specific amino acid residues involved in binding the neutralizing antibody and the receptor. These studies indicate that the - OH groups of several residues are involved in contacting the reovirus type 3 receptor, including Tyr49, Ser50, Ser52, and Thr53 in the anti-idiotypic sequence, corresponding to Tyr326, Ser327, Ser329, and Ser325 in HA3, respectively. In contrast, only Ser50 of the anti-idiotypic sequence, corresponding to Ser327 of HA3, significantly altered neutralizing antibody binding. Additional studies implicate sialic acid as a potential reovirus type 3 receptor on some cells. This includes inhibition of binding of reovirus type 3 and 87.92.6 to L cells by heavily sialylated glycoproteins. Sialic acid was therefore utilized as a candidate receptor to analyze potential interaction schemes with HA3/87.92.6. Sequence similarity to other immunoglobulin structures with similar sequences allowed modeling of the three-dimensional structure of these epitopes. These structures, in combination with peptide studies, allow the development of a model of the interaction of these epitopes with sialic acid, which serves as a reovirus type 3 receptor. These models reveal that similar amino acid residues and side-chain geometries may be utilized by the reovirus type 3 and influenza hemagglutinins in their interactions with cell-surface receptors.	UNIV PENN,SCH MED,DEPT PATHOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT MICROBIOL,PHILADELPHIA,PA 19104; PHILADELPHIA VET AFFAIRS MED CTR,DEPT MED,PHILADELPHIA,PA; WISTAR INST,PHILADELPHIA,PA 19104	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; The Wistar Institute	WILLIAMS, WV (corresponding author), UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104, USA.		Weiner, David B/H-8579-2014	Williams, William/0000-0003-3611-9284				BRUCK C, 1986, P NATL ACAD SCI USA, V83, P6578, DOI 10.1073/pnas.83.17.6578; BURSTIN SJ, 1982, VIROLOGY, V117, P146, DOI 10.1016/0042-6822(82)90514-1; CLOTHIA C, 1989, SCIENCE, V342, P877; CO MS, 1985, P NATL ACAD SCI USA, V82, P5315, DOI 10.1073/pnas.82.16.5315; CO MS, 1985, P NATL ACAD SCI USA, V82, P1491; GAULTON GN, 1989, J EXP MED, V169, P197, DOI 10.1084/jem.169.1.197; GENTSCH JR, 1985, J VIROL, V56, P356, DOI 10.1128/JVI.56.2.356-364.1985; KAUFFMAN RS, 1983, J IMMUNOL, V131, P2539; Kieber-Emmons T, 1987, Int Rev Immunol, V2, P339, DOI 10.3109/08830188709044761; LIU J, 1988, IMMUNOL RES, V7, P232, DOI 10.1007/BF02918138; MARTIN ACR, 1989, P NATL ACAD SCI USA, V86, P9268, DOI 10.1073/pnas.86.23.9268; NEPOM J T, 1982, Survey of Immunologic Research, V1, P255; NEPOM JT, 1982, J EXP MED, V155, P155, DOI 10.1084/jem.155.1.155; NOSEWORTHY JH, 1983, J IMMUNOL, V131, P2533; PACITTI AF, 1987, J VIROL, V61, P1407, DOI 10.1128/JVI.61.5.1407-1415.1987; SAWUTZ DG, 1987, LIFE SCI, V40, P399, DOI 10.1016/0024-3205(87)90142-1; SPRIGGS DR, 1983, VIROLOGY, V127, P220, DOI 10.1016/0042-6822(83)90385-9; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILLIAMS WV, 1988, P NATL ACAD SCI USA, V85, P6488, DOI 10.1073/pnas.85.17.6488; WILLIAMS WV, 1989, J IMMUNOL, V142, P4392; WILLIAMS WV, 1989, P NATL ACAD SCI USA, V86, P5537, DOI 10.1073/pnas.86.14.5537	22	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					9241	9250						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709165				2022-12-27	WOS:A1991FM03800087
J	LOMASNEY, JW; COTECCHIA, S; LORENZ, W; LEUNG, WY; SCHWINN, DA; YANGFENG, TL; BROWNSTEIN, M; LEFKOWITZ, RJ; CARON, MG				LOMASNEY, JW; COTECCHIA, S; LORENZ, W; LEUNG, WY; SCHWINN, DA; YANGFENG, TL; BROWNSTEIN, M; LEFKOWITZ, RJ; CARON, MG			MOLECULAR-CLONING AND EXPRESSION OF THE CDNA FOR THE ALPHA-1A-ADRENERGIC RECEPTOR - THE GENE FOR WHICH IS LOCATED ON HUMAN CHROMOSOME-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE REGULATORY PROTEINS; BETA-ADRENERGIC-RECEPTOR; ALPHA-1-ADRENERGIC RECEPTOR; BETA-2-ADRENERGIC RECEPTORS; ALPHA-2-ADRENERGIC RECEPTOR; SMOOTH-MUSCLE; SUBTYPES; BINDING; CHLORETHYLCLONIDINE; PHOSPHORYLATION	Pharmacological and molecular cloning studies have demonstrated heterogeneity of alpha-1-adrenergic receptors. We have now cloned two alpha-1-adrenergic receptors from a rat cerebral cortex cDNA library, using the hamster alpha-1B-adrenergic receptor as a probe. The deduced amino acid sequence of clone RA42 encodes a protein of 560 amino acids whose putative topology is similar to that of the family of G-protein-coupled receptors. The primary structure though most closely resembles that of an alpha-1-adrenergic receptor, having approximately 73% amino acid identity in the putative transmembrane domains with the previously isolated hamster alpha-1B receptor. Analysis of the ligand binding properties of RA42 expressed in COS-7 cells with a variety of adrenergic ligands demonstrates a unique alpha-1-adrenergic receptor pharmacology. High affinity for the antagonist WB4101 and agonists phenylephrine and methoxamine suggests that cDNA RA42 encodes the alpha-1A receptor subtype. Northern blot analysis of various rat tissues also shows the distribution expected of the alpha-1A receptor subtype with abundant expression in vas deferens followed by hippocampus, cerebral cortex, aorta, brainstem, heart and spleen. The second alpha-1-adrenergic receptor cloned represents the rat homolog of the hamster alpha-1B subtype. Expression of mRNA for this receptor is strongly detected in liver followed by heart, cerebral cortex, brain stem, kidney, lung, and spleen. This study provides definitive evidence for the existence of three alpha-1-adrenergic receptor subtypes.	DUKE UNIV,MED CTR,DEPT ANESTHESIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT CELL BIOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT BIOCHEM,DURHAM,NC 27710; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; NIMH,BETHESDA,MD 20892; YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Duke University; Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Yale University	LOMASNEY, JW (corresponding author), DUKE UNIV,MED CTR,DEPT PATHOL,DURHAM,NC 27710, USA.		Brownstein, Michael/B-8609-2009; Lefkowitz, Robert/AAW-2649-2021	Schwinn, Debra/0000-0002-9696-5231	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R37HL016037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL16037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BOUVIER M, 1987, J BIOL CHEM, V262, P3106; BUCKLAND PR, 1990, NUCLEIC ACIDS RES, V18, P682, DOI 10.1093/nar/18.3.682; BYLUND DB, 1988, TRENDS PHARMACOL SCI, V9, P356, DOI 10.1016/0165-6147(88)90254-4; BYLUND DB, 1988, J PHARMACOL EXP THER, V245, P600; BYLUND DB, 1985, PHARMACOL BIOCHEM BE, V22, P835, DOI 10.1016/0091-3057(85)90536-2; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COTECCHIA S, 1988, P NATL ACAD SCI USA, V85, P7159, DOI 10.1073/pnas.85.19.7159; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; DELEAN A, 1982, MOL PHARMACOL, V21, P5; DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056; DOHLMAN HG, 1987, BIOCHEMISTRY-US, V26, P2657, DOI 10.1021/bi00384a001; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; HAN C, 1987, MOL PHARMACOL, V32, P505; HAN C, 1987, NATURE, V329, P333, DOI 10.1038/329333a0; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; KOBILKA BK, 1987, SCIENCE, V238, P650, DOI 10.1126/science.2823383; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEEBLUNDBERG LMF, 1987, J BIOL CHEM, V262, P3098; LEFKOWITZ RJ, 1988, J BIOL CHEM, V263, P4993; LOMASNEY JW, 1990, P NATL ACAD SCI USA, V87, P5094, DOI 10.1073/pnas.87.13.5094; MANIATIS T, 1982, MOL CLONING LABORATO, P365; MINNEMAN KP, 1988, PHARMACOL REV, V40, P87; MINNEMAN KP, 1988, MOL PHARMACOL, V33, P509; MORROW AL, 1986, MOL PHARMACOL, V29, P321; MURPHY TJ, 1988, J PHARMACOL EXP THER, V244, P571; ODOWD BF, 1989, ANNU REV NEUROSCI, V12, P67, DOI 10.1146/annurev.ne.12.030189.000435; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; REGAN JW, 1988, P NATL ACAD SCI USA, V85, P6301, DOI 10.1073/pnas.85.17.6301; ROSSBY SP, 1989, 71ST ANN M END SOC B, P40; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWINN DA, 1990, J BIOL CHEM, V265, P8183; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; VOIGT MM, 1990, NUCLEIC ACIDS RES, V18, P1053, DOI 10.1093/nar/18.4.1053; WANG HY, 1989, J BIOL CHEM, V264, P14424; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516; YANGFENG TL, 1986, CYTOGENET CELL GENET, V43, P121, DOI 10.1159/000132309; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102	41	460	469	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6365	6369						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706716				2022-12-27	WOS:A1991FE37300055
J	ZU, XW; JAY, FT				ZU, XW; JAY, FT			THE E1 FUNCTIONAL EPITOPE OF THE HUMAN INTERFERON GAMMA IS A NUCLEAR TARGETING SIGNAL-LIKE ELEMENT - MAPPING OF THE E1 EPITOPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							HUMAN IMMUNE INTERFERON; AMINO-ACID-SEQUENCE; GLUCOCORTICOID RECEPTOR; T-ANTIGEN; LOCALIZATION; EXPRESSION; LOCATION; CLONING; CELLS; CDNA	Eight neutralizing monoclonal antibodies (mAbs) directed against the human interferon-gamma (HuIFN-gamma) that were classified in the E1 epitope group were mapped by the synthetic peptide approach. A set of 136 octapeptide homologs of the 143-residue primary sequence of the HuIFN-gamma, each one with a 7-residue sequence overlap with successive peptide, was synthesized. Based on the similar reactivity patterns of all the mAbs with this set of synthetic peptides, the E1 functional epitope was localized to residues 84-94 on the HuIFN-gamma. The epitope sequence is: Ser-Asn-Lys-Lys-Lys-Arg-Asp-Asp-Phe-Gln-Lys. The fact that eight independently isolated mAbs binding to the same domain can neutralize the HuIFN-gamma activity suggests that the E1 domain must be at or adjacent to a functional site. Within this domain is a sequence element, Lys-Lys-Lys-Arg, that resembles the nuclear location signals known to effect the intracellular transportation of a number of nuclear proteins, such as the large tumor antigen (T antigen) of simian virus 40 (SV40) and polyoma virus and steroid hormone receptors. This observation suggests that the HuIFN-gamma molecule and/or its complex with the receptor must function in the nucleus to effect transcription regulation that results in the various biological activities. The signal for that intracellular transportation must be provided by the HuIFN-gamma molecule.	UNIV MANITOBA,DEPT MED MICROBIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA	University of Manitoba								AGNET M, 1988, CELL, V55, P273; ALFA MJ, 1987, HYBRIDOMA, V6, P509, DOI 10.1089/hyb.1987.6.509; ALFA MJ, 1988, J IMMUNOL, V141, P2474; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; BLACK SD, 1985, MSEQ PROTEIN STRUCTU; CELADA A, 1987, J IMMUNOL, V139, P147; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DEVOS R, 1982, NUCLEIC ACIDS RES, V10, P2487, DOI 10.1093/nar/10.8.2487; GEYSEN HM, 1987, J IMMUNOL METHODS, V102, P259, DOI 10.1016/0022-1759(87)90085-8; GRAY PW, 1982, NATURE, V295, P503, DOI 10.1038/295503a0; GUIOCHONMANTEL A, 1989, CELL, V57, P1147, DOI 10.1016/0092-8674(89)90052-4; JAY E, 1984, J BIOL CHEM, V259, P6311; JAY E, 1984, P NATL ACAD SCI-BIOL, V81, P2290, DOI 10.1073/pnas.81.8.2290; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; LANFORD RE, 1986, CELL, V46, P575, DOI 10.1016/0092-8674(86)90883-4; LUK SKS, 1990, J BIOL CHEM, V265, P13314; MORELAND RB, 1985, P NATL ACAD SCI USA, V82, P6561, DOI 10.1073/pnas.82.19.6561; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; RICHARDSON WD, 1986, CELL, V44, P77, DOI 10.1016/0092-8674(86)90486-1; RINDERKNECHT E, 1984, J BIOL CHEM, V259, P6790; STEWART WE, 1979, INTERFERON SYSTEM, P198	22	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6023	6026						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706709				2022-12-27	WOS:A1991FE37300005
J	SAKAMOTO, K; FORDIS, CM; CORSICO, CD; HOWARD, TH; HOWARD, BH				SAKAMOTO, K; FORDIS, CM; CORSICO, CD; HOWARD, TH; HOWARD, BH			MODULATION OF HELA-CELL GROWTH BY TRANSFECTED 7SL RNA AND ALU GENE-SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-III TRANSCRIPTION; SIGNAL RECOGNITION PARTICLE; ADENOVIRUS VA RNA1; SURFACE ANTIGEN; DNA-SEQUENCES; NEURONAL DIFFERENTIATION; REPETITIVE SEQUENCES; NUCLEOTIDE-SEQUENCE; MAMMALIAN GENOMES; RODENT CELLS	Alu and 7SL RNA gene sequences were tested for the potential to regulate mammalian cell growth by introducing these sequences into HeLa cells in a coupled DEAE-dextran transfection/affinity cell sorting system. Both Alu and 7SL RNA genes mediated inhibition of [H-3]thymidine and [S-35]methionine incorporation in recipient cells. In addition, short term growth curves were performed on calcium phosphate/DNA cotransfected, affinity-purified cells. This second assay revealed that transfected Alu and 7SL RNA can also cause suppression of HeLa cell proliferation. To investigate whether transcription or polymerase III (pol III) transcription factor binding was required for inhibitory activity, mutations were introduced into RNA pol III B block promoter elements in each of these genes. Suppression of [H-3]thymidine incorporation was dependent on the presence of this pol III element in both genes; likewise, 7SL RNA-mediated growth suppression required the presence of the pol III B block promoter element. The results of this study indicate that Alu and 7SL RNA gene sequences interact with cellular factors that are important for HeLa cell proliferation and suggest that these pol III-transcribed elements may be involved in the regulation of cellular growth.	NIH,HOWARD HUGHES MED INST,NIH,RES SCHOLARS PROGRAM,BETHESDA,MD 20892; NCI,DIV CANC BIOL & DIAG,MOLEC BIOL LAB,BETHESDA,MD 20892	Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)								ALLAN M, 1984, NUCLEIC ACIDS RES, V12, P1193, DOI 10.1093/nar/12.2.1193; BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BEITEL LK, 1986, NUCLEIC ACIDS RES, V14, P3391, DOI 10.1093/nar/14.8.3391; BREDOW S, 1990, GENE, V86, P217, DOI 10.1016/0378-1119(90)90282-V; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; CAREY MF, 1986, MOL CELL BIOL, V6, P3068, DOI 10.1128/MCB.6.9.3068; CAREY MF, 1988, P NATL ACAD SCI USA, V85, P7059, DOI 10.1073/pnas.85.19.7059; CHAMBERLAIN JW, 1986, NUCLEIC ACIDS RES, V14, P3409, DOI 10.1093/nar/14.8.3409; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CILIBERTO G, 1982, P NATL ACAD SCI-BIOL, V79, P1921, DOI 10.1073/pnas.79.6.1921; COWIE A, 1986, J VIROL, V57, P505, DOI 10.1128/JVI.57.2.505-514.1986; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUNCAN CH, 1981, GENE, V13, P185, DOI 10.1016/0378-1119(81)90007-X; EDWARDS DR, 1985, MOL CELL BIOL, V5, P3280, DOI 10.1128/MCB.5.11.3280; FORDIS CM, 1990, P NATL ACAD SCI USA, V87, P1169, DOI 10.1073/pnas.87.3.1169; FORNACE AJ, 1986, NUCLEIC ACIDS RES, V14, P5793, DOI 10.1093/nar/14.14.5793; GAYNOR RB, 1985, SCIENCE, V230, P447, DOI 10.1126/science.2996135; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUERRERO I, 1986, J CELL PHYSIOL, V129, P71, DOI 10.1002/jcp.1041290111; HAYNES SR, 1981, P NATL ACAD SCI-BIOL, V78, P6130, DOI 10.1073/pnas.78.10.6130; HOEFFLER WK, 1985, CELL, V41, P955, DOI 10.1016/S0092-8674(85)80076-3; HOEFFLER WK, 1988, CELL, V53, P907, DOI 10.1016/S0092-8674(88)90409-6; JELINEK WR, 1980, P NATL ACAD SCI-BIOL, V77, P1398, DOI 10.1073/pnas.77.3.1398; JELINEK WR, 1982, ANNU REV BIOCHEM, V51, P813, DOI 10.1146/annurev.bi.51.070182.004121; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; KARIYA Y, 1987, GENE, V53, P1, DOI 10.1016/0378-1119(87)90087-4; KATZE MG, 1987, EMBO J, V6, P689, DOI 10.1002/j.1460-2075.1987.tb04809.x; KAUFMAN RJ, 1987, MOL CELL BIOL, V7, P1568, DOI 10.1128/MCB.7.4.1568; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; KOGA Y, 1988, P NATL ACAD SCI USA, V85, P4521, DOI 10.1073/pnas.85.12.4521; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; KRAMEROV DA, 1985, NUCLEIC ACIDS RES, V13, P6423, DOI 10.1093/nar/13.18.6423; LANIA L, 1987, FEBS LETT, V219, P400, DOI 10.1016/0014-5793(87)80260-0; LIMBORSKA SA, 1987, FEBS LETT, V212, P208, DOI 10.1016/0014-5793(87)81346-7; LOEKEN M, 1988, CELL, V55, P1171, DOI 10.1016/0092-8674(88)90261-9; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; LUTHMAN H, 1983, NUCLEIC ACIDS RES, V11, P1295, DOI 10.1093/nar/11.5.1295; MCCUTCHAN JH, 1968, JNCI-J NATL CANCER I, V41, P351; MCKNIGHT SL, 1982, SCIENCE, V217, P316, DOI 10.1126/science.6283634; MELLITS KH, 1988, EMBO J, V7, P2849, DOI 10.1002/j.1460-2075.1988.tb03141.x; MURPHY D, 1983, CELL, V35, P865, DOI 10.1016/0092-8674(83)90119-8; OMALLEY RP, 1986, CELL, V44, P391, DOI 10.1016/0092-8674(86)90460-5; PADMANABHAN R, 1987, MOL CELL BIOL, V7, P1894, DOI 10.1128/MCB.7.5.1894; PADMANABHAN R, 1988, ANAL BIOCHEM, V170, P341, DOI 10.1016/0003-2697(88)90640-9; PAULSON KE, 1986, NUCLEIC ACIDS RES, V14, P6145, DOI 10.1093/nar/14.15.6145; PELHAM HRB, 1980, P NATL ACAD SCI-BIOL, V77, P4170, DOI 10.1073/pnas.77.7.4170; PERELYGINA LM, 1988, MOL BIOL MOSC, V21, P1315; PEREZSTABLE C, 1984, P NATL ACAD SCI-BIOL, V81, P5291, DOI 10.1073/pnas.81.17.5291; PEREZSTABLE C, 1986, MOL CELL BIOL, V6, P2041, DOI 10.1128/MCB.6.6.2041; PODGORNAYA OI, 1988, FEBS LETT, V232, P99, DOI 10.1016/0014-5793(88)80394-6; POMERANTZ BJ, 1984, J VIROL, V49, P925, DOI 10.1128/JVI.49.3.925-937.1984; REMENICK J, 1988, J VIROL, V62, P1286, DOI 10.1128/JVI.62.4.1286-1292.1988; RUBIN CM, 1980, NATURE, V284, P372, DOI 10.1038/284372a0; RYSKOV AP, 1985, FEBS LETT, V182, P73, DOI 10.1016/0014-5793(85)81156-X; SANTOS T, 1981, CELL, V23, P699, DOI 10.1016/0092-8674(81)90433-5; SASSONECORSI P, 1989, MOL CELL BIOL, V9, P3174, DOI 10.1128/MCB.9.8.3174; SCHOLER HR, 1984, CELL, V36, P403, DOI 10.1016/0092-8674(84)90233-2; SEGUIN C, 1984, NATURE, V312, P781, DOI 10.1038/312781a0; SHEN C-K J, 1982, Journal of Molecular and Applied Genetics, V1, P343; SIEGEL V, 1986, NATURE, V320, P81, DOI 10.1038/320081a0; SINGER MF, 1982, INT REV CYTOL, V76, P67, DOI 10.1016/S0074-7696(08)61789-1; SINGH K, 1985, NATURE, V314, P553, DOI 10.1038/314553a0; SPORN MB, 1988, NATURE, V332, P217, DOI 10.1038/332217a0; STANNERS CP, 1981, CELL, V27, P211, DOI 10.1016/0092-8674(81)90375-5; SUN LHK, 1986, J STEROID BIOCHEM, V25, P201; TOWER J, 1988, MOL CELL BIOL, V8, P1001, DOI 10.1128/MCB.8.2.1001; UCHIYAMA T, 1981, J IMMUNOL, V126, P1393; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; ULLU E, 1984, EMBO J, V3, P3303, DOI 10.1002/j.1460-2075.1984.tb02294.x; ULLU E, 1984, NATURE, V312, P171, DOI 10.1038/312171a0; ULLU E, 1982, CELL, V29, P195, DOI 10.1016/0092-8674(82)90103-9; VANDYKE MW, 1987, NUCLEIC ACIDS RES, V15, P5031, DOI 10.1093/nar/15.13.5031; WHITE RJ, 1989, CELL, V59, P1081, DOI 10.1016/0092-8674(89)90764-2; WILLARD C, 1987, J MOL EVOL, V26, P180, DOI 10.1007/BF02099850; WRIGHT PJ, 1984, MOL CELL BIOL, V4, P2631, DOI 10.1128/MCB.4.12.2631; YOSHINAGA S, 1986, EMBO J, V5, P343, DOI 10.1002/j.1460-2075.1986.tb04218.x; YOSHINAGA SK, 1987, P NATL ACAD SCI USA, V84, P3585, DOI 10.1073/pnas.84.11.3585	81	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3031	3038						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704372				2022-12-27	WOS:A1991EX60000056
J	OLSON, HM; NAG, B; ETCHISON, JR; TRAUT, RR; GLITZ, DG				OLSON, HM; NAG, B; ETCHISON, JR; TRAUT, RR; GLITZ, DG			DIFFERENTIAL LOCALIZATION OF 2 EPITOPES OF ESCHERICHIA-COLI RIBOSOMAL-PROTEIN L2 ON THE LARGE RIBOSOMAL-SUBUNIT BY IMMUNE ELECTRON-MICROSCOPY USING MONOCLONAL-ANTIBODIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; RNA; 2-IMINOTHIOLANE; IDENTIFICATION; COMPONENTS; LOCATION; SITES	Two monoclonal antibodies (mAb), directed toward different epitopes of Escherichia coli-ribosomal protein L2, have been used as probes in immune electron microscopy. mAb 5-186 recognizes an epitope within residues 5-186 of protein L2; it is seen to bind to 50 S subunits at or near the peptidyl transferase center, beside the subunit head on the L1 shoulder. mAb 187-272 recognizes an epitope within residues 187-272. This antibody binds to the face of the 50 S subunit, below the head and slightly toward the side with the stalk; this site is near the translocation domain. Both antibodies can bind simultaneously to single subunits. This indicates that protein L2 is elongated, reaching from the peptidyl transferase.center to below the subunit head and approaching the translocational domain. The different locations of the two epitopes are consistent with previous biochemical results with the two antibodies.	UNIV CALIF LOS ANGELES, SCH MED, DEPT BIOL CHEM, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH MED, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA; UNIV CALIF DAVIS, SCH MED, DEPT BIOL CHEM, DAVIS, CA 95616 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis					NIGMS NIH HHS [GM 32769, GM 17924] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032769, R01GM017924, R37GM017924] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAUCLERK AAD, 1988, EMBO J, V7, P3589, DOI 10.1002/j.1460-2075.1988.tb03236.x; BERTSCH M, 1985, J BIOL CHEM, V260, P237; COOPERMAN BS, 1987, PHARMACOL THERAPEUT, V34, P271, DOI 10.1016/0163-7258(87)90014-3; FAHNESTOCK SR, 1975, BIOCHEMISTRY-US, V14, P5321, DOI 10.1021/bi00695a016; FRINK RJ, 1978, P NATL ACAD SCI USA, V75, P5778, DOI 10.1073/pnas.75.12.5778; GIRSHOVICH AS, 1981, FEBS LETT, V130, P54, DOI 10.1016/0014-5793(81)80664-3; HACKL W, 1988, FEBS LETT, V233, P119, DOI 10.1016/0014-5793(88)81367-X; HEROLD M, 1987, J BIOL CHEM, V262, P8826; KENNY JW, 1979, J MOL BIOL, V127, P243, DOI 10.1016/0022-2836(79)90328-0; LAKE JA, 1978, ADV TECHNIQUES BIOL, V2, P173; LAMBERT JM, 1981, J MOL BIOL, V149, P451, DOI 10.1016/0022-2836(81)90481-2; LANGER JA, 1986, J MOL BIOL, V187, P617, DOI 10.1016/0022-2836(86)90339-6; LITTLECHILD J, 1987, BIOCHIM BIOPHYS ACTA, V913, P245, DOI 10.1016/0167-4838(87)90336-0; LUHRMANN R, 1981, P NATL ACAD SCI USA, V80, P6780; MOAZED D, 1987, BIOCHIMIE, V69, P897; NAG B, 1987, J BIOL CHEM, V262, P9681; NAG B, 1986, J BIOL CHEM, V261, P13892; NAG B, 1987, FASEB J, V46, P2219; NIERHAUS KH, 1987, COLD SPRING HARB SYM, V52, P665, DOI 10.1101/SQB.1987.052.01.076; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOWOTNY V, 1989, PHYSICA B, V156, P499, DOI 10.1016/0921-4526(89)90714-X; NOWOTNY V, 1986, STRUCTURE FUNCTION G, P101; OFENGAND J, 1980, RIBOSOMES STRUCTURE, P497; OLSON HM, 1985, J BIOL CHEM, V260, P326; OLSON HM, 1986, J BIOL CHEM, V261, P6924; OLSON HM, 1988, J BIOL CHEM, V263, P15196; OMERO DP, 1990, J BIOL CHEM, V265, P18185; SCHMID G, 1984, FEBS LETT, V177, P189, DOI 10.1016/0014-5793(84)81281-8; SCHULZE H, 1982, EMBO J, V1, P609, DOI 10.1002/j.1460-2075.1982.tb01216.x; SCHWARTZ I, 1983, BIOCHEMISTRY-US, V22, P1483, DOI 10.1021/bi00275a024; STOFFLER G, 1986, STRUCTURE FUNCTION G, P28; Traub P, 1971, METHOD ENZYMOL, V20, P391; Traut R. R., 1986, STRUCTURE FUNCTION G, P286; TREMPE MR, 1982, J BIOL CHEM, V257, P9822; WALLECZEK J, 1988, EMBO J, V7, P3571, DOI 10.1002/j.1460-2075.1988.tb03234.x; WALLECZEK J, 1989, BIOCHEMISTRY-US, V28, P4099, DOI 10.1021/bi00435a071; WITTMANN HG, 1982, ANNU REV BIOCHEM, V51, P155, DOI 10.1146/annurev.bi.51.070182.001103; Wittmann-Liebold Brigitte, 1986, STRUCTURE FUNCTION G, P326	38	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1898	1902						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703157				2022-12-27	WOS:A1991EU49700080
J	HINGORANI, VN; HO, YK				HINGORANI, VN; HO, YK			IDENTIFICATION OF MONOCLONAL-ANTIBODY 4A-BINDING SITE ON THE TRANSDUCIN-ALPHA SUBUNIT - IMMUNOBLOTTING OF SUBMAXILLARY ARG-C PROTEASE FRAGMENTS OF TRANSDUCIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV ILLINOIS, HLTH SCI CTR, DEPT BIOL CHEM, CHICAGO, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital					NATIONAL EYE INSTITUTE [R23EY005788, R01EY005788] Funding Source: NIH RePORTER; NEI NIH HHS [EY-05788] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; DERETIC D, 1987, J BIOL CHEM, V262, P10839; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; FUNG BKK, 1983, J BIOL CHEM, V258, P503; FUNG BKK, 1983, J BIOL CHEM, V258, P495; Gray W R, 1972, Methods Enzymol, V25, P333, DOI 10.1016/S0076-6879(72)25029-7; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; HAMM HE, 1989, J BIOL CHEM, V264, P11475; HAMM HE, 1987, J BIOL CHEM, V262, P10831; HINGORANI VN, 1987, FEBS LETT, V220, P15, DOI 10.1016/0014-5793(87)80867-0; HINGORANI VN, 1988, J BIOL CHEM, V263, P6916; HINGORANI VN, 1988, J BIOL CHEM, V263, P19804; HO YK, 1989, CURR TOP CELL REGUL, V30, P171; HO YK, 1984, J BIOL CHEM, V259, P6694; HONG K, 1973, BIOCHEMISTRY-US, V12, P4517, DOI 10.1021/bi00746a033; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001; MAHERAS H, 1989, Investigative Ophthalmology and Visual Science, V30, P171; MEDYNSKI DC, 1985, P NATL ACAD SCI USA, V82, P4311, DOI 10.1073/pnas.82.13.4311; NAVON SE, 1988, J BIOL CHEM, V263, P489; NAVON SE, 1987, J BIOL CHEM, V262, P15746; PHILLIPS WJ, 1989, J BIOL CHEM, V264, P16679; PINES M, 1985, P NATL ACAD SCI USA, V82, P4095, DOI 10.1073/pnas.82.12.4095; TANABE T, 1985, NATURE, V315, P242, DOI 10.1038/315242a0; VANDOP C, 1984, J BIOL CHEM, V259, P23; WATKINS PA, 1985, J BIOL CHEM, V260, P3478; WITT PL, 1984, J GEN PHYSIOL, V84, P251, DOI 10.1085/jgp.84.2.251; WOODS KR, 1967, BIOCHIM BIOPHYS ACTA, V133, P369, DOI 10.1016/0005-2795(67)90078-5; YATANI A, 1988, SCIENCE, V241, P828, DOI 10.1126/science.2457252	31	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19923	19927						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1700981				2022-12-27	WOS:A1990EJ18800085
J	DUBOIS, RN; MCLANE, MW; RYDER, K; LAU, LF; NATHANS, D				DUBOIS, RN; MCLANE, MW; RYDER, K; LAU, LF; NATHANS, D			A GROWTH FACTOR-INDUCIBLE NUCLEAR-PROTEIN WITH A NOVEL CYSTEINE HISTIDINE REPETITIVE SEQUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									JOHNS HOPKINS UNIV, SCH MED, DEPT MOLEC BIOL & GENET, BALTIMORE, MD 21205 USA	Johns Hopkins University	DUBOIS, RN (corresponding author), JOHNS HOPKINS UNIV, SCH MED, HOWARD HUGHES MED INST, BALTIMORE, MD 21205 USA.		DuBois, Raymond N./AAX-8869-2020	Lau, Lester/0000-0002-4364-2914	NCI NIH HHS [5 PO1 CA16519] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA016519] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALT FW, 1982, MOL CELL BIOL, V2, P386, DOI 10.1128/MCB.2.4.386; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BERG JM, 1986, SCIENCE, V232, P485, DOI 10.1126/science.2421409; BRAVO R, 1989, GROWTH FACTORS DIFFE; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; DAILEY L, 1986, P NATL ACAD SCI USA, V83, P7241, DOI 10.1073/pnas.83.19.7241; DANG CV, 1989, J BIOL CHEM, V264, P18019; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; HARLOWE E, 1988, ANTIBODIES LABORATOR; Higgins GM, 1931, ARCH PATHOL, V12, P186; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; JANTZEN K, 1987, NUCLEIC ACIDS RES, V15, P4535, DOI 10.1093/nar/15.11.4535; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KAPPLER J, 1982, P NATL ACAD SCI-BIOL, V79, P3604, DOI 10.1073/pnas.79.11.3604; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LAU LF, 1990, MOL ASPECTS CEULLULA, V6; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; PFEIFER K, 1989, CELL, V56, P291, DOI 10.1016/0092-8674(89)90903-3; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIFF LA, 1988, P NATL ACAD SCI USA, V85, P4195, DOI 10.1073/pnas.85.12.4195; Sharp P A, 1980, Methods Enzymol, V65, P750; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUMMERS MF, 1990, BIOCHEMISTRY-US, V29, P329, DOI 10.1021/bi00454a005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; VARNUM BC, 1989, ONCOGENE, V4, P119; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; 1983, TECHNICAL B PHARMACI, V2	45	229	238	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 5	1990	265	31					19185	19191						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EF739	1699942				2022-12-27	WOS:A1990EF73900078
J	FEUCHT, A; SCHMID, A; BENZ, R; SCHWARZ, H; HELLER, KJ				FEUCHT, A; SCHMID, A; BENZ, R; SCHWARZ, H; HELLER, KJ			PORE FORMATION ASSOCIATED WITH THE TAIL-TIP PROTEIN PB2 OF BACTERIOPHAGE-T5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CONSTANCE, FAK BIOL, POSTFACH 5560, W-7750 CONSTANCE, GERMANY; MAX PLANCK INST BIOL, W-7400 TUBINGEN, GERMANY; UNIV WURZBURG, LEHRSTUHL BIOTECHNOL, W-8700 WURZBURG, GERMANY	University of Konstanz; Max Planck Society; University of Wurzburg				Benz, Roland/0000-0002-9510-9265				BANNER DW, 1981, NATURE, V289, P814, DOI 10.1038/289814a0; BAUER K, 1988, EUR J BIOCHEM, V174, P199, DOI 10.1111/j.1432-1033.1988.tb14082.x; BAYER ME, 1968, J VIROL, V2, P346, DOI 10.1128/JVI.2.4.346-356.1968; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1980, J MEMBRANE BIOL, V56, P19, DOI 10.1007/BF01869348; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; BENZ R, 1985, J BACTERIOL, V162, P722, DOI 10.1128/JB.162.2.722-727.1985; Eiserling F.A, 1983, BACTERIOPHAGE T4, P11; FEUCHT A, 1989, FEBS LETT, V255, P435, DOI 10.1016/0014-5793(89)81140-8; FURUKAWA H, 1979, J BACTERIOL, V140, P1071, DOI 10.1128/JB.140.3.1071-1080.1979; GLASERWUTTKE G, 1989, BIOCHIM BIOPHYS ACTA, V375, P44; GLENN J, 1980, J VIROL, V33, P553, DOI 10.1128/JVI.33.1.553-556.1980; HELLER K, 1979, J BACTERIOL, V139, P32, DOI 10.1128/JB.139.1.32-38.1979; HELLER K, 1982, J VIROL, V41, P222, DOI 10.1128/JVI.41.1.222-227.1982; HELLER KJ, 1984, J VIROL, V49, P20, DOI 10.1128/JVI.49.1.20-25.1984; HELLER KJ, 1984, VIROLOGY, V139, P11, DOI 10.1016/0042-6822(84)90325-8; HELLER KJ, 1985, J BACTERIOL, V162, P621, DOI 10.1128/JB.162.2.621-625.1985; HENDRICKSON HE, 1971, J VIROL, V7, P612, DOI 10.1128/JVI.7.5.612-618.1971; HOFFMANN H, 1986, J BACTERIOL, V166, P404, DOI 10.1128/jb.166.2.404-411.1986; HOFFMANN H, 1986, THESIS U  TUBINGEN F; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; KEWELOH H, 1984, J BACTERIOL, V160, P347, DOI 10.1128/JB.160.1.347-353.1984; KEWELOH HW, 1984, J BACTERIOL, V160, P354, DOI 10.1128/JB.160.1.354-359.1984; KONISKY J, 1982, ANNU REV MICROBIOL, V36, P125, DOI 10.1146/annurev.mi.36.100182.001013; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LABEDAN B, 1981, P NATL ACAD SCI-BIOL, V78, P215, DOI 10.1073/pnas.78.1.215; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETELLIER L, 1989, BIOCHIMIE, V71, P167, DOI 10.1016/0300-9084(89)90147-8; LEWIN B, 1987, GENES, V3, P44; MAIER C, 1988, J BIOL CHEM, V263, P2493; MALTOUF AF, 1983, J BACTERIOL, V153, P124, DOI 10.1128/JB.153.1.124-133.1983; McCorquodale D. J., 1988, BACTERIOPHAGES, V1, P439; MISRA R, 1989, J BACTERIOL, V171, P4105, DOI 10.1128/JB.171.8.4105-4111.1989; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; OLDMIXON E, 1978, BIOCHIM BIOPHYS ACTA, V506, P111, DOI 10.1016/0005-2736(78)90438-8; PONTA H, 1976, MOL GEN GENET, V149, P145, DOI 10.1007/BF00332882; PUCK TT, 1954, J EXP MED, V99, P481, DOI 10.1084/jem.99.5.481; PUGSLEY AP, 1978, J BACTERIOL, V135, P1118, DOI 10.1128/JB.135.3.1118-1129.1978; ROESSNER CA, 1984, J BACTERIOL, V157, P165, DOI 10.1128/JB.157.1.165-170.1984; SAIGO K, 1978, VIROLOGY, V85, P422, DOI 10.1016/0042-6822(78)90449-X; SILVER S, 1968, J VIROL, V2, P763, DOI 10.1128/JVI.2.8.763-771.1968; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; WAGNER EF, 1980, J BIOL CHEM, V255, P534; WILSON DB, 1982, J BACTERIOL, V152, P1091; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; ZWEIG M, 1973, VIROLOGY, V51, P443, DOI 10.1016/0042-6822(73)90443-1	47	38	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 25	1990	265	30					18561	18567						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EE201	1698788				2022-12-27	WOS:A1990EE20100081
J	CLARKE, DM; LOO, TW; MACLENNAN, DH				CLARKE, DM; LOO, TW; MACLENNAN, DH			THE EPITOPE FOR MONOCLONAL ANTIBODY-A20 (AMINO-ACIDS 870-890) IS LOCATED ON THE LUMINAL SURFACE OF THE CA-2+-ATPASE OF SARCOPLASMIC-RETICULUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									UNIV TORONTO,CHARLES H BEST INST,BANTING & BEST DEPT MED RES,TORONTO M5G 1L6,ONTARIO,CANADA	University of Toronto			Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188				BAYER R, 1990, BIOCHEMISTRY-US, V29, P2251, DOI 10.1021/bi00461a007; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; CAMPBELL KP, 1981, J BIOL CHEM, V256, P4626; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, J BIOL CHEM, V264, P11246; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; DIECKMANN CL, 1985, J BIOL CHEM, V248, P8222; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; GREEN NM, 1985, BIOCHEM J, V231, P425, DOI 10.1042/bj2310425; KAWAKAMI K, 1985, NATURE, V316, P733, DOI 10.1038/316733a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEBERER E, 1989, J BIOL CHEM, V264, P3484; LEBERER E, 1986, EUR J BIOCHEM, V156, P489, DOI 10.1111/j.1432-1033.1986.tb09607.x; LUND S, 1989, J BIOL CHEM, V264, P4907; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MATTHEWS I, 1989, BIOCHEM BIOPH RES CO, V161, P683, DOI 10.1016/0006-291X(89)92653-3; OVCHINNIKOV YA, 1987, TRENDS BIOCHEM SCI, V12, P438; REITHMEIER RAF, 1981, J BIOL CHEM, V256, P5957; ROSSI B, 1979, J BIOL CHEM, V254, P2302; SACHS G, 1990, BIOPHYS J, V57, P17; SHULL GE, 1988, J BIOL CHEM, V263, P8646; SHULL GE, 1986, J BIOL CHEM, V261, P6788; SHULL GE, 1985, NATURE, V316, P691, DOI 10.1038/316691a0; STEWART PS, 1974, J BIOL CHEM, V249, P985; THORLEYLAWSON DA, 1977, BIOCHEM J, V167, P739, DOI 10.1042/bj1670739; TOWBIN H, 1989, P NATL ACAD SCI USA, V76, P4650; VERMA AK, 1988, J BIOL CHEM, V263, P14152; ZUBRZYCKAGAARN E, 1984, J BIOENERG BIOMEMBR, V16, P441, DOI 10.1007/BF00743238	29	64	64	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17405	17408						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698776				2022-12-27	WOS:A1990EC76600007
J	STRICKLAND, DK; ASHCOM, JD; WILLIAMS, S; BURGESS, WH; MIGLIORINI, M; ARGRAVES, WS				STRICKLAND, DK; ASHCOM, JD; WILLIAMS, S; BURGESS, WH; MIGLIORINI, M; ARGRAVES, WS			SEQUENCE IDENTITY BETWEEN THE ALPHA-2-MACROGLOBULIN RECEPTOR AND LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN SUGGESTS THAT THIS MOLECULE IS A MULTIFUNCTIONAL RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									AMER RED CROSS, MOLEC BIOL LAB, ROCKVILLE, MD 20855 USA	American Red Cross	STRICKLAND, DK (corresponding author), AMER RED CROSS, BIOCHEM LAB, 15601 CRABBS BRANCH WAY, ROCKVILLE, MD 20855 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL030200, K04HL002113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042581] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-02113, HL30200] Funding Source: Medline; NIGMS NIH HHS [GM42581] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARGRAVES WS, 1989, CELL, V58, P623, DOI 10.1016/0092-8674(89)90097-4; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P737; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BJORK I, 1982, BIOCHEM J, V207, P347; BRADLEY WA, 1986, ANN NY ACAD SCI, V485, P159, DOI 10.1111/j.1749-6632.1986.tb34578.x; BRADLEY WA, 1988, SEMIN THROMB HEMOST, V14, P253, DOI 10.1055/s-2007-1002786; DICKSON RB, 1981, J BIOL CHEM, V256, P3454; ENGVALL E, 1972, J IMMUNOL, V109, P129; FELDMAN SR, 1985, BIOCHEM BIOPH RES CO, V128, P795, DOI 10.1016/0006-291X(85)90117-2; GLIEMANN J, 1989, BIOCHIM BIOPHYS ACTA, V980, P326, DOI 10.1016/0005-2736(89)90320-9; GLIEMANN J, 1986, BIOCHIM BIOPHYS ACTA, V885, P49, DOI 10.1016/0167-4889(86)90037-6; GONIAS SL, 1982, BIOCHIM BIOPHYS ACTA, V705, P306, DOI 10.1016/0167-4838(82)90252-7; HARPEL PC, 1973, J EXP MED, V138, P508, DOI 10.1084/jem.138.3.508; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HOFFMAN M, 1983, BIOCHIM BIOPHYS ACTA, V760, P421, DOI 10.1016/0304-4165(83)90384-7; HOFFMAN MR, 1987, J IMMUNOL, V139, P1885; JENSEN PEH, 1989, BIOCHEM ARCH, V5, P171; JENSEN PH, 1989, FEBS LETT, V255, P275, DOI 10.1016/0014-5793(89)81105-6; JOHNSON WJ, 1982, SCIENCE, V218, P574, DOI 10.1126/science.6289443; KAPLAN J, 1979, J BIOL CHEM, V254, P7323; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; LOBEL P, 1988, J BIOL CHEM, V263, P2563; LUND H, 1989, P NATL ACAD SCI USA, V86, P9318, DOI 10.1073/pnas.86.23.9318; MAXFIELD FR, 1981, BIOCHEMISTRY-US, V20, P5353, DOI 10.1021/bi00521a041; MOESTRUP SK, 1989, J BIOL CHEM, V264, P15574; MORGAN DO, 1987, NATURE, V329, P301, DOI 10.1038/329301a0; ORTHNER CL, 1989, J BIOL CHEM, V264, P18781; OSHIMA A, 1988, J BIOL CHEM, V263, P2553; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; STRAIGHT DL, 1988, BIOCHEMISTRY-US, V27, P2885, DOI 10.1021/bi00408a033; STRICKLAND DK, 1984, BIOCHEMISTRY-US, V23, P3115, DOI 10.1021/bi00309a002; STRICKLAND DK, 1988, BIOCHEMISTRY-US, V27, P1458, DOI 10.1021/bi00405a010	35	640	648	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17401	17404						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698775				2022-12-27	WOS:A1990EC76600006
J	POWELL, DR; SUWANICHKUL, A; CUBBAGE, ML; DEPAOLIS, LA; SNUGGS, MB; LEE, PDK				POWELL, DR; SUWANICHKUL, A; CUBBAGE, ML; DEPAOLIS, LA; SNUGGS, MB; LEE, PDK			INSULIN INHIBITS TRANSCRIPTION OF THE HUMAN GENE FOR INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE; HUMAN CHROMOSOMAL GENE; CHRONIC-RENAL-FAILURE; HUMAN AMNIOTIC-FLUID; HEPATOMA-CELLS; IGF-I; DIABETES-MELLITUS; CHLORAMPHENICOL ACETYLTRANSFERASE; MULTIHORMONAL REGULATION; PROMOTER ACTIVITY	Insulin rapidly lowers serum insulin-like growth factor-binding protein-1 (IGFBP-1) levels in vivo. In studies reported here, HEP G2 cells were used as a model system to investigate how insulin achieves this effect. When HEP G2 cells were incubated with 100 nM insulin for 6, 14, or 24 h, IGFBP-1 protein levels in conditioned medium fell to approximately 50% of control values. This apparently was due to a fall in the rate of IGFBP-1 protein synthesis, since HEP G2 cells incorporated 46% less [S-35]methionine into IGFBP-1 during a 4-h incubation with 100 nM insulin. IGFBP-1 mRNA levels were similarly affected by 100 nM insulin, falling to 45% of control values after 2 h, and to 9% of control values after 4 h of incubation with this hormone. The fall in IGFBP-1 mRNA level is consistent with data from nuclear transcription assays. HEP G2 nuclei isolated from cells that were incubated with 100 nM insulin for 2 h synthesized only approximately 1/3 the number of IGFBP-1 transcripts as did control nuclei. Further evidence that insulin decreases IGFBP-1 gene transcription comes from transient transfections using chimeric IGFBP-1 promoter-chloramphenicol acetyltransferase reporter gene constructs. IGFBP-1 promoter activity fell to approximately 50% of control values when HEP G2 cells transfected with a construct containing the first 1205 base pairs of the IGFBP-1 promoter were incubated with 100 nM insulin for 6, 14, or 24 h. Insulin lowered both IGFBP-1 protein levels and promoter activity in a dose-dependent manner. A half-maximal effect was found at approximately 1 nM insulin and a maximal effect was found at approximately 10 nM insulin in each instance. Transfections with constructs containing smaller IGFBP-1 promoter fragments showed that the region spanning from 103 to 529 base pairs 5' to the IGFBP-1 mRNA cap site was necessary to demonstrate the inhibitory effect of insulin. These studies indicate that insulin lowers IGFBP-1 protein levels, at least in part, by rapidly decreasing the rate of IGFBP-1 gene transcription, and suggest that this insulin-mediated fall in transcription is conferred through a specific region of the IGFBP-1 promoter.			POWELL, DR (corresponding author), BAYLOR COLL MED, DIABET RES CTR, DEPT PEDIAT, 8080 N STADIUM DR, HOUSTON, TX 77054 USA.			Lee, Phillip/0000-0002-6856-4262	NIDDK NIH HHS [DK-38773] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038773, R01DK038773] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0; BAXTER RC, 1987, J CLIN ENDOCR METAB, V65, P432, DOI 10.1210/jcem-65-3-432; BRISMAR K, 1988, J ENDOCRINOL INVEST, V11, P599, DOI 10.1007/BF03350189; BURCH WM, 1990, J CLIN ENDOCR METAB, V70, P173, DOI 10.1210/jcem-70-1-173; BUSBY WH, 1988, J CLIN ENDOCR METAB, V67, P1225, DOI 10.1210/jcem-67-6-1225; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; CONOVER CA, 1990, J CLIN ENDOCR METAB, V70, P1062, DOI 10.1210/jcem-70-4-1062; CONOVER CA, 1990, ENDOCRINOLOGY, V127, P2795, DOI 10.1210/endo-127-6-2795; CONOVER CA, 1990, DIABETES, V39, P1251, DOI 10.2337/diabetes.39.10.1251; COTTERILL AM, 1988, J CLIN ENDOCR METAB, V67, P882, DOI 10.1210/jcem-67-5-882; CUBBAGE ML, 1990, J BIOL CHEM, V265, P12642; CUBBAGE ML, 1989, MOL ENDOCRINOL, V3, P846, DOI 10.1210/mend-3-5-846; DANI C, 1989, MOL CELL ENDOCRINOL, V63, P199, DOI 10.1016/0303-7207(89)90096-8; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DROP SLS, 1984, J CLIN ENDOCR METAB, V59, P908, DOI 10.1210/jcem-59-5-908; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; FEHLMANN M, 1983, BIOCHEM J, V214, P845, DOI 10.1042/bj2140845; FRAUMAN AG, 1989, ENDOCRINOLOGY, V124, P2289, DOI 10.1210/endo-124-5-2289; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Harlow E, 1988, ANTIBODIES LAB MANUA, P139; HOLLY JMP, 1988, CLIN ENDOCRINOL, V29, P667, DOI 10.1111/j.1365-2265.1988.tb03715.x; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JEFFERSON LS, 1980, DIABETES, V29, P487, DOI 10.2337/diab.29.6.487; KELLY JH, 1989, IN VITRO CELL DEV B, V25, P217; LEE PDK, 1989, PEDIATR RES, V26, P308, DOI 10.1203/00006450-198910000-00005; LEE YL, 1988, MOL ENDOCRINOL, V2, P404, DOI 10.1210/mend-2-5-404; LEWITT MS, 1989, J CLIN ENDOCR METAB, V69, P246, DOI 10.1210/jcem-69-2-246; LIU F, 1990, J CLIN ENDOCR METAB, V70, P620, DOI 10.1210/jcem-70-3-620; MAGNUSON MA, 1987, J BIOL CHEM, V262, P14917; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; MOSS M, 1981, MOL CELL BIOL, V1, P289, DOI 10.1128/MCB.1.3.289; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OBRIEN RM, 1990, SCIENCE, V249, P533, DOI 10.1126/science.2166335; OOI GT, 1990, MOL ENDOCRINOL, V4, P321, DOI 10.1210/mend-4-2-321; ORLOWSKI CC, 1990, MOL ENDOCRINOL, V4, P1592, DOI 10.1210/mend-4-10-1592; POWELL DR, 1989, INT CONGR SER, V881, P3; POWELL DR, 1987, J CHROMATOGR-BIOMED, V420, P163, DOI 10.1016/0378-4347(87)80168-8; PRAGER D, 1988, J BIOL CHEM, V263, P16580; RITVOS O, 1988, ENDOCRINOLOGY, V122, P2150, DOI 10.1210/endo-122-5-2150; ROESLER WJ, 1990, TRENDS ENDOCRIN MET, V1, P347, DOI 10.1016/1043-2760(90)90082-E; ROGHANI M, 1989, FEBS LETT, V255, P253, DOI 10.1016/0014-5793(89)81101-9; SASAKI K, 1984, J BIOL CHEM, V259, P5242; SENEVIRATNE C, 1990, MOL ENDOCRINOL, V4, P1199, DOI 10.1210/mend-4-8-1199; SHORT JM, 1986, J BIOL CHEM, V261, P9721; SUIKKARI AM, 1988, J CLIN ENDOCR METAB, V66, P266, DOI 10.1210/jcem-66-2-266; SUWANICHKUL A, 1990, J BIOL CHEM, V265, P21185; UNTERMAN TG, 1990, ENDOCRINOLOGY, V126, P2614, DOI 10.1210/endo-126-5-2614; YEOH SI, 1988, ACTA ENDOCRINOL-COP, V119, P465, DOI 10.1530/acta.0.1190465	50	195	201	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18868	18876						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717456				2022-12-27	WOS:A1991GJ47200072
J	KRANTZ, DD; ZIDOVETZKI, R; KAGAN, BL; ZIPURSKY, SL				KRANTZ, DD; ZIDOVETZKI, R; KAGAN, BL; ZIPURSKY, SL			AMPHIPATHIC BETA-STRUCTURE OF A LEUCINE-RICH REPEAT PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; NUCLEAR MAGNETIC-RESONANCE; LIPID-PROTEIN INTERACTIONS; PLATELET GLYCOPROTEIN-IB; CYTOCHROME-C-OXIDASE; RIBONUCLEASE INHIBITOR; TRANSMEMBRANE PROTEIN; CIRCULAR-DICHROISM; ADENYLATE-CYCLASE; PROTEOGLYCAN-II	Long tandem arrays of a characteristic leucine-rich repeat motif on the order of 24 amino acids in length have been found in the primary structure of an increasing number of proteins. The most striking feature of these repeats is an amphipathic sequence, with leucine as the predominant hydrophobic residue. Based on this amphipathic sequence and the function of the proteins in which they have been found, the repeats have been proposed to be involved in protein-protein and protein-lipid interactions. As a step toward elucidating the structure and biochemical properties of the leucine-rich repeat motif, we have studied a synthetic leucine-rich repeat peptide (LRP32) representing one of the repeats found in Drosophila chaoptin. We have shown that: (i) LRP32 is soluble in aqueous solution but will bind quantitatively to phospholipid vesicles; (ii) LRP32 has a partial beta-structure in aqueous solution and is predominantly a beta-structure in the presence of phospholipid; (iii) LRP32 integrates into lipid bilayers to form 60-angstrom intramembrane particles as seen using freeze-fracture electron microscopy (these putative oligomeric structures appear to contain a central aqueous core as indicated by their ability to generate conductances in planar lipid bilayers); and (iv) LRP32-lipid complexes generate H-2 NMR spectra characteristic of integral membrane proteins. This study is consistent with LRP32 forming an amphipathic beta-sheet. We propose that protein segments containing tandem arrays of leucine-rich repeats also may form amphipathic beta-sheets.	UNIV CALIF LOS ANGELES,SCH MED,DEPT BIOL CHEM,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,INST MOLEC BIOL,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,DEPT PSYCHIAT,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,SCH MED,BRAIN RES INST,LOS ANGELES,CA 90024; W LOS ANGELES VET ADM HOSP,LOS ANGELES,CA 90024; UNIV CALIF RIVERSIDE,DEPT BIOL,RIVERSIDE,CA 92521	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Riverside			Kagan, Bruce/ABD-7389-2020	Zipursky, Stephen/0000-0001-5630-7181				BARANY G, 1987, INT J PEPT PROT RES, V30, P705; BRAHMS S, 1980, J MOL BIOL, V138, P149, DOI 10.1016/0022-2836(80)90282-X; Branton D, 1970, J CELL BIOL, V45, P598, DOI DOI 10.1083/JCB.45.3.598.PMID:4918216; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CRISMA M, 1984, INT J PEPT PROT RES, V23, P411; DAVIS JH, 1979, BIOPHYS J, V27, P339, DOI 10.1016/S0006-3495(79)85222-4; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DAY AA, 1987, BIOCHEM J, V248, P801, DOI 10.1042/bj2480801; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; Eisenberg D., 1982, FARADAY S CHEM SOC, V17, P109, DOI DOI 10.1039/FS9821700109; ERARD M, 1990, EUR J BIOCHEM, V191, P19, DOI 10.1111/j.1432-1033.1990.tb19088.x; FERRERO E, 1990, J IMMUNOL, V145, P331; FERRERO E, 1988, NUCLEIC ACIDS RES, V16, P41; FIELD J, 1990, SCIENCE, V247, P464, DOI 10.1126/science.2405488; FISHER LW, 1989, J BIOL CHEM, V264, P4571; FOX RO, 1982, NATURE, V300, P325, DOI 10.1038/300325a0; FUKUSHIMA D, 1979, J AM CHEM SOC, V101, P3703, DOI 10.1021/ja00507a068; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; HICKEY MJ, 1989, P NATL ACAD SCI USA, V86, P6773, DOI 10.1073/pnas.86.17.6773; Hille B, 1984, IONIC CHANNELS EXCIT; HOFSTEENGE J, 1988, BIOCHEMISTRY-US, V27, P8537, DOI 10.1021/bi00423a006; HORWITZ J, 1987, BIOCHEMISTRY-US, V26, P8092, DOI 10.1021/bi00399a012; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KAISER ET, 1987, ANNU REV BIOPHYS BIO, V16, P561; KANG SY, 1979, BIOCHEMISTRY-US, V18, P3257, DOI 10.1021/bi00582a010; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; KRANTZ DE, 1990, EMBO J, V9, P1969, DOI 10.1002/j.1460-2075.1990.tb08325.x; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; LEE FS, 1988, BIOCHEMISTRY-US, V27, P8545, DOI 10.1021/bi00423a007; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LOPEZ JA, 1987, P NATL ACAD SCI USA, V84, P5615, DOI 10.1073/pnas.84.16.5615; LOPEZ JA, 1988, P NATL ACAD SCI USA, V85, P2135, DOI 10.1073/pnas.85.7.2135; MASSON P, 1986, CURR GENET, V10, P343, DOI 10.1007/BF00418405; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MIKOL DD, 1990, J CELL BIOL, V110, P471, DOI 10.1083/jcb.110.2.471; Montal M, 1974, Methods Enzymol, V32, P545; MORROW MR, 1988, BIOCHEMISTRY-US, V27, P2024, DOI 10.1021/bi00406a032; MULLER L, 1983, J CHEM PHYS, V78, P4341, DOI 10.1063/1.445328; NAEME PJ, 1989, J BIOL CHEM, V264, P8653; OIKI S, 1988, P NATL ACAD SCI USA, V85, P8703, DOI 10.1073/pnas.85.22.8703; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PADDY MR, 1981, BIOCHEMISTRY-US, V20, P3152, DOI 10.1021/bi00514a026; PARRAGA G, 1988, SCIENCE, V241, P1489, DOI 10.1126/science.3047872; PATTHY L, 1987, J MOL BIOL, V198, P567, DOI 10.1016/0022-2836(87)90200-2; REINKE R, 1988, CELL, V52, P291, DOI 10.1016/0092-8674(88)90518-1; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; ROTH GJ, 1990, BIOCHEM BIOPH RES CO, V170, P153, DOI 10.1016/0006-291X(90)91253-O; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; SCHNEIDER R, 1988, EMBO J, V7, P4151, DOI 10.1002/j.1460-2075.1988.tb03310.x; SEGREST JP, 1974, P NATL ACAD SCI USA, V71, P3294, DOI 10.1073/pnas.71.8.3294; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; SETOGUCHI M, 1989, BIOCHIM BIOPHYS ACTA, V1008, P213, DOI 10.1016/0167-4781(80)90012-3; SHIMOMURA T, 1990, BLOOD, V75, P2349; SPARROW JT, 1982, CRC CR REV BIOCH MOL, V13, P87, DOI 10.3109/10409238209108710; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; TAMM LK, 1983, BIOCHEMISTRY-US, V22, P1474, DOI 10.1021/bi00275a023; TAN FL, 1990, J BIOL CHEM, V265, P13; TILLACK TW, 1970, J CELL BIOL, V45, P649, DOI 10.1083/jcb.45.3.649; TITANI K, 1987, P NATL ACAD SCI USA, V84, P5610, DOI 10.1073/pnas.84.16.5610; TOSTESON MT, 1981, BIOPHYS J, V36, P109, DOI 10.1016/S0006-3495(81)84719-4; VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X; WOODY RW, 1974, PEPTIDES POLYPEPTIDE, P339; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; YAMAWAKIKATAOKA Y, 1989, P NATL ACAD SCI USA, V86, P5693, DOI 10.1073/pnas.86.15.5693; ZAMPIGHI G, 1982, J CELL BIOL, V93, P175, DOI 10.1083/jcb.93.1.175	72	62	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16801	16807						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715870				2022-12-27	WOS:A1991GD63500088
J	VEGA, MA; RODRIGUEZ, F; SEGUI, B; CALES, C; ALCALDE, J; SANDOVAL, IV				VEGA, MA; RODRIGUEZ, F; SEGUI, B; CALES, C; ALCALDE, J; SANDOVAL, IV			TARGETING OF LYSOSOMAL INTEGRAL MEMBRANE-PROTEIN LIMP-II - THE TYROSINE-LACKING CARBOXYL CYTOPLASMIC TAIL OF LIMP-II IS SUFFICIENT FOR DIRECT TARGETING TO LYSOSOMES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GOLGI SYSTEM; THROMBOSPONDIN; GLYCOPROTEINS; RECEPTOR; IDENTIFICATION; PURIFICATION; ENDOCYTOSIS; EXPRESSION; SEQUENCE; GENE	Time course experiments of the localization of rat LIMP II expressed in COS cells show that the protein is transported directly from the Golgi complex to lysosomes. Substitution of the tyrosine-lacking carboxyl cytoplasmic tail of LIMP II for the native cytoplasmic tails of the plasma membrane proteins CD36 and CD8 resulted in straight transport of both proteins to lysosomes. The synthetic tyrosine-containing heptapeptide, RGTGVYG, did not replace the natural carboxyl cytoplasmic tail of LIMP II in its ability to transport both CD36 and CD8 to lysosomes, and the two constructs were transported to and expressed at the plasma membrane. Substitution of the cytoplasmic tails of either CD36 or CD8 for the carboxyl cytoplasmic tail of LIMP II resulted in transport of the mutants to the plasma membrane where they underwent endocytosis before accumulating into lysosomes. The results indicate that a motif contained in the tyrosine-lacking carboxyl cytoplasmic tail of LIMP II is sufficient to target proteins directly from the Golgi complex to lysosomes.	UNIV AUTONOMA MADRID,FAC CIENCIAS,CTR BIOL MOLEC,E-28049 MADRID,SPAIN; CSIC,CTR BIOMED,MADRID 6,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Calés, Carmela/AAB-1595-2019; Vega, Miguel A/M-1367-2016	Vega, Miguel A/0000-0001-6151-4193; Rodriguez, Fernando/0000-0001-7361-8408; Cales, Carmela/0000-0002-6987-2259				ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; CHEN JW, 1988, J BIOL CHEM, V263, P8754; DAVIS CG, 1987, J BIOL CHEM, V262, P4075; HUGHES EN, 1982, J BIOL CHEM, V257, P3970; KIEFFER N, 1989, BIOCHEM J, V262, P835, DOI 10.1042/bj2620835; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LAZAROVITS J, 1988, CELL, V53, P743, DOI 10.1016/0092-8674(88)90092-X; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; LITTMAN DR, 1985, CELL, V40, P237, DOI 10.1016/0092-8674(85)90138-2; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MALISSEN B, 1982, EUR J IMMUNOL, V12, P734; MCGREGOR JL, 1989, J BIOL CHEM, V264, P501; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; PETERS C, 1990, EMBO J, V9, P3497, DOI 10.1002/j.1460-2075.1990.tb07558.x; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; VEGA MA, 1991, J BIOL CHEM, V266, P16818; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; YUAN L, 1987, J CELL BIOL, V105, P215, DOI 10.1083/jcb.105.1.215	20	58	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16269	16272						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715864				2022-12-27	WOS:A1991GD63500004
J	BERG, EL; ROBINSON, MK; MANSSON, O; BUTCHER, EC; MAGNANI, JL				BERG, EL; ROBINSON, MK; MANSSON, O; BUTCHER, EC; MAGNANI, JL			A CARBOHYDRATE DOMAIN COMMON TO BOTH SIALYL LE(A) AND SIALYL LE(X) IS RECOGNIZED BY THE ENDOTHELIAL-CELL LEUKOCYTE ADHESION MOLECULE ELAM-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							LYMPHOCYTE HOMING RECEPTOR; MONOCLONAL-ANTIBODY; SURFACE MOLECULE; ANTIGEN; OLIGOSACCHARIDES; IDENTIFICATION; EXPRESSION; PROTEINS; CANCER; DETERMINANTS	The specificity of endothelial cell leukocyte adhesion molecule-1, ELAM-1, for binding to a panel of carbohydrate structures was determined by a sensitive cell binding assay with immobilized synthetic glycoconjugates. ELAM-1 cDNA transfectants were found to bind Sialyl Le(a) (sialylated lacto-N-fucopentaose II) or sialylated Lewis a antigen (NeuAc-alpha-2-3Gal-beta-1-3(Fuc-alpha-1-4)GlcNAc), as well as or slightly better than Sialyl Le(x) (sialylated lacto-N-fucopentaose III) or sialylated Lewis X antigen (NeuAc-alpha-2-3Gal-beta-1-4(Fuc-alpha-1-3)GlcNAc). A monoclonal antibody, HECA-452, which has been identified recently as recognizing ELAM-1 ligands in addition to those containing Sialyl Le(x), was also found to bind both Sialyl Le(x) and Sialyl Le(a). Hard sphere exo-anomeric (HSEA) calculations were performed on these two hexasaccharides. The conformations indicate that Sialyl Le(a) and Sialyl Le(x) show a high degree of similarity in both the nonreducing and reducing termini. As Le(a) and Le(x) show much weaker reactivity, the determinants recognized by ELAM-1 and HECA-452 probably involve neuraminic acid and fucose residues which on one face of both Sialyl Le(x) and Sialyl Le(a) can be similarly positioned. The finding that Sialyl Le(a) is a potent ligand for ELAM-1 is important, as circulating Sialyl Le(a) and Sialyl Le(x) containing mucins which are elevated in the serum of many cancer patients may block leukocyte interactions with ELAM-1 and may contribute to the pathological immunodepression observed in these patients.	BIOCARB INC,300 PROFESSIONAL DR,GAITHERSBURG,MD 20879; STANFORD UNIV,DEPT PATHOL,STANFORD,CA 94305; VET ADM MED CTR,PALO ALTO,CA 94304; BIOCARB TECHNOL AB,S-22370 LUND,SWEDEN	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA)			Berg, Ellen/D-9076-2014	Berg, Ellen/0000-0001-5149-6665	NIGMS NIH HHS [GM37734] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037734, R37GM037734] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOCK K, 1983, PURE APPL CHEM, V55, P605; BRANDLEY BK, 1990, CELL, V63, P861, DOI 10.1016/0092-8674(90)90487-Y; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; COFFMAN RL, 1981, J EXP MED, V153, P269, DOI 10.1084/jem.153.2.269; COTRAN RS, 1986, J EXP MED, V164, P661, DOI 10.1084/jem.164.2.661; FUKUSHIMA K, 1984, CANCER RES, V44, P5279; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; HANSSON GC, 1983, J BIOL CHEM, V258, P4901; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; KALLIN E, 1986, GLYCOCONJUGATE J, V3, P311, DOI 10.1007/BF01049500; KANNAGI R, 1986, CANCER RES, V46, P2619; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; KUMLIEN J, 1989, ARCH BIOCHEM BIOPHYS, V269, P678, DOI 10.1016/0003-9861(89)90152-5; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LOWE JB, 1990, CELL, V63, P475, DOI 10.1016/0092-8674(90)90444-J; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; MAGNANI JL, 1983, CANCER RES, V43, P5489; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; OHMORI K, 1989, BLOOD, V74, P255; PHILLIPS ML, 1990, SCIENCE, V250, P1130, DOI 10.1126/science.1701274; PICKER LJ, 1990, J IMMUNOL, V145, P3247; PICKER LJ, 1990, AM J PATHOL, V136, P1053; PICKER LJ, 1991, NATURE, V349, P796, DOI 10.1038/349796a0; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SPOHR U, 1985, CAN J CHEM, V63, P2644, DOI 10.1139/v85-439; STEPHENS PE, 1989, NUCLEIC ACIDS RES, V17, P7110, DOI 10.1093/nar/17.17.7110; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; SVENSON SB, 1979, J IMMUNOL METHODS, V25, P323, DOI 10.1016/0022-1759(79)90025-5; TEDDER TF, 1989, J EXP MED, V170, P123, DOI 10.1084/jem.170.1.123; WALZ G, 1990, SCIENCE, V250, P1132, DOI 10.1126/science.1701275; WIESLANDER J, 1990, GLYCOCONJUGATE J, V7, P85, DOI 10.1007/BF01050405; Zopf D A, 1978, Methods Enzymol, V50, P171	35	494	527	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					14869	14872						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714447				2022-12-27	WOS:A1991GB09700011
J	HWANG, JJ; CURTHOYS, NP				HWANG, JJ; CURTHOYS, NP			EFFECT OF ACUTE ALTERATIONS IN ACID-BASE-BALANCE ON RAT RENAL GLUTAMINASE AND PHOSPHOENOLPYRUVATE CARBOXYKINASE GENE-EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3' UNTRANSLATED REGION; MESSENGER-RNA; METABOLIC-ACIDOSIS; CYCLIC-AMP; KIDNEY; LIVER; NEPHRON; GTP; TRANSCRIPTION; CDNA	During chronic acidosis, the levels of the rat renal mRNAs that encode the mitochondrial glutaminase (GA) and cytosolic phosphoenolpyruvate carboxykinase (PCK) are increased 6-fold. Following acute recovery of chronic acidosis, the levels of the two mRNAs are rapidly and coordinately decreased, returning to normal within 13-17 h. In contrast, the increases in GA and PCK mRNAs during acute onset of acidosis occur with very different kinetics. The increase in PCK mRNA occurs rapidly and reaches a maximum within 7 h, whereas the GA mRNA is increased after a 4-7-h lag and then plateaus at 14-17 h. Treatment with dexamethasone or with cAMP analogs significantly increases the level of renal PCK mRNA but has no effect on the level of GA mRNA. Nuclear run-on experiments indicate that the acute induction of PCK mRNA is primarily due to an increased rate of transcription. However, transcription of GA mRNA is unaffected by acute acidosis. Therefore, the changes in the two mRNAs are temporally coordinated but occur through different mechanisms. Furthermore, the inductive effects of acidosis are not mediated solely through glucocorticoid or cAMP regulatory elements.	COLORADO STATE UNIV, DEPT BIOCHEM, FT COLLINS, CO 80523 USA	Colorado State University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037124] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-37124] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMASINO RM, 1986, ANAL BIOCHEM, V152, P304, DOI 10.1016/0003-2697(86)90413-6; BANNER C, 1988, MOL BRAIN RES, V3, P247, DOI 10.1016/0169-328X(88)90047-2; BEALE EG, 1985, J BIOL CHEM, V260, P748; Brosnan JT, 1988, PH HOMEOSTASIS MECHA, P281; BURCH HB, 1978, AM J PHYSIOL, V235, pF246, DOI 10.1152/ajprenal.1978.235.3.F246; CELANO P, 1989, BIOTECHNIQUES, V7, P942; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CIMBALA MA, 1982, J BIOL CHEM, V257, P7629; CURTHOYS NP, 1973, J BIOL CHEM, V248, P162; DAVIS LG, 1986, BASIC METHODS MOL BI, P222; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GALLO M, 1987, MOL NEPHROLOGY BIOCH, P191; GOOD DW, 1984, J CLIN INVEST, V73, P602, DOI 10.1172/JCI111250; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HAUSSINGER D, 1990, BIOCHEM J, V267, P281; HAUSSINGER D, 1986, BIOCHEM J, V236, P261; HAUSSINGER D, 1988, PH HOMEOSTASIS, P337; HUGHEY RP, 1980, AM J PHYSIOL, V238, pF199, DOI 10.1152/ajprenal.1980.238.3.F199; IYNEDJIAN PB, 1975, J BIOL CHEM, V250, P5596; KAISER S, 1991, J BIOL CHEM, V266, P9397; KRIEG PA, 1987, METHOD ENZYMOL, V155, P397; KUNKEL GR, 1986, P NATL ACAD SCI USA, V83, P8575, DOI 10.1073/pnas.83.22.8575; LAMERS WH, 1982, P NATL ACAD SCI-BIOL, V79, P5137, DOI 10.1073/pnas.79.17.5137; LOWRY M, 1980, BIOCHEM J, V190, P771, DOI 10.1042/bj1900771; Maniatis T., 1982, MOL CLONING; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; MEISNER H, 1985, BIOCHEMISTRY-US, V24, P421, DOI 10.1021/bi00323a027; MORRIS SM, 1987, ARCH BIOCHEM BIOPHYS, V256, P343, DOI 10.1016/0003-9861(87)90455-3; PARRY DM, 1978, BIOCHEM J, V174, P387, DOI 10.1042/bj1740387; PITTS RF, 1973, HDB PHYSL 8, P445; POLLOCK AS, 1989, BIOCHEM BIOPH RES CO, V164, P81, DOI 10.1016/0006-291X(89)91685-9; REEVES R, 1987, P NATL ACAD SCI USA, V84, P6531, DOI 10.1073/pnas.84.18.6531; SASAKI K, 1988, P NATL ACAD SCI USA, V85, P2954, DOI 10.1073/pnas.85.9.2954; SCHROCK H, 1980, BIOCHEM J, V188, P557, DOI 10.1042/bj1880557; SEYAMA S, 1973, J BIOCHEM-TOKYO, V73, P39; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; TANNEN RL, 1979, CLIN SCI, V56, P353, DOI 10.1042/cs0560353; TANNEN RL, 1984, KIDNEY INT, V25, P1, DOI 10.1038/ki.1984.1; TONG J, 1987, BIOCHEMISTRY-US, V26, P2773, DOI 10.1021/bi00384a018; TONG J, 1986, BIOCHEM J, V233, P139, DOI 10.1042/bj2330139; VINAY P, 1980, INT J BIOCHEM, V12, P89, DOI 10.1016/0020-711X(80)90048-8; WILSON T, 1988, NATURE, V336, P396, DOI 10.1038/336396a0; WRIGHT PA, 1990, AM J PHYSIOL, V259, pF53, DOI 10.1152/ajprenal.1990.259.1.F53; YOOWARREN H, 1983, P NATL ACAD SCI-BIOL, V80, P3656, DOI 10.1073/pnas.80.12.3656	46	99	99	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					9392	9396						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1709637				2022-12-27	WOS:A1991FM45900011
J	MARCEL, YL; PROVOST, PR; KOA, H; RAFFAI, E; DAC, NV; FRUCHART, JC; RASSART, E				MARCEL, YL; PROVOST, PR; KOA, H; RAFFAI, E; DAC, NV; FRUCHART, JC; RASSART, E			THE EPITOPES OF APOLIPOPROTEIN-A-I DEFINE DISTINCT STRUCTURAL DOMAINS INCLUDING A MOBILE MIDDLE REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY LIPOPROTEIN; GRADIENT GEL-ELECTROPHORESIS; AMINO-ACID; CHOLESTEROL ACYLTRANSFERASE; MONOCLONAL-ANTIBODIES; SECONDARY-STRUCTURE; COMPLEXES; PROTEINS; PHOSPHATIDYLCHOLINE; EXPRESSION	The definition of epitopes on apoA-I provides evidence for a very dense packing of the peptide chain and supports the proposed supersecondary structure, made of repetitive antiparallel helices. Screening with overlapping synthetic hexapeptides shows that only a few epitopes are continuous and that all continuous contact sequences identified within the epitopes coincide or are contiguous to a putative beta-turn, such as residues 1-8, 48-55, 98-104, 118-123, and 135-140. On the N-terminal half of apoA-I we identified 6 overlapping tertiary discontinuous epitopes, uniquely constituted by amino acids and discontinuous sequences on helical segments that are far apart and which define a particular region with a complex tertiary structure. Among these are the epitopes for antibody 5G6, which reacts with residues 45-51, 83-92, 119-126, and 136-143; for A16, which reacts with 14-19, 23-28, and 60-82; and for r-FC1, which reacts with 1-8, 29-35, 78-83, and 98-121. The very far apart discontinuous sequences included in these epitopes can be explained by the predicted turns and coiled domains, and thus provide evidence for such a tertiary structure. Alternatively, these results could also be explained by intermolecular epitopes involving the N-terminal region. In contrast, in the middle of apoA-I, all identified epitopes are shorter and discontinuous within the secondary structure and are constituted by residues forming a beta-turn with all or part of an adjacent alpha-helix. We hypothesize that these multiple epitopes, that are mostly limited to a single helix, reflect the existence of a very mobile domain, possibly with hinged pairs of adjacent alpha-helices. On the C-terminal half of apoA-I, several monoclonal antibodies react with overlapping epitopes located between residues 149 and 186, which probably reflects 2 antiparallel alpha-helices interrupted by a beta-turn.	INST PASTEUR,SERV RECH LIPIDES & ATHEROSCLEROSE,F-59019 LILLE,FRANCE; UNIV QUEBEC,DEPT SCI BIOL,MONTREAL H3C 3P8,QUEBEC,CANADA	Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Quebec; University of Quebec Montreal	MARCEL, YL (corresponding author), CLIN RES INST MONTREAL,LIPOPROT METAB LAB,110 PINE AVE W,MONTREAL H2W 1R7,QUEBEC,CANADA.							BARKER WC, 1977, COMP BIOCH PHYSL, V576, P309; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; BETARD C, 1987, J CLIN CHEM CLIN BIO, V25, P893; BOGUSKI MS, 1986, J LIPID RES, V27, P1011; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1043, P245, DOI 10.1016/0005-2760(90)90023-Q; BROUILLETTE CG, 1984, BIOCHEMISTRY-US, V23, P359, DOI 10.1021/bi00297a027; CHEUNG MC, 1987, J LIPID RES, V28, P913; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; CURTISS LK, 1988, J BIOL CHEM, V263, P13779; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; FITCH WM, 1977, GENETICS, V86, P623; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GEYSEN HM, 1987, SCIENCE, V235, P1184, DOI 10.1126/science.3823878; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; JONAS A, 1989, J BIOL CHEM, V264, P4818; KAISER ET, 1983, P NATL ACAD SCI USA, V80, P1137, DOI 10.1073/pnas.80.4.1137; KARATHANASIS SK, 1983, P NATL ACAD SCI-BIOL, V80, P6147, DOI 10.1073/pnas.80.20.6147; LI WH, 1988, J LIPID RES, V29, P245; MARCEL YL, 1987, J LIPID RES, V28, P768; MARCEL YL, 1989, J BIOL CHEM, V264, P19942; MATZ CE, 1982, J BIOL CHEM, V257, P4541; MCLACHLAN AD, 1977, NATURE, V267, P465, DOI 10.1038/267465a0; MILTHORP P, 1986, HUMAN APOLIPOPROTEIN, P103; NAKAGAWA SH, 1985, J AM CHEM SOC, V107, P7087, DOI 10.1021/ja00310a055; NICHOLS AV, 1983, BIOCHIM BIOPHYS ACTA, V750, P353, DOI 10.1016/0005-2760(83)90040-1; NICHOLS AV, 1985, BIOCHIM BIOPHYS ACTA, V834, P285, DOI 10.1016/0005-2760(85)90001-3; NICHOLS AV, 1987, J LIPID RES, V28, P719; PETIT E, 1987, BIOCHIM BIOPHYS ACTA, V919, P287, DOI 10.1016/0005-2760(87)90268-2; PIO F, 1988, BIOCHIM BIOPHYS ACTA, V959, P160, DOI 10.1016/0005-2760(88)90027-6; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; SEGREST JP, 1974, FEBS LETT, V38, P247, DOI 10.1016/0014-5793(74)80064-5; STANLEY KK, 1984, EMBO J, V3, P1429, DOI 10.1002/j.1460-2075.1984.tb01988.x; WEECH PK, 1988, BIOCHIM BIOPHYS ACTA, V835, P390; [No title captured]	36	94	95	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	1991	266	6					3644	3653						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EY682	1704890				2022-12-27	WOS:A1991EY68200047
J	LAWRENCE, DA; STRANDBERG, L; ERICSON, J; NY, T				LAWRENCE, DA; STRANDBERG, L; ERICSON, J; NY, T			STRUCTURE-FUNCTION STUDIES OF THE SERPIN PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 - ANALYSIS OF CHIMERIC STRAINED LOOP MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											LAWRENCE, DA (corresponding author), UMEA UNIV, DEPT APPL CELL & MOLEC BIOL, S-90187 UMEA, SWEDEN.			Lawrence, Daniel/0000-0003-3126-1935; Ericson, Johan/0000-0002-8019-7127				ALESSI MC, 1988, EUR J BIOCHEM, V175, P531, DOI 10.1111/j.1432-1033.1988.tb14225.x; BACHMANN F, 1987, THROMB DIATH HAEMO, P227; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; BODE W, 1986, EMBO J, V5, P2453, DOI 10.1002/j.1460-2075.1986.tb04521.x; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; BOLOGNESI M, 1982, J MOL BIOL, V162, P839, DOI 10.1016/0022-2836(82)90550-2; BRODIN P, 1986, BIOCHEMISTRY-US, V25, P5371, DOI 10.1021/bi00367a004; BRUCH M, 1988, J BIOL CHEM, V263, P16626; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CARRELL RW, 1987, COLD SPRING HARB SYM, V52, P527, DOI 10.1101/SQB.1987.052.01.060; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CHANDRA T, 1983, P NATL ACAD SCI-BIOL, V80, P1845, DOI 10.1073/pnas.80.7.1845; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHEN ZG, 1983, J MOL BIOL, V164, P283, DOI 10.1016/0022-2836(83)90078-5; CHMIELEWSKA J, 1988, BIOCHEM J, V251, P327, DOI 10.1042/bj2510327; COHEN AB, 1977, P NATL ACAD SCI USA, V74, P4311, DOI 10.1073/pnas.74.10.4311; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; DOOLITTLE RF, 1983, SCIENCE, V222, P417, DOI 10.1126/science.6604942; ERDJUMENT H, 1988, J BIOL CHEM, V263, P5589; GLOOR S, 1986, CELL, V47, P687; GRUNDSTROM T, 1985, NUCLEIC ACIDS RES, V13, P3305, DOI 10.1093/nar/13.9.3305; HAMSTEN A, 1985, NEW ENGL J MED, V313, P1557, DOI 10.1056/NEJM198512193132501; HEEB MJ, 1987, J BIOL CHEM, V262, P15813; HEKMAN CM, 1988, ARCH BIOCHEM BIOPHYS, V262, P199, DOI 10.1016/0003-9861(88)90182-8; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HOLMBERG L, 1978, BIOCHIM BIOPHYS ACTA, V544, P128, DOI 10.1016/0304-4165(78)90216-7; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; HOLMES WE, 1987, J BIOL CHEM, V262, P1659; HOLMES WE, 1987, SCIENCE, V238, P209, DOI 10.1126/science.2958938; HSUEH AJW, 1988, MEIOTIC INHIBITION M, P227; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; HUBER R, 1974, J MOL BIOL, V89, P73, DOI 10.1016/0022-2836(74)90163-6; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; JALLAT S, 1986, PROTEIN ENG, V1, P29, DOI 10.1093/protein/1.1.29; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385; KRUITHOF EKO, 1986, J BIOL CHEM, V261, P1207; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE D, 1989, EUR J BIOCHEM, V186, P523, DOI 10.1111/j.1432-1033.1989.tb15238.x; LEVIN EG, 1987, BLOOD, V70, P1090; LINDAHL TL, 1990, BIOCHEM J, V265, P109, DOI 10.1042/bj2650109; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; LOSKUTOFF DJ, 1983, P NATL ACAD SCI-BIOL, V80, P2956, DOI 10.1073/pnas.80.10.2956; MANIATIS T, 1982, MOL CLONING LABORATO, P249; MCGROGAN M, 1988, BIO-TECHNOL, V6, P172, DOI 10.1038/nbt0288-172; MIMURO J, 1989, J BIOL CHEM, V264, P936; MIMURO J, 1989, J BIOL CHEM, V264, P5058; MOSCATELLI D, 1988, BIOCHIM BIOPHYS ACTA, V948, P67, DOI 10.1016/0304-419X(88)90005-4; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; NY T, 1989, FIBRINOLYSIS, V3, P189, DOI 10.1016/0268-9499(89)90045-3; OLSON ST, 1986, J BIOL CHEM, V261, P3151; OLSON ST, 1981, J BIOL CHEM, V256, P1073; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PETERSON CB, 1987, J BIOL CHEM, V262, P7552; RIJKEN DC, 1988, TISSUE TYPE PLASMINO, V1, P101; SAKATA Y, 1986, BLOOD, V68, P1218; SAKSELA O, 1985, BIOCHIM BIOPHYS ACTA, V823, P35, DOI 10.1016/0304-419X(85)90014-9; SALONEN EM, 1989, J BIOL CHEM, V264, P6339; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCOTT RW, 1985, J BIOL CHEM, V260, P7029; SHINGLER V, 1989, J GEN MICROBIOL, V135, P1083; STEPHENS AW, 1987, J BIOL CHEM, V262, P1044; STUMP DC, 1986, J BIOL CHEM, V261, P2759; SUZUKI K, 1987, J BIOL CHEM, V262, P611; SWEET RM, 1974, BIOCHEMISTRY-US, V13, P4212, DOI 10.1021/bi00717a024; TRISLER P, 1984, J BACTERIOL, V160, P184, DOI 10.1128/JB.160.1.184-191.1984; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2; WUN TC, 1987, J BIOL CHEM, V262, P3646	75	128	133	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20293	20301						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700786				2022-12-27	WOS:A1990EJ52500041
J	GAUBATZ, JW; CUTLER, RG				GAUBATZ, JW; CUTLER, RG			MOUSE SATELLITE DNA IS TRANSCRIBED IN SENESCENT CARDIAC-MUSCLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NIA,GERONTOL RES CTR,BALTIMORE,MD 21224	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	GAUBATZ, JW (corresponding author), UNIV SO ALABAMA,COLL MED,DEPT BIOCHEM,MOBILE,AL 36688, USA.				NIA NIH HHS [AG07860] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG007860] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BAKER WK, 1968, ADV GENET, V14, P133, DOI 10.1016/S0065-2660(08)60426-5; BENNETT KL, 1984, MOL CELL BIOL, V4, P1561, DOI 10.1128/MCB.4.8.1561; BIRNSTIEL ML, 1972, J MOL BIOL, V63, P21, DOI 10.1016/0022-2836(72)90519-0; BUTNER KA, 1986, J MOL BIOL, V187, P547, DOI 10.1016/0022-2836(86)90333-5; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN AK, 1973, CAN J BIOCHEM CELL B, V51, P529, DOI 10.1139/o73-065; COLE MD, 1982, J VIROL, V42, P123, DOI 10.1128/JVI.42.1.123-130.1982; CUTLER RG, 1985, MOL BIOL AGING GENE, P307; DIAZ MO, 1981, CELL, V24, P649, DOI 10.1016/0092-8674(81)90091-X; FLAMM WG, 1969, J MOL BIOL, V40, P423, DOI 10.1016/0022-2836(69)90163-6; FLORES SC, 1988, NUCLEIC ACIDS RES, V16, P3889, DOI 10.1093/nar/16.9.3889; GAUBATZ JW, 1989, ARCH GERONTOL GERIAT, V8, P47, DOI 10.1016/0167-4943(89)90069-1; GAUBATZ JW, 1986, J MOL CELL CARDIOL, V18, P1317, DOI 10.1016/S0022-2828(86)80435-7; GJERSET RA, 1977, P NATL ACAD SCI USA, V74, P4337, DOI 10.1073/pnas.74.10.4337; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HAREL J, 1968, BIOCHEM BIOPH RES CO, V33, P696, DOI 10.1016/0006-291X(68)90352-5; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; HOWLETT D, 1989, MUTAT RES, V219, P101, DOI 10.1016/0921-8734(89)90020-9; HSU TC, 1962, EXP CELL RES, V27, P332, DOI 10.1016/0014-4827(62)90238-0; John B, 1979, Int Rev Cytol, V58, P1, DOI 10.1016/S0074-7696(08)61473-4; JONES KW, 1971, NATURE-NEW BIOL, V233, P268, DOI 10.1038/newbio233268a0; JONES KW, 1970, NATURE, V225, P912, DOI 10.1038/225912a0; JOSEPH A, 1989, EXP CELL RES, V183, P494, DOI 10.1016/0014-4827(89)90408-4; KRAMEROV DA, 1985, BIOCHIM BIOPHYS ACTA, V824, P85, DOI 10.1016/0167-4781(85)90084-3; KRAYEV AS, 1980, NUCLEIC ACIDS RES, V8, P1201, DOI 10.1093/nar/8.6.1201; KUFF EL, 1985, MOL CELL BIOL, V5, P474, DOI 10.1128/MCB.5.3.474; KUNSTYR I, 1975, J GERONTOL, V30, P157, DOI 10.1093/geronj/30.2.157; LEWIN B, 1980, GENE EXPRESSION, V2, P504; LEWIN B, 1987, GENES, V3, P432; Maniatis T., 1982, MOL CLONING; MARESCA A, 1984, J MOL BIOL, V179, P629, DOI 10.1016/0022-2836(84)90159-1; PARDUE ML, 1970, SCIENCE, V168, P1356, DOI 10.1126/science.168.3937.1356; PIETRAS DF, 1983, NUCLEIC ACIDS RES, V11, P6965, DOI 10.1093/nar/11.20.6965; PONZETTOZIMMERMAN C, 1984, NUCLEIC ACIDS RES, V12, P2807, DOI 10.1093/nar/12.6.2807; PRASHAD N, 1976, BIOCHIM BIOPHYS ACTA, V418, P1, DOI 10.1016/0005-2787(76)90322-1; PRICE GB, 1971, SCIENCE, V171, P917, DOI 10.1126/science.171.3974.917; REEDER RH, 1973, J MOL BIOL, V80, P229, DOI 10.1016/0022-2836(73)90169-1; SEALY L, 1981, J MOL BIOL, V145, P291, DOI 10.1016/0022-2836(81)90207-2; SEMSEI I, 1989, ONCOGENE, V4, P165; SOUTHERN EM, 1975, J MOL BIOL, V94, P51, DOI 10.1016/0022-2836(75)90404-0; SPERLING K, 1985, CHROMOSOMA, V93, P38, DOI 10.1007/BF01259444; STEPHENSON EC, 1981, CELL, V24, P639, DOI 10.1016/0092-8674(81)90090-8; TALARICO D, 1988, MOL CELL BIOL, V8, P1336, DOI 10.1128/MCB.8.3.1336; WARING M, 1966, SCIENCE, V154, P791, DOI 10.1126/science.154.3750.791; WILSON VL, 1987, J BIOL CHEM, V262, P9948; WORCEL A, 1977, CELL, V12, P83, DOI 10.1016/0092-8674(77)90187-8; WU ZG, 1986, CHROMOSOMA, V93, P291, DOI 10.1007/BF00327586; YUNIS JJ, 1971, SCIENCE, V174, P1200, DOI 10.1126/science.174.4015.1200	48	59	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17753	17758						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698780				2022-12-27	WOS:A1990EC76600061
J	KAYANO, T; BURANT, CF; FUKUMOTO, H; GOULD, GW; FAN, YS; EDDY, RL; BYERS, MG; SHOWS, TB; SEINO, S; BELL, GI				KAYANO, T; BURANT, CF; FUKUMOTO, H; GOULD, GW; FAN, YS; EDDY, RL; BYERS, MG; SHOWS, TB; SEINO, S; BELL, GI			HUMAN FACILITATIVE GLUCOSE TRANSPORTERS - ISOLATION, FUNCTIONAL-CHARACTERIZATION, AND GENE LOCALIZATION OF CDNAS ENCODING AN ISOFORM (GLUT5) EXPRESSED IN SMALL-INTESTINE, KIDNEY, MUSCLE, AND ADIPOSE-TISSUE AND AN UNUSUAL GLUCOSE TRANSPORTER PSEUDOGENE-LIKE SEQUENCE (GLUT6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637; UNIV GLASGOW,DEPT BIOCHEM,GLASGOW G12 8QQ,SCOTLAND; KYOTO UNIV,SCH MED,DEPT INTERNAL MED 2,KYOTO 606,JAPAN; NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT HUMAN GENET,BUFFALO,NY 14263	University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Glasgow; Kyoto University; Roswell Park Cancer Institute			Burant, Charles/GPC-5690-2022	Burant, Charles/0000-0001-9189-5003; Gould, Gwyn/0000-0001-6571-2875	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD005196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020454] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-05196] Funding Source: Medline; NIGMS NIH HHS [GM-20454] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BALDWIN SA, 1989, ANNU REV PHYSIOL, V51, P459, DOI 10.1146/annurev.physiol.51.1.459; BELL GI, 1986, NUCLEIC ACIDS RES, V14, P8427, DOI 10.1093/nar/14.21.8427; BELL GI, 1989, DIABETES, V38, P1072, DOI 10.2337/diabetes.38.8.1072; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5758; BROTLAROCHE E, 1988, P NATL ACAD SCI USA, V85, P6370, DOI 10.1073/pnas.85.17.6370; BROTLAROCHE E, 1986, J BIOL CHEM, V261, P6168; CAIRNS BR, 1989, P NATL ACAD SCI USA, V86, P7682, DOI 10.1073/pnas.86.20.7682; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; CHENG Q, 1989, GENETICS, V123, P477; FLIER JS, 1987, J CLIN INVEST, V79, P657, DOI 10.1172/JCI112864; FUKUMOTO H, 1988, DIABETES, V37, P657, DOI 10.2337/diabetes.37.5.657; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GOULD GW, 1989, BIOCHEMISTRY-US, V28, P9447, DOI 10.1021/bi00450a030; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KAESTNER KH, 1989, P NATL ACAD SCI USA, V86, P3150, DOI 10.1073/pnas.86.9.3150; KASANICKI MA, 1990, DIABETES CARE, V13, P219, DOI 10.2337/diacare.13.3.219; KAYANO T, 1988, J BIOL CHEM, V263, P15245; KELLER K, 1989, J BIOL CHEM, V264, P18884; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; MALLER JL, 1983, METHOD ENZYMOL, V99, P219; Maniatis T., 1982, MOL CLONING; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; ORCI L, 1989, SCIENCE, V245, P295, DOI 10.1126/science.2665080; PERMUTT MA, 1989, P NATL ACAD SCI USA, V86, P8688, DOI 10.1073/pnas.86.22.8688; SAIKI RK, 1988, SCIENCE, V239, P484; SHOWS TB, 1987, DIABETES, V36, P546, DOI 10.2337/diabetes.36.4.546; SZKUTNICKA K, 1989, J BACTERIOL, V171, P4486, DOI 10.1128/JB.171.8.4486-4493.1989; THORENS B, 1988, CELL, V55, P281, DOI 10.1016/0092-8674(88)90051-7; VERA JC, 1989, MOL CELL BIOL, V9, P4187, DOI 10.1128/MCB.9.10.4187; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	34	356	370	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13276	13282						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695905				2022-12-27	WOS:A1990DR20100078
J	TOPPER, JN; CLAYTON, DA				TOPPER, JN; CLAYTON, DA			SECONDARY STRUCTURE OF THE RNA COMPONENT OF A NUCLEAR MITOCHONDRIAL RIBONUCLEOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											TOPPER, JN (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305, USA.				NIGMS NIH HHS [GM33088-19, GM07365-13] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM033088, T32GM007365, R01GM033088] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARTKIEWICZ M, 1989, GENE DEV, V3, P488, DOI 10.1101/gad.3.4.488; BENNETT JL, 1990, MOL CELL BIOL, V10, P2191, DOI 10.1128/MCB.10.5.2191; BIRNSTIEL ML, 1988, STRUCTURE FUNCTION M; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GOLD HA, 1989, SCIENCE, V245, P1377, DOI 10.1126/science.2476849; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; HASHIMOTO C, 1983, J BIOL CHEM, V258, P1379; INOUE T, 1985, P NATL ACAD SCI USA, V82, P648, DOI 10.1073/pnas.82.3.648; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; MOAZED D, 1986, J MOL BIOL, V187, P399, DOI 10.1016/0022-2836(86)90441-9; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; REDDY R, 1983, J BIOL CHEM, V258, P1383; SHIRAISHI H, 1988, EMBO J, V7, P3817, DOI 10.1002/j.1460-2075.1988.tb03266.x; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TOPPER JN, 1990, NUCLEIC ACIDS RES, V18, P793, DOI 10.1093/nar/18.4.793; TOPPER JN, 1988, CANCER CELL, V6, P207; YUAN Y, 1989, J BIOL CHEM, V264, P14835; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	26	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13254	13262						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695904				2022-12-27	WOS:A1990DR20100075
J	DINGUS, J; OBAR, RA; HYAMS, JS; GOEDERT, M; VALLEE, RB				DINGUS, J; OBAR, RA; HYAMS, JS; GOEDERT, M; VALLEE, RB			USE OF A HEAT-STABLE MICROTUBULE-ASSOCIATED PROTEIN CLASS-SPECIFIC ANTIBODY TO INVESTIGATE THE MECHANISM OF MICROTUBULE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAU-PROTEIN; MECHANOCHEMICAL ENZYME; MOLECULAR-CLONING; REPEATED SEQUENCE; BRAIN; IDENTIFICATION; DOMAIN; MAP-2; TUBULIN; SUBUNIT	Members of the heat-stable family of microtubule-associated proteins (MAPs), MAP 2, tau, and MAP 4, contain three or four tandem imperfect repeated sequences close to their carboxyl termini. These sequences lie within the microtubule-binding domains of the MAPs; they have been proposed to be responsible for microtubule binding and the ability of these MAPs to lower the critical concentration for microtubule assembly. Their spacing may reflect that of the regularly arrayed tubulin subunits on the microtubule surface. We here characterize the 32- and 34-kDa chymotryptic microtubule-binding fragments of MAP 2 identified in earlier work. We identify the primary chymotryptic cleavage site in high molecular weight MAP 2 as between Phe1525 and Lys1526, within 13 amino acids of the known MAP 2 splice junction. We have raised a monoclonal antibody to the 32- and 34-kDa fragments and find that it reacts with all members of the heat-stable MAPs class. To determine where it reacts, we sequenced immunoreactive subfragments of the 32- and 34-kDa fragments, selected several cDNA clones with the antibody, and tested for antibody reactivity against a series of synthetic MAP 2 and tau peptides. We identify the epitope sequence as HHVPGGG (His-His-Val-Pro-Gly-Gly-Gly). The antibody also recognized several other MAP 2 and tau repeats. Despite reacting with this highly conserved element, we find that the antibody does not block microtubule binding, but binds to the MAPs and co-sediments with microtubules. These results suggest that there are other regions besides the repeated elements which are essential for microtubule binding.	UNIV LONDON UNIV COLL, DEPT BIOL, LONDON WC1E 6BT, ENGLAND; MRC, MOLEC BIOL LAB, CAMBRIDGE CB2 2QH, ENGLAND	University of London; University College London; MRC Laboratory Molecular Biology	DINGUS, J (corresponding author), WORCESTER FDN EXPTL BIOL INC, CELL BIOL GRP, SHREWSBURY, MA 01545 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026701] Funding Source: NIH RePORTER; NICHD NIH HHS [HD07312] Funding Source: Medline; NIGMS NIH HHS [GM26701] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIZAWA H, 1990, J BIOL CHEM, V265, P13849; BLOOM GS, 1984, J CELL BIOL, V98, P320, DOI 10.1083/jcb.98.1.320; BLOOM GS, 1983, J CELL BIOL, V96, P1523, DOI 10.1083/jcb.96.6.1523; CHAPIN SJ, 1991, J CELL SCI, V98, P27; COLLINS CA, 1989, CELL MOTIL CYTOSKEL, V14, P491, DOI 10.1002/cm.970140407; ENNULAT DJ, 1989, J BIOL CHEM, V264, P5327; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; HAMMARBACK JA, 1991, NEURON, V7, P129, DOI 10.1016/0896-6273(91)90081-A; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; JOLY JC, 1990, BIOCHEMISTRY-US, V29, P8916, DOI 10.1021/bi00490a006; JOLY JC, 1989, J CELL BIOL, V109, P2289, DOI 10.1083/jcb.109.5.2289; KINDLER S, 1990, J BIOL CHEM, V265, P19679; KINDLER S, 1990, NUCLEIC ACIDS RES, V18, P2822, DOI 10.1093/nar/18.9.2822; LEE G, 1990, CELL MOTIL CYTOSKEL, V15, P199, DOI 10.1002/cm.970150402; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEE G, 1989, NEURON, V2, P1615, DOI 10.1016/0896-6273(89)90050-0; LEGENDRE N, 1988, BIOTECHNIQUES, V6, P154; LEWIS SA, 1988, SCIENCE, V242, P936, DOI 10.1126/science.3142041; NOBLE M, 1989, J CELL BIOL, V109, P3367, DOI 10.1083/jcb.109.6.3367; OBAR RA, 1990, NATURE, V347, P256, DOI 10.1038/347256a0; OBAR RA, 1989, NEURON, V3, P639, DOI 10.1016/0896-6273(89)90274-2; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; RIEDERER B, 1985, P NATL ACAD SCI USA, V82, P6006, DOI 10.1073/pnas.82.17.6006; RUBINO HM, 1989, NEURON, V3, P631, DOI 10.1016/0896-6273(89)90273-0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; VALLEE R, 1980, P NATL ACAD SCI-BIOL, V77, P3206, DOI 10.1073/pnas.77.6.3206; VALLEE RB, 1986, METHOD ENZYMOL, V134, P89; VALLEE RB, 1990, CELL MOTIL CYTOSKEL, V15, P204, DOI 10.1002/cm.970150403; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; WAXDAL MJ, 1968, BIOCHEMISTRY-US, V7, P1959, DOI 10.1021/bi00845a046; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2	34	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18854	18860						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717454				2022-12-27	WOS:A1991GJ47200070
J	HILL, KL; LI, HH; SINGER, J; MERCHANT, S				HILL, KL; LI, HH; SINGER, J; MERCHANT, S			ISOLATION AND STRUCTURAL CHARACTERIZATION OF THE CHLAMYDOMONAS-REINHARDTII GENE FOR CYTOCHROME-C6 - ANALYSIS OF THE KINETICS AND METAL SPECIFICITY OF ITS COPPER-RESPONSIVE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; NUCLEAR TRANSFORMATION; METALLOTHIONEIN GENE; TUBULIN GENES; CARBOXYLASE-OXYGENASE; COMPLEMENTARY-DNA; CRYSTAL-STRUCTURE; ELECTRON-DONORS; 2 GENES; PLASTOCYANIN	We have isolated a 5-kilobase pair fragment of genomic DNA containing the entire coding region for the Chlamydomonas reinhardtii gene encoding the copper-repressible Cyt c6. A region comprising 2.6 kilobase pairs contains the entire transcribed region plus 852 nucleotides upstream of the Cyt C6 transcription start site and 495 nucleotides downstream of the conserved C. reinhardtii polyadenylation signal. Comparison of the genomic sequence with the cDNA sequence (Merchant, S., and Bogorad, L. (1987) J. Biol. Chem. 262, 9062-9067) revealed that the coding region is interrupted by two introns, each of which is flanked by C. reinhardtii consensus intron/exon boundaries. Primer extension and S1 nuclease protection analyses identified the 5' border of the Cyt c6 mRNA at approximately 79 base pairs upstream from the initiator methionine. Analysis of the 5' upstream region reveals no significant similarity to sequences found in upstream regions of other copper-regulated genes. Time-course studies indicate that 1) the mature Cyt c6 mRNA has a half-life of approximately 45-60 min and is completely lost within 4 h, and 2) the primary, unspliced transcript has a half-life of approximately 10 min and is completely lost within 30 min after the addition of copper ions to copper-depleted cells. These results indicate that the response to copper occurs very rapidly upon elevation of extracellular copper levels. Although this gene is unresponsive to silver ions in vivo, in contrast to the yeast copper-responsive CUP1 gene (Furst, P., Hu, S., Hackett, R., and Hamer, D. (1988) Cell 55, 705-717), it does respond to mercury ions, albeit with less sensitivity. Mercury ions cannot, however, substitute for copper in allowing the accumulation of plastocyanin in vivo.	UNIV CALIF LOS ANGELES,DEPT CHEM & BIOCHEM,405 HILGARD AVE,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles					NIGMS NIH HHS [GM 42143, GM-07104] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042143, R29GM042143] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BAKER EJ, 1984, J CELL BIOL, V99, P2074, DOI 10.1083/jcb.99.6.2074; BOHNER H, 1981, BIOCHIM BIOPHYS ACTA, V636, P65, DOI 10.1016/0005-2728(81)90076-1; Boulter D., 1977, INT REV BIOCH PLANT, V13, P1; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BRUNKE KJ, 1984, MOL CELL BIOL, V4, P1115, DOI 10.1128/MCB.4.6.1115; BUCHMAN C, 1989, MOL CELL BIOL, V9, P4091, DOI 10.1128/MCB.9.9.4091; CHIANG KS, 1967, P NATL ACAD SCI USA, V57, P1506, DOI 10.1073/pnas.57.5.1506; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CHURCH WB, 1986, J BIOL CHEM, V261, P234; COLMAN PM, 1978, NATURE, V272, P319, DOI 10.1038/272319a0; DEBUCHY R, 1989, EMBO J, V8, P2803, DOI 10.1002/j.1460-2075.1989.tb08426.x; DEHOSTOS EL, 1989, MOL GEN GENET, V218, P229, DOI 10.1007/BF00331273; ENGESETH HR, 1986, BIOCHEMISTRY-US, V25, P2448, DOI 10.1021/bi00357a023; EVANS CF, 1990, MOL CELL BIOL, V10, P426, DOI 10.1128/MCB.10.1.426; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FURST P, 1988, CELL, V55, P705, DOI 10.1016/0092-8674(88)90229-2; GOLDSCHMIDTCLERMONT M, 1986, PLANT MOL BIOL, V6, P13, DOI 10.1007/BF00021302; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; GOODALL GJ, 1989, CELL, V58, P473, DOI 10.1016/0092-8674(89)90428-5; GRAAN T, 1984, J BIOL CHEM, V259, P4003; GRUISSEM W, 1990, PLANT CELL, V2, P827, DOI 10.1105/tpc.2.9.827; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HO KK, 1984, BIOCHIM BIOPHYS ACTA, V766, P310, DOI 10.1016/0005-2728(84)90246-9; HO KK, 1979, BIOCHIM BIOPHYS ACTA, V545, P236; IMBAULT P, 1988, GENE, V73, P397, DOI 10.1016/0378-1119(88)90504-5; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KARIN M, 1984, P NATL ACAD SCI-BIOL, V81, P337, DOI 10.1073/pnas.81.2.337; KIMIMURA M, 1972, BIOCHIM BIOPHYS ACTA, V282, P268; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; KINDLE KL, 1989, J CELL BIOL, V109, P2589, DOI 10.1083/jcb.109.6.2589; LI HM, 1990, P NATL ACAD SCI USA, V87, P6748, DOI 10.1073/pnas.87.17.6748; Maniatis T., 1982, MOL CLONING; MATHEWS FS, 1985, PROG BIOPHYS MOL BIO, V45, P1, DOI 10.1016/0079-6107(85)90004-5; MAYFIELD SP, 1987, P NATL ACAD SCI USA, V84, P749, DOI 10.1073/pnas.84.3.749; MERCHANT S, 1987, EMBO J, V6, P2531, DOI 10.1002/j.1460-2075.1987.tb02540.x; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; MERCHANT S, 1990, J BIOL CHEM, V265, P12372; MERCHANT S, 1987, J BIOL CHEM, V262, P9062; MERCHANT S, 1986, J BIOL CHEM, V261, P5850; RUSKIN B, 1984, CELL, V38, P317, DOI 10.1016/0092-8674(84)90553-1; SANDMANN G, 1980, PLANTA, V147, P330, DOI 10.1007/BF00379841; SANDMANN G, 1983, ARCH MICROBIOL, V134, P23, DOI 10.1007/BF00429401; SANDMANN G, 1981, PHOTOSYNTHESIS, V2, P611; SCHLOSS JA, 1990, MOL GEN GENET, V221, P443, DOI 10.1007/BF00259410; SCHMIDT RJ, 1984, J CELL BIOL, V98, P2011, DOI 10.1083/jcb.98.6.2011; SILFLOW CD, 1985, MOL CELL BIOL, V5, P2389, DOI 10.1128/MCB.5.9.2389; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; THIELE DJ, 1986, MOL CELL BIOL, V6, P1158, DOI 10.1128/MCB.6.4.1158; THIELE DJ, 1988, MOL CELL BIOL, V8, P2745, DOI 10.1128/MCB.8.7.2745; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERPLAS J, 1989, MOL MICROBIOL, V3, P275; WOESSNER JP, 1989, PLANT CELL, V1, P901; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; YOUNGBLOM J, 1984, MOL CELL BIOL, V4, P2686, DOI 10.1128/MCB.4.12.2686; ZIMMER WE, 1988, J BIOL CHEM, V263, P19370	57	65	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15060	15067						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714451				2022-12-27	WOS:A1991GB09700042
J	HASSELAAR, P; LOSKUTOFF, DJ; SAWDEY, M; SAGE, EH				HASSELAAR, P; LOSKUTOFF, DJ; SAWDEY, M; SAGE, EH			SPARC INDUCES THE EXPRESSION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; PLACENTAL ANTICOAGULANT PROTEIN; HUMAN VASCULAR ENDOTHELIUM; BASEMENT-MEMBRANE TUMOR; GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; MESSENGER-RNA; HEMOSTATIC PROPERTIES; FIBRINOLYTIC SYSTEM; POLYACRYLAMIDE GELS	SPARC, a Ca2+-binding glycoprotein that is expressed during tissue morphogenesis and functions as an inhibitor of cell spreading in vitro, was found to induce the secretion of an M(r) = 45,000 protein in bovine aortic endothelial (BAE) cells. This protein was identified as type 1 plasminogen activator inhibitor (PAI-1) on Western blots with anti-PAI-1 antiserum. SPARC stimulated the secretion of PAI-1 protein into the medium of subconfluent BAE cells, but not confluent BAE cells, in a dose- and time-dependent manner. Secretion of PAI-1 into the culture medium was progressive and exhibited an increase of 3- to 7-fold over control values within 24 h after the addition of SPARC. Levels of PAI-1 mRNA were elevated 2-fold within 4 to 24 h after the addition of SPARC and did not increase with higher concentrations of SPARC. Since the induction of PAI-1 mRNA by SPARC was not blocked by cycloheximide, de novo protein synthesis was apparently not required for this stimulation. Control experiments showed that the induction of PAI-1 was not due to contamination of the SPARC preparations with endotoxin. These data demonstrate that SPARC induces the biosynthesis of PAI-1 in BAE cells and suggest a role for SPARC in the regulation of fibrinolysis and in the control of proteolytic events in remodeling tissues.	UNIV WASHINGTON, DEPT BIOL STRUCT, SEATTLE, WA 98195 USA; Scripps Res Inst, RES INST, COMM VASC BIOL, LA JOLLA, CA 92037 USA	University of Washington; University of Washington Seattle; Scripps Research Institute					NHLBI NIH HHS [HL-16411, HL-18645] Funding Source: Medline; NIGMS NIH HHS [GM-40711] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411, P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ASTRUP T, 1978, PROGR CHEM FIBRINOLY, V3, P1; BACHMANN F, 1984, SEMIN THROMB HEMOST, V10, P6, DOI 10.1055/s-2007-1004403; BEVILACQUA MP, 1986, P NATL ACAD SCI USA, V83, P4533, DOI 10.1073/pnas.83.12.4533; BEVILACQUA MP, 1986, J CLIN INVEST, V78, P587, DOI 10.1172/JCI112613; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLUCCI M, 1983, J CLIN INVEST, V71, P1893, DOI 10.1172/JCI110945; COLUCCI M, 1985, J CLIN INVEST, V75, P818, DOI 10.1172/JCI111777; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; DICHEK D, 1989, BLOOD, V74, P222; DIEVAL J, 1991, BLOOD, V77, P528; DZIADEK M, 1986, EUR J BIOCHEM, V161, P455, DOI 10.1111/j.1432-1033.1986.tb10466.x; EMEIS JJ, 1983, BIOCHEM BIOPH RES CO, V110, P392, DOI 10.1016/0006-291X(83)91161-0; EMEIS JJ, 1986, J EXP MED, V163, P1260, DOI 10.1084/jem.163.5.1260; ERICKSON LA, 1985, CLIN HAEMATOL, V14, P513; ERICKSON LA, 1990, NATURE, V346, P74, DOI 10.1038/346074a0; ETINGIN OR, 1991, J BIOL CHEM, V266, P2459; FINDLAY DM, 1988, BIOCHEMISTRY-US, V27, P1483, DOI 10.1021/bi00405a013; FUNAKOSHI T, 1987, BIOCHEMISTRY-US, V26, P5572, DOI 10.1021/bi00391a053; GALDAL KS, 1985, THROMB HAEMOSTASIS, V54, P373; GELEHRTER TD, 1986, J CLIN INVEST, V77, P165, DOI 10.1172/JCI112271; HEKMAN CM, 1988, BIOCHEMISTRY-US, V27, P2911, DOI 10.1021/bi00408a037; HERMAN IM, 1987, TISSUE CELL, V19, P1, DOI 10.1016/0040-8166(87)90052-8; HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473; IRUELAARISPE ML, 1991, LAB INVEST, V64, P174; IRUELAARISPE ML, 1991, IN PRESS ARTERIOSCLE; KELM RJ, 1990, BLOOD, V75, P1105; KOOISTRA T, 1986, BIOCHEM J, V239, P497, DOI 10.1042/bj2390497; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN EG, 1987, J CELL BIOL, V105, P2543, DOI 10.1083/jcb.105.6.2543; LOSKUTOFF DJ, 1989, PROG HEMOST THROMB, V9, P87; LOSKUTOFF DJ, 1983, P NATL ACAD SCI-BIOL, V80, P2956, DOI 10.1073/pnas.80.10.2956; MANN K, 1987, FEBS LETT, V218, P167, DOI 10.1016/0014-5793(87)81040-2; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; MASON IJ, 1986, EMBO J, V5, P1831, DOI 10.1002/j.1460-2075.1986.tb04434.x; MCVEY JH, 1988, J BIOL CHEM, V263, P11111; MEDINA R, 1989, THROMB RES, V54, P41, DOI 10.1016/0049-3848(89)90335-6; MIMURO J, 1987, BLOOD, V70, P721; NACHMAN RL, 1986, J EXP MED, V163, P1595, DOI 10.1084/jem.163.6.1595; NAWROTH PP, 1986, J EXP MED, V163, P740, DOI 10.1084/jem.163.3.740; NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460; NICOSIA RF, 1987, AM J PATHOL, V128, P78; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; REICH E, 1978, MOL BASIS BIOL DEGRA, P155; RODGERS GM, 1988, FASEB J, V2, P116, DOI 10.1096/fasebj.2.2.3277885; ROMBERG RW, 1985, J BIOL CHEM, V260, P2728; SAGE H, 1986, J CELL PHYSIOL, V127, P373, DOI 10.1002/jcp.1041270305; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAKSELA O, 1987, J CELL BIOL, V105, P957, DOI 10.1083/jcb.105.2.957; SAWDEY M, 1989, J BIOL CHEM, V264, P10396; SCHLEEF RR, 1988, J BIOL CHEM, V263, P5797; SCHLEEF RR, 1990, J CELL BIOL, V110, P155, DOI 10.1083/jcb.110.1.155; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; SEIFFERT D, 1990, J CELL BIOL, V111, P1283, DOI 10.1083/jcb.111.3.1283; SPRENGERS ED, 1987, BLOOD, V69, P381; STACK S, 1990, BIOCHEMISTRY-US, V29, P4966, DOI 10.1021/bi00472a029; STENNER DD, 1986, P NATL ACAD SCI USA, V83, P6892, DOI 10.1073/pnas.83.18.6892; TAIT JF, 1989, J BIOL CHEM, V264, P7944; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANHINSBERGH VWM, 1987, THROMB HAEMOSTASIS, V57, P148; VANHINSBERGH VWM, 1988, BLOOD, V72, P1467; VANMOURIK JA, 1984, J BIOL CHEM, V259, P14914; WATSON SW, 1987, PROGR CLIN BIOL RES, V231	64	69	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13178	13184						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712775				2022-12-27	WOS:A1991FX13200061
J	UCHIDA, S; KWON, HM; PRESTON, AS; HANDLER, JS				UCHIDA, S; KWON, HM; PRESTON, AS; HANDLER, JS			EXPRESSION OF MADIN-DARBY CANINE KIDNEY-CELL NA+-DEPENDENT AND CL--DEPENDENT TAURINE TRANSPORTER IN XENOPUS-LAEVIS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASCITES TUMOR-CELLS; MEMBRANE-VESICLES; CDNA CLONING; RENAL-CELLS; RECEPTOR; BRAIN; COTRANSPORTER; CHANNELS; OSMOREGULATION; MYOINOSITOL	Expression of a Madin-Darby canine kidney (MDCK) cell taurine transporter was examined in Xenopus oocytes that had been injected with poly(A)+ RNA extracted from MDCK cells. Compared with water-injected oocytes, injection of total poly(A)+ RNA resulted in an increase in Na+-dependent taurine uptake which was directly related to the amount of RNA injected. The magnitude of expression in poly(A)+ RNA-injected oocytes was 5-10-fold higher than that of water-injected oocytes. Since the V(max) of taurine uptake in MDCK cells is increased by culture in hypertonic medium, we compared oocyte taurine uptake after injection with poly(A)+ RNA from MDCK cells cultured in hypertonic medium with uptake in oocytes injected with poly(A)+ RNA from MDCK cells cultured in isotonic medium. Poly(A)+ RNA from hypertonic cells elicited twice the taurine uptake elicited by poly(A)+ RNA from isotonic cells. The transporter expressed in oocytes was like that in MDCK cells: it was completely dependent on external sodium and was also anion dependent (Cl- greater-than-or-equal-to Br- > SCN- >> gluconate-). Other beta-amino acids, beta-alanine and hypotaurine, inhibited taurine uptake, but L-alanine and 2-(methylamino) isobutyric acid did not. The apparent K(m) of the transporter was 7.0-mu-M. After size fractionation on a sucrose density gradient, poly(A)+ RNA encoding for the MDCK taurine transporter was found in the fraction whose average size was 4.4 kilobases.			UCHIDA, S (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,DIV NEPHROL,BALTIMORE,MD 21205, USA.		Lee-Kwon, Whaseon/D-6021-2011					BARNARD JA, 1988, AM J PHYSIOL, V254, pG334, DOI 10.1152/ajpgi.1988.254.3.G334; BUCUVALAS JC, 1987, AM J PHYSIOL, V253, pG351, DOI 10.1152/ajpgi.1987.253.3.G351; BURNHAM CE, 1990, AM J PHYSIOL, V259, pF383, DOI 10.1152/ajprenal.1990.259.2.F383; Chesney R W, 1985, Adv Pediatr, V32, P1; CHESNEY RW, 1989, FASEB J, V3, P2081, DOI 10.1096/fasebj.3.9.2744305; CHESNEY RW, 1985, J CLIN INVEST, V76, P2213, DOI 10.1172/JCI112230; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; HAGENBUCH B, 1990, J BIOL CHEM, V265, P5357; HEDIGER MA, 1987, P NATL ACAD SCI USA, V84, P2634, DOI 10.1073/pnas.84.9.2634; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; JONES DP, 1990, KIDNEY INT, V38, P219, DOI 10.1038/ki.1990.189; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KARL PI, 1990, AM J PHYSIOL, V258, pC443, DOI 10.1152/ajpcell.1990.258.3.C443; KING PA, 1983, MOL PHYSIOL, V4, P53; KING PA, 1982, J EXP ZOOL, V223, P103, DOI 10.1002/jez.1402230202; KWON HM, 1991, AM J PHYSIOL, V260, pF258, DOI 10.1152/ajprenal.1991.260.2.F258; LAMBERT IH, 1984, MOL PHYSIOL, V6, P233; LAMBERT IH, 1985, MOL PHYSIOL, V7, P323; LIEN YHH, 1990, J CLIN INVEST, V85, P1427, DOI 10.1172/JCI114587; LU L, 1990, J BIOL CHEM, V265, P16190; LUBBERT H, 1987, P NATL ACAD SCI USA, V84, P4332, DOI 10.1073/pnas.84.12.4332; MAHAN LC, 1990, P NATL ACAD SCI USA, V87, P2196, DOI 10.1073/pnas.87.6.2196; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; NAKANISHI T, 1989, P NATL ACAD SCI USA, V86, P6002, DOI 10.1073/pnas.86.15.6002; NAKANISHI T, 1989, AM J PHYSIOL, V257, pC964, DOI 10.1152/ajpcell.1989.257.5.C964; NAKANISHI T, 1990, AM J PHYSIOL, V258, pF1061, DOI 10.1152/ajprenal.1990.258.4.F1061; NAKANISHI T, 1988, AM J PHYSIOL, V255, pC181, DOI 10.1152/ajpcell.1988.255.2.C181; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; PALACIN M, 1990, J BIOL CHEM, V265, P7142; Sambrook J, 1989, MOL CLONING LABORATO; SIEGL E, 1988, J BIOL CHEM, V263, P14614; TARNUZZER RW, 1990, J BIOL CHEM, V265, P13914; TAUB M, 1979, P NATL ACAD SCI USA, V76, P3338, DOI 10.1073/pnas.76.7.3338; TOMASELLI GF, 1989, J CLIN INVEST, V83, P1724, DOI 10.1172/JCI114073; VILIJN F, 1989, J BIOL CHEM, V264, P11901; WADE JV, 1988, J NEUROCHEM, V51, P740, DOI 10.1111/j.1471-4159.1988.tb01807.x; WERNER A, 1990, J BIOL CHEM, V265, P12331; WILLIAMS JA, 1988, P NATL ACAD SCI USA, V85, P4939, DOI 10.1073/pnas.85.13.4939; WOLFF NA, 1986, AM J PHYSIOL, V250, pR984, DOI 10.1152/ajpregu.1986.250.6.R984; YAMAUCHI A, 1991, IN PRESS AM J PHYSL; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; ZELIKOVIC I, 1989, AM J PHYSIOL, V256, pF646, DOI 10.1152/ajprenal.1989.256.4.F646; ZHANG R, 1990, J BIOL CHEM, V265, P15375	44	47	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					9605	9609						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1709638				2022-12-27	WOS:A1991FM45900043
J	PLATICA, O; JANECZKO, R; QUADROS, EV; REGEC, A; ROMAIN, R; ROTHENBERG, SP				PLATICA, O; JANECZKO, R; QUADROS, EV; REGEC, A; ROMAIN, R; ROTHENBERG, SP			THE CDNA SEQUENCE AND THE DEDUCED AMINO-ACID-SEQUENCE OF HUMAN TRANSCOBALAMIN-II SHOW HOMOLOGY WITH RAT INTRINSIC-FACTOR AND HUMAN TRANSCOBALAMIN-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEGALOBLASTIC-ANEMIA; ENDOTHELIAL-CELLS; MESSENGER-RNA; DNA; DEFICIENCY; PURIFICATION; VITAMIN-B12; TRANSPORT; PATIENT; SERUM	The cellular uptake of cobalamin (Cbl, vitamin B-12) is mediated by transcobalamin II (TCII), a plasma protein that binds Cbl and is secreted by human umbilical vein endothelial (HUVE) cells. These cells synthesize and secrete TCII and, therefore, served as the source of the complementary DNA (cDNA) library from which the TCII cDNA was isolated. This full-length cDNA consists of 1866 nucleotides that code for a leader peptide of 18 amino acids, a secreted protein of 409 amino acids, a 5'-untranslated segment of 37 nucleotides, and a 3'-untranslated region of 548 nucleotides. A single 1.9-kilobase species of mRNA corresponding to the size of the cDNA was identified by Northern blot analysis of the RNA isolated from HUVE cells. TCII has 20% amino acid homology and greater than 50% nucleotide homology with human transcobalamin I (TCI) and with rat intrinsic factor (R-IF). TCII has no homology with the amino-terminal region of R-IF that has been reported to have significant primary as well as secondary structural homology with the nucleotide-binding domain of NAD-dependent oxidoreductases. The regions of homology that are common to all three proteins are located in seven domains of the amino acid sequence. One or more of these conserved domains is likely to be involved in Cbl binding, a function that is common to all three proteins. However, the difference in the affinity of TCII, TCI, and R-IF for Cbl and Cbl analogues indicates, a priori, that structural differences in the ligand-binding site of these proteins exist and these probably resulted from divergence of a common ancestral gene.	SUNY HLTH SCI CTR, DEPT MICROBIOL & IMMUNOL, BROOKLYN, NY 11209 USA; VET AFFAIRS MED CTR, BROOKLYN, NY 11209 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	PLATICA, O (corresponding author), SUNY HLTH SCI CTR, DEPT MED, DIV HEMATOL ONCOL, BROOKLYN, NY 11209 USA.				NIDDK NIH HHS [DK28561] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028561] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BERGER SL, 1980, J BIOL CHEM, V255, P2955; BIRKTOFT JJ, 1984, PEPT PROTEIN REV, V4, P1; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BURMAN JF, 1979, BRIT J HAEMATOL, V43, P27, DOI 10.1111/j.1365-2141.1979.tb03716.x; CARMEL R, 1990, BLOOD, V75, P251; Castle WB, 1930, AM J MED SCI, V180, P305, DOI 10.1097/00000441-193009000-00001; CHANARIN I, 1978, BRIT MED J, V1, P1453, DOI 10.1136/bmj.1.6125.1453; DIECKGRAEFE BK, 1988, P NATL ACAD SCI USA, V85, P46, DOI 10.1073/pnas.85.1.46; DIGIROLAMO PM, 1975, ARCH BIOCHEM BIOPHYS, V168, P386, DOI 10.1016/0003-9861(75)90267-2; FRIEDMAN PA, 1977, J CLIN INVEST, V59, P51, DOI 10.1172/JCI108621; GLASS GBJ, 1954, SCIENCE, V120, P74, DOI 10.1126/science.120.3106.74-a; HAKAMI N, 1971, NEW ENGL J MED, V285, P1163, DOI 10.1056/NEJM197111182852103; HALL CA, 1965, J LAB CLIN MED, V65, P459; HALL CA, 1962, J LAB CLIN MED, V60, P765; HAURANI FI, 1979, J CLIN INVEST, V64, P1253, DOI 10.1172/JCI109580; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HITZIG WH, 1974, J PEDIATR-US, V85, P622, DOI 10.1016/S0022-3476(74)80503-2; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; JOHNSTON J, 1989, J BIOL CHEM, V264, P15754; KOLHOUSE JF, 1977, J CLIN INVEST, V60, P1381, DOI 10.1172/JCI108899; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; MEYERS PA, 1984, PEDIATRICS, V74, P866; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; PANT SS, 1968, ACTA NEUROL SCAND, VS 44, P7; PLATICA O, 1989, P SOC EXP BIOL MED, V192, P95; QUADROS EV, 1986, J BIOL CHEM, V261, P5455; QUADROS EV, 1989, AM J PHYSIOL, V256, pC296, DOI 10.1152/ajpcell.1989.256.2.C296; ROTHENBERG SP, 1978, BRIT J HAEMATOL, V40, P401, DOI 10.1111/j.1365-2141.1978.tb05812.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELIGMAN PA, 1980, NEW ENGL J MED, V303, P1209, DOI 10.1056/NEJM198011203032105; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; VERMA M, 1989, BIOTECHNIQUES, V7, P230; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359	37	60	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7860	7863						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708393				2022-12-27	WOS:A1991FJ34200084
J	TARUGI, P; ALBERTAZZI, L; NICOLINI, S; OTTAVIANI, E; CALANDRA, S				TARUGI, P; ALBERTAZZI, L; NICOLINI, S; OTTAVIANI, E; CALANDRA, S			SYNTHESIS AND SECRETION OF APOLIPOPROTEIN-A-I BY CHICK SKIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENOVO STEROLOGENESIS; PLASMA-LIPOPROTEINS; CHOLESTEROL EFFLUX; GENE-EXPRESSION; MESSENGER-RNAS; RAT; EVOLUTION; EPIDERMIS; TISSUES; MUSCLE	Chick skin slices were incubated with [S-35]methionine and labeled apoA-I was immunoprecipitated from incubation medium and tissue homogenate. ApoA-I accounted for approximately 13 and 2.5% of radioactive medium and cell proteins, respectively. After ultracentrifugation of the medium, 55% of labeled apoA-I was found as a constituent of lipoproteins (d < 1.210 g/ml) and 45% in a lipid-poor form (1.210-1.260 g/ml). To ascertain whether this large proportion of lipid-poor apoA-I was due to a dissociation of this peptide from medium lipoproteins during ultracentrifugation, labeled incubation medium was applied to an anti-chick apoA-I immunoaffinity column. The material bound to the column was analyzed by nondenaturing polyacrylamide gradient gel electrophoresis and found to contain three subpopulations of lipoproteins with a particle size of 12, 11, and 9 nm, respectively. The radioactivity of these subpopulations accounted for 82% of total radioactive medium apoA-I. ApoA-I was localized by immunohistochemistry in the viable cells of the epidermis and in the stratum corneum. Rat skin slices were found to synthesize and secrete apoE but no apoA-I. ApoA-I and apoE secreted by chick and rat skin, respectively, may play a role in the secretion of lipids from the differentiating keratinocytes and thus contribute to the formation of the hydrophobic barrier of the skin.	UNIV MODENA, DIPARTMENTO BIOL ANIM, I-41100 MODENA, ITALY	Universita di Modena e Reggio Emilia	TARUGI, P (corresponding author), UNIV MODENA, IST PATOL GEN, VIA CAMPI 287, I-41100 MODENA, ITALY.		Ottaviani, Enzo/D-3006-2015; Tarugi, Patrizia/D-2179-2015	Ottaviani, Enzo/0000-0002-4598-4707; Tarugi, Patrizia/0000-0001-6864-7853				BLUE ML, 1982, J BIOL CHEM, V257, P1151; BYRNES L, 1987, BIOCHEM BIOPH RES CO, V148, P485, DOI 10.1016/0006-291X(87)91137-5; DASHTI N, 1990, J LIPID RES, V31, P113; DAWSON PA, 1989, J LIPID RES, V30, P403; DAWSON PA, 1986, J BIOL CHEM, V261, P5681; DORY L, 1989, J LIPID RES, V30, P809; ELIAS PM, 1983, J INVEST DERMATOL, V80, pS44, DOI 10.1038/jid.1983.12; FEINGOLD KR, 1983, METABOLISM, V32, P75, DOI 10.1016/0026-0495(83)90160-9; FEINGOLD KR, 1983, J INVEST DERMATOL, V81, P365, DOI 10.1111/1523-1747.ep12519974; FEINGOLD KR, 1982, J LAB CLIN MED, V100, P405; FENJVES ES, 1988, ANN NY ACAD SCI, V548, P160, DOI 10.1111/j.1749-6632.1988.tb18802.x; FENJVES ES, 1989, P NATL ACAD SCI USA, V86, P8803, DOI 10.1073/pnas.86.22.8803; FERRARI S, 1987, GENE, V60, P39, DOI 10.1016/0378-1119(87)90211-3; FERRARI S, 1986, GENE, V42, P209, DOI 10.1016/0378-1119(86)90298-2; GORDON DA, 1989, J INVEST DERMATOL, V92, P96, DOI 10.1111/1523-1747.ep13071302; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; HUSSAIN MM, 1988, J LIPID RES, V29, P915; LANDMANN L, 1980, J ULTRA MOL STRUCT R, V72, P245, DOI 10.1016/S0022-5320(80)90062-3; LAVKER RM, 1976, J ULTRA MOL STRUCT R, V55, P79, DOI 10.1016/S0022-5320(76)80083-4; LEBLANC AC, 1989, J CELL BIOL, V109, P1245, DOI 10.1083/jcb.109.3.1245; LENICH C, 1988, J LIPID RES, V29, P755; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUO CC, 1989, J LIPID RES, V30, P1735; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1984, J LIPID RES, V25, P1277; MATOLTSY AG, 1969, J ULTRA MOL STRUCT R, V29, P438, DOI 10.1016/S0022-5320(69)90065-3; MAZZONE T, 1989, J LIPID RES, V30, P1055; NICHOLS AV, 1986, METHOD ENZYMOL, V128, P417; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; PARAKKAL PF, 1968, J ULTRA MOL STRUCT R, V23, P403, DOI 10.1016/S0022-5320(68)80106-6; RAJAVASHISTH TB, 1987, J BIOL CHEM, V262, P7058; SHACKELFORD JE, 1983, J BIOL CHEM, V258, P7175; SHACKELFORD JE, 1983, J BIOL CHEM, V258, P4829; SHACKELFORD JE, 1985, J BIOL CHEM, V260, P288; SMITH KM, 1990, J LIPID RES, V31, P995; TARUGI P, 1986, BIOCHIM BIOPHYS ACTA, V868, P51, DOI 10.1016/0167-4781(86)90086-2; TARUGI P, 1989, J LIPID RES, V30, P9; WERTZ PW, 1986, J LIPID RES, V27, P427; Williams D L, 1986, Methods Enzymol, V129, P254; WYNE KL, 1989, J BIOL CHEM, V264, P16530	40	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7714	7720						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708390				2022-12-27	WOS:A1991FJ34200063
J	DEVICO, AL; COPELAND, TD; OROSZLAN, S; GALLO, RC; SARNGADHARAN, MG				DEVICO, AL; COPELAND, TD; OROSZLAN, S; GALLO, RC; SARNGADHARAN, MG			INTERACTION OF C-TERMINAL SEQUENCES OF HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE WITH TEMPLATE PRIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DNA-POLYMERASE; COMPLETE NUCLEOTIDE-SEQUENCE; MURINE LEUKEMIA-VIRUS; ROUS-SARCOMA VIRUS; AIDS VIRUS; ESCHERICHIA-COLI; HTLV-III; RNASE-H; POL GENES; EXPRESSION	We have raised a rabbit monospecific antibody (designated C2003) against a synthetic peptide (CTP66) derived from a conserved sequence in the C-terminal portion of the p66 component of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) (DeVico, A. L., Copeland, T. D., Veronese, F. D., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G. (1989) AIDS Res. Hum. Retroviruses 5, 51-60). This antibody directly inhibits the polymerase activity of HIV-1 RT and of RTs from a variety of retroviruses. HIV-1 RT is protected from this inhibition by preincubation of the enzyme with template primer prior to treatment with the antibody. Such protection is abrogated when the pretreatment is conducted under conditions of high ionic strength. Kinetic studies showed that the antibody-mediated inhibition is competitive with respect to template primer concentration. These results indicate that C2003 antibody acts to interfere with the template binding function of the enzyme and further indicates that conserved residues recognized by the antibody may be directly involved in this function.	NCI,FREDERICK CANC RES & DEV CTR,ABL BASIC RES PROGRAM,MOLEC VIROL & CARCINOGENESIS LAB,FREDERICK,MD 21702; NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	DEVICO, AL (corresponding author), ADV BIOSCI LABS,DEPT CELL BIOL,KENSINGTON,MD 20895, USA.				NCI NIH HHS [N01-CP-73723, N01-CO-74101] Funding Source: Medline; DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP073723] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; CHAKRABARTI L, 1987, NATURE, V328, P543, DOI 10.1038/328543a0; DEVICO AL, 1989, AIDS RES HUM RETROV, V5, P51, DOI 10.1089/aid.1989.5.51; ENGLUND PT, 1969, J BIOL CHEM, V244, P3045; FARMERIE WG, 1987, SCIENCE, V236, P305, DOI 10.1126/science.2436298; FRANCHINI G, 1989, P NATL ACAD SCI USA, V86, P2433, DOI 10.1073/pnas.86.7.2433; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GRANDGENETT DP, 1975, J VIROL, V15, P526, DOI 10.1128/JVI.15.3.526-533.1975; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HIZI A, 1989, VIROLOGY, V170, P326, DOI 10.1016/0042-6822(89)90389-9; HIZI A, 1990, VIROLOGY, V175, P575, DOI 10.1016/0042-6822(90)90444-V; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KEDAR PS, 1990, BIOCHEMISTRY-US, V29, P3603, DOI 10.1021/bi00467a003; LORI F, 1988, AIDS RES HUM RETROV, V4, P393, DOI 10.1089/aid.1988.4.393; LUO G, 1990, J VIROL, V64, P4321, DOI 10.1128/JVI.64.9.4321-4328.1990; MAJUMDAR C, 1988, J BIOL CHEM, V263, P15657; MULLER B, 1989, J BIOL CHEM, V264, P13975; OYAMA F, 1989, J BIOL CHEM, V264, P18808; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; PRASAD VR, 1989, P NATL ACAD SCI USA, V86, P3104, DOI 10.1073/pnas.86.9.3104; PRASAD VR, 1989, J BIOL CHEM, V264, P16689; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RESTLE T, 1990, J BIOL CHEM, V265, P8986; SCHWARTZ DE, 1983, CELL, V32, P853, DOI 10.1016/0092-8674(83)90071-5; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; SONIGO P, 1985, CELL, V42, P369, DOI 10.1016/S0092-8674(85)80132-X; STEPHENS RM, 1986, SCIENCE, V231, P589, DOI 10.1126/science.3003905; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; TISDALE M, 1988, J VIROL, V62, P3662, DOI 10.1128/JVI.62.10.3662-3667.1988; VERMA IM, 1981, ENZYMES, V14, P87; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504; ZAGURY JF, 1988, P NATL ACAD SCI USA, V85, P5941, DOI 10.1073/pnas.85.16.5941	36	14	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					6774	6779						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707875				2022-12-27	WOS:A1991FG72700023
J	ERUSALIMSKY, JD; BROOKS, SF; HERGET, T; MORRIS, C; ROZENGURT, E				ERUSALIMSKY, JD; BROOKS, SF; HERGET, T; MORRIS, C; ROZENGURT, E			MOLECULAR-CLONING AND CHARACTERIZATION OF THE ACIDIC 80-KDA PROTEIN-KINASE-C SUBSTRATE FROM RAT-BRAIN - IDENTIFICATION AS A GLYCOPROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SWISS 3T3 CELLS; MAJOR SPECIFIC SUBSTRATE; PHORBOL ESTERS; NUCLEOTIDE-SEQUENCE; GROWTH-FACTORS; QUIESCENT FIBROBLASTS; POLYACRYLAMIDE GELS; CELLULAR SUBSTRATE; RAPIDLY STIMULATE; 80,000 PROTEIN	The complete amino acid sequence of 80 K, the major acidic protein kinase C (PKC) substrate of rat brain, was deduced from a cDNA nucleotide sequence. An open reading frame of 927 bases predicted a protein of 309 amino acid residues (M(r) = 29,796, pI = 4.06). 58% of the deduced protein sequence was confirmed by Edman degradation of peptides generated by proteolysis of purified 80 K. The absence of internal methionine residues in the deduced amino acid sequence was confirmed by the inability to cleave 80 K with CNBr. Antiserum raised against a synthetic peptide corresponding to residues 298-309 of the predicted amino acid sequence recognizes the 80-kDa polypeptide in Western blots. The protein shows 65% sequence identity with a closely related PKC substrate from bovine brain. Genomic Southern blot analysis using a probe corresponding to a segment of the 80 K gene devoid of introns showed one major band. Northern blot analysis of rat brain RNA reveals a prominent transcript of 2.2 kilobases which hybridizes to 80 K cDNA. The amino acid composition an dhydropathicity plot suggest an extended structure with no hydrophobic domains. The amino acid sequence showed many short repeats as well as several potential phosphorylation sites, five of which were for PKC, one was for both PKC and cyclic AMP-dependent protein kinase, and one for casein kinase II, and potential glycosylation sites. Indeed, carbohydrate moieties were detected on electroblots of purified 80 K using both a specific glycan stain and Galanthus nivalis plant lectin which binds to terminal D-mannose in the glycan moiety. This is the first time that this major PKC substrate has been identified as a glycoprotein.	IMPERIAL CANC RES FUND,POB 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND	Cancer Research UK				Erusalimsky, Jorge/0000-0002-4253-5789				ADEREM AA, 1988, NATURE, V332, P362, DOI 10.1038/332362a0; ALBERT KA, 1987, P NATL ACAD SCI USA, V84, P7046, DOI 10.1073/pnas.84.20.7046; ALBERT KA, 1986, P NATL ACAD SCI USA, V83, P2822, DOI 10.1073/pnas.83.9.2822; BAIROCH A, 1989, PROSITE DICT PROTEIN; BARNES WM, 1987, METHOD ENZYMOL, V152, P538; BELL RM, 1986, CELL, V45, P631, DOI 10.1016/0092-8674(86)90774-9; BIEMANN HPN, 1990, MOL CELL BIOL, V10, P2122, DOI 10.1128/MCB.10.5.2122; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BROOKS SF, 1990, FEBS LETT, V268, P291, DOI 10.1016/0014-5793(90)81030-R; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLEGG JCS, 1982, ANAL BIOCHEM, V127, P389, DOI 10.1016/0003-2697(82)90192-0; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; DILELLA AG, 1987, METHOD ENZYMOL, V152, P447; DRUBIN DG, 1990, NATURE, V343, P288, DOI 10.1038/343288a0; ERUSALIMSKY JD, 1988, J BIOL CHEM, V263, P19188; ERUSALIMSKY JD, 1989, FEBS LETT, V255, P149, DOI 10.1016/0014-5793(89)81079-8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GEORGES E, 1987, EUR J BIOCHEM, V165, P281, DOI 10.1111/j.1432-1033.1987.tb11439.x; GERSHONI JM, 1982, ANAL BIOCHEM, V124, P396, DOI 10.1016/0003-2697(82)90056-2; GRAFF JM, 1989, SCIENCE, V246, P503, DOI 10.1126/science.2814478; GRAFF JM, 1989, J BIOL CHEM, V264, P21818; HART GW, 1989, ANNU REV BIOCHEM, V58, P841; HIRAI M, 1989, J CELL PHYSIOL, V139, P9, DOI 10.1002/jcp.1041390103; HORNBECK P, 1989, MOL CELL BIOL, V9, P3727, DOI 10.1128/MCB.9.9.3727; HORNBECK P, 1986, J BIOL CHEM, V261, P4817; ISACKE CM, 1986, EMBO J, V5, P2889, DOI 10.1002/j.1460-2075.1986.tb04584.x; ISSANDOU M, 1990, J BIOL CHEM, V265, P11890; JAMES G, 1989, J BIOL CHEM, V264, P20928; KARNS LR, 1987, SCIENCE, V236, P597, DOI 10.1126/science.2437653; KIKKAWA U, 1989, ANNU REV BIOCHEM, V58, P31, DOI 10.1146/annurev.bi.58.070189.000335; KIKKAWA U, 1986, ANNU REV CELL BIOL, V2, P149, DOI 10.1146/annurev.cb.02.110186.001053; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Krebs EG, 1986, ENZYMES, V17, P3, DOI 10.1016/S1874-6047(08)60426-6; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEES JF, 1988, EMBO J, V7, P1947, DOI 10.1002/j.1460-2075.1988.tb03032.x; MARGLIN A, 1970, ANNU REV BIOCHEM, V39, P841, DOI 10.1146/annurev.bi.39.070170.004205; MORRIS C, 1988, FEBS LETT, V231, P311, DOI 10.1016/0014-5793(88)80840-8; NANBERG E, 1990, J CELL PHYSIOL, V143, P232, DOI 10.1002/jcp.1041430206; NELSON CA, 1971, J BIOL CHEM, V246, P3895; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OSHANNESSY DJ, 1987, ANAL BIOCHEM, V163, P204, DOI 10.1016/0003-2697(87)90114-X; PATEL J, 1987, J BIOL CHEM, V262, P16686; RODRIGUEZPENA A, 1986, J CELL PHYSIOL, V129, P124, DOI 10.1002/jcp.1041290117; RODRIGUEZPENA A, 1985, EMBO J, V4, P71, DOI 10.1002/j.1460-2075.1985.tb02319.x; RODRIGUEZPENA A, 1986, BIOCHEM BIOPH RES CO, V140, P379, DOI 10.1016/0006-291X(86)91101-0; RODRIGUEZPENA A, 1986, EMBO J, V5, P77, DOI 10.1002/j.1460-2075.1986.tb04180.x; ROZENGURT E, 1984, P NATL ACAD SCI-BIOL, V81, P5748, DOI 10.1073/pnas.81.18.5748; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; ROZENGURT E, 1988, PROG NUCLEIC ACID RE, V35, P261, DOI 10.1016/S0079-6603(08)60616-9; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAKAI K, 1989, GENOMICS, V5, P309, DOI 10.1016/0888-7543(89)90063-3; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIBUYA N, 1988, J BIOL CHEM, V263, P728; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; STADDON JM, 1990, J BIOL CHEM, V265, P11841; STUMPO DJ, 1989, NUCLEIC ACIDS RES, V17, P3987, DOI 10.1093/nar/17.10.3987; STUMPO DJ, 1989, P NATL ACAD SCI USA, V86, P4012, DOI 10.1073/pnas.86.11.4012; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; TSUDA T, 1985, FEBS LETT, V191, P205, DOI 10.1016/0014-5793(85)80009-0; TYERS M, 1988, NATURE, V333, P470, DOI 10.1038/333470a0; WU CSW, 1982, P NATL ACAD SCI USA, V79, P5249; ZACHARY I, 1986, J CELL BIOL, V102, P2211, DOI 10.1083/jcb.102.6.2211	72	83	84	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					7073	7080						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707878				2022-12-27	WOS:A1991FG72700067
J	ASCH, AS; TEPLER, J; SILBIGER, S; NACHMAN, RL				ASCH, AS; TEPLER, J; SILBIGER, S; NACHMAN, RL			CELLULAR ATTACHMENT TO THROMBOSPONDIN - COOPERATIVE INTERACTIONS BETWEEN RECEPTOR SYSTEMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-IIB/IIIA COMPLEX; HUMAN-PLATELET THROMBOSPONDIN; HUMAN SQUAMOUS CARCINOMA; MELANOMA-CELLS; MONOCLONAL-ANTIBODY; EXTRACELLULAR-MATRIX; ADHESIVE GLYCOPROTEIN; MOLECULAR DOMAINS; ENDOTHELIAL-CELLS; HUMAN FIBRONECTIN	Tumor cell attachment to thrombospondin (TSP) in the extracellular matrix may be of critical importance in the processes of invasion and hematogenous dissemination. To determine the specific receptor systems that mediate the interaction of tumor cells with insoluble TSP, the attachment of HT1080 fibrosarcoma and C32 and G361 melanoma cells to TSP-coated discs was studied in the presence of heparin, Arg-Gly-Asp-Ser, or antibodies to glycoprotein (GP) IV (CD36, GPIIIb), a TSP receptor. HT1080 and C32 cell attachment to TSP was inhibited by the combination of heparin and a monoclonal (or polyclonal) antibody to GPIV but not by either alone. Heparin alone inhibited cell spreading. Neither control monoclonal antibodies nor the cell attachment peptide Arg-Gly-Asp-Ser inhibited tumor cell attachment to TSP, alone or in the presence of heparin. HT1080 cells attached equally as well to a 140-kDa proteolytic TSP fragment lacking the heparin-binding domain as to intact TSP. A monoclonal antibody to GPIV alone inhibited tumor cell attachment to the heparin-domainless 140-kDa TSP fragment. No attachment to the heparin-binding fragment was observed, but the addition of the heparin fragment to 140-kDa heparin-domainless TSP restored the heparin sensitivity of binding. G361 cells that lack GPIV attached well to TSP but were not inhibited by heparin or anti-GPIV alone or in combination. The combination of heparin and Arg-Gly-Asp-Ser inhibited G361 attachment to TSP. These studies suggest that tumor cells may utilize separate receptor systems in a cooperative manner to adhere to TSP. HT1080 fibrosarcoma and C32 melanoma cells utilize GPIV in concert with a heparin-modulated binding system to attach and spread on TSP. G361 cells, which lack GPIV expression, attach and spread on TSP using an integrin system as well as a heparin-modulated system.	CORNELL UNIV,MED CTR,COLL MED,SPECIALIZED CTR RES THROMBOSIS,NEW YORK,NY 10021	Cornell University	ASCH, AS (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DEPT MED,DIV HEMATOL ONCOL,NEW YORK,NY 10021, USA.				NHLBI NIH HHS [HL-01567, HL-18828] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL001567, P50HL018828] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIKEN M, 1986, ARCH BIOCHEM BIOPHYS, V250, P257, DOI 10.1016/0003-9861(86)90724-1; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BARNWELL JW, 1985, J IMMUNOL, V135, P3494; BARSKY SH, 1984, J CLIN INVEST, V74, P843, DOI 10.1172/JCI111501; BEISO P, 1990, BIOCHIM BIOPHYS ACTA, V1033, P7, DOI 10.1016/0304-4165(90)90186-Z; BOUKERCHE H, 1989, BLOOD, V74, P909; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; DIXIT VM, 1986, P NATL ACAD SCI USA, V83, P5449, DOI 10.1073/pnas.83.15.5449; DIXIT VM, 1985, BIOCHEMISTRY-US, V24, P4270, DOI 10.1021/bi00337a003; DIXIT VM, 1985, P NATL ACAD SCI USA, V82, P3472, DOI 10.1073/pnas.82.10.3472; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; GALVIN NJ, 1985, J CELL BIOL, V101, P1434, DOI 10.1083/jcb.101.4.1434; GRAF J, 1987, CELL, V48, P989, DOI 10.1016/0092-8674(87)90707-0; GRANT DS, 1989, CELL, V58, P933, DOI 10.1016/0092-8674(89)90945-8; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; KARCZEWSKI J, 1989, J BIOL CHEM, V264, P21322; KIEFFER N, 1988, BIOCHIM BIOPHYS ACTA, V967, P408, DOI 10.1016/0304-4165(88)90104-3; LAM SCT, 1989, J BIOL CHEM, V264, P3742; LAWLER J, 1989, BLOOD, V74, P2022; LAWLER J, 1985, J BIOL CHEM, V260, P3762; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LEUNG LLK, 1982, J CLIN INVEST, V70, P542, DOI 10.1172/JCI110646; LIOTTA LA, 1983, LAB INVEST, V49, P636; LIOTTA LA, 1986, CANCER RES, V46, P1; MAZZUCATO M, 1989, BRIT J HAEMATOL, V73, P369, DOI 10.1111/j.1365-2141.1989.tb07755.x; MCCARTHY JB, 1988, BIOCHEMISTRY-US, V27, P1380, DOI 10.1021/bi00404a044; MCCARTHY JB, 1986, J CELL BIOL, V102, P179, DOI 10.1083/jcb.102.1.179; MCGREGOR JL, 1989, J BIOL CHEM, V264, P501; MCKEOWNLONGO PJ, 1984, J CELL BIOL, V98, P22, DOI 10.1083/jcb.98.1.22; MURPHYULLRICH JE, 1988, J BIOL CHEM, V263, P6400; MURPHYULLRICH JE, 1987, J CELL BIOL, V105, P1603, DOI 10.1083/jcb.105.4.1603; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; OZ OK, 1989, INT J CANCER, V44, P343, DOI 10.1002/ijc.2910440226; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; RISER BL, 1988, EXP CELL RES, V174, P319, DOI 10.1016/0014-4827(88)90303-5; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; SILVERSTEIN RL, 1987, J CLIN INVEST, V79, P867, DOI 10.1172/JCI112896; SILVERSTEIN RL, 1984, J CLIN INVEST, V74, P1625, DOI 10.1172/JCI111578; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; TERRANOVA VP, 1984, SCIENCE, V226, P982, DOI 10.1126/science.6505678; TERRANOVA VP, 1983, P NATL ACAD SCI-BIOL, V80, P444, DOI 10.1073/pnas.80.2.444; TUSZYNSKI GP, 1987, SCIENCE, V236, P1570, DOI 10.1126/science.2438772; TUSZYNSKI GP, 1987, CANCER RES, V47, P4130; VARANI J, 1988, J CLIN INVEST, V81, P1537, DOI 10.1172/JCI113486; VARANI J, 1986, EXP CELL RES, V167, P376, DOI 10.1016/0014-4827(86)90178-3; WAYNER EA, 1988, J CELL BIOL, V107, P1881, DOI 10.1083/jcb.107.5.1881; WHITE BA, 1982, J BIOL CHEM, V257, P8569; YAMADA KM, 1987, J CELL PHYSIOL, V130, P21, DOI 10.1002/jcp.1041300105	51	98	100	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1740	1745						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703153				2022-12-27	WOS:A1991EU49700061
J	CHARO, IF; NANNIZZI, L; PHILLIPS, DR; HSU, MA; SCARBOROUGH, RM				CHARO, IF; NANNIZZI, L; PHILLIPS, DR; HSU, MA; SCARBOROUGH, RM			INHIBITION OF FIBRINOGEN BINDING TO GP-IIB-IIIA BY A GP-IIIA PEPTIDE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ATTACHMENT SITE; VITRONECTIN RECEPTOR; MONOCLONAL-ANTIBODY; BETA-SUBUNIT; PLATELET-AGGREGATION; EXTRACELLULAR-MATRIX; ADHESION RECEPTOR; GLYCOPROTEIN-IIIA; RECOGNITION SITE; GAMMA-CHAIN	The glycoprotein IIb-IIIa complex (GP IIb-IIIa) mediates platelet aggregation and is a member of the cytoadhesin family of receptors that bind adhesive proteins such as fibrinogen, fibronectin, and von Willebrand factor. Despite the wide range of cell-substrate interactions mediated by these receptors, ligand binding domains have not yet been identified on any of the integrins. The present study was designed to determine potential fibrinogen binding domain(s) on the GP IIb-IIIa complex. Synthetic peptides derived from residues 1-288 of the amino-terminal portion of GP IIIa were tested for their abilities to block the binding of fibrinogen to purified GP IIb-IIIa in a solid-phase microtiter assay. Two overlapping peptides encompassing residues 204-229 of GP IIIa were identified which blocked fibrinogen binding in this assay. Polyclonal antibodies to these peptides blocked fibrinogen binding to purified GP IIb-IIIa as well as platelet aggregation. The overlapping residues of these two peptides GP IIIa (211-222), SVSRNRDAPEGG-NH2, blocked the binding of fibronectin, von Willebrand factor, and vitronectin to purified GP IIb-IIIa. Finally, direct binding of GP IIIa (204-229) to fibrinogen and fibronectin was demonstrated by enzyme-linked immunosorbent assay. We conclude from these studies that the amino acid sequence 211-222 of GP IIIa is critically involved in adhesive protein binding, and may represent an important portion of the GP IIb-IIIa ligand binding domain.			CHARO, IF (corresponding author), COR THERAPEUT INC,256 E GRAND AVE,S SAN FRANCISCO,CA 94080, USA.							ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; BENNETT JS, 1983, P NATL ACAD SCI-BIOL, V80, P2417, DOI 10.1073/pnas.80.9.2417; CALVETE JJ, 1988, BIOCHEM J, V250, P697, DOI 10.1042/bj2500697; CHARO IF, 1987, J BIOL CHEM, V262, P9935; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; COOK JJ, 1990, BLOOD S1, V76, pA452; DSOUZA SE, 1988, SCIENCE, V242, P91, DOI 10.1126/science.3262922; DSOUZA SE, 1990, J BIOL CHEM, V265, P3440; ENGVALL E, 1978, J EXP MED, V147, P1584, DOI 10.1084/jem.147.6.1584; FITZGERALD LA, 1985, ANAL BIOCHEM, V151, P169, DOI 10.1016/0003-2697(85)90067-3; FITZGERALD LA, 1987, J BIOL CHEM, V262, P3936; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; GARTNER TK, 1985, J BIOL CHEM, V260, P1891; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KAZAL LA, 1963, P SOC EXP BIOL MED, V113, P989; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P615; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028; LAM SCT, 1987, J BIOL CHEM, V262, P947; LOFTUS JC, 1989, BLOOD S1, V74, P206; MARGUERIE GA, 1979, J BIOL CHEM, V254, P5357; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NORTON KJ, 1989, BLOOD S1, V74, P333; PARISE LV, 1985, J BIOL CHEM, V260, P698; PHILLIPS DR, 1988, BLOOD, V71, P831; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PIERSCHBACHER MD, 1981, CELL, V26, P259, DOI 10.1016/0092-8674(81)90308-1; PLOW EF, 1986, P NATL ACAD SCI USA, V83, P6002, DOI 10.1073/pnas.83.16.6002; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; SMITH JW, 1988, J BIOL CHEM, V263, P18726; STEINER B, 1988, CIRC 2 S, V78; THORELL L, 1984, THROMB RES, V35, P431, DOI 10.1016/0049-3848(84)90235-4; YATOHGA T, 1938, CELL STRUCT FUNCT, V13, P281	35	212	223	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1415	1421						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703149				2022-12-27	WOS:A1991EU49700013
J	ERICKSON, AK; PAYNE, DM; MARTINO, PA; ROSSOMANDO, AJ; SHABANOWITZ, J; WEBER, MJ; HUNT, DF; STURGILL, TW				ERICKSON, AK; PAYNE, DM; MARTINO, PA; ROSSOMANDO, AJ; SHABANOWITZ, J; WEBER, MJ; HUNT, DF; STURGILL, TW			IDENTIFICATION BY MASS-SPECTROMETRY OF THREONINE-97 IN BOVINE MYELIN BASIC-PROTEIN AS A SPECIFIC PHOSPHORYLATION SITE FOR MITOGEN-ACTIVATED PROTEIN-KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV VIRGINIA,DEPT INTERNAL MED & PHARMACOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,DEPT MICROBIOL,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,DEPT CHEM,CHARLOTTESVILLE,VA 22908	University of Virginia; University of Virginia; University of Virginia			Hunt, Donald F/I-6936-2012	Hunt, Donald F/0000-0003-2815-6368	NATIONAL CANCER INSTITUTE [R01CA039076, R37CA039076, R01CA047815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041077] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39076, CA 47815] Funding Source: Medline; NIDDK NIH HHS [DK 41077] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHN NG, 1988, J CELL BIOL, V107, P695; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BUTLERGRALLA E, 1981, J CELL PHYSIOL, V107, P59, DOI 10.1002/jcp.1041070108; CHAN KFJ, 1987, BIOCHEM BIOPH RES CO, V144, P1287; CHAN KFJ, 1986, BIOCHEM BIOPH RES CO, V134, P1358, DOI 10.1016/0006-291X(86)90399-2; CHOU FCH, 1976, J BIOL CHEM, V251, P2671; CICIRELLI MF, 1988, J BIOL CHEM, V263, P2009; COOPER JA, 1981, MOL CELL BIOL, V1, P165, DOI 10.1128/MCB.1.2.165; COOPER JA, 1985, METHOD ENZYMOL, V99, P387; DEIBLER GE, 1990, PROTEINS, V7, P32, DOI 10.1002/prot.340070104; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FOSTER JL, 1984, J BIOL CHEM, V259, P3049; GOULD KL, 1988, MOL CELL BIOL, V8, P3345, DOI 10.1128/MCB.8.8.3345; GRIFFIN PR, 1989, J BIOL CHEM, V264, P19066; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; HUNT DF, 1987, P NATL ACAD SCI USA, V84, P620, DOI 10.1073/pnas.84.3.620; JONES SW, 1988, P NATL ACAD SCI USA, V85, P3377, DOI 10.1073/pnas.85.10.3377; KISHIMOTO A, 1985, J BIOL CHEM, V260, P2492; LANGAN TA, 1989, MOL CELL BIOL, V9, P3860, DOI 10.1128/MCB.9.9.3860; MARTENSON RE, 1983, J BIOL CHEM, V258, P930; MARTENSON RE, 1986, J NEUROCHEM, V46, P1612, DOI 10.1111/j.1471-4159.1986.tb01784.x; MICHEL H, 1989, FEBS LETT, V254, P165, DOI 10.1016/0014-5793(89)81031-2; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; PARKER PJ, 1984, EMBO J, V3, P953, DOI 10.1002/j.1460-2075.1984.tb01913.x; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; SCHULMAN H, 1985, BIOCHEMISTRY-US, V24, P5320, DOI 10.1021/bi00341a008; SHOJI S, 1987, J BIOCH, V10, P1113; STONER GL, 1984, J NEUROCHEM, V43, P433, DOI 10.1111/j.1471-4159.1984.tb00919.x; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; VULLIET PR, 1989, J BIOL CHEM, V264, P16292	33	242	247	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 15	1990	265	32					19728	19735						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ188	1700979				2022-12-27	WOS:A1990EJ18800057
J	MIYAUCHI, K; MASAKI, R; TAKETANI, S; YAMAMOTO, A; AKAYAMA, M; TASHIRO, Y				MIYAUCHI, K; MASAKI, R; TAKETANI, S; YAMAMOTO, A; AKAYAMA, M; TASHIRO, Y			MOLECULAR-CLONING, SEQUENCING, AND EXPRESSION OF CDNA FOR RAT-LIVER MICROSOMAL ALDEHYDE DEHYDROGENASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-DISTRIBUTION; CYTOPLASMIC ISOENZYME; HEME OXYGENASE; HORSE LIVER; PROTEIN; CYTOCHROME-B5; BINDING; PURIFICATION; FORMS; SITE	The cDNA clone for rat liver microsomal aldehyde dehydrogenase (msALDH) was isolated and sequenced. The deduced amino acid sequence consisting of 484 amino acid residues revealed that the carboxyl-terminal region of msALDH has a hydrophobic segment, which is probably important for the insertion of this enzyme into the endoplasmic reticulum membrane. COS-1 cells transfected with the expression vector pcD containing the full-length cDNA showed that the active enzyme was expressed and localized mainly on the cytoplasmic surface of the endoplasmic reticulum membranes. It has been proposed that ALDH isozymes form a superfamily consisting of class 1, 2, and 3 ALDHs (Hempel, J., Harper, K., and Lindahl, R., (1989) Biochemistry 28, 1160-1167). Comparison of the amino acid sequence of rat liver msALDH with those of rat other class ALDHs showed that msALDH was 24.2, 24.0, and 65.5% identical to phenobarbital-inducible ALDH (variant class 1), mitochondrial ALDH (class 2), and tumor-associated ALDH (class 3), respectively. Several amino acid residues common to the other known ALDHs, however, were found to be conserved in msALDH. Based on these results, we proposed to classify msALDH as a new type, class 4 ALDH.	KANSAI MED UNIV,DEPT HYG,MORIGUCHI,OSAKA 570,JAPAN	Kansai Medical University	MIYAUCHI, K (corresponding author), KANSAI MED UNIV,DEPT PHYSIOL,MORIGUCHI,OSAKA 570,JAPAN.							ABRIOLA DP, 1987, BIOCHEMISTRY-US, V26, P5679, DOI 10.1021/bi00392a015; ANTONENKOV VD, 1985, EUR J BIOCHEM, V149, P159, DOI 10.1111/j.1432-1033.1985.tb08906.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAILEY HA, 1981, J BIOL CHEM, V256, P3951; DEITRICH RA, 1977, J BIOL CHEM, V252, P6169; DUNN TJ, 1989, J BIOL CHEM, V264, P13057; FARRES J, 1989, EUR J BIOCHEM, V180, P67, DOI 10.1111/j.1432-1033.1989.tb14616.x; FUNK CD, 1987, P NATL ACAD SCI USA, V84, P6677, DOI 10.1073/pnas.84.19.6677; GUAN KL, 1988, ALCOHOL CLIN EXP RES, V12, P713, DOI 10.1111/j.1530-0277.1988.tb00270.x; HEMPEL J, 1982, BIOCHEMISTRY-US, V21, P6834, DOI 10.1021/bi00269a032; HEMPEL J, 1985, EUR J BIOCHEM, V153, P13, DOI 10.1111/j.1432-1033.1985.tb09260.x; HEMPEL J, 1989, BIOCHEMISTRY-US, V28, P1160, DOI 10.1021/bi00429a034; HEMPEL J, 1984, EUR J BIOCHEM, V141, P21, DOI 10.1111/j.1432-1033.1984.tb08150.x; HEMPEL J, 1989, ENZYMOLOGY MOL BIOL, V2, P3; HEMPEL J, 1987, ENZYMOLOGY MOL BIOL, P1; HORTON AA, 1975, ARCH BIOCHEM BIOPHYS, V167, P426, DOI 10.1016/0003-9861(75)90483-X; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; JOHANSSON J, 1988, EUR J BIOCHEM, V172, P527, DOI 10.1111/j.1432-1033.1988.tb13920.x; JONES DE, 1988, P NATL ACAD SCI USA, V85, P1782, DOI 10.1073/pnas.85.6.1782; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; KOIVULA T, 1975, BIOCHIM BIOPHYS ACTA, V397, P9, DOI 10.1016/0005-2744(75)90174-6; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LINDAHL R, 1984, J BIOL CHEM, V259, P1991; LINDAHL R, 1984, J BIOL CHEM, V259, P1986; LINDAHL R, 1982, CANCER RES, V42, P577; Maniatis T., 1982, MOL CLONING; MARJANEN L, 1972, BIOCHEM J, V127, P633, DOI 10.1042/bj1270633; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; MASAKI R, 1990, Cell Structure and Function, V15, P444; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; NAKAYASU H, 1978, BIOCHEM BIOPH RES CO, V83, P697, DOI 10.1016/0006-291X(78)91045-8; NELSON DR, 1988, J BIOL CHEM, V263, P6038; OKADA Y, 1982, EUR J BIOCHEM, V122, P393, DOI 10.1111/j.1432-1033.1982.tb05894.x; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; OZOLS J, 1977, P NATL ACAD SCI USA, V74, P3725, DOI 10.1073/pnas.74.9.3725; RACHUBINSKI RA, 1980, J CELL BIOL, V84, P705, DOI 10.1083/jcb.84.3.705; ROBB RJ, 1978, J BIOL CHEM, V253, P5319; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHIBAHARA S, 1979, ARCH BIOCHEM BIOPHYS, V197, P607, DOI 10.1016/0003-9861(79)90285-6; SHIBAHARA S, 1985, P NATL ACAD SCI USA, V82, P7865, DOI 10.1073/pnas.82.23.7865; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; TAKAGI Y, 1985, J BIOCHEM-TOKYO, V98, P1647, DOI 10.1093/oxfordjournals.jbchem.a135435; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; TOTTMAR SOC, 1973, BIOCHEM J, V135, P577, DOI 10.1042/bj1350577a; Vaitukaitis J L, 1981, Methods Enzymol, V73, P46; VONBAHRLINDSTROM H, 1985, BIOCHEMISTRY-US, V24, P5847, DOI 10.1021/bi00342a023; VONBAHRLINDSTROM H, 1984, EUR J BIOCHEM, V141, P37; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4	51	64	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19536	19542						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717467				2022-12-27	WOS:A1991GK66700062
J	MOTTRAM, JC; BELL, SD; NELSON, RG; BARRY, JD				MOTTRAM, JC; BELL, SD; NELSON, RG; BARRY, JD			TRANSFER-RNAS OF TRYPANOSOMA-BRUCEI - UNUSUAL GENE ORGANIZATION AND MITOCHONDRIAL IMPORTATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOMIC ORGANIZATION; KINETOPLASTID PROTOZOA; DNA; TRANSCRIPTION; IDENTIFICATION; MAXICIRCLE; SEQUENCES; EVOLUTION; UNITS	In Trypanosoma brucei the U snRNA B gene (J. C. Mottram, K. L. Perry, P. M. Lizardi, R. Luhrmann, N. Agabian, and R. G. Nelson (1989) Mol. Cell. Biol. 9, 1212-1223) is very tightly linked with other small RNA genes coding for tRNA(ACG)Arg, tRNA(CUU)Lys, and a approximately 275-nucleotide RNA (RNA X) of unknown function. A similar genomic organization is found at the U6 snRNA locus, where the U6 gene is linked to tRNA(CGU)Thr and tRNA(GUA)Tyr genes. The tRNA(Lys) and tRNA(Arg) genes are members of a multigene family, whereas the tRNA(Thr) and tRNA(Tyr) genes are single copy. Two additional tRNA(CUU)Lys genes and one tRNA(UUU)Lys gene were also isolated and sequenced and, together with a sequence previously published (D. A. Campbell (1989) Nucleic Acids Res. 17, 9479), appear to represent the entire gene family. Probes for tRNA(Lys), tRNA(Arg), tRNA(Thr), and tRNA(Tyr) were found to hybridize with mitochondrial and cytoplasmic tRNAs but not with mitochondrial DNA. This supports the hypothesis that mitochondrial tRNAs may be nuclear-encoded and imported from the cytosol into the mitochondrion.	UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT MED,SAN FRANCISCO,CA 94110; UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT PHARMACEUT CHEM,SAN FRANCISCO,CA 94110	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	MOTTRAM, JC (corresponding author), UNIV GLASGOW,INST GENET,WELLCOME UNIT MOLEC PARASITOL,CHURCH ST,GLASGOW G11 5JS,SCOTLAND.			Mottram, Jeremy/0000-0001-5574-3766; Bell, Stephen/0000-0002-8474-6592	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; AMSTUTZ H, 1985, CELL, V40, P879, DOI 10.1016/0092-8674(85)90347-2; BENNE R, 1990, TRENDS GENET, V6, P177, DOI 10.1016/0168-9525(90)90173-4; BENNE R, 1985, TRENDS GENET, V1, P117, DOI 10.1016/0168-9525(85)90044-7; BORST P, 1986, ANNU REV BIOCHEM, V55, P701, DOI 10.1146/annurev.bi.55.070186.003413; BORST P, 1979, BIOCHIM BIOPHYS ACTA, V565, P1, DOI 10.1016/0005-2787(79)90078-9; BUCKLAND RA, 1989, AM J HUM GENET, V45, P283; BUCKLAND RA, 1983, GENE, V22, P211, DOI 10.1016/0378-1119(83)90105-1; CAMPBELL DA, 1989, MOL BIOCHEM PARASIT, V37, P257, DOI 10.1016/0166-6851(89)90157-6; CAMPBELL DA, 1989, NUCLEIC ACIDS RES, V17, P9479, DOI 10.1093/nar/17.22.9479; DEVRIES BF, 1988, MOL BIOCHEM PARASIT, V27, P71, DOI 10.1016/0166-6851(88)90026-6; DIRHEIMER G, 1979, TRANSFER RNA STRUCTU, P19; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; HAUKBER J, 1988, NUCLEIC ACIDS RES, V16, P10623; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; LENARDO MJ, 1985, GENE, V35, P131, DOI 10.1016/0378-1119(85)90165-9; Maniatis T., 1982, MOL CLONING; MICHELS PAM, 1986, J MOL EVOL, V24, P45, DOI 10.1007/BF02099950; MOTTRAM J, 1989, MOL CELL BIOL, V9, P1212, DOI 10.1128/MCB.9.3.1212; MULLER F, 1987, NUCLEIC ACIDS RES, V11, P7695; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; SHIBUYA K, 1985, J BIOCHEM-TOKYO, V97, P1719, DOI 10.1093/oxfordjournals.jbchem.a135230; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; SIMPSON L, 1986, INT REV CYTOL, V99, P119; SIMPSON L, 1989, CELL, V57, P355, DOI 10.1016/0092-8674(89)90911-2; SIMPSON L, 1978, CELL, V14, P169, DOI 10.1016/0092-8674(78)90311-2; SIMPSON L, 1987, ANNU REV MICROBIOL, V41, P363, DOI 10.1146/annurev.mi.41.100187.002051; SPRINZL M, 1987, NUCLEIC ACIDS RES, V15, pR53, DOI 10.1093/nar/15.suppl.r53; SUTER B, 1988, MOL CELL BIOL, V8, P3322, DOI 10.1128/MCB.8.8.3322	30	64	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18313	18317						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717447				2022-12-27	WOS:A1991GG55300090
J	SINE, SM; CLAUDIO, T				SINE, SM; CLAUDIO, T			STABLE EXPRESSION OF THE MOUSE NICOTINIC ACETYLCHOLINE-RECEPTOR IN MOUSE FIBROBLASTS - COMPARISON OF RECEPTORS IN NATIVE AND TRANSFECTED CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN BC3H-1 CELLS; MONOCLONAL-ANTIBODIES; MUSCLE-CELLS; CHOLINERGIC RECEPTOR; XENOPUS OOCYTES; AGONIST; TORPEDO; SUBUNITS; ACTIVATION; KINETICS	A stable cell line expressing mouse acetylcholine receptors (AChRs), named AM4, was established by cotransfecting into NIH 3T3 fibroblasts, alpha-, beta-, gamma-, and delta-subunit cDNAs plus the neo(r) gene by calcium phosphate precipitation. Surface AChRs on AM4 cells contain all four subunits, sediment as a single approximately 9 S peak on sucrose gradients, and have the same ratio of alpha- to beta-subunits as surface AChRs from mouse BC3H-1 cells. The surface AChRs exhibit pharmacological properties identical to those obtained for BC3H-1 cells, including the association and dissociation rates of alpha-bungarotoxin, a low affinity and cooperative instantaneous dose-response curve, cooperative steady state agonist binding and desensitization, cooperative enhancement of agonist binding affinity by local anesthetics, and distinct affinities for curariform antagonists. Patch clamp measurements on AM4 cells reveal AChR single channel properties identical to those obtained from BC3H-1 cells, including a single class of channels with a conductance of 56 pS, short and long duration openings at low and high agonist concentrations, brief and intermediate closed duration components at low agonist concentrations, and six distinct closed duration components at high agonist concentrations. The biochemical, pharmacological, and single channel measurements indicate at least 95% of the surface AChRs on AM4 cells are alpha-2-beta-gamma-delta-pentamers.			SINE, SM (corresponding author), YALE UNIV, SCH MED, DEPT CELLULAR & MOLEC PHYSIOL, NEW HAVEN, CT 06510 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL038156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021714] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38156] Funding Source: Medline; NINDS NIH HHS [NS21714] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANHOLT R, 1982, J BIOL CHEM, V257, P7122; BOULTER J, 1977, BIOCHEMISTRY-US, V16, P4900, DOI 10.1021/bi00641a025; Brown WEL, 1923, P R SOC LOND B-CONTA, V94, P297, DOI 10.1098/rspb.1923.0006; BUONANNO A, 1986, J BIOL CHEM, V261, P6451; CLAUDIO T, 1977, ARCH BIOCHEM BIOPHYS, V181, P484, DOI 10.1016/0003-9861(77)90254-5; CLAUDIO T, 1987, SCIENCE, V238, P1688, DOI 10.1126/science.3686008; CONTITRONCONI BM, 1982, SCIENCE, V218, P1227, DOI 10.1126/science.7146904; CONTITRONCONI BM, 1982, P NATL ACAD SCI-BIOL, V79, P6489, DOI 10.1073/pnas.79.21.6489; COVARRUBIAS M, 1989, J GEN PHYSIOL, V93, P765, DOI 10.1085/jgp.93.5.765; DAVIES J, 1980, AM J TROP MED HYG, V29, P1089, DOI 10.4269/ajtmh.1980.29.1089; FORSAYETH JR, 1990, J NEUROSCI, V10, P2771; FROEHNER SC, 1983, J BIOL CHEM, V258, P7112; GIBB AJ, 1990, P ROY SOC B-BIOL SCI, V242, P108, DOI 10.1098/rspb.1990.0112; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GU Y, 1990, NEURON, V5, P147, DOI 10.1016/0896-6273(90)90305-Y; GULLICK WJ, 1983, BIOCHEMISTRY-US, V22, P3312, DOI 10.1021/bi00283a003; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P3112, DOI 10.1021/bi00282a014; HYMAN C, 1983, J CELL BIOL, V96, P1316, DOI 10.1083/jcb.96.5.1316; ISENBERG KE, 1986, NUCLEIC ACIDS RES, V14, P5111, DOI 10.1093/nar/14.12.5111; JACKSON MB, 1988, J PHYSIOL-LONDON, V397, P555, DOI 10.1113/jphysiol.1988.sp017019; KULLBERG R, 1990, P NATL ACAD SCI USA, V87, P2067, DOI 10.1073/pnas.87.6.2067; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAPOLLA RJ, 1984, P NATL ACAD SCI-BIOL, V81, P7970, DOI 10.1073/pnas.81.24.7970; MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PAPKE RL, 1988, BIOPHYS J, V53, P1, DOI 10.1016/S0006-3495(88)83059-5; PATRICK J, 1977, J BIOL CHEM, V252, P2143; PAULSON H, 1991, IN PRESS J CELL BIOL; PAULSON HL, 1990, J CELL BIOL, V110, P1705, DOI 10.1083/jcb.110.5.1705; POPOT JL, 1984, PHYSIOL REV, V64, P1162, DOI 10.1152/physrev.1984.64.4.1162; RAFTERY MA, 1980, SCIENCE, V208, P1454, DOI 10.1126/science.7384786; ROSS AF, 1991, J CELL BIOL, V113, P623, DOI 10.1083/jcb.113.3.623; SAEDI MS, 1991, J CELL BIOL, V112, P1007, DOI 10.1083/jcb.112.5.1007; SCHUBERT D, 1974, J CELL BIOL, V61, P398, DOI 10.1083/jcb.61.2.398; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SIGWORTH FJ, 1983, SINGLE CHANNEL RECOR, P301; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; SINE SM, 1982, J BIOL CHEM, V257, P8106; SINE SM, 1986, J PHYSIOL-LONDON, V373, P129, DOI 10.1113/jphysiol.1986.sp016039; SINE SM, 1984, BIOPHYS J, V46, P277, DOI 10.1016/S0006-3495(84)84022-9; SINE SM, 1990, J GEN PHYSIOL, V96, P395, DOI 10.1085/jgp.96.2.395; SINE SM, 1988, J BIOL CHEM, V263, P18052; SINE SM, 1980, J BIOL CHEM, V255, P144; SINE SM, 1981, J BIOL CHEM, V256, P6692; TZARTOS SJ, 1980, P NATL ACAD SCI-BIOL, V77, P755, DOI 10.1073/pnas.77.2.755; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; YONG G, 1989, J CELL BIOL, V109, P729, DOI 10.1083/jcb.109.2.729; YOSHII K, 1987, J GEN PHYSIOL, V90, P553, DOI 10.1085/jgp.90.4.553; YU L, 1986, NUCLEIC ACIDS RES, V14, P3539, DOI 10.1093/nar/14.8.3539	51	33	34	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					13679	13689						11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713208				2022-12-27	WOS:A1991FY02700037
J	LUO, Y; HAGLER, J; SHUMAN, S				LUO, Y; HAGLER, J; SHUMAN, S			DISCRETE FUNCTIONAL STAGES OF VACCINIA VIRUS EARLY TRANSCRIPTION DURING A SINGLE ROUND OF RNA-SYNTHESIS INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOVIRUS MAJOR LATE; MESSENGER-RNA; POLYMERASE-II; CAPPING ENZYME; EARLY GENES; SEQUENCES DOWNSTREAM; ESCHERICHIA-COLI; VIRIONS; SUBUNITS; PURIFICATION	We have developed a system for analysis of discrete steps in vaccinia virus early mRNA synthesis during a single round of transcription in vitro. A synthetic early promoter is used to direct transcription by vaccinia RNA polymerase of a G-less cassette in linear duplex DNA. Omission of GTP from transcription reactions leads to the formation of ternary elongation complexes paused stably at the end of the G-less cassette. These complexes can be induced to elongate by provision of GTP. While initiation of transcription is sensitive to low concentrations of salt and Sarkosyl, elongation is relatively resistant to these agents. Termination can be studied in a single synthetic cycle by forming transcription complexes paused just proximal to the termination signal TTTTTNT that can subsequently elongate and terminate. By selectively incorporating the termination-inhibiting analog BrUMP into proximal and distal portions of the nascent transcript, we localize the termination signal within or near the sequence UUUUUNU in the nascent RNA. We show that access of the vaccinia termination factor (VTF/capping enzyme) to the transcriptional apparatus can occur subsequent to initiation and synthesis of a 390-nucleotide nascent RNA. Termination is more sensitive to inhibition by salt and Sarkosyl than is elongation. This sensitivity is not reversed by preincubation of VTF with the transcription complex. Finally, we confirm the identity of VTF and vaccinia mRNA capping enzyme by demonstration of VTF activity associated with capping enzyme expressed in Escherichia coli.			LUO, Y (corresponding author), SLOAN KETTERING MEM CANC CTR,PROGRAM MOLEC BIOL,NEW YORK,NY 10021, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042498] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 42498-02] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHN BY, 1990, J VIROL, V64, P3019, DOI 10.1128/JVI.64.6.3019-3024.1990; AHN BY, 1990, MOL CELL BIOL, V10, P5433, DOI 10.1128/MCB.10.10.5433; BAROUDY BM, 1980, J BIOL CHEM, V255, P4372; BROYLES SS, 1988, J BIOL CHEM, V263, P10754; BROYLES SS, 1987, MOL CELL BIOL, V7, P7, DOI 10.1128/MCB.7.1.7; BROYLES SS, 1988, J BIOL CHEM, V263, P10761; BROYLES SS, 1990, J VIROL, V64, P5376, DOI 10.1128/JVI.64.11.5376-5382.1990; BROYLES SS, 1990, J VIROL, V64, P1523, DOI 10.1128/JVI.64.4.1523-1529.1990; BROYLES SS, 1986, P NATL ACAD SCI USA, V83, P3141, DOI 10.1073/pnas.83.10.3141; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CAI H, 1987, J BIOL CHEM, V262, P298; CARCAMO J, 1989, J BIOL CHEM, V264, P7704; DAVISON AJ, 1989, J MOL BIOL, V210, P749, DOI 10.1016/0022-2836(89)90107-1; GERSHON PD, 1990, P NATL ACAD SCI USA, V87, P4401, DOI 10.1073/pnas.87.11.4401; GERSHOWITZ A, 1978, J VIROL, V27, P399, DOI 10.1128/JVI.27.2.399-408.1978; GOLINI F, 1985, J VIROL, V53, P205, DOI 10.1128/JVI.53.1.205-213.1985; GUO PX, 1990, P NATL ACAD SCI USA, V87, P4023, DOI 10.1073/pnas.87.11.4023; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; HOOPES BC, 1987, ESCHERICHIA COLI SAL, P1231; JONES EV, 1987, J VIROL, V61, P1765, DOI 10.1128/JVI.61.6.1765-1771.1987; KATES J, 1970, J MOL BIOL, V50, P19, DOI 10.1016/0022-2836(70)90101-4; KATES JR, 1967, P NATL ACAD SCI USA, V58, P134, DOI 10.1073/pnas.58.1.134; MARTIN SA, 1976, J BIOL CHEM, V251, P7313; MARTIN SA, 1975, J BIOL CHEM, V250, P9322; MORGAN JR, 1984, J VIROL, V52, P206, DOI 10.1128/JVI.52.1.206-214.1984; MOSS B, VIROLOGY, V72, P341; NEVINS JR, 1977, J BIOL CHEM, V252, P6930; NILES EG, 1989, VIROLOGY, V172, P513, DOI 10.1016/0042-6822(89)90194-3; PAOLETTI E, 1978, VIROLOGY, V87, P317, DOI 10.1016/0042-6822(78)90137-X; PATEL DD, 1989, J VIROL, V63, P1076, DOI 10.1128/JVI.63.3.1076-1086.1989; QUICK SD, 1990, VIROLOGY, V178, P603, DOI 10.1016/0042-6822(90)90362-U; REINBERG D, 1987, J BIOL CHEM, V262, P3322; ROHRMANN G, 1985, J VIROL, V56, P349, DOI 10.1128/JVI.56.2.349-355.1985; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SHUMAN S, 1981, P NATL ACAD SCI-BIOL, V78, P187, DOI 10.1073/pnas.78.1.187; SHUMAN S, 1980, J BIOL CHEM, V255, P5396; SHUMAN S, 1990, J BIOL CHEM, V265, P11960; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; SHUMAN S, 1980, J BIOL CHEM, V255, P15588; SPENCER E, 1980, J BIOL CHEM, V255, P5388; VENKATESAN S, 1980, J BIOL CHEM, V255, P903; WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318; YUEN L, 1986, J VIROL, V60, P320, DOI 10.1128/JVI.60.1.320-323.1986; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	48	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13303	13310						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712778				2022-12-27	WOS:A1991FX13200079
J	GUDMUNDSSON, GH; LIDHOLM, DA; ASLING, B; GAN, RB; BOMAN, HG				GUDMUNDSSON, GH; LIDHOLM, DA; ASLING, B; GAN, RB; BOMAN, HG			THE CECROPIN LOCUS - CLONING AND EXPRESSION OF A GENE-CLUSTER ENCODING 3 ANTIBACTERIAL PEPTIDES IN HYALOPHORA-CECROPIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSECT IMMUNITY; BOMBYX-MORI; SARCOPHAGA-PEREGRINA; PRECURSOR FORMS; MESSENGER-RNA; CDNA CLONES; DROSOPHILA; PROTEIN; PUPAE; ORGANIZATION	Cecropins A, B, and D are antibacterial peptides of 35-37 amino acids that are synthesized in pupae of the Cecropia moth (Hyalophora cecropia) as a response to a bacterial infection. cDNA cloning has shown that the cecropins are made as preproproteins that are processed in four steps to the mature peptides. We have now cloned the genes for preprocecropins A and D, data that together with earlier work on the B gene has made it possible to deduce the arrangement of the cecropin locus. The genes for the three cecropins are organized in a large cluster spanning 20 kilobases of DNA and for each gene there is one copy/haploid genome. The size of the cluster is in part due to long distances between the genes and to the presence of insertion elements in the introns of the A and D genes. The cecropin genes are not expressed in parallel. Transcripts for cecropins A and B appear within 2 h after injection of live bacteria, they reach a maximum after 48 h, and they are continuously expressed at this level for several days. The D gene has a delayed pattern of expression where transcripts appear within 48-96 h and reach a maximum after 144 h. In consonance is also the production of the mature cecropins A, B, and D where the active cecropins A and B are detected in the hemolymph within 10-24 h while the D form is not detected until 48 h post infection. Control injections with sterile saline produced only a weak induction of the cecropin genes.			GUDMUNDSSON, GH (corresponding author), UNIV STOCKHOLM,DEPT MICROBIOL,S-10691 STOCKHOLM,SWEDEN.		Gudmundsson, Gudmundur H/K-9178-2015	Gudmundsson, Gudmundur H/0000-0001-5793-0565				BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BOMAN HG, 1989, J BIOL CHEM, V264, P5852; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; DICKINSON L, 1988, J BIOL CHEM, V263, P19424; EIPPER BA, 1983, P NATL ACAD SCI-BIOL, V80, P5144, DOI 10.1073/pnas.80.16.5144; FRISCHAUF AM, 1983, J MOL BIOL, V170, P827, DOI 10.1016/S0022-2836(83)80190-9; GANZ T, 1989, J IMMUNOL, V143, P1358; GARBER RL, 1983, EMBO J, V2, P2027, DOI 10.1002/j.1460-2075.1983.tb01696.x; GILMAN M, 1987, CURRENT PROTOCOLS MO; HOLAK TA, 1988, BIOCHEMISTRY-US, V27, P7620, DOI 10.1021/bi00420a008; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; HULTMARK D, 1980, EUR J BIOCHEM, V106, P7, DOI 10.1111/j.1432-1033.1980.tb05991.x; HULTMARK D, 1986, CELL, V44, P429, DOI 10.1016/0092-8674(86)90464-2; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; KAISER K, 1986, DNA CLONING, V1, P1; KANIA A, 1989, FEBS LETT, V258, P199; KAWAKAMI A, 1989, P NATL ACAD SCI USA, V86, P6843, DOI 10.1073/pnas.86.18.6843; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; LEE JY, 1989, P NATL ACAD SCI USA, V86, P9159, DOI 10.1073/pnas.86.23.9159; LIDHOLM DA, 1991, J BIOL CHEM, V266, P11518; LIDHOLM DA, 1987, FEBS LETT, V226, P8, DOI 10.1016/0014-5793(87)80540-9; Maniatis T., 1982, MOL CLONING; MATSUMOTO N, 1986, BIOCHEM J, V239, P717, DOI 10.1042/bj2390717; MEAD DA, 1986, PROTEIN ENG, V1, P67, DOI 10.1093/protein/1.1.67; MORISHIMA I, 1990, COMP BIOCHEM PHYS B, V95, P551, DOI 10.1016/0305-0491(90)90019-P; OKADA M, 1985, J BIOL CHEM, V260, P7174; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; QU XM, 1982, EUR J BIOCHEM, V127, P219, DOI 10.1111/j.1432-1033.1982.tb06858.x; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; STEINER H, 1982, FEBS LETT, V137, P283, DOI 10.1016/0014-5793(82)80368-2; SUN SC, 1991, EUR J BIOCHEM, V196, P247, DOI 10.1111/j.1432-1033.1991.tb15811.x; TU YZ, 1989, SCI CHINA SER B, V32, P1072; VONHOFSTEN P, 1985, P NATL ACAD SCI USA, V82, P2240; XANTHOPOULOS KG, 1988, EUR J BIOCHEM, V172, P371, DOI 10.1111/j.1432-1033.1988.tb13896.x	36	73	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11510	11517						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711035				2022-12-27	WOS:A1991FT76200018
J	DETTBARN, C; PALADE, P				DETTBARN, C; PALADE, P			EFFECTS OF ALKALINE PH ON SARCOPLASMIC-RETICULUM CA2+ RELEASE AND CA2+ UPTAKE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; INDUCED CA-2+ RELEASE; SPONTANEOUS CALCIUM RELEASE; ADENOSINE-TRIPHOSPHATASE; TERMINAL CISTERNAE; INTRACELLULAR PH; STEADY-STATE; PUMP; FROG; TRANSPORT	Alkalinization-induced Ca2+ release from isolated frog or rabbit sarcoplasmic reticulum vesicles appears to consist of two distinct components: 1) a direct activation of ruthenium red-sensitive Ca2+ release channels in terminal cisternae and 2) an increased ruthenium red-insensitive Ca2+ efflux through some other efflux pathway distributed throughout the sarcoplasmic reticulum. The first of these releases exhibits an alkalinization-induced inactivation process and does not depend on the ruthenium red-insensitive form of Ca2+ release as a triggering agent for secondary Ca2+-induced Ca2+ release. Both releases are inhibited when the extravesicular (i.e. cytoplasmic) free [Ca2+] is reduced. This may reflect an increased sensitivity of the Ca2+ release channels to Ca2+ at alkaline pH. The pH sensitivity of the ruthenium red-sensitive Ca2+ release channels could be of significance during excitation-contraction coupling. The ruthenium red-insensitive form of Ca2+ release is less likely to be physiologically relevant, but it probably has contributed greatly to reports of alkalinization-induced decreases in net sarcoplasmic reticulum Ca2+ uptake, particularly under conditions where oxalate supported Ca2+ uptake is much less affected, as here.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT PHYSIOL & BIOPHYS,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center					NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR034377] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR34377] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARGAMAN A, 1989, FEBS LETT, V243, P88, DOI 10.1016/0014-5793(89)81223-2; BAYLOR SM, 1982, J PHYSIOL-LONDON, V331, P105, DOI 10.1113/jphysiol.1982.sp014367; BAYLOR SM, 1988, J PHYSIOL-LONDON, V403, P151, DOI 10.1113/jphysiol.1988.sp017244; BRUNDER DG, 1988, J BIOL CHEM, V263, P18785; CARVALHO AP, 1967, J GEN PHYSIOL, V50, P1327, DOI 10.1085/jgp.50.5.1327; CHU A, 1983, J BIOL CHEM, V258, P1656; Curtin N A, 1988, Adv Exp Med Biol, V226, P657; de Meis L, 1977, Biochemistry, V16, P4455, DOI 10.1021/bi00639a020; DIXON DA, 1989, J MEMBRANE BIOL, V112, P169, DOI 10.1007/BF01871278; DUGGAN PF, 1970, J GEN PHYSIOL, V56, P147, DOI 10.1085/jgp.56.2.147; DUGGAN PF, 1977, J BIOL CHEM, V252, P1620; DUNNETT J, 1979, ARCH BIOCHEM BIOPHYS, V198, P434, DOI 10.1016/0003-9861(79)90517-4; DUPONT Y, 1980, EUR J BIOCHEM, V109, P231, DOI 10.1111/j.1432-1033.1980.tb04788.x; FABIATO A, 1985, CELL CALCIUM, V6, P95, DOI 10.1016/0143-4160(85)90037-5; FASSOLD E, 1986, EUR J BIOCHEM, V154, P7, DOI 10.1111/j.1432-1033.1986.tb09352.x; FEHER JJ, 1983, BIOCHIM BIOPHYS ACTA, V727, P389, DOI 10.1016/0005-2736(83)90424-8; GODT RE, 1988, AM J PHYSIOL, V254, pC591, DOI 10.1152/ajpcell.1988.254.5.C591; HAYNES DH, 1983, J MEMBRANE BIOL, V74, P25, DOI 10.1007/BF01870592; INESI G, 1989, J BIOL CHEM, V264, P5929; KASAI M, 1976, J BIOCHEM-TOKYO, V79, P1067, DOI 10.1093/oxfordjournals.jbchem.a131148; KASAI M, 1976, J BIOCHEM-TOKYO, V79, P1053, DOI 10.1093/oxfordjournals.jbchem.a131147; KIM DH, 1983, J BIOL CHEM, V258, P9662; LEA TJ, 1982, J PHYSIOL-LONDON, V334, P39; LEVITSKY DO, 1986, AM J PHYSIOL, V250, pH360, DOI 10.1152/ajpheart.1986.250.3.H360; MA J, 1988, SCIENCE, V242, P99, DOI 10.1126/science.2459777; MACDONALD VW, 1976, J GEN PHYSIOL, V68, P179, DOI 10.1085/jgp.68.2.179; MAKINOSE M, 1969, EUR J BIOCHEM, V10, P74; MARTONOSI A, 1969, J BIOL CHEM, V244, P613; MEISSNER G, 1980, J BIOL CHEM, V255, P6814; MEISSNER G, 1973, BIOCHIM BIOPHYS ACTA, V298, P906, DOI 10.1016/0005-2736(73)90395-7; MEISSNER G, 1976, J MEMBRANE BIOL, V30, P79, DOI 10.1007/BF01869661; MEISSNER G, 1981, J BIOL CHEM, V256, P636; MELTZER S, 1984, J BIOL CHEM, V259, P4244; NAKAMARU Y, 1972, J GEN PHYSIOL, V59, P22, DOI 10.1085/jgp.59.1.22; NAKAMARU Y, 1970, BIOCHEM BIOPH RES CO, V41, P830, DOI 10.1016/0006-291X(70)90157-9; NUNOGAKI K, 1986, BIOCHEM BIOPH RES CO, V140, P934, DOI 10.1016/0006-291X(86)90725-4; OTTOLENGHI P, 1975, BIOCHEM J, V151, P61, DOI 10.1042/bj1510061; PALADE P, 1982, J GEN PHYSIOL, V79, P679, DOI 10.1085/jgp.79.4.679; PALADE P, 1987, J BIOL CHEM, V262, P6142; PALADE P, 1987, J BIOL CHEM, V262, P6135; PALADE P, 1983, J BIOL CHEM, V258, P8098; RENAUD JM, 1989, J PHYSIOL-LONDON, V416, P31, DOI 10.1113/jphysiol.1989.sp017747; ROSSI B, 1979, J BIOL CHEM, V254, P2302; ROUSSEAU E, 1990, PFLUG ARCH EUR J PHY, V415, P645, DOI 10.1007/BF02583520; SAITO A, 1984, J CELL BIOL, V99, P875, DOI 10.1083/jcb.99.3.875; SALAMA G, 1984, J BIOL CHEM, V259, P3363; SCARPA A, 1972, J GEN PHYSIOL, V60, P735, DOI 10.1085/jgp.60.6.735; SHOSHAN V, 1980, P NATL ACAD SCI-BIOL, V77, P4435, DOI 10.1073/pnas.77.8.4435; SHOSHAN V, 1981, J BIOL CHEM, V256, P887; SHOSHAN V, 1981, P NATL ACAD SCI-BIOL, V78, P4828, DOI 10.1073/pnas.78.8.4828; SMITH JS, 1985, NATURE, V316, P446, DOI 10.1038/316446a0; SMITH JS, 1986, BIOPHYS J, V50, P921, DOI 10.1016/S0006-3495(86)83533-0; SOMLYO AV, 1981, J CELL BIOL, V90, P557; SORENSON MM, 1977, BIOCHIM BIOPHYS ACTA, V465, P210, DOI 10.1016/0005-2736(77)90075-X; SUMBILLA C, 1987, FEBS LETT, V210, P31, DOI 10.1016/0014-5793(87)81292-9; TATE CA, 1981, J BIOL CHEM, V256, P2934; UENO T, 1986, JPN J PHYSIOL, V36, P231, DOI 10.2170/jjphysiol.36.231; VERJOVSKIALMEIDA S, 1977, BIOCHEMISTRY-US, V16, P329, DOI 10.1021/bi00621a026; VOLPE P, 1986, J GEN PHYSIOL, V87, P271, DOI 10.1085/jgp.87.2.271; VOLPE P, 1983, J BIOL CHEM, V258, P2434; VOLPE P, 1988, J BIOL CHEM, V263, P9901; WESTERBLAD H, 1988, ACTA PHYSIOL SCAND, V133, P83, DOI 10.1111/j.1748-1716.1988.tb08383.x; YAMAMOTO N, 1982, J BIOCHEM-TOKYO, V92, P465, DOI 10.1093/oxfordjournals.jbchem.a133954	63	35	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					8993	9001						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709160				2022-12-27	WOS:A1991FM03800053
J	FORCE, T; KYRIAKIS, JM; AVRUCH, J; BONVENTRE, JV				FORCE, T; KYRIAKIS, JM; AVRUCH, J; BONVENTRE, JV			ENDOTHELIN, VASOPRESSIN, AND ANGIOTENSIN-II ENHANCE TYROSINE PHOSPHORYLATION BY PROTEIN KINASE-C-DEPENDENT AND KINASE-C-INDEPENDENT PATHWAYS IN GLOMERULAR MESANGIAL CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PHOSPHOLIPASE-C; SIGNAL TRANSDUCTION; PHOSPHATIDYLINOSITOL KINASE; HUMAN-PLATELETS; THROMBIN; PDGF; ACTIVATION; CALCIUM; IDENTIFICATION	Protein tyrosine phosphorylation has not been considered to be important for cellular activation by phospholipase C-linked vasoactive peptides. We found that endothelin, angiotensin II, and vasopressin (AVP), peptides that signal via phospholipase C activation, rapidly enhanced tyrosine phosphorylation of proteins of approximate molecular mass 225, 190, 135, 120, and 70 kDa in rat renal mesangial cells. The phosphorylated proteins were cytosolic or membrane-associated, and none were integral to the membrane, suggesting that the peptide receptors are not phosphorylated on tyrosine. Epidermal growth factor (EGF), which does not activate phospholipase C in these cells, induced the tyrosine phosphorylation of its own 175-kDa receptor, in addition to five proteins of identical molecular mass to those phosphorylated in response to endothelin, AVP, and angiotensin II. This suggests that in mesangial cells there is a common signaling pathway for phospholipase C-coupled agonists and agonists classically assumed to signal via receptor tyrosine kinase pathways, such as EGF. The phorbol ester, phorbol 12-myristate 13-acetate, and the synthetic diacylglycerol, oleoyl acetylglycerol, stimulated the tyrosine phosphorylation of proteins identical to those phosphorylated by the phospholipase C-linked peptides, suggesting that protein kinase C (PKC) activation is sufficient to active tyrosine phosphorylation. However, the PKC inhibitor, staurosporine, and down-regulation of PKC activity by prolonged exposure to phorbol esters completely inhibited tyrosine phosphorylation in response to PMA but not to endothelin, AVP, or EGF. In conclusion, endothelin, angiotensin II, and AVP enhances protein tyrosine phosphorylation via at least two pathways, PKC-dependent and PKC-independent. Although activation of PKC may be sufficient to enhance protein tyrosine phosphorylation, PKC is not necessary and may not be the primary route by which these agents act. At least one of these pathways is shared with the growth factor EGF, suggesting not only common intermediates in the signaling pathways for growth factors and vasoactive peptides but also perhaps common cellular tyrosine kinases which phosphorylate these intermediates.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PREVENT MED,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	FORCE, T (corresponding author), MASSACHUSETTS GEN HOSP,MED SERV,BIGELOW 840,BOSTON,MA 02114, USA.			Force, Thomas/0000-0002-0450-8659	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039773, P01DK038452, R37DK039773, K08DK001986] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 38452, DK 39773, DK 01986] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERKOW RL, 1990, BLOOD, V75, P2445; BLACKSHEAR PJ, 1989, CLIN RES, V37, P554; BONVENTRE JV, 1988, J CLIN INVEST, V82, P168, DOI 10.1172/JCI113566; BONVENTRE JV, 1990, J BIOL CHEM, V265, P4934; BONVENTRE JV, 1986, AM J PHYSIOL, V251, pF94, DOI 10.1152/ajprenal.1986.251.1.F94; CALES C, 1988, NATURE, V332, P548, DOI 10.1038/332548a0; COUGHLIN SR, 1989, SCIENCE, V243, P1191; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FERRELL JE, 1988, MOL CELL BIOL, V8, P3603, DOI 10.1128/MCB.8.9.3603; FORCE T, 1990, J AM SOC NEPHROL, V1, P415; GANZ MB, 1988, AM J PHYSIOL, V255, pF898, DOI 10.1152/ajprenal.1988.255.5.F898; GILMORE T, 1983, NATURE, V306, P487, DOI 10.1038/306487a0; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAZLAUSKAS A, 1988, J CELL BIOL, V106, P1395, DOI 10.1083/jcb.106.4.1395; KLARLUND JK, 1988, BIOCHIM BIOPHYS ACTA, V971, P112, DOI 10.1016/0167-4889(88)90167-X; MARGOLIS B, 1990, SCIENCE, V248, P607, DOI 10.1126/science.2333512; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARGOLIS B, 1990, MOL CELL BIOL, V10, P435, DOI 10.1128/MCB.10.2.435; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MENE P, 1989, AM J PHYSIOL, V256, pF375, DOI 10.1152/ajprenal.1989.256.3.F375; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MORRISON DK, 1988, P NATL ACAD SCI USA, V85, P8855, DOI 10.1073/pnas.85.23.8855; NAKAMURA S, 1989, J BIOL CHEM, V264, P7089; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; TAUBMAN MB, 1989, J BIOL CHEM, V264, P526; THOMPSON DM, 1985, J BIOL CHEM, V260, P8824; TORNQVIST HE, 1988, J BIOL CHEM, V263, P350; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VARTICOVSKI L, 1989, NATURE, V342, P699, DOI 10.1038/342699a0; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; WANG JYJ, 1985, MOL CELL BIOL, V5, P3640, DOI 10.1128/MCB.5.12.3640; WATSON SP, 1988, BIOCHEM J, V249, P345, DOI 10.1042/bj2490345; WILLIAMS LT, 1989, CLIN RES, V37, P564; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	43	210	210	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6650	6656						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706722				2022-12-27	WOS:A1991FE37300095
J	DEMEIS, L				DEMEIS, L			FAST EFFLUX OF CA2+ MEDIATED BY THE SARCOPLASMIC-RETICULUM CA2+-ATPASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-PUMP; ADENOSINE-TRIPHOSPHATASE; MECHANISTIC IMPLICATIONS; INORGANIC-PHOSPHATE; REACTION CYCLE; CA-2+ ATPASE; PHOSPHORYLATION; INHIBITION; MITOCHONDRIA; RELEASE	The Ca2+-ATPase found in the light fraction of sarcoplasmic reticulum vesicles can be phosphorylated by P(i), forming an acylphosphate residue at the catalytic site of the enzyme. This reaction was inhibited by the phenothiazines trifluoperazine, chlorpromazine, imipramine, and fluphenazine and by the beta-adrenergic blocking agents propranolol and alprenolol. The inhibition was reversed by raising either the P(i) or the Mg2+ concentration in the medium and was not affected by the presence of K+. Phosphorylation of the Ca2+-ATPase by P(i) was also inhibited by ruthenium red and spermidine. These compounds compete with Mg2+, but, unlike the phenothiazines, they did not compete with P(i) at the catalytic site, and the inhibition was abolished when K+ was included in the assay medium. The efflux of Ca2+ from loaded vesicles was greatly increased by the phenothiazines and by propranolol and alprenolol. In the presence of 200-mu-M trifluoperazine, the rate of Ca2+ efflux was higher than 3-mu-mol of Ca2+/mg of protein/10 s. The activation of efflux by these drugs was antagonized by P(i), Mg2+, K+, Ca2+, ADP, dimethyl sulfoxide, ruthenium red, and spermidine. The increase of Ca2+ efflux caused by trifluoperazine was not correlated with binding of the drug to the membrane lipids. It is concluded that the Ca2+ pump can be uncoupled by different drugs, thereby greatly increasing the efflux of Ca2+ through the ATPase. Displacement of these drugs by the natural ligands of the ATPase blocks the efflux through the uncoupled pathway and limits it to a much smaller rate. Thus, the Ca2+-ATPase can operate either as a pump (coupled) or as a Ca2+ channel (uncoupled).			DEMEIS, L (corresponding author), UNIV FED RIO DE JANEIRO, INST CIENCIAS BIOMED, DEPT BIOQUIM, CIDADE UNIV, ILHA FUNDAO, BR-21910 RIO DE JANEIRO, BRAZIL.							ALVES EW, 1986, J BIOL CHEM, V261, P6854; ALVES EW, 1987, EUR J BIOCHEM, V166, P647, DOI 10.1111/j.1432-1033.1987.tb13562.x; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; CARAFOLI E, 1979, FEBS LETT, V104, P1, DOI 10.1016/0014-5793(79)81073-X; CHALOUB RM, 1980, J BIOL CHEM, V255, P6168; CHAMPEIL P, 1985, BIOCHEMISTRY-US, V24, P69, DOI 10.1021/bi00322a012; CHARUK JHM, 1990, ANAL BIOCHEM, V188, P123, DOI 10.1016/0003-2697(90)90539-L; CHIESI M, 1979, J BIOL CHEM, V254, P370; CLARKE DM, 1990, J BIOL CHEM, V265, P6262; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; COELHO JLC, 1980, ARCH BIOCHEM BIOPHYS, V204, P141, DOI 10.1016/0003-9861(80)90016-8; De Meis L, 1971, J Biol Chem, V246, P4764; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1989, BIOCHIM BIOPHYS ACTA, V973, P333, DOI 10.1016/S0005-2728(89)80440-2; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; DEMEIS L, 1982, J BIOL CHEM, V257, P4993; DEMEIS L, 1990, J BIOL CHEM, V265, P18848; DEMEIS L, 1988, EUR J BIOCHEM, V171, P343; DEMEIS L, 1988, METHOD ENZYMOL, V157, P190; DEMEIS L, 1981, SARCOPLASMIC RETICUL, V2; ELETR S, 1972, BIOCHIM BIOPHYS ACTA, V282, P174, DOI 10.1016/0005-2736(72)90321-5; EUSEBI F, 1980, NATURE, V284, P560, DOI 10.1038/284560a0; FROUD RJ, 1986, BIOCHEM J, V237, P207, DOI 10.1042/bj2370207; GERDES U, 1983, BIOCHIM BIOPHYS ACTA, V734, P191, DOI 10.1016/0005-2736(83)90117-7; GOULD GW, 1987, BIOCHEM J, V245, P739, DOI 10.1042/bj2450739; GOULD GW, 1987, BIOCHIM BIOPHYS ACTA, V904, P45, DOI 10.1016/0005-2736(87)90085-X; GREEN NM, 1986, CIBA F SYMP, V122, P93; HASSELBACH W, 1972, FEBS LETT, V20, P311, DOI 10.1016/0014-5793(72)80094-2; INESI G, 1989, J BIOL CHEM, V264, P5929; MACLENNAN DH, 1985, NATURE, V317, P831, DOI 10.1038/317831d0; MARTIN DW, 1981, BIOCHEMISTRY-US, V20, P4597, DOI 10.1021/bi00519a013; MASUDA H, 1973, BIOCHEMISTRY-US, V12, P4581, DOI 10.1021/bi00747a006; MESZAROS LG, 1985, BIOCHEM BIOPH RES CO, V127, P836, DOI 10.1016/S0006-291X(85)80019-X; MISSIAEN L, 1990, BIOCHIM BIOPHYS ACTA, V1023, P449, DOI 10.1016/0005-2736(90)90138-E; MOISESCU DG, 1976, NATURE, V262, P610, DOI 10.1038/262610a0; PALADE P, 1989, J BIOENERG BIOMEMBR, V21, P295, DOI 10.1007/BF00812074; PETRETSKI JH, 1989, J BIOL CHEM, V264, P20339; PICK U, 1982, EUR J BIOCHEM, V131, P393; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; RIDGWAY EB, 1970, J PHYSL, V209, P105; RILEY WW, 1985, J BIOL CHEM, V260, P2416; SANDELEMOS MP, 1988, EUR J BIOCHEM, V171, P273, DOI 10.1111/j.1432-1033.1988.tb13786.x; SANDELEMOS MP, 1988, J BIOL CHEM, V263, P3795; TANFORD C, 1984, CRC CR REV BIOCH MOL, V17, P123, DOI 10.3109/10409238409113603; TANFORD C, 1984, FEBS LETT, V166, P1, DOI 10.1016/0014-5793(84)80033-2; TUENADEGOMEZPUYOU M, 1980, BIOCHIM BIOPHYS ACTA, V592, P396, DOI 10.1016/0005-2728(80)90087-0	46	92	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5736	5742						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706338				2022-12-27	WOS:A1991FD37000059
J	HOLLINGSWORTH, HC; NOSSAL, NG				HOLLINGSWORTH, HC; NOSSAL, NG			BACTERIOPHAGE-T4 ENCODES AN RNASE-H WHICH REMOVES RNA PRIMERS MADE BY THE T4 DNA-REPLICATION SYSTEM INVITRO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE LEUKEMIA-VIRUS; ESCHERICHIA-COLI; RIBONUCLEASE-H; PRIMASE-HELICASE; REVERSE-TRANSCRIPTASE; NUCLEOTIDE-SEQUENCE; DEFECTIVE-MUTANTS; STRONG PROMOTERS; POLYMERASE-I; GENE	RNase H activity increases markedly after bacteriophage T4 infection of Escherichia coli MIC2003, an RNase H-deficient host. We have extensively purified the RNase H from these T4-infected cells and have shown that the RNase H activity copurifies with a 5' to 3' DNA exonulcease activity. The N-terminal sequence of a 35-kDa protein copurifying with the RNase H activity matches the terminus of the predicted product of an open reading frame (designated ORF A or 33.2) upstream of T4 gene 33, identified previously by Hahn and co-workers (Hahn, S., Kruse, U., and Ruger, W. (1986) Nucleic Acids Res. 14, 9311-9327). Plasmids containing ORF A under the control of the T7 promoter express RNase H and 5' to 3' DNA exonuclease activities as well as a protein that comigrates on sodium dodecyl sulfate-polyacrylamide gels with the 35-kDa protein present in the RNase H purified from T4-infected cells. T4 RNase H removes the pentamer RNA primers from DNA chains initiated by the T4 primase-helicase (gene products 61 and 41). Addition of T4 RNase H and T4 DNA ligase leads to extensive joining of discontinuous lagging strand fragments in the T4 DNA replication system in vitro.	NIDDKD,BIOCHEM PHARMACOL LAB,NUCL ACID BIOCHEM SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								Alberts B.M., 1971, METHODS ENZYMOL, V21, P198; BERKOWER I, 1973, J BIOL CHEM, V248, P5914; BROWN WE, 1982, J BIOL CHEM, V257, P1965; CARL PL, 1980, J BACTERIOL, V144, P28, DOI 10.1128/JB.144.1.28-35.1980; CLARK RW, 1980, J VIROL, V33, P438, DOI 10.1128/JVI.33.1.438-448.1980; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; DIFRANCESCO RA, 1985, J BIOL CHEM, V260, P4764; DUNN JJ, 1983, J MOL BIOL, V166, P477, DOI 10.1016/S0022-2836(83)80282-4; EIGNER J, 1968, J VIROL, V2, P320, DOI 10.1128/JVI.2.4.320-326.1968; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; GENTZ R, 1981, P NATL ACAD SCI-BIOL, V78, P4936, DOI 10.1073/pnas.78.8.4936; GRAM H, 1984, MOL GEN GENET, V194, P232, DOI 10.1007/BF00383522; HACKER K, 1989, J CELL BIOCHEM, V130, P87; HAHN S, 1986, NUCLEIC ACIDS RES, V14, P9311, DOI 10.1093/nar/14.23.9311; HAHN S, 1989, NUCLEIC ACIDS RES, V7, P6729; HALL SH, 1977, J BIOL CHEM, V252, P4092; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HERCULES K, 1971, J VIROL, V19, P1012; HINTON DM, 1985, J BIOL CHEM, V260, P2851; HINTON DM, 1989, J BIOL CHEM, V264, P14432; HINTON DM, 1987, J BIOL CHEM, V262, P10873; HINTON DM, 1986, J BIOL CHEM, V261, P5663; HUBBARD MJ, 1989, BIOCHEMISTRY-US, V28, P1868, DOI 10.1021/bi00430a066; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; JOHNSON MS, 1986, P NATL ACAD SCI USA, V83, P7648, DOI 10.1073/pnas.83.20.7648; KANAYA S, 1984, P NATL ACAD SCI-BIOL, V81, P3447, DOI 10.1073/pnas.81.11.3447; KANAYA S, 1983, J BIOL CHEM, V258, P1276; KARWAN R, 1983, BIOCHEMISTRY-US, V22, P5500, DOI 10.1021/bi00293a008; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; KOGOMA T, 1986, J BACTERIOL, V166, P361, DOI 10.1128/jb.166.2.361-363.1986; KUROSAWA Y, 1975, J MOL BIOL, V96, P653, DOI 10.1016/0022-2836(75)90144-8; KUROSAWA Y, 1979, J MOL BIOL, V135, P841, DOI 10.1016/0022-2836(79)90515-1; KUTTER E, 1990, GENETIC MAPS, V5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWYER FC, 1989, J BIOL CHEM, V264, P6427; LIEBIG HD, 1989, J MOL BIOL, V208, P517, DOI 10.1016/0022-2836(89)90145-9; LIN TC, 1987, P NATL ACAD SCI USA, V84, P7000, DOI 10.1073/pnas.84.20.7000; LIU CC, 1980, P NATL ACAD SCI-BIOL, V77, P5698, DOI 10.1073/pnas.77.10.5698; LOPEZ P, 1989, J BIOL CHEM, V264, P4255; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCKENNEY K, 1981, GENE AMPLIFICATION A, V2, P384; MICKELSON C, 1981, J VIROL, V40, P65, DOI 10.1128/JVI.40.1.65-77.1981; NOSSAL NG, 1979, J BIOL CHEM, V254, P6026; NOSSAL NG, 1987, J BIOL CHEM, V262, P10879; NOSSAL NG, 1980, J BIOL CHEM, V255, P2176; OGAWA T, 1984, MOL GEN GENET, V193, P231, DOI 10.1007/BF00330673; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989; RICHARDSON RW, 1990, UCLA SYM BI, V127, P247; RICHARDSON RW, 1989, J BIOL CHEM, V264, P4732; SCHEKMAN R, 1972, P NATL ACAD SCI USA, V69, P2691, DOI 10.1073/pnas.69.9.2691; SEKI T, 1979, NUCLEIC ACIDS RES, V7, P1603, DOI 10.1093/nar/7.6.1603; SHAMOO Y, 1986, P NATL ACAD SCI USA, V83, P8844, DOI 10.1073/pnas.83.23.8844; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; SHINOZAKI K, 1978, NUCLEIC ACIDS RES, V5, P4245, DOI 10.1093/nar/5.11.4245; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1990, CURRENT PROTOCOLS MO, V3; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; VENKATESAN M, 1982, J BIOL CHEM, V257, P2435; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; WAKEM LP, 1984, VIROLOGY, V137, P324, DOI 10.1016/0042-6822(84)90224-1; WILLIAMS KP, 1989, J BACTERIOL, V171, P3579, DOI 10.1128/jb.171.6.3579-3582.1989; WOOD WB, 1983, BACTERIOPHAGE T4, P259	63	55	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1888	1897						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703156				2022-12-27	WOS:A1991EU49700079
J	MCKENZIE, RJ; AZZONE, GF; CONOVER, TE				MCKENZIE, RJ; AZZONE, GF; CONOVER, TE			BULK PHASE PROTON FLUXES DURING THE GENERATION OF MEMBRANE-POTENTIAL IN RAT-LIVER MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOPSEUDOMONAS-CAPSULATA; ESCHERICHIA-COLI; INTACT-CELLS; ENERGIZATION; TRANSLOCATION; TRANSPORT; PH	The addition of oxygen to anaerobic rat liver mitochondria incubated at 15-degrees-C in the absence of permeant cations produced negligible rapid H+ ejection, monitored spectroscopically with phenol red, which corresponded kinetically to the rise in DELTA-psi, as monitored by merocyanine 540. Slow H+ translocation was observed under these conditions during the aerobic phase, the extent of which was proportional to the amount of oxygen added and the rate dependent on the rate of counter-ion movement. Measurement of H+ disappearance in the mitochondrial matrix, as monitored by neutral red, likewise showed little or no rapid H+ change in the absence of counter-ion movements. In the presence of permeant cations, the H+ disappearance in the matrix was readily measured. This observation argues against the importance of the mitochondrial outer membrane and intermembrane space in masking H+ movements. The H+ translocation required in the generation of maximal or static head DELTA-psi was determined by following the spectral response of merocyanine to increasing oxygen additions. The amount of oxygen giving maximal DELTA-psi corresponds to an extrusion of 2-3 ng ions of H+ . mg of protein-1. The absence of H+ movement of near this magnitude during the development of the DELTA-psi argues against the DELTA-psi-driven backflow of H+ ions as the sole explanation of these observations.	HAHNEMANN UNIV, DEPT BIOL CHEM, BROAD & VINE ST, PHILADELPHIA, PA 19102 USA; UNIV PADUA, INST PATOL GEN, CNR, STUDY PHYSIOL MITOCHONDRIA UNIT, I-35121 PADUA, ITALY	Drexel University; Consiglio Nazionale delle Ricerche (CNR); University of Padua								ARCHBOLD GPR, 1979, BIOCHEM J, V180, P161, DOI 10.1042/bj1800161; BRIERLEY GP, 1968, J BIOL CHEM, V243, P5035; CHANCE B, 1966, NATURE, V212, P369, DOI 10.1038/212369a0; Chappell J.B., 1967, BIOCH MITOCHONDRIA, P75; Conover T. E., 1981, Mitochondria and microsomes, P481; CONOVER TE, 1981, J BIOL CHEM, V256, P402; DILLEY RA, 1987, ANNU REV PLANT PHYS, V38, P347; ESTABROOK R, 1961, J BIOPHYS BIOCHEM CY, V9, P19, DOI 10.1083/jcb.9.1.19; GOULD JM, 1979, J BACTERIOL, V138, P176, DOI 10.1128/JB.138.1.176-184.1979; GOULD JM, 1977, J BIOL CHEM, V252, P5875; HITCHENS GD, 1984, BIOCHIM BIOPHYS ACTA, V766, P222, DOI 10.1016/0005-2728(84)90235-4; JUNGE W, 1979, BIOCHIM BIOPHYS ACTA, V546, P121, DOI 10.1016/0005-2728(79)90175-0; JUNGE W, 1987, P NATL ACAD SCI USA, V84, P7084, DOI 10.1073/pnas.84.20.7084; KAMP F, 1988, BIOPHYS CHEM, V30, P113, DOI 10.1016/0301-4622(88)85009-9; KELL DB, 1982, FARADAY DISCUSS, V74, P377, DOI 10.1039/dc9827400377; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P16, DOI 10.1016/0005-2728(72)90093-X; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; MITCHELL P, 1967, BIOCHEM J, V105, P1147, DOI 10.1042/bj1051147; MITCHELL P, 1965, NATURE, V208, P147, DOI 10.1038/208147a0; MITCHELL P, 1977, FEBS LETT, V78, P1, DOI 10.1016/0014-5793(77)80263-9; MITCHELL P, 1981, OXYGEN FUELS LIVIN 1, P1; POZZAN T, 1976, FEBS LETT, V71, P62, DOI 10.1016/0014-5793(76)80899-X; SCHOLES P, 1970, J BIOENERG, V1, P309; TAYLOR MA, 1985, BIOCHIM BIOPHYS ACTA, V810, P209, DOI 10.1016/0005-2728(85)90136-7; TAYLOR MA, 1985, FEBS LETT, V180, P145, DOI 10.1016/0014-5793(85)81060-7; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; WIKSTROM M, 1984, NATURE, V308, P558, DOI 10.1038/308558a0; WIKSTROM M, 1980, CURR TOP BIOENERG, V10, P52	29	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					803	809						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702439				2022-12-27	WOS:A1991ET17700023
J	LUTTRELL, L; KILGOUR, E; LARNER, J; ROMERO, G				LUTTRELL, L; KILGOUR, E; LARNER, J; ROMERO, G			A PERTUSSIS TOXIN-SENSITIVE G-PROTEIN MEDIATES SOME ASPECTS OF INSULIN ACTION IN BC3H-1 MURINE MYOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV VIRGINIA,HLTH SCI CTR,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908	University of Virginia				Luttrell, Louis/0000-0003-2805-6949	NIDDK NIH HHS [DK14334, DK38942, DK40753] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK014334, P30DK038942, R29DK040753] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASANO T, 1984, BIOCHEMISTRY-US, V23, P5460, DOI 10.1021/bi00318a013; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; CASEY PJ, 1988, COLD SPRING HARB SYM, V53, P203, DOI 10.1101/SQB.1988.053.01.026; CASSEL D, 1976, BIOCHIM BIOPHYS ACTA, V452, P538, DOI 10.1016/0005-2744(76)90206-0; DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056; DUBLER RE, 1985, ARCH BIOCHEM BIOPHYS, V236, P119, DOI 10.1016/0003-9861(85)90611-3; GAWLER D, 1987, FEBS LETT, V216, P94, DOI 10.1016/0014-5793(87)80763-9; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOREN HJ, 1985, CAN J PHYSIOL PHARM, V63, P1017, DOI 10.1139/y85-167; HEYWORTH CM, 1986, BIOCHEM J, V235, P145, DOI 10.1042/bj2350145; IRVINE FJ, 1988, BIOCHEM J, V251, P447, DOI 10.1042/bj2510447; KAMPS MP, 1988, ONCOGENE, V2, P305; KANNER SB, 1989, J IMMUNOL METHODS, V120, P115, DOI 10.1016/0022-1759(89)90296-2; KRUPINSKI J, 1988, J BIOL CHEM, V263, P12333; LUTTRELL LM, 1988, J BIOL CHEM, V263, P6134; MUMBY SM, 1986, P NATL ACAD SCI USA, V83, P265, DOI 10.1073/pnas.83.2.265; NISHIMOTO I, 1989, J BIOL CHEM, V264, P14029; NISHIMOTO I, 1987, BIOCHEM BIOPH RES CO, V148, P407; OKAJIMA F, 1985, J BIOL CHEM, V260, P6761; ROMERO G, 1988, SCIENCE, V240, P509, DOI 10.1126/science.3282305; ROSEN OM, 1987, SCIENCE, V237, P1452, DOI 10.1126/science.2442814; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; ROTHENBERG PL, 1988, J BIOL CHEM, V263, P15546; SUZUKI S, 1987, J BIOL CHEM, V262, P3199; TAYLOR SI, 1973, J BIOL CHEM, V248, P73; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WILLIAMSON K, 1988, BIOCHEMISTRY-US, V27, P5371, DOI 10.1021/bi00414a062	27	93	93	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1990	265	28					16873	16879						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA857	1698770				2022-12-27	WOS:A1990EA85700031
J	KAETZEL, DM; SINGH, N; KENNEDY, GC; VIRGIN, JB; FARR, G; KITAGAWA, Y; NILSON, JH; TARTAKOFF, AM				KAETZEL, DM; SINGH, N; KENNEDY, GC; VIRGIN, JB; FARR, G; KITAGAWA, Y; NILSON, JH; TARTAKOFF, AM			COMPLETE AND PARTIAL GLYCOPHOSPHOLIPID ANCHORS ARE FOUND ON A FUSION PROTEIN CONSISTING OF LUTEINIZING-HORMONE BETA-SUBUNIT FOLLOWED BY A CARBOXYL-TERMINAL DOMAIN OF THY-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CASE WESTERN RESERVE UNIV,SCH MED,DEPT PATHOL,CLEVELAND,OH 44106; CASE WESTERN RESERVE UNIV,SCH MED,DEPT PHARMACOL,CLEVELAND,OH 44106; NAGOYA UNIV,FAC AGR,NAGOYA,AICHI 464,JAPAN	Case Western Reserve University; Case Western Reserve University; Nagoya University					NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [K04AM001316] Funding Source: NIH RePORTER; NIADDK NIH HHS [AM-01316, AM-06981] Funding Source: Medline; NIDDK NIH HHS [DK 3818] Funding Source: Medline	NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKINSON PH, 1984, J CELL BIOL, V98, P2245, DOI 10.1083/jcb.98.6.2245; BANGS JD, 1986, J CELL BIOL, V103, P255, DOI 10.1083/jcb.103.1.255; BENNETT CF, 1988, NATURE, V334, P268, DOI 10.1038/334268a0; BERGER J, 1988, J BIOL CHEM, V263, P10016; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; CHANEY WG, 1986, SOMAT CELL MOLEC GEN, V12, P237, DOI 10.1007/BF01570782; CONZELMANN A, 1987, BIOCHEM J, V246, P605, DOI 10.1042/bj2460605; CORLESS CL, 1987, J CELL BIOL, V104, P1173, DOI 10.1083/jcb.104.5.1173; CRISE B, 1989, J VIROL, V63, P5328, DOI 10.1128/JVI.63.12.5328-5333.1989; FATEMI SH, 1987, J BIOL CHEM, V262, P4728; FATEMI SH, 1988, J BIOL CHEM, V263, P1288; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FREEDMAN RB, 1989, CELL, V57, P1069, DOI 10.1016/0092-8674(89)90043-3; GREEN ED, 1985, J BIOL CHEM, V260, P5623; HEMPERLY JJ, 1986, P NATL ACAD SCI USA, V83, P9822, DOI 10.1073/pnas.83.24.9822; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HIRAKI DD, 1986, J IMMUNOL, V136, P4291; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; KAETZEL DM, 1988, J BIOL CHEM, V263, P6344; KAETZEL DM, 1985, P NATL ACAD SCI USA, V82, P7280, DOI 10.1073/pnas.82.21.7280; KAETZEL DM, 1989, MOL ENDOCRINOL, V3, P1765, DOI 10.1210/mend-3-11-1765; KASSENBROCK CK, 1988, NATURE, V333, P90, DOI 10.1038/333090a0; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; KRAKOW JL, 1986, J BIOL CHEM, V261, P2147; KROCZEK RA, 1986, NATURE, V322, P181, DOI 10.1038/322181a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIEFER D, 1984, SCIENCE, V224, P303; MACDONALD HR, 1985, EUR J IMMUNOL, V15, P495, DOI 10.1002/eji.1830150514; MATZUK MM, 1988, MOL ENDOCRINOL, V2, P95, DOI 10.1210/mend-2-2-95; MENON AK, 1988, J BIOL CHEM, V263, P1970; MENTLEIN R, 1984, ARCH BIOCHEM BIOPHYS, V234, P612, DOI 10.1016/0003-9861(84)90311-4; NORCROSS MA, 1984, J IMMUNOL, V132, P833; PONT S, 1985, EUR J IMMUNOL, V15, P1222, DOI 10.1002/eji.1830151215; ROSENBERRY TL, 1989, J BIOL CHEM, V264, P7096; RYAN RJ, 1988, FASEB J, V2, P2661, DOI 10.1096/fasebj.2.11.2456242; SALEH M, 1988, P NATL ACAD SCI USA, V85, P4543, DOI 10.1073/pnas.85.12.4543; SMITH PL, 1989, J BIOL CHEM, V265, P874; TISDALE EJ, 1988, J BIOL CHEM, V263, P8244; TSE AGD, 1985, SCIENCE, V230, P1003, DOI 10.1126/science.2865810; WANECK GL, 1988, P NATL ACAD SCI USA, V85, P577, DOI 10.1073/pnas.85.2.577	41	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15932	15937						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1697596				2022-12-27	WOS:A1990DY96400090
J	EHRLICH, HJ; GEBBINK, RK; KEIJER, J; LINDERS, M; PREISSNER, KT; PANNEKOEK, H				EHRLICH, HJ; GEBBINK, RK; KEIJER, J; LINDERS, M; PREISSNER, KT; PANNEKOEK, H			ALTERATION OF SERPIN SPECIFICITY BY A PROTEIN COFACTOR - VITRONECTIN ENDOWS PLASMINOGEN-ACTIVATOR INHIBITOR-1 WITH THROMBIN INHIBITORY PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV,DEPT MOLEC BIOL,CENT LAB, PLESMANLAAN 125, 1066 CX AMSTERDAM, NETHERLANDS; MAX PLANCK GESELL, CLIN RES UNIT BLOOD COAGULAT & THROMBOSIS, W-6300 GIESSEN, GERMANY	Max Planck Society			Keijer, Jaap/J-8089-2013	Keijer, Jaap/0000-0002-9720-7491				ANDREASEN PA, 1986, FEBS LETT, V209, P213, DOI 10.1016/0014-5793(86)81113-9; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; BARSHAVIT R, 1989, J CLIN INVEST, V84, P1096, DOI 10.1172/JCI114272; BOCK SC, 1982, NUCLEIC ACIDS RES, V10, P8113, DOI 10.1093/nar/10.24.8113; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CHANG JY, 1989, J BIOL CHEM, V264, P3111; CHASE T, 1970, METHOD ENZYMOL, V19, P20; CHRISTENSEN U, 1978, BIOCHEM J, V175, P635, DOI 10.1042/bj1750635; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; DEGROOT PG, 1987, J CELL BIOL, V104, P697, DOI 10.1083/jcb.104.3.697; DELVOS U, 1987, THROMB HAEMOSTASIS, V57, P87; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761; GRIFFITH MJ, 1982, J BIOL CHEM, V257, P7360; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JORDAN R, 1979, J BIOL CHEM, V254, P2902; KEIJER J, 1990, IN PRESS FIBRINOLYSI; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; KRUITHOF EKO, 1986, THROMB HAEMOSTASIS, V55, P201; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERS JWJ, 1987, J BIOL CHEM, V262, P17492; LAMBERS JWJ, 1988, FIBRINOLYSIS S1, V2; LANE DA, 1987, J BIOL CHEM, V262, P16343; LOEBERMANN H, 1984, J MOL BIOL, V177, P531, DOI 10.1016/0022-2836(84)90298-5; Maniatis T., 1982, MOL CLONING; MILLERANDERSSON M, 1974, THROMB RES, V5, P439, DOI 10.1016/0049-3848(74)90001-2; MIMURO J, 1987, BLOOD, V70, P721; MIMURO J, 1989, J BIOL CHEM, V264, P936; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NESHEIM ME, 1983, J BIOL CHEM, V258, P4708; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; POMERANTZ MW, 1978, BIOCHIM BIOPHYS ACTA, V535, P66, DOI 10.1016/0005-2795(78)90033-8; PREISSNER KT, 1985, BIOCHEM J, V231, P349, DOI 10.1042/bj2310349; PREISSNER KT, 1989, BLOOD, V74, P1989; PREISSNER KT, 1987, J BIOL CHEM, V262, P12247; PREISSNER KT, 1986, EUR J BIOCHEM, V156, P645, DOI 10.1111/j.1432-1033.1986.tb09626.x; PREISSNER KT, 1988, THROMB HAEMOSTASIS, V60, P399; ROSENBERG RD, 1973, J BIOL CHEM, V248, P6490; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHLEEF RR, 1988, HAEMOSTASIS, V18, P328; SPRENGERS ED, 1987, BLOOD, V69, P381; SUZUKI K, 1984, J BIOCHEM, V95, P187, DOI 10.1093/oxfordjournals.jbchem.a134583; TOLLEFSEN DM, 1981, J CLIN INVEST, V68, P589, DOI 10.1172/JCI110292; TOMASINI BR, 1989, BIOCHEMISTRY-US, V28, P7617, DOI 10.1021/bi00445a017; TOMASINI BR, 1988, BLOOD, V72, P903; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WALKER FJ, 1979, J BIOL CHEM, V254, P5618; WIMAN B, 1977, EUR J BIOCHEM, V78, P19, DOI 10.1111/j.1432-1033.1977.tb11709.x; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2	56	177	179	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13029	13035						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695900				2022-12-27	WOS:A1990DR20100045
J	CUBBAGE, ML; SUWANICHKUL, A; POWELL, DR				CUBBAGE, ML; SUWANICHKUL, A; POWELL, DR			INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 - ORGANIZATION OF THE HUMAN CHROMOSOMAL GENE AND DEMONSTRATION OF PROMOTER ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									BAYLOR UNIV,DEPT PEDIAT,HOUSTON,TX 77030	Baylor University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038773, R01DK038773] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-38773] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BACHRACH LK, 1989, ENDOCRINOLOGY, V125, P2831, DOI 10.1210/endo-125-6-2831; BALLARD FJ, 1987, BIOCHEM BIOPH RES CO, V149, P398, DOI 10.1016/0006-291X(87)90380-9; Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0; BAXTER RC, 1989, J BIOL CHEM, V264, P11843; BAXTER RC, 1986, J CLIN INVEST, V78, P1504, DOI 10.1172/JCI112742; BINKERT C, 1989, EMBO J, V8, P2497, DOI 10.1002/j.1460-2075.1989.tb08386.x; BOHREN KM, 1989, J BIOL CHEM, V264, P9547; BREWER MT, 1988, BIOCHEM BIOPH RES CO, V152, P1289, DOI 10.1016/S0006-291X(88)80425-X; BRINKMAN A, 1988, BIOCHEM BIOPH RES CO, V157, P898, DOI 10.1016/S0006-291X(88)80959-8; BRINKMAN A, 1988, EMBO J, V7, P2417, DOI 10.1002/j.1460-2075.1988.tb03087.x; BROWN AL, 1989, J BIOL CHEM, V264, P5148; BURCH WM, 1990, J CLIN ENDOCR METAB, V70, P173, DOI 10.1210/jcem-70-1-173; CASCIERI MA, 1988, ENDOCRINOLOGY, V123, P373, DOI 10.1210/endo-123-1-373; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONOVER CA, 1989, J CLIN INVEST, V83, P852, DOI 10.1172/JCI113968; CONOVER CA, 1990, IN PRESS ENDOCRINOLO; CUBBAGE ML, 1989, MOL ENDOCRINOL, V3, P846, DOI 10.1210/mend-3-5-846; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DROP SLS, 1984, J CLIN ENDOCR METAB, V59, P908, DOI 10.1210/jcem-59-5-908; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; FEUERMAN MH, 1989, MOL CELL BIOL, V9, P4204, DOI 10.1128/MCB.9.10.4204; FRAUMAN AG, 1989, ENDOCRINOLOGY, V124, P2289, DOI 10.1210/endo-124-5-2289; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HARDOUIN S, 1989, J CLIN ENDOCR METAB, V69, P1291, DOI 10.1210/jcem-69-6-1291; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; JULKUNEN M, 1988, FEBS LETT, V236, P295, DOI 10.1016/0014-5793(88)80041-3; KNAUER DJ, 1980, P NATL ACAD SCI-BIOL, V77, P7252, DOI 10.1073/pnas.77.12.7252; LEE YL, 1988, MOL ENDOCRINOL, V2, P404, DOI 10.1210/mend-2-5-404; LEWITT MS, 1989, J CLIN ENDOCR METAB, V69, P246, DOI 10.1210/jcem-69-2-246; LIU F, 1990, J CLIN ENDOCR METAB, V70, P620, DOI 10.1210/jcem-70-3-620; LUTHMAN H, 1989, EUR J BIOCHEM, V180, P259, DOI 10.1111/j.1432-1033.1989.tb14641.x; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Maniatis T., 1982, MOL CLONING; MARGOT JB, 1989, MOL ENDOCRINOL, V3, P1053, DOI 10.1210/mend-3-7-1053; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; MARTIN JL, 1988, ENDOCRINOLOGY, V123, P1907, DOI 10.1210/endo-123-4-1907; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; POWELL DR, 1989, INSULIN LIKE GROWTH, P3; RITVOS O, 1988, ENDOCRINOLOGY, V122, P2150, DOI 10.1210/endo-122-5-2150; ROESLER WJ, 1988, J BIOL CHEM, V263, P9063; ROMANUS JA, 1986, ENDOCRINOLOGY, V118, P1743, DOI 10.1210/endo-118-5-1743; SHIMASAKI S, 1990, J BIOL CHEM, V265, P2198; SHIMASAKI S, 1989, BIOCHEM BIOPH RES CO, V165, P907, DOI 10.1016/S0006-291X(89)80052-X; SHIMONAKA M, 1989, BIOCHEM BIOPH RES CO, V165, P189, DOI 10.1016/0006-291X(89)91053-X; STUMPO DJ, 1988, J BIOL CHEM, V263, P1611; SUIKKARI AM, 1989, J CLIN ENDOCR METAB, V68, P135, DOI 10.1210/jcem-68-1-135; UI M, 1989, ENDOCRINOLOGY, V125, P912, DOI 10.1210/endo-125-2-912; WOOD WI, 1988, MOL ENDOCRINOL, V2, P1176, DOI 10.1210/mend-2-12-1176; YEE D, 1989, BIOCHEM BIOPH RES CO, V158, P38, DOI 10.1016/S0006-291X(89)80173-1; ZAPF J, 1988, BIOCHEM BIOPH RES CO, V156, P1187, DOI 10.1016/S0006-291X(88)80758-7	54	133	137	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1990	265	21					12642	12649						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DP458	1695633				2022-12-27	WOS:A1990DP45800079
J	JUST, M; HERBST, H; HUMMEL, M; DURKOP, H; TRIPIER, D; STEIN, H; SCHUPPAN, D				JUST, M; HERBST, H; HUMMEL, M; DURKOP, H; TRIPIER, D; STEIN, H; SCHUPPAN, D			UNDULIN IS A NOVEL MEMBER OF THE FIBRONECTIN-TENASCIN FAMILY OF EXTRACELLULAR-MATRIX GLYCOPROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION GLYCOPROTEIN; AMINO-ACID-SEQUENCE; VONWILLEBRAND-FACTOR; VI COLLAGEN; GLOBULAR DOMAINS; ALPHA-SUBUNIT; MESSENGER-RNA; IMMUNOGLOBULIN SUPERFAMILY; MOSAIC STRUCTURE; BINDING DOMAINS	We characterized cDNA clones specific for the extra-cellular matrix glycoprotein undulin. Two sets of cDNA clones were isolated from a human placental lambda-gt11 expression library and from a rhabdomyosarcoma cell line encoding two partially identical carboxyl-terminal polypeptides of 843 (Un1) and 443 (Un2) amino acids suggesting differential splicing of a single gene transcript. Northern blot analysis of human rhabdomyosarcoma cell poly(A) RNA with cDNA specific for Un1 identified transcripts of approximately 4.2, 6.5, and 8.5 kilobases, whereas a probe specific for Un2 detected a single mRNA of approximately 5 kilobases. Since a monoclonal antibody that is reactive with a sequence encoded by Un1 and not by Un2 detects the bands considered characteristic for undulin in Western blots, the mRNAs related to Un1 may code for the major part of the undulin molecule. The protein sequences deduced from Un1 and Un2 reveal an amino-terminal differentially spliced von Willebrand factor A domain, characteristic of proteins that interact with interstitial collagens, which is linked to fibronectin-like type III homology units by a unique sequence of 57 amino acids. Whereas Un2 encodes two complete and one incomplete type III homologies followed by a unique acidic carboxyl-terminal domain of 118 amino acids, Un1 codes for seven complete and one truncated type III homologies, followed by a short proline-rich carboxyl-terminal segment of 23 amino acids. Considering the 298 amino acids occurring in identical segments, the 989 different amino acid positions deduced from clones Un1 and Un2 represent an estimated 40% of the overall undulin sequence. In the context of 1) rotary shadowing electron microscopy data showing undulin as a structure composed of nodules that are interconnected by flexible rods of varying size, 2) the presence of three major bands of M(r) 270,000, 190,000, and 180,000 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis, with 3) common antigenic epitopes and similar peptide maps (Schuppan, D., Cantaluppi, M. C., Becker, J., Veit, A., Bunte, T., Troyer, D., Schuppan, F., Schmid, M., Ackermann, R., and Hahn, E. G. (1990) J. Biol. Chem. 265, 8823-8832), our finding of differentially spliced type III homology units, as found in tenascin and fibronectin, suggests that undulin is another member of the fibronectin-tenascin family of extracellular matrix glycoproteins. Furthermore, as in fibronectin and tenascin, undulin bears an additional subset of interactive domains tailored to specific structural and functional roles in development and differentiation.	FREE UNIV BERLIN,KLINIKUM STEGLITZ,GASTROENTEROL LAB,HINDENBURGDAMM 30,W-1000 BERLIN 45,GERMANY; FREE UNIV BERLIN,KLINIKUM STEGLITZ,INST PATHOL,W-1000 BERLIN 45,GERMANY; HOECHST AG,PGE STOFFWECHSEL,W-6000 FRANKFURT,GERMANY	Free University of Berlin; Free University of Berlin; Sanofi-Aventis								ARGRAVES WS, 1987, P NATL ACAD SCI USA, V84, P464, DOI 10.1073/pnas.84.2.464; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; BONALDO P, 1989, J BIOL CHEM, V264, P5575; BONALDO P, 1989, J BIOL CHEM, V264, P20235; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; CHIQUETEHRISMANN R, 1990, FASEB J, V4, P2598, DOI 10.1096/fasebj.4.9.1693347; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; CHUNG AE, 1979, CELL, V16, P277, DOI 10.1016/0092-8674(79)90005-9; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; CORBI AL, 1988, J BIOL CHEM, V263, P12403; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DUBLET B, 1989, J BIOL CHEM, V264, P13150; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GORDON MK, 1989, J BIOL CHEM, V264, P19772; GULCHER JR, 1989, P NATL ACAD SCI USA, V86, P1588, DOI 10.1073/pnas.86.5.1588; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; IGNATIUS MJ, 1990, J CELL BIOL, V111, P709, DOI 10.1083/jcb.111.2.709; JONES FS, 1988, P NATL ACAD SCI USA, V85, P2186, DOI 10.1073/pnas.85.7.2186; JONES FS, 1989, P NATL ACAD SCI USA, V86, P1905, DOI 10.1073/pnas.86.6.1905; KOLLER E, 1989, EMBO J, V8, P1073, DOI 10.1002/j.1460-2075.1989.tb03475.x; KORNBLIHTT AR, 1985, EMBO J, V4, P1755, DOI 10.1002/j.1460-2075.1985.tb03847.x; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MIERENDORF RC, 1987, METHOD ENZYMOL, V152, P458; MILLER H, 1987, METHOD ENZYMOL, V152, P145; MOOS M, 1988, NATURE, V334, P701, DOI 10.1038/334701a0; PARETI FI, 1987, J BIOL CHEM, V262, P13835; PEARSON CA, 1988, EMBO J, V7, P2977, DOI 10.1002/j.1460-2075.1988.tb03160.x; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; SEKIGUCHI K, 1986, BIOCHEMISTRY-US, V25, P4936, DOI 10.1021/bi00365a032; SPRING J, 1989, CELL, V59, P325, DOI 10.1016/0092-8674(89)90294-8; STREULI M, 1988, J EXP MED, V168, P1523, DOI 10.1084/jem.168.5.1523; SUZUKI S, 1990, EMBO J, V9, P757, DOI 10.1002/j.1460-2075.1990.tb08170.x; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; YAMADA KM, 1977, BIOCHEMISTRY-US, V16, P5552, DOI 10.1021/bi00644a025	45	65	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17326	17332						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1716629				2022-12-27	WOS:A1991GF44500055
J	HERZ, JM; KOLB, SJ; ERLINGER, T; SCHMID, E				HERZ, JM; KOLB, SJ; ERLINGER, T; SCHMID, E			CHANNEL PERMEANT CATIONS COMPETE SELECTIVELY WITH NONCOMPETITIVE INHIBITORS OF THE NICOTINIC ACETYLCHOLINE-RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH MEMBRANE-FRAGMENTS; MULTIPLE AFFINITY STATES; ENDPLATE CHANNELS; TORPEDO-MARMORATA; LOCAL-ANESTHETICS; MONO-VALENT; <H-3>PHENCYCLIDINE BINDING; ACTIVATED CHANNELS; SODIUM-CHANNELS; ION PERMEATION	Previous work suggests that noncompetitive inhibitor (NCI) ligands and channel permeant cations bind to sites within the nicotinic acetylcholine receptor ion channel. We have used ethidium as a fluorescent probe of the NCI site to investigate interactions between NCI ligands and channel permeant cations. We found that ethidium can be completely displaced from the receptor by a variety of inorganic monovalent and divalent cations. The rank order of monovalent cation affinities was found to be Tl+ > Rb+ greater-than-or-equal-to K+ > Cs+ > Na+ > Li+. The monovalent cation K(d) values vary markedly over a 40-fold range, from 3 to 121 mM. The K(d) values and rank order correspond to values determined previously from electrophysiological data. Hill plots of the back titrations yield slopes of 1.0 for all monovalent cations, indicating a single class of independent sites, as shown previously for NCI ligands. Scatchard analysis of ethidium binding in the presence of Tl+ reveals a reduction in affinity and no changes in the maximal number of sites. In the presence of agonist the kinetics of ethidium dissociation induced by the addition of phencyclidine or cations alone or the simultaneous addition of both are nearly identical. The ethidium dissociation rate induced by either phencyclidine or cations is regulated by the occupation of the agonist sites in a similar manner. These results indicate that the effect of cations on NCI ligand binding occurs by mutually exclusive competition. We suggest that NCIs can regulate cation binding at a physiological cation recognition site that is likely part of the cation permeation path through the receptor channel.	UNIV TEXAS,CELL RES INST,AUSTIN,TX 78712	University of Texas System; University of Texas Austin	HERZ, JM (corresponding author), UNIV TEXAS,INST NEUROSCI,AUSTIN,TX 78712, USA.		Kolb, Stephen/E-3415-2011					ADAMS DJ, 1981, J GEN PHYSIOL, V78, P593, DOI 10.1085/jgp.78.6.593; ADAMS DJ, 1980, J GEN PHYSIOL, V75, P493, DOI 10.1085/jgp.75.5.493; ADAMS PR, 1981, J MEMBRANE BIOL, V58, P161, DOI 10.1007/BF01870902; ATHERTON SJ, 1984, PHOTOBIOCH PHOTOBIOP, V8, P103; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; COHEN JB, 1985, EFFECTS ANESTHESIA, P53; DANI JA, 1987, J GEN PHYSIOL, V89, P959, DOI 10.1085/jgp.89.6.959; DECKER ER, 1990, J NEUROSCI, V10, P3413; DIPAOLA M, 1990, J BIOL CHEM, V265, P11017; EARNEST JP, 1986, BIOCHEMISTRY-US, V25, P5809, DOI 10.1021/bi00367a070; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; ELLIOTT J, 1982, BIOCHEMISTRY-US, V18, P1868; GAGE PW, 1979, J PHYSIOL-LONDON, V288, P509; GREEN WN, 1987, J GEN PHYSIOL, V89, P873, DOI 10.1085/jgp.89.6.873; HEIDMANN T, 1983, BIOCHEMISTRY-US, V22, P3112, DOI 10.1021/bi00282a014; HEIDMANN T, 1986, BIOCHEMISTRY-US, V25, P6109, DOI 10.1021/bi00368a041; HERZ JM, 1989, J BIOL CHEM, V264, P12439; HERZ JM, 1987, J BIOL CHEM, V262, P7238; HILLE B, 1984, IONIC CHANNELS EXCIT, P249; HOFFMANN HM, 1983, J GEN PHYSIOL, V81, P687, DOI 10.1085/jgp.81.5.687; HORN R, 1980, P NATL ACAD SCI-BIOL, V77, P6930, DOI 10.1073/pnas.77.11.6930; HUANG LYM, 1978, J GEN PHYSIOL, V71, P397, DOI 10.1085/jgp.71.4.397; HUGANIR RL, 1983, SOC NEUR ABSTR, V9, P578; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; OSWALD RE, 1983, J NEUROCHEM, V41, P1077, DOI 10.1111/j.1471-4159.1983.tb09054.x; OSWALD RE, 1984, MOL PHARMACOL, V25, P360; OSWALD RE, 1983, BIOCHEMISTRY-US, V22, P3128, DOI 10.1021/bi00282a015; PEDERSEN SE, 1990, BIOPHYS J, V57, P126; POSTMA SW, 1984, MOL PHARMACOL, V25, P219; REDMANN GA, 1982, BIOPHYS J, V37, P324; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SINE SM, 1987, J PHYSIOL-LONDON, V385, P325, DOI 10.1113/jphysiol.1987.sp016496; TAKEDA K, 1982, PROC R SOC SER B-BIO, V216, P225, DOI 10.1098/rspb.1982.0072; TANK DW, 1983, P NATL ACAD SCI-BIOL, V80, P5129, DOI 10.1073/pnas.80.16.5129; TAYLOR P, 1975, BIOCHEMISTRY-US, V14, P1989, DOI 10.1021/bi00680a029	36	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16691	16698						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715868				2022-12-27	WOS:A1991GD63500072
J	SWINNEN, JV; DSOUZA, B; CONTI, M; ASCOLI, M				SWINNEN, JV; DSOUZA, B; CONTI, M; ASCOLI, M			ATTENUATION OF CAMP-MEDIATED RESPONSES IN MA-10 LEYDIG TUMOR-CELLS BY GENETIC MANIPULATION OF A CAMP-PHOSPHODIESTERASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL GROWTH-FACTOR; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; BETA-ADRENERGIC-RECEPTOR; DEPENDENT PROTEIN-KINASE; MAMMALIAN-CELLS; GONADOTROPIN RECEPTORS; CHORIO-GONADOTROPIN; RIBONUCLEIC-ACID; CLONAL STRAIN; SERTOLI-CELL	In order to assess the effect of increased cAMP degradation on the responsiveness on an endocrine cell, we have obtained stable transfectants of MA-10 Leydig tumor cells that overexpress a mammalian cAMP-phosphodiesterase. Two novel cell lines, designated MA-10(P+8) and MA-10(P+29), that express high levels of the transfected enzyme were characterized. Although the basal levels of cAMP in the mutant cell lines are comparable to those of the wild-type cells, the increase in cAMP accumulation elicited by human choriogonadotropin (hCG) is severely blunted. Further studies with MA-10(P+29) show that the ability of hCG to stimulate adenylyl cyclase activity is normal. The failure of MA-10(P+29) cells to accumulate cAMP in response to hCG can be correlated with a similar reduction in hCG-stimulated steroidogenesis. On the other hand, the maximal steroidogenic response of MA-10(P+29) cells to dibutyryl cAMP, a cAMP analogue that is fairly resistant to phosphodiesterase degradation, is normal. We also show that the ability of these cells to respond to hCG with increased cAMP accumulation and steroid synthesis can be restored with a specific phosphodiesterase inhibitor. These results demonstrate that overexpression of a cAMP-phosphodiesterase in MA-10 cells limits the levels of cAMP attained under hCG stimulation and suppresses the steroidogenic response of these cells to hCG. Since gonadotropins increase the cAMP-phosphodiesterase activity in their target cells, these findings also provide evidence that this regulation plays a major role in the modulation of cell responsiveness. Last, these new cell lines should be valuable in the study of the actions of cAMP because they express a conditional and reversible cAMP-resistant phenotype.	UNIV IOWA, COLL MED, DEPT PHARMACOL, IOWA CITY, IA 52242 USA; UNIV N CAROLINA, DEPT PEDIAT, REPROD BIOL LABS, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, DEPT PHYSIOL, CHAPEL HILL, NC 27599 USA	University of Iowa; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill			Swinnen, Johannes V/AAA-2214-2022	Swinnen, Johannes V/0000-0002-7720-5077	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020788] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA040629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NCI NIH HHS [CA-40629] Funding Source: Medline; NICHD NIH HHS [HD-20788] Funding Source: Medline; NIDDK NIH HHS [DK-25295] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; ASCOLI M, 1989, ANN NY ACAD SCI, V564, P99, DOI 10.1111/j.1749-6632.1989.tb25891.x; ASCOLI M, 1987, J BIOL CHEM, V262, P9196; ASCOLI M, 1981, J BIOL CHEM, V256, P179; Beavo J., 1990, CYCLIC NUCLEOTIDE PH, P3; BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1; BEEBE SJ, 1985, J BIOL CHEM, V260, P5781; BOURNE HR, 1973, SCIENCE, V181, P952, DOI 10.1126/science.181.4103.952; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROTHERS VM, 1982, J BIOL CHEM, V257, P9349; CAMPAGNE MMV, 1990, J BIOL CHEM, V265, P5840; CAMPAGNE MMV, 1990, J BIOL CHEM, V265, P5847; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONTI M, 1986, ENDOCRINOLOGY, V118, P901, DOI 10.1210/endo-118-3-901; CONTI M, 1982, ENDOCRINOLOGY, V110, P1189, DOI 10.1210/endo-110-4-1189; CONTI M, 1984, ENDOCRINOLOGY, V114, P2361, DOI 10.1210/endo-114-6-2361; DEGERMAN E, 1990, P NATL ACAD SCI USA, V87, P533, DOI 10.1073/pnas.87.2.533; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; ERNEUX C, 1985, MOL CELL ENDOCRINOL, V43, P123, DOI 10.1016/0303-7207(85)90075-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GETTYS TW, 1988, J BIOL CHEM, V263, P10359; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GRANT PG, 1988, P NATL ACAD SCI USA, V85, P9071, DOI 10.1073/pnas.85.23.9071; HAFEZ MM, 1990, ENDOCRINOLOGY, V127, P394, DOI 10.1210/endo-127-1-394; HAUSDORFF WP, 1990, FASEB J, V4, P2881, DOI 10.1096/fasebj.4.11.2165947; LEFKOWITZ RJ, 1990, TRENDS PHARMACOL SCI, V11, P190, DOI 10.1016/0165-6147(90)90113-M; MACPHEE CH, 1988, J BIOL CHEM, V263, P10353; MEEKER RB, 1982, MOL PHARMACOL, V22, P310; OLESHANSKY MA, 1975, MOL PHARMACOL, V11, P552; ONALI P, 1981, BIOCHIM BIOPHYS ACTA, V675, P285, DOI 10.1016/0304-4165(81)90239-7; PARKER BA, 1979, J VIROL, V31, P360, DOI 10.1128/JVI.31.2.360-369.1979; PEREIRA ME, 1987, J BIOL CHEM, V262, P6093; PEREIRA ME, 1988, J BIOL CHEM, V263, P9761; SEGALOFF DL, 1981, J BIOL CHEM, V256, P1420; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P8197, DOI 10.1073/pnas.86.21.8197; SWINNEN JV, 1989, P NATL ACAD SCI USA, V86, P5325, DOI 10.1073/pnas.86.14.5325; Thompson W J, 1979, Adv Cyclic Nucleotide Res, V10, P69; WANG H, 1991, J BIOL CHEM, V266, P780; WANG HY, 1990, MOL ENDOCRINOL, V4, P80, DOI 10.1210/mend-4-1-80	40	57	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14383	14389						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713581				2022-12-27	WOS:A1991FZ35100044
J	CAILLAUD, C; LYONNET, S; REY, F; MELLE, D; FREBOURG, T; BERTHELON, M; VILARINHO, L; OSORIO, RV; REY, J; MUNNICH, A				CAILLAUD, C; LYONNET, S; REY, F; MELLE, D; FREBOURG, T; BERTHELON, M; VILARINHO, L; OSORIO, RV; REY, J; MUNNICH, A			A 3-BASE PAIR IN-FRAME DELETION OF THE PHENYLALANINE-HYDROXYLASE GENE RESULTS IN A KINETIC VARIANT OF PHENYLKETONURIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							MOLECULAR-GENETICS; COMPLEMENTARY-DNA; DEFICIENCY ALLELE; BETA-GLOBIN; MUTATION; HYPERPHENYLALANINEMIA; ALPHA-1-ANTITRYPSIN; TRANSCRIPTS; HAPLOTYPE-2; MMALTON	Phenylketonuria (PKU) is an autosomal recessive disease due to deficiency of a hepatic enzyme, phenylalanine hydroxylase (PAH). The absence of PAH activity results in typical PKU while persistence of a residual enzyme activity gives rise to variant forms of the disease. We report here a 3-base pair in-frame deletion of the PAH gene (DELTA-I94) in a mild variant, with markedly reduced affinity of the enzyme for phenylalanine (K(m) = 160 nM), and we provide functional evidence for responsibility of the deletion in the mutant phenotype. Since the deletion was located in third exon of the gene, which presents no homology with other hydroxylases, we suggest that exon 3 is involved in the specificity of the enzyme for phenylalanine. Finally, since none of the 98 PKU patients tested were found to carry this particular deletion, our study suggests that this molecular event probably occurred recently on the background of a haplotype 2 gene in Portugal.	HOP NECKER ENFANTS MALAD,UNITE RECH HANDICAPS GENET ENFANT,INSERM,U12,149 RUE SEVRES,F-75743 PARIS 15,FRANCE; INST GENET MED JACINTO MAGALHAES,P-4000 OPORTO,PORTUGAL	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Lyonnet, Stanislas/H-5483-2017; Frebourg, Thierry/AAK-8390-2020	Lyonnet, Stanislas/0000-0001-5426-9417; Vilarinho, Laura/0000-0001-6186-779X				ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; ADAMS JG, 1981, P NATL ACAD SCI-BIOL, V78, P469, DOI 10.1073/pnas.78.1.469; AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; BARTHOLOME K, 1975, PEDIATR RES, V9, P899, DOI 10.1203/00006450-197509120-00006; CASEY R, 1976, BRIT J HAEMATOL, V33, P143; CHAKRABORTY R, 1987, HUM GENET, V76, P40; CURIEL DT, 1989, J BIOL CHEM, V264, P13938; DAVIDSON BL, 1989, J CLIN INVEST, V84, P342, DOI 10.1172/JCI114160; DEJONG WWW, 1968, NATURE, V220, P788, DOI 10.1038/220788a0; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; EFSTRATIADIS A, 1980, CELL, V21, P653, DOI 10.1016/0092-8674(80)90429-8; FISHER DB, 1973, J BIOL CHEM, V248, P4345; FRAIZER GC, 1989, AM J HUM GENET, V44, P894; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRIFFIN RF, 1975, J PEDIATR-US, V86, P512, DOI 10.1016/S0022-3476(75)80139-9; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; JOHN SWM, 1989, AM J HUM GENET, V45, P905; JOHNSON CS, 1981, BLOOD S1, V58; JONES RT, 1966, SCIENCE, V154, P1024, DOI 10.1126/science.154.3752.1024; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; LEDLEY FD, 1985, BIOCHEMISTRY-US, V24, P3389, DOI 10.1021/bi00335a001; LENKE RR, 1980, NEW ENGL J MED, V303, P1202, DOI 10.1056/NEJM198011203032104; LEVY HL, 1989, AM J HUM GENET, V45, P667; LUTCHER CL, 1976, BLOOD, V47, P99; LYONNET S, 1988, LANCET, V2, P507; LYONNET S, 1989, AM J HUM GENET, V44, P511; MOOPENN WF, 1975, BIOCHEM BIOPH RES CO, V85, P8; MUNNICH A, 1982, PEDIATR RES, V16, P335, DOI 10.1203/00006450-198205000-00001; NAKAMAYE KL, 1986, NUCLEIC ACIDS RES, V14, P9679, DOI 10.1093/nar/14.24.9679; REY F, 1988, AM J HUM GENET, V43, P914; RIORDAN JR, 1989, SCIENCE, V245, P1066; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; WAJCMAN H, 1973, BIOCHIM BIOPHYS ACTA, V295, P495, DOI 10.1016/0005-2795(73)90045-7; WATSON CJ, 1985, DNA CLONING PRACTICA, V1, P79	34	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 25	1991	266	15					9351	9354						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM459	1709636				2022-12-27	WOS:A1991FM45900004
J	LU, HS; CLOGSTON, CL; WYPYCH, J; FAUSSET, PR; LAUREN, S; MENDIAZ, EA; ZSEBO, KM; LANGLEY, KE				LU, HS; CLOGSTON, CL; WYPYCH, J; FAUSSET, PR; LAUREN, S; MENDIAZ, EA; ZSEBO, KM; LANGLEY, KE			AMINO-ACID-SEQUENCE AND POSTTRANSLATIONAL MODIFICATION OF STEM-CELL FACTOR ISOLATED FROM BUFFALO RAT-LIVER CELL-CONDITIONED MEDIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; COLONY-STIMULATING FACTORS; PROTO-ONCOGENE; W-LOCUS	Stem cell factor (SCF) isolated from culture medium conditioned by Buffalo rat liver cells was subjected to detailed structural analysis. Attempts at direct N-terminal sequencing of the factor indicated that its N terminus is blocked as pyroglutamic acid (Zsebo, K. M., Wypych, J., McNiece, I. K., Lu, H. S., Smith, K. A., Karkare, S. B., Sachdev, R. K., Yuschenkoff, V. N., Birkett, N. C., Williams, L. R., Satyagal, V. N., Bosselman, R. A., Mendiaz, E. A., and Langley, K. E. (1990) Cell 63, 195-201). The removal of the blocking pyroglutamate by pyroglutamate aminopeptidase allowed sequencing of the polypeptide chain to position 47. Stem cell factor was also digested with CNBr, trypsin, Staphylococcus aureus protease (strain V8), and AspN peptidase to generate different sets of peptides that were then separated by reverse-phase high-performance liquid chromatography and sequenced. Sequence of an internal peptide fragment obtained by cleavage of stem cell factor at a single tryptophanyl peptide bond was also obtained. From these analyses, the complete amino acid sequence could be constructed. The factor as isolated is a single polypeptide of 164 or 165 amino acids. The sequence is confirmatory to a sequence deduced from a cDNA sequence and provides important evidence for C-terminal processing of the polypeptide encoded by cDNA. There are four potential N-linked glycosylation sites, Asn65, Asn72, Asn109, and Asn120. Sequence determination of isolated peptides suggested that Asn120 is glycosylated, Asn65 and Asn109 glycosylated in some molecules but not in others, and Asn72 not glycosylated. Amino acids at three positions, i.e. 142, 143, and 155, could not be detected during sequence analysis. Since the gene sequence codes for Ser, Thr, and Thr at these positions (Martin, F. H., Suggs, S. V., Langley, K. E., Lu, H. S., Ting, J., Okino, K. H., Morris, C. F., McNiece, I. K., Jacobsen, F. W., Mendiaz, E. A., Birkett, N. C., Smith, K. C., Johnson, M. J., Parker, V. P., Flores, J. C., Patel, A. C., Fisher, E. F., Erjavec, H. O., Herrera, C. J., Wypych, J., Sachdev, R. K., Pope, J. A., Leslie, I., Wen, D., Lin, C. W., Cupples, R. L., and Zsebo, K. M. (1990) Cell 63, 203-211), they could be sites of O-linked carbohydrate attachment. The four cysteines form two intramolecular disulfide bonds, Cys4-Cys89 and Cys43-Cys138.			LU, HS (corresponding author), AMGEN INC,AMGEN CTR,THOUSAND OAKS,CA 91320, USA.							ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHANG JY, 1989, TECHNIQUES PROTEIN C, P305; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; Fontana A, 1972, Methods Enzymol, V25, P419, DOI 10.1016/S0076-6879(72)25037-6; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUNKAPILLER MW, 1986, MICROCHARACTERIZATIO, P223; JOHNSON GP, 1986, ANAL CHEM, V58, P1084; KISHIMOTO T, 1988, ANNU REV IMMUNOL, V6, P485, DOI 10.1146/annurev.iy.06.040188.002413; KISHIMOTO T, 1985, ANNU REV IMMUNOL, V3, P133, DOI 10.1146/annurev.iy.03.040185.001025; KNECHT R, 1986, ANAL CHEM, V58, P2375, DOI 10.1021/ac00125a006; LU HS, 1986, J CHROMATOGR, V368, P215, DOI 10.1016/S0021-9673(00)91065-3; LU HS, 1988, J CHROMATOGR, V447, P351; MARTIN FH, 1990, CELL, V63, P203, DOI 10.1016/0092-8674(90)90301-T; METCALF D, 1985, SCIENCE, V229, P16, DOI 10.1126/science.2990035; METCALF D, 1984, HEMOPOIETIC COLONIES; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; PODELL DN, 1978, BIOCHEM BIOPH RES CO, V81, P176, DOI 10.1016/0006-291X(78)91646-7; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	23	76	82	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8102	8107						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1708771				2022-12-27	WOS:A1991FK44100026
J	BARBOSA, P; CIALKOWSKI, M; OBRIEN, WE				BARBOSA, P; CIALKOWSKI, M; OBRIEN, WE			ANALYSIS OF NATURALLY-OCCURRING AND SITE-DIRECTED MUTATIONS IN THE ARGININOSUCCINATE LYASE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-CRYSTALLIN; SEQUENCE; ACID; CDNA; EXPRESSION; DEFICIENCY; CLONING; ENZYME; LIVER	Argininosuccinic aciduria is an inborn error of metabolism due to the genetic deficiency of argininosuccinate lyase. In order to determine the molecular basis for the disease, RNA isolated from cultured skin fibroblasts derived from four unrelated patients was reverse-transcribed and amplified using the polymerase chain reaction and the products were cloned and sequenced. Three single base missense mutations were identified: Arg111 --> Trp, Gln286 --> Arg, and Arg193 --> Gln. One single base amber mutation was identified at Gln454. One mutation involved a 13-base pair deletion within exon 13, and it was noted that the majority of the mature RNA derived from this allele was deleted for the entire exon rather than containing the exon with the 13 bases deleted. A final mutation was observed in which exon 2 was deleted from the mature RNA. The molecular basis for this deletion was not determined. Of the eight potential mutations present in the four cell lines studied, six mutations were identified and further data indicate that the remaining two unidentified mutations were different from those identified. Two site-directed mutations were created in the cDNA, Lys51 --> Asn and His89 --> Gln, and these were expressed in yeast. The Lys51 mutation caused an approximate 2-fold reduction in activity and the His89 mutation resulted in an approximate 10-fold reduction in activity. The combination of determination of naturally occurring mutations and the study of the effect of site-directed mutations on the activity of argininosuccinate lyase provide insight into the amino acid residues critical to the function of the enzyme.	BAYLOR UNIV,INST MOLEC GENET,1 BAYLOR PLAZA,HOUSTON,TX 77030; BAYLOR UNIV,DEPT BIOCHEM,HOUSTON,TX 77030; BAYLOR UNIV,HOWARD HUGHES MED INST,HOUSTON,TX 77030	Baylor College of Medicine; Baylor University; Baylor University; Baylor University; Howard Hughes Medical Institute					NATIONAL EYE INSTITUTE [R55EY007612, R01EY007612] Funding Source: NIH RePORTER; NEI NIH HHS [EY07612] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AUSUBEL FM, 1990, CURRENT PROTOCOLS MO; BEACHAM IR, 1984, GENE, V29, P271, DOI 10.1016/0378-1119(84)90056-8; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BRAY RC, 1971, ARCH BIOCHEM BIOPHYS, V146, P531, DOI 10.1016/0003-9861(71)90158-5; Brusilow S.W., 1989, METABOLIC BASIS INHE, P629; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DALES S, 1971, BIOCHIM BIOPHYS ACTA, V229, P771, DOI 10.1016/0005-2795(71)90295-9; GARRARD LJ, 1985, J BIOL CHEM, V260, P5548; HAVIR EA, 1965, J BIOL CHEM, V240, P3079; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KOBAYASHI K, 1990, J BIOL CHEM, V265, P11361; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAMBERT MA, 1986, MOL CELL BIOL, V6, P1722, DOI 10.1128/MCB.6.5.1722; LUSTY CJ, 1987, P NATL ACAD SCI USA, V84, P3176, DOI 10.1073/pnas.84.10.3176; MATSUBASA T, 1989, P NATL ACAD SCI USA, V86, P592, DOI 10.1073/pnas.86.2.592; MATUO S, 1988, FEBS LETT, V234, P395, DOI 10.1016/0014-5793(88)80124-8; MCINNES RR, 1984, P NATL ACAD SCI-BIOL, V81, P4480, DOI 10.1073/pnas.81.14.4480; MURAKAMIMUROFUSHI K, 1979, ANAL BIOCHEM, V95, P139, DOI 10.1016/0003-2697(79)90197-0; NICKERSON JM, 1986, J BIOL CHEM, V261, P552; NICKERSON JM, 1984, P NATL ACAD SCI-BIOL, V81, P2611, DOI 10.1073/pnas.81.9.2611; OBRIEN WE, 1981, BIOCHEMISTRY-US, V20, P2056, DOI 10.1021/bi00510a049; OBRIEN WE, 1986, P NATL ACAD SCI USA, V83, P7211, DOI 10.1073/pnas.83.19.7211; PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479; PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2; RATNER S, 1973, ADV ENZYMOL RAMB, V39, P1; Ratner S, 1972, ENZYMES, P167; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIMARD L, 1986, AM J HUM GENET, V39, P38; TODD S, 1989, GENOMICS, V4, P53, DOI 10.1016/0888-7543(89)90314-5; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; WALKER D C, 1989, American Journal of Human Genetics, V45, pA227; Walker DC, 1990, AM J HUM GENET, V47, pA169; WISTOW G, 1991, IN PRESS GENE AMST	36	42	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					5286	5290						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1705937				2022-12-27	WOS:A1991FC21700088
J	CLAVERIEMARTIN, F; DIAZTORRES, MR; YANCEY, SD; KUSHNER, SR				CLAVERIEMARTIN, F; DIAZTORRES, MR; YANCEY, SD; KUSHNER, SR			ANALYSIS OF THE ALTERED MESSENGER-RNA STABILITY (AMS) GENE FROM ESCHERICHIA-COLI - NUCLEOTIDE-SEQUENCE, TRANSCRIPTIONAL ANALYSIS, AND HOMOLOGY OF ITS PRODUCT TO MRP3, A MITOCHONDRIAL RIBOSOMAL-PROTEIN FROM NEUROSPORA-CRASSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYNUCLEOTIDE PHOSPHORYLASE; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE GELS; BETA-GALACTOSIDASE; RIBONUCLEASE-II; PLASMID VECTORS; K-12; EXPRESSION; CLONING; DECAY	The product of the altered mRNA stability (ams) gene of Escherichia coli is involved in decay of mRNA. The complete nucleotide sequence of a 4-kilobase BamHI restriction fragment containing the ams coding sequence was determined. Transcription of the ams gene was analyzed by high resolution S1 mapping. A promoter was found with a homology score of 58% 361 nucleotides upstream from the start codon of ams. The ams structural gene consists of an open reading frame of 2,445 nucleotides. The protein predicted from this open reading frame has a molecular mass of 91,327 Da, which is significantly smaller than that determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis. Confirmation of the ams coding sequence was obtained by comparing the predicted amino acid sequence with that derived by amino-terminal analysis of gel-purified Ams protein. The predicted protein sequence of the ams gene was screened against translations of the GenBank DNA sequence data base. A homology of 18% over a region of 315 amino acids of the carboxyl terminus of the Ams product was found to MRP3, a mitochondrial ribosomal protein from Neurospora crassa. A smaller region of homology (29% in 86 residues) was found to the human U1 small nuclear ribonucleoparticle 70,000-Da protein.	MIT,DEPT BIOL,CAMBRIDGE,MA 02139; TUFTS UNIV,DEPT MOLEC BIOL & MICROBIOL,BOSTON,MA 02111; UNIV GEORGIA,DEPT GENET,ATHENS,GA 30602	Massachusetts Institute of Technology (MIT); Tufts University; University System of Georgia; University of Georgia			Kushner, Sidney R/B-1128-2015	Kushner, Sidney R/0000-0001-6961-6530; Claverie-Martin, Felix/0000-0003-2468-3267	NIGMS NIH HHS [GM28760] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028760] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARRAIANO CM, 1988, J BACTERIOL, V170, P4625, DOI 10.1128/jb.170.10.4625-4633.1988; BAGA M, 1988, CELL, V52, P197, DOI 10.1016/0092-8674(88)90508-9; BARDWELL JCA, 1989, EMBO J, V8, P3401, DOI 10.1002/j.1460-2075.1989.tb08504.x; BELASCO JG, 1988, GENE, V72, P15, DOI 10.1016/0378-1119(88)90123-0; BONI IV, 1982, EUR J BIOCHEM, V121, P371, DOI 10.1111/j.1432-1033.1982.tb05796.x; BORST P, 1971, FEBS LETT, V13, P73, DOI 10.1016/0014-5793(71)80204-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; BURTON Z, 1981, NUCLEIC ACIDS RES, V9, P2889, DOI 10.1093/nar/9.12.2889; CANNISTRARO VJ, 1986, J MOL BIOL, V192, P257, DOI 10.1016/0022-2836(86)90363-3; CLAVERIEMARTIN F, 1989, J BACTERIOL, V171, P5479, DOI 10.1128/jb.171.10.5479-5486.1989; CLOSE TJ, 1982, GENE, V20, P305, DOI 10.1016/0378-1119(82)90048-8; DAYHOFF MO, 1978, ATLAS PROTEIN SEQ S3, V5, P363; DEUTSCHER MP, 1985, CELL, V40, P731, DOI 10.1016/0092-8674(85)90330-7; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONOVAN WP, 1983, NUCLEIC ACIDS RES, V11, P265, DOI 10.1093/nar/11.2.265; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; DUNN JJ, 1973, P NATL ACAD SCI USA, V70, P3296, DOI 10.1073/pnas.70.12.3296; ERICKSON PF, 1982, J IMMUNOL METHODS, V51, P241, DOI 10.1016/0022-1759(82)90263-0; FEINBERG AP, 1983, ANAL BIOCHEM, V124, P396; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GERSHONI JM, 1982, ANAL BIOCHEM, V124, P396, DOI 10.1016/0003-2697(82)90056-2; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; GRACEFFA P, 1988, J BIOL CHEM, V263, P14196; HALLING SM, 1982, P NATL ACAD SCI-BIOL, V79, P2608, DOI 10.1073/pnas.79.8.2608; HALLING SM, 1982, CELL, V28, P155, DOI 10.1016/0092-8674(82)90385-3; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HOLMES DS, 1981, ANAL BIOCHEM, V114, P193, DOI 10.1016/0003-2697(81)90473-5; ISHII S, 1984, NUCLEIC ACIDS RES, V12, P333; KING TC, 1987, CELLULAR MOL BIOL, V1, P705; KINSCHERF TG, 1975, MOL GEN GENET, V139, P357, DOI 10.1007/BF00267975; KOZAK M, 1983, MICROBIOL REV, V47, P1; KREADER CA, 1989, J BIOL CHEM, V264, P317; KUWANO M, 1977, MOL GEN GENET, V154, P279, DOI 10.1007/BF00571283; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MELEFORS O, 1988, CELL, V52, P893, DOI 10.1016/0092-8674(88)90431-X; MERRICK MJ, 1985, NUCLEIC ACIDS RES, V13, P7607, DOI 10.1093/nar/13.21.7607; Miller J. H., 1972, EXPT MOL GENETICS, P433; MUDD EA, 1988, EMBO J, V7, P3601, DOI 10.1002/j.1460-2075.1988.tb03238.x; MULLIGAN ME, 1984, NUCLEIC ACIDS RES, V12, P789, DOI 10.1093/nar/12.1Part2.789; NILSSON G, 1988, EMBO J, V7, P2269, DOI 10.1002/j.1460-2075.1988.tb03067.x; ONO M, 1979, J MOL BIOL, V129, P343, DOI 10.1016/0022-2836(79)90500-X; ONO M, 1980, J BACTERIOL, V142, P325, DOI 10.1128/JB.142.1.325-326.1980; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PORTIER C, 1987, EMBO J, V6, P2165, DOI 10.1002/j.1460-2075.1987.tb02484.x; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; REGNIER P, 1986, J MOL BIOL, V187, P23, DOI 10.1016/0022-2836(86)90403-1; REGNIER P, 1989, J MOL BIOL, V210, P293, DOI 10.1016/0022-2836(89)90331-8; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAPIRA SK, 1983, GENE, V25, P71, DOI 10.1016/0378-1119(83)90169-5; Shaw W V, 1975, Methods Enzymol, V43, P737; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; STEITZ JA, 1980, RIBOSOMES STRUCTURE, P479; STOKER NG, 1982, GENE, V18, P335, DOI 10.1016/0378-1119(82)90172-X; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2971, DOI 10.1093/nar/10.9.2971; TAKANO E, 1988, BIOCHEMISTRY-US, V27, P1964, DOI 10.1021/bi00406a024; THEISSEN H, 1986, EMBO J, V5, P3209, DOI 10.1002/j.1460-2075.1986.tb04631.x; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WALLACE BJ, 1984, GENE, V32, P399, DOI 10.1016/0378-1119(84)90015-5; WILLIAMS MG, 1987, J BACTERIOL, V169, P1644, DOI 10.1128/jb.169.4.1644-1650.1987; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	66	59	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2843	2851						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704367				2022-12-27	WOS:A1991EX60000030
J	IHARA, H; NAKANISHI, S				IHARA, H; NAKANISHI, S			SELECTIVE-INHIBITION OF EXPRESSION OF THE SUBSTANCE-P RECEPTOR MESSENGER-RNA IN PANCREATIC ACINAR AR42J CELLS BY GLUCOCORTICOIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; MOLECULAR CHARACTERIZATION; GENE-EXPRESSION; K RECEPTOR; TRANSCRIPTION; SEQUENCES; MECHANISM; INCREASE; REGION; CDNA	The effect of glucocorticoids on the regulation of the substance P receptor (SPR) mRNA was studied in rat pancreatic acinar AR42J cells by Northern blot analysis with the cloned cDNA. After a lag period of about 1 h, dexamethasone rapidly decreased steady-state SPR mRNA to almost negligible levels by 2 h. This decrease occurred in a dose-dependent manner by dexamethasone and was caused by various steroids in accordance with their relative potencies as glucocorticoids. These results indicate that the expression of the SPR mRNA is selectively and negatively regulated by glucocorticoids through interaction with the glucocorticoid receptor. The mechanism of reduction of SPR mRNA levels were studied by treatment of AR42J cells with actinomycin D or cycloheximide. The SPR mRNA half-life was approximately 30 min, and this rate remained unchanged by dexamethasone treatment. Furthermore, the rapid turnover of the SPR mRNA required ongoing protein synthesis. On the basis of the result of actinomycin D treatment, together with kinetics of dexamethasone-induced changes in SPR mRNA levels, we discuss the mechanism in which glucocorticoids act at transcription initiation to reduce SPR mRNA levels.			IHARA, H (corresponding author), KYOTO UNIV, FAC MED, INST IMMUNOL, KYOTO 606, JAPAN.							BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BURNSTEIN KL, 1989, ANNU REV PHYSIOL, V51, P683, DOI 10.1146/annurev.ph.51.030189.003343; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CLAMAN HN, 1987, HORMONES IMMUNITY, P38; Cleveland DW, 1989, CURR OPIN CELL BIOL, V1, P1148, DOI 10.1016/S0955-0674(89)80065-1; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HERSHEY AD, 1990, SCIENCE, V247, P958, DOI 10.1126/science.2154852; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; KURIBAYASHI K, 1988, NUCLEIC ACIDS RES S, V19, P61; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; LOGSDON CD, 1985, J CELL BIOL, V100, P1200, DOI 10.1083/jcb.100.4.1200; LOGSDON CD, 1987, J BIOL CHEM, V262, P15765; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MIYAKOSHI J, 1990, CANCER RES, V50, P278; NAKAJIMAIIJIMA S, 1985, P NATL ACAD SCI USA, V82, P6133, DOI 10.1073/pnas.82.18.6133; NAKAMURA Y, 1984, GENE, V28, P263, DOI 10.1016/0378-1119(84)90265-8; Nakanishi S, 1990, Recent Prog Horm Res, V46, P59; NAKANISHI S, 1987, PHYSIOL REV, V67, P1117, DOI 10.1152/physrev.1987.67.4.1117; OTSUKA M, 1975, COLD SPRING HARB SYM, V40, P135; PADGETT RA, 1986, ANNU REV BIOCHEM, V55, P1119, DOI 10.1146/annurev.bi.55.070186.005351; PAYAN DG, 1989, ANNU REV MED, V40, P341; PERNOW B, 1983, PHARMACOL REV, V35, P85; RAGHOW R, 1987, TRENDS BIOCHEM SCI, V12, P358, DOI 10.1016/0968-0004(87)90165-4; RORIES C, 1989, ANNU REV PHYSIOL, V51, P653, DOI 10.1146/annurev.physiol.51.1.653; ROSEWICZ S, 1988, J BIOL CHEM, V263, P2581; SASAI Y, 1989, BIOCHEM BIOPH RES CO, V165, P695, DOI 10.1016/S0006-291X(89)80022-1; SEHGAL PB, 1976, SCIENCE, V194, P431, DOI 10.1126/science.982026; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHIGEMOTO R, 1990, J BIOL CHEM, V265, P623; WOMACK MD, 1985, J NEUROSCI, V5, P3370; YOKOTA Y, 1989, J BIOL CHEM, V264, P17649	32	90	90	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	1990	265	36					22441	22445						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP556	1702421				2022-12-27	WOS:A1990EP55600060
J	VOYIATZAKI, CS; SOTERIADOU, KP				VOYIATZAKI, CS; SOTERIADOU, KP			EVIDENCE OF TRANSFERRIN BINDING-SITES ON THE SURFACE OF LEISHMANIA PROMASTIGOTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; CUTANEOUS LEISHMANIASIS; TRYPANOSOMA-CRUZI; RECEPTOR; ANTIGENS; IRON; IDENTIFICATION; PROTEINS; MEMBRANE; GLYCOPROTEIN	A glycoprotein of 78,000 molecular mass (78 kDa), associated with the membrane of Leishmania infantum promastigotes, was identified and immunopurified by monoclonal antibody (mAb) LD9 produced against isolated membrane preparations. mAb LD9 was subsequently found to bind to human transferrin, also of 78 kDa. Binding of LD9 to transferrin was completely abolished when the mAb was preabsorbed by Leishmania membranes, thereby indicating that the 78-kDa Leishmania membrane-associated glycoprotein and transferrin have common antigenic epitope(s). The 78-kDa Leishmania membrane-associated protein was released in soluble nonaggregated form by mild treatment with acetic acid saline. Anti-transferrin polyclonal antibodies, recognized both the membrane-associated and the soluble form of the 78-kDa glycoprotein. The 78-kDa soluble form was characterized further as an iron-containing protein. The above data combined with iron uptake by promastigotes as demonstrated by the Prussian blue reaction indicate that the 78-kDa Leishmania membrane-associated glycoprotein is transferrin. The binding of I-125-human transferrin to Leishmania-purified membrane preparations was then investigated. The results indicate the presence of a high affinity saturable binding site (K(d) = 2.2 10(-8) M) that is specific for transferrin. We suggest that the 78-kDa glycoprotein recognized by mAb LD9 is transferrin that binds to the surface of Leishmania promastigotes via a transferrin receptor.	HELLEN INST PASTEUR,BIOCHEM LAB,127 VASSILISSIS SOFIAS AVE,GR-11521 ATHENS,GREECE									AISEN P, 1977, BIOINORG CHEM, V2, P104; BORDIER C, 1987, PARASITOL TODAY, V3, P151, DOI 10.1016/0169-4758(87)90199-2; BOTHWELL TH, 1979, IRON METABOLISM MAN, P284; CHANG CS, 1986, P NATL ACAD SCI USA, V83, P100, DOI 10.1073/pnas.83.1.100; COLOMERGOULD V, 1985, J EXP MED, V162, P902, DOI 10.1084/jem.162.3.902; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; DEIBARRA AAL, 1982, PARASITOLOGY, V85, P523, DOI 10.1017/S0031182000056304; DELIA D, 1982, INT J CANCER, V29, P23, DOI 10.1002/ijc.2910290106; DWYER DM, 1990, J PROTOZOOL, V27, P176; GEE NS, 1985, BIOCHEM J, V228, P119, DOI 10.1042/bj2280119; GLOSSMANN H, 1971, J BIOL CHEM, V246, P6339; GREENBLATT CL, 1983, J CLIN MICROBIOL, V18, P191, DOI 10.1128/JCM.18.1.191-193.1983; HAMILTON TA, 1979, P NATL ACAD SCI USA, V76, P6406, DOI 10.1073/pnas.76.12.6406; HAMILTON TA, 1984, J IMMUNOL, V132, P2285; HANDMAN E, 1985, EMBO J, V4, P329, DOI 10.1002/j.1460-2075.1985.tb03633.x; HANDMAN E, 1982, INFECT IMMUN, V37, P28, DOI 10.1128/IAI.37.1.28-33.1982; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; JAFFE CL, 1983, J IMMUNOL, V131, P1987; JAFFE CL, 1984, J IMMUNOL, V133, P440; JAFFE CL, 1988, J IMMUNOL, V139, P1310; KUO CF, 1988, ANAL BIOCHEM, V170, P183, DOI 10.1016/0003-2697(88)90106-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LALONDE RG, 1984, J CLIN INVEST, V73, P470, DOI 10.1172/JCI111233; LARRICK JW, 1979, BIOCHIM BIOPHYS ACTA, V583, P483, DOI 10.1016/0304-4165(79)90065-5; LEPAY DA, 1983, J EXP MED, V157, P1562, DOI 10.1084/jem.157.5.1562; LIMA MF, 1990, MOL BIOCHEM PARASIT, V38, P245, DOI 10.1016/0166-6851(90)90027-J; LOO VG, 1984, INFECT IMMUN, V45, P726, DOI 10.1128/IAI.45.3.726-730.1984; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCONVILLE MJ, 1987, P NATL ACAD SCI USA, V84, P8941, DOI 10.1073/pnas.84.24.8941; MEHDI SQ, 1985, BIOCHEM J, V145, P105; NEWMAN R, 1982, TRENDS BIOCHEM SCI, V7, P397, DOI 10.1016/0968-0004(82)90184-0; OCTAVE JN, 1979, FEBS LETT, V108, P127, DOI 10.1016/0014-5793(79)81193-X; PATSAVOUDI E, 1989, NEUROSCIENCE, V30, P463, DOI 10.1016/0306-4522(89)90266-2; REDHEAD K, 1987, J GEN MICROBIOL, V133, P891; RODRIGUEZ MH, 1986, NATURE, V324, P388, DOI 10.1038/324388a0; RUSSELL DG, 1988, J IMMUNOL, V140, P1274; RUSSELL DG, 1987, EUR J BIOCHEM, V164, P213, DOI 10.1111/j.1432-1033.1987.tb11013.x; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SCHRYVERS AB, 1989, J MED MICROBIOL, V29, P121, DOI 10.1099/00222615-29-2-121; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P281, DOI 10.1111/j.1365-2958.1988.tb00029.x; SELIGMAN PA, 1979, J BIOL CHEM, V254, P9943; SOTERIADOU KP, 1988, INFECT IMMUN, V56, P1180, DOI 10.1128/IAI.56.5.1180-1186.1988; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TZARTOS SJ, 1984, TRENDS BIOCHEM SCI, V9, P63, DOI 10.1016/0968-0004(84)90185-3	44	27	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 25	1990	265	36					22380	22385						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EP556	1702420				2022-12-27	WOS:A1990EP55600052
J	ALTMAN, S				ALTMAN, S			RIBONUCLEASE-P - POSTSCRIPT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review											ALTMAN, S (corresponding author), YALE UNIV, DEPT BIOL, NEW HAVEN, CT 06520 USA.				NIGMS NIH HHS [GM 19422] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM019422, R37GM019422] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; ALTMAN S, 1986, BIOCHEMISTRY-US, V25, P1205, DOI 10.1021/bi00354a002; BAER M, 1989, NUCLEIC ACIDS MOL BI, P231; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; BROWN RS, 1985, BIOCHEMISTRY-US, V24, P4785, DOI 10.1021/bi00339a012; CARRARA G, 1989, CELL, V58, P37, DOI 10.1016/0092-8674(89)90400-5; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; FRANCKLYN C, 1989, NATURE, V337, P478, DOI 10.1038/337478a0; GOLD H, 1988, THESIS YALE U; GOLD HA, 1986, CELL, V44, P243, DOI 10.1016/0092-8674(86)90758-0; GREEN CJ, 1989, MOL BIOL RNA, P89; GUERRIERTAKADA C, 1988, CELL, V53, P267, DOI 10.1016/0092-8674(88)90388-1; GUERRIERTAKADA C, 1986, BIOCHEMISTRY-US, V25, P1509, DOI 10.1021/bi00355a006; GUERRIERTAKADA C, 1989, SCIENCE, V246, P1578, DOI 10.1126/science.2480641; GUERRIERTAKADA C, 1984, CELL, V38, P219, DOI 10.1016/0092-8674(84)90543-9; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; JAMES BD, 1988, CELL, V52, P19, DOI 10.1016/0092-8674(88)90527-2; KIRSEBOM LA, 1989, J MOL BIOL, V207, P837, DOI 10.1016/0022-2836(89)90250-7; LAWRENCE N, 1987, COLD SPRING HARB SYM, V52, P233, DOI 10.1101/SQB.1987.052.01.028; LAWRENCE NP, 1987, P NATL ACAD SCI USA, V84, P6825, DOI 10.1073/pnas.84.19.6825; LEE JY, 1989, MOL CELL BIOL, V9, P2536, DOI 10.1128/MCB.9.6.2536; LUMELSKY N, 1988, J MOL BIOL, V202, P443, DOI 10.1016/0022-2836(88)90277-X; MCCLAIN WH, 1988, SCIENCE, V242, P1681, DOI 10.1126/science.2462282; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; MILLER DL, 1983, CELL, V34, P911, DOI 10.1016/0092-8674(83)90548-2; MORALES MJ, 1989, NUCLEIC ACIDS RES, V17, P6865, DOI 10.1093/nar/17.17.6865; PACE NR, 1987, COLD SPRING HARB SYM, V52, P239, DOI 10.1101/SQB.1987.052.01.029; PACE NR, 1990, J BIOL CHEM, V265, P3587; PARK SJ, 1989, BIOCHEMISTRY-US, V28, P2740, DOI 10.1021/bi00432a056; PECK K, 1990, THESIS YALE U; REICH C, 1988, SCIENCE, V239, P178, DOI 10.1126/science.3122322; RICHARDS FM, 1971, ENZYMES, V4, P647; VIOQUE A, 1986, P NATL ACAD SCI USA, V83, P5904, DOI 10.1073/pnas.83.16.5904; VOLD BS, 1988, J BIOL CHEM, V263, P14390; WAUGH DS, 1989, SCIENCE, V244, P1569, DOI 10.1126/science.2472671; WOESE C, 1967, ORIGINS GENETIC CODE	37	55	59	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20053	20056						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700778				2022-12-27	WOS:A1990EJ52500001
J	IWAKI, K; SUKHATME, VP; SHUBEITA, HE; CHIEN, KR				IWAKI, K; SUKHATME, VP; SHUBEITA, HE; CHIEN, KR			ALPHA-ADRENERGIC AND BETA-ADRENERGIC STIMULATION INDUCES DISTINCT PATTERNS OF IMMEDIATE EARLY GENE-EXPRESSION IN NEONATAL RAT MYOCARDIAL-CELLS - FOS JUN EXPRESSION IS ASSOCIATED WITH SARCOMERE ASSEMBLY - EGR-1 INDUCTION IS PRIMARILY AN ALPHA-1-MEDIATED RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV CALIF SAN DIEGO,SCH MED,DEPT MED,M-013C,LA JOLLA,CA 92093; UNIV CHICAGO,DEPT MED MOLEC GENET & CELL BIOL,CHICAGO,IL 60637; UNIV CHICAGO,HOWARD HUGHES MED INST,CHICAGO,IL 60637; UNIV CALIF SAN DIEGO,SCH MED,CTR MOLEC GENET,LA JOLLA,CA 92093	University of California System; University of California San Diego; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of California System; University of California San Diego			Sukhatme, Vikas/W-2776-2019					ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BISHOPRIC NH, 1987, J CLIN INVEST, V80, P1194, DOI 10.1172/JCI113179; BOYLE WJ, 1986, P NATL ACAD SCI USA, V83, P4685, DOI 10.1073/pnas.83.13.4685; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brostrom M A, 1970, Adv Enzyme Regul, V8, P191, DOI 10.1016/0065-2571(70)90017-8; BROWN J H, 1986, P245; CHAVRIER P, 1988, EMBO J, V7, P29, DOI 10.1002/j.1460-2075.1988.tb02780.x; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHRISTY BA, 1988, P NATL ACAD SCI USA, V85, P7857, DOI 10.1073/pnas.85.21.7857; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; COHEN DR, 1988, MOL CELL BIOL, V8, P2063, DOI 10.1128/MCB.8.5.2063; COHEN R, 1977, NATURE, V266, P538, DOI 10.1038/266538a0; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; COSSU G, 1982, DIFFERENTIATION, V21, P62, DOI 10.1111/j.1432-0436.1982.tb01197.x; CURRAN T, 1988, CELL, V55, P395, DOI 10.1016/0092-8674(88)90024-4; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANZA BR, 1987, ONCOGENE, V1, P213; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; HALAZONETIS TD, 1988, CELL, V55, P917, DOI 10.1016/0092-8674(88)90147-X; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HENDERSON SA, 1989, J BIOL CHEM, V264, P18142; HENDERSON SA, 1988, NUCLEIC ACIDS RES, V16, P4722, DOI 10.1093/nar/16.10.4722; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; JONES LR, 1986, PROTEIN PHOSPHORYLAT, P85; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; KATADA T, 1982, P NATL ACAD SCI-BIOL, V79, P3129, DOI 10.1073/pnas.79.10.3129; KNOWLTON KU, 1990, CLIN RES, V38, P776; KOMURO I, 1988, CIRC RES, V62, P1075, DOI 10.1161/01.RES.62.6.1075; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; LEE HR, 1988, J BIOL CHEM, V263, P7352; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LETTERIO JJ, 1986, SCIENCE, V234, P1117, DOI 10.1126/science.3465038; LIM RW, 1987, ONCOGENE, V1, P263; LIN ZX, 1987, J CELL BIOL, V105, P1365, DOI 10.1083/jcb.105.3.1365; LONG CS, 1989, J CLIN INVEST, V83, P1078, DOI 10.1172/JCI113951; MCMAHON AP, 1990, DEVELOPMENT, V108, P281; MEIDELL RS, 1986, AM J PHYSIOL, V251, P238; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; MULVAGH SL, 1987, BIOCHEM BIOPH RES CO, V147, P627, DOI 10.1016/0006-291X(87)90977-6; MURAYAMA T, 1987, J BIOL CHEM, V262, P12463; NAKABEPPU Y, 1988, CELL, V55, P777; NISHIKURA K, 1987, MOL CELL BIOL, V7, P639, DOI 10.1128/MCB.7.2.639; RANSNAS LA, 1988, J BIOL CHEM, V263, P17239; RAUSCHER FJ, 1988, GENE DEV, V2, P1687, DOI 10.1101/gad.2.12b.1687; RIABOWOL KT, 1988, MOL CELL BIOL, V8, P1670, DOI 10.1128/MCB.8.4.1670; RYDER K, 1988, P NATL ACAD SCI USA, V85, P1487, DOI 10.1073/pnas.85.5.1487; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SASSONECORSI P, 1988, NATURE, V336, P692, DOI 10.1038/336692a0; SCHONTHAL A, 1988, CELL, V54, P325, DOI 10.1016/0092-8674(88)90195-X; SEN A, 1988, J CLIN INVEST, V82, P1333, DOI 10.1172/JCI113735; SEN A, 1988, J BIOL CHEM, V263, P19132; SEUWEN K, 1988, NATURE, V335, P254, DOI 10.1038/335254a0; SILLS MN, 1989, J CLIN INVEST, V84, P331, DOI 10.1172/JCI114158; SIMPSON P, 1983, J CLIN INVEST, V72, P732, DOI 10.1172/JCI111023; STARKSEN NF, 1986, P NATL ACAD SCI USA, V83, P8348, DOI 10.1073/pnas.83.21.8348; STEINBERG SF, 1987, ENDOCRINOLOGY, V120, P1889, DOI 10.1210/endo-120-5-1889; STEINBERG SF, 1985, SCIENCE, V230, P186, DOI 10.1126/science.2994230; STULL JT, 1977, HDB PHYSL CARDIOVASC, V1, P741; SUKHATME VP, 1987, ONCOGENE RES, V1, P343; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Tsien R W, 1977, Adv Cyclic Nucleotide Res, V8, P363; Zar JH, 1974, BIOSTATISTICAL ANAL	68	470	486	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13809	13817						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696258				2022-12-27	WOS:A1990DU27500063
J	ZURAW, BL; LOTZ, M				ZURAW, BL; LOTZ, M			REGULATION OF THE HEPATIC SYNTHESIS OF C1 INHIBITOR BY THE HEPATOCYTE STIMULATING FACTORS INTERLEUKIN-6 AND INTERFERON-GAMMA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											ZURAW, BL (corresponding author), SCRIPPS CLIN & RES FDN, DEPT MOLEC & EXPTL MED, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.			Zuraw, Bruce/0000-0003-0640-6768	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL039773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR021175] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NHLBI NIH HHS [HL39773] Funding Source: Medline; NIAMS NIH HHS [AR21175] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; ASTRUP J, 1977, ACTA RADIOL THER PHY, V16, P394, DOI 10.3109/02841867709133960; BAUER J, 1989, J EXP MED, V170, P1537, DOI 10.1084/jem.170.5.1537; BAUMANN H, 1987, J IMMUNOL, V139, P4122; BAUMANN H, 1987, J BIOL CHEM, V262, P9756; BAUMANN H, 1986, J CELL BIOL, V102, P370, DOI 10.1083/jcb.102.2.370; BENSA JC, 1983, BIOCHEM J, V216, P385, DOI 10.1042/bj2160385; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CICARDI M, 1987, J CLIN INVEST, V79, P698, DOI 10.1172/JCI112873; DARLINGTON GJ, 1986, J CELL BIOL, V103, P787, DOI 10.1083/jcb.103.3.787; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; DONALDSON VH, 1966, J LAB CLIN MED, V68, P369; DOWTON SB, 1988, SEMIN HEMATOL, V25, P84; EDGE SB, 1986, J BIOL CHEM, V261, P3800; FEY GH, 1987, MOL BIOL MED, V4, P323; FORBES CD, 1970, J LAB CLIN MED, V76, P809; FULLER GM, 1987, BIOCHEM BIOPH RES CO, V144, P1003, DOI 10.1016/S0006-291X(87)80063-3; GARMAN RD, 1987, P NATL ACAD SCI USA, V84, P7629, DOI 10.1073/pnas.84.21.7629; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; GAULDIE J, 1987, IMMUNOLOGY, V60, P203; GIGLI I, 1970, J IMMUNOL, V104, P574; GIGLI I, 1968, J IMMUNOL, V100, P1154; GUERNE PA, 1989, J CLIN INVEST, V83, P585, DOI 10.1172/JCI113921; HAMILTON AO, 1987, BIOCHEM J, V242, P809, DOI 10.1042/bj2420809; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; JIRIK FR, 1989, J IMMUNOL, V142, P144; JOHNSON AM, 1971, SCIENCE, V173, P553, DOI 10.1126/science.173.3996.553; KATZ Y, 1988, ARTHRITIS RHEUM, V31, P1365, DOI 10.1002/art.1780311104; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; LAIWAH ACY, 1985, BIOCHEM J, V226, P199, DOI 10.1042/bj2260199; LANDERMAN NS, 1962, J ALLERGY, V33, P330, DOI 10.1016/0021-8707(62)90032-1; LE PT, 1986, J IMMUNOL, V136, P2526; LOTZ M, 1987, J IMMUNOL, V139, P3382; LOTZ M, 1989, ANN NY ACAD SCI, V557, P509; LOTZ M, 1988, J EXP MED, V167, P1253, DOI 10.1084/jem.167.3.1253; MACNAB GM, 1976, BRIT J CANCER, V34, P509, DOI 10.1038/bjc.1976.205; MAGIELSKAZERO D, 1988, BIOCHEM INT, V17, P17; MIURA N, 1987, J BIOL CHEM, V262, P7298; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; MULLEREBERHARD HJ, 1977, METHODS IMMUNOLOGY I, P127; NIJSTEN MWN, 1987, LANCET, V2, P921; OLIVIERO S, 1987, EMBO J, V6, P1905, DOI 10.1002/j.1460-2075.1987.tb02450.x; OUDIN J, 1971, METHODS IMMUNOLOGY I, P213; PERLMUTTER DH, 1986, MOL IMMUNOL, V23, P1263, DOI 10.1016/0161-5890(86)90162-8; PIXLEY RA, 1985, J BIOL CHEM, V260, P1723; PRANDINI MH, 1986, BIOCHEM J, V237, P93, DOI 10.1042/bj2370093; RANDAZZO BP, 1985, J IMMUNOL, V135, P1313; RATNOFF OD, 1969, J EXP MED, V129, P315, DOI 10.1084/jem.129.2.315; RITCHIE DG, 1983, ANN NY ACAD SCI, V408, P490, DOI 10.1111/j.1749-6632.1983.tb23268.x; SALVESEN GS, 1985, J BIOL CHEM, V260, P2432; SCHAPIRA M, 1982, J CLIN INVEST, V69, P462, DOI 10.1172/JCI110470; SCHMAIER AH, 1989, J BIOL CHEM, V264, P18173; SCHREIBER AD, 1973, J CLIN INVEST, V52, P1402, DOI 10.1172/JCI107313; SEHGAL PB, 1987, SCIENCE, V235, P731, DOI 10.1126/science.3492764; SIM RB, 1981, METHOD ENZYMOL, V80, P26; SIM RB, 1980, BIOCHIM BIOPHYS ACTA, V612, P433, DOI 10.1016/0005-2744(80)90126-6; TAGA T, 1987, J EXP MED, V166, P967, DOI 10.1084/jem.166.4.967; TAKAI Y, 1988, J IMMUNOL, V140, P508; TOSATO G, 1988, SCIENCE, V239, P502, DOI 10.1126/science.2829354; VANDERGRAAF F, 1983, J CLIN INVEST, V71, P149, DOI 10.1172/JCI110743; ZURAW B, 1984, J ALLERGY CLIN IMMUN, V73, pA155; ZURAW BL, 1986, J CLIN INVEST, V78, P567, DOI 10.1172/JCI112610	64	59	61	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	1990	265	21					12664	12670						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DP458	1695634				2022-12-27	WOS:A1990DP45800082
J	PAINTER, GR; WRIGHT, LL; HOPKINS, S; FURMAN, PA				PAINTER, GR; WRIGHT, LL; HOPKINS, S; FURMAN, PA			INITIAL BINDING OF 2'-DEOXYNUCLEOSIDE 5'-TRIPHOSPHATES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; KINETIC MECHANISM; SUBSTRATE; DOMAIN; KLENOW	Human immunodeficiency virus type 1 reverse transcriptase (EC 2.7.7.49), a heterodimer consisting of two polypeptide chains of molecular weights 66,000 and 51,000, fluoresces due to the presence of 36 tryptophan residues with an emission peak centered at 338 nm. The association of 2'-deoxynucleoside 5'-triphosphates with the enzyme results in a decrease in the intensity of the tryptophan emission spectrum, which can be used to calculate apparent dissociation constants. The K(d) values determined for binding of the four natural 2'-deoxynucleoside 5'-triphosphates to the free enzyme range from 36.7 +/- 1.8-mu-M for dTTP to 47.3 +/- 3.9-mu-M for dATP. The 5'-triphosphate of zidovudine has a K(d) of 54.1 +/- 1.3-mu-M. The enzyme shows no preference for purine or pyrimidine nucleotides. Hill coefficients and the results of dual ligand titration experiments demonstrate that the free enzyme possesses a single dNTP binding site for which the four natural substrates and the 5'-triphosphate of zidovudine compete. The presence of homopolymeric template-primers does not result in selective binding of the complementary 2'-deoxynucleoside 5'-triphosphate, indicating that Watson-Crick base pairing is not involved in the initial binding reaction. The major force driving the association of the ligands with the binding site is hydrophobic. Approximately 14% of the binding energy is derived from electrostatic interactions. Although Mg2+ is required for catalytic activity, it is not absolutely required for initial binding.	BURROUGHS WELLCOME CO, DIV VIROL, RES TRIANGLE PK, NC 27709 USA	Burroughs Wellcome Fund								BASU A, 1989, J BIOL CHEM, V264, P8746; CHA S, 1968, MOL PHARMACOL, V4, P621; CHENG N, 1991, BIOCHEM BIOPH RES CO, V174, P785, DOI 10.1016/0006-291X(91)91486-V; EDELHOCH H, 1968, BIOCHEMISTRY-US, V7, P3893, DOI 10.1021/bi00851a016; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; ENGLUND PT, 1969, J BIOL CHEM, V244, P3038; FERRIN LJ, 1986, BIOCHEMISTRY-US, V25, P5131, DOI 10.1021/bi00366a023; FERRIN LJ, 1987, DNA REPLICATION RECO, P75; FERSHT A, 1985, ENZYME STRUCTURE MEC, P272; FURMAN PA, 1991, IN PRESS P NATL ACAD; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; HOPKINS S, 1989, BIOCHEM BIOPH RES CO, V163, P106, DOI 10.1016/0006-291X(89)92105-0; JOYCE CM, 1986, PROTEIN STRUCTURE FO, P197; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; KUCHTA RD, 1988, BIOCHEMISTRY-US, V27, P6716, DOI 10.1021/bi00418a012; Lakowicz J.R., 2010, PRINCIPLE FLUORESCEN, DOI 10.1007/978-0-387-46312-4/COVER; LARDER B, 1987, EMBO J, V6, P3133, DOI 10.1002/j.1460-2075.1987.tb02623.x; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; LOWE DM, 1988, BIOCHEMISTRY-US, V27, P8884, DOI 10.1021/bi00425a002; MAJUMDAR C, 1988, J BIOL CHEM, V263, P15657; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MILLER WH, 1982, BIOCHEM PHARMACOL, V31, P3879, DOI 10.1016/0006-2952(82)90305-7; PAINTER GR, 1991, GWUMC DEPT, P35; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; SCOTT TG, 1970, J AM CHEM SOC, V92, P687, DOI 10.1021/ja00706a043; STCLAIR MH, 1987, ANTIMICROB AGENTS CH, V31, P1972, DOI 10.1128/AAC.31.12.1972; TEALE FWJ, 1957, BIOCHEM J, V65, P476, DOI 10.1042/bj0650476; TISDALE M, 1988, J VIROL, V62, P3662, DOI 10.1128/JVI.62.10.3662-3667.1988; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223	29	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19362	19368						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717463				2022-12-27	WOS:A1991GK66700040
J	FEDER, D; BISHOP, JM				FEDER, D; BISHOP, JM			IDENTIFICATION OF PLATELET MEMBRANE-PROTEINS THAT INTERACT WITH AMINO-TERMINAL PEPTIDES OF PP60C-SRC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ROUS-SARCOMA VIRUS; CELL SURFACE-ANTIGENS; BOVINE CARDIAC-MUSCLE; TYROSINE KINASE PP58; HUMAN LYMPHOCYTES-T; TRANSFORMING PROTEIN; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL KINASE; CATALYTIC SUBUNIT; PLASMA-MEMBRANES	Platelets contain exceptionally high levels of pp60c-src and, thus, provide a convenient system for investigating the physiological function of this protein-tyrosine kinase. We have employed chemical cross-linking of myristylated amino-terminal peptides of pp60c-src to platelet membranes in order to identify platelet membrane components that interact with pp60c-src to regulate or mediate its activity. We detected specific binding of radioiodinated peptides to platelet membrane proteins of 32, 50, 92, and 105 kDa. The 32-kDa protein may be related to the putative src receptor component recently identified in fibroblast membranes. The most reactive platelet protein, however, is the 50-kDa protein, which is either absent or nonreactive in fibroblast membranes. Binding of src peptides to this protein was saturable, and we estimate the presence of approximately 1 x 10(6) of the 50-kDa binding sites per platelet. The specificity of the peptide binding to the 50- and 32-kDa platelet proteins was analyzed by competition with different peptides. The binding sites displayed an absolute requirement for an N-myristoyl moiety and a strong preference for pp60c-src amino-terminal sequences. The identification of these src-interacting proteins may help to decipher the biochemical pathways in which platelet pp60c-src is involved.	UNIV CALIF SAN FRANCISCO, GEORGE WILLIAMS HOOPER FDN, BOX 0552, 1542 HSW, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco					NATIONAL CANCER INSTITUTE [R35CA044338] Funding Source: NIH RePORTER; NCI NIH HHS [CA 44338] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARBER AJ, 1970, J BIOL CHEM, V245, P6357; BUSS JE, 1985, J VIROL, V53, P7, DOI 10.1128/JVI.53.1.7-12.1985; BUSS JE, 1984, MOL CELL BIOL, V4, P2697, DOI 10.1128/MCB.4.12.2697; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; CARR SA, 1982, P NATL ACAD SCI-BIOL, V79, P6128, DOI 10.1073/pnas.79.20.6128; COOPER JA, 1990, PEPTIDES PROTEIN PHO, P86; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; FEDER D, 1990, J BIOL CHEM, V265, P8205; FERRELL JE, 1989, P NATL ACAD SCI USA, V86, P2234, DOI 10.1073/pnas.86.7.2234; FERRELL JE, 1990, ONCOGENE, V5, P1033; FERRELL JE, 1988, MOL CELL BIOL, V8, P3603, DOI 10.1128/MCB.8.9.3603; GARBER EA, 1985, MOL CELL BIOL, V5, P2781, DOI 10.1128/MCB.5.10.2781; GODDARD C, 1989, J BIOL CHEM, V264, P15173; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GOLDEN A, 1990, J CELL BIOL, V111, P3117, DOI 10.1083/jcb.111.6.3117; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; GUTKIND JS, 1990, MOL CELL BIOL, V10, P3806, DOI 10.1128/MCB.10.7.3806; HAWIGER J, 1989, METHOD ENZYMOL, V169, P191; HORAK ID, 1990, ONCOGENE, V5, P597; HUNTER T, 1986, ENZYMES, V17, P192; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KAPLAN JM, 1990, MOL CELL BIOL, V10, P1000, DOI 10.1128/MCB.10.3.1000; KRUEGER JG, 1983, CURR TOP MICROBIOL, V107, P51; KUMJIAN DA, 1989, P NATL ACAD SCI USA, V86, P8232, DOI 10.1073/pnas.86.21.8232; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINSON AD, 1981, P NATL ACAD SCI-BIOL, V78, P1624, DOI 10.1073/pnas.78.3.1624; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MERRIL CR, 1979, P NATL ACAD SCI USA, V76, P4335, DOI 10.1073/pnas.76.9.4335; NAIRN AC, 1985, ANNU REV BIOCHEM, V54, P931, DOI 10.1146/annurev.bi.54.070185.004435; NAKAMURA S, 1985, FEBS LETT, V184, P56, DOI 10.1016/0014-5793(85)80652-9; NAKAMURA S, 1989, J BIOL CHEM, V264, P7089; NAKAMURA S, 1988, EUR J BIOCHEM, V174, P471, DOI 10.1111/j.1432-1033.1988.tb14122.x; PELLMAN D, 1985, NATURE, V314, P374, DOI 10.1038/314374a0; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PHANDINHTUY F, 1983, NATURE, V305, P435; Phillips D, 1986, BIOCH PLATELETS; PRESEK P, 1988, BIOCHIM BIOPHYS ACTA, V969, P271, DOI 10.1016/0167-4889(88)90062-6; QUINTRELL N, 1987, MOL CELL BIOL, V7, P2267, DOI 10.1128/MCB.7.6.2267; RENDU F, 1989, BLOOD, V73, P1545; RESH MD, 1990, NATURE, V346, P84, DOI 10.1038/346084a0; RESH MD, 1985, J CELL BIOL, V100, P409, DOI 10.1083/jcb.100.2.409; RESH MD, 1988, MOL CELL BIOL, V8, P1896, DOI 10.1128/MCB.8.5.1896; RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; SCHULTZ AM, 1985, SCIENCE, V227, P427, DOI 10.1126/science.3917576; SHOJI S, 1981, P NATL ACAD SCI-BIOL, V78, P848, DOI 10.1073/pnas.78.2.848; TANAKA A, 1987, MOL CELL BIOL, V7, P1978, DOI 10.1128/MCB.7.5.1978; VARSHNEY GC, 1986, FEBS LETT, V205, P97, DOI 10.1016/0014-5793(86)80873-0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; YAMANASHI Y, 1991, SCIENCE, V251, P192, DOI 10.1126/science.1702903; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	53	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					19040	19046						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717459				2022-12-27	WOS:A1991GJ47200097
J	NEWBURGER, PE; DAI, Q; WHITNEY, C				NEWBURGER, PE; DAI, Q; WHITNEY, C			INVITRO REGULATION OF HUMAN PHAGOCYTE CYTOCHROME-B HEAVY AND LIGHT CHAIN GENE-EXPRESSION BY BACTERIAL LIPOPOLYSACCHARIDE AND RECOMBINANT HUMAN CYTOKINES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; CHRONIC GRANULOMATOUS-DISEASE; FACTOR PRIMES NEUTROPHILS; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; RESPIRATORY BURST; POLYMORPHONUCLEAR LEUKOCYTES; SUPEROXIDE PRODUCTION; CHEMOTACTIC PEPTIDE	We examined the effects of bacterial lipopolysaccharide and several recombinant human cytokines (tumor necrosis factor-alpha and granulocyte-, macrophage-, and granulocyte-macrophage colony-stimulating factors) on the expression of the genes for the phagocyte cytochrome b, an essential component of the superoxide-generating oxidase. In vitro treatment with lipopolysaccharide, tumor necrosis factor-alpha, or macrophage- or granulocyte-macrophage colony-stimulating factors increased the levels of transcripts for the cytochrome b heavy chain (gp9lphox) 9- to 22-fold and transcripts for the light chain (p22phox) 2- to 5-fold in cultured human monocyte-derived macrophages. The same agents, except for macrophage colony-stimulating factor, induced the expression of the cytochrome b heavy chain gene 2- to 12-fold and light chain gene 2- to 6-fold in human granulocytes. The expression of the cytochrome b heavy and light chain genes was coordinated in both macrophages and neutrophils with regard to stimulus specificity and dose-response pattern. The time course for induction of the two genes was parallel in both cell types for all stimuli. The macrophage response to lipopolysaccharide occurred at least in part at the transcriptional level. These results show that a variety of physiological regulators modulate the coordinated expression of the cytochrome b genes.	UNIV MASSACHUSETTS,SCH MED,DEPT MOLEC GENET & MICROBIOL,WORCESTER,MA 01655	University of Massachusetts System; University of Massachusetts Worcester	NEWBURGER, PE (corresponding author), UNIV MASSACHUSETTS,SCH MED,DEPT PEDIAT,WORCESTER,MA 01655, USA.			Newburger, Peter/0000-0002-8615-673X	NCI NIH HHS [CA38325] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA038325] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283; BABIOR BM, 1984, BLOOD, V64, P959; BABIOR BM, 1987, TRENDS BIOCHEM SCI, V12, P241, DOI 10.1016/0968-0004(87)90118-6; BABIOR BM, 1981, LEUKOCYTE FUNCTION, P1; BERKOW RL, 1987, J IMMUNOL, V139, P3783; BERKOW RL, 1988, J LEUKOCYTE BIOL, V44, P345, DOI 10.1002/jlb.44.5.345; BERTON G, 1986, J IMMUNOL, V136, P1393; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; CASSATELLA MA, 1989, J CLIN INVEST, V83, P1570, DOI 10.1172/JCI114054; COREY SJ, 1989, J BIOL CHEM, V264, P14165; CUMMINGS NP, 1980, J EXP MED, V152, P1659, DOI 10.1084/jem.152.6.1659; DETITTO EH, 1986, J IMMUNOL, V137, P1342; EDWARDS SW, 1989, FEBS LETT, V256, P62, DOI 10.1016/0014-5793(89)81718-1; EID NS, 1987, J EXP MED, V165, P1448, DOI 10.1084/jem.165.5.1448; ENGLISH D, 1988, J IMMUNOL, V141, P2400; EZEKOWITZ RAB, 1985, J CLIN INVEST, V76, P2368, DOI 10.1172/JCI112249; EZEKOWITZ RAB, 1987, J CLIN INVEST, V80, P1009, DOI 10.1172/JCI113153; EZEKOWITZ RAB, 1988, NEW ENGL J MED, V319, P146, DOI 10.1056/NEJM198807213190305; FOREHAND JR, 1989, J CLIN INVEST, V83, P74, DOI 10.1172/JCI113887; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GATTI R A, 1984, Biotechniques, V2, P148; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; HALLORAN PF, 1988, TRANSPLANTATION, V46, pS68; ITAMI M, 1987, FEBS LETT, V222, P289, DOI 10.1016/0014-5793(87)80388-5; JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205; KATZ RA, 1983, BIOCHIM BIOPHYS ACTA, V739, P258, DOI 10.1016/0167-4781(83)90099-4; KAUSHANSKY K, 1988, J IMMUNOL, V141, P3410; KITAGAWA S, 1987, BIOCHEM BIOPH RES CO, V144, P1143, DOI 10.1016/0006-291X(87)91430-6; LINDEMANN A, 1989, J CLIN INVEST, V83, P1308, DOI 10.1172/JCI114016; Maniatis T., 1982, MOL CLONING; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MICHELSON AM, 1983, P NATL ACAD SCI-BIOL, V80, P472, DOI 10.1073/pnas.80.2.472; NATHAN CF, 1986, CIBA F SYMP, V118, P211, DOI 10.1002/9780470720998.ch14; NATHAN CF, 1985, MONONUCLEAR PHAGOCYT; NEWBURGER PE, 1988, P NATL ACAD SCI USA, V85, P5215, DOI 10.1073/pnas.85.14.5215; PABST MJ, 1980, J EXP MED, V151, P101, DOI 10.1084/jem.151.1.101; PARKOS CA, 1988, P NATL ACAD SCI USA, V85, P3319, DOI 10.1073/pnas.85.10.3319; REED SG, 1987, J EXP MED, V166, P1734, DOI 10.1084/jem.166.6.1734; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SARIBAN E, 1988, BLOOD, V71, P488; SHALABY MR, 1985, J IMMUNOL, V135, P2069; SHE ZW, 1989, AM J PHYSIOL, V257, pL338, DOI 10.1152/ajplung.1989.257.6.L338; SMITH RM, 1991, BLOOD, V77, P673; WARREN MK, 1986, J IMMUNOL, V137, P2281; WEISBART RH, 1985, NATURE, V314, P361, DOI 10.1038/314361a0; WING EJ, 1985, J IMMUNOL, V135, P2052; WOODMAN RC, 1988, FREE RADICAL BIO MED, V5, P355, DOI 10.1016/0891-5849(88)90108-6; YU SF, 1990, J LEUKOCYTE BIOL, V48, P412, DOI 10.1002/jlb.48.5.412; 1991, NEW ENGL J MED, V324, P509	52	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					16171	16177						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714908				2022-12-27	WOS:A1991GB97700096
J	SAGE, EH; BORNSTEIN, P				SAGE, EH; BORNSTEIN, P			EXTRACELLULAR PROTEINS THAT MODULATE CELL-MATRIX INTERACTIONS - SPARC, TENASCIN, AND THROMBOSPONDIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENDOTHELIAL-CELLS; BASEMENT-MEMBRANE; FOCAL ADHESIONS; INSITU HYBRIDIZATION; MOLECULAR-CLONING; MOUSE EMBRYO; OSTEONECTIN; BINDING; GLYCOPROTEIN; EXPRESSION		UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOL STRUCT, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE008229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040711] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 18645] Funding Source: Medline; NIDCR NIH HHS [DE 08229] Funding Source: Medline; NIGMS NIH HHS [GM 40711] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; ASCH AS, 1989, PROG HEMOST THROMB, V9, P157; ASCH AS, 1991, J BIOL CHEM, V266, P1740; AUFDERHEIDE E, 1987, J CELL BIOL, V105, P599, DOI 10.1083/jcb.105.1.599; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; BERNFIELD M, 1990, PHILOS T R SOC B, V327, P171, DOI 10.1098/rstb.1990.0052; BOLANDER ME, 1988, P NATL ACAD SCI USA, V85, P2919, DOI 10.1073/pnas.85.9.2919; BORNSTEIN P, 1991, J BIOL CHEM, V266, P12821; BRONNERFRASER M, 1988, J NEUROSCI RES, V21, P135, DOI 10.1002/jnr.490210206; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CHIQUETEHRISMANN R, 1990, FASEB J, V4, P2598, DOI 10.1096/fasebj.4.9.1693347; CHIQUETEHRISMANN R, 1988, CELL, V53, P383, DOI 10.1016/0092-8674(88)90158-4; DANILOFF JK, 1989, J CELL BIOL, V108, P625, DOI 10.1083/jcb.108.2.625; DOMENICUCCI C, 1988, BIOCHEM J, V253, P139, DOI 10.1042/bj2530139; DONOVIEL DB, 1990, J CELL PHYSIOL, V145, P16, DOI 10.1002/jcp.1041450104; DZIADEK M, 1986, EUR J BIOCHEM, V161, P455, DOI 10.1111/j.1432-1033.1986.tb10466.x; ENGEL J, 1987, BIOCHEMISTRY-US, V26, P6958, DOI 10.1021/bi00396a015; ERICKSON HP, 1989, ANNU REV CELL BIOL, V5, P71, DOI 10.1146/annurev.cb.05.110189.000443; EVERITT EA, 1990, J CELL BIOCHEM, V14, P121; FAISSNER A, 1990, NEURON, V5, P627, DOI 10.1016/0896-6273(90)90217-4; FRAZIER WA, 1987, J CELL BIOL, V105, P625, DOI 10.1083/jcb.105.2.625; FUNK SE, 1991, P NATL ACAD SCI USA, V88, P2648, DOI 10.1073/pnas.88.7.2648; GATCHALIAN CL, 1989, J CELL BIOL, V108, P1873, DOI 10.1083/jcb.108.5.1873; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; GOULD RJ, 1990, P SOC EXP BIOL MED, V195, P168, DOI 10.3181/00379727-195-43129B; HASSELAAR P, 1991, J BIOL CHEM, V266, P13178; HOLLAND PWH, 1987, J CELL BIOL, V105, P473, DOI 10.1083/jcb.105.1.473; HUMPHRIES MJ, 1990, J CELL SCI, V97, P585; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; IRUELAARISPE ML, 1991, LAB INVEST, V64, P174; IRUELAARISPE ML, 1991, P NATL ACAD SCI USA, V88, P5026, DOI 10.1073/pnas.88.11.5026; IRUELAARISPE ML, 1991, IN PRESS ARTERIOSCLE; JAKEN S, 1989, J CELL BIOL, V109, P697, DOI 10.1083/jcb.109.2.697; JOHNSTON IG, 1990, NEURON, V4, P165, DOI 10.1016/0896-6273(90)90452-L; KEYNES R, 1990, CELL, V62, P609, DOI 10.1016/0092-8674(90)90103-L; LANE TF, 1990, J CELL BIOL, V111, P3065, DOI 10.1083/jcb.111.6.3065; LANE TF, 1991, J CELL BIOCH F, V15, P182; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER J, 1987, SEMIN THROMB HEMOST, V13, P245, DOI 10.1055/s-2007-1003499; LIGHTNER VA, 1990, J CELL SCI, V95, P263; LOTZ MM, 1989, J CELL BIOL, V109, P1795, DOI 10.1083/jcb.109.4.1795; MACKIE EJ, 1988, J CELL BIOL, V107, P2757, DOI 10.1083/jcb.107.6.2757; MACKIE EJ, 1987, P NATL ACAD SCI USA, V84, P4621, DOI 10.1073/pnas.84.13.4621; MACKIE EJ, 1987, J CELL BIOL, V105, P2569, DOI 10.1083/jcb.105.6.2569; MAJACK RA, 1986, P NATL ACAD SCI USA, V83, P9050, DOI 10.1073/pnas.83.23.9050; MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415; MAJACK RA, 1987, CELL MEMBRANES METHO, V3, P55; MANSFIELD PJ, 1990, J CELL BIOL, V111, P3077, DOI 10.1083/jcb.111.6.3077; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; METSARANTA M, 1989, CALCIFIED TISSUE INT, V45, P146, DOI 10.1007/BF02556057; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; MOSHER DF, 1990, ANNU REV MED, V41, P85; MUMBY SM, 1984, J CELL PHYSIOL, V120, P280, DOI 10.1002/jcp.1041200304; MURPHY-ULLRICH J E, 1990, Journal of Cell Biology, V111, p148A; MURPHY-ULLRICH J E, 1990, Journal of Cell Biology, V111, p144A; MURPHYULLRICH JE, 1987, SEMIN THROMB HEMOST, V13, P343, DOI 10.1055/s-2007-1003510; MURPHYULLRICH JE, 1989, J CELL BIOL, V109, P1309, DOI 10.1083/jcb.109.3.1309; OSHEA KS, 1988, J CELL BIOL, V107, P2737, DOI 10.1083/jcb.107.6.2737; PACIFICI M, 1990, CALCIFIED TISSUE INT, V47, P51, DOI 10.1007/BF02555866; PRATER CA, 1991, J CELL BIOL, V112, P1031, DOI 10.1083/jcb.112.5.1031; PROBSTMEIER R, 1990, DEVELOPMENT, V109, P313; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; RAUGI GJ, 1987, J INVEST DERMATOL, V89, P551, DOI 10.1111/1523-1747.ep12461198; ROBERTS DD, 1987, J CELL BIOL, V104, P131, DOI 10.1083/jcb.104.1.131; ROSEN EM, 1990, J CELL SCI, V96, P639; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SAGE H, 1989, J CELL BIOL, V109, P341, DOI 10.1083/jcb.109.1.341; SAGE H, 1989, J HISTOCHEM CYTOCHEM, V37, P819, DOI 10.1177/37.6.2723400; SAGE H, 1984, J BIOL CHEM, V259, P3993; SAGE H, 1990, J CELL BIOCH E, V14, P127; SILVERSTEIN RL, 1985, J BIOL CHEM, V260, P346; SPRING J, 1989, CELL, V59, P325, DOI 10.1016/0092-8674(89)90294-8; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; VARANI J, 1988, J CLIN INVEST, V81, P1537, DOI 10.1172/JCI113486; VERNON RB, 1989, BIOL REPROD, V40, P1329, DOI 10.1095/biolreprod40.6.1329; VILLARREAL XC, 1989, BIOCHEMISTRY-US, V28, P6483, DOI 10.1021/bi00441a049; WATT FM, 1986, TRENDS BIOCHEM SCI, V11, P482, DOI 10.1016/0968-0004(86)90252-5; WEHRLE B, 1990, DEVELOPMENT, V110, P401; WEWER UM, 1988, AM J PATHOL, V132, P345; WOODS A, 1988, COLLAGEN REL RES, V8, P155	81	541	560	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					14831	14834						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714444				2022-12-27	WOS:A1991GB09700001
J	SKERKA, C; HORSTMANN, RD; ZIPFEL, PF				SKERKA, C; HORSTMANN, RD; ZIPFEL, PF			MOLECULAR-CLONING OF A HUMAN SERUM-PROTEIN STRUCTURALLY RELATED TO COMPLEMENT FACTOR-H	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CR-1 GENE; SEQUENCE; IDENTIFICATION; POLYMORPHISMS; ORGANIZATION; FRAGMENT; REGION; LIVER; ACID; SITE	Two cDNA clones termed H36-1 and H36-2 were isolated from a human liver cDNA library. Clone H36-1 appears to represent the recently isolated human serum proteins h37 and h42, which are two differently glycosylated forms of a protein antigenically related to human complement factor H. The H36-1 deduced protein sequence is 327 amino acid long and possesses a leader sequence. The secreted part of the protein is comprised of five tandem repeating units, termed short consensus repeats (SCRs). SCR 1 and 2 display high homology to the corresponding region of the recently isolated murine factor H-related cDNA clone 13G1. In contrast, the 3'-end of the H36-1 clone shows sequence homology to the 3'-end of human complement factor H. The second clone, H36-2, is nearly identical to H36-1. Within 1148 base pairs, where the two clones overlap, their nucleotide sequences differed at nine positions. One nucleotide exchange in the sequence of H36-2 which was located within SCR 1 creates a stop codon (TAA). Consequently, the corresponding mRNA cannot code for a functional protein, suggesting that this clone is a transcribed pseudogene. These two clones represent new human members of the family of proteins structurally related to complement factor H.	BERNHARD NOCHT INST TROP MED,BERNHARD NOCHT STR 74,W-2000 HAMBURG 36,GERMANY	Bernhard Nocht Institut fur Tropenmedizin								CAMPBELL RD, 1988, ANNU REV IMMUNOL, V6, P161, DOI 10.1146/annurev.iy.06.040188.001113; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FONTAINE M, 1989, BIOCHEM J, V258, P927, DOI 10.1042/bj2580927; FUJISAKU A, 1989, J BIOL CHEM, V264, P2118; HOURCADE D, 1990, J BIOL CHEM, V265, P974; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KRISTENSEN T, 1986, P NATL ACAD SCI USA, V83, P3963, DOI 10.1073/pnas.83.11.3963; KRISTENSEN T, 1986, J IMMUNOL, V136, P3407; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; REYCAMPOS J, 1988, J EXP MED, V167, P664, DOI 10.1084/jem.167.2.664; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHULZ TF, 1986, EUR J IMMUNOL, V16, P1351, DOI 10.1002/eji.1830161107; SCHWAEBLE W, 1987, EUR J IMMUNOL, V17, P1485, DOI 10.1002/eji.1830171015; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; TIMMANN C, 1991, J IMMUNOL, V146, P1265; VIK DP, 1990, J BIOL CHEM, V265, P3193; VIK DP, 1989, CURR TOP MICROBIOL I, V153, P147; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WONG WW, 1989, J EXP MED, V169, P847, DOI 10.1084/jem.169.3.847	21	67	70	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					12015	12020						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711047				2022-12-27	WOS:A1991FT76200090
J	MEHTA, KD; BROWN, MS; BILHEIMER, DW; GOLDSTEIN, JL				MEHTA, KD; BROWN, MS; BILHEIMER, DW; GOLDSTEIN, JL			THE LOW-DENSITY-LIPOPROTEIN RECEPTOR IN XENOPUS-LAEVIS .2. FEEDBACK REPRESSION MEDIATED BY CONSERVED STEROL REGULATORY ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL HOMEOSTASIS; TRANSCRIPTION FACTOR; PLASMA-LIPOPROTEINS; PROMOTER; HYPERCHOLESTEROLEMIA; POLYMERASE; PATHWAY; CHICKEN; GENE; RNA	The 5'-flanking regions of the two low density lipoprotein (LDL) receptor genes in Xenopus laevis contain three repeat sequences that are virtually identical to the repeats that mediate sterol-regulated transcription of the human LDL receptor gene. Like their human counterparts, Xenopus repeats 1 and 3, but not repeat 2, bind the transcription factor Sp1 and thus probably function as positive transcription elements. Xenopus repeat 2, like human repeat 2, contains all of the nucleotides that are required for sterol regulation. Administration of sterols repressed Xenopus LDL receptor mRNA in cultured A6 kidney cells and in the liver of intact frogs. In frogs this repression was associated with a 2-fold increase in plasma LDL levels. Xenopus LDL contains a protein corresponding in size to human apoB-100, a ligand for the LDL receptor. We found no evidence that frog plasma contains B-48, nor did we observe a clear-cut protein corresponding to apoE. We conclude that the structural gene for the LDL receptor has been under sterol-mediated regulation at least since the time of amphibian development more than 350 million years ago.	UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	MEHTA, KD (corresponding author), UNIV TEXAS, SW MED CTR, DEPT MOLEC GENET, DALLAS, TX 75235 USA.				NHLBI NIH HHS [HL 20948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAIN CC, 1974, CLIN CHEM, V20, P470; BARAKAT HA, 1985, J LIPID RES, V26, P1252; BRIGGS MR, 1986, SCIENCE, V234, P47, DOI 10.1126/science.3529394; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; DAWSON PA, 1988, J BIOL CHEM, V263, P3372; FOX JC, 1987, J BIOL CHEM, V262, P7014; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HA YC, 1985, J CHROMATOGR, V341, P154, DOI 10.1016/S0378-4347(00)84020-7; HERMIER D, 1985, BIOCHIM BIOPHYS ACTA, V836, P105, DOI 10.1016/0005-2760(85)90226-7; KADONAGA JT, 1986, TRENDS BIOCHEM SCI, V11, P20, DOI 10.1016/0968-0004(86)90226-4; KOVANEN PT, 1981, P NATL ACAD SCI-BIOL, V78, P1396, DOI 10.1073/pnas.78.3.1396; MAHLEY RW, 1983, BIOCHIM BIOPHYS ACTA, V737, P197, DOI 10.1016/0304-4157(83)90001-1; Maxam A M, 1980, Methods Enzymol, V65, P499; MEHTA KD, 1991, J BIOL CHEM, V266, P10406; SCOTT J, 1989, MOL BIOL MED, V6, P65; SMITH JR, 1990, J BIOL CHEM, V265, P2306; SMITH JR, 1988, J BIOL CHEM, V263, P18480; SORCITHOMAS M, 1989, J BIOL CHEM, V264, P9039; STEYRER E, 1990, J BIOL CHEM, V265, P19575; SUDHOF TC, 1987, CELL, V48, P1061, DOI 10.1016/0092-8674(87)90713-6; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; YOKODE M, 1990, SCIENCE, V250, P1273, DOI 10.1126/science.2244210	23	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10415	10419						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709932				2022-12-27	WOS:A1991FP08600065
J	LARSEN, GR; TIMONY, GA; HORGAN, PG; BARONE, KM; HENSON, KS; ANGUS, LB; STOUDEMIRE, JB				LARSEN, GR; TIMONY, GA; HORGAN, PG; BARONE, KM; HENSON, KS; ANGUS, LB; STOUDEMIRE, JB			PROTEIN ENGINEERING OF NOVEL PLASMINOGEN ACTIVATORS WITH INCREASED THROMBOLYTIC POTENCY IN RABBITS RELATIVE TO ACTIVASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR DOMAINS; MYOCARDIAL-INFARCTION; PHARMACOKINETICS; THROMBOSIS; PREVENTION; LACKING; FINGER; FORMS	Human tissue-type plasminogen activator (t-PA) is a glycoprotein used currently in thrombolytic therapy for patients with acute myocardial infarction. Due to its rapid rate of clearance from the circulation, continuous intravenous administration of approximately 100 mg over 3 h is recommended. We have previously characterized novel thrombolytic variant forms of t-PA which offer the potential of administration by bolus injection and reduced dosage due to their slower rates of clearance, relative to t-PA. This study was undertaken to quantitatively compare the pharmacokinetics, thrombolytic activity, and hemostatic effects of two of these variant forms, called ELTA-FE1X and DELTA-FE3X plasminogen activator (PA), with commercially available recombinant t-PA (Activase). These evaluations were performed in rabbits after bolus intravenous injection of the proteins. Following injection of 0.25 mg of protein/kg of body weight, the rates of clearance for DELTA-FE3X and DELTA-FE1X PA antigen were decreased approximately 9- and 18-fold, respectively, relative to Activase. Plasma plasminogen activator activity was also measured and the rates of clearance for DELTA-FE3X and DELTA-FE1X PA activity were similarly decreased by approximately 9- and 22-fold, respectively, relative to Activase. To quantitate thrombolytic activity we used the rabbit jugular vein thrombosis model and demonstrated that approximately 50% thrombolysis was achieved with DELTA-FE1X and DELTA-FE3X PA at approximately an 8.6- and 3-fold lower dose than Activase, respectively. No major differences in fibrinogen and alpha-2-antiplasmin depletion were observed among the agents at doses required to produce 50% thrombolysis, indicating similarities in fibrin specificities among these agents. These results demonstrate a reciprocal relationship between thrombolysis and rate of clearance for these thrombolytic proteins. The 8.6-fold increase in potency of DELTA-FE1X PA relative to Activase supports the future clinical testing of this novel engineered protein as a thrombolytic agent.			LARSEN, GR (corresponding author), GENET INST,CAMBRIDGE,MA 02140, USA.							[Anonymous], 1986, Lancet, V1, P397; CAMBIER P, 1988, J CARDIOVASC PHARM, V11, P468, DOI 10.1097/00005344-198804000-00013; COLLEN D, 1983, J CLIN INVEST, V71, P368, DOI 10.1172/JCI110778; COLLEN D, 1988, BLOOD, V71, P216; EISENBERG PR, 1987, THROMB HAEMOSTASIS, V57, P35; FOX KAA, 1985, CIRCULATION, V72, P1346, DOI 10.1161/01.CIR.72.6.1346; GOLD HK, 1986, CIRCULATION, V73, P347, DOI 10.1161/01.CIR.73.2.347; HANSEN L, 1988, J BIOL CHEM, V263, P15713; LARSEN GR, 1989, BLOOD, V73, P1842, DOI 10.1182/blood.V73.7.1842.1842; LARSEN GR, 1988, J BIOL CHEM, V263, P1023; LARSEN GR, 1987, THROMB HAEMOSTASIS, V58, P49; MUELLER HS, 1987, J AM COLL CARDIOL, V10, P479, DOI 10.1016/S0735-1097(87)80188-2; SIMOONS ML, 1986, J AM COLL CARDIOL, V7, P717, DOI 10.1016/S0735-1097(86)80329-1; TRANCHESI B, 1990, CORONARY ARTERY DIS, V1, P83, DOI 10.1097/00019501-199001000-00012; VERSTRAETE M, 1986, THROMB HAEMOSTASIS, V56, P1	15	36	43	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8156	8161						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1708773				2022-12-27	WOS:A1991FK44100034
J	PODOLIN, PL; PRYSTOWSKY, MB				PODOLIN, PL; PRYSTOWSKY, MB			THE KINETICS OF VIMENTIN RNA AND PROTEIN EXPRESSION IN INTERLEUKIN 2-STIMULATED LYMPHOCYTES-T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE FILAMENT PROTEINS; CELLS; CYTOSKELETAL; DEGRADATION; TURNOVER; SITE; GENE; PHOSPHORYLATION; PROLIFERATION; SURFACE	In this paper, we examine the regulation of vimentin expression during interleukin 2-induced proliferation of the cloned helper T cell line, L2. We observe a 10-20-fold increase in steady-state vimentin RNA that is accompanied by a 14-fold increase in the rate of vimentin protein synthesis. This indicates that translation is occurring, and thus that vimentin expression is regulated, at least in part, at the level of transcription and/or RNA stability, rather than at the level of protein synthesis. In contrast to the increases in steady-state vimentin RNA and the rate of protein synthesis, steady-state vimentin protein levels increase maximally only 1.3-3-fold in proliferating L2 cells. The rate of vimentin protein turnover remains relatively constant throughout L2 cell activation, active proliferation, and return to quiescence, indicating that an increased rate of turnover does not account for the minimal increase in vimentin content. These observations are consistent with a transient increase in vimentin protein synthesis necessary to support L2 cell growth and/or vimentin network reorganization. Because cell division occurs before an equilibrium state is reached, the maximal increase in steady-state vimentin protein content is never attained.	UNIV PENN,DEPT PATHOL & LAB MED,547 CLIN RES BLDG,422 CURIE BLVD,PHILADELPHIA,PA 19104	University of Pennsylvania					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041226] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-41226] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMENTA JS, 1981, LIFE SCI, V28, P1195, DOI 10.1016/0024-3205(81)90444-6; BOURGUIGNON LYW, 1984, INT REV CYTOL, V87, P195, DOI 10.1016/S0074-7696(08)62443-2; BRADLEY MO, 1975, INTRACELLULAR PROTEI, P311; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU FC, 1984, J NEUROCHEM, V42, P166, DOI 10.1111/j.1471-4159.1984.tb09713.x; CHOU YH, 1990, CELL, V62, P1063, DOI 10.1016/0092-8674(90)90384-Q; CLEVENGER CV, 1985, CYTOMETRY, V6, P208, DOI 10.1002/cyto.990060306; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; DELLAGI K, 1982, NATURE, V298, P284, DOI 10.1038/298284a0; EBERT RF, 1986, ANAL BIOCHEM, V154, P431, DOI 10.1016/0003-2697(86)90010-2; EVANS RM, 1984, J BIOL CHEM, V259, P5372; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614; FRANKE WW, 1982, CELL, V30, P103, DOI 10.1016/0092-8674(82)90016-2; FRANKE WW, 1987, CELL, V48, P3, DOI 10.1016/0092-8674(87)90345-X; FRANKE WW, 1984, EXP CELL RES, V154, P567, DOI 10.1016/0014-4827(84)90181-2; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117; GLASEBROOK AL, 1980, J EXP MED, V151, P876, DOI 10.1084/jem.151.4.876; GOLDBERG AL, 1974, ANNU REV BIOCHEM, V43, P835, DOI 10.1146/annurev.bi.43.070174.004155; GOLDMAN R, 1985, ANN NY ACAD SCI, V455, P1, DOI 10.1111/j.1749-6632.1985.tb50400.x; GRONE HJ, 1987, AM J PATHOL, V129, P1; INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0; KACZMAREK L, 1987, EXP CELL RES, V173, P70, DOI 10.1016/0014-4827(87)90332-6; KACZMAREK L, 1985, P NATL ACAD SCI USA, V82, P5375, DOI 10.1073/pnas.82.16.5375; KAMMER GM, 1988, J IMMUNOL, V141, P2924; KNOWLES SE, 1976, BIOCHEM J, V156, P609, DOI 10.1042/bj1560609; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARIDES E, 1982, METHOD CELL BIOL, V25, P333, DOI 10.1016/S0091-679X(08)61432-6; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; LEE SC, 1986, J CELL BIOL, V102, P1200, DOI 10.1083/jcb.102.4.1200; LILIENBAUM A, 1986, EMBO J, V5, P2809, DOI 10.1002/j.1460-2075.1986.tb04572.x; LOW RB, 1985, J CELL BIOL, V101, P500, DOI 10.1083/jcb.101.2.500; MANIATIS T, 1982, MOL CLONING LABORATO, P466; MCTAVISH CF, 1983, FEBS LETT, V154, P251, DOI 10.1016/0014-5793(83)80159-8; NATH K, 1970, J BIOL CHEM, V245, P2889; PAULINLEVASSEUR M, 1987, CELL MOTIL CYTOSKEL, V8, P227, DOI 10.1002/cm.970080304; SABATH DE, 1986, P NATL ACAD SCI USA, V83, P4739, DOI 10.1073/pnas.83.13.4739; SABATH DE, 1990, J BIOL CHEM, V265, P12671; SCHLAEPFER WW, 1983, BANBURY REPORT, V15, P107; SIEBERT PD, 1985, J BIOL CHEM, V260, P3868; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; TRAUB P, 1985, INTERMEDIATE FILAMEN, P186; ZACKROFF RV, 1979, P NATL ACAD SCI USA, V76, P6226, DOI 10.1073/pnas.76.12.6226; ZIEVE GW, 1985, ANN NY ACAD SCI, V455, P720, DOI 10.1111/j.1749-6632.1985.tb50456.x	45	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5870	5875						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706341				2022-12-27	WOS:A1991FD37000080
J	DICHEK, HL; FOJO, SS; BEG, OU; SKARLATOS, SI; BRUNZELL, JD; CUTLER, GB; BREWER, HB				DICHEK, HL; FOJO, SS; BEG, OU; SKARLATOS, SI; BRUNZELL, JD; CUTLER, GB; BREWER, HB			IDENTIFICATION OF 2 SEPARATE ALLELIC MUTATIONS IN THE LIPOPROTEIN-LIPASE GENE OF A PATIENT WITH THE FAMILIAL HYPERCHYLOMICRONEMIA SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; SEQUENCE; DNA; DEFICIENCY; EVOLUTION; PROTEIN; ENZYME	The molecular defects resulting in a deficiency of lipoprotein lipase activity in a patient with the familial hyperchylomicronemia syndrome have been identified. Increased lipoprotein lipase mass but undetectable lipoprotein lipase activity in the patient's post-heparin plasma indicate the presence of an inactive enzyme. No major gene rearrangements were identified by Southern blot analysis of the patient's lipoprotein lipase gene and Northern blot hybridization revealed an lipoprotein lipase mRNA of normal size. Sequence analysis of polymerase chain reaction-amplified lipoprotein lipase cDNA identified two separate allelic mutations. A T to C transition at nucleotide 836 results in the substitution of Ile194, located near the putative interfacial recognition site of lipoprotein lipase, to a Thr. A G to A mutation at base 983 leads to the substitution of a His a for Arg243 and the loss of a HhaI restriction enzyme site. Arg243 is near His241, which has been postulated to be part of the catalytic triad of lipoprotein lipase. Direct sequencing of amplified cDNA and digestion with HhaI established that the proband is a compound heterozygote for each base substitution. Transient expression of each of the mutant lipoprotein lipase cDNAs in human embryonal kidney-293 cells resulted in the synthesis of enzymically inactive proteins, establishing the functional significance of the mutations. We conclude that the Ile194 to Thr194 and Arg243 to His243 substitutions occur in lipoprotein lipase regions essential for normal enzyme activity and each mutation results in the expression of a nonfunctional enzyme leading to the hyperchylomicronemia syndrome manifested in the proband.	NICHHD, DEV ENDOCRINOL BRANCH, BETHESDA, MD 20892 USA; UNIV WASHINGTON, DEPT MED, DIV METAB ENDOCRINOL & NUTR, SEATTLE, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle	DICHEK, HL (corresponding author), NHLBI, MOLEC DIS BRANCH, BETHESDA, MD 20892 USA.				NIDDK NIH HHS [DK-02456] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD N, 1988, SCIENCE, V241, P1481, DOI 10.1126/science.3262235; AUWERX JH, 1989, EUR J CLIN INVEST, V19, P433, DOI 10.1111/j.1365-2362.1989.tb00255.x; BABIRAK SP, 1989, ARTERIOSCLEROSIS, V9, P326, DOI 10.1161/01.ATV.9.3.326; BEG OU, 1990, P NATL ACAD SCI USA, V87, P3474, DOI 10.1073/pnas.87.9.3474; BENAVRAM CM, 1986, P NATL ACAD SCI USA, V83, P4185, DOI 10.1073/pnas.83.12.4185; Brunzell JD, 1989, METABOLIC BASIS INHE, P1165; CHAIT A, 1982, J CLIN INVEST, V69, P490, DOI 10.1172/JCI110473; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEEB SS, 1989, BIOCHEMISTRY-US, V28, P4132, DOI 10.1021/bi00436a001; DEVLIN RH, 1990, AM J HUM GENET, V46, P112; EMI M, 1990, J BIOL CHEM, V265, P5910; ENERBACK S, 1987, GENE, V58, P1, DOI 10.1016/0378-1119(87)90023-0; ENERBACK S, 1989, GENE, V84, P391, DOI 10.1016/0378-1119(89)90513-1; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; IVERIUS PH, 1985, AM J PHYSIOL, V249, pE107, DOI 10.1152/ajpendo.1985.249.1.E107; KIRCHGESSNER TG, 1989, P NATL ACAD SCI USA, V86, P9647, DOI 10.1073/pnas.86.24.9647; KIRCHGESSNER TG, 1987, J BIOL CHEM, V262, P8463; LANGLOIS S, 1989, P NATL ACAD SCI USA, V86, P948, DOI 10.1073/pnas.86.3.948; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; MONSALVE MV, 1990, J CLIN INVEST, V86, P728, DOI 10.1172/JCI114769; PERSSON B, 1989, EUR J BIOCHEM, V179, P39, DOI 10.1111/j.1432-1033.1989.tb14518.x; ROSENTHAL N, 1987, METHOD ENZYMOL, V152, P704; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SEMENKOVICH CF, 1989, J LIPID RES, V30, P423; SENDA M, 1987, P NATL ACAD SCI USA, V84, P4369, DOI 10.1073/pnas.84.13.4369; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; WION KL, 1987, SCIENCE, V235, P1638, DOI 10.1126/science.3823907; WONG C, 1987, NATURE, V330, P384, DOI 10.1038/330384a0; YANG CY, 1989, J BIOL CHEM, V264, P16822	30	58	60	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					473	477						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702428				2022-12-27	WOS:A1991EQ33900069
J	FURFINE, ES; REARDON, JE				FURFINE, ES; REARDON, JE			REVERSE TRANSCRIPTASE.RNASE-H FROM THE HUMAN-IMMUNODEFICIENCY-VIRUS - RELATIONSHIP OF THE DNA-POLYMERASE AND RNA HYDROLYSIS ACTIVITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MURINE LEUKEMIA-VIRUS; RIBONUCLEASE-H; HTLV-III; RETROVIRUS; INHIBITION; TYPE-1; AIDS; TRANSCRIPTION; ENDONUCLEASE; INITIATION	Human immunodeficiency virus reverse transcriptase.RNase H (RT-RNase H) has an RNA hydrolysis specificity which was influenced both by the sequence of the DNA primer-RNA template and by binding of the polymerase active site to the primer 3' terminus. RT.RNase H selectively hydrolyzed the phosphodiester bond between the 15th and 16th ribonucleotide back from the ribonucleotide that is complementary to the primer 3'-terminal deoxynucleotide. The cleavage site for RT.RNase H remained a fixed distance behind the 3'-primer terminus as the polymerase extended the primer. This cleavage was not strongly affected by the position of the DNA primer on the template nor was it affected by reducing the primer length from 40 to 25 nucleotides. These results suggest that the distance between the RNase H and polymerase active sites corresponds to the length of a 15-16-nucleotide DNA-RNA heteroduplex. Since one helical turn is approximately 10 nucleotides, the distance between the active sites is 1.5 helical turns of heteroduplex. Therefore, the two active sites (catalyzing reactions on opposites strands) binds the same side of the RNA-DNA double helix. RT.RNase H also showed some sequence dependence for the site of hydrolysis. This sequence dependence has not been fully characterized. The rate of RT.RNase H cleavage was weakly inhibited by the next coded deoxynucleoside triphosphate following the incorporation of a dideoxynucleotide.			FURFINE, ES (corresponding author), WELLCOME RES LABS,DIV EXPTL THERAPY,3030 CORNWALLIS RD,RES TRIANGLE PK,NC 27709, USA.							BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; FINSTON WI, 1984, J VIROL, V51, P26, DOI 10.1128/JVI.51.1.26-33.1984; HANSEN J, 1988, EMBO J, V7, P239, DOI 10.1002/j.1460-2075.1988.tb02805.x; HANSEN J, 1987, J BIOL CHEM, V262, P12393; KRUG MS, 1989, P NATL ACAD SCI USA, V86, P3539, DOI 10.1073/pnas.86.10.3539; LARDER B, 1987, EMBO J, V6, P3133, DOI 10.1002/j.1460-2075.1987.tb02623.x; LIGHTFOOTE MM, 1986, J VIROL, V60, P771, DOI 10.1128/JVI.60.2.771-775.1986; Maniatis T., 1982, MOL CLONING; MITRA SW, 1982, J BIOL CHEM, V257, P5983; MITRA SW, 1979, P NATL ACAD SCI USA, V76, P4355, DOI 10.1073/pnas.76.9.4355; OMER CA, 1982, CELL, V30, P797, DOI 10.1016/0092-8674(82)90284-7; OYAMA F, 1989, J BIOL CHEM, V264, P18808; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; RATTRAY AJ, 1989, J MOL BIOL, V208, P445, DOI 10.1016/0022-2836(89)90508-1; RATTRAY AJ, 1987, J VIROL, V61, P2843, DOI 10.1128/JVI.61.9.2843-2851.1987; REARDON JE, 1989, J BIOL CHEM, V264, P19039; REARDON JE, 1989, J BIOL CHEM, V264, P7405; REPASKE R, 1989, J VIROL, V63, P1460, DOI 10.1128/JVI.63.3.1460-1464.1989; RESNICK R, 1984, J VIROL, V51, P813, DOI 10.1128/JVI.51.3.813-821.1984; SCHATZ O, 1990, EMBO J, V9, P1171, DOI 10.1002/j.1460-2075.1990.tb08224.x; STARNES MC, 1989, J BIOL CHEM, V264, P7073; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; TISDALE M, 1988, J VIROL, V62, P3662, DOI 10.1128/JVI.62.10.3662-3667.1988; VERONESE FD, 1986, SCIENCE, V231, P1289, DOI 10.1126/science.2418504	24	179	180	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					406	412						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702425				2022-12-27	WOS:A1991EQ33900059
J	SULLIVAN, PM; PETRUSZ, P; SZPIRER, C; JOSEPH, DR				SULLIVAN, PM; PETRUSZ, P; SZPIRER, C; JOSEPH, DR			ALTERNATIVE PROCESSING OF ANDROGEN-BINDING PROTEIN RNA TRANSCRIPTS IN FETAL-RAT LIVER - IDENTIFICATION OF A TRANSCRIPT FORMED BY TRANSSPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; MESSENGER-RNA; DNA-POLYMERASE; DEOXYRIBONUCLEIC-ACID; IDENTICAL SUBUNITS; WOLFFIAN DUCT; GENE; GLOBULIN; EPIDIDYMIS; EXPRESSION	Androgens and their nuclear receptor regulate genes necessary for development of the male phenotype, a process that is thought to be modulated by extracellular androgen carrier proteins. Two of these carrier proteins, testicular androgen-binding protein (ABP) and plasma sex hormone-binding globulin (SHBG), are encoded by the same gene, but differ in glycosylation and possibly amino acid sequence. To investigate ABP-SHBG gene expression in fetal rat liver, we analyzed RNA transcripts and expressed protein. These studies demonstrated a transient expression of ABP in hepatocytes during the time of testosterone-dependent differentiation of the Wolffian duct. Analysis of cDNA clones derived from fetal rat liver cDNA libraries identified two cDNAs encoded by the ABP-SHBG gene that represented alternatively spliced RNAs. One cDNA had an alternate exon 1, suggesting the function of another promoter in fetal liver. This cDNA also lacked testicular exon 6 DNA, an alteration that implicates the encoded protein in regulatory functions. The other cDNA represented a fused transcript of the ABP-SHBG gene (exons 1-5) and the histidine decarboxylase (HDC) gene, encoding a M(r) 98,000 precursor protein. The two domains were joined at splice junctions of the ABP-SHBG and HDC genes, which were localized to rat chromosomes 10 and 3, respectively. Our results indicate that the joining of the two domains was by a trans (donor and acceptor)-splicing mechanism. Data from Northern hybridization experiments suggest the fusion transcript is present in fetal liver RNA. Polymerase chain reaction experiments with fetal liver cDNA further support the existence of an ABP-HDC fusion transcript, as well as the other alternate mRNA. Moroever, a M(r) 93,000 immunoreactive protein was transiently expressed in fetal liver during the time of ABP and HDC gene expression. Expression of the fusion cDNA in COS cells yielded HDc activity and the predicted size protein (M(r) = 93,000) on Western immunoblots.	UNIV N CAROLINA,DEPT PEDIAT,CHAPEL HILL,NC 27599; UNIV LIBRE BRUXELLES,DEPT MOLEC BIOL,B-1640 RHODE ST GENESE,BELGIUM; UNIV N CAROLINA,DEPT BIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT PHYSIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT ANAT,REPROD BIOL LABS,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; Universite Libre de Bruxelles; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD018968, R01HD021744] Funding Source: NIH RePORTER; NICHD NIH HHS [5-P30-HD-18968, HD-21744] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; CARREAU S, 1986, BINDING PROTEINS STE, P293; CHENG CY, 1985, J BIOL CHEM, V260, P5631; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOQUET Y, 1988, CELL, V52, P903, DOI 10.1016/0092-8674(88)90432-1; DANZO BJ, 1988, J BIOL CHEM, V263, P2402; DANZO BJ, 1977, BIOL REPROD, V17, P64, DOI 10.1095/biolreprod17.1.64; DEANS RJ, 1984, P NATL ACAD SCI-BIOL, V81, P1292, DOI 10.1073/pnas.81.5.1292; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; DEWET JR, 1980, J VIROL, V33, P401, DOI 10.1128/JVI.33.1.401-410.1980; EVELETH DD, 1986, EMBO J, V5, P2663, DOI 10.1002/j.1460-2075.1986.tb04549.x; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FELDMAN M, 1981, J BIOL CHEM, V256, P5170; GERARD A, 1988, ENDOCRINOLOGY, V122, P1297, DOI 10.1210/endo-122-4-1297; GERSHAGEN S, 1989, NUCLEIC ACIDS RES, V17, P9245, DOI 10.1093/nar/17.22.9245; Gunsalus G. L., 1984, Sexual differentiation: basic and clinical aspects., P53; GUNSALUS GL, 1978, SCIENCE, V200, P65, DOI 10.1126/science.635573; HAMMOND GL, 1986, J STEROID BIOCHEM, V24, P815, DOI 10.1016/0022-4731(86)90442-5; HAMMOND GL, 1987, FEBS LETT, V215, P100, DOI 10.1016/0014-5793(87)80121-7; HAMMOND GL, 1989, MOL ENDOCRINOL, V3, P1869, DOI 10.1210/mend-3-11-1869; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; HANSSON V, 1975, MOL CELL ENDOCRINOL, V3, P1, DOI 10.1016/0303-7207(75)90028-3; HANSSON V, 1975, HDB PHYSIOLOGY     7, V5, P173; HEGSTRAND LR, 1985, BIOCHEM PHARMACOL, V34, P3711, DOI 10.1016/0006-2952(85)90235-7; HEPLER JR, 1988, J HISTOCHEM CYTOCHEM, V36, P13, DOI 10.1177/36.1.2891743; HRYB DJ, 1989, J BIOL CHEM, V264, P5378; HRYB DJ, 1990, J BIOL CHEM, V265, P6048; ISLAM MQ, 1989, J CELL SCI, V92, P147; JOSEPH DR, 1985, J ANDROL, V6, P392; JOSEPH DR, 1990, P NATL ACAD SCI USA, V87, P733, DOI 10.1073/pnas.87.2.733; JOSEPH DR, 1987, P NATL ACAD SCI USA, V84, P339, DOI 10.1073/pnas.84.2.339; JOSEPH DR, 1988, MOL ENDOCRINOL, V2, P3, DOI 10.1210/mend-2-1-3; JOSEPH DR, 1990, IN PRESS CYTOGENET C; JOSSO N, 1970, ARCH ANAT MICROSC MO, V59, P37; KASLOW DC, 1986, NUCLEIC ACIDS RES, V14, P6767, DOI 10.1093/nar/14.16.6767; KEEPING HS, 1985, ENDOCRINOLOGY, V117, P1521, DOI 10.1210/endo-117-4-1521; KIMURA H, 1989, J BIOL CHEM, V264, P2338; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; KONARSKA MM, 1985, CELL, V42, P165, DOI 10.1016/S0092-8674(85)80112-4; KOVACS WJ, 1988, ENDOCRINOLOGY, V122, P2639, DOI 10.1210/endo-122-6-2639; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEE CC, 1988, SCIENCE, V239, P1288, DOI 10.1126/science.3344434; Maniatis T., 1982, MOL CLONING; MCKINNON RD, 1987, MOL CELL BIOL, V7, P2148, DOI 10.1128/MCB.7.6.2148; MCKINNON RD, 1986, P NATL ACAD SCI USA, V83, P3751, DOI 10.1073/pnas.83.11.3751; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILNER RJ, 1984, P NATL ACAD SCI-BIOL, V81, P713, DOI 10.1073/pnas.81.3.713; MURPHY WJ, 1986, CELL, V47, P517, DOI 10.1016/0092-8674(86)90616-1; NAKHLA AM, 1988, BIOCHEM BIOPH RES CO, V153, P1012, DOI 10.1016/S0006-291X(88)81329-9; ORDRONNEAU P, 1981, J HISTOCHEM CYTOCHEM, V29, P1397, DOI 10.1177/29.12.7033366; PETRA PH, 1986, BINDING PROTEINS STE, P137; RAISMAN G, 1971, SCIENCE, V173, P731, DOI 10.1126/science.173.3998.731; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RITZEN EM, 1971, ENDOCRINOLOGY, V89, P143; RITZEN EM, 1982, MOL CELL ENDOCRINOL, V25, P25, DOI 10.1016/0303-7207(82)90166-6; ROSKOSKI R, 1978, ANAL BIOCHEM, V87, P293, DOI 10.1016/0003-2697(78)90599-7; ROSNER W, 1990, ENDOCR REV, V11, P80, DOI 10.1210/edrv-11-1-80; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1975, J MOL BIOL, V94, P441, DOI 10.1016/0022-2836(75)90213-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SCHULTZ FM, 1974, ENDOCRINOLOGY, V94, P979; SINGER CJ, 1988, ENDOCRINOLOGY, V122, P89, DOI 10.1210/endo-122-1-89; SOLNICK D, 1985, CELL, V42, P157, DOI 10.1016/S0092-8674(85)80111-2; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; SZPIRER C, 1988, CURR TOP MICROBIOL, V137, P33; SZPIRER J, 1984, CYTOGENET CELL GENET, V38, P142, DOI 10.1159/000132047; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TINDALL DJ, 1974, ENDOCRINOLOGY, V95, P1119, DOI 10.1210/endo-95-4-1119; WADA H, 1990, IN PRESS ANN NY ACAD; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P6383; WALSH KA, 1986, BIOCHEMISTRY-US, V25, P7584, DOI 10.1021/bi00371a048; WANG YM, 1989, MOL CELL ENDOCRINOL, V63, P85, DOI 10.1016/0303-7207(89)90084-1; WEISZ J, 1980, ENDOCRINOLOGY, V106, P306, DOI 10.1210/endo-106-1-306; WILSON EM, 1979, J BIOL CHEM, V254, P6310; WILSON JD, 1989, METABOLIC BASIS INHE, P1919	79	104	111	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					143	154						12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702422				2022-12-27	WOS:A1991EQ33900024
J	KONKLE, BA; KOLLROS, PR; KELLY, MD				KONKLE, BA; KOLLROS, PR; KELLY, MD			HEPARIN-BINDING GROWTH FACTOR-I MODULATION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 EXPRESSION - INTERACTION WITH CAMP AND PROTEIN-KINASE C-MEDIATED PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PEDIAT,PHILADELPHIA,PA 19107	Jefferson University	KONKLE, BA (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MED,CARDEZA FDN HEMATOL RES,PHILADELPHIA,PA 19107, USA.		Konkle, Barbara/GPX-3325-2022; Konkle, Barbara A/AAD-7712-2022	Konkle, Barbara A/0000-0002-3959-8797				BACHMANN F, 1987, THROMB DIATH HAEMO, P227; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BERTOZZI P, 1990, NEW ENGL J MED, V322, P890, DOI 10.1056/NEJM199003293221304; BOSMA PJ, 1988, J BIOL CHEM, V263, P9129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BROWN KD, 1989, FEBS LETT, V247, P227, DOI 10.1016/0014-5793(89)81340-7; BRUZDZINSKI CJ, 1990, J BIOL CHEM, V265, P2078; CANALIS E, 1987, J CLIN INVEST, V79, P52, DOI 10.1172/JCI112807; DEGEN SJF, 1986, J BIOL CHEM, V261, P6972; DERIAN CK, 1986, J BIOL CHEM, V261, P3831; DUMONT JE, 1989, TRENDS BIOCHEM SCI, V14, P67, DOI 10.1016/0968-0004(89)90046-7; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FRIESEL R, 1988, BIOCHEM BIOPH RES CO, V151, P957, DOI 10.1016/S0006-291X(88)80459-5; GAY CG, 1990, J BIOL CHEM, V265, P3284; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761; GLANTZ SA, 1987, PRIMER BIOSTATISTICS, P64; HARPER JF, 1975, J CYCLIC NUCL PROT, V1, P207; HEATON JH, 1989, MOL ENDOCRINOL, V3, P185, DOI 10.1210/mend-3-1-185; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HOSH H, 1989, FASEB J, V2, P2797; HUANG SS, 1986, J BIOL CHEM, V261, P9568; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; KAN M, 1988, J BIOL CHEM, V263, P11306; KOLLROS PE, 1990, BRAIN RES, V511, P259, DOI 10.1016/0006-8993(90)90170-G; KOLLROS PR, 1987, LAB INVEST, V56, P410; KONKLE BA, 1988, J CLIN INVEST, V82, P579, DOI 10.1172/JCI113635; KOOISTRA T, 1987, BIOCHEM J, V247, P605, DOI 10.1042/bj2470605; LEVIN EG, 1989, J BIOL CHEM, V264, P16030; LINDSTEN T, 1988, EMBO J, V7, P2787, DOI 10.1002/j.1460-2075.1988.tb03133.x; LOBB R, 1986, J BIOL CHEM, V261, P1924; LOSKUTOFF DJ, 1987, BIOCHEMISTRY-US, V26, P3763, DOI 10.1021/bi00387a004; MACIAG T, 1981, J CELL BIOL, V91, P420, DOI 10.1083/jcb.91.2.420; MAGNALDO I, 1986, J BIOL CHEM, V261, P6916; MANIATIS T, 1982, MOL CLONING LABORATO, P187; MAYER M, 1988, J BIOL CHEM, V263, P15688; MICHELSON AM, 1983, P NATL ACAD SCI-BIOL, V80, P472, DOI 10.1073/pnas.80.2.472; MIGNATTI P, 1989, J CELL BIOL, V108, P671, DOI 10.1083/jcb.108.2.671; MIOH H, 1987, BIOCHEM BIOPH RES CO, V146, P771; MOSCAT J, 1988, P NATL ACAD SCI USA, V85, P659, DOI 10.1073/pnas.85.3.659; NISHIKAWA M, 1986, LIFE SCI, V39, P1101, DOI 10.1016/0024-3205(86)90202-X; RAPPAPORT RS, 1988, THROMB HAEMOSTASIS, V59, P514; ROZENGURT E, 1983, CELL, V34, P265, DOI 10.1016/0092-8674(83)90157-5; SANTELL L, 1988, J BIOL CHEM, V263, P16802; SAWDEY M, 1989, J BIOL CHEM, V264, P10396; SCHLEEF RR, 1988, J BIOL CHEM, V263, P5797; SLIVKA S, 1989, FIBRINOLYSIS S, V3, P40; SPRENGERS ED, 1987, BLOOD, V69, P381; THORNTON SC, 1983, SCIENCE, V222, P623, DOI 10.1126/science.6635659; VANDENBERG EA, 1988, THROMB HAEMOSTASIS, V60, P63; VANZONNEVELD AJ, 1988, P NATL ACAD SCI USA, V85, P5525; WALLER EK, 1985, J BIOL CHEM, V260, P6354; WEINMASTER G, 1990, EMBO J, V9, P915, DOI 10.1002/j.1460-2075.1990.tb08189.x; WERB Z, 1980, J EXP MED, V152, P1340, DOI 10.1084/jem.152.5.1340; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; WINKLES JA, 1987, P NATL ACAD SCI USA, V84, P7124, DOI 10.1073/pnas.84.20.7124; WU PH, 1984, GEN PHARMACOL, V15, P251, DOI 10.1016/0306-3623(84)90169-1; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303	61	25	25	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21867	21873						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1701436				2022-12-27	WOS:A1990EM45600075
J	MOESTRUP, SK; KALTOFT, K; SOTTRUPJENSEN, L; GLIEMANN, J				MOESTRUP, SK; KALTOFT, K; SOTTRUPJENSEN, L; GLIEMANN, J			THE HUMAN ALPHA-2-MACROGLOBULIN RECEPTOR CONTAINS HIGH-AFFINITY CALCIUM-BINDING SITES IMPORTANT FOR RECEPTOR CONFORMATION AND LIGAND RECOGNITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									AARHUS UNIV,INST HUMAN GENET,DK-8000 AARHUS,DENMARK; AARHUS UNIV,DEPT MOLEC BIOL,DK-8000 AARHUS,DENMARK	Aarhus University; Aarhus University	MOESTRUP, SK (corresponding author), AARHUS UNIV,INST PHYSIOL,DK-8000 AARHUS,DENMARK.		Moestrup, Søren Kragh/A-1403-2014; Moestrup, Søren Kragh/AAD-1735-2019	Moestrup, Søren Kragh/0000-0003-3862-2107; 				ANDERSEN TT, 1982, J BIOL CHEM, V257, P8036; BARKHOLT V, 1989, ANAL BIOCHEM, V177, P318, DOI 10.1016/0003-2697(89)90059-6; BLOMHOFF R, 1982, J BIOL CHEM, V257, P7456; BURGER D, 1984, BIOCHEMISTRY-US, V23, P1966, DOI 10.1021/bi00304a013; COX JA, 1981, J BIOL CHEM, V256, P3218; DAVIDSEN O, 1985, BIOCHIM BIOPHYS ACTA, V846, P85, DOI 10.1016/0167-4889(85)90113-2; DIXON SJ, 1987, J CELL PHYSIOL, V132, P215, DOI 10.1002/jcp.1041320205; FELDMAN SR, 1985, BIOCHEM BIOPH RES CO, V128, P795, DOI 10.1016/0006-291X(85)90117-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GLIEMANN J, 1989, BIOCHIM BIOPHYS ACTA, V980, P326, DOI 10.1016/0005-2736(89)90320-9; GLIEMANN J, 1986, BIOCHIM BIOPHYS ACTA, V885, P49, DOI 10.1016/0167-4889(86)90037-6; GLIEMANN J, 1983, BIOCHIM BIOPHYS ACTA, V756, P230, DOI 10.1016/0304-4165(83)90096-X; GLIEMANN J, 1986, BIOCHIM BIOPHYS ACTA, V883, P400, DOI 10.1016/0304-4165(86)90276-X; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; Hirs CHW, 1967, METHOD ENZYMOL, P59, DOI [10.1016/S0076-6879(67)11008-2, DOI 10.1016/S0076-6879(67)11008-2]; JENSEN PH, 1988, PLACENTA, V9, P463, DOI 10.1016/0143-4004(88)90019-7; JENSEN PH, 1989, FEBS LETT, V255, P275, DOI 10.1016/0014-5793(89)81105-6; JOHNSON JD, 1979, J BIOL CHEM, V254, P3497; KAPLAN J, 1979, J BIOL CHEM, V254, P7323; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOEB JA, 1988, J BIOL CHEM, V263, P9752; MAGNUSSON S, 1975, PROTEASES BIOL CONTR, P123; MARAYUMA K, 1984, J BIOCH, V95, P511; MOESTRUP SK, 1989, J BIOL CHEM, V264, P15574; MOESTRUP SK, 1987, BIOCHIM BIOPHYS ACTA, V930, P927; MOESTRUP SK, 1990, IN PRESS EXP CELL RE; PETERSEN CM, 1988, EUR J CLIN INVEST, V18, P184, DOI 10.1111/j.1365-2362.1988.tb02411.x; PETERSEN CM, 1987, SCAND J CLIN LAB INV, V47, P55; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; VANLEUVEN F, 1979, J BIOL CHEM, V254, P5155; VANLEUVEN F, 1986, J BIOL CHEM, V261, P6622; VYAS MN, 1989, J BIOL CHEM, V264, P20817; WANG CL, 1985, BIOCHEM BIOPH RES CO, V130, P126	38	78	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1990	265	21					12623	12628						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DP458	1695632				2022-12-27	WOS:A1990DP45800076
J	DHAR, A; SHUKLA, SD				DHAR, A; SHUKLA, SD			INVOLVEMENT OF PP60C-SRC IN PLATELET-ACTIVATING FACTOR-STIMULATED PLATELETS - EVIDENCE FOR TRANSLOCATION FROM CYTOSOL TO MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; RABBIT PLATELETS; PHOSPHOLIPASE-C; CYTOPLASMIC DOMAINS; PHOSPHORYLATION; RECEPTOR; THROMBIN; P56LCK; CD4; DESENSITIZATION	We have investigated the characteristics of platelet-activating factor (PAF)-stimulated protein tyrosine phosphorylation in rabbit platelets and its relationship to pp60c-src P-32-Labeled platelets were challenged with PAF (10(-7) M) for 15 s, the reaction was killed by lysis at 4-degrees-C, and samples were loaded onto a phosphotyrosine monoclonal antibody (Tyr(P)-mAb)-agarose column. The column was eluted with 10 mM phenyl phosphate, and the fractions were collected. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, followed by autoradiography of the column fractions, showed that PAF increased the radioactivity of about a dozen protein bands with predominant ones of approximate molecular masses of 50, 60, 71, 82, and 300 kDa. When Tyr(P)-mAb-agarose column fractions were subjected to immunoblotting with pp60v-src mAb, it was observed that PAF treatment increased the reactivity of 50- and 60-kDa protein species. Immuno-precipitation with pp60v-src mAb further confirmed that PAF treatment increased phosphorylation of the 60- and 50-kDa proteins. Polyclonal antibody to G-protein (alpha-subunit) did not exhibit any reactivity to the column fractions and thus ruled out this protein as substrate for the tyrosine kinase. We next attempted to localize the pp60c-src. Platelet membrane particulate and cytosol fractions were separated from control and PAF-treated platelets, and it was observed that the immunoreactivity to pp60v-src mAb dramatically increased in the particulate membrane fraction from PAF-treated platelets. A concomitant decrease in the immunoreactivity in the cytosol fraction of PAF-treated platelets was also noted. It is concluded that PAF stimulates phosphorylation of pp60c-src tyrosine kinase and causes its rapid translocation from cytosol to membranes in rabbit platelets.	UNIV MISSOURI,SCH MED,DEPT PHARMACOL,M517B MED SCI BLDG,1 HOSP DR,COLUMBIA,MO 65212	University of Missouri System; University of Missouri Columbia					NIDDK NIH HHS [1 K04 DK 01782, 5R01 DK 35170] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035170, K04DK001782] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; DHAR A, 1990, MOL PHARMACOL, V37, P519; DHAR A, 1991, BIOCHIM BIOPHYS ACTA, V1091, P15, DOI 10.1016/0167-4889(91)90215-J; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FEDER D, 1990, J BIOL CHEM, V265, P8205; FERRELL JE, 1988, MOL CELL BIOL, V8, P3603, DOI 10.1128/MCB.8.9.3603; GLAZER KB, 1990, J BIOL CHEM, V265, P8658; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; GOMEZCAMBRONERO J, 1991, J BIOL CHEM, V266, P6240; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.bi.55.070186.002411; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; HWANG SB, 1990, J LIPID MEDIATOR, V2, P123; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORRISON WJ, 1989, J PHARMACOL EXP THER, V250, P831; MORRISON WJ, 1989, LIFE SCI, V45, P333, DOI 10.1016/0024-3205(89)90143-4; MORRISON WJ, 1988, MOL PHARMACOL, V35, P409; NAKAMURA S, 1985, FEBS LETT, V184, P56, DOI 10.1016/0014-5793(85)80652-9; NAKAMURA S, 1989, J BIOL CHEM, V264, P7089; OKADA M, 1989, J BIOL CHEM, V264, P20886; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; RENDU F, 1989, BLOOD, V73, P1545; REUTER C, 1990, EUR J BIOCHEM, V190, P343, DOI 10.1111/j.1432-1033.1990.tb15581.x; SALARI H, 1990, FEBS LETT, V263, P104, DOI 10.1016/0014-5793(90)80715-U; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SHAW AS, 1990, MOL CELL BIOL, V10, P1853, DOI 10.1128/MCB.10.5.1853; SHUKLA SD, 1989, MOL PHARMACOL, V35, P409; SHUKLA SD, 1982, BIOCHEM BIOPH RES CO, V106, P697, DOI 10.1016/0006-291X(82)91767-3; SHUKLA SD, 1991, IN PRESS LIPIDS, V26; SNYDER F, 1985, MED RES REV, V5, P107, DOI 10.1002/med.2610050105; TAKAYAMA H, 1991, BIOCHEM BIOPH RES CO, V174, P922, DOI 10.1016/0006-291X(91)91506-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; TUY FPD, 1983, NATURE, V305, P435	37	64	65	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18797	18801						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717453				2022-12-27	WOS:A1991GJ47200061
J	ROYCHOWDHURY, J; HUANG, TJ; KESARI, K; LEDERSTEIN, M; ARIAS, IM; ROYCHOWDHURY, N				ROYCHOWDHURY, J; HUANG, TJ; KESARI, K; LEDERSTEIN, M; ARIAS, IM; ROYCHOWDHURY, N			MOLECULAR-BASIS FOR THE LACK OF BILIRUBIN-SPECIFIC AND 3-METHYLCHOLANTHRENE-INDUCIBLE UDP-GLUCURONOSYLTRANSFERASE ACTIVITIES IN GUNN-RATS - THE 2 ISOFORMS ARE ENCODED BY DISTINCT MESSENGER-RNA SPECIES THAT SHARE AN IDENTICAL SINGLE BASE DELETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROID 21-HYDROXYLASE DEFICIENCY; LIVER; INDUCTION; MECHANISM; MUTATIONS; CDNA; DNA	Gunn rats lack UDP-glucuronosyltransferase (UDPGT) activity toward bilirubin. In addition, a UDPGT isoform which is active toward 4-nitrophenol and is induced by 3-methylcholanthrene (3-MC) in normal rats, is produced in a nonfunctional truncated form in Gunn rats due to the deletion of a single guanosine residue in the coding region of its mRNA. The hepatic concentration of bilirubin-UDPGT mRNA was lower in Gunn rats than in congenic normal rats. However, bilirubin-UDPGT mRNA was of apparently normal length and was induced by clofibrate, a known inducer of bilirubin-UDPGT activity. 3' regions of bilirubin- and 3-MC-inducible UDPGT mRNAs have identical nucleotide sequences; the single base deletion in the 3-MC-inducible UDPGT in Gunn rats occurs within this region. Using oligonucleotide primers corresponding to the identical and unique regions of the two mRNAs, and polymerase chain reaction, we amplified segments of mRNAs for the bilirubin- and 3-MC-inducible UDPGTs from normal and Gunn rat livers. Both amplified DNAs in Gunn rats lacked the restriction site for BstNI. Nucleotide sequence determination revealed that bilirubin- and 3-MC-inducible UDPGT mRNAs in Gunn rats contain an identical frame-shift deletion of a single guanosine residue within the common region of their coding sequences.	ROCKEFELLER UNIV, HOWARD HUGHES MED INST, NEW YORK, NY 10021 USA; TUFTS UNIV, SCH MED, DEPT PHYSIOL, BOSTON, MA 02155 USA; TUFTS UNIV, SCH MED, DEPT MED, BOSTON, MA 02155 USA	Howard Hughes Medical Institute; Rockefeller University; Tufts University; Tufts University	ROYCHOWDHURY, J (corresponding author), YESHIVA UNIV ALBERT EINSTEIN COLL MED, LIVER RES CTR, ULLMAN 625, 1300 MORRIS PK AVE, BRONX, NY 10461 USA.				NIDDK NIH HHS [DK35652, DK34357, DK39137] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039137, R01DK035652, R37DK035652, R01DK034357] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; BOCK KW, 1988, BIOCHEM PHARMACOL, V37, P1439, DOI 10.1016/0006-2952(88)90004-4; BURCHELL B, 1981, REV BIOCHEM TOXICOL, V3, P1; CARBONE JV, 1957, P SOC EXP BIOL MED, V94, P461; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOWDHURY JR, 1986, BIOCHEM J, V233, P827, DOI 10.1042/bj2330827; CHOWDHURY NR, 1987, J CLIN INVEST, V79, P327, DOI 10.1172/JCI112816; DAAR IO, 1988, MOL CELL BIOL, V8, P802, DOI 10.1128/MCB.8.2.802; DRUCKER WD, 1968, P SOC EXP BIOL MED, V129, P308; Dutton G., 1980, GLUCURONIDATION DRUG, P3; ELAWADY M, 1990, J BIOL CHEM, V265, P10752; FALANY CN, 1986, BIOCHEM J, V238, P65, DOI 10.1042/bj2380065; Gunn CH, 1938, J HERED, V29, P137, DOI 10.1093/oxfordjournals.jhered.a104478; HARADA F, 1987, P NATL ACAD SCI USA, V84, P8091, DOI 10.1073/pnas.84.22.8091; HIGASHI Y, 1988, P NATL ACAD SCI USA, V85, P7486, DOI 10.1073/pnas.85.20.7486; IYANAGI T, 1989, J BIOL CHEM, V264, P21302; IYANAGI T, 1986, J BIOL CHEM, V261, P5607; JANSEN PLM, 1977, J BIOL CHEM, V252, P2710; KIMURA H, 1989, J BIOL CHEM, V264, P2338; MACKENZIE PI, 1990, J BIOL CHEM, V265, P3432; MACKENZIE PI, 1989, CLIN EXP PHARMACOL P, V16, P501, DOI 10.1111/j.1440-1681.1989.tb01595.x; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; ROYCHOWDHURY N, 1986, HEPATOLOGY, V6, P123; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SATO H, 1990, BIOCHEM BIOPH RES CO, V169, P260, DOI 10.1016/0006-291X(90)91462-2; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; VAINIO H, 1974, BIOCHIM BIOPHYS ACTA, V362, P92, DOI 10.1016/0304-4165(74)90030-0; WATKINS JB, 1982, DRUG METAB DISPOS, V10, P590; WEATHERILL PJ, 1978, FEBS LETT, V87, P207, DOI 10.1016/0014-5793(78)80333-0	30	29	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					18294	18298						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717446				2022-12-27	WOS:A1991GG55300087
J	GRONDIN, P; PLANTAVID, M; SULTAN, C; BRETON, M; MAUCO, G; CHAP, H				GRONDIN, P; PLANTAVID, M; SULTAN, C; BRETON, M; MAUCO, G; CHAP, H			INTERACTION OF PP60C-SRC, PHOSPHOLIPASE-C, INOSITOL-LIPID, AND DIACYLGLYCEROL KINASES WITH THE CYTOSKELETONS OF THROMBIN-STIMULATED PLATELETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I PHOSPHATIDYLINOSITOL KINASE; BLOOD-PLATELETS; TYROSINE PHOSPHORYLATION; POLYPHOSPHOINOSITIDES; 4,5-BISPHOSPHATE; ACTIVATION; 3,4-BISPHOSPHATE; TRANSFORMATION; LOCALIZATION; PURIFICATION	Phosphatidylinositol (PtdIns)-4- and -3-kinases, PtdIns(4)P-5-kinase, diacylglycerol (DAG) kinase, and PtdIns-phospholipase C were all detected in cytoskeletons of resting human platelets. The total cytoskeletal enzyme activities were greatly increased upon thrombin stimulation of the intact cells. Those reached a maximum after a 60-s stimulation for PtdIns(4)P-5-kinase and phospholipase C, while the other kinases appeared to be slightly delayed. Specific activities were stimulated from about 4-fold (Ptdlns-3-kinase) to about 6-fold (PtdIns-4-kinase). Thrombin treatment also promoted a co-extraction of pp60c-src with the cytoskeletons and its disappearance from the Triton X-100 soluble fraction. These results suggest that stimulation of platelets by thrombin causes the association of enzymes responsible for lipid phosphorylation and hydrolysis with the cytoskeletons. This could occur at cytoskeleton anchoring points to the membranes.	HOP PURPAN,INSERM,UNITE 326,F-31059 TOULOUSE,FRANCE	CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)			Mauco, Gerard/A-3164-2016	Mauco, Gerard/0000-0003-2998-2397; Racaud-Sultan, Claire/0000-0002-6549-1088				ARDLIE NG, 1970, BRIT J HAEMATOL, V19, P7, DOI 10.1111/j.1365-2141.1970.tb01596.x; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURN P, 1985, NATURE, V314, P469, DOI 10.1038/314469a0; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; COUGHLIN SR, 1989, SCIENCE, V243, P1191; COURTNEIDGE SA, 1987, CELL, V50, P1031, DOI 10.1016/0092-8674(87)90169-3; FERRELL JE, 1990, ONCOGENE, V5, P1033; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; GOLDEN A, 1989, P NATL ACAD SCI USA, V86, P901, DOI 10.1073/pnas.86.3.901; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GUTKIND JS, 1990, MOL CELL BIOL, V10, P3806, DOI 10.1128/MCB.10.7.3806; IRVINE RF, 1989, BIOCHEM SOC T, V17, P6, DOI 10.1042/bst0170006; JANMEY PA, 1988, J BIOL CHEM, V263, P16738; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; KANOH H, 1990, BIOCHIM BIOPHYS ACTA, V1046, P120, DOI 10.1016/0005-2760(90)90178-Z; KAPLAN DR, 1986, P NATL ACAD SCI USA, V83, P3624, DOI 10.1073/pnas.83.11.3624; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; KUCERA GL, 1990, J BIOL CHEM, V265, P5345; LASSING I, 1988, EXP CELL RES, V174, P1, DOI 10.1016/0014-4827(88)90136-X; LASSING I, 1990, FEBS LETT, V262, P231, DOI 10.1016/0014-5793(90)80197-Q; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; MAUCO G, 1987, BIOCHEM J, V244, P757, DOI 10.1042/bj2440757; MORGAN SJ, 1990, EUR J BIOCHEM, V191, P761, DOI 10.1111/j.1432-1033.1990.tb19185.x; NAHAS N, 1989, FEBS LETT, V246, P30, DOI 10.1016/0014-5793(89)80247-9; NOLAN RD, 1990, J BIOL CHEM, V265, P2441; PAYRASTRE B, 1990, BIOCHEM J, V272, P665, DOI 10.1042/bj2720665; PERRET BP, 1983, BIOCHEM BIOPH RES CO, V110, P660, DOI 10.1016/0006-291X(83)91200-7; PHO DB, 1984, FEBS LETT, V173, P164, DOI 10.1016/0014-5793(84)81039-X; RENDU F, 1989, BLOOD, V73, P1545; ROCK CO, 1987, J BIOL CHEM, V262, P5492; Schacht J, 1981, Methods Enzymol, V72, P626; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; TRAYNORKAPLAN AE, 1989, J BIOL CHEM, V264, P15668; TUSZYNSKI GP, 1984, J BIOL CHEM, V259, P6947; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WHITMAN M, 1987, BIOCHEM J, V247, P165, DOI 10.1042/bj2470165; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0	40	197	197	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15705	15709						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714896				2022-12-27	WOS:A1991GB97700031
J	LIN, D; HARIKRISHNA, JA; MOORE, CCD; JONES, KL; MILLER, WL				LIN, D; HARIKRISHNA, JA; MOORE, CCD; JONES, KL; MILLER, WL			MISSENSE MUTATION SERINE-106 -] PROLINE CAUSES 17-ALPHA-HYDROXYLASE DEFICIENCY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN-CLEAVAGE; NEONATAL PIG TESTIS; MICROSOMAL CYTOCHROME-P-450; SACCHAROMYCES-CEREVISIAE; P450SCC 20,22-DESMOLASE; GENE; EXPRESSION; LYASE; CELLS; ENZYME	Steroid 17-alpha-hydroxylase deficiency is caused by defects in cytochrome P450c17, the single enzyme that has 17-alpha-hydroxylase and 17,20-lyase activities. We describe a rapid and efficient polymerase chain reaction tactic for identifying these genetic lesions and identify Ser106 --> Pro as the cause of 17-alpha-hydroxylase deficiency in two unrelated homozygous patients from Guam. We used site-directed mutagenesis of the normal P450cl7 cDNA to construct the Pro106 mutant, and expressed both the normal and mutant sequences in monkey COS-1 cells and in yeast. Expression of the normal sequence permitted the cells to convert pregnenolone to 17-OH pregnenolone, progesterone to 17-OH progesterone, and 17-OH pregnenolone to dehydroepiandrosterone, showing the normal sequence conferred both 17-alpha-hydroxylase and 17,20-lyase activities. Expression of the mutant sequence generated P450c17 mRNA, but conferred none of these activities, proving that the Ser106 --> Pro mutation abolished the 17-alpha-hydroxylase and 17,20-lyase activities. An HhaI restriction site created by the mutation should permit screening of large populations.	UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,BLDG MR-IV,RM 209,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,METAB RES UNIT,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,GRAD PROGRAM ENDOCRINOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN DIEGO,DEPT PEDIAT,LA JOLLA,CA 92093	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego			Miller, Walter L/J-3696-2012; Harikrishna, Jennifer Ann/B-2778-2010	Harikrishna, Jennifer Ann/0000-0002-4687-709X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037922, R01DK042154] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 42154, DK37922] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHLGREN R, 1990, J BIOL CHEM, V265, P3313; BRENTANO ST, 1990, MOL ENDOCRINOL, V4, P1972, DOI 10.1210/mend-4-12-1972; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHUNG BC, 1987, P NATL ACAD SCI USA, V84, P407, DOI 10.1073/pnas.84.2.407; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FEVOLD HR, 1989, MOL ENDOCRINOL, V3, P968, DOI 10.1210/mend-3-6-968; GOLDSMITH.O, 1967, NEW ENGL J MED, V277, P673, DOI 10.1056/NEJM196709282771302; HADFIELD C, 1986, GENE, V45, P149, DOI 10.1016/0378-1119(86)90249-0; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KRONBACH T, 1991, J BIOL CHEM, V266, P6215; LAUGHTON CA, 1990, BIOCHEM BIOPH RES CO, V171, P1160, DOI 10.1016/0006-291X(90)90806-X; LINDBERG RLP, 1989, NATURE, V339, P632, DOI 10.1038/339632a0; LUND J, 1990, J BIOL CHEM, V265, P3304; MATTESON KJ, 1986, J CLIN ENDOCR METAB, V63, P789, DOI 10.1210/jcem-63-3-789; MELLON SH, 1989, P NATL ACAD SCI USA, V86, P7775, DOI 10.1073/pnas.86.20.7775; MELLON SH, 1991, J CLIN ENDOCR METAB, V72, P19, DOI 10.1210/jcem-72-1-19; MOORE CCD, 1990, MOL CELL BIOL, V10, P6013, DOI 10.1128/MCB.10.11.6013; MOREL Y, 1989, J CLIN ENDOCR METAB, V68, P592, DOI 10.1210/jcem-68-3-592; NAKAJIN S, 1981, J BIOL CHEM, V256, P6134; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; NAKAJIN S, 1981, BIOCHEMISTRY-US, V20, P4037, DOI 10.1021/bi00517a014; NAKAJIN S, 1984, J BIOL CHEM, V259, P3971; NEBERT DW, 1991, DNA CELL BIOL, V10, P1, DOI 10.1089/dna.1991.10.1; OZOLS J, 1981, J BIOL CHEM, V266, P6215; PENHOAT A, 1991, J CLIN ENDOCR METAB, V72, P23, DOI 10.1210/jcem-72-1-23; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; PICADOLEONARD J, 1988, MOL ENDOCRINOL, V2, P1145, DOI 10.1210/mend-2-11-1145; SAENGER P, 1984, J PEDIATR-US, V104, P1, DOI 10.1016/S0022-3476(84)80581-8; SAKAKI T, 1989, DNA-J MOLEC CELL BIO, V8, P409, DOI 10.1089/dna.1.1989.8.409; SPARKES RS, 1991, DNA CELL BIOL, V10, P359, DOI 10.1089/dna.1991.10.359; TOWNSEND SF, 1990, J BIOL CHEM, V265, P22117; VOUTILAINEN R, 1987, P NATL ACAD SCI USA, V84, P1590, DOI 10.1073/pnas.84.6.1590; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P202, DOI 10.1210/jcem-63-1-202; VOUTILAINEN R, 1986, J CLIN ENDOCR METAB, V63, P1145, DOI 10.1210/jcem-63-5-1145; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P8429; YANASE T, 1991, ENDOCR REV, V12, P91, DOI 10.1210/edrv-12-1-91; ZUBER MX, 1986, SCIENCE, V234, P1258, DOI 10.1126/science.3535074	39	135	140	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15992	15998						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714904				2022-12-27	WOS:A1991GB97700071
J	ATTANASIO, R; DILLEY, D; BUCK, D; MAINO, VC; LOHMAN, KL; KANDA, P; KENNEDY, RC				ATTANASIO, R; DILLEY, D; BUCK, D; MAINO, VC; LOHMAN, KL; KANDA, P; KENNEDY, RC			STRUCTURAL CHARACTERIZATION OF A CROSS-REACTIVE IDIOTYPE SHARED BY MONOCLONAL-ANTIBODIES SPECIFIC FOR THE HUMAN CD4 MOLECULE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SEQUENCE; HYPERVARIABLE REGION; REGULATORY IDIOTOPE; NUCLEAR TRANSPORT; MYELOMA PROTEINS; ANTI-IDIOTYPES; LIGHT CHAIN; BINDING; DETERMINANTS; SITE	A panel of mouse monoclonal anti-CD4 antibodies was characterized in terms of idiotypic expression by using specific anti-idiotypic antibody (anti-Id) reagents generated in rabbits immunized with anti-Leu3a, a monoclonal anti-CD4 which inhibits the human immunodeficiency virus (HIV) gp120 binding to CD4. Direct binding and competitive inhibition assays demonstrate that the majority of monoclonal anti-CD4 antibodies able to recognize CD4 epitopes overlapping the epitope recognized by anti-Leu3a expressed an antigen-combining site-related cross-reactive idiotype (IdX). Western blot analysis was used to demonstrate that this IdX is associated primarily with the light (L) chain of the monoclonal anti-CD4 antibodies. To further characterize the structural basis of the IdX, the nucleotide sequence of the variable region of the L kappa-chain of anti-Leu3a was determined. Peptides corresponding to the first, second, and third complementarity determining regions (CDRs) of the L chain of anti-Leu3a were synthesized and used to immunize rabbits. All anti-peptide antisera recognized the immunizing peptide, the cognate anti-Leu3a molecule, and several other monoclonal anti-CD4 antibodies by direct binding assays. Western blot analysis utilizing the anti-CDR peptide reagents demonstrates that the reactivity to the monoclonal anti-CD4 antibodies was L chain-specific. The anti-Id generated by immunizing with the intact anti-Leu3a molecule failed to recognize the three L chain-derived CDR synthetic peptides, suggesting that the IdX requires the presence of the three-dimensional configuration of the L chain for its expression. The broad range of reactivity exhibited by the antipeptide antisera indicates that the majority of mouse monoclonal anti-CD4 antibodies characterized in this study utilize L chains encoded by a single germ line variable (V) region-kappa (V-kappa) chain gene or by V-kappa-genes that belong to the same gene family.	SW FDN BIOMED RES, DEPT VIROL & IMMUNOL, POB 28147, SAN ANTONIO, TX 78228 USA; BECKMAN DICKINSON IMMUNOCYTOMETRY SYST, SAN JOSE, CA 95131 USA	Texas Biomedical Research Institute					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI026462, P30AI028696] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-28696, AI-26462] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHOS J, 1989, CELL, V57, P469, DOI 10.1016/0092-8674(89)90922-7; ATTANASIO R, 1991, J IMMUNOL, V146, P507; ATTANASIO R, 1990, MOL IMMUNOL, V27, P513, DOI 10.1016/0161-5890(90)90070-G; BLACKWELL TK, 1989, ANNU REV GENET, V23, P605, DOI 10.1146/annurev.ge.23.120189.003133; BONA CA, 1988, BIOL APPLICATIONS AN, V1; BORDEN P, 1988, MOL IMMUNOL, V25, P251, DOI 10.1016/0161-5890(88)90016-8; BRIENT BW, 1971, P NATL ACAD SCI USA, V68, P3136, DOI 10.1073/pnas.68.12.3136; CANNON LE, 1983, MOL IMMUNOL, V20, P1283, DOI 10.1016/0161-5890(83)90158-X; CARSON D, 1973, P NATL ACAD SCI USA, V70, P235, DOI 10.1073/pnas.70.1.235; CHEN PP, 1985, J EXP MED, V162, P487, DOI 10.1084/jem.162.2.487; CHEN PP, 1984, P NATL ACAD SCI-BIOL, V81, P1784, DOI 10.1073/pnas.81.6.1784; CLAFLIN JL, 1984, BIOL IDIOTYPES, P171; CLEVINGER B, 1980, J EXP MED, V151, P1059, DOI 10.1084/jem.151.5.1059; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DAVIS LG, 1986, BASIC METHODS MOL BI, P130; DICKERMAN J, 1981, J EXP MED, V153, P1275, DOI 10.1084/jem.153.5.1275; IMANISHIKARI T, 1979, EUR J IMMUNOL, V9, P324, DOI 10.1002/eji.1830090414; JACK RS, 1977, EUR J IMMUNOL, V7, P559, DOI 10.1002/eji.1830070813; JANEWAY CA, 1988, IMMUNOL REV, V101, P39, DOI 10.1111/j.1600-065X.1988.tb00732.x; JERNE NK, 1984, IMMUNOL REV, V79, P5, DOI 10.1111/j.1600-065X.1984.tb00484.x; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; JU ST, 1978, P NATL ACAD SCI USA, V75, P6192, DOI 10.1073/pnas.75.12.6192; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KELUS AS, 1968, J EXP MED, V127, P215, DOI 10.1084/jem.127.1.215; KENNEDY RC, 1983, J IMMUNOL, V130, P1943; KENNETT RH, 1980, MONOCLONAL ANTIBODIE, P365; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KOHNO Y, 1982, J IMMUNOL, V128, P1742; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; LANFORD RE, 1986, CELL, V46, P575, DOI 10.1016/0092-8674(86)90883-4; LANFORD RE, 1990, EXP CELL RES, V186, P32, DOI 10.1016/0014-4827(90)90206-P; LIEBERMAN R, 1975, J EXP MED, V142, P106, DOI 10.1084/jem.142.1.106; LKIU YN, 1981, J EXP MED, V154, P1525; LUCEY DR, 1989, J EXP MED, V169, P327, DOI 10.1084/jem.169.1.327; MADDON PJ, 1987, P NATL ACAD SCI USA, V84, P9155, DOI 10.1073/pnas.84.24.9155; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; MCKINNEY MM, 1987, J IMMUNOL METHODS, V96, P271, DOI 10.1016/0022-1759(87)90324-3; MCMILLAN S, 1983, CELL, V35, P859, DOI 10.1016/0092-8674(83)90118-6; METZGER DW, 1980, NATURE, V287, P540, DOI 10.1038/287540a0; METZGER DW, 1981, J EXP MED, V154, P701, DOI 10.1084/jem.154.3.701; MORAN T, 1984, P NATL ACAD SCI-BIOL, V81, P1809, DOI 10.1073/pnas.81.6.1809; MUDGETT M, 1978, J IMMUNOL, V120, P293; OUDIN J, 1966, J CELL PHYSIOL, V67, P77, DOI 10.1002/jcp.1040670409; PROBER JM, 1987, SCIENCE, V238, P336, DOI 10.1126/science.2443975; RADBRUCH A, 1985, NATURE, V315, P506, DOI 10.1038/315506a0; RATHBUN G, 1988, ADV IMMUNOL, V42, P95, DOI 10.1016/S0065-2776(08)60843-3; Reichlin M, 1980, Methods Enzymol, V70, P159; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; RICHARDSON NE, 1988, P NATL ACAD SCI USA, V85, P6102, DOI 10.1073/pnas.85.16.6102; RUDIKOFF S, 1983, J EXP MED, V158, P1385, DOI 10.1084/jem.158.5.1385; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SATTENTAU QJ, 1989, J EXP MED, V170, P1319, DOI 10.1084/jem.170.4.1319; SCHICK MR, 1989, METHOD ENZYMOL, V178, P36; SCHICK MR, 1987, J IMMUNOL, V138, P3419; SHARON J, 1990, J IMMUNOL, V144, P4863; SIRISINHA S, 1971, P NATL ACAD SCI USA, V68, P3130, DOI 10.1073/pnas.68.12.3130; STREICHER HZ, 1986, J IMMUNOL, V136, P1007; SVASTI J, 1972, BIOCHEM J, V128, P427, DOI 10.1042/bj1280427; VICTORKOBRIN C, 1989, IMMUNOL REV, V110, P151, DOI 10.1111/j.1600-065X.1989.tb00032.x; ZAGHOUANI H, 1989, P NATL ACAD SCI USA, V86, P2341, DOI 10.1073/pnas.86.7.2341	61	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14611	14619						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713585				2022-12-27	WOS:A1991FZ35100078
J	KAWAHARA, RS; DENG, ZW; DEUEL, TF				KAWAHARA, RS; DENG, ZW; DEUEL, TF			GLUCOCORTICOIDS INHIBIT THE TRANSCRIPTIONAL INDUCTION OF JE, A PLATELET-DERIVED GROWTH FACTOR-INDUCIBLE GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLACTIN GENE; MESSENGER-RNA; DNA-BINDING; C-JUN; EXPRESSION; CELLS; CLONING; FAMILY; IDENTIFICATION; ACTIVATION	Macrophages and monocytes have essential roles in normal wound healing, in the immune response, and in the pathogenesis of atherosclerosis. Platelet-derived growth factor (PDGF) stimulates the transcription of the early response gene, JE, and its human homolog, macrophage chemotactic protein-1 (MCP-1) in fibroblasts. JE/MCP-1 encodes a cytokine which is a member of a superfamily of small inducible genes that include platelet factor 4, beta-thromboglobulin, 310-C/NAP-1/IL-8, IP-10, KC/gro/MGSA, and others which may play important roles in the inflammatory and immune response. We now report that glucocorticoids inhibit the transcriptional induction of the JE gene by PDGF and serum in a dose-dependent manner. The glucocorticoid response followed the expected anti-inflammatory rank order of potency and was not due to a shift in the time course of induction. Nonsteroidal anti-inflammatory agents were ineffective in reducing JE mRNA levels. Dexamethasone inhibited the accumulation of JE transcripts induced by PDGF, 12-O-tetradecanoylphorbol-13-acetate, and double-stranded synthetic RNA. Nuclear runoff assays demonstrated that the negative regulation occurred by decreasing the transcriptional induction of the JE gene. No effects on JE message stability could be detected in the presence of dexamethasone. The protein synthesis inhibitors cycloheximide and puromycin reversed the glucocorticoid-mediated inhibition and suggested that new protein synthesis was necessary. These results suggest that the transcriptional inhibition of glucocorticoids is mediated by the expression of a labile transcriptional repressor for the JE gene.	WASHINGTON UNIV, JEWISH HOSP ST LOUIS, DEPT MED, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, JEWISH HOSP ST LOUIS, DEPT BIOCHEM & MOLEC BIOPHYS, ST LOUIS, MO 63110 USA	Barnes-Jewish Hospital; Washington University (WUSTL); Barnes-Jewish Hospital; Washington University (WUSTL)					NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL031102, P50HL014147, R01HL031102] Funding Source: NIH RePORTER; NCI NIH HHS [CA49712] Funding Source: Medline; NHLBI NIH HHS [HL14147, HL31102] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADLER S, 1988, CELL, V52, P685, DOI 10.1016/0092-8674(88)90406-0; AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BROWN KD, 1989, J IMMUNOL, V142, P679; BURNSTEIN KL, 1989, ANNU REV PHYSIOL, V51, P683, DOI 10.1146/annurev.ph.51.030189.003343; CHARRON J, 1986, P NATL ACAD SCI USA, V83, P8903, DOI 10.1073/pnas.83.23.8903; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; DEUEL TF, 1981, J BIOL CHEM, V256, P8896; DROUIN J, 1987, J CELL BIOCHEM, V35, P293, DOI 10.1002/jcb.240350404; GESSANI S, 1988, J BIOL CHEM, V263, P7454; GRAVES DT, 1989, SCIENCE, V245, P1490, DOI 10.1126/science.2781291; GREEN CJ, 1989, MOL CELL BIOL, V9, P1445, DOI 10.1128/MCB.9.4.1445; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GUYRE PM, 1988, J STEROID BIOCHEM, V30, P89, DOI 10.1016/0022-4731(88)90080-5; HALL DJ, 1987, J BIOL CHEM, V262, P15302; HALL DJ, 1989, MOL CELL BIOL, V9, P1705, DOI 10.1128/MCB.9.4.1705; HANSON RD, 1990, J BIOL CHEM, V265, P1524; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KAWAHARA RS, 1989, J BIOL CHEM, V264, P679; KINGSTON RE, 1989, CURR PROT MOL BIOL, V1; KNUDSEN PJ, 1987, J IMMUNOL, V139, P4129; LEE SW, 1988, P NATL ACAD SCI USA, V85, P1204, DOI 10.1073/pnas.85.4.1204; LIPES MA, 1988, P NATL ACAD SCI USA, V85, P9704, DOI 10.1073/pnas.85.24.9704; ROLLINS BJ, 1989, MOL CELL BIOL, V9, P4687, DOI 10.1128/MCB.9.11.4687; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; WILKINSON PC, 1988, METHOD ENZYMOL, V162, P127; WOLPE SD, 1989, FASEB J, V3, P2565, DOI 10.1096/fasebj.3.14.2687068; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; ZIPFEL PF, 1989, J IMMUNOL, V142, P1582	35	66	67	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13261	13266						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712776				2022-12-27	WOS:A1991FX13200072
J	KEIJER, J; EHRLICH, HJ; LINDERS, M; PREISSNER, KT; PANNEKOEK, H				KEIJER, J; EHRLICH, HJ; LINDERS, M; PREISSNER, KT; PANNEKOEK, H			VITRONECTIN GOVERNS THE INTERACTION BETWEEN PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN S-PROTEIN; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; ALPHA-1-PROTEINASE INHIBITOR; KRINGLE-2 DOMAIN; BINDING-SITES; HUMAN-PLASMA; FIBRIN; CDNA; IDENTIFICATION	The "serpin" plasminogen activator inhibitor 1 (PAI-1) is the fast acting inhibitor of plasminogen activators (tissue-type (t-PA) and urokinase type-PA) and is an essential regulatory protein of the fibrinolytic system. Its P1-P1' reactive center (R346 M347) acts as a "bait" for tight binding to t-PA/urokinase-type PA. In vivo, PAI-1 is encountered in complex with vitronectin, an interaction known to stabilize its activity but not to affect the second-order association rate constant (k1) between PAI-1 and t-PA. Nevertheless, by using PAI-1 reactive site variants (R346M, M347S, and R346M M347S), we show that the binding of vitronectin to the PAI-1 mutant proteins improves plasminogen activator inhibition. In the absence of vitronectin the PAI-1 R346M mutants are virtually inactive toward t-PA (k1 < 1 x 10(3) M-1 s-1). In contrast, in the presence of vitronectin the rate of association increases about 1,000-fold (k1 of 6-8 x 10(5) M-1 s-1). This inhibition coincides with the formation of serpin-typical, sodium dodecyl sulfide-stable t-PA.PAI-1 R346M (R346M M347S) complexes. As evidenced by amino acid sequence analysis, the newly created M346-M/S347 peptide bond is susceptible to attack by t-PA, similar to the wild-type R346-M347 peptide bond, indicating that in the presence of vitronectin M346 functions as an efficient P1 residue. In addition, we show that the inhibition of t-PA and urokinase-type PA by PAI-1 mutant proteins is accelerated by the presence of the nonprotease A chains of the plasminogen activators.	NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV,DEPT MOLEC BIOL,CENT LAB, PLESMANLAAN 125, 1066 CX AMSTERDAM, NETHERLANDS; KERCKHOFF KLIN, DEPT HEMOSTASIS RES, W-6350 BAD NAUHEIM, GERMANY	Kerckhoff Clinic			Keijer, Jaap/J-8089-2013	Keijer, Jaap/0000-0002-9720-7491				ANDREASEN PA, 1986, FEBS LETT, V209, P213, DOI 10.1016/0014-5793(86)81113-9; CAMI B, 1978, NUCLEIC ACIDS RES, V5, P2381, DOI 10.1093/nar/5.7.2381; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; DAHLBACK B, 1985, BIOCHEMISTRY-US, V24, P2368, DOI 10.1021/bi00330a036; DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454; DESERRANO VS, 1990, J BIOL CHEM, V265, P10473; DEVRIES C, 1989, J BIOL CHEM, V264, P12604; DEVRIES C, 1990, J BIOL CHEM, V265, P13547; EHRLICH HJ, 1991, BIOCHEMISTRY-US, V30, P1021, DOI 10.1021/bi00218a020; EHRLICH HJ, 1990, J BIOL CHEM, V265, P13029; ERICKSON LA, 1984, ANAL BIOCHEM, V137, P454, DOI 10.1016/0003-2697(84)90113-1; GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761; HEKMAN CM, 1988, BIOCHEMISTRY-US, V27, P2911, DOI 10.1021/bi00408a037; HEKMAN CM, 1985, J BIOL CHEM, V260, P11581; HOLMES WE, 1987, J BIOL CHEM, V262, P1659; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; JOHNSON D, 1978, J BIOL CHEM, V253, P7142; KATAGIRI K, 1988, EUR J BIOCHEM, V176, P81, DOI 10.1111/j.1432-1033.1988.tb14253.x; KEIJER J, 1990, FIBRINOLYSIS, V4, P153, DOI 10.1016/S0268-9499(05)80047-5; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBERS JWJ, 1987, J BIOFL CHEM, V262; LEVIN EG, 1986, BLOOD, V67, P1309; LEYTE A, 1989, BIOCHEM J, V257, P679, DOI 10.1042/bj2570679; LIJNEN HR, 1986, PROTEINASE INHIBITOR, P456; LINDAHL TL, 1990, BIOCHEM J, V265, P109, DOI 10.1042/bj2650109; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; MATHESON N, 1989, BIOCHEM BIOPH RES CO, V159, P271, DOI 10.1016/0006-291X(89)92433-9; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIMURO J, 1989, J BIOL CHEM, V264, P936; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NY T, 1986, P NATL ACAD SCI USA, V83, P6776, DOI 10.1073/pnas.83.18.6776; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; PENNICA D, 1983, NATURE, V301, P214, DOI 10.1038/301214a0; PREISSNER KT, 1985, BIOCHEM J, V231, P349, DOI 10.1042/bj2310349; PREISSNER KT, 1989, BLOOD, V74, P1989; PREISSNER KT, 1989, BLUT, V59, P419, DOI 10.1007/BF00349063; RIFKIN DB, 1974, J EXP MED, V139, P1317, DOI 10.1084/jem.139.5.1317; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; Sambrook J, 1989, MOL CLONING LABORATO; SCHLEEF RR, 1988, HAEMOSTASIS, V18, P328; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SPRENGERS ED, 1987, BLOOD, V69, P381; STEPHENS AW, 1988, J BIOL CHEM, V263, P15849; STEPHENS AW, 1987, J BIOL CHEM, V262, P1044; STOPPELLI M P, 1990, Fibrinolysis, V4, P90; TRANTHANG C, 1986, EUR J BIOCHEM, V160, P599, DOI 10.1111/j.1432-1033.1986.tb10080.x; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; WAGNER OF, 1989, J CLIN INVEST, V84, P647, DOI 10.1172/JCI114211; WILHELM OG, 1990, J BIOL CHEM, V265, P14606; WIMAN B, 1988, FEBS LETT, V242, P125, DOI 10.1016/0014-5793(88)80999-2; WIMAN B, 1990, Fibrinolysis, V4, P85	53	45	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10700	10707						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709939				2022-12-27	WOS:A1991FP08600104
J	ENG, J; ANDREWS, PC; KLEINMAN, WA; SINGH, L; RAUFMAN, JP				ENG, J; ANDREWS, PC; KLEINMAN, WA; SINGH, L; RAUFMAN, JP			PURIFICATION AND STRUCTURE OF EXENDIN-3, A NEW PANCREATIC SECRETAGOGUE ISOLATED FROM HELODERMA-HORRIDUM VENOM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CUNY MT SINAI SCH MED,NEW YORK,NY 10029; UNIV MICHIGAN,SCH MED,DEPT BIOL SCI,ANN ARBOR,MI 48109; SUNY HLTH SCI CTR,DEPT MED,BROOKLYN,NY 11203	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	ENG, J (corresponding author), VET AFFAIRS MED CTR,SOLOMON A BERSON RES LAB,BRONX,NY 10468, USA.			Andrews, Philip/0000-0001-6843-5420				ANDREWS PC, 1987, J BIOL CHEM, V262, P12692; ANDREWS PC, 1986, J BIOL CHEM, V261, P8128; BELL GI, 1983, NATURE, V304, P368, DOI 10.1038/304368a0; BELL GI, 1986, PEPTIDES, V7, P27, DOI 10.1016/0196-9781(86)90160-9; BODANSZKY M, 1977, HORMONAL RECEPTORS D, P15; CESKA M, 1969, CLIN CHIM ACTA, V26, P437, DOI 10.1016/0009-8981(69)90071-0; ENG J, 1990, PEPTIDES, V11, P683, DOI 10.1016/0196-9781(90)90180-D; GARDNER JD, 1986, ANNU REV PHYSIOL, V48, P103, DOI 10.1146/annurev.ph.48.030186.000535; GARDNER JD, 1979, BIOCHIM BIOPHYS ACTA, V583, P491, DOI 10.1016/0304-4165(79)90066-7; GOSSEN D, 1990, PEPTIDES, V11, P123, DOI 10.1016/0196-9781(90)90120-T; GUILLEMIN R, 1982, SCIENCE, V218, P585, DOI 10.1126/science.6812220; HAKANSON R, 1971, ACTA PHYSIOL SCAND, V83, P427, DOI 10.1111/j.1748-1716.1971.tb05098.x; HOLST JJ, 1987, FEBS LETT, V211, P169, DOI 10.1016/0014-5793(87)81430-8; HOSHINO M, 1984, FEBS LETT, V178, P233, DOI 10.1016/0014-5793(84)80607-9; ITOH N, 1983, NATURE, V304, P547, DOI 10.1038/304547a0; JORNVALL H, 1981, FEBS LETT, V123, P205, DOI 10.1016/0014-5793(81)80288-8; LIN MC, 1975, BIOCHEMISTRY-US, V14, P1559, DOI 10.1021/bi00679a002; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; ORSKOV C, 1989, J BIOL CHEM, V264, P12826; PARKER DS, 1984, J BIOL CHEM, V259, P1751; PEIKIN SR, 1978, AM J PHYSIOL, V235, pE743, DOI 10.1152/ajpendo.1978.235.6.E743; SCHWARTZ TW, 1984, J CHROMATOGR, V299, P513, DOI 10.1016/S0021-9673(01)97876-8; TATEMOTO K, 1978, P NATL ACAD SCI USA, V75, P4115, DOI 10.1073/pnas.75.9.4115; TATEMOTO K, 1983, FEBS LETT, V164, P124, DOI 10.1016/0014-5793(83)80033-7; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2514, DOI 10.1073/pnas.79.8.2514; TATEMOTO K, 1982, NATURE, V296, P659, DOI 10.1038/296659a0; TATEMOTO K, 1981, P NATL ACAD SCI-BIOL, V78, P6603, DOI 10.1073/pnas.78.11.6603; VANDERMEEERS A, 1987, EUR J BIOCHEM, V164, P321, DOI 10.1111/j.1432-1033.1987.tb11061.x	30	58	102	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20259	20262						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700785				2022-12-27	WOS:A1990EJ52500036
J	HUANG, P; CHUBB, S; PLUNKETT, W				HUANG, P; CHUBB, S; PLUNKETT, W			TERMINATION OF DNA-SYNTHESIS BY 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE - A MECHANISM FOR CYTOTOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST,CTR CANC, DEPT MED ONCOL,BOX 52, HOUSTON, TX 77030 USA; UNIV TEXAS, HLTH SCI CTR, GRAD SCH BIOMED SCI, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston					NCI NIH HHS [CA28596] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA028596] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ARMITAGE P, 1987, STATISTICAL METHODS, P104; AVRAMIS VI, 1982, CANCER RES, V42, P2587; BRINK JJ, 1964, CANCER RES, V24, P312; BROCKMAN RW, 1977, BIOCHEM PHARMACOL, V26, P2193, DOI 10.1016/0006-2952(77)90275-1; Burgers P M, 1989, Prog Nucleic Acid Res Mol Biol, V37, P235; BURGERS PMJ, 1990, EUR J BIOCHEM, V191, P617, DOI 10.1111/j.1432-1033.1990.tb19165.x; BYRNES JJ, 1977, BIOCHEMISTRY-US, V16, P3740, DOI 10.1021/bi00636a002; CELIS JE, 1986, FEBS LETT, V209, P277, DOI 10.1016/0014-5793(86)81127-9; CHOU J, 1985, DOSE EFFECT ANAL MIC, P5; DERSE D, 1981, J BIOL CHEM, V256, P8525; DOW LW, 1980, CANCER RES, V40, P1405; FAIRMAN MP, 1990, J CELL SCI, V95, P1; FOCHER F, 1989, NUCLEIC ACIDS RES, V17, P1805, DOI 10.1093/nar/17.5.1805; FOCHER F, 1988, NUCLEIC ACIDS RES, V16, P6279, DOI 10.1093/nar/16.14.6279; FOCHER F, 1988, FEBS LETT, V229, P6, DOI 10.1016/0014-5793(88)80786-5; FOCHER F, 1990, FEBS LETT, V259, P349, DOI 10.1016/0014-5793(90)80045-K; GANDHI V, 1988, CANCER RES, V48, P329; GRAHAM FL, 1970, CANCER RES, V30, P2627; GREVER MR, 1988, NOUV REV FR HEMATOL, V30, P457; HILLEBRAND GG, 1985, J BIOL CHEM, V260, P3116; HUANG P, 1986, P AM ASSOC CANC RES, V27, P21; HUANG P, 1990, J BIOL CHEM, V265, P11914; HUBERMAN JA, 1981, CELL, V23, P647, DOI 10.1016/0092-8674(81)90426-8; KEATING MJ, 1989, BLOOD, V74, P19; KUFE DW, 1983, CANCER RES, V43, P2000; KUNKEL TA, 1987, P NATL ACAD SCI USA, V84, P4865, DOI 10.1073/pnas.84.14.4865; LEE MYWT, 1980, BIOCHEMISTRY-US, V19, P215, DOI 10.1021/bi00542a032; LEE MYWT, 1984, BIOCHEMISTRY-US, V23, P1906, DOI 10.1021/bi00304a003; LONN U, 1988, BIOCHEMISTRY-US, V27, P566; MAJOR PP, 1982, BIOCHEM PHARMACOL, V31, P2937, DOI 10.1016/0006-2952(82)90266-0; MANIATIS T, 1982, MOL CLONING LABORATO, P196; Marzluff W. F., 1984, TRANSCRIPTION TRANSL, P89; NISHIDA C, 1988, J BIOL CHEM, V263, P501; NOVOTNY L, 1989, NUCLEIC ACID CHEM 4, V210, P291; PARKER WB, 1988, MOL PHARMACOL, V34, P485; PLUNKETT W, 1975, CANCER RES, V35, P1547; PLUNKETT W, 1975, CANCER RES, V35, P415; PLUNKETT W, 1980, CANCER RES, V40, P2349; PLUNKETT W, 1985, P AM ASSOC CANC RES, V26, P19; PRELICH G, 1988, CELL, V53, P117, DOI 10.1016/0092-8674(88)90493-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SPRIGGS D, 1986, BIOCHEM PHARMACOL, V35, P247, DOI 10.1016/0006-2952(86)90521-6; SYVAOJA J, 1989, J BIOL CHEM, V264, P2489; TAN CK, 1986, J BIOL CHEM, V261, P2310; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; TSENG WC, 1982, MOL PHARMACOL, V21, P474; TSURIMOTO T, 1989, EMBO J, V8, P3883, DOI 10.1002/j.1460-2075.1989.tb08567.x; WHITE EL, 1982, CANCER RES, V42, P2260	48	195	202	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16617	16625						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697861				2022-12-27	WOS:A1990DZ95000087
J	VEGA, MA; SEGUIREAL, B; GARCIA, JA; CALES, C; RODRIGUEZ, F; VANDERKERCKHOVE, J; SANDOVAL, IV				VEGA, MA; SEGUIREAL, B; GARCIA, JA; CALES, C; RODRIGUEZ, F; VANDERKERCKHOVE, J; SANDOVAL, IV			CLONING, SEQUENCING, AND EXPRESSION OF A CDNA-ENCODING RAT LIMP-II, A NOVEL 74-KDA LYSOSOMAL MEMBRANE-PROTEIN RELATED TO THE SURFACE-ADHESION PROTEIN-CD36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; GLYCOPROTEIN-IV CD36; GROWTH FACTOR-II; MONOCLONAL-ANTIBODY; CYTOPLASMIC TAIL; ACID-PHOSPHATASE; GOLGI-COMPLEX; CELLS; IDENTIFICATION; LOCALIZATION	LIMP II is a glycoprotein expressed in the membrane of lysosomes and secretory granules with lysosomal properties. Sequence analysis of a CNBr-cleaved peptide allowed the synthesis of a 47-mer oligonucleotide that was used to screen a rat liver cDNA library in lambda-gt11. This resulted in isolation of a 2-kilobase cDNA containing 1,434 bases encoding the entire protein. The deduced amino acid sequence indicates that LIMP II consists of 478 amino acid residues. The segment spanning residues 4-6 to 26 constitute an uncleavable signal peptide. LIMP II possesses a hydrophobic amino acid segment near the carboxyl end, that together with the uncleaved signal peptide may anchor the protein to the membrane through two distant segments. The major portion of the protein resides on the luminal side and displays 11 potential N-glycosylation sites and 5 cysteine residues. Two short cytoplasmic tails, 2-4 and 20-21 amino acids long, correspond to the NH2- and COOH-terminal ends of the protein, respectively. Transfection of COS cells with the cDNA of LIMP II resulted in expression of the protein and its transport to lysosomes. Comparison of the entire sequence to various data bases of known proteins revealed extensive homology between LIMP II and the cell surface protein CD36 involved in cell adhesion. No significant homology was detected with the two families of lysosomal membrane proteins A and B, recently described.	CSIC,CTR BIOMED,MADRID 6,SPAIN; STATE UNIV GHENT,GENET LAB,B-9000 GHENT,BELGIUM	Consejo Superior de Investigaciones Cientificas (CSIC); Ghent University	VEGA, MA (corresponding author), UNIV AUTONOMA MADRID,FAC CIENCIAS,CTR BIOL MOLEC,E-28049 MADRID,SPAIN.		Garcia, Juan Antonio/N-3723-2014; Calés, Carmela/AAB-1595-2019; Vega, Miguel A/M-1367-2016	Garcia, Juan Antonio/0000-0002-4861-9609; Vega, Miguel A/0000-0001-6151-4193; Rodriguez, Fernando/0000-0001-7361-8408; Cales, Carmela/0000-0002-6987-2259				ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BARNWELL JW, 1985, J IMMUNOL, V135, P3494; BARRIOCANAL JG, 1986, J BIOL CHEM, V261, P6755; BERNSTEIN ID, 1982, J IMMUNOL, V128, P876; BONIFACINO JS, 1990, J CELL SCI, V92, P701; BROWN WJ, 1986, J CELL BIOL, V103, P1235, DOI 10.1083/jcb.103.4.1235; CHA Y, 1990, J BIOL CHEM, V265, P5008; CHEN JW, 1985, ARCH BIOCHEM BIOPHYS, V239, P574, DOI 10.1016/0003-9861(85)90727-1; CHEN JW, 1988, J BIOL CHEM, V263, P8754; de Duve D, 1963, CIBA F S LYSOSOMES, P1; DSOUZA MP, 1986, ARCH BIOCHEM BIOPHYS, V249, P522, DOI 10.1016/0003-9861(86)90030-5; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; FUKUDA M, 1988, J BIOL CHEM, V263, P18920; GAROFF H, 1985, ANNU REV CELL BIOL, V1, P403, DOI 10.1146/annurev.cb.01.110185.002155; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; GEUZE HJ, 1984, J CELL BIOL, V98, P2047, DOI 10.1083/jcb.98.6.2047; GLICKMAN JN, 1989, EMBO J, V8, P1041, DOI 10.1002/j.1460-2075.1989.tb03471.x; GODA Y, 1988, CELL, V55, P309, DOI 10.1016/0092-8674(88)90054-2; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HOWE CL, 1988, P NATL ACAD SCI USA, V85, P7577, DOI 10.1073/pnas.85.20.7577; HUGHES EN, 1982, J BIOL CHEM, V257, P3970; JIN M, 1989, J BIOL CHEM, V264, P7675; KNOWLES DM, 1984, J IMMUNOL, V132, P2170; KORNFELD S, 1987, FASEB J, V1, P462, DOI 10.1096/fasebj.1.6.3315809; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; LIPPINCOTTSCHWARTZ J, 1987, CELL, V49, P669, DOI 10.1016/0092-8674(87)90543-5; LOBEL P, 1989, CELL, V57, P787, DOI 10.1016/0092-8674(89)90793-9; LOPATA MA, 1984, NUCLEIC ACIDS RES, V12, P5707, DOI 10.1093/nar/12.14.5707; MCGREGOR JL, 1989, J BIOL CHEM, V264, P501; MILLER J, 1986, J EXP MED, V164, P1478, DOI 10.1084/jem.164.5.1478; NOGUCHI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1113, DOI 10.1016/0006-291X(89)91784-1; Nolan C M, 1987, Adv Exp Med Biol, V225, P199; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETERS C, 1990, EMBO J, V9, P3497, DOI 10.1002/j.1460-2075.1990.tb07558.x; PFEFFER SR, 1988, J MEMBRANE BIOL, V103, P7, DOI 10.1007/BF01871928; POHLMANN R, 1988, EMBO J, V7, P2343, DOI 10.1002/j.1460-2075.1988.tb03078.x; ROBBINS AR, 1988, PROTEIN TRANSFER ORG, P463; ROTH RA, 1988, SCIENCE, V239, P1269, DOI 10.1126/science.2964085; RUSSO AF, 1983, SCIENCE, V220, P1016, DOI 10.1126/science.6302843; SANDOVAL IV, 1989, ARCH BIOCHEM BIOPHYS, V271, P157, DOI 10.1016/0003-9861(89)90266-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SKUDLAREK MD, 1984, LYSOSOM BIOL PATHOL, V7, P17; SLY WS, 1982, J CELL BIOCHEM, V18, P67, DOI 10.1002/jcb.1982.240180107; TANDON NN, 1989, J BIOL CHEM, V264, P7570; TANDON NN, 1989, J BIOL CHEM, V264, P7576; VANDEKERCKHOVE J, 1985, EUR J BIOCHEM, V152, P9, DOI 10.1111/j.1432-1033.1985.tb09157.x; VIITALA J, 1988, P NATL ACAD SCI USA, V85, P3743, DOI 10.1073/pnas.85.11.3743; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; WILLINGHAM MC, 1983, J HISTOCHEM CYTOCHEM, V31, P1	58	132	144	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1991	266	25					16818	16824						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GD635	1715871				2022-12-27	WOS:A1991GD63500091
J	SEI, CA; IRONS, CE; SPRENKLE, AB; MCDONOUGH, PM; BROWN, JH; GLEMBOTSKI, CC				SEI, CA; IRONS, CE; SPRENKLE, AB; MCDONOUGH, PM; BROWN, JH; GLEMBOTSKI, CC			THE ALPHA-ADRENERGIC STIMULATION OF ATRIAL-NATRIURETIC-FACTOR EXPRESSION IN CARDIAC MYOCYTES REQUIRES CALCIUM INFLUX, PROTEIN-KINASE-C, AND CALMODULIN-REGULATED PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR GENE-EXPRESSION; VENTRICULAR MYOCYTES; TRISPHOSPHATE FORMATION; PITUITARY-CELLS; PROLACTIN GENE; MESSENGER-RNA; HEART-CELLS; RAT; FOS; SECRETION	It has been shown recently that alpha-adrenergic agonists can stimulate atrial natriuretic factor (ANF) expression in ventricular cardiac myocytes; however, little is known about the intracellular signals mediating this activation. The present study focused on the potential roles of calcium-regulated kinases and calcium influx in the alpha-adrenergic stimulation of ANF gene expression in ventricular myocardial cell cultures. Myocardial cells maintained for 48 h in serum-free medium supplemented with phenylephrine (PE) possessed up to 15-fold higher levels of ANF peptide and ANF mRNA than control cells. The removal of PE, or the addition of nifedipine, resulted in a rapid decline in ANF expression, suggesting that the sustained elevation of some intracellular messenger (e.g. calcium and/or phospholipid hydrolysis products) was required for the adrenergic response. The calcium channel agonist BAY K 8644 was capable of increasing ANF expression in a nifedipine-sensitive manner; however, unlike PE, it did not stimulate phosphoinositide hydrolysis. The protein kinase C inhibitor, H7, caused an approximate 75% reduction in PE-stimulated ANF expression, but had no effect on BAY K-stimulated expression. W7, a calcium/calmodulin inhibitor, completely blocked the effects of both PE and BAY K 8644. The addition of either H7 or W7 24 h after the PE addition resulted in a decline of ANF expression. These results indicate that alpha-adrenergic agonists augment ANF gene expression through at least two pathways, one that is H7-sensitive, perhaps involving the sustained activation of protein kinase C, and the other that is W7-sensitive, perhaps involving the sustained activation of calmodulin-regulated kinases. Further, it appears that BAY K 8644-mediated increases in ANF expression are independent of protein kinase C activation and dependent on calmodulin-regulated events.	SAN DIEGO STATE UNIV,INST MOLEC BIOL,SAN DIEGO,CA 92182; UNIV CALIF SAN DIEGO,DEPT PHARMACOL,LA JOLLA,CA 92093	California State University System; San Diego State University; University of California System; University of California San Diego					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025037] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-28143] Funding Source: Medline; NINDS NIH HHS [NS-25037] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARGENTIN S, 1987, BIOCHEM BIOPH RES CO, V146, P1336, DOI 10.1016/0006-291X(87)90796-0; BALS S, 1990, CELL CALCIUM, V11, P385, DOI 10.1016/0143-4160(90)90050-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCH KD, 1986, CELL, V47, P695, DOI 10.1016/0092-8674(86)90512-X; BROWN JH, 1985, CIRC RES, V57, P532, DOI 10.1161/01.RES.57.4.532; CARAFOLI E, 1985, J MOL CELL CARDIOL, V17, P203, DOI 10.1016/S0022-2828(85)80003-1; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS JRE, 1990, TRENDS ENDOCRIN MET, V1, P319, DOI 10.1016/1043-2760(90)90072-B; DAVIS JRE, 1989, 71ST ANN M END SOC S; ENDOH M, 1988, CIRC RES, V62, P247, DOI 10.1161/01.RES.62.2.247; ENYEART JJ, 1984, BIOCHEM BIOPH RES CO, V122, P991, DOI 10.1016/0006-291X(84)91189-6; FABIATO A, 1985, J GEN PHYSIOL, V85, P189, DOI 10.1085/jgp.85.2.189; FEARON CW, 1985, J BIOL CHEM, V260, P8366; FEDIDA D, 1989, AM J PHYSIOL, V256, pH1500, DOI 10.1152/ajpheart.1989.256.5.H1500; FUKUDA Y, 1989, BIOCHEM BIOPH RES CO, V164, P1431, DOI 10.1016/0006-291X(89)91830-5; GARDNER DG, 1987, MOL ENDOCRINOL, V1, P260, DOI 10.1210/mend-1-3-260; GLEMBOTSKI CC, 1986, ENDOCRINOLOGY, V12, P843; HEISLER S, 1985, J PHARMACOL EXP THER, V235, P741; HENRICH CJ, 1988, J MOL CELL CARDIOL, V20, P1081, DOI 10.1016/0022-2828(88)90588-3; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HINKLE PM, 1988, MOL ENDOCRINOL, V2, P1132, DOI 10.1210/mend-2-11-1132; ITO M, 1986, BIOCHEMISTRY-US, V25, P4179, DOI 10.1021/bi00363a002; IWAKI K, 1990, J BIOL CHEM, V265, P13809; JACKSON AE, 1988, MOL ENDOCRINOL, V2, P1139, DOI 10.1210/mend-2-11-1139; JONES LG, 1988, CIRC RES, V62, P299, DOI 10.1161/01.RES.62.2.299; KNOWLTON KU, 1991, J BIOL CHEM, V266, P7759; LAPOINTE MC, 1988, J BIOL CHEM, V263, P9075; LAPOINTE MC, 1990, HYPERTENSION, V15, P20, DOI 10.1161/01.HYP.15.1.20; LOEFFLER JP, 1989, J NEUROCHEM, V52, P1279, DOI 10.1111/j.1471-4159.1989.tb01876.x; MATSUBARA H, 1987, BIOCHEM BIOPH RES CO, V148, P1030, DOI 10.1016/S0006-291X(87)80235-8; MATSUBARA H, 1987, BIOCHEM BIOPH RES CO, V145, P336, DOI 10.1016/0006-291X(87)91326-X; MOCHLYROSEN D, 1990, CELL REGUL, V1, P693, DOI 10.1091/mbc.1.9.693; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MORGAN JI, 1988, CELL CALCIUM, V9, P303, DOI 10.1016/0143-4160(88)90011-5; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; NGUYEN TV, 1990, J NEUROSCI, V10, P2825; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; RESENDEZ E, 1988, MOL CELL BIOL, V8, P4579, DOI 10.1128/MCB.8.10.4579; SCHATZMAN RC, 1983, BIOCHIM BIOPHYS ACTA, V755, P144, DOI 10.1016/0304-4165(83)90284-2; SEIDMAN CE, 1988, P NATL ACAD SCI USA, V85, P4104, DOI 10.1073/pnas.85.11.4104; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHIELDS PP, 1988, J BIOL CHEM, V263, P12619; SHUBEITA HE, 1990, J BIOL CHEM, V265, P20555; STEINBERG SF, 1989, J PHARMACOL EXP THER, V250, P1141; STOJILKOVIC SS, 1988, J BIOL CHEM, V263, P13054; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; TANAKA T, 1980, J BIOL CHEM, V255, P1078; WOLFE SE, 1986, MOL PHARMACOL, V29, P420; WU JP, 1989, J BIOL CHEM, V264, P6472; ZIEGLER A, 1990, J BIOL CHEM, V265, P21194	54	121	125	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					15910	15916						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714900				2022-12-27	WOS:A1991GB97700060
J	HELLERHARRISON, RA; CZECH, MP				HELLERHARRISON, RA; CZECH, MP			ENHANCED CASEIN KINASE-II ACTIVITY IN COS-1 CELLS UPON OVEREXPRESSION OF EITHER ITS CATALYTIC OR NONCATALYTIC SUBUNIT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-SUBUNIT; ALPHA-SUBUNIT; PROTEIN-KINASE; IDENTIFICATION; EXPRESSION; CLONING	Casein kinase 11 consists of catalytic (alpha) and regulatory (beta) subunits complexed into a heterotetrameric alpha-2-beta-2 structure. Full-length cDNAs encoding the alpha and beta-subunits of human casein kinase II were subcloned into an expression vector containing the cytomegalovirus promotor, yielding the expression constructs pCMV-alpha and pCMV-beta. Northern analyses of total cellular RNA prepared from COS-1 fibroblasts 65 h after transfection with pCMV-alpha or pCMV-beta or with both expression constructs showed marked specific increases in corresponding alpha and beta-subunit RNAs. Immunoblot analysis utilizing anti-casein kinase II antiserum of cytosolic extracts prepared from COS-1 cells co-transfected with pCMV-alpha and pCMV-beta showed 2- and 4-fold increases in immunoreactive alpha and beta-subunit protein, respectively, relative to vector-transfected cells. These same cytosolic fractions exhibited an average 5-fold increase in casein kinase II catalytic activity. COS-1 cells transfected with pCMV-alpha alone exhibited a 3-fold increase in immunoreactive alpha-subunit protein and a nearly 2-fold increase in cytosolic casein kinase II catalytic activity. Transfection with the cDNA coding for the noncatalytic beta-subunit alone also caused a near doubling of cytosolic casein kinase II catalytic activity. No increase in immunoreactive alpha-subunit protein was observed in pCMV-beta-transfected cells, and no increase in immunoreactive beta-subunit protein was observed in pCMV-alpha-transfected cells. These results indicate that a portion of the endogenous cellular casein kinase II protein is not fully active and that raising the concentration of the alpha or beta-subunit stimulates this latent activity.	UNIV MASSACHUSETTS,MED CTR,DEPT BIOCHEM & MOLEC BIOL,WORCESTER,MA 01605	University of Massachusetts System; University of Massachusetts Worcester	HELLERHARRISON, RA (corresponding author), UNIV MASSACHUSETTS,MED CTR,PROGRAM MOLEC MED,WORCESTER,MA 01605, USA.				NATIONAL CANCER INSTITUTE [P01CA039240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007302] Funding Source: NIH RePORTER; NCI NIH HHS [CA 39240] Funding Source: Medline; NIDDK NIH HHS [DK 07302] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACKERMAN P, 1990, P NATL ACAD SCI USA, V87, P821, DOI 10.1073/pnas.87.2.821; AHMED K, 1988, Journal of Cell Biology, V107, p280A; ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; COCHET C, 1983, J BIOL CHEM, V258, P1403; DAVIS LG, 1986, BASIC METHODS MOL BI, P286; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FEIGE JJ, 1983, BIOCHEMISTRY-US, V22, P1452, DOI 10.1021/bi00275a020; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; HATHAWAY GM, 1983, METHOD ENZYMOL, V99, P317, DOI 10.1016/0076-6879(83)99067-5; HATHAWAY GM, 1980, J BIOL CHEM, V255, P8038; HATHAWAY GM, 1982, CURR TOP CELL REGUL, V21, P101; HATHAWAY GM, 1981, J BIOL CHEM, V256, P1442; HELLERHARRISON RA, 1989, BIOCHEMISTRY-US, V28, P9053, DOI 10.1021/bi00449a014; HU E, 1990, J BIOL CHEM, V265, P20609; KUENZEL EA, 1985, P NATL ACAD SCI USA, V82, P737, DOI 10.1073/pnas.82.3.737; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIN WJ, 1991, J BIOL CHEM, V266, P5664; LITCHFIELD D, 1990, J BIOL CHEM, V264, P7638; LOZEMAN FJ, 1990, BIOCHEMISTRY-US, V29, P8436, DOI 10.1021/bi00488a034; MEGGIO F, 1984, EUR J BIOCHEM, V145, P593, DOI 10.1111/j.1432-1033.1984.tb08598.x; MEISNER H, 1989, BIOCHEMISTRY-US, V28, P4072, DOI 10.1021/bi00435a066; MULNERLORILLON O, 1990, EUR J BIOCHEM, V193, P529, DOI 10.1111/j.1432-1033.1990.tb19368.x; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; PIROLLET F, 1981, BIOCHEM BIOPH RES CO, V100, P613, DOI 10.1016/S0006-291X(81)80220-3; TAKIO K, 1987, P NATL ACAD SCI USA, V84, P4851, DOI 10.1073/pnas.84.14.4851; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHLER MD, 1987, J BIOL CHEM, V262, P15202	28	45	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14435	14439						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713582				2022-12-27	WOS:A1991FZ35100052
J	HUSSAIN, MM; MAXFIELD, FR; MASOLIVA, J; TABAS, I; JI, ZS; INNERARITY, TL; MAHLEY, RW				HUSSAIN, MM; MAXFIELD, FR; MASOLIVA, J; TABAS, I; JI, ZS; INNERARITY, TL; MAHLEY, RW			CLEARANCE OF CHYLOMICRON REMNANTS BY THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN-ALPHA-2-MACROGLOBULIN RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E; ALPHA-2-MACROGLOBULIN RECEPTOR; BINDING DOMAIN; BONE-MARROW; RAT-LIVER; PROTEIN; LDL; METABOLISM; VESICLES; PLASMA	The involvement of the low density lipoprotein receptor-related protein (LRP) in chylomicron remnant (CR) catabolism was investigated. Ligand blot analyses demonstrated that beta-very low density lipoproteins (beta-VLDL) incubated with apolipoprotein E (beta-VLDL+E) bound to the LRP and low density lipoprotein receptors, whereas active (receptor-binding) alpha-2-macroglobulin (alpha-2M) bound only to LRP partially purified from rat liver membranes. Iodinated-beta-VLDL + E and active alpha-2M showed high affinity binding to the LRP/alpha-2M receptor of low density lipoprotein receptor-negative fibroblasts. The binding and degradation of radiolabeled alpha-2M by these cells were partially inhibited by beta-VLDL+E. Furthermore, alpha-2M interfered with the internalization of beta-VLDL+E and subsequent induction in the cholesterol esterification by these cells. These studies suggested that remnant lipoproteins and active alpha-2M compete for binding to the LRP/alpha-2M receptor. Next, we examined whether the LRP/alpha-2M receptor plays a role, in the presence of low density lipoprotein receptors, in the in vivo catabolism of CR in mice. In vivo studies demonstrated that the unlabeled active, but not the native, alpha-2M partially inhibited the plasma clearance and hepatic uptake of radiolabeled CR or apoE-enriched radiolabeled CR. Likewise, apoE-enriched CR retarded the plasma clearance and hepatic uptake of radiolabeled active alpha-2M. These studies provide physiological evidence that the LRP/alpha-2M receptor may function as a CR receptor that removes CR from the plasma.	UNIV CALIF SAN FRANCISCO,INST CARDIOVASC RES,DEPT MED,GLADSTONE FDN LABS CARDIOVASC DIS,SAN FRANCISCO,CA 94140; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT MED,NEW YORK,NY 10032	University of California System; University of California San Francisco; The J David Gladstone Institutes; Columbia University; Columbia University			Maxfield, Fred/A-1718-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK027083, R01DK027083] Funding Source: NIH RePORTER; NHLBI NIH HHS [HI-41633, HL39303] Funding Source: Medline; NIDDK NIH HHS [DK27083] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNOLD KS, 1991, PRACTICAL APPROACH S; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BROWN MS, 1983, J CLIN INVEST, V72, P743, DOI 10.1172/JCI111044; HARPEL PC, 1983, ANN NY ACAD SCI, V421, P1, DOI 10.1111/j.1749-6632.1983.tb18088.x; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; HERZ J, 1990, J BIOL CHEM, V265, P21355; HUSSAIN MM, 1989, J BIOL CHEM, V264, P9571; HUSSAIN MM, 1989, J BIOL CHEM, V264, P17931; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; KOWAL RC, 1990, J BIOL CHEM, V265, P10771; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LAMARRE J, 1991, J CLIN INVEST, V87, P39, DOI 10.1172/JCI114998; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUND H, 1989, P NATL ACAD SCI USA, V86, P9318, DOI 10.1073/pnas.86.23.9318; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MAHLEY RW, 1990, CURRENT OPINION LIPI, V1, P87; NAGATA Y, 1988, J BIOL CHEM, V263, P15151; ROCHE PA, 1988, J BIOL CHEM, V263, P6715; RUBINSZTEIN DC, 1990, J CLIN INVEST, V86, P1306, DOI 10.1172/JCI114839; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; TABAS I, 1990, J CELL BIOL, V111, P929, DOI 10.1083/jcb.111.3.929; TYCKO B, 1983, ANN NY ACAD SCI, V421, P424, DOI 10.1111/j.1749-6632.1983.tb18136.x; VANLEUVEN F, 1986, J BIOL CHEM, V261, P1369; WEISGRABER KH, 1990, J BIOL CHEM, V265, P22453	26	205	205	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					13936	13940						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713211				2022-12-27	WOS:A1991FY02700076
J	ARIAS, JA; PETERSON, SR; DYNAN, WS				ARIAS, JA; PETERSON, SR; DYNAN, WS			PROMOTER-DEPENDENT PHOSPHORYLATION OF RNA POLYMERASE-II BY A TEMPLATE-BOUND KINASE - ASSOCIATION WITH TRANSCRIPTIONAL INITIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; MAJOR LATE PROMOTER; LARGEST SUBUNIT; PROTEIN-KINASE; REPEAT DOMAIN; WHEAT-GERM; INVITRO; INVIVO; COMPLEXES; ADENOVIRUS-2	The largest subunit of eukaryotic RNA polymerase II (RNAP II) has a serine- and threonine-rich C-terminal domain (CTD) that may interact both with DNA and with the activating region of transcription factors. It has been proposed, in one model, that a protein kinase phosphorylates the promoter-associated CTD, facilitating the transition between promoter-binding and RNA-elongating forms of RNAP II. An immobilized template transcription system was used to test the predictions of this model directly. A protein kinase that phosphorylated the CTD at multiple sites was detected. This activity was tightly bound to the template, as evidenced by continued association after multiple rounds of washing. Phosphorylation was promoter sequence-dependent and exhibited the same nucleotide substrate specificity as the previously characterized ATP-requiring step in initiation. It was necessary for [gamma-P-32]ATP and initiating rNTPs to be present simultaneously in the reaction in order to efficiently chase-radiolabel into elongating RNAP II-containing complexes, consistent with the idea that initiation and phosphorylation are temporally associated reactions.	UNIV COLORADO,DEPT CHEM & BIOCHEM,CAMPUS BOX 215,BOULDER,CO 80309; UNIV COLORADO,DEPT MOLEC CELLULAR & DEV BIOL,BOULDER,CO 80309	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder				Dynan, William/0000-0002-4045-5662	NIGMS NIH HHS [GM 35866] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035866] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; ALLISON LA, 1989, P NATL ACAD SCI USA, V86, P2794, DOI 10.1073/pnas.86.8.2794; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; ARIAS JA, 1989, J BIOL CHEM, V264, P3223; ARIAS JA, 1990, BIOCH ATP REQUIRING, V2; BARTHOLOMEW B, 1986, J BIOL CHEM, V261, P14226; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CAI H, 1987, J BIOL CHEM, V262, P298; CISEK LJ, 1989, NATURE, V339, P679, DOI 10.1038/339679a0; CISEK LJ, 1991, IN PRESS METHODS ENZ; CONAWAY RC, 1988, J BIOL CHEM, V263, P2962; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; CORDEN JL, 1985, P NATL ACAD SCI USA, V82, P7934, DOI 10.1073/pnas.82.23.7934; DAHMUS ME, 1981, J BIOL CHEM, V256, P3332; DAHMUS ME, 1983, J BIOL CHEM, V258, P2303; GARIGLIO P, 1974, FEBS LETT, V44, P330, DOI 10.1016/0014-5793(74)81170-1; GUILFOYLE TJ, 1989, PLANT CELL, V1, P827, DOI 10.1105/tpc.1.8.827; HAWLEY DK, 1985, J BIOL CHEM, V260, P8163; KIM WY, 1989, J BIOL CHEM, V264, P3169; LAYBOURN PJ, 1989, J BIOL CHEM, V264, P6693; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; LEESMILLER SP, 1989, J BIOL CHEM, V264, P2431; MOYLE M, 1989, MOL CELL BIOL, V9, P5750, DOI 10.1128/MCB.9.12.5750; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SCAFE C, 1990, NATURE, V347, P491, DOI 10.1038/347491a0; SIGLER PB, 1988, NATURE, V333, P210, DOI 10.1038/333210a0; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SOPTA M, 1989, NATURE, V341, P410, DOI 10.1038/341410a0; STEVENS A, 1989, BIOCHEM BIOPH RES CO, V159, P508, DOI 10.1016/0006-291X(89)90022-3; SUZUKI M, 1990, NATURE, V344, P562, DOI 10.1038/344562a0; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; WALKER AI, 1985, EMBO J, V4, P139, DOI 10.1002/j.1460-2075.1985.tb02328.x; ZANDOMENI R, 1986, J BIOL CHEM, V261, P3414; ZEHRING WA, 1988, P NATL ACAD SCI USA, V85, P3698, DOI 10.1073/pnas.85.11.3698	39	73	73	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8055	8061						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1708770				2022-12-27	WOS:A1991FK44100018
J	HIGURASHI, M; COLE, RD				HIGURASHI, M; COLE, RD			THE COMBINATION OF DNA METHYLATION AND H1 HISTONE BINDING INHIBITS THE ACTION OF A RESTRICTION NUCLEASE ON PLASMID DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN STRUCTURE; CIRCULAR-DICHROISM; SUPERHELICAL DNA; GENE ACTIVITY; H-1 HISTONE; RAT-LIVER; SUBFRACTIONS; PHOSPHORYLATION; NUCLEOSOME; MOLECULES	To investigate the potentials of DNA methylation and H1 histone in regulating the action of DNA binding proteins, well ordered complexes were formed by slow salt gradient dialysis of mixtures of H1 histone with either methylated or nonmethylated DNA. The sites methylated in the plasmids were CCGG. Methylation of cytosine in this site protects the DNA against HpaII endonuclease but not against MspI. However, when the methylated DNA was complexed to H1, it was protected against MspI. The protection was only effective for a subset of the MspI restriction sites. The protection of DNA afforded by the combination of H1 binding and DNA methylation did not apply to EcoRI, PstI, or BamHI sites and so did not seem to be due to aggregation of the DNA by H1 histone. Gel retardation assays indicated that the affinity of H1 for methylated DNA was not detectably different from its affinity for nonmethylated DNA. Probably methylated DNA when bound to H1 is in a conformation that is resistant to MspI endonuclease. Such conformational changes induced by DNA methylation and H1 binding might affect the action of other DNA binding proteins, perhaps in chromatin as well as in H1.DNA complexes.			HIGURASHI, M (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020338] Funding Source: NIH RePORTER; NIGMS NIH HHS [GMS 20338] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN J, 1980, NATURE, V288, P675, DOI 10.1038/288675a0; ANTIQUERA F, 1989, CELL, V58, P509; BALHORN R, 1971, BIOCHEMISTRY-US, V10, P3952, DOI 10.1021/bi00797a024; BERNARDIN WD, 1986, J MOL BIOL, V189, P503; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BONNER WM, 1975, BIOCHEM BIOPH RES CO, V64, P282, DOI 10.1016/0006-291X(75)90250-8; BUSCHHAUSEN G, 1987, P NATL ACAD SCI USA, V84, P1177, DOI 10.1073/pnas.84.5.1177; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CLARK DJ, 1986, J MOL BIOL, V187, P569, DOI 10.1016/0022-2836(86)90335-9; Coggins LW, 1987, ELECTRON MICROS, P1; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; FASMAN GD, 1970, BIOCHEMISTRY-US, V9, P2814, DOI 10.1021/bi00816a010; FASMAN GD, 1977, CHROMATIN CHROMOSOME, P71; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; LABHART P, 1981, EUR J CELL BIOL, V25, P19; LENNARD AC, 1985, EMBO J, V4, P3455, DOI 10.1002/j.1460-2075.1985.tb04104.x; LIAO LW, 1981, J BIOL CHEM, V256, P1145; LIAO LW, 1981, J BIOL CHEM, V256, P6751; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maniatis T., 1982, MOL CLONING; MCGHEE JD, 1980, CELL, V22, P87, DOI 10.1016/0092-8674(80)90157-9; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; OHBA Y, 1984, J BIOL CHEM, V259, P2942; OLINS AL, 1974, SCIENCE, V183, P130; OLINS DE, 1971, J MOL BIOL, V57, P437, DOI 10.1016/0022-2836(71)90102-1; RING D, 1983, J BIOL CHEM, V258, P5361; SINGER DS, 1978, BIOCHEMISTRY-US, V17, P2086, DOI 10.1021/bi00604a011; THOMA F, 1977, CELL, V12, P101, DOI 10.1016/0092-8674(77)90188-X; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; VANHOLDE KE, 1988, CHROMATIN, P317; WATANABE F, 1986, NUCLEIC ACIDS RES, V14, P3573, DOI 10.1093/nar/14.8.3573; WELCH SL, 1979, J BIOL CHEM, V254, P662	34	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 5	1991	266	13					8619	8625						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FK441	1708775				2022-12-27	WOS:A1991FK44100098
J	KARLSEN, AE; FUJIMOTO, WY; RABINOVITCH, P; DUBE, S; LERNMARK, A				KARLSEN, AE; FUJIMOTO, WY; RABINOVITCH, P; DUBE, S; LERNMARK, A			EFFECTS OF SODIUM-BUTYRATE ON PROLIFERATION-DEPENDENT INSULIN GENE-EXPRESSION AND INSULIN RELEASE IN GLUCOSE-SENSITIVE RIN-5AH CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; ISLET GLUTAMATE-DEHYDROGENASE; PREPROINSULIN MESSENGER-RNA; GROWTH-HORMONE-BINDING; CHINESE-HAMSTER CELLS; ISOLATED PERFUSED RAT; LINE RINM5F; MAMMALIAN-CELLS; AMINO-ACID; L-LEUCINE	A rat islet tumor subclone, RIN-5AH-T2-B, was cultured with 2 mmol/liter of the proliferation-arresting compound sodium butyrate (NaB). Insulin gene expression and glucose-stimulated insulin release were analyzed and compared with logarithmically proliferating and confluent control cells cultured without NaB. Logarithmically proliferating control cells revealed high insulin gene expression. In the presence of amino acids, these cells showed a dose-dependent insulin response to glucose with a half-maximal and maximal 6.5-fold stimulation by 0.8 and 5.6 mmol/liter D-glucose, respectively. However, as the control cells approached growth arrest, insulin gene expression subsided to below detectability, an occurrence that is associated with decreased insulin release and accumulation of cells in the G1 phase of the cell cycle. In contrast, NaB-arrested cells showed continuous insulin gene expression throughout the experiment. Despite this, insulin release in response to glucose was lost. NaB revealed a biphasic effect on the cell-cycle: after an initial leaky G1 arrest during the first 24 h, the 5AH-B cells were arrested in G2 during the following 3 days. These data suggest that insulin gene expressionand glucose-stimulated insulin release are affected by the cell cycle. These glucose-sensitive RIN-5AH-T2-B cells may be useful in studies of insulin secretion and gene regulation.	UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	KARLSEN, AE (corresponding author), UNIV WASHINGTON, DEPT MED, RH WILLIAMS LAB, RG-20, SEATTLE, WA 98195 USA.		Lernmark, Åke/F-8140-2015	Lernmark, Åke/0000-0003-1735-0499	NIDDK NIH HHS [R01 DK026190, DK 26190, DK 33873, DK 17047] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033873, P30DK017047, R01DK026190] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASHCROFT SJH, 1980, DIABETOLOGIA, V18, P5, DOI 10.1007/BF01228295; BARTHOLOMEUSZ RK, 1990, ENDOCRINOLOGY, V126, P1927, DOI 10.1210/endo-126-4-1927; BARTHOLOMEUSZ RK, 1989, ENDOCRINOLOGY, V124, P2680, DOI 10.1210/endo-124-6-2680; Battey, 1986, BASIC METHODS MOL BI; BILLESTRUP N, 1985, ENDOCRINOLOGY, V116, P1175, DOI 10.1210/endo-116-3-1175; BLATHENA SJ, 1984, P SOC EXP BIOL MED, V175, P35; BOYD AW, 1984, LEUKEMIA RES, V8, P27, DOI 10.1016/0145-2126(84)90029-8; BRUNSTEDT J, 1982, BIOCHEM BIOPH RES CO, V106, P1383, DOI 10.1016/0006-291X(82)91267-0; CHATHAM J, 1988, FEBS LETT, V238, P445, DOI 10.1016/0014-5793(88)80529-5; CHICK WL, 1977, P NATL ACAD SCI USA, V74, P628, DOI 10.1073/pnas.74.2.628; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DANNA JA, 1980, BIOCHEMISTRY-US, V19, P2656, DOI 10.1021/bi00553a019; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; FALLON RJ, 1979, J CELL PHYSIOL, V100, P251, DOI 10.1002/jcp.1041000206; FUJIMOTO WY, 1978, P SOC EXP BIOL MED, V157, P89; FUJIMOTO WY, 1977, IN VITRO CELL DEV B, V13, P237; GAZDAR AF, 1980, P NATL ACAD SCI-BIOL, V77, P3519, DOI 10.1073/pnas.77.6.3519; GIDDINGS SJ, 1981, J CLIN INVEST, V67, P952, DOI 10.1172/JCI110145; GINSBURG E, 1973, P NATL ACAD SCI USA, V70, P2457, DOI 10.1073/pnas.70.8.2457; HALBAN PA, 1983, BIOCHEM J, V212, P439, DOI 10.1042/bj2120439; HALBAN PA, 1982, ENDOCRINOLOGY, V111, P86, DOI 10.1210/endo-111-1-86; HEDESKOV CJ, 1980, PHYSIOL REV, V60, P442, DOI 10.1152/physrev.1980.60.2.442; HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393; KNUDSEN P, 1983, AM J PHYSIOL, V245, pE338, DOI 10.1152/ajpendo.1983.245.4.E338; KRUH J, 1982, MOL CELL BIOCHEM, V42, P65; LECLERCQMEYER V, 1988, INT J PANCREATOL, V3, P17; LEDER A, 1975, CELL, V5, P319, DOI 10.1016/0092-8674(75)90107-5; LENZEN S, 1979, AM J PHYSIOL, V236, pE391, DOI 10.1152/ajpendo.1979.236.4.E391; LERNMARK A, 1972, HORMONES, V3, P14, DOI 10.1159/000178253; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; MADSEN OD, 1986, J CELL BIOL, V103, P2025, DOI 10.1083/jcb.103.5.2025; MADSEN OD, 1988, P NATL ACAD SCI USA, V85, P6652, DOI 10.1073/pnas.85.18.6652; MOLDRUP A, 1989, MOL ENDOCRINOL, V3, P1173, DOI 10.1210/mend-3-8-1173; NEWMAN JD, 1989, BIOCHEM BIOPH RES CO, V161, P101, DOI 10.1016/0006-291X(89)91566-0; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; NIELSEN JH, 1989, EXP CLIN ENDOCRINOL, V93, P277; NISHIMUNE Y, 1983, EXP CELL RES, V146, P439, DOI 10.1016/0014-4827(83)90147-7; OIE HK, 1983, ENDOCRINOLOGY, V112, P1070, DOI 10.1210/endo-112-3-1070; PAGLIARA AS, 1974, J CLIN INVEST, V54, P819, DOI 10.1172/JCI107822; PHILIPPE J, 1987, MOL CELL BIOL, V7, P560, DOI 10.1128/MCB.7.1.560; PHILIPPE J, 1987, J CLIN INVEST, V79, P351, DOI 10.1172/JCI112819; PIPELEERS D, 1982, P NATL ACAD SCI-BIOL, V79, P7322, DOI 10.1073/pnas.79.23.7322; POWERS AC, 1988, DIABETES, V37, P1405, DOI 10.2337/diabetes.37.10.1405; PRASAD KN, 1976, IN VITRO CELL DEV B, V12, P125; PRAZ GA, 1983, BIOCHEM J, V210, P345, DOI 10.1042/bj2100345; RIGGS MG, 1977, NATURE, V268, P462, DOI 10.1038/268462a0; RITTLING SR, 1986, P NATL ACAD SCI USA, V83, P3316, DOI 10.1073/pnas.83.10.3316; RUBENSTEIN P, 1979, NATURE, V280, P692, DOI 10.1038/280692a0; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; SCOTT RE, 1982, P NATL ACAD SCI-BIOL, V79, P845, DOI 10.1073/pnas.79.3.845; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; SWANSTONFLATT SK, 1988, GEN PHARMACOL, V19, P239, DOI 10.1016/0306-3623(88)90068-7; SWANSTONFLATT SK, 1987, BIOMED RES-TOKYO, V8, P215, DOI 10.2220/biomedres.8.215; SWENNE I, 1986, DIABETES RES CLIN EX, V3, P207; TOSCANI A, 1988, ONCOGENE RES, V3, P223; TURK J, 1987, PROG LIPID RES, V26, P125, DOI 10.1016/0163-7827(87)90010-5; UCHIDA S, 1979, J NATL CANCER I, V63, P119; WELSH M, 1985, J BIOL CHEM, V260, P3590; WELSH N, 1986, BIOCHIM BIOPHYS ACTA, V887, P58, DOI 10.1016/0167-4889(86)90122-9; WELSH N, 1987, BIOCHEM J, V246, P245, DOI 10.1042/bj2460245; WINTERSBERGER E, 1983, J CELL BIOCHEM, V21, P239, DOI 10.1002/jcb.240210306; WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914, DOI 10.1152/physrev.1981.61.4.914; WOLLHEIM CB, 1984, J BIOL CHEM, V259, P2262; WRIGHT JA, 1973, EXP CELL RES, V78, P456, DOI 10.1016/0014-4827(73)90091-8	68	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	1991	266	12					7542	7548						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ342	1708388				2022-12-27	WOS:A1991FJ34200037
J	ERNST, JD; HOYE, E; BLACKWOOD, RA; MOK, TL				ERNST, JD; HOYE, E; BLACKWOOD, RA; MOK, TL			IDENTIFICATION OF A DOMAIN THAT MEDIATES VESICLE AGGREGATION REVEALS FUNCTIONAL DIVERSITY OF ANNEXIN REPEATS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PLACENTAL ANTICOAGULANT PROTEIN; CA-2+ BINDING; LIPOCORTIN-I; CALPACTIN; PHOSPHORYLATION; CALCIUM; EXOCYTOSIS; EXPRESSION; TERMINUS; CLONING	Annexins are structurally related proteins that bind phospholipids in a Ca2+-dependent manner and possess at least four conserved 70-amino acid repeat domains. The ability of certain annexins to promote contact between vesicle membranes in vitro has prompted the suggestion that these proteins regulate membrane traffic in exocytosis. We have previously found that annexins I and II promote contact between vesicles whereas annexin V does not. In order to understand the mechanism of annexin I-mediated vesicle-vesicle contact, we prepared a monoclonal antibody that specifically inhibits annexin I-mediated vesicle aggregation. We identified the domain of annexin I recognized by this monoclonal antibody by using it to screen an expression library containing random fragments of annexin I cDNA. The antibody identified a fragment encoding amino acids 41-118 (the first repeat plus 8 residues of the amino-terminal tail). We constructed a chimeric protein containing these amino acids of annexin I fused to the second, third, and fourth repeats of annexin V. Transfer of this domain conferred the ability to promote vesicle aggregation, confirming that this domain participates directly in mediating contact between vesicle membranes.	UNIV CALIF SAN FRANCISCO,DIV INFECT DIS,SAN FRANCISCO,CA 94143; SAN FRANCISCO GEN HOSP,ROSALIND RUSSELL ARTHRIT RES LABS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	ERNST, JD (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MED,BOX 0868,SAN FRANCISCO,CA 94143, USA.							ALI SM, 1989, NATURE, V340, P313, DOI 10.1038/340313a0; AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; ANDO Y, 1989, J BIOL CHEM, V264, P6948; BLACKWOOD RA, 1990, BIOCHEM J, V266, P195, DOI 10.1042/bj2660195; BURGOYNE RD, 1988, NATURE, V331, P20, DOI 10.1038/331020a0; DRUST DS, 1988, NATURE, V331, P88, DOI 10.1038/331088a0; ERNST JD, 1990, J CLIN INVEST, V85, P1065, DOI 10.1172/JCI114537; FONG HKW, 1987, P NATL ACAD SCI USA, V84, P3792, DOI 10.1073/pnas.84.11.3792; FUNAKOSHI T, 1987, BIOCHEMISTRY-US, V26, P8087, DOI 10.1021/bi00399a011; GLENNEY J, 1988, BIOCHEMISTRY-US, V27, P2069, DOI 10.1021/bi00406a038; GLENNEY J, 1986, J BIOL CHEM, V261, P7247; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; GLENNEY JR, 1986, J BIOL CHEM, V261, P485; HAIGLER HT, 1987, J BIOL CHEM, V262, P6921; HARLOW E, 1988, ANTIBODIES LABORATOR; KAPLAN R, 1988, J BIOL CHEM, V263, P8037; MEERS P, 1987, J BIOL CHEM, V262, P7850; MEERS P, 1990, BIOCHEMISTRY-US, V29, P3325, DOI 10.1021/bi00465a025; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1989, MOL CLONING LABORATO; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; TAIT JF, 1989, J BIOL CHEM, V264, P7944	22	53	53	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					6670	6673						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707872				2022-12-27	WOS:A1991FG72700004
J	PADH, H; LAVASA, M; STECK, TL				PADH, H; LAVASA, M; STECK, TL			ENDOSOMES ARE ACIDIFIED BY ASSOCIATION WITH DISCRETE PROTON-PUMPING VACUOLES IN DICTYOSTELIUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H+-ATPASE; CELLS; HEPATOCYTES; DISCOIDEUM; DIGITONIN	The endocytic compartment in the amoeba Dictyostelium discoideum was labeled by feeding fluorescein 5-isothiocyanate-dextran. In homogenates containing 2 mM Mg2+, the compartments so labeled copurified with all of the vacuolar H+-ATPase activity in a dense peak. The fluorescence properties of the probe showed that these dense vacuoles were inherently acidic. Furthermore, after purging their residual acidity, they could be re-acidified by the addition of ATP. These data suggest that the H+-ATPase was structurally and functionally coupled to the endocytic space. The association of the H+-ATPase and endocytic compartment was reversed by the removal of either Mg2+ or traces of the cytosol. Endocytic vacuoles prepared in this way were deficient in vacuolar H+-ATPase activity and were not acidified upon addition of MgATP. The missing proton pumps were recovered in large buoyant vacuoles that lacked ingested fluorescein 5-isothiocyanate-dextran, acid hydrolases, and residual acidity. These vacuoles were also less susceptible than endosomes to disruption by digitonin, suggesting that their bilayers were low in sterols. These results indicate that the endocytic circuit in Dictyostelium is acidified by a discrete and separable proton-pumping organelle.			PADH, H (corresponding author), UNIV CHICAGO,DEPT BIOCHEM & MOLEC BIOL,920 E 58TH ST,CHICAGO,IL 60637, USA.			Padh, Harish/0000-0003-2305-6229	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086, P30DK026678] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK26678, DK42086] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ADACHI T, 1990, J BIOL CHEM, V265, P967; ALMERS W, 1990, ANNU REV PHYSIOL, V52, P607, DOI 10.1146/annurev.ph.52.030190.003135; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; BROWN D, 1987, J CELL BIOL, V105, P1637, DOI 10.1083/jcb.105.4.1637; COOK GA, 1983, BIOCHIM BIOPHYS ACTA, V763, P356, DOI 10.1016/0167-4889(83)90097-6; FISKUM G, 1980, P NATL ACAD SCI-BIOL, V77, P3430, DOI 10.1073/pnas.77.6.3430; Fok A.K., 1990, International Review of Cytology, V123, P61, DOI 10.1016/S0074-7696(08)60671-3; Fok A.K., 1988, P301; FORGAC M, 1989, PHYSIOL REV, V69, P765, DOI 10.1152/physrev.1989.69.3.765; HEUSER J E, 1990, Journal of Cell Biology, V111, p315A; HOLTMAN E, 1989, LYSOSOMES; KANE PM, 1989, J BIOL CHEM, V264, P19236; LEE HC, 1982, INTRACELLULAR PH ITS, P135; MORIYAMA Y, 1989, J BIOL CHEM, V264, P18445; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OHKUMA S, 1987, LYSOSOMES THEIR ROLE, P115; PADH H, 1989, J CELL BIOL, V108, P865, DOI 10.1083/jcb.108.3.865; PADH H, 1989, BIOCHIM BIOPHYS ACTA, V982, P271, DOI 10.1016/0005-2736(89)90064-3; PADH H, 1990, Journal of Cell Biology, V111, p314A; PARRY RV, 1989, J BIOL CHEM, V264, P20025; REVEL JP, 1985, ANNU REV PHYSIOL, V47, P263; SCHNEIDER E, 1987, MICROBIOL REV, V51, P477, DOI 10.1128/MMBR.51.4.477-497.1987; SENIOR AE, 1990, ANNU REV BIOPHYS BIO, V19, P7; THILO L, 1985, BIOCHIM BIOPHYS ACTA, V822, P243, DOI 10.1016/0304-4157(85)90010-3; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247	25	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5514	5520						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706336				2022-12-27	WOS:A1991FD37000026
J	MYLLYLA, R; PIHLAJANIEMI, T; PAJUNEN, L; TURPEENNIEMIHUJANEN, T; KIVIRIKKO, KI				MYLLYLA, R; PIHLAJANIEMI, T; PAJUNEN, L; TURPEENNIEMIHUJANEN, T; KIVIRIKKO, KI			MOLECULAR-CLONING OF CHICK LYSYL HYDROXYLASE - LITTLE HOMOLOGY IN PRIMARY STRUCTURE TO THE 2 TYPES OF SUBUNIT OF PROLYL 4-HYDROXYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; HORMONE-BINDING-PROTEIN; AMINO-ACID SEQUENCES; BETA-SUBUNIT; ENDOPLASMIC-RETICULUM; ALPHA-SUBUNIT; COLLAGEN-SYNTHESIS; ENZYME; INHIBITORS; CLONES	Lysyl hydroxylase (EC 1.14.11.4), an alpha-2 dimer, catalyzes the formation of hydroxylysine in collagens by the hydroxylation of lysine residues in X-Lys-Gly sequences. We report here on the isolation of cDNA clones coding for the enzyme from a chick embryo lambda-gt11 library. Several overlapping clones covering all the coding sequences of the 4-kilobase mRNA and virtually all the noncoding sequences were characterized. These clones encode a polypeptide of 710 amino acid residues and a signal peptide of 20 amino acids. The polypeptide has four potential attachment sites for asparagine-linked oligosaccharides and 9 cysteine residues, at least one of which is likely to be involved in the binding of the Fe2+ atom to a catalytic site. A surprising finding was that no significant homology was found between the primary structures of lysyl hydroxylase and prolyl 4-hydroxylase in spite of the marked similarities in kinetic properties between these two enzymes. A computer-assisted comparison indicated only an 18% identity between lysyl hydroxylase and the alpha-subunit of prolyl 4-hydroxylase and a 19% identity between lysyl hydroxylase and the beta-subunit of prolyl 4-hydroxylase. Visual inspection of the most homologous areas nevertheless indicated the presence of several regions of 20-40 amino acids in which the identity between lysyl hydroxylase and one of the prolyl 4-hydroxylase subunits exceeded 30% or similarity exceeded 40%. Southern blot analyses of chick genomic DNA indicated the presence of only one gene coding for lysyl hydroxylase.	UNIV OULU, DEPT MED BIOCHEM, SF-90220 OULU, FINLAND	University of Oulu	MYLLYLA, R (corresponding author), UNIV OULU, BIOCTR, COLLAGEN RES UNIT, SF-90220 OULU, FINLAND.			Pihlajaniemi, Taina/0000-0002-1664-9045				AEBERSOLD RH, 1986, J BIOL CHEM, V261, P4229; ARGOS P, 1987, J MOL BIOL, V193, P385, DOI 10.1016/0022-2836(87)90226-9; BASSUK JA, 1989, P NATL ACAD SCI USA, V86, P7382, DOI 10.1073/pnas.86.19.7382; CHENG SY, 1987, J BIOL CHEM, V262, P11221; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DEWET JR, 1984, DNA-J MOLEC CELL BIO, V3, P437, DOI 10.1089/dna.1.1984.3.437; GEETHAHABIB M, 1988, CELL, V54, P1053, DOI 10.1016/0092-8674(88)90120-1; HANAUSKEABEL HM, 1982, J THEOR BIOL, V94, P421, DOI 10.1016/0022-5193(82)90320-4; HELAAKOSKI T, 1989, P NATL ACAD SCI USA, V86, P4392, DOI 10.1073/pnas.86.12.4392; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KAO WWY, 1988, CONNECT TISSUE RES, V18, P157, DOI 10.3109/03008208809016805; KASKA DD, 1988, BIOCHEM J, V256, P257, DOI 10.1042/bj2560257; KIVIRIKKO KI, 1985, ANN NY ACAD SCI, V460, P187, DOI 10.1111/j.1749-6632.1985.tb51167.x; KIVIRIKKO KI, 1982, METHOD ENZYMOL, V82, P245; KIVIRIKKO KI, 1989, FASEB J, V3, P1609, DOI 10.1096/fasebj.3.5.2537773; KIVIRIKKO KI, 1990, ANN NY ACAD SCI, V580, P132, DOI 10.1111/j.1749-6632.1990.tb17925.x; KIVIRIKKO KI, 1980, ENZYMOLOGY POST TRAN, P53; KIVIRIKKO KI, 1987, CONNECTIVE TISSUE DI, P263; KOIVU J, 1987, J BIOL CHEM, V262, P6447; KRANE SM, 1984, EXTRACELLULAR MATRIX, P413; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MYLLYLA R, 1988, BIOCHEM J, V253, P489, DOI 10.1042/bj2530489; PARKKONEN T, 1988, BIOCHEM J, V256, P1005, DOI 10.1042/bj2561005; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; PIHLAJANIEMI T, 1987, METHOD ENZYMOL, V145, P213; PORUCHYNSKY MS, 1988, J CELL BIOL, V107, P1697, DOI 10.1083/jcb.107.5.1697; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Smith B J, 1988, Methods Mol Biol, V3, P71, DOI 10.1385/0-89603-126-8:71; TURPEENNIEMIHUJANEN TM, 1980, BIOCHEM J, V189, P247, DOI 10.1042/bj1890247; TURPEENNIEMIHUJANEN TM, 1981, COLLAGEN REL RES, V1, P355; TURPEENNIEMIHUJANEN TM, 1981, BIOCHEM J, V195, P669, DOI 10.1042/bj1950669; VARTIO T, 1981, J BIOL CHEM, V256, P3085; WADA KN, 1990, NUCLEIC ACIDS RES, V18, P2367, DOI 10.1093/nar/18.suppl.2367; YAMAUCHI K, 1987, BIOCHEM BIOPH RES CO, V146, P1485, DOI 10.1016/0006-291X(87)90817-5; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194	39	58	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2805	2810						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704364				2022-12-27	WOS:A1991EX60000024
J	AIBA, H; HANAMURA, A; YAMANO, H				AIBA, H; HANAMURA, A; YAMANO, H			TRANSCRIPTIONAL TERMINATOR IS A POSITIVE REGULATORY ELEMENT IN THE EXPRESSION OF THE ESCHERICHIA-COLI CRP GENE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; AMP RECEPTOR PROTEIN; ADENOSINE-MONOPHOSPHATE RECEPTOR; CYCLIC-AMP; OPERON; SUPPRESSOR; SEQUENCES; CLONING; POLYMERASE; MUTATIONS	Plasmids were constructed that contain deletions in the stem region of the presumed rho-independent terminator of the cloned crp gene of Escherichia coli. The level of cyclic AMP binding activity and the amount of CRP in cells harboring the deletion plasmids were found to be significantly lower than those in cells harboring the wild-type crp plasmid. Quantitative S1 assays indicated that the steady-state levels of crp mRNA were markedly reduced in cells harboring the deletion plasmids. Evidence was also presented to show that the crp mRNAs produced from deletion plasmids are less stable than that from the intact crp gene. In vitro transcription assays revealed that the putative crp terminator is indeed a rho-independent terminator. Using the galK expression system and Northern blot analysis we showed that the crp terminator is functional in vivo. Moreover it was shown that the deletion mutations in the stem region of the crp terminator cause a significant readthrough. We conclude that the 3'-flanking sequence of the crp gene acts to stabilize its own mRNA as well as to terminate transcription.			AIBA, H (corresponding author), UNIV TSUKUBA,DEPT CHEM,SAKURA,IBARAKI 305,JAPAN.							ADHYA S, 1979, NATURE, V279, P492, DOI 10.1038/279492a0; AIBA H, 1985, EMBO J, V4, P3329, DOI 10.1002/j.1460-2075.1985.tb04084.x; AIBA H, 1981, J BIOL CHEM, V256, P1905; AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; ALEXANDER JK, 1980, J BACTERIOL, V144, P205, DOI 10.1128/JB.144.1.205-209.1980; BARTON JW, 1987, J BACTERIOL, V169, P654, DOI 10.1128/jb.169.2.654-659.1987; BELASCO JG, 1985, CELL, V40, P171, DOI 10.1016/0092-8674(85)90320-4; BIVILLE F, 1983, BIOCHIMIE, V65, P339, DOI 10.1016/S0300-9084(83)80155-2; BOTSFORD JL, 1978, MOL GEN GENET, V165, P47, DOI 10.1007/BF00270375; BRAWERMAN G, 1989, CELL, V57, P9, DOI 10.1016/0092-8674(89)90166-9; BRAWERMAN G, 1987, CELL, V48, P5, DOI 10.1016/0092-8674(87)90346-1; BURTON ZF, 1983, CELL, V32, P335, DOI 10.1016/0092-8674(83)90453-1; CAMPBELL A, 1961, VIROLOGY, V14, P22, DOI 10.1016/0042-6822(61)90128-3; DECROMBRUGGHE B, 1984, SCIENCE, V224, P831, DOI 10.1126/science.6372090; DESSEIN A, 1978, MOL GEN GENET, V162, P83, DOI 10.1007/BF00333853; EILEN E, 1978, BIOCHEMISTRY-US, V17, P2469, DOI 10.1021/bi00606a001; FUKUDA R, 1974, J MOL BIOL, V83, P353, DOI 10.1016/0022-2836(74)90284-8; GARGES S, 1985, CELL, V41, P745, DOI 10.1016/S0092-8674(85)80055-6; GEORGE SE, 1986, J BACTERIOL, V166, P533, DOI 10.1128/jb.166.2.533-540.1986; GUARNEROS G, 1982, P NATL ACAD SCI-BIOL, V79, P238, DOI 10.1073/pnas.79.2.238; HARMAN JG, 1983, J BACTERIOL, V153, P191, DOI 10.1128/JB.153.1.191-199.1983; HARMAN JG, 1986, J BIOL CHEM, V261, P6332; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HAYASHI MN, 1985, NUCLEIC ACIDS RES, V13, P5937, DOI 10.1093/nar/13.16.5937; KLECKNER N, 1977, J MOL BIOL, V116, P125, DOI 10.1016/0022-2836(77)90123-1; KRAKOW JS, 1973, P NATL ACAD SCI USA, V70, P2529, DOI 10.1073/pnas.70.9.2529; LUPSKI JR, 1984, MOL GEN GENET, V195, P391, DOI 10.1007/BF00341439; Maniatis T., 1982, MOL CLONING; McKenney K, 1981, Gene Amplif Anal, V2, P383; MELTON T, 1981, MOL GEN GENET, V182, P480, DOI 10.1007/BF00293939; Miller J.H., 1972, EXPT MOL GENETICS; MOTT JE, 1985, EMBO J, V4, P1887, DOI 10.1002/j.1460-2075.1985.tb03865.x; NEWBURY SF, 1987, CELL, V51, P1131, DOI 10.1016/0092-8674(87)90599-X; PLAMANN MD, 1985, J BACTERIOL, V161, P650, DOI 10.1128/JB.161.2.650-654.1985; ROY A, 1983, EMBO J, V2, P791, DOI 10.1002/j.1460-2075.1983.tb01502.x; SANDERS R, 1973, P NATL ACAD SCI USA, V70, P1017, DOI 10.1073/pnas.70.4.1017; TAKEBE Y, 1978, J BIOCHEM-TOKYO, V83, P1615, DOI 10.1093/oxfordjournals.jbchem.a132073; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; ULLMANN A, 1983, ADV CYCL NUCL RES<D>, V15, P1; WONG HC, 1986, P NATL ACAD SCI USA, V83, P3233, DOI 10.1073/pnas.83.10.3233; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	41	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1721	1727						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703152				2022-12-27	WOS:A1991EU49700058
J	KIM, UH; FINK, D; KIM, HS; PARK, DJ; CONTRERAS, ML; GUROFF, G; RHEE, SG				KIM, UH; FINK, D; KIM, HS; PARK, DJ; CONTRERAS, ML; GUROFF, G; RHEE, SG			NERVE GROWTH-FACTOR STIMULATES PHOSPHORYLATION OF PHOSPHOLIPASE C-GAMMA IN PC12 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							PROTEIN KINASE-C; TYROSINE PHOSPHORYLATION; PHEOCHROMOCYTOMA CELLS; SIGNAL TRANSDUCTION; RECEPTOR; ACETYLCHOLINE; ACTIVATION; MECHANISM; CALCIUM; GAMMA	PC12 cells contain at least three immunologically distinct phospholipase C (PLC) isozymes, PLC-beta, PLC-gamma, and PLC-delta. Treatment of PC12 cells with nerve growth factor (NGF) leads to an increase in the phosphorylation of PLC-gamma, but not of PLC-beta or PLC-delta. This increase can be seen in as little as 1 minute. The increased phosphorylation occurs on both serine and tyrosine residues, with the major increase being in the former. This result suggests the possibility that the NGF-dependent increase in phosphoinositide hydrolysis in PC12 cells is due to selective phosphorylation of PLC-gamma by serine and tyrosine protein kinases associated with the NGF receptor.	NHLBI,ZENTRUM BIOCHEM,SIGNAL TRANSDUCT SECT,BETHESDA,MD 20892; NICHHD,GROWTH FACTORS SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)			Park, Do-Joon/J-2736-2012	Kim, Uh-Hyun/0000-0003-3304-7190				ALTIN JG, 1990, J NEUROCHEM, V54, P1666, DOI 10.1111/j.1471-4159.1990.tb01220.x; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BOCCHINI V, 1969, P NATL ACAD SCI USA, V64, P787, DOI 10.1073/pnas.64.2.787; CONTRERAS ML, 1987, J NEUROCHEM, V48, P1466, DOI 10.1111/j.1471-4159.1987.tb05687.x; CREMINS J, 1986, J CELL BIOL, V103, P887, DOI 10.1083/jcb.103.3.887; DICHTER MA, 1977, NATURE, V268, P501, DOI 10.1038/268501a0; END D, 1983, J BIOL CHEM, V258, P6549; GREENE LA, 1977, NATURE, V268, P349, DOI 10.1038/268349a0; GREENE LA, 1980, ANNU REV NEUROSCI, V3, P353, DOI 10.1146/annurev.ne.03.030180.002033; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2425; HALEGOUA S, 1980, CELL, V22, P571, DOI 10.1016/0092-8674(80)90367-0; HAMA T, 1986, P NATL ACAD SCI USA, V83, P2353, DOI 10.1073/pnas.83.8.2353; HEASLEY LE, 1989, J BIOL CHEM, V264, P8646; HUFF K, 1981, J CELL BIOL, V88, P189, DOI 10.1083/jcb.88.1.189; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAMPS MP, 1989, ANAL BIOCHEM, V176, P22, DOI 10.1016/0003-2697(89)90266-2; KIM UH, 1990, FED PROC, V4, P1780; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; LEVIMONTALCINI R, 1968, PHYSIOL REV, V48, P534, DOI 10.1152/physrev.1968.48.3.534; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P6576, DOI 10.1073/pnas.82.19.6576; MAHER PA, 1988, J CELL BIOL, V106, P1747, DOI 10.1083/jcb.106.5.1747; MAHER PA, 1989, J NEUROSCI RES, V24, P29, DOI 10.1002/jnr.490240106; MAHER PA, 1988, P NATL ACAD SCI USA, V85, P6788, DOI 10.1073/pnas.85.18.6788; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MCTIGUE M, 1985, J BIOL CHEM, V260, P9047; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MUSTELIN T, 1990, SCIENCE, V247, P1584, DOI 10.1126/science.2138816; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; ROWLAND EA, 1987, J BIOL CHEM, V262, P7504; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SAVAGE CR, 1972, J BIOL CHEM, V247, P7609; SCHECHTER AL, 1981, CELL, V24, P867, DOI 10.1016/0092-8674(81)90112-4; SUH PG, 1988, J BIOL CHEM, V263, P14497; THOENEN H, 1980, PHYSIOL REV, V60, P1284, DOI 10.1152/physrev.1980.60.4.1284; TRAYNOR AE, 1982, J NEUROCHEM, V39, P1677, DOI 10.1111/j.1471-4159.1982.tb08002.x; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; YU MW, 1980, J BIOL CHEM, V255, P481	40	164	165	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 25	1991	266	3					1359	1362						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU497	1703147				2022-12-27	WOS:A1991EU49700002
J	SHAI, Y; BACH, D; YANOVSKY, A				SHAI, Y; BACH, D; YANOVSKY, A			CHANNEL FORMATION PROPERTIES OF SYNTHETIC PARDAXIN AND ANALOGS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											SHAI, Y (corresponding author), WEIZMANN INST SCI, DEPT MEMBRANE RES, IL-76100 REHOVOT, ISRAEL.							ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; ANDREU D, 1983, P NATL ACAD SCI-BIOL, V80, P6475, DOI 10.1073/pnas.80.21.6475; [Anonymous], [No title captured]; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BATENBURG AM, 1985, BIOCHEMISTRY-US, V24, P7101, DOI 10.1021/bi00346a013; BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007; BRANDL CJ, 1986, P NATL ACAD SCI USA, V83, P917, DOI 10.1073/pnas.83.4.917; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; CORONADO R, 1983, BIOPHYS J, V43, P231, DOI 10.1016/S0006-3495(83)84343-4; DUFOURCQ J, 1977, BIOCHIM BIOPHYS ACTA, V467, P1, DOI 10.1016/0005-2736(77)90236-X; FAUCON JF, 1983, BIOCHEMISTRY-US, V22, P2179, DOI 10.1021/bi00278a019; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1984, BIOPHYS J, V45, P249, DOI 10.1016/S0006-3495(84)84152-1; GUY HR, 1987, TRENDS NEUROSCI, V10, P318, DOI 10.1016/0166-2236(87)90087-7; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HANKE W, 1983, BIOCHIM BIOPHYS ACTA, V727, P108, DOI 10.1016/0005-2736(83)90374-7; HARSHMAN S, 1989, J BIOL CHEM, V264, P14978; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; KINI RM, 1989, INT J PEPT PROT RES, V34, P277; KINI RM, 1989, BIOCHEMISTRY-US, V28, P9209, DOI 10.1021/bi00449a037; LAZAROVICI P, 1988, E H S BIOT, P219; LAZAROVICI P, 1990, ACS SYM SER, V418, P347; LAZAROVICI P, 1986, J BIOL CHEM, V261, P6704; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Lelkes P. I., 1984, LIPOSOME TECHNOLOGY, P225; LOEW LM, 1985, BIOCHEMISTRY-US, V24, P2101, DOI 10.1021/bi00330a001; LOEW LM, 1983, BIOCHEMISTRY-US, V22, P837, DOI 10.1021/bi00273a020; MERRIFIELD RB, 1982, BIOCHEMISTRY-US, V21, P5020, DOI 10.1021/bi00263a028; MOOR JF, 1984, P NATL ACAD SCI USA, V81, P155; Moran A., 1984, P13; PARNESS J, 1976, TOXICON, V14, P85, DOI 10.1016/0041-0101(76)90097-0; PRIMOR N, 1984, BRIT J PHARMACOL, V82, P43, DOI 10.1111/j.1476-5381.1984.tb16440.x; REGNIER FE, 1987, SCIENCE, V238, P319, DOI 10.1126/science.3310233; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SESSA G, 1969, J BIOL CHEM, V244, P3575; SHAI Y, 1987, BIOCHEMISTRY-US, V26, P669, DOI 10.1021/bi00377a002; SHAI Y, 1988, FEBS LETT, V242, P161, DOI 10.1016/0014-5793(88)81007-X; SIMS PJ, 1974, BIOCHEMISTRY-US, V13, P3315, DOI 10.1021/bi00713a022; THOMPSON SA, 1986, SCIENCE, V233, P341, DOI 10.1126/science.233.4761.341; TOSTESON MT, 1985, J MEMBRANE BIOL, V87, P35, DOI 10.1007/BF01870697; TOSTESON MT, 1987, BIOCHEMISTRY-US, V26, P6627, DOI 10.1021/bi00395a010; TOSTESON MT, 1981, BIOPHYS J, V36, P109, DOI 10.1016/S0006-3495(81)84719-4; VOGEL H, 1981, FEBS LETT, V134, P37, DOI 10.1016/0014-5793(81)80545-5; VOGEL H, 1986, BIOPHYS J, V50, P573, DOI 10.1016/S0006-3495(86)83497-X; WEAVER AJ, 1989, BIOCHEMISTRY-US, V28, P8614, DOI 10.1021/bi00447a052; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019	47	181	182	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20202	20209						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700783				2022-12-27	WOS:A1990EJ52500028
J	DODGE, GR; KOVALSZKY, I; HASSELL, JR; IOZZO, RV				DODGE, GR; KOVALSZKY, I; HASSELL, JR; IOZZO, RV			TRANSFORMING GROWTH-FACTOR-BETA ALTERS THE EXPRESSION OF HEPARAN-SULFATE PROTEOGLYCAN IN HUMAN COLON-CARCINOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									THOMAS JEFFERSON UNIV,DEPT PATHOL & CELL BIOL,JEFFERSON ALUMNI HALL,ROOM 249,PHILADELPHIA,PA 19107; UNIV PITTSBURGH,INST EYE & EAR,PITTSBURGH,PA 15213	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Kovalszky, Ilona/ABH-2832-2020; Iozzo, Renato/AAS-1980-2020	Kovalszky, Ilona/0000-0002-0179-3378; Iozzo, Renato/0000-0002-5908-5112	NIA NIH HHS [AG-5707] Funding Source: Medline; PHS HHS [A-39481] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADANY R, 1990, J BIOL CHEM, V265, P11389; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BASCOM CC, 1989, J CELL BIOCHEM, V39, P25, DOI 10.1002/jcb.240390104; BASSOLS A, 1988, J BIOL CHEM, V263, P3039; CARLSON DM, 1968, J BIOL CHEM, V243, P616; CHEN JK, 1987, P NATL ACAD SCI USA, V84, P5287, DOI 10.1073/pnas.84.15.5287; CHEN TR, 1987, CANCER GENET CYTOGEN, V27, P125, DOI 10.1016/0165-4608(87)90267-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COFFEY RJ, 1986, CANCER RES, V46, P1164; CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477; DAVIS LG, 1986, BASIC METHODS MOL BI, P129; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FINE A, 1987, J BIOL CHEM, V262, P3897; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; HEINO J, 1989, J BIOL CHEM, V264, P380; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; IGNOTZ RA, 1987, J BIOL CHEM, V262, P6443; INOUE H, 1989, J CELL PHYSIOL, V138, P329, DOI 10.1002/jcp.1041380216; IOZZO RV, 1987, J BIOL CHEM, V262, P1888; IOZZO RV, 1986, FEBS LETT, V206, P304, DOI 10.1016/0014-5793(86)81001-8; IOZZO RV, 1985, LAB INVEST, V53, P373; IOZZO RV, 1987, J BIOL CHEM, V262, P11188; IOZZO RV, 1985, J BIOL CHEM, V260, P7464; IOZZO RV, 1989, ARCH BIOCHEM BIOPHYS, V269, P239, DOI 10.1016/0003-9861(89)90105-7; IOZZO RV, 1988, CANCER METAST REV, V7, P39, DOI 10.1007/BF00048277; IOZZO RV, 1989, J BIOL CHEM, V264, P2690; IOZZO RV, 1989, J CELL BIOCHEM, V39, P355, DOI 10.1002/jcb.240390403; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; IOZZO RV, 1988, J CELL BIOCHEM, V31, P67; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linker A., 1972, METHODS ENZYMOL, P902; MASSAGUE J, 1987, CELL, V49, P437, DOI 10.1016/0092-8674(87)90443-0; MORALES TI, 1988, J BIOL CHEM, V263, P12828; NEVINS JR, 1987, METHOD ENZYMOL, V152, P238; NOONAN DM, 1988, J BIOL CHEM, V263, P16379; OLSEN AS, 1989, MATRIX, V9, P73, DOI 10.1016/S0934-8832(89)80024-1; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; RASMUSSEN S, 1988, J CELL BIOL, V107, P1959, DOI 10.1083/jcb.107.5.1959; ROBERTS AB, 1986, P NATL ACAD SCI USA, V83, P4167, DOI 10.1073/pnas.83.12.4167; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; SAKU T, 1989, J BIOL CHEM, V264, P3514; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SPORN MB, 1986, SCIENCE, V233, P532, DOI 10.1126/science.3487831; TAN EML, 1989, BIOCHEM BIOPH RES CO, V163, P84, DOI 10.1016/0006-291X(89)92102-5; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; VARGA J, 1986, BIOCHEM BIOPH RES CO, V138, P974, DOI 10.1016/S0006-291X(86)80591-5; WAKEFIELD LM, 1987, J CELL BIOL, V105, P965, DOI 10.1083/jcb.105.2.965; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915; YAMAGATA T, 1968, J BIOL CHEM, V243, P1523	53	63	63	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					18023	18029						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698783				2022-12-27	WOS:A1990EC76600099
J	RENNEISEN, K; LESERMAN, L; MATTHES, E; SCHRODER, HC; MULLER, WEG				RENNEISEN, K; LESERMAN, L; MATTHES, E; SCHRODER, HC; MULLER, WEG			INHIBITION OF EXPRESSION OF HUMAN IMMUNODEFICIENCY VIRUS-1 INVITRO BY ANTIBODY-TARGETED LIPOSOMES CONTAINING ANTISENSE RNA TO THE ENV REGION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MAINZ,INST PHYSIOL CHEM,ANGEW MOLEK BIOL ABT,DUESBERGWEG 6,W-6500 MAINZ,GERMANY; CNRS,INSERM,CTR IMMUNOL,F-13288 MARSEILLE 9,FRANCE; ACAD SCI GDR,ZENT INST MOLEK BIOL,O-1115 BERLIN,GERMANY	Johannes Gutenberg University of Mainz; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); German Academy of Sciences at Berlin			Müller, W. E. G./AAR-8651-2020	Müller, W. E. G./0000-0002-8223-3689; Schroder, Heinz C./0000-0003-0992-6427				AGRAWAL S, 1989, P NATL ACAD SCI USA, V86, P7790, DOI 10.1073/pnas.86.20.7790; ALEXANDER MC, 1988, P NATL ACAD SCI USA, V85, P5092, DOI 10.1073/pnas.85.14.5092; ARYA SK, 1985, SCIENCE, V229, P69, DOI 10.1126/science.2990040; BALTIMORE D, 1988, NATURE, V335, P395, DOI 10.1038/335395a0; CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; GOODCHILD J, 1988, P NATL ACAD SCI USA, V85, P5507, DOI 10.1073/pnas.85.15.5507; GRAMZOW M, 1986, J CELL BIOL, V102, P1344, DOI 10.1083/jcb.102.4.1344; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; HUET T, 1989, AIDS, V3, P707, DOI 10.1097/00002030-198911000-00004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEONETTI JP, 1990, IN PRESS P NATL ACAD; LESERMAN LD, 1981, NATURE, V293, P226, DOI 10.1038/293226a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACHY P, 1988, P NATL ACAD SCI USA, V85, P8027, DOI 10.1073/pnas.85.21.8027; MACHY P, 1982, P NATL ACAD SCI-BIOL, V79, P4148, DOI 10.1073/pnas.79.13.4148; Maniatis T., 1982, MOL CLONING; MATSUKURA M, 1989, P NATL ACAD SCI USA, V86, P4244, DOI 10.1073/pnas.86.11.4244; MILHAUD PG, 1989, BIOCHIM BIOPHYS ACTA, V987, P15, DOI 10.1016/0005-2736(89)90449-5; MULLER WEG, 1975, CANCER RES, V35, P3673; MULLER WEG, 1988, J ACQ IMMUN DEF SYND, V1, P453; Perbal B., 1988, PRACTICAL GUIDE MOL; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; POPOVIC M, 1984, SCIENCE, V224, P497, DOI 10.1126/science.6200935; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RUBSAMENWAIGMAN.M, 1987, 3 INT C AIDS WASH; SCHRODER HC, 1990, AIDS RES HUM RETROV, V6, P659, DOI 10.1089/aid.1990.6.659; SCHRODER HC, 1989, J BIOL CHEM, V264, P5669; SCHRODER HC, 1989, CANCER RES, V49, P2069; SCUDIERO DA, 1988, CANCER RES, V48, P4827; SODROSKI J, 1986, NATURE, V321, P412, DOI 10.1038/321412a0; SONNENBERG A, 1988, J BIOL CHEM, V263, P14030; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WHITE BA, 1982, J BIOL CHEM, V257, P8569; WICKSTROM EL, 1988, P NATL ACAD SCI USA, V85, P1028, DOI 10.1073/pnas.85.4.1028; WITTE ON, 1978, J VIROL, V26, P750, DOI 10.1128/JVI.26.3.750-761.1978; ZAIA JA, 1988, J VIROL, V62, P3914, DOI 10.1128/JVI.62.10.3914-3917.1988; ZAMECNIK PC, 1986, P NATL ACAD SCI USA, V83, P4143, DOI 10.1073/pnas.83.12.4143	41	61	92	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16337	16342						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697856				2022-12-27	WOS:A1990DZ95000048
J	WANG, LH; COY, DH; TAYLOR, JE; JIANG, NY; MOREAU, JP; HUANG, SC; FRUCHT, H; HAFFAR, BM; JENSEN, RT				WANG, LH; COY, DH; TAYLOR, JE; JIANG, NY; MOREAU, JP; HUANG, SC; FRUCHT, H; HAFFAR, BM; JENSEN, RT			DES-MET CARBOXYL-TERMINALLY MODIFIED ANALOGS OF BOMBESIN FUNCTION AS POTENT BOMBESIN RECEPTOR ANTAGONISTS, PARTIAL AGONISTS, OR AGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									IDDKD, DIGEST BRANCH, BLDG 10, RM 9C103, BETHESDA, MD 20892 USA; TULANE UNIV, MED CTR, DEPT MED, PEPTIDE RES LABS, NEW ORLEANS, LA 70112 USA; BIOMEASURE INC, HOPKINTON, MA 01748 USA	Tulane University					NATIONAL CANCER INSTITUTE [R01CA045153, R55CA045153] Funding Source: NIH RePORTER; NCI NIH HHS [CA-45153] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CAMBLE R, 1989, LIFE SCI, V45, P1521, DOI 10.1016/0024-3205(89)90417-7; CESKA M, 1969, CLIN CHIM ACTA, V26, P437, DOI 10.1016/0009-8981(69)90071-0; CESKA M, 1969, CLIN CHIM ACTA, V26, P781; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CORPS AN, 1985, BIOCHEM J, V231, P781, DOI 10.1042/bj2310781; COY DH, 1988, J BIOL CHEM, V263, P5056; COY DH, 1989, J BIOL CHEM, V264, P14691; COY DH, 1988, TETRAHEDRON, V44, P835, DOI 10.1016/S0040-4020(01)86120-2; COY DH, 1990, P A BENZOU S, V29; CUTTITTA F, 1985, NATURE, V316, P823, DOI 10.1038/316823a0; DICKER P, 1980, NATURE, V287, P607, DOI 10.1038/287607a0; DICKINSON KEJ, 1988, BIOCHEM BIOPH RES CO, V157, P1154, DOI 10.1016/S0006-291X(88)80994-X; Erspamer V., 1973, PURE APPL CHEM, V35, P463, DOI [10.1351/pac197335040463, DOI 10.1351/PAC197335040463]; GALAS MC, 1988, AM J PHYSIOL, V254, pG176, DOI 10.1152/ajpgi.1988.254.2.G176; GHATEI MA, 1982, J CLIN ENDOCR METAB, V54, P980, DOI 10.1210/jcem-54-5-980; HEIMBROOK DC, 1989, J BIOL CHEM, V264, P11258; HEIMBROOK DC, 1989, UCLA S MOL CELL BIOL, P295; HEINZERIAN P, 1987, AM J PHYSIOL, V252, pG439, DOI 10.1152/ajpgi.1987.252.3.G439; HOWARD JM, 1984, AM J PHYSIOL, V247, pG261, DOI 10.1152/ajpgi.1984.247.3.G261; JENSEN RT, 1988, AM J PHYSIOL, V254, pG883, DOI 10.1152/ajpgi.1988.254.6.G883; JENSEN RT, 1982, J BIOL CHEM, V257, P5554; JENSEN RT, 1988, ANN NY ACAD SCI, V547, P138, DOI 10.1111/j.1749-6632.1988.tb23882.x; JENSEN RT, 1986, AM J PHYSIOL, V251, pG839, DOI 10.1152/ajpgi.1986.251.6.G839; JENSEN RT, 1978, P NATL ACAD SCI USA, V75, P6139, DOI 10.1073/pnas.75.12.6139; JENSEN RT, 1985, AM J PHYSIOL, V249, pG214, DOI 10.1152/ajpgi.1985.249.2.G214; JENSEN RT, 1984, NATURE, V309, P61, DOI 10.1038/309061a0; LIGNON MF, 1987, J BIOL CHEM, V262, P7226; MAHMOUD S, 1989, LIFE SCI, V44, P367, DOI 10.1016/0024-3205(89)90231-2; MAKOVEC F, 1986, EUR J MED CHEM, V21, P9; MAKOVEC F, 1985, ARZNEIMITTELFORSCH, V35-2, P1048; MARKI W, 1981, PEPTIDES, V2, P169, DOI 10.1016/0196-9781(81)90027-9; MARTINEZ J, 1985, J MED CHEM, V28, P273, DOI 10.1021/jm00381a002; MARTINEZ J, 1986, INT J PEPT PROT RES, V28, P529; MARTINEZ J, 1986, J MED CHEM, V29, P2201, DOI 10.1021/jm00161a012; MINAMINO N, 1983, BIOCHEM BIOPH RES CO, V114, P541, DOI 10.1016/0006-291X(83)90814-8; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; NAGAIN C, 1987, PEPTIDES, V8, P1023, DOI 10.1016/0196-9781(87)90131-8; OTSUKI M, 1987, AM J PHYSIOL, V252, pG491, DOI 10.1152/ajpgi.1987.252.4.G491; PEIKIN SR, 1978, AM J PHYSIOL, V235, pE743, DOI 10.1152/ajpendo.1978.235.6.E743; RIVIER JE, 1978, BIOCHEMISTRY-US, V17, P1766, DOI 10.1021/bi00602a030; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; RUFF M, 1985, CLIN IMMUNOL IMMUNOP, V37, P387, DOI 10.1016/0090-1229(85)90108-4; SAEED ZA, 1989, PEPTIDES, V10, P597, DOI 10.1016/0196-9781(89)90149-6; SASAKI Y, 1987, PEPTIDES, V8, P119, DOI 10.1016/0196-9781(87)90174-4; SPANARKEL M, 1983, J BIOL CHEM, V258, P6746; TREPEL JB, 1988, BIOCHEM BIOPH RES CO, V156, P1383, DOI 10.1016/S0006-291X(88)80785-X; VONSCHRENCK T, 1989, AM J PHYSIOL, V256, pG747, DOI 10.1152/ajpgi.1989.256.4.G747; WANG LH, 1990, BIOCHEMISTRY-US, V29, P616, DOI 10.1021/bi00455a004; WOLL PJ, 1988, BIOCHEM BIOPH RES CO, V155, P359, DOI 10.1016/S0006-291X(88)81093-3; ZACHARY I, 1985, P NATL ACAD SCI USA, V82, P7616, DOI 10.1073/pnas.82.22.7616	50	105	117	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15695	15703						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1697594				2022-12-27	WOS:A1990DY96400057
J	COX, GS; COSGROVE, DE; SULLIVAN, TT; HAAS, MJ				COX, GS; COSGROVE, DE; SULLIVAN, TT; HAAS, MJ			INDUCTION BY CYCLOHEXIMIDE OF THE GLYCOPROTEIN HORMONE ALPHA-SUBUNIT GENE IN HUMAN TUMOR-CELL LINES AND IDENTIFICATION OF A POSSIBLE NEGATIVE REGULATORY FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											COX, GS (corresponding author), UNIV NEBRASKA,MED CTR,DEPT BIOCHEM,600 S 42ND ST,OMAHA,NE 68198, USA.							ACKERBLOM IE, 1988, SCIENCE, V241, P350; BAKER EJ, 1986, MOL CELL BIOL, V6, P54, DOI 10.1128/MCB.6.1.54; BANIAHMAD A, 1987, EMBO J, V6, P2297, DOI 10.1002/j.1460-2075.1987.tb02504.x; BENVENISTE R, 1975, ENDOCRINOLOGY, V105, P581; BHAT NK, 1987, P NATL ACAD SCI USA, V84, P3161, DOI 10.1073/pnas.84.10.3161; BITTER GA, 1978, BIOCHEMISTRY-US, V17, P2198, DOI 10.1021/bi00604a028; Blackman M R, 1978, Adv Intern Med, V23, P85; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUNSTEIN GD, 1973, ANN INTERN MED, V78, P39, DOI 10.7326/0003-4819-78-1-39; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; BURNSIDE J, 1985, J BIOL CHEM, V260, P2705; CHOU JY, 1978, IN VITRO CELL DEV B, V14, P775; CHOU JY, 1977, NATURE, V268, P543, DOI 10.1038/268543a0; CLAYTON DF, 1983, MOL CELL BIOL, V3, P1552, DOI 10.1128/MCB.3.9.1552; COLE LA, 1981, CANCER RES, V41, P1615; COSGROVE DE, 1989, BIOCHIM BIOPHYS ACTA, V1007, P44, DOI 10.1016/0167-4781(89)90128-0; COX GS, 1981, BIOCHEMISTRY-US, V20, P4893, DOI 10.1021/bi00520a014; COX GS, 1982, ARCH BIOCHEM BIOPHYS, V216, P234, DOI 10.1016/0003-9861(82)90208-9; COX GS, 1989, ARCH BIOCHEM BIOPHYS, V268, P49, DOI 10.1016/0003-9861(89)90564-X; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; DELISLE AJ, 1983, MOL CELL BIOL, V3, P1920, DOI 10.1128/MCB.3.11.1920; ELDER PK, 1988, MOL CELL BIOL, V8, P480, DOI 10.1128/MCB.8.1.480; ELDER PK, 1984, P NATL ACAD SCI-BIOL, V81, P7476, DOI 10.1073/pnas.81.23.7476; GAUB MP, 1987, EMBO J, V6, P2313, DOI 10.1002/j.1460-2075.1987.tb02506.x; GHOSH NK, 1976, NATURE, V259, P416, DOI 10.1038/259416a0; GIRARD M, 1967, METHODS ENZYMOLOGY A, V12, P581; GONG ZY, 1988, MOL CELL BIOL, V8, P3518, DOI 10.1128/MCB.8.8.3518; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; GREENBERG ME, 1986, MOL CELL BIOL, V6, P1050, DOI 10.1128/MCB.6.4.1050; HINES RN, 1988, CARCINOGENESIS, V9, P1599, DOI 10.1093/carcin/9.9.1599; IMLER JL, 1987, MOL CELL BIOL, V7, P2558, DOI 10.1128/MCB.7.7.2558; JAMESON JL, 1988, J BIOL CHEM, V263, P9879; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANGER SJ, 1988, MOL CELL BIOL, V8, P3872, DOI 10.1128/MCB.8.9.3872; LIEBLICH JM, 1977, NATURE, V265, P746, DOI 10.1038/265746a0; LIEBLICH JM, 1976, NATURE, V260, P530, DOI 10.1038/260530a0; LINDELL TJ, 1979, J BIOL CHEM, V254, P1454; LOWERY OH, 1951, J BIOL CHEM, V193, P265; LUSCHER B, 1985, P NATL ACAD SCI USA, V82, P4389, DOI 10.1073/pnas.82.13.4389; MARZLUFF WF, 1984, TRANSCRIPTION TRANSL, P97; MCKNIGHT GS, 1979, J BIOL CHEM, V254, P9050; MEISTER RK, 1979, J CELL PHYSIOL, V100, P531, DOI 10.1002/jcp.1041000315; MILSTED A, 1985, ENDOCRINOLOGY, V117, P2033, DOI 10.1210/endo-117-5-2033; MORRIS T, 1986, P NATL ACAD SCI USA, V83, P981, DOI 10.1073/pnas.83.4.981; NEUWALD PD, 1980, J NATL CANCER I, V64, P447; NGUYENHUU MC, 1978, P NATL ACAD SCI USA, V75, P686, DOI 10.1073/pnas.75.2.686; NIR U, 1986, P NATL ACAD SCI USA, V83, P3180, DOI 10.1073/pnas.83.10.3180; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; PATTILLO RA, 1968, CANCER RES, V28, P1231; RABSON AS, 1973, JNCI-J NATL CANCER I, V50, P669; REES LH, 1975, J ENDOCRINOL, V67, P143, DOI 10.1677/joe.0.0670143; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RINGOLD GM, 1984, P NATL ACAD SCI-BIOL, V81, P3964, DOI 10.1073/pnas.81.13.3964; ROSEN SW, 1974, NEW ENGL J MED, V290, P1441, DOI 10.1056/NEJM197406272902601; RUDDON RW, 1980, CANCER RES, V40, P4519; RUDDON RW, 1979, CANCER RES, V39, P3885; SASSONECORSI P, 1987, NATURE, V326, P507, DOI 10.1038/326507a0; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHETH NA, 1974, BRIT J CANCER, V30, P566, DOI 10.1038/bjc.1974.236; SIVE HL, 1984, MOL CELL BIOL, V4, P2723, DOI 10.1128/MCB.4.12.2723; STALLCUP MR, 1978, BIOCHEMISTRY-US, V17, P1515, DOI 10.1021/bi00601a025; STIMAC E, 1984, MOL CELL BIOL, V4, P2082, DOI 10.1128/MCB.4.10.2082; STORY MT, 1980, J CLIN ENDOCR METAB, V50, P1057, DOI 10.1210/jcem-50-6-1057; TAMURA RN, 1988, BIOCHIM BIOPHYS ACTA, V968, P151, DOI 10.1016/0167-4889(88)90002-X; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WEINTRAUB BD, 1973, J CLIN INVEST, V52, P3135, DOI 10.1172/JCI107513; WHITE BA, 1982, J BIOL CHEM, V257, P8569; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209	70	20	20	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1990	265	22					13190	13197						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR201	1695903				2022-12-27	WOS:A1990DR20100067
J	KIKUTA, Y; SOGAWA, K; HANIU, M; KINOSAKI, M; KUSUNOSE, E; NOJIMA, Y; YAMAMOTO, S; ICHIHARA, K; KUSUNOSE, M; FUJIIKURIYAMA, Y				KIKUTA, Y; SOGAWA, K; HANIU, M; KINOSAKI, M; KUSUNOSE, E; NOJIMA, Y; YAMAMOTO, S; ICHIHARA, K; KUSUNOSE, M; FUJIIKURIYAMA, Y			A NOVEL SPECIES OF CYTOCHROME-P-450 (P-450IB) SPECIFIC FOR THE SMALL-INTESTINE OF RABBITS - CDNA CLONING AND ITS EXPRESSION IN COS CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; ENZYMATIC AMPLIFICATION; HYDROXYLASE-ACTIVITIES; OMEGA-HYDROXYLASE; PROSTAGLANDIN-A; GENE SUBFAMILY; MESSENGER-RNA; 2 FORMS	We have isolated a cDNA clone for a P-450, designated P-450ib (Ichihara, K., Kusunose, E., Kaku, M., Yamamoto, S., and Kusunose, M. (1985) Biochim. Biophys. Acta 831, 99-105), from a cDNA library of rabbit small intestine mucosa by using synthetic DNA fragment by the polymerase chain reaction, as a hybridization probe. The cDNA with a 1,829-base pair insert encodes a polypeptide of 501 amino acids. The deduced amino acid sequence contains all of the sequences of the NH2-terminal and 14 tryptic fragments from purified P-450ib. As the NH2-terminal methionine was not found in the sequence from the purified protein, the apoprotein of P-450ib is composed of 500 amino acids with a molecular weight of 57,193. P-450ib shows 35-41% sequence similarity with several members of 8 subfamilies in the P-450 II family, whereas it has a less than 30% sequence similarity with other P-450 families, suggesting that this P-450 is the first member of a novel subfamily within the P-450 II family. RNA blot analysis shows that mRNA hybridized to the cDNA is expressed in the small intestine, but not significantly in other tissues including liver, colon, kidney, lung, spleen, brain, stomach, and cecum, indicating that P-450ib is a P-450 specific to the small intestine. The protein expressed in COS-7 cells using the cDNA in an expression vector, pKCRH2, shows benzphetamine N-demethylase activity and gives a band identical with that of P-450ib in its mobility on sodium dodecyl sulfate-polyacrylamide gel electrophoresis.	TOHOKU UNIV, FAC SCI,DEPT CHEM,AOBA KU, SENDAI, MIYAGI 980, JAPAN; OSAKA CITY UNIV, SCH MED,TONEYAMA INST TB RES, TOYONAKA, OSAKA 560, JAPAN; CITY HOPE NATL MED CTR, BECKMAN RES INT,DIV IMMUNOL, DUARTE, CA 91010 USA; KAWASAKI MED SCH, DEPT BIOCHEM, KURASHIKI, OKAYAMA 70101, JAPAN	Tohoku University; Osaka Metropolitan University; City of Hope; Beckman Research Institute of City of Hope; Kawasaki Medical School	KIKUTA, Y (corresponding author), FUKUYAMA UNIV, FAC ENGN, DEPT FOOD SCI & TECHNOL, FUKUYAMA, HIROSHIMA 72902, JAPAN.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; FUJIIKURIYAMA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2793, DOI 10.1073/pnas.79.9.2793; GONZALEZ FJ, 1987, DNA-J MOLEC CELL BIO, V6, P149, DOI 10.1089/dna.1987.6.149; GONZALEZ FJ, 1985, J BIOL CHEM, V260, P7435; GOTOH O, 1983, J BIOCHEM, V93, P807, DOI 10.1093/jb/93.3.807; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HARADA N, 1988, BIOCHEM BIOPH RES CO, V156, P725, DOI 10.1016/S0006-291X(88)80903-3; HEINEMANN FS, 1983, J BIOL CHEM, V258, P4195; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HOBBS AA, 1986, J BIOL CHEM, V261, P9444; ICHIHARA K, 1979, J BIOCHEM-TOKYO, V86, P139; ICHIHARA K, 1981, J BIOCHEM, V89, P1821, DOI 10.1093/oxfordjournals.jbchem.a133383; ICHIHARA K, 1985, BIOCHIM BIOPHYS ACTA, V831, P99, DOI 10.1016/0167-4838(85)90155-4; ICHIHARA K, 1983, BIOCHEM INT, V7, P179; JOHNSON EF, 1987, J BIOL CHEM, V262, P5918; KAKU M, 1984, J BIOCHEM, V96, P1883, DOI 10.1093/oxfordjournals.jbchem.a135023; KHANI SC, 1987, P NATL ACAD SCI USA, V84, P638, DOI 10.1073/pnas.84.3.638; KUSUNOSE E, 1989, J BIOCHEM-TOKYO, V106, P194, DOI 10.1093/oxfordjournals.jbchem.a122831; Maniatis T, 1982, MOL CLONING LABORATO; MATSUBARA S, 1987, J BIOL CHEM, V262, P13366; MINOWA O, 1990, CELL STRUCT FUNCT, V15, P21, DOI 10.1247/csf.15.21; MISHINA M, 1984, NATURE, V307, P604, DOI 10.1038/307604a0; MOROHASHI K, 1984, P NATL ACAD SCI-BIOL, V81, P4647, DOI 10.1073/pnas.81.15.4647; MOROHASHI K, 1987, J BIOCHEM-TOKYO, V102, P559, DOI 10.1093/oxfordjournals.jbchem.a122089; NAGATA K, 1987, J BIOL CHEM, V262, P2787; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NEF P, 1989, J BIOL CHEM, V264, P6780, DOI 10.1016/S0021-9258(18)83497-4; NHAMBURO PT, 1990, BIOCHEMISTRY-US, V29, P5491, DOI 10.1021/bi00475a012; NOSHIRO M, 1989, FEBS LETT, V257, P97, DOI 10.1016/0014-5793(89)81795-8; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; SOGAWA K, 1984, P NATL ACAD SCI-BIOL, V81, P5066, DOI 10.1073/pnas.81.16.5066; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNGER BP, 1986, J BIOL CHEM, V261, P1158; YOKOTANI N, 1989, J BIOL CHEM, V264, P21665; ZUBER MX, 1986, J BIOL CHEM, V261, P2475	42	31	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 25	1991	266	27					17821	17825						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GG553	1717443				2022-12-27	WOS:A1991GG55300020
J	ICELY, PL; GROS, P; BERGERON, JJM; DEVAULT, A; AFAR, DEH; BELL, JC				ICELY, PL; GROS, P; BERGERON, JJM; DEVAULT, A; AFAR, DEH; BELL, JC			TIK, A NOVEL SERINE THREONINE KINASE, IS RECOGNIZED BY ANTIBODIES DIRECTED AGAINST PHOSPHOTYROSINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-TYROSINE KINASE; MESSENGER-RNAS; SELECTIVE EXPRESSION; PURIFICATION; ACTIVATION; SIMILARITY; TRANSCRIPT; POLYMERASE; SEQUENCES	We have isolated cDNAs encoding kinases from a murine pre-B cell line by screening a lambda-gt11 cDNA expression library with anti-phosphotyrosine antibodies. One cDNA was identified to encode the previously isolated tyrosine kinase c-lyn. Among the remaining clones, we have characterized a cDNA encoding a novel kinase which we have designated TIK. Sequence analysis of this cDNA indicates that the TIK enzyme lacks the features thought to be conserved among protein tyrosine kinases. Although isolated on the basis of its reactivity with the anti-phosphotyrosine antibody, the TIK enzyme was found to have only serine and threonine kinase activity. The amino-terminal portion of the TIK protein contains a cdc2 phosphorylation consensus sequence. Three mRNA transcripts derived from the TIK gene are detected in a variety of adult murine tissues.	UNIV OTTAWA,DEPT BIOCHEM,OTTAWA K1H 8M5,ONTARIO,CANADA; MCGILL UNIV,DEPT BIOCHEM,MONTREAL H3G 1Y6,QUEBEC,CANADA; MCGILL UNIV,DEPT ANAT,MONTREAL H3G 1Y6,QUEBEC,CANADA	University of Ottawa; McGill University; McGill University	ICELY, PL (corresponding author), UNIV OTTAWA,DEPT MED,451 SMYTH RD,OTTAWA K1H 8M5,ONTARIO,CANADA.		Bergeron, John/AAW-1893-2021					AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BEN-NERIAH Y, 1986, CELL, V44, P577, DOI 10.1016/0092-8674(86)90267-9; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; EDWARDS AM, 1988, MOL CELL BIOL, V8, P2655, DOI 10.1128/MCB.8.6.2655; EISEMAN L, 1990, CANCER CELLS, V2, P303; FERRELL JE, 1989, J BIOL CHEM, V264, P20723; GALLIONE CJ, 1981, J VIROL, V39, P529, DOI 10.1128/JVI.39.2.529-535.1981; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HOWELL BW, 1991, MOL CELL BIOL, V11, P568, DOI 10.1128/MCB.11.1.568; JACOBSON A, 1987, METHOD ENZYMOL, V152, P254; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KORNBLUTH S, 1988, MOL CELL BIOL, V8, P5541, DOI 10.1128/MCB.8.12.5541; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LETWIN K, 1988, ONCOGENE, V3, P621; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; PETCH LA, 1990, MOL CELL BIOL, V10, P2973, DOI 10.1128/MCB.10.6.2973; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; VANETTEN RA, 1989, CELL, V58, P669, DOI 10.1016/0092-8674(89)90102-5; VU TH, 1989, MOL CELL BIOL, V9, P4563, DOI 10.1128/MCB.9.10.4563; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YEE SP, 1983, J VIROL, V46, P1003, DOI 10.1128/JVI.46.3.1003-1013.1983	30	76	81	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					16073	16077						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714905				2022-12-27	WOS:A1991GB97700082
J	ZAMARRON, C; GINSBERG, MH; PLOW, EF				ZAMARRON, C; GINSBERG, MH; PLOW, EF			A RECEPTOR-INDUCED BINDING-SITE IN FIBRINOGEN ELICITED BY ITS INTERACTION WITH PLATELET MEMBRANE GLYCOPROTEIN-IIB-IIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTARY DEOXYRIBONUCLEIC-ACID; POLYMERIZATION DEFECT; SYNTHETIC PEPTIDES; CELLULAR ADHESION; GAMMA-CHAIN; GPIIB-IIIA; EXPRESSION; CONFORMATION; AGGREGATION; SEQUENCE	The interaction of fibrinogen with membrane glycoprotein GPIIb-IIIa regulates platelet aggregation. This ligand:integrin receptor interaction elicits conformational changes in GPIIb-IIIa as evidenced by the induction of ligand-induced binding sites which are recognized by antibodies that react selectively with the occupied receptor. The dynamic nature of these conformational changes is now demonstrated by the identification and characterization of a receptor-induced binding site (RIBS) elicited in fibrinogen bound to GPIIb-IIIa. A monoclonal antibody to fibrinogen, anti-Fg-RIBS-I, failed to bind to nonstimulated platelets in the presence or absence of fibrinogen. However, when platelets were stimulated with an agonist, the antibody reacted with platelet-bound fibrinogen even in the presence of a marked excess of unbound fibrinogen. A key element of the RIBS epitope has been precisely localized to residues 373-385 of the gamma chain of fibrinogen. Conformational elements also are important in defining the epitope. Fab fragments of the antibody inhibited platelet aggregation. As these fragments also inhibited fibrin polymerization, a commonality between these two diverse functions of fibrinogen in thrombus formation is indicated. In general, antibodies to RIBS and ligand-induced binding site provide unique probes for characterizing ligand:receptor interactions.			ZAMARRON, C (corresponding author), SCRIPPS RES INST, COMM VASC BIOL CVB1, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411, R01HL028235, R01HL038292] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28235, HL38292, HL16411] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAMS CS, 1990, BLOOD, V75, P128; ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; APPEL JR, 1990, J IMMUNOL, V144, P976; BANTIA S, 1990, BLOOD, V75, P1659; BANTIA S, 1990, BLOOD, V76, P2279; BERZOFSKY JA, 1985, SCIENCE, V229, P932, DOI 10.1126/science.2410982; CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; CHUNG DW, 1983, BIOCHEMISTRY-US, V22, P3244, DOI 10.1021/bi00282a032; CHUNG DW, 1983, BIOCHEMISTRY-US, V22, P3250, DOI 10.1021/bi00282a033; CIERNIEWSKI CS, 1986, J BIOL CHEM, V261, P9116; COHEN S, 1980, J BIOL CHEM, V255, P4834; COURTOIS G, 1986, EUR J BIOCHEM, V159, P61, DOI 10.1111/j.1432-1033.1986.tb09833.x; COVERA S, 1986, J BIOL CHEM, V261, P7675; CRABTREE GR, 1982, CELL, V31, P159, DOI 10.1016/0092-8674(82)90415-9; DOOLITTLE RF, 1967, ARCH BIOCHEM BIOPHYS, V118, P456, DOI 10.1016/0003-9861(67)90374-8; FRELINGER AL, 1988, J BIOL CHEM, V263, P12397; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUDANO AP, 1980, BIOCHEMISTRY-US, V19, P1013, DOI 10.1021/bi00546a028; LAUDANO AP, 1981, SCIENCE, V212, P457, DOI 10.1126/science.7209542; LEVESQUE JP, 1990, J BIOL CHEM, V265, P328; MARGUERIE G, 1989, PLATELET RESPONSES M, V3, P285; MARGUERIE GA, 1980, J BIOL CHEM, V255, P154; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MCCONAHEY PJ, 1966, INT ARCH ALLER A IMM, V29, P185, DOI 10.1159/000229699; NIIYA K, 1987, BLOOD, V70, P475; OTOOLE TE, 1990, CELL REGUL, V1, P883, DOI 10.1091/mbc.1.12.883; PARISE LV, 1987, J BIOL CHEM, V262, P12597; PEERSCHKE EI, 1981, BLOOD, V57, P663; PEERSCHKE EIB, 1985, SEMIN HEMATOL, V22, P241; PEERSCHKE EIB, 1985, J LAB CLIN MED, V106, P111; PHILLIPS DR, 1988, BLOOD, V71, P831; PLOW EF, 1989, PROG HEMOST THROMB, V9, P117; PLOW EF, 1982, P NATL ACAD SCI-BIOL, V79, P3711, DOI 10.1073/pnas.79.12.3711; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; REBER P, 1986, BLOOD, V67, P1751; REBER P, 1986, THROMB HAEMOSTASIS, V56, P401; RIXON MW, 1983, BIOCHEMISTRY-US, V22, P3237, DOI 10.1021/bi00282a031; SINGER II, 1987, J CELL BIOL, V104, P573, DOI 10.1083/jcb.104.3.573; SOUTHAN C, 1985, J BIOL CHEM, V260, P3095; TERUKINA S, 1989, BLOOD, V74, P2681; TODD PEE, 1982, TRENDS BIOCHEM SCI, V7, P212, DOI 10.1016/0968-0004(82)90093-7; VARADI A, 1986, BIOCHEMISTRY-US, V25, P519, DOI 10.1021/bi00351a001; WEISEL JW, 1985, SCIENCE, V230, P1388, DOI 10.1126/science.4071058; ZAMARRON C, 1990, THROMB HAEMOSTASIS, V64, P41	48	73	80	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 25	1991	266	24					16193	16199						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB977	1714910				2022-12-27	WOS:A1991GB97700099
J	JOMORI, T; NATORI, S				JOMORI, T; NATORI, S			MOLECULAR-CLONING OF CDNA FOR LIPOPOLYSACCHARIDE-BINDING PROTEIN FROM THE HEMOLYMPH OF THE AMERICAN COCKROACH, PERIPLANETA-AMERICANA - SIMILARITY OF THE PROTEIN WITH ANIMAL LECTINS AND ITS ACUTE PHASE EXPRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAINS; PERMEABILITY-INCREASING PROTEIN; PROTEOGLYCAN CORE PROTEIN; COAGULATION FACTOR-X; AMINO-ACID-SEQUENCE; FULL-LENGTH CDNA; SARCOPHAGA-PEREGRINA; FACTOR-IX; ASIALOGLYCOPROTEIN RECEPTOR; ESCHERICHIA-COLI	A previous paper described the purification of a calcium-dependent lipopolysaccharide-binding protein from the hemolymph of Periplaneta americana (Jomori, T., Kubo, T., and Natori, S. (1990) Eur. J. Biochem. 190, 201-206). This paper describes the molecular cloning and characterization of cDNA for the LPS-binding protein. This protein was found to have a carbohydrate-recognition domain at its carboxyl terminus containing amino acid sequences that are conserved in various mammalian C-type lectins. It was also shown to contain an N-linked carbohydrate chain, and the amino acid residue carrying this chain was assigned as Asn at position 56 (23rd amino acid residue from the amino terminus). Northern blot analysis revealed the presence of multiple mRNAs that hybridized with this cDNA and transient increases in their content after injection of Escherichia coli into adult Periplaneta, suggesting that the LPS-binding protein plays a role in the acute phase response of this insect.	UNIV TOKYO,FAC PHARMACEUT SCI,BUNKYO KU,TOKYO 113,JAPAN	University of Tokyo								AKETAGAWA J, 1986, J BIOL CHEM, V261, P7357; ANDO K, 1988, BIOCHEMISTRY-US, V27, P1715, DOI 10.1021/bi00405a050; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BENTLEY AK, 1986, CELL, V45, P343, DOI 10.1016/0092-8674(86)90319-3; CAPT D, 1986, P NATL ACAD SCI USA, V83, P1670; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHOO KH, 1982, NATURE, V299, P178, DOI 10.1038/299178a0; DEGAN SJF, 1983, BIOCHEMISTRY-US, V22, P2087; DOEGE K, 1987, J BIOL CHEM, V262, P17757; DRICKAMER K, 1981, J BIOL CHEM, V256, P5827; DRICKAMER K, 1988, J BIOL CHEM, V263, P9557; DRICKAMER K, 1986, J BIOL CHEM, V261, P6878; DROGE W, 1968, EUR J BIOCHEM, V4, P126, DOI 10.1111/j.1432-1033.1968.tb00182.x; ELSBACH P, 1979, J BIOL CHEM, V254, P1000; EZEKOWITZ RAB, 1988, J EXP MED, V167, P1034, DOI 10.1084/jem.167.3.1034; FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FUNG MR, 1984, NUCLEIC ACIDS RES, V12, P4481, DOI 10.1093/nar/12.11.4481; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; GABAY JE, 1986, J EXP MED, V164, P1407, DOI 10.1084/jem.164.5.1407; GIGA Y, 1987, J BIOL CHEM, V262, P6197; GOLDBERG DA, 1980, P NATL ACAD SCI-BIOL, V77, P5794, DOI 10.1073/pnas.77.10.5794; HANAHAN D, 1980, GENE, V10, P63, DOI 10.1016/0378-1119(80)90144-4; HENIKOFF S, 1987, METHOD ENZYMOL, V155, P156; HILL ROBERT L., 1965, ADVANCE PROTEIN CHEM, V20, P37, DOI 10.1016/S0065-3233(08)60388-5; HIRS CHW, 1967, METHOD ENZYMOL, V11, P199; HOLLAND EC, 1984, P NATL ACAD SCI-BIOL, V81, P7338, DOI 10.1073/pnas.81.23.7338; II M, 1990, J BIOL CHEM, V265, P11295; JOMORI T, 1990, EUR J BIOCHEM, V190, P201, DOI 10.1111/j.1432-1033.1990.tb15565.x; KURACHI K, 1982, P NATL ACAD SCI-BIOL, V79, P6461, DOI 10.1073/pnas.79.21.6461; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MACGILLIVRAY RTA, 1984, BIOCHEMISTRY-US, V23, P1624; Morrison D C, 1979, Adv Immunol, V28, P293; MORRISON DC, 1978, AM J PATHOL, V93, P527; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; NAKAMURA T, 1986, EUR J BIOCHEM, V154, P511, DOI 10.1111/j.1432-1033.1986.tb09427.x; OKA S, 1987, J BIOCHEM-TOKYO, V101, P135, DOI 10.1093/oxfordjournals.jbchem.a121884; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; OOI CE, 1987, J BIOL CHEM, V262, P14891; PREHM P, 1976, EUR J BIOCHEM, V66, P369, DOI 10.1111/j.1432-1033.1976.tb10526.x; REICHHART JM, 1989, EUR J BIOCHEM, V182, P423, DOI 10.1111/j.1432-1033.1989.tb14848.x; SAI S, 1986, P NATL ACAD SCI USA, V83, P5081, DOI 10.1073/pnas.83.14.5081; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SGARAMELLA V, 1972, J MOL BIOL, V72, P427, DOI 10.1016/0022-2836(72)90155-6; SHAFER WM, 1986, INFECT IMMUN, V53, P651, DOI 10.1128/IAI.53.3.651-655.1986; SHOW G, 1986, CELL, V46, P659; SJOBERG O, 1972, EUR J IMMUNOL, V2, P326, DOI 10.1002/eji.1830020406; SPIESS M, 1985, P NATL ACAD SCI USA, V82, P6465, DOI 10.1073/pnas.82.19.6465; SUTHERLAND IW, 1965, BIOCHEM J, V96, P439, DOI 10.1042/bj0960439; TAKAHASHI H, 1986, J INSECT PHYSIOL, V32, P771, DOI 10.1016/0022-1910(86)90080-6; TAKAHASHI H, 1985, J BIOL CHEM, V260, P2228; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Westphal O., 1986, ADV IMMUNOPHARMACOLO, P13; WIGGLESWORTH VB, 1974, INSECT PHYSL, P81; WRIGHT SD, 1986, J EXP MED, V164, P1876, DOI 10.1084/jem.164.6.1876	54	89	98	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13318	13323						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712779				2022-12-27	WOS:A1991FX13200081
J	ZHAO, J; ROLLINS, SA; MAHER, SE; BOTHWELL, ALM; SIMS, PJ				ZHAO, J; ROLLINS, SA; MAHER, SE; BOTHWELL, ALM; SIMS, PJ			AMPLIFIED GENE-EXPRESSION IN CD59-TRANSFECTED CHINESE-HAMSTER OVARY CELLS CONFERS PROTECTION AGAINST THE MEMBRANE ATTACK COMPLEX OF HUMAN-COMPLEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HOMOLOGOUS SPECIES RESTRICTION; HUMAN-ERYTHROCYTES; TRANSMEMBRANE CHANNELS; REGULATORY CONTROL; PROTEINS; C5B-9; LYSIS; CD59; SURFACE	Protection against the pore-forming activity of the human C5b-9 proteins was conferred on a nonprimate cell by transfection with cDNA encoding the human complement regulatory protein CD59. CD59 was stably expressed in Chinese hamster ovary cells using the pFRSV mammalian expression vector. After cloning and selection, the transfected cells were maintained in media containing various concentrations of methotrexate, which induced surface expression of up to 4.2 x 10(6) molecules of CD59/cell. Phosphatidylinositol-specific phospholipase C removed > 95% of surface-expressed CD59 antigen, confirming that recombinant CD59 was tethered to the Chinese hamster ovary plasma membrane by a lipid anchor. The recombinant protein exhibited an apparent molecular mass of 21-24 kDa (versus 18-21 kDa for human erythrocyte CD59). After N-glycanase digestion, recombinant and erythrocyte CD59 comigrated with apparent molecular masses of 12-14 kDa, suggesting altered structure of asparagine-linked carbohydrate in recombinant versus erythrocyte CD59. The function of the recombinant protein was evaluated by changes in the sensitivity of the CD59 transfectants to the pore-forming activity of human C5b-9. Induction of cell-surface expression of CD59 antigen inhibited C5b-9 pore formation in a dose-dependent fashion. CD59 transfectants expressing greater-than-or-equal-to 1.2 x 10(6) molecules of CD59/cell were completely resistant to human serum complement. By contrast, CD59 transfectants remained sensitive to the pore-forming activity of guinea pig C8 and C9 (bound to human C5b67). Functionally blocking antibody against erythrocyte CD59 abolished the human complement resistance observed for the CD59-transfected Chinese hamster ovary cells. These results confirm that the C5b-9 inhibitory function of the human erythrocyte membrane is provided by CD59 and suggest that the gene for this protein can be expressed in xenotypic cells to confer protection against human serum complement.	OKLAHOMA MED RES FDN,CARDIOVASC BIOL RES PROGRAM,825 NE 13TH ST,OKLAHOMA CITY,OK 73104; UNIV OKLAHOMA,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,OKLAHOMA CITY,OK 73104; YALE UNIV,SCH MED,IMMUNOBIOL SECT,NEW HAVEN,CT 06510	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Yale University					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036061, R37HL036061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040924] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL36061] Funding Source: Medline; NIGMS NIH HHS [GM40924] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHENG KH, 1985, J IMMUNOL, V135, P459; DAVIES A, 1989, J EXP MED, V170, P637, DOI 10.1084/jem.170.3.637; ESSER AF, 1990, YEAR IMMUNOLOGY, V6, P229; HAMILTON KK, 1990, J BIOL CHEM, V265, P3809; HAMILTON KK, 1990, BLOOD, V76, P2572; HANSCH GM, 1981, P NATL ACAD SCI-BIOL, V78, P5118, DOI 10.1073/pnas.78.8.5118; HATTORI R, 1989, J BIOL CHEM, V264, P9053; HOLGUIN MH, 1989, J CLIN INVEST, V84, P7, DOI 10.1172/JCI114172; HOULE JJ, 1988, BLOOD, V71, P280; KAUFMAN RJ, 1982, J MOL BIOL, V159, P601, DOI 10.1016/0022-2836(82)90103-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MERI S, 1990, IMMUNOLOGY, V71, P1; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; OKADA N, 1989, J IMMUNOL, V143, P2262; OKADA N, 1990, CLIN EXP IMMUNOL, V80, P109; PACKMAN CH, 1979, J CLIN INVEST, V64, P428, DOI 10.1172/JCI109479; PHILBRICK WM, 1990, EUR J IMMUNOL, V20, P87, DOI 10.1002/eji.1830200113; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; SCHONERMARK S, 1988, IMMUNOLOGY, V63, P585; SCHONERMARK S, 1986, J IMMUNOL, V136, P1772; SHIN ML, 1986, J IMMUNOL, V136, P1777; SIMS PJ, 1989, J BIOL CHEM, V264, P19228; SIMS PJ, 1988, J BIOL CHEM, V263, P18205; SIMS PJ, 1984, BIOCHEMISTRY-US, V23, P3248, DOI 10.1021/bi00309a020; SIMS PJ, 1989, PLATELET IMMUNOBIOLO, P354; SLANETZ AE, 1991, EUR J IMMUNOL, V21, P179, DOI 10.1002/eji.1830210127; SUGITA Y, 1988, J BIOCHEM-TOKYO, V104, P633, DOI 10.1093/oxfordjournals.jbchem.a122524; YAMAMOTO KI, 1977, J IMMUNOL, V119, P1482; YAMASHINA M, 1990, NEW ENGL J MED, V323, P1184, DOI 10.1056/NEJM199010253231707; ZALMAN LS, 1986, P NATL ACAD SCI USA, V83, P6975, DOI 10.1073/pnas.83.18.6975; ZALMAN LS, 1987, J EXP MED, V165, P572, DOI 10.1084/jem.165.2.572	32	72	81	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 15	1991	266	20					13418	13422						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX132	1712784				2022-12-27	WOS:A1991FX13200096
J	AVIRAM, M; KEIDAR, S; ROSENBLAT, M; BROOK, GJ				AVIRAM, M; KEIDAR, S; ROSENBLAT, M; BROOK, GJ			REDUCED UPTAKE OF CHOLESTEROL ESTERASE-MODIFIED LOW-DENSITY-LIPOPROTEIN BY MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE-DERIVED MACROPHAGES; VERY-LOW-DENSITY; APOLIPOPROTEIN-E; FAMILIAL HYPERCHOLESTEROLEMIA; PLASMA-LIPOPROTEINS; HUMAN-FIBROBLASTS; RECEPTOR PATHWAY; ENHANCED UPTAKE; LDL RECEPTOR; CELLS	Changes in low density lipoprotein (LDL) lipid composition were shown to alter its interaction with the LDL receptor, thus affecting its cellular uptake. Upon incubation of LDL with 5 units/ml cholesterol esterase (CEase) for 1 h at 37-degrees-C, there was a 33% reduction in lipoprotein cholesteryl ester content, paralleled by an increment in its unesterified cholesterol. CEase-LDL, in comparison to native LDL, was smaller in size, possessed fewer free lysine amino groups (by 14%), and demonstrated reduced binding to heparin (by 83%) and reduced immunoreactivity against monoclonal antibodies directed toward epitopes along the LDL apoB-100. Incubation of CEase-LDL with the J-774 macrophage-like cell line resulted in about a 30% reduction in lipoprotein binding and degradation in comparison to native LDL, and this was associated with a 20% reduction in macrophage cholesterol mass. Similarly, CEase-LDL degradation by mouse peritoneal macrophages, human monocyte-derived macrophages, and human skin fibroblasts was reduced by 20-44% in comparison to native LDL. CEase-LDL uptake by macrophages was mediated via the LDL receptor and not the scavenger receptor. CEase activity toward LDL was demonstrated in plasma and in cells of the arterial wall such as macrophages and endothelial cells. Thus, CEase modification of LDL may take place in vivo, and this phenomenon may have a role in atherosclerosis.	TECHNION ISRAEL INST TECHNOL, FAC MED, HAIFA, ISRAEL	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	AVIRAM, M (corresponding author), RAMBAM MED CTR, RAPPAPORT FAMILY INST RES MED SCI, LIPID RES UNIT, HAIFA, ISRAEL.							AVIRAM M, 1983, BIOCHEM MED METAB B, V30, P111, DOI 10.1016/0006-2944(83)90013-3; AVIRAM M, 1988, J BIOL CHEM, V263, P15416; AVIRAM M, 1988, J BIOL CHEM, V263, P16842; AVIRAM M, 1991, BLOOD CELL BIOCH, V2, P179; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BIERMAN EL, 1974, CIRC RES, V35, P136, DOI 10.1161/01.RES.35.1.136; BIHAIN BE, 1989, J BIOL CHEM, V264, P17316; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; BROWN MS, 1980, J BIOL CHEM, V255, P9344; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Buege J A, 1978, Methods Enzymol, V52, P302; CHAIT A, 1979, J CLIN INVEST, V64, P1309, DOI 10.1172/JCI109587; DALBEY RE, 1990, TRENDS BIOCHEM SCI, V15, P253, DOI 10.1016/0968-0004(90)90047-F; DAUGHERTY A, 1988, ARTERIOSCLEROSIS, V8, P768, DOI 10.1161/01.ATV.8.6.768; FANG S, 1990, ATHEROSCLEROSIS, V85, P127, DOI 10.1016/0021-9150(90)90104-Q; GALEANO NF, 1989, ARTERIOSCLEROSIS, V9, pA711; GIANTURCO SH, 1983, J BIOL CHEM, V258, P4526; GOLDBERG DI, 1990, BIOCHIM BIOPHYS ACTA, V1042, P132, DOI 10.1016/0005-2760(90)90067-8; HAJJAR DP, 1983, J BIOL CHEM, V258, P192; HAYASHI H, 1987, ATHEROSCLEROSIS, V66, P139, DOI 10.1016/0021-9150(87)90189-4; HEIDER JG, 1978, J LIPID RES, V19, P514; HENRIKSEN T, 1982, ANN NY ACAD SCI, V401, P102, DOI 10.1111/j.1749-6632.1982.tb25711.x; IHM J, 1980, BIOCHEM BIOPH RES CO, V93, P1114, DOI 10.1016/0006-291X(80)90604-X; INNERARITY JG, 1986, METHOD ENZYMOL, V124, P542; KEIDAR S, 1990, METABOLISM, V29, P937; KHOO JC, 1981, J BIOL CHEM, V256, P2659; KLEINMAN Y, 1988, J LIPID RES, V29, P729; KOO C, 1986, J BIOL CHEM, V261, P1194; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARZETTA CA, 1986, J LIPID RES, V27, P753; MIMS MP, 1990, BIOCHEMISTRY-US, V29, P6639, DOI 10.1021/bi00480a013; MORTON RE, 1986, J LIPID RES, V27, P1124; MUSLINER TA, 1987, BIOCHIM BIOPHYS ACTA, V919, P97, DOI 10.1016/0005-2760(87)90196-2; POLACEK D, 1988, J LIPID RES, V29, P797; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SPARROW CP, 1988, J LIPID RES, V29, P745; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135, DOI 10.1161/01.ATV.7.2.135; SUITS AG, 1989, P NATL ACAD SCI USA, V86, P2713, DOI 10.1073/pnas.86.8.2713; TOLLESHAUG H, 1983, CELL, V32, P941, DOI 10.1016/0092-8674(83)90079-X; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; WINDLER E, 1980, J BIOL CHEM, V255, P8303; WITZTUM JL, 1985, J LIPID RES, V26, P92	44	37	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11567	11574						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711036				2022-12-27	WOS:A1991FT76200026
J	SHIMASAKI, S; SHIMONAKA, M; ZHANG, HP; LING, N				SHIMASAKI, S; SHIMONAKA, M; ZHANG, HP; LING, N			IDENTIFICATION OF 5 DIFFERENT INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEINS (IGFBPS) FROM ADULT-RAT SERUM AND MOLECULAR-CLONING OF A NOVEL IGFBP-5 IN RAT AND HUMAN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; AMINO-ACID SEQUENCE; HUMAN CHROMOSOMAL GENE; STRUCTURAL CHARACTERIZATION; TISSUE DISTRIBUTION; COMPLEMENTARY-DNA; MESSENGER-RNA; FACTOR-I; EXPRESSION; ORGANIZATION	Five different insulin-like growth factor binding proteins (IGFBPs) were isolated from adult rat serum using gel filtration, ligand affinity chromatography, and two steps of reversed-phase high performance liquid chromatography. Three of them were identified as IGFBP-2, -3, and -4 by their amino-terminal amino acid sequences. One of the remaining two proteins was the rat homologue of the partially characterized IGFBP isolated originally from human cerebrospinal fluid, while the other appeared to be a novel member of the IGFBP family. IGFBP-1 was not found in the adult rat serum under our experimental procedures. cDNAs encoding the novel IGFBP were isolated and characterized from a rat ovary and a human placenta library. The mature protein predicted for both species contained 252 amino acids including 18 cysteines that were located in the homologous positions as IGFBP-1, -2, -3, and -4. We propose to name this protein IGFBP-5. Northern analysis of IGFBP-5 mRNA in rat tissues demonstrated that transcription of this gene is highly active in kidney, although the mRNA was detectable in all tissues examined. Alignment of the amino acid sequences of the five rat IGFBPs revealed a 47-60% similarity, indicating that their individual genes diverged from a single ancestral gene by successive gene duplication in a short time frame during evolution. The chromosomal localizations of IGFBP-1, -2, -3, -4, and -5 genes in human have been determined using polymerase chain reaction on somatic cell hybrid DNAs of human and hamster, and the results showed that they were located on chromosomes 7, 2, 7, 17, and 5, respectively.			SHIMASAKI, S (corresponding author), WHITTIER INST DIABET & ENDOCRINOL,DEPT MOLEC ENDOCRINOL,9894 GENESEE AVE,LA JOLLA,CA 92037, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD009690, P01HD009690, N01HD002902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK018811] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-0-2902, HD-09690] Funding Source: Medline; NIDDK NIH HHS [DK-18811] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGARWAL N, 1990, IN PRESS EXP EYE RES; ALBISTON AL, 1990, BIOCHEM BIOPH RES CO, V166, P892, DOI 10.1016/0006-291X(90)90894-S; ALITALO T, 1989, HUM GENET, V83, P335, DOI 10.1007/BF00291377; Baxter R C, 1989, Prog Growth Factor Res, V1, P49, DOI 10.1016/0955-2235(89)90041-0; BAXTER RC, 1986, ADV CLIN CHEM, V25, P49, DOI 10.1016/S0065-2423(08)60124-9; BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6898, DOI 10.1073/pnas.86.18.6898; BINKERT C, 1989, EMBO J, V8, P2497, DOI 10.1002/j.1460-2075.1989.tb08386.x; BREWER MT, 1988, BIOCHEM BIOPH RES CO, V152, P1289, DOI 10.1016/S0006-291X(88)80425-X; BRINKMAN A, 1988, BIOCHEM BIOPH RES CO, V157, P898, DOI 10.1016/S0006-291X(88)80959-8; BRINKMAN A, 1988, EMBO J, V7, P2417, DOI 10.1002/j.1460-2075.1988.tb03087.x; BROWN AL, 1989, J BIOL CHEM, V264, P5148; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CUBBAGE ML, 1990, J BIOL CHEM, V265, P12642; CUBBAGE ML, 1989, MOL ENDOCRINOL, V3, P846, DOI 10.1210/mend-3-5-846; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DROP SLS, 1989, MOL CELL ENDOCRINOL, V67, P243, DOI 10.1016/0303-7207(89)90214-1; EKSTRAND J, 1990, GENOMICS, V6, P413, DOI 10.1016/0888-7543(90)90470-F; ESCH FS, 1984, ANAL BIOCHEM, V136, P39, DOI 10.1016/0003-2697(84)90305-1; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; GIUDICE LC, 1990, J CLIN ENDOCR METAB, V71, P806, DOI 10.1210/jcem-71-4-806; HABENER JF, 1978, P NATL ACAD SCI USA, V75, P2616, DOI 10.1073/pnas.75.6.2616; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HINTZ RL, 1977, J CLIN ENDOCR METAB, V45, P988, DOI 10.1210/jcem-45-5-988; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; HOSSENLOPP P, 1990, J CLIN ENDOCR METAB, V71, P797, DOI 10.1210/jcem-71-4-797; JAMES R, 1977, NATURE, V267, P544, DOI 10.1038/267544a0; LEE YL, 1988, MOL ENDOCRINOL, V2, P404, DOI 10.1210/mend-2-5-404; LING N, 1986, BIOCHEM BIOPH RES CO, V138, P1129, DOI 10.1016/S0006-291X(86)80400-4; LING N, 1984, P NATL ACAD SCI-BIOL, V81, P4302, DOI 10.1073/pnas.81.14.4302; MACIAG T, 1979, P NATL ACAD SCI USA, V76, P5674, DOI 10.1073/pnas.76.11.5674; MARGOT JB, 1989, MOL ENDOCRINOL, V3, P1053, DOI 10.1210/mend-3-7-1053; MARTIN JL, 1990, J BIOL CHEM, V265, P4124; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; MOSES AC, 1976, NATURE, V263, P137, DOI 10.1038/263137a0; MURPHY LJ, 1990, MOL ENDOCRINOL, V4, P329, DOI 10.1210/mend-4-2-329; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; RINDERKNECHT E, 1978, FEBS LETT, V89, P285; ROGHANI M, 1989, FEBS LETT, V255, P253, DOI 10.1016/0014-5793(89)81101-9; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SCHWABE C, 1977, SCIENCE, V197, P914, DOI 10.1126/science.887933; SHIMASAKI S, 1990, J BIOL CHEM, V265, P2198; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMASAKI S, 1989, BIOCHEM BIOPH RES CO, V165, P907, DOI 10.1016/S0006-291X(89)80052-X; SHIMASAKI S, 1990, MOL ENDOCRINOL, V4, P1451, DOI 10.1210/mend-4-10-1451; SHIMONAKA M, 1989, BIOCHEM BIOPH RES CO, V165, P189, DOI 10.1016/0006-291X(89)91053-X; SPRITZ RA, 1983, AM J HUM GENET, V35, P333; TAM JP, 1983, J AM CHEM SOC, V105, P6442, DOI 10.1021/ja00359a014; UI M, 1989, ENDOCRINOLOGY, V125, P912, DOI 10.1210/endo-125-2-912; WOOD WI, 1988, MOL ENDOCRINOL, V2, P1176, DOI 10.1210/mend-2-12-1176; ZAPF J, 1984, CLIN ENDOCRINOL META, V13, P3, DOI 10.1016/S0300-595X(84)80006-7; ZAPF J, 1990, J BIOL CHEM, V265, P14892; ZAPF J, 1975, ARCH BIOCHEM BIOPHYS, V168, P638, DOI 10.1016/0003-9861(75)90296-9	55	356	374	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10646	10653						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709938				2022-12-27	WOS:A1991FP08600096
J	HIZI, A; TAL, R; SHAHARABANY, M; LOYA, S				HIZI, A; TAL, R; SHAHARABANY, M; LOYA, S			CATALYTIC PROPERTIES OF THE REVERSE TRANSCRIPTASES OF HUMAN IMMUNODEFICIENCY VIRUSES TYPE-1 AND TYPE-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AVIAN-MYELOBLASTOSIS VIRUS; DEPENDENT DNA-POLYMERASE; SUBSTRATE-BINDING DOMAIN; RNASE-H ACTIVITIES; ESCHERICHIA-COLI; ROSE-BENGAL; AIDS VIRUS; EXPRESSION; ZINC; IDENTIFICATION	The enzyme reverse transcriptase (RT) is crucial in the early steps of the life cycle of retroviruses. We have expressed in bacteria the RTs from human immunodeficiency viruses (HIV) types 1 and 2 in order to study the structural-functional relationships of these two multifunctional enzymes that share a relatively high degree of amino acid sequence homology. For comparison purposes, we have analyzed several catalytic functions of both enzymes. The two HIV RTs show a high similarity in many aspects studied but exhibit profound differences in several other properties. For instance, the specific RNase H activity of HIV-2 RT is about 10 times lower than the corresponding activity of HIV-1 RT. There are also significant dissimilarities between some of the apparent K(m) values calculated for the DNA polymerizing functions of both enzymes. Furthermore, the heat stability of the DNA polymerizing activity of HIV-2 RT is about 15-fold higher than that of HIV-1 RT. On the other hand, the susceptibility of the RNase H activities of the two enzymes to heat inactivation was found to be similar. Other treatments also enable discrimination between the RNase H and DNA polymerizing catalytic properties of the two enzymes (although both reverse transcriptases respond similarly). Thus, the RNase H activity was inactivated by N-ethylmaleimide, suggesting the possible involvement of cysteine residues in performing this activity, whereas the DNA polymerizing functions of the two enzymes were fully resistant to this chemical modification. The zinc chelator 1,10-phenanthroline affected the DNA polymerase activities of both enzymes to a significantly higher extent than the RNase H activity. In all, the two HIV RTs were shown to be substantially different one from the other in several of their properties and also distinct from other RTs thus far studied.			HIZI, A (corresponding author), TEL AVIV UNIV, SACKLER SCH MED, DEPT CELL BIOL & HISTOL, IL-69978 TEL AVIV, ISRAEL.				NIAID NIH HHS [R01-AI27035] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI027035] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AULD DS, 1974, P NATL ACAD SCI USA, V71, P2091, DOI 10.1073/pnas.71.5.2091; AULD DS, 1975, BIOCHEM BIOPH RES CO, V62, P296, DOI 10.1016/S0006-291X(75)80137-9; BASU A, 1988, J BIOL CHEM, V263, P1648; BASU A, 1989, J BIOL CHEM, V264, P8746; BEAUSSOLEIL S, 1989, REV INFECT DIS, V11, P732; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CLARK PK, 1990, AIDS RES HUM RETROV, V6, P753, DOI 10.1089/aid.1990.6.753; CLAVEL F, 1986, SCIENCE, V233, P343, DOI 10.1126/science.2425430; DEVICO AL, 1989, AIDS RES HUM RETROV, V5, P51, DOI 10.1089/aid.1989.5.51; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; GERARD GF, 1980, MOL BIOL RNA TUMOR V, P345; GOFF SP, 1990, J ACQ IMMUN DEF SYND, V3, P817; GORECKI M, 1978, BIOCHEMISTRY-US, V17, P2438, DOI 10.1021/bi00605a030; GUYADER M, 1987, NATURE, V326, P662, DOI 10.1038/326662a0; HAMMARSKJOLD ML, 1989, BIOCHIM BIOPHYS ACTA, V989, P269; HIZI A, 1989, VIROLOGY, V170, P326, DOI 10.1016/0042-6822(89)90389-9; HIZI A, 1991, VIROLOGY, V180, P339, DOI 10.1016/0042-6822(91)90038-D; HIZI A, 1990, VIROLOGY, V175, P575, DOI 10.1016/0042-6822(90)90444-V; HIZI A, 1988, GENE, V66, P319, DOI 10.1016/0378-1119(88)90369-1; HIZI A, 1988, P NATL ACAD SCI USA, V85, P1218, DOI 10.1073/pnas.85.4.1218; HIZI A, 1977, J BIOL CHEM, V252, P2281; HUBER HE, 1989, J BIOL CHEM, V264, P4669; KORENBERG A, 1982, DNA REPLICATION; KOTEWICZ ML, 1988, NUCLEIC ACIDS RES, V16, P265, DOI 10.1093/nar/16.1.265; LARDER B, 1987, EMBO J, V6, P3133, DOI 10.1002/j.1460-2075.1987.tb02623.x; LEGRICE SFJ, 1988, J VIROL, V62, P2525, DOI 10.1128/JVI.62.7.2525-2529.1988; MAJUMDAR C, 1988, J BIOL CHEM, V263, P15657; MILLER AD, 1984, J VIROL, V49, P214, DOI 10.1128/JVI.49.1.214-222.1984; MITSUYA H, 1987, NATURE, V325, P773, DOI 10.1038/325773a0; MODAK MJ, 1979, J BIOL CHEM, V254, P4756; OXFORD JS, 1989, J ANTIMICROB CHEMOTH, V23, P9, DOI 10.1093/jac/23.suppl_A.9; PAUWELS R, 1990, NATURE, V343, P470, DOI 10.1038/343470a0; PRASAD VR, 1989, P NATL ACAD SCI USA, V86, P3104, DOI 10.1073/pnas.86.9.3104; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; SALLAFRANQUEANDREOLA ML, 1989, EUR J BIOCHEM, V184, P367, DOI 10.1111/j.1432-1033.1989.tb15028.x; SPANOS A, 1981, NUCLEIC ACIDS RES, V9, P1825, DOI 10.1093/nar/9.8.1825; SRIVASTAVA SK, 1982, BIOCHEMISTRY-US, V21, P4633, DOI 10.1021/bi00262a018; STARNES MC, 1989, J BIOL CHEM, V264, P7073; TANESE N, 1988, P NATL ACAD SCI USA, V85, P1777, DOI 10.1073/pnas.85.6.1777; VARMUS H, 1989, MOBILE DNA, P53; VERMA IM, 1981, ENZYMES, V14, P87; Weiss R, 1985, RNA TUMOR VIRUSES; WU CW, 1973, BIOCHEMISTRY-US, V12, P4349, DOI 10.1021/bi00746a008	43	129	132	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6230	6239						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706712				2022-12-27	WOS:A1991FE37300037
J	ORTEGA, S; SCHAEFFER, MT; SODERMAN, D; DISALVO, J; LINEMEYER, DL; GIMENEZGALLEGO, G; THOMAS, KA				ORTEGA, S; SCHAEFFER, MT; SODERMAN, D; DISALVO, J; LINEMEYER, DL; GIMENEZGALLEGO, G; THOMAS, KA			CONVERSION OF CYSTEINE TO SERINE RESIDUES ALTERS THE ACTIVITY, STABILITY, AND HEPARIN DEPENDENCE OF ACIDIC FIBROBLAST GROWTH-FACTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELLS-INVITRO; EXTRACELLULAR-MATRIX; BOVINE BRAIN; FACTOR-I; SEQUENCE; PROTEIN; FGF; INACTIVATION; GENE	Acidic fibroblast growth factor (aFGF) is a broad spectrum mitogen that is stabilized by complexation with heparin and heparan proteoglycans. The monomeric human protein contains 3 reduced cysteine residues of unknown function, the first 2 of which are conserved among all seven known fibroblast growth factors. The influence of these free sulfhydryl groups on the level, stability, and heparin dependence of the mitogenic activity at physiological temperature and pH is characterized using a complete set of site-directed mutants in which either any 1,2, or all 3 of the cysteine residues are converted to serines. Mutants of aFGF in which either any 2 or all 3 cysteine residues are substituted by serines are more active, have longer activity half-lives, and are less heparin dependent than wild-type aFGF. In contrast, wild-type aFGF and the three mutants that each retain 2 cysteine residues inactivate more rapidly in the absence of heparin by a nonproteolytic mechanism but are markedly stabilized by heparin. This cysteine-mediated destabilization of aFGF not only diminishes its activity in the absence of heparin in tissue culture but also could functionally restrict its activity in vivo to the vicinity of mast cell-derived heparins and heparan proteoglycans associated with cell surfaces and basement membranes.	MERCK SHARP & DOHME LTD, DEPT BIOCHEM, RM 80W-243, POB 2000, RAHWAY, NJ 07065 USA									ARAKAWA T, 1989, BIOCHEM BIOPH RES CO, V161, P335, DOI 10.1016/0006-291X(89)91601-X; BAIRD A, 1987, BIOCHEM BIOPH RES CO, V142, P428, DOI 10.1016/0006-291X(87)90292-0; BOVI PD, 1987, CELL, V50, P729, DOI 10.1016/0092-8674(87)90331-X; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; DAMON DH, 1989, J CELL PHYSIOL, V138, P221, DOI 10.1002/jcp.1041380202; DELAPEYRIERE O, 1990, ONCOGENE, V5, P823; DENNIS PA, 1989, J BIOL CHEM, V264, P7210; DICKSON C, 1987, NATURE, V326, P833, DOI 10.1038/326833a0; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FOLKMAN J, 1988, AM J PATHOL, V130, P393; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V138, P611, DOI 10.1016/S0006-291X(86)80540-X; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V135, P541, DOI 10.1016/0006-291X(86)90028-8; GIMENEZGALLEGO G, 1985, SCIENCE, V230, P1385, DOI 10.1126/science.4071057; GOODRICH SP, 1989, NUCLEIC ACIDS RES, V17, P2867, DOI 10.1093/nar/17.7.2867; GOSPODAROWICZ D, 1986, J CELL PHYSIOL, V128, P475, DOI 10.1002/jcp.1041280317; HALL JA, 1990, J CELL BIOCHEM, V43, P17, DOI 10.1002/jcb.240430103; Klagsbrun M, 1989, Prog Growth Factor Res, V1, P207, DOI 10.1016/0955-2235(89)90012-4; Linemeyer DL, 1990, GROWTH FACTORS, V3, P287, DOI 10.3109/08977199009003671; LINEMEYER DL, 1987, BIO-TECHNOL, V5, P960, DOI 10.1038/nbt0987-960; LOBB RR, 1988, BIOCHEMISTRY-US, V27, P2572, DOI 10.1021/bi00407a045; MUELLER SN, 1989, J CELL PHYSIOL, V140, P439, DOI 10.1002/jcp.1041400306; ROSENGART TK, 1988, BIOCHEM BIOPH RES CO, V152, P432, DOI 10.1016/S0006-291X(88)80732-0; Schulz G. E., 1979, PRINCIPLES PROTEIN S, P53; SENO M, 1988, BIOCHEM BIOPH RES CO, V151, P701, DOI 10.1016/S0006-291X(88)80337-1; THOMAS KA, 1987, FASEB J, V1, P434, DOI 10.1096/fasebj.1.6.3315806; THOMAS KA, 1984, P NATL ACAD SCI-BIOL, V81, P357, DOI 10.1073/pnas.81.2.357; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; UHLRICH S, 1986, BIOCHEM BIOPH RES CO, V137, P1205, DOI 10.1016/0006-291X(86)90353-0; VLODAVSKY I, 1987, P NATL ACAD SCI USA, V84, P2292, DOI 10.1073/pnas.84.8.2292; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; ZHAN XI, 1988, MOL CELL BIOL, V8, P3487, DOI 10.1128/MCB.8.8.3487	32	101	112	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5842	5846						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706340				2022-12-27	WOS:A1991FD37000076
J	ROTH, KA; RUBIN, DC; BIRKENMEIER, EH; GORDON, JI				ROTH, KA; RUBIN, DC; BIRKENMEIER, EH; GORDON, JI			EXPRESSION OF LIVER FATTY ACID-BINDING PROTEIN HUMAN GROWTH-HORMONE FUSION GENES WITHIN THE ENTEROCYTE AND ENTEROENDOCRINE CELL-POPULATIONS OF FETAL TRANSGENIC MICE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIUM; ENDOCRINE-CELLS; DIFFERENTIATION	The intestinal epithelium establishes and maintains a precise spatial organization despite its continuous and rapid renewal. We have used transgenic mice containing liver fatty acid-binding protein/human growth hormone (L-FABP/hGH) fusion genes to begin to define the molecular mechanisms which are responsible for appropriate regional and cell-specific expression of genes in the gut. Multilabel immunocytochemical methods were employed to characterize the patterns of expression of two transgenes in the enteroendocrine and enterocytic populations of late gestation fetal mice at the time of initial cytodifferentiation of the gastrointestinal epithelium (fetal days 16-19). Surveys of the enteroendocrine cell population using a panel of antibodies directed against 11 neuroendocrine products revealed that these cells are scarce prior to fetal day 17, show a progressive increase in number through day 19, and while the relative proportion of subpopulations (defined by their principal peptide product) are somewhat different than in adults, their geographic distribution along the duodenal to colonic and intervillus(crypt) to villus axes are very similar to that encountered in adult (2-5 month old) mice. Immunoreactive L-FABP is first detectable at fetal day 17 and at this time of first appearance shows an adult pattern of regional enterocytic expression: i.e. it is present in cells overlying nascent villi but not those in the intervillus zone, it is highest in proximal small bowel, declines distally, and is absent from colonocytes. Colocalization studies indicate that L-FABP is not present in enteroendocrine cells during fetal life. Mapping studies indicate that nucleotides -596 to +21 of the rat L-FABP gene are sufficient to reproduce an appropriate temporal, cellular, and regional pattern of reporter (hGH) expression in fetal transgenic mice (with the exception that a subset(s) of enteroendocrine cells, typically containing immunoreactive gastric inhibitory peptide, support transgene but not L-FABP expression). This is in marked contrast to adult transgenic mice where inappropriate hGH accumulation occurs in crypt-associated epithelial cells, in colonocytes, and in many enteroendocrine populations. These studies indicate the importance of considering developmental stage when interpreting the results of any mapping study of cis-acting elements that regulate cell-specific and regional expression of genes in the perpetually renewing intestinal epithelium. Moreover, they also raise the possibility of using transgenes to define fundamental temporal changes in the gut's epithelial cell populations.	WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110; JACKSON LAB,BAR HARBOR,ME 04609	Washington University (WUSTL); Washington University (WUSTL); Jackson Laboratory	ROTH, KA (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110, USA.			Rubin, Deborah/0000-0002-4192-909X; Roth, Kevin/0000-0002-0643-995X	NIDDK NIH HHS [DK30292, DK37960] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK030292, R01DK030292, R01DK037960] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHANG H, 1974, AM J ANAT, V141, P537; COLONY PC, 1985, GASTROENTEROLOGY, V89, P294, DOI 10.1016/0016-5085(85)90329-4; GORDON JI, 1989, J CELL BIOL, V108, P1187, DOI 10.1083/jcb.108.4.1187; HAUFT SM, 1989, J BIOL CHEM, V264, P8419; LARSSON LI, 1978, CELL TISSUE RES, V194, P79, DOI 10.1007/BF00209235; LECHAGO J, 1987, AM J SURG PATHOL, V11, P63, DOI 10.1097/00000478-198700111-00006; MACDONALD MR, 1989, J BIOL CHEM, V264, P15578; MCKEEL DW, 1978, ARCH PATHOL LAB MED, V102, P122; Potten C, 1983, STEM CELLS THEIR IDE, V155-99; POTTEN CS, 1979, BIOCHIM BIOPHYS ACTA, V560, P281, DOI 10.1016/0304-419X(79)90022-2; ROTH KA, 1990, P NATL ACAD SCI USA, V87, P6408, DOI 10.1073/pnas.87.16.6408; ROTH KA, 1990, J CELL BIOL, V110, P1791, DOI 10.1083/jcb.110.5.1791; SCHMIDT GH, 1990, MUTAT RES, V228, P149, DOI 10.1016/0027-5107(90)90071-B; SCHMIDT GH, 1988, DEVELOPMENT, V103, P785; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; SWEETSER DA, 1987, J BIOL CHEM, V262, P16060; SWEETSER DA, 1988, GENE DEV, V2, P1310; Trier J S, 1979, Ciba Found Symp, P3; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0	20	44	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 25	1991	266	9					5949	5954						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FD370	1706343				2022-12-27	WOS:A1991FD37000092
J	KIRCHHOFER, D; GRZESIAK, J; PIERSCHBACHER, MD				KIRCHHOFER, D; GRZESIAK, J; PIERSCHBACHER, MD			CALCIUM AS A POTENTIAL PHYSIOLOGICAL REGULATOR OF INTEGRIN-MEDIATED CELL-ADHESION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE GLYCOPROTEIN-IIB; AMINO-ACID SEQUENCE; GROWTH FACTOR-BETA; ARG-GLY-ASP; RECEPTOR ALPHA-SUBUNIT; OSTEO-SARCOMA CELLS; VITRONECTIN RECEPTOR; FIBRONECTIN RECEPTOR; IIIA COMPLEX; VONWILLEBRAND-FACTOR	Alpha-v-beta-1 and alpha-v-beta-3 are two related members of the integrin family of cell surface receptors both of which interact with their ligands through the Arg-Gly-Asp recognition sequence. Alpha-v-beta-1 and alpha-v-beta-3 share the same cation-binding subunit, alpha-v, suggesting a similar cation requirement for both integrins. Instead, we observed that Ca2+ exerts different effects on their binding function. The attachment of alpha-v-beta-3-loaded liposomes to vitronectin and the alpha-v-beta-3-mediated adhesion of U 251 cells to an Arg-Gly-Asp-containing peptide was supported equally well by Ca2+ and Mg2+. However, IMR 32 cells which bind to Arg-Gly-Asp-containing peptides through alpha-v-beta-1 adhered in Mg2+ but not in Ca2+. In agreement, Ca2+ did not support the attachment of alpha-v-beta-1-loaded liposomes to the macromolecular ligand fibronectin or the binding of alpha-v-beta-1 to Gly-Arg-Gly-Asp-Ser-Pro-Lys-Sepharose in affinity chromatography experiments. Furthermore, in the presence of a constant Mg2+ concentration, Ca2+ had opposite effects on the two receptors in that it inhibited the alpha-v-beta-1-mediated adhesion of IMR 32 cells to the peptide substrate while enhancing alpha-v-beta-3-mediated adhesion of U251 cells. The Ca2+ effects occurred at physiological cation concentrations and therefore, our data suggest a physiological role for Ca2+ as a regulator of integrin function and indicate a possible involvement of the beta-subunits in cation binding.	LA JOLLA CANC RES FDN,10901 N TORREY PINES RD,LA JOLLA,CA 92037	Sanford Burnham Prebys Medical Discovery Institute					NCI NIH HHS [CA30199] Funding Source: Medline; NHLBI NIH HHS [HL38417] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038417] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1988, J IMMUNOL, V141, P2656; ARGRAVES WS, 1987, J CELL BIOL, V105, P1183, DOI 10.1083/jcb.105.3.1183; BIGNER DD, 1981, J NEUROPATH EXP NEUR, V40, P201, DOI 10.1097/00005072-198105000-00001; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; BRAY PF, 1990, J BIOL CHEM, V265, P9587; BROWN NH, 1989, CELL, V59, P185, DOI 10.1016/0092-8674(89)90880-5; CHAMBERS TJ, 1986, BONE MINER, V1, P127; CHATILA TA, 1989, J CELL BIOL, V109, P3435, DOI 10.1083/jcb.109.6.3435; CHERESH DA, 1987, J CELL BIOL, V105, P1163, DOI 10.1083/jcb.105.3.1163; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CIERNIEWSKI CS, 1989, J BIOL CHEM, V264, P12158; CONFORTI G, 1990, J BIOL CHEM, V265, P4011; CORBI AL, 1987, EMBO J, V6, P4023, DOI 10.1002/j.1460-2075.1987.tb02746.x; COX JA, 1988, BIOCHEM J, V249, P621, DOI 10.1042/bj2490621; CROBI A, 1988, J BIOL CHEM, V263, P12403; DAHL SC, 1989, J CELL BIOL, V108, P183, DOI 10.1083/jcb.108.1.183; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; DRANSFIELD I, 1989, EMBO J, V8, P3759, DOI 10.1002/j.1460-2075.1989.tb08552.x; EDWARDS JG, 1987, J CELL SCI, V87, P657; EDWARDS JG, 1988, J CELL SCI, V89, P507; FITZGERALD LA, 1985, J BIOL CHEM, V260, P1366; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; FUJIMURA K, 1983, J BIOL CHEM, V258, P247; GAILIT J, 1988, J BIOL CHEM, V263, P12927; GINSBERG MH, 1986, J CLIN INVEST, V78, P1103, DOI 10.1172/JCI112667; HARA T, 1986, LEUKOCYTE TYPING 2, V3, P77; HAYMAN EG, 1983, P NATL ACAD SCI-BIOL, V80, P4003, DOI 10.1073/pnas.80.13.4003; HEINO J, 1989, J BIOL CHEM, V264, P21806; HEINO J, 1989, J BIOL CHEM, V264, P380; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HICKSTEIN DD, 1989, P NATL ACAD SCI USA, V86, P257, DOI 10.1073/pnas.86.1.257; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; IGNOTZ RA, 1989, J BIOL CHEM, V264, P389; KRETSINGER RH, 1976, ANNU REV BIOCHEM, V45, P239, DOI 10.1146/annurev.bi.45.070176.001323; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; LEBIEN TW, 1982, J IMMUNOL, V129, P2287; LOFTUS JC, 1988, J BIOL CHEM, V263, P11025; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; MARGUERIE GA, 1983, ANN NY ACAD SCI, V408, P556, DOI 10.1111/j.1749-6632.1983.tb23272.x; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MILOS M, 1986, BIOCHEMISTRY-US, V25, P6279, DOI 10.1021/bi00368a067; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; OLDBERG A, 1988, J BIOL CHEM, V263, P19433; PARISE LV, 1990, BLOOD, V75, P2263; PHILLIPS DR, 1988, BLOOD, V71, P831; PIERSCHBACHER M, 1983, P NATL ACAD SCI-BIOL, V80, P1224, DOI 10.1073/pnas.80.5.1224; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PONCZ M, 1987, J BIOL CHEM, V262, P8476; PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766; PYTELA R, 1988, EMBO J, V7, P1371, DOI 10.1002/j.1460-2075.1988.tb02953.x; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; SANTORO SA, 1989, BLOOD, V73, P484; SHAW LM, 1990, J CELL BIOL, V110, P2167, DOI 10.1083/jcb.110.6.2167; SMITH JW, 1988, J BIOL CHEM, V263, P18726; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAATZ WD, 1989, J CELL BIOL, V108, P1917, DOI 10.1083/jcb.108.5.1917; STALLCUP WB, 1989, DEV BIOL, V132, P212, DOI 10.1016/0012-1606(89)90218-2; SUZUKI S, 1987, J BIOL CHEM, V262, P14080; SUZUKI S, 1984, J BIOL CHEM, V259, P5307; TAKADA Y, 1989, EMBO J, V8, P1361, DOI 10.1002/j.1460-2075.1989.tb03516.x; TAKADA Y, 1989, J CELL BIOL, V109, P397, DOI 10.1083/jcb.109.1.397; TSUJI T, 1990, J BIOL CHEM, V265, P7016; VANKUPPEVELT THMSM, 1989, P NATL ACAD SCI USA, V86, P5415; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; VYAS NK, 1987, NATURE, V327, P635, DOI 10.1038/327635a0; WRIGHT SD, 1986, J IMMUNOL, V136, P1759	70	156	158	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4471	4477						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705553				2022-12-27	WOS:A1991FA69400070
J	HANSEN, TR; LEAMAN, DW; CROSS, JC; MATHIALAGAN, N; BIXBY, JA; ROBERTS, RM				HANSEN, TR; LEAMAN, DW; CROSS, JC; MATHIALAGAN, N; BIXBY, JA; ROBERTS, RM			THE GENES FOR THE TROPHOBLAST INTERFERONS AND THE RELATED INTERFERON-ALPHA-II POSSESS DISTINCT 5'-PROMOTER AND 3'-FLANKING SEQUENCES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA GENES; REGULATORY ELEMENT; MOLECULAR-CLONING; ESCHERICHIA-COLI; MESSENGER-RNA; IFN-ALPHA; OVINE; EXPRESSION; DNA; PROTEIN	The genes for trophoblast interferons (IFN) bovine trophoblast protein-1 (bTP-1) and ovine trophoblast protein-1 (oTP-1) are expressed massively in the trophectoderm of preimplantation bovine and ovine concepti during the period of maternal recognition of pregnancy. These 172-amino acid IFN are closely related to the IFN-alpha-II, a family of "long" IFN expressed in virus-induced leukocytes. Genomic Southern blotting with a full-length bTP-1 cDNA revealed about 15 genes that bind the probe with varying intensities. By using more specific probes for the 3'-ends of the cDNA, we have shown that only four to five of these represent bTP-1 genes, whereas no more than another four are IFN-alpha-II. Genes for bTP-1 and IFN-alpha-II, all of which are intronless, have been isolated from bovine genomic libraries, and their nucleotide sequences were compared. Additional bTP-1 genes and two distinct oTP-1 genes have been isolated from bovine and ovine genomic DNA by using the polymerase chain reaction procedure in conjunction with specific 3'- and 5'-primers (derived from the bTP-1 gene sequences determined above). The promoter region up to 100 bases upstream from the transcription start sites of the trophoblast IFN are almost completely conserved across different genes and across species, yet show only limited sequence identity with IFN-alpha-II. Two putative binding regions for interferon regulatory factor-I as well as several GAAANN motifs (where N is any nucleotide) that have been implicated in viral responsiveness of alpha-I- and beta-IFN genes are retained at identical positions in all of the trophoblast genes. Putative interferon regulatory factor-1-binding nucleotide hexamers and GAAANN motifs are also present in the IFN-alpha-II genes, but these are organized very differently than in the trophoblast IFN genes. A GAAATG motif is present in IFN-alpha-II promoters but is absent in trophoblast IFN genes. Based on the evidence presented, it is proposed that the trophoblast interferons constitute a separate subclass of IFN-alpha distinct from IFN-alpha-II and IFN-alpha-I.	UNIV MISSOURI, DEPT ANIM SCI, 158 ANIM SCI RES CTR, COLUMBIA, MO 65211 USA; UNIV MISSOURI, DEPT BIOCHEM, COLUMBIA, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia			Hansen, Thomas/GWZ-2858-2022; Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378	NICHD NIH HHS [HD21896] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021896, R37HD021896] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADOLF GR, 1987, J GEN VIROL, V68, P1669, DOI 10.1099/0022-1317-68-6-1669; ADOLF GR, 1990, J BIOL CHEM, V265, P9290; BAZER FW, 1986, J REPROD FERTIL, V76, P841, DOI 10.1530/jrf.0.0760841; CAPON DJ, 1985, MOL CELL BIOL, V5, P768, DOI 10.1128/MCB.5.4.768; CHARPIGNY G, 1988, FEBS LETT, V228, P12, DOI 10.1016/0014-5793(88)80574-X; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CROSS JC, 1990, FASEB J, V4, pA1771; DAMJANOV I, 1985, J EMBRYOL EXP MORPH, V86, P125; Demaeyer E., 1988, INTERFERONS OTHER RE; FARIN CE, 1989, MOL ENDOCRINOL, V3, P1099, DOI 10.1210/mend-3-7-1099; FARIN CE, 1990, BIOL REPROD, V43, P210, DOI 10.1095/biolreprod43.2.210; FISH EN, 1983, BIOCHEM BIOPH RES CO, V112, P537, DOI 10.1016/0006-291X(83)91498-5; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; HAUPTMANN R, 1985, NUCLEIC ACIDS RES, V13, P4739, DOI 10.1093/nar/13.13.4739; HIMMLER A, 1987, J INTERFERON RES, V7, P173, DOI 10.1089/jir.1987.7.173; HIMMLER A, 1986, DNA-J MOLEC CELL BIO, V5, P345, DOI 10.1089/dna.1986.5.345; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; IMAKAWA K, 1989, MOL ENDOCRINOL, V3, P127, DOI 10.1210/mend-3-1-127; KELLER AD, 1988, P NATL ACAD SCI USA, V85, P3309, DOI 10.1073/pnas.85.10.3309; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; MACDONALD NJ, 1990, CELL, V60, P767, DOI 10.1016/0092-8674(90)90091-R; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; ORTALDO JR, 1984, P NATL ACAD SCI-BIOL, V81, P4926, DOI 10.1073/pnas.81.15.4926; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; PONTZER CH, 1988, BIOCHEM BIOPH RES CO, V152, P801, DOI 10.1016/S0006-291X(88)80109-8; RAJ NBK, 1989, J BIOL CHEM, V264, P11149; RAJ NBK, 1989, J BIOL CHEM, V264, P16658; RINGLER GE, 1990, ENDOCR REV, V11, P105, DOI 10.1210/edrv-11-1-105; ROBERTS RM, 1990, J REPROD FERTIL, P63; ROBERTS RM, 1989, J INTERFERON RES, V9, P175, DOI 10.1089/jir.1989.9.175; ROBERTS RM, 1989, J INTERFERON RES, V9, P373, DOI 10.1089/jir.1989.9.373; ROBERTS RM, 1990, SERONO SYM, V66, P257; Rossi G B, 1985, Interferon, V6, P31; RUBINSTEIN M, 1986, CRIT REV BIOCHEM MOL, V21, P249, DOI 10.3109/10409238609113613; RYALS J, 1985, CELL, V41, P497, DOI 10.1016/S0092-8674(85)80023-4; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEPARD HM, 1985, BIOL INTERFERON SYST, P147; SHIRONO H, 1990, BIOCHEM BIOPH RES CO, V168, P16, DOI 10.1016/0006-291X(90)91668-I; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STEWART HJ, 1989, J MOL ENDOCRINOL, V2, P65, DOI 10.1677/jme.0.0020065; STEWART HJ, 1990, J MOL ENDOCRINOL, V4, P275, DOI 10.1677/jme.0.0040275; STEWART HJ, 1987, J ENDOCRINOL, V115, pR13, DOI 10.1677/joe.0.115R013; Tamm I, 1987, Interferon, V9, P13; VELAN B, 1985, J BIOL CHEM, V260, P5498; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4; WOYCHIK RP, 1982, NUCLEIC ACIDS RES, V10, P7197, DOI 10.1093/nar/10.22.7197; XANTHOUDAKIS S, 1989, J BIOL CHEM, V264, P1139; ZINN K, 1986, CELL, V45, P611, DOI 10.1016/0092-8674(86)90293-X	53	52	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					3060	3067						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704373				2022-12-27	WOS:A1991EX60000060
J	KAMEDA, K; GOODRIDGE, AG				KAMEDA, K; GOODRIDGE, AG			ISOLATION AND PARTIAL CHARACTERIZATION OF THE GENE FOR GOOSE FATTY-ACID SYNTHASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; NUCLEOTIDE-SEQUENCE; HORMONAL-REGULATION; LIPOGENIC ENZYMES; MAMMALIAN-CELLS; THYROID-HORMONE; FAS2 GENE; EXPRESSION; LIVER; TRANSCRIPTION	Fatty acid synthase is regulated by diet and hormones, with regulation being primarily transcriptional. In chick embryo hepatocytes in culture, triiodothyronine stimulates accumulation of enzyme and transcription of the gene. Since the 5'-flanking region of this gene is likely involved in hormonal regulation of its expression, we have isolated and partially characterized an avian fatty acid synthase gene. A genomic DNA library was constructed in a cosmid vector and screened with cDNa clones that contained sequence complementary to the 3' end of goose fatty acid synthase mRNA. A genomic clone (approximately 35 kilobase pairs (kb)) was isolated, and a 6.5-kb EcoRI fragment thereof contained DNA complementary to the 3' noncoding region of fatty acid synthase mRNA. Additional cosmid libraries were screened with 5' fragments of previously isolated genomic clones, resulting in the isolation oof five overlapping cosmid DNAs. The entire region of cloned DNA spans approximately 105 kb. Exon-containing fragments were identified by hybridization with end-labeled poly(A)+ RNA and by hybridization of labeled exon-containing genomic DNA fragments to fatty acid synthase mRNA. A new set of cDNA clones spanning approximately 3.2 kb was isolated from a lambda-ZAP goose liver cDNA library using the 5'-most exon-containing fragment of the 5'-most genomic DNA clone. This region of mRNA contains a 5'-untranslated sequence and a continuous open reading frame which includes a region that codes for the essential cysteine of the beta-ketoacyl synthase domain. The entire fatty acid synthase gene spans about 50 kb. The 5' 15 kb of the gene contain 7 exons. S1 nuclease and primer extension analyses were used to identify a single site for initiation of transcription, 174 nucleotides upstream from the putatitive translation initiation codon. Putative "TATA" and "CCAAT" boxes are located 28 and 60 base pairs (bp), respectively, upstream of the site of initiation of transcription. The 5'-flanking 597 bp of DNA contains G/C-rich sequences including several "GC" boxes corresponding to binding sites for the nuclear transcription factor Sp1. Putative sites for AP-2, C/EBP, and the triiodothyronine and glucocorticoid receptors also were found in this region. A chimeric DNA, containing approximately 1.6 kb of 5'-flanking sequence and 139 bp of untranslated sequence of the goose fatty acid synthase gene ligated to the bacterial chloramphenicol acetyltransferase (CAT) gene, was transfected into chick embryo hepatocytes in culture. Cells treated with triiodothyronine contained increased chloramphenicol acetyltransferase and fatty acid synthase activities. Thus, the fatty acid synthase promoter region appears to contain elements that mediate the response to triiodothyronine.	UNIV IOWA, DEPT BIOCHEM, IOWA CITY, IA 52242 USA	University of Iowa					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR27978] Funding Source: Medline; NIDDK NIH HHS [DK21954, DK25295] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALTON NK, 1979, NATURE, V282, P864, DOI 10.1038/282864a0; AMY CM, 1989, P NATL ACAD SCI USA, V86, P3114, DOI 10.1073/pnas.86.9.3114; BACK DW, 1986, J BIOL CHEM, V261, P4190; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CRABB DW, 1989, METHOD ENZYMOL, V168, P690; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DILLELA AG, 1985, FOCUS, V7, P1; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fourney R.M., 1988, FOCUS, V10, P5; GOODRIDGE AG, 1972, J BIOL CHEM, V247, P6946; GOODRIDGE AG, 1974, J BIOL CHEM, V249, P1469; GOODRIDGE AG, 1984, ARCH BIOCHEM BIOPHYS, V230, P82, DOI 10.1016/0003-9861(84)90088-2; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; GREENE JM, 1987, CURRENT PROTOCOLS MO, V1, P461; HOLZER KP, 1989, P NATL ACAD SCI USA, V86, P4387, DOI 10.1073/pnas.86.12.4387; ISHHOROWICZ D, 1981, NUCLEIC ACIDS RES, V9, P2989, DOI 10.1093/nar/9.13.2989; KAUPPINEN S, 1988, CARLSBERG RES COMMUN, V53, P357, DOI 10.1007/BF02983311; MANIATIS T, 1982, MOL CLONING LABORATO, P300; MCCARTHY AD, 1983, FEBS LETT, V162, P300, DOI 10.1016/0014-5793(83)80776-5; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MOHAMED AH, 1988, J BIOL CHEM, V263, P12315; MORRIS SM, 1984, MUTAT RES, V126, P63, DOI 10.1016/0027-5107(84)90170-2; MORRIS SM, 1982, J BIOL CHEM, V257, P3225; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; POULOSE AJ, 1984, ARCH BIOCHEM BIOPHYS, V230, P117, DOI 10.1016/0003-9861(84)90092-4; SAMUELS HH, 1989, ANNU REV PHYSIOL, V51, P623, DOI 10.1146/annurev.ph.51.030189.003203; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWEIZER M, 1989, NUCLEIC ACIDS RES, V17, P567, DOI 10.1093/nar/17.2.567; STAPLETON SR, 1990, J BIOL CHEM, V265, P18442; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WIESNER P, 1988, EUR J BIOCHEM, V177, P69, DOI 10.1111/j.1432-1033.1988.tb14346.x; WILSON SB, 1986, J BIOL CHEM, V261, P5179; ZILZ ND, 1990, J BIOL CHEM, V265, P8136	38	42	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 5	1991	266	1					419	426						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ339	1702426				2022-12-27	WOS:A1991EQ33900061
J	PEREZ, M; ISHIOKA, GY; WALKER, LE; CHESNUT, RW				PEREZ, M; ISHIOKA, GY; WALKER, LE; CHESNUT, RW			CDNA CLONING AND IMMUNOLOGICAL CHARACTERIZATION OF THE RYE GRASS ALLERGEN LOL-P-I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article											PEREZ, M (corresponding author), CYTEL CORP,LA JOLLA,CA 92037, USA.							ANSARI AA, 1989, BIOCHEMISTRY-US, V28, P8665, DOI 10.1021/bi00447a058; ANSARI AA, 1989, J BIOL CHEM, V264, P11181; ANSARI AA, 1987, J IMMUNOL, V139, P4034; BAULCOMBE DC, 1987, MOL GEN GENET, V209, P33, DOI 10.1007/BF00329833; BLACK PL, 1980, J ALLERGY CLIN IMMUN, V66, P394, DOI 10.1016/0091-6749(80)90119-0; BUCKLEY RH, 1977, J ALLERGY CLIN IMMUN, V59, P70, DOI 10.1016/0091-6749(77)90180-4; COTTAM GP, 1986, BIOCHEM J, V234, P305, DOI 10.1042/bj2340305; DELISI C, 1985, P NATL ACAD SCI USA, V82, P7048, DOI 10.1073/pnas.82.20.7048; ESCH RE, 1987, J ALLERGY CLIN IMMUN, V79, P489, DOI 10.1016/0091-6749(87)90367-8; ESCH RE, 1989, MOL IMMUNOL, V26, P557, DOI 10.1016/0161-5890(89)90007-2; FORDE J, 1983, FEBS LETT, V162, P360, DOI 10.1016/0014-5793(83)80788-1; FRIEDHOFF LR, 1988, TISSUE ANTIGENS, V31, P211; FRIEDHOFF LR, 1986, J ALLERGY CLIN IMMUN, V78, P1190; GASTON JSH, 1990, J EXP MED, V171, P831, DOI 10.1084/jem.171.3.831; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JOHNSON P, 1966, IMMUNOCHEMISTRY, V3, P91, DOI 10.1016/0019-2791(66)90290-4; JOHNSON P, 1965, NATURE, V206, P935, DOI 10.1038/206935b0; JOHNSON P, 1965, EUR POLYM J, V1, P63; KAHN CR, 1986, MOL IMMUNOL, V23, P1281, DOI 10.1016/0161-5890(86)90013-1; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANZAVECCHIA A, 1983, CLIN EXP IMMUNOL, V52, P21; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LITTS JC, 1987, NUCLEIC ACIDS RES, V15, P3607, DOI 10.1093/nar/15.8.3607; Maniatis T., 1982, MOL CLONING; Maniatis T, 1989, DECONTAMINATION DILU; MARSH DG, 1970, J ALLERGY, V46, P107, DOI 10.1016/0021-8707(70)90078-X; MURRAY EE, 1989, NUCLEIC ACIDS RES, V17, P477, DOI 10.1093/nar/17.2.477; OHEHIR RE, 1987, IMMUNOLOGY, V62, P635; RAWLE FC, 1984, J IMMUNOL, V133, P195; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SETTE A, 1988, J IMMUNOL, V141, P45; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; SMITH SM, 1983, NUCLEIC ACIDS RES, V11, P8719, DOI 10.1093/nar/11.24.8719; TABATA T, 1983, NUCLEIC ACIDS RES, V11, P5865, DOI 10.1093/nar/11.17.5865	34	166	184	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16210	16215						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697854				2022-12-27	WOS:A1990DZ95000029
J	KONDO, H; ABE, K; NISHIMURA, I; WATANABE, H; EMORI, Y; ARAI, S				KONDO, H; ABE, K; NISHIMURA, I; WATANABE, H; EMORI, Y; ARAI, S			2 DISTINCT CYSTATIN SPECIES IN RICE SEEDS WITH DIFFERENT SPECIFICITIES AGAINST CYSTEINE PROTEINASES - MOLECULAR-CLONING, EXPRESSION, AND BIOCHEMICAL-STUDIES ON ORYZACYSTATIN-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV TOKYO, DEPT AGR CHEM, YAYOI CHO, BUNKYO KU, TOKYO 113, JAPAN; TOKYO METROPOLITAN INST MED SCI, DEPT MOLEC BIOL, BUNKYO KU, TOKYO 113, JAPAN	University of Tokyo; Tokyo Metropolitan Institute of Medical Science								ABE K, 1988, J BIOL CHEM, V263, P7655; ABE K, 1987, AGR BIOL CHEM TOKYO, V51, P2763; ABE K, 1987, J BIOL CHEM, V262, P16793; ABE K, 1985, AGR BIOL CHEM TOKYO, V49, P3349, DOI 10.1080/00021369.1985.10867271; ABE K, 1987, AGR BIOL CHEM TOKYO, V51, P1509, DOI 10.1080/00021369.1987.10868238; ALHASHIMI I, 1988, J BIOL CHEM, V263, P9381; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515; Barrett AJ, 1986, PROTEINASE INHIBITOR, P515; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; BRAWERMAN G, 1972, BIOCHEMISTRY-US, V11, P637, DOI 10.1021/bi00754a027; DIXON M, 1979, ENZYMES, P332; GRUBB A, 1982, P NATL ACAD SCI-BIOL, V79, P3024, DOI 10.1073/pnas.79.9.3024; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HIRADO M, 1985, FEBS LETT, V186, P41, DOI 10.1016/0014-5793(85)81335-1; ISEMURA S, 1986, FEBS LETT, V198, P145, DOI 10.1016/0014-5793(86)81201-7; ISEMURA S, 1984, J BIOCHEM-TOKYO, V96, P489, DOI 10.1093/oxfordjournals.jbchem.a134861; ISEMURA S, 1986, CYSTEINE PROTEINASES, P497; KITAMURA N, 1985, J BIOL CHEM, V260, P8610; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; MACHLEIDT W, 1983, H-S Z PHYSIOL CHEM, V364, P1481, DOI 10.1515/bchm2.1983.364.2.1481; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; Maniatis T., 1982, MOL CLONING LABORATO, P149; Maxam A M, 1980, Methods Enzymol, V65, P499; OKITANI A, 1988, EUR J BIOCHEM, V171, P377, DOI 10.1111/j.1432-1033.1988.tb13801.x; RITONJA A, 1985, BIOCHEM BIOPH RES CO, V131, P1187, DOI 10.1016/0006-291X(85)90216-5; ROHRLICH ST, 1986, CYSTEINE PROTEINASES, P455; SALVESEN G, 1986, BIOCHEM J, V234, P429, DOI 10.1042/bj2340429; SALVESEN G, 1986, CYSTEINE PROTEINASES, P413; TAKIO K, 1984, BIOCHEM BIOPH RES CO, V121, P149, DOI 10.1016/0006-291X(84)90699-5; TURK V, 1983, H-S Z PHYSIOL CHEM, V364, P1487, DOI 10.1515/bchm2.1983.364.2.1487; WOOD L, 1986, CYSTEINE PROTEINASE, P667	34	193	204	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15832	15837						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1697595				2022-12-27	WOS:A1990DY96400076
J	ELBRECHT, A; DIRENZO, J; SMITH, RG; SHENOLIKAR, S				ELBRECHT, A; DIRENZO, J; SMITH, RG; SHENOLIKAR, S			MOLECULAR-CLONING OF PROTEIN PHOSPHATASE INHIBITOR-1 AND ITS EXPRESSION IN RAT AND RABBIT-TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									UNIV TEXAS, HLTH SCI CTR, DEPT PHARMACOL, HOUSTON, TX 77025 USA	University of Texas System; University of Texas Health Science Center Houston	ELBRECHT, A (corresponding author), MERCK SHARP & DOHME LTD, DEPT GROWTH BIOCHEM & PHYSIOL, POB 2000, MAIL DROP R80Y-265, RAHWAY, NJ 07065 USA.				NIDDK NIH HHS [DK36466, DK41190] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK041190, R01DK036466] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AHMAD Z, 1989, J BIOL CHEM, V264, P3859; AITKEN A, 1982, FEBS LETT, V147, P54, DOI 10.1016/0014-5793(82)81010-7; AITKEN A, 1982, EUR J BIOCHEM, V126, P235, DOI 10.1111/j.1432-1033.1982.tb06771.x; ALEMANY S, 1986, EUR J BIOCHEM, V156, P101, DOI 10.1111/j.1432-1033.1986.tb09554.x; ALEMANY S, 1984, EUR J BIOCHEM, V145, P51, DOI 10.1111/j.1432-1033.1984.tb08520.x; BIENSTIEL ML, 1985, CELL, V41, P349; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHISHOLM AAK, 1988, BIOCHIM BIOPHYS ACTA, V971, P163, DOI 10.1016/0167-4889(88)90188-7; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1988, PROC R SOC SER B-BIO, V234, P115, DOI 10.1098/rspb.1988.0040; DAVIS LG, 1986, BASIC METHODS MOL BI, P47; FOULKES JG, 1979, EUR J BIOCHEM, V97, P251, DOI 10.1111/j.1432-1033.1979.tb13109.x; FOULKES JG, 1982, J BIOL CHEM, V257, P2493; HIRAGA A, 1986, EUR J BIOCHEM, V161, P763, DOI 10.1111/j.1432-1033.1986.tb10505.x; KHATRA BS, 1980, FEBS LETT, V114, P253, DOI 10.1016/0014-5793(80)81127-6; KURIHARA T, 1988, J NEUROSCI, V8, P508; MACDOUGALL LK, 1989, BIOCHIM BIOPHYS ACTA, V1010, P218, DOI 10.1016/0167-4889(89)90164-X; Maniatis T, 1982, MOL CLONING LABORATO; MARUYAMA T, 1986, NUCLEIC ACIDS RES, V14, pR151, DOI 10.1093/nar/14.suppl.r151; NAIRN AC, 1988, J NEUROCHEM, V50, P257, DOI 10.1111/j.1471-4159.1988.tb13258.x; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NEMENOFF RA, 1983, J BIOL CHEM, V258, P9437; NIMMO GA, 1978, EUR J BIOCHEM, V87, P341, DOI 10.1111/j.1432-1033.1978.tb12383.x; PATO MD, 1985, J BIOL CHEM, V260, P2359; SCHELLING D, 1988, BIOCHIM BIOPHYS ACTA, V972, P221, DOI 10.1016/S0005-2728(88)80082-3; SHENOLIKAR S, 1984, ADV CYCLIC NUCL PROT, V17, P405; SHENOLIKAR S, 1988, FASEB J, V2, P2753, DOI 10.1096/fasebj.2.12.2842213; SHENOLIKAR S, 1990, IN PRESS ADV CYCLIC, V26; SHENOLIKAR S, 1979, BIOCH T, V6, P935; STRALFORS P, 1989, EUR J BIOCHEM, V180, P143, DOI 10.1111/j.1432-1033.1989.tb14624.x; STRALFORS P, 1985, EUR J BIOCHEM, V149, P295, DOI 10.1111/j.1432-1033.1985.tb08926.x; TAO SH, 1978, BIOCHEM J, V176, P347, DOI 10.1042/bj1760347; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VIERA J, 1989, THESIS U MINNESOTA; WILLIAMS KR, 1986, J BIOL CHEM, V261, P1890	35	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13415	13418						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696252				2022-12-27	WOS:A1990DU27500002
J	MAGNUSON, VL; YOUNG, M; SCHATTENBERG, DG; MANCINI, MA; CHEN, DL; STEFFENSEN, B; KLEBE, RJ				MAGNUSON, VL; YOUNG, M; SCHATTENBERG, DG; MANCINI, MA; CHEN, DL; STEFFENSEN, B; KLEBE, RJ			THE ALTERNATIVE SPLICING OF FIBRONECTIN PRE-MESSENGER-RNA IS ALTERED DURING AGING AND IN RESPONSE TO GROWTH-FACTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORMED HUMAN-CELLS; RETINOIC ACID; MONOCLONAL-ANTIBODIES; PLASMA FIBRONECTIN; HUMAN-FIBROBLASTS; A FIBRONECTIN; GENE; EXPRESSION; SEQUENCE; IDENTIFICATION	The reverse transcription-polymerase chain reaction was used to examine alternative splicing at each of the three fibronectin exons known to undergo alternative splicing, i.e. extra domain A (ED-A), extra domain B (ED-B), and type III connecting sequence (IIICS). Ratios of fibronectin mRNAs with or without a given exon were determined in several rat tissues and human cell lines during aging in vivo and cellular senescence in vitro. We demonstrate that statistically significant shifts in the alternative splicing of fibronectin occur during aging in vivo and in vitro. Since all three alternatively spliced exons are spliced out at a higher frequency in aging tissues and cells, the fibronectin protein produced by old cells should be slightly smaller than that obtained from young cells. The reverse transcription-polymerase chain reaction demonstrates tissue-specific patterns of alternative splicing in several tissues. Whereas fibronectin mRNAs from adult rat tissues were found to range from 0 to 25% ED-A+ and from 0 to 10% ED-B+, fibronectin mRNAs from cultured cell lines were found to be approximately 50-60% ED-A+ and 15-25% ED-B+. We observed similarity in splicing of fibronectin RNA by the different cultured cell lines obtained from many tissues and attribute this observation to the effect of growth factors. We demonstrate that serum deprivation; placement of cells into primary culture; and growth factors such as transforming growth factor-beta-1, retinoic acid, and 1,25-dihydroxyvitamin D3 can all change the alternative splicing of fibronectin pre-mRNA in the ED-A, ED-B, and type III connecting sequence exons. Possible mechanisms for the regulation of the alternative splicing of fibronectin RNA by growth factors are discussed.			MAGNUSON, VL (corresponding author), UNIV TEXAS,HLTH SCI CTR,DEPT CELLULAR & STRUCT BIOL,SAN ANTONIO,TX 78284, USA.				NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG006872] Funding Source: NIH RePORTER; NIA NIH HHS [AG06872] Funding Source: Medline; NIDCR NIH HHS [DE08144] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BARONE MV, 1989, EMBO J, V8, P1079, DOI 10.1002/j.1460-2075.1989.tb03476.x; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; BORSI L, 1990, FEBS LETT, V261, P175, DOI 10.1016/0014-5793(90)80664-5; BORSI L, 1987, J CELL BIOL, V104, P595, DOI 10.1083/jcb.104.3.595; BURTONWURSTER N, 1988, BIOCHEM BIOPH RES CO, V154, P1088, DOI 10.1016/0006-291X(88)90252-5; CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139; CASTELLANI P, 1986, J CELL BIOL, V103, P1671, DOI 10.1083/jcb.103.5.1671; CHANDRASEKHAR S, 1983, CELL BIOL INT REP, V7, P11, DOI 10.1016/0309-1651(83)90100-5; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CONBOY JG, 1988, P NATL ACAD SCI USA, V85, P9062, DOI 10.1073/pnas.85.23.9062; EDICK GF, 1984, MECH AGEING DEV, V27, P249, DOI 10.1016/0047-6374(84)90050-2; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FRANCESCHI RT, 1988, J BIOL CHEM, V263, P18938; FRANCESCHI RT, 1985, J CELL PHYSIOL, V123, P401, DOI 10.1002/jcp.1041230316; FRANCESCHI RT, 1987, J BIOL CHEM, V262, P4165; FRENCHCONSTANT C, 1989, J CELL BIOL, V109, P903; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GLUKHOVA MA, 1989, J CELL BIOL, V109, P357, DOI 10.1083/jcb.109.1.357; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; HEATH JK, 1989, ENDOCRINOLOGY, V124, P3060; HERSHBERGER RP, 1990, MOL CELL BIOL, V10, P662, DOI 10.1128/MCB.10.2.662; HUMPHRIES MJ, 1987, J BIOL CHEM, V262, P6886; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; JOSHI B, 1990, Journal of Cell Biology, V111, p233A; KORNBLIHTT AR, 1983, P NATL ACAD SCI-BIOL, V80, P3218, DOI 10.1073/pnas.80.11.3218; MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671; MANIATIS T, 1991, SCIENCE, V251, P33, DOI 10.1126/science.1824726; MARDON HJ, 1987, NUCLEIC ACIDS RES, V15, P7725, DOI 10.1093/nar/15.19.7725; MILLIS AJT, 1989, FIBRONECTIN HLTH DIS, P38; MOULD AP, 1991, J BIOL CHEM, V266, P3579; NORTON PA, 1990, NUCLEIC ACIDS RES, V18, P4089, DOI 10.1093/nar/18.14.4089; OYAMA F, 1989, BIOCHEMISTRY-US, V28, P1428, DOI 10.1021/bi00429a072; OYAMA F, 1990, CANCER RES, V50, P1075; PAOLELLA G, 1988, NUCLEIC ACIDS RES, V16, P3545, DOI 10.1093/nar/16.8.3545; PAUL JI, 1984, J BIOL CHEM, V259, P3477; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; PETKOVICH PM, 1987, J NATL CANCER I, V78, P265; PORTER MB, 1990, J CELL PHYSIOL, V142, P425, DOI 10.1002/jcp.1041420228; PROWSE KR, 1986, CYTOGENET CELL GENET, V41, P42, DOI 10.1159/000132194; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; RUOSLAHTI E, 1989, CANCER CELL-MON REV, V1, P119; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; SCHULE R, 1990, CELL, V61, P497, DOI 10.1016/0092-8674(90)90531-I; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; SCHWARZBAUER JE, 1983, CELL, V35, P421, DOI 10.1016/0092-8674(83)90175-7; SESHADRI T, 1989, EXP GERONTOL, V24, P515, DOI 10.1016/0531-5565(89)90057-0; SONG CS, 1991, ENDOCRINOLOGY, V128, P349, DOI 10.1210/endo-128-1-349; SORRENTINO JA, 1984, MECH AGEING DEV, V28, P83, DOI 10.1016/0047-6374(84)90155-6; VOGEL KG, 1981, MECH AGEING DEV, V16, P295, DOI 10.1016/0047-6374(81)90013-0; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; ZARDI L, 1987, EMBO J, V6, P2337, DOI 10.1002/j.1460-2075.1987.tb02509.x	53	162	162	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 5	1991	266	22					14654	14662						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ351	1713586				2022-12-27	WOS:A1991FZ35100083
J	BUDNIK, LT; MUKHOPADHYAY, AK				BUDNIK, LT; MUKHOPADHYAY, AK			EPIDERMAL GROWTH-FACTOR, A MODULATOR OF LUTEAL ADENYLATE-CYCLASE - CHARACTERIZATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS AND ITS INTERACTION WITH ADENYLATE-CYCLASE SYSTEM IN BOVINE LUTEAL CELL-MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; CYCLIC-AMP ACCUMULATION; RAT GRANULOSA-CELLS; PHORBOL ESTER; SIGNAL TRANSDUCTION; CULTURED GRANULOSA; C-FOS; PROTEIN; BINDING; CAMP	The epidermal growth factor (EGF) binding sites on bovine luteal cell membrane have been characterized in detail, and evidence has been obtained for a direct stimulatory effect of EGF on membrane-associated adenylate cyclase activity. The membrane fraction prepared showed the presence of high affinity (K(a) = 1.2 +/- 0.7 x 10(11) m-1), specific, and saturable EGF receptors of M(r) = 170,000. The EGF receptors underwent rapid autophosphorylation and down-regulation following treatment of the cells with EGF. Treatment of the cells with 4-beta-phorbol 12-myristate 13-acetate resulted in a diminished binding of I-125-EGF to the receptors. When luteal cells were preincubated with EGF, both basal and forskolin-stimulated adenylate cyclase activity was increased severalfold. This enhancement of the adenylate cyclase activity was dependent upon the duration of the exposure to EGF and on the concentration of the growth factor. An optimal enhancement was observed when the cells were preincubated with 10 ng/ml EGF for 10-15 min. Furthermore, when the membrane fraction prepared from luteal cells was preincubated in vitro with EGF, a similar dose-related and time-dependent increase in basal, as well as forskolin-stimulated, adenylate cyclase activity was observed. These results demonstrate that luteal cell adenylate cyclase activity is finely regulated by EGF. Such a direct interaction between EGF and membrane-associated adenylate cyclase has not been previously recognized.	INST HORMONE & FERTIL RES,GRANDWEG 64,W-2000 HAMBURG 54,GERMANY									BALL RL, 1990, J BIOL CHEM, V265, P12836; BENDELL JJ, 1990, ENDOCRINOLOGY, V127, P533, DOI 10.1210/endo-127-2-533; BOSCH F, 1986, BIOCHEM J, V239, P523, DOI 10.1042/bj2390523; BOUHELAL R, 1985, J BIOL CHEM, V260, P901; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAVO R, 1987, CELL, V48, P251, DOI 10.1016/0092-8674(87)90428-4; BRUNSWIG B, 1986, ENDOCRINOLOGY, V118, P743, DOI 10.1210/endo-118-2-743; BUDNIK LT, 1990, MOL CELL ENDOCRINOL, V69, P245, DOI 10.1016/0303-7207(90)90018-4; BUDNIK LT, 1987, MOL CELL ENDOCRINOL, V54, P51, DOI 10.1016/0303-7207(87)90139-0; CARPENTER G, 1990, J BIOL CHEM, V265, P7709; DARFLER FJ, 1982, J BIOL CHEM, V257, P1901; DAVIS RJ, 1985, CANCER CELL, V3, P101; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; GILL GN, 1987, MOL CELL ENDOCRINOL, V51, P169, DOI 10.1016/0303-7207(87)90027-X; GLANNEY JR, 1988, J IMMUNOL METHODS, V109, P277; GOSPODAROWICZ D, 1979, ENDOCRINOLOGY, V104, P757, DOI 10.1210/endo-104-3-757; HAFEZ MM, 1990, ENDOCRINOLOGY, V127, P394, DOI 10.1210/endo-127-1-394; IWASHITA S, 1990, J BIOL CHEM, V265, P10702; JONES PBC, 1982, J BIOL CHEM, V257, P1268; KIRCHICK HJ, 1984, REGULATION TARGET CE, P87; KNECHT M, 1983, J BIOL CHEM, V258, P2789; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAYES ELV, 1984, EMBO J, V3, P531, DOI 10.1002/j.1460-2075.1984.tb01842.x; MONDSCHEIN JS, 1981, SCIENCE, V211, P1179, DOI 10.1126/science.6258228; NORTHWOOD IC, 1989, J BIOL CHEM, V264, P5746; RAN W, 1986, P NATL ACAD SCI USA, V83, P8216, DOI 10.1073/pnas.83.21.8216; RICHARDS JS, 1987, RECENT PROG HORM RES, V43, P231; ROZENGURT E, 1981, P NATL ACAD SCI-BIOL, V78, P4392, DOI 10.1073/pnas.78.7.4392; SEAMON K, 1981, J BIOL CHEM, V256, P9799; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VLODAVSKY I, 1978, J BIOL CHEM, V253, P3744; WILLEY KP, 1989, J BIOL CHEM, V264, P19716	32	39	39	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 25	1991	266	21					13908	13913						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY027	1713210				2022-12-27	WOS:A1991FY02700071
J	AMITAY, R; BARNUN, S; HAIMOVICH, J; RABINOVICH, E; SHACHAR, I				AMITAY, R; BARNUN, S; HAIMOVICH, J; RABINOVICH, E; SHACHAR, I			POSTTRANSLATIONAL REGULATION OF IGM EXPRESSION IN LYMPHOCYTES-B - SELECTIVE NONLYSOSOMAL DEGRADATION OF ASSEMBLED SECRETORY IGM IS TEMPERATURE-DEPENDENT AND OCCURS PRIOR TO THE TRANS-GOLGI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN BINDING-PROTEIN; CELL ANTIGEN RECEPTOR; IMMUNOGLOBULIN-M MOLECULES; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; MESSENGER-RNAS; HEAVY-CHAINS; PRE-GOLGI; DISULFIDE ISOMERASE; LIGHT-CHAIN	B cells express on their surface the membrane form of IgM (mIgM). Upon differentiation, the resulting plasma cells synthesize and secrete large amounts of the secretory form of IgM (sIgM). Surprisingly, B lymphocytes synthesize an excess of secretory mu-chain over the expressed membrane mu-chain. However, the sIgM is degraded intracellularly, indicating regulation of IgM expression at the post-translational level. In the present report, we show that the assembly, maturation, and degradation of IgM in 38C B lymphocytes are highly accelerated above a certain threshold temperature. Furthermore, the degradation of sIgM is delayed and takes place by the time the maturation of mIgM in the trans-Golgi is almost completed. Neither chloroquine nor monensin has any effect on this degradation, demonstrating a nonlysosomal pre-trans-Golgi process. In addition, the degradation is of endoglycosidase H-sensitive assembled sIgM molecules. We conclude that the degradation of sIgM in 38C B lymphocytes is a postendoplasmic reticulum, pre-trans-Golgi process. We suggest that this degradation process plays a role in the post-translational regulation of expression of soluble lumenal sIgM.	TEL AVIV UNIV,GEORGE S WISE FAC LIFE SCI,DEPT BIOCHEM,IL-69978 TEL AVIV,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN MICROBIOL,IL-69978 TEL AVIV,ISRAEL	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine								ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; AMARA JF, 1989, J CELL BIOL, V109, P3315, DOI 10.1083/jcb.109.6.3315; BERGMAN Y, 1977, EUR J IMMUNOL, V7, P413, DOI 10.1002/eji.1830070702; BERGMAN Y, 1977, EUR J IMMUNOL, V7, P574, DOI 10.1002/eji.1830070815; BERGMAN Y, 1978, EUR J IMMUNOL, V8, P876, DOI 10.1002/eji.1830081210; BLATT C, 1981, EUR J IMMUNOL, V11, P65, DOI 10.1002/eji.1830110114; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BONIFACINO JS, 1989, J CELL BIOL, V109, P73, DOI 10.1083/jcb.109.1.73; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CALAME KL, 1985, ANNU REV IMMUNOL, V3, P159, DOI 10.1146/annurev.iy.03.040185.001111; CATTANEO A, 1987, EMBO J, V6, P2753, DOI 10.1002/j.1460-2075.1987.tb02569.x; CHEN C, 1988, J CELL BIOL, V107, P2149, DOI 10.1083/jcb.107.6.2149; CIECHANOVER A, 1989, TRENDS BIOCHEM SCI, V14, P483, DOI 10.1016/0968-0004(89)90180-1; COOK GP, 1988, MOL GENETICS IMMUNOG, V17, P153; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; DAVIS AC, 1988, EUR J IMMUNOL, V18, P1001, DOI 10.1002/eji.1830180705; DAVIS RA, 1990, J BIOL CHEM, V265, P10005; DULIS BH, 1983, J BIOL CHEM, V258, P2181; DULIS BH, 1982, J BIOL CHEM, V257, P4369; DUNN WA, 1980, J BIOL CHEM, V255, P5971; ESHHAR Z, 1979, J IMMUNOL, V122, P2430; FREEDMAN RB, 1984, TRENDS BIOCHEM SCI, V9, P438, DOI 10.1016/0968-0004(84)90152-X; GETHING MJ, 1986, CELL, V46, P939, DOI 10.1016/0092-8674(86)90076-0; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HENDERSHOT L, 1987, J CELL BIOL, V104, P761, DOI 10.1083/jcb.104.3.761; HOMBACH J, 1988, J EXP MED, V167, P652, DOI 10.1084/jem.167.2.652; HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x; HUBER C, 1976, CLIN EXP IMMUNOL, V25, P367; KEHRY M, 1980, CELL, V21, P393, DOI 10.1016/0092-8674(80)90476-6; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; KOSHLAND ME, 1985, ANNU REV IMMUNOL, V3, P425; KREIS TE, 1986, CELL, V46, P929, DOI 10.1016/0092-8674(86)90075-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAU MMH, 1989, J BIOL CHEM, V264, P21376; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; MALONEY DG, 1985, HYBRIDOMA, V4, P191, DOI 10.1089/hyb.1985.4.191; MARSH M, 1983, CELL, V32, P931, DOI 10.1016/0092-8674(83)90078-8; MATHER EL, 1984, CELL, V36, P329, DOI 10.1016/0092-8674(84)90226-5; MELCHERS F, 1974, EUR J IMMUNOL, V4, P181, DOI 10.1002/eji.1830040306; MILLER RA, 1982, NEW ENGL J MED, V306, P517, DOI 10.1056/NEJM198203043060906; MINAMI Y, 1987, P NATL ACAD SCI USA, V84, P2688, DOI 10.1073/pnas.84.9.2688; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; PARKHOUSE RM, 1971, BIOCHEM J, V123, P635, DOI 10.1042/bj1230635; PELHAM HRB, 1989, EMBO J, V8, P3171, DOI 10.1002/j.1460-2075.1989.tb08475.x; PEREK Y, 1983, J IMMUNOL, V131, P1600; PERRY RP, 1979, CELL, V18, P1333, DOI 10.1016/0092-8674(79)90243-5; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; ROTH RA, 1987, BIOCHEMISTRY-US, V26, P4179, DOI 10.1021/bi00388a001; ROTUNDO RL, 1989, J BIOL CHEM, V264, P3146; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; SATO R, 1990, J BIOL CHEM, V265, P11880; SCHIBLER U, 1978, CELL, V15, P1495, DOI 10.1016/0092-8674(78)90072-7; SIDMAN C, 1981, CELL, V23, P379, DOI 10.1016/0092-8674(81)90133-1; SITIA R, 1984, MOL IMMUNOL, V21, P709, DOI 10.1016/0161-5890(84)90023-3; SITIA R, 1988, MOL IMMUNOL, V25, P189, DOI 10.1016/0161-5890(88)90067-3; SITIA R, 1987, EMBO J, V6, P3969, DOI 10.1002/j.1460-2075.1987.tb02739.x; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; TARENTINO AL, 1974, J BIOL CHEM, V249, P811; TARTAKOFF A, 1979, J CELL BIOL, V83, P284, DOI 10.1083/jcb.83.2.284; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; VITETTA ES, 1975, J EXP MED, V141, P206, DOI 10.1084/jem.141.1.206; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WHITESELL RR, 1989, BIOCHEMISTRY-US, V28, P5618, DOI 10.1021/bi00439a042; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501	67	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12568	12573						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712024				2022-12-27	WOS:A1991FV18000073
J	CHAKRABARTI, R; ENGLEMAN, EG				CHAKRABARTI, R; ENGLEMAN, EG			INTERRELATIONSHIPS BETWEEN MEVALONATE METABOLISM AND THE MITOGENIC SIGNALING PATHWAY IN LYMPHOCYTE-T PROLIFERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; PROTEIN KINASE-C; LOW-DENSITY LIPOPROTEIN; STEROL SYNTHESIS; CULTURED-CELLS; DNA-SYNTHESIS; POSTTRANSLATIONAL MODIFICATION; MOUSE LYMPHOCYTES; ACID METABOLISM; LAMIN-B	Upon stimulation with antigen or antibodies directed at the CD3.T cell receptor complex, T lymphocytes undergo a series of biochemical events that result in DNA synthesis and cellular proliferation. The purpose of the current study was to explore the role of mevalonic acid and its metabolites in this process. Stimulation of freshly isolated human T cells with immobilized anti-CD3 monoclonal antibody (mAb) results in the induction of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase message, with maximum induction occurring at 24 h of culture, approximately 12 h before the onset of DNA synthesis. Protein kinase C (PKC) probably mediates this induction, as H7, which inhibits PKC and cyclic nucleotide-dependent protein kinases, but not HA1004, which inhibits all of these protein kinases except PKC, completely abrogates the appearance of HMG-CoA reductase message. The importance of HMG-CoA reductase induction and mevalonate production in cell cycle progression was demonstrated by the observation that either 25-hydroxycholesterol, which inhibits this induction, or lovastatin, a competitive inhibitor of HMG-CoA reductase, inhibited anti-CD3-induced T cell mitogenesis in a dose-dependent manner. The presence of lovastatin during the first 24-36 h of culture results in a progressive delay of cell cycle progression, whereas this agent, when present only for the first 12 h of culture, had no effect on T cell proliferation. These results suggest that mevalonate is required for cell cycle progression from mid-G1 into late G1. Exogenous mevalonate overcomes the antiproliferative effect of lovastatin but not of 25-hydroxycholesterol. Since 25-hydroxycholesterol suppresses the metabolism of mevalonic acid at multiple points, this result suggests that one or more metabolites of mevalonate, rather than mevalonate itself, plays an essential role in cell cycle progression. One metabolite of mevalonate, farnesol pyrophosphate, may play such a role, since free farnesol suppresses anti-CD3 mAb-induced T cell proliferation in a concentration-dependent manner. In induction of T cell mitogenesis with anti-CD3 mAb is associated with PKC-dependent induction of HMG-CoA reductase which, in turn, leads to the generation of mevalonic acid and its metabolites, one or more of which play a requisite role in cell cycle progression.	STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,STANFORD,CA 94305	Stanford University					NATIONAL CANCER INSTITUTE [R37CA024607, R01CA024607] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL033811] Funding Source: NIH RePORTER; NCI NIH HHS [CA24607] Funding Source: Medline; NHLBI NIH HHS [HL33811] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AUSUBEL FM, CURRENT PROTOCOLS MO, V1; AUWERX JH, 1989, P NATL ACAD SCI USA, V86, P1133, DOI 10.1073/pnas.86.4.1133; BECK LA, 1988, J CELL BIOL, V107, P1307, DOI 10.1083/jcb.107.4.1307; BECK LA, 1990, J CELL BIOL, V110, P1489, DOI 10.1083/jcb.110.5.1489; BJORKHEM I, 1974, J BIOL CHEM, V249, P2528; CASEY PJ, 1989, P NATL ACAD SCI USA, V86, P8323, DOI 10.1073/pnas.86.21.8323; CHANG TY, 1983, ENZYMES, V16, P163; CHEN HW, 1975, P NATL ACAD SCI USA, V72, P1950, DOI 10.1073/pnas.72.5.1950; CHEN HW, 1974, NATURE, V251, P419, DOI 10.1038/251419a0; CHEN HW, 1979, J BIOL CHEM, V254, P715; CHEN SSH, 1979, J CELL PHYSIOL, V100, P147, DOI 10.1002/jcp.1041000115; CORNELL R, 1977, EXP CELL RES, V109, P299, DOI 10.1016/0014-4827(77)90009-X; CRISSMAN HA, 1987, TECHNIQUES CELL CYCL, P163; DAMLE NK, 1985, J IMMUNOL, V135, P1724; DOYLE JW, 1988, J CELL PHYSIOL, V137, P133, DOI 10.1002/jcp.1041370116; FARNSWORTH CC, 1989, J BIOL CHEM, V264, P20422; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; HABENICHT AJR, 1980, J BIOL CHEM, V255, P5134; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; JACKSON JH, 1990, P NATL ACAD SCI USA, V87, P3042, DOI 10.1073/pnas.87.8.3042; KANDUTSCH AA, 1977, J BIOL CHEM, V252, P409; KANEKO I, 1978, EUR J BIOCHEM, V87, P313; LARSSON O, 1987, J CELL PHYSIOL, V133, P163, DOI 10.1002/jcp.1041330121; LEONARD S, 1990, J BIOL CHEM, V265, P5157; LINCH DC, 1987, IMMUNOL REV, V95, P137, DOI 10.1111/j.1600-065X.1987.tb00503.x; LUSKEY KL, 1985, J BIOL CHEM, V260, P271; MALTESE WA, 1990, J BIOL CHEM, V265, P2148; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARKS DR, 1979, P NATL ACAD SCI USA, V76, P1962, DOI 10.1073/pnas.76.4.1962; PERKINS SL, 1982, BIOCHIM BIOPHYS ACTA, V711, P83, DOI 10.1016/0005-2760(82)90012-1; QUESNEYHUNEEUS V, 1979, P NATL ACAD SCI USA, V76, P5056, DOI 10.1073/pnas.76.10.5056; QUESNEYHUNEEUS V, 1980, P NATL ACAD SCI USA, V77, P5842; REISS Y, 1990, CELL, V62, P81, DOI 10.1016/0092-8674(90)90242-7; SCHABER MD, 1990, J BIOL CHEM, V265, P14701; SCHAFER WR, 1989, SCIENCE, V245, P379, DOI 10.1126/science.2569235; SCHMIDT RA, 1984, J BIOL CHEM, V259, P175; SINENSKY M, 1985, P NATL ACAD SCI USA, V82, P3257, DOI 10.1073/pnas.82.10.3257; WACHTEL N, 1968, J BIOL CHEM, V243, P5207; WILKIN DJ, 1990, J BIOL CHEM, V265, P4607; WITTE LD, 1985, ANN NY ACAD SCI, V454, P261, DOI 10.1111/j.1749-6632.1985.tb11866.x; WOLDA SL, 1988, J BIOL CHEM, V263, P5997	43	117	117	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	1991	266	19					12216	12222						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FV180	1712015				2022-12-27	WOS:A1991FV18000021
J	SMITH, JW; CHERESH, DA				SMITH, JW; CHERESH, DA			LABELING OF INTEGRIN-ALPHA-V-BETA-3 WITH CO-58(III) - EVIDENCE OF METAL-ION COORDINATION SPHERE INVOLVEMENT IN LIGAND-BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note							GLYCOPROTEIN-IIB-IIIA; VITRONECTIN RECEPTOR; ADHESION; INTEGRIN; PROTEIN; SUBUNIT; SITE; IDENTIFICATION; FIBRINOGEN; DOMAIN	Integrin-mediated cell adhesion to the extracellular matrix is divalent metal ion-dependent; however, a demonstration of the interaction between native integrins and divalent metal ions is lacking. Here we provide direct evidence that the vitronectin receptor (VNR) is a metalloprotein. The unique electron shell of Co(II), an ion which we show supports ligand recognition by VNR, enables its oxidative conversion to inert Co(III). This property facilitated "affinity labeling" of VNR with Co-58(III) by oxidation of the metal ion in situ (i.e. in position). An average of 3.5 +/- 0.5 mol of cobalt were incorporated per mol of VNR. The ability of VNR to bind metal ions was independently confirmed by examining the interaction between VNR and Mn2+ under native conditions. The apparent high affinity between VNR and Mn2+ allowed us to observe the specific binding between Mn-54(2+) and VNR by equilibrium gel filtration studies. Interestingly, the oxidative incorporation of Co(III) into VNR specifically blocked ligand binding, suggesting that the coordination sphere of metal ion bound to VNR is a critical determinant in integrin-ligand recognition. Furthermore, Mn2+ abolished the oxidative affinity labeling of VNR with Co(III) and consequently blocked the inactivation of VNR by in situ incorporation of Co(III). Thus, Mn2+ and CO2+, bind to the same or mutually exclusive sites on VNR. These observations provide the first demonstration that an integrin, specifically VNR, is a metalloprotein and demonstrate a functional link between the coordination sphere of the bound metal ion and ligand recognition by this receptor.	Scripps Res Inst, RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	Scripps Research Institute					NATIONAL CANCER INSTITUTE [R37CA050286, R01CA050286, R01CA045726] Funding Source: NIH RePORTER; NCI NIH HHS [CA50286, CA45726] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BUCK CA, 1986, J CELL BIOL, V103, P2421, DOI 10.1083/jcb.103.6.2421; CHARO IF, 1990, J CELL BIOL, V111, P275; CHERESH DA, 1987, J BIOL CHEM, V262, P17703; DSOUZA SE, 1990, J BIOL CHEM, V265, P3440; FITZGERALD LA, 1987, BIOCHEMISTRY-US, V26, P8158, DOI 10.1021/bi00399a021; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GAILIT J, 1988, J BIOL CHEM, V263, P12927; GREEN LM, 1989, P NATL ACAD SCI USA, V86, P4047, DOI 10.1073/pnas.86.11.4047; HADDY AE, 1989, BIOCHEMISTRY-US, V28, P3664, DOI 10.1021/bi00435a007; HUMMEL JP, 1962, BIOCHIM BIOPHYS ACTA, V63, P530, DOI 10.1016/0006-3002(62)90124-5; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P18525; LOFTUS JC, 1990, SCIENCE, V249, P915, DOI 10.1126/science.2392682; PHILLIPS DR, 1988, BLOOD, V71, P831; PYTELA R, 1987, METHOD ENZYMOL, V144, P475; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANTORO SA, 1986, CELL, V46, P913, DOI 10.1016/0092-8674(86)90073-5; SMITH JW, 1990, J BIOL CHEM, V265, P2168; SMITH JW, 1990, J BIOL CHEM, V265, P12267; SMITH JW, 1990, J BIOL CHEM, V265, P11008; SMITH JW, 1988, J BIOL CHEM, V263, P18726; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TAUBE H, 1952, CHEM REV, V50, P69, DOI 10.1021/cr60155a003; VANWART HE, 1988, METHOD ENZYMOL, V158, P95; WRIGHT JK, 1976, BIOCHEMISTRY-US, V15, P3704, DOI 10.1021/bi00662a010; WRIGHT JK, 1976, BIOCHEM BIOPH RES CO, V72, P1456; WU CW, 1977, BIOCHEMISTRY-US, V16, P5449, DOI 10.1021/bi00644a008; YATAHOGO T, 1988, CELL STRUCT FUNCT, V13, P281	28	53	54	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 25	1991	266	18					11429	11432						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FT762	1711032				2022-12-27	WOS:A1991FT76200007
J	HESSION, C; TIZARD, R; VASSALLO, C; SCHIFFER, SB; GOFF, D; MOY, P; CHIROSSO, G; LUHOWSKYJ, S; LOBB, R; OSBORN, L				HESSION, C; TIZARD, R; VASSALLO, C; SCHIFFER, SB; GOFF, D; MOY, P; CHIROSSO, G; LUHOWSKYJ, S; LOBB, R; OSBORN, L			CLONING OF AN ALTERNATE FORM OF VASCULAR CELL-ADHESION MOLECULE-1 (VCAM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note								Vascular cell adhesion molecule-1 (VCAM1) of the Ig superfamily is induced by the inflammatory cytokines interleukin-1 and tumor necrosis factor on human umbilical vein endothelial cells (HUVECs). It binds to mononuclear leukocytes via the integrin VLA-4. We have cloned and expressed a cDNA encoding a new form of human VCAM1 containing an additional Ig homologous domain inserted between the third and fourth domains of the original six-domain protein. Characterization of mRNA from HUVECs from three individuals at various time points after induction by tumor necrosis factor indicates that both the long and short VCAM1 mRNAs are made by all three individuals, with the long form predominating quantitatively. Immunoprecipitation of VCAM1 protein from cos7 cells transfected with each cDNA and from cultured endothelial cells followed by deglycosylation suggests that the long form is the major form found on endothelium. The two forms may result from alternate splicing of a precursor mRNA. Both forms support adhesion of VLA-4-expressing cell lines.	BIOGEN INC, 14 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA	Biogen								BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; CARLOS TM, 1990, BLOOD, V76, P965; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HESSION C, 1990, P NATL ACAD SCI USA, V87, P1673, DOI 10.1073/pnas.87.5.1673; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; Maxam A M, 1980, Methods Enzymol, V65, P499; NEWMAN PJ, 1988, J CLIN INVEST, V82, P739, DOI 10.1172/JCI113656; OSBORN L, 1989, CELL, V59, P1203, DOI 10.1016/0092-8674(89)90775-7; RICE GE, 1990, J EXP MED, V171, P1369, DOI 10.1084/jem.171.4.1369; RICE GE, 1989, SCIENCE, V246, P1303, DOI 10.1126/science.2588007	11	126	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					6682	6685						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707873				2022-12-27	WOS:A1991FG72700007
J	LEBLOND, L; MARCEL, YL				LEBLOND, L; MARCEL, YL			THE AMPHIPATHIC ALPHA-HELICAL REPEATS OF APOLIPOPROTEIN-A-I ARE RESPONSIBLE FOR BINDING OF HIGH-DENSITY-LIPOPROTEINS TO HEPG2 CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ADIPOCYTE PLASMA-MEMBRANES; ESTER TRANSFER PROTEIN; HIGH-AFFINITY BINDING; SMOOTH-MUSCLE CELLS; MONOCLONAL-ANTIBODIES; RAT-LIVER; RECEPTOR-BINDING; SELECTIVE UPTAKE; IMMUNOCHEMICAL HETEROGENEITY	Nine monoclonal antibodies (mAbs) against apoA-I reacting with distinct but overlapping epitopes covering more than 90% of the sequence have been used to block the interaction of I-125-labeled high density lipoprotein (I-125-HDL) with HepG2 cells in order to delineate the cell binding domain of apolipoprotein A-I (apoA-I). While 2 mAbs reacting with epitopes exclusively localized in the N-terminal region (residues 1 to 86) enhanced slightly association of I-125-HDL, all other mAbs, which react with epitopes localized in the regions of amphipathic alpha-helical repeats, inhibited that association by 9 to 15%. Although this inhibition is not significant compared to the effect of an irrelevant mAb, combination of these mAbs could significantly inhibit the association of I-125-HDL (32 to 43%) as could polyclonal antibodies (up to 95%). These results are compatible with the concept of HDL binding to these cells via the nonexclusive interaction of each of the amphipathic alpha-helical repeats of apoA-I. When the same approach was applied to block the association of H-3-cholesteryl ether (CE)-labeled HDL to HepG2 cells, each anti-apoA-I could inhibit by 15 to 25% the cellular association of cholesteryl ether while mAbs in combination or polyclonal antibodies could inhibit this association up to 45% or 60%, respectively. The cholesteryl ether radioactivity that remained associated with the cells (40%) in the presence of polyclonal antibodies could be effectively blocked by addition of an antibody against the receptor binding domain of apoE (1D7). Therefore, the differential cellular association of cholesteryl ether compared to apolipoprotein can be explained by the presence of apoE secreted by HepG2 and apoE or apoB/E receptors. Thus, we conclude that the optimum uptake of both cholesteryl ether and apoA-I of HDL by cells requires the accessibility of the entire apoA-I and the cooperative binding of the amphipathic alpha-helical repeats to HepG2 cell membranes. This type of interaction would explain the competitive binding observed for apoA-I, -A-II, and -A-IV by others.			LEBLOND, L (corresponding author), CLIN RES INST MONTREAL, LIPOPROT METAB LAB, 110 PINE AVE W, MONTREAL H2W 1R7, QUEBEC, CANADA.							ARBEENY CM, 1987, BIOCHIM BIOPHYS ACTA, V917, P9, DOI 10.1016/0005-2760(87)90277-3; BACHORIK PS, 1985, ARTERIOSCLEROSIS, V5, P142, DOI 10.1161/01.ATV.5.2.142; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V149, P545, DOI 10.1016/0006-291X(87)90402-5; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BETARD C, 1987, J CLIN CHEM CLIN BIO, V25, P893; BIESBROECK R, 1983, J CLIN INVEST, V71, P525, DOI 10.1172/JCI110797; BILHEIMER DW, 1972, BIOCHIM BIOPHYS ACTA, V260, P212, DOI 10.1016/0005-2760(72)90034-3; BRINTON EA, 1986, J BIOL CHEM, V261, P495; CASTRO GR, 1988, BIOCHEMISTRY-US, V27, P25, DOI 10.1021/bi00401a005; CHACKO GK, 1984, BIOCHIM BIOPHYS ACTA, V795, P417, DOI 10.1016/0005-2760(84)90093-6; CHACKO GK, 1987, J LIPID RES, V28, P332; CHACKO GK, 1985, J LIPID RES, V26, P745; CHEN CH, 1986, BIOCHIM BIOPHYS ACTA, V877, P433; CHEN CH, 1982, J LIPID RES, V23, P680; CHEUNG MC, 1988, J LIPID RES, V29, P15; CHEUNG MC, 1987, J LIPID RES, V28, P913; CURTISS LK, 1985, J BIOL CHEM, V260, P2982; DASHTI N, 1985, BIOCHIM BIOPHYS ACTA, V833, P100, DOI 10.1016/0005-2760(85)90257-7; DAVIES DR, 1988, J BIOL CHEM, V263, P10541; DESPRES JP, 1988, AM J PHYSIOL, V254, pE667, DOI 10.1152/ajpendo.1988.254.5.E667; EISENBERG S, 1984, J LIPID RES, V25, P1017; FAUST RA, 1987, ARTERIOSCLEROSIS, V7, P267, DOI 10.1161/01.ATV.7.3.267; FIDGE NH, 1985, J BIOL CHEM, V260, P3570; FIDGE NH, 1986, FEBS LETT, V199, P265, DOI 10.1016/0014-5793(86)80492-6; FIDGE NH, 1983, BIOCHIM BIOPHYS ACTA, V753, P14, DOI 10.1016/0005-2760(83)90092-9; FIELDING C J, 1981, Proceedings of the National Academy of Sciences of the United States of America, V78, P3911, DOI 10.1073/pnas.78.6.3911; FONG BS, 1987, BIOCHIM BIOPHYS ACTA, V920, P105, DOI 10.1016/0005-2760(87)90249-9; FONG BS, 1985, J CLIN INVEST, V75, P1804, DOI 10.1172/JCI111893; GHISELLI G, 1990, BIOCHIM BIOPHYS ACTA, V1044, P173, DOI 10.1016/0005-2760(90)90234-O; GLASS C, 1985, J BIOL CHEM, V260, P744; Glomset J A, 1973, Adv Lipid Res, V11, P1; GRAHAM DL, 1987, J BIOL CHEM, V262, P7439; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; HERZYK E, 1988, BIOCHIM BIOPHYS ACTA, V962, P131, DOI 10.1016/0005-2760(88)90104-X; HOEG JM, 1985, ARTERIOSCLEROSIS, V5, P228, DOI 10.1161/01.ATV.5.3.228; HWANG JL, 1985, J BIOL CHEM, V260, P5660; JOHNSON WJ, 1986, J BIOL CHEM, V261, P5766; JURGENS G, 1989, J BIOL CHEM, V264, P8549; KARLIN JB, 1987, J BIOL CHEM, V262, P12557; KRONVALL G, 1970, J IMMUNOL, V104, P140; LEITERSDORF E, 1986, BIOCHIM BIOPHYS ACTA, V878, P320, DOI 10.1016/0005-2760(86)90239-0; LI WH, 1988, J LIPID RES, V29, P245; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACFARLANE AS, 1958, NATURE, V182, P53; MARCEL YL, 1987, J LIPID RES, V28, P768; MARCEL YL, 1991, IN PRESS J BIOL CHEM; MARCOVINA S, 1990, J LIPID RES, V31, P375; MCCALL RM, 1988, J LIPID RES, V29, P1127; MENDEL CM, 1988, BIOCHIM BIOPHYS ACTA, V961, P188, DOI 10.1016/0005-2760(88)90113-0; MENDEL CM, 1986, BIOCHIM BIOPHYS ACTA, V875, P59, DOI 10.1016/0005-2760(86)90011-1; MENDEL CM, 1988, J BIOL CHEM, V263, P1314; MILNE R, 1987, MOL IMMUNOL, V24, P127, DOI 10.1016/0161-5890(87)90084-8; MILNE R, 1989, J BIOL CHEM, V264, P19754; MILNE RW, 1981, J CLIN INVEST, V68, P111, DOI 10.1172/JCI110225; MILNE RW, 1983, ARTERIOSCLEROSIS, V3, P23, DOI 10.1161/01.ATV.3.1.23; MILTHORP P, 1986, HUMAN APOLIPOPROTEIN, P103; MITCHEL YB, 1987, BIOCHIM BIOPHYS ACTA, V917, P324, DOI 10.1016/0005-2760(87)90137-8; MONACO L, 1987, EMBO J, V6, P3253, DOI 10.1002/j.1460-2075.1987.tb02643.x; MULLER R, 1980, J IMMUNOL METHODS, V34, P3435; PERRET BP, 1987, EUR J BIOCHEM, V162, P279, DOI 10.1111/j.1432-1033.1987.tb10597.x; PETIT E, 1987, BIOCHIM BIOPHYS ACTA, V919, P287, DOI 10.1016/0005-2760(87)90268-2; PIO F, 1988, BIOCHIM BIOPHYS ACTA, V959, P160, DOI 10.1016/0005-2760(88)90027-6; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; RAJAN VP, 1988, BIOCHIM BIOPHYS ACTA, V959, P206, DOI 10.1016/0005-2760(88)90192-0; RENNINGER F, 1987, J LIPID RES, V28, P1313; RIFICI VA, 1984, J BIOL CHEM, V259, P3814; RINNINGER F, 1989, J BIOL CHEM, V264, P6111; ROBERTS DCK, 1985, BIOCHEM J, V226, P319, DOI 10.1042/bj2260319; SCHMITZ G, 1985, EMBO J, V4, P613, DOI 10.1002/j.1460-2075.1985.tb03674.x; SEGREST JP, 1977, BIOPOLYMERS, V16, P2053, DOI 10.1002/bip.1977.360160916; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; STEINBERG J, 1986, NEW STATESMAN SOC, V75, P151; STEINMETZ A, 1990, J BIOL CHEM, V265, P7859; SVIRIDOV DD, 1986, METABOLISM, V35, P588, DOI 10.1016/0026-0495(86)90162-9; TABAS I, 1984, J BIOL CHEM, V259, P3897; TERPSTRA AHM, 1981, ANAL BIOCHEM, V111, P149, DOI 10.1016/0003-2697(81)90243-8; THRIFT RN, 1986, J LIPID RES, V27, P236; TSAO BP, 1982, J BIOL CHEM, V257, P5222; WEECH PK, 1988, J LIPID RES, V29, P85; WEISGRABER KH, 1983, J BIOL CHEM, V258, P2348	80	57	61	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6058	6067						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706710				2022-12-27	WOS:A1991FE37300012
J	WATERLOH, K; FOX, KR				WATERLOH, K; FOX, KR			THE EFFECTS OF ACTINOMYCIN ON THE STRUCTURE OF DAN.DTN AND (DA-DT)N REGIONS SURROUNDING ITS GC BINDING-SITE - A FOOTPRINTING STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNASE-I; MICROCOCCAL NUCLEASE; SEQUENCE SPECIFICITY; DIETHYL PYROCARBONATE; ALTERNATING STRUCTURE; CONFORMATION; EQUILIBRIUM; ANTIBIOTICS; ECHINOMYCIN; NETROPSIN	The effect of actinomycin on the structure of DNA fragments containing the sequences (AT)5GC(AT)5, (TA)5GC(TA)5, A9GCT9, and T9GCA9, cloned into the SmaI site of pUC19, has been studied by footprinting analysis using a variety of probes known to be sensitive to DNA structure. In each case clear footprints are found around the central GC sites. DNase I cleavage of fragments containing alternating AT shows much greater cutting at ApT than TpA; in the presence of actinomycin, although this preference is retained, there is a large increase in the cutting efficiency at the closest TpA steps. DNase I cleavage in homopolymeric regions of A and T, which is normally very poor, is greatly enhanced by drug binding. With T9GCA9 the enhancements are propagated in both directions, whereas changes are only found to the 5'-side of the GC site in A9GCT9. The results are confirmed by similar experiments with micrococcal nuclease and DNase II. Small increases in sensitivity to diethylpyrocarbonate are found at adenines proximal to GC. Experiments performed at 4-degrees-C suggest that conformational changes are a necessary consequence of drug binding.	UNIV SOUTHAMPTON,DEPT PHYSIOL & PHARMACOL,BASSETT CRESCENT E,SOUTHAMPTON SO9 3TU,HANTS,ENGLAND	University of Southampton					Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARNOTT S, 1983, NUCLEIC ACIDS RES, V11, P4141, DOI 10.1093/nar/11.12.4141; AYMAMI J, 1989, NUCLEIC ACIDS RES, V17, P3229, DOI 10.1093/nar/17.8.3229; BRESLOFF JL, 1981, BIOCHEMISTRY-US, V20, P3547, DOI 10.1021/bi00515a038; BURD JF, 1975, J BIOL CHEM, V250, P6002; BURD JF, 1975, J BIOL CHEM, V250, P5109; CHAIRES JB, 1987, BIOCHEMISTRY-US, V26, P8227, DOI 10.1021/bi00399a031; DINGWALL C, 1981, NUCLEIC ACIDS RES, V9, P2659, DOI 10.1093/nar/9.12.2659; DREW HR, 1984, J MOL BIOL, V176, P535, DOI 10.1016/0022-2836(84)90176-1; DREW HR, 1984, CELL, V37, P491, DOI 10.1016/0092-8674(84)90379-9; FLICK JT, 1986, J MOL BIOL, V190, P619, DOI 10.1016/0022-2836(86)90247-0; FOX KR, 1986, BIOCHEMISTRY-US, V25, P4349, DOI 10.1021/bi00363a026; FOX KR, 1987, NUCLEIC ACIDS RES, V15, P491, DOI 10.1093/nar/15.2.491; FOX KR, 1982, BIOCHIM BIOPHYS ACTA, V696, P315, DOI 10.1016/0167-4781(82)90063-X; FOX KR, 1988, NUCLEIC ACIDS RES, V16, P2063, DOI 10.1093/nar/16.5.2063; FOX KR, 1984, NUCLEIC ACIDS RES, V12, P9271, DOI 10.1093/nar/12.24.9271; FOX KR, 1987, BIOCHIM BIOPHYS ACTA, V909, P145, DOI 10.1016/0167-4781(87)90036-4; HOGAN M, 1979, NATURE, V278, P521, DOI 10.1038/278521a0; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P2643, DOI 10.1093/nar/9.12.2643; HUANG YQ, 1988, NUCLEIC ACIDS RES, V16, P11125, DOI 10.1093/nar/16.23.11125; JEPPESEN C, 1988, FEBS LETT, V231, P172, DOI 10.1016/0014-5793(88)80725-7; KLUG A, 1979, J MOL BIOL, V131, P669, DOI 10.1016/0022-2836(79)90196-7; KRUGH TR, 1977, BIOCHEMISTRY-US, V16, P740, DOI 10.1021/bi00623a028; LANE MJ, 1987, NUCLEIC ACIDS RES, V15, P839, DOI 10.1093/nar/15.2.839; LANE MJ, 1983, P NATL ACAD SCI-BIOL, V80, P3260, DOI 10.1073/pnas.80.11.3260; LEE JS, 1978, BIOCHEM J, V173, P128; LOW CML, 1984, NUCLEIC ACIDS RES, V12, P4865, DOI 10.1093/nar/12.12.4865; MCCLELLAN JA, 1986, NUCLEIC ACIDS RES, V14, P9291, DOI 10.1093/nar/14.23.9291; McLean M J, 1988, J Mol Recognit, V1, P138, DOI 10.1002/jmr.300010307; MENDEL D, 1987, P NATL ACAD SCI USA, V84, P910, DOI 10.1073/pnas.84.4.910; MULLER W, 1968, J MOL BIOL, V35, P251, DOI 10.1016/S0022-2836(68)80024-5; NELSON HCM, 1987, NATURE, V330, P221, DOI 10.1038/330221a0; PORTUGAL J, 1988, NUCLEIC ACIDS RES, V16, P3655, DOI 10.1093/nar/16.9.3655; SCAMROV AV, 1983, FEBS LETT, V164, P97, DOI 10.1016/0014-5793(83)80027-1; SNYDER JG, 1989, P NATL ACAD SCI USA, V86, P3968, DOI 10.1073/pnas.86.11.3968; Sobell H M, 1973, Prog Nucleic Acid Res Mol Biol, V13, P153, DOI 10.1016/S0079-6603(08)60103-8; SOBELL HM, 1972, J MOL BIOL, V68, P21, DOI 10.1016/0022-2836(72)90259-8; SUCK D, 1988, NATURE, V332, P464, DOI 10.1038/332464a0; SUCK D, 1986, NATURE, V321, P620, DOI 10.1038/321620a0; SUGGS JW, 1986, NUCLEIC ACIDS RES, V14, P3703; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; WARD B, 1988, BIOCHEMISTRY-US, V27, P1198, DOI 10.1021/bi00404a020; WARD B, 1988, NUCLEIC ACIDS RES, V16, P1359; WARING M, 1970, Journal of Molecular Biology, V54, P247, DOI 10.1016/0022-2836(70)90429-8; WATERLOH K, 1990, ANTI-CANCER DRUG DES, V5, P89; WELLS RD, 1970, J MOL BIOL, V49, P319, DOI 10.1016/0022-2836(70)90248-2; WINKLE SA, 1981, NUCLEIC ACIDS RES, V9, P3175, DOI 10.1093/nar/9.13.3175	46	20	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6381	6388						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706717				2022-12-27	WOS:A1991FE37300058
J	KOBAYASHI, S; GOTO, S; ANZAI, K				KOBAYASHI, S; GOTO, S; ANZAI, K			BRAIN-SPECIFIC SMALL RNA TRANSCRIPT OF THE IDENTIFIER SEQUENCES IS PRESENT AS A 10-S RIBONUCLEOPROTEIN PARTICLE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYADENYLATE-BINDING-PROTEIN; MESSENGER-RNA; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; ID SEQUENCE; NUCLEAR-RNA; CDNA; CONSERVATION; ELEMENT; INVIVO	BC-1 RNA is a small RNA transcript of the identifier repetitive sequences present in rodent genomes. The RNA has been reported to be specific to the brain and confined to the cytoplasm. The RNA level increases during the 1st month after birth. To understand its cytoplasmic function, it seems important to examine whether BC-1 RNA is present as an RNP. It is believed that the protein component may govern the functions of BC-1 RNA in the brain cells. In the present report, we have demonstrated that BC-1 RNA is not free but complexed with proteins to form a 10 S RNP in the cytoplasm. We have also shown that the 10 S RNP is not associated with cytoplasmic structures such as polysomes/ribosomes or microsomes. The buoyant density of the RNP was 1.26 g/cm3 in metrizamide. Furthermore, some of the protein components were shown to be in direct contact with RNA, since photo-cross-linking adducts of protein to BC-1 RNA were identified upon UV irradiation of the 10 S BC-1 RNP.	NIHON UNIV,COLL SCI & TECHNOL,DEPT BIOCHEM,KANDASURUGADAI,CHIYODA KU,TOKYO 101,JAPAN; TOHO UNIV,SCH PHARMACEUT SCI,DEPT BIOCHEM,FUNABASHI,CHIBA 274,JAPAN	Nihon University; Toho University								ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; ANZAI K, 1987, MECH AGEING DEV, V39, P129, DOI 10.1016/0047-6374(87)90004-2; ANZAI K, 1986, J NEUROCHEM, V47, P673; ANZAI K, 1988, NEUROSCI LETT, V89, P246, DOI 10.1016/0304-3940(88)90389-8; ANZAI K, 1987, MOL BRAIN RES, V2, P43, DOI 10.1016/0169-328X(87)90019-2; BLOBEL G, 1973, P NATL ACAD SCI USA, V70, P924, DOI 10.1073/pnas.70.3.924; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; DREYFUSS G, 1986, ANNU REV CELL BIOL, V2, P459, DOI 10.1146/annurev.cellbio.2.1.459; ENGELKE DR, 1980, CELL, V19, P717, DOI 10.1016/S0092-8674(80)80048-1; GINSBERG AM, 1984, CELL, V39, P479, DOI 10.1016/0092-8674(84)90455-0; GRANGE T, 1987, NUCLEIC ACIDS RES, V15, P4771, DOI 10.1093/nar/15.12.4771; KUWANO R, 1984, NUCLEIC ACIDS RES, V12, P7455, DOI 10.1093/nar/12.19.7455; LEBLANC JM, 1989, DEV BIOL, V132, P139, DOI 10.1016/0012-1606(89)90212-1; LI S, 1989, P NATL ACAD SCI USA, V86, P9778, DOI 10.1073/pnas.86.24.9778; MCKINNON RD, 1987, MOL CELL BIOL, V7, P2148, DOI 10.1128/MCB.7.6.2148; MCKINNON RD, 1986, P NATL ACAD SCI USA, V83, P3751, DOI 10.1073/pnas.83.11.3751; OWENS GP, 1985, SCIENCE, V229, P1263, DOI 10.1126/science.2412293; PICARD B, 1979, P NATL ACAD SCI USA, V76, P241, DOI 10.1073/pnas.76.1.241; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; SAKIMURA K, 1985, P NATL ACAD SCI USA, V82, P7543; SAPIENZA C, 1986, NATURE, V319, P418, DOI 10.1038/319418a0; SHATKIN AJ, 1985, CELL, V40, P223, DOI 10.1016/0092-8674(85)90132-1; SONNENBERG N, 1981, NUCLEIC ACIDS RES, V9, P1643; SUTCLIFFE JG, 1984, SCIENCE, V225, P1308, DOI 10.1126/science.6474179; SUTCLIFFE JG, 1982, P NATL ACAD SCI-BIOL, V79, P4942, DOI 10.1073/pnas.79.16.4942; SUTCLIFFE JG, 1984, NATURE, V308, P237, DOI 10.1038/308237a0; ULLU E, 1985, NATURE, V318, P371, DOI 10.1038/318371a0; WALTER P, 1982, NATURE, V299, P691, DOI 10.1038/299691a0; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7	29	55	55	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 15	1991	266	8					4726	4730						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FC217	1705932				2022-12-27	WOS:A1991FC21700012
J	RAUFMAN, JP; SINGH, L; ENG, J				RAUFMAN, JP; SINGH, L; ENG, J			EXENDIN-3, A NOVEL PEPTIDE FROM HELODERMA-HORRIDUM VENOM, INTERACTS WITH VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS AND A NEWLY DESCRIBED RECEPTOR ON DISPERSED ACINI FROM GUINEA-PIG PANCREAS - DESCRIPTION OF EXENDIN-3(9-39) AMIDE, A SPECIFIC EXENDIN RECEPTOR ANTAGONIST	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GILA MONSTER VENOM; VIP; SECRETIN; ANALOGS	Exendin-3 increased cellular cAMP levels and amylase release from dispersed acini from guinea pig pancreas. Low concentrations (0.1-3 nM) caused a 12-fold increase in cAMP, whereas higher concentrations (0.3-3-mu-M) caused an additional 24-fold increase in cAMP. Maximal cAMP with the highest concentration tested was the same as the maximal response with secretin, vasoactive intestinal peptide (VIP), peptide histidine isoleucine, helodermin, or helospectin-I. In terms of amylase release, exendin-3 had the same efficacy but was the least potent of these peptides. Exendin-3-induced increases in amylase release were inhibited by VIP receptor antagonists and the new peptide (> 0.1-mu-M) competed with radiolabeled VIP for binding sites on dispersed acini. Increasing concentrations of an exendin-3 fragment, exendin-3(9-39) amide, did not increase cAMP or amylase release but inhibited the increase in cAMP observed with 0.1-3 nM exendin-3. The fragment did not alter the effects of other peptides that are known to increase acinar cAMP. We conclude that exendin-3 interacts with at least two receptors on guinea pig pancreatic acini; at high concentrations (> 100 nM) the peptide interacts with VIP receptors, thereby causing a large increase in cAMP and stimulating amylase release; at lower concentrations (0.1-3 nM) the peptide interacts with a putative exendin receptor, thereby causing a smaller increase in cAMP of undetermined function. Exendin-3(9-39) amide is a specific exendin receptor antagonist.	VET AFFAIRS MED CTR,SOLOMON A BERSON RES LAB,BRONX,NY 10468	US Department of Veterans Affairs; Veterans Health Administration (VHA)	RAUFMAN, JP (corresponding author), SUNY HLTH SCI CTR,DEPT MED,DIV DIGEST DIS,BOX 1196,450 CLARKSON AVE,BROOKLYN,NY 11203, USA.							CESKA M, 1969, CLIN CHIM ACTA, V26, P437, DOI 10.1016/0009-8981(69)90071-0; CHERNER JA, 1988, AM J PHYSIOL, V254, pG151, DOI 10.1152/ajpgi.1988.254.2.G151; CRISTOPHE J, 1976, J BIOL CHEM, V251, P4629; ENG J, 1990, J BIOL CHEM, V265, P20259; GARDNER JD, 1986, ANNU REV PHYSIOL, V48, P103, DOI 10.1146/annurev.ph.48.030186.000535; GARDNER JD, 1979, BIOCHIM BIOPHYS ACTA, V583, P491, DOI 10.1016/0304-4165(79)90066-7; GARDNER JD, 1989, HDB PHYSL NEURAL END, P171; GARDNER JD, 1986, EXOCRINE PANCREAS BI, P109; HOSHINO M, 1984, FEBS LETT, V178, P233, DOI 10.1016/0014-5793(84)80607-9; JENSEN RT, 1983, AM J PHYSIOL, V245, pG186, DOI 10.1152/ajpgi.1983.245.2.G186; JENSEN RT, 1979, HORMONE RECEPTORS DI, P167; PANDOL SJ, 1986, AM J PHYSIOL, V250, pG553, DOI 10.1152/ajpgi.1986.250.4.G553; PARKER DS, 1984, J BIOL CHEM, V259, P1751; PEIKIN SR, 1978, AM J PHYSIOL, V235, pE743, DOI 10.1152/ajpendo.1978.235.6.E743; RAUFMAN JP, 1982, AM J PHYSIOL, V242, pG470, DOI 10.1152/ajpgi.1982.242.5.G470; RAUFMAN JP, 1986, REGUL PEPTIDES, V14, P93, DOI 10.1016/0167-0115(86)90208-9; RAUFMAN JP, 1981, GASTROENTEROLOGY, V80, P1257; WAELBROECK M, 1985, ENDOCRINOLOGY, V116, P2643, DOI 10.1210/endo-116-6-2643; ZHOU ZC, 1989, AM J PHYSIOL, V256, pG283, DOI 10.1152/ajpgi.1989.256.2.G283	19	50	104	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 15	1991	266	5					2897	2902						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX600	1704369				2022-12-27	WOS:A1991EX60000038
J	VARRO, A; NEMETH, J; BRIDSON, J; LEE, C; MOORE, S; DOCKRAY, GJ				VARRO, A; NEMETH, J; BRIDSON, J; LEE, C; MOORE, S; DOCKRAY, GJ			PROCESSING OF THE GASTRIN PRECURSOR - MODULATION OF PHOSPHORYLATED, SULFATED, AND AMIDATED PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV LIVERPOOL, DEPT PHYSIOL,MRC,SECRETORY CONTROL RES GRP,POB 147, LIVERPOOL L69 3BX, ENGLAND; PENINSULA EUROPE, ST HELENS, LANCS, ENGLAND	University of Liverpool			Varro, Andras/M-2647-2016					AZUMA T, 1987, GASTROENTEROLOGY, V93, P322, DOI 10.1016/0016-5085(87)91022-5; BOEL E, 1983, P NATL ACAD SCI-BIOL, V80, P2866, DOI 10.1073/pnas.80.10.2866; BRAND SJ, 1984, NATURE, V309, P456, DOI 10.1038/309456a0; DAVIDSON HW, 1988, NATURE, V333, P93, DOI 10.1038/333093a0; DELVALLE J, 1987, GASTROENTEROLOGY, V92, P1908, DOI 10.1016/0016-5085(87)90623-8; DESMOND H, 1989, REGUL PEPTIDES, V25, P223, DOI 10.1016/0167-0115(89)90264-4; DESMOND H, 1985, REGUL PEPTIDES, V11, P133, DOI 10.1016/0167-0115(85)90073-4; DICKINSON CJ, 1990, REGUL PEPTIDES, V28, P223, DOI 10.1016/0167-0115(90)90020-W; DOCKRAY GJ, 1987, J BIOL CHEM, V262, P8643; DOCKRAY GJ, 1977, J ENDOCRINOL, V72, P143, DOI 10.1677/joe.0.0720143; DOCKRAY GJ, 1973, Q J EXP PHYSIOL CMS, V58, P163; DOCKRAY GJ, 1989, HDB PHYSL 6, V2, P311; DOCKRAY GJ, 1989, PEPTIDE HORMONES PRO, P244; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; GREGORY RA, 1974, J PHYSIOL-LONDON, V241, P1, DOI 10.1113/jphysiol.1974.sp010637; HILSTED L, 1987, J BIOL CHEM, V262, P16953; HORTIN G, 1986, BIOCHEM BIOPH RES CO, V141, P326, DOI 10.1016/S0006-291X(86)80372-2; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; KATO K, 1983, NUCLEIC ACIDS RES, V11, P8197, DOI 10.1093/nar/11.23.8197; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MURTHY ASN, 1987, MOL ENDOCRINOL, V1, P290, DOI 10.1210/mend-1-4-290; NIEHRS C, 1990, EMBO J, V9, P35, DOI 10.1002/j.1460-2075.1990.tb08077.x; PAUWELS S, 1987, GASTROENTEROLOGY, V92, P1220, DOI 10.1016/S0016-5085(87)91081-X; PAUWELS S, 1986, J CLIN INVEST, V77, P376, DOI 10.1172/JCI112315; RAHIER J, 1987, GASTROENTEROLOGY, V92, P1146, DOI 10.1016/S0016-5085(87)91070-5; REEVE JR, 1981, PEPTIDES, V2, P453, DOI 10.1016/S0196-9781(81)80104-0; SUGANO K, 1987, AM J PHYSIOL, V253, pG502, DOI 10.1152/ajpgi.1987.253.4.G502; VARNDELL IM, 1983, EXPERIENTIA, V39, P713, DOI 10.1007/BF01990288; VARRO A, 1986, FEBS LETT, V204, P386, DOI 10.1016/0014-5793(86)80849-3; VARRO A, 1990, AM J PHYSIOL, V258, pG904, DOI 10.1152/ajpgi.1990.258.6.G904; VARRO A, 1988, BIOCHEM J, V256, P951, DOI 10.1042/bj2560951; WU SV, 1989, BIOCHEM BIOPH RES CO, V161, P69, DOI 10.1016/0006-291X(89)91561-1; YOO OJ, 1982, P NATL ACAD SCI-BIOL, V79, P1049, DOI 10.1073/pnas.79.4.1049	35	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 15	1990	265	35					21476	21481						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EM456	1701434				2022-12-27	WOS:A1990EM45600018
J	CHANG, PK; DIGNAM, JD				CHANG, PK; DIGNAM, JD			PRIMARY STRUCTURE OF ALANYL-TRANSFER RNA-SYNTHETASE AND THE REGULATION OF ITS MESSENGER-RNA LEVELS IN BOMBYX-MORI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MED COLL OHIO,DEPT BIOCHEM,POB 10008,TOLEDO,OH 43699; UNIV MISSISSIPPI,MED CTR,DEPT BIOCHEM,JACKSON,MS 39216	University of Mississippi; University of Mississippi Medical Center					NIGMS NIH HHS [GM32410] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032410] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMIRI I, 1985, BIOCHIMIE, V67, P607, DOI 10.1016/S0300-9084(85)80200-5; ARCHIBOLD ER, 1973, J BACTERIOL, V114, P1007, DOI 10.1128/JB.114.3.1007-1013.1973; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BLUMENTHAL RM, 1976, MOL GEN GENET, V149, P291, DOI 10.1007/BF00268530; BOCHNER BR, 1984, CELL, V37, P225, DOI 10.1016/0092-8674(84)90318-0; CHAVANCY G, 1975, FEBS LETT, V49, P380, DOI 10.1016/0014-5793(75)80790-3; CHAVANCY G, 1979, BIOCHIMIE, V61, P71, DOI 10.1016/S0300-9084(79)80314-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COUBLE P, 1987, DEV BIOL, V124, P431, DOI 10.1016/0012-1606(87)90496-9; DARDEL F, 1984, J BACTERIOL, V160, P1115, DOI 10.1128/JB.160.3.1115-1122.1984; DELMONTE U, 1972, FEBS LETT, V20, P33, DOI 10.1016/0014-5793(72)80010-3; DIGNAM SS, 1984, J BIOL CHEM, V259, P4043; FREEDMAN R, 1985, J BIOL CHEM, V260, P10063; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HENTZEN D, 1981, NATURE, V290, P267, DOI 10.1038/290267a0; HILL K, 1989, BIOCHEMISTRY-US, V28, P2577, DOI 10.1021/bi00432a035; HIRSHFIELD IN, 1977, J BACTERIOL, V131, P589, DOI 10.1128/JB.131.2.589-597.1977; Huynh TV, 1985, DNA CLONING TECHNIQU, V1, P49; ISHIKOWA E, 1985, DEV GROWTH, V1, P73; JASIN M, 1983, NATURE, V306, P441, DOI 10.1038/306441a0; JASIN M, 1985, J BIOL CHEM, V260, P2226; JONES MD, 1986, BIOCHEMISTRY-US, V25, P1887, DOI 10.1021/bi00356a008; KOZAK M, 1983, MICROBIOL REV, V47, P1; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZARD M, 1987, J BIOL CHEM, V262, P3982; MAJIMA R, 1975, J BIOCHEM-TOKYO, V78, P391, DOI 10.1093/oxfordjournals.jbchem.a130919; MANIATIS T, 1982, MOL CLONING LABORATO, P108; MIRANDE M, 1989, J BIOL CHEM, V264, P842; MIRANDE M, 1988, J BIOL CHEM, V263, P18443; Morgan S D, 1978, Prog Nucleic Acid Res Mol Biol, V21, P181, DOI 10.1016/S0079-6603(08)60270-6; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; NEIDHARDT FC, 1975, ANNU REV MICROBIOL, V29, P215, DOI 10.1146/annurev.mi.29.100175.001243; NEIDHARDT FC, 1977, J BACTERIOL, V129, P378, DOI 10.1128/JB.129.1.378-387.1977; NISHIO K, 1984, J BIOCHEM-TOKYO, V96, P1867, DOI 10.1093/oxfordjournals.jbchem.a135021; OKAMOTO H, 1982, J BIOL CHEM, V257, P5192; PROUDFOOT NJ, 1976, NATURE, V263, P211, DOI 10.1038/263211a0; PUTNEY SD, 1981, SCIENCE, V213, P1497, DOI 10.1126/science.7025207; PUTNEY SD, 1981, NATURE, V291, P632, DOI 10.1038/291632a0; REGAN L, 1987, SCIENCE, V235, P1651, DOI 10.1126/science.2435005; REGAN L, 1986, J BIOL CHEM, V261, P5241; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SELLAMI M, 1986, NUCLEIC ACIDS RES, V14, P1657, DOI 10.1093/nar/14.4.1657; SUGGS SV, 1981, P NATL ACAD SCI-BIOL, V78, P6613, DOI 10.1073/pnas.78.11.6613; SUZUKI Y, 1974, J MOL BIOL, V88, P393, DOI 10.1016/0022-2836(74)90490-2; TRIPOULAS NA, 1986, DEV BIOL, V116, P328, DOI 10.1016/0012-1606(86)90136-3; TSUI FWL, 1987, NUCLEIC ACIDS RES, V15, P3349, DOI 10.1093/nar/15.8.3349; TSUJIMOTO Y, 1979, CELL, V18, P591, DOI 10.1016/0092-8674(79)90075-8; VISWANATHAN S, 1988, DEV BIOL, V129, P350, DOI 10.1016/0012-1606(88)90382-X	51	26	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					20898	20906						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701172				2022-12-27	WOS:A1990EL02000030
J	KUNITAKE, ST; YOUNG, SG; CHEN, GC; PULLINGER, CR; ZHU, S; PEASE, RJ; SCOTT, J; HASS, P; SCHILLING, J; KANE, JP				KUNITAKE, ST; YOUNG, SG; CHEN, GC; PULLINGER, CR; ZHU, S; PEASE, RJ; SCOTT, J; HASS, P; SCHILLING, J; KANE, JP			CONFORMATION OF APOLIPOPROTEIN-B-100 IN THE LOW-DENSITY LIPOPROTEINS OF TANGIER DISEASE - IDENTIFICATION OF LOCALIZED CONFORMATIONAL RESPONSE TO TRIGLYCERIDE CONTENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CALIF BIOTECHNOL INC,MT VIEW,CA 94043; GENENTECH INC,S SAN FRANCISCO,CA 94080; UNIV CALIF SAN FRANCISCO,GLADSTONE FDN LABS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; CLIN RES CTR,MRC,HARROW HA1 3UJ,MIDDX,ENGLAND	Roche Holding; Genentech; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Medical Research Council Clinical Trials Unit	KUNITAKE, ST (corresponding author), UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143, USA.			Young, Stephen/0000-0001-7270-3176	NHLBI NIH HHS [HL 14237, HL 01672, HL 31210] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031210, R23HL031210, P50HL014237] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASSMANN G, 1990, FAMILIAL HDL DEFICIE, P1267; AVIRAM M, 1988, J BIOL CHEM, V263, P16842; BUCOLO G, 1973, CLIN CHEM, V19, P476; CARDIN AD, 1984, J BIOL CHEM, V259, P8522; CARLSSON P, 1986, GENE, V49, P29, DOI 10.1016/0378-1119(86)90383-5; CHEN GC, 1989, J BIOL CHEM, V264, P14369; CHEN GC, 1984, BIOCHEMISTRY-US, V23, P1119, DOI 10.1021/bi00301a013; CHEN GC, 1975, BIOCHEMISTRY-US, V14, P3357, DOI 10.1021/bi00686a011; CHEN GC, 1983, BIOCHIM BIOPHYS ACTA, V754, P451; CHEN SH, 1986, J BIOL CHEM, V261, P2918; CHOU DY, 1978, ANNU REV BIOCHEM, V47, P251; CLADARAS C, 1986, EMBO J, V5, P3495, DOI 10.1002/j.1460-2075.1986.tb04675.x; CURTISS LK, 1982, J BIOL CHEM, V257, P5213; DUNNING AM, 1988, CLIN GENET, V33, P181; FREDRICKSON DS, 1964, J CLIN INVEST, V43, P228, DOI 10.1172/JCI104907; GRETEN H, 1974, NEW ENGL J MED, V291, P548, DOI 10.1056/NEJM197409122911103; HOFFMAN HN, 1965, AM J MED, V39, P582, DOI 10.1016/0002-9343(65)90081-1; HUANG HS, 1975, CLIN CHEM, V21, P1605; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P486; KANE JP, 1975, J CLIN INVEST, V56, P1622, DOI 10.1172/JCI108245; KLEINMAN Y, 1987, J LIPID RES, V28, P540; KNOTT TJ, 1986, NATURE, V323, P734, DOI 10.1038/323734a0; KRUL ES, 1988, J LIPID RES, V29, P937; LAW SW, 1985, J BIOL CHEM, V260, P2810; LAW SW, 1986, P NATL ACAD SCI USA, V83, P8142, DOI 10.1073/pnas.83.21.8142; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDWIG EH, 1987, DNA-J MOLEC CELL BIO, V6, P363, DOI 10.1089/dna.1987.6.363; MAKRIDES SC, 1988, EUR J BIOCHEM, V173, P465, DOI 10.1111/j.1432-1033.1988.tb14022.x; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MILNE R, 1989, J BIOL CHEM, V264, P19754; MILNE RW, 1987, MOL IMMUNOL, V24, P435, DOI 10.1016/0161-5890(87)90017-4; PEASE RJ, 1990, J BIOL CHEM, V265, P553; PROTTER AA, 1986, P NATL ACAD SCI USA, V83, P5678, DOI 10.1073/pnas.83.15.5678; SALMON S, 1984, BIOCHEM BIOPH RES CO, V125, P704, DOI 10.1016/0006-291X(84)90596-5; Sambrook J., 1989, MOL CLONING; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; SCHUMAKER VN, 1984, J BIOL CHEM, V259, P6423; Stewart C P, 1935, Biochem J, V29, P1683; TIKKANEN MJ, 1983, J LIPID RES, V24, P1494; TIKKANEN MJ, 1984, ARTERIOSCLEROSIS, V4, P138, DOI 10.1161/01.ATV.4.2.138; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSAO BP, 1982, J BIOL CHEM, V257, P5222; WEISGRABER KH, 1987, J BIOL CHEM, V262, P11097; YANG CY, 1989, ARTERIOSCLEROSIS, V9, P96, DOI 10.1161/01.ATV.9.1.96; YOUNG SG, 1986, P NATL ACAD SCI USA, V83, P1101, DOI 10.1073/pnas.83.4.1101	45	29	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 5	1990	265	34					20739	20746						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EL020	1701170				2022-12-27	WOS:A1990EL02000007
J	STGERMAIN, DL; DITTRICH, W; MORGANELLI, CM; CRYNS, V				STGERMAIN, DL; DITTRICH, W; MORGANELLI, CM; CRYNS, V			MOLECULAR-CLONING BY HYBRID ARREST OF TRANSLATION IN XENOPUS-LAEVIS OOCYTES - IDENTIFICATION OF A CDNA-ENCODING THE TYPE-I IODOTHYRONINE 5'-DEIODINASE FROM RAT-LIVER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT PHYSIOL,HANOVER,NH 03756	Dartmouth College	STGERMAIN, DL (corresponding author), DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT MED,HANOVER,NH 03756, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK008352, R01DK042271, K08DK001389] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-01389, DK-08352, DK-42271] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERRY MJ, 1990, MOL ENDOCRINOL, V4, P743, DOI 10.1210/mend-4-5-743; BOADO RJ, 1988, BIOCHEM BIOPH RES CO, V155, P1297, DOI 10.1016/S0006-291X(88)81282-8; COCHRAN BH, 1987, METHOD ENZYMOL, V147, P64; JAGUS R, 1987, METHOD ENZYMOL, V152, P567; JULIUS D, 1988, SCIENCE, V241, P558, DOI 10.1126/science.3399891; KAWASAKI ES, 1985, NUCLEIC ACIDS RES, V13, P4991, DOI 10.1093/nar/13.13.4991; KOHRLE J, 1990, J BIOL CHEM, V265, P6155; Leonard JL, 1986, THYROID HORMONE META, P189; MANIATIS T, 1982, MOL CLONING LABORATO, P90; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0; SARGENT TD, 1987, METHOD ENZYMOL, V152, P423; SCHOENMAKERS CHH, 1989, BIOCHEM BIOPH RES CO, V162, P857, DOI 10.1016/0006-291X(89)92389-9; SIVE HL, 1988, NUCLEIC ACIDS RES, V16, P10937, DOI 10.1093/nar/16.22.10937; STGERMAIN DL, 1989, J BIOL CHEM, V264, P3054; STGERMAIN DL, 1988, J CLIN INVEST, V81, P1476, DOI 10.1172/JCI113479; STGERMAIN DL, 1989, ENDOCRINOLOGY, V125, P2735; TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0; VELAN B, 1989, CURRENT PROTOCOLS MO; Winer BJ, 1971, STATISTICAL PRINCIPL, P201	20	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20087	20090						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700781				2022-12-27	WOS:A1990EJ52500010
J	SZCZEPANIAK, A; CRAMER, WA				SZCZEPANIAK, A; CRAMER, WA			THYLAKOID MEMBRANE-PROTEIN TOPOGRAPHY - LOCATION OF THE TERMINI OF THE CHLOROPLAST CYTOCHROME-B6 ON THE STROMAL SIDE OF THE MEMBRANE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									PURDUE UNIV, DEPT BIOL SCI, W LAFAYETTE, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus			Szczepaniak, Andrzej/C-1263-2010		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038323, R56GM038323] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-38323] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALT J, 1984, CURR GENET, V8, P551, DOI 10.1007/BF00410443; AMBLER RP, 1967, METHOD ENZYMOL, V11, P436; ANDERSSON B, 1978, BIOCHIM BIOPHYS ACTA, V503, P462, DOI 10.1016/0005-2728(78)90145-7; [Anonymous], 1985, ENZYMES BIOL MEMBRAN, DOI DOI 10.1007/978-1-4684-4604-3_10; BLACK MT, 1987, ARCH BIOCHEM BIOPHYS, V252, P655, DOI 10.1016/0003-9861(87)90071-3; BRASSEUR R, 1988, J BIOL CHEM, V263, P12571; CHOW WS, 1980, BIOCHIM BIOPHYS ACTA, V593, P149, DOI 10.1016/0005-2728(80)90016-X; CHOW WS, 1980, ARCH BIOCHEM BIOPHYS, V201, P347, DOI 10.1016/0003-9861(80)90520-2; CRAMER WA, 1987, LIGHT REACTIONS, P447; DALDAL F, 1989, EMBO J, V8, P3951, DOI 10.1002/j.1460-2075.1989.tb08578.x; DALDAL F, 1987, CYTOCHROME SYSTEMS M, P23; DIRAGO JP, 1989, J BIOL CHEM, V264, P14543; DIRAGO JP, 1988, J BIOL CHEM, V263, P12564; DOYLE MP, 1989, J BIOL CHEM, V264, P1387; DUMONT ME, 1985, J MEMBRANE BIOL, V88, P233, DOI 10.1007/BF01871088; FURBACHER PN, 1989, BIOCHEMISTRY-US, V28, P8990, DOI 10.1021/bi00449a006; HAUSKA G, 1983, BIOCHIM BIOPHYS ACTA, V726, P97, DOI 10.1016/0304-4173(83)90002-2; HAUSKA G, 1988, J BIOENERG BIOMEMBR, V20, P211, DOI 10.1007/BF00768395; HOWELL N, 1988, J MOL BIOL, V203, P607, DOI 10.1016/0022-2836(88)90195-7; ISOGAI Y, 1985, FEBS LETT, V187, P240, DOI 10.1016/0014-5793(85)81250-3; JANSEN T, 1987, FEBS LETT, V216, P234, DOI 10.1016/0014-5793(87)80696-8; KUWABARA T, 1983, PLANT CELL PHYSIOL, V24, P741, DOI 10.1093/oxfordjournals.pcp.a076571; PICCIONI R, 1982, METHODS CHLOROPLAST, P985; SARASTE M, 1984, FEBS LETT, V166, P367, DOI 10.1016/0014-5793(84)80114-3; SEIBERT M, 1987, J CELL BIOL, V105, P2257, DOI 10.1083/jcb.105.5.2257; SHIVER JW, 1989, METHOD ENZYMOL, V172, P439; SZCZEPANIAK A, 1989, Z NATURFORSCH C, V44, P453; SZCZEPANIAK A, 1990, 8 P INT C PHOT, V3, P255; TAE GS, 1989, FEBS LETT, V259, P161, DOI 10.1016/0014-5793(89)81518-2; WIDGER WR, 1984, P NATL ACAD SCI-BIOL, V81, P674, DOI 10.1073/pnas.81.3.674; WILLEY DL, 1984, CELL, V36, P555, DOI 10.1016/0092-8674(84)90248-4	31	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 15	1990	265	29					17720	17726						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC766	1698778				2022-12-27	WOS:A1990EC76600057
J	GREENWALT, DE; WATT, KWK; HASLER, T; HOWARD, RJ; PATEL, S				GREENWALT, DE; WATT, KWK; HASLER, T; HOWARD, RJ; PATEL, S			STRUCTURAL, FUNCTIONAL, AND ANTIGENIC DIFFERENCES BETWEEN BOVINE HEART ENDOTHELIAL CD36 AND HUMAN PLATELET CD36	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									SAN JOSE STATE UNIV,DEPT CHEM,SAN JOSE,CA 95192; CETUS CORP,DEPT PROT CHEM,EMERYVILLE,CA 94608; DNAX INC,PALO ALTO,CA 94304	California State University System; San Jose State University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL038664] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38664] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AIKAWA M, 1972, Z ZELLFORSCH MIKROSK, V124, P722; ASCH AS, 1987, J CLIN INVEST, V79, P1054, DOI 10.1172/JCI112918; BARNWELL JW, 1985, J IMMUNOL, V135, P3494; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BORDIER C, 1981, J BIOL CHEM, V256, P1604; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; GREENWALT DE, 1985, J CELL BIOL, V100, P397, DOI 10.1083/jcb.100.2.397; GREENWALT DE, 1985, BIOCHEM J, V228, P233, DOI 10.1042/bj2280233; GREENWALT DE, 1990, IN PRESS BIOCHEMISTR; HANDUNNETTI SM, 1990, IN PRESS J CELL BIOC; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HOWARD RJ, 1988, PROG ALLERGY, V41, P98; HOWARD RJ, 1989, BLOOD, V74, P2603; JENSEN JB, 1978, AM J TROP MED HYG, V27, P1274, DOI 10.4269/ajtmh.1978.27.1274; KNOWLES DM, 1984, J IMMUNOL, V132, P2170; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUSE SA, 1971, AM J TROP MED HYG, V20, P655, DOI 10.4269/ajtmh.1971.20.655; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MAGOWAN C, 1988, J EXP MED, V168, P1307, DOI 10.1084/jem.168.4.1307; MATHER IH, 1982, BIOCHEM J, V202, P317, DOI 10.1042/bj2020317; MCGREGOR JL, 1989, J BIOL CHEM, V264, P501; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; OO MM, 1987, J NEUROPATH EXP NEUR, V46, P223, DOI 10.1097/00005072-198703000-00009; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; ROCK EP, 1988, BLOOD, V71, P71; SHAW S, 1987, IMMUNOL TODAY, V8, P1, DOI 10.1016/0167-5699(87)90816-4; SILVERSTEIN RL, 1989, J CLIN INVEST, V84, P546, DOI 10.1172/JCI114197; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SO OY, 1989, THESIS SAN JOSE STAT; TALLE MA, 1983, CELL IMMUNOL, V78, P83, DOI 10.1016/0008-8749(83)90262-9; TANDON NN, 1989, J BIOL CHEM, V264, P7570; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRAGER W, 1966, B WORLD HEALTH ORGAN, V35, P883; WINOGRAD E, 1989, J CELL BIOL, V108, P23, DOI 10.1083/jcb.108.1.23	37	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16296	16299						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697855				2022-12-27	WOS:A1990DZ95000041
J	SCHMIDT, W; POLLJORDAN, G; LOFFLER, G				SCHMIDT, W; POLLJORDAN, G; LOFFLER, G			ADIPOSE CONVERSION OF 3T3-L1 CELLS IN A SERUM-FREE CULTURE SYSTEM DEPENDS ON EPIDERMAL GROWTH-FACTOR, INSULIN-LIKE GROWTH FACTOR-I, CORTICOSTERONE, AND CYCLIC-AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV REGENSBURG, INST BIOCHEM MICROBIOL & GENET, DEPT BIOCHEM MICROBIOL & GENET, W-8400 REGENSBURG, GERMANY	University of Regensburg								AMRI EZ, 1986, BIOCHEM J, V239, P363, DOI 10.1042/bj2390363; AMRI EZ, 1986, BIOCHEM BIOPH RES CO, V137, P903, DOI 10.1016/0006-291X(86)91165-4; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLACKSHEAR PJ, 1986, J BIOL CHEM, V261, P1459; BLACKSHEAR PJ, 1985, J BIOL CHEM, V260, P3304; DOGLIO A, 1986, BIOCHEM J, V238, P123, DOI 10.1042/bj2380123; DOGLIO A, 1987, EMBO J, V6, P4011, DOI 10.1002/j.1460-2075.1987.tb02744.x; FEICK P, 1986, BIOL CHEM H-S, V367, P549, DOI 10.1515/bchm3.1986.367.2.549; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; GAILLARD D, 1985, BIOCHIM BIOPHYS ACTA, V846, P185, DOI 10.1016/0167-4889(85)90125-9; GRATZNER HG, 1985, CYTOMETRY, V6, P563, DOI 10.1002/cyto.990060610; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; GULLER S, 1988, ENDOCRINOLOGY, V122, P2084, DOI 10.1210/endo-122-5-2084; HAUNER H, 1986, INT J OBESITY, V10, P323; HAYASHI I, 1981, P NATL ACAD SCI-BIOL, V78, P3969, DOI 10.1073/pnas.78.6.3969; HESS HH, 1978, ANAL BIOCHEM, V85, P295, DOI 10.1016/0003-2697(78)90304-4; HINEGARDNER RT, 1971, ANAL BIOCHEM, V39, P197, DOI 10.1016/0003-2697(71)90476-3; KISSANE JM, 1958, J BIOL CHEM, V233, P184; KOZAK LP, 1974, J BIOL CHEM, V249, P7775; KURIHARCUCH W, 1983, J CELL PHYSIOL, V114, P39, DOI 10.1002/jcp.1041140107; KURIHARCUCH W, 1978, P NATL ACAD SCI USA, V75, P6107, DOI 10.1073/pnas.75.12.6107; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADOFF DH, 1988, BIOCHEM J, V252, P7, DOI 10.1042/bj2520007; MORIKAWA M, 1982, CELL, V29, P783, DOI 10.1016/0092-8674(82)90440-8; NAVRE M, 1988, J CELL BIOL, V107, P279, DOI 10.1083/jcb.107.1.279; NEGREL R, 1989, BIOCHEM J, V257, P399, DOI 10.1042/bj2570399; NISSLEY SP, 1984, HORMONAL PROTEINS PE, V12, P128; NIXON T, 1984, ENDOCRINOLOGY, V114, P527, DOI 10.1210/endo-114-2-527; PAIRAULT J, 1987, J CELL PHYSIOL, V132, P279, DOI 10.1002/jcp.1041320212; PAIRAULT J, 1979, P NATL ACAD SCI USA, V76, P5138, DOI 10.1073/pnas.76.10.5138; RINGOLD GM, 1988, RECENT PROG HORM RES, V44, P115; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; RUSSELL TR, 1976, P NATL ACAD SCI USA, V73, P4516, DOI 10.1073/pnas.73.12.4516; SCHIWEK DR, 1987, ENDOCRINOLOGY, V120, P469, DOI 10.1210/endo-120-2-469; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; YUN K, 1983, J CELL PHYSIOL, V117, P249, DOI 10.1002/jcp.1041170217; ZEZULAK KM, 1986, SCIENCE, V233, P551, DOI 10.1126/science.3726546	41	131	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15489	15495						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1697591				2022-12-27	WOS:A1990DY96400025
J	NIELSEN, FC; GAMMELTOFT, S; CHRISTIANSEN, J				NIELSEN, FC; GAMMELTOFT, S; CHRISTIANSEN, J			TRANSLATIONAL DISCRIMINATION OF MESSENGER-RNAS CODING FOR HUMAN INSULIN-LIKE GROWTH FACTOR-II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Note									BISPEBJERG HOSP,DEPT CLIN CHEM,DK-2400 COPENHAGEN,DENMARK	University of Copenhagen; Bispebjerg Hospital			Nielsen, Finn Cilius/AAA-4926-2020; Christiansen, Jan/L-3312-2014	Christiansen, Jan/0000-0001-8624-4601				AMREIN K, 1988, GENE, V65, P277, DOI 10.1016/0378-1119(88)90464-7; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEPAGTERHOLTHUIZEN P, 1988, BIOCHIM BIOPHYS ACTA, V950, P282, DOI 10.1016/0167-4781(88)90124-8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443; FRUNZIO R, 1986, J BIOL CHEM, V261, P7138; GAMMELTOFT S, 1989, PEPTIDE HORMONES PRO, P176; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; HASELBACHER GK, 1987, P NATL ACAD SCI USA, V84, P1104, DOI 10.1073/pnas.84.4.1104; HENSHAW EC, 1968, J MOL BIOL, V36, P401, DOI 10.1016/0022-2836(68)90164-2; IRMINGER JC, 1987, P NATL ACAD SCI USA, V84, P6330, DOI 10.1073/pnas.84.18.6330; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; LARSON DE, 1987, MOL CELL BIOCHEM, V74, P5; LEFF SE, 1986, ANNU REV BIOCHEM, V55, P1091, DOI 10.1146/annurev.bi.55.070186.005303; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; MANSOUR SL, 1988, EMBO J, V7, P2035, DOI 10.1002/j.1460-2075.1988.tb03043.x; MCPHEETERS DS, 1986, NUCLEIC ACIDS RES, V14, P5813, DOI 10.1093/nar/14.14.5813; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PERRY RP, 1968, J MOL BIOL, V35, P36; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; RAO CD, 1988, MOL CELL BIOL, V8, P284, DOI 10.1128/MCB.8.1.284; REISMAN D, 1988, P NATL ACAD SCI USA, V85, P5146, DOI 10.1073/pnas.85.14.5146; REYNOLDS GA, 1985, J BIOL CHEM, V260, P369; SAVAKIS C, 1986, DEV BIOL, V114, P194, DOI 10.1016/0012-1606(86)90395-7; SCHIBLER U, 1983, CELL, V33, P501, DOI 10.1016/0092-8674(83)90431-2; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; STYLIANOPOULOU F, 1988, P NATL ACAD SCI USA, V85, P141, DOI 10.1073/pnas.85.1.141; Sussenbach J S, 1989, Prog Growth Factor Res, V1, P33, DOI 10.1016/0955-2235(89)90040-9; WARNER JR, 1963, P NATL ACAD SCI USA, V49, P122, DOI 10.1073/pnas.49.1.122	31	96	96	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13431	13434						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696253				2022-12-27	WOS:A1990DU27500006
J	CHING, GY; LIEM, RKH				CHING, GY; LIEM, RKH			STRUCTURE OF THE GENE FOR THE NEURONAL INTERMEDIATE FILAMENT PROTEIN ALPHA-INTERNEXIN AND FUNCTIONAL-ANALYSIS OF ITS PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEIGHT NEUROFILAMENT PROTEIN; CELL-SPECIFIC EXPRESSION; AMINO-ACID-SEQUENCE; NF-M; DNA-BINDING; TRANSCRIPTION INVITRO; REGULATORY ELEMENTS; MOUSE EMBRYOGENESIS; TRANSGENIC MICE; NERVOUS TISSUES	We have isolated the gene encoding the neuronal intermediate filament protein alpha-internexin using low stringency hybridization conditions and an NF-M (neurofilament middle molecular weight subunit) cDNA probe. This gene consists of three exons and two introns. The sequence data and the exon-intron organization of the gene establish its classification as a type IV intermediate filament gene. Transient transfection experiments showed that up to 5 kilobases of the alpha-internexin promoter region transcribed equally well in both the alpha-internexin-expressing and -nonexpressing cell lines. The results also demonstrated that the region from -77 to +73 relative to the transcription start site was sufficient for accurate basal transcription, but inclusion of the -254 to -78 region was required for efficient transcription. Sequence analysis shows that the -254 to -78 region contains several potential positive regulatory elements.	COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,630 W 168 ST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT ANAT & CELL BIOL,NEW YORK,NY 10032	Columbia University; Columbia University					NINDS NIH HHS [NS151812] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMANO T, 1972, P NATL ACAD SCI USA, V69, P258, DOI 10.1073/pnas.69.1.258; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BYRNE GW, 1989, P NATL ACAD SCI USA, V86, P5473, DOI 10.1073/pnas.86.14.5473; CHIN SSM, 1989, EUR J CELL BIOL, V50, P475; CHIN SSM, 1990, J NEUROSCI, V10, P3714; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHIU FC, 1989, NEURON, V2, P1435, DOI 10.1016/0896-6273(89)90189-X; COMB M, 1988, EMBO J, V7, P3793, DOI 10.1002/j.1460-2075.1988.tb03264.x; CRABB DW, 1987, ANAL BIOCHEM, V163, P88, DOI 10.1016/0003-2697(87)90096-0; DYNAN WS, 1985, NATURE, V316, P774, DOI 10.1038/316774a0; EDLUND T, 1985, SCIENCE, V230, P912, DOI 10.1126/science.3904002; FARRELL FX, 1990, MOL CELL BIOL, V10, P2349, DOI 10.1128/MCB.10.5.2349; FLIEGNER KH, 1990, EMBO J, V9, P749, DOI 10.1002/j.1460-2075.1990.tb08169.x; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; HIRSCH MR, 1990, MOL CELL BIOL, V10, P1959, DOI 10.1128/MCB.10.5.1959; HOFFMAN PN, 1975, J CELL BIOL, V66, P351, DOI 10.1083/jcb.66.2.351; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; JONES NC, 1988, GENE DEV, V2, P267, DOI 10.1101/gad.2.3.267; JULIEN JP, 1990, J PHYSIOLOGY PARIS, V84, P50; JULIEN JP, 1988, GENE, V68, P307, DOI 10.1016/0378-1119(88)90033-9; JULIEN JP, 1987, BIOCHIM BIOPHYS ACTA, V909, P10, DOI 10.1016/0167-4781(87)90041-8; JULIEN JP, 1987, GENE DEV, V1, P1085, DOI 10.1101/gad.1.10.1085; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KAPLAN MP, 1990, J NEUROSCI, V10, P2735; LASEK RJ, 1983, COLD SPRING HARB SYM, V8, P41; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; LEVY E, 1987, EUR J BIOCHEM, V166, P71, DOI 10.1111/j.1432-1033.1987.tb13485.x; LEWIS SA, 1986, MOL CELL BIOL, V6, P1529, DOI 10.1128/MCB.6.5.1529; Liem RKH, 1990, CURR OPIN CELL BIOL, V2, P86, DOI 10.1016/S0955-0674(05)80036-5; LIEM RKH, 1978, J CELL BIOL, V79, P637, DOI 10.1083/jcb.79.3.637; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAEDA H, 1987, NUCLEIC ACIDS RES, V15, P2851, DOI 10.1093/nar/15.7.2851; MALOUF AT, 1984, J BIOL CHEM, V259, P2756; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; Maniatis T., 1982, MOL CLONING; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; Miller J. H, 1972, EXPT MOL GENETICS; MITCHELL PJ, 1987, CELL, V50, P847, DOI 10.1016/0092-8674(87)90512-5; MIURA M, 1990, J NEUROCHEM, V55, P1180, DOI 10.1111/j.1471-4159.1990.tb03123.x; MONTEIRO MJ, 1989, J CELL BIOL, V108, P579, DOI 10.1083/jcb.108.2.579; NAKAHIRA K, 1990, J BIOL CHEM, V265, P19786; NAPOLITANO EW, 1987, J NEUROSCI, V7, P2590; NELSON C, 1990, GENE DEV, V4, P1035, DOI 10.1101/gad.4.6.1035; NELSON P, 1976, P NATL ACAD SCI USA, V73, P123, DOI 10.1073/pnas.73.1.123; OBLINGER MM, 1989, J NEUROSCI, V9, P3766; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; PACHTER JS, 1985, J CELL BIOL, V101, P1316, DOI 10.1083/jcb.101.4.1316; PARYSEK LM, 1988, J NEUROSCI, V8, P555; PIEPER FR, 1987, EMBO J, V6, P3611, DOI 10.1002/j.1460-2075.1987.tb02692.x; PLEASURE SJ, 1990, J NEUROSCI, V10, P2428; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; ROSALES R, 1987, EMBO J, V6, P3015, DOI 10.1002/j.1460-2075.1987.tb02607.x; SAX CM, 1988, NUCLEIC ACIDS RES, V16, P8057, DOI 10.1093/nar/16.16.8057; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; SEED B, 1988, GENE, V67, P271, DOI 10.1016/0378-1119(88)90403-9; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; TAMURA T, 1990, EMBO J, V9, P3101, DOI 10.1002/j.1460-2075.1990.tb07507.x; THOMPSON MA, 1989, NEURON, V2, P1043, DOI 10.1016/0896-6273(89)90228-6; TROY CM, 1990, BRAIN RES, V529, P232, DOI 10.1016/0006-8993(90)90832-V; TRUDEL M, 1987, GENE DEV, V1, P954, DOI 10.1101/gad.1.9.954; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; WIGLER M, 1979, P NATL ACAD SCI USA, V76, P1373, DOI 10.1073/pnas.76.3.1373; WINGENDER E, 1988, NUCLEIC ACIDS RES, V16, P1879, DOI 10.1093/nar/16.5.1879; ZOPF D, 1990, NUCLEIC ACIDS RES, V18, P521, DOI 10.1093/nar/18.3.521	73	67	69	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19459	19468						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717465				2022-12-27	WOS:A1991GK66700052
J	BRAND, SH; LAURIE, SM; MIXON, MB; CASTLE, JD				BRAND, SH; LAURIE, SM; MIXON, MB; CASTLE, JD			SECRETORY CARRIER MEMBRANE-PROTEINS 31-35 DEFINE A COMMON PROTEIN-COMPOSITION AMONG SECRETORY CARRIER MEMBRANES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL-SPECIFIC PHOSPHOPROTEIN; ADRENAL CHROMAFFIN GRANULES; RABBIT PAROTID-GLAND; CELL-FREE SYSTEM; ENDOCRINE-CELLS; SUCCESSIVE COMPARTMENTS; MONOCLONAL-ANTIBODIES; PLASMA-MEMBRANE; ELECTRIC ORGAN; VESICLES	A novel compositional overlap between membranes of exocrine and endocrine granules, synaptic vesicles, and a liver Golgi fraction has been identified using a monoclonal antibody (SG7C12) raised against parotid secretion granule membranes. This antibody binds secretory carrier membrane proteins with apparent M(r) 31,000, 33,000 and 35,000 (designated SCAMPs 31, 33, 35). The proteins are nonglycosylated integral membrane components, and the epitope recognized by SG7C12 is on the cytoplasmic side of the granule membrane. SCAMP 33 is found in all secretory carrier membranes studied so far while SCAMP 35 is found in exocrine and certain endocrine granules and liver Golgi membranes and SCAMP31 only in exocrine granules. They are not related to other similar-sized proteins that have been studied previously in relation to vesicular transport and secretion. Immunocytochemical staining shows that these SCAMPs are highly concentrated in the apical cytoplasm of exocrine cells. Antigens are present not only on exocrine granules and synaptic vesicles but also on other smooth membrane vesicles of exocrine and neural origin as revealed by immunolocalization in subcellular fractions and immunoadsorption to antibody-coated magnetic beads. The wide tissue distribution and localization to secretory carriers and related membranes suggest that SCAMPs 31-35 may be essential components in vesicle-mediated transport/secretion.	UNIV VIRGINIA, HLTH SCI CTR, DEPT ANAT & CELL BIOL, BOX 439 MED CTR, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, INST MOLEC BIOL, CHARLOTTESVILLE, VA 22908 USA	University of Virginia; University of Virginia					NCRR NIH HHS [5-S07-RR05431] Funding Source: Medline; NIDCR NIH HHS [DE09655] Funding Source: Medline; NIDDK NIH HHS [DK29868] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR005431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029868] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARVAN P, 1986, J CELL BIOL, V103, P1257, DOI 10.1083/jcb.103.4.1257; ARVAN P, 1982, J CELL BIOL, V95, P8, DOI 10.1083/jcb.95.1.8; ARVAN P, 1987, J CELL BIOL, V104, P243, DOI 10.1083/jcb.104.2.243; BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3; BARTLES JR, 1985, J BIOL CHEM, V260, P2792; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRAELL WA, 1984, CELL, V39, P511, DOI 10.1016/0092-8674(84)90458-6; BRAND SH, 1990, J CELL BIOL, V111, P319; BRUGGE JS, 1977, NATURE, V269, P346, DOI 10.1038/269346a0; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; CAMERON RS, 1986, J CELL BIOL, V103, P1299, DOI 10.1083/jcb.103.4.1299; CAMERON RS, 1984, J MEMBRANE BIOL, V79, P127, DOI 10.1007/BF01872117; CAMERON RS, 1989, HDB PHYSL, P107; CARTY SE, 1980, ANAL BIOCHEM, V106, P438, DOI 10.1016/0003-2697(80)90545-X; CASTLE JD, 1985, J MEMBRANE BIOL, V87, P13; CASTLE JD, 1975, J CELL BIOL, V64, P182, DOI 10.1083/jcb.64.1.182; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CLARY DO, 1990, J BIOL CHEM, V265, P10109; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; CREUTZ CE, 1983, J BIOL CHEM, V258, P4664; CREUTZ CE, 1987, J BIOL CHEM, V262, P1860; DECAMILLI P, 1987, ANN NY ACAD SCI, V493, P461; DECAMILLI P, 1990, ANNU REV PHYSIOL, V52, P625, DOI 10.1146/annurev.ph.52.030190.003205; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; DRUST DS, 1991, J NEUROCHEM, V56, P469, DOI 10.1111/j.1471-4159.1991.tb08174.x; DUONG LT, 1984, J BIOL CHEM, V259, P4885; Engvall E, 1980, Methods Enzymol, V70, P419; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GLUCK S, 1987, J BIOL CHEM, V262, P15780; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; HOOPER JE, 1980, J CELL BIOL, V87, P104, DOI 10.1083/jcb.87.1.104; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; HUTTON JC, 1982, DIABETOLOGIA, V23, P365; Johnson D. A., 1984, Gene Analysis Techniques, V1, P3, DOI 10.1016/0735-0651(84)90049-9; JOHNSTON PA, 1990, J BIOL CHEM, V265, P8869; JOHNSTON PA, 1989, EMBO J, V8, P2863, DOI 10.1002/j.1460-2075.1989.tb08434.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAH JJ, 1990, J CELL BIOL, V111, P81; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MELDOLESI J, 1971, J CELL BIOL, V49, P109, DOI 10.1083/jcb.49.1.109; NAVONE F, 1986, J CELL BIOL, V103, P2511, DOI 10.1083/jcb.103.6.2511; OBENDORF D, 1988, NEUROSCIENCE, V25, P343, DOI 10.1016/0306-4522(88)90030-9; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; SMITH AD, 1967, BIOCHEM J, V103, P480, DOI 10.1042/bj1030480; SPITZ M, 1986, METHOD ENZYMOL, V121, P33; Tartakoff A M, 1974, Methods Enzymol, V31, P41; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; VOLKNANDT W, 1990, EMBO J, V9, P2465, DOI 10.1002/j.1460-2075.1990.tb07424.x; VONZASTROW M, 1987, J CELL BIOL, V105, P2675, DOI 10.1083/jcb.105.6.2675; WATTIAUX R, 1978, J CELL BIOL, V78, P349, DOI 10.1083/jcb.78.2.349; WEILER R, 1989, FEBS LETT, V257, P457, DOI 10.1016/0014-5793(89)81595-9; YAMASHITA S, 1989, ACTA HISTOCHEM CYTOC, V22, P517, DOI 10.1267/ahc.22.517; YURKO MA, 1987, J BIOL CHEM, V262, P15770	59	88	89	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18949	18957						9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717458				2022-12-27	WOS:A1991GJ47200083
J	SHYAMALA, V; BAICHWAL, V; BEALL, E; AMES, GF				SHYAMALA, V; BAICHWAL, V; BEALL, E; AMES, GF			STRUCTURE-FUNCTION ANALYSIS OF THE HISTIDINE PERMEASE AND COMPARISON WITH CYSTIC-FIBROSIS MUTATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GEL-ELECTROPHORESIS; BACTERIAL PERIPLASMIC PERMEASES; DEPENDENT TRANSPORT-SYSTEMS; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; BINDING-PROTEIN; ATP HYDROLYSIS; MEMBRANE; RECONSTITUTION	Traffic ATPases constitute a superfamily of transporters that include prokaryotic permeases and medically important eukaryotic proteins, such as the multidrug resistance P-glycoprotein and the cystic fibrosis gene product. We present a structure-function analysis of a member of this superfamily, the prokaryotic histidine permease, using mutations generated both in vitro and in vivo, and assaying several biochemical functions. The analysis supports a previously predicted structural model and allows the assignment of specific functions to several predicted structural features. Mutations in the secondary structure features which form the nucleotide-binding pocket in general cause the loss of ATP binding activity. Mutations in the helical domain retain ATP binding activity. Several mutations have been identified which may affect the signaling mechanism between ATP hydrolysis and membrane translocation. We relate our findings to those emerging from the recent biochemical and genetic analyses of cystic fibrosis mutations.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV BIOCHEM & MOLEC BIOL, 401 BARKER HALL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley					NIDDK NIH HHS [DK12121] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK012121, R37DK012121] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; AMES GF, 1964, ARCH BIOCHEM BIOPHYS, V104, P1, DOI 10.1016/S0003-9861(64)80028-X; AMES GFL, 1981, EUR J BIOCHEM, V115, P525; AMES GFL, 1990, J BACTERIOL, V172, P4133, DOI 10.1128/jb.172.8.4133-4137.1990; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; AMES GFL, 1974, J BIOL CHEM, V249, P634; AMES GFL, 1977, J BACTERIOL, V129, P1289, DOI 10.1128/JB.129.3.1289-1297.1977; AMES GFL, IN PRESS INT REV CYT; AMES GFL, 1991, IN PRESS ADV ENZYMOL; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; DAVIDSON AL, 1990, J BIOL CHEM, V265, P4254; DAVIES K, 1990, NATURE, V348, P110, DOI 10.1038/348110a0; FERROLUZZIAMES G, 1976, P NATL ACAD SCI USA, V73, P1877, DOI 10.1073/pnas.73.6.1877; HIGGINS CF, 1990, J BIOENERG BIOMEMBR, V22, P571, DOI 10.1007/BF00762962; HOBSON AC, 1984, P NATL ACAD SCI-BIOL, V81, P7333, DOI 10.1073/pnas.81.23.7333; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; KERPPOLA RE, 1991, J BIOL CHEM, V266, P9857; KRAFT R, 1987, NUCLEIC ACIDS RES, V15, P8568, DOI 10.1093/nar/15.20.8568; MIMMACK ML, 1989, P NATL ACAD SCI USA, V86, P8257, DOI 10.1073/pnas.86.21.8257; MIMURA CS, 1990, J BIOL CHEM, V265, P19535; MIMURA CS, 1991, P NATL ACAD SCI USA, V88, P84, DOI 10.1073/pnas.88.1.84; NOEL D, 1979, BIOCHEMISTRY-US, V18, P4159, DOI 10.1021/bi00586a017; PETRONILLI V, 1991, J BIOL CHEM, V266, P16293; PROSSNITZ E, 1988, J BIOL CHEM, V263, P17917; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; SCHNEIDER E, 1991, IN PRESS MOL MICROBI; SHYAMALA V, 1991, GENE, V97, P1, DOI 10.1016/0378-1119(91)90002-S; SHYAMALA V, 1989, J BACTERIOL, V171, P1602, DOI 10.1128/jb.171.3.1602-1608.1989; SPEISER DM, 1991, J BACTERIOL, V173, P1444, DOI 10.1128/jb.173.4.1444-1451.1991; THOMAS PJ, 1991, SCIENCE, V251, P555, DOI 10.1126/science.1703660; WOOTTON JC, 1989, PROTEIN ENG, V2, P535, DOI 10.1093/protein/2.7.535	35	161	161	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18714	18719						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717452				2022-12-27	WOS:A1991GJ47200049
J	LALANI, EN; BERDICHEVSKY, F; BOSHELL, M; SHEARER, M; WILSON, D; STAUSS, H; GENDLER, SJ; TAYLORPAPADIMITRIOU, J				LALANI, EN; BERDICHEVSKY, F; BOSHELL, M; SHEARER, M; WILSON, D; STAUSS, H; GENDLER, SJ; TAYLORPAPADIMITRIOU, J			EXPRESSION OF THE GENE CODING FOR A HUMAN MUCIN IN MOUSE MAMMARY-TUMOR CELLS CAN AFFECT THEIR TUMORIGENICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMORPHIC EPITHELIAL MUCIN; MONOCLONAL-ANTIBODIES HMFG-1; PHENOL-CHLOROFORM EXTRACTION; SINGLE-STEP METHOD; MOLECULAR-CLONING; BREAST-CANCER; RNA ISOLATION; CORE PROTEIN; ANTIGEN; CDNA	The human epithelial mucin which is the product of the MUC1 gene is expressed by many carcinomas, including those of breast, ovary, colon, and lung. The core protein is aberrantly glycosylated in the tumors resulting in the exposure or appearance of novel epitopes. To examine the possibility of using the MUC1 gene and its products in active immunization against breast and other carcinomas, we have developed a syngeneic mouse model, by transfecting the gene into the mouse mammary epithelial tumor cell 410.4. An 8.3-kilobase EcoRI fragment of the gene was transfected using the expression vector pEMSV scribe alpha-2. Transcripts of the correct size, initiating from the transcriptional start site seen in human cells, were observed in the transfectants. The mucin was expressed in the cytoplasm and in the membrane, and the glycosylation pattern appeared to be similar to that seen in human tumor cells, since the core protein epitopes recognized by antibodies HMFG-1, HMFG-2, and SM-3 were exposed. The 410.4 transfectants expressing the human mucin showed a reduction in tumor incidence at low inocula and a delay in tumor growth at higher inocula. Pretreatment with 10(4) transfected cells could inhibit the development of tumors from a subsequent inoculum of 10(6) transfectants, but had no effect on the tumor development of the untransfected 410.4 cells. Our results suggest that the human mucin expressed by the 410.4 cells may mobilize an immune response which inhibits tumor development. They also indicate that the mouse model will be useful for evaluation of efficacy of immunogens based on the MUC1 gene and its product.	IMPERIAL CANC RES FUND, POB 123, LINCOLNS INN FIELDS, LONDON WC2A 3PX, ENGLAND; UNIV LONDON UNIV COLL, IMPERIAL CANC RES FUND, DEPT BIOL, TUMOUR IMMUNOL UNIT, LONDON WC1E 6BT, ENGLAND	Cancer Research UK; Cancer Research UK; University of London; University College London				Lalani, El-Nasir/0000-0001-9733-459X				ARKLIE J, 1981, INT J CANCER, V28, P23, DOI 10.1002/ijc.2910280105; BARND DL, 1989, P NATL ACAD SCI USA, V86, P7159, DOI 10.1073/pnas.86.18.7159; BARTEK J, 1985, J CELL SCI, V75, P17; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; BURCHELL J, 1983, J IMMUNOL, V131, P508; BURCHELL J, 1989, INT J CANCER, V44, P691, DOI 10.1002/ijc.2910440423; BURCHELL J, 1989, CANCER INVEST, V7, P53, DOI 10.3109/07357908909038267; BURCHELL J, 1987, CANCER RES, V47, P5476; BURCHELL J, 1984, INT J CANCER, V34, P763, DOI 10.1002/ijc.2910340605; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GENDLER SJ, 1990, INT J CANCER, V45, P431, DOI 10.1002/ijc.2910450309; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1987, P NATL ACAD SCI USA, V84, P6060, DOI 10.1073/pnas.84.17.6060; GIRLING A, 1989, INT J CANCER, V43, P1072, DOI 10.1002/ijc.2910430620; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; GUM JR, 1989, J BIOL CHEM, V264, P6480; HANISCH FG, 1989, J BIOL CHEM, V264, P872; HAREUVENI M, 1990, P NATL ACAD SCI USA, V87, P9498, DOI 10.1073/pnas.87.23.9498; Hull S R, 1989, Cancer Commun, V1, P261; JEROME KR, 1990, UCLA SYM BI, V135, P321; LAN MS, 1990, J BIOL CHEM, V265, P15294; MILLER FR, 1983, INVAS METAST, V3, P22; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; SWALLOW DM, 1987, ANN HUM GENET, V51, P289, DOI 10.1111/j.1469-1809.1987.tb01063.x; TAYLOR-PAPADIMITRIOU J-T, 1988, Cancer Reviews, V11-12, P11; TAYLORPAPADIMITRIOU J, 1981, INT J CANCER, V28, P17, DOI 10.1002/ijc.2910280104; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WILLIAMS CJ, 1990, BIOCHEM BIOPH RES CO, V170, P1331, DOI 10.1016/0006-291X(90)90540-4	31	69	74	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1991	266	23					15420	15426						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB097	1714457				2022-12-27	WOS:A1991GB09700088
J	ANDERSON, NG; KILGOUR, E; STURGILL, TW				ANDERSON, NG; KILGOUR, E; STURGILL, TW			ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE IN BC3H1 MYOCYTESD BY FLUOROALUMINATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SERINE-THREONINE KINASE; CELL-CYCLE CONTROL; PERTUSSIS TOXIN; PHORBOL ESTER; HAMSTER FIBROBLASTS; BINDING PROTEINS; PHOSPHOLIPASE-C; DOWN-REGULATION; 3T3-L1 CELLS	Treatment of BC3H1 myocytes or 3T3 -L1 fibroblasts with fluoroaluminate (AlF4-), a direct activator of G proteins, increased the tyrosine phosphorylation of a 42-kDa cytosolic protein. AlF4- induced a parallel increase in protein kinase activity toward myelin basic protein (MBP) in partially purified cell extracts. To test whether AlF4- was activating the 42-kDa MAP (mitogen-activated protein) kinase, extracts from AlF4--treated cells were taken through the chromatographic steps routinely used to purify MAP kinase from growth factor-stimulated cells. Following phenyl-Superose chromatography, a peak of MBP kinase activity eluted at a position characteristic of MAP kinase. Immunoblotting of the active fractions with anti-phosphotyrosine antibodies revealed a single reactive protein band of M(r) 42,000. Stimulation of MAP kinase by AlF4- was rapid, peaking within 15 min and persisting for at least 1 h. In contrast, the activation of MAP kinase by insulin was transient, characteristic of its activation by growth factors in other cell types. Although concentrations of sodium fluoride greater than 1 mM also activated MAP kinase, this effect was shown to be dependent upon the simultaneous presence of aluminum ions in the medium. Activation of MAP kinase by AlF4- was not affected by either cellular depletion of protein kinase C or pretreatment of cells with pertussis toxin. Potential sites of action of AlF4- are discussed. These findings suggest that activation of a G protein(s) in intact cells can initiate events that result in tyrosine phosphorylation and activation of MAP kinase.	UNIV VIRGINIA,DEPT INTERNAL MED,CHARLOTTESVILLE,VA 22908; UNIV VIRGINIA,DEPT PHARMACOL,CHARLOTTESVILLE,VA 22908	University of Virginia; University of Virginia					NIDDK NIH HHS [DK 38942, DK 41077] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041077, P30DK038942] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ackrill P, 1984, Contrib Nephrol, V38, P78; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BISHOP R, 1983, BIOCHEM BIOPH RES CO, V115, P536, DOI 10.1016/S0006-291X(83)80178-8; BLACKMORE PF, 1985, J BIOL CHEM, V260, P4477; BOULTON TG, 1990, SCIENCE, V249, P64, DOI 10.1126/science.2164259; BUTLERGRALLA E, 1981, J CELL PHYSIOL, V107, P59, DOI 10.1002/jcp.1041070108; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; COCHET C, 1984, J BIOL CHEM, V259, P2553; COCKCROFT S, 1987, TRENDS BIOCHEM SCI, V12, P75, DOI 10.1016/0968-0004(87)90035-1; COLLINS MKL, 1982, J CELL PHYSIOL, V112, P42, DOI 10.1002/jcp.1041120108; COOPER DR, 1989, BIOCHEM BIOPH RES CO, V161, P327, DOI 10.1016/0006-291X(89)91600-8; COOPER DR, 1990, BIOCHIM BIOPHYS ACTA, V1054, P95, DOI 10.1016/0167-4889(90)90210-5; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; DUNLAP K, 1987, TRENDS NEUROSCI, V10, P241, DOI 10.1016/0166-2236(87)90166-4; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; GIBBS JB, 1990, J BIOL CHEM, V265, P20437; GILMORE T, 1983, NATURE, V306, P487, DOI 10.1038/306487a0; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; INOUE Y, 1990, J BIOL CHEM, V265, P10645; ISAKOV N, 1990, J BIOL CHEM, V265, P2091; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; KELVIN DJ, 1989, J CELL BIOL, V108, P169, DOI 10.1083/jcb.108.1.169; KEUNZEL EA, 1985, P NATL ACAD SCI USA, V82, P737; LALLEMAIN G, 1991, MOL CELL BIOL, V11, P1002, DOI 10.1128/MCB.11.2.1002; LUND KA, 1990, J BIOL CHEM, V265, P20517; LUTRELL L, 1990, J BIOL CHEM, V265, P16873; LUTRELL LM, 1988, J BIOL CHEM, V263, P6134; PARIS S, 1986, EMBO J, V5, P55, DOI 10.1002/j.1460-2075.1986.tb04177.x; PARIS S, 1987, J BIOL CHEM, V262, P1970; PELECH SL, 1990, BIOCHEM CELL BIOL, V68, P1297, DOI 10.1139/o90-194; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; RAY LB, 1988, J BIOL CHEM, V263, P12721; ROSSOMANDO AJ, 1989, P NATL ACAD SCI USA, V86, P6940, DOI 10.1073/pnas.86.18.6940; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; SPACH DH, 1986, J BIOL CHEM, V261, P2750; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0; TAYLOR SJ, 1990, J BIOL CHEM, V265, P17150; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; ZACHARY I, 1987, DEV BIOL, V124, P295, DOI 10.1016/0012-1606(87)90483-0	44	91	91	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 5	1991	266	16					10131	10135						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FP086	1709925				2022-12-27	WOS:A1991FP08600023
J	WOLFE, SA; GRIMES, SR				WOLFE, SA; GRIMES, SR			PROTEIN-DNA INTERACTIONS WITHIN THE RAT HISTONE-H4T PROMOTER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN H4-HISTONE GENE; CELL-SPECIFIC VARIANT; RNA POLYMERASE-II; PLASMID DNA; TRANSCRIPTIONAL REGULATION; EXPRESSION; TESTIS; UPSTREAM; SPERMATOGENESIS; ELEMENTS	The histone H4t gene is actively transcribed in rat testis germinal cells and in several non-testis cell types including cells from liver. This histone H-4 gene is expressed most actively in testis premeiotic pachytene spermatocytes, and its expression is down-regulated in postmeiotic early spermatids. The histone H-4 gene promoter is functional as demonstrated by finding significant levels of chloramphenicol acetyltransferase (CAT) mRNA in mammalian cells transiently transfected with a histone H-4-promoted CAT expression vector compared to cells transfected with an expression vector lacking the promoter. Examination of the proximal promoter of the histone H-4 gene by electrophoretic mobility shift assays indicates that specific protein-DNA interactions occur when pachytene spermatocyte nuclear proteins are mixed with promoter fragments containing regions designated site I and site II, consensus sequence elements essential for regulating transcription of the histone H-4 gene. These specific protein-DNA interactions are eliminated by competition with identical DNA fragments, but are not eliminated by competition with nonhomologous DNA fragments. Significant differences are found in mobility shift patterns upon comparison of nuclear proteins from germinal cell populations enriched in pachytene spermatocytes where the gene is actively expressed and early spermatids where the gene is not expressed.	OVERTON BROOKS VET ADM MED CTR,RES SERV 151,510 E STONER AVE,SHREVEPORT,LA 71101; LOUISIANA STATE UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOL,SHREVEPORT,LA 71130	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport			Grimes, Sidney/R-8492-2019					BIRNBOIM HC, 1983, METHOD ENZYMOL, V100, P243; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BRANSON RE, 1975, ARCH BIOCHEM BIOPHYS, V168, P403, DOI 10.1016/0003-9861(75)90269-6; BUCCI LR, 1982, EXP CELL RES, V140, P111, DOI 10.1016/0014-4827(82)90162-8; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CLERMONT Y, 1965, ENDOCRINOLOGY, V76, P80, DOI 10.1210/endo-76-1-80; COLE KD, 1986, J BIOL CHEM, V261, P7178; COLIN AM, 1988, P NATL ACAD SCI USA, V85, P507, DOI 10.1073/pnas.85.2.507; DAILEY L, 1988, GENE DEV, V2, P1700, DOI 10.1101/gad.2.12b.1700; DALTON S, 1988, EMBO J, V7, P49, DOI 10.1002/j.1460-2075.1988.tb02782.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; GASSER SM, 1986, CELL, V46, P521, DOI 10.1016/0092-8674(86)90877-9; GRIMES S, 1987, EXP CELL RES, V173, P534, DOI 10.1016/0014-4827(87)90293-X; GRIMES SR, 1990, J CELL BIOCHEM, V44, P1, DOI 10.1002/jcb.240440102; GRIMES SR, 1986, COMP BIOCHEM PHYS B, V83, P495, DOI 10.1016/0305-0491(86)90285-3; GROUDINE M, 1981, MOL CELL BIOL, V1, P281, DOI 10.1128/MCB.1.3.281; GUO LH, 1983, NUCLEIC ACIDS RES, V11, P5521, DOI 10.1093/nar/11.16.5521; HANLY SM, 1985, MOL CELL BIOL, V5, P380, DOI 10.1128/MCB.5.2.380; Hecht N.B., 1989, P396; Hecht NB, 1989, HISTONES OTHER BASIC, P347; HELMS SR, 1987, J CELL PHYSIOL, V132, P552, DOI 10.1002/jcp.1041320319; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; KISTLER WS, 1989, HISTONES OTHER BASIC, P331; KROEGER P, 1987, P NATL ACAD SCI USA, V84, P3982, DOI 10.1073/pnas.84.12.3982; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; LIEBER T, 1986, MOL CELL BIOL, V6, P2602, DOI 10.1128/MCB.6.7.2602; Maniatis T., 1982, MOL CLONING; Marzluff W F Jr, 1978, Methods Cell Biol, V19, P317; MAXSON R, 1983, ANNU REV GENET, V17, P239, DOI 10.1146/annurev.ge.17.120183.001323; MEISTRICH ML, 1981, BIOL REPROD, V25, P1065, DOI 10.1095/biolreprod25.5.1065; MEISTRICH ML, 1989, HISTONES OTHER BASIC, P166; OWEN TA, 1990, P NATL ACAD SCI USA, V87, P5129, DOI 10.1073/pnas.87.13.5129; PAULI U, 1987, SCIENCE, V236, P1308, DOI 10.1126/science.3035717; PAULI U, 1989, J CELL PHYSIOL, V139, P320, DOI 10.1002/jcp.1041390214; REEVES R, 1987, P NATL ACAD SCI USA, V84, P6531, DOI 10.1073/pnas.84.18.6531; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; SCHMITT JJ, 1983, ANAL BIOCHEM, V133, P462, DOI 10.1016/0003-2697(83)90109-4; SHIPIRO DJ, 1988, DNA, V7, P47; SIERRA F, 1983, NUCLEIC ACIDS RES, V11, P7069, DOI 10.1093/nar/11.20.7069; SPITZNER JR, 1990, NUCLEIC ACIDS RES, V18, P1, DOI 10.1093/nar/18.1.1; STRUHL K, 1983, GENE, V26, P231, DOI 10.1016/0378-1119(83)90193-2; TROSTLEWEIGE PK, 1982, J BIOL CHEM, V257, P5560; TROSTLEWEIGE PK, 1984, J BIOL CHEM, V259, P8769; VANWIJNEN AJ, 1989, J BIOL CHEM, V264, P15034; WELLS DE, 1986, NUCLEIC ACIDS RES, V14, pR119, DOI 10.1093/nar/14.suppl.r119; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WOLFE SA, 1989, BIOCHIM BIOPHYS ACTA, V1007, P140, DOI 10.1016/0167-4781(89)90032-8; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	50	12	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6637	6643						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706721				2022-12-27	WOS:A1991FE37300093
J	HARRISON, ML; RATHINAVELU, P; ARESE, P; GEAHLEN, RL; LOW, PS				HARRISON, ML; RATHINAVELU, P; ARESE, P; GEAHLEN, RL; LOW, PS			ROLE OF BAND-3 TYROSINE PHOSPHORYLATION IN THE REGULATION OF ERYTHROCYTE GLYCOLYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL MEMBRANE; GROWTH-FACTOR RECEPTOR; EXPRESS HIGH-LEVELS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; KINASE-ACTIVITY; STRUCTURAL CHARACTERIZATION; PHOSPHATASE-ACTIVITY; CYTOPLASMIC DOMAIN; HYDROGEN-PEROXIDE; ACID-PHOSPHATASE	Previous studies demonstrated that the in vitro tyrosine phosphorylation of the human erythrocyte anion transporter, band 3, prevented the binding of various glycolytic enzymes to the N terminus of the cytoplasmic tail. Since these enzymes are inhibited in their bound state, the functional consequences of band 3 tyrosine phosphorylation in the red cell should be to activate the enzymes and elevate glycolysis. We searched for various enhancers of band 3 tyrosine phosphorylation using a novel assay designed to measure the phosphotyrosine levels at the band 3 tyrosine phosphorylation/glycolytic enzyme-binding site. This assay measures the extent of phosphorylation of a synthetic band 3 peptide entrapped within resealed red cells. Using this assay, three distinct compounds, all mild oxidants, were found to stimulate the tyrosine phosphorylation of band 3. All three compounds were also found to elevate glycolytic rates in intact erythrocytes. Moreover, the antitumor drug adriamycin was found to coordinately prevent these agents from stimulating both band 3 tyrosine phosphorylation and erythrocyte glycolysis. These results suggest a possible function for a protein tyrosine kinase in human erythrocytes, to regulate glycolysis through the tyrosine phosphorylation of band 3.	PURDUE UNIV, DEPT CHEM, W LAFAYETTE, IN 47907 USA; UNIV TURIN, DEPT GENET BIOL & MED CHEM, I-10124 TURIN, ITALY	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Turin	HARRISON, ML (corresponding author), PURDUE UNIV, DEPT MED CHEM & PHARMACOGNOSY, W LAFAYETTE, IN 47907 USA.			Low, Philip/0000-0001-9042-5528; Geahlen, Robert/0000-0001-8400-2924	NIGMS NIH HHS [GM40983] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040983] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLEN RW, 1987, J BIOL CHEM, V262, P649; ALPER SL, 1988, J BIOL CHEM, V263, P17092; APPELL KC, 1981, J BIOL CHEM, V256, P1104; ARESE P, 1977, ACTA BIOL MED GER, V36, P481; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, V2, P509; BRAUN S, 1983, ANAL BIOCHEM, V135, P369, DOI 10.1016/0003-2697(83)90698-X; BRUGGE JS, 1985, NATURE, V316, P554, DOI 10.1038/316554a0; CRANE FL, 1985, BIOCHIM BIOPHYS ACTA, V811, P233, DOI 10.1016/0304-4173(85)90013-8; CZECH MP, 1974, P NATL ACAD SCI USA, V71, P4173, DOI 10.1073/pnas.71.10.4173; DANO K, 1972, CANCER RES, V32, P1307; DEKOWSKI SA, 1983, J BIOL CHEM, V258, P2750; DEMUTH DR, 1986, EMBO J, V5, P1205, DOI 10.1002/j.1460-2075.1986.tb04348.x; DIMARCO A, 1975, CANCER CHEMOTH REP 3, V6, P91; DONELLADEANA A, 1989, BIOCHEM BIOPH RES CO, V160, P1309, DOI 10.1016/S0006-291X(89)80146-9; DUHN VJ, 1969, HOPPESEYLERS Z PHYSL, V350, P1008; DURRIEU C, 1987, ARCH BIOCHEM BIOPHYS, V252, P32, DOI 10.1016/0003-9861(87)90005-1; GOLDEN A, 1986, P NATL ACAD SCI USA, V83, P852, DOI 10.1073/pnas.83.4.852; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; HEFFETZ D, 1989, J BIOL CHEM, V264, P10126; HENNIPMAN A, 1989, CANCER RES, V49, P516; HIGASHI T, 1979, J BIOL CHEM, V254, P9542; JAKSCHIK B, 1973, BIOCHEM BIOPH RES CO, V53, P539; JENKINS JD, 1984, J BIOL CHEM, V259, P9374; KANT JA, 1973, J BIOL CHEM, V248, P8457; KAUL RK, 1983, J BIOL CHEM, V258, P7891; KELLOKUMPU S, 1988, SCIENCE, V242, P1308, DOI 10.1126/science.2461589; KLIMAN HJ, 1980, J BIOL CHEM, V255, P6314; KOSHIO O, 1988, BIOCHEM J, V250, P95, DOI 10.1042/bj2500095; LOW PS, 1987, J BIOL CHEM, V262, P4592; LOW PS, 1986, BIOCHIM BIOPHYS ACTA, V864, P145, DOI 10.1016/0304-4157(86)90009-2; MAGNANI M, 1984, BIOCHIM BIOPHYS ACTA, V804, P145, DOI 10.1016/0167-4889(84)90143-5; MCDANIEL CF, 1974, J BIOL CHEM, V249, P6478; MCLOUGHLIN PM, 1984, BIOCHIM BIOPHYS ACTA, V802, P71, DOI 10.1016/0304-4165(84)90035-7; MINAKAMI S, 1965, BIOCHIM BIOPHYS ACTA, V99, P175, DOI 10.1016/S0926-6593(65)80020-0; MISHRA RK, 1969, J MEMBRANE BIOL, V1, P214, DOI 10.1007/BF01869782; MOHAMED AH, 1986, J BIOL CHEM, V261, P2804; MURTHY SNP, 1981, J BIOL CHEM, V256, P1203; PAGLIARO L, 1988, J CELL BIOL, V107, P981, DOI 10.1083/jcb.107.3.981; PARKER DJ, 1969, J BIOL CHEM, V244, P180; RAMPONI G, 1989, FEBS LETT, V250, P469, DOI 10.1016/0014-5793(89)80778-1; RAPOPORT I, 1978, ACTA BIOL MED GER, V37, P393; REGLINSKI J, 1988, J BIOL CHEM, V263, P12360; ROGALSKI AA, 1989, J BIOL CHEM, V264, P6438; ROSS WE, 1981, BIOCHIM BIOPHYS ACTA, V654, P129, DOI 10.1016/0005-2787(81)90145-3; SCHIPFER W, 1985, INT J BIOCHEM, V17, P819, DOI 10.1016/0020-711X(85)90270-8; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; STANTON RC, 1988, AM J PHYSIOL, V254, pC267, DOI 10.1152/ajpcell.1988.254.2.C267; STRAPAZON E, 1977, BIOCHEMISTRY-US, V16, P2966, DOI 10.1021/bi00632a025; SUN IL, 1988, PLASMA MEMBRANE OXID, P181; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TRITTON TR, 1982, SCIENCE, V217, P248, DOI 10.1126/science.7089561; TSAI IH, 1982, J BIOL CHEM, V257, P1438; TUY FPD, 1983, NATURE, V305, P435; TUY FPD, 1985, BIOCHEM BIOPH RES CO, V126, P304; VIJAYA S, 1984, MOL CELL BIOCHEM, V62, P175; WAHEED A, 1988, BIOCHEMISTRY-US, V27, P4265, DOI 10.1021/bi00412a010; WILLARDSON BM, 1989, J BIOL CHEM, V264, P15893; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YU J, 1975, J BIOL CHEM, V250, P9176	59	168	169	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	1991	266	7					4106	4111						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FA694	1705546				2022-12-27	WOS:A1991FA69400016
J	HSU, WH; XIANG, HD; RAJAN, AS; KUNZE, DL; BOYD, AE				HSU, WH; XIANG, HD; RAJAN, AS; KUNZE, DL; BOYD, AE			SOMATOSTATIN INHIBITS INSULIN-SECRETION BY A G-PROTEIN-MEDIATED DECREASE IN CA2+ ENTRY THROUGH VOLTAGE-DEPENDENT CA2+ CHANNELS IN THE BETA-CELL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC FREE-CALCIUM; INTRACELLULAR FREE CALCIUM; FREE CA-2+ CONCENTRATION; AMP-INDEPENDENT ACTIONS; BINDING PROTEIN; PITUITARY-CELLS; K+ CHANNELS; RAT; RELEASE; RECEPTORS	We tested the hypothesis that somatostatin (SRIF) inhibits insulin secretion from an SV40 transformed hamster beta cell line (HIT cells) by an effect on the voltage-dependent Ca2+ channels and examined whether G-proteins were involved in the process. Ca2+ current were recorded by the whole cell patch-clamp method, the free cytosolic calcium, [Ca2+]i, was monitored in HIT cells by fura-2, and cAMP and insulin secretion were measured by radioimmunoassay. SRIF decreased Ca2+ currents, [Ca2+]i, and basal insulin secretion in a dose-dependent manner over the range of 10(-12)-10(-7) M. The increase in [Ca2+]i and insulin secretion induced by either depolarization with K+ (15 mM) or by the Ca2+ channel agonist, Bay K 8644 (1-mu-M) was attenuated by SRIF in a dose-dependent manner over the same range of 10(-12)-10(-7) M. The half-maximal inhibitory concentrations (IC50) for SRIF inhibition of insulin secretion were 8.6 x 10(-12) M and 8.3 x 10(-11) M for K+ and Bay K 8644-stimulated secretion and 1 x 10(-10) M and 2.9 x 10(-10) M for the SRIF inhibition of the K+ and Bay K 8644-induced rise in [Ca2+]i, respectively. SRIF also attenuated the rise in [Ca2+]i induced by the cAMP-elevating agent, isobutylmethylxanthine (1 mM) in the presence of glucose. Bay K 8644, K+ and SRIF had no significant effects on cAMP levels and SRIF had no effects on adenylyl cyclase activity at concentrations lower than 1-mu-M. SRIF (100 nM) did not change K+ efflux (measured by Rb-86+) through ATP-sensitive K+ channels in HIT cells. SRIF (up to 1-mu-M) had no significant effect on membrane potential measured by bisoxonal fluorescence. Pretreatment of the HIT cells with pertussis toxin (0.1-mu-g/ml) overnight abolished the effects of SRIF on Ca2+ currents, [Ca2+]i and insulin secretion implying a G-protein dependence in SRIF's actions. Thus, one mechanism by which SRIF decreases insulin secretion is by inhibiting Ca2+ influx through voltage-dependent Ca2+ channels, an action mediated through a pertussis toxin-sensitive G-protein.	BAYLOR UNIV,DEPT MED,HOUSTON,TX 77030; BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030; BAYLOR UNIV,DEPT PHYSIOL & MOLEC BIOPHYS,HOUSTON,TX 77030	Baylor University; Baylor University; Baylor University					NHLBI NIH HHS [HL 37044] Funding Source: Medline; NIDDK NIH HHS [DK 207685, DK 34447] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034447, R55DK034447] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BHATHENA SJ, 1982, DIABETES, V31, P521, DOI 10.2337/diabetes.31.6.521; BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; BIRNBAUMER L, 1988, LABORATORY METHODS M, P1; BOYD AE, 1982, J CELL BIOL, V92, P425, DOI 10.1083/jcb.92.2.425; BROWN M, 1976, ENDOCRINOLOGY, V98, P336, DOI 10.1210/endo-98-2-336; COTRONEO P, 1988, EUR J BIOCHEM, V174, P219, DOI 10.1111/j.1432-1033.1988.tb14085.x; DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971; DORFLINGER LJ, 1983, ENDOCRINOLOGY, V113, P1541, DOI 10.1210/endo-113-5-1541; EFENDIC S, 1975, FEBS LETT, V55, P131, DOI 10.1016/0014-5793(75)80977-X; EWALD DA, 1988, P NATL ACAD SCI USA, V85, P3633, DOI 10.1073/pnas.85.10.3633; FOSSET M, 1988, FEBS LETT, V242, P94, DOI 10.1016/0014-5793(88)80992-X; GAINES KL, 1988, J BIOL CHEM, V263, P2589; HESCHELER J, 1987, NATURE, V325, P445, DOI 10.1038/325445a0; HILL RS, 1984, METHODS DIABETES RES, P267; HOLL RW, 1989, AM J PHYSIOL, V256, pE375, DOI 10.1152/ajpendo.1989.256.3.E375; HOLZ GG, 1986, NATURE, V319, P670, DOI 10.1038/319670a0; HSU WH, 1989, DIABETES, V38, pA6; HURST RD, 1989, BIOCHEM SOC T, V17, P1085, DOI 10.1042/bst0171085; IKEDA SR, 1989, J PHYSIOL-LONDON, V409, P221, DOI 10.1113/jphysiol.1989.sp017494; KEAHEY HH, 1989, AM J PHYSIOL, V257, pC1171, DOI 10.1152/ajpcell.1989.257.6.C1171; KEAHEY HH, 1989, DIABETES, V38, P188, DOI 10.2337/diabetes.38.2.188; KOCH BD, 1988, J BIOL CHEM, V263, P216; KOCH BD, 1985, J BIOL CHEM, V260, P3138; KOCH BD, 1984, ENDOCRINOLOGY, V114, P1784, DOI 10.1210/endo-114-5-1784; LEWIS DL, 1986, P NATL ACAD SCI USA, V83, P9035, DOI 10.1073/pnas.83.23.9035; LUINI A, 1986, J NEUROSCI, V6, P3128; MASTERS SB, 1988, SCIENCE, V241, P448, DOI 10.1126/science.2899356; NILSSON T, 1989, J BIOL CHEM, V264, P973; OLIVER JR, 1976, ENDOCRINOLOGY, V99, P910, DOI 10.1210/endo-99-3-910; PACE CS, 1981, DIABETES, V30, P836, DOI 10.2337/diabetes.30.10.836; PANDIELLA A, 1988, ENDOCRINOLOGY, V122, P1419, DOI 10.1210/endo-122-4-1419; PIPELEERS D, 1987, DIABETOLOGIA, V30, P277, DOI 10.1007/BF00299019; RAJAN AS, 1989, DIABETES, V38, P874, DOI 10.2337/diabetes.38.7.874; REICHLIN S, 1983, NEW ENGL J MED, V309, P1556, DOI 10.1056/NEJM198312223092506; RICHARDSON UI, 1983, ENDOCRINOLOGY, V113, P62, DOI 10.1210/endo-113-1-62; SCHLEGEL W, 1984, CELL CALCIUM, V5, P223, DOI 10.1016/0143-4160(84)90038-1; SULLIVAN SJ, 1987, ENDOCRINOLOGY, V121, P544, DOI 10.1210/endo-121-2-544; SUSSMAN KE, 1987, DIABETES, V36, P571, DOI 10.2337/diabetes.36.5.571; WOLLHEIM CB, 1984, J BIOL CHEM, V259, P2262; WOLLHEIM CB, 1986, J BIOL CHEM, V261, P8314	40	141	142	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					837	843						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702440				2022-12-27	WOS:A1991ET17700028
J	NIKAIDO, H; NIKAIDO, K; HARAYAMA, S				NIKAIDO, H; NIKAIDO, K; HARAYAMA, S			IDENTIFICATION AND CHARACTERIZATION OF PORINS IN PSEUDOMONAS-AERUGINOSA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE PERMEABILITY; GRAM-NEGATIVE BACTERIA; LAMBDA-RECEPTOR PROTEIN; ESCHERICHIA-COLI; TRANSMEMBRANE CHANNELS; DEFICIENT MUTANTS; DIFFUSION PORES; CELL-WALL; SPECIFICITY; SALMONELLA	Earlier studies have shown that the major porin species in Pseudomonas aeruginosa outer membrane is protein F (OprF), which produces channels wider than those produced by Escherichia coli porins. In contrast, Yoshihara and Nakae ((1989) J. Biol. Chem. 264, 6297-6301) reported that protein F has no pore-forming activity as measured by the flux of L-arabinose, and that the channels in P. aeruginosa outer membrane, being produced by proteins C, "D", and "E", are much narrower than E. coli porin channels. In this study, we followed the protein purification scheme of Yoshihara and Nakae as closely as possible, and found that protein F had a specific activity for pore formation similar to that of proteins D1, D2, and E2. Furthermore, proteoliposome reconstitution assays showed conclusively that the channels formed by protein F, as well as by unfractionated outer membranes, allowed the diffusion of a tetrasaccharide, stachyose, at a significant rate, indicating that these channels are much larger than E. coli porin channels. It appears likely that in the study of Yoshihara and Nakae protein F was inadvertently inactivated during purification. We further suggest a hypothesis that resolves the apparent conflict between the presence of large diameter channels and the low permeability of the outer membrane in P. aeruginosa.	UNIV GENEVA,MED CTR,DEPT MED BIOCHEM,CH-1211 GENEVA 4,SWITZERLAND	University of Geneva				Harayama, Shigeaki/0000-0003-2103-7796	FIC NIH HHS [1 FO6 TW01531-01] Funding Source: Medline; NIAID NIH HHS [AI-09644] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [F06TW001531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009644, R01AI009644] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANGUS BL, 1982, ANTIMICROB AGENTS CH, V21, P299, DOI 10.1128/AAC.21.2.299; Beauchop T, 1960, J GEN MICROBIOL, V23, P457; CAULCOTT CA, 1984, FEMS MICROBIOL LETT, V21, P119, DOI 10.1016/0378-1097(84)90189-7; CHONG CS, 1976, BIOCHIM BIOPHYS ACTA, V436, P260, DOI 10.1016/0005-2736(76)90192-9; CULLIS PR, 1978, BIOCHIM BIOPHYS ACTA, V513, P31, DOI 10.1016/0005-2736(78)90109-8; DECAD GM, 1976, J BACTERIOL, V128, P325, DOI 10.1128/JB.128.1.325-336.1976; Doggett RG, 1979, PSEUDOMONAS AERUGINO; DUCHENE M, 1988, J BACTERIOL, V170, P155, DOI 10.1128/jb.170.1.155-162.1988; DUCHENE M, 1989, J BACTERIOL, V171, P4130; GOTOH N, 1989, J BACTERIOL, V171, P983, DOI 10.1128/jb.171.2.983-990.1989; HANCOCK REW, 1979, BIOCHIM BIOPHYS ACTA, V554, P323, DOI 10.1016/0005-2736(79)90373-0; HANCOCK REW, 1980, FEMS MICROBIOL LETT, V8, P105, DOI 10.1111/j.1574-6968.1980.tb05060.x; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; JAP BK, 1989, J MOL BIOL, V205, P407, DOI 10.1016/0022-2836(89)90351-3; KALCKAR HM, 1947, J BIOL CHEM, V167, P429; KLOSE M, 1988, J BIOL CHEM, V263, P13297; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; Miller J.H., 1972, EXPT MOL GENETICS; MIZUNO T, 1978, J BIOCHEM, V84, P179, DOI 10.1093/oxfordjournals.jbchem.a132106; NAKAE T, 1976, BIOCHEM BIOPH RES CO, V71, P877, DOI 10.1016/0006-291X(76)90913-X; NAKAE T, 1976, J BIOL CHEM, V251, P2176; NIKAIDO H, 1977, BIOCHEM BIOPH RES CO, V76, P324, DOI 10.1016/0006-291X(77)90728-8; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; NIKAIDO H, 1983, METHOD ENZYMOL, V97, P85; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; Nikaido H., 1986, BACTERIA, V10, P145; NIKAIDO H, 1989, HDB EXPT PHARM, V91, P1; PAGE WJ, 1989, ANTIMICROB AGENTS CH, V33, P297, DOI 10.1128/AAC.33.3.297; SANDERMANN H, 1972, J BIOL CHEM, V247, P5123; SATAKE S, 1990, ANTIMICROB AGENTS CH, V34, P685, DOI 10.1128/AAC.34.5.685; SHAAFI RI, 1970, J GEN PHYSIOL, V55, P427, DOI 10.1085/jgp.55.4.427; SMIT J, 1975, J BACTERIOL, V124, P942, DOI 10.1128/JB.124.2.942-958.1975; TRIAS J, 1990, J BIOL CHEM, V265, P15680; TRIAS J, 1988, BIOCHIM BIOPHYS ACTA, V938, P493, DOI 10.1016/0005-2736(88)90148-4; TRIAS J, 1989, ANTIMICROB AGENTS CH, V33, P1201, DOI 10.1128/AAC.33.8.1202; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; VONMEYENBURG K, 1977, BIOCHEM BIOPH RES CO, V78, P1100, DOI 10.1016/0006-291X(77)90534-4; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; WOODRUFF WA, 1988, J BACTERIOL, V170, P2592, DOI 10.1128/jb.170.6.2592-2598.1988; WOODRUFF WA, 1989, J BACTERIOL, V171, P3304, DOI 10.1128/jb.171.6.3304-3309.1989; WOODRUFF WA, 1986, J BACTERIOL, V167, P473, DOI 10.1128/jb.167.2.473-479.1986; YAMANO Y, 1990, J ANTIMICROB CHEMOTH, V26, P175, DOI 10.1093/jac/26.2.175; YONEYAMA H, 1986, BIOCHEM BIOPH RES CO, V134, P106; YONEYAMA H, 1986, EUR J BIOCHEM, V157, P33, DOI 10.1111/j.1432-1033.1986.tb09634.x; YOSHIHARA E, 1989, J BIOL CHEM, V264, P6297; YOSHIHARA E, 1988, BIOCHEM BIOPH RES CO, V156, P470, DOI 10.1016/S0006-291X(88)80865-9; YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84; YOSHIMURA F, 1983, J BIOL CHEM, V258, P2308	53	171	177	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					770	779						10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702438				2022-12-27	WOS:A1991ET17700018
J	CHEIFETZ, S; HERNANDEZ, H; LAIHO, M; TENDIJKE, P; IWATA, KK; MASSAGUE, J				CHEIFETZ, S; HERNANDEZ, H; LAIHO, M; TENDIJKE, P; IWATA, KK; MASSAGUE, J			DISTINCT TRANSFORMING GROWTH-FACTOR-BETA (TGF-BETA) RECEPTOR SUBSETS AS DETERMINANTS OF CELLULAR RESPONSIVENESS TO 3 TGF-BETA ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									ONCOGENE SCI INC,MANHASSET,NY 11030; MEM SLOAN KETTERING CANC CTR,CELL BIOL & GENET PROGRAM,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center	CHEIFETZ, S (corresponding author), MEM SLOAN KETTERING CANC CTR,HOWARD HUGHES MED INST,NEW YORK,NY 10021, USA.		Dijke, Peter ten/AAG-4660-2021	Dijke, Peter ten/0000-0002-7234-342X; Massague, Joan/0000-0001-9324-8408	NATIONAL CANCER INSTITUTE [R01CA034610, R37CA034610] Funding Source: NIH RePORTER; NCI NIH HHS [CA 34610] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDRES JL, 1989, J CELL BIOL, V109, P3137, DOI 10.1083/jcb.109.6.3137; BOYD FT, 1989, J BIOL CHEM, V264, P2272; CCHEIFETZ S, 1988, J BIOL CHEM, V263, P10783; CHEIFETZ S, 1987, CELL, V48, P409, DOI 10.1016/0092-8674(87)90192-9; CHEIFETZ S, 1988, J BIOL CHEM, V263, P16984; CHEIFETZ S, 1989, J BIOL CHEM, V264, P12025; DANIELPOUR D, 1990, J BIOL CHEM, V265, P6973; DERYNCK R, 1988, EMBO J, V7, P3737, DOI 10.1002/j.1460-2075.1988.tb03257.x; GRAYCAR JL, 1989, MOL ENDOCRINOL, V3, P1977, DOI 10.1210/mend-3-12-1977; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; HUANG SS, 1988, J BIOL CHEM, V263, P1535; IKEDA T, 1987, BIOCHEMISTRY-US, V26, P2406, DOI 10.1021/bi00383a002; JAKOWLEW SB, 1988, MOL ENDOCRINOL, V2, P747, DOI 10.1210/mend-2-8-747; JENNINGS JC, 1988, J CELL PHYSIOL, V137, P167, DOI 10.1002/jcp.1041370120; KONDAIAH P, 1990, J BIOL CHEM, V265, P1089; LAIHO M, 1990, J BIOL CHEM, V265, P18518; MASSAGUE J, 1987, METHOD ENZYMOL, V146, P174; MASSAGUE J, 1986, P NATL ACAD SCI USA, V83, P8206, DOI 10.1073/pnas.83.21.8206; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; MCCAFFREY TA, 1989, J CELL BIOL, V109, P441, DOI 10.1083/jcb.109.1.441; MILLER DA, 1989, MOL ENDOCRINOL, V3, P1926, DOI 10.1210/mend-3-12-1926; NADALGINARD B, 1978, CELL, V15, P855, DOI 10.1016/0092-8674(78)90270-2; OCONNORMCCOURT MD, 1987, J BIOL CHEM, V262, P14090; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; RAPPOLEE DA, 1988, SCIENCE, V241, P1823, DOI 10.1126/science.3175624; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; ROSA F, 1988, SCIENCE, V239, P783, DOI 10.1126/science.3422517; SEGARINI PR, 1988, J BIOL CHEM, V263, P8366; SEGARINI PR, 1987, J BIOL CHEM, V262, P14655; SEYEDIN SM, 1985, P NATL ACAD SCI USA, V82, P2267, DOI 10.1073/pnas.82.8.2267; SEYEDIN SM, 1987, J BIOL CHEM, V262, P1946; TENDIJKE P, 1988, P NATL ACAD SCI USA, V85, P4715; TENDIJKE P, 1990, ANN NY ACAD SCI, V593, P26; THOMPSON NL, 1989, J CELL BIOL, V108, P661, DOI 10.1083/jcb.108.2.661; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0	35	333	345	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	NOV 25	1990	265	33					20533	20538						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ525	1700790				2022-12-27	WOS:A1990EJ52500073
J	ENGLE, DB; OSMANI, SA; OSMANI, AH; ROSBOROUGH, S; XIN, X; MORRIS, NR				ENGLE, DB; OSMANI, SA; OSMANI, AH; ROSBOROUGH, S; XIN, X; MORRIS, NR			A NEGATIVE REGULATOR OF MITOSIS IN ASPERGILLUS IS A PUTATIVE MEMBRANE-SPANNING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,DEPT PHARMACOL,675 HOES LA,PISCATAWAY,NJ 08854	Rutgers State University New Brunswick; Rutgers State University Medical Center			Osmani, Stephen A./AAS-3904-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034711] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 34711] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clutterbuck A.J, 1974, HDB GENETICS, V1, P447; COVE DJ, 1977, GENETICS PHYSL ASPER; DALE RMK, 1987, METHOD ENZYMOL, V155, P204; DRAETTA G, 1987, CELL, V50, P319, DOI 10.1016/0092-8674(87)90227-3; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; ENGLE DB, 1988, CELL MOTIL CYTOSKEL, V10, P432, DOI 10.1002/cm.970100310; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LEE MG, 1987, NATURE, V327, P31, DOI 10.1038/327031a0; LOHKA M J, 1987, Journal of Cell Biology, V105, p103A; Maniatis T., 1982, MOL CLONING; MAY GS, 1985, J CELL BIOL, V101, P712, DOI 10.1083/jcb.101.3.712; MESSING J, 1983, METHOD ENZYMOL, V101, P20; MILLER BL, 1985, MOL CELL BIOL, V5, P1714, DOI 10.1128/MCB.5.7.1714; MORRIS NR, 1976, EXP CELL RES, V98, P204, DOI 10.1016/0014-4827(76)90480-8; MORRIS NR, 1975, GENET RES, V26, P237, DOI 10.1017/S0016672300016049; NISHIMOTO T, 1978, CELL, V15, P475, DOI 10.1016/0092-8674(78)90017-X; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; ORR WC, 1982, P NATL ACAD SCI-BIOL, V79, P5976, DOI 10.1073/pnas.79.19.5976; OSMANI SA, 1988, CELL, V52, P241, DOI 10.1016/0092-8674(88)90513-2; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHIESTL RH, 1989, MOL CELL BIOL, V9, P1882, DOI 10.1128/MCB.9.5.1882; SCHLEGEL R, 1987, P NATL ACAD SCI USA, V84, P9025, DOI 10.1073/pnas.84.24.9025; SCHLEGEL R, 1986, SCIENCE, V232, P1264, DOI 10.1126/science.2422760; SMITH AE, 1985, PROC R SOC SER B-BIO, V226, P43, DOI 10.1098/rspb.1985.0078; SUNKARA PS, 1979, P NATL ACAD SCI USA, V76, P2799, DOI 10.1073/pnas.76.6.2799; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120	32	39	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16132	16137						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697851				2022-12-27	WOS:A1990DZ95000018
J	LU, L; MONTROSERAFIZADEH, C; GUGGINO, WB				LU, L; MONTROSERAFIZADEH, C; GUGGINO, WB			CA-2+-ACTIVATED K+ CHANNELS FROM RABBIT KIDNEY MEDULLARY THICK ASCENDING LIMB CELLS EXPRESSED IN XENOPUS OOCYTES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									JOHNS HOPKINS UNIV,SCH MED,DEPT PHYSIOL,725 N WOLFE ST,BALTIMORE,MD 21205	Johns Hopkins University					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK032753, R01DK032753] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK32753] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AUGUSTINE GJ, 1988, J PHYSIOL-LONDON, V398, P149, DOI 10.1113/jphysiol.1988.sp017035; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; CHRISTIE MJ, 1989, SCI LETT, V244, P222; CORNEJO M, 1989, J MEMBRANE BIOL, V110, P49, DOI 10.1007/BF01870992; DASCAL N, 1986, SCIENCE, V231, P1147, DOI 10.1126/science.2418503; EDMONDS M, 1971, P NATL ACAD SCI USA, V68, P1336, DOI 10.1073/pnas.68.6.1336; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GALLIN EK, 1988, J MEMBRANE BIOL, V103, P55, DOI 10.1007/BF01871932; GILLO B, 1989, J PHYSIOL-LONDON, V417, P47, DOI 10.1113/jphysiol.1989.sp017789; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GOGELEIN H, 1988, BIOCHIM BIOPHYS ACTA, V947, P521, DOI 10.1016/0304-4157(88)90006-8; GREEN N, 1985, AM J PHYSIOL, V249, P97; GUGGINO SE, 1987, AM J PHYSIOL, V252, pC128, DOI 10.1152/ajpcell.1987.252.2.C128; GUGGINO SE, 1987, AM J PHYSIOL, V252, pC123; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; LEONARD JP, 1987, J NEUROSCI, V7, P875; LU L, 1990, BIOPHYS J, V57, P1117, DOI 10.1016/S0006-3495(90)82632-1; LUBBERT H, 1987, P NATL ACAD SCI USA, V84, P4332, DOI 10.1073/pnas.84.12.4332; MACKINNON R, 1988, J GEN PHYSIOL, V91, P335, DOI 10.1085/jgp.91.3.335; MARUYAMA Y, 1983, NATURE, V305, P228, DOI 10.1038/305228a0; MASU Y, 1987, NATURE, V329, P836, DOI 10.1038/329836a0; MEECH R W, 1970, Federation Proceedings, V29, P834; MEYUHAS O, 1979, CELL, V16, P139, DOI 10.1016/0092-8674(79)90195-8; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; MONTROSERAFIZADEH C, 1990, ANNU REV PHYSIOL, V52, P761; PALLOTTA BS, 1981, NATURE, V293, P471, DOI 10.1038/293471a0; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; STUHMER W, 1987, EUR BIOPHYS J BIOPHY, V14, P131, DOI 10.1007/BF00253837; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; ULLRICH A, 1977, SCIENCE, V196, P1313, DOI 10.1126/science.325648; VERGARA C, 1983, J GEN PHYSIOL, V82, P543, DOI 10.1085/jgp.82.4.543	39	15	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 25	1990	265	27					16190	16194						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ950	1697853				2022-12-27	WOS:A1990DZ95000026
J	ROGERS, JT; BRIDGES, KR; DURMOWICZ, GP; GLASS, J; AURON, PE; MUNRO, HN				ROGERS, JT; BRIDGES, KR; DURMOWICZ, GP; GLASS, J; AURON, PE; MUNRO, HN			TRANSLATIONAL CONTROL DURING THE ACUTE PHASE RESPONSE - FERRITIN SYNTHESIS IN RESPONSE TO INTERLEUKIN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MIT,DEPT APPL BIOL SCI,CAMBRIDGE,MA 02139; MIT,DIV HLTH SCI & TECHNOL,CAMBRIDGE,MA 02139; TUFTS UNIV,USDA,HUMAN NUTR RES CTR,BOSTON,MA 02111	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Tufts University; United States Department of Agriculture (USDA)	ROGERS, JT (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DIV HEMATOL,75 FRANCIS ST,BOSTON,MA 02115, USA.			Rogers, Jack/0000-0003-1262-8578				AURON PE, 1984, P NATL ACAD SCI-BIOL, V81, P7907, DOI 10.1073/pnas.81.24.7907; AZIZ N, 1986, NUCLEIC ACIDS RES, V14, P915, DOI 10.1093/nar/14.2.915; AZIZ N, 1987, P NATL ACAD SCI USA, V84, P8478, DOI 10.1073/pnas.84.23.8478; BABIOR BM, 1984, BLOOD, V64, P959; BAUMANN H, 1987, J BIOL CHEM, V262, P9756; BEISEL WR, 1977, AM J CLIN NUTR, V30, P1236, DOI 10.1093/ajcn/30.8.1236; BRIDGES KR, 1984, J BIOL CHEM, V259, P2970; CAMPBELL CH, 1989, BIOCHEM BIOPH RES CO, V160, P453, DOI 10.1016/0006-291X(89)92454-6; CARRAZANA EJ, 1988, MOL CELL BIOL, V8, P2267, DOI 10.1128/MCB.8.6.2267; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIS RJ, 1986, EMBO J, V5, P653, DOI 10.1002/j.1460-2075.1986.tb04263.x; DENTE L, 1985, NUCLEIC ACIDS RES, V13, P3941, DOI 10.1093/nar/13.11.3941; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; DINARELLO CA, 1988, FASEB J, V2, P108, DOI 10.1096/fasebj.2.2.3277884; DORNER MH, 1985, P NATL ACAD SCI USA, V82, P3139, DOI 10.1073/pnas.82.10.3139; FRISCH SM, 1987, J BIOL CHEM, V262, P16300; GEHRING MR, 1987, J BIOL CHEM, V262, P446; GEIGER T, 1988, J BIOL CHEM, V263, P7141; HENTZE MW, 1987, SCIENCE, V238, P1570, DOI 10.1126/science.3685996; KARIN M, 1985, MOL CELL BIOL, V5, P2866, DOI 10.1128/MCB.5.10.2866; KLASING KC, 1984, AM J PHYSIOL, V247, pR901, DOI 10.1152/ajpregu.1984.247.5.R901; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; KONIJN AM, 1981, BRIT J HAEMATOL, V49, P361, DOI 10.1111/j.1365-2141.1981.tb07238.x; KONIJN AM, 1977, BRIT J HAEMATOL, V37, P7, DOI 10.1111/j.1365-2141.1977.tb08806.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; LIN JJ, 1990, SCIENCE, V247, P74, DOI 10.1126/science.2294594; MATTIA E, 1984, J BIOL CHEM, V259, P2689; MCCLELLAND A, 1984, CELL, V39, P267, DOI 10.1016/0092-8674(84)90004-7; MORRONE G, 1988, J BIOL CHEM, V263, P12554; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; MULLNER EW, 1988, CELL, V53, P815, DOI 10.1016/0092-8674(88)90098-0; PERLMUTTER DH, 1986, SCIENCE, V232, P850, DOI 10.1126/science.3010455; RAMADORI G, 1985, J EXP MED, V162, P930, DOI 10.1084/jem.162.3.930; RAO K, 1986, MOL CELL BIOL, V6, P236, DOI 10.1128/MCB.6.1.236; RAVE N, 1979, NUCLEIC ACIDS RES, V6, P3559, DOI 10.1093/nar/6.11.3559; ROGERS J, 1987, P NATL ACAD SCI USA, V84, P2277, DOI 10.1073/pnas.84.8.2277; ROGERS JT, 1989, REGULATION LIVER GEN, P144; ROUAULT TA, 1988, SCIENCE, V241, P1207, DOI 10.1126/science.3413484; RUDOLPH NS, 1985, J CELL PHYSIOL, V122, P441, DOI 10.1002/jcp.1041220315; SCHULL GE, 1982, J BIOL CHEM, V257, P14187; SIPE JD, 1985, BIOCHEMISTRY-US, V24, P2931, DOI 10.1021/bi00333a018; THEIL EC, 1987, ANNU REV BIOCHEM, V56, P289, DOI 10.1146/annurev.biochem.56.1.289; THOMAS CE, 1985, J BIOL CHEM, V260, P3275; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TORTI SV, 1988, J BIOL CHEM, V263, P12638; WALDEN WE, 1986, BIOCHEMISTRY-US, V25, P2033, DOI 10.1021/bi00356a030; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; WEINBERG ED, 1985, CLIN PHYSIOL BIOCH, V4, P50; WHITE K, 1988, J BIOL CHEM, V263, P8938	51	233	237	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 25	1990	265	24					14572	14578						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV278	1696948				2022-12-27	WOS:A1990DV27800077
J	QUIGLEY, JP; IKAI, A; ARAKAWA, H; OSADA, T; ARMSTRONG, PB				QUIGLEY, JP; IKAI, A; ARAKAWA, H; OSADA, T; ARMSTRONG, PB			REACTION OF PROTEINASES WITH ALPHA-2-MACROGLOBULIN FROM THE AMERICAN HORSESHOE-CRAB, LIMULUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN ALPHA-MACROGLOBULINS; LYSYL AMINO-GROUPS; COMPLEX-FORMATION; CLEAVAGE SITES; CROSS-LINKING; THIOL-ESTER; COVALENT; BINDING; INHIBITION; TRYPSIN	The products generated by the reaction of Limulus alpha-2-macroglobulin with trypsin were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. Unreacted Limulus alpha-2-macroglobulin had a subunit molecular mass of 185 kDa. Trypsin-reacted samples contained two prominent peptides smaller (85 and 100 kDa) and three peptides larger (200, 250, and 300-350 kDa) than the unreacted subunit. Reaction of methylamine-treated Limulus alpha-2-macroglobulin with trypsin resulted in the same two prominent reaction products smaller than 185 kDa, but all of the reaction products larger than 185 kDa were absent. The covalent binding of biotinylated trypsin with Limulus alpha-2-macroglobulin was detected by probing Western blots with horseradish peroxidase-avidin. Surprisingly, the only reaction products that contained trypsin were bands at 100 and 120 kDa. The staining of these bands with horseradish peroxidase-avidin was weak: most of the biotinylated trypsin that remained associated with alpha-2-macroglobulin during gel filtration chromatography was located at the dye front following reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The reaction products larger than 185 kDa did not contain trypsin. Methylamine-reacted Limulus alpha-2-macroglobulin failed to bind any biotinylated trypsin. In contrast to the reaction of trypsin with Limulus alpha-2-macroglobulin, all high molecular mass bands generated by the reaction of human alpha-2-macroglobulin with biotinylated trypsin stained intensely with horseradish peroxidase-avidin. Thus, Limulus alpha-2-macroglobulin forms thiol ester-dependent, high molecular mass products involving isopeptide bonding between trypsin-generated fragments, without the incorporation of trypsin into the complexes. Most of the alpha-2-macroglobulin-associated trypsin is non-covalently trapped rather than covalently cross-linked.	MARINE BIOL LAB,WOODS HOLE,MA 02543; TOKYO INST TECHNOL,BIODYNAM LAB,MIDORI KU,YOKOHAMA,KANAGAWA 227,JAPAN; UNIV CALIF DAVIS,DEPT ZOOL,CELL BIOL LAB,DAVIS,CA 95616	Marine Biological Laboratory - Woods Hole; Tokyo Institute of Technology; University of California System; University of California Davis	QUIGLEY, JP (corresponding author), SUNY STONY BROOK,HLTH SCI CTR,DEPT PATHOL,STONY BROOK,NY 11794, USA.				NIGMS NIH HHS [GM 38185] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARAKAWA H, 1989, J BIOL CHEM, V264, P2350; ARMSTRONG PB, 1990, BIOL BULL, V178, P137, DOI 10.2307/1541972; ARMSTRONG PB, 1985, J EXP ZOOL, V236, P1, DOI 10.1002/jez.1402360102; ARMSTRONG PB, 1991, J BIOL CHEM, V266, P2526; ARMSTRONG PB, 1987, BIOCHEM J, V248, P703, DOI 10.1042/bj2480703; ARMSTRONG PB, 1991, IN PRESS IMMUNOLOGY; ARMSTRONG PB, 1985, BLOOD CELLS MARINE I, P253; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BARRETT AJ, 1973, BIOCHEM J, V133, P709, DOI 10.1042/bj1330709; BJORK I, 1984, BIOCHEM J, V217, P303; BJORK I, 1985, BIOCHEMISTRY-US, V24, P2653; BJORK I, 1982, BIOCHEM J, V207, P347; BOYDE TRC, 1968, CLIN CHIM ACTA, V21, P9, DOI 10.1016/0009-8981(68)90003-X; CHRISTENSEN U, 1989, BIOCHEMISTRY-US, V28, P9324, DOI 10.1021/bi00450a012; CREWS BC, 1987, BIOCHEMISTRY-US, V26, P5963, DOI 10.1021/bi00393a003; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; ENGHILD JJ, 1990, BIOCHEMISTRY-US, V29, P10070, DOI 10.1021/bi00495a009; FEINMAN RD, 1983, ANN NY ACAD SCI, V421, P178, DOI 10.1111/j.1749-6632.1983.tb18108.x; FEINMAN RD, 1985, BIOCHEM J, V231, P417, DOI 10.1042/bj2310417; FEINMAN RD, 1983, CHEM BIOL ALPHA2 MAC; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; GANROT PO, 1966, CLIN CHIM ACTA, V14, P493, DOI 10.1016/0009-8981(66)90037-4; GONIAS SL, 1983, BIOCHEMISTRY-US, V22, P536, DOI 10.1021/bi00272a003; GONIAS SL, 1983, BIOCHEMISTRY-US, V22, P4933, DOI 10.1021/bi00290a009; GONIAS SL, 1983, J BIOL CHEM, V258, P14628; HALL PK, 1978, BIOCHEM J, V173, P27, DOI 10.1042/bj1730027; HARPEL PC, 1983, ANN NY ACAD SCI, V421, P1, DOI 10.1111/j.1749-6632.1983.tb18088.x; HOWARD JB, 1981, P NATL ACAD SCI-BIOL, V78, P2235, DOI 10.1073/pnas.78.4.2235; HOWELL JB, 1983, ARCH BIOCHEM BIOPHYS, V221, P261, DOI 10.1016/0003-9861(83)90143-1; HUANG JS, 1989, AM J RESP CELL MOL, V1, P169, DOI 10.1165/ajrcmb/1.3.169; IKAI A, 1990, J BIOL CHEM, V265, P8280; JAMES K, 1990, IMMUNOL TODAY, V11, P163, DOI 10.1016/0167-5699(90)90067-J; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE RP, 1989, CURR TOP MICROBIOL I, V153, P73; LONBERGHOLM K, 1987, J BIOL CHEM, V262, P4844; MCPHERSON TA, 1970, IMMUNOLOGY, V19, P929; MEIJERS JCM, 1987, BIOCHEMISTRY-US, V26, P5932, DOI 10.1021/bi00392a053; NAGASE H, 1983, J BIOL CHEM, V258, P7490; NELLES LP, 1980, BIOCHIM BIOPHYS ACTA, V623, P677; OSADA T, 1986, J ULTRA MOL STRUCT R, V96, P136, DOI 10.1016/0889-1605(86)90014-5; PETERSON CGB, 1987, BIOCHEM J, V245, P781, DOI 10.1042/bj2450781; PIZZO SV, 1986, BIOL CHEM H-S, V367, P1177, DOI 10.1515/bchm3.1986.367.2.1177; POCHON F, 1987, FEBS LETT, V217, P101, DOI 10.1016/0014-5793(87)81251-6; POCHON F, 1981, J BIOL CHEM, V256, P547; QUIGLEY JP, 1983, J BIOL CHEM, V258, P7903; QUIGLEY JP, 1985, J BIOL CHEM, V260, P2715; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SALVESEN GS, 1980, BIOCHEM J, V187, P695, DOI 10.1042/bj1870695; SANTAMBROGIO P, 1989, BRIT J HAEMATOL, V71, P281, DOI 10.1111/j.1365-2141.1989.tb04268.x; Sottrup-Jensen L., 1987, PLASMA PROTEINS, V5, P191; SOTTRUPJENSEN L, 1981, FEBS LETT, V128, P127, DOI 10.1016/0014-5793(81)81097-6; SOTTRUPJENSEN L, 1980, FEBS LETT, V121, P275, DOI 10.1016/0014-5793(80)80361-9; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P393; SOTTRUPJENSEN L, 1990, COMP BIOCHEM PHYS B, V96, P621, DOI 10.1016/0305-0491(90)90066-3; SOTTRUPJENSEN L, 1981, FEBS LETT, V128, P123, DOI 10.1016/0014-5793(81)81096-4; STOLLAR BD, 1978, ARCH BIOCHEM BIOPHYS, V190, P398, DOI 10.1016/0003-9861(78)90292-8; TACK BF, 1983, SPRINGER SEMIN IMMUN, V6, P259, DOI 10.1007/BF02116276; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANDERGRAAF F, 1984, BIOCHEMISTRY-US, V23, P1760, DOI 10.1021/bi00303a027; VANLEUVEN F, 1981, J BIOL CHEM, V256, P9023; VANLEUVEN F, 1981, J BIOL CHEM, V256, P9016; VANLEUVEN F, 1984, MOL CELL BIOCHEM, V58, P121, DOI 10.1007/BF00240611; WALLER EK, 1983, BIOCHEM J, V215, P123, DOI 10.1042/bj2150123; WANG D, 1981, ARCH BIOCHEM BIOPHYS, V211, P500, DOI 10.1016/0003-9861(81)90483-5; WANG D, 1984, BIOCHEMISTRY-US, V23, P2807, DOI 10.1021/bi00307a042; WU K, 1981, J BIOL CHEM, V256, P409	68	23	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 15	1991	266	29					19426	19431						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK667	1717464				2022-12-27	WOS:A1991GK66700048
J	BATES, RC; RANKIN, LM; LUCAS, CM; SCOTT, JL; KRISSANSEN, GW; BURNS, GF				BATES, RC; RANKIN, LM; LUCAS, CM; SCOTT, JL; KRISSANSEN, GW; BURNS, GF			INDIVIDUAL EMBRYONIC FIBROBLASTS EXPRESS MULTIPLE BETA-CHAINS IN ASSOCIATION WITH THE ALPHA-V INTEGRIN SUBUNIT - LOSS OF BETA-3 EXPRESSION WITH CELL CONFLUENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH FACTOR-BETA; VITRONECTIN RECEPTOR; ADHESION RECEPTORS; VONWILLEBRAND-FACTOR; FIBRONECTIN; ATTACHMENT; ANTIGEN; FAMILY; IDENTIFICATION; SYNTHESIZE	The alpha-chain of the vitronectin receptor, alpha-v, has been found in association with the integrin subunits beta-1, beta-3, or beta-5 on different cell types. We show here that cultured embryonic fibroblasts simultaneously display alpha-v-beta-3, alpha-v-beta-1, and alpha-v in association with two other beta-subunits, one of which is probably beta-5. Polymerase chain reaction analysis of single cells isolated by micromanipulation identified mRNA for alpha-v, beta-1, beta-3, and beta-5 in six of eight clones. Immunoprecipitation of iodinated cell surface proteins with a monoclonal antibody to alpha-v indicated that the relative proportions of the different beta-chains in association with alpha-v varied, particularly between two different cell lines. The cytokines platelet-derived growth factor, transforming growth factor-beta-1, and tumor necrosis factor-alpha did not appear to alter this ratio although tumor necrosis factor-alpha increased the surface expression of the alpha-v-associated integrins; but overnight culture in basic fibroblast growth factor caused a lower expression of alpha-v-beta-1 and alpha-v-beta-5 with no reduction in alpha-v-beta-3 expression. When the cell cultures were grown to complete confluence, surface expression of beta-3 was abolished, and the expression of an unknown beta-chain (beta-u) became more prominent. This effect was not overcome by culturing confluent cells with basic fibroblast growth factor. Affinity column chromatography showed that alpha-v-beta-5 bound to vitronectin but alpha-v-beta-1 did not, whereas alpha-v-beta-1 but not alpha-v-beta-5 bound to fibronectin. These results suggest that, on individual cells, the beta-subunits found in association with alpha-v may vary according to the proliferative capacity of the cell and that the promiscuous beta-3 subunit is progressively replaced by beta-subunits of individual ligand specificity.	UNIV NEWCASTLE,FAC MED,CANC RES UNIT,NEWCASTLE,NSW 2308,AUSTRALIA; UNIV AUCKLAND,SCH MED,DEPT MOLEC MED,AUCKLAND,NEW ZEALAND	University of Newcastle; University of Auckland								BODARY SC, 1990, J BIOL CHEM, V265, P5938; BOURDON MA, 1989, J CELL BIOL, V108, P1149, DOI 10.1083/jcb.108.3.1149; BURNS GF, 1982, CELL IMMUNOL, V71, P12, DOI 10.1016/0008-8749(82)90492-0; CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795; CHERESH DA, 1989, CELL, V57, P59, DOI 10.1016/0092-8674(89)90172-4; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; DAVIES J, 1989, J CELL BIOL, V109, P1817, DOI 10.1083/jcb.109.4.1817; DEDHAR S, 1990, J CELL BIOL, V110, P2185, DOI 10.1083/jcb.110.6.2185; DUNN SM, 1988, TRANSPLANT P, V21, P31; FINGERMAN E, 1988, EXP CELL RES, V177, P132, DOI 10.1016/0014-4827(88)90031-6; FREED E, 1989, EMBO J, V8, P2955, DOI 10.1002/j.1460-2075.1989.tb08445.x; GANI JS, 1990, LIFE SCI, V2, P32; HEINO J, 1989, J BIOL CHEM, V264, P380; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; IGNOTZ RA, 1989, J BIOL CHEM, V264, P389; KIRCHHOFER D, 1990, J BIOL CHEM, V265, P615; KRISSANSEN GW, 1990, J BIOL CHEM, V265, P823; KRISSANSEN GW, 1986, EMBO J, V5, P1799, DOI 10.1002/j.1460-2075.1986.tb04429.x; KRISSANSEN GW, 1990, INT IMMUNOL, V2, P267, DOI 10.1093/intimm/2.3.267; MACDONALD RJ, 1987, METHOD ENZYMOL, V152, P219; MCLEAN JW, 1990, J BIOL CHEM, V265, P17126; PYTELA R, 1986, SCIENCE, V231, P1559, DOI 10.1126/science.2420006; RAMASWAMY H, 1990, EMBO J, V9, P1561, DOI 10.1002/j.1460-2075.1990.tb08275.x; RAPPOLEE DA, 1989, J CELL BIOCHEM, V39, P1, DOI 10.1002/jcb.240390102; RUAN CG, 1987, BLOOD, V69, P570; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SMITH JW, 1990, J BIOL CHEM, V265, P11008; STAMATOGLOU SC, 1990, J CELL BIOL, V111, P2117, DOI 10.1083/jcb.111.5.2117; SUZUKI S, 1990, P NATL ACAD SCI USA, V87, P5354, DOI 10.1073/pnas.87.14.5354; TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593; VANKUPPEVELT THMSM, 1989, P NATL ACAD SCI USA, V86, P5415; VANNOESEL C, 1988, NATURE, V333, P850, DOI 10.1038/333850a0; VOGEL BE, 1990, J BIOL CHEM, V265, P5934; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P218	34	54	56	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18593	18599						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717451				2022-12-27	WOS:A1991GJ47200032
J	SIHAG, RK; NIXON, RA				SIHAG, RK; NIXON, RA			IDENTIFICATION OF SER-55 AS A MAJOR PROTEIN KINASE-A PHOSPHORYLATION SITE ON THE 70-KDA SUBUNIT OF NEUROFILAMENTS - EARLY TURNOVER DURING AXONAL-TRANSPORT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL GANGLION-CELLS; TERMINAL HEAD DOMAIN; INTERMEDIATE FILAMENTS; MITOTIC CELLS; MEMBRANE INTERACTIONS; DESMIN DERIVATIVES; TRIPLET PROTEINS; PLASMA-MEMBRANE; NF-L; VIMENTIN	The 70-kDa neurofilament protein subunit (NF-L) is phosphorylated in vivo on at least three sites (L1 to L3) (Sihag, R. K., and Nixon, R. A. (1989) J. Biol. Chem. 264, 457-464). The turnover of phosphate groups on NF-L during axonal transport was determined after the neurofilaments in retinal ganglion cells were phosphorylated in vivo by injecting mice intravitreally with [P-32]orthophosphate. Two-dimensional phosphopeptide maps of NF-L from optic axons of mice 10 to 90 h after injection showed that radiolabel decreased faster from peptides L2 and L3 than from L1 as neurofilaments were transported. To identify phosphorylation sites on peptide L2, axonal cytoskeletons were phosphorylated by protein kinase A in the presence of heparin. After the isolated NF-L subunits were digested with alpha-chymotrypsin, P-32-peptides were separated by high performance liquid chromatography on a reverse-phase C8 column. Two-dimensional peptide mapping showed that the alpha-chymotrypsin P-32-peptide accepting most of the phosphates from protein kinase A migrated identically with the in vivo-labeled phosphopeptide L2. The sequence of this peptide (S-V-R-R-S-Y) analyzed by automated Edman degradation corresponded to amino acid residues 51-56 of the NF-L sequence. A synthetic 13-mer (S-L-S-V-R-R-S-Y-S-S-S-S-G) corresponding to amino acid residues 49-61 of NF-L was also phosphorylated by protein kinase A. alpha-Chymotryptic digestion of the 13-mer generated a peptide which contained most of the phosphates and co-migrated with the phosphopeptide L2 on two-dimensional phosphopeptide maps. Edman degradation of the phosphorylated 13-mer identified serine residue 55 which is located within a consensus phosphorylation sequence for protein kinase A as the major site of phosphorylation. Since protein kinase A-mediated phosphorylation influences intermediate filament assembly/disassembly in vitro, we propose that the phosphopeptide L2 region is a neurofilament-assembly domain and that the cycle of phosphorylation and dephosphorylation of Ser-55 on NF-L, which occurs relatively early after subunit synthesis in vivo, regulaaes a step in neurofilament assembly or initial interactions during axonal transport.	HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PSYCHIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM NEUROSCI,BOSTON,MA 02115	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	SIHAG, RK (corresponding author), MCLEAN HOSP,MAILMAN RES CTR,MOLEC NEUROSCI LABS,115 MILL ST,BELMONT,MA 02178, USA.				NATIONAL INSTITUTE ON AGING [R37AG005604, R01AG005604, P01AG002126] Funding Source: NIH RePORTER; NIA NIH HHS [AG05604, AG02126] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANGELIDES KJ, 1989, J CELL BIOL, V108, P1495, DOI 10.1083/jcb.108.4.1495; BLACK MM, 1988, J NEUROSCI, V8, P3296; CARDEN MJ, 1985, J BIOL CHEM, V260, P9805; CELIS JE, 1983, J CELL BIOL, V97, P1429, DOI 10.1083/jcb.97.5.1429; CHOU YH, 1989, P NATL ACAD SCI USA, V86, P1885, DOI 10.1073/pnas.86.6.1885; EVANS RM, 1984, J BIOL CHEM, V259, P5372; FRANKE WW, 1987, CELL, V48, P38; FRAPPIER T, 1987, EUR J BIOCHEM, V109, P651; GEISLER N, 1985, FEBS LETT, V182, P475, DOI 10.1016/0014-5793(85)80357-4; Geisler N., 1986, P41; GEISLER N, 1988, EMBO J, V7, P15, DOI 10.1002/j.1460-2075.1988.tb02778.x; GEISLER N, 1987, FEBS LETT, V221, P403, DOI 10.1016/0014-5793(87)80964-X; GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; GILL SR, 1990, J CELL BIOL, V111, P2005, DOI 10.1083/jcb.111.5.2005; GONDA Y, 1990, BIOCHEM BIOPH RES CO, V167, P1316, DOI 10.1016/0006-291X(90)90667-C; HISANAGA S, 1990, CELL REGUL, V1, P237, DOI 10.1091/mbc.1.2.237; INAGAKI M, 1989, J BIOL CHEM, V264, P18119; INAGAKI M, 1988, J BIOL CHEM, V263, P5970; JULIEN JP, 1982, J BIOL CHEM, V257, P467; JULIEN JP, 1983, J BIOL CHEM, V258, P4019; JULIEN JP, 1986, MOL BRAIN RES, V1, P243, DOI 10.1016/0169-328X(86)90030-6; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETERRIER JF, 1982, J CELL BIOL, V95, P982, DOI 10.1083/jcb.95.3.982; MEYER HE, 1986, FEBS LETT, V204, P61, DOI 10.1016/0014-5793(86)81388-6; NAKAMURA Y, 1990, BIOCHEM BIOPH RES CO, V169, P744, DOI 10.1016/0006-291X(90)90394-3; NIXON RA, 1980, BRAIN RES, V200, P69, DOI 10.1016/0006-8993(80)91095-1; NIXON RA, 1986, J BIOL CHEM, V261, P6298; NIXON RA, 1989, MOL BRAIN RES, V5, P93, DOI 10.1016/0169-328X(89)90001-6; NIXON RA, 1991, IN PRESS TRENDS NEUR; PAPPIN DJC, 1990, CURRENT RES PROTEIN, P191; SHARP GA, 1982, EXP CELL RES, V137, P403, DOI 10.1016/0014-4827(82)90042-8; SHAW G, 1990, J NEUROSCI RES, V25, P561, DOI 10.1002/jnr.490250414; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; SIHAG R K, 1987, Journal of Cell Biology, V105, p207A; SIHAG R K, 1990, Journal of Cell Biology, V111, p433A; SIHAG RK, 1988, FEBS LETT, V233, P181, DOI 10.1016/0014-5793(88)81380-2; SIHAG RK, 1989, J BIOL CHEM, V264, P457; SIHAG RK, 1990, J BIOL CHEM, V265, P4166; SIHAG RK, 1989, J CELL BIOL, V107, pA463; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; TOLLE HG, 1987, EUR J CELL BIOL, V43, P35; TRAUB P, 1984, J CELL SCI, V65, P1; WILLARD M, 1983, CELL, V35, P551, DOI 10.1016/0092-8674(83)90189-7	46	115	116	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 5	1991	266	28					18861	18867						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ472	1717455				2022-12-27	WOS:A1991GJ47200071
J	WANG, CC; SPREMULLI, LL				WANG, CC; SPREMULLI, LL			CHLOROPLAST TRANSLATIONAL INITIATION FACTOR-III - PURIFICATION AND CHARACTERIZATION OF MULTIPLE FORMS FROM EUGLENA-GRACILIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; FACTOR-III; NUCLEAR LOCATION; FACTOR IF-3; START-SITE; BINDING; GENE; RNA; IDENTIFICATION	The chloroplast translational initiation factor 3 (IF-3chl) has been purified by a combination of gravity and high pressure liquid chromatographic steps. IF-3chl activity has been resolved into three forms designated alpha, beta, and gamma. Analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicates that the alpha-form corresponds to a single polypeptide with a molecular mass of approximately 34 kDa. The beta and gamma-forms have been purified to near homogeneity, and both forms appear to function as monomers with molecular masses of about 39-42 kDa. All three forms are heat stable. All the forms of IF-3chl detected enhance the poly (A,U,G)-dependent binding of the initiator tRNA to chloroplast 30 S ribosomal subunits in the presence of Escherichia coli IF-1 and IF-2. the chloroplast factor, unlike the corresponding bacterial factor, does not have a strong RNA binding activity.	UNIV N CAROLINA,DEPT BIOL,CHAPEL HILL,NC 27599; UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024963] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24963] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEARDEN JC, 1978, BIOCHIM BIOPHYS ACTA, V533, P525, DOI 10.1016/0005-2795(78)90398-7; BOYNTON JE, 1980, RIBOSOMES STRUCTURE, P903; BRAUER D, 1977, FEBS LETT, V79, P269, DOI 10.1016/0014-5793(77)80801-6; BREITENBERGER CA, 1979, ARCH BIOCHEM BIOPHYS, V194, P265, DOI 10.1016/0003-9861(79)90617-9; CIGAN AM, 1988, SCIENCE, V242, P93, DOI 10.1126/science.3051379; DONAHUE TF, 1988, CELL, V54, P621, DOI 10.1016/S0092-8674(88)80006-0; EBERLY SL, 1986, ARCH BIOCHEM BIOPHYS, V245, P338, DOI 10.1016/0003-9861(86)90224-9; EHRESMANN C, 1986, NUCLEIC ACIDS RES, V14, P4803, DOI 10.1093/nar/14.12.4803; FAKUNDING JL, 1973, J BIOL CHEM, V248, P4206; FOX L, 1981, J BIOL CHEM, V256, P7796; FOX L, 1980, J BIOL CHEM, V255, P6018; GOLD JC, 1985, J BIOL CHEM, V260, P4897; GRAVES MC, 1983, ARCH BIOCHEM BIOPHYS, V222, P192, DOI 10.1016/0003-9861(83)90516-7; Gualerzi C, 1981, STRUCTURAL ASPECTS R, P805; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; HARTZ D, 1989, GENE DEV, V3, P1899, DOI 10.1101/gad.3.12a.1899; HERSHEY JWB, 1977, ARCH BIOCHEM BIOPHYS, V182, P626, DOI 10.1016/0003-9861(77)90543-4; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; KAY AC, 1976, BIOCHIMIE, V58, P183, DOI 10.1016/S0300-9084(76)80369-0; KOZAK M, 1983, MICROBIOL REV, V47, P1; KRAUS BL, 1986, J BIOL CHEM, V261, P4781; KRAUS BL, 1988, PLANT PHYSIOL, V88, P993, DOI 10.1104/pp.88.4.993; KRAUS BL, 1987, THESIS U N CAROLINA, P26; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEFFLER S, 1974, J BIOL CHEM, V249, P1458; MA L, 1990, J BIOL CHEM, V265, P13560; PAIN VM, 1986, BIOCHEM J, V235, P625, DOI 10.1042/bj2350625; SCHLEICH T, 1980, BIOCHEMISTRY-US, V19, P4486, DOI 10.1021/bi00560a016; SCHMIDT BF, 1985, ARCH BIOCHEM BIOPHYS, V240, P217, DOI 10.1016/0003-9861(85)90026-8; SCHMIDT BF, 1985, ARCH BIOCHEM BIOPHYS, V240, P207, DOI 10.1016/0003-9861(85)90025-6; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SPREMULLI LL, 1982, ARCH BIOCHEM BIOPHYS, V214, P734, DOI 10.1016/0003-9861(82)90080-7; WANG CC, 1989, NUCLEIC ACIDS RES, V17, P9735, DOI 10.1093/nar/17.23.9735	33	8	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1991	266	26					17079	17083						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GF445	1716626				2022-12-27	WOS:A1991GF44500020
J	YOSHIMURA, K; NAKAMURA, H; TRAPNELL, BC; DALEMANS, W; PAVIRANI, A; LECOCQ, JP; CRYSTAL, RG				YOSHIMURA, K; NAKAMURA, H; TRAPNELL, BC; DALEMANS, W; PAVIRANI, A; LECOCQ, JP; CRYSTAL, RG			THE CYSTIC-FIBROSIS GENE HAS A HOUSEKEEPING-TYPE PROMOTER AND IS EXPRESSED AT LOW-LEVELS IN CELLS OF EPITHELIAL ORIGIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; DEPENDENT PROTEIN-KINASE; CHLORIDE CHANNELS; AIRWAY EPITHELIA; MAMMALIAN-CELLS; DNA; IDENTIFICATION; TRANSCRIPTION; MUTATIONS; ELEMENTS	Evaluation of the expression of the cystic fibrosis (CF) gene in human epithelial cell lines demonstrated active, but low level, transcription of the gene. Analysis of 3.8 kilobases of genomic sequences 5' to exon 1 of the CF gene demonstrated no TATA promoter element, but a high G + C content, multiple transcription start sites, and several potential Sp1 binding sites. Fragments of 5'-flanking sequences from 2.2 kilobases to as small as 102 base pairs 5' to the major transcription start site supported constitutive reporter gene expression in epithelial cells, but at low levels, and independent of the length of the 5' fragment. CF gene transcription was down-regulated by phorbol myristate acetate. Importantly, evaluation of freshly isolated normal human bronchial cells also demonstrated CF gene transcription at a relatively low rate. Together, these observations suggest that although the normal CF gene promoter has characteristics of a "housekeeping"-type gene, and the gene is expressed at low levels in cells of organs that manifest the clinical disorder "cystic fibrosis," its expression can be modulated transcriptionally, implying a possible therapeutic approach for the disease.	TRANSGENE SA,F-67082 STRASBOURG,FRANCE	Transgene SA	YOSHIMURA, K (corresponding author), NHLBI,PULM BRANCH,BLDG 10,RM 6D03,BETHESDA,MD 20892, USA.							al-Awqati Q, 1989, Soc Gen Physiol Ser, V44, P283; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; BORNSTEIN P, 1987, P NATL ACAD SCI USA, V84, P8869, DOI 10.1073/pnas.84.24.8869; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLIFF WH, 1990, P NATL ACAD SCI USA, V87, P4956, DOI 10.1073/pnas.87.13.4956; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DRUMM ML, 1990, CELL, V62, P1227, DOI 10.1016/0092-8674(90)90398-X; DYNAN WS, 1986, TRENDS GENET, V2, P196, DOI 10.1016/0168-9525(86)90226-X; FRIZZELL RA, 1986, SCIENCE, V233, P558, DOI 10.1126/science.2425436; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GREGORY RJ, 1990, NATURE, V347, P382, DOI 10.1038/347382a0; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HWANG TC, 1989, SCIENCE, V244, P1351, DOI 10.1126/science.2472005; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES MR, 1983, SCIENCE, V221, P1067, DOI 10.1126/science.6308769; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; LI M, 1989, SCIENCE, V244, P1353, DOI 10.1126/science.2472006; LI M, 1988, NATURE, V331, P358, DOI 10.1038/331358a0; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MEEKER TC, 1990, MOL CELL BIOL, V10, P1680, DOI 10.1128/MCB.10.4.1680; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHOUMACHER RA, 1990, P NATL ACAD SCI USA, V87, P4012, DOI 10.1073/pnas.87.10.4012; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; TRAPNELL BC, 1991, IN PRESS P NATL ACAD; WELSH MJ, 1986, NATURE, V322, P467, DOI 10.1038/322467a0; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WIDDICOMBE JH, 1986, AM J PHYSIOL, V251, pR818, DOI 10.1152/ajpregu.1986.251.4.R818	37	167	169	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 15	1991	266	14					9140	9144						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FM038	1709163				2022-12-27	WOS:A1991FM03800073
J	CHAMBERS, C; RUSSELL, P				CHAMBERS, C; RUSSELL, P			DELETION MUTATION IN AN EYE LENS BETA-CRYSTALLIN - AN ANIMAL-MODEL FOR INHERITED CATARACTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CRYSTALLIN; HEREDITARY CATARACT; MESSENGER-RNAS; PHILLY MOUSE; GENE FAMILY; PROTEINS; DNA; LOCUS; SEQUENCE; CDNA	The most prevalent proteins in the lens of the eye are called crystallins, and it is thought that aberrant crystallins may cause opacification of lens tissue. The Philly mouse, a strain with an inherited cataract, has an abnormal beta-B2-crystallin, the principal beta-crystallin in the mouse. The cDNA that codes for the beta-B2-crystallin protein has been cloned and sequenced from both the normal and the cataractous Philly mouse. The normal mouse beta-B2 cDNA is 756 nucleotides in length with 618 nucleotides of open reading frame. An in-frame deletion of 12 nucleotides has occurred in the Philly mouse cDNA, which results in the loss of 4 amino acids. The sequence of the mutant beta-B2 was analyzed against the reported structure of the normal bovine beta-B2-crystallin determined by x-ray crystallography. The region, in which the deletion of the amino acids occurs near the COOH terminus, is essential for the formation of the tertiary structure of the beta-B2-crystallin. The loss of these residues could explain the alterations that are seen with the Philly beta-B2 protein and may account for the instability of the Philly beta-B2 protein. This abnormal beta-B2-crystallin may be the cause of the cataract in this animal.			CHAMBERS, C (corresponding author), NEI,MECHANISMS OCULAR DIS LAB,BLDG 6,RM 228,BETHESDA,MD 20892, USA.							AARTS HJM, 1989, EUR J BIOCHEM, V183, P31, DOI 10.1111/j.1432-1033.1989.tb14892.x; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; BERBERS GAM, 1984, EUR J BIOCHEM, V139, P467, DOI 10.1111/j.1432-1033.1984.tb08029.x; BERBERS GAM, 1982, EUR J BIOCHEM, V128, P495; BETTELHEIM FA, 1982, CELL BIOL EYE, P243; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DERMAN E, 1981, CELL, V23, P731, DOI 10.1016/0092-8674(81)90436-0; GORIN MB, 1984, CURR EYE RES, V3, P939, DOI 10.3109/02713688409167211; Harding J.J., 1981, MOL CELLULAR BIOL EY, P327; HOGG D, 1987, CURR EYE RES, V6, P1335, DOI 10.3109/02713688708997559; KADOR PF, 1980, EXP EYE RES, V30, P59, DOI 10.1016/0014-4835(80)90124-4; KLEIMAN NJ, 1988, J BIOL CHEM, V263, P14978; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LUBSEN NH, 1988, PROG BIOPHYS MOL BIO, V51, P47, DOI 10.1016/0079-6107(88)90010-7; LUBSEN NH, 1987, P NATL ACAD SCI USA, V84, P489, DOI 10.1073/pnas.84.2.489; MAITI M, 1988, FEBS LETT, V236, P109, DOI 10.1016/0014-5793(88)80295-3; NAKAMURA M, 1989, J BIOFL CHEM, V263, P19218; OSTRER H, 1981, DEV BIOL, V86, P403, DOI 10.1016/0012-1606(81)90198-6; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; PIATIGORSKY J, 1984, CELL, V38, P620, DOI 10.1016/0092-8674(84)90254-X; RAMAEKERS F, 1982, EUR J BIOCHEM, V128, P503; RUSSELL P, 1979, EXP EYE RES, V29, P245, DOI 10.1016/0014-4835(79)90005-8; RUSSELL P, 1990, EXP EYE RES, V50, P683, DOI 10.1016/0014-4835(90)90114-A; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIEZEN RJ, 1985, P NATL ACAD SCI USA, V82, P1701, DOI 10.1073/pnas.82.6.1701; SLINGSBY C, 1990, BIOCHEMISTRY-US, V29, P6592, DOI 10.1021/bi00480a007; SLINGSBY C, 1988, EXP EYE RES, V46, P375, DOI 10.1016/S0014-4835(88)80027-7; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; WISTOW G, 1981, FEBS LETT, V133, P9, DOI 10.1016/0014-5793(81)80460-7; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754; YOUNG RA, 1983, P NATL ACAD SCI-BIOL, V80, P1194, DOI 10.1073/pnas.80.5.1194; ZIGLER JS, 1981, OPHTHALMIC RES, V13, P237, DOI 10.1159/000265154; ZIGLER JS, 1980, EXP EYE RES, V31, P41, DOI 10.1016/0014-4835(80)90089-5; ZIGLER JS, 1990, EXP EYE RES, V50, P651, DOI 10.1016/0014-4835(90)90109-8; ZIGLER JS, 1976, COMP BIOCHEM PHYS B, V53, P349, DOI 10.1016/0305-0491(76)90340-0	37	104	107	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 15	1991	266	11					6742	6746						5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FG727	1707874				2022-12-27	WOS:A1991FG72700018
J	MAGNI, M; MELDOLESI, J; PANDIELLA, A				MAGNI, M; MELDOLESI, J; PANDIELLA, A			IONIC EVENTS INDUCED BY EPIDERMAL GROWTH-FACTOR - EVIDENCE THAT HYPERPOLARIZATION AND STIMULATED CATION INFLUX PLAY A ROLE IN THE STIMULATION OF CELL-GROWTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC CA-2+; FACTOR RECEPTOR; A431 CELLS; TYROSINE PHOSPHORYLATION; INTRACELLULAR STORES; INOSITOL PHOSPHATES; CALCIUM ENTRY; A-431 CELLS; GENERATION; ONCOGENE	Charybdotoxin, a blocker of K+ channels, and the imidazole drug SC38249, a blocker of both voltage- and second messenger-operated Ca2+ channels, were employed in mouse NIH-3T3 fibroblasts overexpressing the epidermal growth factor (EGF) receptor 1) to characterize the ionic events activated by EGF; and 2) to establish the role of those events in cell growth. The [Ca2+]i response by EGF was little changed by charybdotoxin while the parallel hyperpolarization was inhibited in a dose-dependent manner. At high toxin concentrations (> 3 X 10(-8) M), the effect of EGF on membrane potential was turned into a persistent depolarization sustained by both Na+ and Ca2+. Pretreatment with 10-mu-M SC38249 induced only minor changes of the intracellular Ca2+ release by EGF (the process responsible for the initial phase of the [Ca2+]i and membrane potential responses) and blocked the persistent, second phase [Ca2+]i and the hyperpolarization responses, both dependent on Ca2+ influx, as well as the depolarization in the charybdotoxin-pretreated cells. Long term (up to 2-day) treatment with either charybdotoxin or SC38249 failed to affect the viability and growth of unstimulated EGFR-T17 cells. Moreover, in these cells, the ionic responses to EGF were restored after a 30-min incubation in fresh medium. In contrast, growth stimulated by EGF was inhibited, moderately (-20%) by charybdotoxin and markedly (-60%) by SC38249. These results indicate for the first time that both hyperpolarization and, especially, the persistent increase of [Ca2+]i sustained by Ca2+ influx play a role in the activity of EGF, ultimately cooperating with other intracellular events in mitogenesis.			MAGNI, M (corresponding author), UNIV MILANO,SCI INST S RAFFAELE,CNR,CTR CYTOPHARMACOL,DEPT PHARMACOL,I-20132 MILAN,ITALY.		Pandiella, Atanasio/O-5180-2014	Pandiella, Atanasio/0000-0002-4704-8971				ASHKENAZI A, 1989, NATURE, V340, P146, DOI 10.1038/340146a0; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; FASOLATO C, 1988, J BIOL CHEM, V263, P17350; FUKAMI K, 1988, P NATL ACAD SCI USA, V85, P9057, DOI 10.1073/pnas.85.23.9057; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HEPLER JR, 1987, J BIOL CHEM, V262, P2951; HIGASHIDA H, 1986, NATURE, V323, P333, DOI 10.1038/323333a0; HOUSEY GM, 1988, CELL, V52, P343, DOI 10.1016/S0092-8674(88)80027-8; JACKSON TR, 1988, NATURE, V335, P437, DOI 10.1038/335437a0; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; LOPEZRIVAS A, 1987, P NATL ACAD SCI USA, V84, P5768, DOI 10.1073/pnas.84.16.5768; LYALL RM, 1989, J BIOL CHEM, V264, P14503; MARGOLIS B, 1989, CELL, V57, P1101, DOI 10.1016/0092-8674(89)90047-0; MARTY A, 1989, TRENDS NEUROSCI, V12, P420, DOI 10.1016/0166-2236(89)90090-8; MEISENHELDER J, 1989, CELL, V57, P1109, DOI 10.1016/0092-8674(89)90048-2; MELDOLESI J, 1987, EXP CELL RES, V171, P2871; MERRITT JE, 1989, BRIT J PHARMACOL, V98, P6749; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MOOLENAAR WH, 1986, J BIOL CHEM, V261, P279; MOZHAYEVA GN, 1989, BIOCHIM BIOPHYS ACTA, V1011, P171, DOI 10.1016/0167-4889(89)90206-1; NISHIBE S, 1989, J BIOL CHEM, V264, P10335; PANDIELLA A, 1989, TRENDS PHARMACOL SCI, V10, P411; PANDIELLA A, 1989, J BIOL CHEM, V264, P12914; PANDIELLA A, 1987, EXP CELL RES, V170, P175, DOI 10.1016/0014-4827(87)90127-3; PANDIELLA A, 1989, J BIOL CHEM, V264, P3122; PANDIELLA A, 1988, BIOCHEM J, V254, P223, DOI 10.1042/bj2540223; PIKE LJ, 1987, J BIOL CHEM, V262, P1644; POUYSSEGUR J, 1985, TRENDS BIOCHEM SCI, V10, P453, DOI 10.1016/0968-0004(85)90030-1; POZZAN T, 1986, BIOCHEM J, V234, P547, DOI 10.1042/bj2340547; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; RUEGG UT, 1990, CALCIUM CHANNEL MODU; SAGE SO, 1989, BIOCHEM J, V258, P923, DOI 10.1042/bj2580923; SAWYER ST, 1981, BIOCHEMISTRY-US, V20, P6280, DOI 10.1021/bi00524a057; SCHLESSINGER J, 1988, BIOCHEMISTRY-US, V27, P3119, DOI 10.1021/bi00409a002; SMITH C, 1986, J BIOL CHEM, V261, P4607; TAKEMURA H, 1989, J BIOL CHEM, V264, P12266; TSIEN RY, 1982, J CELL BIOL, V94, P325, DOI 10.1083/jcb.94.2.325; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; VONTSCHARNER V, 1986, NATURE, V324, P369, DOI 10.1038/324369a0; WAGGONER AS, 1979, ANNU REV BIOPHYS BIO, V8, P47, DOI 10.1146/annurev.bb.08.060179.000403; WAHL MI, 1989, P NATL ACAD SCI USA, V86, P1568, DOI 10.1073/pnas.86.5.1568; WAHL MI, 1988, SCIENCE, V241, P968, DOI 10.1126/science.2457254	43	90	91	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 5	1991	266	10					6329	6335						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FE373	1706715				2022-12-27	WOS:A1991FE37300051
J	MOSS, JA; FRANCIS, GL; ROSS, M; WALLACE, JC; BALLARD, FJ				MOSS, JA; FRANCIS, GL; ROSS, M; WALLACE, JC; BALLARD, FJ			INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND IGF-II BINDING TO AN IGF BINDING-PROTEIN - AN INVESTIGATION USING CHEMICAL MODIFICATION OF TYROSINE RESIDUES AS A STRUCTURAL PROBE FOR THE SITES OF INTERACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL-ACTIVITIES; HYBRID MOLECULES; A-DOMAIN; SEQUENCES; RECEPTOR; PURIFICATION; FIBROBLASTS; AFFINITY; ANALOGS	We have investigated insulin-like growth factor (IGF)-I and IGF-II binding to bovine insulin-like growth factor binding protein-2 (bIGFBP-2) using chemical modification to locate sites on the IGF involved in the binding interaction. bIGFBP-2 was incubated with either recombinant human (hIGF-I) or purified ovine (oIGF-II) to form a mixture of bound and free IGF. Sites of interaction between the binding protein and IGF were then probed by iodination of the available tyrosine residues. Subsequently, the mixture of free IGF and IGF.bIGFBP-2 complex was resolved by neutral chromatography, and the IGF component of the complex with bIGFBP-2 was recovered by reverse-phase high performance liquid chromatography at pH 2.1. The tyrosine labeling patterns of the two populations of IGF, one iodinated while free and the other iodinated while associated with binding protein, were determined following endoproteinase Glu-C peptide mapping. Binding of hIGF-I or oIGF-II to bIGFBP-2 resulted in reduced iodination of the tyrosines in both hIGF-I and oIGF-II that are near the carboxyl-terminal, Tyr-60 and Tyr-59, respectively. The reduction in labeling of these tyrosine residues was 2-fold and 6-fold for hIGF-I and oIGF-II, respectively. On the other hand, labeling of the other 2 tyrosines in hIGF-I and oIGF-II was not different between the free and complexed growth factors. From these results we conclude that Tyr-60 and Tyr-59 in the carboxyl-terminal regions of hIGF-I and oIGF-II, respectively, are either directly involved in the binding reaction or lie in a region of the IGF molecule encompassed by the association with bIGFBP-2. Conversely, the labeling pattern of the other tyrosines, Tyr-24 and Tyr-31 in hIGF-I and Tyr-2 and Tyr-27 in oIGF-II, implies that they are not involved in binding to bIGFBP-2. To examine the role of IGF tyrosine residues in the association with bIGFBP-2, we prepared nonradioactive I-127-labeled oIGF-II. In bIGFBP-2 competition binding assays, I-127-labeled oIGF-II was 2.5-fold and 5-fold less potent than native oIGF-II when competing for binding of I-125-labeled IGF-I or IGF-II tracers, respectively. We interpret these results as indicating that at least 1 tyrosine in oIGF-II is involved in binding to bIGFBP-2.	CSIRO, DIV HUMAN NUTR, POB 10041, ADELAIDE, SA 5000, AUSTRALIA; UNIV ADELAIDE, DEPT BIOCHEM, ADELAIDE, SA 5000, AUSTRALIA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Adelaide			, John/AAP-5150-2020					BAGLEY CJ, 1989, BIOCHEM J, V259, P665, DOI 10.1042/bj2590665; BAYNE ML, 1988, J BIOL CHEM, V263, P6233; BLUNDELL TL, 1983, FED PROC, V42, P2592; CASCIERI MA, 1989, J BIOL CHEM, V264, P2199; CHEN ZZ, 1988, BIOCHEMISTRY-US, V27, P6105, DOI 10.1021/bi00416a041; CLEMMONS DR, 1989, MOLECULAR AND CELLULAR BIOLOGY OF INSULIN-LIKE GROWTH FACTORS AND THEIR RECEPTORS, P381; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; DEVROEDE MA, 1985, P NATL ACAD SCI USA, V82, P3010; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; FORBES B, 1988, BIOCHEM BIOPH RES CO, V157, P196, DOI 10.1016/S0006-291X(88)80032-9; FRANCIS GL, 1989, J ENDOCRINOL, V122, P681, DOI 10.1677/joe.0.1220681; FRANCIS GL, 1989, ENDOCRINOLOGY, V124, P1173, DOI 10.1210/endo-124-3-1173; FRANCIS GL, 1988, BIOCHEM J, V251, P95, DOI 10.1042/bj2510095; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; KALLINCOS NC, 1990, J ENDOCRINOL, V124, P89, DOI 10.1677/joe.0.1240089; MALY P, 1988, J BIOL CHEM, V263, P7068; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; OOI GT, 1988, J ENDOCRINOL, V118, P7, DOI 10.1677/joe.0.1180007; RITVOS O, 1988, ENDOCRINOLOGY, V122, P2150, DOI 10.1210/endo-122-5-2150; ROSS M, 1989, BIOCHEM J, V258, P267, DOI 10.1042/bj2580267; SZABO L, 1988, BIOCHEM BIOPH RES CO, V151, P207, DOI 10.1016/0006-291X(88)90580-3; TSENG LYH, 1987, BIOCHEM BIOPH RES CO, V149, P672, DOI 10.1016/0006-291X(87)90420-7; UPTON Z, 1990, J MOL ENDOCRINOL, V5, P77, DOI 10.1677/jme.0.0050077; VANOBBERGHENSCHILLING E, 1983, EXP CELL RES, V147, P369, DOI 10.1016/0014-4827(83)90219-7; VANWYK JJ, 1984, HORMONAL PROTEINS PE, V12, P82	25	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JAN 15	1991	266	2					909	914						6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	ET177	1702441				2022-12-27	WOS:A1991ET17700038
J	VAZQUEZ, J; FEIGENBAUM, P; KING, VF; KACZOROWSKI, GJ; GARCIA, ML				VAZQUEZ, J; FEIGENBAUM, P; KING, VF; KACZOROWSKI, GJ; GARCIA, ML			CHARACTERIZATION OF HIGH-AFFINITY BINDING-SITES FOR CHARYBDOTOXIN IN SYNAPTIC PLASMA-MEMBRANES FROM RAT-BRAIN - EVIDENCE FOR A DIRECT ASSOCIATION WITH AN INACTIVATING, VOLTAGE-DEPENDENT, POTASSIUM CHANNEL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									MERCK INST THERAPEUT RES,DEPT MEMBRANE BIOCHEM & BIOPHYS,POB 2000,RAHWAY,NJ 07065	Merck & Company			Vazquez, Jesus/B-7697-2015	Vazquez, Jesus/0000-0003-1461-5092				ANDERSON CS, 1988, J GEN PHYSIOL, V91, P317, DOI 10.1085/jgp.91.3.317; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; BARROS F, 1986, MODERN METHOD PHARMA, V3, P149; BENISHIN CG, 1988, MOL PHARMACOL, V34, P152; CARBONE E, 1987, PFLUG ARCH EUR J PHY, V408, P423, DOI 10.1007/BF00585064; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CHICCHI GG, 1988, J BIOL CHEM, V263, P10192; CHRISTIE MJ, 1989, SCIENCE, V244, P221, DOI 10.1126/science.2539643; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; FEIGENBAUM P, 1988, BIOCHEM BIOPH RES CO, V154, P298, DOI 10.1016/0006-291X(88)90684-5; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; GARCIA ML, 1988, FASEB J, V2, P799; GIMENEZGALLEGO G, 1988, P NATL ACAD SCI USA, V85, P3329, DOI 10.1073/pnas.85.10.3329; HALLIWELL JV, 1986, P NATL ACAD SCI USA, V83, P493, DOI 10.1073/pnas.83.2.493; HARVEY AL, 1989, BIOCHEM BIOPH RES CO, V163, P394, DOI 10.1016/0006-291X(89)92148-7; HERMANN A, 1987, J GEN PHYSIOL, V90, P27, DOI 10.1085/jgp.90.1.27; HILLE B, 1984, IONIC CHANNELS EXCIT, P112; KING VF, 1989, J CELL BIOL, V107, P143; LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUCCHESI K, 1989, J MEMBRANE BIOL, V109, P269, DOI 10.1007/BF01870284; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; MACKINNON R, 1988, NEURON, V1, P997, DOI 10.1016/0896-6273(88)90156-0; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; PENNEFATHER PS, 1989, 32ND ANN M CAN FED B, P95; PRESTIPINO G, 1989, FEBS LETT, V250, P570, DOI 10.1016/0014-5793(89)80798-7; PRICE M, 1989, P NATL ACAD SCI USA, V86, P10171, DOI 10.1073/pnas.86.24.10171; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; SALACINSKI PRP, 1981, ANAL BIOCHEM, V117, P136, DOI 10.1016/0003-2697(81)90703-X; SANDS SB, 1989, J GEN PHYSIOL, V93, P1061, DOI 10.1085/jgp.93.6.1061; SCHNEIDER MJ, 1989, FEBS LETT, V250, P433, DOI 10.1016/0014-5793(89)80771-9; SCHWEITZ H, 1989, BIOCHEMISTRY-US, V28, P9708, DOI 10.1021/bi00451a025; SCHWEITZ H, 1989, FEBS LETT, V250, P519, DOI 10.1016/0014-5793(89)80788-4; SLAUGHTER RS, 1988, J CELL BIOL, V107, P143; SORENSEN RG, 1989, J PHARMACOL EXP THER, V36, P689; STANSFELD C, 1988, NEUROSCI LETT, V93, P49, DOI 10.1016/0304-3940(88)90011-0; VAZQUEZ J, 1989, J BIOL CHEM, V264, P20902; WEILAND GA, 1981, LIFE SCI, V29, P313, DOI 10.1016/0024-3205(81)90324-6; YELLEN G, 1987, ANNU REV BIOPHYS BIO, V16, P227	40	86	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 15	1990	265	26					15564	15571						8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DY964	1697593				2022-12-27	WOS:A1990DY96400037
J	ZAPF, J; KIEFER, M; MERRYWEATHER, J; MASIARZ, F; BAUER, D; BORN, W; FISCHER, JA; FROESCH, ER				ZAPF, J; KIEFER, M; MERRYWEATHER, J; MASIARZ, F; BAUER, D; BORN, W; FISCHER, JA; FROESCH, ER			ISOLATION FROM ADULT HUMAN SERUM OF 4 INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING-PROTEINS AND MOLECULAR-CLONING OF ONE OF THEM THAT IS INCREASED BY IGF-I ADMINISTRATION AND IN EXTRAPANCREATIC TUMOR HYPOGLYCEMIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									CHIRON CORP,EMERYVILLE,CA 94608; UNIV ZURICH,DEPT ORTHOPED SURG,CALCIUM METAB RES LAB,CH-8008 ZURICH,SWITZERLAND; UNIV ZURICH,DEPT MED,CH-8008 ZURICH,SWITZERLAND	Novartis; University of Zurich; University of Zurich	ZAPF, J (corresponding author), UNIV HOSP ZURICH,DEPT MED,METAB UNIT,CH-8091 ZURICH,SWITZERLAND.							ALBISTON AL, 1990, BIOCHEM BIOPH RES CO, V166, P892, DOI 10.1016/0006-291X(90)90894-S; ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; BALLARD J, 1989, ACTA ENDOCRINOL-COP, V121, P751, DOI 10.1530/acta.0.1210751; BARR PJ, 1986, BIOTECHNIQUES, V4, P428; BAXTER RC, 1989, P NATL ACAD SCI USA, V86, P6898, DOI 10.1073/pnas.86.18.6898; BENTON WD, 1977, SCIENCE, V196, P180, DOI 10.1126/science.322279; BINKERT C, 1989, EMBO J, V8, P2497, DOI 10.1002/j.1460-2075.1989.tb08386.x; BREWER MT, 1988, BIOCHEM BIOPH RES CO, V152, P1289, DOI 10.1016/S0006-291X(88)80425-X; BRINKMAN A, 1988, EMBO J, V7, P2417, DOI 10.1002/j.1460-2075.1988.tb03087.x; BROWN AL, 1989, J BIOL CHEM, V264, P5148; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN KL, 1976, ACTA ENDOCRINOL-COP, V83, P243, DOI 10.1530/acta.0.0830243; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; DEMELLOW JSM, 1988, BIOCHEM BIOPH RES CO, V156, P199, DOI 10.1016/S0006-291X(88)80824-6; ELGIN RG, 1987, P NATL ACAD SCI USA, V84, P3254, DOI 10.1073/pnas.84.10.3254; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FREEMAN GJ, 1983, P NATL ACAD SCI-BIOL, V80, P4094, DOI 10.1073/pnas.80.13.4094; FRIEDMAN M, 1970, J BIOL CHEM, V245, P3868; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; HINTZ RL, 1981, J CLIN ENDOCR METAB, V53, P100, DOI 10.1210/jcem-53-1-100; HOSSENLOPP P, 1986, ANAL BIOCHEM, V154, P138, DOI 10.1016/0003-2697(86)90507-5; HUHTALA ML, 1986, BIOCHEM BIOPH RES CO, V141, P263, DOI 10.1016/S0006-291X(86)80363-1; HUNKAPILLER MW, 1983, METHOD ENZYMOL, V91, P399; JULKUNEN M, 1988, FEBS LETT, V236, P295, DOI 10.1016/0014-5793(88)80041-3; KNAUER DJ, 1980, P NATL ACAD SCI-BIOL, V77, P7252, DOI 10.1073/pnas.77.12.7252; LARON Z, 1974, ISRAEL J MED SCI, V10, P1247; LEE YL, 1988, MOL ENDOCRINOL, V2, P404, DOI 10.1210/mend-2-5-404; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LUTHMAN H, 1989, EUR J BIOCHEM, V180, P259, DOI 10.1111/j.1432-1033.1989.tb14641.x; Maniatis T., 1982, MOL CLONING; MARGOT JB, 1989, MOL ENDOCRINOL, V3, P1053, DOI 10.1210/mend-3-7-1053; MARTIN JL, 1990, J BIOL CHEM, V265, P4124; MARTIN JL, 1985, J CLIN ENDOCR METAB, V61, P799, DOI 10.1210/jcem-61-4-799; MARTIN JL, 1986, J BIOL CHEM, V261, P8754; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; MOTTOLA C, 1986, J BIOL CHEM, V261, P1180; NILSON BL, 1984, ANAL BIOCHEM, V141, P311; NISSLEY SP, 1984, HORMONAL PROTEINS PE, V12, P127; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Pfeiffer B., 1983, NUCLEIC ACIDS RES, V11, P7853; ROGHANI M, 1989, FEBS LETT, V255, P253, DOI 10.1016/0014-5793(89)81101-9; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHMID C, 1989, FEBS LETT, V244, P328, DOI 10.1016/0014-5793(89)80556-3; SCHMID C, 1989, BIOCHEM BIOPH RES CO, V160, P788, DOI 10.1016/0006-291X(89)92502-3; SZABO L, 1988, BIOCHEM BIOPH RES CO, V151, P207, DOI 10.1016/0006-291X(88)90580-3; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; WOOD WI, 1988, MOL ENDOCRINOL, V2, P1176, DOI 10.1210/mend-2-12-1176; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YUEN SW, 1988, APPLIED BIOSYSTEMS U, V36, P1; ZAPF J, 1988, BIOCHEM BIOPH RES CO, V156, P1187, DOI 10.1016/S0006-291X(88)80758-7; ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379; ZAPF J, 1986, J CLIN INVEST, V77, P1768, DOI 10.1172/JCI112500; ZAPF J, 1989, P NATL ACAD SCI USA, V86, P3813, DOI 10.1073/pnas.86.10.3813; ZAPF J, 1975, ARCH BIOCHEM BIOPHYS, V168, P638, DOI 10.1016/0003-9861(75)90296-9; ZAPF J, 1990, IN PRESS J CLIN INVE	59	121	131	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	SEP 5	1990	265	25					14892	14898						7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX400	1697583				2022-12-27	WOS:A1990DX40000038
J	HORIKAWA, S; SASUGA, J; SHIMIZU, K; OZASA, H; TSUKADA, K				HORIKAWA, S; SASUGA, J; SHIMIZU, K; OZASA, H; TSUKADA, K			MOLECULAR-CLONING AND NUCLEOTIDE-SEQUENCE OF CDNA-ENCODING THE RAT-KIDNEY S-ADENOSYLMETHIONINE SYNTHETASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article									TOKYO WOMENS MED COLL,CTR KIDNEY,TOKYO 162,JAPAN	Tokyo Women's Medical University	HORIKAWA, S (corresponding author), TOKYO MED & DENT UNIV,MED RES INST,DEPT PATHOL BIOCHEM,TOKYO 101,JAPAN.							AVIV H, 1972, P NATL ACAD SCI USA, V69, P1408, DOI 10.1073/pnas.69.6.1408; CABRERO C, 1987, EUR J BIOCHEM, V170, P299, DOI 10.1111/j.1432-1033.1987.tb13699.x; CANTONI GL, 1953, J BIOL CHEM, V204, P403; CHIANG PK, 1977, J BIOL CHEM, V252, P4506; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HOFFMAN JL, 1977, BIOCHEM BIOPH RES CO, V77, P1231, DOI 10.1016/S0006-291X(77)80111-3; HORIKAWA S, 1989, EUR J BIOCHEM, V184, P497, DOI 10.1111/j.1432-1033.1989.tb15042.x; HUYNH TV, 1984, DNA CLONING TECHNIQU, P49; KAMPS MP, 1984, NATURE, V310, P589, DOI 10.1038/310589a0; KOTB M, 1985, J BIOL CHEM, V260, P3923; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LIAU MC, 1977, CANCER RES, V37, P427; LIAU MC, 1979, CANCER RES, V39, P162; Maniatis T., 1982, MOL CLONING; MARKHAM GD, 1984, J BIOL CHEM, V259, P4505; MITSUI KI, 1988, J BIOL CHEM, V263, P11211; OKADA G, 1979, FEBS LETT, V106, P25, DOI 10.1016/0014-5793(79)80687-0; OKADA G, 1981, BIOCHEMISTRY-US, V20, P934, DOI 10.1021/bi00507a045; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SULLIVAN DM, 1983, BIOCHEMISTRY-US, V22, P1636, DOI 10.1021/bi00276a017; SUMA Y, 1986, J BIOCHEM, V100, P67, DOI 10.1093/oxfordjournals.jbchem.a121707; THOMAS D, 1988, MOL CELL BIOL, V8, P5132, DOI 10.1128/MCB.8.12.5132; THOMAS D, 1987, J BIOL CHEM, V262, P16704; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TSUKADA K, 1980, BIOCHEM BIOPH RES CO, V94, P1078, DOI 10.1016/0006-291X(80)90529-X	27	76	79	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 15	1990	265	23					13683	13686						4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DU275	1696256				2022-12-27	WOS:A1990DU27500046
